<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:cik0002058261="http://cik0002058261/20260630"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:ifrs-full="https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="cik0002058261-20260630.xsd" xlink:type="simple"/>
    <context id="From2026-01-01to2026-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_dei_BusinessContactMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-09-252024-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
        </entity>
        <period>
            <startDate>2024-09-25</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-09-24_custom_CommonStocksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">cik0002058261:CommonStocksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-24</instant>
        </period>
    </context>
    <context id="AsOf2024-09-24_ifrs-full_OtherReserves">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherReserves</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-24</instant>
        </period>
    </context>
    <context id="AsOf2024-09-24_ifrs-full_RetainedEarnings">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarnings</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-24</instant>
        </period>
    </context>
    <context id="AsOf2024-09-24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
        </entity>
        <period>
            <instant>2024-09-24</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_CommonStocksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">cik0002058261:CommonStocksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_OtherReserves">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherReserves</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_RetainedEarnings">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarnings</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_CommonStocksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">cik0002058261:CommonStocksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_RetainedEarnings">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarnings</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_ShareCapitalMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">cik0002058261:ShareCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_SharePremiumMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_ShareSubscriptionReceivableMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">cik0002058261:ShareSubscriptionReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_OtherReservesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherReservesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_AccumulatedOtherComprehensiveIncomeMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_RetainedEarningsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_TotalMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">cik0002058261:TotalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_ShareCapitalMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">cik0002058261:ShareCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_SharePremiumMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_ShareSubscriptionReceivableMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">cik0002058261:ShareSubscriptionReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_OtherReservesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherReservesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_AccumulatedOtherComprehensiveIncomeMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_RetainedEarningsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_TotalMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">cik0002058261:TotalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_ShareCapitalMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">cik0002058261:ShareCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_SharePremiumMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_ShareSubscriptionReceivableMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">cik0002058261:ShareSubscriptionReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_OtherReservesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherReservesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_AccumulatedOtherComprehensiveIncomeMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_RetainedEarningsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_TotalMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">cik0002058261:TotalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="From2024-09-252024-12-31_custom_CommonStocksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">cik0002058261:CommonStocksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-25</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-09-252024-12-31_ifrs-full_OtherReserves">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherReserves</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-25</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-09-252024-12-31_ifrs-full_RetainedEarnings">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarnings</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-25</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_CommonStocksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">cik0002058261:CommonStocksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_OtherReserves">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherReserves</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_RetainedEarnings">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarnings</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-06-30_custom_CommonStocksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">cik0002058261:CommonStocksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-06-30_ifrs-full_RetainedEarnings">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarnings</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_custom_CommonStocksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">cik0002058261:CommonStocksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_ifrs-full_RetainedEarnings">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarnings</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_ShareCapitalMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">cik0002058261:ShareCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_SharePremiumMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_ShareSubscriptionReceivableMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">cik0002058261:ShareSubscriptionReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_OtherReservesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherReservesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_AccumulatedOtherComprehensiveIncomeMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_RetainedEarningsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_TotalMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">cik0002058261:TotalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_ShareCapitalMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">cik0002058261:ShareCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_SharePremiumMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_ShareSubscriptionReceivableMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">cik0002058261:ShareSubscriptionReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_OtherReservesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherReservesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_AccumulatedOtherComprehensiveIncomeMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_RetainedEarningsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_TotalMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">cik0002058261:TotalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-06-30_custom_ShareCapitalMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">cik0002058261:ShareCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-06-30_ifrs-full_SharePremiumMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-06-30_custom_ShareSubscriptionReceivableMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">cik0002058261:ShareSubscriptionReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-06-30_ifrs-full_OtherReservesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherReservesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-06-30_ifrs-full_AccumulatedOtherComprehensiveIncomeMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-06-30_ifrs-full_RetainedEarningsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-06-30_custom_TotalMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">cik0002058261:TotalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_custom_ShareCapitalMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">cik0002058261:ShareCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_ifrs-full_SharePremiumMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_custom_ShareSubscriptionReceivableMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">cik0002058261:ShareSubscriptionReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_ifrs-full_OtherReservesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherReservesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_ifrs-full_AccumulatedOtherComprehensiveIncomeMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_ifrs-full_RetainedEarningsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_custom_TotalMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">cik0002058261:TotalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_OtherReserves">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherReserves</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_custom_CommonStocksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">cik0002058261:CommonStocksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_ifrs-full_RetainedEarnings">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarnings</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_custom_CommonStocksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">cik0002058261:CommonStocksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_ifrs-full_RetainedEarnings">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarnings</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_custom_ShareCapitalMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">cik0002058261:ShareCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_ifrs-full_SharePremiumMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_custom_ShareSubscriptionReceivableMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">cik0002058261:ShareSubscriptionReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_ifrs-full_OtherReservesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherReservesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_ifrs-full_AccumulatedOtherComprehensiveIncomeMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_ifrs-full_RetainedEarningsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_custom_TotalMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">cik0002058261:TotalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_custom_ShareCapitalMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">cik0002058261:ShareCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_ifrs-full_SharePremiumMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_custom_ShareSubscriptionReceivableMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">cik0002058261:ShareSubscriptionReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_ifrs-full_OtherReservesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherReservesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_ifrs-full_AccumulatedOtherComprehensiveIncomeMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_ifrs-full_RetainedEarningsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_custom_TotalMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">cik0002058261:TotalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="From2024-09-012024-09-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
        </entity>
        <period>
            <startDate>2024-09-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_RelatedPartiesMember_custom_EunJongChoiMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:EunJongChoiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_RelatedPartiesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_RelatedPartiesMember_custom_EunJongChoiMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:EunJongChoiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_CubebioCo.Ltd.Member273609218">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_ifrs-full_RelatedPartiesMember_custom_EunJongChoiMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:EunJongChoiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_RelatedPartiesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_ifrs-full_RelatedPartiesMember_custom_CubeBioHoldingsLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:CubeBioHoldingsLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_custom_CubebioCo.Ltd.Member273609250">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_RelatedPartiesMember_custom_DongsungDAndCMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:DongsungDAndCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_RelatedPartiesMember_custom_DongsungDAndCMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:DongsungDAndCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_RelatedPartiesMember_custom_CubeBioHoldingsLtdMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:CubeBioHoldingsLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_RelatedPartiesMember_custom_CubeBioHoldingsLtdMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:CubeBioHoldingsLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_RelatedPartiesMember_custom_EunJongChoiMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:EunJongChoiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_RelatedPartiesMember_custom_EunJongChoiMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:EunJongChoiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_RelatedPartiesMember_custom_NohBinParkMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:NohBinParkMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_RelatedPartiesMember_custom_NohBinParkMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:NohBinParkMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_RelatedPartiesMember_custom_HoSungHanMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:HoSungHanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_RelatedPartiesMember_custom_HoSungHanMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:HoSungHanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_RelatedPartiesMember_custom_JungGonKimMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:JungGonKimMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_RelatedPartiesMember_custom_JungGonKimMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:JungGonKimMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_RelatedPartiesMember_custom_GyungHaYuMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:GyungHaYuMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_RelatedPartiesMember_custom_GyungHaYuMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:GyungHaYuMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_ifrs-full_RelatedPartiesMember_custom_WellCoreMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:WellCoreMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_RelatedPartiesMember_custom_WellCoreMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:WellCoreMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_ifrs-full_RelatedPartiesMember_custom_DongsungDAndCMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:DongsungDAndCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_ifrs-full_RelatedPartiesMember_custom_CubeBioHoldingsLtdMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:CubeBioHoldingsLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_ifrs-full_RelatedPartiesMember_custom_EunJongChoiMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:EunJongChoiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_ifrs-full_RelatedPartiesMember_custom_YunWooChooMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:YunWooChooMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_RelatedPartiesMember_custom_YunWooChooMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:YunWooChooMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_ifrs-full_RelatedPartiesMember_custom_JungGonKimMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:JungGonKimMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_RelatedPartiesMember_custom_EunJongChoiMember_custom_OtherReceivablesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:OtherReceivablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:EunJongChoiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_RelatedPartiesMember_custom_EunJongChoiMember_custom_OtherReceivablesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:OtherReceivablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:EunJongChoiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_RelatedPartiesMember_custom_EunJongChoiMember_custom_OtherReceivablesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:OtherReceivablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:EunJongChoiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_RelatedPartiesMember_custom_CubebioCo.Ltd.Member_custom_PromissoryNotePayablesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:PromissoryNotePayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_RelatedPartiesMember_custom_CubebioCo.Ltd.Member_custom_PromissoryNotePayablesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:PromissoryNotePayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_RelatedPartiesMember_custom_CubebioCo.Ltd.Member_custom_PromissoryNotePayablesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:PromissoryNotePayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-09-24_ifrs-full_RelatedPartiesMember_custom_EunJongChoiMember_custom_OtherReceivablesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:OtherReceivablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:EunJongChoiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-24</instant>
        </period>
    </context>
    <context id="From2024-09-252024-12-31_ifrs-full_RelatedPartiesMember_custom_EunJongChoiMember_custom_OtherReceivablesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:OtherReceivablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:EunJongChoiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-25</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-09-23_ifrs-full_RelatedPartiesMember_custom_CubebioCo.Ltd.Member_custom_PromissoryNotePayablesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:PromissoryNotePayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-23</instant>
        </period>
    </context>
    <context id="From2024-09-252024-12-31_ifrs-full_RelatedPartiesMember_custom_CubebioCo.Ltd.Member_custom_PromissoryNotePayablesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:PromissoryNotePayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-25</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-09-242024-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
        </entity>
        <period>
            <startDate>2024-09-24</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_ifrs-full_RelatedPartiesMember_custom_EunJongChoiMember_custom_OtherReceivablesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:OtherReceivablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:EunJongChoiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2026-06-30_ifrs-full_RelatedPartiesMember_custom_EunJongChoiMember_custom_OtherReceivablesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:OtherReceivablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:EunJongChoiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="From2025-01-012025-06-30_ifrs-full_RelatedPartiesMember_custom_CubebioCo.Ltd.Member_custom_PromissoryNotePayablesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:PromissoryNotePayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2026-06-30_ifrs-full_RelatedPartiesMember_custom_CubebioCo.Ltd.Member_custom_PromissoryNotePayablesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:PromissoryNotePayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_ifrs-full_RelatedPartiesMember_custom_CubeBioHoldingsLtdMember_custom_OtherReceivablesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:OtherReceivablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:CubeBioHoldingsLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_ifrs-full_RelatedPartiesMember_custom_CubebioCo.Ltd.Member_custom_PromissoryNotePayablesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:PromissoryNotePayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_RelatedPartiesMember_custom_WellCoreMember_custom_BorrowingMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:BorrowingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:WellCoreMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_RelatedPartiesMember_custom_WellCoreMember_custom_BorrowingMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:BorrowingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:WellCoreMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_RelatedPartiesMember_custom_WellCoreMember_custom_BorrowingMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:BorrowingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:WellCoreMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_RelatedPartiesMember_custom_DongsungDAndCMember_custom_ShortTermLoanReceivableMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:ShortTermLoanReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:DongsungDAndCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_RelatedPartiesMember_custom_DongsungDAndCMember_custom_ShortTermLoanReceivableMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:ShortTermLoanReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:DongsungDAndCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_RelatedPartiesMember_custom_DongsungDAndCMember_custom_ShortTermLoanReceivableMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:ShortTermLoanReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:DongsungDAndCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_RelatedPartiesMember_custom_DongsungDAndCMember_custom_ShortTermLoanReceivablesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:ShortTermLoanReceivablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:DongsungDAndCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_RelatedPartiesMember_custom_DongsungDAndCMember_custom_ShortTermLoanReceivablesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:ShortTermLoanReceivablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:DongsungDAndCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_RelatedPartiesMember_custom_DongsungDAndCMember_custom_ShortTermLoanReceivablesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:ShortTermLoanReceivablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:DongsungDAndCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_RelatedPartiesMember_custom_EunJongChoiMember_custom_ShortTermLoanReceivableMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:ShortTermLoanReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:EunJongChoiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_RelatedPartiesMember_custom_EunJongChoiMember_custom_ShortTermLoanReceivableMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:ShortTermLoanReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:EunJongChoiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_RelatedPartiesMember_custom_EunJongChoiMember_custom_ShortTermLoanReceivableMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:ShortTermLoanReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:EunJongChoiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_RelatedPartiesMember_custom_EunJongChoiMember_custom_ShortTermLoanReceivablesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:ShortTermLoanReceivablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:EunJongChoiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_RelatedPartiesMember_custom_EunJongChoiMember_custom_ShortTermLoanReceivablesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:ShortTermLoanReceivablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:EunJongChoiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_RelatedPartiesMember_custom_EunJongChoiMember_custom_ShortTermLoanReceivablesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:ShortTermLoanReceivablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:EunJongChoiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_RelatedPartiesMember_custom_CubeBioHoldingsLtdMember_custom_ShortTermLoanReceivableMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:ShortTermLoanReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:CubeBioHoldingsLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_RelatedPartiesMember_custom_CubeBioHoldingsLtdMember_custom_ShortTermLoanReceivableMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:ShortTermLoanReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:CubeBioHoldingsLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_RelatedPartiesMember_custom_CubeBioHoldingsLtdMember_custom_ShortTermLoanReceivableMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:ShortTermLoanReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:CubeBioHoldingsLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_RelatedPartiesMember_custom_CubeBioHoldingsLtdMember_custom_ShortTermLoanReceivablesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:ShortTermLoanReceivablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:CubeBioHoldingsLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_RelatedPartiesMember_custom_CubeBioHoldingsLtdMember_custom_ShortTermLoanReceivablesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:ShortTermLoanReceivablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:CubeBioHoldingsLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_RelatedPartiesMember_custom_CubeBioHoldingsLtdMember_custom_ShortTermLoanReceivablesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:ShortTermLoanReceivablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:CubeBioHoldingsLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_RelatedPartiesMember_custom_NohBinParkMember_custom_BondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:BondWithWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:NohBinParkMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_RelatedPartiesMember_custom_NohBinParkMember_custom_BondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:BondWithWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:NohBinParkMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_RelatedPartiesMember_custom_NohBinParkMember_custom_BondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:BondWithWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:NohBinParkMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_RelatedPartiesMember_custom_HoSungHanMember_custom_BondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:BondWithWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:HoSungHanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_RelatedPartiesMember_custom_HoSungHanMember_custom_BondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:BondWithWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:HoSungHanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_RelatedPartiesMember_custom_HoSungHanMember_custom_BondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:BondWithWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:HoSungHanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_RelatedPartiesMember_custom_JungGonKimMember_custom_OtherPayablesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:OtherPayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:JungGonKimMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_RelatedPartiesMember_custom_JungGonKimMember_custom_OtherPayablesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:OtherPayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:JungGonKimMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_RelatedPartiesMember_custom_JungGonKimMember_custom_OtherPayablesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:OtherPayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:JungGonKimMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_RelatedPartiesMember_custom_GyungHaYuMember_custom_BondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:BondWithWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:GyungHaYuMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_RelatedPartiesMember_custom_GyungHaYuMember_custom_BondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:BondWithWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:GyungHaYuMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_RelatedPartiesMember_custom_GyungHaYuMember_custom_BondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:BondWithWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:GyungHaYuMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_RelatedPartiesMember_custom_WellCoreMember_custom_ShortTermLoanReceivableMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:ShortTermLoanReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:WellCoreMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_RelatedPartiesMember_custom_WellCoreMember_custom_ShortTermLoanReceivableMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:ShortTermLoanReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:WellCoreMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_RelatedPartiesMember_custom_WellCoreMember_custom_ShortTermLoanReceivableMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:ShortTermLoanReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:WellCoreMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_RelatedPartiesMember_custom_WellCoreMember_ifrs-full_ShorttermBorrowingsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">ifrs-full:ShorttermBorrowingsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:WellCoreMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_RelatedPartiesMember_custom_WellCoreMember_ifrs-full_ShorttermBorrowingsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">ifrs-full:ShorttermBorrowingsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:WellCoreMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_RelatedPartiesMember_custom_WellCoreMember_ifrs-full_ShorttermBorrowingsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">ifrs-full:ShorttermBorrowingsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:WellCoreMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_RelatedPartiesMember_custom_EunJongChoiMember_custom_ShortTermLoanReceivableMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:ShortTermLoanReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:EunJongChoiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_RelatedPartiesMember_custom_EunJongChoiMember_custom_ShortTermLoanReceivableMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:ShortTermLoanReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:EunJongChoiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_RelatedPartiesMember_custom_EunJongChoiMember_custom_ShortTermLoanReceivablesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:ShortTermLoanReceivablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:EunJongChoiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_RelatedPartiesMember_custom_EunJongChoiMember_custom_ShortTermLoanReceivablesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:ShortTermLoanReceivablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:EunJongChoiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_RelatedPartiesMember_custom_CubeBioHoldingsLtdMember_custom_ShortTermLoanReceivableMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:ShortTermLoanReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:CubeBioHoldingsLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_RelatedPartiesMember_custom_CubeBioHoldingsLtdMember_custom_ShortTermLoanReceivableMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:ShortTermLoanReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:CubeBioHoldingsLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_RelatedPartiesMember_custom_CubeBioHoldingsLtdMember_custom_ShortTermLoanReceivablesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:ShortTermLoanReceivablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:CubeBioHoldingsLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_RelatedPartiesMember_custom_CubeBioHoldingsLtdMember_custom_ShortTermLoanReceivablesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:ShortTermLoanReceivablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:CubeBioHoldingsLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_RelatedPartiesMember_custom_JaeMyungKimMember_custom_BondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:BondWithWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:JaeMyungKimMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_RelatedPartiesMember_custom_JaeMyungKimMember_custom_BondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:BondWithWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:JaeMyungKimMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_RelatedPartiesMember_custom_JaeMyungKimMember_custom_BondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:BondWithWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:JaeMyungKimMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_RelatedPartiesMember_custom_NohBinParkMember_custom_BondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:BondWithWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:NohBinParkMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_RelatedPartiesMember_custom_NohBinParkMember_custom_BondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:BondWithWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:NohBinParkMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_RelatedPartiesMember_custom_HoSungHanMember_custom_BondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:BondWithWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:HoSungHanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_RelatedPartiesMember_custom_HoSungHanMember_custom_BondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:BondWithWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:HoSungHanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_RelatedPartiesMember_custom_SeYoonKimMember_custom_BondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:BondWithWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:SeYoonKimMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_RelatedPartiesMember_custom_SeYoonKimMember_custom_BondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:BondWithWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:SeYoonKimMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_RelatedPartiesMember_custom_SeYoonKimMember_custom_BondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:BondWithWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:SeYoonKimMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_RelatedPartiesMember_custom_GyungHaYuMember_custom_BondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:BondWithWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:GyungHaYuMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_RelatedPartiesMember_custom_GyungHaYuMember_custom_BondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:BondWithWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:GyungHaYuMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_RelatedPartiesMember_custom_JungGonKimMember_custom_BondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:BondWithWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:JungGonKimMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_RelatedPartiesMember_custom_JungGonKimMember_custom_BondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:BondWithWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:JungGonKimMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_RelatedPartiesMember_custom_JungGonKimMember_custom_BondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:BondWithWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:JungGonKimMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_ifrs-full_RelatedPartiesMember_custom_WellCoreMember_custom_BorrowingMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:BorrowingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:WellCoreMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2026-06-30_ifrs-full_RelatedPartiesMember_custom_WellCoreMember_custom_BorrowingMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:BorrowingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:WellCoreMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_RelatedPartiesMember_custom_WellCoreMember_custom_AccruedExpenseMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:AccruedExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:WellCoreMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_ifrs-full_RelatedPartiesMember_custom_WellCoreMember_custom_AccruedExpenseMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:AccruedExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:WellCoreMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2026-06-30_ifrs-full_RelatedPartiesMember_custom_WellCoreMember_custom_AccruedExpenseMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:AccruedExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:WellCoreMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_ifrs-full_RelatedPartiesMember_custom_DongsungDAndCMember_custom_ShortTermLoanReceivableMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:ShortTermLoanReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:DongsungDAndCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2026-06-30_ifrs-full_RelatedPartiesMember_custom_DongsungDAndCMember_custom_ShortTermLoanReceivableMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:ShortTermLoanReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:DongsungDAndCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_ifrs-full_RelatedPartiesMember_custom_DongsungDAndCMember_custom_ShortTermLoanReceivablesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:ShortTermLoanReceivablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:DongsungDAndCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2026-06-30_ifrs-full_RelatedPartiesMember_custom_DongsungDAndCMember_custom_ShortTermLoanReceivablesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:ShortTermLoanReceivablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:DongsungDAndCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_RelatedPartiesMember_custom_DongsungDAndCMember_custom_OtherPayablesAdvancesReceivedForAllotmentOfCommonSharesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:OtherPayablesAdvancesReceivedForAllotmentOfCommonSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:DongsungDAndCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_ifrs-full_RelatedPartiesMember_custom_DongsungDAndCMember_custom_OtherPayablesAdvancesReceivedForAllotmentOfCommonSharesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:OtherPayablesAdvancesReceivedForAllotmentOfCommonSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:DongsungDAndCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2026-06-30_ifrs-full_RelatedPartiesMember_custom_DongsungDAndCMember_custom_OtherPayablesAdvancesReceivedForAllotmentOfCommonSharesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:OtherPayablesAdvancesReceivedForAllotmentOfCommonSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:DongsungDAndCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_ifrs-full_RelatedPartiesMember_custom_EunJongChoiMember_custom_ShortTermLoanReceivableMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:ShortTermLoanReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:EunJongChoiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2026-06-30_ifrs-full_RelatedPartiesMember_custom_EunJongChoiMember_custom_ShortTermLoanReceivableMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:ShortTermLoanReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:EunJongChoiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_ifrs-full_RelatedPartiesMember_custom_EunJongChoiMember_custom_ShortTermLoanReceivablesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:ShortTermLoanReceivablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:EunJongChoiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2026-06-30_ifrs-full_RelatedPartiesMember_custom_EunJongChoiMember_custom_ShortTermLoanReceivablesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:ShortTermLoanReceivablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:EunJongChoiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_ifrs-full_RelatedPartiesMember_custom_CubeBioHoldingsLtdMember_custom_ShortTermLoanReceivableMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:ShortTermLoanReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:CubeBioHoldingsLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2026-06-30_ifrs-full_RelatedPartiesMember_custom_CubeBioHoldingsLtdMember_custom_ShortTermLoanReceivableMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:ShortTermLoanReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:CubeBioHoldingsLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_ifrs-full_RelatedPartiesMember_custom_CubeBioHoldingsLtdMember_custom_ShortTermLoanReceivablesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:ShortTermLoanReceivablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:CubeBioHoldingsLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2026-06-30_ifrs-full_RelatedPartiesMember_custom_CubeBioHoldingsLtdMember_custom_ShortTermLoanReceivablesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:ShortTermLoanReceivablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:CubeBioHoldingsLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_ifrs-full_RelatedPartiesMember_custom_JungGonKimMember_custom_OtherPayablesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:OtherPayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:JungGonKimMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2026-06-30_ifrs-full_RelatedPartiesMember_custom_JungGonKimMember_custom_OtherPayablesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:OtherPayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:JungGonKimMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_WellCoreCoLtdMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">cik0002058261:WellCoreCoLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_WellCoreCoLtdMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">cik0002058261:WellCoreCoLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_TreasurySharesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_TreasurySharesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_OthersMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">cik0002058261:OthersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_OthersMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">cik0002058261:OthersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_custom_WellCoreCoLtdMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">cik0002058261:WellCoreCoLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-06-30_custom_WellCoreCoLtdMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">cik0002058261:WellCoreCoLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_ifrs-full_TreasurySharesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-06-30_ifrs-full_TreasurySharesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_custom_OthersMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">cik0002058261:OthersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-06-30_custom_OthersMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">cik0002058261:OthersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_MachineryMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_VehiclesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_OfficeEquipmentMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_FurnitureAndFixtureMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cik0002058261:FurnitureAndFixtureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_RightofuseAssetsMember_ifrs-full_BottomOfRangeMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:RightofuseAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_RightofuseAssetsMember_ifrs-full_TopOfRangeMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:RightofuseAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_SoftwareMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">cik0002058261:SoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_PatentMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">cik0002058261:PatentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_BrandMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">cik0002058261:BrandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_EunJongChoiMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAcquiredReceivablesAxis">cik0002058261:EunJongChoiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_EunJongChoi1Member_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAcquiredReceivablesAxis">cik0002058261:EunJongChoi1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_CubeBioHoldingsLtdMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAcquiredReceivablesAxis">cik0002058261:CubeBioHoldingsLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_DongsungDAndCMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAcquiredReceivablesAxis">cik0002058261:DongsungDAndCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_SubtotalMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAcquiredReceivablesAxis">cik0002058261:SubtotalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_MagiumCorpMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAcquiredReceivablesAxis">cik0002058261:MagiumCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_MERITinCorpMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAcquiredReceivablesAxis">cik0002058261:MERITinCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_POEXHoldingsCorpMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAcquiredReceivablesAxis">cik0002058261:POEXHoldingsCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_EunJongChoiMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAcquiredReceivablesAxis">cik0002058261:EunJongChoiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_EunJongChoi1Member_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAcquiredReceivablesAxis">cik0002058261:EunJongChoi1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_CubeBioHoldingsLtdMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAcquiredReceivablesAxis">cik0002058261:CubeBioHoldingsLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_SubtotalMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAcquiredReceivablesAxis">cik0002058261:SubtotalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_MagiumCorpMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAcquiredReceivablesAxis">cik0002058261:MagiumCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_CarryingAmountMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:CarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_FairValueMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">cik0002058261:FairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_FairValueMember_custom_FinancialAssetsMember_ifrs-full_Level1OfFairValueHierarchyMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">cik0002058261:FairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cik0002058261:FinancialAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_FairValueMember_custom_FinancialAssetsMember_ifrs-full_Level2OfFairValueHierarchyMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">cik0002058261:FairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cik0002058261:FinancialAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_FairValueMember_custom_FinancialAssetsMember_ifrs-full_Level3OfFairValueHierarchyMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">cik0002058261:FairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cik0002058261:FinancialAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_FairValueMember_custom_FinancialAssetsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">cik0002058261:FairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cik0002058261:FinancialAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_CarryingAmountMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:CarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_FairValueMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">cik0002058261:FairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_FairValueMember_custom_FinancialAssetsMember_ifrs-full_Level1OfFairValueHierarchyMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">cik0002058261:FairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cik0002058261:FinancialAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_FairValueMember_custom_FinancialAssetsMember_ifrs-full_Level2OfFairValueHierarchyMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">cik0002058261:FairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cik0002058261:FinancialAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_FairValueMember_custom_FinancialAssetsMember_ifrs-full_Level3OfFairValueHierarchyMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">cik0002058261:FairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cik0002058261:FinancialAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_FairValueMember_custom_FinancialAssetsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">cik0002058261:FairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cik0002058261:FinancialAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_ifrs-full_CarryingAmountMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:CarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_custom_FairValueMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">cik0002058261:FairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_custom_FairValueMember_custom_FinancialLiabilityMember_ifrs-full_Level1OfFairValueHierarchyMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">cik0002058261:FairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">cik0002058261:FinancialLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_custom_FairValueMember_custom_FinancialLiabilityMember_ifrs-full_Level2OfFairValueHierarchyMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">cik0002058261:FairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">cik0002058261:FinancialLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_custom_FairValueMember_custom_FinancialLiabilityMember_ifrs-full_Level3OfFairValueHierarchyMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">cik0002058261:FairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">cik0002058261:FinancialLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_custom_FairValueMember_custom_FinancialLiabilityMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">cik0002058261:FairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">cik0002058261:FinancialLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_Level3OfFairValueHierarchyMember_ifrs-full_BottomOfRangeMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_Level3OfFairValueHierarchyMember_ifrs-full_TopOfRangeMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_Level3OfFairValueHierarchyMember_ifrs-full_BottomOfRangeMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_Level3OfFairValueHierarchyMember_ifrs-full_TopOfRangeMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_ifrs-full_Level3OfFairValueHierarchyMember_ifrs-full_BottomOfRangeMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_ifrs-full_Level3OfFairValueHierarchyMember_ifrs-full_TopOfRangeMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_custom_EarlyRedemptionRightsMember_custom_ProfitOrLossMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cik0002058261:IncomeStatementsLocationAxis">cik0002058261:ProfitOrLossMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">cik0002058261:EarlyRedemptionRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_custom_EarlyRedemptionRightsMember_custom_OtherComprehensiveIncomeOrLossMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cik0002058261:IncomeStatementsLocationAxis">cik0002058261:OtherComprehensiveIncomeOrLossMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">cik0002058261:EarlyRedemptionRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_EarlyRedemptionRightsMember_custom_ProfitOrLossMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cik0002058261:IncomeStatementsLocationAxis">cik0002058261:ProfitOrLossMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">cik0002058261:EarlyRedemptionRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_EarlyRedemptionRightsMember_custom_OtherComprehensiveIncomeOrLossMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cik0002058261:IncomeStatementsLocationAxis">cik0002058261:OtherComprehensiveIncomeOrLossMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">cik0002058261:EarlyRedemptionRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_EarlyRedemptionRightsMember_custom_ProfitOrLossMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cik0002058261:IncomeStatementsLocationAxis">cik0002058261:ProfitOrLossMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">cik0002058261:EarlyRedemptionRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_EarlyRedemptionRightsMember_custom_OtherComprehensiveIncomeOrLossMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cik0002058261:IncomeStatementsLocationAxis">cik0002058261:OtherComprehensiveIncomeOrLossMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">cik0002058261:EarlyRedemptionRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_CarryingAmountMember_custom_CubebioCo.Ltd.Member273615343">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">ifrs-full:CarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_FinancialLiabilityMember_custom_LessThan3MonthsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">cik0002058261:FinancialLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">cik0002058261:LessThan3MonthsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_FinancialLiabilityMember_custom_N3Months1YearMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">cik0002058261:FinancialLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">cik0002058261:N3Months1YearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_FinancialLiabilityMember_custom_N1To2YearsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">cik0002058261:FinancialLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">cik0002058261:N1To2YearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_FinancialLiabilityMember_custom_N2To5YearsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">cik0002058261:FinancialLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">cik0002058261:N2To5YearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_FinancialLiabilityMember_custom_MoreThan5YearsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">cik0002058261:FinancialLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">cik0002058261:MoreThan5YearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_FinancialLiabilityMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">cik0002058261:FinancialLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_CarryingAmountMember_custom_CubebioCo.Ltd.Member273615390">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">ifrs-full:CarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_FinancialLiabilityMember_custom_LessThan3MonthsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">cik0002058261:FinancialLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">cik0002058261:LessThan3MonthsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_FinancialLiabilityMember_custom_N3Months1YearMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">cik0002058261:FinancialLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">cik0002058261:N3Months1YearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_FinancialLiabilityMember_custom_N1To2YearsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">cik0002058261:FinancialLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">cik0002058261:N1To2YearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_FinancialLiabilityMember_custom_N2To5YearsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">cik0002058261:FinancialLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">cik0002058261:N2To5YearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_FinancialLiabilityMember_custom_MoreThan5YearsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">cik0002058261:FinancialLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">cik0002058261:MoreThan5YearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_FinancialLiabilityMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">cik0002058261:FinancialLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_CostMember_custom_MachineryAndEquipmentsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">cik0002058261:CostMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cik0002058261:MachineryAndEquipmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_custom_MachineryAndEquipmentsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cik0002058261:MachineryAndEquipmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_AccumulatedImpairmentMember_custom_MachineryAndEquipmentsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cik0002058261:MachineryAndEquipmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_MachineryAndEquipmentsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cik0002058261:MachineryAndEquipmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_CostMember_ifrs-full_MotorVehiclesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">cik0002058261:CostMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_MotorVehiclesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_AccumulatedImpairmentMember_ifrs-full_MotorVehiclesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_MotorVehiclesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_CostMember_custom_OfficeAndOtherEquipmentMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">cik0002058261:CostMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cik0002058261:OfficeAndOtherEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_custom_OfficeAndOtherEquipmentMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cik0002058261:OfficeAndOtherEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_AccumulatedImpairmentMember_custom_OfficeAndOtherEquipmentMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cik0002058261:OfficeAndOtherEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_OfficeAndOtherEquipmentMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cik0002058261:OfficeAndOtherEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_CostMember_custom_FurnitureAndFixtureMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">cik0002058261:CostMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cik0002058261:FurnitureAndFixtureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_custom_FurnitureAndFixtureMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cik0002058261:FurnitureAndFixtureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_AccumulatedImpairmentMember_custom_FurnitureAndFixtureMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cik0002058261:FurnitureAndFixtureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_FurnitureAndFixtureMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cik0002058261:FurnitureAndFixtureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_CostMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">cik0002058261:CostMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_AccumulatedImpairmentMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_CostMember_custom_MachineryAndEquipmentsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">cik0002058261:CostMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cik0002058261:MachineryAndEquipmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_custom_MachineryAndEquipmentsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cik0002058261:MachineryAndEquipmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_AccumulatedImpairmentMember_custom_MachineryAndEquipmentsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cik0002058261:MachineryAndEquipmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_MachineryAndEquipmentsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cik0002058261:MachineryAndEquipmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_CostMember_ifrs-full_MotorVehiclesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">cik0002058261:CostMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_MotorVehiclesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_AccumulatedImpairmentMember_ifrs-full_MotorVehiclesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_MotorVehiclesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_CostMember_custom_OfficeAndOtherEquipmentMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">cik0002058261:CostMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cik0002058261:OfficeAndOtherEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_custom_OfficeAndOtherEquipmentMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cik0002058261:OfficeAndOtherEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_AccumulatedImpairmentMember_custom_OfficeAndOtherEquipmentMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cik0002058261:OfficeAndOtherEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_OfficeAndOtherEquipmentMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cik0002058261:OfficeAndOtherEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_CostMember_custom_FurnitureAndFixtureMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">cik0002058261:CostMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cik0002058261:FurnitureAndFixtureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_custom_FurnitureAndFixtureMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cik0002058261:FurnitureAndFixtureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_AccumulatedImpairmentMember_custom_FurnitureAndFixtureMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cik0002058261:FurnitureAndFixtureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_FurnitureAndFixtureMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cik0002058261:FurnitureAndFixtureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_CostMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">cik0002058261:CostMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_AccumulatedImpairmentMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_custom_CostMember_custom_MachineryAndEquipmentsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">cik0002058261:CostMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cik0002058261:MachineryAndEquipmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_custom_MachineryAndEquipmentsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cik0002058261:MachineryAndEquipmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_ifrs-full_AccumulatedImpairmentMember_custom_MachineryAndEquipmentsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cik0002058261:MachineryAndEquipmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_custom_MachineryAndEquipmentsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cik0002058261:MachineryAndEquipmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_custom_CostMember_ifrs-full_MotorVehiclesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">cik0002058261:CostMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_MotorVehiclesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_ifrs-full_AccumulatedImpairmentMember_ifrs-full_MotorVehiclesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_ifrs-full_MotorVehiclesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_custom_CostMember_custom_OfficeAndOtherEquipmentMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">cik0002058261:CostMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cik0002058261:OfficeAndOtherEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_custom_OfficeAndOtherEquipmentMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cik0002058261:OfficeAndOtherEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_ifrs-full_AccumulatedImpairmentMember_custom_OfficeAndOtherEquipmentMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cik0002058261:OfficeAndOtherEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_custom_OfficeAndOtherEquipmentMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cik0002058261:OfficeAndOtherEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_custom_CostMember_custom_FurnitureAndFixtureMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">cik0002058261:CostMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cik0002058261:FurnitureAndFixtureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_custom_FurnitureAndFixtureMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cik0002058261:FurnitureAndFixtureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_ifrs-full_AccumulatedImpairmentMember_custom_FurnitureAndFixtureMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cik0002058261:FurnitureAndFixtureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_custom_FurnitureAndFixtureMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cik0002058261:FurnitureAndFixtureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_custom_CostMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">cik0002058261:CostMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_ifrs-full_AccumulatedImpairmentMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_MachineryMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_VehiclesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_OfficeAndOtherEquipmentMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cik0002058261:OfficeAndOtherEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_MachineryMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_VehiclesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_MachineryMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_VehiclesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_OfficeAndOtherEquipmentMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cik0002058261:OfficeAndOtherEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_FurnitureAndFixtureMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cik0002058261:FurnitureAndFixtureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_MachineryMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_VehiclesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_OfficeAndOtherEquipmentMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cik0002058261:OfficeAndOtherEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_FurnitureAndFixtureMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cik0002058261:FurnitureAndFixtureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_ifrs-full_MachineryMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_ifrs-full_VehiclesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_custom_OfficeAndOtherEquipmentMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cik0002058261:OfficeAndOtherEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_custom_FurnitureAndFixtureMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cik0002058261:FurnitureAndFixtureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2026-06-30_ifrs-full_MachineryMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_ifrs-full_VehiclesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="From2025-01-012025-06-30_ifrs-full_MachineryMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-06-30_ifrs-full_VehiclesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-06-30_custom_OfficeAndOtherEquipmentMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cik0002058261:OfficeAndOtherEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-06-30_custom_FurnitureAndFixtureMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cik0002058261:FurnitureAndFixtureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2025-06-30_ifrs-full_MachineryMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_ifrs-full_VehiclesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_custom_OfficeAndOtherEquipmentMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cik0002058261:OfficeAndOtherEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_custom_FurnitureAndFixtureMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cik0002058261:FurnitureAndFixtureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_SellingGeneralAndAdministrativesExpensesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cik0002058261:IncomeStatementLocationsAxis">cik0002058261:SellingGeneralAndAdministrativesExpensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_SellingGeneralAndAdministrativesExpensesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cik0002058261:IncomeStatementLocationsAxis">cik0002058261:SellingGeneralAndAdministrativesExpensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_custom_SellingGeneralAndAdministrativesExpensesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cik0002058261:IncomeStatementLocationsAxis">cik0002058261:SellingGeneralAndAdministrativesExpensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-06-30_custom_SellingGeneralAndAdministrativesExpensesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cik0002058261:IncomeStatementLocationsAxis">cik0002058261:SellingGeneralAndAdministrativesExpensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_custom_ResearchAndDevelopmentCostsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cik0002058261:IncomeStatementLocationsAxis">cik0002058261:ResearchAndDevelopmentCostsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-06-30_custom_ResearchAndDevelopmentCostsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cik0002058261:IncomeStatementLocationsAxis">cik0002058261:ResearchAndDevelopmentCostsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_BuildingsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_BuildingsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_ifrs-full_BuildingsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_BuildingsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_BuildingsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_BuildingsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_ifrs-full_BuildingsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="From2025-01-012025-06-30_ifrs-full_BuildingsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2025-06-30_ifrs-full_BuildingsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_AcquisitionPriceMember_ifrs-full_ComputerSoftwareMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">cik0002058261:AcquisitionPriceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_AccumulatedAmortisationMember_ifrs-full_ComputerSoftwareMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">cik0002058261:AccumulatedAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_ComputerSoftwareMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_AcquisitionPriceMember_custom_PatentMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">cik0002058261:AcquisitionPriceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">cik0002058261:PatentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_AccumulatedAmortisationMember_custom_PatentMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">cik0002058261:AccumulatedAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">cik0002058261:PatentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_PatentMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">cik0002058261:PatentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_AcquisitionPriceMember_custom_BrandMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">cik0002058261:AcquisitionPriceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">cik0002058261:BrandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_AccumulatedAmortisationMember_custom_BrandMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">cik0002058261:AccumulatedAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">cik0002058261:BrandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_BrandMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">cik0002058261:BrandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_AcquisitionPriceMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">cik0002058261:AcquisitionPriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_AccumulatedAmortisationMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">cik0002058261:AccumulatedAmortisationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_CostMember_ifrs-full_ComputerSoftwareMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">cik0002058261:CostMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_AccumulatedAmortisationMember_ifrs-full_ComputerSoftwareMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">cik0002058261:AccumulatedAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_CostMember_custom_CubebioCo.Ltd.Member273618875">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">cik0002058261:CostMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_CostMember_custom_PatentMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">cik0002058261:CostMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">cik0002058261:PatentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_AccumulatedAmortisationMember_custom_PatentMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">cik0002058261:AccumulatedAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">cik0002058261:PatentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_PatentMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">cik0002058261:PatentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_CostMember_custom_BrandMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">cik0002058261:CostMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">cik0002058261:BrandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_AccumulatedAmortisationMember_custom_BrandMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">cik0002058261:AccumulatedAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">cik0002058261:BrandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_BrandMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">cik0002058261:BrandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_AccumulatedAmortisationMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">cik0002058261:AccumulatedAmortisationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_ComputerSoftwareMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_ComputerSoftwareMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_PatentMember_custom_CubebioCo.Ltd.Member273619093">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">cik0002058261:PatentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_BrandMember_custom_CubebioCo.Ltd.Member273619093">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">cik0002058261:BrandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_ComputerSoftwareMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_PatentMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">cik0002058261:PatentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_BrandMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">cik0002058261:BrandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_ComputerSoftwareMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_PatentMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">cik0002058261:PatentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_BrandMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">cik0002058261:BrandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_ifrs-full_ComputerSoftwareMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_custom_PatentMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">cik0002058261:PatentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_custom_BrandMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">cik0002058261:BrandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2026-06-30_ifrs-full_ComputerSoftwareMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_custom_PatentMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">cik0002058261:PatentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_custom_BrandMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">cik0002058261:BrandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="From2025-01-012025-06-30_ifrs-full_ComputerSoftwareMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-06-30_custom_PatentMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">cik0002058261:PatentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-06-30_custom_BrandMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">cik0002058261:BrandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2025-06-30_ifrs-full_ComputerSoftwareMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_custom_PatentMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">cik0002058261:PatentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_custom_BrandMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">cik0002058261:BrandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_ImpairmentLossesOnIntangibleAssetsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">cik0002058261:ImpairmentLossesOnIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_ImpairmentLossesOnIntangibleAssetsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">cik0002058261:ImpairmentLossesOnIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_ImpairmentLossesOnIntangibleAssetsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">cik0002058261:ImpairmentLossesOnIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_AllowanceForDoubtfulAccountsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">cik0002058261:AllowanceForDoubtfulAccountsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_AllowanceForDoubtfulAccountsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">cik0002058261:AllowanceForDoubtfulAccountsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_AllowanceForDoubtfulAccountsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">cik0002058261:AllowanceForDoubtfulAccountsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_LeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_LeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_LeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_PropertyAndEquipmentMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">cik0002058261:PropertyAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_PropertyAndEquipmentMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">cik0002058261:PropertyAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_PropertyAndEquipmentMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">cik0002058261:PropertyAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_BondWithWarrantsNetMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">cik0002058261:BondWithWarrantsNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_BondWithWarrantsNetMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">cik0002058261:BondWithWarrantsNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_BondWithWarrantsNetMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">cik0002058261:BondWithWarrantsNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_LeaseholdDepositReceivablesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">cik0002058261:LeaseholdDepositReceivablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_LeaseholdDepositReceivablesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">cik0002058261:LeaseholdDepositReceivablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_LeaseholdDepositReceivablesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">cik0002058261:LeaseholdDepositReceivablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_DefinedBenefitLiabilitiesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">cik0002058261:DefinedBenefitLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_DefinedBenefitLiabilitiesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">cik0002058261:DefinedBenefitLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_DefinedBenefitLiabilitiesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">cik0002058261:DefinedBenefitLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_DerivativeLiabilitiesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">cik0002058261:DerivativeLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_DerivativeLiabilitiesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">cik0002058261:DerivativeLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_DerivativeLiabilitiesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">cik0002058261:DerivativeLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_AccruedExpensesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">cik0002058261:AccruedExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_AccruedExpensesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">cik0002058261:AccruedExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_AccruedExpensesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">cik0002058261:AccruedExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_AccruedIncomeMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">cik0002058261:AccruedIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_AccruedIncomeMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">cik0002058261:AccruedIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_AccruedIncomeMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">cik0002058261:AccruedIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_InventoriesNetMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">cik0002058261:InventoriesNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_InventoriesNetMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">cik0002058261:InventoriesNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_InventoriesNetMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">cik0002058261:InventoriesNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_ProvisionsForRestorationMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">cik0002058261:ProvisionsForRestorationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_ProvisionsForRestorationMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">cik0002058261:ProvisionsForRestorationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_ProvisionsForRestorationMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">cik0002058261:ProvisionsForRestorationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_OthersMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">cik0002058261:OthersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_OthersMember_custom_CubebioCo.Ltd.Member273621031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">cik0002058261:OthersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_OthersMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">cik0002058261:OthersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_TotalMember_custom_CubebioCo.Ltd.Member273621031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">cik0002058261:TotalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_TotalMember_custom_CubebioCo.Ltd.Member273621046">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">cik0002058261:TotalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_TotalMember_custom_CubebioCo.Ltd.Member273621046">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">cik0002058261:TotalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_LossCarriedForwardMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">cik0002058261:LossCarriedForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_LossCarriedForwardMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">cik0002058261:LossCarriedForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_LossCarriedForwardMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">cik0002058261:LossCarriedForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_CarryoverTaxCreditMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">cik0002058261:CarryoverTaxCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_CarryoverTaxCreditMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">cik0002058261:CarryoverTaxCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_CarryoverTaxCreditMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">cik0002058261:CarryoverTaxCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_UnrecognizedDeferredTaxLiabilitiesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">cik0002058261:UnrecognizedDeferredTaxLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_UnrecognizedDeferredTaxLiabilitiesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">cik0002058261:UnrecognizedDeferredTaxLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_UnrecognizedDeferredTaxLiabilitiesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">cik0002058261:UnrecognizedDeferredTaxLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_DeferredTaxAssetsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">cik0002058261:DeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_DeferredTaxAssetsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">cik0002058261:DeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_DeferredTaxAssetsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">cik0002058261:DeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_ImpairmentLossesOnIntangibleAssetsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">cik0002058261:ImpairmentLossesOnIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_ImpairmentLossesOnIntangibleAssetsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">cik0002058261:ImpairmentLossesOnIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_AllowanceForDoubtfulAccountsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">cik0002058261:AllowanceForDoubtfulAccountsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_AllowanceForDoubtfulAccountsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">cik0002058261:AllowanceForDoubtfulAccountsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_LeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_LeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_PropertyAndEquipmentMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">cik0002058261:PropertyAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_PropertyAndEquipmentMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">cik0002058261:PropertyAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_BondWithWarrantsNetMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">cik0002058261:BondWithWarrantsNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_BondWithWarrantsNetMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">cik0002058261:BondWithWarrantsNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_LeaseholdDepositReceivablesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">cik0002058261:LeaseholdDepositReceivablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_LeaseholdDepositReceivablesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">cik0002058261:LeaseholdDepositReceivablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_DefinedBenefitLiabilitiesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">cik0002058261:DefinedBenefitLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_DefinedBenefitLiabilitiesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">cik0002058261:DefinedBenefitLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_DerivativeLiabilitiesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">cik0002058261:DerivativeLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_DerivativeLiabilitiesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">cik0002058261:DerivativeLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_AccruedExpensesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">cik0002058261:AccruedExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_AccruedExpensesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">cik0002058261:AccruedExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_AccruedIncomeMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">cik0002058261:AccruedIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_AccruedIncomeMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">cik0002058261:AccruedIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_InventoriesNetMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">cik0002058261:InventoriesNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_InventoriesNetMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">cik0002058261:InventoriesNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_ProvisionsForRestorationMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">cik0002058261:ProvisionsForRestorationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_ProvisionsForRestorationMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">cik0002058261:ProvisionsForRestorationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_OthersMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">cik0002058261:OthersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_OthersMember_custom_CubebioCo.Ltd.Member273621437">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">cik0002058261:OthersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_TotalMember_custom_CubebioCo.Ltd.Member273621437">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">cik0002058261:TotalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_TotalMember_custom_CubebioCo.Ltd.Member273621453">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">cik0002058261:TotalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_LossCarriedForwardMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">cik0002058261:LossCarriedForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_LossCarriedForwardMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">cik0002058261:LossCarriedForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_CarryoverTaxCreditMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">cik0002058261:CarryoverTaxCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_CarryoverTaxCreditMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">cik0002058261:CarryoverTaxCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_UnrecognizedDeferredTaxLiabilitiesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">cik0002058261:UnrecognizedDeferredTaxLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_UnrecognizedDeferredTaxLiabilitiesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">cik0002058261:UnrecognizedDeferredTaxLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_DeferredTaxAssetsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">cik0002058261:DeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_DeferredTaxAssetsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">cik0002058261:DeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_TaxPeriodTwoThousandAndTwentySixMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cik0002058261:TaxExpirationPeriodAxis">cik0002058261:TaxPeriodTwoThousandAndTwentySixMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_TaxPeriodTwoThousandAndTwentySevenMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cik0002058261:TaxExpirationPeriodAxis">cik0002058261:TaxPeriodTwoThousandAndTwentySevenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_TaxPeriodTwoThousandAndTwentyEightMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cik0002058261:TaxExpirationPeriodAxis">cik0002058261:TaxPeriodTwoThousandAndTwentyEightMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_TaxPeriodTwoThousandAndTwentyNineMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cik0002058261:TaxExpirationPeriodAxis">cik0002058261:TaxPeriodTwoThousandAndTwentyNineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_TaxPeriodTwoThousandAndThirtyMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cik0002058261:TaxExpirationPeriodAxis">cik0002058261:TaxPeriodTwoThousandAndThirtyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_TaxPeriodTwoThousandAndThirtyOneMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cik0002058261:TaxExpirationPeriodAxis">cik0002058261:TaxPeriodTwoThousandAndThirtyOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_After2031Member_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cik0002058261:TaxExpirationPeriodAxis">cik0002058261:After2031Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_NotLaterThanOneYearMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_NotLaterThanOneYearMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LaterThanOneYearMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LaterThanOneYearMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_ShareOptionExercisePriceMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">cik0002058261:ShareOptionExercisePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_ShareOptionExercisePriceMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">cik0002058261:ShareOptionExercisePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_ShareOptionPotentialOrdinaryShareMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">cik0002058261:ShareOptionPotentialOrdinaryShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_ShareOptionPotentialOrdinaryShareMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">cik0002058261:ShareOptionPotentialOrdinaryShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_BondsWithWarrantsExercisePriceMember_ifrs-full_BottomOfRangeMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">cik0002058261:BondsWithWarrantsExercisePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_BondsWithWarrantsExercisePriceMember_ifrs-full_TopOfRangeMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">cik0002058261:BondsWithWarrantsExercisePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_BondsWithWarrantsExercisePriceMember_ifrs-full_BottomOfRangeMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">cik0002058261:BondsWithWarrantsExercisePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_BondsWithWarrantsExercisePriceMember_ifrs-full_TopOfRangeMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">cik0002058261:BondsWithWarrantsExercisePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_BondsWithWarrantsPotentialOrdinaryShareMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">cik0002058261:BondsWithWarrantsPotentialOrdinaryShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_BondsWithWarrantsPotentialOrdinaryShareMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">cik0002058261:BondsWithWarrantsPotentialOrdinaryShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_custom_ShareOptionExercisePriceMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">cik0002058261:ShareOptionExercisePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-06-30_custom_ShareOptionExercisePriceMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">cik0002058261:ShareOptionExercisePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_custom_ShareOptionPotentialOrdinaryShareMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">cik0002058261:ShareOptionPotentialOrdinaryShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-06-30_custom_ShareOptionPotentialOrdinaryShareMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">cik0002058261:ShareOptionPotentialOrdinaryShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_custom_BondsWithWarrantsExercisePriceMember_ifrs-full_BottomOfRangeMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">cik0002058261:BondsWithWarrantsExercisePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_custom_BondsWithWarrantsExercisePriceMember_ifrs-full_TopOfRangeMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">cik0002058261:BondsWithWarrantsExercisePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-06-30_custom_BondsWithWarrantsExercisePriceMember_ifrs-full_BottomOfRangeMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">cik0002058261:BondsWithWarrantsExercisePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-06-30_custom_BondsWithWarrantsExercisePriceMember_ifrs-full_TopOfRangeMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">cik0002058261:BondsWithWarrantsExercisePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_custom_BondsWithWarrantsPotentialOrdinaryShareMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">cik0002058261:BondsWithWarrantsPotentialOrdinaryShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-06-30_custom_BondsWithWarrantsPotentialOrdinaryShareMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">cik0002058261:BondsWithWarrantsPotentialOrdinaryShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_BuildingRestorationMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">cik0002058261:BuildingRestorationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_BuildingRestorationMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">cik0002058261:BuildingRestorationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_BuildingRestorationMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">cik0002058261:BuildingRestorationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_BuildingRestorationMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">cik0002058261:BuildingRestorationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_BuildingRestorationMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">cik0002058261:BuildingRestorationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_custom_BuildingRestorationMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">cik0002058261:BuildingRestorationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-06-30_custom_BuildingRestorationMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">cik0002058261:BuildingRestorationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2026-06-30_custom_BuildingRestorationMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">cik0002058261:BuildingRestorationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_custom_BuildingRestorationMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">cik0002058261:BuildingRestorationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_DefinedBenefitObligationMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">cik0002058261:DefinedBenefitObligationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_DefinedBenefitObligationMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">cik0002058261:DefinedBenefitObligationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_FairValueOfPlanAssetsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">cik0002058261:FairValueOfPlanAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_FairValueOfPlanAssetsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">cik0002058261:FairValueOfPlanAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_NetDefinedBenefitLiabilitiesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">cik0002058261:NetDefinedBenefitLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_NetDefinedBenefitLiabilitiesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">cik0002058261:NetDefinedBenefitLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_DefinedBenefitObligationMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">cik0002058261:DefinedBenefitObligationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_DefinedBenefitObligationMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">cik0002058261:DefinedBenefitObligationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_FairValueOfPlanAssetsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">cik0002058261:FairValueOfPlanAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_FairValueOfPlanAssetsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">cik0002058261:FairValueOfPlanAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_NetDefinedBenefitLiabilitiesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">cik0002058261:NetDefinedBenefitLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_NetDefinedBenefitLiabilitiesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">cik0002058261:NetDefinedBenefitLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_DefinedBenefitObligationMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">cik0002058261:DefinedBenefitObligationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_FairValueOfPlanAssetsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">cik0002058261:FairValueOfPlanAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_NetDefinedBenefitLiabilitiesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">cik0002058261:NetDefinedBenefitLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_custom_DefinedBenefitObligationMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">cik0002058261:DefinedBenefitObligationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_custom_FairValueOfPlanAssetsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">cik0002058261:FairValueOfPlanAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_custom_NetDefinedBenefitLiabilitiesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">cik0002058261:NetDefinedBenefitLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2026-06-30_custom_DefinedBenefitObligationMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">cik0002058261:DefinedBenefitObligationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_custom_FairValueOfPlanAssetsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">cik0002058261:FairValueOfPlanAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_custom_NetDefinedBenefitLiabilitiesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">cik0002058261:NetDefinedBenefitLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_N12thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:N12thBondWithWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_N12thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:N12thBondWithWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_N13thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:N13thBondWithWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_N13thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:N13thBondWithWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_N14thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:N14thBondWithWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_N14thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:N14thBondWithWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_N15thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:N15thBondWithWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_N15thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:N15thBondWithWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_N18thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:N18thBondWithWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_N18thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:N18thBondWithWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_N20thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:N20thBondWithWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_N20thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:N20thBondWithWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_N21stBondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:N21stBondWithWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_N21stBondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:N21stBondWithWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_custom_N15thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:N15thBondWithWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_custom_N20thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:N20thBondWithWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_custom_N21stBondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:N21stBondWithWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_custom_N12thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:N12thBondWithWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_custom_N13thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:N13thBondWithWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_custom_N15thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:N15thBondWithWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_custom_N18thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:N18thBondWithWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_custom_N19thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:N19thBondWithWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_custom_N20thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:N20thBondWithWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_custom_N21stBondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:N21stBondWithWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="From2025-04-012025-06-30_custom_N12thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:N12thBondWithWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2025-04-012025-06-30_custom_N13thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:N13thBondWithWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2025-04-012025-06-30_custom_N15thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:N15thBondWithWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2025-04-012025-06-30_custom_N18thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:N18thBondWithWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2025-04-012025-06-30_custom_N19thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:N19thBondWithWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2025-04-012025-06-30_custom_N20thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:N20thBondWithWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2025-04-012025-06-30_custom_N21stBondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:N21stBondWithWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2025-04-012025-06-30_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2025-06-30_custom_N12thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:N12thBondWithWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_custom_N13thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:N13thBondWithWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_custom_N15thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:N15thBondWithWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_custom_N18thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:N18thBondWithWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_custom_N19thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:N19thBondWithWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_custom_N20thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:N20thBondWithWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_custom_N21stBondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:N21stBondWithWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-03-31_custom_N12thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:N12thBondWithWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="AsOf2024-03-31_custom_N13thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:N13thBondWithWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="AsOf2024-03-31_custom_N14thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:N14thBondWithWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="AsOf2024-03-31_custom_N15thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:N15thBondWithWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="AsOf2024-03-31_custom_N17thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:N17thBondWithWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="AsOf2024-03-31_custom_N18thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:N18thBondWithWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="AsOf2024-03-31_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="From2024-04-012024-06-30_custom_N12thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:N12thBondWithWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2024-04-012024-06-30_custom_N13thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:N13thBondWithWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2024-04-012024-06-30_custom_N14thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:N14thBondWithWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2024-04-012024-06-30_custom_N15thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:N15thBondWithWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2024-04-012024-06-30_custom_N17thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:N17thBondWithWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2024-04-012024-06-30_custom_N18thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:N18thBondWithWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2024-04-012024-06-30_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_N12thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:N12thBondWithWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_N13thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:N13thBondWithWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_N14thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:N14thBondWithWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_N15thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:N15thBondWithWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_N17thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:N17thBondWithWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_N18thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:N18thBondWithWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_N21stDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:N21stDetachableWarrantsBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_custom_N15thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:N15thBondWithWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_custom_N20thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:N20thBondWithWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_custom_N21stDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:N21stDetachableWarrantsBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2026-06-30_custom_N21stDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:N21stDetachableWarrantsBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_N19thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:N19thBondWithWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_N12thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:N12thBondWithWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_N13thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:N13thBondWithWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_N15thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:N15thBondWithWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_N18thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:N18thBondWithWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_N19thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:N19thBondWithWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_N20thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:N20thBondWithWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_N21stBondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:N21stBondWithWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_N19thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:N19thBondWithWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_N12thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:N12thBondWithWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_N13thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:N13thBondWithWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_N14thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:N14thBondWithWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_N15thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:N15thBondWithWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_N17thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:N17thBondWithWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_N18thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:N18thBondWithWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_N12thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:N12thBondWithWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_N13thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:N13thBondWithWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_N14thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:N14thBondWithWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_N15thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:N15thBondWithWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_N17thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:N17thBondWithWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_N18thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:N18thBondWithWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_N17thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:N17thBondWithWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_custom_N21stBondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:N21stBondWithWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_N11thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:N11thDetachableWarrantsBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_N12thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:N12thDetachableWarrantsBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_N13thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:N13thDetachableWarrantsBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_N14thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:N14thDetachableWarrantsBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_N15thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:N15thDetachableWarrantsBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_N16thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:N16thDetachableWarrantsBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_N17thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:N17thDetachableWarrantsBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_N18thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:N18thDetachableWarrantsBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_N19thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:N19thDetachableWarrantsBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_N20thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:N20thDetachableWarrantsBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_N21stDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:N21stDetachableWarrantsBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_custom_N11thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:N11thDetachableWarrantsBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_custom_N12thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:N12thDetachableWarrantsBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_custom_N13thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:N13thDetachableWarrantsBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_custom_N14thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:N14thDetachableWarrantsBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_custom_N15thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:N15thDetachableWarrantsBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_custom_N16thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:N16thDetachableWarrantsBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_custom_N17thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:N17thDetachableWarrantsBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_custom_N18thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:N18thDetachableWarrantsBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_custom_N19thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:N19thDetachableWarrantsBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_custom_N20thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:N20thDetachableWarrantsBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_CashAndCashEquivalentMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">cik0002058261:CashAndCashEquivalentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_CashAndCashEquivalentMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">cik0002058261:CashAndCashEquivalentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_CurrentPortionOfLongTermBankDepositMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">cik0002058261:CurrentPortionOfLongTermBankDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_CurrentPortionOfLongTermBankDepositMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">cik0002058261:CurrentPortionOfLongTermBankDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_ShortTermLoanReceivableNetMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">cik0002058261:ShortTermLoanReceivableNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_ShortTermLoanReceivableNetMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">cik0002058261:ShortTermLoanReceivableNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_OtherReceivablesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">cik0002058261:OtherReceivablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_OtherReceivablesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">cik0002058261:OtherReceivablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_LongtermBankDepositMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">cik0002058261:LongtermBankDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_LongtermBankDepositMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">cik0002058261:LongtermBankDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_LongTermLoanReceivableNetMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">cik0002058261:LongTermLoanReceivableNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_LongTermLoanReceivableNetMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">cik0002058261:LongTermLoanReceivableNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_LongTermOtherReceivablesNetMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">cik0002058261:LongTermOtherReceivablesNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_LongTermOtherReceivablesNetMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">cik0002058261:LongTermOtherReceivablesNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_OtherNoncurrentFinancialAssetsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">cik0002058261:OtherNoncurrentFinancialAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_OtherNoncurrentFinancialAssetsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">cik0002058261:OtherNoncurrentFinancialAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_AccountsPayableOtherMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">cik0002058261:AccountsPayableOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_AccountsPayableOtherMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">cik0002058261:AccountsPayableOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_BondWithWarrantsNetMember_custom_CubebioCo.Ltd.Member273629718">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">cik0002058261:BondWithWarrantsNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_BondWithWarrantsNetMember_custom_CubebioCo.Ltd.Member273629718">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">cik0002058261:BondWithWarrantsNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_LeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member273629718">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_LeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member273629734">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_DerivativeLiabilitiesMember_custom_CubebioCo.Ltd.Member273629734">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">cik0002058261:DerivativeLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_DerivativeLiabilitiesMember_custom_CubebioCo.Ltd.Member273629750">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">cik0002058261:DerivativeLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_custom_CashAndCashEquivalentMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">cik0002058261:CashAndCashEquivalentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_custom_CurrentPortionOfLongTermBankDepositMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">cik0002058261:CurrentPortionOfLongTermBankDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_custom_ShortTermLoanReceivableNetMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">cik0002058261:ShortTermLoanReceivableNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_custom_OtherReceivablesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">cik0002058261:OtherReceivablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_custom_LongtermBankDepositMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">cik0002058261:LongtermBankDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_custom_LongTermLoanReceivableNetMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">cik0002058261:LongTermLoanReceivableNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_custom_LongTermOtherReceivablesNetMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">cik0002058261:LongTermOtherReceivablesNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_custom_OtherNoncurrentFinancialAssetsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">cik0002058261:OtherNoncurrentFinancialAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_custom_AccountsPayableOtherMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">cik0002058261:AccountsPayableOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_custom_BondWithWarrantsNetMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">cik0002058261:BondWithWarrantsNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_ifrs-full_LeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_ifrs-full_ShorttermBorrowingsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:ShorttermBorrowingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_ifrs-full_ShorttermBorrowingsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:ShorttermBorrowingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_custom_DerivativeLiabilitiesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">cik0002058261:DerivativeLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_FinancialAssetsAtAmortisedCostCategoryMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtAmortisedCostCategoryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostCategoryMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_FinancialAssetsAtAmortisedCostCategoryMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtAmortisedCostCategoryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostCategoryMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_ifrs-full_FinancialAssetsAtAmortisedCostCategoryMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtAmortisedCostCategoryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_ifrs-full_FinancialLiabilitiesAtAmortisedCostCategoryMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_ifrs-full_FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-06-30_ifrs-full_FinancialAssetsAtAmortisedCostCategoryMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtAmortisedCostCategoryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-06-30_ifrs-full_FinancialLiabilitiesAtAmortisedCostCategoryMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-06-30_ifrs-full_FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_RemeasurementsOfDefinedBenefitLiabilityMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">cik0002058261:RemeasurementsOfDefinedBenefitLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_EmployeeShareOptionMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">cik0002058261:EmployeeShareOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_TreasurySharesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_RemeasurementsOfDefinedBenefitLiabilityMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">cik0002058261:RemeasurementsOfDefinedBenefitLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_EmployeeShareOptionMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">cik0002058261:EmployeeShareOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_TreasurySharesMember_custom_CubebioCo.Ltd.Member273631421">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_RemeasurementsOfDefinedBenefitLiabilityMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">cik0002058261:RemeasurementsOfDefinedBenefitLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_EmployeeShareOptionMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">cik0002058261:EmployeeShareOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_TreasurySharesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_RemeasurementsOfDefinedBenefitLiabilityMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">cik0002058261:RemeasurementsOfDefinedBenefitLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_EmployeeShareOptionMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">cik0002058261:EmployeeShareOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_TreasurySharesMember_custom_CubebioCo.Ltd.Member273631453">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_RemeasurementsOfDefinedBenefitLiabilityMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">cik0002058261:RemeasurementsOfDefinedBenefitLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_EmployeeShareOptionMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">cik0002058261:EmployeeShareOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_TreasurySharesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="From2015-09-292015-10-01_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2015-09-29</startDate>
            <endDate>2015-10-01</endDate>
        </period>
    </context>
    <context id="From2016-06-012016-06-29_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-06-01</startDate>
            <endDate>2016-06-29</endDate>
        </period>
    </context>
    <context id="From2020-06-012020-06-15_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-01</startDate>
            <endDate>2020-06-15</endDate>
        </period>
    </context>
    <context id="AsOf2020-06-15_custom_ShareOptionPlanEquitySettledMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cik0002058261:ShareOptionPlanEquitySettledMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-15</instant>
        </period>
    </context>
    <context id="From2020-06-012020-06-15_custom_ShareOptionPlanEquitySettledMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cik0002058261:ShareOptionPlanEquitySettledMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-01</startDate>
            <endDate>2020-06-15</endDate>
        </period>
    </context>
    <context id="From2020-06-012020-06-15_custom_ShareOptionPlanEquitySettledMember_ifrs-full_BottomOfRangeMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cik0002058261:ShareOptionPlanEquitySettledMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-01</startDate>
            <endDate>2020-06-15</endDate>
        </period>
    </context>
    <context id="From2020-06-012020-06-15_custom_ShareOptionPlanEquitySettledMember_ifrs-full_TopOfRangeMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cik0002058261:ShareOptionPlanEquitySettledMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-01</startDate>
            <endDate>2020-06-15</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_ShareOptionPlanEquitySettledMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cik0002058261:ShareOptionPlanEquitySettledMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_ShareOptionPlanEquitySettledMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cik0002058261:ShareOptionPlanEquitySettledMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_ShareOptionPlanEquitySettledMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cik0002058261:ShareOptionPlanEquitySettledMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_ShareOptionPlanEquitySettledMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cik0002058261:ShareOptionPlanEquitySettledMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_ShareOptionPlanEquitySettledMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cik0002058261:ShareOptionPlanEquitySettledMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_custom_ShareOptionPlanEquitySettledMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cik0002058261:ShareOptionPlanEquitySettledMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-06-30_custom_ShareOptionPlanEquitySettledMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cik0002058261:ShareOptionPlanEquitySettledMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2026-06-30_custom_ShareOptionPlanEquitySettledMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cik0002058261:ShareOptionPlanEquitySettledMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_custom_ShareOptionPlanEquitySettledMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">cik0002058261:ShareOptionPlanEquitySettledMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_RelatedPartiesMember_custom_WellCoreMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:WellCoreMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_RelatedPartiesMember_custom_WellCoreMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:WellCoreMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_RelatedPartiesMember_custom_DongsungDAndCMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:DongsungDAndCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_RelatedPartiesMember_custom_DongsungDAndCMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:DongsungDAndCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_RelatedPartiesMember_custom_CubeBioHoldingsLtdMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:CubeBioHoldingsLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_RelatedPartiesMember_custom_CubeBioHoldingsLtdMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:CubeBioHoldingsLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_RelatedPartiesMember_custom_JaeMyungKimMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:JaeMyungKimMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_RelatedPartiesMember_custom_JaeMyungKimMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:JaeMyungKimMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_RelatedPartiesMember_custom_NohBinParkNohBinParkMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:NohBinParkNohBinParkMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_RelatedPartiesMember_custom_NohBinParkNohBinParkMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:NohBinParkNohBinParkMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_RelatedPartiesMember_custom_HoSungHanMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:HoSungHanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_RelatedPartiesMember_custom_HoSungHanMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:HoSungHanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_RelatedPartiesMember_custom_EunJongChoiMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:EunJongChoiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_RelatedPartiesMember_custom_EunJongChoiMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:EunJongChoiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_RelatedPartiesMember_custom_SeYoonKimMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:SeYoonKimMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_RelatedPartiesMember_custom_SeYoonKimMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:SeYoonKimMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_RelatedPartiesMember_custom_GyungHaYuMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:GyungHaYuMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_RelatedPartiesMember_custom_GyungHaYuMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:GyungHaYuMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_RelatedPartiesMember_custom_JungGonKimMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:JungGonKimMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_RelatedPartiesMember_custom_JungGonKimMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:JungGonKimMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_RelatedPartiesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_RelatedPartiesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_ifrs-full_RelatedPartiesMember_custom_WellCoreMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:WellCoreMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-06-30_ifrs-full_RelatedPartiesMember_custom_WellCoreMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:WellCoreMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_ifrs-full_RelatedPartiesMember_custom_DongsungDAndCMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:DongsungDAndCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-06-30_ifrs-full_RelatedPartiesMember_custom_DongsungDAndCMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:DongsungDAndCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_ifrs-full_RelatedPartiesMember_custom_CubeBioHoldingsLtdMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:CubeBioHoldingsLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-06-30_ifrs-full_RelatedPartiesMember_custom_CubeBioHoldingsLtdMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:CubeBioHoldingsLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_ifrs-full_RelatedPartiesMember_custom_JaeMyungKimMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:JaeMyungKimMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_ifrs-full_RelatedPartiesMember_custom_NohBinParkNohBinParkMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:NohBinParkNohBinParkMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-06-30_ifrs-full_RelatedPartiesMember_custom_NohBinParkNohBinParkMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:NohBinParkNohBinParkMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_ifrs-full_RelatedPartiesMember_custom_HoSungHanMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:HoSungHanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-06-30_ifrs-full_RelatedPartiesMember_custom_HoSungHanMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:HoSungHanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_ifrs-full_RelatedPartiesMember_custom_EunJongChoiMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:EunJongChoiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-06-30_ifrs-full_RelatedPartiesMember_custom_EunJongChoiMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:EunJongChoiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_ifrs-full_RelatedPartiesMember_custom_SeYoonKimMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:SeYoonKimMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_ifrs-full_RelatedPartiesMember_custom_GyungHaYuMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:GyungHaYuMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-06-30_ifrs-full_RelatedPartiesMember_custom_GyungHaYuMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:GyungHaYuMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_ifrs-full_RelatedPartiesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-06-30_ifrs-full_RelatedPartiesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_IncomeAndExpensesFromOperatingActivitiesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cik0002058261:IncomeAndExpensesFromOperatingActivitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_IncomeAndExpensesFromOperatingActivitiesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cik0002058261:IncomeAndExpensesFromOperatingActivitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_CurrentBondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:CurrentBondWithWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_NonCurrentBondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:NonCurrentBondWithWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_CurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:CurrentLeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_NonCurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:NonCurrentLeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_CurrentBondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:CurrentBondWithWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_NonCurrentBondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:NonCurrentBondWithWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_CurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:CurrentLeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_NonCurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:NonCurrentLeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_CurrentBondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:CurrentBondWithWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_NonCurrentBondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:NonCurrentBondWithWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_CurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:CurrentLeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_NonCurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:NonCurrentLeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_CurrentBondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:CurrentBondWithWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_NonCurrentBondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:NonCurrentBondWithWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_CurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:CurrentLeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_NonCurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:NonCurrentLeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_CurrentBondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:CurrentBondWithWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_NonCurrentBondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:NonCurrentBondWithWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_CurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:CurrentLeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_NonCurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:NonCurrentLeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_ShorttermBorrowingsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">ifrs-full:ShorttermBorrowingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-06-30_custom_CurrentBondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:CurrentBondWithWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-06-30_ifrs-full_ShorttermBorrowingsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">ifrs-full:ShorttermBorrowingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-06-30_custom_CurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:CurrentLeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-06-30_custom_NonCurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:NonCurrentLeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2025-06-30_custom_CurrentBondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:CurrentBondWithWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_ifrs-full_ShorttermBorrowingsMember_custom_CubebioCo.Ltd.Member273638953">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">ifrs-full:ShorttermBorrowingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_custom_CurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:CurrentLeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_custom_NonCurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:NonCurrentLeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_ShorttermBorrowingsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">ifrs-full:ShorttermBorrowingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_custom_CurrentBondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:CurrentBondWithWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_ifrs-full_ShorttermBorrowingsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">ifrs-full:ShorttermBorrowingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_custom_CurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:CurrentLeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_custom_NonCurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:NonCurrentLeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2026-06-30_custom_CurrentBondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:CurrentBondWithWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_ifrs-full_ShorttermBorrowingsMember_custom_CubebioCo.Ltd.Member273639125">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">ifrs-full:ShorttermBorrowingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_custom_CurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:CurrentLeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_custom_NonCurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:NonCurrentLeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_ShortTermFinancialInstrumentsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cik0002058261:ShortTermFinancialInstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_custom_ShortTermFinancialInstrumentsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cik0002058261:ShortTermFinancialInstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_FinancialInstitutionsMember_custom_KYOBOSecuritiesCoLtdMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cik0002058261:KYOBOSecuritiesCoLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cik0002058261:FinancialInstitutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_FinancialInstitutionsMember_custom_ShinhanCardCoLtdMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cik0002058261:ShinhanCardCoLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cik0002058261:FinancialInstitutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_FinancialInstitutionsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cik0002058261:FinancialInstitutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_FinancialInstitutionsMember_custom_KYOBOSecuritiesCoLtdMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cik0002058261:KYOBOSecuritiesCoLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cik0002058261:FinancialInstitutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_FinancialInstitutionsMember_custom_ShinhanCardCoLtdMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cik0002058261:ShinhanCardCoLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cik0002058261:FinancialInstitutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_FinancialInstitutionsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cik0002058261:FinancialInstitutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_custom_FinancialInstitutionsMember_custom_KYOBOSecuritiesCoLtdMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cik0002058261:KYOBOSecuritiesCoLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cik0002058261:FinancialInstitutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_custom_FinancialInstitutionsMember_custom_ShinhanCardCoLtdMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cik0002058261:ShinhanCardCoLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cik0002058261:FinancialInstitutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_custom_FinancialInstitutionsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">cik0002058261:FinancialInstitutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="From2026-01-012026-01-11_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-01-11</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-01-12_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-01-12</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-01-13_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-01-13</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-01-12_custom_N20thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:N20thBondWithWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-01-12</endDate>
        </period>
    </context>
    <context id="From2026-02-012026-02-24_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-02-01</startDate>
            <endDate>2026-02-24</endDate>
        </period>
    </context>
    <context id="AsOf2026-03-27_custom_WellCoreCoLtdMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:WellCoreCoLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-27</instant>
        </period>
    </context>
    <context id="From2026-03-012026-03-31_custom_WellCoreCoLtdMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:WellCoreCoLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-03-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="From2026-04-012026-04-10_custom_N22ndBondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:N22ndBondWithWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-04-10</endDate>
        </period>
    </context>
    <context id="AsOf2026-05-18_custom_DongsungDAndCMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:DongsungDAndCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-05-18</instant>
        </period>
    </context>
    <context id="AsOf2026-05-18_custom_EffibarCDSPrivateLimitedMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:EffibarCDSPrivateLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-05-18</instant>
        </period>
    </context>
    <context id="From2026-04-012026-04-10_custom_DongSungDAndCCoLtd.Member_custom_N22ndBondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:N22ndBondWithWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:DongSungDAndCCoLtd.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-04-10</endDate>
        </period>
    </context>
    <context id="AsOf2026-07-02_custom_GoldenTreeNetworksCoLtdMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:GoldenTreeNetworksCoLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-07-02</instant>
        </period>
    </context>
    <context id="AsOf2026-07-08_custom_WellCoreCoLtdMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:WellCoreCoLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-07-08</instant>
        </period>
    </context>
    <context id="From2026-07-012026-07-16_custom_N15thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">cik0002058261:N15thBondWithWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-07-01</startDate>
            <endDate>2026-07-16</endDate>
        </period>
    </context>
    <context id="AsOf2026-07-24_custom_WellCoreCoLtdMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:WellCoreCoLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-07-24</instant>
        </period>
    </context>
    <context id="From2026-07-012026-10-31_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-07-01</startDate>
            <endDate>2026-10-31</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_custom_EunJongChoiMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAcquiredReceivablesAxis">cik0002058261:EunJongChoiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-06-30_custom_EunJongChoiMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAcquiredReceivablesAxis">cik0002058261:EunJongChoiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_custom_EunJongChoi1Member_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAcquiredReceivablesAxis">cik0002058261:EunJongChoi1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-06-30_custom_EunJongChoi1Member_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAcquiredReceivablesAxis">cik0002058261:EunJongChoi1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_custom_CubeBioHoldingsLtdMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAcquiredReceivablesAxis">cik0002058261:CubeBioHoldingsLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-06-30_custom_CubeBioHoldingsLtdMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAcquiredReceivablesAxis">cik0002058261:CubeBioHoldingsLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_custom_CubeBioHoldingsLtd1Member_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAcquiredReceivablesAxis">cik0002058261:CubeBioHoldingsLtd1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-06-30_custom_CubeBioHoldingsLtd1Member_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAcquiredReceivablesAxis">cik0002058261:CubeBioHoldingsLtd1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_custom_DongsungDAndCMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAcquiredReceivablesAxis">cik0002058261:DongsungDAndCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-06-30_custom_DongsungDAndCMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAcquiredReceivablesAxis">cik0002058261:DongsungDAndCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_custom_DongsungDAndC1Member_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAcquiredReceivablesAxis">cik0002058261:DongsungDAndC1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-06-30_custom_DongsungDAndC1Member_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAcquiredReceivablesAxis">cik0002058261:DongsungDAndC1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_custom_SubtotalMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAcquiredReceivablesAxis">cik0002058261:SubtotalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-06-30_custom_SubtotalMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAcquiredReceivablesAxis">cik0002058261:SubtotalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_custom_MagiumCorpMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAcquiredReceivablesAxis">cik0002058261:MagiumCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-06-30_custom_MagiumCorpMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAcquiredReceivablesAxis">cik0002058261:MagiumCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2026-06-30_custom_WellCoreMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:WellCoreMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_custom_WellCoreMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:WellCoreMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_WellCoreMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">cik0002058261:WellCoreMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-06-30_custom_RemeasurementsOfDefinedBenefitLiabilityMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">cik0002058261:RemeasurementsOfDefinedBenefitLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-06-30_custom_EmployeeShareOptionMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">cik0002058261:EmployeeShareOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-06-30_ifrs-full_TreasurySharesMember_custom_CubebioCo.Ltd.Member273646953">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2025-06-30_custom_RemeasurementsOfDefinedBenefitLiabilityMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">cik0002058261:RemeasurementsOfDefinedBenefitLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_custom_EmployeeShareOptionMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">cik0002058261:EmployeeShareOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_ifrs-full_TreasurySharesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_custom_RemeasurementsOfDefinedBenefitLiabilityMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">cik0002058261:RemeasurementsOfDefinedBenefitLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_custom_EmployeeShareOptionMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">cik0002058261:EmployeeShareOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_ifrs-full_TreasurySharesMember_custom_CubebioCo.Ltd.Member273647062">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2026-06-30_custom_RemeasurementsOfDefinedBenefitLiabilityMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">cik0002058261:RemeasurementsOfDefinedBenefitLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_custom_EmployeeShareOptionMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">cik0002058261:EmployeeShareOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_ifrs-full_TreasurySharesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_custom_IncomeAndExpensesFromOperatingActivitiesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cik0002058261:IncomeAndExpensesFromOperatingActivitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-06-30_custom_IncomeAndExpensesFromOperatingActivitiesMember_custom_CubebioCo.Ltd.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002058261</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0002058261:CubebioCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">cik0002058261:IncomeAndExpensesFromOperatingActivitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Pure">
        <measure>pure</measure>
    </unit>
    <unit id="KRWShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:KRW</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Decimal">
        <measure>cik0002058261:Decimal</measure>
    </unit>
    <unit id="KRW">
        <measure>iso4217:KRW</measure>
    </unit>
    <dei:AmendmentFlag contextRef="From2026-01-01to2026-06-30" id="Fact000003">true</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="From2026-01-01to2026-06-30" id="Fact000004">0002058261</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="From2026-01-01to2026-06-30" id="xdx2ixbrl0014">POS AM</dei:DocumentType>
    <ifrs-full:OtherPayables
      contextRef="AsOf2024-12-31"
      id="xdx2ixbrl0054"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:Revenue
      contextRef="From2025-01-012025-12-31"
      id="xdx2ixbrl0080"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:Revenue
      contextRef="From2024-09-252024-12-31"
      id="xdx2ixbrl0081"
      unitRef="USD"
      xsi:nil="true"/>
    <cik0002058261:TotalRevenues
      contextRef="From2025-01-012025-12-31"
      id="xdx2ixbrl0083"
      unitRef="USD"
      xsi:nil="true"/>
    <cik0002058261:TotalRevenues
      contextRef="From2024-09-252024-12-31"
      id="xdx2ixbrl0084"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:CostOfSales
      contextRef="From2025-01-012025-12-31"
      id="xdx2ixbrl0086"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:CostOfSales
      contextRef="From2024-09-252024-12-31"
      id="xdx2ixbrl0087"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:GrossProfit
      contextRef="From2025-01-012025-12-31"
      id="xdx2ixbrl0089"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:GrossProfit
      contextRef="From2024-09-252024-12-31"
      id="xdx2ixbrl0090"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:EquityAttributableToOwnersOfParent
      contextRef="AsOf2024-09-24_custom_CommonStocksMember"
      id="xdx2ixbrl0124"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:EquityAttributableToOwnersOfParent
      contextRef="AsOf2024-09-24_ifrs-full_OtherReserves"
      id="xdx2ixbrl0125"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:EquityAttributableToOwnersOfParent
      contextRef="AsOf2024-09-24_ifrs-full_RetainedEarnings"
      id="xdx2ixbrl0126"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:EquityAttributableToOwnersOfParent
      contextRef="AsOf2024-09-24"
      id="xdx2ixbrl0127"
      unitRef="USD"
      xsi:nil="true"/>
    <cik0002058261:ShareIssued
      contextRef="AsOf2024-09-24_custom_CommonStocksMember"
      id="xdx2ixbrl0129"
      unitRef="Shares"
      xsi:nil="true"/>
    <cik0002058261:SharesIssuedForRelatedPartyReceivable
      contextRef="From2024-09-252024-12-31_ifrs-full_OtherReserves"
      id="xdx2ixbrl0132"
      unitRef="USD"
      xsi:nil="true"/>
    <cik0002058261:SharesIssuedForRelatedPartyReceivable
      contextRef="From2024-09-252024-12-31_ifrs-full_RetainedEarnings"
      id="xdx2ixbrl0133"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="From2024-09-252024-12-31_custom_CommonStocksMember"
      id="xdx2ixbrl0138"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="From2024-09-252024-12-31_ifrs-full_OtherReserves"
      id="xdx2ixbrl0139"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:EquityAttributableToOwnersOfParent
      contextRef="AsOf2024-12-31_ifrs-full_OtherReserves"
      id="xdx2ixbrl0144"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="From2025-01-012025-12-31_custom_CommonStocksMember"
      id="xdx2ixbrl0150"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="From2025-01-012025-12-31_ifrs-full_OtherReserves"
      id="xdx2ixbrl0151"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:EquityAttributableToOwnersOfParent
      contextRef="AsOf2025-12-31_ifrs-full_OtherReserves"
      id="xdx2ixbrl0156"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable
      contextRef="From2024-09-252024-12-31"
      id="xdx2ixbrl0175"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:CashFlowsFromUsedInOperatingActivities
      contextRef="From2025-01-012025-12-31"
      id="xdx2ixbrl0183"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:CashFlowsFromUsedInInvestingActivities
      contextRef="From2025-01-012025-12-31"
      id="xdx2ixbrl0189"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:CashFlowsFromUsedInInvestingActivities
      contextRef="From2024-09-252024-12-31"
      id="xdx2ixbrl0190"
      unitRef="USD"
      xsi:nil="true"/>
    <cik0002058261:ProceedsFromPromissoryNotePayablesRelatedParties
      contextRef="From2025-01-012025-12-31"
      id="xdx2ixbrl0198"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:CashFlowsFromUsedInFinancingActivities
      contextRef="From2025-01-012025-12-31"
      id="xdx2ixbrl0201"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:CashAndCashEquivalents
      contextRef="AsOf2024-12-31"
      id="xdx2ixbrl0204"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:CashAndCashEquivalents
      contextRef="AsOf2024-09-24"
      id="xdx2ixbrl0205"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:CashAndCashEquivalents
      contextRef="AsOf2025-12-31"
      id="xdx2ixbrl0207"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:CashAndCashEquivalents
      contextRef="AsOf2024-12-31"
      id="xdx2ixbrl0208"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:TradeAndOtherPayables
      contextRef="AsOf2025-12-31_ifrs-full_RelatedPartiesMember_custom_EunJongChoiMember"
      id="xdx2ixbrl0271"
      unitRef="USD"
      xsi:nil="true"/>
    <cik0002058261:OtherReceivable
      contextRef="AsOf2024-12-31_ifrs-full_RelatedPartiesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl0277"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:TradeAndOtherPayables
      contextRef="AsOf2024-12-31_ifrs-full_RelatedPartiesMember_custom_EunJongChoiMember"
      id="xdx2ixbrl0283"
      unitRef="USD"
      xsi:nil="true"/>
    <cik0002058261:OtherReceivable
      contextRef="AsOf2024-12-31_ifrs-full_RelatedPartiesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl0289"
      unitRef="USD"
      xsi:nil="true"/>
    <cik0002058261:Decrease
      contextRef="From2025-01-012025-12-31_ifrs-full_RelatedPartiesMember_custom_EunJongChoiMember_custom_OtherReceivablesMember"
      id="xdx2ixbrl0301"
      unitRef="USD"
      xsi:nil="true"/>
    <cik0002058261:Decrease
      contextRef="From2025-01-012025-12-31_ifrs-full_RelatedPartiesMember_custom_CubebioCo.Ltd.Member_custom_PromissoryNotePayablesMember"
      id="xdx2ixbrl0309"
      unitRef="USD"
      xsi:nil="true"/>
    <cik0002058261:Decrease
      contextRef="From2025-01-012025-12-31"
      id="xdx2ixbrl0317"
      unitRef="USD"
      xsi:nil="true"/>
    <cik0002058261:RelatedPartyBalances
      contextRef="AsOf2024-09-24_ifrs-full_RelatedPartiesMember_custom_EunJongChoiMember_custom_OtherReceivablesMember"
      id="xdx2ixbrl0321"
      unitRef="USD"
      xsi:nil="true"/>
    <cik0002058261:Decrease
      contextRef="From2024-09-252024-12-31_ifrs-full_RelatedPartiesMember_custom_EunJongChoiMember_custom_OtherReceivablesMember"
      id="xdx2ixbrl0325"
      unitRef="USD"
      xsi:nil="true"/>
    <cik0002058261:RelatedPartyBalances
      contextRef="AsOf2024-09-23_ifrs-full_RelatedPartiesMember_custom_CubebioCo.Ltd.Member_custom_PromissoryNotePayablesMember"
      id="xdx2ixbrl0329"
      unitRef="USD"
      xsi:nil="true"/>
    <cik0002058261:Decrease
      contextRef="From2024-09-252024-12-31_ifrs-full_RelatedPartiesMember_custom_CubebioCo.Ltd.Member_custom_PromissoryNotePayablesMember"
      id="xdx2ixbrl0333"
      unitRef="USD"
      xsi:nil="true"/>
    <cik0002058261:RelatedPartyBalances
      contextRef="AsOf2024-09-24"
      id="xdx2ixbrl0337"
      unitRef="USD"
      xsi:nil="true"/>
    <cik0002058261:Decrease
      contextRef="From2024-09-252024-12-31"
      id="xdx2ixbrl0341"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:Revenue
      contextRef="From2026-01-01to2026-06-30"
      id="xdx2ixbrl0404"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:Revenue
      contextRef="From2025-01-012025-06-30"
      id="xdx2ixbrl0405"
      unitRef="USD"
      xsi:nil="true"/>
    <cik0002058261:TotalRevenues
      contextRef="From2026-01-01to2026-06-30"
      id="xdx2ixbrl0407"
      unitRef="USD"
      xsi:nil="true"/>
    <cik0002058261:TotalRevenues
      contextRef="From2025-01-012025-06-30"
      id="xdx2ixbrl0408"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:CostOfSales
      contextRef="From2026-01-01to2026-06-30"
      id="xdx2ixbrl0410"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:CostOfSales
      contextRef="From2025-01-012025-06-30"
      id="xdx2ixbrl0411"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:GrossProfit
      contextRef="From2026-01-01to2026-06-30"
      id="xdx2ixbrl0413"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:GrossProfit
      contextRef="From2025-01-012025-06-30"
      id="xdx2ixbrl0414"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:SellingGeneralAndAdministrativeExpense
      contextRef="From2026-01-01to2026-06-30"
      id="xdx2ixbrl0416"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:SellingGeneralAndAdministrativeExpense
      contextRef="From2025-01-012025-06-30"
      id="xdx2ixbrl0417"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:OperatingExpense
      contextRef="From2026-01-01to2026-06-30"
      id="xdx2ixbrl0419"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:OperatingExpense
      contextRef="From2025-01-012025-06-30"
      id="xdx2ixbrl0420"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:ProfitLossFromContinuingOperations
      contextRef="From2026-01-01to2026-06-30"
      id="xdx2ixbrl0422"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:ProfitLossFromContinuingOperations
      contextRef="From2025-01-012025-06-30"
      id="xdx2ixbrl0423"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="From2025-01-012025-06-30_custom_CommonStocksMember"
      id="xdx2ixbrl0457"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="From2026-01-012026-06-30_custom_CommonStocksMember"
      id="xdx2ixbrl0473"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable
      contextRef="From2026-01-01to2026-06-30"
      id="xdx2ixbrl0495"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable
      contextRef="From2025-01-012025-06-30"
      id="xdx2ixbrl0496"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:CashFlowsFromUsedInOperatingActivities
      contextRef="From2026-01-01to2026-06-30"
      id="xdx2ixbrl0504"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:CashFlowsFromUsedInOperatingActivities
      contextRef="From2025-01-012025-06-30"
      id="xdx2ixbrl0505"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:CashFlowsFromUsedInInvestingActivities
      contextRef="From2026-01-01to2026-06-30"
      id="xdx2ixbrl0510"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:CashFlowsFromUsedInInvestingActivities
      contextRef="From2025-01-012025-06-30"
      id="xdx2ixbrl0511"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:CashFlowsFromUsedInFinancingActivities
      contextRef="From2026-01-01to2026-06-30"
      id="xdx2ixbrl0516"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:CashFlowsFromUsedInFinancingActivities
      contextRef="From2025-01-012025-06-30"
      id="xdx2ixbrl0517"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges
      contextRef="From2026-01-01to2026-06-30"
      id="xdx2ixbrl0519"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges
      contextRef="From2025-01-012025-06-30"
      id="xdx2ixbrl0520"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:CashAndCashEquivalents
      contextRef="AsOf2025-12-31"
      id="xdx2ixbrl0522"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:CashAndCashEquivalents
      contextRef="AsOf2024-12-31"
      id="xdx2ixbrl0523"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:CashAndCashEquivalents
      contextRef="AsOf2026-06-30"
      id="xdx2ixbrl0525"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:CashAndCashEquivalents
      contextRef="AsOf2025-06-30"
      id="xdx2ixbrl0526"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:TradeAndOtherPayables
      contextRef="AsOf2026-06-30_ifrs-full_RelatedPartiesMember_custom_EunJongChoiMember"
      id="xdx2ixbrl0602"
      unitRef="USD"
      xsi:nil="true"/>
    <cik0002058261:OtherReceivable
      contextRef="AsOf2025-12-31_ifrs-full_RelatedPartiesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl0608"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:TradeAndOtherPayables
      contextRef="AsOf2025-12-31_ifrs-full_RelatedPartiesMember_custom_EunJongChoiMember"
      id="xdx2ixbrl0621"
      unitRef="USD"
      xsi:nil="true"/>
    <cik0002058261:OtherReceivable
      contextRef="AsOf2026-06-30_custom_CubebioCo.Ltd.Member273609250"
      id="xdx2ixbrl0627"
      unitRef="USD"
      xsi:nil="true"/>
    <cik0002058261:Decrease
      contextRef="From2026-01-012026-06-30_ifrs-full_RelatedPartiesMember_custom_EunJongChoiMember_custom_OtherReceivablesMember"
      id="xdx2ixbrl0639"
      unitRef="USD"
      xsi:nil="true"/>
    <cik0002058261:Decrease
      contextRef="From2025-01-012025-06-30_ifrs-full_RelatedPartiesMember_custom_CubebioCo.Ltd.Member_custom_PromissoryNotePayablesMember"
      id="xdx2ixbrl0646"
      unitRef="USD"
      xsi:nil="true"/>
    <cik0002058261:Decrease
      contextRef="From2026-01-012026-06-30_ifrs-full_RelatedPartiesMember_custom_EunJongChoiMember_custom_OtherReceivablesMember"
      id="xdx2ixbrl0654"
      unitRef="USD"
      xsi:nil="true"/>
    <cik0002058261:Decrease
      contextRef="From2025-01-012025-06-30_ifrs-full_RelatedPartiesMember_custom_CubebioCo.Ltd.Member_custom_PromissoryNotePayablesMember"
      id="xdx2ixbrl0662"
      unitRef="USD"
      xsi:nil="true"/>
    <cik0002058261:CurrentPortionOfLongtermBankDeposit
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl0694"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:LongtermBankDeposit
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl0708"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:LongtermOtherReceivablesNet
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl0726"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:AccountsPayableOtherRelatedPartiesNet
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl0745"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:BondWithWarrantsRelatedPartiesNet
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl0750"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:ShareSubscriptionReceivable
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl0790"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:Revenue
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl0810"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:Revenue
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl0811"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:TotalRevenues
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl0813"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:TotalRevenues
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl0814"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:CostOfSales
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl0816"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:CostOfSales
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl0817"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:GrossProfit
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl0819"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:GrossProfit
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl0820"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl0855"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl0856"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:EquityAttributableToOwnersOfParent
      contextRef="AsOf2023-12-31_custom_ShareSubscriptionReceivableMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl0884"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:ProfitLossFromContinuingOperation
      contextRef="From2024-01-012024-12-31_custom_ShareCapitalMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl0898"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:ProfitLossFromContinuingOperation
      contextRef="From2024-01-012024-12-31_ifrs-full_SharePremiumMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl0899"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:ProfitLossFromContinuingOperation
      contextRef="From2024-01-012024-12-31_custom_ShareSubscriptionReceivableMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl0900"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:ProfitLossFromContinuingOperation
      contextRef="From2024-01-012024-12-31_ifrs-full_OtherReservesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl0901"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:ProfitLossFromContinuingOperation
      contextRef="From2024-01-012024-12-31_ifrs-full_AccumulatedOtherComprehensiveIncomeMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl0902"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:RemeasurementOfDefinedBenefitLiabilitie
      contextRef="From2024-01-012024-12-31_custom_ShareCapitalMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl0906"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:RemeasurementOfDefinedBenefitLiabilitie
      contextRef="From2024-01-012024-12-31_ifrs-full_SharePremiumMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl0907"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:RemeasurementOfDefinedBenefitLiabilitie
      contextRef="From2024-01-012024-12-31_custom_ShareSubscriptionReceivableMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl0908"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:RemeasurementOfDefinedBenefitLiabilitie
      contextRef="From2024-01-012024-12-31_ifrs-full_OtherReservesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl0909"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:RemeasurementOfDefinedBenefitLiabilitie
      contextRef="From2024-01-012024-12-31_ifrs-full_RetainedEarningsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl0911"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2024-01-012024-12-31_custom_ShareCapitalMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl0914"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2024-01-012024-12-31_ifrs-full_SharePremiumMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl0915"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2024-01-012024-12-31_custom_ShareSubscriptionReceivableMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl0916"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2024-01-012024-12-31_ifrs-full_OtherReservesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl0917"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:WarrantsExercised
      contextRef="From2024-01-012024-12-31_custom_ShareSubscriptionReceivableMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl0932"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:WarrantsExercised
      contextRef="From2024-01-012024-12-31_ifrs-full_OtherReservesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl0933"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:WarrantsExercised
      contextRef="From2024-01-012024-12-31_ifrs-full_AccumulatedOtherComprehensiveIncomeMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl0934"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:WarrantsExercised
      contextRef="From2024-01-012024-12-31_ifrs-full_RetainedEarningsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl0935"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:BondWithWarrantsIssued
      contextRef="From2024-01-012024-12-31_custom_ShareCapitalMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl0938"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:BondWithWarrantsIssued
      contextRef="From2024-01-012024-12-31_custom_ShareSubscriptionReceivableMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl0940"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:BondWithWarrantsIssued
      contextRef="From2024-01-012024-12-31_ifrs-full_OtherReservesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl0941"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:BondWithWarrantsIssued
      contextRef="From2024-01-012024-12-31_ifrs-full_AccumulatedOtherComprehensiveIncomeMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl0942"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:BondWithWarrantsIssued
      contextRef="From2024-01-012024-12-31_ifrs-full_RetainedEarningsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl0943"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:StockOptionExercised
      contextRef="From2024-01-012024-12-31_custom_ShareSubscriptionReceivableMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl0948"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:StockOptionExercised
      contextRef="From2024-01-012024-12-31_ifrs-full_AccumulatedOtherComprehensiveIncomeMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl0950"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:StockOptionExercised
      contextRef="From2024-01-012024-12-31_ifrs-full_RetainedEarningsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl0951"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:StockOptionExpired
      contextRef="From2024-01-012024-12-31_custom_ShareCapitalMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl0954"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:StockOptionExpired
      contextRef="From2024-01-012024-12-31_custom_ShareSubscriptionReceivableMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl0956"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:StockOptionExpired
      contextRef="From2024-01-012024-12-31_ifrs-full_AccumulatedOtherComprehensiveIncomeMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl0958"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:StockOptionExpired
      contextRef="From2024-01-012024-12-31_ifrs-full_RetainedEarningsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl0959"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:StockOptionExpired
      contextRef="From2024-01-012024-12-31_custom_TotalMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl0960"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:DisposalOfTreasuryShares
      contextRef="From2024-01-012024-12-31_custom_ShareCapitalMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl0962"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:DisposalOfTreasuryShares
      contextRef="From2024-01-012024-12-31_custom_ShareSubscriptionReceivableMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl0964"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:DisposalOfTreasuryShares
      contextRef="From2024-01-012024-12-31_ifrs-full_AccumulatedOtherComprehensiveIncomeMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl0966"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:DisposalOfTreasuryShares
      contextRef="From2024-01-012024-12-31_ifrs-full_RetainedEarningsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl0967"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:EquityAttributableToOwnersOfParent
      contextRef="AsOf2024-12-31_custom_ShareSubscriptionReceivableMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl0972"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:ProfitLossFromContinuingOperation
      contextRef="From2025-01-012025-12-31_custom_ShareCapitalMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl0986"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:ProfitLossFromContinuingOperation
      contextRef="From2025-01-012025-12-31_ifrs-full_SharePremiumMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl0987"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:ProfitLossFromContinuingOperation
      contextRef="From2025-01-012025-12-31_custom_ShareSubscriptionReceivableMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl0988"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:ProfitLossFromContinuingOperation
      contextRef="From2025-01-012025-12-31_ifrs-full_OtherReservesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl0989"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:ProfitLossFromContinuingOperation
      contextRef="From2025-01-012025-12-31_ifrs-full_AccumulatedOtherComprehensiveIncomeMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl0990"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:RemeasurementOfDefinedBenefitLiabilitie
      contextRef="From2025-01-012025-12-31_custom_ShareCapitalMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl0994"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:RemeasurementOfDefinedBenefitLiabilitie
      contextRef="From2025-01-012025-12-31_ifrs-full_SharePremiumMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl0995"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:RemeasurementOfDefinedBenefitLiabilitie
      contextRef="From2025-01-012025-12-31_custom_ShareSubscriptionReceivableMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl0996"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:RemeasurementOfDefinedBenefitLiabilitie
      contextRef="From2025-01-012025-12-31_ifrs-full_OtherReservesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl0997"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:RemeasurementOfDefinedBenefitLiabilitie
      contextRef="From2025-01-012025-12-31_ifrs-full_RetainedEarningsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl0999"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2025-01-012025-12-31_custom_ShareCapitalMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl1002"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2025-01-012025-12-31_ifrs-full_SharePremiumMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl1003"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2025-01-012025-12-31_custom_ShareSubscriptionReceivableMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl1004"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2025-01-012025-12-31_ifrs-full_OtherReservesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl1005"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:WarrantsExercised
      contextRef="From2025-01-012025-12-31_custom_ShareSubscriptionReceivableMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl1020"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:WarrantsExercised
      contextRef="From2025-01-012025-12-31_ifrs-full_OtherReservesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl1021"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:WarrantsExercised
      contextRef="From2025-01-012025-12-31_ifrs-full_AccumulatedOtherComprehensiveIncomeMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl1022"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:WarrantsExercised
      contextRef="From2025-01-012025-12-31_ifrs-full_RetainedEarningsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl1023"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:BondWithWarrantsIssued
      contextRef="From2025-01-012025-12-31_custom_ShareCapitalMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl1026"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:BondWithWarrantsIssued
      contextRef="From2025-01-012025-12-31_custom_ShareSubscriptionReceivableMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl1028"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:BondWithWarrantsIssued
      contextRef="From2025-01-012025-12-31_ifrs-full_OtherReservesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl1029"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:BondWithWarrantsIssued
      contextRef="From2025-01-012025-12-31_ifrs-full_AccumulatedOtherComprehensiveIncomeMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl1030"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:BondWithWarrantsIssued
      contextRef="From2025-01-012025-12-31_ifrs-full_RetainedEarningsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl1031"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:DisposalOfTreasuryShares
      contextRef="From2025-01-012025-12-31_custom_ShareCapitalMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl1034"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:DisposalOfTreasuryShares
      contextRef="From2025-01-012025-12-31_ifrs-full_AccumulatedOtherComprehensiveIncomeMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl1038"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:DisposalOfTreasuryShares
      contextRef="From2025-01-012025-12-31_ifrs-full_RetainedEarningsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl1039"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:ReversalOfOtherBadDebtExpenses
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl1068"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl1080"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:AdjustmentsForImpairmentLossRecognisedInProfitOrLossGoodwill
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl1083"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:AdjustmentsForLossOnDisposalsPropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl1086"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:AdjustmentsForPrepayments
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl1120"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:LoanRepaymentsReceived
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl1143"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:DepositRefunded
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl1146"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:ProceedFromDisposalOfPropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl1149"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:PurchaseOfIntangibleAssets
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl1153"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:RepaymentOfShorttermBorrowings
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl1165"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:ProceedsFromShorttermBorrowings
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl1168"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:ProceedsFromWarrantsExercised
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl1179"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:ProceedsFromShareOptionsExercised
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl1182"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:ProceedsFromTreasuryStocksDisposedWithRefundObligation
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl1189"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:SegmentRevenue
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl1436"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:SegmentRevenue
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl1437"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:AccruedInterestIncome
      contextRef="From2025-01-012025-12-31_custom_MagiumCorpMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl1524"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:AccruedInterestIncome
      contextRef="From2024-01-012024-12-31_custom_MERITinCorpMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl1543"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:CarryingAmount
      contextRef="From2024-01-012024-12-31_custom_MERITinCorpMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl1545"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:AccruedInterestIncome
      contextRef="From2024-01-012024-12-31_custom_POEXHoldingsCorpMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl1553"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:CarryingAmount
      contextRef="From2024-01-012024-12-31_custom_POEXHoldingsCorpMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl1555"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:AccruedInterestIncome
      contextRef="From2024-01-012024-12-31_custom_MagiumCorpMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl1599"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:WriteoffOfAllowanceForDoubtfulAccounts
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl1629"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:ShortTermLoanReceivable
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl1631"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:ReversalOfAllowanceForDoubtfulAccounts
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl1639"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:CurrentAccruedInterestIncomeProvisionForImpairment
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl1657"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:VatRefundReceivableProvisionForImpairment
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl1663"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:SubtotalProvisionForImpairment
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl1669"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:NoncurrentAccruedInterestIncomeCarryingAmount
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl1677"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:CurrentAccruedInterestIncomeProvisionForImpairment
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl1694"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:AllowanceForDoubtfulAccountsOtherReceivables
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl1713"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:AllowanceForDoubtfulAccountsOtherReceivables
      contextRef="AsOf2023-12-31_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl1714"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:BadDebtExpensesOtherReceivables
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl1716"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:ReclassificationFromCurrent
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl1719"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:ReclassificationFromCurrent
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl1720"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:AllowanceForDoubtfulAccountsOtherReceivables
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl1722"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:AllowanceForDoubtfulAccountsOtherReceivables
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl1723"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:ReclassificationFromCurrentToNoncurrent
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl1731"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:ReclassificationFromCurrentToNoncurrent
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl1732"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:Merchandise
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl1741"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:AllowanceForInventoriesValuation
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl1744"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:Inventories
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl1747"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:Inventories
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl1748"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:CurrentPrepayments
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl1772"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:DerivativeFinancialLiabilities
      contextRef="AsOf2025-12-31_custom_FairValueMember_custom_FinancialAssetsMember_ifrs-full_Level1OfFairValueHierarchyMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl1794"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:DerivativeFinancialLiabilities
      contextRef="AsOf2025-12-31_custom_FairValueMember_custom_FinancialAssetsMember_ifrs-full_Level2OfFairValueHierarchyMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl1796"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:DerivativeFinancialLiabilities
      contextRef="AsOf2024-12-31_custom_FairValueMember_custom_FinancialAssetsMember_ifrs-full_Level1OfFairValueHierarchyMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl1806"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:DerivativeFinancialLiabilities
      contextRef="AsOf2024-12-31_custom_FairValueMember_custom_FinancialAssetsMember_ifrs-full_Level2OfFairValueHierarchyMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl1808"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:FavorableChanges
      contextRef="AsOf2025-12-31_custom_EarlyRedemptionRightsMember_custom_OtherComprehensiveIncomeOrLossMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl1845"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:UnfavorableChanges
      contextRef="AsOf2025-12-31_custom_EarlyRedemptionRightsMember_custom_OtherComprehensiveIncomeOrLossMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl1847"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:FavorableChanges
      contextRef="AsOf2024-12-31_custom_EarlyRedemptionRightsMember_custom_OtherComprehensiveIncomeOrLossMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl1854"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:UnfavorableChanges
      contextRef="AsOf2024-12-31_custom_EarlyRedemptionRightsMember_custom_OtherComprehensiveIncomeOrLossMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl1856"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:CurrentPortionOfLongtermBankDeposits
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl1872"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:LongtermBankDeposit
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl1880"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:LongtermOtherReceivablesNet
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl1886"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:AccountsPayable
      contextRef="AsOf2025-12-31_custom_FinancialLiabilityMember_custom_N1To2YearsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl1915"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:AccountsPayable
      contextRef="AsOf2025-12-31_custom_FinancialLiabilityMember_custom_N2To5YearsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl1916"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:AccountsPayable
      contextRef="AsOf2025-12-31_custom_FinancialLiabilityMember_custom_MoreThan5YearsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl1917"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:BondWithWarrants
      contextRef="AsOf2025-12-31_custom_FinancialLiabilityMember_custom_N1To2YearsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl1923"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:BondWithWarrants
      contextRef="AsOf2025-12-31_custom_FinancialLiabilityMember_custom_N2To5YearsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl1924"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:BondWithWarrants
      contextRef="AsOf2025-12-31_custom_FinancialLiabilityMember_custom_MoreThan5YearsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl1925"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:LeaseLiabilities
      contextRef="AsOf2025-12-31_custom_FinancialLiabilityMember_custom_MoreThan5YearsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl1933"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2025-12-31_custom_FinancialLiabilityMember_custom_MoreThan5YearsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl1941"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:AccountsPayable
      contextRef="AsOf2024-12-31_custom_FinancialLiabilityMember_custom_N1To2YearsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl1956"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:AccountsPayable
      contextRef="AsOf2024-12-31_custom_FinancialLiabilityMember_custom_N2To5YearsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl1957"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:AccountsPayable
      contextRef="AsOf2024-12-31_custom_FinancialLiabilityMember_custom_MoreThan5YearsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl1958"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:BondWithWarrants
      contextRef="AsOf2024-12-31_custom_FinancialLiabilityMember_custom_N3Months1YearMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl1963"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:BondWithWarrants
      contextRef="AsOf2024-12-31_custom_FinancialLiabilityMember_custom_N1To2YearsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl1964"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:BondWithWarrants
      contextRef="AsOf2024-12-31_custom_FinancialLiabilityMember_custom_N2To5YearsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl1965"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:BondWithWarrants
      contextRef="AsOf2024-12-31_custom_FinancialLiabilityMember_custom_MoreThan5YearsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl1966"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2025-12-31_ifrs-full_AccumulatedImpairmentMember_custom_MachineryAndEquipmentsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl2028"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2025-12-31_ifrs-full_AccumulatedImpairmentMember_ifrs-full_MotorVehiclesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl2035"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2025-12-31_ifrs-full_AccumulatedImpairmentMember_custom_OfficeAndOtherEquipmentMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl2042"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2025-12-31_ifrs-full_AccumulatedImpairmentMember_custom_FurnitureAndFixtureMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl2049"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2025-12-31_ifrs-full_AccumulatedImpairmentMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl2056"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2024-12-31_ifrs-full_AccumulatedImpairmentMember_ifrs-full_MotorVehiclesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl2072"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2024-12-31_ifrs-full_AccumulatedImpairmentMember_custom_OfficeAndOtherEquipmentMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl2079"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2024-12-31_ifrs-full_AccumulatedImpairmentMember_custom_FurnitureAndFixtureMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl2086"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:AcquisitionsCost
      contextRef="From2025-01-012025-12-31_ifrs-full_VehiclesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl2106"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:AcquisitionsCost
      contextRef="From2025-01-012025-12-31_custom_OfficeAndOtherEquipmentMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl2107"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:AcquisitionsCost
      contextRef="From2025-01-012025-12-31_custom_FurnitureAndFixtureMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl2108"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:DepreciationInvestmentProperty
      contextRef="From2025-01-012025-12-31_custom_FurnitureAndFixtureMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl2114"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:ImpairmentLoss
      contextRef="From2025-01-012025-12-31_custom_FurnitureAndFixtureMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl2120"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:ImpairmentLoss
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl2121"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:Disposals
      contextRef="From2025-01-012025-12-31_custom_FurnitureAndFixtureMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl2126"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:Disposals
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl2127"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:AcquisitionsCost
      contextRef="From2024-01-012024-12-31_custom_FurnitureAndFixtureMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl2144"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:DepreciationInvestmentProperty
      contextRef="From2024-01-012024-12-31_custom_FurnitureAndFixtureMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl2150"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:ImpairmentLoss
      contextRef="From2024-01-012024-12-31_ifrs-full_VehiclesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl2154"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:ImpairmentLoss
      contextRef="From2024-01-012024-12-31_custom_OfficeAndOtherEquipmentMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl2155"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:ImpairmentLoss
      contextRef="From2024-01-012024-12-31_custom_FurnitureAndFixtureMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl2156"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:Disposals
      contextRef="From2024-01-012024-12-31_ifrs-full_VehiclesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl2160"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:Disposals
      contextRef="From2024-01-012024-12-31_custom_FurnitureAndFixtureMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl2162"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:LeaseReassessments
      contextRef="From2025-01-012025-12-31_ifrs-full_VehiclesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl2241"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:LeaseReassessments
      contextRef="From2024-01-012024-12-31_ifrs-full_VehiclesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl2257"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:NewLeases
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl2270"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:NewLeases
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl2272"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:Over5Years
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl2315"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="From2025-01-012025-12-31_ifrs-full_ComputerSoftwareMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl2410"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="From2025-01-012025-12-31_custom_PatentMember_custom_CubebioCo.Ltd.Member273619093"
      id="xdx2ixbrl2411"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2024-01-012024-12-31_custom_BrandMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl2439"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl2500"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl2501"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:MovementInDeferredTaxBalancesIncreaseDecrease
      contextRef="From2025-01-012025-12-31_custom_InventoriesNetMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl2571"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:MovementInDeferredTaxBalances
      contextRef="AsOf2024-12-31_custom_DeferredTaxAssetsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl2611"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:MovementInDeferredTaxBalancesIncreaseDecrease
      contextRef="From2025-01-012025-12-31_custom_DeferredTaxAssetsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl2613"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:MovementInDeferredTaxBalances
      contextRef="AsOf2025-12-31_custom_DeferredTaxAssetsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl2615"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:MovementInDeferredTaxBalancesIncreaseDecrease
      contextRef="From2024-01-012024-12-31_custom_ImpairmentLossesOnIntangibleAssetsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl2626"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:MovementInDeferredTaxBalancesIncreaseDecrease
      contextRef="From2024-01-012024-12-31_custom_InventoriesNetMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl2686"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:MovementInDeferredTaxBalances
      contextRef="AsOf2023-12-31_custom_DeferredTaxAssetsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl2726"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:MovementInDeferredTaxBalancesIncreaseDecrease
      contextRef="From2024-01-012024-12-31_custom_DeferredTaxAssetsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl2728"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:MovementInDeferredTaxBalances
      contextRef="AsOf2024-12-31_custom_DeferredTaxAssetsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl2730"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:UnusedTaxCreditsForWhichNoDeferredTaxAssetRecognised
      contextRef="AsOf2025-12-31_custom_TaxPeriodTwoThousandAndTwentySixMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl2757"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:UnusedTaxCreditsForWhichNoDeferredTaxAssetRecognised
      contextRef="AsOf2025-12-31_custom_TaxPeriodTwoThousandAndTwentySevenMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl2761"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:UnusedTaxCreditsForWhichNoDeferredTaxAssetRecognised
      contextRef="AsOf2025-12-31_custom_TaxPeriodTwoThousandAndTwentyEightMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl2765"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:UnusedTaxCreditsForWhichNoDeferredTaxAssetRecognised
      contextRef="AsOf2025-12-31_custom_TaxPeriodTwoThousandAndTwentyNineMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl2769"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:UnusedTaxCreditsForWhichNoDeferredTaxAssetRecognised
      contextRef="AsOf2025-12-31_custom_TaxPeriodTwoThousandAndThirtyMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl2773"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:UnusedTaxCreditsForWhichNoDeferredTaxAssetRecognised
      contextRef="AsOf2025-12-31_custom_TaxPeriodTwoThousandAndThirtyOneMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl2777"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:NetDeferredTaxLiabilities
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl2817"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:NetDeferredTaxLiabilities
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl2819"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:ShareOptionsExercised
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl2845"
      unitRef="Shares"
      xsi:nil="true"/>
    <cik0002058261:DefinedBenefitObligation
      contextRef="AsOf2024-12-31_custom_FairValueOfPlanAssetsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl2939"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:DefinedBenefitObligation
      contextRef="AsOf2023-12-31_custom_FairValueOfPlanAssetsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl2940"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:CurrentServiceCostDefinedBenefitPlans
      contextRef="From2025-01-012025-12-31_custom_FairValueOfPlanAssetsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl2953"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:CurrentServiceCostDefinedBenefitPlans
      contextRef="From2024-01-012024-12-31_custom_FairValueOfPlanAssetsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl2954"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:InterestExpenseDefinedBenefitPlans
      contextRef="From2025-01-012025-12-31_custom_FairValueOfPlanAssetsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl2960"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:InterestExpenseDefinedBenefitPlans
      contextRef="From2024-01-012024-12-31_custom_FairValueOfPlanAssetsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl2961"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:IncludedInProfitOrLoss
      contextRef="From2025-01-012025-12-31_custom_FairValueOfPlanAssetsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl2967"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:IncludedInProfitOrLoss
      contextRef="From2024-01-012024-12-31_custom_FairValueOfPlanAssetsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl2968"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:RemeasurementLossgain
      contextRef="From2025-01-012025-12-31_custom_FairValueOfPlanAssetsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl2981"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:RemeasurementLossgain
      contextRef="From2024-01-012024-12-31_custom_FairValueOfPlanAssetsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl2982"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:DemographicAssumption
      contextRef="From2025-01-012025-12-31_custom_DefinedBenefitObligationMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl2986"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:DemographicAssumption
      contextRef="From2025-01-012025-12-31_custom_FairValueOfPlanAssetsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl2988"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:DemographicAssumption
      contextRef="From2024-01-012024-12-31_custom_FairValueOfPlanAssetsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl2989"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:DemographicAssumption
      contextRef="From2025-01-012025-12-31_custom_NetDefinedBenefitLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl2990"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:FinancialAssumption
      contextRef="From2025-01-012025-12-31_custom_FairValueOfPlanAssetsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl2995"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:FinancialAssumption
      contextRef="From2024-01-012024-12-31_custom_FairValueOfPlanAssetsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl2996"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:AdjustmentBasedOnExperience
      contextRef="From2025-01-012025-12-31_custom_FairValueOfPlanAssetsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3002"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:AdjustmentBasedOnExperience
      contextRef="From2024-01-012024-12-31_custom_FairValueOfPlanAssetsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3003"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset
      contextRef="From2025-01-012025-12-31_custom_FairValueOfPlanAssetsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3009"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset
      contextRef="From2024-01-012024-12-31_custom_FairValueOfPlanAssetsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3010"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:GainsOnSettlement
      contextRef="From2025-01-012025-12-31_custom_FairValueOfPlanAssetsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3023"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:GainsOnSettlement
      contextRef="From2024-01-012024-12-31_custom_FairValueOfPlanAssetsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3024"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:BenefitsPaidOrPayable
      contextRef="From2025-01-012025-12-31_custom_FairValueOfPlanAssetsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3030"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:BenefitsPaidOrPayable
      contextRef="From2024-01-012024-12-31_custom_FairValueOfPlanAssetsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3031"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:DefinedBenefitObligation
      contextRef="AsOf2025-12-31_custom_FairValueOfPlanAssetsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3037"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:DefinedBenefitObligation
      contextRef="AsOf2024-12-31_custom_FairValueOfPlanAssetsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3038"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:BondsIssued
      contextRef="AsOf2025-12-31_custom_N12thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3081"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:BondsIssued
      contextRef="AsOf2025-12-31_custom_N13thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3085"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:BondsIssued
      contextRef="AsOf2025-12-31_custom_N14thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3089"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:BondsIssued
      contextRef="AsOf2024-12-31_custom_N14thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3091"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:BondsIssued
      contextRef="AsOf2025-12-31_custom_N18thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3097"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:BondsIssued
      contextRef="AsOf2024-12-31_custom_N20thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3103"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:BondsIssued
      contextRef="AsOf2024-12-31_custom_N21stBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3107"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:BondsIssued
      contextRef="AsOf2025-03-31_custom_N19thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3126"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:BondsIssued
      contextRef="AsOf2025-03-31_custom_N20thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3127"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:BondsIssued
      contextRef="AsOf2025-03-31_custom_N21stBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3128"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:ShareIssueRelatedCost
      contextRef="From2025-04-012025-06-30_custom_N12thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3131"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:ShareIssueRelatedCost
      contextRef="From2025-04-012025-06-30_custom_N13thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3132"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:ShareIssueRelatedCost
      contextRef="From2025-04-012025-06-30_custom_N15thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3133"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:ShareIssueRelatedCost
      contextRef="From2025-04-012025-06-30_custom_N18thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3134"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:EarlyRedemption
      contextRef="From2025-04-012025-06-30_custom_N12thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3140"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:EarlyRedemption
      contextRef="From2025-04-012025-06-30_custom_N13thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3141"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:EarlyRedemption
      contextRef="From2025-04-012025-06-30_custom_N15thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3142"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:EarlyRedemption
      contextRef="From2025-04-012025-06-30_custom_N21stBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3146"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:RedemptionAtMaturity
      contextRef="From2025-04-012025-06-30_custom_N12thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3149"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:RedemptionAtMaturity
      contextRef="From2025-04-012025-06-30_custom_N15thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3151"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:RedemptionAtMaturity
      contextRef="From2025-04-012025-06-30_custom_N18thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3152"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:RedemptionAtMaturity
      contextRef="From2025-04-012025-06-30_custom_N19thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3153"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:RedemptionAtMaturity
      contextRef="From2025-04-012025-06-30_custom_N20thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3154"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:RedemptionAtMaturity
      contextRef="From2025-04-012025-06-30_custom_N21stBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3155"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:SettledThroughDebttoequitySwap
      contextRef="From2025-04-012025-06-30_custom_N18thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3161"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:SettledThroughDebttoequitySwap
      contextRef="From2025-04-012025-06-30_custom_N19thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3162"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:SettledThroughDebttoequitySwap
      contextRef="From2025-04-012025-06-30_custom_N20thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3163"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:SettledThroughDebttoequitySwap
      contextRef="From2025-04-012025-06-30_custom_N21stBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3164"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:BondsIssued
      contextRef="AsOf2025-06-30_custom_N12thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3167"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:BondsIssued
      contextRef="AsOf2025-06-30_custom_N13thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3168"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:BondsIssued
      contextRef="AsOf2025-06-30_custom_N18thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3170"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:BondsIssued
      contextRef="AsOf2025-06-30_custom_N19thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3171"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:BondsIssued
      contextRef="AsOf2024-03-31_custom_N17thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3181"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:BondsIssued
      contextRef="AsOf2024-03-31_custom_N18thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3182"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:ShareIssueRelatedCost
      contextRef="From2024-04-012024-06-30_custom_N12thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3185"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:ShareIssueRelatedCost
      contextRef="From2024-04-012024-06-30_custom_N13thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3186"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:ShareIssueRelatedCost
      contextRef="From2024-04-012024-06-30_custom_N14thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3187"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:ShareIssueRelatedCost
      contextRef="From2024-04-012024-06-30_custom_N15thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3188"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:EarlyRedemption
      contextRef="From2024-04-012024-06-30_custom_N12thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3193"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:EarlyRedemption
      contextRef="From2024-04-012024-06-30_custom_N13thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3194"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:EarlyRedemption
      contextRef="From2024-04-012024-06-30_custom_N15thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3196"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:EarlyRedemption
      contextRef="From2024-04-012024-06-30_custom_N18thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3198"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:SettledThroughDebttoequitySwap
      contextRef="From2024-04-012024-06-30_custom_N12thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3201"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:SettledThroughDebttoequitySwap
      contextRef="From2024-04-012024-06-30_custom_N14thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3203"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:SettledThroughDebttoequitySwap
      contextRef="From2024-04-012024-06-30_custom_N17thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3205"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:SettledThroughDebttoequitySwap
      contextRef="From2024-04-012024-06-30_custom_N18thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3206"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:BondsIssued
      contextRef="AsOf2024-06-30_custom_N14thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3211"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:BondsIssued
      contextRef="AsOf2024-06-30_custom_N17thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3213"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:DerivativeFinancialLiabilities
      contextRef="AsOf2024-12-31_custom_N19thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3231"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:DerivativeFinancialLiabilities
      contextRef="AsOf2024-12-31_custom_N20thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3232"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:DerivativeFinancialLiabilities
      contextRef="AsOf2024-12-31_custom_N21stBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3233"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:Issuance
      contextRef="From2025-01-012025-12-31_custom_N12thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3236"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:Issuance
      contextRef="From2025-01-012025-12-31_custom_N13thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3237"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:Issuance
      contextRef="From2025-01-012025-12-31_custom_N15thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3238"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:Issuance
      contextRef="From2025-01-012025-12-31_custom_N18thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3239"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:Redemption
      contextRef="From2025-01-012025-12-31_custom_N12thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3245"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:Redemption
      contextRef="From2025-01-012025-12-31_custom_N13thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3246"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:Redemption
      contextRef="From2025-01-012025-12-31_custom_N15thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3247"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:Redemption
      contextRef="From2025-01-012025-12-31_custom_N21stBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3251"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:DerecognizedUponBondSettlement
      contextRef="From2025-01-012025-12-31_custom_N18thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3266"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:DerecognizedUponBondSettlement
      contextRef="From2025-01-012025-12-31_custom_N19thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3267"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:DerecognizedUponBondSettlement
      contextRef="From2025-01-012025-12-31_custom_N20thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3268"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:DerecognizedUponBondSettlement
      contextRef="From2025-01-012025-12-31_custom_N21stBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3269"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:DerivativeFinancialLiabilities
      contextRef="AsOf2025-12-31_custom_N12thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3272"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:DerivativeFinancialLiabilities
      contextRef="AsOf2025-12-31_custom_N13thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3273"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:DerivativeFinancialLiabilities
      contextRef="AsOf2025-12-31_custom_N18thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3275"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:DerivativeFinancialLiabilities
      contextRef="AsOf2025-12-31_custom_N19thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3276"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:DerivativeFinancialLiabilities
      contextRef="AsOf2023-12-31_custom_N17thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3285"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:DerivativeFinancialLiabilities
      contextRef="AsOf2023-12-31_custom_N18thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3286"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:Issuance
      contextRef="From2024-01-012024-12-31_custom_N12thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3289"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:Issuance
      contextRef="From2024-01-012024-12-31_custom_N13thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3290"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:Issuance
      contextRef="From2024-01-012024-12-31_custom_N14thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3291"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:Issuance
      contextRef="From2024-01-012024-12-31_custom_N15thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3292"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:Redemption
      contextRef="From2024-01-012024-12-31_custom_N12thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3297"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:Redemption
      contextRef="From2024-01-012024-12-31_custom_N13thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3298"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:Redemption
      contextRef="From2024-01-012024-12-31_custom_N15thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3300"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:Redemption
      contextRef="From2024-01-012024-12-31_custom_N18thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3302"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:DerecognizedUponBondSettlement
      contextRef="From2024-01-012024-12-31_custom_N12thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3313"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:DerecognizedUponBondSettlement
      contextRef="From2024-01-012024-12-31_custom_N14thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3315"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:DerecognizedUponBondSettlement
      contextRef="From2024-01-012024-12-31_custom_N17thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3317"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:DerecognizedUponBondSettlement
      contextRef="From2024-01-012024-12-31_custom_N18thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3318"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:DerivativeFinancialLiabilities
      contextRef="AsOf2024-12-31_custom_N14thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3323"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:DerivativeFinancialLiabilities
      contextRef="AsOf2024-12-31_custom_N17thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3325"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:CouponRate
      contextRef="From2025-01-012025-12-31_custom_N11thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3350"
      unitRef="Pure"
      xsi:nil="true"/>
    <cik0002058261:CouponRate
      contextRef="From2025-01-012025-12-31_custom_N12thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3352"
      unitRef="Pure"
      xsi:nil="true"/>
    <cik0002058261:CouponRate
      contextRef="From2025-01-012025-12-31_custom_N13thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3354"
      unitRef="Pure"
      xsi:nil="true"/>
    <cik0002058261:YieldToMaturity
      contextRef="From2025-01-012025-12-31_custom_N11thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3356"
      unitRef="Pure"
      xsi:nil="true"/>
    <cik0002058261:YieldToMaturity
      contextRef="From2025-01-012025-12-31_custom_N12thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3358"
      unitRef="Pure"
      xsi:nil="true"/>
    <cik0002058261:YieldToMaturity
      contextRef="From2025-01-012025-12-31_custom_N13thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3360"
      unitRef="Pure"
      xsi:nil="true"/>
    <cik0002058261:CouponRate
      contextRef="From2025-01-012025-12-31_custom_N14thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3443"
      unitRef="Pure"
      xsi:nil="true"/>
    <cik0002058261:CouponRate
      contextRef="From2025-01-012025-12-31_custom_N15thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3445"
      unitRef="Pure"
      xsi:nil="true"/>
    <cik0002058261:CouponRate
      contextRef="From2025-01-012025-12-31_custom_N16thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3447"
      unitRef="Pure"
      xsi:nil="true"/>
    <cik0002058261:YieldToMaturity
      contextRef="From2025-01-012025-12-31_custom_N14thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3449"
      unitRef="Pure"
      xsi:nil="true"/>
    <cik0002058261:YieldToMaturity
      contextRef="From2025-01-012025-12-31_custom_N15thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3451"
      unitRef="Pure"
      xsi:nil="true"/>
    <cik0002058261:CouponRate
      contextRef="From2025-01-012025-12-31_custom_N17thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3535"
      unitRef="Pure"
      xsi:nil="true"/>
    <cik0002058261:CouponRate
      contextRef="From2025-01-012025-12-31_custom_N18thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3537"
      unitRef="Pure"
      xsi:nil="true"/>
    <cik0002058261:CouponRate
      contextRef="From2025-01-012025-12-31_custom_N19thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3539"
      unitRef="Pure"
      xsi:nil="true"/>
    <cik0002058261:YieldToMaturity
      contextRef="From2025-01-012025-12-31_custom_N17thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3541"
      unitRef="Pure"
      xsi:nil="true"/>
    <cik0002058261:YieldToMaturity
      contextRef="From2025-01-012025-12-31_custom_N18thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3543"
      unitRef="Pure"
      xsi:nil="true"/>
    <cik0002058261:YieldToMaturity
      contextRef="From2025-01-012025-12-31_custom_N19thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3545"
      unitRef="Pure"
      xsi:nil="true"/>
    <cik0002058261:CouponRate
      contextRef="From2025-01-012025-12-31_custom_N20thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3623"
      unitRef="Pure"
      xsi:nil="true"/>
    <cik0002058261:CouponRate
      contextRef="From2025-01-012025-12-31_custom_N21stDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3625"
      unitRef="Pure"
      xsi:nil="true"/>
    <cik0002058261:YieldToMaturity
      contextRef="From2025-01-012025-12-31_custom_N20thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3627"
      unitRef="Pure"
      xsi:nil="true"/>
    <cik0002058261:YieldToMaturity
      contextRef="From2025-01-012025-12-31_custom_N21stDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3629"
      unitRef="Pure"
      xsi:nil="true"/>
    <ifrs-full:FinancialAssets
      contextRef="AsOf2024-12-31_custom_CurrentPortionOfLongTermBankDepositMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3683"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:FinancialAssets
      contextRef="AsOf2025-12-31_custom_LongtermBankDepositMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3693"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:FinancialAssets
      contextRef="AsOf2025-12-31_custom_LongTermOtherReceivablesNetMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3701"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:AdjustmentsForInterestIncome
      contextRef="From2025-01-012025-12-31_ifrs-full_FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3737"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:AdjustmentsForInterestIncome
      contextRef="From2025-01-012025-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostCategoryMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3739"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:AdjustmentsForInterestIncome
      contextRef="From2025-01-012025-12-31_ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3741"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:InterestExpense
      contextRef="From2025-01-012025-12-31_ifrs-full_FinancialAssetsAtAmortisedCostCategoryMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3745"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:InterestExpense
      contextRef="From2025-01-012025-12-31_ifrs-full_FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3747"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:InterestExpense
      contextRef="From2025-01-012025-12-31_ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3751"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss
      contextRef="From2025-01-012025-12-31_ifrs-full_FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3757"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss
      contextRef="From2025-01-012025-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostCategoryMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3759"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss
      contextRef="From2025-01-012025-12-31_ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3761"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:GainOnValuation
      contextRef="From2025-01-012025-12-31_ifrs-full_FinancialAssetsAtAmortisedCostCategoryMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3765"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:GainOnValuation
      contextRef="From2025-01-012025-12-31_ifrs-full_FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3767"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:GainOnValuation
      contextRef="From2025-01-012025-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostCategoryMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3769"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:LossOnBondRedemption
      contextRef="From2025-01-012025-12-31_ifrs-full_FinancialAssetsAtAmortisedCostCategoryMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3775"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:LossOnBondRedemption
      contextRef="From2025-01-012025-12-31_ifrs-full_FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3777"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:LossOnBondRedemption
      contextRef="From2025-01-012025-12-31_ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3781"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:Total
      contextRef="From2025-01-012025-12-31_ifrs-full_FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3787"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:AdjustmentsForInterestIncome
      contextRef="From2024-01-012024-12-31_ifrs-full_FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3804"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:AdjustmentsForInterestIncome
      contextRef="From2024-01-012024-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostCategoryMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3806"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:AdjustmentsForInterestIncome
      contextRef="From2024-01-012024-12-31_ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3808"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:InterestExpense
      contextRef="From2024-01-012024-12-31_ifrs-full_FinancialAssetsAtAmortisedCostCategoryMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3812"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:InterestExpense
      contextRef="From2024-01-012024-12-31_ifrs-full_FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3814"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:InterestExpense
      contextRef="From2024-01-012024-12-31_ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3818"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss
      contextRef="From2024-01-012024-12-31_ifrs-full_FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3824"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss
      contextRef="From2024-01-012024-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostCategoryMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3826"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss
      contextRef="From2024-01-012024-12-31_ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3828"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:GainOnValuation
      contextRef="From2024-01-012024-12-31_ifrs-full_FinancialAssetsAtAmortisedCostCategoryMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3832"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:GainOnValuation
      contextRef="From2024-01-012024-12-31_ifrs-full_FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3834"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:GainOnValuation
      contextRef="From2024-01-012024-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostCategoryMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3836"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:LossOnBondRedemption
      contextRef="From2024-01-012024-12-31_ifrs-full_FinancialAssetsAtAmortisedCostCategoryMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3842"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:LossOnBondRedemption
      contextRef="From2024-01-012024-12-31_ifrs-full_FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3844"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:LossOnBondRedemption
      contextRef="From2024-01-012024-12-31_ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3848"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:Total
      contextRef="From2024-01-012024-12-31_ifrs-full_FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3854"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:ChangesNetOfTaxes
      contextRef="From2025-01-012025-12-31_custom_EmployeeShareOptionMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3939"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:NetDebtToEquityRatio
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl3996"
      unitRef="Pure"
      xsi:nil="true"/>
    <ifrs-full:NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement
      contextRef="From2025-01-012025-12-31_custom_ShareOptionPlanEquitySettledMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4081"
      unitRef="Shares"
      xsi:nil="true"/>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019
      contextRef="From2024-01-012024-12-31_custom_ShareOptionPlanEquitySettledMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4085"
      unitRef="KRWShares"
      xsi:nil="true"/>
    <ifrs-full:NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement
      contextRef="From2025-01-012025-12-31_custom_ShareOptionPlanEquitySettledMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4087"
      unitRef="Shares"
      xsi:nil="true"/>
    <ifrs-full:GainsOnDisposalsOfPropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4117"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:ReversalOfAllowanceForDoubtfulAccount
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4120"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:LossesOnDisposalOfPropertyAndEquipment
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4131"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:ImpairmentLossOnPropertyAndEquipment
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4134"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:ForeignExchangeGains
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4198"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:ForeignExchangeLosses
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4216"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:InterestIncome
      contextRef="From2025-01-012025-12-31_ifrs-full_RelatedPartiesMember_custom_WellCoreMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4246"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:InterestExpenses
      contextRef="From2025-01-012025-12-31_ifrs-full_RelatedPartiesMember_custom_DongsungDAndCMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4260"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:InterestIncome
      contextRef="From2024-01-012024-12-31_ifrs-full_RelatedPartiesMember_custom_DongsungDAndCMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4262"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:InterestExpenses
      contextRef="From2024-01-012024-12-31_ifrs-full_RelatedPartiesMember_custom_DongsungDAndCMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4264"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:InterestExpenses
      contextRef="From2025-01-012025-12-31_ifrs-full_RelatedPartiesMember_custom_CubeBioHoldingsLtdMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4272"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:InterestExpenses
      contextRef="From2024-01-012024-12-31_ifrs-full_RelatedPartiesMember_custom_CubeBioHoldingsLtdMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4276"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:InterestIncome
      contextRef="From2025-01-012025-12-31_ifrs-full_RelatedPartiesMember_custom_JaeMyungKimMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4282"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:InterestExpenses
      contextRef="From2025-01-012025-12-31_ifrs-full_RelatedPartiesMember_custom_JaeMyungKimMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4284"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:InterestIncome
      contextRef="From2024-01-012024-12-31_ifrs-full_RelatedPartiesMember_custom_JaeMyungKimMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4286"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:InterestIncome
      contextRef="From2025-01-012025-12-31_ifrs-full_RelatedPartiesMember_custom_NohBinParkNohBinParkMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4294"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:InterestIncome
      contextRef="From2024-01-012024-12-31_ifrs-full_RelatedPartiesMember_custom_NohBinParkNohBinParkMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4298"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:InterestIncome
      contextRef="From2025-01-012025-12-31_ifrs-full_RelatedPartiesMember_custom_HoSungHanMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4306"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:InterestIncome
      contextRef="From2024-01-012024-12-31_ifrs-full_RelatedPartiesMember_custom_HoSungHanMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4310"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:InterestExpenses
      contextRef="From2025-01-012025-12-31_ifrs-full_RelatedPartiesMember_custom_EunJongChoiMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4320"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:InterestExpenses
      contextRef="From2024-01-012024-12-31_ifrs-full_RelatedPartiesMember_custom_EunJongChoiMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4324"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:InterestIncome
      contextRef="From2025-01-012025-12-31_ifrs-full_RelatedPartiesMember_custom_SeYoonKimMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4330"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:InterestExpenses
      contextRef="From2025-01-012025-12-31_ifrs-full_RelatedPartiesMember_custom_SeYoonKimMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4332"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:InterestIncome
      contextRef="From2024-01-012024-12-31_ifrs-full_RelatedPartiesMember_custom_SeYoonKimMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4334"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:InterestIncome
      contextRef="From2025-01-012025-12-31_ifrs-full_RelatedPartiesMember_custom_GyungHaYuMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4342"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:InterestIncome
      contextRef="From2024-01-012024-12-31_ifrs-full_RelatedPartiesMember_custom_GyungHaYuMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4346"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:InterestIncome
      contextRef="From2025-01-012025-12-31_ifrs-full_RelatedPartiesMember_custom_JungGonKimMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4354"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:InterestExpenses
      contextRef="From2025-01-012025-12-31_ifrs-full_RelatedPartiesMember_custom_JungGonKimMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4356"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:InterestIncome
      contextRef="From2024-01-012024-12-31_ifrs-full_RelatedPartiesMember_custom_JungGonKimMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4358"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:TradeAndOtherPayables
      contextRef="AsOf2025-12-31_ifrs-full_RelatedPartiesMember_custom_DongsungDAndCMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4374"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:TradeAndOtherPayables
      contextRef="AsOf2024-12-31_ifrs-full_RelatedPartiesMember_custom_DongsungDAndCMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4378"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:OtherReceivable
      contextRef="AsOf2024-12-31_ifrs-full_RelatedPartiesMember_custom_DongsungDAndCMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4380"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:TradeAndOtherPayables
      contextRef="AsOf2025-12-31_ifrs-full_RelatedPartiesMember_custom_CubeBioHoldingsLtdMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4382"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:TradeAndOtherPayables
      contextRef="AsOf2024-12-31_ifrs-full_RelatedPartiesMember_custom_CubeBioHoldingsLtdMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4386"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:TradeAndOtherPayables
      contextRef="AsOf2024-12-31_ifrs-full_RelatedPartiesMember_custom_EunJongChoiMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4394"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:TradeAndOtherPayables
      contextRef="AsOf2025-12-31_ifrs-full_RelatedPartiesMember_custom_NohBinParkMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4398"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:OtherReceivable
      contextRef="AsOf2025-12-31_ifrs-full_RelatedPartiesMember_custom_NohBinParkMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4400"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:OtherReceivable
      contextRef="AsOf2024-12-31_ifrs-full_RelatedPartiesMember_custom_NohBinParkMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4404"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:TradeAndOtherPayables
      contextRef="AsOf2025-12-31_ifrs-full_RelatedPartiesMember_custom_HoSungHanMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4406"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:OtherReceivable
      contextRef="AsOf2025-12-31_ifrs-full_RelatedPartiesMember_custom_HoSungHanMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4408"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:OtherReceivable
      contextRef="AsOf2024-12-31_ifrs-full_RelatedPartiesMember_custom_HoSungHanMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4412"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:OtherReceivable
      contextRef="AsOf2025-12-31_ifrs-full_RelatedPartiesMember_custom_JungGonKimMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4416"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:TradeAndOtherPayables
      contextRef="AsOf2024-12-31_ifrs-full_RelatedPartiesMember_custom_JungGonKimMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4418"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:OtherReceivable
      contextRef="AsOf2024-12-31_ifrs-full_RelatedPartiesMember_custom_JungGonKimMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4420"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:TradeAndOtherPayables
      contextRef="AsOf2025-12-31_ifrs-full_RelatedPartiesMember_custom_GyungHaYuMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4422"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:OtherReceivable
      contextRef="AsOf2025-12-31_ifrs-full_RelatedPartiesMember_custom_GyungHaYuMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4424"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:OtherReceivable
      contextRef="AsOf2024-12-31_ifrs-full_RelatedPartiesMember_custom_GyungHaYuMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4428"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:RelatedPartyBalances
      contextRef="AsOf2024-12-31_ifrs-full_RelatedPartiesMember_custom_WellCoreMember_custom_BorrowingMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4448"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:RelatedPartyBalances
      contextRef="AsOf2025-12-31_ifrs-full_RelatedPartiesMember_custom_WellCoreMember_custom_BorrowingMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4454"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:RelatedPartyBalances
      contextRef="AsOf2024-12-31_ifrs-full_RelatedPartiesMember_custom_DongsungDAndCMember_custom_ShortTermLoanReceivableMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4456"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:Decrease
      contextRef="From2025-01-012025-12-31_ifrs-full_RelatedPartiesMember_custom_DongsungDAndCMember_custom_ShortTermLoanReceivableMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4460"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:RelatedPartyBalances
      contextRef="AsOf2024-12-31_ifrs-full_RelatedPartiesMember_custom_DongsungDAndCMember_custom_ShortTermLoanReceivablesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4464"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:Decrease
      contextRef="From2025-01-012025-12-31_ifrs-full_RelatedPartiesMember_custom_DongsungDAndCMember_custom_ShortTermLoanReceivablesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4468"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:Increase
      contextRef="From2025-01-012025-12-31_ifrs-full_RelatedPartiesMember_custom_EunJongChoiMember_custom_ShortTermLoanReceivableMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4474"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:Decrease
      contextRef="From2025-01-012025-12-31_ifrs-full_RelatedPartiesMember_custom_EunJongChoiMember_custom_ShortTermLoanReceivableMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4476"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:Decrease
      contextRef="From2025-01-012025-12-31_ifrs-full_RelatedPartiesMember_custom_EunJongChoiMember_custom_ShortTermLoanReceivablesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4484"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:Increase
      contextRef="From2025-01-012025-12-31_ifrs-full_RelatedPartiesMember_custom_CubeBioHoldingsLtdMember_custom_ShortTermLoanReceivableMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4490"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:Decrease
      contextRef="From2025-01-012025-12-31_ifrs-full_RelatedPartiesMember_custom_CubeBioHoldingsLtdMember_custom_ShortTermLoanReceivablesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4500"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:Increase
      contextRef="From2025-01-012025-12-31_ifrs-full_RelatedPartiesMember_custom_NohBinParkMember_custom_BondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4506"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:RelatedPartyBalances
      contextRef="AsOf2025-12-31_ifrs-full_RelatedPartiesMember_custom_NohBinParkMember_custom_BondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4510"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:Increase
      contextRef="From2025-01-012025-12-31_ifrs-full_RelatedPartiesMember_custom_HoSungHanMember_custom_BondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4514"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:RelatedPartyBalances
      contextRef="AsOf2025-12-31_ifrs-full_RelatedPartiesMember_custom_HoSungHanMember_custom_BondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4518"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:RelatedPartyBalances
      contextRef="AsOf2024-12-31_ifrs-full_RelatedPartiesMember_custom_JungGonKimMember_custom_OtherPayablesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4520"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:Decrease
      contextRef="From2025-01-012025-12-31_ifrs-full_RelatedPartiesMember_custom_JungGonKimMember_custom_OtherPayablesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4524"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:Increase
      contextRef="From2025-01-012025-12-31_ifrs-full_RelatedPartiesMember_custom_GyungHaYuMember_custom_BondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4530"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:RelatedPartyBalances
      contextRef="AsOf2025-12-31_ifrs-full_RelatedPartiesMember_custom_GyungHaYuMember_custom_BondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4534"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:Increase
      contextRef="From2024-01-012024-12-31_ifrs-full_RelatedPartiesMember_custom_WellCoreMember_custom_ShortTermLoanReceivableMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4554"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:RelatedPartyBalances
      contextRef="AsOf2024-12-31_ifrs-full_RelatedPartiesMember_custom_WellCoreMember_custom_ShortTermLoanReceivableMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4558"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:RelatedPartyBalances
      contextRef="AsOf2023-12-31_ifrs-full_RelatedPartiesMember_custom_WellCoreMember_ifrs-full_ShorttermBorrowingsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4560"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:RelatedPartyBalances
      contextRef="AsOf2024-12-31_ifrs-full_RelatedPartiesMember_custom_WellCoreMember_ifrs-full_ShorttermBorrowingsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4566"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:Increase
      contextRef="From2024-01-012024-12-31_ifrs-full_RelatedPartiesMember_custom_EunJongChoiMember_custom_ShortTermLoanReceivableMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4570"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:Decrease
      contextRef="From2024-01-012024-12-31_ifrs-full_RelatedPartiesMember_custom_EunJongChoiMember_custom_ShortTermLoanReceivablesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4580"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:RelatedPartyBalances
      contextRef="AsOf2023-12-31_ifrs-full_RelatedPartiesMember_custom_CubeBioHoldingsLtdMember_custom_ShortTermLoanReceivableMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4584"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:Decrease
      contextRef="From2024-01-012024-12-31_ifrs-full_RelatedPartiesMember_custom_CubeBioHoldingsLtdMember_custom_ShortTermLoanReceivableMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4588"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:RelatedPartyBalances
      contextRef="AsOf2023-12-31_ifrs-full_RelatedPartiesMember_custom_CubeBioHoldingsLtdMember_custom_ShortTermLoanReceivablesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4592"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:Decrease
      contextRef="From2024-01-012024-12-31_ifrs-full_RelatedPartiesMember_custom_CubeBioHoldingsLtdMember_custom_ShortTermLoanReceivablesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4596"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:Increase
      contextRef="From2024-01-012024-12-31_ifrs-full_RelatedPartiesMember_custom_JaeMyungKimMember_custom_BondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4602"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:RelatedPartyBalances
      contextRef="AsOf2024-12-31_ifrs-full_RelatedPartiesMember_custom_JaeMyungKimMember_custom_BondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4606"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:Increase
      contextRef="From2024-01-012024-12-31_ifrs-full_RelatedPartiesMember_custom_NohBinParkMember_custom_BondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4610"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:Decrease
      contextRef="From2024-01-012024-12-31_ifrs-full_RelatedPartiesMember_custom_NohBinParkMember_custom_BondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4612"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:Increase
      contextRef="From2024-01-012024-12-31_ifrs-full_RelatedPartiesMember_custom_HoSungHanMember_custom_BondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4618"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:Decrease
      contextRef="From2024-01-012024-12-31_ifrs-full_RelatedPartiesMember_custom_HoSungHanMember_custom_BondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4620"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:Increase
      contextRef="From2024-01-012024-12-31_ifrs-full_RelatedPartiesMember_custom_SeYoonKimMember_custom_BondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4626"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:RelatedPartyBalances
      contextRef="AsOf2024-12-31_ifrs-full_RelatedPartiesMember_custom_SeYoonKimMember_custom_BondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4630"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:Increase
      contextRef="From2024-01-012024-12-31_ifrs-full_RelatedPartiesMember_custom_GyungHaYuMember_custom_BondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4634"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:Decrease
      contextRef="From2024-01-012024-12-31_ifrs-full_RelatedPartiesMember_custom_GyungHaYuMember_custom_BondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4636"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:Increase
      contextRef="From2024-01-012024-12-31_ifrs-full_RelatedPartiesMember_custom_JungGonKimMember_custom_BondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4642"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:RelatedPartyBalances
      contextRef="AsOf2024-12-31_ifrs-full_RelatedPartiesMember_custom_JungGonKimMember_custom_BondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4646"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:Borrowings
      contextRef="AsOf2023-12-31_custom_NonCurrentBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4687"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:ProceedsFromIssuanceOfBondWithWarrants
      contextRef="From2024-01-012024-12-31_custom_NonCurrentBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4697"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:ProceedsFromIssuanceOfBondWithWarrants
      contextRef="From2024-01-012024-12-31_custom_CurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4699"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:ProceedsFromIssuanceOfBondWithWarrants
      contextRef="From2024-01-012024-12-31_custom_NonCurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4701"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:RepaymentOfBondWithWarrants
      contextRef="From2024-01-012024-12-31_custom_NonCurrentBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4707"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:RepaymentOfBondWithWarrants
      contextRef="From2024-01-012024-12-31_custom_CurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4709"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:RepaymentOfBondWithWarrants
      contextRef="From2024-01-012024-12-31_custom_NonCurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4711"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:PaymentOfLeaseLiabilityPrincipal
      contextRef="From2024-01-012024-12-31_custom_CurrentBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4715"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:PaymentOfLeaseLiabilityPrincipal
      contextRef="From2024-01-012024-12-31_custom_NonCurrentBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4717"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:PaymentOfLeaseLiabilityPrincipal
      contextRef="From2024-01-012024-12-31_custom_NonCurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4721"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities
      contextRef="From2024-01-012024-12-31_custom_NonCurrentBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4727"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities
      contextRef="From2024-01-012024-12-31_custom_NonCurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4731"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:WarrantsSettledThroughDebtToEquitySwap
      contextRef="From2024-01-012024-12-31_custom_NonCurrentBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4737"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:WarrantsSettledThroughDebtToEquitySwap
      contextRef="From2024-01-012024-12-31_custom_CurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4739"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:WarrantsSettledThroughDebtToEquitySwap
      contextRef="From2024-01-012024-12-31_custom_NonCurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4741"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:OtherNoncashTransactions
      contextRef="From2024-01-012024-12-31_custom_NonCurrentBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4747"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:OtherNoncashTransactions
      contextRef="From2024-01-012024-12-31_custom_CurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4749"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:OtherNoncashTransactions
      contextRef="From2024-01-012024-12-31_custom_NonCurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4751"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:LeaseReassessment
      contextRef="From2024-01-012024-12-31_custom_CurrentBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4755"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:LeaseReassessment
      contextRef="From2024-01-012024-12-31_custom_NonCurrentBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4757"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:LeaseReassessment
      contextRef="From2024-01-012024-12-31_custom_CurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4759"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:OtherInterestExpense
      contextRef="From2024-01-012024-12-31_custom_NonCurrentBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4767"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:OtherInterestExpense
      contextRef="From2024-01-012024-12-31_custom_NonCurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4771"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:InterestPaidClassifiedAsFinancingActivities
      contextRef="From2024-01-012024-12-31_custom_CurrentBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4775"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:InterestPaidClassifiedAsFinancingActivities
      contextRef="From2024-01-012024-12-31_custom_NonCurrentBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4777"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:InterestPaidClassifiedAsFinancingActivities
      contextRef="From2024-01-012024-12-31_custom_NonCurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4781"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:Reclassification
      contextRef="From2024-01-012024-12-31_custom_CurrentBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4785"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:Reclassification
      contextRef="From2024-01-012024-12-31_custom_NonCurrentBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4787"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:Reclassification
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4793"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:TotalOtherChanges
      contextRef="From2024-01-012024-12-31_custom_NonCurrentBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4797"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:Borrowings
      contextRef="AsOf2024-12-31_custom_NonCurrentBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4807"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:ProceedsFromIssuanceOfBondWithWarrants
      contextRef="From2025-01-012025-12-31_custom_NonCurrentBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4817"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:ProceedsFromIssuanceOfBondWithWarrants
      contextRef="From2025-01-012025-12-31_custom_CurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4819"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:ProceedsFromIssuanceOfBondWithWarrants
      contextRef="From2025-01-012025-12-31_custom_NonCurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4821"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:RepaymentOfBondWithWarrants
      contextRef="From2025-01-012025-12-31_custom_NonCurrentBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4827"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:RepaymentOfBondWithWarrants
      contextRef="From2025-01-012025-12-31_custom_CurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4829"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:RepaymentOfBondWithWarrants
      contextRef="From2025-01-012025-12-31_custom_NonCurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4831"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:PaymentOfLeaseLiabilityPrincipal
      contextRef="From2025-01-012025-12-31_custom_CurrentBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4835"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:PaymentOfLeaseLiabilityPrincipal
      contextRef="From2025-01-012025-12-31_custom_NonCurrentBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4837"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:PaymentOfLeaseLiabilityPrincipal
      contextRef="From2025-01-012025-12-31_custom_NonCurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4841"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities
      contextRef="From2025-01-012025-12-31_custom_NonCurrentBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4847"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities
      contextRef="From2025-01-012025-12-31_custom_NonCurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4851"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:WarrantsSettledThroughDebtToEquitySwap
      contextRef="From2025-01-012025-12-31_custom_NonCurrentBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4857"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:WarrantsSettledThroughDebtToEquitySwap
      contextRef="From2025-01-012025-12-31_custom_CurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4859"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:WarrantsSettledThroughDebtToEquitySwap
      contextRef="From2025-01-012025-12-31_custom_NonCurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4861"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:OtherNoncashTransactions
      contextRef="From2025-01-012025-12-31_custom_NonCurrentBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4867"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:OtherNoncashTransactions
      contextRef="From2025-01-012025-12-31_custom_CurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4869"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:OtherNoncashTransactions
      contextRef="From2025-01-012025-12-31_custom_NonCurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4871"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:LeaseReassessment
      contextRef="From2025-01-012025-12-31_custom_CurrentBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4875"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:LeaseReassessment
      contextRef="From2025-01-012025-12-31_custom_NonCurrentBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4877"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:LeaseReassessment
      contextRef="From2025-01-012025-12-31_custom_CurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4879"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:OtherInterestExpense
      contextRef="From2025-01-012025-12-31_custom_NonCurrentBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4887"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:OtherInterestExpense
      contextRef="From2025-01-012025-12-31_custom_NonCurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4891"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:InterestPaidClassifiedAsFinancingActivities
      contextRef="From2025-01-012025-12-31_custom_CurrentBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4895"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:InterestPaidClassifiedAsFinancingActivities
      contextRef="From2025-01-012025-12-31_custom_NonCurrentBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4897"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:InterestPaidClassifiedAsFinancingActivities
      contextRef="From2025-01-012025-12-31_custom_NonCurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4901"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:Reclassification
      contextRef="From2025-01-012025-12-31_custom_CurrentBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4905"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:Reclassification
      contextRef="From2025-01-012025-12-31_custom_NonCurrentBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4907"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:Reclassification
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4913"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:TotalOtherChanges
      contextRef="From2025-01-012025-12-31_custom_NonCurrentBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4917"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:Borrowings
      contextRef="AsOf2025-12-31_custom_NonCurrentBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4927"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:BorrowingsAmount
      contextRef="AsOf2025-12-31_custom_FinancialInstitutionsMember_custom_KYOBOSecuritiesCoLtdMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4952"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:BorrowingsAmount
      contextRef="AsOf2024-12-31_custom_FinancialInstitutionsMember_custom_KYOBOSecuritiesCoLtdMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl4965"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:CurrentPortionOfLongtermBankDeposit
      contextRef="AsOf2026-06-30_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl5041"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:LongtermBankDeposit
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl5057"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:LongtermOtherReceivablesNet
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl5075"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:BondWithWarrantsRelatedPartiesNet
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl5099"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:Revenue
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl5158"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:Revenue
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl5159"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:TotalRevenues
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl5161"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:TotalRevenues
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl5162"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:CostOfSales
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl5164"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:CostOfSales
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl5165"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:GrossProfit
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl5167"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:GrossProfit
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl5168"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl5203"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl5204"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:EquityAttributableToOwnersOfParent
      contextRef="AsOf2024-12-31_custom_ShareSubscriptionReceivableMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl5226"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:ProfitLossFromContinuingOperation
      contextRef="From2025-01-012025-06-30_custom_ShareCapitalMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl5240"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:ProfitLossFromContinuingOperation
      contextRef="From2025-01-012025-06-30_ifrs-full_SharePremiumMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl5241"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:ProfitLossFromContinuingOperation
      contextRef="From2025-01-012025-06-30_custom_ShareSubscriptionReceivableMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl5242"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:ProfitLossFromContinuingOperation
      contextRef="From2025-01-012025-06-30_ifrs-full_OtherReservesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl5243"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:ProfitLossFromContinuingOperation
      contextRef="From2025-01-012025-06-30_ifrs-full_AccumulatedOtherComprehensiveIncomeMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl5244"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:RemeasurementOfDefinedBenefitLiabilitie
      contextRef="From2025-01-012025-06-30_custom_ShareCapitalMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl5248"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:RemeasurementOfDefinedBenefitLiabilitie
      contextRef="From2025-01-012025-06-30_ifrs-full_SharePremiumMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl5249"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:RemeasurementOfDefinedBenefitLiabilitie
      contextRef="From2025-01-012025-06-30_custom_ShareSubscriptionReceivableMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl5250"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:RemeasurementOfDefinedBenefitLiabilitie
      contextRef="From2025-01-012025-06-30_ifrs-full_OtherReservesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl5251"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:RemeasurementOfDefinedBenefitLiabilitie
      contextRef="From2025-01-012025-06-30_ifrs-full_RetainedEarningsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl5253"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2025-01-012025-06-30_custom_ShareCapitalMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl5256"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2025-01-012025-06-30_ifrs-full_SharePremiumMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl5257"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2025-01-012025-06-30_custom_ShareSubscriptionReceivableMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl5258"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2025-01-012025-06-30_ifrs-full_OtherReservesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl5259"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:IssuanceOfBondWithWarrants
      contextRef="From2025-01-012025-06-30_custom_ShareCapitalMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl5272"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:IssuanceOfBondWithWarrants
      contextRef="From2025-01-012025-06-30_custom_ShareSubscriptionReceivableMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl5274"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:IssuanceOfBondWithWarrants
      contextRef="From2025-01-012025-06-30_ifrs-full_OtherReservesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl5275"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:IssuanceOfBondWithWarrants
      contextRef="From2025-01-012025-06-30_ifrs-full_AccumulatedOtherComprehensiveIncomeMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl5276"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:IssuanceOfBondWithWarrants
      contextRef="From2025-01-012025-06-30_ifrs-full_RetainedEarningsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl5277"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:DisposalOfTreasuryShares
      contextRef="From2025-01-012025-06-30_custom_ShareCapitalMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl5280"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:DisposalOfTreasuryShares
      contextRef="From2025-01-012025-06-30_ifrs-full_AccumulatedOtherComprehensiveIncomeMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl5284"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:DisposalOfTreasuryShares
      contextRef="From2025-01-012025-06-30_ifrs-full_RetainedEarningsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl5285"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:ProfitLossFromContinuingOperation
      contextRef="From2026-01-012026-06-30_custom_ShareCapitalMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl5312"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:ProfitLossFromContinuingOperation
      contextRef="From2026-01-012026-06-30_ifrs-full_SharePremiumMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl5313"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:ProfitLossFromContinuingOperation
      contextRef="From2026-01-012026-06-30_custom_ShareSubscriptionReceivableMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl5314"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:ProfitLossFromContinuingOperation
      contextRef="From2026-01-012026-06-30_ifrs-full_OtherReservesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl5315"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:ProfitLossFromContinuingOperation
      contextRef="From2026-01-012026-06-30_ifrs-full_AccumulatedOtherComprehensiveIncomeMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl5316"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:RemeasurementOfDefinedBenefitLiabilitie
      contextRef="From2026-01-012026-06-30_custom_ShareCapitalMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl5320"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:RemeasurementOfDefinedBenefitLiabilitie
      contextRef="From2026-01-012026-06-30_ifrs-full_SharePremiumMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl5321"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:RemeasurementOfDefinedBenefitLiabilitie
      contextRef="From2026-01-012026-06-30_custom_ShareSubscriptionReceivableMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl5322"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:RemeasurementOfDefinedBenefitLiabilitie
      contextRef="From2026-01-012026-06-30_ifrs-full_OtherReservesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl5323"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:RemeasurementOfDefinedBenefitLiabilitie
      contextRef="From2026-01-012026-06-30_ifrs-full_RetainedEarningsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl5325"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2026-01-012026-06-30_custom_ShareCapitalMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl5328"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2026-01-012026-06-30_ifrs-full_SharePremiumMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl5329"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2026-01-012026-06-30_custom_ShareSubscriptionReceivableMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl5330"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2026-01-012026-06-30_ifrs-full_OtherReservesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl5331"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:DisposalOfTreasuryShares
      contextRef="From2026-01-012026-06-30_custom_ShareCapitalMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl5344"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:DisposalOfTreasuryShares
      contextRef="From2026-01-012026-06-30_custom_ShareSubscriptionReceivableMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl5346"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:DisposalOfTreasuryShares
      contextRef="From2026-01-012026-06-30_ifrs-full_AccumulatedOtherComprehensiveIncomeMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl5348"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:DisposalOfTreasuryShares
      contextRef="From2026-01-012026-06-30_ifrs-full_RetainedEarningsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl5349"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:LoansAdvanceToRelatedParty
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl5385"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:LoanRepaymentsReceived
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl5388"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:ProceedFromDisposalOfPropertyPlantAndEquipment
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl5391"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl5393"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:ProceedsFromIssuanceOfBondWithWarrants
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl5405"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:ProceedsFromTreasuryStocksDisposedWithRefundObligation
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl5421"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:SegmentRevenue
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl5520"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:SegmentRevenue
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl5521"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:FaceValue
      contextRef="From2025-01-012025-06-30_custom_CubeBioHoldingsLtd1Member_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl5600"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:CarryingAmount
      contextRef="From2025-01-012025-06-30_custom_CubeBioHoldingsLtd1Member_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl5602"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:FaceValue
      contextRef="From2025-01-012025-06-30_custom_DongsungDAndC1Member_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl5624"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:CarryingAmount
      contextRef="From2025-01-012025-06-30_custom_DongsungDAndC1Member_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl5626"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:ShortTermLoanReceivable
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl5669"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:WriteoffOfAllowanceForDoubtfulAccounts
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl5671"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:ReclassificationOfLongtermToShortterm
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl5673"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:ShortTermLoanReceivable
      contextRef="AsOf2026-06-30_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl5675"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:OtherBadDebtExpenses
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl5679"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:DerivativeFinancialLiabilities
      contextRef="AsOf2026-06-30_custom_FairValueMember_custom_FinancialLiabilityMember_ifrs-full_Level1OfFairValueHierarchyMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl5699"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:DerivativeFinancialLiabilities
      contextRef="AsOf2026-06-30_custom_FairValueMember_custom_FinancialLiabilityMember_ifrs-full_Level2OfFairValueHierarchyMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl5701"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:DerivativeFinancialLiabilities
      contextRef="AsOf2025-12-31_custom_FairValueMember_custom_FinancialAssetsMember_ifrs-full_Level1OfFairValueHierarchyMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl5719"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:DerivativeFinancialLiabilities
      contextRef="AsOf2025-12-31_custom_FairValueMember_custom_FinancialAssetsMember_ifrs-full_Level2OfFairValueHierarchyMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl5721"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:FavorableChanges
      contextRef="AsOf2026-06-30_custom_EarlyRedemptionRightsMember_custom_OtherComprehensiveIncomeOrLossMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl5751"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:UnfavorableChanges
      contextRef="AsOf2026-06-30_custom_EarlyRedemptionRightsMember_custom_OtherComprehensiveIncomeOrLossMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl5753"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:FavorableChanges
      contextRef="AsOf2025-12-31_custom_EarlyRedemptionRightsMember_custom_OtherComprehensiveIncomeOrLossMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl5767"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:UnfavorableChanges
      contextRef="AsOf2025-12-31_custom_EarlyRedemptionRightsMember_custom_OtherComprehensiveIncomeOrLossMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl5769"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2026-06-30_ifrs-full_AccumulatedImpairmentMember_custom_MachineryAndEquipmentsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl5779"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2026-06-30_ifrs-full_AccumulatedImpairmentMember_ifrs-full_MotorVehiclesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl5786"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2026-06-30_ifrs-full_AccumulatedImpairmentMember_custom_OfficeAndOtherEquipmentMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl5793"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2026-06-30_ifrs-full_AccumulatedImpairmentMember_custom_FurnitureAndFixtureMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl5800"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2026-06-30_ifrs-full_AccumulatedImpairmentMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl5808"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2025-12-31_ifrs-full_AccumulatedImpairmentMember_custom_MachineryAndEquipmentsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl5815"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2025-12-31_ifrs-full_AccumulatedImpairmentMember_ifrs-full_MotorVehiclesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl5822"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2025-12-31_ifrs-full_AccumulatedImpairmentMember_custom_OfficeAndOtherEquipmentMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl5829"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2025-12-31_ifrs-full_AccumulatedImpairmentMember_custom_FurnitureAndFixtureMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl5836"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2025-12-31_ifrs-full_AccumulatedImpairmentMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl5843"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:DepreciationInvestmentProperty
      contextRef="From2026-01-012026-06-30_custom_FurnitureAndFixtureMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl5872"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:Disposals
      contextRef="From2026-01-012026-06-30_ifrs-full_VehiclesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl5878"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:Disposals
      contextRef="From2026-01-012026-06-30_custom_OfficeAndOtherEquipmentMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl5880"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:Disposals
      contextRef="From2026-01-012026-06-30_custom_FurnitureAndFixtureMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl5882"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:AcquisitionsCost
      contextRef="From2025-01-012025-06-30_ifrs-full_VehiclesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl5908"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:AcquisitionsCost
      contextRef="From2025-01-012025-06-30_custom_OfficeAndOtherEquipmentMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl5910"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:AcquisitionsCost
      contextRef="From2025-01-012025-06-30_custom_FurnitureAndFixtureMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl5912"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:DepreciationInvestmentProperty
      contextRef="From2025-01-012025-06-30_custom_FurnitureAndFixtureMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl5922"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:LeaseReassessments
      contextRef="From2026-01-012026-06-30_ifrs-full_VehiclesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl6013"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:Acquisitions
      contextRef="From2025-01-012025-06-30_ifrs-full_BuildingsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl6035"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:Acquisitions
      contextRef="From2025-01-012025-06-30_ifrs-full_VehiclesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl6037"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:Acquisitions
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl6039"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:LeaseReassessments
      contextRef="From2025-01-012025-06-30_ifrs-full_VehiclesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl6043"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:NewLeases
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl6064"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:ExpenseRelatingToShorttermLeases
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl6080"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:CashOutflowsForPaymentsForShorttermLease
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl6094"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="From2026-01-012026-06-30_ifrs-full_ComputerSoftwareMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl6121"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="From2026-01-012026-06-30_custom_PatentMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl6123"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="From2026-01-012026-06-30_custom_BrandMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl6125"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl6127"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="From2025-01-012025-06-30_ifrs-full_ComputerSoftwareMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl6153"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="From2025-01-012025-06-30_custom_PatentMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl6155"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="From2025-01-012025-06-30_custom_BrandMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl6157"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl6159"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2025-01-012025-06-30_custom_BrandMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl6165"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:DefinedBenefitObligation
      contextRef="AsOf2025-12-31_custom_FairValueOfPlanAssetsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl6329"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:CurrentServiceCostDefinedBenefitPlans
      contextRef="From2026-01-012026-06-30_custom_FairValueOfPlanAssetsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl6337"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:InterestExpenseDefinedBenefitPlans
      contextRef="From2026-01-012026-06-30_custom_FairValueOfPlanAssetsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl6341"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:IncludedInProfitOrLoss
      contextRef="From2026-01-012026-06-30_custom_FairValueOfPlanAssetsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl6345"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:DemographicAssumption
      contextRef="From2026-01-012026-06-30_custom_DefinedBenefitObligationMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl6356"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:DemographicAssumption
      contextRef="From2026-01-012026-06-30_custom_FairValueOfPlanAssetsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl6357"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:DemographicAssumption
      contextRef="From2026-01-012026-06-30_custom_NetDefinedBenefitLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl6358"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:FinancialAssumption
      contextRef="From2026-01-012026-06-30_custom_FairValueOfPlanAssetsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl6361"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:AdjustmentBasedOnExperience
      contextRef="From2026-01-012026-06-30_custom_FairValueOfPlanAssetsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl6365"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset
      contextRef="From2026-01-012026-06-30_custom_FairValueOfPlanAssetsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl6369"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:InterimSettlement
      contextRef="From2026-01-012026-06-30_custom_DefinedBenefitObligationMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl6376"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:InterimSettlement
      contextRef="From2026-01-012026-06-30_custom_FairValueOfPlanAssetsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl6377"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:InterimSettlement
      contextRef="From2026-01-012026-06-30_custom_NetDefinedBenefitLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl6378"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:BenefitsPaidOrPayable
      contextRef="From2026-01-012026-06-30_custom_FairValueOfPlanAssetsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl6381"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:OtherSubtotal
      contextRef="From2026-01-012026-06-30_custom_FairValueOfPlanAssetsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl6385"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:DefinedBenefitObligation
      contextRef="AsOf2026-06-30_custom_FairValueOfPlanAssetsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl6389"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:ShorttermBorrowings
      contextRef="AsOf2025-12-31_custom_WellCoreMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl6402"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:ShorttermBorrowings
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl6406"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:BondsIssued
      contextRef="AsOf2026-06-30_custom_N20thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl6424"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:ShareIssueRelatedCost
      contextRef="From2026-01-012026-06-30_custom_N15thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl6448"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:ShareIssueRelatedCost
      contextRef="From2026-01-012026-06-30_custom_N20thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl6450"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:ShareIssueRelatedCost
      contextRef="From2026-01-012026-06-30_custom_N21stDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl6452"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:ShareIssueRelatedCost
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl6454"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:EarlyRedemption
      contextRef="From2026-01-012026-06-30_custom_N15thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl6456"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:EarlyRedemption
      contextRef="From2026-01-012026-06-30_custom_N21stDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl6460"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:BondsIssued
      contextRef="AsOf2026-06-30_custom_N20thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl6466"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:Issuance
      contextRef="From2026-01-012026-06-30_custom_N15thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl6482"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:Issuance
      contextRef="From2026-01-012026-06-30_custom_N20thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl6484"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:Issuance
      contextRef="From2026-01-012026-06-30_custom_N21stBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl6486"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:Issuance
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl6488"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:Redemption
      contextRef="From2026-01-012026-06-30_custom_N15thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl6490"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:Redemption
      contextRef="From2026-01-012026-06-30_custom_N21stBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl6494"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:LossesGainsOnValuationOfDerivatives
      contextRef="From2026-01-012026-06-30_custom_N20thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl6500"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:DerivativeFinancialLiabilities
      contextRef="AsOf2026-06-30_custom_N15thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl6506"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:DerivativeFinancialLiabilities
      contextRef="AsOf2026-06-30_custom_N20thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl6508"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:CouponRate
      contextRef="From2026-01-012026-06-30_custom_N11thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl6535"
      unitRef="Pure"
      xsi:nil="true"/>
    <cik0002058261:CouponRate
      contextRef="From2026-01-012026-06-30_custom_N12thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl6537"
      unitRef="Pure"
      xsi:nil="true"/>
    <cik0002058261:CouponRate
      contextRef="From2026-01-012026-06-30_custom_N13thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl6539"
      unitRef="Pure"
      xsi:nil="true"/>
    <cik0002058261:YieldToMaturity
      contextRef="From2026-01-012026-06-30_custom_N11thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl6541"
      unitRef="Pure"
      xsi:nil="true"/>
    <cik0002058261:YieldToMaturity
      contextRef="From2026-01-012026-06-30_custom_N12thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl6543"
      unitRef="Pure"
      xsi:nil="true"/>
    <cik0002058261:YieldToMaturity
      contextRef="From2026-01-012026-06-30_custom_N13thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl6545"
      unitRef="Pure"
      xsi:nil="true"/>
    <cik0002058261:CouponRate
      contextRef="From2026-01-012026-06-30_custom_N14thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl6628"
      unitRef="Pure"
      xsi:nil="true"/>
    <cik0002058261:CouponRate
      contextRef="From2026-01-012026-06-30_custom_N15thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl6630"
      unitRef="Pure"
      xsi:nil="true"/>
    <cik0002058261:CouponRate
      contextRef="From2026-01-012026-06-30_custom_N16thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl6632"
      unitRef="Pure"
      xsi:nil="true"/>
    <cik0002058261:YieldToMaturity
      contextRef="From2026-01-012026-06-30_custom_N14thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl6634"
      unitRef="Pure"
      xsi:nil="true"/>
    <cik0002058261:YieldToMaturity
      contextRef="From2026-01-012026-06-30_custom_N15thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl6636"
      unitRef="Pure"
      xsi:nil="true"/>
    <cik0002058261:CouponRate
      contextRef="From2026-01-012026-06-30_custom_N17thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl6713"
      unitRef="Pure"
      xsi:nil="true"/>
    <cik0002058261:CouponRate
      contextRef="From2026-01-012026-06-30_custom_N18thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl6715"
      unitRef="Pure"
      xsi:nil="true"/>
    <cik0002058261:CouponRate
      contextRef="From2026-01-012026-06-30_custom_N19thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl6717"
      unitRef="Pure"
      xsi:nil="true"/>
    <cik0002058261:YieldToMaturity
      contextRef="From2026-01-012026-06-30_custom_N17thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl6719"
      unitRef="Pure"
      xsi:nil="true"/>
    <cik0002058261:YieldToMaturity
      contextRef="From2026-01-012026-06-30_custom_N18thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl6721"
      unitRef="Pure"
      xsi:nil="true"/>
    <cik0002058261:YieldToMaturity
      contextRef="From2026-01-012026-06-30_custom_N19thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl6723"
      unitRef="Pure"
      xsi:nil="true"/>
    <cik0002058261:CouponRate
      contextRef="From2026-01-012026-06-30_custom_N20thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl6801"
      unitRef="Pure"
      xsi:nil="true"/>
    <cik0002058261:CouponRate
      contextRef="From2026-01-012026-06-30_custom_N21stDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl6803"
      unitRef="Pure"
      xsi:nil="true"/>
    <cik0002058261:YieldToMaturity
      contextRef="From2026-01-012026-06-30_custom_N20thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl6805"
      unitRef="Pure"
      xsi:nil="true"/>
    <cik0002058261:YieldToMaturity
      contextRef="From2026-01-012026-06-30_custom_N21stDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl6807"
      unitRef="Pure"
      xsi:nil="true"/>
    <ifrs-full:RepairsAndMaintenanceExpense
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl6891"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:OtherExpense
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl6926"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:FinancialAssets
      contextRef="AsOf2026-06-30_custom_CurrentPortionOfLongTermBankDepositMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl6947"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:FinancialAssets
      contextRef="AsOf2025-12-31_custom_LongtermBankDepositMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl6961"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:FinancialAssets
      contextRef="AsOf2025-12-31_custom_LongTermOtherReceivablesNetMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl6969"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2025-06-30_ifrs-full_ShorttermBorrowingsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl6993"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:AdjustmentsForInterestIncome
      contextRef="From2026-01-012026-06-30_ifrs-full_FinancialLiabilitiesAtAmortisedCostCategoryMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7007"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:AdjustmentsForInterestIncome
      contextRef="From2026-01-012026-06-30_ifrs-full_FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7008"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:InterestExpense
      contextRef="From2026-01-012026-06-30_ifrs-full_FinancialAssetsAtAmortisedCostCategoryMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7011"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:InterestExpense
      contextRef="From2026-01-012026-06-30_ifrs-full_FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7013"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss
      contextRef="From2026-01-012026-06-30_ifrs-full_FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7018"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:GainsOnDisposal
      contextRef="From2026-01-012026-06-30_ifrs-full_FinancialLiabilitiesAtAmortisedCostCategoryMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7022"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:GainsOnDisposal
      contextRef="From2026-01-012026-06-30_ifrs-full_FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7023"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:GainOnValuation
      contextRef="From2026-01-012026-06-30_ifrs-full_FinancialAssetsAtAmortisedCostCategoryMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7026"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:GainOnValuation
      contextRef="From2026-01-012026-06-30_ifrs-full_FinancialLiabilitiesAtAmortisedCostCategoryMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7027"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:LossesOnRepayment
      contextRef="From2026-01-012026-06-30_ifrs-full_FinancialAssetsAtAmortisedCostCategoryMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7031"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:LossesOnRepayment
      contextRef="From2026-01-012026-06-30_ifrs-full_FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7033"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:LossesOnValuation
      contextRef="From2026-01-012026-06-30_ifrs-full_FinancialAssetsAtAmortisedCostCategoryMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7036"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:LossesOnValuation
      contextRef="From2026-01-012026-06-30_ifrs-full_FinancialLiabilitiesAtAmortisedCostCategoryMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7037"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:AdjustmentsForInterestIncome
      contextRef="From2025-01-012025-06-30_ifrs-full_FinancialLiabilitiesAtAmortisedCostCategoryMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7054"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:AdjustmentsForInterestIncome
      contextRef="From2025-01-012025-06-30_ifrs-full_FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7055"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:InterestExpense
      contextRef="From2025-01-012025-06-30_ifrs-full_FinancialAssetsAtAmortisedCostCategoryMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7058"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:InterestExpense
      contextRef="From2025-01-012025-06-30_ifrs-full_FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7060"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss
      contextRef="From2025-01-012025-06-30_ifrs-full_FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7065"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:GainOnValuation
      contextRef="From2025-01-012025-06-30_ifrs-full_FinancialAssetsAtAmortisedCostCategoryMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7068"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:GainOnValuation
      contextRef="From2025-01-012025-06-30_ifrs-full_FinancialLiabilitiesAtAmortisedCostCategoryMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7069"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:LossesOnRepayment
      contextRef="From2025-01-012025-06-30_ifrs-full_FinancialAssetsAtAmortisedCostCategoryMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7073"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:LossesOnRepayment
      contextRef="From2025-01-012025-06-30_ifrs-full_FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7075"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:ChangesNetOfTaxes
      contextRef="From2025-01-012025-06-30_custom_EmployeeShareOptionMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7144"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:ChangesNetOfTaxes
      contextRef="From2026-01-012026-06-30_custom_EmployeeShareOptionMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7168"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:NetDebtToEquityRatio
      contextRef="AsOf2026-06-30_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7233"
      unitRef="Pure"
      xsi:nil="true"/>
    <cik0002058261:NetDebtToEquityRatio
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7234"
      unitRef="Pure"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement
      contextRef="From2026-01-012026-06-30_custom_ShareOptionPlanEquitySettledMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7318"
      unitRef="Shares"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement
      contextRef="From2025-01-012025-06-30_custom_ShareOptionPlanEquitySettledMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7320"
      unitRef="Shares"
      xsi:nil="true"/>
    <cik0002058261:InterestIncome
      contextRef="From2026-01-012026-06-30_ifrs-full_RelatedPartiesMember_custom_WellCoreMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7354"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:InterestIncome
      contextRef="From2025-01-012025-06-30_ifrs-full_RelatedPartiesMember_custom_WellCoreMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7358"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:InterestExpenses
      contextRef="From2026-01-012026-06-30_ifrs-full_RelatedPartiesMember_custom_DongsungDAndCMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7368"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:InterestIncome
      contextRef="From2025-01-012025-06-30_ifrs-full_RelatedPartiesMember_custom_DongsungDAndCMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7370"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:InterestExpenses
      contextRef="From2025-01-012025-06-30_ifrs-full_RelatedPartiesMember_custom_DongsungDAndCMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7372"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:InterestExpenses
      contextRef="From2026-01-012026-06-30_ifrs-full_RelatedPartiesMember_custom_CubeBioHoldingsLtdMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7380"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:InterestExpenses
      contextRef="From2025-01-012025-06-30_ifrs-full_RelatedPartiesMember_custom_CubeBioHoldingsLtdMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7384"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:InterestIncome
      contextRef="From2026-01-012026-06-30_ifrs-full_RelatedPartiesMember_custom_NohBinParkNohBinParkMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7390"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:InterestExpenses
      contextRef="From2026-01-012026-06-30_ifrs-full_RelatedPartiesMember_custom_NohBinParkNohBinParkMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7392"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:InterestIncome
      contextRef="From2025-01-012025-06-30_ifrs-full_RelatedPartiesMember_custom_NohBinParkNohBinParkMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7394"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:InterestIncome
      contextRef="From2026-01-012026-06-30_ifrs-full_RelatedPartiesMember_custom_HoSungHanMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7402"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:InterestExpenses
      contextRef="From2026-01-012026-06-30_ifrs-full_RelatedPartiesMember_custom_HoSungHanMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7404"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:InterestIncome
      contextRef="From2025-01-012025-06-30_ifrs-full_RelatedPartiesMember_custom_HoSungHanMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7406"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:InterestExpenses
      contextRef="From2026-01-012026-06-30_ifrs-full_RelatedPartiesMember_custom_EunJongChoiMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7416"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:InterestExpenses
      contextRef="From2025-01-012025-06-30_ifrs-full_RelatedPartiesMember_custom_EunJongChoiMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7420"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:InterestIncome
      contextRef="From2026-01-012026-06-30_ifrs-full_RelatedPartiesMember_custom_GyungHaYuMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7426"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:InterestExpenses
      contextRef="From2026-01-012026-06-30_ifrs-full_RelatedPartiesMember_custom_GyungHaYuMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7428"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:InterestIncome
      contextRef="From2025-01-012025-06-30_ifrs-full_RelatedPartiesMember_custom_GyungHaYuMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7430"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:OtherReceivable
      contextRef="AsOf2026-06-30_ifrs-full_RelatedPartiesMember_custom_WellCoreMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7446"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:TradeAndOtherPayables
      contextRef="AsOf2025-12-31_ifrs-full_RelatedPartiesMember_custom_DongsungDAndCMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7448"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:OtherReceivable
      contextRef="AsOf2025-12-31_ifrs-full_RelatedPartiesMember_custom_WellCoreMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7450"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:TradeAndOtherPayables
      contextRef="AsOf2025-12-31_ifrs-full_RelatedPartiesMember_custom_DongsungDAndCMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7456"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:TradeAndOtherPayables
      contextRef="AsOf2026-06-30_ifrs-full_RelatedPartiesMember_custom_CubeBioHoldingsLtdMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7460"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:TradeAndOtherPayables
      contextRef="AsOf2025-12-31_ifrs-full_RelatedPartiesMember_custom_CubeBioHoldingsLtdMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7464"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:OtherReceivable
      contextRef="AsOf2026-06-30_ifrs-full_RelatedPartiesMember_custom_YunWooChooMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7478"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:TradeAndOtherPayables
      contextRef="AsOf2025-12-31_ifrs-full_RelatedPartiesMember_custom_YunWooChooMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7480"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:OtherReceivable
      contextRef="AsOf2025-12-31_ifrs-full_RelatedPartiesMember_custom_YunWooChooMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7482"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:OtherReceivable
      contextRef="AsOf2026-06-30_ifrs-full_RelatedPartiesMember_custom_JungGonKimMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7486"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:OtherReceivable
      contextRef="AsOf2025-12-31_ifrs-full_RelatedPartiesMember_custom_JungGonKimMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7490"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:RelatedPartyBalances
      contextRef="AsOf2025-12-31_ifrs-full_RelatedPartiesMember_custom_WellCoreMember_custom_BorrowingMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7510"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:Decrease
      contextRef="From2026-01-012026-06-30_ifrs-full_RelatedPartiesMember_custom_WellCoreMember_custom_BorrowingMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7514"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:RelatedPartyBalances
      contextRef="AsOf2025-12-31_ifrs-full_RelatedPartiesMember_custom_WellCoreMember_custom_AccruedExpenseMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7518"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:Decrease
      contextRef="From2026-01-012026-06-30_ifrs-full_RelatedPartiesMember_custom_WellCoreMember_custom_AccruedExpenseMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7522"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:Decrease
      contextRef="From2026-01-012026-06-30_ifrs-full_RelatedPartiesMember_custom_DongsungDAndCMember_custom_ShortTermLoanReceivableMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7530"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:Decrease
      contextRef="From2026-01-012026-06-30_ifrs-full_RelatedPartiesMember_custom_DongsungDAndCMember_custom_ShortTermLoanReceivablesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7538"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:RelatedPartyBalances
      contextRef="AsOf2025-12-31_ifrs-full_RelatedPartiesMember_custom_DongsungDAndCMember_custom_OtherPayablesAdvancesReceivedForAllotmentOfCommonSharesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7542"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:Decrease
      contextRef="From2026-01-012026-06-30_ifrs-full_RelatedPartiesMember_custom_DongsungDAndCMember_custom_OtherPayablesAdvancesReceivedForAllotmentOfCommonSharesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7546"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:Increase
      contextRef="From2026-01-012026-06-30_ifrs-full_RelatedPartiesMember_custom_EunJongChoiMember_custom_ShortTermLoanReceivableMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7552"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:Decrease
      contextRef="From2026-01-012026-06-30_ifrs-full_RelatedPartiesMember_custom_EunJongChoiMember_custom_ShortTermLoanReceivableMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7554"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:Decrease
      contextRef="From2026-01-012026-06-30_ifrs-full_RelatedPartiesMember_custom_EunJongChoiMember_custom_ShortTermLoanReceivablesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7562"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:Decrease
      contextRef="From2026-01-012026-06-30_ifrs-full_RelatedPartiesMember_custom_CubeBioHoldingsLtdMember_custom_ShortTermLoanReceivableMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7570"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:Decrease
      contextRef="From2026-01-012026-06-30_ifrs-full_RelatedPartiesMember_custom_CubeBioHoldingsLtdMember_custom_ShortTermLoanReceivablesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7578"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:Decrease
      contextRef="From2026-01-012026-06-30_ifrs-full_RelatedPartiesMember_custom_JungGonKimMember_custom_OtherPayablesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7586"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:Decrease
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7594"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:ReversalOfAllowanceForDoubtfulAccounts
      contextRef="From2025-01-012025-06-30_custom_IncomeAndExpensesFromOperatingActivitiesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7635"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:LossesOnValuationOfDerivatives
      contextRef="From2025-01-012025-06-30_custom_IncomeAndExpensesFromOperatingActivitiesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7638"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:GainsOnLongtermInvestmentSecurities
      contextRef="From2025-01-012025-06-30_custom_IncomeAndExpensesFromOperatingActivitiesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7650"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:GainsLossesOnDisposalsOfPropertyPlantAndEquipment
      contextRef="From2025-01-012025-06-30_custom_IncomeAndExpensesFromOperatingActivitiesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7662"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:AdditionsToNoncurrentAssets
      contextRef="From2026-01-012026-06-30_custom_IncomeAndExpensesFromOperatingActivitiesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7673"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:AdditionsToNoncurrentAssets
      contextRef="From2025-01-012025-06-30_custom_IncomeAndExpensesFromOperatingActivitiesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7674"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:Borrowings
      contextRef="AsOf2024-12-31_ifrs-full_ShorttermBorrowingsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7716"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:ProceedsFromIssuanceOfBondWithWarrants
      contextRef="From2025-01-012025-06-30_ifrs-full_ShorttermBorrowingsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7726"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:ProceedsFromIssuanceOfBondWithWarrants
      contextRef="From2025-01-012025-06-30_custom_CurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7728"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:ProceedsFromIssuanceOfBondWithWarrants
      contextRef="From2025-01-012025-06-30_custom_NonCurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7730"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:RepaymentOfBondWithWarrants
      contextRef="From2025-01-012025-06-30_ifrs-full_ShorttermBorrowingsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7736"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:RepaymentOfBondWithWarrants
      contextRef="From2025-01-012025-06-30_custom_CurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7738"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:RepaymentOfBondWithWarrants
      contextRef="From2025-01-012025-06-30_custom_NonCurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7740"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:PaymentOfLeaseLiabilityPrincipal
      contextRef="From2025-01-012025-06-30_custom_CurrentBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7744"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:PaymentOfLeaseLiabilityPrincipal
      contextRef="From2025-01-012025-06-30_ifrs-full_ShorttermBorrowingsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7746"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:PaymentOfLeaseLiabilityPrincipal
      contextRef="From2025-01-012025-06-30_custom_NonCurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7750"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities
      contextRef="From2025-01-012025-06-30_ifrs-full_ShorttermBorrowingsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7756"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities
      contextRef="From2025-01-012025-06-30_custom_NonCurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7760"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:ProceedsFromWarrantsExercised
      contextRef="From2025-01-012025-06-30_custom_CurrentBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7764"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:ProceedsFromWarrantsExercised
      contextRef="From2025-01-012025-06-30_ifrs-full_ShorttermBorrowingsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7766"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:ProceedsFromWarrantsExercised
      contextRef="From2025-01-012025-06-30_custom_CurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7768"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:ProceedsFromWarrantsExercised
      contextRef="From2025-01-012025-06-30_custom_NonCurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7770"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:ProceedsFromWarrantsExercised
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7772"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:ProceedsFromCurrentBorrowings
      contextRef="From2025-01-012025-06-30_custom_CurrentBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7774"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:ProceedsFromCurrentBorrowings
      contextRef="From2025-01-012025-06-30_custom_CurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7778"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:ProceedsFromCurrentBorrowings
      contextRef="From2025-01-012025-06-30_custom_NonCurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7780"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:OtherNoncashTransactions
      contextRef="From2025-01-012025-06-30_ifrs-full_ShorttermBorrowingsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7786"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:OtherNoncashTransactions
      contextRef="From2025-01-012025-06-30_custom_CurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7788"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:OtherNoncashTransactions
      contextRef="From2025-01-012025-06-30_custom_NonCurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7790"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:LeaseReassessment
      contextRef="From2025-01-012025-06-30_custom_CurrentBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7794"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:LeaseReassessment
      contextRef="From2025-01-012025-06-30_ifrs-full_ShorttermBorrowingsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7796"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:LeaseReassessment
      contextRef="From2025-01-012025-06-30_custom_CurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7798"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:OtherInterestExpense
      contextRef="From2025-01-012025-06-30_ifrs-full_ShorttermBorrowingsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7806"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:OtherInterestExpense
      contextRef="From2025-01-012025-06-30_custom_NonCurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7810"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:InterestPaidClassifiedAsFinancingActivities
      contextRef="From2025-01-012025-06-30_custom_CurrentBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7814"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:InterestPaidClassifiedAsFinancingActivities
      contextRef="From2025-01-012025-06-30_ifrs-full_ShorttermBorrowingsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7816"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:InterestPaidClassifiedAsFinancingActivities
      contextRef="From2025-01-012025-06-30_custom_NonCurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7820"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:Reclassification
      contextRef="From2025-01-012025-06-30_custom_CurrentBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7824"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:Reclassification
      contextRef="From2025-01-012025-06-30_ifrs-full_ShorttermBorrowingsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7826"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:Reclassification
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7832"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:Borrowings
      contextRef="AsOf2025-12-31_ifrs-full_ShorttermBorrowingsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7856"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:ProceedsFromIssuanceOfBondWithWarrants
      contextRef="From2026-01-012026-06-30_custom_CurrentBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7864"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:ProceedsFromIssuanceOfBondWithWarrants
      contextRef="From2026-01-012026-06-30_ifrs-full_ShorttermBorrowingsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7866"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:ProceedsFromIssuanceOfBondWithWarrants
      contextRef="From2026-01-012026-06-30_custom_CurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7868"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:ProceedsFromIssuanceOfBondWithWarrants
      contextRef="From2026-01-012026-06-30_custom_NonCurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7870"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:ProceedsFromIssuanceOfBondWithWarrants
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7872"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:RepaymentOfBondWithWarrants
      contextRef="From2026-01-012026-06-30_ifrs-full_ShorttermBorrowingsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7876"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:RepaymentOfBondWithWarrants
      contextRef="From2026-01-012026-06-30_custom_CurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7878"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:RepaymentOfBondWithWarrants
      contextRef="From2026-01-012026-06-30_custom_NonCurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7880"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:PaymentOfLeaseLiabilityPrincipal
      contextRef="From2026-01-012026-06-30_custom_CurrentBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7884"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:PaymentOfLeaseLiabilityPrincipal
      contextRef="From2026-01-012026-06-30_ifrs-full_ShorttermBorrowingsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7886"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:PaymentOfLeaseLiabilityPrincipal
      contextRef="From2026-01-012026-06-30_custom_NonCurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7890"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities
      contextRef="From2026-01-012026-06-30_ifrs-full_ShorttermBorrowingsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7896"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities
      contextRef="From2026-01-012026-06-30_custom_NonCurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7900"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:ProceedsFromWarrantsExercised
      contextRef="From2026-01-012026-06-30_custom_CurrentBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7904"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:ProceedsFromWarrantsExercised
      contextRef="From2026-01-012026-06-30_ifrs-full_ShorttermBorrowingsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7906"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:ProceedsFromWarrantsExercised
      contextRef="From2026-01-012026-06-30_custom_CurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7908"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:ProceedsFromWarrantsExercised
      contextRef="From2026-01-012026-06-30_custom_NonCurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7910"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:ProceedsFromWarrantsExercised
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7912"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:ProceedsFromCurrentBorrowings
      contextRef="From2026-01-012026-06-30_custom_CurrentBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7914"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:ProceedsFromCurrentBorrowings
      contextRef="From2026-01-012026-06-30_custom_CurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7918"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:ProceedsFromCurrentBorrowings
      contextRef="From2026-01-012026-06-30_custom_NonCurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7920"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:OtherNoncashTransactions
      contextRef="From2026-01-012026-06-30_ifrs-full_ShorttermBorrowingsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7926"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:OtherNoncashTransactions
      contextRef="From2026-01-012026-06-30_custom_CurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7928"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:OtherNoncashTransactions
      contextRef="From2026-01-012026-06-30_custom_NonCurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7930"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:LeaseReassessment
      contextRef="From2026-01-012026-06-30_custom_CurrentBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7934"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:LeaseReassessment
      contextRef="From2026-01-012026-06-30_ifrs-full_ShorttermBorrowingsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7936"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:LeaseReassessment
      contextRef="From2026-01-012026-06-30_custom_CurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7938"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:OtherInterestExpense
      contextRef="From2026-01-012026-06-30_ifrs-full_ShorttermBorrowingsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7946"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:OtherInterestExpense
      contextRef="From2026-01-012026-06-30_custom_NonCurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7950"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:InterestPaidClassifiedAsFinancingActivities
      contextRef="From2026-01-012026-06-30_custom_CurrentBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7954"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:InterestPaidClassifiedAsFinancingActivities
      contextRef="From2026-01-012026-06-30_ifrs-full_ShorttermBorrowingsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7956"
      unitRef="KRW"
      xsi:nil="true"/>
    <ifrs-full:InterestPaidClassifiedAsFinancingActivities
      contextRef="From2026-01-012026-06-30_custom_NonCurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7960"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:Reclassification
      contextRef="From2026-01-012026-06-30_custom_CurrentBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7964"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:Reclassification
      contextRef="From2026-01-012026-06-30_ifrs-full_ShorttermBorrowingsMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7966"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:Reclassification
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl7972"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:BorrowingsAmount
      contextRef="AsOf2026-06-30_custom_FinancialInstitutionsMember_custom_KYOBOSecuritiesCoLtdMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl8011"
      unitRef="KRW"
      xsi:nil="true"/>
    <cik0002058261:BorrowingsAmount
      contextRef="AsOf2025-12-31_custom_FinancialInstitutionsMember_custom_KYOBOSecuritiesCoLtdMember_custom_CubebioCo.Ltd.Member"
      id="xdx2ixbrl8024"
      unitRef="KRW"
      xsi:nil="true"/>
    <dei:AmendmentDescription contextRef="From2026-01-01to2026-06-30" id="Fact000013">Amendment No.&#160;2</dei:AmendmentDescription>
    <dei:EntityRegistrantName contextRef="From2026-01-01to2026-06-30" id="Fact000015">CUBEBIO HOLDINGS LIMITED</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2026-01-01to2026-06-30" id="Fact000016">E9</dei:EntityIncorporationStateCountryCode>
    <dei:EntityAddressAddressLine1 contextRef="From2026-01-01to2026-06-30" id="Fact000017">8F HYHILL Building</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2026-01-01to2026-06-30" id="Fact000018">Digital-ro 10-gil 9</dei:EntityAddressAddressLine2>
    <dei:EntityAddressAddressLine3 contextRef="From2026-01-01to2026-06-30" id="Fact000019">Geumcheon-gu</dei:EntityAddressAddressLine3>
    <dei:EntityAddressCityOrTown contextRef="From2026-01-01to2026-06-30" id="Fact000020">Seoul</dei:EntityAddressCityOrTown>
    <dei:CountryRegion contextRef="From2026-01-01to2026-06-30" id="Fact000021">+82</dei:CountryRegion>
    <dei:CityAreaCode contextRef="From2026-01-01to2026-06-30" id="Fact000022">02</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2026-01-01to2026-06-30" id="Fact000023">4607-3869</dei:LocalPhoneNumber>
    <dei:ContactPersonnelName
      contextRef="From2026-01-012026-06-30_dei_BusinessContactMember"
      id="Fact000024">Cogency Global Inc.</dei:ContactPersonnelName>
    <dei:EntityAddressAddressLine1
      contextRef="From2026-01-012026-06-30_dei_BusinessContactMember"
      id="Fact000025">122 East 42nd Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="From2026-01-012026-06-30_dei_BusinessContactMember"
      id="Fact000026">18th Floor</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="From2026-01-012026-06-30_dei_BusinessContactMember"
      id="Fact000027">New York</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="From2026-01-012026-06-30_dei_BusinessContactMember"
      id="Fact000028">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="From2026-01-012026-06-30_dei_BusinessContactMember"
      id="Fact000029">10168</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="From2026-01-012026-06-30_dei_BusinessContactMember"
      id="Fact000030">212</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="From2026-01-012026-06-30_dei_BusinessContactMember"
      id="Fact000031">947-7200</dei:LocalPhoneNumber>
    <dei:EntityEmergingGrowthCompany contextRef="From2026-01-01to2026-06-30" id="Fact000032">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="From2026-01-01to2026-06-30" id="Fact000033">false</dei:EntityExTransitionPeriod>
    <ifrs-full:OtherReceivables
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000038"
      unitRef="USD">52918</ifrs-full:OtherReceivables>
    <ifrs-full:OtherReceivables
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000039"
      unitRef="USD">50618</ifrs-full:OtherReceivables>
    <ifrs-full:CurrentAssets
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000041"
      unitRef="USD">52918</ifrs-full:CurrentAssets>
    <ifrs-full:CurrentAssets
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000042"
      unitRef="USD">50618</ifrs-full:CurrentAssets>
    <ifrs-full:Assets
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000044"
      unitRef="USD">52918</ifrs-full:Assets>
    <ifrs-full:Assets
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000045"
      unitRef="USD">50618</ifrs-full:Assets>
    <cik0002058261:PromissoryNotePayablesRelatedParties
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000050"
      unitRef="USD">31751</cik0002058261:PromissoryNotePayablesRelatedParties>
    <cik0002058261:PromissoryNotePayablesRelatedParties
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000051"
      unitRef="USD">30371</cik0002058261:PromissoryNotePayablesRelatedParties>
    <ifrs-full:OtherPayables
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000053"
      unitRef="USD">7725</ifrs-full:OtherPayables>
    <ifrs-full:CurrentLiabilities
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000056"
      unitRef="USD">39476</ifrs-full:CurrentLiabilities>
    <ifrs-full:CurrentLiabilities
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000057"
      unitRef="USD">30371</ifrs-full:CurrentLiabilities>
    <ifrs-full:Liabilities
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000059"
      unitRef="USD">39476</ifrs-full:Liabilities>
    <ifrs-full:Liabilities
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000060"
      unitRef="USD">30371</ifrs-full:Liabilities>
    <ifrs-full:IssuedCapital
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000065"
      unitRef="USD">50000</ifrs-full:IssuedCapital>
    <ifrs-full:IssuedCapital
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000066"
      unitRef="USD">50000</ifrs-full:IssuedCapital>
    <ifrs-full:RetainedEarnings
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000068"
      unitRef="USD">-36558</ifrs-full:RetainedEarnings>
    <ifrs-full:RetainedEarnings
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000069"
      unitRef="USD">-29753</ifrs-full:RetainedEarnings>
    <ifrs-full:Equity
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000071"
      unitRef="USD">13442</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000072"
      unitRef="USD">20247</ifrs-full:Equity>
    <ifrs-full:EquityAndLiabilities
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000074"
      unitRef="USD">52918</ifrs-full:EquityAndLiabilities>
    <ifrs-full:EquityAndLiabilities
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000075"
      unitRef="USD">50618</ifrs-full:EquityAndLiabilities>
    <ifrs-full:SellingGeneralAndAdministrativeExpense
      contextRef="From2025-01-012025-12-31"
      decimals="0"
      id="Fact000092"
      unitRef="USD">7725</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <ifrs-full:SellingGeneralAndAdministrativeExpense
      contextRef="From2024-09-252024-12-31"
      decimals="0"
      id="Fact000093"
      unitRef="USD">30000</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <ifrs-full:OperatingExpense
      contextRef="From2025-01-012025-12-31"
      decimals="0"
      id="Fact000095"
      unitRef="USD">7725</ifrs-full:OperatingExpense>
    <ifrs-full:OperatingExpense
      contextRef="From2024-09-252024-12-31"
      decimals="0"
      id="Fact000096"
      unitRef="USD">30000</ifrs-full:OperatingExpense>
    <ifrs-full:ProfitLossFromContinuingOperations
      contextRef="From2025-01-012025-12-31"
      decimals="0"
      id="Fact000098"
      unitRef="USD">-7725</ifrs-full:ProfitLossFromContinuingOperations>
    <ifrs-full:ProfitLossFromContinuingOperations
      contextRef="From2024-09-252024-12-31"
      decimals="0"
      id="Fact000099"
      unitRef="USD">-30000</ifrs-full:ProfitLossFromContinuingOperations>
    <cik0002058261:InterestIncomes
      contextRef="From2025-01-012025-12-31"
      decimals="0"
      id="Fact000101"
      unitRef="USD">2300</cik0002058261:InterestIncomes>
    <cik0002058261:InterestIncomes
      contextRef="From2024-09-252024-12-31"
      decimals="0"
      id="Fact000102"
      unitRef="USD">618</cik0002058261:InterestIncomes>
    <cik0002058261:InterestsExpense
      contextRef="From2025-01-012025-12-31"
      decimals="0"
      id="Fact000104"
      unitRef="USD">1380</cik0002058261:InterestsExpense>
    <cik0002058261:InterestsExpense
      contextRef="From2024-09-252024-12-31"
      decimals="0"
      id="Fact000105"
      unitRef="USD">371</cik0002058261:InterestsExpense>
    <ifrs-full:ProfitLoss
      contextRef="From2025-01-012025-12-31"
      decimals="0"
      id="Fact000107"
      unitRef="USD">-6805</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="From2024-09-252024-12-31"
      decimals="0"
      id="Fact000108"
      unitRef="USD">-29753</ifrs-full:ProfitLoss>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="From2025-01-012025-12-31"
      decimals="0"
      id="Fact000110"
      unitRef="USD">-6805</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="From2024-09-252024-12-31"
      decimals="0"
      id="Fact000111"
      unitRef="USD">-29753</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:WeightedAverageShares
      contextRef="From2025-01-012025-12-31"
      decimals="INF"
      id="Fact000113"
      unitRef="Shares">50000</ifrs-full:WeightedAverageShares>
    <ifrs-full:WeightedAverageShares
      contextRef="From2024-09-252024-12-31"
      decimals="INF"
      id="Fact000114"
      unitRef="Shares">50000</ifrs-full:WeightedAverageShares>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="From2025-01-012025-12-31"
      decimals="INF"
      id="Fact000116"
      unitRef="USDPShares">-0.14</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="From2025-01-012025-12-31"
      decimals="INF"
      id="Fact000118"
      unitRef="USDPShares">-0.14</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="From2024-09-252024-12-31"
      decimals="INF"
      id="Fact000120"
      unitRef="USDPShares">-0.60</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="From2024-09-252024-12-31"
      decimals="INF"
      id="Fact000122"
      unitRef="USDPShares">-0.60</ifrs-full:DilutedEarningsLossPerShare>
    <cik0002058261:SharesIssuedForRelatedPartyReceivableShares
      contextRef="From2024-09-252024-12-31_custom_CommonStocksMember"
      decimals="INF"
      id="Fact000136"
      unitRef="Shares">50000</cik0002058261:SharesIssuedForRelatedPartyReceivableShares>
    <cik0002058261:SharesIssuedForRelatedPartyReceivable
      contextRef="From2024-09-252024-12-31_custom_CommonStocksMember"
      decimals="0"
      id="Fact000131"
      unitRef="USD">50000</cik0002058261:SharesIssuedForRelatedPartyReceivable>
    <cik0002058261:SharesIssuedForRelatedPartyReceivable
      contextRef="From2024-09-252024-12-31"
      decimals="0"
      id="Fact000134"
      unitRef="USD">50000</cik0002058261:SharesIssuedForRelatedPartyReceivable>
    <ifrs-full:ProfitLoss
      contextRef="From2024-09-252024-12-31_ifrs-full_RetainedEarnings"
      decimals="0"
      id="Fact000140"
      unitRef="USD">-29753</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="From2024-09-252024-12-31"
      decimals="0"
      id="Fact000141"
      unitRef="USD">-29753</ifrs-full:ProfitLoss>
    <cik0002058261:ShareIssued
      contextRef="AsOf2024-12-31_custom_CommonStocksMember"
      decimals="INF"
      id="Fact000148"
      unitRef="Shares">50000</cik0002058261:ShareIssued>
    <ifrs-full:EquityAttributableToOwnersOfParent
      contextRef="AsOf2024-12-31_custom_CommonStocksMember"
      decimals="0"
      id="Fact000143"
      unitRef="KRW">50000</ifrs-full:EquityAttributableToOwnersOfParent>
    <ifrs-full:EquityAttributableToOwnersOfParent
      contextRef="AsOf2024-12-31_ifrs-full_RetainedEarnings"
      decimals="0"
      id="Fact000145"
      unitRef="KRW">-29753</ifrs-full:EquityAttributableToOwnersOfParent>
    <ifrs-full:EquityAttributableToOwnersOfParent
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000146"
      unitRef="KRW">20247</ifrs-full:EquityAttributableToOwnersOfParent>
    <ifrs-full:ProfitLoss
      contextRef="From2025-01-012025-12-31_ifrs-full_RetainedEarnings"
      decimals="0"
      id="Fact000152"
      unitRef="USD">-6805</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="From2025-01-012025-12-31"
      decimals="0"
      id="Fact000153"
      unitRef="USD">-6805</ifrs-full:ProfitLoss>
    <cik0002058261:ShareIssued
      contextRef="AsOf2025-12-31_custom_CommonStocksMember"
      decimals="INF"
      id="Fact000160"
      unitRef="Shares">50000</cik0002058261:ShareIssued>
    <ifrs-full:EquityAttributableToOwnersOfParent
      contextRef="AsOf2025-12-31_custom_CommonStocksMember"
      decimals="0"
      id="Fact000155"
      unitRef="KRW">50000</ifrs-full:EquityAttributableToOwnersOfParent>
    <ifrs-full:EquityAttributableToOwnersOfParent
      contextRef="AsOf2025-12-31_ifrs-full_RetainedEarnings"
      decimals="0"
      id="Fact000157"
      unitRef="KRW">-36558</ifrs-full:EquityAttributableToOwnersOfParent>
    <ifrs-full:EquityAttributableToOwnersOfParent
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000158"
      unitRef="KRW">13442</ifrs-full:EquityAttributableToOwnersOfParent>
    <ifrs-full:ProfitLoss
      contextRef="From2025-01-012025-12-31"
      decimals="0"
      id="Fact000165"
      unitRef="USD">-6805</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="From2024-09-252024-12-31"
      decimals="0"
      id="Fact000166"
      unitRef="USD">-29753</ifrs-full:ProfitLoss>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable
      contextRef="From2025-01-012025-12-31"
      decimals="0"
      id="Fact000174"
      unitRef="USD">7725</ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable>
    <cik0002058261:PromissoryNotePayablesRelatedPartie
      contextRef="From2025-01-012025-12-31"
      decimals="0"
      id="Fact000177"
      unitRef="USD">1380</cik0002058261:PromissoryNotePayablesRelatedPartie>
    <cik0002058261:PromissoryNotePayablesRelatedPartie
      contextRef="From2024-09-252024-12-31"
      decimals="0"
      id="Fact000178"
      unitRef="USD">371</cik0002058261:PromissoryNotePayablesRelatedPartie>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables
      contextRef="From2025-01-012025-12-31"
      decimals="0"
      id="Fact000180"
      unitRef="USD">-2300</ifrs-full:AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables
      contextRef="From2024-09-252024-12-31"
      decimals="0"
      id="Fact000181"
      unitRef="USD">-618</ifrs-full:AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables>
    <ifrs-full:CashFlowsFromUsedInOperatingActivities
      contextRef="From2024-09-252024-12-31"
      decimals="0"
      id="Fact000184"
      unitRef="USD">-30000</ifrs-full:CashFlowsFromUsedInOperatingActivities>
    <cik0002058261:ProceedsFromPromissoryNotePayablesRelatedParties
      contextRef="From2024-09-252024-12-31"
      decimals="-3"
      id="Fact000199"
      unitRef="USD">30000</cik0002058261:ProceedsFromPromissoryNotePayablesRelatedParties>
    <ifrs-full:CashFlowsFromUsedInFinancingActivities
      contextRef="From2024-09-252024-12-31"
      decimals="0"
      id="Fact000202"
      unitRef="USD">30000</ifrs-full:CashFlowsFromUsedInFinancingActivities>
    <cik0002058261:DisclosureOfGeneralInformationExplanatory contextRef="From2025-01-012025-12-31" id="Fact000211">&lt;p id="xdx_809_ecustom--DisclosureOfGeneralInformationExplanatory_zJZLKB0TFqmh" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;1.&lt;span id="xdx_82F_z2bswVrD9P87"&gt; General Information&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;CUBEBIO Holdings Limited (the &#x201c;Company,&#x201d; or &#x201c;CHL&#x201d;) was incorporated on September&#160;24, 2024 and the Company&#x2019;s registered office is at c/o Maples Corporate Services Limited, PO Box 309, Ugland House Grand Cayman, KY1-1104 Cayman Islands. The Company was incorporated for the purpose of becoming the ultimate parent company following the transactions contemplated in the Business Combination Agreement (as described in the next paragraph). The Company will maintain two direct wholly-owned subsidiaries, CHL SPAC Merger Sub Inc. (the &#x201c;SPAC Merger Sub&#x201d;), a Delaware corporation and CHL Korea Exchange Sub Ltd. (the &#x201c;Exchange Sub&#x2019;), a stock corporation to be organized under the laws of the Republic of Korea. SPAC Merger Sub and Exchange Sub will be incorporated to facilitate the consummation of the Business Combination Agreement. As of December&#160;31, 2025, these two wholly-owned entities have not yet been incorporated and therefore have had no operations.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;On August&#160;29, 2024, Mountain Crest Acquisition Corp., V, a Delaware corporation (&#x201c;MCAG&#x201d;), entered into the Business Combination Agreement, as may be amended, supplemented or otherwise modified from time to time, the &#x201c;BCA&#x201d;, by and between MCAG and CUBEBIO Co., Ltd., a corporation organized under the laws of Korea (the &#x201c;CUBEBIO&#x201d;), pursuant to which the following transactions will occur: subject to the approval and adoption of the BCA by the stockholders of MCAG and CUBEBIO, (1) SPAC Merger Sub will be merged with and into MCAG with MCAG being the surviving entity (the &#x201c;SPAC Merger&#x201d;) as a direct wholly owned subsidiary of the Company, and (2) all shareholders of CUBEBIO shall transfer their respective common shares to the Exchange Sub, in exchange for the right to receive the Company&#x2019;s common shares (the &#x201c;Share Swap&#x201d; and collectively with the SPAC Merger the &#x201c;Business Combination&#x201d;). Following the closing of the Business Combination, the Company expects the Company&#x2019;s common shares to be listed and traded on The Nasdaq Stock Market.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Following the consummation of the transactions contemplated by the BCA, the Company will be the surviving publicly-traded entity. However, the consummation of the transactions contemplated by the BCA is subject to numerous conditions, and there can be no assurances that such conditions will be satisfied.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

</cik0002058261:DisclosureOfGeneralInformationExplanatory>
    <cik0002058261:BasisOfAccountingTextBlock contextRef="From2025-01-012025-12-31" id="Fact000213">&lt;p id="xdx_80C_ecustom--BasisOfAccountingTextBlock_zLaMIxKVxvQf" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;2. &lt;span id="xdx_82B_zOY7uWGEGBrf"&gt;Basis of Accounting&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;These financial statements have been prepared in accordance with the International Financial Reporting Standards (&#x201c;IFRS&#x201d;) issued by the International Accounting Standards Board (&#x201c;IASB&#x201d;), on the historical cost basis, and in the presentation currency U.S. dollar (&#x201c;$&#x201d;). All amounts are in actual U.S. Dollar unless otherwise stated. These financial statements were authorized for issuance by the board of directors on July&#160;10, 2026.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The number of shares used to calculate diluted loss per share of common shares attributable to common shareholders is the same as the number of shares used to calculate basic loss per share of common shares attributable to common shareholders for the period presented because there were no potentially dilutive securities outstanding during the period.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The loss per share presented in the statement of operations and comprehensive loss is based on the following for the year ended December&#160;31, 2025 and for the period from September 24, 2024 (inception) to December 31, 2024:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_88E_ecustom--DisclosureOfDetailedInformationAboutBasicAndDilutedLossPerShareExplanatory_zDk4nWIKSRY8" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Basis of Accounting (Details)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td id="xdx_8BF_zgfwLJucQS9l" style="font: 10pt Times New Roman; display: none; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Basis of Accounting&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;i&gt;Basic and diluted net loss per share:&lt;/i&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Numerator&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Allocation of net loss&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--ProfitLoss_pp0d_uUSD_c20250101__20251231_zuEjmayqwOS7" title="Allocation of net loss"&gt;(6,805&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--ProfitLoss_pp0d_uUSD_c20240925__20241231_z3jBp1Yno6za" title="Allocation of net loss"&gt;(29,753&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Denominator:&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Basic and diluted weighted average number of shares outstanding&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--WeightedAverageShares_c20250101__20251231_pd" title="Basic and diluted weighted average number of shares outstanding"&gt;50,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--WeightedAverageShares_c20240925__20241231_zHrszz5sYxTl" title="Basic and diluted weighted average number of shares outstanding"&gt;50,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1.25pt"&gt;Basic and diluted net loss per share&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--BasicEarningsLossPerShare_pid_c20250101__20251231_zjfMVIgyw0zf" title="Basic earnings per share"&gt;&lt;span id="xdx_90B_eifrs-full--DilutedEarningsLossPerShare_pid_c20250101__20251231_z0uFmbzsV1J9" title="Diluted net loss per share"&gt;(0.14&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--BasicEarningsLossPerShare_pid_c20240925__20241231_zeX4OoiZXJ54" title="Basic earnings per share"&gt;&lt;span id="xdx_903_eifrs-full--DilutedEarningsLossPerShare_pid_c20240925__20241231_zqdkwHyw84y4" title="Diluted net loss per share"&gt;(0.60&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

</cik0002058261:BasisOfAccountingTextBlock>
    <cik0002058261:DisclosureOfDetailedInformationAboutBasicAndDilutedLossPerShareExplanatory contextRef="From2025-01-012025-12-31" id="Fact000215">&lt;table cellpadding="0" cellspacing="0" id="xdx_88E_ecustom--DisclosureOfDetailedInformationAboutBasicAndDilutedLossPerShareExplanatory_zDk4nWIKSRY8" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Basis of Accounting (Details)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td id="xdx_8BF_zgfwLJucQS9l" style="font: 10pt Times New Roman; display: none; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Basis of Accounting&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;i&gt;Basic and diluted net loss per share:&lt;/i&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Numerator&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Allocation of net loss&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--ProfitLoss_pp0d_uUSD_c20250101__20251231_zuEjmayqwOS7" title="Allocation of net loss"&gt;(6,805&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--ProfitLoss_pp0d_uUSD_c20240925__20241231_z3jBp1Yno6za" title="Allocation of net loss"&gt;(29,753&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Denominator:&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Basic and diluted weighted average number of shares outstanding&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--WeightedAverageShares_c20250101__20251231_pd" title="Basic and diluted weighted average number of shares outstanding"&gt;50,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--WeightedAverageShares_c20240925__20241231_zHrszz5sYxTl" title="Basic and diluted weighted average number of shares outstanding"&gt;50,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1.25pt"&gt;Basic and diluted net loss per share&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--BasicEarningsLossPerShare_pid_c20250101__20251231_zjfMVIgyw0zf" title="Basic earnings per share"&gt;&lt;span id="xdx_90B_eifrs-full--DilutedEarningsLossPerShare_pid_c20250101__20251231_z0uFmbzsV1J9" title="Diluted net loss per share"&gt;(0.14&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--BasicEarningsLossPerShare_pid_c20240925__20241231_zeX4OoiZXJ54" title="Basic earnings per share"&gt;&lt;span id="xdx_903_eifrs-full--DilutedEarningsLossPerShare_pid_c20240925__20241231_zqdkwHyw84y4" title="Diluted net loss per share"&gt;(0.60&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;</cik0002058261:DisclosureOfDetailedInformationAboutBasicAndDilutedLossPerShareExplanatory>
    <ifrs-full:ProfitLoss
      contextRef="From2025-01-012025-12-31"
      decimals="0"
      id="Fact000217"
      unitRef="USD">-6805</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="From2024-09-252024-12-31"
      decimals="0"
      id="Fact000219"
      unitRef="USD">-29753</ifrs-full:ProfitLoss>
    <ifrs-full:WeightedAverageShares
      contextRef="From2025-01-012025-12-31"
      decimals="INF"
      id="Fact000221"
      unitRef="Shares">50000</ifrs-full:WeightedAverageShares>
    <ifrs-full:WeightedAverageShares
      contextRef="From2024-09-252024-12-31"
      decimals="INF"
      id="Fact000223"
      unitRef="Shares">50000</ifrs-full:WeightedAverageShares>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="From2025-01-012025-12-31"
      decimals="INF"
      id="Fact000225"
      unitRef="KRWShares">-0.14</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="From2025-01-012025-12-31"
      decimals="INF"
      id="Fact000227"
      unitRef="KRWShares">-0.14</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="From2024-09-252024-12-31"
      decimals="INF"
      id="Fact000229"
      unitRef="KRWShares">-0.60</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="From2024-09-252024-12-31"
      decimals="INF"
      id="Fact000231"
      unitRef="KRWShares">-0.60</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory contextRef="From2025-01-012025-12-31" id="Fact000233">&lt;p id="xdx_80D_eifrs-full--DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory_znXAtY2mykZ8" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;3. &lt;span id="xdx_822_zpsc9fKj9gG2"&gt;Material accounting policies&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The material following accounting policies followed by the Company in preparation of its financial statements are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_84A_ecustom--FinancialAssetsAndFinancialLiabilitiesPoliciesTextBlock_zLwnsrulm1Z7" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;b&gt;A. &lt;span id="xdx_862_z8HP89zfQTDh"&gt;Financial assets and Financial liabilities&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Financial instruments are any form of contract that gives rise to a financial asset in one company and a financial liability or equity instrument in another company. A financial asset or financial liability is included in the statement of financial position when the entity becomes a party to the contractual terms of the instrument. Other financial liabilities and other financial assets, including liabilities to and receivables from related parties, are valued at amortized cost. A financial asset is removed from the statement of financial position when the contractual right to cash flow from the asset has ceased or been settled. The same applies where the risks and benefits associated with the holding are essentially transferred to another party and the entity no longer has control over the financial asset. Financial liability is derecognized when the agreed obligation has been fulfilled or ceased.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_840_ecustom--OrganizationCostPoliciesTextBlock_zHQyJWaC7b7l" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;b&gt;B. &lt;span id="xdx_864_zZDe9MKKZL7k"&gt;Organization cost&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;When issuing common share, incremental costs directly attributable to the equity transaction that otherwise would have been avoided are accounted for as a deduction from equity while other issuing-related costs and organization costs are expensed as incurred.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;On September&#160;24, 2024, the amount of $&lt;span id="xdx_906_ecustom--OrganizationCost_pp0d_uUSD_c20250101__20251231_zFcvvyMb66Ih" title="Organization cost"&gt;30,000&lt;/span&gt; was expensed as incurred whose amount was paid on behalf of the Company and accordingly the Company owed CubeBio Co., Ltd. that would go through the Share Swap with the Exchange Sub, to be organized under the laws of the Republic of Korea, to pay $30,000 USD in accordance with the&#160;terms and conditions of its&#160;corresponding promissory note in return in a year. It was recorded as a payable under the caption Promissory note payables &#x2013; related parties in the Company&#x2019;s Statement of Financial Position. On September&#160;24, 2025, the Company entered into an agreement that extends the maturity date of the promissory note from September&#160;24, 2025 to September&#160;24, 2026, with all other material terms remaining unchanged.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

</ifrs-full:DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory>
    <cik0002058261:FinancialAssetsAndFinancialLiabilitiesPoliciesTextBlock contextRef="From2025-01-012025-12-31" id="Fact000235">&lt;p id="xdx_84A_ecustom--FinancialAssetsAndFinancialLiabilitiesPoliciesTextBlock_zLwnsrulm1Z7" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;b&gt;A. &lt;span id="xdx_862_z8HP89zfQTDh"&gt;Financial assets and Financial liabilities&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Financial instruments are any form of contract that gives rise to a financial asset in one company and a financial liability or equity instrument in another company. A financial asset or financial liability is included in the statement of financial position when the entity becomes a party to the contractual terms of the instrument. Other financial liabilities and other financial assets, including liabilities to and receivables from related parties, are valued at amortized cost. A financial asset is removed from the statement of financial position when the contractual right to cash flow from the asset has ceased or been settled. The same applies where the risks and benefits associated with the holding are essentially transferred to another party and the entity no longer has control over the financial asset. Financial liability is derecognized when the agreed obligation has been fulfilled or ceased.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</cik0002058261:FinancialAssetsAndFinancialLiabilitiesPoliciesTextBlock>
    <cik0002058261:OrganizationCostPoliciesTextBlock contextRef="From2025-01-012025-12-31" id="Fact000237">&lt;p id="xdx_840_ecustom--OrganizationCostPoliciesTextBlock_zHQyJWaC7b7l" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;b&gt;B. &lt;span id="xdx_864_zZDe9MKKZL7k"&gt;Organization cost&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;When issuing common share, incremental costs directly attributable to the equity transaction that otherwise would have been avoided are accounted for as a deduction from equity while other issuing-related costs and organization costs are expensed as incurred.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;On September&#160;24, 2024, the amount of $&lt;span id="xdx_906_ecustom--OrganizationCost_pp0d_uUSD_c20250101__20251231_zFcvvyMb66Ih" title="Organization cost"&gt;30,000&lt;/span&gt; was expensed as incurred whose amount was paid on behalf of the Company and accordingly the Company owed CubeBio Co., Ltd. that would go through the Share Swap with the Exchange Sub, to be organized under the laws of the Republic of Korea, to pay $30,000 USD in accordance with the&#160;terms and conditions of its&#160;corresponding promissory note in return in a year. It was recorded as a payable under the caption Promissory note payables &#x2013; related parties in the Company&#x2019;s Statement of Financial Position. On September&#160;24, 2025, the Company entered into an agreement that extends the maturity date of the promissory note from September&#160;24, 2025 to September&#160;24, 2026, with all other material terms remaining unchanged.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

</cik0002058261:OrganizationCostPoliciesTextBlock>
    <cik0002058261:OrganizationCost
      contextRef="From2025-01-012025-12-31"
      decimals="0"
      id="Fact000239"
      unitRef="USD">30000</cik0002058261:OrganizationCost>
    <ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory contextRef="From2025-01-012025-12-31" id="Fact000241">&lt;p id="xdx_807_eifrs-full--DisclosureOfClassesOfShareCapitalExplanatory_z97gbBoRnyE" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;4. &lt;span id="xdx_82F_zvP8JbzJZ8Nh"&gt;Share capital&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Details of share capital as of December&#160;31, 2025 and 2024 are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_88A_ecustom--ScheduleOfShareCapitalTableTextBlock_zklZWEPpCBw5" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Share capital (Details)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td id="xdx_8B1_znyiBQU5NuAk" style="font: 10pt Times New Roman; display: none; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Schedule of share capital&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Number of authorized shares&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_900_ecustom--NumberOfAuthorizedShares_c20251231_pd" title="Number of authorized shares"&gt;50,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_901_ecustom--NumberOfAuthorizedShares_c20241231_pd" title="Number of authorized shares"&gt;50,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Value per share&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--ParValuePerShare_c20251231_pd" title="Value per share"&gt;1&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--ParValuePerShare_c20241231_pd" title="Value per share"&gt;1&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Number of shares issued&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--NumberOfSharesIssued_c20251231_pd" title="Number of shares issued"&gt;50,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--NumberOfSharesIssued_c20241231_pd" title="Number of shares issued"&gt;50,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.25pt"&gt;Common shares&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_ecustom--CommonShares_c20251231_pp0p" title="Common shares"&gt;50,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_905_ecustom--CommonShares_c20241231_pp0p" title="Common shares"&gt;50,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;During September&#160;2024, the Company entered into an agreement to issue &lt;span id="xdx_90A_eifrs-full--IncreaseDecreaseInNumberOfOrdinarySharesIssued_c20240901__20240930_pd" title="Number of shares issued"&gt;50,000&lt;/span&gt; shares of common shares for gross proceeds of $&lt;span id="xdx_907_eifrs-full--ProceedsFromIssuingShares_pp0d_uUSD_c20240901__20240930_zR2Tze5VUEie" title="Proceeds from shares issued"&gt;50,000&lt;/span&gt;. Each ordinary share maintains one voting right. The entire amount of this equity is held by the CEO of the Company and remains recorded as receivable under the caption Other receivables &#x2013; related parties in the Company&#x2019;s Statement of Financial Position as of December&#160;31, 2025 and 2024.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

</ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory>
    <cik0002058261:ScheduleOfShareCapitalTableTextBlock contextRef="From2025-01-012025-12-31" id="Fact000243">&lt;table cellpadding="0" cellspacing="0" id="xdx_88A_ecustom--ScheduleOfShareCapitalTableTextBlock_zklZWEPpCBw5" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Share capital (Details)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td id="xdx_8B1_znyiBQU5NuAk" style="font: 10pt Times New Roman; display: none; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Schedule of share capital&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Number of authorized shares&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_900_ecustom--NumberOfAuthorizedShares_c20251231_pd" title="Number of authorized shares"&gt;50,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_901_ecustom--NumberOfAuthorizedShares_c20241231_pd" title="Number of authorized shares"&gt;50,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Value per share&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--ParValuePerShare_c20251231_pd" title="Value per share"&gt;1&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--ParValuePerShare_c20241231_pd" title="Value per share"&gt;1&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Number of shares issued&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--NumberOfSharesIssued_c20251231_pd" title="Number of shares issued"&gt;50,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--NumberOfSharesIssued_c20241231_pd" title="Number of shares issued"&gt;50,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.25pt"&gt;Common shares&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_ecustom--CommonShares_c20251231_pp0p" title="Common shares"&gt;50,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_905_ecustom--CommonShares_c20241231_pp0p" title="Common shares"&gt;50,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;</cik0002058261:ScheduleOfShareCapitalTableTextBlock>
    <cik0002058261:NumberOfAuthorizedShares
      contextRef="AsOf2025-12-31"
      decimals="INF"
      id="Fact000245"
      unitRef="Shares">50000</cik0002058261:NumberOfAuthorizedShares>
    <cik0002058261:NumberOfAuthorizedShares
      contextRef="AsOf2024-12-31"
      decimals="INF"
      id="Fact000247"
      unitRef="Shares">50000</cik0002058261:NumberOfAuthorizedShares>
    <ifrs-full:ParValuePerShare
      contextRef="AsOf2025-12-31"
      decimals="INF"
      id="Fact000249"
      unitRef="KRWShares">1</ifrs-full:ParValuePerShare>
    <ifrs-full:ParValuePerShare
      contextRef="AsOf2024-12-31"
      decimals="INF"
      id="Fact000251"
      unitRef="KRWShares">1</ifrs-full:ParValuePerShare>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2025-12-31"
      decimals="INF"
      id="Fact000253"
      unitRef="Shares">50000</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2024-12-31"
      decimals="INF"
      id="Fact000255"
      unitRef="Shares">50000</ifrs-full:NumberOfSharesIssued>
    <cik0002058261:CommonShares
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000257"
      unitRef="KRW">50000</cik0002058261:CommonShares>
    <cik0002058261:CommonShares
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000259"
      unitRef="KRW">50000</cik0002058261:CommonShares>
    <ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued
      contextRef="From2024-09-012024-09-30"
      decimals="INF"
      id="Fact000261"
      unitRef="Shares">50000</ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued>
    <ifrs-full:ProceedsFromIssuingShares
      contextRef="From2024-09-012024-09-30"
      decimals="0"
      id="Fact000263"
      unitRef="USD">50000</ifrs-full:ProceedsFromIssuingShares>
    <cik0002058261:OperatingSegmentsTextBlock contextRef="From2025-01-012025-12-31" id="Fact000265">&lt;p id="xdx_805_ecustom--OperatingSegmentsTextBlock_z7vOwGQu9Nj9" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;5. &lt;span id="xdx_82B_zXUHXbYqi68j"&gt;Operating Segments&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Segment Information: IFRS 8, Operating Segments (&#x201c;IFRS 8&#x201d;), defines operating segments as components of an enterprise where discrete financial information is available that is evaluated regularly by the chief operating decision-maker (&#x201c;CODM&#x201d;) in deciding how to allocate resources and in assessing performance. The Company operates as a single operating segment. The Company&#x2019;s CODM is the chief executive officer, who has ultimate responsibility for the operating performance of the Company and the allocation of resources. The CODM uses cash flows as the primary measure to manage the business and does not segment the business for internal reporting or decision making.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

</cik0002058261:OperatingSegmentsTextBlock>
    <ifrs-full:DisclosureOfRelatedPartyExplanatory contextRef="From2025-01-012025-12-31" id="Fact000267">&lt;p id="xdx_805_eifrs-full--DisclosureOfRelatedPartyExplanatory_zV7UWNlCkNt1" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;6. &lt;span id="xdx_82F_z8Bf5lO4Ci8"&gt;Related Parties&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;A. List of related parties&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;List of related parties that had transactions with the Company for the periods covered by the financial statements as of December&#160;31, 2025 and 2024 is as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; vertical-align: bottom; width: 49%; text-align: center"&gt;&lt;b&gt;Relationship&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; width: 2%; text-align: center; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; vertical-align: bottom; width: 49%; text-align: center"&gt;&lt;b&gt;Name of entity&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: top; background-color: #CAEDFB; text-align: center"&gt;Individual that has control over the Company (*1)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: top; background-color: #CAEDFB; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: top; background-color: #CAEDFB; text-align: center"&gt;EUN JONG CHOI&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: top; text-align: center"&gt;Other related party (*2)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: top; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: top; text-align: center"&gt;CUBEBIO Co., Ltd.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;div style="width: 25%; margin-left: 0; margin-right: auto"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.35in; text-align: left"&gt;(*1)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;The Company recognized &#x201c;EUN JONG CHOI&#x201d; as a related party as EUN JONG CHOI is a key management personnel member as the CEO of the Company, holding 100% of its equity share.&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;(*2)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;The Company recognized &#x201c;CUBEBIO Co., Ltd.&#x201d; as a related party as EUN JONG CHOI, an individual that has control over the Company, is simultaneously the CEO of &#x201c;CUBEBIO Co., Ltd.&#x201d;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;B. Account balances with related parties&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Details of receivables and payables account balances with related parties as of December&#160;31, 2025 and 2024 are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_892_ecustom--ScheduleOfPayablesAndReceivablesRelatedPartiesTableTextBlock_zJIHV8gbbxb7" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Related parties (Details)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td id="xdx_8B3_zefo3hUm2rSa" style="font: 10pt Times New Roman; display: none"&gt;Schedule of receivables and payables account balances related parties&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font: 10pt Times New Roman; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt; 2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman"&gt;&lt;b&gt;Related party&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Name&#160;of entity&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Payables&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Receivables&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In U.S. Dollar)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; width: 39%"&gt;Individual that has control over the Company&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 35%; text-align: left; vertical-align: top"&gt;EUN JONG CHOI&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--TradeAndOtherPayables_iI_pp0d_uUSD_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember_zgdkRpCayYM4" title="Payables"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0271"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_908_ecustom--OtherReceivable_iI_pp0d_uUSD_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember_zVDY99LbRok2" title="Receivables"&gt;52,918&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Other related party&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;CUBEBIO Co., Ltd.&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--TradeAndOtherPayables_iI_pp0d_uUSD_c20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubebioCo.Ltd.Member_zkVikhcSyjRd" title="Payables"&gt;31,751&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_907_ecustom--OtherReceivable_iI_pp0d_uUSD_c20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubebioCo.Ltd.Member_zSLv9kM9sZt9" title="Receivables"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0277"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; vertical-align: top; padding-bottom: 1.25pt"&gt;Total&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman; text-align: center; vertical-align: top; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--TradeAndOtherPayables_iI_pp0d_uUSD_c20251231_zxCkx1EpIBGa" title="Payables"&gt;31,751&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--OtherReceivable_iI_pp0d_uUSD_c20251231_zAh7ZpoLzGyk" title="Receivables"&gt;52,918&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt; 2024&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman"&gt;&lt;b&gt;Related party&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Name&#160;of entity&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Payables&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Receivables&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In U.S. Dollar)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; width: 39%"&gt;Individual that has control over the Company&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 35%; vertical-align: top; text-align: left"&gt;EUN JONG CHOI&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--TradeAndOtherPayables_iI_pp0d_uUSD_c20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember_zQJJza6Ey4Q4" title="Payables"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0283"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--OtherReceivable_iI_pp0d_uUSD_c20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember_zOrIUjTF6i2i" title="Receivables"&gt;50,618&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Other related party&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: top; text-align: left; padding-bottom: 0.5pt"&gt;CUBEBIO Co., Ltd.&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--TradeAndOtherPayables_iI_pp0d_uUSD_c20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CubebioCo.Ltd.Member_zny8MeWGP89c" title="Payables"&gt;30,371&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--OtherReceivable_iI_pp0d_uUSD_c20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubebioCo.Ltd.Member_zptR7G516vgk" title="Receivables"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0289"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; vertical-align: top; padding-left: 0.25in; padding-bottom: 1.25pt"&gt;Total&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman; text-align: center; vertical-align: top; padding-left: 0.25in; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--TradeAndOtherPayables_iI_pp0d_uUSD_c20241231_zDZLS4fNmyT9" title="Payables"&gt;30,371&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_900_ecustom--OtherReceivable_iI_pp0d_uUSD_c20241231_zJoN2p7j6718" title="Receivables"&gt;50,618&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A9_zxx65OPPtSqc" style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;C. Financing transactions with related parties&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Details of significant financing transactions with related parties for the years ended December&#160;31, 2025 and 2024 are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89C_ecustom--ScheduleOfSignificantFinancialTransactionsWithRelatedPartiesTableTextBlock_zefnnokR9a5k" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Related parties (Details 1)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td id="xdx_8B4_zxXBNOjG54Lj" style="font: 10pt Times New Roman; display: none; padding-bottom: 0.5pt"&gt;Schedule of significant financial transactions with related parties&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: top; text-align: left; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="font: 10pt Times New Roman; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: top; text-align: left; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman"&gt;&lt;b&gt;Related party&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; vertical-align: bottom; text-align: center"&gt;&lt;b&gt;Name&#160;of entity&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Account Name&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;January&#160;1&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Increase&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Decrease&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;December&#160;31&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In U.S. Dollar)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; width: 20%"&gt;Individual that has control over the Company&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 16%; text-align: left; vertical-align: top"&gt;EUN JONG CHOI&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 20%; text-align: left; vertical-align: top"&gt;
        &lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Other receivables&lt;/p&gt; &lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 7%; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--RelatedPartyBalances_iS_pp0d_uUSD_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember__ifrs-full--BorrowingsByNameAxis__custom--OtherReceivablesMember_zokAZtAhSGZ3" title="Beginning Balance"&gt;50,618&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 7%; text-align: right"&gt;&lt;span id="xdx_901_ecustom--Increase_pp0d_uUSD_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember__ifrs-full--BorrowingsByNameAxis__custom--OtherReceivablesMember_fKCoxKQ_____z7QaUSprE7B3" title="Increase"&gt;2,300&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;(*1)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 7%; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--Decrease_pp0d_uUSD_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember__ifrs-full--BorrowingsByNameAxis__custom--OtherReceivablesMember_zHsbZ5yqNXpa" title="Decrease"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0301"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 7%; text-align: right"&gt;&lt;span id="xdx_907_ecustom--RelatedPartyBalances_iE_pp0d_uUSD_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember__ifrs-full--BorrowingsByNameAxis__custom--OtherReceivablesMember_ziHKOAGgGqt7" title="Ending Balance"&gt;52,918&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Other related party&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;CUBEBIO Co., Ltd.&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;Promissory note payables&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--RelatedPartyBalances_iS_pp0d_uUSD_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubebioCo.Ltd.Member__ifrs-full--BorrowingsByNameAxis__custom--PromissoryNotePayablesMember_zfM1swBicXt7" title="Beginning Balance"&gt;30,371&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--Increase_pp0d_uUSD_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubebioCo.Ltd.Member__ifrs-full--BorrowingsByNameAxis__custom--PromissoryNotePayablesMember_fKCoyKQ_____zfpJyjL6bKh" title="Increase"&gt;1,380&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;(*2)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_909_ecustom--Decrease_pp0d_uUSD_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubebioCo.Ltd.Member__ifrs-full--BorrowingsByNameAxis__custom--PromissoryNotePayablesMember_zu4DLeieTghg" title="Decrease"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0309"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_906_ecustom--RelatedPartyBalances_iE_pp0d_uUSD_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubebioCo.Ltd.Member__ifrs-full--BorrowingsByNameAxis__custom--PromissoryNotePayablesMember_zMB0mocDWpB7" title="Ending Balance"&gt;31,751&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; padding-bottom: 1.25pt"&gt;Total&lt;/td&gt;
    &lt;td colspan="4" style="font: 10pt Times New Roman; text-align: center; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_909_ecustom--RelatedPartyBalances_iS_pp0d_uUSD_c20250101__20251231_zLgMidTCoffd" title="Beginning Balance"&gt;80,989&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_902_ecustom--Increase_pp0d_uUSD_c20250101__20251231_zrfdL3xb7rX6" title="Increase"&gt;3,680&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--Decrease_pp0d_uUSD_c20250101__20251231_zrvdPQ9EfzD4" title="Decrease"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0317"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--RelatedPartyBalances_iE_pp0d_uUSD_c20250101__20251231_zppEYKxZj1Gc" title="Ending Balance"&gt;84,669&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: top; text-align: left; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman"&gt;&lt;b&gt;Related party&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; vertical-align: bottom; text-align: center"&gt;&lt;b&gt;Name&#160;of entity&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Account Name&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;September&#160;24&lt;br/&gt; (Inception)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Increase&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Decrease&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;December&#160;31&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In U.S. Dollar)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; width: 20%"&gt;Individual that has control over the Company&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 16%; text-align: left; vertical-align: top"&gt;EUN JONG CHOI&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 20%; text-align: left; vertical-align: top"&gt;
        &lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Other receivables&lt;/p&gt; &lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 7%; text-align: right"&gt;&lt;span id="xdx_902_ecustom--RelatedPartyBalances_iS_pp0d_uUSD_c20240925__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember__ifrs-full--BorrowingsByNameAxis__custom--OtherReceivablesMember_zq7LCzM5qsua" title="Beginning Balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0321"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 7%; text-align: right"&gt;&lt;span id="xdx_906_ecustom--Increase_pp0d_uUSD_c20240925__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember__ifrs-full--BorrowingsByNameAxis__custom--OtherReceivablesMember_fKCozKQ_____zXue8mtFuEz1" title="Increase"&gt;50,618&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;(*3)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 7%; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--Decrease_pp0d_uUSD_c20240925__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember__ifrs-full--BorrowingsByNameAxis__custom--OtherReceivablesMember_zNeFrYsw5c12" title="Decrease"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0325"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 7%; text-align: right"&gt;&lt;span id="xdx_900_ecustom--RelatedPartyBalances_iE_pp0d_uUSD_c20240925__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember__ifrs-full--BorrowingsByNameAxis__custom--OtherReceivablesMember_z4MPV7tibZQh" title="Ending Balance"&gt;50,618&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Other related party&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;CUBEBIO Co., Ltd.&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;Promissory note payables&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--RelatedPartyBalances_iS_pp0d_uUSD_c20240924__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubebioCo.Ltd.Member__ifrs-full--BorrowingsByNameAxis__custom--PromissoryNotePayablesMember_zfrUBYGJiMA1" title="Beginning Balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0329"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_906_ecustom--Increase_pp0d_uUSD_c20240925__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubebioCo.Ltd.Member__ifrs-full--BorrowingsByNameAxis__custom--PromissoryNotePayablesMember_fKCo0KQ_____zScqEqleaL8c" title="Increase"&gt;30,371&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;(*4)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--Decrease_pp0d_uUSD_c20240925__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubebioCo.Ltd.Member__ifrs-full--BorrowingsByNameAxis__custom--PromissoryNotePayablesMember_zPm7Ef0NuoV3" title="Decrease"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0333"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--RelatedPartyBalances_iE_pp0d_uUSD_c20240925__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubebioCo.Ltd.Member__ifrs-full--BorrowingsByNameAxis__custom--PromissoryNotePayablesMember_zlN2LQbLWiv8" title="Ending Balance"&gt;30,371&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; padding-bottom: 1.25pt"&gt;Total&lt;/td&gt;
    &lt;td colspan="4" style="font: 10pt Times New Roman; text-align: center; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_905_ecustom--RelatedPartyBalances_iS_pp0d_uUSD_c20240925__20241231_z24Q75hz3e4i" title="Beginning Balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0337"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_ecustom--Increase_pp0d_uUSD_c20240924__20241231_zEGrt4kumTQd" title="Increase"&gt;80,989&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_907_ecustom--Decrease_pp0d_uUSD_c20240925__20241231_znNj2HLgUnv6" title="Decrease"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0341"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--RelatedPartyBalances_iE_pp0d_uUSD_c20240925__20241231_znJqZ61zBpld" title="Ending Balance"&gt;80,989&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;div style="width: 25%; margin-left: 0; margin-right: auto"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td id="xdx_F02_zjIgj3FCkQF9" style="font: 10pt Times New Roman; width: 0.35in; text-align: left"&gt;(*1)&lt;/td&gt;
    &lt;td id="xdx_F19_zq2IaDvtN9Ha" style="font: 10pt Times New Roman; text-align: justify"&gt;The Company recognized interest income accrued under an agreement to issue 50,000 shares of common share in consideration for gross proceeds of $50,000 during the year ended December&#160;31, 2025, which originally commenced in 2024 and was subsequently extended from 2025 to 2026.&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td id="xdx_F0B_zUNFXElnS7o3" style="font: 10pt Times New Roman; text-align: left"&gt;(*2)&lt;/td&gt;
    &lt;td id="xdx_F1E_znDTC0U6nGR8" style="font: 10pt Times New Roman; text-align: justify"&gt;The Company recognized interest expense accrued under a promissory note to pay $30,000 issued for common share issuing-related costs and organization costs paid by CubeBio Co., Ltd. on behalf of the Company&#160;during the year ended December&#160;31, 2025, which originally commenced in 2024 and was subsequently extended from 2025 to 2026.&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td id="xdx_F00_z3SVom8Kg9o" style="font: 10pt Times New Roman; text-align: left"&gt;(*3)&lt;/td&gt;
    &lt;td id="xdx_F14_zoQiMrwfdKRb" style="font: 10pt Times New Roman; text-align: justify"&gt;The Company recognized interest income accrued under an agreement to issue 50,000 shares of common share in consideration for gross proceeds of $50,000 during the period from September&#160;24, 2024 (inception), through December&#160;31, 2024.&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td id="xdx_F07_zf3Bksrc7Hdd" style="font: 10pt Times New Roman; text-align: left"&gt;(*4)&lt;/td&gt;
    &lt;td id="xdx_F1A_zJKRRwxT4lu7" style="font: 10pt Times New Roman; text-align: justify"&gt;The Company recognized interest expense accrued under a promissory note to pay $30,000 issued for common share issuing-related costs and organization costs paid by CubeBio Co., Ltd. on behalf of the Company during the period from September&#160;24, 2024 (inception), through December&#160;31, 2024.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A3_zPO2CDAkeQQl" style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

</ifrs-full:DisclosureOfRelatedPartyExplanatory>
    <cik0002058261:ScheduleOfPayablesAndReceivablesRelatedPartiesTableTextBlock contextRef="From2025-01-012025-12-31" id="Fact000269">&lt;table cellpadding="0" cellspacing="0" id="xdx_892_ecustom--ScheduleOfPayablesAndReceivablesRelatedPartiesTableTextBlock_zJIHV8gbbxb7" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Related parties (Details)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td id="xdx_8B3_zefo3hUm2rSa" style="font: 10pt Times New Roman; display: none"&gt;Schedule of receivables and payables account balances related parties&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font: 10pt Times New Roman; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt; 2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman"&gt;&lt;b&gt;Related party&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Name&#160;of entity&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Payables&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Receivables&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In U.S. Dollar)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; width: 39%"&gt;Individual that has control over the Company&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 35%; text-align: left; vertical-align: top"&gt;EUN JONG CHOI&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--TradeAndOtherPayables_iI_pp0d_uUSD_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember_zgdkRpCayYM4" title="Payables"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0271"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_908_ecustom--OtherReceivable_iI_pp0d_uUSD_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember_zVDY99LbRok2" title="Receivables"&gt;52,918&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Other related party&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;CUBEBIO Co., Ltd.&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--TradeAndOtherPayables_iI_pp0d_uUSD_c20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubebioCo.Ltd.Member_zkVikhcSyjRd" title="Payables"&gt;31,751&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_907_ecustom--OtherReceivable_iI_pp0d_uUSD_c20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubebioCo.Ltd.Member_zSLv9kM9sZt9" title="Receivables"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0277"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; vertical-align: top; padding-bottom: 1.25pt"&gt;Total&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman; text-align: center; vertical-align: top; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--TradeAndOtherPayables_iI_pp0d_uUSD_c20251231_zxCkx1EpIBGa" title="Payables"&gt;31,751&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--OtherReceivable_iI_pp0d_uUSD_c20251231_zAh7ZpoLzGyk" title="Receivables"&gt;52,918&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt; 2024&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman"&gt;&lt;b&gt;Related party&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Name&#160;of entity&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Payables&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Receivables&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In U.S. Dollar)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; width: 39%"&gt;Individual that has control over the Company&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 35%; vertical-align: top; text-align: left"&gt;EUN JONG CHOI&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--TradeAndOtherPayables_iI_pp0d_uUSD_c20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember_zQJJza6Ey4Q4" title="Payables"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0283"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--OtherReceivable_iI_pp0d_uUSD_c20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember_zOrIUjTF6i2i" title="Receivables"&gt;50,618&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Other related party&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: top; text-align: left; padding-bottom: 0.5pt"&gt;CUBEBIO Co., Ltd.&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--TradeAndOtherPayables_iI_pp0d_uUSD_c20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CubebioCo.Ltd.Member_zny8MeWGP89c" title="Payables"&gt;30,371&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--OtherReceivable_iI_pp0d_uUSD_c20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubebioCo.Ltd.Member_zptR7G516vgk" title="Receivables"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0289"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; vertical-align: top; padding-left: 0.25in; padding-bottom: 1.25pt"&gt;Total&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman; text-align: center; vertical-align: top; padding-left: 0.25in; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--TradeAndOtherPayables_iI_pp0d_uUSD_c20241231_zDZLS4fNmyT9" title="Payables"&gt;30,371&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_900_ecustom--OtherReceivable_iI_pp0d_uUSD_c20241231_zJoN2p7j6718" title="Receivables"&gt;50,618&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:ScheduleOfPayablesAndReceivablesRelatedPartiesTableTextBlock>
    <cik0002058261:OtherReceivable
      contextRef="AsOf2025-12-31_ifrs-full_RelatedPartiesMember_custom_EunJongChoiMember"
      decimals="0"
      id="Fact000273"
      unitRef="USD">52918</cik0002058261:OtherReceivable>
    <ifrs-full:TradeAndOtherPayables
      contextRef="AsOf2024-12-31_ifrs-full_RelatedPartiesMember_custom_CubebioCo.Ltd.Member"
      decimals="0"
      id="Fact000275"
      unitRef="USD">31751</ifrs-full:TradeAndOtherPayables>
    <ifrs-full:TradeAndOtherPayables
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000279"
      unitRef="USD">31751</ifrs-full:TradeAndOtherPayables>
    <cik0002058261:OtherReceivable
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000281"
      unitRef="USD">52918</cik0002058261:OtherReceivable>
    <cik0002058261:OtherReceivable
      contextRef="AsOf2024-12-31_ifrs-full_RelatedPartiesMember_custom_EunJongChoiMember"
      decimals="0"
      id="Fact000285"
      unitRef="USD">50618</cik0002058261:OtherReceivable>
    <ifrs-full:TradeAndOtherPayables
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member273609218"
      decimals="0"
      id="Fact000287"
      unitRef="USD">30371</ifrs-full:TradeAndOtherPayables>
    <ifrs-full:TradeAndOtherPayables
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000291"
      unitRef="USD">30371</ifrs-full:TradeAndOtherPayables>
    <cik0002058261:OtherReceivable
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000293"
      unitRef="USD">50618</cik0002058261:OtherReceivable>
    <cik0002058261:ScheduleOfSignificantFinancialTransactionsWithRelatedPartiesTableTextBlock contextRef="From2025-01-012025-12-31" id="Fact000295">&lt;table cellpadding="0" cellspacing="0" id="xdx_89C_ecustom--ScheduleOfSignificantFinancialTransactionsWithRelatedPartiesTableTextBlock_zefnnokR9a5k" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Related parties (Details 1)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td id="xdx_8B4_zxXBNOjG54Lj" style="font: 10pt Times New Roman; display: none; padding-bottom: 0.5pt"&gt;Schedule of significant financial transactions with related parties&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: top; text-align: left; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="font: 10pt Times New Roman; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: top; text-align: left; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman"&gt;&lt;b&gt;Related party&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; vertical-align: bottom; text-align: center"&gt;&lt;b&gt;Name&#160;of entity&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Account Name&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;January&#160;1&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Increase&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Decrease&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;December&#160;31&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In U.S. Dollar)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; width: 20%"&gt;Individual that has control over the Company&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 16%; text-align: left; vertical-align: top"&gt;EUN JONG CHOI&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 20%; text-align: left; vertical-align: top"&gt;
        &lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Other receivables&lt;/p&gt; &lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 7%; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--RelatedPartyBalances_iS_pp0d_uUSD_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember__ifrs-full--BorrowingsByNameAxis__custom--OtherReceivablesMember_zokAZtAhSGZ3" title="Beginning Balance"&gt;50,618&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 7%; text-align: right"&gt;&lt;span id="xdx_901_ecustom--Increase_pp0d_uUSD_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember__ifrs-full--BorrowingsByNameAxis__custom--OtherReceivablesMember_fKCoxKQ_____z7QaUSprE7B3" title="Increase"&gt;2,300&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;(*1)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 7%; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--Decrease_pp0d_uUSD_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember__ifrs-full--BorrowingsByNameAxis__custom--OtherReceivablesMember_zHsbZ5yqNXpa" title="Decrease"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0301"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 7%; text-align: right"&gt;&lt;span id="xdx_907_ecustom--RelatedPartyBalances_iE_pp0d_uUSD_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember__ifrs-full--BorrowingsByNameAxis__custom--OtherReceivablesMember_ziHKOAGgGqt7" title="Ending Balance"&gt;52,918&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Other related party&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;CUBEBIO Co., Ltd.&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;Promissory note payables&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--RelatedPartyBalances_iS_pp0d_uUSD_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubebioCo.Ltd.Member__ifrs-full--BorrowingsByNameAxis__custom--PromissoryNotePayablesMember_zfM1swBicXt7" title="Beginning Balance"&gt;30,371&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--Increase_pp0d_uUSD_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubebioCo.Ltd.Member__ifrs-full--BorrowingsByNameAxis__custom--PromissoryNotePayablesMember_fKCoyKQ_____zfpJyjL6bKh" title="Increase"&gt;1,380&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;(*2)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_909_ecustom--Decrease_pp0d_uUSD_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubebioCo.Ltd.Member__ifrs-full--BorrowingsByNameAxis__custom--PromissoryNotePayablesMember_zu4DLeieTghg" title="Decrease"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0309"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_906_ecustom--RelatedPartyBalances_iE_pp0d_uUSD_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubebioCo.Ltd.Member__ifrs-full--BorrowingsByNameAxis__custom--PromissoryNotePayablesMember_zMB0mocDWpB7" title="Ending Balance"&gt;31,751&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; padding-bottom: 1.25pt"&gt;Total&lt;/td&gt;
    &lt;td colspan="4" style="font: 10pt Times New Roman; text-align: center; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_909_ecustom--RelatedPartyBalances_iS_pp0d_uUSD_c20250101__20251231_zLgMidTCoffd" title="Beginning Balance"&gt;80,989&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_902_ecustom--Increase_pp0d_uUSD_c20250101__20251231_zrfdL3xb7rX6" title="Increase"&gt;3,680&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--Decrease_pp0d_uUSD_c20250101__20251231_zrvdPQ9EfzD4" title="Decrease"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0317"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--RelatedPartyBalances_iE_pp0d_uUSD_c20250101__20251231_zppEYKxZj1Gc" title="Ending Balance"&gt;84,669&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: top; text-align: left; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman"&gt;&lt;b&gt;Related party&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; vertical-align: bottom; text-align: center"&gt;&lt;b&gt;Name&#160;of entity&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Account Name&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;September&#160;24&lt;br/&gt; (Inception)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Increase&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Decrease&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;December&#160;31&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In U.S. Dollar)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; width: 20%"&gt;Individual that has control over the Company&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 16%; text-align: left; vertical-align: top"&gt;EUN JONG CHOI&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 20%; text-align: left; vertical-align: top"&gt;
        &lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Other receivables&lt;/p&gt; &lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 7%; text-align: right"&gt;&lt;span id="xdx_902_ecustom--RelatedPartyBalances_iS_pp0d_uUSD_c20240925__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember__ifrs-full--BorrowingsByNameAxis__custom--OtherReceivablesMember_zq7LCzM5qsua" title="Beginning Balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0321"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 7%; text-align: right"&gt;&lt;span id="xdx_906_ecustom--Increase_pp0d_uUSD_c20240925__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember__ifrs-full--BorrowingsByNameAxis__custom--OtherReceivablesMember_fKCozKQ_____zXue8mtFuEz1" title="Increase"&gt;50,618&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;(*3)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 7%; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--Decrease_pp0d_uUSD_c20240925__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember__ifrs-full--BorrowingsByNameAxis__custom--OtherReceivablesMember_zNeFrYsw5c12" title="Decrease"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0325"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 7%; text-align: right"&gt;&lt;span id="xdx_900_ecustom--RelatedPartyBalances_iE_pp0d_uUSD_c20240925__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember__ifrs-full--BorrowingsByNameAxis__custom--OtherReceivablesMember_z4MPV7tibZQh" title="Ending Balance"&gt;50,618&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Other related party&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;CUBEBIO Co., Ltd.&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;Promissory note payables&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--RelatedPartyBalances_iS_pp0d_uUSD_c20240924__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubebioCo.Ltd.Member__ifrs-full--BorrowingsByNameAxis__custom--PromissoryNotePayablesMember_zfrUBYGJiMA1" title="Beginning Balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0329"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_906_ecustom--Increase_pp0d_uUSD_c20240925__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubebioCo.Ltd.Member__ifrs-full--BorrowingsByNameAxis__custom--PromissoryNotePayablesMember_fKCo0KQ_____zScqEqleaL8c" title="Increase"&gt;30,371&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;(*4)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--Decrease_pp0d_uUSD_c20240925__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubebioCo.Ltd.Member__ifrs-full--BorrowingsByNameAxis__custom--PromissoryNotePayablesMember_zPm7Ef0NuoV3" title="Decrease"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0333"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--RelatedPartyBalances_iE_pp0d_uUSD_c20240925__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubebioCo.Ltd.Member__ifrs-full--BorrowingsByNameAxis__custom--PromissoryNotePayablesMember_zlN2LQbLWiv8" title="Ending Balance"&gt;30,371&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; padding-bottom: 1.25pt"&gt;Total&lt;/td&gt;
    &lt;td colspan="4" style="font: 10pt Times New Roman; text-align: center; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_905_ecustom--RelatedPartyBalances_iS_pp0d_uUSD_c20240925__20241231_z24Q75hz3e4i" title="Beginning Balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0337"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_ecustom--Increase_pp0d_uUSD_c20240924__20241231_zEGrt4kumTQd" title="Increase"&gt;80,989&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_907_ecustom--Decrease_pp0d_uUSD_c20240925__20241231_znNj2HLgUnv6" title="Decrease"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0341"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--RelatedPartyBalances_iE_pp0d_uUSD_c20240925__20241231_znJqZ61zBpld" title="Ending Balance"&gt;80,989&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;div style="width: 25%; margin-left: 0; margin-right: auto"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td id="xdx_F02_zjIgj3FCkQF9" style="font: 10pt Times New Roman; width: 0.35in; text-align: left"&gt;(*1)&lt;/td&gt;
    &lt;td id="xdx_F19_zq2IaDvtN9Ha" style="font: 10pt Times New Roman; text-align: justify"&gt;The Company recognized interest income accrued under an agreement to issue 50,000 shares of common share in consideration for gross proceeds of $50,000 during the year ended December&#160;31, 2025, which originally commenced in 2024 and was subsequently extended from 2025 to 2026.&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td id="xdx_F0B_zUNFXElnS7o3" style="font: 10pt Times New Roman; text-align: left"&gt;(*2)&lt;/td&gt;
    &lt;td id="xdx_F1E_znDTC0U6nGR8" style="font: 10pt Times New Roman; text-align: justify"&gt;The Company recognized interest expense accrued under a promissory note to pay $30,000 issued for common share issuing-related costs and organization costs paid by CubeBio Co., Ltd. on behalf of the Company&#160;during the year ended December&#160;31, 2025, which originally commenced in 2024 and was subsequently extended from 2025 to 2026.&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td id="xdx_F00_z3SVom8Kg9o" style="font: 10pt Times New Roman; text-align: left"&gt;(*3)&lt;/td&gt;
    &lt;td id="xdx_F14_zoQiMrwfdKRb" style="font: 10pt Times New Roman; text-align: justify"&gt;The Company recognized interest income accrued under an agreement to issue 50,000 shares of common share in consideration for gross proceeds of $50,000 during the period from September&#160;24, 2024 (inception), through December&#160;31, 2024.&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td id="xdx_F07_zf3Bksrc7Hdd" style="font: 10pt Times New Roman; text-align: left"&gt;(*4)&lt;/td&gt;
    &lt;td id="xdx_F1A_zJKRRwxT4lu7" style="font: 10pt Times New Roman; text-align: justify"&gt;The Company recognized interest expense accrued under a promissory note to pay $30,000 issued for common share issuing-related costs and organization costs paid by CubeBio Co., Ltd. on behalf of the Company during the period from September&#160;24, 2024 (inception), through December&#160;31, 2024.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:ScheduleOfSignificantFinancialTransactionsWithRelatedPartiesTableTextBlock>
    <cik0002058261:RelatedPartyBalances
      contextRef="AsOf2024-12-31_ifrs-full_RelatedPartiesMember_custom_EunJongChoiMember_custom_OtherReceivablesMember"
      decimals="0"
      id="Fact000297"
      unitRef="USD">50618</cik0002058261:RelatedPartyBalances>
    <cik0002058261:Increase
      contextRef="From2025-01-012025-12-31_ifrs-full_RelatedPartiesMember_custom_EunJongChoiMember_custom_OtherReceivablesMember"
      decimals="0"
      id="Fact000299"
      unitRef="USD">2300</cik0002058261:Increase>
    <cik0002058261:RelatedPartyBalances
      contextRef="AsOf2025-12-31_ifrs-full_RelatedPartiesMember_custom_EunJongChoiMember_custom_OtherReceivablesMember"
      decimals="0"
      id="Fact000303"
      unitRef="USD">52918</cik0002058261:RelatedPartyBalances>
    <cik0002058261:RelatedPartyBalances
      contextRef="AsOf2024-12-31_ifrs-full_RelatedPartiesMember_custom_CubebioCo.Ltd.Member_custom_PromissoryNotePayablesMember"
      decimals="0"
      id="Fact000305"
      unitRef="USD">30371</cik0002058261:RelatedPartyBalances>
    <cik0002058261:Increase
      contextRef="From2025-01-012025-12-31_ifrs-full_RelatedPartiesMember_custom_CubebioCo.Ltd.Member_custom_PromissoryNotePayablesMember"
      decimals="0"
      id="Fact000307"
      unitRef="USD">1380</cik0002058261:Increase>
    <cik0002058261:RelatedPartyBalances
      contextRef="AsOf2025-12-31_ifrs-full_RelatedPartiesMember_custom_CubebioCo.Ltd.Member_custom_PromissoryNotePayablesMember"
      decimals="0"
      id="Fact000311"
      unitRef="USD">31751</cik0002058261:RelatedPartyBalances>
    <cik0002058261:RelatedPartyBalances
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000313"
      unitRef="USD">80989</cik0002058261:RelatedPartyBalances>
    <cik0002058261:Increase
      contextRef="From2025-01-012025-12-31"
      decimals="0"
      id="Fact000315"
      unitRef="USD">3680</cik0002058261:Increase>
    <cik0002058261:RelatedPartyBalances
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000319"
      unitRef="USD">84669</cik0002058261:RelatedPartyBalances>
    <cik0002058261:Increase
      contextRef="From2024-09-252024-12-31_ifrs-full_RelatedPartiesMember_custom_EunJongChoiMember_custom_OtherReceivablesMember"
      decimals="0"
      id="Fact000323"
      unitRef="USD">50618</cik0002058261:Increase>
    <cik0002058261:RelatedPartyBalances
      contextRef="AsOf2024-12-31_ifrs-full_RelatedPartiesMember_custom_EunJongChoiMember_custom_OtherReceivablesMember"
      decimals="0"
      id="Fact000327"
      unitRef="USD">50618</cik0002058261:RelatedPartyBalances>
    <cik0002058261:Increase
      contextRef="From2024-09-252024-12-31_ifrs-full_RelatedPartiesMember_custom_CubebioCo.Ltd.Member_custom_PromissoryNotePayablesMember"
      decimals="0"
      id="Fact000331"
      unitRef="USD">30371</cik0002058261:Increase>
    <cik0002058261:RelatedPartyBalances
      contextRef="AsOf2024-12-31_ifrs-full_RelatedPartiesMember_custom_CubebioCo.Ltd.Member_custom_PromissoryNotePayablesMember"
      decimals="0"
      id="Fact000335"
      unitRef="USD">30371</cik0002058261:RelatedPartyBalances>
    <cik0002058261:Increase
      contextRef="From2024-09-242024-12-31"
      decimals="0"
      id="Fact000339"
      unitRef="USD">80989</cik0002058261:Increase>
    <cik0002058261:RelatedPartyBalances
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000343"
      unitRef="USD">80989</cik0002058261:RelatedPartyBalances>
    <ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory contextRef="From2025-01-012025-12-31" id="Fact000349">&lt;p id="xdx_808_eifrs-full--DisclosureOfTradeAndOtherPayablesExplanatory_zPGBnd1YIAje" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;7. &lt;span id="xdx_82E_zrQTXHpWZ6O8"&gt;Other Payables&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;As of December&#160;31, 2025, the Company recorded an accrued liability of $&lt;span id="xdx_903_eifrs-full--CurrentAccruedExpensesAndOtherCurrentLiabilities_iI_pp0d_uUSD_c20251231_zDzXumJWj971" title="Accrued liability"&gt;7,725&lt;/span&gt; in &#x201c;Other payables.&#x201d; This amount represents unpaid legal and corporate services fees, including the 2026 annual fees and disbursements for the provision of registered office services, due to Maples and Calder (Cayman) LLP.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

</ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory>
    <ifrs-full:CurrentAccruedExpensesAndOtherCurrentLiabilities
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000351"
      unitRef="USD">7725</ifrs-full:CurrentAccruedExpensesAndOtherCurrentLiabilities>
    <cik0002058261:GoingConcernsTextBlock contextRef="From2025-01-012025-12-31" id="Fact000353">&lt;p id="xdx_801_ecustom--GoingConcernsTextBlock_zBSAWu8OxHUc" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;8. &lt;span id="xdx_82B_zeacr2vZsHLc"&gt;Going concern&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0; color: #242424"&gt;The Company is a holding company and does not expect to generate operating revenues. Since incorporation, the Company&#x2019;s activities have been limited to formation and corporate establishment matters. For the year ended December&#160;31, 2025, the Company incurred a net loss of $&lt;span id="xdx_903_eifrs-full--ProfitLoss_iN_di_uUSD_c20250101__20251231_zEhSMGMj3pri" title="Net loss"&gt;6,805&lt;/span&gt;, primarily attributable to organization and establishment costs. The Company will continue to incur ongoing corporate and reporting costs and will require funding from its shareholder(s) or other financing sources to meet its obligations as they fall due. These conditions indicate the existence of a material uncertainty that may cast significant doubt on the Company&#x2019;s ability to continue as a going concern. The financial statements have been prepared on a going concern basis and do not include any adjustments that might result from the outcome of this uncertainty.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

</cik0002058261:GoingConcernsTextBlock>
    <ifrs-full:ProfitLoss
      contextRef="From2025-01-012025-12-31"
      decimals="0"
      id="Fact000355"
      unitRef="USD">-6805</ifrs-full:ProfitLoss>
    <cik0002058261:DisclosureOfEventAfterReportingPeriodExplanatory contextRef="From2025-01-012025-12-31" id="Fact000357">&lt;p id="xdx_807_ecustom--DisclosureOfEventAfterReportingPeriodExplanatory_ztT0cUhW95Wb" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;9. &lt;span id="xdx_82D_z5KzFDadH5Ue"&gt;Subsequent events&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to July&#160;10, 2026, the date when the financial statements were available to be issued. Based upon the review, the Company did not identify any subsequent events that would have required adjustments or disclosure in the financial statements.&lt;/p&gt;

</cik0002058261:DisclosureOfEventAfterReportingPeriodExplanatory>
    <ifrs-full:OtherReceivables
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000362"
      unitRef="USD">54058</ifrs-full:OtherReceivables>
    <ifrs-full:OtherReceivables
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000363"
      unitRef="USD">52918</ifrs-full:OtherReceivables>
    <ifrs-full:CurrentAssets
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000365"
      unitRef="USD">54058</ifrs-full:CurrentAssets>
    <ifrs-full:CurrentAssets
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000366"
      unitRef="USD">52918</ifrs-full:CurrentAssets>
    <ifrs-full:Assets
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000368"
      unitRef="USD">54058</ifrs-full:Assets>
    <ifrs-full:Assets
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000369"
      unitRef="USD">52918</ifrs-full:Assets>
    <cik0002058261:PromissoryNotePayablesRelatedParties
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000374"
      unitRef="USD">32435</cik0002058261:PromissoryNotePayablesRelatedParties>
    <cik0002058261:PromissoryNotePayablesRelatedParties
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000375"
      unitRef="USD">31751</cik0002058261:PromissoryNotePayablesRelatedParties>
    <ifrs-full:OtherPayables
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000377"
      unitRef="USD">7725</ifrs-full:OtherPayables>
    <ifrs-full:OtherPayables
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000378"
      unitRef="USD">7725</ifrs-full:OtherPayables>
    <ifrs-full:CurrentLiabilities
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000380"
      unitRef="USD">40160</ifrs-full:CurrentLiabilities>
    <ifrs-full:CurrentLiabilities
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000381"
      unitRef="USD">39476</ifrs-full:CurrentLiabilities>
    <ifrs-full:Liabilities
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000383"
      unitRef="USD">40160</ifrs-full:Liabilities>
    <ifrs-full:Liabilities
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000384"
      unitRef="USD">39476</ifrs-full:Liabilities>
    <ifrs-full:IssuedCapital
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000389"
      unitRef="USD">50000</ifrs-full:IssuedCapital>
    <ifrs-full:IssuedCapital
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000390"
      unitRef="USD">50000</ifrs-full:IssuedCapital>
    <ifrs-full:RetainedEarnings
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000392"
      unitRef="USD">-36102</ifrs-full:RetainedEarnings>
    <ifrs-full:RetainedEarnings
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000393"
      unitRef="USD">-36558</ifrs-full:RetainedEarnings>
    <ifrs-full:Equity
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000395"
      unitRef="USD">13898</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000396"
      unitRef="USD">13442</ifrs-full:Equity>
    <ifrs-full:EquityAndLiabilities
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000398"
      unitRef="USD">54058</ifrs-full:EquityAndLiabilities>
    <ifrs-full:EquityAndLiabilities
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000399"
      unitRef="USD">52918</ifrs-full:EquityAndLiabilities>
    <cik0002058261:InterestIncomes
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000425"
      unitRef="USD">1140</cik0002058261:InterestIncomes>
    <cik0002058261:InterestIncomes
      contextRef="From2025-01-012025-06-30"
      decimals="0"
      id="Fact000426"
      unitRef="USD">1140</cik0002058261:InterestIncomes>
    <cik0002058261:InterestsExpense
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000428"
      unitRef="USD">684</cik0002058261:InterestsExpense>
    <cik0002058261:InterestsExpense
      contextRef="From2025-01-012025-06-30"
      decimals="0"
      id="Fact000429"
      unitRef="USD">684</cik0002058261:InterestsExpense>
    <ifrs-full:ProfitLoss
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000431"
      unitRef="USD">456</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="From2025-01-012025-06-30"
      decimals="0"
      id="Fact000432"
      unitRef="USD">456</ifrs-full:ProfitLoss>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000437"
      unitRef="USD">456</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="From2025-01-012025-06-30"
      decimals="0"
      id="Fact000438"
      unitRef="USD">456</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:WeightedAverageShares
      contextRef="From2026-01-01to2026-06-30"
      decimals="INF"
      id="Fact000440"
      unitRef="Shares">50000</ifrs-full:WeightedAverageShares>
    <ifrs-full:WeightedAverageShares
      contextRef="From2025-01-012025-06-30"
      decimals="INF"
      id="Fact000441"
      unitRef="Shares">50000</ifrs-full:WeightedAverageShares>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="From2026-01-01to2026-06-30"
      decimals="INF"
      id="Fact000443"
      unitRef="USDPShares">0.01</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="From2026-01-01to2026-06-30"
      decimals="INF"
      id="Fact000445"
      unitRef="USDPShares">0.01</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="From2025-01-012025-06-30"
      decimals="INF"
      id="Fact000447"
      unitRef="USDPShares">0.01</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="From2025-01-012025-06-30"
      decimals="INF"
      id="Fact000449"
      unitRef="USDPShares">0.01</ifrs-full:DilutedEarningsLossPerShare>
    <cik0002058261:ShareIssued
      contextRef="AsOf2024-12-31_custom_CommonStocksMember"
      decimals="INF"
      id="Fact000455"
      unitRef="Shares">50000</cik0002058261:ShareIssued>
    <ifrs-full:EquityAttributableToOwnersOfParent
      contextRef="AsOf2024-12-31_custom_CommonStocksMember"
      decimals="0"
      id="Fact000451"
      unitRef="USD">50000</ifrs-full:EquityAttributableToOwnersOfParent>
    <ifrs-full:EquityAttributableToOwnersOfParent
      contextRef="AsOf2024-12-31_ifrs-full_RetainedEarnings"
      decimals="0"
      id="Fact000452"
      unitRef="USD">-29753</ifrs-full:EquityAttributableToOwnersOfParent>
    <ifrs-full:EquityAttributableToOwnersOfParent
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000453"
      unitRef="USD">20247</ifrs-full:EquityAttributableToOwnersOfParent>
    <ifrs-full:ProfitLoss
      contextRef="From2025-01-012025-06-30_ifrs-full_RetainedEarnings"
      decimals="0"
      id="Fact000458"
      unitRef="USD">456</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="From2025-01-012025-06-30"
      decimals="0"
      id="Fact000459"
      unitRef="USD">456</ifrs-full:ProfitLoss>
    <cik0002058261:ShareIssued
      contextRef="AsOf2025-06-30_custom_CommonStocksMember"
      decimals="INF"
      id="Fact000465"
      unitRef="Shares">50000</cik0002058261:ShareIssued>
    <ifrs-full:EquityAttributableToOwnersOfParent
      contextRef="AsOf2025-06-30_custom_CommonStocksMember"
      decimals="0"
      id="Fact000461"
      unitRef="USD">50000</ifrs-full:EquityAttributableToOwnersOfParent>
    <ifrs-full:EquityAttributableToOwnersOfParent
      contextRef="AsOf2025-06-30_ifrs-full_RetainedEarnings"
      decimals="0"
      id="Fact000462"
      unitRef="USD">-29297</ifrs-full:EquityAttributableToOwnersOfParent>
    <ifrs-full:EquityAttributableToOwnersOfParent
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000463"
      unitRef="USD">20703</ifrs-full:EquityAttributableToOwnersOfParent>
    <cik0002058261:ShareIssued
      contextRef="AsOf2025-12-31_custom_CommonStocksMember"
      decimals="INF"
      id="Fact000471"
      unitRef="Shares">50000</cik0002058261:ShareIssued>
    <ifrs-full:EquityAttributableToOwnersOfParent
      contextRef="AsOf2025-12-31_custom_CommonStocksMember"
      decimals="0"
      id="Fact000467"
      unitRef="USD">50000</ifrs-full:EquityAttributableToOwnersOfParent>
    <ifrs-full:EquityAttributableToOwnersOfParent
      contextRef="AsOf2025-12-31_ifrs-full_RetainedEarnings"
      decimals="0"
      id="Fact000468"
      unitRef="USD">-36558</ifrs-full:EquityAttributableToOwnersOfParent>
    <ifrs-full:EquityAttributableToOwnersOfParent
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000469"
      unitRef="USD">13442</ifrs-full:EquityAttributableToOwnersOfParent>
    <ifrs-full:ProfitLoss
      contextRef="From2026-01-012026-06-30_ifrs-full_RetainedEarnings"
      decimals="0"
      id="Fact000474"
      unitRef="USD">456</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000475"
      unitRef="USD">456</ifrs-full:ProfitLoss>
    <cik0002058261:ShareIssued
      contextRef="AsOf2025-12-31_custom_CommonStocksMember"
      decimals="INF"
      id="Fact000481"
      unitRef="Shares">50000</cik0002058261:ShareIssued>
    <ifrs-full:EquityAttributableToOwnersOfParent
      contextRef="AsOf2026-06-30_custom_CommonStocksMember"
      decimals="0"
      id="Fact000477"
      unitRef="USD">50000</ifrs-full:EquityAttributableToOwnersOfParent>
    <ifrs-full:EquityAttributableToOwnersOfParent
      contextRef="AsOf2026-06-30_ifrs-full_RetainedEarnings"
      decimals="0"
      id="Fact000478"
      unitRef="USD">-36102</ifrs-full:EquityAttributableToOwnersOfParent>
    <ifrs-full:EquityAttributableToOwnersOfParent
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000479"
      unitRef="USD">13898</ifrs-full:EquityAttributableToOwnersOfParent>
    <ifrs-full:ProfitLoss
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000486"
      unitRef="USD">456</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="From2025-01-012025-06-30"
      decimals="0"
      id="Fact000487"
      unitRef="USD">456</ifrs-full:ProfitLoss>
    <cik0002058261:PromissoryNotePayablesRelatedPartie
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000498"
      unitRef="USD">684</cik0002058261:PromissoryNotePayablesRelatedPartie>
    <cik0002058261:PromissoryNotePayablesRelatedPartie
      contextRef="From2025-01-012025-06-30"
      decimals="0"
      id="Fact000499"
      unitRef="USD">684</cik0002058261:PromissoryNotePayablesRelatedPartie>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000501"
      unitRef="USD">-1140</ifrs-full:AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables
      contextRef="From2025-01-012025-06-30"
      decimals="0"
      id="Fact000502"
      unitRef="USD">-1140</ifrs-full:AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables>
    <cik0002058261:DisclosureOfGeneralInformationExplanatory contextRef="From2026-01-01to2026-06-30" id="Fact000528">&lt;p id="xdx_80C_ecustom--DisclosureOfGeneralInformationExplanatory_zRleIy7T0mOk" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;1. &lt;span id="xdx_82D_z706psWn3ENf"&gt;General Information&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;CUBEBIO
Holdings Limited (the &#x201c;Company,&#x201d; or &#x201c;CHL&#x201d;) was incorporated on September&#160;24, 2024 and the Company&#x2019;s
registered office is at c/o Maples Corporate Services Limited, PO Box 309, Ugland House Grand Cayman, KY1-1104 Cayman Islands. The Company
was formed for the purpose of becoming the ultimate parent company following the transactions contemplated in the Business Combination
Agreement (as described in the next paragraph). The Company will maintain two direct wholly-owned subsidiaries, CHL SPAC Merger Sub Inc.
(the &#x201c;SPAC Merger Sub&#x201d;), a Delaware corporation and CHL Korea Exchange Sub Ltd. (the &#x201c;Exchange Sub&#x2019;), a stock
corporation to be organized under the laws of the Republic of Korea. SPAC Merger Sub was incorporated on June 25, 2026, to facilitate
the consummation of the Business Combination. As of June 30, 2026, Exchange Sub had not yet been formed and was subsequently formed on
August 28, 2026.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;On August&#160;29, 2024, Mountain Crest Acquisition Corp., V, a Delaware corporation (&#x201c;MCAG&#x201d;), entered into the Business Combination Agreement, as may be amended, supplemented or otherwise modified from time to time, the &#x201c;BCA&#x201d;, by and between MCAG and CUBEBIO Co., Ltd., a corporation organized under the laws of Korea (the &#x201c;CUBEBIO&#x201d;), pursuant to which the following transactions will occur: subject to the approval and adoption of the BCA by the stockholders of MCAG and CUBEBIO, (1) SPAC Merger Sub will be merged with and into MCAG with MCAG being the surviving entity (the &#x201c;SPAC Merger&#x201d;) as a direct wholly owned subsidiary of the Company, and (2) all shareholders of CUBEBIO shall transfer their respective common shares to the Exchange Sub, in exchange for the right to receive the Company&#x2019;s common shares (the &#x201c;Share Swap&#x201d; and collectively with the SPAC Merger the &#x201c;Business Combination&#x201d;). Following the closing of the Business Combination, the Company expects the Company&#x2019;s common shares to be listed and traded on The Nasdaq Stock Market.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Following the consummation of the transactions contemplated by the BCA, the Company will be the surviving publicly-traded entity. However, the consummation of the transactions contemplated by the BCA is subject to numerous conditions, and there can be no assurances that such conditions will be satisfied.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

</cik0002058261:DisclosureOfGeneralInformationExplanatory>
    <cik0002058261:BasisOfAccountingTextBlock contextRef="From2026-01-01to2026-06-30" id="Fact000530">&lt;p id="xdx_80B_ecustom--BasisOfAccountingTextBlock_zLj1Vi2xt6li" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;2. &lt;span id="xdx_82C_zSrzSzHZlLeb"&gt;Basis of Accounting&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;These unaudited interim condensed financial statements have been prepared in accordance with the International Financial Reporting Standards (&#x201c;IFRS&#x201d;) issued by the International Accounting Standards Board (&#x201c;IASB&#x201d;), on the historical cost basis, and in the presentation currency U.S. dollar (&#x201c;$&#x201d;). All amounts are in actual U.S. Dollar unless otherwise stated. These unaudited interim condensed financial statements were authorized for issuance by the board of directors on October&#160;13, 2026.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The number of shares used to calculate diluted income per share of common shares attributable to common shareholders is the same as the number of shares used to calculate basic income per share of common shares attributable to common shareholders for the period presented because there were no potentially dilutive securities outstanding during the period.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The income per share presented in the statement of operations and comprehensive income is based on the following for the six-month periods ended June&#160;30, 2026 and 2025:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_889_ecustom--DisclosureOfDetailedInformationAboutBasicAndDilutedLossPerShareExplanatory_zj3VXyklARN5" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Basis of Accounting (Details)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td id="xdx_8BD_zgnFkx3xqE0j" style="display: none; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Basis of Accounting&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 0.5pt; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Six-month&lt;br/&gt; period ended&lt;br/&gt; June&#160;30,&lt;br/&gt; 2026&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Six-month&lt;br/&gt; period ended&lt;br/&gt; June&#160;30,&lt;br/&gt; 2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&lt;i&gt;Basic and diluted net income per share:&lt;/i&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Numerator&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left; vertical-align: top"&gt;Allocation of net income (loss)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--ProfitLoss_pp0d_uUSD_c20260101__20260630_zDPIDP2gpPxd" title="Allocation of net loss"&gt;456&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--ProfitLoss_pp0d_uUSD_c20250101__20250630_zzhHfw0q8hqj" title="Allocation of net loss"&gt;456&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Denominator:&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;Basic and diluted weighted average number of shares outstanding&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--WeightedAverageShares_c20260101__20260630_pd" title="Basic and diluted weighted average number of shares outstanding"&gt;50,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--WeightedAverageShares_c20250101__20250630_pd" title="Basic and diluted weighted average number of shares outstanding"&gt;50,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;Basic and diluted net income (loss) per share&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--BasicEarningsLossPerShare_c20260101__20260630_pd" title="Basic earnings per share"&gt;&lt;span id="xdx_905_eifrs-full--DilutedEarningsLossPerShare_c20260101__20260630_pd" title="Diluted net loss per share"&gt;0.01&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--BasicEarningsLossPerShare_c20250101__20250630_pd" title="Basic earnings per share"&gt;&lt;span id="xdx_907_eifrs-full--DilutedEarningsLossPerShare_c20250101__20250630_pd" title="Diluted net loss per share"&gt;0.01&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

















</cik0002058261:BasisOfAccountingTextBlock>
    <cik0002058261:DisclosureOfDetailedInformationAboutBasicAndDilutedLossPerShareExplanatory contextRef="From2026-01-01to2026-06-30" id="Fact000532">&lt;table cellpadding="0" cellspacing="0" id="xdx_889_ecustom--DisclosureOfDetailedInformationAboutBasicAndDilutedLossPerShareExplanatory_zj3VXyklARN5" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Basis of Accounting (Details)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td id="xdx_8BD_zgnFkx3xqE0j" style="display: none; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Basis of Accounting&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 0.5pt; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Six-month&lt;br/&gt; period ended&lt;br/&gt; June&#160;30,&lt;br/&gt; 2026&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Six-month&lt;br/&gt; period ended&lt;br/&gt; June&#160;30,&lt;br/&gt; 2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&lt;i&gt;Basic and diluted net income per share:&lt;/i&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Numerator&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left; vertical-align: top"&gt;Allocation of net income (loss)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--ProfitLoss_pp0d_uUSD_c20260101__20260630_zDPIDP2gpPxd" title="Allocation of net loss"&gt;456&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--ProfitLoss_pp0d_uUSD_c20250101__20250630_zzhHfw0q8hqj" title="Allocation of net loss"&gt;456&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Denominator:&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;Basic and diluted weighted average number of shares outstanding&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--WeightedAverageShares_c20260101__20260630_pd" title="Basic and diluted weighted average number of shares outstanding"&gt;50,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--WeightedAverageShares_c20250101__20250630_pd" title="Basic and diluted weighted average number of shares outstanding"&gt;50,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;Basic and diluted net income (loss) per share&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--BasicEarningsLossPerShare_c20260101__20260630_pd" title="Basic earnings per share"&gt;&lt;span id="xdx_905_eifrs-full--DilutedEarningsLossPerShare_c20260101__20260630_pd" title="Diluted net loss per share"&gt;0.01&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--BasicEarningsLossPerShare_c20250101__20250630_pd" title="Basic earnings per share"&gt;&lt;span id="xdx_907_eifrs-full--DilutedEarningsLossPerShare_c20250101__20250630_pd" title="Diluted net loss per share"&gt;0.01&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;</cik0002058261:DisclosureOfDetailedInformationAboutBasicAndDilutedLossPerShareExplanatory>
    <ifrs-full:ProfitLoss
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000534"
      unitRef="USD">456</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="From2025-01-012025-06-30"
      decimals="0"
      id="Fact000536"
      unitRef="USD">456</ifrs-full:ProfitLoss>
    <ifrs-full:WeightedAverageShares
      contextRef="From2026-01-01to2026-06-30"
      decimals="INF"
      id="Fact000538"
      unitRef="Shares">50000</ifrs-full:WeightedAverageShares>
    <ifrs-full:WeightedAverageShares
      contextRef="From2025-01-012025-06-30"
      decimals="INF"
      id="Fact000540"
      unitRef="Shares">50000</ifrs-full:WeightedAverageShares>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="From2026-01-01to2026-06-30"
      decimals="INF"
      id="Fact000542"
      unitRef="KRWShares">0.01</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="From2026-01-01to2026-06-30"
      decimals="INF"
      id="Fact000544"
      unitRef="KRWShares">0.01</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="From2025-01-012025-06-30"
      decimals="INF"
      id="Fact000546"
      unitRef="KRWShares">0.01</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="From2025-01-012025-06-30"
      decimals="INF"
      id="Fact000548"
      unitRef="KRWShares">0.01</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory contextRef="From2026-01-01to2026-06-30" id="Fact000557">&lt;p id="xdx_80A_eifrs-full--DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory_zdV8iHkLI3Ya" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;3. &lt;span id="xdx_82B_z0kIDtoSsDld"&gt;Material accounting policies&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The material following accounting policies followed by the Company in preparation of its unaudited interim condensed financial statements are as follows:&lt;/p&gt;

&lt;p id="xdx_84A_ecustom--FinancialAssetsAndFinancialLiabilitiesPoliciesTextBlock_zQH5ajCJZTTf" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in; text-align: justify"&gt;A.&lt;/td&gt;
    &lt;td id="xdx_860_zYCGArPY0HG6" style="text-align: justify"&gt;Financial assets and Financial liabilities&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Financial instruments are any form of contract that gives rise to a financial asset in one company and a financial liability or equity instrument in another company. A financial asset or financial liability is included in the balance sheet when the entity becomes a party to the contractual terms of the instrument. Other financial liabilities and other financial assets, including liabilities to and receivables from related parties, are valued at amortized cost. A financial asset is removed from the balance sheet when the contractual right to cash flow from the asset has ceased or been settled. The same applies where the risks and benefits associated with the holding are essentially transferred to another party and the entity no longer has control over the financial asset. Financial liability is derecognized when the agreed obligation has been fulfilled or ceased.&lt;/p&gt;

&lt;p id="xdx_84B_ecustom--OrganizationCostPoliciesTextBlock_zPXMAe7NZ2A5" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in; text-align: justify"&gt;B.&lt;/td&gt;
    &lt;td id="xdx_860_zl9favqox8Zi" style="text-align: justify"&gt;Organization cost&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;When issuing common share, incremental costs directly attributable to the equity transaction that otherwise would have been avoided are accounted for as a deduction from equity while other issuing-related costs and organization costs are expensed as incurred.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;On September&#160;24, 2024, the amount of $&lt;span id="xdx_903_ecustom--OrganizationCost_pp0d_uUSD_c20260101__20260630_zgu1S0RPIXUh" title="Organization cost"&gt;30,000&lt;/span&gt; was expensed as incurred whose amount was paid on behalf of the Company and accordingly the Company owed CubeBio Co., Ltd. that would go through the Share Swap with the Exchange Sub, to be organized under the laws of the Republic of Korea, to pay $30,000 USD in accordance with the&#160;terms and conditions of its&#160;corresponding promissory note in return in a year. It was recorded as a payable under the caption Promissory note payables &#x2013; related parties in the Company&#x2019;s Statement of Financial Position. On September&#160;24, 2025, the Company entered into an agreement that extends the maturity date of the promissory note from September&#160;24, 2025 to September&#160;24, 2026, with all other material terms remaining unchanged. On September&#160;24, 2026, the Company entered into an agreement that extends the maturity date of the promissory note from September&#160;24, 2026 to September&#160;24, 2027, with all other material terms remaining unchanged.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

</ifrs-full:DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory>
    <cik0002058261:FinancialAssetsAndFinancialLiabilitiesPoliciesTextBlock contextRef="From2026-01-01to2026-06-30" id="Fact000559">&lt;p id="xdx_84A_ecustom--FinancialAssetsAndFinancialLiabilitiesPoliciesTextBlock_zQH5ajCJZTTf" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in; text-align: justify"&gt;A.&lt;/td&gt;
    &lt;td id="xdx_860_zYCGArPY0HG6" style="text-align: justify"&gt;Financial assets and Financial liabilities&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Financial instruments are any form of contract that gives rise to a financial asset in one company and a financial liability or equity instrument in another company. A financial asset or financial liability is included in the balance sheet when the entity becomes a party to the contractual terms of the instrument. Other financial liabilities and other financial assets, including liabilities to and receivables from related parties, are valued at amortized cost. A financial asset is removed from the balance sheet when the contractual right to cash flow from the asset has ceased or been settled. The same applies where the risks and benefits associated with the holding are essentially transferred to another party and the entity no longer has control over the financial asset. Financial liability is derecognized when the agreed obligation has been fulfilled or ceased.&lt;/p&gt;

</cik0002058261:FinancialAssetsAndFinancialLiabilitiesPoliciesTextBlock>
    <cik0002058261:OrganizationCostPoliciesTextBlock contextRef="From2026-01-01to2026-06-30" id="Fact000561">&lt;p id="xdx_84B_ecustom--OrganizationCostPoliciesTextBlock_zPXMAe7NZ2A5" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in; text-align: justify"&gt;B.&lt;/td&gt;
    &lt;td id="xdx_860_zl9favqox8Zi" style="text-align: justify"&gt;Organization cost&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;When issuing common share, incremental costs directly attributable to the equity transaction that otherwise would have been avoided are accounted for as a deduction from equity while other issuing-related costs and organization costs are expensed as incurred.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;On September&#160;24, 2024, the amount of $&lt;span id="xdx_903_ecustom--OrganizationCost_pp0d_uUSD_c20260101__20260630_zgu1S0RPIXUh" title="Organization cost"&gt;30,000&lt;/span&gt; was expensed as incurred whose amount was paid on behalf of the Company and accordingly the Company owed CubeBio Co., Ltd. that would go through the Share Swap with the Exchange Sub, to be organized under the laws of the Republic of Korea, to pay $30,000 USD in accordance with the&#160;terms and conditions of its&#160;corresponding promissory note in return in a year. It was recorded as a payable under the caption Promissory note payables &#x2013; related parties in the Company&#x2019;s Statement of Financial Position. On September&#160;24, 2025, the Company entered into an agreement that extends the maturity date of the promissory note from September&#160;24, 2025 to September&#160;24, 2026, with all other material terms remaining unchanged. On September&#160;24, 2026, the Company entered into an agreement that extends the maturity date of the promissory note from September&#160;24, 2026 to September&#160;24, 2027, with all other material terms remaining unchanged.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

</cik0002058261:OrganizationCostPoliciesTextBlock>
    <cik0002058261:OrganizationCost
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000563"
      unitRef="USD">30000</cik0002058261:OrganizationCost>
    <ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory contextRef="From2026-01-01to2026-06-30" id="Fact000565">&lt;p id="xdx_804_eifrs-full--DisclosureOfClassesOfShareCapitalExplanatory_zAL72VctwMoh" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;4. &lt;span id="xdx_82E_zzYlmA0msx4d"&gt;Share capital&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Details of share capital as of June&#160;30, 2026 and December&#160;31, 2025 are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89F_ecustom--ScheduleOfShareCapitalTableTextBlock_zJ5Zn3fcVBAb" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Share capital (Details)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td id="xdx_8BB_zLgnbJX0U2Jb" style="display: none; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Schedule of share capital&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;b&gt;June&#160;30,&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 0.5pt; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;2026&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Number of authorized shares&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--NumberOfAuthorizedShares_c20260630_pd" title="Number of authorized shares"&gt;50,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_904_ecustom--NumberOfAuthorizedShares_iI_c20251231_zft55whuBys7" title="Number of authorized shares"&gt;50,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Value per share&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--ParValuePerShare_c20260630_pd" title="Value per share"&gt;1&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--ParValuePerShare_iI_c20251231_zJvdc4TnKAi1" title="Value per share"&gt;1&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;Number of shares issued&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--NumberOfSharesIssued_c20260630_pd" title="Number of shares issued"&gt;50,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--NumberOfSharesIssued_iI_c20251231_zXsILIhnN7h4" title="Number of shares issued"&gt;50,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;Common shares&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_901_ecustom--CommonShares_c20260630_pp0p" title="Common shares"&gt;50,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_903_ecustom--CommonShares_iI_pp0d_c20251231_zp3g9OFSrvJ" title="Common shares"&gt;50,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;During September&#160;2024, the Company entered into an agreement to issue &lt;span id="xdx_904_eifrs-full--IncreaseDecreaseInNumberOfOrdinarySharesIssued_c20240901__20240930_zv1P1TWnDvba" title="Number of shares issued"&gt;50,000&lt;/span&gt; shares of common shares for gross proceeds of $&lt;span id="xdx_90A_eifrs-full--ProceedsFromIssuingShares_pp0d_uUSD_c20240901__20240930_zPqy6CqF96Rk" title="Proceeds from shares issued"&gt;50,000&lt;/span&gt;. Each ordinary share maintains one voting right. The entire amount of this equity is held by the CEO of the Company and remains recorded as receivable under the caption Other receivables &#x2013; related parties in the Company&#x2019;s Statement of Financial Position as of June&#160;30, 2026 and December&#160;31, 2025.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

















</ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory>
    <cik0002058261:ScheduleOfShareCapitalTableTextBlock contextRef="From2026-01-01to2026-06-30" id="Fact000567">&lt;table cellpadding="0" cellspacing="0" id="xdx_89F_ecustom--ScheduleOfShareCapitalTableTextBlock_zJ5Zn3fcVBAb" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Share capital (Details)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td id="xdx_8BB_zLgnbJX0U2Jb" style="display: none; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Schedule of share capital&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;b&gt;June&#160;30,&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 0.5pt; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;2026&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Number of authorized shares&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--NumberOfAuthorizedShares_c20260630_pd" title="Number of authorized shares"&gt;50,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_904_ecustom--NumberOfAuthorizedShares_iI_c20251231_zft55whuBys7" title="Number of authorized shares"&gt;50,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Value per share&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--ParValuePerShare_c20260630_pd" title="Value per share"&gt;1&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--ParValuePerShare_iI_c20251231_zJvdc4TnKAi1" title="Value per share"&gt;1&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;Number of shares issued&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--NumberOfSharesIssued_c20260630_pd" title="Number of shares issued"&gt;50,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--NumberOfSharesIssued_iI_c20251231_zXsILIhnN7h4" title="Number of shares issued"&gt;50,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;Common shares&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_901_ecustom--CommonShares_c20260630_pp0p" title="Common shares"&gt;50,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_903_ecustom--CommonShares_iI_pp0d_c20251231_zp3g9OFSrvJ" title="Common shares"&gt;50,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;During September&#160;2024, the Company entered into an agreement to issue &lt;span id="xdx_904_eifrs-full--IncreaseDecreaseInNumberOfOrdinarySharesIssued_c20240901__20240930_zv1P1TWnDvba" title="Number of shares issued"&gt;50,000&lt;/span&gt; shares of common shares for gross proceeds of $&lt;span id="xdx_90A_eifrs-full--ProceedsFromIssuingShares_pp0d_uUSD_c20240901__20240930_zPqy6CqF96Rk" title="Proceeds from shares issued"&gt;50,000&lt;/span&gt;. Each ordinary share maintains one voting right. The entire amount of this equity is held by the CEO of the Company and remains recorded as receivable under the caption Other receivables &#x2013; related parties in the Company&#x2019;s Statement of Financial Position as of June&#160;30, 2026 and December&#160;31, 2025.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

















</cik0002058261:ScheduleOfShareCapitalTableTextBlock>
    <cik0002058261:NumberOfAuthorizedShares
      contextRef="AsOf2026-06-30"
      decimals="INF"
      id="Fact000569"
      unitRef="Shares">50000</cik0002058261:NumberOfAuthorizedShares>
    <cik0002058261:NumberOfAuthorizedShares
      contextRef="AsOf2025-12-31"
      decimals="INF"
      id="Fact000571"
      unitRef="Shares">50000</cik0002058261:NumberOfAuthorizedShares>
    <ifrs-full:ParValuePerShare
      contextRef="AsOf2026-06-30"
      decimals="INF"
      id="Fact000573"
      unitRef="KRWShares">1</ifrs-full:ParValuePerShare>
    <ifrs-full:ParValuePerShare
      contextRef="AsOf2025-12-31"
      decimals="INF"
      id="Fact000575"
      unitRef="KRWShares">1</ifrs-full:ParValuePerShare>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2026-06-30"
      decimals="INF"
      id="Fact000577"
      unitRef="Shares">50000</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2025-12-31"
      decimals="INF"
      id="Fact000579"
      unitRef="Shares">50000</ifrs-full:NumberOfSharesIssued>
    <cik0002058261:CommonShares
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000581"
      unitRef="KRW">50000</cik0002058261:CommonShares>
    <cik0002058261:CommonShares
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000583"
      unitRef="KRW">50000</cik0002058261:CommonShares>
    <ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued
      contextRef="From2024-09-012024-09-30"
      decimals="INF"
      id="Fact000585"
      unitRef="Shares">50000</ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued>
    <ifrs-full:ProceedsFromIssuingShares
      contextRef="From2024-09-012024-09-30"
      decimals="0"
      id="Fact000587"
      unitRef="USD">50000</ifrs-full:ProceedsFromIssuingShares>
    <cik0002058261:OperatingSegmentsTextBlock contextRef="From2026-01-01to2026-06-30" id="Fact000596">&lt;p id="xdx_806_ecustom--OperatingSegmentsTextBlock_z7aaX32wjCf6" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;5. &lt;span id="xdx_829_z5vJ5TYqsiLf"&gt;Operating Segments&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Segment Information: IFRS 8, Operating Segments (&#x201c;IFRS 8&#x201d;), defines operating segments as components of an enterprise where discrete financial information is available that is evaluated regularly by the chief operating decision-maker (&#x201c;CODM&#x201d;) in deciding how to allocate resources and in assessing performance. The Company operates as a single operating segment. The Company&#x2019;s CODM is the chief executive officer, who has ultimate responsibility for the operating performance of the Company and the allocation of resources. The CODM uses cash flows as the primary measure to manage the business and does not segment the business for internal reporting or decision making.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

</cik0002058261:OperatingSegmentsTextBlock>
    <ifrs-full:DisclosureOfRelatedPartyExplanatory contextRef="From2026-01-01to2026-06-30" id="Fact000598">&lt;p id="xdx_800_eifrs-full--DisclosureOfRelatedPartyExplanatory_zsXPzN3truwj" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;6. &lt;span id="xdx_820_zzujDHN1J7sh"&gt;Related Parties&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;A. List of related parties&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;List of related parties that had transactions with the Company for the periods covered by the unaudited interim condensed financial statements as of June&#160;30, 2026 and December&#160;31, 2025 is as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 49%; text-align: center"&gt;&lt;b&gt;Relationship&lt;/b&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 2%; text-align: center; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 49%; text-align: center"&gt;&lt;b&gt;Name of entity&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; background-color: #CAEDFB; text-align: center"&gt;Individual that has control over the Company (*1)&lt;/td&gt;
    &lt;td style="vertical-align: top; background-color: #CAEDFB; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; background-color: #CAEDFB; text-align: center"&gt;EUN JONG CHOI&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;Other related party (*2)&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;CUBEBIO Co., Ltd.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;div style="width: 25%"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;(*1)&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;The Company recognized &#x201c;EUN JONG CHOI&#x201d; as a related party as EUN JONG CHOI is a key management personnel member as the CEO of the Company, holding 100% of its equity share.&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;(*2)&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;The Company recognized &#x201c;CUBEBIO Co., Ltd.&#x201d; as a related party since EUN JONG CHOI, an individual who has control over the Company, was simultaneously the CEO of &#x201c;CUBEBIO Co., Ltd.&#x201d; through January&#160;30, 2026. Effective January&#160;30, 2026, JAEMYUNG KIM was appointed as the CEO of &#x201c;CUBEBIO Co., Ltd.&#x201d;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;B. Account balances with related parties&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Details of receivables and payables account balances with related parties as of June&#160;30, 2026 and December&#160;31, 2025 are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--ScheduleOfPayablesAndReceivablesRelatedPartiesTableTextBlock_zBzgPQ5nL0t1" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Related parties (Details)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td id="xdx_8B0_z31gbaTbflc7" style="display: none"&gt;Schedule of receivables and payables account balances related parties&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 0.5pt"&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;
        &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;June&#160;30,&lt;/b&gt;&lt;/p&gt;
        &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;2026&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&lt;b&gt;Related party&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Name of entity&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Payables&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Receivables&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center"&gt;&lt;b&gt;(In U.S. Dollar)&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; width: 39%"&gt;Individual that has control over the Company&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 35%; text-align: left; vertical-align: top"&gt;EUN JONG CHOI&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--TradeAndOtherPayables_iI_pp0d_uUSD_c20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember_zTaxOiz25fib" title="Payables"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0602"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--OtherReceivable_iI_pp0d_uUSD_c20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember_z72jIKdMGgk9" title="Receivables"&gt;54,058&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Other related party&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;CUBEBIO Co., Ltd.&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--TradeAndOtherPayables_iI_pp0d_uUSD_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubebioCo.Ltd.Member_z2Ylwr00ceC3" title="Payables"&gt;32,435&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_906_ecustom--OtherReceivable_iI_pp0d_uUSD_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubebioCo.Ltd.Member_zdKUGmVhbvqc" title="Receivables"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0608"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; text-align: center; vertical-align: top; padding-left: 0.25in"&gt;Total&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: right; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--TradeAndOtherPayables_iI_pp0d_uUSD_c20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubeBioHoldingsLtdMember_zM4eh3G6JEDe" title="Payables"&gt;32,435&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--OtherReceivable_iI_pp0d_uUSD_c20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubeBioHoldingsLtdMember_zI82KnkQ6A67" title="Receivables"&gt;54,058&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

















&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt; 2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&lt;b&gt;Related party&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Name of entity&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Payables&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Receivables&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center"&gt;&lt;b&gt;(In U.S. Dollar)&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; width: 39%"&gt;Individual that has control over the Company&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 35%; text-align: left; vertical-align: top"&gt;EUN JONG CHOI&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--TradeAndOtherPayables_iI_pp0d_uUSD_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember_zAUMiBDjYU3i" title="Payables"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0621"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--OtherReceivable_iI_pp0d_uUSD_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember_ze9I2ZSIBGec" title="Receivables"&gt;52,918&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Other related party&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;CUBEBIO Co., Ltd.&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--TradeAndOtherPayables_iI_pp0d_uUSD_c20260630__ifrs-full--CounterpartiesAxis__custom--CubebioCo.Ltd.Member_zHhKWCaCsWNc" title="Payables"&gt;31,751&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_909_ecustom--OtherReceivable_iI_pp0d_uUSD_c20260630__ifrs-full--CounterpartiesAxis__custom--CubebioCo.Ltd.Member_z6d5Vb3FjV08" title="Receivables"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0627"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; text-align: center; vertical-align: top; padding-left: 0.25in"&gt;Total&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: right; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--TradeAndOtherPayables_iI_pp0d_uUSD_c20251231_zG5tvO80Y3u4" title="Payables"&gt;31,751&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_902_ecustom--OtherReceivable_iI_pp0d_uUSD_c20251231_zWOEDPnVq6x6" title="Receivables"&gt;52,918&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A5_zFav65G4lcib" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;C. Financing transactions with related parties&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Details of significant financing transactions with related parties for the six-months ended June&#160;30, 2026 and 2025:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_898_ecustom--ScheduleOfSignificantFinancialTransactionsWithRelatedPartiesTableTextBlock_zhlyvVg14W4" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Related parties (Details 1)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td id="xdx_8BD_zLTKJZHkm0t3" style="display: none"&gt;Schedule of significant financial transactions with related parties&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 0.5pt"&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;2026&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&lt;b&gt;Related party&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Name of entity&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Account Name&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;January&#160;1&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Increase&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Decrease&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;June&#160;30&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="text-align: center"&gt;&lt;b&gt;(In U.S. Dollar)&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; width: 20%"&gt;Individual that has control over the Company&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 16%; text-align: left; vertical-align: top"&gt;EUN JONG CHOI&lt;/td&gt;
    &lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 20%; text-align: left; vertical-align: top"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Other receivables&lt;/p&gt; &lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 7%; text-align: right"&gt;&lt;span id="xdx_909_ecustom--RelatedPartyBalances_iS_pp0d_uUSD_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember__ifrs-full--BorrowingsByNameAxis__custom--OtherReceivablesMember_zQRNWP57D4al" title="Beginning Balance"&gt;52,918&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 7%; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--Increase_pp0d_uUSD_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember__ifrs-full--BorrowingsByNameAxis__custom--OtherReceivablesMember_fKCoxKQ_____zC4u843pPO3g" title="Increase"&gt;1,140&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;(*1)&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 7%; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--Decrease_pp0d_uUSD_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember__ifrs-full--BorrowingsByNameAxis__custom--OtherReceivablesMember_zk2LAzM7q8Ta" title="Decrease"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0639"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 7%; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--RelatedPartyBalances_iE_pp0d_uUSD_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember__ifrs-full--BorrowingsByNameAxis__custom--OtherReceivablesMember_zesH2Z5JRG3b" title="Ending Balance"&gt;54,058&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Other related party&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;CUBEBIO Co., Ltd.&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;Promissory note payables&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_ecustom--RelatedPartyBalances_iS_pp0d_uUSD_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubebioCo.Ltd.Member__ifrs-full--BorrowingsByNameAxis__custom--PromissoryNotePayablesMember_zj09gbkJXVc9"&gt;31,751&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_ecustom--Increase_pp0d_uUSD_c20250101__20250630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubebioCo.Ltd.Member__ifrs-full--BorrowingsByNameAxis__custom--PromissoryNotePayablesMember_fKCoyKQ_____zZRgZycdXJYd" title="Increase"&gt;684&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;(*2)&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_ecustom--Decrease_pp0d_uUSD_c20250101__20250630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubebioCo.Ltd.Member__ifrs-full--BorrowingsByNameAxis__custom--PromissoryNotePayablesMember_zcTLSaFrrCvg" title="Decrease"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0646"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_ecustom--RelatedPartyBalances_iE_pp0d_uUSD_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubebioCo.Ltd.Member__ifrs-full--BorrowingsByNameAxis__custom--PromissoryNotePayablesMember_zMFZ0VRX87w3" title="Ending Balance"&gt;32,435&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&lt;b&gt;Related party&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Name of entity&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Account Name&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;January&#160;1&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Increase&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Decrease&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;June&#160;30&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="text-align: center"&gt;&lt;b&gt;(In U.S. Dollar)&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; width: 20%"&gt;Individual that has control over the Company&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 16%; text-align: left; vertical-align: top"&gt;EUN JONG CHOI&lt;/td&gt;
    &lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 20%; text-align: left; vertical-align: top"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Other receivables&lt;/p&gt; &lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 7%; text-align: right"&gt;&lt;span id="xdx_909_ecustom--RelatedPartyBalances_iS_pp0d_uUSD_c20250101__20250630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember__ifrs-full--BorrowingsByNameAxis__custom--OtherReceivablesMember_zLEKoTUQPzm9" title="Beginning Balance"&gt;50,618&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 7%; text-align: right"&gt;&lt;span id="xdx_904_ecustom--Increase_pp0d_uUSD_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember__ifrs-full--BorrowingsByNameAxis__custom--OtherReceivablesMember_fKCozKQ_____zYiVjjdvzWnd" title="Increase"&gt;1,140&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;(*3)&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 7%; text-align: right"&gt;&lt;span id="xdx_907_ecustom--Decrease_pp0d_uUSD_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember__ifrs-full--BorrowingsByNameAxis__custom--OtherReceivablesMember_zqqlZd2RvPme" title="Decrease"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0654"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 7%; text-align: right"&gt;&lt;span id="xdx_902_ecustom--RelatedPartyBalances_iE_pp0d_uUSD_c20250101__20250630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubeBioHoldingsLtdMember__ifrs-full--BorrowingsByNameAxis__custom--OtherReceivablesMember_zkh2Mk6TITb2" title="Ending Balance"&gt;51,758&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Other related party&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;CUBEBIO Co., Ltd.&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;Promissory note payables&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_908_ecustom--RelatedPartyBalances_iS_pp0d_uUSD_c20250101__20250630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubebioCo.Ltd.Member__ifrs-full--BorrowingsByNameAxis__custom--PromissoryNotePayablesMember_zB2VRWAavs8h" title="Beginning Balance"&gt;30,371&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_904_ecustom--Increase_pp0d_uUSD_c20250101__20250630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubebioCo.Ltd.Member__ifrs-full--BorrowingsByNameAxis__custom--PromissoryNotePayablesMember_fKCo0KQ_____zTP3coI7Rnh5" title="Increase"&gt;684&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;(*4)&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_903_ecustom--Decrease_pp0d_uUSD_c20250101__20250630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubebioCo.Ltd.Member__ifrs-full--BorrowingsByNameAxis__custom--PromissoryNotePayablesMember_ztrapz1QSKei" title="Decrease"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0662"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_907_ecustom--RelatedPartyBalances_iE_pp0d_uUSD_c20250101__20250630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubebioCo.Ltd.Member__ifrs-full--BorrowingsByNameAxis__custom--PromissoryNotePayablesMember_zrbYJpAZLraa" title="Ending Balance"&gt;31,055&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;div style="width: 25%"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&lt;span id="xdx_F0B_zgeT6zYmvhB4"&gt;(*1)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_F1C_zjLPyjxiPzFl"&gt;The Company recognized interest income accrued under an agreement to issue 50,000 shares of common share in consideration for gross proceeds of $50,000 during the six months ended June&#160;30, 2026.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&lt;span id="xdx_F06_zPq6a24BmCxh"&gt;(*2)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_F12_zn92AEc2wMri"&gt;The Company recognized interest expense accrued under a promissory note to pay $30,000 issued for common share issuing-related costs and organization costs paid by CubeBio Co., Ltd. on behalf of the Company during the six months ended June&#160;30, 2026.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&lt;span id="xdx_F0F_zb7weKN1CLRh"&gt;(*3)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_F1B_zYWOhARkgAFk"&gt;The Company recognized interest income accrued under an agreement to issue 50,000 shares of common share in consideration for gross proceeds of $50,000 during the six months ended June&#160;30, 2025.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&lt;span id="xdx_F03_zqpRiFqyufQa"&gt;(*4)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_F1F_zHqG6Nb0OAK1"&gt;The Company recognized interest expense accrued under a promissory note to pay $30,000 issued for common share issuing-related costs and organization costs paid by CubeBio Co., Ltd. on behalf of the Company during the six months ended June&#160;30, 2025.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A7_z9I1PxKYMAYf" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

















</ifrs-full:DisclosureOfRelatedPartyExplanatory>
    <cik0002058261:ScheduleOfPayablesAndReceivablesRelatedPartiesTableTextBlock contextRef="From2026-01-01to2026-06-30" id="Fact000600">&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--ScheduleOfPayablesAndReceivablesRelatedPartiesTableTextBlock_zBzgPQ5nL0t1" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Related parties (Details)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td id="xdx_8B0_z31gbaTbflc7" style="display: none"&gt;Schedule of receivables and payables account balances related parties&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 0.5pt"&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;
        &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;June&#160;30,&lt;/b&gt;&lt;/p&gt;
        &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;2026&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&lt;b&gt;Related party&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Name of entity&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Payables&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Receivables&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center"&gt;&lt;b&gt;(In U.S. Dollar)&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; width: 39%"&gt;Individual that has control over the Company&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 35%; text-align: left; vertical-align: top"&gt;EUN JONG CHOI&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--TradeAndOtherPayables_iI_pp0d_uUSD_c20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember_zTaxOiz25fib" title="Payables"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0602"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--OtherReceivable_iI_pp0d_uUSD_c20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember_z72jIKdMGgk9" title="Receivables"&gt;54,058&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Other related party&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;CUBEBIO Co., Ltd.&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--TradeAndOtherPayables_iI_pp0d_uUSD_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubebioCo.Ltd.Member_z2Ylwr00ceC3" title="Payables"&gt;32,435&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_906_ecustom--OtherReceivable_iI_pp0d_uUSD_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubebioCo.Ltd.Member_zdKUGmVhbvqc" title="Receivables"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0608"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; text-align: center; vertical-align: top; padding-left: 0.25in"&gt;Total&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: right; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--TradeAndOtherPayables_iI_pp0d_uUSD_c20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubeBioHoldingsLtdMember_zM4eh3G6JEDe" title="Payables"&gt;32,435&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--OtherReceivable_iI_pp0d_uUSD_c20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubeBioHoldingsLtdMember_zI82KnkQ6A67" title="Receivables"&gt;54,058&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

















&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt; 2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&lt;b&gt;Related party&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Name of entity&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Payables&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Receivables&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center"&gt;&lt;b&gt;(In U.S. Dollar)&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; width: 39%"&gt;Individual that has control over the Company&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 35%; text-align: left; vertical-align: top"&gt;EUN JONG CHOI&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--TradeAndOtherPayables_iI_pp0d_uUSD_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember_zAUMiBDjYU3i" title="Payables"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0621"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--OtherReceivable_iI_pp0d_uUSD_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember_ze9I2ZSIBGec" title="Receivables"&gt;52,918&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Other related party&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;CUBEBIO Co., Ltd.&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--TradeAndOtherPayables_iI_pp0d_uUSD_c20260630__ifrs-full--CounterpartiesAxis__custom--CubebioCo.Ltd.Member_zHhKWCaCsWNc" title="Payables"&gt;31,751&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_909_ecustom--OtherReceivable_iI_pp0d_uUSD_c20260630__ifrs-full--CounterpartiesAxis__custom--CubebioCo.Ltd.Member_z6d5Vb3FjV08" title="Receivables"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0627"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; text-align: center; vertical-align: top; padding-left: 0.25in"&gt;Total&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: right; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--TradeAndOtherPayables_iI_pp0d_uUSD_c20251231_zG5tvO80Y3u4" title="Payables"&gt;31,751&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_902_ecustom--OtherReceivable_iI_pp0d_uUSD_c20251231_zWOEDPnVq6x6" title="Receivables"&gt;52,918&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:ScheduleOfPayablesAndReceivablesRelatedPartiesTableTextBlock>
    <cik0002058261:OtherReceivable
      contextRef="AsOf2026-06-30_ifrs-full_RelatedPartiesMember_custom_EunJongChoiMember"
      decimals="0"
      id="Fact000604"
      unitRef="USD">54058</cik0002058261:OtherReceivable>
    <ifrs-full:TradeAndOtherPayables
      contextRef="AsOf2025-12-31_ifrs-full_RelatedPartiesMember_custom_CubebioCo.Ltd.Member"
      decimals="0"
      id="Fact000606"
      unitRef="USD">32435</ifrs-full:TradeAndOtherPayables>
    <ifrs-full:TradeAndOtherPayables
      contextRef="AsOf2026-06-30_ifrs-full_RelatedPartiesMember_custom_CubeBioHoldingsLtdMember"
      decimals="0"
      id="Fact000610"
      unitRef="USD">32435</ifrs-full:TradeAndOtherPayables>
    <cik0002058261:OtherReceivable
      contextRef="AsOf2026-06-30_ifrs-full_RelatedPartiesMember_custom_CubeBioHoldingsLtdMember"
      decimals="0"
      id="Fact000612"
      unitRef="USD">54058</cik0002058261:OtherReceivable>
    <cik0002058261:OtherReceivable
      contextRef="AsOf2025-12-31_ifrs-full_RelatedPartiesMember_custom_EunJongChoiMember"
      decimals="0"
      id="Fact000623"
      unitRef="USD">52918</cik0002058261:OtherReceivable>
    <ifrs-full:TradeAndOtherPayables
      contextRef="AsOf2026-06-30_custom_CubebioCo.Ltd.Member273609250"
      decimals="0"
      id="Fact000625"
      unitRef="USD">31751</ifrs-full:TradeAndOtherPayables>
    <ifrs-full:TradeAndOtherPayables
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000629"
      unitRef="USD">31751</ifrs-full:TradeAndOtherPayables>
    <cik0002058261:OtherReceivable
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000631"
      unitRef="USD">52918</cik0002058261:OtherReceivable>
    <cik0002058261:ScheduleOfSignificantFinancialTransactionsWithRelatedPartiesTableTextBlock contextRef="From2026-01-01to2026-06-30" id="Fact000633">&lt;table cellpadding="0" cellspacing="0" id="xdx_898_ecustom--ScheduleOfSignificantFinancialTransactionsWithRelatedPartiesTableTextBlock_zhlyvVg14W4" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Related parties (Details 1)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td id="xdx_8BD_zLTKJZHkm0t3" style="display: none"&gt;Schedule of significant financial transactions with related parties&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 0.5pt"&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;2026&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&lt;b&gt;Related party&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Name of entity&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Account Name&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;January&#160;1&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Increase&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Decrease&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;June&#160;30&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="text-align: center"&gt;&lt;b&gt;(In U.S. Dollar)&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; width: 20%"&gt;Individual that has control over the Company&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 16%; text-align: left; vertical-align: top"&gt;EUN JONG CHOI&lt;/td&gt;
    &lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 20%; text-align: left; vertical-align: top"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Other receivables&lt;/p&gt; &lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 7%; text-align: right"&gt;&lt;span id="xdx_909_ecustom--RelatedPartyBalances_iS_pp0d_uUSD_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember__ifrs-full--BorrowingsByNameAxis__custom--OtherReceivablesMember_zQRNWP57D4al" title="Beginning Balance"&gt;52,918&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 7%; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--Increase_pp0d_uUSD_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember__ifrs-full--BorrowingsByNameAxis__custom--OtherReceivablesMember_fKCoxKQ_____zC4u843pPO3g" title="Increase"&gt;1,140&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;(*1)&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 7%; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--Decrease_pp0d_uUSD_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember__ifrs-full--BorrowingsByNameAxis__custom--OtherReceivablesMember_zk2LAzM7q8Ta" title="Decrease"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0639"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 7%; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--RelatedPartyBalances_iE_pp0d_uUSD_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember__ifrs-full--BorrowingsByNameAxis__custom--OtherReceivablesMember_zesH2Z5JRG3b" title="Ending Balance"&gt;54,058&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Other related party&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;CUBEBIO Co., Ltd.&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;Promissory note payables&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_ecustom--RelatedPartyBalances_iS_pp0d_uUSD_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubebioCo.Ltd.Member__ifrs-full--BorrowingsByNameAxis__custom--PromissoryNotePayablesMember_zj09gbkJXVc9"&gt;31,751&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_ecustom--Increase_pp0d_uUSD_c20250101__20250630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubebioCo.Ltd.Member__ifrs-full--BorrowingsByNameAxis__custom--PromissoryNotePayablesMember_fKCoyKQ_____zZRgZycdXJYd" title="Increase"&gt;684&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;(*2)&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_ecustom--Decrease_pp0d_uUSD_c20250101__20250630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubebioCo.Ltd.Member__ifrs-full--BorrowingsByNameAxis__custom--PromissoryNotePayablesMember_zcTLSaFrrCvg" title="Decrease"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0646"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_ecustom--RelatedPartyBalances_iE_pp0d_uUSD_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubebioCo.Ltd.Member__ifrs-full--BorrowingsByNameAxis__custom--PromissoryNotePayablesMember_zMFZ0VRX87w3" title="Ending Balance"&gt;32,435&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&lt;b&gt;Related party&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Name of entity&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Account Name&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;January&#160;1&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Increase&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Decrease&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;June&#160;30&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="text-align: center"&gt;&lt;b&gt;(In U.S. Dollar)&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; width: 20%"&gt;Individual that has control over the Company&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 16%; text-align: left; vertical-align: top"&gt;EUN JONG CHOI&lt;/td&gt;
    &lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 20%; text-align: left; vertical-align: top"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Other receivables&lt;/p&gt; &lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 7%; text-align: right"&gt;&lt;span id="xdx_909_ecustom--RelatedPartyBalances_iS_pp0d_uUSD_c20250101__20250630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember__ifrs-full--BorrowingsByNameAxis__custom--OtherReceivablesMember_zLEKoTUQPzm9" title="Beginning Balance"&gt;50,618&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 7%; text-align: right"&gt;&lt;span id="xdx_904_ecustom--Increase_pp0d_uUSD_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember__ifrs-full--BorrowingsByNameAxis__custom--OtherReceivablesMember_fKCozKQ_____zYiVjjdvzWnd" title="Increase"&gt;1,140&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;(*3)&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 7%; text-align: right"&gt;&lt;span id="xdx_907_ecustom--Decrease_pp0d_uUSD_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember__ifrs-full--BorrowingsByNameAxis__custom--OtherReceivablesMember_zqqlZd2RvPme" title="Decrease"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0654"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 7%; text-align: right"&gt;&lt;span id="xdx_902_ecustom--RelatedPartyBalances_iE_pp0d_uUSD_c20250101__20250630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubeBioHoldingsLtdMember__ifrs-full--BorrowingsByNameAxis__custom--OtherReceivablesMember_zkh2Mk6TITb2" title="Ending Balance"&gt;51,758&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Other related party&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;CUBEBIO Co., Ltd.&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;Promissory note payables&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_908_ecustom--RelatedPartyBalances_iS_pp0d_uUSD_c20250101__20250630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubebioCo.Ltd.Member__ifrs-full--BorrowingsByNameAxis__custom--PromissoryNotePayablesMember_zB2VRWAavs8h" title="Beginning Balance"&gt;30,371&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_904_ecustom--Increase_pp0d_uUSD_c20250101__20250630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubebioCo.Ltd.Member__ifrs-full--BorrowingsByNameAxis__custom--PromissoryNotePayablesMember_fKCo0KQ_____zTP3coI7Rnh5" title="Increase"&gt;684&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;(*4)&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_903_ecustom--Decrease_pp0d_uUSD_c20250101__20250630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubebioCo.Ltd.Member__ifrs-full--BorrowingsByNameAxis__custom--PromissoryNotePayablesMember_ztrapz1QSKei" title="Decrease"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0662"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_907_ecustom--RelatedPartyBalances_iE_pp0d_uUSD_c20250101__20250630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubebioCo.Ltd.Member__ifrs-full--BorrowingsByNameAxis__custom--PromissoryNotePayablesMember_zrbYJpAZLraa" title="Ending Balance"&gt;31,055&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;div style="width: 25%"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&lt;span id="xdx_F0B_zgeT6zYmvhB4"&gt;(*1)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_F1C_zjLPyjxiPzFl"&gt;The Company recognized interest income accrued under an agreement to issue 50,000 shares of common share in consideration for gross proceeds of $50,000 during the six months ended June&#160;30, 2026.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&lt;span id="xdx_F06_zPq6a24BmCxh"&gt;(*2)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_F12_zn92AEc2wMri"&gt;The Company recognized interest expense accrued under a promissory note to pay $30,000 issued for common share issuing-related costs and organization costs paid by CubeBio Co., Ltd. on behalf of the Company during the six months ended June&#160;30, 2026.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&lt;span id="xdx_F0F_zb7weKN1CLRh"&gt;(*3)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_F1B_zYWOhARkgAFk"&gt;The Company recognized interest income accrued under an agreement to issue 50,000 shares of common share in consideration for gross proceeds of $50,000 during the six months ended June&#160;30, 2025.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&lt;span id="xdx_F03_zqpRiFqyufQa"&gt;(*4)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_F1F_zHqG6Nb0OAK1"&gt;The Company recognized interest expense accrued under a promissory note to pay $30,000 issued for common share issuing-related costs and organization costs paid by CubeBio Co., Ltd. on behalf of the Company during the six months ended June&#160;30, 2025.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:ScheduleOfSignificantFinancialTransactionsWithRelatedPartiesTableTextBlock>
    <cik0002058261:RelatedPartyBalances
      contextRef="AsOf2025-12-31_ifrs-full_RelatedPartiesMember_custom_EunJongChoiMember_custom_OtherReceivablesMember"
      decimals="0"
      id="Fact000635"
      unitRef="USD">52918</cik0002058261:RelatedPartyBalances>
    <cik0002058261:Increase
      contextRef="From2026-01-012026-06-30_ifrs-full_RelatedPartiesMember_custom_EunJongChoiMember_custom_OtherReceivablesMember"
      decimals="0"
      id="Fact000637"
      unitRef="USD">1140</cik0002058261:Increase>
    <cik0002058261:RelatedPartyBalances
      contextRef="AsOf2026-06-30_ifrs-full_RelatedPartiesMember_custom_EunJongChoiMember_custom_OtherReceivablesMember"
      decimals="0"
      id="Fact000641"
      unitRef="USD">54058</cik0002058261:RelatedPartyBalances>
    <cik0002058261:RelatedPartyBalances
      contextRef="AsOf2025-12-31_ifrs-full_RelatedPartiesMember_custom_CubebioCo.Ltd.Member_custom_PromissoryNotePayablesMember"
      decimals="0"
      id="Fact000642"
      unitRef="USD">31751</cik0002058261:RelatedPartyBalances>
    <cik0002058261:Increase
      contextRef="From2025-01-012025-06-30_ifrs-full_RelatedPartiesMember_custom_CubebioCo.Ltd.Member_custom_PromissoryNotePayablesMember"
      decimals="0"
      id="Fact000644"
      unitRef="USD">684</cik0002058261:Increase>
    <cik0002058261:RelatedPartyBalances
      contextRef="AsOf2026-06-30_ifrs-full_RelatedPartiesMember_custom_CubebioCo.Ltd.Member_custom_PromissoryNotePayablesMember"
      decimals="0"
      id="Fact000648"
      unitRef="USD">32435</cik0002058261:RelatedPartyBalances>
    <cik0002058261:RelatedPartyBalances
      contextRef="AsOf2024-12-31_ifrs-full_RelatedPartiesMember_custom_EunJongChoiMember_custom_OtherReceivablesMember"
      decimals="0"
      id="Fact000650"
      unitRef="USD">50618</cik0002058261:RelatedPartyBalances>
    <cik0002058261:Increase
      contextRef="From2026-01-012026-06-30_ifrs-full_RelatedPartiesMember_custom_EunJongChoiMember_custom_OtherReceivablesMember"
      decimals="0"
      id="Fact000652"
      unitRef="USD">1140</cik0002058261:Increase>
    <cik0002058261:RelatedPartyBalances
      contextRef="AsOf2025-06-30_ifrs-full_RelatedPartiesMember_custom_CubeBioHoldingsLtdMember_custom_OtherReceivablesMember"
      decimals="0"
      id="Fact000656"
      unitRef="USD">51758</cik0002058261:RelatedPartyBalances>
    <cik0002058261:RelatedPartyBalances
      contextRef="AsOf2024-12-31_ifrs-full_RelatedPartiesMember_custom_CubebioCo.Ltd.Member_custom_PromissoryNotePayablesMember"
      decimals="0"
      id="Fact000658"
      unitRef="USD">30371</cik0002058261:RelatedPartyBalances>
    <cik0002058261:Increase
      contextRef="From2025-01-012025-06-30_ifrs-full_RelatedPartiesMember_custom_CubebioCo.Ltd.Member_custom_PromissoryNotePayablesMember"
      decimals="0"
      id="Fact000660"
      unitRef="USD">684</cik0002058261:Increase>
    <cik0002058261:RelatedPartyBalances
      contextRef="AsOf2025-06-30_ifrs-full_RelatedPartiesMember_custom_CubebioCo.Ltd.Member_custom_PromissoryNotePayablesMember"
      decimals="0"
      id="Fact000664"
      unitRef="USD">31055</cik0002058261:RelatedPartyBalances>
    <ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory contextRef="From2026-01-01to2026-06-30" id="Fact000677">&lt;p id="xdx_807_eifrs-full--DisclosureOfTradeAndOtherPayablesExplanatory_z93S93plKGC8" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;7. &lt;span id="xdx_825_ztJxukCSPX3i"&gt;Other Payables&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;As of June&#160;30, 2026, the Company recorded an accrued liability of $&lt;span id="xdx_90C_eifrs-full--CurrentAccruedExpensesAndOtherCurrentLiabilities_iI_pp0d_uUSD_c20260630_zBx0OkFO8Xbc" title="Accrued liability"&gt;7,725&lt;/span&gt; in &#x201c;Other payables.&#x201d; This amount represents unpaid legal and corporate services fees, including the 2026 annual fees and disbursements for the provision of registered office services, due to Maples and Calder (Cayman) LLP.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

</ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory>
    <ifrs-full:CurrentAccruedExpensesAndOtherCurrentLiabilities
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000679"
      unitRef="USD">7725</ifrs-full:CurrentAccruedExpensesAndOtherCurrentLiabilities>
    <cik0002058261:GoingConcernsTextBlock contextRef="From2026-01-01to2026-06-30" id="Fact000681">&lt;p id="xdx_80D_ecustom--GoingConcernsTextBlock_zzALvtvba9sj" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;8. &lt;span id="xdx_824_zYeiiq7hznF2"&gt;Going concern&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company is a holding company and does not expect to generate operating revenues. Since incorporation, the Company&#x2019;s activities have been limited to formation and corporate establishment matters. For the six-month ended June&#160;30, 2026, the Company incurred a net income of $&lt;span id="xdx_90C_eifrs-full--ProfitLoss_iN_pp0d_uUSD_c20260101__20260630_zGTPt6JholM5" title="Net loss"&gt;456&lt;/span&gt;, primarily attributable to interest income exceeding interest expense, resulting in net interest income. The Company will continue to incur ongoing corporate and reporting costs and will require funding from its shareholder(s) or other financing sources to meet its obligations as they fall due. These conditions indicate the existence of a material uncertainty that may cast significant doubt on the Company&#x2019;s ability to continue as a going concern. The unaudited interim condensed financial statements have been prepared on a going concern basis and do not include any adjustments that might result from the outcome of this uncertainty.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

</cik0002058261:GoingConcernsTextBlock>
    <ifrs-full:ProfitLoss
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000683"
      unitRef="USD">456</ifrs-full:ProfitLoss>
    <cik0002058261:DisclosureOfEventAfterReportingPeriodExplanatory contextRef="From2026-01-01to2026-06-30" id="Fact000685">&lt;p id="xdx_802_ecustom--DisclosureOfEventAfterReportingPeriodExplanatory_zZOJj4PV6r85" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;9. &lt;span id="xdx_826_z09Ggq31cLy"&gt;Subsequent events&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to October&#160;13, 2026, the date when the unaudited interim condensed financial statements were available to be issued. Based upon the review, the Company did not identify any subsequent events that would have required adjustments or disclosure in the unaudited interim condensed financial statements.&lt;/p&gt;

</cik0002058261:DisclosureOfEventAfterReportingPeriodExplanatory>
    <ifrs-full:CashAndCashEquivalents
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000690"
      unitRef="KRW">335814000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000691"
      unitRef="KRW">3662174000</ifrs-full:CashAndCashEquivalents>
    <cik0002058261:CurrentPortionOfLongtermBankDeposit
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000693"
      unitRef="KRW">30000000</cik0002058261:CurrentPortionOfLongtermBankDeposit>
    <cik0002058261:ShorttermFinancialInstruments
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000696"
      unitRef="KRW">442894000</cik0002058261:ShorttermFinancialInstruments>
    <cik0002058261:ShorttermFinancialInstruments
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000697"
      unitRef="KRW">214245000</cik0002058261:ShorttermFinancialInstruments>
    <ifrs-full:OtherReceivables
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000699"
      unitRef="KRW">33411000</ifrs-full:OtherReceivables>
    <ifrs-full:OtherReceivables
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000700"
      unitRef="KRW">202477000</ifrs-full:OtherReceivables>
    <ifrs-full:OtherCurrentAssets
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000702"
      unitRef="KRW">137151000</ifrs-full:OtherCurrentAssets>
    <ifrs-full:OtherCurrentAssets
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000703"
      unitRef="KRW">57700000</ifrs-full:OtherCurrentAssets>
    <ifrs-full:CurrentAssets
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000705"
      unitRef="KRW">979270000</ifrs-full:CurrentAssets>
    <ifrs-full:CurrentAssets
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000706"
      unitRef="KRW">4136596000</ifrs-full:CurrentAssets>
    <cik0002058261:LongtermBankDeposit
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000709"
      unitRef="KRW">30000000</cik0002058261:LongtermBankDeposit>
    <cik0002058261:LongtermLoanReceivablesNet
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000711"
      unitRef="KRW">1671780000</cik0002058261:LongtermLoanReceivablesNet>
    <cik0002058261:LongtermLoanReceivablesNet
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000712"
      unitRef="KRW">1917960000</cik0002058261:LongtermLoanReceivablesNet>
    <ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000714"
      unitRef="KRW">344055000</ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000715"
      unitRef="KRW">420836000</ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000717"
      unitRef="KRW">512493000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000718"
      unitRef="KRW">649394000</ifrs-full:RightofuseAssets>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000720"
      unitRef="KRW">5242000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000721"
      unitRef="KRW">6009000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:OtherNoncurrentFinancialAssets
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000723"
      unitRef="KRW">525042000</ifrs-full:OtherNoncurrentFinancialAssets>
    <ifrs-full:OtherNoncurrentFinancialAssets
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000724"
      unitRef="KRW">473682000</ifrs-full:OtherNoncurrentFinancialAssets>
    <cik0002058261:LongtermOtherReceivablesNet
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000727"
      unitRef="KRW">2065000</cik0002058261:LongtermOtherReceivablesNet>
    <cik0002058261:DeferredTransactionCostsSponsorSharePurchase
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000729"
      unitRef="KRW">2393915000</cik0002058261:DeferredTransactionCostsSponsorSharePurchase>
    <cik0002058261:DeferredTransactionCostsSponsorSharePurchase
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000730"
      unitRef="KRW">1025730000</cik0002058261:DeferredTransactionCostsSponsorSharePurchase>
    <ifrs-full:OtherNoncurrentAssets
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000732"
      unitRef="KRW">38114000</ifrs-full:OtherNoncurrentAssets>
    <ifrs-full:OtherNoncurrentAssets
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000733"
      unitRef="KRW">79693000</ifrs-full:OtherNoncurrentAssets>
    <ifrs-full:NoncurrentAssets
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000735"
      unitRef="KRW">5490641000</ifrs-full:NoncurrentAssets>
    <ifrs-full:NoncurrentAssets
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000736"
      unitRef="KRW">4605369000</ifrs-full:NoncurrentAssets>
    <ifrs-full:Assets
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000738"
      unitRef="KRW">6469911000</ifrs-full:Assets>
    <ifrs-full:Assets
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000739"
      unitRef="KRW">8741965000</ifrs-full:Assets>
    <cik0002058261:AccountsPayableOtherRelatedPartiesNet
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000744"
      unitRef="KRW">324855000</cik0002058261:AccountsPayableOtherRelatedPartiesNet>
    <cik0002058261:AccountsPayableOtherNonrelatedPartiesNet
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000747"
      unitRef="KRW">3228194000</cik0002058261:AccountsPayableOtherNonrelatedPartiesNet>
    <cik0002058261:AccountsPayableOtherNonrelatedPartiesNet
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000748"
      unitRef="KRW">1254802000</cik0002058261:AccountsPayableOtherNonrelatedPartiesNet>
    <cik0002058261:BondWithWarrantsRelatedPartiesNet
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000751"
      unitRef="KRW">39769000</cik0002058261:BondWithWarrantsRelatedPartiesNet>
    <cik0002058261:BondWithWarrantsNonrelatedPartiesNet
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000753"
      unitRef="KRW">3265312000</cik0002058261:BondWithWarrantsNonrelatedPartiesNet>
    <cik0002058261:BondWithWarrantsNonrelatedPartiesNet
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000754"
      unitRef="KRW">3479370000</cik0002058261:BondWithWarrantsNonrelatedPartiesNet>
    <ifrs-full:DerivativeFinancialLiabilities
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000756"
      unitRef="KRW">1267801000</ifrs-full:DerivativeFinancialLiabilities>
    <ifrs-full:DerivativeFinancialLiabilities
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000757"
      unitRef="KRW">1473823000</ifrs-full:DerivativeFinancialLiabilities>
    <ifrs-full:CurrentLeaseLiabilities
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000759"
      unitRef="KRW">122626000</ifrs-full:CurrentLeaseLiabilities>
    <ifrs-full:CurrentLeaseLiabilities
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000760"
      unitRef="KRW">117351000</ifrs-full:CurrentLeaseLiabilities>
    <ifrs-full:CurrentLiabilities
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000762"
      unitRef="KRW">8208788000</ifrs-full:CurrentLiabilities>
    <ifrs-full:CurrentLiabilities
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000763"
      unitRef="KRW">6365115000</ifrs-full:CurrentLiabilities>
    <ifrs-full:CurrentRecognisedLiabilitiesDefinedBenefitPlan
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000765"
      unitRef="KRW">980841000</ifrs-full:CurrentRecognisedLiabilitiesDefinedBenefitPlan>
    <ifrs-full:CurrentRecognisedLiabilitiesDefinedBenefitPlan
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000766"
      unitRef="KRW">950220000</ifrs-full:CurrentRecognisedLiabilitiesDefinedBenefitPlan>
    <cik0002058261:OtherNoncurrentProvisions
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000768"
      unitRef="KRW">48658000</cik0002058261:OtherNoncurrentProvisions>
    <cik0002058261:OtherNoncurrentProvisions
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000769"
      unitRef="KRW">48341000</cik0002058261:OtherNoncurrentProvisions>
    <cik0002058261:NoncurrentLeasesLiabilities
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000771"
      unitRef="KRW">430005000</cik0002058261:NoncurrentLeasesLiabilities>
    <cik0002058261:NoncurrentLeasesLiabilities
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000772"
      unitRef="KRW">551681000</cik0002058261:NoncurrentLeasesLiabilities>
    <ifrs-full:NoncurrentLiabilities
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000774"
      unitRef="KRW">1459504000</ifrs-full:NoncurrentLiabilities>
    <ifrs-full:NoncurrentLiabilities
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000775"
      unitRef="KRW">1550242000</ifrs-full:NoncurrentLiabilities>
    <ifrs-full:Liabilities
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000777"
      unitRef="KRW">9668292000</ifrs-full:Liabilities>
    <ifrs-full:Liabilities
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000778"
      unitRef="KRW">7915357000</ifrs-full:Liabilities>
    <cik0002058261:ShareCapital
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000783"
      unitRef="KRW">26407738000</cik0002058261:ShareCapital>
    <cik0002058261:ShareCapital
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000784"
      unitRef="KRW">26147238000</cik0002058261:ShareCapital>
    <ifrs-full:SharePremium
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000786"
      unitRef="KRW">46566573000</ifrs-full:SharePremium>
    <ifrs-full:SharePremium
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000787"
      unitRef="KRW">44749618000</ifrs-full:SharePremium>
    <cik0002058261:ShareSubscriptionReceivable
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000789"
      unitRef="KRW">-50000000</cik0002058261:ShareSubscriptionReceivable>
    <ifrs-full:OtherReserves
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000792"
      unitRef="KRW">-690292000</ifrs-full:OtherReserves>
    <ifrs-full:OtherReserves
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000793"
      unitRef="KRW">-727203000</ifrs-full:OtherReserves>
    <ifrs-full:AccumulatedOtherComprehensiveIncome
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000795"
      unitRef="KRW">125654000</ifrs-full:AccumulatedOtherComprehensiveIncome>
    <ifrs-full:AccumulatedOtherComprehensiveIncome
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000796"
      unitRef="KRW">73533000</ifrs-full:AccumulatedOtherComprehensiveIncome>
    <ifrs-full:RetainedEarnings
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000798"
      unitRef="KRW">-75558054000</ifrs-full:RetainedEarnings>
    <ifrs-full:RetainedEarnings
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000799"
      unitRef="KRW">-69416578000</ifrs-full:RetainedEarnings>
    <ifrs-full:Equity
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000801"
      unitRef="KRW">-3198381000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000802"
      unitRef="KRW">826608000</ifrs-full:Equity>
    <ifrs-full:EquityAndLiabilities
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000804"
      unitRef="KRW">6469911000</ifrs-full:EquityAndLiabilities>
    <ifrs-full:EquityAndLiabilities
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000805"
      unitRef="KRW">8741965000</ifrs-full:EquityAndLiabilities>
    <ifrs-full:SellingGeneralAndAdministrativeExpense
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000822"
      unitRef="KRW">-5781058000</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <ifrs-full:SellingGeneralAndAdministrativeExpense
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000823"
      unitRef="KRW">-7449087000</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <ifrs-full:OtherIncome
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000825"
      unitRef="KRW">191076000</ifrs-full:OtherIncome>
    <ifrs-full:OtherIncome
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000826"
      unitRef="KRW">525695000</ifrs-full:OtherIncome>
    <ifrs-full:OtherExpenseByFunction
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000828"
      unitRef="KRW">373378000</ifrs-full:OtherExpenseByFunction>
    <ifrs-full:OtherExpenseByFunction
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000829"
      unitRef="KRW">677439000</ifrs-full:OtherExpenseByFunction>
    <ifrs-full:ProfitLossFromContinuingOperations
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000831"
      unitRef="KRW">-5963360000</ifrs-full:ProfitLossFromContinuingOperations>
    <ifrs-full:ProfitLossFromContinuingOperations
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000832"
      unitRef="KRW">-7600831000</ifrs-full:ProfitLossFromContinuingOperations>
    <ifrs-full:FinanceIncome
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000834"
      unitRef="KRW">698329000</ifrs-full:FinanceIncome>
    <ifrs-full:FinanceIncome
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000835"
      unitRef="KRW">876504000</ifrs-full:FinanceIncome>
    <cik0002058261:FinanceIncomeRelatedParties
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000837"
      unitRef="KRW">9716000</cik0002058261:FinanceIncomeRelatedParties>
    <cik0002058261:FinanceIncomeRelatedParties
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000838"
      unitRef="KRW">24374000</cik0002058261:FinanceIncomeRelatedParties>
    <cik0002058261:FinanceIncomeNonrelatedParties
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000840"
      unitRef="KRW">688613000</cik0002058261:FinanceIncomeNonrelatedParties>
    <cik0002058261:FinanceIncomeNonrelatedParties
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000841"
      unitRef="KRW">852130000</cik0002058261:FinanceIncomeNonrelatedParties>
    <ifrs-full:FinanceCosts
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000843"
      unitRef="KRW">876445000</ifrs-full:FinanceCosts>
    <ifrs-full:FinanceCosts
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000844"
      unitRef="KRW">1341007000</ifrs-full:FinanceCosts>
    <cik0002058261:FinanceCostsRelatedParties
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000846"
      unitRef="KRW">-6789000</cik0002058261:FinanceCostsRelatedParties>
    <cik0002058261:FinanceCostsRelatedParties
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000847"
      unitRef="KRW">-321827000</cik0002058261:FinanceCostsRelatedParties>
    <cik0002058261:FinanceCostsNonrelatedParties
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000849"
      unitRef="KRW">-869656000</cik0002058261:FinanceCostsNonrelatedParties>
    <cik0002058261:FinanceCostsNonrelatedParties
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000850"
      unitRef="KRW">-1019180000</cik0002058261:FinanceCostsNonrelatedParties>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000852"
      unitRef="KRW">-6141476000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000853"
      unitRef="KRW">-8065334000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:ProfitLoss
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000858"
      unitRef="KRW">-6141476000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000859"
      unitRef="KRW">-8065334000</ifrs-full:ProfitLoss>
    <cik0002058261:RemeasurementOfDefinedBenefitLiabilities
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000867"
      unitRef="KRW">52121000</cik0002058261:RemeasurementOfDefinedBenefitLiabilities>
    <cik0002058261:RemeasurementOfDefinedBenefitLiabilities
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000868"
      unitRef="KRW">-127853000</cik0002058261:RemeasurementOfDefinedBenefitLiabilities>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000870"
      unitRef="KRW">-6089355000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000871"
      unitRef="KRW">-8193187000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact000876"
      unitRef="KRWShares">-126</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact000877"
      unitRef="KRWShares">-178</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact000879"
      unitRef="KRWShares">-126</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact000880"
      unitRef="KRWShares">-178</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:EquityAttributableToOwnersOfParent
      contextRef="AsOf2023-12-31_custom_ShareCapitalMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000882"
      unitRef="KRW">23808105000</ifrs-full:EquityAttributableToOwnersOfParent>
    <ifrs-full:EquityAttributableToOwnersOfParent
      contextRef="AsOf2023-12-31_ifrs-full_SharePremiumMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000883"
      unitRef="KRW">32610201000</ifrs-full:EquityAttributableToOwnersOfParent>
    <ifrs-full:EquityAttributableToOwnersOfParent
      contextRef="AsOf2023-12-31_ifrs-full_OtherReservesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000885"
      unitRef="KRW">1340781000</ifrs-full:EquityAttributableToOwnersOfParent>
    <ifrs-full:EquityAttributableToOwnersOfParent
      contextRef="AsOf2023-12-31_ifrs-full_AccumulatedOtherComprehensiveIncomeMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000886"
      unitRef="KRW">201386000</ifrs-full:EquityAttributableToOwnersOfParent>
    <ifrs-full:EquityAttributableToOwnersOfParent
      contextRef="AsOf2023-12-31_ifrs-full_RetainedEarningsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000887"
      unitRef="KRW">-61351244000</ifrs-full:EquityAttributableToOwnersOfParent>
    <ifrs-full:EquityAttributableToOwnersOfParent
      contextRef="AsOf2023-12-31_custom_TotalMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000888"
      unitRef="KRW">-3390771000</ifrs-full:EquityAttributableToOwnersOfParent>
    <cik0002058261:ProfitLossFromContinuingOperation
      contextRef="From2024-01-012024-12-31_ifrs-full_RetainedEarningsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000903"
      unitRef="KRW">-8065334000</cik0002058261:ProfitLossFromContinuingOperation>
    <cik0002058261:ProfitLossFromContinuingOperation
      contextRef="From2024-01-012024-12-31_custom_TotalMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000904"
      unitRef="KRW">-8065334000</cik0002058261:ProfitLossFromContinuingOperation>
    <cik0002058261:RemeasurementOfDefinedBenefitLiabilitie
      contextRef="From2024-01-012024-12-31_ifrs-full_AccumulatedOtherComprehensiveIncomeMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000910"
      unitRef="KRW">-127853000</cik0002058261:RemeasurementOfDefinedBenefitLiabilitie>
    <cik0002058261:RemeasurementOfDefinedBenefitLiabilitie
      contextRef="From2024-01-012024-12-31_custom_TotalMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000912"
      unitRef="KRW">-127853000</cik0002058261:RemeasurementOfDefinedBenefitLiabilitie>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2024-01-012024-12-31_ifrs-full_AccumulatedOtherComprehensiveIncomeMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000918"
      unitRef="KRW">-127853000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2024-01-012024-12-31_ifrs-full_RetainedEarningsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000919"
      unitRef="KRW">-8065334000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2024-01-012024-12-31_custom_TotalMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000920"
      unitRef="KRW">-8193187000</ifrs-full:ComprehensiveIncome>
    <cik0002058261:WarrantsExercised
      contextRef="From2024-01-012024-12-31_custom_ShareCapitalMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000930"
      unitRef="KRW">1312333000</cik0002058261:WarrantsExercised>
    <cik0002058261:WarrantsExercised
      contextRef="From2024-01-012024-12-31_ifrs-full_SharePremiumMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000931"
      unitRef="KRW">5882662000</cik0002058261:WarrantsExercised>
    <cik0002058261:WarrantsExercised
      contextRef="From2024-01-012024-12-31_custom_TotalMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000936"
      unitRef="KRW">7194995000</cik0002058261:WarrantsExercised>
    <cik0002058261:BondWithWarrantsIssued
      contextRef="From2024-01-012024-12-31_ifrs-full_SharePremiumMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000939"
      unitRef="KRW">176911000</cik0002058261:BondWithWarrantsIssued>
    <cik0002058261:BondWithWarrantsIssued
      contextRef="From2024-01-012024-12-31_custom_TotalMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000944"
      unitRef="KRW">176911000</cik0002058261:BondWithWarrantsIssued>
    <cik0002058261:StockOptionExercised
      contextRef="From2024-01-012024-12-31_custom_ShareCapitalMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000946"
      unitRef="KRW">1026800000</cik0002058261:StockOptionExercised>
    <cik0002058261:StockOptionExercised
      contextRef="From2024-01-012024-12-31_ifrs-full_SharePremiumMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000947"
      unitRef="KRW">2324675000</cik0002058261:StockOptionExercised>
    <cik0002058261:StockOptionExercised
      contextRef="From2024-01-012024-12-31_ifrs-full_OtherReservesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000949"
      unitRef="KRW">-2324675000</cik0002058261:StockOptionExercised>
    <cik0002058261:StockOptionExercised
      contextRef="From2024-01-012024-12-31_custom_TotalMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000952"
      unitRef="KRW">1026800000</cik0002058261:StockOptionExercised>
    <cik0002058261:StockOptionExpired
      contextRef="From2024-01-012024-12-31_ifrs-full_SharePremiumMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000955"
      unitRef="KRW">100092000</cik0002058261:StockOptionExpired>
    <cik0002058261:StockOptionExpired
      contextRef="From2024-01-012024-12-31_ifrs-full_OtherReservesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000957"
      unitRef="KRW">-100092000</cik0002058261:StockOptionExpired>
    <cik0002058261:DisposalOfTreasuryShares
      contextRef="From2024-01-012024-12-31_ifrs-full_SharePremiumMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000963"
      unitRef="KRW">3655077000</cik0002058261:DisposalOfTreasuryShares>
    <cik0002058261:DisposalOfTreasuryShares
      contextRef="From2024-01-012024-12-31_ifrs-full_OtherReservesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000965"
      unitRef="KRW">356783000</cik0002058261:DisposalOfTreasuryShares>
    <cik0002058261:DisposalOfTreasuryShares
      contextRef="From2024-01-012024-12-31_custom_TotalMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000968"
      unitRef="KRW">4011860000</cik0002058261:DisposalOfTreasuryShares>
    <ifrs-full:EquityAttributableToOwnersOfParent
      contextRef="AsOf2024-12-31_custom_ShareCapitalMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000970"
      unitRef="KRW">26147238000</ifrs-full:EquityAttributableToOwnersOfParent>
    <ifrs-full:EquityAttributableToOwnersOfParent
      contextRef="AsOf2024-12-31_ifrs-full_SharePremiumMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000971"
      unitRef="KRW">44749618000</ifrs-full:EquityAttributableToOwnersOfParent>
    <ifrs-full:EquityAttributableToOwnersOfParent
      contextRef="AsOf2024-12-31_ifrs-full_OtherReservesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000973"
      unitRef="KRW">-727203000</ifrs-full:EquityAttributableToOwnersOfParent>
    <ifrs-full:EquityAttributableToOwnersOfParent
      contextRef="AsOf2024-12-31_ifrs-full_AccumulatedOtherComprehensiveIncomeMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000974"
      unitRef="KRW">73533000</ifrs-full:EquityAttributableToOwnersOfParent>
    <ifrs-full:EquityAttributableToOwnersOfParent
      contextRef="AsOf2024-12-31_ifrs-full_RetainedEarningsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000975"
      unitRef="KRW">-69416578000</ifrs-full:EquityAttributableToOwnersOfParent>
    <ifrs-full:EquityAttributableToOwnersOfParent
      contextRef="AsOf2024-12-31_custom_TotalMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000976"
      unitRef="KRW">826608000</ifrs-full:EquityAttributableToOwnersOfParent>
    <cik0002058261:ProfitLossFromContinuingOperation
      contextRef="From2025-01-012025-12-31_ifrs-full_RetainedEarningsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000991"
      unitRef="KRW">-6141476000</cik0002058261:ProfitLossFromContinuingOperation>
    <cik0002058261:ProfitLossFromContinuingOperation
      contextRef="From2025-01-012025-12-31_custom_TotalMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000992"
      unitRef="KRW">-6141476000</cik0002058261:ProfitLossFromContinuingOperation>
    <cik0002058261:RemeasurementOfDefinedBenefitLiabilitie
      contextRef="From2025-01-012025-12-31_ifrs-full_AccumulatedOtherComprehensiveIncomeMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact000998"
      unitRef="KRW">52121000</cik0002058261:RemeasurementOfDefinedBenefitLiabilitie>
    <cik0002058261:RemeasurementOfDefinedBenefitLiabilitie
      contextRef="From2025-01-012025-12-31_custom_TotalMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001000"
      unitRef="KRW">52121000</cik0002058261:RemeasurementOfDefinedBenefitLiabilitie>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2025-01-012025-12-31_ifrs-full_AccumulatedOtherComprehensiveIncomeMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001006"
      unitRef="KRW">52121000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2025-01-012025-12-31_ifrs-full_RetainedEarningsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001007"
      unitRef="KRW">-6141476000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2025-01-012025-12-31_custom_TotalMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001008"
      unitRef="KRW">-6089355000</ifrs-full:ComprehensiveIncome>
    <cik0002058261:WarrantsExercised
      contextRef="From2025-01-012025-12-31_custom_ShareCapitalMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001018"
      unitRef="KRW">260500000</cik0002058261:WarrantsExercised>
    <cik0002058261:WarrantsExercised
      contextRef="From2025-01-012025-12-31_ifrs-full_SharePremiumMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001019"
      unitRef="KRW">1044500000</cik0002058261:WarrantsExercised>
    <cik0002058261:WarrantsExercised
      contextRef="From2025-01-012025-12-31_custom_TotalMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001024"
      unitRef="KRW">1305000000</cik0002058261:WarrantsExercised>
    <cik0002058261:BondWithWarrantsIssued
      contextRef="From2025-01-012025-12-31_ifrs-full_SharePremiumMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001027"
      unitRef="KRW">609366000</cik0002058261:BondWithWarrantsIssued>
    <cik0002058261:BondWithWarrantsIssued
      contextRef="From2025-01-012025-12-31_custom_TotalMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001032"
      unitRef="KRW">609366000</cik0002058261:BondWithWarrantsIssued>
    <cik0002058261:DisposalOfTreasuryShares
      contextRef="From2025-01-012025-12-31_ifrs-full_SharePremiumMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001035"
      unitRef="KRW">163089000</cik0002058261:DisposalOfTreasuryShares>
    <cik0002058261:DisposalOfTreasuryShares
      contextRef="From2025-01-012025-12-31_custom_ShareSubscriptionReceivableMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001036"
      unitRef="KRW">-50000000</cik0002058261:DisposalOfTreasuryShares>
    <cik0002058261:DisposalOfTreasuryShares
      contextRef="From2025-01-012025-12-31_ifrs-full_OtherReservesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001037"
      unitRef="KRW">36911000</cik0002058261:DisposalOfTreasuryShares>
    <cik0002058261:DisposalOfTreasuryShares
      contextRef="From2025-01-012025-12-31_custom_TotalMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001040"
      unitRef="KRW">150000000</cik0002058261:DisposalOfTreasuryShares>
    <ifrs-full:EquityAttributableToOwnersOfParent
      contextRef="AsOf2025-12-31_custom_ShareCapitalMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001042"
      unitRef="KRW">26407738000</ifrs-full:EquityAttributableToOwnersOfParent>
    <ifrs-full:EquityAttributableToOwnersOfParent
      contextRef="AsOf2025-12-31_ifrs-full_SharePremiumMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001043"
      unitRef="KRW">46566573000</ifrs-full:EquityAttributableToOwnersOfParent>
    <ifrs-full:EquityAttributableToOwnersOfParent
      contextRef="AsOf2025-12-31_custom_ShareSubscriptionReceivableMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001044"
      unitRef="KRW">-50000000</ifrs-full:EquityAttributableToOwnersOfParent>
    <ifrs-full:EquityAttributableToOwnersOfParent
      contextRef="AsOf2025-12-31_ifrs-full_OtherReservesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001045"
      unitRef="KRW">-690292000</ifrs-full:EquityAttributableToOwnersOfParent>
    <ifrs-full:EquityAttributableToOwnersOfParent
      contextRef="AsOf2025-12-31_ifrs-full_AccumulatedOtherComprehensiveIncomeMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001046"
      unitRef="KRW">125654000</ifrs-full:EquityAttributableToOwnersOfParent>
    <ifrs-full:EquityAttributableToOwnersOfParent
      contextRef="AsOf2025-12-31_ifrs-full_RetainedEarningsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001047"
      unitRef="KRW">-75558054000</ifrs-full:EquityAttributableToOwnersOfParent>
    <ifrs-full:EquityAttributableToOwnersOfParent
      contextRef="AsOf2025-12-31_custom_TotalMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001048"
      unitRef="KRW">-3198381000</ifrs-full:EquityAttributableToOwnersOfParent>
    <ifrs-full:ProfitLoss
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001053"
      unitRef="KRW">-6141476000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001054"
      unitRef="KRW">-8065334000</ifrs-full:ProfitLoss>
    <ifrs-full:AdjustmentsForDepreciationExpense
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001059"
      unitRef="KRW">222589000</ifrs-full:AdjustmentsForDepreciationExpense>
    <ifrs-full:AdjustmentsForDepreciationExpense
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001060"
      unitRef="KRW">335918000</ifrs-full:AdjustmentsForDepreciationExpense>
    <ifrs-full:AdjustmentsForAmortisationExpense
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001062"
      unitRef="KRW">2303000</ifrs-full:AdjustmentsForAmortisationExpense>
    <ifrs-full:AdjustmentsForAmortisationExpense
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001063"
      unitRef="KRW">2760000</ifrs-full:AdjustmentsForAmortisationExpense>
    <cik0002058261:OtherBadDebtExpenses
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001065"
      unitRef="KRW">341816000</cik0002058261:OtherBadDebtExpenses>
    <cik0002058261:OtherBadDebtExpenses
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001066"
      unitRef="KRW">71412000</cik0002058261:OtherBadDebtExpenses>
    <cik0002058261:ReversalOfOtherBadDebtExpenses
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001069"
      unitRef="KRW">-489720000</cik0002058261:ReversalOfOtherBadDebtExpenses>
    <cik0002058261:GainsOnValuationOfDerivatives
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001071"
      unitRef="KRW">-461422000</cik0002058261:GainsOnValuationOfDerivatives>
    <cik0002058261:GainsOnValuationOfDerivatives
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001072"
      unitRef="KRW">-673637000</cik0002058261:GainsOnValuationOfDerivatives>
    <cik0002058261:LossesOnForeignCurrencyTranslation
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001074"
      unitRef="KRW">2145000</cik0002058261:LossesOnForeignCurrencyTranslation>
    <cik0002058261:LossesOnForeignCurrencyTranslation
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001075"
      unitRef="KRW">661000</cik0002058261:LossesOnForeignCurrencyTranslation>
    <cik0002058261:GainsOnForeignCurrencyTranslation
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001077"
      unitRef="KRW">6350000</cik0002058261:GainsOnForeignCurrencyTranslation>
    <cik0002058261:GainsOnForeignCurrencyTranslation
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001078"
      unitRef="KRW">9162000</cik0002058261:GainsOnForeignCurrencyTranslation>
    <ifrs-full:AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001081"
      unitRef="KRW">-4172000</ifrs-full:AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment>
    <ifrs-full:AdjustmentsForImpairmentLossRecognisedInProfitOrLossGoodwill
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001084"
      unitRef="KRW">601792000</ifrs-full:AdjustmentsForImpairmentLossRecognisedInProfitOrLossGoodwill>
    <cik0002058261:AdjustmentsForLossOnDisposalsPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001087"
      unitRef="KRW">-5616000</cik0002058261:AdjustmentsForLossOnDisposalsPropertyPlantAndEquipment>
    <cik0002058261:InterestExpenses
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001089"
      unitRef="KRW">798129000</cik0002058261:InterestExpenses>
    <cik0002058261:InterestExpenses
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001090"
      unitRef="KRW">1050584000</cik0002058261:InterestExpenses>
    <cik0002058261:InterestsIncome
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001092"
      unitRef="KRW">230557000</cik0002058261:InterestsIncome>
    <cik0002058261:InterestsIncome
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001093"
      unitRef="KRW">46559000</cik0002058261:InterestsIncome>
    <cik0002058261:LossesOnBondRedemption
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001095"
      unitRef="KRW">69890000</cik0002058261:LossesOnBondRedemption>
    <cik0002058261:LossesOnBondRedemption
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001096"
      unitRef="KRW">283780000</cik0002058261:LossesOnBondRedemption>
    <ifrs-full:AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001098"
      unitRef="KRW">-6281000</ifrs-full:AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives>
    <ifrs-full:AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001099"
      unitRef="KRW">-5802000</ifrs-full:AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives>
    <cik0002058261:SeveranceBenefits
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001101"
      unitRef="KRW">238148000</cik0002058261:SeveranceBenefits>
    <cik0002058261:SeveranceBenefits
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001102"
      unitRef="KRW">212265000</cik0002058261:SeveranceBenefits>
    <ifrs-full:AdditionsToNoncurrentAssets
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001107"
      unitRef="KRW">41579000</ifrs-full:AdditionsToNoncurrentAssets>
    <ifrs-full:AdditionsToNoncurrentAssets
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001108"
      unitRef="KRW">41579000</ifrs-full:AdditionsToNoncurrentAssets>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001110"
      unitRef="KRW">193852000</ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001111"
      unitRef="KRW">709264000</ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001113"
      unitRef="KRW">172212000</ifrs-full:AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001114"
      unitRef="KRW">-302872000</ifrs-full:AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInPrepaidExpenses
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001116"
      unitRef="KRW">5130000</ifrs-full:AdjustmentsForDecreaseIncreaseInPrepaidExpenses>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInPrepaidExpenses
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001117"
      unitRef="KRW">18457000</ifrs-full:AdjustmentsForDecreaseIncreaseInPrepaidExpenses>
    <cik0002058261:AdjustmentsForPrepayments
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001119"
      unitRef="KRW">-83673000</cik0002058261:AdjustmentsForPrepayments>
    <cik0002058261:LiabilitiesDueToBenefitsPaid
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001122"
      unitRef="KRW">-155405000</cik0002058261:LiabilitiesDueToBenefitsPaid>
    <cik0002058261:LiabilitiesDueToBenefitsPaid
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001123"
      unitRef="KRW">-108281000</cik0002058261:LiabilitiesDueToBenefitsPaid>
    <ifrs-full:InterestReceivedClassifiedAsOperatingActivities
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001125"
      unitRef="KRW">72764000</ifrs-full:InterestReceivedClassifiedAsOperatingActivities>
    <ifrs-full:InterestReceivedClassifiedAsOperatingActivities
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001126"
      unitRef="KRW">49582000</ifrs-full:InterestReceivedClassifiedAsOperatingActivities>
    <ifrs-full:InterestPaidClassifiedAsOperatingActivities
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001128"
      unitRef="KRW">53044000</ifrs-full:InterestPaidClassifiedAsOperatingActivities>
    <ifrs-full:InterestPaidClassifiedAsOperatingActivities
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001129"
      unitRef="KRW">62090000</ifrs-full:InterestPaidClassifiedAsOperatingActivities>
    <ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001131"
      unitRef="KRW">907000</ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities>
    <ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001132"
      unitRef="KRW">-4014000</ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities>
    <ifrs-full:CashFlowsFromUsedInOperatingActivities
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001134"
      unitRef="KRW">-4965996000</ifrs-full:CashFlowsFromUsedInOperatingActivities>
    <ifrs-full:CashFlowsFromUsedInOperatingActivities
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001135"
      unitRef="KRW">-6371229000</ifrs-full:CashFlowsFromUsedInOperatingActivities>
    <cik0002058261:LoansAdvanceToRelatedParty
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001140"
      unitRef="KRW">220000000</cik0002058261:LoansAdvanceToRelatedParty>
    <cik0002058261:LoansAdvanceToRelatedParty
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001141"
      unitRef="KRW">44100000</cik0002058261:LoansAdvanceToRelatedParty>
    <cik0002058261:LoanRepaymentsReceived
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001144"
      unitRef="KRW">760000000</cik0002058261:LoanRepaymentsReceived>
    <cik0002058261:DepositRefunded
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001147"
      unitRef="KRW">18931000</cik0002058261:DepositRefunded>
    <cik0002058261:ProceedFromDisposalOfPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001150"
      unitRef="KRW">7518000</cik0002058261:ProceedFromDisposalOfPropertyPlantAndEquipment>
    <cik0002058261:PurchaseOfIntangibleAssets
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001152"
      unitRef="KRW">-1536000</cik0002058261:PurchaseOfIntangibleAssets>
    <ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001155"
      unitRef="KRW">7961000</ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001156"
      unitRef="KRW">74216000</ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
    <ifrs-full:CashFlowsFromUsedInInvestingActivities
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001158"
      unitRef="KRW">-229497000</ifrs-full:CashFlowsFromUsedInInvestingActivities>
    <ifrs-full:CashFlowsFromUsedInInvestingActivities
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001159"
      unitRef="KRW">668133000</ifrs-full:CashFlowsFromUsedInInvestingActivities>
    <cik0002058261:RepaymentOfShorttermBorrowings
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001164"
      unitRef="KRW">270000000</cik0002058261:RepaymentOfShorttermBorrowings>
    <cik0002058261:ProceedsFromShorttermBorrowings
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001167"
      unitRef="KRW">270000000</cik0002058261:ProceedsFromShorttermBorrowings>
    <cik0002058261:ProceedsFromIssuanceOfBondWithWarrants
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001170"
      unitRef="KRW">9200000000</cik0002058261:ProceedsFromIssuanceOfBondWithWarrants>
    <cik0002058261:ProceedsFromIssuanceOfBondWithWarrants
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001171"
      unitRef="KRW">4500000000</cik0002058261:ProceedsFromIssuanceOfBondWithWarrants>
    <cik0002058261:RepaymentOfBondWithWarrants
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001173"
      unitRef="KRW">8105000000</cik0002058261:RepaymentOfBondWithWarrants>
    <cik0002058261:RepaymentOfBondWithWarrants
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001174"
      unitRef="KRW">2750005000</cik0002058261:RepaymentOfBondWithWarrants>
    <cik0002058261:PaymentOfOfferingCost
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001176"
      unitRef="KRW">1368185000</cik0002058261:PaymentOfOfferingCost>
    <cik0002058261:PaymentOfOfferingCost
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001177"
      unitRef="KRW">1025730000</cik0002058261:PaymentOfOfferingCost>
    <cik0002058261:ProceedsFromWarrantsExercised
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001180"
      unitRef="KRW">3035000000</cik0002058261:ProceedsFromWarrantsExercised>
    <cik0002058261:ProceedsFromShareOptionsExercised
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001183"
      unitRef="KRW">1026800000</cik0002058261:ProceedsFromShareOptionsExercised>
    <cik0002058261:PaymentOfLeaseLiabilityPrincipal
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001185"
      unitRef="KRW">117348000</cik0002058261:PaymentOfLeaseLiabilityPrincipal>
    <cik0002058261:PaymentOfLeaseLiabilityPrincipal
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001186"
      unitRef="KRW">109391000</cik0002058261:PaymentOfLeaseLiabilityPrincipal>
    <cik0002058261:ProceedsFromTreasuryStocksDisposedWithRefundObligation
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001188"
      unitRef="KRW">2110000000</cik0002058261:ProceedsFromTreasuryStocksDisposedWithRefundObligation>
    <cik0002058261:ProceedsFromTreasuryStocksDisposed
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001191"
      unitRef="KRW">150000000</cik0002058261:ProceedsFromTreasuryStocksDisposed>
    <cik0002058261:ProceedsFromTreasuryStocksDisposed
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001192"
      unitRef="KRW">4011860000</cik0002058261:ProceedsFromTreasuryStocksDisposed>
    <ifrs-full:CashFlowsFromUsedInFinancingActivities
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001194"
      unitRef="KRW">1869467000</ifrs-full:CashFlowsFromUsedInFinancingActivities>
    <ifrs-full:CashFlowsFromUsedInFinancingActivities
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001195"
      unitRef="KRW">8688534000</ifrs-full:CashFlowsFromUsedInFinancingActivities>
    <ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001197"
      unitRef="KRW">-334000</ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents>
    <ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001198"
      unitRef="KRW">8501000</ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001200"
      unitRef="KRW">-3326026000</ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001201"
      unitRef="KRW">2985438000</ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges>
    <ifrs-full:CashAndCashEquivalents
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001203"
      unitRef="KRW">3662174000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="AsOf2023-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001204"
      unitRef="KRW">668235000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001206"
      unitRef="KRW">335814000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001207"
      unitRef="KRW">3662174000</ifrs-full:CashAndCashEquivalents>
    <cik0002058261:ReportingEntityTextBlock
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact001209">&lt;p id="xdx_80F_ecustom--ReportingEntityTextBlock_zJNMjCtNJu3h" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;1. &lt;span id="xdx_82A_zQpp4q7bvmG1"&gt;Reporting entity&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;The Company&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;CubeBio Co., Ltd. (the &#x201c;Company&#x201d;) was incorporated in November 2011 and the Company&#x2019;s registered office is at 9, Digital-ro 10-gil, Geumcheon-gu, Seoul, Republic of Korea. The Company primarily engages in discovering, designing, developing, manufacturing, and selling in-vitro diagnostics using liquid biopsies for strategic cancer treatment.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company&#x2019;s major shareholders and their respective percentage of ownership as of December&#160;31, 2025 are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_88C_ecustom--ScheduleOfMajorShareholdersAndTheirRespectivePercentageOfOwnershipTableTextBlock_pn3n3_zRBCtAj5UTZ1" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Reporting entity (Details)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_8BB_zE7BlPg7ef63" style="display: none"&gt;Schedule of major shareholders and their respective percentage of ownership&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2024&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Number&#160;of&lt;br/&gt; shares&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Ownership&lt;br/&gt; (%)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Number&#160;of&lt;br/&gt; shares&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Ownership&lt;br/&gt; (%)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Well Core Co., Ltd.&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_909_ecustom--NumberOfShares_pid_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--WellCoreCoLtdMember_zRr28Y5EKdt7" title="Number of shares"&gt;12,110,698&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--WellCoreCoLtdMember_zCldN7Z4Nswl" title="Ownership (%)"&gt;22.93&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_905_ecustom--NumberOfShares_pid_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--WellCoreCoLtdMember_zlyWtdqJoApc" title="Number of shares"&gt;12,110,698&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--WellCoreCoLtdMember_zul1Ez8tb967" title="Ownership (%)"&gt;23.16&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Treasury shares&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--NumberOfShares_pid_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__ifrs-full--TreasurySharesMember_zog66Gp9EYNf" title="Number of shares"&gt;3,833,400&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__ifrs-full--TreasurySharesMember_zg2igDtlPakl" title="Ownership (%)"&gt;7.26&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_902_ecustom--NumberOfShares_pid_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__ifrs-full--TreasurySharesMember_ze4XXrvjtRTa" title="Number of shares"&gt;3,933,400&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__ifrs-full--TreasurySharesMember_zcCI1itwTZne" title="Ownership (%)"&gt;7.52&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Others&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--NumberOfShares_pid_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--OthersMember_z2BK4KyC8f01" title="Number of shares"&gt;36,871,377&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--OthersMember_znBxp7TqfIe3" title="Ownership (%)"&gt;69.81&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;%&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_901_ecustom--NumberOfShares_pid_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--OthersMember_zdStEU8DWLeb" title="Number of shares"&gt;36,250,377&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--OthersMember_z2whyVMZxMkb" title="Ownership (%)"&gt;69.32&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;%&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; vertical-align: top; padding-bottom: 1.25pt"&gt;Total&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--NumberOfShares_pid_c20250101__20251231_zYYYGsWS12hd" title="Number of shares"&gt;52,815,475&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_c20250101__20251231_z1e56NH3Xgf" title="Ownership (%)"&gt;100.00&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;%&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--NumberOfShares_pid_c20240101__20241231_zNdGKpDB1ak3" title="Number of shares"&gt;52,294,475&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_c20240101__20241231_zUUaDyFuetce" title="Ownership (%)"&gt;100.00&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;%&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

</cik0002058261:ReportingEntityTextBlock>
    <cik0002058261:ScheduleOfMajorShareholdersAndTheirRespectivePercentageOfOwnershipTableTextBlock
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact001211">&lt;table cellpadding="0" cellspacing="0" id="xdx_88C_ecustom--ScheduleOfMajorShareholdersAndTheirRespectivePercentageOfOwnershipTableTextBlock_pn3n3_zRBCtAj5UTZ1" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Reporting entity (Details)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_8BB_zE7BlPg7ef63" style="display: none"&gt;Schedule of major shareholders and their respective percentage of ownership&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2024&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Number&#160;of&lt;br/&gt; shares&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Ownership&lt;br/&gt; (%)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Number&#160;of&lt;br/&gt; shares&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Ownership&lt;br/&gt; (%)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Well Core Co., Ltd.&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_909_ecustom--NumberOfShares_pid_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--WellCoreCoLtdMember_zRr28Y5EKdt7" title="Number of shares"&gt;12,110,698&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--WellCoreCoLtdMember_zCldN7Z4Nswl" title="Ownership (%)"&gt;22.93&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_905_ecustom--NumberOfShares_pid_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--WellCoreCoLtdMember_zlyWtdqJoApc" title="Number of shares"&gt;12,110,698&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--WellCoreCoLtdMember_zul1Ez8tb967" title="Ownership (%)"&gt;23.16&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Treasury shares&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--NumberOfShares_pid_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__ifrs-full--TreasurySharesMember_zog66Gp9EYNf" title="Number of shares"&gt;3,833,400&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__ifrs-full--TreasurySharesMember_zg2igDtlPakl" title="Ownership (%)"&gt;7.26&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_902_ecustom--NumberOfShares_pid_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__ifrs-full--TreasurySharesMember_ze4XXrvjtRTa" title="Number of shares"&gt;3,933,400&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__ifrs-full--TreasurySharesMember_zcCI1itwTZne" title="Ownership (%)"&gt;7.52&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Others&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--NumberOfShares_pid_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--OthersMember_z2BK4KyC8f01" title="Number of shares"&gt;36,871,377&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--OthersMember_znBxp7TqfIe3" title="Ownership (%)"&gt;69.81&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;%&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_901_ecustom--NumberOfShares_pid_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--OthersMember_zdStEU8DWLeb" title="Number of shares"&gt;36,250,377&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--OthersMember_z2whyVMZxMkb" title="Ownership (%)"&gt;69.32&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;%&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; vertical-align: top; padding-bottom: 1.25pt"&gt;Total&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--NumberOfShares_pid_c20250101__20251231_zYYYGsWS12hd" title="Number of shares"&gt;52,815,475&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_c20250101__20251231_z1e56NH3Xgf" title="Ownership (%)"&gt;100.00&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;%&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--NumberOfShares_pid_c20240101__20241231_zNdGKpDB1ak3" title="Number of shares"&gt;52,294,475&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_c20240101__20241231_zUUaDyFuetce" title="Ownership (%)"&gt;100.00&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;%&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;</cik0002058261:ScheduleOfMajorShareholdersAndTheirRespectivePercentageOfOwnershipTableTextBlock>
    <cik0002058261:NumberOfShares
      contextRef="From2025-01-012025-12-31_custom_WellCoreCoLtdMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact001213"
      unitRef="Shares">12110698</cik0002058261:NumberOfShares>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="From2025-01-012025-12-31_custom_WellCoreCoLtdMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact001215"
      unitRef="Pure">0.2293</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <cik0002058261:NumberOfShares
      contextRef="From2024-01-012024-12-31_custom_WellCoreCoLtdMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact001217"
      unitRef="Shares">12110698</cik0002058261:NumberOfShares>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="From2024-01-012024-12-31_custom_WellCoreCoLtdMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact001219"
      unitRef="Pure">0.2316</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <cik0002058261:NumberOfShares
      contextRef="From2025-01-012025-12-31_ifrs-full_TreasurySharesMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact001221"
      unitRef="Shares">3833400</cik0002058261:NumberOfShares>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="From2025-01-012025-12-31_ifrs-full_TreasurySharesMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact001223"
      unitRef="Pure">0.0726</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <cik0002058261:NumberOfShares
      contextRef="From2024-01-012024-12-31_ifrs-full_TreasurySharesMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact001225"
      unitRef="Shares">3933400</cik0002058261:NumberOfShares>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="From2024-01-012024-12-31_ifrs-full_TreasurySharesMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact001227"
      unitRef="Pure">0.0752</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <cik0002058261:NumberOfShares
      contextRef="From2025-01-012025-12-31_custom_OthersMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact001229"
      unitRef="Shares">36871377</cik0002058261:NumberOfShares>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="From2025-01-012025-12-31_custom_OthersMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact001231"
      unitRef="Pure">0.6981</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <cik0002058261:NumberOfShares
      contextRef="From2024-01-012024-12-31_custom_OthersMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact001233"
      unitRef="Shares">36250377</cik0002058261:NumberOfShares>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="From2024-01-012024-12-31_custom_OthersMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact001235"
      unitRef="Pure">0.6932</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <cik0002058261:NumberOfShares
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact001237"
      unitRef="Shares">52815475</cik0002058261:NumberOfShares>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact001239"
      unitRef="Pure">1.0000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <cik0002058261:NumberOfShares
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact001241"
      unitRef="Shares">52294475</cik0002058261:NumberOfShares>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact001243"
      unitRef="Pure">1.0000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <cik0002058261:BasisOfPreparationTextBlock
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact001245">&lt;p id="xdx_80E_ecustom--BasisOfPreparationTextBlock_z6nWvMZfssg2" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;2. &lt;span id="xdx_829_z6wXAxJyOnT7"&gt;Basis of Preparation&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;These financial statements have been prepared in accordance with International Financial Reporting Standards as issued by International Accounting Standard Board (&#x201c;IFRS&#x201d;). These financial statements were authorized for issuance by the board of directors on July&#160;10, 2026.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Details of the Company&#x2019;s accounting policies, including changes thereto, are included in Note 5.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;Basis of measurement&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;These financial statements have been prepared on the historical cost basis except for the following items, which are measured on an alternative basis on each reporting date.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_88B_ecustom--ScheduleOfMeasuredOnAlternativeTableTextBlock_pn3n3_zyClU9gIQUJ7" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Basis of Preparation (Details)"&gt;
  &lt;tr style="background-color: #FFFFFF"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_8BE_z6uHdSkp1xr8" style="display: none"&gt;Schedule
    of measured  an alternative&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; vertical-align: bottom; text-align: left"&gt;&lt;b&gt;Items&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; vertical-align: bottom; width: 25%; text-align: center"&gt;&lt;b&gt;Measurement bases&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom; padding-left: 0.125in; text-indent: -0.125in"&gt;Defined benefit liabilities&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;Present value&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom; padding-left: 0.125in; text-indent: -0.125in"&gt;Financial instruments measured at fair value through profit or loss (&#x201c;FVTPL&#x201d;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; text-align: center"&gt;Fair value&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt; &lt;b&gt;&lt;i&gt;Reclassifications&lt;/i&gt;&lt;/b&gt; &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt; &lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt; &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt; Certain previously reported balances have been reclassified to conform to the current presentation. These reclassifications had no effect on total assets, liabilities, shareholders&#x2019; equity or income as previously reported. &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

</cik0002058261:BasisOfPreparationTextBlock>
    <cik0002058261:ScheduleOfMeasuredOnAlternativeTableTextBlock
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact001247">&lt;table cellpadding="0" cellspacing="0" id="xdx_88B_ecustom--ScheduleOfMeasuredOnAlternativeTableTextBlock_pn3n3_zyClU9gIQUJ7" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Basis of Preparation (Details)"&gt;
  &lt;tr style="background-color: #FFFFFF"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_8BE_z6uHdSkp1xr8" style="display: none"&gt;Schedule
    of measured  an alternative&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; vertical-align: bottom; text-align: left"&gt;&lt;b&gt;Items&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; vertical-align: bottom; width: 25%; text-align: center"&gt;&lt;b&gt;Measurement bases&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom; padding-left: 0.125in; text-indent: -0.125in"&gt;Defined benefit liabilities&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;Present value&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom; padding-left: 0.125in; text-indent: -0.125in"&gt;Financial instruments measured at fair value through profit or loss (&#x201c;FVTPL&#x201d;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; text-align: center"&gt;Fair value&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;</cik0002058261:ScheduleOfMeasuredOnAlternativeTableTextBlock>
    <cik0002058261:FunctionalAndPresentationCurrencyTextBlock
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact001249">&lt;p id="xdx_80A_ecustom--FunctionalAndPresentationCurrencyTextBlock_zuYNk7gSAVr4" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;3. &lt;span id="xdx_82A_zm8zbu5gcei4"&gt;Functional and presentation currency&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;These financial statements are presented in Korean won, which is the Company&#x2019;s functional currency.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

















</cik0002058261:FunctionalAndPresentationCurrencyTextBlock>
    <cik0002058261:UseOfJudgementsAndEstimatesTextBlock
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact001258">&lt;p id="xdx_805_ecustom--UseOfJudgementsAndEstimatesTextBlock_zOpfvrg2IlU3" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;4. &lt;span id="xdx_82D_zP2SBjvMYIK1"&gt;Use of judgements and estimates&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;In preparing these financial statements, management has made judgements and estimates that affect the application of the Company&#x2019;s accounting policies and the reported amounts of assets, liabilities, income, and expenses. Actual results may differ from these estimates.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to estimates are recognized prospectively.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.25in; text-align: left"&gt;&lt;b&gt;A.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;&lt;b&gt;Judgements&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Information about judgements made in applying accounting policies that have the most significant effects on the amounts recognized in the financial statements is included in the following notes:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Note 15(A): lease term: whether the Company is reasonably certain to exercise extension options.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.25in; text-align: left"&gt;&lt;b&gt;B.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;&lt;b&gt;Assumptions and estimation uncertainties&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; width: 0.5in"&gt;i.&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;Estimation uncertainties&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Information about assumptions and estimation uncertainties at the reporting date that have a significant risk of resulting in material adjustments to the carrying amounts of assets and liabilities within the next financial year is as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company establishes additional current tax liabilities for income taxes when, despite the belief that tax positions are fully supportable, there remain positions that do not meet the minimum probability threshold, which is a tax position that is more likely than not to be sustained upon examination by the applicable taxation authority. The impact of current tax liabilities for uncertain tax positions, as well as the related net interest and penalties, is included in income taxes in the statements of operations.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.5in; text-align: left"&gt;ii.&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;Measurement of fair values&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;A number of the Company&#x2019;s accounting policies and disclosures require the measurement of fair values for financial assets and liabilities.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;When measuring the fair value of financial instruments measured at FVTPL and FVOCI, the Company uses observable market data as far as possible. Fair values are categorized into different levels in a fair value hierarchy based on the inputs used in the valuation techniques as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&#x25cf;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;Level 1: quoted prices (unadjusted) in active markets for identical assets or liabilities.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&#x25cf;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;Level 2: inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly (i.e., as prices) or indirectly (i.e., derived from prices).&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&#x25cf;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;Level 3: inputs for the asset or liability that are not based on observable market data (unobservable inputs).&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

















&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;If the inputs used to measure the fair value of an asset or a liability fall into different levels of the fair value hierarchy, then the fair value measurement is categorized in its entirety in the same level of the fair value hierarchy as the lowest level input that is significant to the entire measurement.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company recognizes transfers between levels of the fair value hierarchy at the end of the reporting period during which the change has occurred.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Further information about the assumptions made in measuring fair values is included in the following notes:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&#x25cf;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;Note 22: Derivative instruments;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&#x25cf;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;Note 23: Financial instruments;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&#x25cf;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;Note 26(B): Share-based payment arrangements.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

</cik0002058261:UseOfJudgementsAndEstimatesTextBlock>
    <ifrs-full:DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact001267">&lt;p id="xdx_80D_eifrs-full--DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory_zyuLjDq8Jde4" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;5. &lt;span id="xdx_821_zZAnDunLRMvl"&gt;Material accounting policies&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The material accounting policies followed by the Company in the preparation of its financial statements are as follows:&lt;/p&gt;

&lt;p id="xdx_849_eifrs-full--DescriptionOfAccountingPolicyForOffsettingOfFinancialInstrumentsExplanatory_zpz0Q5cCj7bc" style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.25in; text-align: left"&gt;&lt;b&gt;A.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_86A_zc0aJELQYCte"&gt;New and amended standards or interpretations not yet adopted by the Company&lt;/span&gt;&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The following new accounting standards and interpretations have been published but are not mandatory for December&#160;31, 2025 reporting period and have not been early adopted by the Company.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;IFRS 9 Financial Instruments - IFRS 7 Financial Instruments: Disclosures &#x2013; Classification and Measurement of Financial Instruments&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The amendments clarify that a financial liability is derecognized on the &#x2018;settlement date&#x2019; and introduce an accounting policy choice to derecognize financial liabilities settled using an electronic payment system before the settlement date. Other clarifications include the classification of financial assets with ESG linked features via additional guidance on the assessment of contingent features. Clarifications have been made to non-recourse loans and contractually linked instruments. Additional disclosures are introduced for financial instruments with contingent features and equity instruments classified at fair value through OCI. The amendments should be applied for annual periods beginning on or after January&#160;1, 2026, and earlier application is permitted, with an option to early adopt the amendments for contingent features only. The amendments do not have a significant impact on the financial statements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;IFRS 18 Presentation and Disclosure in Financial Statements&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Items in the statement of profit or loss will need to be classified into one of five categories: operating, investing, financing, income taxes and discontinued operations. IFRS 18 requires the Company to present specified totals and subtotals: &#x2018;Operating profit or loss&#x2019;, &#x2018;Profit or loss&#x2019; and &#x2018;Profit or loss before financing and income taxes&#x2019;. Information related to management-defined performance measures should be disclosed. IFRS 18 also provides enhanced guidance on the principles of aggregation and disaggregation which focus on grouping items based on their shared characteristics. The new standard should be applied for annual periods beginning on or after January&#160;1, 2027, and earlier application is permitted. The Company is in review for the impact of this new standard on the financial statements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

















&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;IFRS 19 Subsidiaries without Public Accountability: Disclosures&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;IFRS 19 allows eligible subsidiaries to apply IFRS Accounting Standards with the reduced disclosure requirements of IFRS 19. A subsidiary may choose to apply the new standard in its consolidated, separate or individual financial statements provided that, at the reporting date, it does not have public accountability, and its parent produces consolidated financial statements under IFRS Accounting Standards. A subsidiary applying IFRS 19 is required to disclose in its explicit and unreserved statements of compliance with IFRS Accounting Standards that IFRS 19 has been adopted. The new standard should be applied for annual periods beginning on or after January&#160;1, 2027, and earlier application is permitted. The Company does not expect that this new standard has a significant impact on the financial statements.&lt;/p&gt;

&lt;p id="xdx_845_ecustom--DisclosureOfForeignCurrencyExplanatory_zVJRW5KogXn8" style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.25in; text-align: left"&gt;&lt;b&gt;B.&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_868_ztOiyIOaXaEd" style="font: 10pt Times New Roman; text-align: justify"&gt;&lt;b&gt;Foreign currency&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Transactions in foreign currencies are translated into the respective functional currencies of the company at the exchange rates at the dates of the transactions.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Monetary assets and liabilities denominated in foreign currencies are translated into the functional currency at the exchange rate on the reporting date. Non-monetary assets and liabilities that are measured at fair value in a foreign currency are translated into the functional currency at the exchange rate when the fair value was determined. Non-monetary items that are measured based on historical cost in a foreign currency are translated at the exchange rate on the date of the transaction. Foreign currency differences are generally recognized in profit or loss and presented within finance costs. Translation differences on non-monetary assets and liabilities carried at fair value are reported as part of the fair value gain or loss.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;However, foreign currency differences arising from the translation of the following items are recognized in OCI:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&#x25cf;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;an investment in equity securities designated as at FVOCI;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&#x25cf;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;a financial liability designated as a hedge of the net investment in a foreign operation to the extent that the hedge is effective; and&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&#x25cf;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;qualifying cash flow hedges to the extent that the hedges are effective.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_84E_eifrs-full--DisclosureOfOperatingSegmentsExplanatory_z9MIoZntXAWl" style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.25in; text-align: left"&gt;&lt;b&gt;C.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_868_z5lYk7r0h0hh"&gt;Operating segments&lt;/span&gt;&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;An operating segment is a component of the Company that engages in business activities from which it may earn revenues and incur expenses, including revenues and expenses that relate to transactions with any of the Company&#x2019;s other components. The chief operating decision-maker has been identified as the chief executive officer. The Company&#x2019;s operating segment has been determined to be a single business unit, for which the Company generates identifiable financial information that is regularly reported to the chief executive officer for the purpose of resource allocation and assessment of segment performance. The Company has a reportable segment as described in Note 6. Segment results that are reported to the chief operating decision maker include items directly attributable to the segment, as well as those that can be allocated on a reasonable basis.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;















&lt;p id="xdx_841_ecustom--DisclosureOfEmployeeBenefitsExplanatoryPolicyTextBlock_z8b9YtGN9Xu1" style="font: 10pt Times New Roman, Times, serif; margin: 0px"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.25in; text-align: left"&gt;&lt;b&gt;D.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_869_zcTtDJybNLC6"&gt;Employee benefits&lt;/span&gt;&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.5in; text-align: left"&gt;i.&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;Short-term employee benefits&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Short-term employee benefits are employee benefits due to be settled within 12 months after the end of the period in which the employees render the related services. When an employee has rendered a service to the Company during an accounting period, the Company recognizes the undiscounted amount of short-term employee benefits expected to be paid in exchange for that service.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.5in; text-align: left"&gt;ii.&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;Share-based payment arrangements&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The grant-date fair value of equity-settled share-based payment arrangements granted to employees is generally recognized as an expense, with a corresponding increase in equity, over the vesting period of the awards. The amount recognized as an expense is adjusted to reflect the number of awards for which the related service and non-market performance conditions are expected to be met, such that the amount ultimately recognized is based on the number of awards that meet the related service and non-market performance conditions at the vesting date. For share-based payment awards with non-vesting conditions, the grant-date fair value of the share-based payment is measured to reflect such conditions and there is no true-up for differences between expected and actual outcomes.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The fair value of the amount payable to employees in respect of share-based payment arrangements, which are settled in cash, is recognized as an expense with a corresponding increase in liabilities, over the period during which the employees become unconditionally entitled to payment. The liability is remeasured at each reporting date and at settlement date based on the fair value of the share-based payment arrangements. Any changes in the liability are recognized in profit or loss.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The fair value of the share-based payment arrangements with cash alternatives granted to employees, which is sum of the fair values of the equity component and liabilities component, is recognized as an expense, with a corresponding increase in equity and liabilities, over the vesting period of the awards. The liability is remeasured at each reporting date and at settlement date based on the fair value of the share-based payment arrangements. Any changes in the liability are recognized in profit or loss.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.5in; text-align: left"&gt;iii.&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;Defined benefit plans&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company&#x2019;s net obligation in respect of defined benefit plans is calculated separately for each plan by estimating the amount of future benefits that employees have earned in the current and prior periods, discounting that amount and deducting the fair value of any plan assets.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The calculation of defined benefit obligations is performed annually using the projected unit credit method. When the calculation results in a potential asset for the Company, the recognized asset is limited to the present value of economic benefits available in the form of any future refunds from the plan or reductions in future contributions to the plan. To calculate the present value of economic benefits, consideration is given to any applicable minimum funding requirements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

















&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Remeasurements of the net defined benefit liability, which comprise actuarial gains and losses, the return on plan assets (excluding interest) and the effect of the asset ceiling (if any, excluding interest), are recognized immediately in OCI. The Company determines the net interest expense (income) on the net defined benefit liability (asset) for the period by applying the discount rate used to measure the defined benefit obligation at the beginning of the annual period to the then- net defined benefit liability (asset), taking into account any changes in the net defined benefit liability (asset) during the period as a result of contributions and benefit payments. Net interest expense and other expenses related to defined benefit plans are recognized in profit or loss.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;When the benefits of a plan are changed or when a plan is curtailed, the resulting change in benefits that relates to past service or the gain or loss on curtailment is recognized immediately in profit or loss. The Company recognizes gains and losses on the settlement of a defined benefit plan when the settlement occurs.&lt;/p&gt;

&lt;p id="xdx_84E_ecustom--DisclosureOfFinanceIncomeAndFinanceCostsExplanatory_z0JEs7ZggE3l" style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.25in; text-align: left"&gt;&lt;b&gt;E.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_862_zJCvfnEe3Oy3"&gt;Finance income and finance costs&lt;/span&gt;&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company&#x2019;s finance income and finance costs include:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&#x25cf;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;interest income;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&#x25cf;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;interest expense;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&#x25cf;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;dividend income;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&#x25cf;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;the net gain or loss on financial assets at FVTPL;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&#x25cf;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;the foreign currency gain or loss on financial assets and financial liabilities.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The &#x2018;effective interest rate&#x2019; is the rate that exactly discounts estimated future cash payments or receipts through the expected life of the financial instrument to:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&#x25cf;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;the gross carrying amount of the financial asset; or&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&#x25cf;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;the amortized cost of the financial liability.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;In calculating interest income and expense, the effective interest rate is applied to the gross carrying amount of the asset (when the asset is not credit-impaired) or to the amortized cost of the liability. However, for financial assets that have become credit-impaired subsequent to initial recognition, interest income is calculated by applying the effective interest rate to the amortized cost of the financial asset. If the asset is no longer credit-impaired, then the calculation of interest income reverts to the gross basis.&lt;/p&gt;

&lt;p id="xdx_846_ecustom--DisclosureOfIncomeTaxExpenseExplanatory_zWtGTfqcS0W5" style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.25in; text-align: left"&gt;&lt;b&gt;F.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_868_zkWBroAoskse"&gt;Income tax&lt;/span&gt;&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Income tax expense comprises current and deferred tax. It is recognized in profit or loss except to the extent that it relates to a business combination, or items recognized directly in equity or in OCI.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

















&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.5in; text-align: left"&gt;i.&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;Current income tax&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Current tax comprises the expected tax payable or receivable on the taxable income or loss for the year and any adjustment to the tax payable or receivable in respect of previous years. The amount of current tax payable or receivable is the best estimate of the tax amount expected to be paid or received that reflects uncertainty related to income taxes, if any. It is measured using tax rates enacted or substantively enacted at the reporting date. Current tax also includes any tax arising from dividends.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Current tax assets and liabilities are offset only if certain criteria are met.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; width: 0.25in"&gt;-&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;Has a legally enforceable right to set off the recognized amounts; and&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.25in; text-align: left"&gt;-&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;Intends either to settle on a net basis, or to realize the asset and settle the liability simultaneously.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.5in; text-align: left"&gt;ii.&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;Deferred income tax&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Deferred tax is recognized in respect of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for taxation purposes. Deferred tax is not recognized for:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&#x25cf;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;temporary differences on the initial recognition of assets or liabilities in a transaction that is not a business combination and that affects neither accounting nor taxable profit or loss;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&#x25cf;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;temporary differences related to investments in subsidiaries, associates and joint arrangements to the extent that the Company is able to control the timing of the reversal of the temporary differences and it is probable that they will not reverse in the foreseeable future; and&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&#x25cf;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;taxable temporary differences arising on the initial recognition of goodwill.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Deferred tax assets are recognized for unused tax losses, unused tax credits and deductible temporary differences to the extent that it is probable that future taxable profits will be available against which they can be used. Future taxable profits are determined based on the reversal of relevant taxable temporary differences. If there are insufficient taxable temporary differences to recognize the deferred tax asset, the business plan of the Company and the reversal of existing temporary differences are considered in determining the future taxable profit. Deferred tax assets are reviewed at each reporting date and are reduced to the extent that it is no longer probable that the related tax benefit will be realized; such reductions are reversed when the probability of future taxable profits improves.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The measurement of deferred tax reflects the tax consequences that would follow from the manner in which the Company expects, at the reporting date, to recover or settle the carrying amount of its assets and liabilities. For this purpose, the carrying amount of investment property measured at fair value is presumed to be recovered through sale, and the Company has not rebutted this presumption.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Deferred tax assets and liabilities are offset only if certain criteria are met.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.25in; text-align: left"&gt;-&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;Has a legally enforceable right to set off the recognized amounts; and&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.25in; text-align: left"&gt;-&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;Intends either to settle on a net basis, or to realize the asset and settle the liability simultaneously.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;















&lt;p id="xdx_849_eifrs-full--DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_zePgbO4DvL89" style="font: 10pt Times New Roman, Times, serif; margin: 0px"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.25in; text-align: left"&gt;&lt;b&gt;G.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_86D_zhpzXgzH3JS3"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Cash and cash equivalents comprise cash on hand, deposits held at banks, and investment securities with maturities of three months or less from the acquisition date that are easily convertible to cash and subject to an insignificant risk of changes in their fair value.&lt;/p&gt;

&lt;p id="xdx_84F_eifrs-full--DisclosureOfInventoriesExplanatory_zVrChZGGfDL5" style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.25in; text-align: left"&gt;&lt;b&gt;H.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_86B_zz0cPhnartP9"&gt;Inventories&lt;/span&gt;&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Inventories are measured at the lower of cost and net realizable value. The cost of inventories is based on the first-in, first-out allocation method, and includes expenditures incurred in acquiring the inventories, production or conversion costs and other costs incurred in bringing them to their existing location and condition. Net realizable value is the estimated selling price in the ordinary course of business less the estimated costs of completion and the estimated selling expenses.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company makes adjustments to reduce the cost of inventory to its net realizable value for estimated excess, obsolescence, or impaired balances.&lt;/p&gt;

&lt;p id="xdx_84A_ecustom--DisclosureOfPropertyAndEquipmentExplanatory_zsOJBVDhOhl5" style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.25in; text-align: left"&gt;&lt;b&gt;I.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_863_ziqhSTzEh5uk"&gt;Property and equipment&lt;/span&gt;&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.5in; text-align: left"&gt;i.&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;Recognition and measurement&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Items of property and equipment are measured at cost, which includes capitalized borrowing costs, less accumulated depreciation and any accumulated impairment losses.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;If significant parts of an item of property and equipment have different useful lives, then they are accounted for as separate items (major components) of property and equipment.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Any gain or loss on disposal of an item of property and equipment is recognized in profit or loss.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.5in; text-align: left"&gt;ii.&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;Subsequent expenditure&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Subsequent expenditure is capitalized only if it is probable that the future economic benefits associated with the expenditure will flow to the Company. The carrying amount of the replaced parts is derecognized, and the repairs and maintenance expenses are recognized in profit or loss in the period they are incurred.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.5in; text-align: left"&gt;iii.&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;Depreciation&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Depreciation is calculated using the straight-line method to allocate the cost or revalued amounts of the assets, net of their residual values, over their estimated useful lives as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--ScheduleOfpropertyAndEquipmentTableTextBlock_pn3n3_zo7FJaQPRLzi" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Material Accounting Policies (Details)"&gt;
  &lt;tr style="background-color: #FFFFFF"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_8BB_zPzkmRJEDurc" style="display: none"&gt;Schedule of property and equipment useful lives&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: top; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Machinery&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: top; text-align: center; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; text-align: center; width: 25%"&gt;&lt;span id="xdx_907_ecustom--EstimatedUsefulLivesOfPropertyAndEquipment_dtY_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember_zaEExc1oMl74" title="Estimated useful lives of property and equipment"&gt;10&lt;/span&gt; years&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Vehicles&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: top; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;
        &lt;p style="font: 10pt Times New Roman; text-align: center; margin-top: 0; margin-bottom: 0"&gt;&lt;span id="xdx_90E_ecustom--EstimatedUsefulLivesOfPropertyAndEquipment_dtY_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_zUiqTuaM4So5" title="Estimated useful lives of property and equipment"&gt;5&lt;/span&gt; years&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Office equipment&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: top; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; text-align: center"&gt;&lt;span id="xdx_90D_ecustom--EstimatedUsefulLivesOfPropertyAndEquipment_dtY_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OfficeEquipmentMember_zAi8iSgun6Zb" title="Estimated useful lives of property and equipment"&gt;5&lt;/span&gt; years&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Furniture and fixtures&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: top; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; text-align: center"&gt;&lt;span id="xdx_907_ecustom--EstimatedUsefulLivesOfPropertyAndEquipment_dtY_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndFixtureMember_zMtt8QUOy5A9" title="Estimated useful lives of property and equipment"&gt;5&lt;/span&gt; years&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Right-of-use assets&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: top; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; text-align: center"&gt;&lt;span id="xdx_90F_ecustom--EstimatedUsefulLivesOfPropertyAndEquipment_dtY_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--RightofuseAssetsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zyxHTF4e9z5" title="Estimated useful lives of property and equipment"&gt;2&lt;/span&gt; ~ &lt;span id="xdx_907_ecustom--EstimatedUsefulLivesOfPropertyAndEquipment_dtY_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--RightofuseAssetsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zZ6rOIw4g7Ge" title="Estimated useful lives of property and equipment"&gt;10&lt;/span&gt; years&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A3_zRCUdvYoceH2" style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Depreciation methods, useful lives and residual values are reviewed at each reporting date and adjusted if appropriate.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;















&lt;p id="xdx_843_eifrs-full--DisclosureOfIntangibleAssetsAndGoodwillExplanatory_zfEANa7XL7D4" style="font: 10pt Times New Roman, Times, serif; margin: 0px"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.25in; text-align: left"&gt;&lt;b&gt;J.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_86E_zJ4sPXcyfD3a"&gt;Intangible assets&lt;/span&gt;&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.5in; text-align: left"&gt;i.&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;Recognition and measurement&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Intangible assets, including patents that are acquired by the Company and have finite useful lives are measured at cost less accumulated amortization and any accumulated impairment losses.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.5in; text-align: left"&gt;ii.&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;Subsequent expenditure&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Subsequent expenditure is capitalized only when it increases the future economic benefits embodied in the specific asset to which it relates. All other expenditure, including expenditure on software, patents, and brands, is recognized in profit or loss as incurred.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.5in; text-align: left"&gt;iii.&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;Amortization&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Amortization is calculated using the straight-line method to allocate the cost or revalued amounts of the assets, net of their residual values, over their estimated useful lives as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89C_ecustom--AmortizationOfEstimatedUsefulLivesTableTextBlock_pn3n3_zck1jJXUQoej" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Material Accounting Policies (Details 1)"&gt;
  &lt;tr&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: middle; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span id="xdx_8B2_zcgcIWhTNqQ3" style="display: none"&gt;Schedule of amortization of estimated useful lives&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: top; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-left: 0.125in; text-indent: -0.125in"&gt;Software&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; width: 1%; background-color: #CCEEFF; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; width: 25%; background-color: #CCEEFF; text-align: center"&gt;&lt;span id="xdx_906_ecustom--EstimatedUsefulLives_dtY_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__custom--SoftwareMember_zjBgCw9hn2Fj" title="Estimated useful lives"&gt;5&lt;/span&gt; years&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: middle; padding-left: 0.25in; text-indent: -0.125in"&gt; Patents &lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: top; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&lt;span id="xdx_904_ecustom--EstimatedUsefulLives_dtY_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__custom--PatentMember_zHoFN8dsM7Ra" title="Estimated useful lives"&gt;5&lt;/span&gt; years&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: middle; background-color: #CCEEFF; padding-left: 0.125in; text-indent: -0.125in"&gt;Brand&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: top; background-color: #CCEEFF; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; background-color: #CCEEFF; text-align: center"&gt;&lt;span id="xdx_907_ecustom--EstimatedUsefulLives_dtY_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__custom--BrandMember_zK4y8jVOVao5" title="Estimated useful lives"&gt;5&lt;/span&gt; years&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A1_zTKsGAdTATvb" style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Amortization methods, useful lives and residual values are reviewed at each reporting date and adjusted if appropriate.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.5in; text-align: left"&gt;iv.&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;Research and development expenses&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Research and development expenses are expensed as incurred when it does not meet the recognition criteria for intangible assets. Research and development expenses may consist of costs incurred in connection with acquired in-process research and development and performing research and development activities, including amounts incurred under agreements with external vendors and consultants engaged to perform preclinical studies and to manufacture research and development materials for use in such studies, salaries and related personnel costs, share-based compensation, and consultant fees.&lt;/p&gt;

&lt;p id="xdx_84C_eifrs-full--DisclosureOfFinancialInstrumentsExplanatory_zh9zHWOT38qk" style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.25in; text-align: left"&gt;&lt;b&gt;K.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_86E_zDNwqzips0r6"&gt;Financial instruments&lt;/span&gt;&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.5in; text-align: left"&gt;i.&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;Recognition and initial measurement&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;All financial assets and financial liabilities are initially recognized when the Company becomes a party to the contractual provisions of the instrument.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;A non-derivative financial asset (unless it is an account receivable without a significant financing component) or a non-derivative financial liability is initially measured at fair value plus or minus, for an item not at FVTPL, transaction costs that are directly attributable to its acquisition or issue. An account receivable without a significant financing component is initially measured at the transaction price.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

















&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.5in; text-align: left"&gt;ii.&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;Classification and subsequent measurement&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;Financial assets&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;On initial recognition, a financial asset is classified as measured at:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&#x25cf;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;amortized cost;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&#x25cf;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;FVOCI - debt investment;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&#x25cf;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;FVOCI - equity investment;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&#x25cf;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;or FVTPL.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Financial assets are not reclassified subsequent to their initial recognition unless the Company changes its business model for managing financial assets, in which case all affected financial assets are reclassified on the first day of the first reporting period following the change in the business model.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;A financial asset is measured at amortized cost if it meets both of the following conditions and is not designated as at FVTPL:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&#x25cf;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;it is held within a business model whose objective is to hold assets to collect contractual cash flows; and&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&#x25cf;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;its contractual terms give rise on specified dates to cash flows that are solely payments of principal and interest on the principal amount outstanding.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;A debt investment is measured at FVOCI if it meets both of the following conditions and is not designated as at FVTPL:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&#x25cf;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;it is held within a business model whose objective is achieved by both collecting contractual cash flows and selling financial assets; and&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&#x25cf;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;its contractual terms give rise on specified dates to cash flows that are solely payments of principal and interest on the principal amount outstanding.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;On initial recognition of an equity investment that is not held for trading, the Company may irrevocably elect to present subsequent changes in the investment&#x2019;s fair value in OCI. This election is made on an investment-by-investment basis.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;All financial assets not classified as measured at amortized cost or FVOCI as described above are measured at FVTPL. On initial recognition, the Company may irrevocably designate a financial asset that otherwise meets the requirements to be measured at amortized cost or at FVOCI as at FVTPL if doing so eliminates or significantly reduces an accounting mismatch that would otherwise arise.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

















&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;Financial assets - Business model assessment&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company makes an assessment of the objective of the business model in which a financial asset is held at a portfolio level because this best reflects the way the business is managed and information is provided to management. The information considered includes:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&#x25cf;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;the stated policies and objectives for the portfolio and the operation of those policies in practice. These include whether management&#x2019;s strategy focuses on earning contractual interest income, maintaining a particular interest rate profile, matching the duration of the financial assets to the duration of any related liabilities or expected cash outflows or realizing cash flows through the sale of the assets;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&#x25cf;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;how the performance of the portfolio is evaluated and reported to the Company&#x2019;s management;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&#x25cf;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;the risks that affect the performance of the business model (and the financial assets held within that business model) and how those risks are managed;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&#x25cf;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;how managers of the business are compensated - e.g., whether compensation is based on the fair value of the assets managed or the contractual cash flows collected; and&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&#x25cf;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;the frequency, volume and timing of sales of financial assets in prior periods, the reasons for such sales and expectations about future sales activity.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Transfers of financial assets to third parties in transactions that do not qualify for derecognition are not considered sales for this purpose, consistent with the Company&#x2019;s continuing recognition of the assets.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Financial assets that are held for trading or are managed and whose performance is evaluated on a fair value basis are measured at FVTPL.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;Financial assets - Assessment whether contractual cash flows are solely payments of principal and interest&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;For the purposes of this assessment, &#x2018;principal&#x2019; is defined as the fair value of the financial asset on initial recognition. &#x2018;Interest&#x2019; is defined as consideration for the time value of money and for the credit risk associated with the principal amount outstanding during a particular period of time and for other basic lending risks and costs (e.g., liquidity risk and administrative costs), as well as a profit margin.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;In assessing whether the contractual cash flows are solely payments of principal and interest, the Company considers the contractual terms of the instrument. This includes assessing whether the financial asset contains a contractual term that could change the timing or amount of contractual cash flows such that it would not meet this condition. In making this assessment, the Company considers:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&#x25cf;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;contingent events that would change the amount or timing of cash flows;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&#x25cf;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;terms that may adjust the contractual coupon rate, including variable-rate features;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&#x25cf;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;prepayment and extension features; and&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&#x25cf;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;terms that limit the Company&#x2019;s claim to cash flows from specified assets (e.g., non-recourse features).&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

















&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;A prepayment feature is consistent with the solely payments of principal and interest criterion if the prepayment amount substantially represents unpaid amounts of principal and interest on the principal amount outstanding, which may include reasonable compensation for early termination of the contract. Additionally, for a financial asset acquired at a discount or premium to its contractual par amount, a feature that permits or requires prepayment at an amount that substantially represents the contractual par amount plus accrued (but unpaid) contractual interest (which may also include reasonable compensation for early termination) is treated as consistent with this criterion if the fair value of the prepayment feature is insignificant at initial recognition.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;Financial assets - Subsequent measurement and gains and losses&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Financial assets at FVTPL: These assets are subsequently measured at fair value. Net gains and losses, including any interest or dividend income, are recognized in profit or loss.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Financial assets at amortized cost: These assets are subsequently measured at amortized cost using the effective interest method. The amortized cost is reduced by impairment losses. Interest income, foreign exchange gains and losses and impairment are recognized in profit or loss. Any gain or loss on derecognition is recognized in profit or loss.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;Financial liabilities - Classification, subsequent measurement and gains and losses&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Financial liabilities are classified as measured at amortized cost or FVTPL. A financial liability is classified as at FVTPL if it is classified as held-for-trading, it is a derivative or it is designated as such on initial recognition. Financial liabilities at FVTPL are measured at fair value and net gains and losses are recognized in profit or loss. Other financial liabilities are subsequently measured at amortized cost using the effective interest method. Interest expense and foreign exchange gains and losses are recognized in profit or loss. Any gain or loss on derecognition is also recognized in profit or loss.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 0.5in"&gt;iii.&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;Derecognition&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;Financial assets&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company derecognizes a financial asset when:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&#x25cf;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;the contractual rights to the cash flows from the financial asset expire; or&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&#x25cf;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;it transfers the rights to receive the contractual cash flows in a transaction in which either:&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.75in"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 0.25in"&gt;-&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;substantially all of the risks and rewards of ownership of the financial asset are transferred; or&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.75in"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;-&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;the Company neither transfers nor retains substantially all of the risks and rewards of ownership and it does not retain control of the financial asset.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;Financial liabilities&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company derecognizes a financial liability when its contractual obligations are discharged or cancelled, or expire. The Company also derecognizes a financial liability when its terms are modified and the cash flows of the modified liability are substantially different, in which case a new financial liability based on the modified terms is recognized at fair value.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

















&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;On derecognition of a financial liability, the difference between the carrying amount extinguished and the consideration paid (including any non-cash assets transferred or liabilities assumed) is recognized in profit or loss.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;When changes were made to a financial asset or financial liability in addition to changes to the basis for determining the contractual cash flows required by interest rate benchmark reform, the Company first updated the effective interest rate of the financial asset or financial liability to reflect the changes required by interest rate benchmark reform. Subsequently, the Company applied the policies on accounting for modifications to the additional changes.&lt;/p&gt;

&lt;p id="xdx_840_eifrs-full--DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsExplanatory_zBwYKLYJtava" style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.25in; text-align: left"&gt;&lt;b&gt;L.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_86D_z30neqFxeHHg"&gt;Derivative financial instruments&lt;/span&gt;&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Derivatives are initially recognized at fair value. Subsequent to initial recognition, derivatives are measured at fair value, and changes therein are accounted for as described below.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 0.5in; text-align: left"&gt;i.&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;Embedded derivative&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Certain financial instruments issued by the Company contain a right to buy by the issuer (call option) or a right to call for redemption at the option of the holder (put option).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;As the economic characteristics and risks of the early redemption rights are not closely related to the host contract, early redemption rights are separated from the host contract and accounted separately&#160;for a derivative liability. Changes in its fair value in subsequent periods are recognized in profit or loss.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The host debt instrument, after separation of the embedded derivative and any detachable warrant features, is initially recognized at its fair value. Although bonds issued by the Company bear a stated interest rate of 0%, the Company recognizes interest expense on the host debt instrument using the effective interest rate method. The effective interest rate reflects the estimated market yield at the issuance date for comparable unsecured privately placed corporate debt with similar credit risk and maturity.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 0.5in; text-align: left"&gt;ii.&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;Other derivative financial instruments&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Other derivative financial instruments are measured at fair value and changes in their fair value are recognized in profit or loss.&lt;/p&gt;

&lt;p id="xdx_84C_ecustom--DisclosureOfImpairmentExplanatory_zAFAMNk0C0M4" style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.25in; text-align: left"&gt;&lt;b&gt;M.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_86E_zzKYZoHX1E0d"&gt;Impairment&lt;/span&gt;&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 0.5in; text-align: left"&gt;i.&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;Non-derivative financial assets&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company regularly estimates the expected credit losses (&#x201c;ECL&#x201d;) of each borrower or counterparty considering the party&#x2019;s provided collateral, past experience, its own trading records and other factors. In relation to the impairment of financial assets subsequent to initial recognition, the Company recognizes the impairment loss based on ECL, which reflect expected cash shortfalls taking into account expected recoveries from collateral in profit or loss at each reporting date.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;When determining whether the credit risk of a financial asset has increased significantly since initial recognition, the Company considers reasonable and supportable information that is relevant and available without undue cost or effort. This includes both quantitative and qualitative information and analysis, based on the Company&#x2019;s historical experience and informed credit assessment, that includes forward-looking information.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

















&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;Presentation of allowance in the statement of financial position&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Loss allowances for financial assets measured at amortized cost are deducted from the gross carrying amount of the assets.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 0.5in; text-align: left"&gt;ii.&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;Non-financial assets&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;At each reporting date, the Company reviews the carrying amounts of its non-financial assets (other than biological assets, investment property, inventories, contract assets and deferred tax assets) to determine whether there is any indication of impairment. If any such indication exists, then the asset&#x2019;s recoverable amount is estimated. Goodwill is tested annually for impairment, or more frequently if events or changes in circumstances indicate that they might be impaired.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;For impairment testing, assets are grouped into the smallest group of assets that generates cash inflows from continuing use that are largely independent of the cash inflows of other assets or CGUs. Goodwill arising from a business combination is allocated to CGUs or groups of CGUs that are expected to benefit from the synergies of the combination.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The recoverable amount of an asset or CGU is the greater of its value in use and its fair value less costs of disposal. Value in use is based on the estimated future cash flows, discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset or CGU.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;An impairment loss is recognized if the carrying amount of an asset or CGU exceeds its recoverable amount.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Impairment losses are recognized in profit or loss. The Company recognizes an impairment loss if there is any indication of impairment of an individual CGU. Subsequently, the Company performs an impairment test of goodwill for groups of CGUs.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;An impairment loss in respect of goodwill is not reversed. For other assets, an impairment loss is reversed only to the extent that the asset&#x2019;s carrying amount does not exceed the carrying amount that would have been determined, net of depreciation or amortization, if no impairment loss had been recognized.&lt;/p&gt;

&lt;p id="xdx_84B_eifrs-full--DisclosureOfProvisionsExplanatory_zy1tV4rAXRVc" style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.25in; text-align: left"&gt;&lt;b&gt;N.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_868_zn656CVpXdAd"&gt;Provisions&lt;/span&gt;&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Provisions are determined by discounting the expected future cash flows at a pre-tax rate that reflects current market assessments of the time value of money and the risks specific to the liability. The unwinding of the discount is recognized as finance cost.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Building restoration: In accordance with the Company&#x2019;s policy and applicable legal requirements, a provision for restoration and the related expense for leased buildings are recognized when the lease term commences.&lt;/p&gt;

&lt;p id="xdx_84D_eifrs-full--DisclosureOfLeasesExplanatory_zQKIinZS2Pce" style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.25in; text-align: left"&gt;&lt;b&gt;O.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_86C_zGfQKCDRF4Qa"&gt;Leases&lt;/span&gt;&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;At the inception of a contract, the Company assesses whether a contract is, or contains, a lease. A contract is, or contains, a lease if it conveys the right to control the use of an identified asset for a period of time in exchange for consideration.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

















&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;As a lessee, at the commencement or upon modification of a contract that contains a lease component, the Company allocates the consideration in the contract to each lease component on the basis of its relative stand-alone prices. However, for the leases of property the Company has elected not to separate non-lease components and to account for the lease and non-lease components as a single lease component.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company recognizes a right-of-use asset and a lease liability at the lease commencement date. The right-of-use asset is initially measured at cost, which comprises the initial amount of the lease liability adjusted for any lease payments made at or before the commencement date, plus any initial direct costs incurred and an estimate of costs to dismantle and remove the underlying asset or to restore the underlying asset or the site on which it is located, less any lease incentives received.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The right-of-use asset is subsequently depreciated using the straight-line method from the commencement date to the end of the lease term, unless the lease transfers ownership of the underlying asset to the Company by the end of the lease term or the cost of the right-of-use asset reflects that the Company will exercise a purchase option. In that case, the right-of-use asset will be depreciated over the useful life of the underlying asset, which is determined on the same basis as those of property and equipment. In addition, the right-of-use asset is periodically reduced by impairment losses, if any, and adjusted for certain remeasurements of the lease liability.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The lease liability is initially measured at the present value of the lease payments that are not paid at the commencement date, discounted using the interest rate implicit in the lease or, if that rate cannot be readily determined, the Company&#x2019;s incremental borrowing rate. Generally, the Company uses its incremental borrowing rate as the discount rate.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company determines its incremental borrowing rate by obtaining interest rates from various external financing sources and makes certain adjustments to reflect the terms of the lease and type of the asset leased.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Lease payments included in the measurement of the lease liability comprise the following:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&#x25cf;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;fixed payments, including in-substance fixed payments;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&#x25cf;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;variable lease payments that depend on an index or a rate, initially measured using the index or rate as at the commencement date;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&#x25cf;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;amounts expected to be payable under a residual value guarantee; and&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&#x25cf;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;the exercise price under a purchase option that the Company is reasonably certain to exercise, lease payments in an optional renewal period if the Company is reasonably certain to exercise an extension option; and penalties for early termination of a lease unless the Company is reasonably certain not to terminate early.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The lease liability is measured at amortized cost using the effective interest method. It is remeasured when there is a change in future lease payments arising from a change in an index or rate; if there is a change in the Company&#x2019;s estimate of the amount expected to be payable under a residual value guarantee; if the Company changes its assessment of whether it will exercise a purchase, extension or termination option; or if there is a revised in-substance fixed lease payment.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;When the lease liability is remeasured in this way, a corresponding adjustment is made to the carrying amount of the right-of-use asset, or it is recorded in profit or loss if the carrying amount of the right-of-use asset has been reduced to zero.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

















&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;At the date of transition to IFRSs, the Company applies the following approach to all of its leases:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company measures the lease liability at the present value of the remaining lease payments, discounted using the lessee&#x2019;s incremental borrowing rate at the date of transition to IFRSs.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company measures the right-of-use asset at its carrying amount as if IFRS 16 had been applied since the commencement date of the lease, but discounted using the lessee&#x2019;s incremental borrowing rate at the date of transition to IFRSs.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company uses hindsight in applying IFRS 16 such as the determination of the lease term for contracts that contain options to extend or terminate a lease.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company has elected not to recognize right-of-use assets and lease liabilities for leases of low-value assets (those valued at Korea won 7,000 thousand or less, equivalent to approximately USD&#160;5,000) and short-term leases (those with a lease term of 12 months or less at the commencement date), including IT equipment. The Company recognizes the lease payments associated with these leases as an expense on a straight-line basis over the lease term.&lt;/p&gt;

&lt;p id="xdx_840_eifrs-full--DisclosureOfFairValueMeasurementExplanatory_zyIjDSAjotEi" style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.25in; text-align: left"&gt;&lt;b&gt;P.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_86F_zzVAYSHnpDEh"&gt;Fair value measurement&lt;/span&gt;&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&#x2018;Fair value&#x2019; is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date in the principal or, in its absence, the most advantageous market to which the Company has access at that date. The fair value of a liability reflects its non-performance risk.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;A number of the Company&#x2019;s accounting policies and disclosures require the measurement of fair values for both financial and non-financial assets and liabilities.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;When one is available, the Company measures the fair value of an instrument using the quoted price in an active market for that instrument. A market is regarded as &#x2018;active&#x2019; if transactions for the asset or liability take place with sufficient frequency and volume to provide pricing information on an ongoing basis.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;If there is no quoted price in an active market, then the Company uses valuation techniques that maximize the use of relevant observable inputs and minimize the use of unobservable inputs. The chosen valuation technique incorporates all of the factors that market participants would take into account in pricing a transaction.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The best evidence of the fair value of a financial instrument on initial recognition is normally the transaction price - i. e. the fair value of the consideration given or received.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;If that fair value is evidenced by a quoted price in an active market for an identical asset or liability or based on a valuation technique that uses only data from observable markets, an entity shall recognize the difference between the fair value at initial recognition and the transaction price as a gain or loss. In all other cases, the financial instrument is initially measured at fair value, adjusted to defer the difference between the fair value on initial recognition and the transaction price. After initial recognition, the entity shall recognize that deferred difference as a gain or loss only to the extent that it arises from a change in a factor (including time) that market participants would take into account when pricing the asset or liability.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;















&lt;p id="xdx_84B_ecustom--DisclosureOfEarningsPerSharetExplanatory_zkfV7mvaDWYa" style="font: 10pt Times New Roman, Times, serif; margin: 0px"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.25in; text-align: left"&gt;&lt;b&gt;Q.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_86A_zTafVsOhK1d"&gt;Earnings per share&lt;/span&gt;&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Basic earnings per share is calculated by dividing the net profit for the period available to the ordinary shareholders by the weighted-average number of ordinary shares outstanding during the year.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Diluted earnings per share is determined by adjusting the profit or loss for the year attributable to ordinary shareholders and the weighted average number of ordinary shares outstanding, adjusted for own shares held, for the effects of all dilutive potential ordinary shares, which comprise share options granted to employees, if any. Potential dilutive shares are used in the calculation of dilutive earnings per share only when they have dilutive effects.&lt;/p&gt;

&lt;p id="xdx_845_ecustom--DisclosureOfConcentrationOfCreditRiskExplanatory_zVM459SQDBGd" style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.25in; text-align: left"&gt;&lt;b&gt;R.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_86B_zvndlJFoLht1"&gt;Concentration of credit risk&lt;/span&gt;&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company performs periodic credit evaluations of its customers&#x2019; financial condition and generally does not require collateral for accounts receivable. The Company maintains reserves for potential credit losses, which are periodically reviewed.&lt;/p&gt;

&lt;p id="xdx_849_ecustom--TreasurySharesPoliciesTextBlock_zMo0MgJmApYj" style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.25in; text-align: left"&gt;&lt;b&gt;S.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_861_zSxsSbyWjop9"&gt;Treasury shares&lt;/span&gt;&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;If the Company acquires its own equity instruments, these are accounted for as treasury shares and are deducted directly from equity. No gains or losses are recognized in profit or loss on the purchase, sale, issue or retirement of own equity instruments. If a member of the Group acquires and retains treasury shares, the consideration paid or received, along with additional costs associated with the transaction, is directly recognized in equity.&lt;/p&gt;

&lt;p id="xdx_840_ecustom--DeferredTransactionCostsSponsorSharePurchasePoliciesTextBlock_zzVokPJBRMP5" style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.25in; text-align: left"&gt;&lt;b&gt;T.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_862_zN8DMLQx2uSg"&gt;Deferred transaction costs &#x2013; Sponsor share purchase&lt;/span&gt;&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;During the process of the pending Business Combination, contractual disbursements made by the Company to Mountain Crest Global Holdings LLC (the &#x201c;Sponsor&#x201d;) to facilitate the acquisition, restructuring, or structural reallocation of founder shares in connection with a capital reorganization are recognized as deferred capital transaction costs within non-current assets.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Such disbursements are capitalized provided they do not represent payment for ongoing corporate, administrative, or management services. Upon the legal consummation and closing of the capital reorganization, these aggregated deferred balances will be charged directly against equity as a capitalization adjustment via Treasury Shares elimination. If the pending transaction is subsequently terminated or aborted, any associated non-refundable deferred capital disbursements are recognized as an expense within the consolidated statement of comprehensive income (loss) in the period during which the termination occurs.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

</ifrs-full:DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForOffsettingOfFinancialInstrumentsExplanatory
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact001269">&lt;p id="xdx_849_eifrs-full--DescriptionOfAccountingPolicyForOffsettingOfFinancialInstrumentsExplanatory_zpz0Q5cCj7bc" style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.25in; text-align: left"&gt;&lt;b&gt;A.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_86A_zc0aJELQYCte"&gt;New and amended standards or interpretations not yet adopted by the Company&lt;/span&gt;&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The following new accounting standards and interpretations have been published but are not mandatory for December&#160;31, 2025 reporting period and have not been early adopted by the Company.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;IFRS 9 Financial Instruments - IFRS 7 Financial Instruments: Disclosures &#x2013; Classification and Measurement of Financial Instruments&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The amendments clarify that a financial liability is derecognized on the &#x2018;settlement date&#x2019; and introduce an accounting policy choice to derecognize financial liabilities settled using an electronic payment system before the settlement date. Other clarifications include the classification of financial assets with ESG linked features via additional guidance on the assessment of contingent features. Clarifications have been made to non-recourse loans and contractually linked instruments. Additional disclosures are introduced for financial instruments with contingent features and equity instruments classified at fair value through OCI. The amendments should be applied for annual periods beginning on or after January&#160;1, 2026, and earlier application is permitted, with an option to early adopt the amendments for contingent features only. The amendments do not have a significant impact on the financial statements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;IFRS 18 Presentation and Disclosure in Financial Statements&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Items in the statement of profit or loss will need to be classified into one of five categories: operating, investing, financing, income taxes and discontinued operations. IFRS 18 requires the Company to present specified totals and subtotals: &#x2018;Operating profit or loss&#x2019;, &#x2018;Profit or loss&#x2019; and &#x2018;Profit or loss before financing and income taxes&#x2019;. Information related to management-defined performance measures should be disclosed. IFRS 18 also provides enhanced guidance on the principles of aggregation and disaggregation which focus on grouping items based on their shared characteristics. The new standard should be applied for annual periods beginning on or after January&#160;1, 2027, and earlier application is permitted. The Company is in review for the impact of this new standard on the financial statements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

















&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;IFRS 19 Subsidiaries without Public Accountability: Disclosures&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;IFRS 19 allows eligible subsidiaries to apply IFRS Accounting Standards with the reduced disclosure requirements of IFRS 19. A subsidiary may choose to apply the new standard in its consolidated, separate or individual financial statements provided that, at the reporting date, it does not have public accountability, and its parent produces consolidated financial statements under IFRS Accounting Standards. A subsidiary applying IFRS 19 is required to disclose in its explicit and unreserved statements of compliance with IFRS Accounting Standards that IFRS 19 has been adopted. The new standard should be applied for annual periods beginning on or after January&#160;1, 2027, and earlier application is permitted. The Company does not expect that this new standard has a significant impact on the financial statements.&lt;/p&gt;

</ifrs-full:DescriptionOfAccountingPolicyForOffsettingOfFinancialInstrumentsExplanatory>
    <cik0002058261:DisclosureOfForeignCurrencyExplanatory
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact001278">&lt;p id="xdx_845_ecustom--DisclosureOfForeignCurrencyExplanatory_zVJRW5KogXn8" style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.25in; text-align: left"&gt;&lt;b&gt;B.&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_868_ztOiyIOaXaEd" style="font: 10pt Times New Roman; text-align: justify"&gt;&lt;b&gt;Foreign currency&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Transactions in foreign currencies are translated into the respective functional currencies of the company at the exchange rates at the dates of the transactions.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Monetary assets and liabilities denominated in foreign currencies are translated into the functional currency at the exchange rate on the reporting date. Non-monetary assets and liabilities that are measured at fair value in a foreign currency are translated into the functional currency at the exchange rate when the fair value was determined. Non-monetary items that are measured based on historical cost in a foreign currency are translated at the exchange rate on the date of the transaction. Foreign currency differences are generally recognized in profit or loss and presented within finance costs. Translation differences on non-monetary assets and liabilities carried at fair value are reported as part of the fair value gain or loss.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;However, foreign currency differences arising from the translation of the following items are recognized in OCI:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&#x25cf;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;an investment in equity securities designated as at FVOCI;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&#x25cf;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;a financial liability designated as a hedge of the net investment in a foreign operation to the extent that the hedge is effective; and&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&#x25cf;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;qualifying cash flow hedges to the extent that the hedges are effective.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:DisclosureOfForeignCurrencyExplanatory>
    <ifrs-full:DisclosureOfOperatingSegmentsExplanatory
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact001280">&lt;p id="xdx_84E_eifrs-full--DisclosureOfOperatingSegmentsExplanatory_z9MIoZntXAWl" style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.25in; text-align: left"&gt;&lt;b&gt;C.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_868_z5lYk7r0h0hh"&gt;Operating segments&lt;/span&gt;&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;An operating segment is a component of the Company that engages in business activities from which it may earn revenues and incur expenses, including revenues and expenses that relate to transactions with any of the Company&#x2019;s other components. The chief operating decision-maker has been identified as the chief executive officer. The Company&#x2019;s operating segment has been determined to be a single business unit, for which the Company generates identifiable financial information that is regularly reported to the chief executive officer for the purpose of resource allocation and assessment of segment performance. The Company has a reportable segment as described in Note 6. Segment results that are reported to the chief operating decision maker include items directly attributable to the segment, as well as those that can be allocated on a reasonable basis.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;















</ifrs-full:DisclosureOfOperatingSegmentsExplanatory>
    <cik0002058261:DisclosureOfEmployeeBenefitsExplanatoryPolicyTextBlock
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact001288">&lt;p id="xdx_841_ecustom--DisclosureOfEmployeeBenefitsExplanatoryPolicyTextBlock_z8b9YtGN9Xu1" style="font: 10pt Times New Roman, Times, serif; margin: 0px"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.25in; text-align: left"&gt;&lt;b&gt;D.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_869_zcTtDJybNLC6"&gt;Employee benefits&lt;/span&gt;&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.5in; text-align: left"&gt;i.&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;Short-term employee benefits&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Short-term employee benefits are employee benefits due to be settled within 12 months after the end of the period in which the employees render the related services. When an employee has rendered a service to the Company during an accounting period, the Company recognizes the undiscounted amount of short-term employee benefits expected to be paid in exchange for that service.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.5in; text-align: left"&gt;ii.&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;Share-based payment arrangements&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The grant-date fair value of equity-settled share-based payment arrangements granted to employees is generally recognized as an expense, with a corresponding increase in equity, over the vesting period of the awards. The amount recognized as an expense is adjusted to reflect the number of awards for which the related service and non-market performance conditions are expected to be met, such that the amount ultimately recognized is based on the number of awards that meet the related service and non-market performance conditions at the vesting date. For share-based payment awards with non-vesting conditions, the grant-date fair value of the share-based payment is measured to reflect such conditions and there is no true-up for differences between expected and actual outcomes.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The fair value of the amount payable to employees in respect of share-based payment arrangements, which are settled in cash, is recognized as an expense with a corresponding increase in liabilities, over the period during which the employees become unconditionally entitled to payment. The liability is remeasured at each reporting date and at settlement date based on the fair value of the share-based payment arrangements. Any changes in the liability are recognized in profit or loss.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The fair value of the share-based payment arrangements with cash alternatives granted to employees, which is sum of the fair values of the equity component and liabilities component, is recognized as an expense, with a corresponding increase in equity and liabilities, over the vesting period of the awards. The liability is remeasured at each reporting date and at settlement date based on the fair value of the share-based payment arrangements. Any changes in the liability are recognized in profit or loss.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.5in; text-align: left"&gt;iii.&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;Defined benefit plans&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company&#x2019;s net obligation in respect of defined benefit plans is calculated separately for each plan by estimating the amount of future benefits that employees have earned in the current and prior periods, discounting that amount and deducting the fair value of any plan assets.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The calculation of defined benefit obligations is performed annually using the projected unit credit method. When the calculation results in a potential asset for the Company, the recognized asset is limited to the present value of economic benefits available in the form of any future refunds from the plan or reductions in future contributions to the plan. To calculate the present value of economic benefits, consideration is given to any applicable minimum funding requirements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

















&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Remeasurements of the net defined benefit liability, which comprise actuarial gains and losses, the return on plan assets (excluding interest) and the effect of the asset ceiling (if any, excluding interest), are recognized immediately in OCI. The Company determines the net interest expense (income) on the net defined benefit liability (asset) for the period by applying the discount rate used to measure the defined benefit obligation at the beginning of the annual period to the then- net defined benefit liability (asset), taking into account any changes in the net defined benefit liability (asset) during the period as a result of contributions and benefit payments. Net interest expense and other expenses related to defined benefit plans are recognized in profit or loss.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;When the benefits of a plan are changed or when a plan is curtailed, the resulting change in benefits that relates to past service or the gain or loss on curtailment is recognized immediately in profit or loss. The Company recognizes gains and losses on the settlement of a defined benefit plan when the settlement occurs.&lt;/p&gt;

</cik0002058261:DisclosureOfEmployeeBenefitsExplanatoryPolicyTextBlock>
    <cik0002058261:DisclosureOfFinanceIncomeAndFinanceCostsExplanatory
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact001297">&lt;p id="xdx_84E_ecustom--DisclosureOfFinanceIncomeAndFinanceCostsExplanatory_z0JEs7ZggE3l" style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.25in; text-align: left"&gt;&lt;b&gt;E.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_862_zJCvfnEe3Oy3"&gt;Finance income and finance costs&lt;/span&gt;&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company&#x2019;s finance income and finance costs include:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&#x25cf;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;interest income;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&#x25cf;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;interest expense;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&#x25cf;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;dividend income;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&#x25cf;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;the net gain or loss on financial assets at FVTPL;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&#x25cf;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;the foreign currency gain or loss on financial assets and financial liabilities.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The &#x2018;effective interest rate&#x2019; is the rate that exactly discounts estimated future cash payments or receipts through the expected life of the financial instrument to:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&#x25cf;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;the gross carrying amount of the financial asset; or&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&#x25cf;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;the amortized cost of the financial liability.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;In calculating interest income and expense, the effective interest rate is applied to the gross carrying amount of the asset (when the asset is not credit-impaired) or to the amortized cost of the liability. However, for financial assets that have become credit-impaired subsequent to initial recognition, interest income is calculated by applying the effective interest rate to the amortized cost of the financial asset. If the asset is no longer credit-impaired, then the calculation of interest income reverts to the gross basis.&lt;/p&gt;

</cik0002058261:DisclosureOfFinanceIncomeAndFinanceCostsExplanatory>
    <cik0002058261:DisclosureOfIncomeTaxExpenseExplanatory
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact001299">&lt;p id="xdx_846_ecustom--DisclosureOfIncomeTaxExpenseExplanatory_zWtGTfqcS0W5" style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.25in; text-align: left"&gt;&lt;b&gt;F.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_868_zkWBroAoskse"&gt;Income tax&lt;/span&gt;&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Income tax expense comprises current and deferred tax. It is recognized in profit or loss except to the extent that it relates to a business combination, or items recognized directly in equity or in OCI.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

















&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.5in; text-align: left"&gt;i.&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;Current income tax&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Current tax comprises the expected tax payable or receivable on the taxable income or loss for the year and any adjustment to the tax payable or receivable in respect of previous years. The amount of current tax payable or receivable is the best estimate of the tax amount expected to be paid or received that reflects uncertainty related to income taxes, if any. It is measured using tax rates enacted or substantively enacted at the reporting date. Current tax also includes any tax arising from dividends.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Current tax assets and liabilities are offset only if certain criteria are met.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; width: 0.25in"&gt;-&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;Has a legally enforceable right to set off the recognized amounts; and&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.25in; text-align: left"&gt;-&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;Intends either to settle on a net basis, or to realize the asset and settle the liability simultaneously.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.5in; text-align: left"&gt;ii.&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;Deferred income tax&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Deferred tax is recognized in respect of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for taxation purposes. Deferred tax is not recognized for:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&#x25cf;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;temporary differences on the initial recognition of assets or liabilities in a transaction that is not a business combination and that affects neither accounting nor taxable profit or loss;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&#x25cf;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;temporary differences related to investments in subsidiaries, associates and joint arrangements to the extent that the Company is able to control the timing of the reversal of the temporary differences and it is probable that they will not reverse in the foreseeable future; and&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&#x25cf;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;taxable temporary differences arising on the initial recognition of goodwill.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Deferred tax assets are recognized for unused tax losses, unused tax credits and deductible temporary differences to the extent that it is probable that future taxable profits will be available against which they can be used. Future taxable profits are determined based on the reversal of relevant taxable temporary differences. If there are insufficient taxable temporary differences to recognize the deferred tax asset, the business plan of the Company and the reversal of existing temporary differences are considered in determining the future taxable profit. Deferred tax assets are reviewed at each reporting date and are reduced to the extent that it is no longer probable that the related tax benefit will be realized; such reductions are reversed when the probability of future taxable profits improves.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The measurement of deferred tax reflects the tax consequences that would follow from the manner in which the Company expects, at the reporting date, to recover or settle the carrying amount of its assets and liabilities. For this purpose, the carrying amount of investment property measured at fair value is presumed to be recovered through sale, and the Company has not rebutted this presumption.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Deferred tax assets and liabilities are offset only if certain criteria are met.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.25in; text-align: left"&gt;-&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;Has a legally enforceable right to set off the recognized amounts; and&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.25in; text-align: left"&gt;-&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;Intends either to settle on a net basis, or to realize the asset and settle the liability simultaneously.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;















</cik0002058261:DisclosureOfIncomeTaxExpenseExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact001314">&lt;p id="xdx_849_eifrs-full--DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_zePgbO4DvL89" style="font: 10pt Times New Roman, Times, serif; margin: 0px"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.25in; text-align: left"&gt;&lt;b&gt;G.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_86D_zhpzXgzH3JS3"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Cash and cash equivalents comprise cash on hand, deposits held at banks, and investment securities with maturities of three months or less from the acquisition date that are easily convertible to cash and subject to an insignificant risk of changes in their fair value.&lt;/p&gt;

</ifrs-full:DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents>
    <ifrs-full:DisclosureOfInventoriesExplanatory
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact001316">&lt;p id="xdx_84F_eifrs-full--DisclosureOfInventoriesExplanatory_zVrChZGGfDL5" style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.25in; text-align: left"&gt;&lt;b&gt;H.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_86B_zz0cPhnartP9"&gt;Inventories&lt;/span&gt;&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Inventories are measured at the lower of cost and net realizable value. The cost of inventories is based on the first-in, first-out allocation method, and includes expenditures incurred in acquiring the inventories, production or conversion costs and other costs incurred in bringing them to their existing location and condition. Net realizable value is the estimated selling price in the ordinary course of business less the estimated costs of completion and the estimated selling expenses.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company makes adjustments to reduce the cost of inventory to its net realizable value for estimated excess, obsolescence, or impaired balances.&lt;/p&gt;

</ifrs-full:DisclosureOfInventoriesExplanatory>
    <cik0002058261:DisclosureOfPropertyAndEquipmentExplanatory
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact001318">&lt;p id="xdx_84A_ecustom--DisclosureOfPropertyAndEquipmentExplanatory_zsOJBVDhOhl5" style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.25in; text-align: left"&gt;&lt;b&gt;I.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_863_ziqhSTzEh5uk"&gt;Property and equipment&lt;/span&gt;&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.5in; text-align: left"&gt;i.&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;Recognition and measurement&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Items of property and equipment are measured at cost, which includes capitalized borrowing costs, less accumulated depreciation and any accumulated impairment losses.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;If significant parts of an item of property and equipment have different useful lives, then they are accounted for as separate items (major components) of property and equipment.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Any gain or loss on disposal of an item of property and equipment is recognized in profit or loss.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.5in; text-align: left"&gt;ii.&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;Subsequent expenditure&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Subsequent expenditure is capitalized only if it is probable that the future economic benefits associated with the expenditure will flow to the Company. The carrying amount of the replaced parts is derecognized, and the repairs and maintenance expenses are recognized in profit or loss in the period they are incurred.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.5in; text-align: left"&gt;iii.&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;Depreciation&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Depreciation is calculated using the straight-line method to allocate the cost or revalued amounts of the assets, net of their residual values, over their estimated useful lives as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--ScheduleOfpropertyAndEquipmentTableTextBlock_pn3n3_zo7FJaQPRLzi" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Material Accounting Policies (Details)"&gt;
  &lt;tr style="background-color: #FFFFFF"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_8BB_zPzkmRJEDurc" style="display: none"&gt;Schedule of property and equipment useful lives&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: top; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Machinery&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: top; text-align: center; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; text-align: center; width: 25%"&gt;&lt;span id="xdx_907_ecustom--EstimatedUsefulLivesOfPropertyAndEquipment_dtY_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember_zaEExc1oMl74" title="Estimated useful lives of property and equipment"&gt;10&lt;/span&gt; years&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Vehicles&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: top; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;
        &lt;p style="font: 10pt Times New Roman; text-align: center; margin-top: 0; margin-bottom: 0"&gt;&lt;span id="xdx_90E_ecustom--EstimatedUsefulLivesOfPropertyAndEquipment_dtY_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_zUiqTuaM4So5" title="Estimated useful lives of property and equipment"&gt;5&lt;/span&gt; years&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Office equipment&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: top; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; text-align: center"&gt;&lt;span id="xdx_90D_ecustom--EstimatedUsefulLivesOfPropertyAndEquipment_dtY_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OfficeEquipmentMember_zAi8iSgun6Zb" title="Estimated useful lives of property and equipment"&gt;5&lt;/span&gt; years&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Furniture and fixtures&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: top; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; text-align: center"&gt;&lt;span id="xdx_907_ecustom--EstimatedUsefulLivesOfPropertyAndEquipment_dtY_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndFixtureMember_zMtt8QUOy5A9" title="Estimated useful lives of property and equipment"&gt;5&lt;/span&gt; years&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Right-of-use assets&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: top; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; text-align: center"&gt;&lt;span id="xdx_90F_ecustom--EstimatedUsefulLivesOfPropertyAndEquipment_dtY_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--RightofuseAssetsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zyxHTF4e9z5" title="Estimated useful lives of property and equipment"&gt;2&lt;/span&gt; ~ &lt;span id="xdx_907_ecustom--EstimatedUsefulLivesOfPropertyAndEquipment_dtY_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--RightofuseAssetsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zZ6rOIw4g7Ge" title="Estimated useful lives of property and equipment"&gt;10&lt;/span&gt; years&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A3_zRCUdvYoceH2" style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Depreciation methods, useful lives and residual values are reviewed at each reporting date and adjusted if appropriate.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;















</cik0002058261:DisclosureOfPropertyAndEquipmentExplanatory>
    <cik0002058261:ScheduleOfpropertyAndEquipmentTableTextBlock
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact001320">&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--ScheduleOfpropertyAndEquipmentTableTextBlock_pn3n3_zo7FJaQPRLzi" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Material Accounting Policies (Details)"&gt;
  &lt;tr style="background-color: #FFFFFF"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_8BB_zPzkmRJEDurc" style="display: none"&gt;Schedule of property and equipment useful lives&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: top; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Machinery&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: top; text-align: center; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; text-align: center; width: 25%"&gt;&lt;span id="xdx_907_ecustom--EstimatedUsefulLivesOfPropertyAndEquipment_dtY_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember_zaEExc1oMl74" title="Estimated useful lives of property and equipment"&gt;10&lt;/span&gt; years&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Vehicles&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: top; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;
        &lt;p style="font: 10pt Times New Roman; text-align: center; margin-top: 0; margin-bottom: 0"&gt;&lt;span id="xdx_90E_ecustom--EstimatedUsefulLivesOfPropertyAndEquipment_dtY_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_zUiqTuaM4So5" title="Estimated useful lives of property and equipment"&gt;5&lt;/span&gt; years&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Office equipment&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: top; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; text-align: center"&gt;&lt;span id="xdx_90D_ecustom--EstimatedUsefulLivesOfPropertyAndEquipment_dtY_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OfficeEquipmentMember_zAi8iSgun6Zb" title="Estimated useful lives of property and equipment"&gt;5&lt;/span&gt; years&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Furniture and fixtures&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: top; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; text-align: center"&gt;&lt;span id="xdx_907_ecustom--EstimatedUsefulLivesOfPropertyAndEquipment_dtY_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndFixtureMember_zMtt8QUOy5A9" title="Estimated useful lives of property and equipment"&gt;5&lt;/span&gt; years&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Right-of-use assets&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: top; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; text-align: center"&gt;&lt;span id="xdx_90F_ecustom--EstimatedUsefulLivesOfPropertyAndEquipment_dtY_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--RightofuseAssetsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zyxHTF4e9z5" title="Estimated useful lives of property and equipment"&gt;2&lt;/span&gt; ~ &lt;span id="xdx_907_ecustom--EstimatedUsefulLivesOfPropertyAndEquipment_dtY_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--RightofuseAssetsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zZ6rOIw4g7Ge" title="Estimated useful lives of property and equipment"&gt;10&lt;/span&gt; years&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:ScheduleOfpropertyAndEquipmentTableTextBlock>
    <cik0002058261:EstimatedUsefulLivesOfPropertyAndEquipment
      contextRef="From2025-01-012025-12-31_ifrs-full_MachineryMember_custom_CubebioCo.Ltd.Member"
      id="Fact001322">P10Y</cik0002058261:EstimatedUsefulLivesOfPropertyAndEquipment>
    <cik0002058261:EstimatedUsefulLivesOfPropertyAndEquipment
      contextRef="From2025-01-012025-12-31_ifrs-full_VehiclesMember_custom_CubebioCo.Ltd.Member"
      id="Fact001324">P5Y</cik0002058261:EstimatedUsefulLivesOfPropertyAndEquipment>
    <cik0002058261:EstimatedUsefulLivesOfPropertyAndEquipment
      contextRef="From2025-01-012025-12-31_ifrs-full_OfficeEquipmentMember_custom_CubebioCo.Ltd.Member"
      id="Fact001326">P5Y</cik0002058261:EstimatedUsefulLivesOfPropertyAndEquipment>
    <cik0002058261:EstimatedUsefulLivesOfPropertyAndEquipment
      contextRef="From2025-01-012025-12-31_custom_FurnitureAndFixtureMember_custom_CubebioCo.Ltd.Member"
      id="Fact001328">P5Y</cik0002058261:EstimatedUsefulLivesOfPropertyAndEquipment>
    <cik0002058261:EstimatedUsefulLivesOfPropertyAndEquipment
      contextRef="From2025-01-012025-12-31_ifrs-full_RightofuseAssetsMember_ifrs-full_BottomOfRangeMember_custom_CubebioCo.Ltd.Member"
      id="Fact001330">P2Y</cik0002058261:EstimatedUsefulLivesOfPropertyAndEquipment>
    <cik0002058261:EstimatedUsefulLivesOfPropertyAndEquipment
      contextRef="From2025-01-012025-12-31_ifrs-full_RightofuseAssetsMember_ifrs-full_TopOfRangeMember_custom_CubebioCo.Ltd.Member"
      id="Fact001332">P10Y</cik0002058261:EstimatedUsefulLivesOfPropertyAndEquipment>
    <ifrs-full:DisclosureOfIntangibleAssetsAndGoodwillExplanatory
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact001340">&lt;p id="xdx_843_eifrs-full--DisclosureOfIntangibleAssetsAndGoodwillExplanatory_zfEANa7XL7D4" style="font: 10pt Times New Roman, Times, serif; margin: 0px"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.25in; text-align: left"&gt;&lt;b&gt;J.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_86E_zJ4sPXcyfD3a"&gt;Intangible assets&lt;/span&gt;&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.5in; text-align: left"&gt;i.&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;Recognition and measurement&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Intangible assets, including patents that are acquired by the Company and have finite useful lives are measured at cost less accumulated amortization and any accumulated impairment losses.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.5in; text-align: left"&gt;ii.&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;Subsequent expenditure&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Subsequent expenditure is capitalized only when it increases the future economic benefits embodied in the specific asset to which it relates. All other expenditure, including expenditure on software, patents, and brands, is recognized in profit or loss as incurred.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.5in; text-align: left"&gt;iii.&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;Amortization&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Amortization is calculated using the straight-line method to allocate the cost or revalued amounts of the assets, net of their residual values, over their estimated useful lives as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89C_ecustom--AmortizationOfEstimatedUsefulLivesTableTextBlock_pn3n3_zck1jJXUQoej" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Material Accounting Policies (Details 1)"&gt;
  &lt;tr&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: middle; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span id="xdx_8B2_zcgcIWhTNqQ3" style="display: none"&gt;Schedule of amortization of estimated useful lives&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: top; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-left: 0.125in; text-indent: -0.125in"&gt;Software&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; width: 1%; background-color: #CCEEFF; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; width: 25%; background-color: #CCEEFF; text-align: center"&gt;&lt;span id="xdx_906_ecustom--EstimatedUsefulLives_dtY_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__custom--SoftwareMember_zjBgCw9hn2Fj" title="Estimated useful lives"&gt;5&lt;/span&gt; years&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: middle; padding-left: 0.25in; text-indent: -0.125in"&gt; Patents &lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: top; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&lt;span id="xdx_904_ecustom--EstimatedUsefulLives_dtY_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__custom--PatentMember_zHoFN8dsM7Ra" title="Estimated useful lives"&gt;5&lt;/span&gt; years&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: middle; background-color: #CCEEFF; padding-left: 0.125in; text-indent: -0.125in"&gt;Brand&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: top; background-color: #CCEEFF; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; background-color: #CCEEFF; text-align: center"&gt;&lt;span id="xdx_907_ecustom--EstimatedUsefulLives_dtY_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__custom--BrandMember_zK4y8jVOVao5" title="Estimated useful lives"&gt;5&lt;/span&gt; years&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A1_zTKsGAdTATvb" style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Amortization methods, useful lives and residual values are reviewed at each reporting date and adjusted if appropriate.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.5in; text-align: left"&gt;iv.&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;Research and development expenses&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Research and development expenses are expensed as incurred when it does not meet the recognition criteria for intangible assets. Research and development expenses may consist of costs incurred in connection with acquired in-process research and development and performing research and development activities, including amounts incurred under agreements with external vendors and consultants engaged to perform preclinical studies and to manufacture research and development materials for use in such studies, salaries and related personnel costs, share-based compensation, and consultant fees.&lt;/p&gt;

</ifrs-full:DisclosureOfIntangibleAssetsAndGoodwillExplanatory>
    <cik0002058261:AmortizationOfEstimatedUsefulLivesTableTextBlock
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact001342">&lt;table cellpadding="0" cellspacing="0" id="xdx_89C_ecustom--AmortizationOfEstimatedUsefulLivesTableTextBlock_pn3n3_zck1jJXUQoej" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Material Accounting Policies (Details 1)"&gt;
  &lt;tr&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: middle; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span id="xdx_8B2_zcgcIWhTNqQ3" style="display: none"&gt;Schedule of amortization of estimated useful lives&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: top; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-left: 0.125in; text-indent: -0.125in"&gt;Software&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; width: 1%; background-color: #CCEEFF; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; width: 25%; background-color: #CCEEFF; text-align: center"&gt;&lt;span id="xdx_906_ecustom--EstimatedUsefulLives_dtY_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__custom--SoftwareMember_zjBgCw9hn2Fj" title="Estimated useful lives"&gt;5&lt;/span&gt; years&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: middle; padding-left: 0.25in; text-indent: -0.125in"&gt; Patents &lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: top; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&lt;span id="xdx_904_ecustom--EstimatedUsefulLives_dtY_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__custom--PatentMember_zHoFN8dsM7Ra" title="Estimated useful lives"&gt;5&lt;/span&gt; years&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: middle; background-color: #CCEEFF; padding-left: 0.125in; text-indent: -0.125in"&gt;Brand&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: top; background-color: #CCEEFF; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; background-color: #CCEEFF; text-align: center"&gt;&lt;span id="xdx_907_ecustom--EstimatedUsefulLives_dtY_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__custom--BrandMember_zK4y8jVOVao5" title="Estimated useful lives"&gt;5&lt;/span&gt; years&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:AmortizationOfEstimatedUsefulLivesTableTextBlock>
    <cik0002058261:EstimatedUsefulLives
      contextRef="From2025-01-012025-12-31_custom_SoftwareMember_custom_CubebioCo.Ltd.Member"
      id="Fact001344">P5Y</cik0002058261:EstimatedUsefulLives>
    <cik0002058261:EstimatedUsefulLives
      contextRef="From2025-01-012025-12-31_custom_PatentMember_custom_CubebioCo.Ltd.Member"
      id="Fact001346">P5Y</cik0002058261:EstimatedUsefulLives>
    <cik0002058261:EstimatedUsefulLives
      contextRef="From2025-01-012025-12-31_custom_BrandMember_custom_CubebioCo.Ltd.Member"
      id="Fact001348">P5Y</cik0002058261:EstimatedUsefulLives>
    <ifrs-full:DisclosureOfFinancialInstrumentsExplanatory
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact001350">&lt;p id="xdx_84C_eifrs-full--DisclosureOfFinancialInstrumentsExplanatory_zh9zHWOT38qk" style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.25in; text-align: left"&gt;&lt;b&gt;K.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_86E_zDNwqzips0r6"&gt;Financial instruments&lt;/span&gt;&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.5in; text-align: left"&gt;i.&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;Recognition and initial measurement&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;All financial assets and financial liabilities are initially recognized when the Company becomes a party to the contractual provisions of the instrument.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;A non-derivative financial asset (unless it is an account receivable without a significant financing component) or a non-derivative financial liability is initially measured at fair value plus or minus, for an item not at FVTPL, transaction costs that are directly attributable to its acquisition or issue. An account receivable without a significant financing component is initially measured at the transaction price.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

















&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.5in; text-align: left"&gt;ii.&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;Classification and subsequent measurement&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;Financial assets&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;On initial recognition, a financial asset is classified as measured at:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&#x25cf;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;amortized cost;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&#x25cf;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;FVOCI - debt investment;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&#x25cf;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;FVOCI - equity investment;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&#x25cf;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;or FVTPL.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Financial assets are not reclassified subsequent to their initial recognition unless the Company changes its business model for managing financial assets, in which case all affected financial assets are reclassified on the first day of the first reporting period following the change in the business model.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;A financial asset is measured at amortized cost if it meets both of the following conditions and is not designated as at FVTPL:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&#x25cf;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;it is held within a business model whose objective is to hold assets to collect contractual cash flows; and&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&#x25cf;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;its contractual terms give rise on specified dates to cash flows that are solely payments of principal and interest on the principal amount outstanding.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;A debt investment is measured at FVOCI if it meets both of the following conditions and is not designated as at FVTPL:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&#x25cf;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;it is held within a business model whose objective is achieved by both collecting contractual cash flows and selling financial assets; and&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&#x25cf;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;its contractual terms give rise on specified dates to cash flows that are solely payments of principal and interest on the principal amount outstanding.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;On initial recognition of an equity investment that is not held for trading, the Company may irrevocably elect to present subsequent changes in the investment&#x2019;s fair value in OCI. This election is made on an investment-by-investment basis.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;All financial assets not classified as measured at amortized cost or FVOCI as described above are measured at FVTPL. On initial recognition, the Company may irrevocably designate a financial asset that otherwise meets the requirements to be measured at amortized cost or at FVOCI as at FVTPL if doing so eliminates or significantly reduces an accounting mismatch that would otherwise arise.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

















&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;Financial assets - Business model assessment&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company makes an assessment of the objective of the business model in which a financial asset is held at a portfolio level because this best reflects the way the business is managed and information is provided to management. The information considered includes:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&#x25cf;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;the stated policies and objectives for the portfolio and the operation of those policies in practice. These include whether management&#x2019;s strategy focuses on earning contractual interest income, maintaining a particular interest rate profile, matching the duration of the financial assets to the duration of any related liabilities or expected cash outflows or realizing cash flows through the sale of the assets;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&#x25cf;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;how the performance of the portfolio is evaluated and reported to the Company&#x2019;s management;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&#x25cf;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;the risks that affect the performance of the business model (and the financial assets held within that business model) and how those risks are managed;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&#x25cf;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;how managers of the business are compensated - e.g., whether compensation is based on the fair value of the assets managed or the contractual cash flows collected; and&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&#x25cf;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;the frequency, volume and timing of sales of financial assets in prior periods, the reasons for such sales and expectations about future sales activity.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Transfers of financial assets to third parties in transactions that do not qualify for derecognition are not considered sales for this purpose, consistent with the Company&#x2019;s continuing recognition of the assets.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Financial assets that are held for trading or are managed and whose performance is evaluated on a fair value basis are measured at FVTPL.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;Financial assets - Assessment whether contractual cash flows are solely payments of principal and interest&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;For the purposes of this assessment, &#x2018;principal&#x2019; is defined as the fair value of the financial asset on initial recognition. &#x2018;Interest&#x2019; is defined as consideration for the time value of money and for the credit risk associated with the principal amount outstanding during a particular period of time and for other basic lending risks and costs (e.g., liquidity risk and administrative costs), as well as a profit margin.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;In assessing whether the contractual cash flows are solely payments of principal and interest, the Company considers the contractual terms of the instrument. This includes assessing whether the financial asset contains a contractual term that could change the timing or amount of contractual cash flows such that it would not meet this condition. In making this assessment, the Company considers:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&#x25cf;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;contingent events that would change the amount or timing of cash flows;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&#x25cf;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;terms that may adjust the contractual coupon rate, including variable-rate features;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&#x25cf;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;prepayment and extension features; and&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&#x25cf;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;terms that limit the Company&#x2019;s claim to cash flows from specified assets (e.g., non-recourse features).&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

















&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;A prepayment feature is consistent with the solely payments of principal and interest criterion if the prepayment amount substantially represents unpaid amounts of principal and interest on the principal amount outstanding, which may include reasonable compensation for early termination of the contract. Additionally, for a financial asset acquired at a discount or premium to its contractual par amount, a feature that permits or requires prepayment at an amount that substantially represents the contractual par amount plus accrued (but unpaid) contractual interest (which may also include reasonable compensation for early termination) is treated as consistent with this criterion if the fair value of the prepayment feature is insignificant at initial recognition.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;Financial assets - Subsequent measurement and gains and losses&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Financial assets at FVTPL: These assets are subsequently measured at fair value. Net gains and losses, including any interest or dividend income, are recognized in profit or loss.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Financial assets at amortized cost: These assets are subsequently measured at amortized cost using the effective interest method. The amortized cost is reduced by impairment losses. Interest income, foreign exchange gains and losses and impairment are recognized in profit or loss. Any gain or loss on derecognition is recognized in profit or loss.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;Financial liabilities - Classification, subsequent measurement and gains and losses&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Financial liabilities are classified as measured at amortized cost or FVTPL. A financial liability is classified as at FVTPL if it is classified as held-for-trading, it is a derivative or it is designated as such on initial recognition. Financial liabilities at FVTPL are measured at fair value and net gains and losses are recognized in profit or loss. Other financial liabilities are subsequently measured at amortized cost using the effective interest method. Interest expense and foreign exchange gains and losses are recognized in profit or loss. Any gain or loss on derecognition is also recognized in profit or loss.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 0.5in"&gt;iii.&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;Derecognition&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;Financial assets&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company derecognizes a financial asset when:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&#x25cf;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;the contractual rights to the cash flows from the financial asset expire; or&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&#x25cf;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;it transfers the rights to receive the contractual cash flows in a transaction in which either:&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.75in"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 0.25in"&gt;-&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;substantially all of the risks and rewards of ownership of the financial asset are transferred; or&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.75in"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;-&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;the Company neither transfers nor retains substantially all of the risks and rewards of ownership and it does not retain control of the financial asset.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;Financial liabilities&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company derecognizes a financial liability when its contractual obligations are discharged or cancelled, or expire. The Company also derecognizes a financial liability when its terms are modified and the cash flows of the modified liability are substantially different, in which case a new financial liability based on the modified terms is recognized at fair value.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

















&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;On derecognition of a financial liability, the difference between the carrying amount extinguished and the consideration paid (including any non-cash assets transferred or liabilities assumed) is recognized in profit or loss.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;When changes were made to a financial asset or financial liability in addition to changes to the basis for determining the contractual cash flows required by interest rate benchmark reform, the Company first updated the effective interest rate of the financial asset or financial liability to reflect the changes required by interest rate benchmark reform. Subsequently, the Company applied the policies on accounting for modifications to the additional changes.&lt;/p&gt;

</ifrs-full:DisclosureOfFinancialInstrumentsExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsExplanatory
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact001380">&lt;p id="xdx_840_eifrs-full--DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsExplanatory_zBwYKLYJtava" style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.25in; text-align: left"&gt;&lt;b&gt;L.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_86D_z30neqFxeHHg"&gt;Derivative financial instruments&lt;/span&gt;&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Derivatives are initially recognized at fair value. Subsequent to initial recognition, derivatives are measured at fair value, and changes therein are accounted for as described below.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 0.5in; text-align: left"&gt;i.&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;Embedded derivative&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Certain financial instruments issued by the Company contain a right to buy by the issuer (call option) or a right to call for redemption at the option of the holder (put option).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;As the economic characteristics and risks of the early redemption rights are not closely related to the host contract, early redemption rights are separated from the host contract and accounted separately&#160;for a derivative liability. Changes in its fair value in subsequent periods are recognized in profit or loss.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The host debt instrument, after separation of the embedded derivative and any detachable warrant features, is initially recognized at its fair value. Although bonds issued by the Company bear a stated interest rate of 0%, the Company recognizes interest expense on the host debt instrument using the effective interest rate method. The effective interest rate reflects the estimated market yield at the issuance date for comparable unsecured privately placed corporate debt with similar credit risk and maturity.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 0.5in; text-align: left"&gt;ii.&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;Other derivative financial instruments&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Other derivative financial instruments are measured at fair value and changes in their fair value are recognized in profit or loss.&lt;/p&gt;

</ifrs-full:DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsExplanatory>
    <cik0002058261:DisclosureOfImpairmentExplanatory
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact001382">&lt;p id="xdx_84C_ecustom--DisclosureOfImpairmentExplanatory_zAFAMNk0C0M4" style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.25in; text-align: left"&gt;&lt;b&gt;M.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_86E_zzKYZoHX1E0d"&gt;Impairment&lt;/span&gt;&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 0.5in; text-align: left"&gt;i.&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;Non-derivative financial assets&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company regularly estimates the expected credit losses (&#x201c;ECL&#x201d;) of each borrower or counterparty considering the party&#x2019;s provided collateral, past experience, its own trading records and other factors. In relation to the impairment of financial assets subsequent to initial recognition, the Company recognizes the impairment loss based on ECL, which reflect expected cash shortfalls taking into account expected recoveries from collateral in profit or loss at each reporting date.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;When determining whether the credit risk of a financial asset has increased significantly since initial recognition, the Company considers reasonable and supportable information that is relevant and available without undue cost or effort. This includes both quantitative and qualitative information and analysis, based on the Company&#x2019;s historical experience and informed credit assessment, that includes forward-looking information.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

















&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;Presentation of allowance in the statement of financial position&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Loss allowances for financial assets measured at amortized cost are deducted from the gross carrying amount of the assets.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 0.5in; text-align: left"&gt;ii.&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;Non-financial assets&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;At each reporting date, the Company reviews the carrying amounts of its non-financial assets (other than biological assets, investment property, inventories, contract assets and deferred tax assets) to determine whether there is any indication of impairment. If any such indication exists, then the asset&#x2019;s recoverable amount is estimated. Goodwill is tested annually for impairment, or more frequently if events or changes in circumstances indicate that they might be impaired.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;For impairment testing, assets are grouped into the smallest group of assets that generates cash inflows from continuing use that are largely independent of the cash inflows of other assets or CGUs. Goodwill arising from a business combination is allocated to CGUs or groups of CGUs that are expected to benefit from the synergies of the combination.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The recoverable amount of an asset or CGU is the greater of its value in use and its fair value less costs of disposal. Value in use is based on the estimated future cash flows, discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset or CGU.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;An impairment loss is recognized if the carrying amount of an asset or CGU exceeds its recoverable amount.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Impairment losses are recognized in profit or loss. The Company recognizes an impairment loss if there is any indication of impairment of an individual CGU. Subsequently, the Company performs an impairment test of goodwill for groups of CGUs.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;An impairment loss in respect of goodwill is not reversed. For other assets, an impairment loss is reversed only to the extent that the asset&#x2019;s carrying amount does not exceed the carrying amount that would have been determined, net of depreciation or amortization, if no impairment loss had been recognized.&lt;/p&gt;

</cik0002058261:DisclosureOfImpairmentExplanatory>
    <ifrs-full:DisclosureOfProvisionsExplanatory
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact001391">&lt;p id="xdx_84B_eifrs-full--DisclosureOfProvisionsExplanatory_zy1tV4rAXRVc" style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.25in; text-align: left"&gt;&lt;b&gt;N.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_868_zn656CVpXdAd"&gt;Provisions&lt;/span&gt;&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Provisions are determined by discounting the expected future cash flows at a pre-tax rate that reflects current market assessments of the time value of money and the risks specific to the liability. The unwinding of the discount is recognized as finance cost.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Building restoration: In accordance with the Company&#x2019;s policy and applicable legal requirements, a provision for restoration and the related expense for leased buildings are recognized when the lease term commences.&lt;/p&gt;

</ifrs-full:DisclosureOfProvisionsExplanatory>
    <ifrs-full:DisclosureOfLeasesExplanatory
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact001393">&lt;p id="xdx_84D_eifrs-full--DisclosureOfLeasesExplanatory_zQKIinZS2Pce" style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.25in; text-align: left"&gt;&lt;b&gt;O.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_86C_zGfQKCDRF4Qa"&gt;Leases&lt;/span&gt;&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;At the inception of a contract, the Company assesses whether a contract is, or contains, a lease. A contract is, or contains, a lease if it conveys the right to control the use of an identified asset for a period of time in exchange for consideration.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

















&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;As a lessee, at the commencement or upon modification of a contract that contains a lease component, the Company allocates the consideration in the contract to each lease component on the basis of its relative stand-alone prices. However, for the leases of property the Company has elected not to separate non-lease components and to account for the lease and non-lease components as a single lease component.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company recognizes a right-of-use asset and a lease liability at the lease commencement date. The right-of-use asset is initially measured at cost, which comprises the initial amount of the lease liability adjusted for any lease payments made at or before the commencement date, plus any initial direct costs incurred and an estimate of costs to dismantle and remove the underlying asset or to restore the underlying asset or the site on which it is located, less any lease incentives received.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The right-of-use asset is subsequently depreciated using the straight-line method from the commencement date to the end of the lease term, unless the lease transfers ownership of the underlying asset to the Company by the end of the lease term or the cost of the right-of-use asset reflects that the Company will exercise a purchase option. In that case, the right-of-use asset will be depreciated over the useful life of the underlying asset, which is determined on the same basis as those of property and equipment. In addition, the right-of-use asset is periodically reduced by impairment losses, if any, and adjusted for certain remeasurements of the lease liability.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The lease liability is initially measured at the present value of the lease payments that are not paid at the commencement date, discounted using the interest rate implicit in the lease or, if that rate cannot be readily determined, the Company&#x2019;s incremental borrowing rate. Generally, the Company uses its incremental borrowing rate as the discount rate.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company determines its incremental borrowing rate by obtaining interest rates from various external financing sources and makes certain adjustments to reflect the terms of the lease and type of the asset leased.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Lease payments included in the measurement of the lease liability comprise the following:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&#x25cf;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;fixed payments, including in-substance fixed payments;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&#x25cf;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;variable lease payments that depend on an index or a rate, initially measured using the index or rate as at the commencement date;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&#x25cf;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;amounts expected to be payable under a residual value guarantee; and&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&#x25cf;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;the exercise price under a purchase option that the Company is reasonably certain to exercise, lease payments in an optional renewal period if the Company is reasonably certain to exercise an extension option; and penalties for early termination of a lease unless the Company is reasonably certain not to terminate early.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The lease liability is measured at amortized cost using the effective interest method. It is remeasured when there is a change in future lease payments arising from a change in an index or rate; if there is a change in the Company&#x2019;s estimate of the amount expected to be payable under a residual value guarantee; if the Company changes its assessment of whether it will exercise a purchase, extension or termination option; or if there is a revised in-substance fixed lease payment.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;When the lease liability is remeasured in this way, a corresponding adjustment is made to the carrying amount of the right-of-use asset, or it is recorded in profit or loss if the carrying amount of the right-of-use asset has been reduced to zero.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

















&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;At the date of transition to IFRSs, the Company applies the following approach to all of its leases:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company measures the lease liability at the present value of the remaining lease payments, discounted using the lessee&#x2019;s incremental borrowing rate at the date of transition to IFRSs.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company measures the right-of-use asset at its carrying amount as if IFRS 16 had been applied since the commencement date of the lease, but discounted using the lessee&#x2019;s incremental borrowing rate at the date of transition to IFRSs.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company uses hindsight in applying IFRS 16 such as the determination of the lease term for contracts that contain options to extend or terminate a lease.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company has elected not to recognize right-of-use assets and lease liabilities for leases of low-value assets (those valued at Korea won 7,000 thousand or less, equivalent to approximately USD&#160;5,000) and short-term leases (those with a lease term of 12 months or less at the commencement date), including IT equipment. The Company recognizes the lease payments associated with these leases as an expense on a straight-line basis over the lease term.&lt;/p&gt;

</ifrs-full:DisclosureOfLeasesExplanatory>
    <ifrs-full:DisclosureOfFairValueMeasurementExplanatory
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact001409">&lt;p id="xdx_840_eifrs-full--DisclosureOfFairValueMeasurementExplanatory_zyIjDSAjotEi" style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.25in; text-align: left"&gt;&lt;b&gt;P.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_86F_zzVAYSHnpDEh"&gt;Fair value measurement&lt;/span&gt;&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&#x2018;Fair value&#x2019; is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date in the principal or, in its absence, the most advantageous market to which the Company has access at that date. The fair value of a liability reflects its non-performance risk.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;A number of the Company&#x2019;s accounting policies and disclosures require the measurement of fair values for both financial and non-financial assets and liabilities.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;When one is available, the Company measures the fair value of an instrument using the quoted price in an active market for that instrument. A market is regarded as &#x2018;active&#x2019; if transactions for the asset or liability take place with sufficient frequency and volume to provide pricing information on an ongoing basis.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;If there is no quoted price in an active market, then the Company uses valuation techniques that maximize the use of relevant observable inputs and minimize the use of unobservable inputs. The chosen valuation technique incorporates all of the factors that market participants would take into account in pricing a transaction.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The best evidence of the fair value of a financial instrument on initial recognition is normally the transaction price - i. e. the fair value of the consideration given or received.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;If that fair value is evidenced by a quoted price in an active market for an identical asset or liability or based on a valuation technique that uses only data from observable markets, an entity shall recognize the difference between the fair value at initial recognition and the transaction price as a gain or loss. In all other cases, the financial instrument is initially measured at fair value, adjusted to defer the difference between the fair value on initial recognition and the transaction price. After initial recognition, the entity shall recognize that deferred difference as a gain or loss only to the extent that it arises from a change in a factor (including time) that market participants would take into account when pricing the asset or liability.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;















</ifrs-full:DisclosureOfFairValueMeasurementExplanatory>
    <cik0002058261:DisclosureOfEarningsPerSharetExplanatory
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact001417">&lt;p id="xdx_84B_ecustom--DisclosureOfEarningsPerSharetExplanatory_zkfV7mvaDWYa" style="font: 10pt Times New Roman, Times, serif; margin: 0px"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.25in; text-align: left"&gt;&lt;b&gt;Q.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_86A_zTafVsOhK1d"&gt;Earnings per share&lt;/span&gt;&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Basic earnings per share is calculated by dividing the net profit for the period available to the ordinary shareholders by the weighted-average number of ordinary shares outstanding during the year.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Diluted earnings per share is determined by adjusting the profit or loss for the year attributable to ordinary shareholders and the weighted average number of ordinary shares outstanding, adjusted for own shares held, for the effects of all dilutive potential ordinary shares, which comprise share options granted to employees, if any. Potential dilutive shares are used in the calculation of dilutive earnings per share only when they have dilutive effects.&lt;/p&gt;

</cik0002058261:DisclosureOfEarningsPerSharetExplanatory>
    <cik0002058261:DisclosureOfConcentrationOfCreditRiskExplanatory
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact001419">&lt;p id="xdx_845_ecustom--DisclosureOfConcentrationOfCreditRiskExplanatory_zVM459SQDBGd" style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.25in; text-align: left"&gt;&lt;b&gt;R.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_86B_zvndlJFoLht1"&gt;Concentration of credit risk&lt;/span&gt;&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company performs periodic credit evaluations of its customers&#x2019; financial condition and generally does not require collateral for accounts receivable. The Company maintains reserves for potential credit losses, which are periodically reviewed.&lt;/p&gt;

</cik0002058261:DisclosureOfConcentrationOfCreditRiskExplanatory>
    <cik0002058261:TreasurySharesPoliciesTextBlock
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact001421">&lt;p id="xdx_849_ecustom--TreasurySharesPoliciesTextBlock_zMo0MgJmApYj" style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.25in; text-align: left"&gt;&lt;b&gt;S.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_861_zSxsSbyWjop9"&gt;Treasury shares&lt;/span&gt;&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;If the Company acquires its own equity instruments, these are accounted for as treasury shares and are deducted directly from equity. No gains or losses are recognized in profit or loss on the purchase, sale, issue or retirement of own equity instruments. If a member of the Group acquires and retains treasury shares, the consideration paid or received, along with additional costs associated with the transaction, is directly recognized in equity.&lt;/p&gt;

</cik0002058261:TreasurySharesPoliciesTextBlock>
    <cik0002058261:DeferredTransactionCostsSponsorSharePurchasePoliciesTextBlock
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact001423">&lt;p id="xdx_840_ecustom--DeferredTransactionCostsSponsorSharePurchasePoliciesTextBlock_zzVokPJBRMP5" style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.25in; text-align: left"&gt;&lt;b&gt;T.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_862_zN8DMLQx2uSg"&gt;Deferred transaction costs &#x2013; Sponsor share purchase&lt;/span&gt;&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;During the process of the pending Business Combination, contractual disbursements made by the Company to Mountain Crest Global Holdings LLC (the &#x201c;Sponsor&#x201d;) to facilitate the acquisition, restructuring, or structural reallocation of founder shares in connection with a capital reorganization are recognized as deferred capital transaction costs within non-current assets.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Such disbursements are capitalized provided they do not represent payment for ongoing corporate, administrative, or management services. Upon the legal consummation and closing of the capital reorganization, these aggregated deferred balances will be charged directly against equity as a capitalization adjustment via Treasury Shares elimination. If the pending transaction is subsequently terminated or aborted, any associated non-refundable deferred capital disbursements are recognized as an expense within the consolidated statement of comprehensive income (loss) in the period during which the termination occurs.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

</cik0002058261:DeferredTransactionCostsSponsorSharePurchasePoliciesTextBlock>
    <cik0002058261:OperatingSegmentsTextBlock
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact001425">&lt;p id="xdx_809_ecustom--OperatingSegmentsTextBlock_zaxS2k0RIEGe" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;6. &lt;span id="xdx_82C_zZjk91zF5mgb"&gt;Operating segments&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.25in; text-align: left"&gt;&lt;b&gt;A.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;&lt;b&gt;Basis for segmentation&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company&#x2019;s operating segments have been identified as a single business unit, by which the Company currently engages in discovering and developing in-vitro diagnostics products for cancers.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company&#x2019;s chief executive officer reviews the internal management reports of the business at least annually.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

















&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.25in; text-align: left"&gt;&lt;b&gt;B.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;&lt;b&gt;Information about reportable segments&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Information related to the reportable segment is set out below. Segment operating profit is used to measure performance because management believes that this information is the most relevant for evaluating the results of the segment relative to other entities that operate in the same industry.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The segment information for the years ended December&#160;31, 2025 and 2024 is as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_885_ecustom--DisclosureOfOperatingSegmentsExplanatoryTableTextBlock_pn3n3_zzcIZdCKXhQc" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Operating segments (Details)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_8BE_z35VVn8EtsJd" style="display: none"&gt;Schedule of segment information&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_497_20250101__20251231_zz56j75SZGy5" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_497_20240101__20241231_zhOeXwi41Vk2" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--SegmentRevenue_i_pn3n" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Segment revenue&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1436"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1437"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--DepreciationAmortization_i_pn3n" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Depreciation/Amortization&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;224,892&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;338,678&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--SegmentOperatingProfitloss_i_pn3n" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Segment operating loss&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;(5,963,360&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;(7,600,831&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--SegmentLoss_i_pn3n" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Segment loss for the year&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;(6,141,476&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;(8,065,334&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.25in; text-align: left"&gt;&lt;b&gt;C.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;&lt;b&gt;Geographic information&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company is managed and operated in Seoul, South Korea. In presenting the geographic information, non-current assets are based on the geographic location of the Company&#x2019;s operations.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

</cik0002058261:OperatingSegmentsTextBlock>
    <cik0002058261:DisclosureOfOperatingSegmentsExplanatoryTableTextBlock
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact001434">&lt;table cellpadding="0" cellspacing="0" id="xdx_885_ecustom--DisclosureOfOperatingSegmentsExplanatoryTableTextBlock_pn3n3_zzcIZdCKXhQc" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Operating segments (Details)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_8BE_z35VVn8EtsJd" style="display: none"&gt;Schedule of segment information&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_497_20250101__20251231_zz56j75SZGy5" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_497_20240101__20241231_zhOeXwi41Vk2" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--SegmentRevenue_i_pn3n" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Segment revenue&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1436"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1437"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--DepreciationAmortization_i_pn3n" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Depreciation/Amortization&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;224,892&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;338,678&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--SegmentOperatingProfitloss_i_pn3n" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Segment operating loss&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;(5,963,360&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;(7,600,831&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--SegmentLoss_i_pn3n" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Segment loss for the year&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;(6,141,476&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;(8,065,334&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;</cik0002058261:DisclosureOfOperatingSegmentsExplanatoryTableTextBlock>
    <cik0002058261:DepreciationAmortization
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001439"
      unitRef="KRW">224892000</cik0002058261:DepreciationAmortization>
    <cik0002058261:DepreciationAmortization
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001440"
      unitRef="KRW">338678000</cik0002058261:DepreciationAmortization>
    <cik0002058261:SegmentOperatingProfitloss
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001442"
      unitRef="KRW">-5963360000</cik0002058261:SegmentOperatingProfitloss>
    <cik0002058261:SegmentOperatingProfitloss
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001443"
      unitRef="KRW">-7600831000</cik0002058261:SegmentOperatingProfitloss>
    <cik0002058261:SegmentLoss
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001445"
      unitRef="KRW">-6141476000</cik0002058261:SegmentLoss>
    <cik0002058261:SegmentLoss
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001446"
      unitRef="KRW">-8065334000</cik0002058261:SegmentLoss>
    <ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact001448">&lt;p id="xdx_80F_eifrs-full--DisclosureOfCashAndCashEquivalentsExplanatory_z7p0bnKvKnMc" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;7. &lt;span id="xdx_823_zxLNOOpdKnd"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Cash and cash equivalents as of December&#160;31, 2025 and 2024 are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_889_ecustom--ScheduleOfRestrictedCashAndCashEquivalentsTableTextBlock_pn3n3_z9n2D0eeVR06" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Cash and cash equivalents (Details)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;&lt;span id="xdx_8B9_z5RZ39m2EU9b" style="display: none"&gt;Schedule of cash and cash equivalents&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_497_20251231_zwcj7fXBWjW3" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_498_20241231_zz4K26BUsLH5" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 1pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 1pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 1pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2024&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40A_eifrs-full--BalancesWithBanks_iI_pn3n3_zTVGqYwtfb8e" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Deposit in banks&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;322,177&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;3,648,204&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--ForeignCurrencyDepositInBanks_iI_pn3n3_zTlnf5vLpnd2" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;Foreign currency deposit in banks&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;13,637&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;13,970&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40A_eifrs-full--CashAndCashEquivalents_iI_pn3n3_zS6nFmj8LLm5" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-left: 0.125in; text-align: center; vertical-align: top; padding-bottom: 1.25pt"&gt;Total&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;335,814&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;3,662,174&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company does not have any restricted cash and cash equivalents as of December&#160;31, 2025.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

















</ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory>
    <cik0002058261:ScheduleOfRestrictedCashAndCashEquivalentsTableTextBlock
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact001450">&lt;table cellpadding="0" cellspacing="0" id="xdx_889_ecustom--ScheduleOfRestrictedCashAndCashEquivalentsTableTextBlock_pn3n3_z9n2D0eeVR06" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Cash and cash equivalents (Details)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;&lt;span id="xdx_8B9_z5RZ39m2EU9b" style="display: none"&gt;Schedule of cash and cash equivalents&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_497_20251231_zwcj7fXBWjW3" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_498_20241231_zz4K26BUsLH5" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 1pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 1pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 1pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2024&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40A_eifrs-full--BalancesWithBanks_iI_pn3n3_zTVGqYwtfb8e" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Deposit in banks&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;322,177&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;3,648,204&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--ForeignCurrencyDepositInBanks_iI_pn3n3_zTlnf5vLpnd2" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;Foreign currency deposit in banks&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;13,637&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;13,970&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40A_eifrs-full--CashAndCashEquivalents_iI_pn3n3_zS6nFmj8LLm5" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-left: 0.125in; text-align: center; vertical-align: top; padding-bottom: 1.25pt"&gt;Total&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;335,814&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;3,662,174&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;</cik0002058261:ScheduleOfRestrictedCashAndCashEquivalentsTableTextBlock>
    <ifrs-full:BalancesWithBanks
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001452"
      unitRef="KRW">322177000</ifrs-full:BalancesWithBanks>
    <ifrs-full:BalancesWithBanks
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001453"
      unitRef="KRW">3648204000</ifrs-full:BalancesWithBanks>
    <cik0002058261:ForeignCurrencyDepositInBanks
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001455"
      unitRef="KRW">13637000</cik0002058261:ForeignCurrencyDepositInBanks>
    <cik0002058261:ForeignCurrencyDepositInBanks
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001456"
      unitRef="KRW">13970000</cik0002058261:ForeignCurrencyDepositInBanks>
    <ifrs-full:CashAndCashEquivalents
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001458"
      unitRef="KRW">335814000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001459"
      unitRef="KRW">3662174000</ifrs-full:CashAndCashEquivalents>
    <cik0002058261:LoansReceivablesTextBlock
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact001468">&lt;p id="xdx_808_ecustom--LoansReceivablesTextBlock_zVESW317fAU6" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;8. &lt;span id="xdx_825_znLa8Vu5ItD4"&gt;Loans receivables&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.25in; text-align: left"&gt;&lt;b&gt;A.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;&lt;b&gt;Terms and collection schedule&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The terms and conditions of outstanding loans as of December&#160;31, 2025 and 2024 are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_894_ecustom--ScheduleOfTermsAndConditionTableTextBlock_pn3n3_z7YSazC1onfb" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Loans receivables (Details )"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&lt;span id="xdx_8B3_znlmya8AEExl" style="display: none"&gt;Schedule of terms and condition&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman; text-align: center; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;December&#160;31, 2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Currency&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Nominal&lt;br/&gt;interest rate&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Maturity&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Face value&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Accrued&lt;br/&gt; interest income&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Carrying&lt;br/&gt;amount&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&lt;b&gt;Short-term loan receivable &#x2013; related parties, net&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 10%; text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 10%; text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Eun Jong, Choi (*1)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; vertical-align: top"&gt;KRW&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--NominalInterestRate_pid_dp_c20250101__20251231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--EunJongChoiMember_fKCoxKQ_____zq7vq4XAesr1" title="Nominal interest rate"&gt;4.60&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; vertical-align: top"&gt;&lt;span id="xdx_903_ecustom--Maturity_c20250101__20251231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--EunJongChoiMember_fKCoxKQ_____zKAvcrhTPG29" title="Maturity"&gt;30-Jun-26&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_906_ecustom--FaceValue_pn3n3_c20250101__20251231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--EunJongChoiMember_fKCoxKQ_____zZCEmyNCXac6" title="Face value"&gt;100,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_905_ecustom--AccruedInterestIncome_pn3n3_c20250101__20251231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--EunJongChoiMember_fKCoxKQ_____zjGu6vdPwada" title="Accrued interest income"&gt;25,739&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_903_ecustom--CarryingAmount_pn3n3_c20250101__20251231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--EunJongChoiMember_fKCoxKQ_____ztIyYDHhYLZg" title="Carrying amount"&gt;125,739&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Eun Jong, Choi (*1)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; vertical-align: top"&gt;KRW&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--NominalInterestRate_pid_dp_c20250101__20251231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--EunJongChoi1Member_fKCoxKQ_____zskp9twcA5Ri" title="Nominal interest rate"&gt;4.60&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; vertical-align: top"&gt;&lt;span id="xdx_903_ecustom--Maturity_c20250101__20251231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--EunJongChoi1Member_fKCoxKQ_____zKgYX1TzlkOd" title="Maturity"&gt;30-Jun-26&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--FaceValue_pn3n3_c20250101__20251231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--EunJongChoi1Member_fKCoxKQ_____z1iRoTk4MqQk" title="Face value"&gt;40,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--AccruedInterestIncome_pn3n3_c20250101__20251231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--EunJongChoi1Member_fKCoxKQ_____z7CvVvjKyo16" title="Accrued interest income"&gt;10,296&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_909_ecustom--CarryingAmount_pn3n3_c20250101__20251231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--EunJongChoi1Member_fKCoxKQ_____zB2yCtlXDjv6" title="Carrying amount"&gt;50,296&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;CubeBio Holdings., Ltd. (*2)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; vertical-align: top"&gt;KRW&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_901_ecustom--NominalInterestRate_pid_dp_c20250101__20251231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--CubeBioHoldingsLtdMember_fKCoyKQ_____z3iLGxTam342" title="Nominal interest rate"&gt;4.60&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; vertical-align: top"&gt;&lt;span id="xdx_909_ecustom--Maturity_c20250101__20251231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--CubeBioHoldingsLtdMember_fKCoyKQ_____zGmUHL8cJvma" title="Maturity"&gt;24-Sep-26&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_ecustom--FaceValue_pn3n3_c20250101__20251231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--CubeBioHoldingsLtdMember_fKCoyKQ_____zPF6fxYgxwlk" title="Face value"&gt;43,047&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--AccruedInterestIncome_pn3n3_c20250101__20251231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--CubeBioHoldingsLtdMember_fKCoyKQ_____zMKsocfdqyR5" title="Accrued interest income"&gt;2,517&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_908_ecustom--CarryingAmount_pn3n3_c20250101__20251231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--CubeBioHoldingsLtdMember_fKCoyKQ_____zE39RRvTvTFj" title="Carrying amount"&gt;45,564&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;Dongsung D&amp;amp;C&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; vertical-align: top; padding-bottom: 0.5pt"&gt;KRW&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right; padding-bottom: 0.5pt"&gt;&lt;span id="xdx_909_ecustom--NominalInterestRate_pid_dp_c20250101__20251231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--DongsungDAndCMember_zJmcJHrYBDB2" title="Nominal interest rate"&gt;4.60&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;%&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; vertical-align: top; padding-bottom: 0.5pt"&gt;&lt;span id="xdx_906_ecustom--Maturity_c20250101__20251231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--DongsungDAndCMember_zA8YTjMf8XPk" title="Maturity"&gt;04-Nov-26&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_902_ecustom--FaceValue_pn3n3_c20250101__20251231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--DongsungDAndCMember_zzBcIvDVhchi" title="Face value"&gt;220,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--AccruedInterestIncome_pn3n3_c20250101__20251231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--DongsungDAndCMember_zXxjo3VkXg3a" title="Accrued interest income"&gt;1,295&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_903_ecustom--CarryingAmount_pn3n3_c20250101__20251231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--DongsungDAndCMember_zimIsyV2asM8" title="Carrying amount"&gt;221,295&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-left: 0.125in; text-align: center; padding-bottom: 0.5pt"&gt;&lt;b&gt;Subtotal&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="8" style="font: 10pt Times New Roman; padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_ecustom--FaceValue_pn3n3_c20250101__20251231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--SubtotalMember_zeQPJ5fHymeb" title="Face value"&gt;403,047&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_903_ecustom--AccruedInterestIncome_pn3n3_c20250101__20251231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--SubtotalMember_zrALmaUoV8Af" title="Accrued interest income"&gt;39,847&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_ecustom--CarryingAmount_pn3n3_c20250101__20251231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--SubtotalMember_z99IT9nylGLa" title="Carrying amount"&gt;442,894&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&lt;b&gt;Long-term loan receivable, net&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;Magium Corp. (*3)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; vertical-align: top; padding-bottom: 0.5pt"&gt;KRW&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right; padding-bottom: 0.5pt"&gt;&lt;span id="xdx_90C_ecustom--NominalInterestRate_pid_dp_c20250101__20251231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--MagiumCorpMember_fKCozKQ_____zrZIxPrifVN1" title="Nominal interest rate"&gt;5.00&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;%&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; vertical-align: top; padding-bottom: 0.5pt"&gt;&lt;span id="xdx_90F_ecustom--Maturity_c20250101__20251231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--MagiumCorpMember_fKCozKQ_____zsHLJA2cckR3" title="Maturity"&gt;31-Mar-27&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_903_ecustom--FaceValue_pn3n3_c20250101__20251231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--MagiumCorpMember_fKCozKQ_____zB4ZK7rACwA8" title="Face value"&gt;2,300,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_909_ecustom--AccruedInterestIncome_pn3n3_c20250101__20251231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--MagiumCorpMember_fKCozKQ_____zOsl0h5PL9oj" title="Accrued interest income"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1524"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_ecustom--CarryingAmount_pn3n3_c20250101__20251231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--MagiumCorpMember_fKCozKQ_____zVrbtSE7uIF6" title="Carrying amount"&gt;1,671,780&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-left: 0.125in; text-align: center; padding-bottom: 1.25pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="8" style="font: 10pt Times New Roman; padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_908_ecustom--FaceValue_pn3n3_c20250101__20251231_zQPezTeJ7Qa3" title="Face value"&gt;2,703,047&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_903_ecustom--AccruedInterestIncome_pn3n3_c20250101__20251231_z94c7rWLjSk4" title="Accrued interest income"&gt;39,847&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--CarryingAmount_pn3n3_c20250101__20251231_z25BKGdG99Gk" title="Carrying amount"&gt;2,114,674&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;div style="width: 25%; margin-left: 0; margin-right: auto"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td id="xdx_F0C_zMeOJcTLwQM7" style="width: 0.25in; text-align: left"&gt;(*1)&lt;/td&gt;
    &lt;td id="xdx_F1F_z45umshKHnNg" style="text-align: justify"&gt;The loan to Eun Jong Choi is a related party transaction.&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td id="xdx_F0D_zFF27aD2zbm2" style="text-align: left"&gt;(*2)&lt;/td&gt;
    &lt;td id="xdx_F18_z85TRA5Wb4w6" style="text-align: justify"&gt;The loan to CubeBio Holdings Ltd. (Affiliate) is denominated in USD&#160;30,000 and presented in Korean won for reporting purposes. It is a related party transaction.&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td id="xdx_F0E_zQe2egtS3uw3" style="text-align: left"&gt;(*3)&lt;/td&gt;
    &lt;td id="xdx_F18_ziysDibvdku3" style="text-align: justify"&gt;The loan was classified as long-term as it is expected not to be recovered within 12 months after the December&#160;31, 2025 reporting period. In March&#160;2026, the maturity date of the loan was extended to March&#160;31, 2027.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman; text-align: center; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;December&#160;31, 2024&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Currency&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Nominal&lt;br/&gt;interest rate&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Maturity&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Face value&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Accrued&lt;br/&gt; interest income&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Carrying&lt;br/&gt;amount&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&lt;b&gt;Short-term loan receivable &#x2013; related parties, net&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 10%; text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 10%; text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;MERITin Corp. (*1)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; vertical-align: top"&gt;KRW&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--NominalInterestRate_pid_dp_c20240101__20241231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--MERITinCorpMember_fKCoxKQ_____zg3CgtNCW897" title="Nominal interest rate"&gt;6.90&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; vertical-align: top"&gt;&lt;span id="xdx_90A_ecustom--Maturity_c20240101__20241231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--MERITinCorpMember_fKCoxKQ_____zCP63odLruuf" title="Maturity"&gt;30-Sep-15&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_902_ecustom--FaceValue_pn3n3_c20240101__20241231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--MERITinCorpMember_fKCoxKQ_____zkuSGEFLTOg5" title="Face value"&gt;1,803,750&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_900_ecustom--AccruedInterestIncome_pn3n3_c20240101__20241231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--MERITinCorpMember_fKCoxKQ_____zQFxT88TAdfd" title="Accrued interest income"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1543"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--CarryingAmount_pn3n3_c20240101__20241231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--MERITinCorpMember_fKCoxKQ_____zu8mTqt3R9Eb" title="Carrying amount"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1545"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;POEX Holdings Corp. (*2)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; vertical-align: top"&gt;KRW&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_909_ecustom--NominalInterestRate_pid_dp_c20240101__20241231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--POEXHoldingsCorpMember_fKCoyKQ_____zNVxhl0wgKPl" title="Nominal interest rate"&gt;4.60&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; vertical-align: top"&gt;&lt;span id="xdx_904_ecustom--Maturity_c20240101__20241231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--POEXHoldingsCorpMember_fKCoyKQ_____zKxknHmVyWDf" title="Maturity"&gt;24-Feb-20&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_902_ecustom--FaceValue_pn3n3_c20240101__20241231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--POEXHoldingsCorpMember_fKCoyKQ_____zcTrpa5sIf48" title="Face value"&gt;50,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_909_ecustom--AccruedInterestIncome_pn3n3_c20240101__20241231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--POEXHoldingsCorpMember_fKCoyKQ_____zopELg1Ja0pe" title="Accrued interest income"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1553"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_908_ecustom--CarryingAmount_pn3n3_c20240101__20241231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--POEXHoldingsCorpMember_fKCoyKQ_____zgXMKzrnAoG2" title="Carrying amount"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1555"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Eun Jong Choi (*3)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; vertical-align: top"&gt;KRW&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_905_ecustom--NominalInterestRate_pid_dp_c20240101__20241231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--EunJongChoiMember_fKCozKQ_____zkNIW1aIliFg" title="Nominal interest rate"&gt;4.60&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; vertical-align: top"&gt;&lt;span id="xdx_90C_ecustom--Maturity_c20240101__20241231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--EunJongChoiMember_fKCozKQ_____zH3D58Jk0wyf" title="Maturity"&gt;30-Jun-25&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_902_ecustom--FaceValue_pn3n3_c20240101__20241231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--EunJongChoiMember_fKCozKQ_____zDDZTcTI8hp8" title="Face value"&gt;100,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_906_ecustom--AccruedInterestIncome_pn3n3_c20240101__20241231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--EunJongChoiMember_fKCozKQ_____zDGOIrdBl329" title="Accrued interest income"&gt;21,139&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_900_ecustom--CarryingAmount_pn3n3_c20240101__20241231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--EunJongChoiMember_fKCozKQ_____zvhwa9F3smf" title="Carrying amount"&gt;121,139&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Eun Jong Choi (*3)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; vertical-align: top"&gt;KRW&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_901_ecustom--NominalInterestRate_pid_dp_c20240101__20241231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--EunJongChoi1Member_fKCozKQ_____z9B57cPL92Md" title="Nominal interest rate"&gt;4.60&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; vertical-align: top"&gt;&lt;span id="xdx_901_ecustom--Maturity_c20240101__20241231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--EunJongChoi1Member_fKCozKQ_____z9MCmBcR9EW1" title="Maturity"&gt;30-Jun-25&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_908_ecustom--FaceValue_pn3n3_c20240101__20241231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--EunJongChoi1Member_fKCozKQ_____zMJ3895970cg" title="Face value"&gt;40,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_905_ecustom--AccruedInterestIncome_pn3n3_c20240101__20241231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--EunJongChoi1Member_fKCozKQ_____zPAok7LRVSJg" title="Accrued interest income"&gt;8,456&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--CarryingAmount_pn3n3_c20240101__20241231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--EunJongChoi1Member_fKCozKQ_____zo1W2de7wRHg" title="Carrying amount"&gt;48,456&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;CubeBio Holdings., Ltd. (*4)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; vertical-align: top; padding-bottom: 0.5pt"&gt;KRW&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right; padding-bottom: 0.5pt"&gt;&lt;span id="xdx_902_ecustom--NominalInterestRate_pid_dp_c20240101__20241231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--CubeBioHoldingsLtdMember_fKCo0KQ_____zdyMxcOjtkEd" title="Nominal interest rate"&gt;4.60&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;%&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; vertical-align: top; padding-bottom: 0.5pt"&gt;&lt;span id="xdx_909_ecustom--Maturity_c20240101__20241231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--CubeBioHoldingsLtdMember_fKCo0KQ_____zyqHutsQxkad" title="Maturity"&gt;24-Sep-25&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_ecustom--FaceValue_pn3n3_c20240101__20241231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--CubeBioHoldingsLtdMember_fKCo0KQ_____zla7oi3ZVbp2" title="Face value"&gt;44,100&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--AccruedInterestIncome_pn3n3_c20240101__20241231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--CubeBioHoldingsLtdMember_fKCo0KQ_____zhwvm2E5oI18" title="Accrued interest income"&gt;550&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_907_ecustom--CarryingAmount_pn3n3_c20240101__20241231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--CubeBioHoldingsLtdMember_fKCo0KQ_____zSmEgP6o02Wg" title="Carrying amount"&gt;44,650&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-left: 0.125in; text-align: center; padding-bottom: 0.5pt"&gt;&lt;b&gt;Subtotal&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="8" style="font: 10pt Times New Roman; padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--FaceValue_pn3n3_c20240101__20241231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--SubtotalMember_z9o4oIygqYV3" title="Face value"&gt;2,037,850&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_ecustom--AccruedInterestIncome_pn3n3_c20240101__20241231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--SubtotalMember_zos0bJpgCZj6" title="Accrued interest income"&gt;30,145&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--CarryingAmount_pn3n3_c20240101__20241231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--SubtotalMember_zUvd1Dqyafz5" title="Carrying amount"&gt;214,245&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&lt;b&gt;Long-term loan receivable, net&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;Magium Corp. (*5)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; vertical-align: top; padding-bottom: 0.5pt"&gt;KRW&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right; padding-bottom: 0.5pt"&gt;&lt;span id="xdx_90C_ecustom--NominalInterestRate_pid_dp_c20240101__20241231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--MagiumCorpMember_fKCo1KQ_____zYNV6lavcc81" title="Nominal interest rate"&gt;5.00&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;%&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; vertical-align: top; padding-bottom: 0.5pt"&gt;&lt;span id="xdx_90D_ecustom--Maturity_c20240101__20241231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--MagiumCorpMember_fKCo1KQ_____z8E9Bk1M6bTb" title="Maturity"&gt;31-Mar-27&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--FaceValue_pn3n3_c20240101__20241231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--MagiumCorpMember_fKCo1KQ_____zJWX3nasJPva" title="Face value"&gt;2,300,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_907_ecustom--AccruedInterestIncome_pn3n3_c20240101__20241231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--MagiumCorpMember_fKCo1KQ_____zqksOw66C1sl" title="Accrued interest income"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1599"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_ecustom--CarryingAmount_pn3n3_c20240101__20241231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--MagiumCorpMember_fKCo1KQ_____zsQcUhG0By0h" title="Carrying amount"&gt;1,917,960&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-left: 0.125in; text-align: center; padding-bottom: 1.25pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="8" style="font: 10pt Times New Roman; padding-left: 0.125in; text-align: center; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_909_ecustom--FaceValue_pn3n3_c20240101__20241231_z4SfDhg1mrUf" title="Face value"&gt;4,337,850&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_ecustom--AccruedInterestIncome_pn3n3_c20240101__20241231_zgK2EwfUuwDl" title="Accrued interest income"&gt;30,145&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--CarryingAmount_pn3n3_c20240101__20241231_ziWOl8Ezz9D8" title="Carrying amount"&gt;2,132,205&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;div style="width: 25%; margin-left: 0; margin-right: auto"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td id="xdx_F01_zEoELEI7Z3Da" style="width: 0.25in; text-align: left"&gt;(*1)&lt;/td&gt;
    &lt;td id="xdx_F1F_zrJqKSQPIQL5" style="text-align: justify"&gt;The Company recognized a full provision for the balance of loan as of December&#160;31, 2015.&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td id="xdx_F06_zkHEvBqLm0c6" style="text-align: left"&gt;(*2)&lt;/td&gt;
    &lt;td id="xdx_F1F_zrNvLcsaC7aj" style="text-align: justify"&gt;The Company recognized a full provision for the balance of loan as of December&#160;31, 2020.&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td id="xdx_F01_z8XSqYy8w7x1" style="text-align: left"&gt;(*3)&lt;/td&gt;
    &lt;td id="xdx_F10_zu3Mb8EKvWBg" style="text-align: justify"&gt;The loan to Eun Jong Choi is a related party transaction.&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td id="xdx_F05_zzAQJuVhW0pd" style="text-align: left"&gt;(*4)&lt;/td&gt;
    &lt;td id="xdx_F10_z001nQ2mG7pl" style="text-align: justify"&gt;The loan to CubeBio Holdings., Ltd. (Affiliate) is denominated in USD&#160;30,000 and presented in Korean won for reporting purposes. It is a related party transaction.&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td id="xdx_F05_zlcBDrTx8pgh" style="text-align: left"&gt;(*5)&lt;/td&gt;
    &lt;td id="xdx_F15_zmVFru4Bf4og" style="text-align: justify"&gt;The loan was classified as long-term as it is expected not to be recovered within 12 months after the December&#160;31, 2024 reporting period. In February&#160;2025, the maturity date of the loan was extended to March&#160;31, 2026.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A7_znFXefTJ1CDa" style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

















&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.25in; text-align: left"&gt;&lt;b&gt;B.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;&lt;b&gt;Details of loss allowance for expected credit losses&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Changes in the loss allowance for expected credit losses on Loan receivables for the years ended December&#160;31, 2025 and 2024 are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89C_ecustom--ChangesInLossAllowanceForExpectedCreditLossesOnLoanReceivablesTableTextBlock_pn3n3_zAlqMca65cR3" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Loans receivables (Details 1)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span id="xdx_8B6_zxuGiPGFWQek" style="display: none"&gt;Changes in loss allowance for expected credit losses on Loan receivables&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2025&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center"&gt;(In thousands of Korean won)&lt;/td&gt;
    &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"&gt;Short-term loan receivable &#x2013; related parties, net&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Beginning of the year&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_905_ecustom--ShortTermLoanReceivable_iS_pn3n3_c20250101__20251231_zflMPUND0Fpa" title="Beginning of the year"&gt;1,853,750&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--ShortTermLoanReceivable_iS_pn3n3_c20240101__20241231_zjfs5E7FDJ33" title="Beginning of the year"&gt;1,853,750&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1pt"&gt;Write-off of allowance for doubtful accounts&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_901_ecustom--WriteoffOfAllowanceForDoubtfulAccounts_pn3n3_c20250101__20251231_zOMSsMAQYwp9" title="Write-off of allowance for doubtful accounts"&gt;(1,853,750&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_905_ecustom--WriteoffOfAllowanceForDoubtfulAccounts_pn3n3_c20240101__20241231_zpXnH6etd1ob" title="Write-off of allowance for doubtful accounts"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1629"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1pt"&gt;Ending of the year&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--ShortTermLoanReceivable_iE_pn3n3_c20250101__20251231_zfT04qd7YCug" title="Ending of the year"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1631"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--ShortTermLoanReceivable_iE_pn3n3_c20240101__20241231_z3eayZUjIYY" title="Ending of the year"&gt;1,853,750&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"&gt;Long-term loan receivable, net (*)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Beginning of the year&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_ecustom--LongTermLoanReceivable_iS_pn3n3_c20250101__20251231_fKCop_z2HDkvfQ3WF4" title="Beginning of the year"&gt;533,862&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_904_ecustom--LongTermLoanReceivable_iS_pn3n3_c20240101__20241231_fKCop_zGWBYSqUr8Si" title="Beginning of the year"&gt;952,170&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Reversal of allowance for doubtful accounts&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_ecustom--ReversalOfAllowanceForDoubtfulAccounts_pn3n3_c20250101__20251231_fKCop_zPVxf8ktQ1Fd" title="Reversal of allowance for doubtful accounts"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1639"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_904_ecustom--ReversalOfAllowanceForDoubtfulAccounts_pn3n3_c20240101__20241231_fKCop_zC6OxuaR5wjf" title="Reversal of allowance for doubtful accounts"&gt;(489,720&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1pt"&gt;Other bad debt expenses&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_905_ecustom--OtherBadDebtExpenses_pn3n3_c20250101__20251231_fKCop_z4at4wXbl5y1" title="Other bad debt expenses"&gt;341,816&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_904_ecustom--OtherBadDebtExpenses_pn3n3_c20240101__20241231_fKCop_zduymEiUU6xi" title="Other bad debt expenses"&gt;71,412&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt"&gt;Ending of the year&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_903_ecustom--LongTermLoanReceivable_iE_pn3n3_c20250101__20251231_fKCop_ziLqCi7S8Cf5" title="Ending of the year"&gt;875,678&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--LongTermLoanReceivable_iE_pn3n3_c20240101__20241231_fKCop_zrpvt92UUC52" title="Ending of the year"&gt;533,862&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;div style="width: 25%"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; margin-top: 0pt; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="text-align: justify; width: 0in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: justify"&gt;(*)&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;Includes allowance for expected credit losses relating to long-term other receivables.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A1_zCpAmYcWH8O2" style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

</cik0002058261:LoansReceivablesTextBlock>
    <cik0002058261:ScheduleOfTermsAndConditionTableTextBlock
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact001470">&lt;table cellpadding="0" cellspacing="0" id="xdx_894_ecustom--ScheduleOfTermsAndConditionTableTextBlock_pn3n3_z7YSazC1onfb" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Loans receivables (Details )"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&lt;span id="xdx_8B3_znlmya8AEExl" style="display: none"&gt;Schedule of terms and condition&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman; text-align: center; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;December&#160;31, 2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Currency&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Nominal&lt;br/&gt;interest rate&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Maturity&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Face value&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Accrued&lt;br/&gt; interest income&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Carrying&lt;br/&gt;amount&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&lt;b&gt;Short-term loan receivable &#x2013; related parties, net&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 10%; text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 10%; text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Eun Jong, Choi (*1)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; vertical-align: top"&gt;KRW&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--NominalInterestRate_pid_dp_c20250101__20251231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--EunJongChoiMember_fKCoxKQ_____zq7vq4XAesr1" title="Nominal interest rate"&gt;4.60&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; vertical-align: top"&gt;&lt;span id="xdx_903_ecustom--Maturity_c20250101__20251231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--EunJongChoiMember_fKCoxKQ_____zKAvcrhTPG29" title="Maturity"&gt;30-Jun-26&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_906_ecustom--FaceValue_pn3n3_c20250101__20251231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--EunJongChoiMember_fKCoxKQ_____zZCEmyNCXac6" title="Face value"&gt;100,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_905_ecustom--AccruedInterestIncome_pn3n3_c20250101__20251231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--EunJongChoiMember_fKCoxKQ_____zjGu6vdPwada" title="Accrued interest income"&gt;25,739&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_903_ecustom--CarryingAmount_pn3n3_c20250101__20251231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--EunJongChoiMember_fKCoxKQ_____ztIyYDHhYLZg" title="Carrying amount"&gt;125,739&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Eun Jong, Choi (*1)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; vertical-align: top"&gt;KRW&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--NominalInterestRate_pid_dp_c20250101__20251231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--EunJongChoi1Member_fKCoxKQ_____zskp9twcA5Ri" title="Nominal interest rate"&gt;4.60&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; vertical-align: top"&gt;&lt;span id="xdx_903_ecustom--Maturity_c20250101__20251231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--EunJongChoi1Member_fKCoxKQ_____zKgYX1TzlkOd" title="Maturity"&gt;30-Jun-26&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--FaceValue_pn3n3_c20250101__20251231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--EunJongChoi1Member_fKCoxKQ_____z1iRoTk4MqQk" title="Face value"&gt;40,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--AccruedInterestIncome_pn3n3_c20250101__20251231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--EunJongChoi1Member_fKCoxKQ_____z7CvVvjKyo16" title="Accrued interest income"&gt;10,296&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_909_ecustom--CarryingAmount_pn3n3_c20250101__20251231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--EunJongChoi1Member_fKCoxKQ_____zB2yCtlXDjv6" title="Carrying amount"&gt;50,296&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;CubeBio Holdings., Ltd. (*2)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; vertical-align: top"&gt;KRW&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_901_ecustom--NominalInterestRate_pid_dp_c20250101__20251231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--CubeBioHoldingsLtdMember_fKCoyKQ_____z3iLGxTam342" title="Nominal interest rate"&gt;4.60&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; vertical-align: top"&gt;&lt;span id="xdx_909_ecustom--Maturity_c20250101__20251231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--CubeBioHoldingsLtdMember_fKCoyKQ_____zGmUHL8cJvma" title="Maturity"&gt;24-Sep-26&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_ecustom--FaceValue_pn3n3_c20250101__20251231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--CubeBioHoldingsLtdMember_fKCoyKQ_____zPF6fxYgxwlk" title="Face value"&gt;43,047&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--AccruedInterestIncome_pn3n3_c20250101__20251231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--CubeBioHoldingsLtdMember_fKCoyKQ_____zMKsocfdqyR5" title="Accrued interest income"&gt;2,517&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_908_ecustom--CarryingAmount_pn3n3_c20250101__20251231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--CubeBioHoldingsLtdMember_fKCoyKQ_____zE39RRvTvTFj" title="Carrying amount"&gt;45,564&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;Dongsung D&amp;amp;C&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; vertical-align: top; padding-bottom: 0.5pt"&gt;KRW&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right; padding-bottom: 0.5pt"&gt;&lt;span id="xdx_909_ecustom--NominalInterestRate_pid_dp_c20250101__20251231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--DongsungDAndCMember_zJmcJHrYBDB2" title="Nominal interest rate"&gt;4.60&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;%&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; vertical-align: top; padding-bottom: 0.5pt"&gt;&lt;span id="xdx_906_ecustom--Maturity_c20250101__20251231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--DongsungDAndCMember_zA8YTjMf8XPk" title="Maturity"&gt;04-Nov-26&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_902_ecustom--FaceValue_pn3n3_c20250101__20251231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--DongsungDAndCMember_zzBcIvDVhchi" title="Face value"&gt;220,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--AccruedInterestIncome_pn3n3_c20250101__20251231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--DongsungDAndCMember_zXxjo3VkXg3a" title="Accrued interest income"&gt;1,295&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_903_ecustom--CarryingAmount_pn3n3_c20250101__20251231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--DongsungDAndCMember_zimIsyV2asM8" title="Carrying amount"&gt;221,295&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-left: 0.125in; text-align: center; padding-bottom: 0.5pt"&gt;&lt;b&gt;Subtotal&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="8" style="font: 10pt Times New Roman; padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_ecustom--FaceValue_pn3n3_c20250101__20251231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--SubtotalMember_zeQPJ5fHymeb" title="Face value"&gt;403,047&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_903_ecustom--AccruedInterestIncome_pn3n3_c20250101__20251231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--SubtotalMember_zrALmaUoV8Af" title="Accrued interest income"&gt;39,847&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_ecustom--CarryingAmount_pn3n3_c20250101__20251231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--SubtotalMember_z99IT9nylGLa" title="Carrying amount"&gt;442,894&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&lt;b&gt;Long-term loan receivable, net&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;Magium Corp. (*3)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; vertical-align: top; padding-bottom: 0.5pt"&gt;KRW&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right; padding-bottom: 0.5pt"&gt;&lt;span id="xdx_90C_ecustom--NominalInterestRate_pid_dp_c20250101__20251231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--MagiumCorpMember_fKCozKQ_____zrZIxPrifVN1" title="Nominal interest rate"&gt;5.00&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;%&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; vertical-align: top; padding-bottom: 0.5pt"&gt;&lt;span id="xdx_90F_ecustom--Maturity_c20250101__20251231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--MagiumCorpMember_fKCozKQ_____zsHLJA2cckR3" title="Maturity"&gt;31-Mar-27&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_903_ecustom--FaceValue_pn3n3_c20250101__20251231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--MagiumCorpMember_fKCozKQ_____zB4ZK7rACwA8" title="Face value"&gt;2,300,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_909_ecustom--AccruedInterestIncome_pn3n3_c20250101__20251231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--MagiumCorpMember_fKCozKQ_____zOsl0h5PL9oj" title="Accrued interest income"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1524"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_ecustom--CarryingAmount_pn3n3_c20250101__20251231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--MagiumCorpMember_fKCozKQ_____zVrbtSE7uIF6" title="Carrying amount"&gt;1,671,780&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-left: 0.125in; text-align: center; padding-bottom: 1.25pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="8" style="font: 10pt Times New Roman; padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_908_ecustom--FaceValue_pn3n3_c20250101__20251231_zQPezTeJ7Qa3" title="Face value"&gt;2,703,047&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_903_ecustom--AccruedInterestIncome_pn3n3_c20250101__20251231_z94c7rWLjSk4" title="Accrued interest income"&gt;39,847&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--CarryingAmount_pn3n3_c20250101__20251231_z25BKGdG99Gk" title="Carrying amount"&gt;2,114,674&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;div style="width: 25%; margin-left: 0; margin-right: auto"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td id="xdx_F0C_zMeOJcTLwQM7" style="width: 0.25in; text-align: left"&gt;(*1)&lt;/td&gt;
    &lt;td id="xdx_F1F_z45umshKHnNg" style="text-align: justify"&gt;The loan to Eun Jong Choi is a related party transaction.&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td id="xdx_F0D_zFF27aD2zbm2" style="text-align: left"&gt;(*2)&lt;/td&gt;
    &lt;td id="xdx_F18_z85TRA5Wb4w6" style="text-align: justify"&gt;The loan to CubeBio Holdings Ltd. (Affiliate) is denominated in USD&#160;30,000 and presented in Korean won for reporting purposes. It is a related party transaction.&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td id="xdx_F0E_zQe2egtS3uw3" style="text-align: left"&gt;(*3)&lt;/td&gt;
    &lt;td id="xdx_F18_ziysDibvdku3" style="text-align: justify"&gt;The loan was classified as long-term as it is expected not to be recovered within 12 months after the December&#160;31, 2025 reporting period. In March&#160;2026, the maturity date of the loan was extended to March&#160;31, 2027.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman; text-align: center; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;December&#160;31, 2024&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Currency&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Nominal&lt;br/&gt;interest rate&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Maturity&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Face value&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Accrued&lt;br/&gt; interest income&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Carrying&lt;br/&gt;amount&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&lt;b&gt;Short-term loan receivable &#x2013; related parties, net&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 10%; text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 10%; text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;MERITin Corp. (*1)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; vertical-align: top"&gt;KRW&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--NominalInterestRate_pid_dp_c20240101__20241231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--MERITinCorpMember_fKCoxKQ_____zg3CgtNCW897" title="Nominal interest rate"&gt;6.90&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; vertical-align: top"&gt;&lt;span id="xdx_90A_ecustom--Maturity_c20240101__20241231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--MERITinCorpMember_fKCoxKQ_____zCP63odLruuf" title="Maturity"&gt;30-Sep-15&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_902_ecustom--FaceValue_pn3n3_c20240101__20241231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--MERITinCorpMember_fKCoxKQ_____zkuSGEFLTOg5" title="Face value"&gt;1,803,750&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_900_ecustom--AccruedInterestIncome_pn3n3_c20240101__20241231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--MERITinCorpMember_fKCoxKQ_____zQFxT88TAdfd" title="Accrued interest income"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1543"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--CarryingAmount_pn3n3_c20240101__20241231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--MERITinCorpMember_fKCoxKQ_____zu8mTqt3R9Eb" title="Carrying amount"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1545"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;POEX Holdings Corp. (*2)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; vertical-align: top"&gt;KRW&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_909_ecustom--NominalInterestRate_pid_dp_c20240101__20241231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--POEXHoldingsCorpMember_fKCoyKQ_____zNVxhl0wgKPl" title="Nominal interest rate"&gt;4.60&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; vertical-align: top"&gt;&lt;span id="xdx_904_ecustom--Maturity_c20240101__20241231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--POEXHoldingsCorpMember_fKCoyKQ_____zKxknHmVyWDf" title="Maturity"&gt;24-Feb-20&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_902_ecustom--FaceValue_pn3n3_c20240101__20241231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--POEXHoldingsCorpMember_fKCoyKQ_____zcTrpa5sIf48" title="Face value"&gt;50,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_909_ecustom--AccruedInterestIncome_pn3n3_c20240101__20241231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--POEXHoldingsCorpMember_fKCoyKQ_____zopELg1Ja0pe" title="Accrued interest income"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1553"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_908_ecustom--CarryingAmount_pn3n3_c20240101__20241231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--POEXHoldingsCorpMember_fKCoyKQ_____zgXMKzrnAoG2" title="Carrying amount"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1555"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Eun Jong Choi (*3)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; vertical-align: top"&gt;KRW&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_905_ecustom--NominalInterestRate_pid_dp_c20240101__20241231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--EunJongChoiMember_fKCozKQ_____zkNIW1aIliFg" title="Nominal interest rate"&gt;4.60&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; vertical-align: top"&gt;&lt;span id="xdx_90C_ecustom--Maturity_c20240101__20241231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--EunJongChoiMember_fKCozKQ_____zH3D58Jk0wyf" title="Maturity"&gt;30-Jun-25&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_902_ecustom--FaceValue_pn3n3_c20240101__20241231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--EunJongChoiMember_fKCozKQ_____zDDZTcTI8hp8" title="Face value"&gt;100,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_906_ecustom--AccruedInterestIncome_pn3n3_c20240101__20241231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--EunJongChoiMember_fKCozKQ_____zDGOIrdBl329" title="Accrued interest income"&gt;21,139&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_900_ecustom--CarryingAmount_pn3n3_c20240101__20241231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--EunJongChoiMember_fKCozKQ_____zvhwa9F3smf" title="Carrying amount"&gt;121,139&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Eun Jong Choi (*3)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; vertical-align: top"&gt;KRW&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_901_ecustom--NominalInterestRate_pid_dp_c20240101__20241231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--EunJongChoi1Member_fKCozKQ_____z9B57cPL92Md" title="Nominal interest rate"&gt;4.60&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; vertical-align: top"&gt;&lt;span id="xdx_901_ecustom--Maturity_c20240101__20241231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--EunJongChoi1Member_fKCozKQ_____z9MCmBcR9EW1" title="Maturity"&gt;30-Jun-25&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_908_ecustom--FaceValue_pn3n3_c20240101__20241231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--EunJongChoi1Member_fKCozKQ_____zMJ3895970cg" title="Face value"&gt;40,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_905_ecustom--AccruedInterestIncome_pn3n3_c20240101__20241231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--EunJongChoi1Member_fKCozKQ_____zPAok7LRVSJg" title="Accrued interest income"&gt;8,456&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--CarryingAmount_pn3n3_c20240101__20241231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--EunJongChoi1Member_fKCozKQ_____zo1W2de7wRHg" title="Carrying amount"&gt;48,456&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;CubeBio Holdings., Ltd. (*4)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; vertical-align: top; padding-bottom: 0.5pt"&gt;KRW&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right; padding-bottom: 0.5pt"&gt;&lt;span id="xdx_902_ecustom--NominalInterestRate_pid_dp_c20240101__20241231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--CubeBioHoldingsLtdMember_fKCo0KQ_____zdyMxcOjtkEd" title="Nominal interest rate"&gt;4.60&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;%&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; vertical-align: top; padding-bottom: 0.5pt"&gt;&lt;span id="xdx_909_ecustom--Maturity_c20240101__20241231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--CubeBioHoldingsLtdMember_fKCo0KQ_____zyqHutsQxkad" title="Maturity"&gt;24-Sep-25&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_ecustom--FaceValue_pn3n3_c20240101__20241231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--CubeBioHoldingsLtdMember_fKCo0KQ_____zla7oi3ZVbp2" title="Face value"&gt;44,100&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--AccruedInterestIncome_pn3n3_c20240101__20241231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--CubeBioHoldingsLtdMember_fKCo0KQ_____zhwvm2E5oI18" title="Accrued interest income"&gt;550&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_907_ecustom--CarryingAmount_pn3n3_c20240101__20241231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--CubeBioHoldingsLtdMember_fKCo0KQ_____zSmEgP6o02Wg" title="Carrying amount"&gt;44,650&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-left: 0.125in; text-align: center; padding-bottom: 0.5pt"&gt;&lt;b&gt;Subtotal&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="8" style="font: 10pt Times New Roman; padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--FaceValue_pn3n3_c20240101__20241231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--SubtotalMember_z9o4oIygqYV3" title="Face value"&gt;2,037,850&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_ecustom--AccruedInterestIncome_pn3n3_c20240101__20241231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--SubtotalMember_zos0bJpgCZj6" title="Accrued interest income"&gt;30,145&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--CarryingAmount_pn3n3_c20240101__20241231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--SubtotalMember_zUvd1Dqyafz5" title="Carrying amount"&gt;214,245&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&lt;b&gt;Long-term loan receivable, net&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;Magium Corp. (*5)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; vertical-align: top; padding-bottom: 0.5pt"&gt;KRW&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right; padding-bottom: 0.5pt"&gt;&lt;span id="xdx_90C_ecustom--NominalInterestRate_pid_dp_c20240101__20241231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--MagiumCorpMember_fKCo1KQ_____zYNV6lavcc81" title="Nominal interest rate"&gt;5.00&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;%&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; vertical-align: top; padding-bottom: 0.5pt"&gt;&lt;span id="xdx_90D_ecustom--Maturity_c20240101__20241231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--MagiumCorpMember_fKCo1KQ_____z8E9Bk1M6bTb" title="Maturity"&gt;31-Mar-27&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--FaceValue_pn3n3_c20240101__20241231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--MagiumCorpMember_fKCo1KQ_____zJWX3nasJPva" title="Face value"&gt;2,300,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_907_ecustom--AccruedInterestIncome_pn3n3_c20240101__20241231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--MagiumCorpMember_fKCo1KQ_____zqksOw66C1sl" title="Accrued interest income"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1599"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_ecustom--CarryingAmount_pn3n3_c20240101__20241231__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--MagiumCorpMember_fKCo1KQ_____zsQcUhG0By0h" title="Carrying amount"&gt;1,917,960&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-left: 0.125in; text-align: center; padding-bottom: 1.25pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="8" style="font: 10pt Times New Roman; padding-left: 0.125in; text-align: center; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_909_ecustom--FaceValue_pn3n3_c20240101__20241231_z4SfDhg1mrUf" title="Face value"&gt;4,337,850&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_ecustom--AccruedInterestIncome_pn3n3_c20240101__20241231_zgK2EwfUuwDl" title="Accrued interest income"&gt;30,145&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--CarryingAmount_pn3n3_c20240101__20241231_ziWOl8Ezz9D8" title="Carrying amount"&gt;2,132,205&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;div style="width: 25%; margin-left: 0; margin-right: auto"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td id="xdx_F01_zEoELEI7Z3Da" style="width: 0.25in; text-align: left"&gt;(*1)&lt;/td&gt;
    &lt;td id="xdx_F1F_zrJqKSQPIQL5" style="text-align: justify"&gt;The Company recognized a full provision for the balance of loan as of December&#160;31, 2015.&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td id="xdx_F06_zkHEvBqLm0c6" style="text-align: left"&gt;(*2)&lt;/td&gt;
    &lt;td id="xdx_F1F_zrNvLcsaC7aj" style="text-align: justify"&gt;The Company recognized a full provision for the balance of loan as of December&#160;31, 2020.&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td id="xdx_F01_z8XSqYy8w7x1" style="text-align: left"&gt;(*3)&lt;/td&gt;
    &lt;td id="xdx_F10_zu3Mb8EKvWBg" style="text-align: justify"&gt;The loan to Eun Jong Choi is a related party transaction.&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td id="xdx_F05_zzAQJuVhW0pd" style="text-align: left"&gt;(*4)&lt;/td&gt;
    &lt;td id="xdx_F10_z001nQ2mG7pl" style="text-align: justify"&gt;The loan to CubeBio Holdings., Ltd. (Affiliate) is denominated in USD&#160;30,000 and presented in Korean won for reporting purposes. It is a related party transaction.&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td id="xdx_F05_zlcBDrTx8pgh" style="text-align: left"&gt;(*5)&lt;/td&gt;
    &lt;td id="xdx_F15_zmVFru4Bf4og" style="text-align: justify"&gt;The loan was classified as long-term as it is expected not to be recovered within 12 months after the December&#160;31, 2024 reporting period. In February&#160;2025, the maturity date of the loan was extended to March&#160;31, 2026.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:ScheduleOfTermsAndConditionTableTextBlock>
    <cik0002058261:NominalInterestRate
      contextRef="From2025-01-012025-12-31_custom_EunJongChoiMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact001472"
      unitRef="Pure">0.0460</cik0002058261:NominalInterestRate>
    <cik0002058261:Maturity
      contextRef="From2025-01-012025-12-31_custom_EunJongChoiMember_custom_CubebioCo.Ltd.Member"
      id="Fact001474">2026-06-30</cik0002058261:Maturity>
    <cik0002058261:FaceValue
      contextRef="From2025-01-012025-12-31_custom_EunJongChoiMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001476"
      unitRef="KRW">100000000</cik0002058261:FaceValue>
    <cik0002058261:AccruedInterestIncome
      contextRef="From2025-01-012025-12-31_custom_EunJongChoiMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001478"
      unitRef="KRW">25739000</cik0002058261:AccruedInterestIncome>
    <cik0002058261:CarryingAmount
      contextRef="From2025-01-012025-12-31_custom_EunJongChoiMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001480"
      unitRef="KRW">125739000</cik0002058261:CarryingAmount>
    <cik0002058261:NominalInterestRate
      contextRef="From2025-01-012025-12-31_custom_EunJongChoi1Member_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact001482"
      unitRef="Pure">0.0460</cik0002058261:NominalInterestRate>
    <cik0002058261:Maturity
      contextRef="From2025-01-012025-12-31_custom_EunJongChoi1Member_custom_CubebioCo.Ltd.Member"
      id="Fact001484">2026-06-30</cik0002058261:Maturity>
    <cik0002058261:FaceValue
      contextRef="From2025-01-012025-12-31_custom_EunJongChoi1Member_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001486"
      unitRef="KRW">40000000</cik0002058261:FaceValue>
    <cik0002058261:AccruedInterestIncome
      contextRef="From2025-01-012025-12-31_custom_EunJongChoi1Member_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001488"
      unitRef="KRW">10296000</cik0002058261:AccruedInterestIncome>
    <cik0002058261:CarryingAmount
      contextRef="From2025-01-012025-12-31_custom_EunJongChoi1Member_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001490"
      unitRef="KRW">50296000</cik0002058261:CarryingAmount>
    <cik0002058261:NominalInterestRate
      contextRef="From2025-01-012025-12-31_custom_CubeBioHoldingsLtdMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact001492"
      unitRef="Pure">0.0460</cik0002058261:NominalInterestRate>
    <cik0002058261:Maturity
      contextRef="From2025-01-012025-12-31_custom_CubeBioHoldingsLtdMember_custom_CubebioCo.Ltd.Member"
      id="Fact001494">2026-09-24</cik0002058261:Maturity>
    <cik0002058261:FaceValue
      contextRef="From2025-01-012025-12-31_custom_CubeBioHoldingsLtdMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001496"
      unitRef="KRW">43047000</cik0002058261:FaceValue>
    <cik0002058261:AccruedInterestIncome
      contextRef="From2025-01-012025-12-31_custom_CubeBioHoldingsLtdMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001498"
      unitRef="KRW">2517000</cik0002058261:AccruedInterestIncome>
    <cik0002058261:CarryingAmount
      contextRef="From2025-01-012025-12-31_custom_CubeBioHoldingsLtdMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001500"
      unitRef="KRW">45564000</cik0002058261:CarryingAmount>
    <cik0002058261:NominalInterestRate
      contextRef="From2025-01-012025-12-31_custom_DongsungDAndCMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact001502"
      unitRef="Pure">0.0460</cik0002058261:NominalInterestRate>
    <cik0002058261:Maturity
      contextRef="From2025-01-012025-12-31_custom_DongsungDAndCMember_custom_CubebioCo.Ltd.Member"
      id="Fact001504">2026-11-04</cik0002058261:Maturity>
    <cik0002058261:FaceValue
      contextRef="From2025-01-012025-12-31_custom_DongsungDAndCMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001506"
      unitRef="KRW">220000000</cik0002058261:FaceValue>
    <cik0002058261:AccruedInterestIncome
      contextRef="From2025-01-012025-12-31_custom_DongsungDAndCMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001508"
      unitRef="KRW">1295000</cik0002058261:AccruedInterestIncome>
    <cik0002058261:CarryingAmount
      contextRef="From2025-01-012025-12-31_custom_DongsungDAndCMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001510"
      unitRef="KRW">221295000</cik0002058261:CarryingAmount>
    <cik0002058261:FaceValue
      contextRef="From2025-01-012025-12-31_custom_SubtotalMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001512"
      unitRef="KRW">403047000</cik0002058261:FaceValue>
    <cik0002058261:AccruedInterestIncome
      contextRef="From2025-01-012025-12-31_custom_SubtotalMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001514"
      unitRef="KRW">39847000</cik0002058261:AccruedInterestIncome>
    <cik0002058261:CarryingAmount
      contextRef="From2025-01-012025-12-31_custom_SubtotalMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001516"
      unitRef="KRW">442894000</cik0002058261:CarryingAmount>
    <cik0002058261:NominalInterestRate
      contextRef="From2025-01-012025-12-31_custom_MagiumCorpMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact001518"
      unitRef="Pure">0.0500</cik0002058261:NominalInterestRate>
    <cik0002058261:Maturity
      contextRef="From2025-01-012025-12-31_custom_MagiumCorpMember_custom_CubebioCo.Ltd.Member"
      id="Fact001520">2027-03-31</cik0002058261:Maturity>
    <cik0002058261:FaceValue
      contextRef="From2025-01-012025-12-31_custom_MagiumCorpMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001522"
      unitRef="KRW">2300000000</cik0002058261:FaceValue>
    <cik0002058261:CarryingAmount
      contextRef="From2025-01-012025-12-31_custom_MagiumCorpMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001526"
      unitRef="KRW">1671780000</cik0002058261:CarryingAmount>
    <cik0002058261:FaceValue
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001528"
      unitRef="KRW">2703047000</cik0002058261:FaceValue>
    <cik0002058261:AccruedInterestIncome
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001530"
      unitRef="KRW">39847000</cik0002058261:AccruedInterestIncome>
    <cik0002058261:CarryingAmount
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001532"
      unitRef="KRW">2114674000</cik0002058261:CarryingAmount>
    <cik0002058261:NominalInterestRate
      contextRef="From2024-01-012024-12-31_custom_MERITinCorpMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact001537"
      unitRef="Pure">0.0690</cik0002058261:NominalInterestRate>
    <cik0002058261:Maturity
      contextRef="From2024-01-012024-12-31_custom_MERITinCorpMember_custom_CubebioCo.Ltd.Member"
      id="Fact001539">2015-09-30</cik0002058261:Maturity>
    <cik0002058261:FaceValue
      contextRef="From2024-01-012024-12-31_custom_MERITinCorpMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001541"
      unitRef="KRW">1803750000</cik0002058261:FaceValue>
    <cik0002058261:NominalInterestRate
      contextRef="From2024-01-012024-12-31_custom_POEXHoldingsCorpMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact001547"
      unitRef="Pure">0.0460</cik0002058261:NominalInterestRate>
    <cik0002058261:Maturity
      contextRef="From2024-01-012024-12-31_custom_POEXHoldingsCorpMember_custom_CubebioCo.Ltd.Member"
      id="Fact001549">2020-02-24</cik0002058261:Maturity>
    <cik0002058261:FaceValue
      contextRef="From2024-01-012024-12-31_custom_POEXHoldingsCorpMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001551"
      unitRef="KRW">50000000</cik0002058261:FaceValue>
    <cik0002058261:NominalInterestRate
      contextRef="From2024-01-012024-12-31_custom_EunJongChoiMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact001557"
      unitRef="Pure">0.0460</cik0002058261:NominalInterestRate>
    <cik0002058261:Maturity
      contextRef="From2024-01-012024-12-31_custom_EunJongChoiMember_custom_CubebioCo.Ltd.Member"
      id="Fact001559">2025-06-30</cik0002058261:Maturity>
    <cik0002058261:FaceValue
      contextRef="From2024-01-012024-12-31_custom_EunJongChoiMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001561"
      unitRef="KRW">100000000</cik0002058261:FaceValue>
    <cik0002058261:AccruedInterestIncome
      contextRef="From2024-01-012024-12-31_custom_EunJongChoiMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001563"
      unitRef="KRW">21139000</cik0002058261:AccruedInterestIncome>
    <cik0002058261:CarryingAmount
      contextRef="From2024-01-012024-12-31_custom_EunJongChoiMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001565"
      unitRef="KRW">121139000</cik0002058261:CarryingAmount>
    <cik0002058261:NominalInterestRate
      contextRef="From2024-01-012024-12-31_custom_EunJongChoi1Member_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact001567"
      unitRef="Pure">0.0460</cik0002058261:NominalInterestRate>
    <cik0002058261:Maturity
      contextRef="From2024-01-012024-12-31_custom_EunJongChoi1Member_custom_CubebioCo.Ltd.Member"
      id="Fact001569">2025-06-30</cik0002058261:Maturity>
    <cik0002058261:FaceValue
      contextRef="From2024-01-012024-12-31_custom_EunJongChoi1Member_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001571"
      unitRef="KRW">40000000</cik0002058261:FaceValue>
    <cik0002058261:AccruedInterestIncome
      contextRef="From2024-01-012024-12-31_custom_EunJongChoi1Member_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001573"
      unitRef="KRW">8456000</cik0002058261:AccruedInterestIncome>
    <cik0002058261:CarryingAmount
      contextRef="From2024-01-012024-12-31_custom_EunJongChoi1Member_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001575"
      unitRef="KRW">48456000</cik0002058261:CarryingAmount>
    <cik0002058261:NominalInterestRate
      contextRef="From2024-01-012024-12-31_custom_CubeBioHoldingsLtdMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact001577"
      unitRef="Pure">0.0460</cik0002058261:NominalInterestRate>
    <cik0002058261:Maturity
      contextRef="From2024-01-012024-12-31_custom_CubeBioHoldingsLtdMember_custom_CubebioCo.Ltd.Member"
      id="Fact001579">2025-09-24</cik0002058261:Maturity>
    <cik0002058261:FaceValue
      contextRef="From2024-01-012024-12-31_custom_CubeBioHoldingsLtdMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001581"
      unitRef="KRW">44100000</cik0002058261:FaceValue>
    <cik0002058261:AccruedInterestIncome
      contextRef="From2024-01-012024-12-31_custom_CubeBioHoldingsLtdMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001583"
      unitRef="KRW">550000</cik0002058261:AccruedInterestIncome>
    <cik0002058261:CarryingAmount
      contextRef="From2024-01-012024-12-31_custom_CubeBioHoldingsLtdMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001585"
      unitRef="KRW">44650000</cik0002058261:CarryingAmount>
    <cik0002058261:FaceValue
      contextRef="From2024-01-012024-12-31_custom_SubtotalMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001587"
      unitRef="KRW">2037850000</cik0002058261:FaceValue>
    <cik0002058261:AccruedInterestIncome
      contextRef="From2024-01-012024-12-31_custom_SubtotalMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001589"
      unitRef="KRW">30145000</cik0002058261:AccruedInterestIncome>
    <cik0002058261:CarryingAmount
      contextRef="From2024-01-012024-12-31_custom_SubtotalMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001591"
      unitRef="KRW">214245000</cik0002058261:CarryingAmount>
    <cik0002058261:NominalInterestRate
      contextRef="From2024-01-012024-12-31_custom_MagiumCorpMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact001593"
      unitRef="Pure">0.0500</cik0002058261:NominalInterestRate>
    <cik0002058261:Maturity
      contextRef="From2024-01-012024-12-31_custom_MagiumCorpMember_custom_CubebioCo.Ltd.Member"
      id="Fact001595">2027-03-31</cik0002058261:Maturity>
    <cik0002058261:FaceValue
      contextRef="From2024-01-012024-12-31_custom_MagiumCorpMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001597"
      unitRef="KRW">2300000000</cik0002058261:FaceValue>
    <cik0002058261:CarryingAmount
      contextRef="From2024-01-012024-12-31_custom_MagiumCorpMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001601"
      unitRef="KRW">1917960000</cik0002058261:CarryingAmount>
    <cik0002058261:FaceValue
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001603"
      unitRef="KRW">4337850000</cik0002058261:FaceValue>
    <cik0002058261:AccruedInterestIncome
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001605"
      unitRef="KRW">30145000</cik0002058261:AccruedInterestIncome>
    <cik0002058261:CarryingAmount
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001607"
      unitRef="KRW">2132205000</cik0002058261:CarryingAmount>
    <cik0002058261:ChangesInLossAllowanceForExpectedCreditLossesOnLoanReceivablesTableTextBlock
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact001621">&lt;table cellpadding="0" cellspacing="0" id="xdx_89C_ecustom--ChangesInLossAllowanceForExpectedCreditLossesOnLoanReceivablesTableTextBlock_pn3n3_zAlqMca65cR3" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Loans receivables (Details 1)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span id="xdx_8B6_zxuGiPGFWQek" style="display: none"&gt;Changes in loss allowance for expected credit losses on Loan receivables&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2025&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center"&gt;(In thousands of Korean won)&lt;/td&gt;
    &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"&gt;Short-term loan receivable &#x2013; related parties, net&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Beginning of the year&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_905_ecustom--ShortTermLoanReceivable_iS_pn3n3_c20250101__20251231_zflMPUND0Fpa" title="Beginning of the year"&gt;1,853,750&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--ShortTermLoanReceivable_iS_pn3n3_c20240101__20241231_zjfs5E7FDJ33" title="Beginning of the year"&gt;1,853,750&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1pt"&gt;Write-off of allowance for doubtful accounts&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_901_ecustom--WriteoffOfAllowanceForDoubtfulAccounts_pn3n3_c20250101__20251231_zOMSsMAQYwp9" title="Write-off of allowance for doubtful accounts"&gt;(1,853,750&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_905_ecustom--WriteoffOfAllowanceForDoubtfulAccounts_pn3n3_c20240101__20241231_zpXnH6etd1ob" title="Write-off of allowance for doubtful accounts"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1629"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1pt"&gt;Ending of the year&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--ShortTermLoanReceivable_iE_pn3n3_c20250101__20251231_zfT04qd7YCug" title="Ending of the year"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1631"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--ShortTermLoanReceivable_iE_pn3n3_c20240101__20241231_z3eayZUjIYY" title="Ending of the year"&gt;1,853,750&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"&gt;Long-term loan receivable, net (*)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Beginning of the year&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_ecustom--LongTermLoanReceivable_iS_pn3n3_c20250101__20251231_fKCop_z2HDkvfQ3WF4" title="Beginning of the year"&gt;533,862&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_904_ecustom--LongTermLoanReceivable_iS_pn3n3_c20240101__20241231_fKCop_zGWBYSqUr8Si" title="Beginning of the year"&gt;952,170&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Reversal of allowance for doubtful accounts&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_ecustom--ReversalOfAllowanceForDoubtfulAccounts_pn3n3_c20250101__20251231_fKCop_zPVxf8ktQ1Fd" title="Reversal of allowance for doubtful accounts"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1639"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_904_ecustom--ReversalOfAllowanceForDoubtfulAccounts_pn3n3_c20240101__20241231_fKCop_zC6OxuaR5wjf" title="Reversal of allowance for doubtful accounts"&gt;(489,720&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1pt"&gt;Other bad debt expenses&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_905_ecustom--OtherBadDebtExpenses_pn3n3_c20250101__20251231_fKCop_z4at4wXbl5y1" title="Other bad debt expenses"&gt;341,816&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_904_ecustom--OtherBadDebtExpenses_pn3n3_c20240101__20241231_fKCop_zduymEiUU6xi" title="Other bad debt expenses"&gt;71,412&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt"&gt;Ending of the year&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_903_ecustom--LongTermLoanReceivable_iE_pn3n3_c20250101__20251231_fKCop_ziLqCi7S8Cf5" title="Ending of the year"&gt;875,678&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--LongTermLoanReceivable_iE_pn3n3_c20240101__20241231_fKCop_zrpvt92UUC52" title="Ending of the year"&gt;533,862&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;div style="width: 25%"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; margin-top: 0pt; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="text-align: justify; width: 0in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: justify"&gt;(*)&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;Includes allowance for expected credit losses relating to long-term other receivables.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:ChangesInLossAllowanceForExpectedCreditLossesOnLoanReceivablesTableTextBlock>
    <cik0002058261:ShortTermLoanReceivable
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001623"
      unitRef="KRW">1853750000</cik0002058261:ShortTermLoanReceivable>
    <cik0002058261:ShortTermLoanReceivable
      contextRef="AsOf2023-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001625"
      unitRef="KRW">1853750000</cik0002058261:ShortTermLoanReceivable>
    <cik0002058261:WriteoffOfAllowanceForDoubtfulAccounts
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001627"
      unitRef="KRW">-1853750000</cik0002058261:WriteoffOfAllowanceForDoubtfulAccounts>
    <cik0002058261:ShortTermLoanReceivable
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001633"
      unitRef="KRW">1853750000</cik0002058261:ShortTermLoanReceivable>
    <cik0002058261:LongTermLoanReceivable
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001635"
      unitRef="KRW">533862000</cik0002058261:LongTermLoanReceivable>
    <cik0002058261:LongTermLoanReceivable
      contextRef="AsOf2023-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001637"
      unitRef="KRW">952170000</cik0002058261:LongTermLoanReceivable>
    <cik0002058261:ReversalOfAllowanceForDoubtfulAccounts
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001641"
      unitRef="KRW">-489720000</cik0002058261:ReversalOfAllowanceForDoubtfulAccounts>
    <cik0002058261:OtherBadDebtExpenses
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001643"
      unitRef="KRW">341816000</cik0002058261:OtherBadDebtExpenses>
    <cik0002058261:OtherBadDebtExpenses
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001645"
      unitRef="KRW">71412000</cik0002058261:OtherBadDebtExpenses>
    <cik0002058261:LongTermLoanReceivable
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001647"
      unitRef="KRW">875678000</cik0002058261:LongTermLoanReceivable>
    <cik0002058261:LongTermLoanReceivable
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001649"
      unitRef="KRW">533862000</cik0002058261:LongTermLoanReceivable>
    <cik0002058261:OtherReceivablesTextBlock
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact001651">&lt;p id="xdx_80C_ecustom--OtherReceivablesTextBlock_zG5H5OOP8qP8" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;9. &lt;span id="xdx_826_zyWyJv2CNek"&gt;Other receivables&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Details of other receivables as of December&#160;31, 2025 and 2024 are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89A_ecustom--DetailsOfOtherReceivablesTableTextBlock_pn3n3_zvcqMZrgXSX2" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Other receivables (Details)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span id="xdx_8BB_zfkRruWMYxma" style="display: none"&gt;Details of other receivables&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="10" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;December&#160;31, 2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="10" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Gross&lt;br/&gt; amount&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Provision&#160;for&lt;br/&gt; impairment&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Carrying&lt;br/&gt; amount&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;b&gt;Current&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Accrued interest income&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#x20a9;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_909_ecustom--CurrentAccruedInterestIncomeGrossAmount_iI_pn3n3_c20251231_zk4D5uYx3jH2" title="Current accrued interest income, gross amount"&gt;3,146&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_909_ecustom--CurrentAccruedInterestIncomeProvisionForImpairment_iNI_pn3n3_di_c20251231_zco37kD4pb01" title="Current accrued interest income, provision for impairment"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1657"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--CurrentAccruedInterestIncomeCarryingAmount_iI_pn3n3_c20251231_zuAuieEAbO05" title="Current accrued interest income, carrying amount"&gt;3,146&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;VAT refund receivable (*)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--VatRefundReceivableGrossAmount_iI_pn3n3_c20251231_fKCop_zA2J5DykPjee" title="VAT refund receivable, gross amount"&gt;30,265&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_908_ecustom--VatRefundReceivableProvisionForImpairment_iNI_pn3n3_di_c20251231_fKCop_zCj018ugdrFh" title="VAT refund receivable, provision for impairment"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1663"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_909_ecustom--VatRefundReceivableCarryingAmount_iI_pn3n3_c20251231_fKCop_zu8vpUGJwPBa" title="VAT refund receivable, carrying amount"&gt;30,265&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; vertical-align: top; padding-left: 0.25in; padding-bottom: 0.5pt"&gt;Subtotal&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_901_ecustom--SubtotalGrossAmount_iI_pn3n3_c20251231_zVeDkO5hukml" title="Subtotal, gross amount"&gt;33,411&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--SubtotalProvisionForImpairment_iNI_pn3n3_di_c20251231_zAWAQkhDGNb7" title="Subtotal, provision for impairment"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1669"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--SubtotalCarryingAmount_iI_pn3n3_c20251231_zk9s5aBqViM4" title="Subtotal, carrying amount"&gt;33,411&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;b&gt;Non-Current&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Accrued interest income&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_909_ecustom--NoncurrentAccruedInterestIncomeGrossAmount_iI_pn3n3_c20251231_zil3uJ1iqDPl" title="Non-Current accrued interest income, gross amount"&gt;247,458&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--NoncurrentAccruedInterestIncomeProvisionForImpairment_iNI_pn3n3_di_c20251231_zXYobtB31o11" title="Non-Current accrued interest income, provision for impairment"&gt;(247,458&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--NoncurrentAccruedInterestIncomeCarryingAmount_iI_pn3n3_c20251231_zUsHHJ7eLFX5" title="Non-Current accrued interest income, carrying amount"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1677"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; vertical-align: top; padding-left: 0.25in; padding-bottom: 1.25pt"&gt;Total&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_909_ecustom--TotalGrossAmount_iI_pn3n3_c20251231_zRXI013tMB5e" title="Total, gross amount"&gt;280,869&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_906_ecustom--TotalProvisionForImpairment_iNI_pn3n3_di_c20251231_zF1875dYoDJe" title="Total, provision for impairment"&gt;(247,458&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_903_ecustom--TotalCarryingAmount_iI_pn3n3_c20251231_zkv5fbpWLnLj" title="Total, carrying amount"&gt;33,411&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;div style="width: 25%; margin-left: 0; margin-right: auto"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td id="xdx_F03_zCaAs2RLKei9" style="width: 0.25in; text-align: left"&gt;(*)&lt;/td&gt;
    &lt;td id="xdx_F1E_z4PDYAovZEZj" style="text-align: justify"&gt;The net amount of VAT refund receivable from, or payable to, the taxation authority is included as part of receivables or payables in the statement of financial position.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;







&lt;p style="font: 10pt Times New Roman, Times, serif; margin: 0px; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;









&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="10" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;December&#160;31, 2024&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="10" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Gross&lt;br/&gt; amount&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Provision&#160;for&lt;br/&gt; impairment&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Carrying&lt;br/&gt; amount&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;b&gt;Current&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;VAT refund receivable (*)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_906_ecustom--VatRefundReceivableGrossAmount_iI_pn3n3_c20241231_fKCop_z3Mt8KABnxFb" title="VAT refund receivable, gross amount"&gt;202,477&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--CurrentAccruedInterestIncomeProvisionForImpairment_iNI_pn3n3_di_c20241231_zXhlnvbnoaK" title="Current accrued interest income, provision for impairment"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1694"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--VatRefundReceivableCarryingAmount_iI_pn3n3_c20241231_fKCop_zbMXcpKCBKTl" title="VAT refund receivable, carrying amount"&gt;202,477&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;b&gt;Non-Current&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Accrued interest income&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_909_ecustom--NoncurrentAccruedInterestIncomeGrossAmount_iI_pn3n3_c20241231_zEGw33NSo3gf" title="Non-Current accrued interest income, gross amount"&gt;153,887&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_903_ecustom--NoncurrentAccruedInterestIncomeProvisionForImpairment_iNI_pn3n3_di_c20241231_zy5e6KPcZUfh" title="Non-Current accrued interest income, provision for impairment"&gt;(151,822&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_901_ecustom--NoncurrentAccruedInterestIncomeCarryingAmount_iI_pn3n3_c20241231_zvPWYqoj9UF7" title="Non-Current accrued interest income, carrying amount"&gt;2,065&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; vertical-align: top; padding-left: 0.25in; padding-bottom: 1.25pt"&gt;Total&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_902_ecustom--TotalGrossAmount_iI_pn3n3_c20241231_zklF2d9g3Voh" title="Total, gross amount"&gt;356,364&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--TotalProvisionForImpairment_iNI_pn3n3_di_c20241231_zSDsWX0MTtWg" title="Total, provision for impairment"&gt;(151,822&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_ecustom--TotalCarryingAmount_iI_pn3n3_c20241231_zkW68bxABu2" title="Total, carrying amount"&gt;204,542&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;div style="width: 25%; margin-left: 0; margin-right: auto"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td id="xdx_F05_zbEJZrQQFMI2" style="width: 0.25in; text-align: left"&gt;(*)&lt;/td&gt;
    &lt;td id="xdx_F10_zrKF9AMCUs7l" style="text-align: justify"&gt;The net amount of VAT refund receivable from, or payable to, the taxation authority is included as part of receivables or payables in the statement of financial position.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AE_znA1YK1qZMCd" style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Details of the changes in the loss allowance of accrued interest income for the years ended December&#160;31, 2025 and 2024 are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89A_ecustom--DetailsOfChangesInLossAllowanceOfAccruedInterestIncomeTableTextBlock_pn3n3_zlwf5Lp7BYZ" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Other receivables (Details 1)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_8B3_zQl1dUq4P30h" style="display: none"&gt;Details of changes in loss allowance of accrued interest income&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_495_20250101__20251231_z3BOkLxeu694" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_491_20240101__20241231_zQRDC20A6KIl" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;b&gt;Allowance for doubtful accounts (Short-term accrued interest income)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--AllowanceForDoubtfulAccountsOtherReceivables_iS_pp0p" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Beginning of the year&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#x20a9;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1713"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1714"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--BadDebtExpensesOtherReceivables_i_pp0p" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Bad debt expenses &#x2013; other&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1716"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--ReclassificationFromCurrent_i_pp0p" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Reclassification from current to non-current&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1719"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1720"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--AllowanceForDoubtfulAccountsOtherReceivables_iE_pp0p" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.25pt"&gt;Ending of the year&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1722"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1723"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;b&gt;Allowance for doubtful accounts (Long-term accrued interest income)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--AllowanceForDoubtfulAccountsLongtermAccruedInterestIncome_iS_pp0p" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Beginning of the year&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#x20a9;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;151,822&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;80,410&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--BadDebtExpensesOther_i_pp0p" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Bad debt expenses &#x2013; other&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;95,636&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;71,412&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--ReclassificationFromCurrentToNoncurrent_i_pp0p" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Reclassification from current to non-current&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1731"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1732"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--AllowanceForDoubtfulAccountsLongtermAccruedInterestIncome_iE_pp0p" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.25pt"&gt;Ending of the year&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;247,458&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;151,822&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A5_zlR6e3quMgyh" style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

</cik0002058261:OtherReceivablesTextBlock>
    <cik0002058261:DetailsOfOtherReceivablesTableTextBlock
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact001653">&lt;table cellpadding="0" cellspacing="0" id="xdx_89A_ecustom--DetailsOfOtherReceivablesTableTextBlock_pn3n3_zvcqMZrgXSX2" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Other receivables (Details)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span id="xdx_8BB_zfkRruWMYxma" style="display: none"&gt;Details of other receivables&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="10" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;December&#160;31, 2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="10" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Gross&lt;br/&gt; amount&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Provision&#160;for&lt;br/&gt; impairment&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Carrying&lt;br/&gt; amount&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;b&gt;Current&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Accrued interest income&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#x20a9;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_909_ecustom--CurrentAccruedInterestIncomeGrossAmount_iI_pn3n3_c20251231_zk4D5uYx3jH2" title="Current accrued interest income, gross amount"&gt;3,146&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_909_ecustom--CurrentAccruedInterestIncomeProvisionForImpairment_iNI_pn3n3_di_c20251231_zco37kD4pb01" title="Current accrued interest income, provision for impairment"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1657"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--CurrentAccruedInterestIncomeCarryingAmount_iI_pn3n3_c20251231_zuAuieEAbO05" title="Current accrued interest income, carrying amount"&gt;3,146&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;VAT refund receivable (*)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--VatRefundReceivableGrossAmount_iI_pn3n3_c20251231_fKCop_zA2J5DykPjee" title="VAT refund receivable, gross amount"&gt;30,265&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_908_ecustom--VatRefundReceivableProvisionForImpairment_iNI_pn3n3_di_c20251231_fKCop_zCj018ugdrFh" title="VAT refund receivable, provision for impairment"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1663"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_909_ecustom--VatRefundReceivableCarryingAmount_iI_pn3n3_c20251231_fKCop_zu8vpUGJwPBa" title="VAT refund receivable, carrying amount"&gt;30,265&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; vertical-align: top; padding-left: 0.25in; padding-bottom: 0.5pt"&gt;Subtotal&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_901_ecustom--SubtotalGrossAmount_iI_pn3n3_c20251231_zVeDkO5hukml" title="Subtotal, gross amount"&gt;33,411&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--SubtotalProvisionForImpairment_iNI_pn3n3_di_c20251231_zAWAQkhDGNb7" title="Subtotal, provision for impairment"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1669"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--SubtotalCarryingAmount_iI_pn3n3_c20251231_zk9s5aBqViM4" title="Subtotal, carrying amount"&gt;33,411&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;b&gt;Non-Current&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Accrued interest income&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_909_ecustom--NoncurrentAccruedInterestIncomeGrossAmount_iI_pn3n3_c20251231_zil3uJ1iqDPl" title="Non-Current accrued interest income, gross amount"&gt;247,458&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--NoncurrentAccruedInterestIncomeProvisionForImpairment_iNI_pn3n3_di_c20251231_zXYobtB31o11" title="Non-Current accrued interest income, provision for impairment"&gt;(247,458&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--NoncurrentAccruedInterestIncomeCarryingAmount_iI_pn3n3_c20251231_zUsHHJ7eLFX5" title="Non-Current accrued interest income, carrying amount"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1677"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; vertical-align: top; padding-left: 0.25in; padding-bottom: 1.25pt"&gt;Total&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_909_ecustom--TotalGrossAmount_iI_pn3n3_c20251231_zRXI013tMB5e" title="Total, gross amount"&gt;280,869&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_906_ecustom--TotalProvisionForImpairment_iNI_pn3n3_di_c20251231_zF1875dYoDJe" title="Total, provision for impairment"&gt;(247,458&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_903_ecustom--TotalCarryingAmount_iI_pn3n3_c20251231_zkv5fbpWLnLj" title="Total, carrying amount"&gt;33,411&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;div style="width: 25%; margin-left: 0; margin-right: auto"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td id="xdx_F03_zCaAs2RLKei9" style="width: 0.25in; text-align: left"&gt;(*)&lt;/td&gt;
    &lt;td id="xdx_F1E_z4PDYAovZEZj" style="text-align: justify"&gt;The net amount of VAT refund receivable from, or payable to, the taxation authority is included as part of receivables or payables in the statement of financial position.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;







&lt;p style="font: 10pt Times New Roman, Times, serif; margin: 0px; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;









&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="10" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;December&#160;31, 2024&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="10" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Gross&lt;br/&gt; amount&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Provision&#160;for&lt;br/&gt; impairment&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Carrying&lt;br/&gt; amount&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;b&gt;Current&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;VAT refund receivable (*)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_906_ecustom--VatRefundReceivableGrossAmount_iI_pn3n3_c20241231_fKCop_z3Mt8KABnxFb" title="VAT refund receivable, gross amount"&gt;202,477&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--CurrentAccruedInterestIncomeProvisionForImpairment_iNI_pn3n3_di_c20241231_zXhlnvbnoaK" title="Current accrued interest income, provision for impairment"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1694"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--VatRefundReceivableCarryingAmount_iI_pn3n3_c20241231_fKCop_zbMXcpKCBKTl" title="VAT refund receivable, carrying amount"&gt;202,477&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;b&gt;Non-Current&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Accrued interest income&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_909_ecustom--NoncurrentAccruedInterestIncomeGrossAmount_iI_pn3n3_c20241231_zEGw33NSo3gf" title="Non-Current accrued interest income, gross amount"&gt;153,887&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_903_ecustom--NoncurrentAccruedInterestIncomeProvisionForImpairment_iNI_pn3n3_di_c20241231_zy5e6KPcZUfh" title="Non-Current accrued interest income, provision for impairment"&gt;(151,822&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_901_ecustom--NoncurrentAccruedInterestIncomeCarryingAmount_iI_pn3n3_c20241231_zvPWYqoj9UF7" title="Non-Current accrued interest income, carrying amount"&gt;2,065&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; vertical-align: top; padding-left: 0.25in; padding-bottom: 1.25pt"&gt;Total&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_902_ecustom--TotalGrossAmount_iI_pn3n3_c20241231_zklF2d9g3Voh" title="Total, gross amount"&gt;356,364&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--TotalProvisionForImpairment_iNI_pn3n3_di_c20241231_zSDsWX0MTtWg" title="Total, provision for impairment"&gt;(151,822&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_ecustom--TotalCarryingAmount_iI_pn3n3_c20241231_zkW68bxABu2" title="Total, carrying amount"&gt;204,542&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;div style="width: 25%; margin-left: 0; margin-right: auto"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td id="xdx_F05_zbEJZrQQFMI2" style="width: 0.25in; text-align: left"&gt;(*)&lt;/td&gt;
    &lt;td id="xdx_F10_zrKF9AMCUs7l" style="text-align: justify"&gt;The net amount of VAT refund receivable from, or payable to, the taxation authority is included as part of receivables or payables in the statement of financial position.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:DetailsOfOtherReceivablesTableTextBlock>
    <cik0002058261:CurrentAccruedInterestIncomeGrossAmount
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001655"
      unitRef="KRW">3146000</cik0002058261:CurrentAccruedInterestIncomeGrossAmount>
    <cik0002058261:CurrentAccruedInterestIncomeCarryingAmount
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001659"
      unitRef="KRW">3146000</cik0002058261:CurrentAccruedInterestIncomeCarryingAmount>
    <cik0002058261:VatRefundReceivableGrossAmount
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001661"
      unitRef="KRW">30265000</cik0002058261:VatRefundReceivableGrossAmount>
    <cik0002058261:VatRefundReceivableCarryingAmount
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001665"
      unitRef="KRW">30265000</cik0002058261:VatRefundReceivableCarryingAmount>
    <cik0002058261:SubtotalGrossAmount
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001667"
      unitRef="KRW">33411000</cik0002058261:SubtotalGrossAmount>
    <cik0002058261:SubtotalCarryingAmount
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001671"
      unitRef="KRW">33411000</cik0002058261:SubtotalCarryingAmount>
    <cik0002058261:NoncurrentAccruedInterestIncomeGrossAmount
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001673"
      unitRef="KRW">247458000</cik0002058261:NoncurrentAccruedInterestIncomeGrossAmount>
    <cik0002058261:NoncurrentAccruedInterestIncomeProvisionForImpairment
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001675"
      unitRef="KRW">247458000</cik0002058261:NoncurrentAccruedInterestIncomeProvisionForImpairment>
    <cik0002058261:TotalGrossAmount
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001679"
      unitRef="KRW">280869000</cik0002058261:TotalGrossAmount>
    <cik0002058261:TotalProvisionForImpairment
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001681"
      unitRef="KRW">247458000</cik0002058261:TotalProvisionForImpairment>
    <cik0002058261:TotalCarryingAmount
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001683"
      unitRef="KRW">33411000</cik0002058261:TotalCarryingAmount>
    <cik0002058261:VatRefundReceivableGrossAmount
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001692"
      unitRef="KRW">202477000</cik0002058261:VatRefundReceivableGrossAmount>
    <cik0002058261:VatRefundReceivableCarryingAmount
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001696"
      unitRef="KRW">202477000</cik0002058261:VatRefundReceivableCarryingAmount>
    <cik0002058261:NoncurrentAccruedInterestIncomeGrossAmount
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001698"
      unitRef="KRW">153887000</cik0002058261:NoncurrentAccruedInterestIncomeGrossAmount>
    <cik0002058261:NoncurrentAccruedInterestIncomeProvisionForImpairment
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001700"
      unitRef="KRW">151822000</cik0002058261:NoncurrentAccruedInterestIncomeProvisionForImpairment>
    <cik0002058261:NoncurrentAccruedInterestIncomeCarryingAmount
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001702"
      unitRef="KRW">2065000</cik0002058261:NoncurrentAccruedInterestIncomeCarryingAmount>
    <cik0002058261:TotalGrossAmount
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001704"
      unitRef="KRW">356364000</cik0002058261:TotalGrossAmount>
    <cik0002058261:TotalProvisionForImpairment
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001706"
      unitRef="KRW">151822000</cik0002058261:TotalProvisionForImpairment>
    <cik0002058261:TotalCarryingAmount
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001708"
      unitRef="KRW">204542000</cik0002058261:TotalCarryingAmount>
    <cik0002058261:DetailsOfChangesInLossAllowanceOfAccruedInterestIncomeTableTextBlock
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact001711">&lt;table cellpadding="0" cellspacing="0" id="xdx_89A_ecustom--DetailsOfChangesInLossAllowanceOfAccruedInterestIncomeTableTextBlock_pn3n3_zlwf5Lp7BYZ" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Other receivables (Details 1)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_8B3_zQl1dUq4P30h" style="display: none"&gt;Details of changes in loss allowance of accrued interest income&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_495_20250101__20251231_z3BOkLxeu694" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_491_20240101__20241231_zQRDC20A6KIl" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;b&gt;Allowance for doubtful accounts (Short-term accrued interest income)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--AllowanceForDoubtfulAccountsOtherReceivables_iS_pp0p" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Beginning of the year&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#x20a9;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1713"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1714"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--BadDebtExpensesOtherReceivables_i_pp0p" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Bad debt expenses &#x2013; other&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1716"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--ReclassificationFromCurrent_i_pp0p" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Reclassification from current to non-current&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1719"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1720"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--AllowanceForDoubtfulAccountsOtherReceivables_iE_pp0p" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.25pt"&gt;Ending of the year&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1722"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1723"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;b&gt;Allowance for doubtful accounts (Long-term accrued interest income)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--AllowanceForDoubtfulAccountsLongtermAccruedInterestIncome_iS_pp0p" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Beginning of the year&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#x20a9;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;151,822&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;80,410&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--BadDebtExpensesOther_i_pp0p" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Bad debt expenses &#x2013; other&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;95,636&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;71,412&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--ReclassificationFromCurrentToNoncurrent_i_pp0p" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Reclassification from current to non-current&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1731"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1732"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--AllowanceForDoubtfulAccountsLongtermAccruedInterestIncome_iE_pp0p" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.25pt"&gt;Ending of the year&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;247,458&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;151,822&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:DetailsOfChangesInLossAllowanceOfAccruedInterestIncomeTableTextBlock>
    <cik0002058261:AllowanceForDoubtfulAccountsLongtermAccruedInterestIncome
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="0"
      id="Fact001725"
      unitRef="KRW">151822</cik0002058261:AllowanceForDoubtfulAccountsLongtermAccruedInterestIncome>
    <cik0002058261:AllowanceForDoubtfulAccountsLongtermAccruedInterestIncome
      contextRef="AsOf2023-12-31_custom_CubebioCo.Ltd.Member"
      decimals="0"
      id="Fact001726"
      unitRef="KRW">80410</cik0002058261:AllowanceForDoubtfulAccountsLongtermAccruedInterestIncome>
    <cik0002058261:BadDebtExpensesOther
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001728"
      unitRef="KRW">95636000</cik0002058261:BadDebtExpensesOther>
    <cik0002058261:BadDebtExpensesOther
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001729"
      unitRef="KRW">71412000</cik0002058261:BadDebtExpensesOther>
    <cik0002058261:AllowanceForDoubtfulAccountsLongtermAccruedInterestIncome
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="0"
      id="Fact001734"
      unitRef="KRW">247458</cik0002058261:AllowanceForDoubtfulAccountsLongtermAccruedInterestIncome>
    <cik0002058261:AllowanceForDoubtfulAccountsLongtermAccruedInterestIncome
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="0"
      id="Fact001735"
      unitRef="KRW">151822</cik0002058261:AllowanceForDoubtfulAccountsLongtermAccruedInterestIncome>
    <cik0002058261:InventoriesTextBlock
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact001737">&lt;p id="xdx_808_ecustom--InventoriesTextBlock_zGtgaaO0F9k8" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;10. &lt;span id="xdx_82A_zwVcfnTG8luh"&gt;Inventories&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Details of inventories as of December&#160;31, 2025 and 2024 are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_897_ecustom--InventoryDisclosureTableTextBlock_pn3n3_zIbTm8h1WGz1" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Inventories (Details)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;&lt;span id="xdx_8BA_z6GRifLLL2v4" style="display: none"&gt;Schedule of inventories&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49B_20251231_zFtyleRgKT96" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_496_20241231_zllLMPCUhW12" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2024&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr id="xdx_402_eifrs-full--Merchandise_iI_maCznMH_zegJrD3jLj52" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Merchandise&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1741"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;256,286&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--AllowanceForInventoriesValuation_iI_maCznMH_zuyCsQVt4ibb" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Allowance
    for inventory valuation &lt;span id="xdx_F4F_zNXYcyw2aemg"&gt;(*)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1744"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;(256,286&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40E_eifrs-full--Inventories_iTI_mtCznMH_zCmdkUID2Xu5" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; vertical-align: top; padding-left: 0.125in; padding-bottom: 1.25pt"&gt;Total&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1747"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1748"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;div style="width: 25%; margin-left: 0; margin-right: auto"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td id="xdx_F05_zKmgE64F8gQ4" style="width: 0.25in; text-align: left"&gt;(*)&lt;/td&gt;
    &lt;td id="xdx_F12_zD51X8aeiPR" style="text-align: justify"&gt;For the year ended December&#160;31, 2021, the Company recognized a 100% valuation allowance against custom-made inventory intended for the Russian market due to delivery restrictions arising from the Russia-Ukraine conflict. As of December&#160;31, 2025, this inventory, with a net carrying amount of nil, has been written off.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AE_zy4UpZipMmEi" style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

















</cik0002058261:InventoriesTextBlock>
    <cik0002058261:InventoryDisclosureTableTextBlock
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact001739">&lt;table cellpadding="0" cellspacing="0" id="xdx_897_ecustom--InventoryDisclosureTableTextBlock_pn3n3_zIbTm8h1WGz1" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Inventories (Details)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;&lt;span id="xdx_8BA_z6GRifLLL2v4" style="display: none"&gt;Schedule of inventories&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49B_20251231_zFtyleRgKT96" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_496_20241231_zllLMPCUhW12" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2024&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr id="xdx_402_eifrs-full--Merchandise_iI_maCznMH_zegJrD3jLj52" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Merchandise&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1741"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;256,286&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--AllowanceForInventoriesValuation_iI_maCznMH_zuyCsQVt4ibb" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Allowance
    for inventory valuation &lt;span id="xdx_F4F_zNXYcyw2aemg"&gt;(*)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1744"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;(256,286&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40E_eifrs-full--Inventories_iTI_mtCznMH_zCmdkUID2Xu5" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; vertical-align: top; padding-left: 0.125in; padding-bottom: 1.25pt"&gt;Total&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1747"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1748"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;div style="width: 25%; margin-left: 0; margin-right: auto"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td id="xdx_F05_zKmgE64F8gQ4" style="width: 0.25in; text-align: left"&gt;(*)&lt;/td&gt;
    &lt;td id="xdx_F12_zD51X8aeiPR" style="text-align: justify"&gt;For the year ended December&#160;31, 2021, the Company recognized a 100% valuation allowance against custom-made inventory intended for the Russian market due to delivery restrictions arising from the Russia-Ukraine conflict. As of December&#160;31, 2025, this inventory, with a net carrying amount of nil, has been written off.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:InventoryDisclosureTableTextBlock>
    <ifrs-full:Merchandise
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001742"
      unitRef="KRW">256286000</ifrs-full:Merchandise>
    <cik0002058261:AllowanceForInventoriesValuation
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001745"
      unitRef="KRW">-256286000</cik0002058261:AllowanceForInventoriesValuation>
    <cik0002058261:OtherAssetsTextBlock
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact001758">&lt;p id="xdx_801_ecustom--OtherAssetsTextBlock_zWRkgsgy7yzc" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;11. &lt;span id="xdx_822_zpi1GIUIz96f"&gt;Other assets&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Details of other assets as of December&#160;31, 2025 and 2024 are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_889_ecustom--OtherAssetsDisclosureTableTextBlock_pn3n3_zfF89zHsXAL4" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Other assets (Details)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span id="xdx_8B4_zm4Fc3wqmVd7" style="display: none"&gt;Schedule of other assets&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_492_20251231_zn4ic72674m7" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49B_20241231_z6Bk6aSxywCi" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2024&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr id="xdx_403_eifrs-full--CurrentAssetsAbstract_iB_zer3cKszw0y4" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;b&gt;Current&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--CurrentPrepaidExpenses_iI_zYeN3nWP2RSe" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Prepaid expenses&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#x20a9;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;42,277&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;47,406&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eifrs-full--CurrentTaxAssets_iI_zEKn4uPg8NPf" style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Current tax assets&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;11,201&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;10,294&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40E_eifrs-full--CurrentPrepayments_iI_zIkrfpTa9Jq2" style="background-color: White; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Prepayments&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;83,673&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1772"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--CurrentAsset_iI_zzCJPBm7vkI1" style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; vertical-align: top; padding-left: 0.25in"&gt;Sub-total&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;137,151&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;57,700&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eifrs-full--NoncurrentAssetsAbstract_iB_zYlsLZtUTeDk" style="background-color: White; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;b&gt;Non-Current&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--NoncurrentPrepaidExpenses_iI_zP4KKZtxQfl" style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Prepaid expenses&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;38,114&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;79,693&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--Asset_iI_zedQ2MLAyAlf" style="background-color: White; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; vertical-align: top; padding-left: 0.125in; padding-bottom: 1.25pt"&gt;Total&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;175,265&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;137,393&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

</cik0002058261:OtherAssetsTextBlock>
    <cik0002058261:OtherAssetsDisclosureTableTextBlock
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact001760">&lt;table cellpadding="0" cellspacing="0" id="xdx_889_ecustom--OtherAssetsDisclosureTableTextBlock_pn3n3_zfF89zHsXAL4" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Other assets (Details)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span id="xdx_8B4_zm4Fc3wqmVd7" style="display: none"&gt;Schedule of other assets&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_492_20251231_zn4ic72674m7" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49B_20241231_z6Bk6aSxywCi" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2024&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr id="xdx_403_eifrs-full--CurrentAssetsAbstract_iB_zer3cKszw0y4" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;b&gt;Current&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--CurrentPrepaidExpenses_iI_zYeN3nWP2RSe" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Prepaid expenses&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#x20a9;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;42,277&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;47,406&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eifrs-full--CurrentTaxAssets_iI_zEKn4uPg8NPf" style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Current tax assets&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;11,201&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;10,294&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40E_eifrs-full--CurrentPrepayments_iI_zIkrfpTa9Jq2" style="background-color: White; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Prepayments&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;83,673&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1772"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--CurrentAsset_iI_zzCJPBm7vkI1" style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; vertical-align: top; padding-left: 0.25in"&gt;Sub-total&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;137,151&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;57,700&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eifrs-full--NoncurrentAssetsAbstract_iB_zYlsLZtUTeDk" style="background-color: White; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;b&gt;Non-Current&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--NoncurrentPrepaidExpenses_iI_zP4KKZtxQfl" style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Prepaid expenses&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;38,114&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;79,693&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--Asset_iI_zedQ2MLAyAlf" style="background-color: White; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; vertical-align: top; padding-left: 0.125in; padding-bottom: 1.25pt"&gt;Total&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;175,265&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;137,393&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;</cik0002058261:OtherAssetsDisclosureTableTextBlock>
    <ifrs-full:CurrentPrepaidExpenses
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001765"
      unitRef="KRW">42277000</ifrs-full:CurrentPrepaidExpenses>
    <ifrs-full:CurrentPrepaidExpenses
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001766"
      unitRef="KRW">47406000</ifrs-full:CurrentPrepaidExpenses>
    <ifrs-full:CurrentTaxAssets
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001768"
      unitRef="KRW">11201000</ifrs-full:CurrentTaxAssets>
    <ifrs-full:CurrentTaxAssets
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001769"
      unitRef="KRW">10294000</ifrs-full:CurrentTaxAssets>
    <ifrs-full:CurrentPrepayments
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001771"
      unitRef="KRW">83673000</ifrs-full:CurrentPrepayments>
    <cik0002058261:CurrentAsset
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001774"
      unitRef="KRW">137151000</cik0002058261:CurrentAsset>
    <cik0002058261:CurrentAsset
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001775"
      unitRef="KRW">57700000</cik0002058261:CurrentAsset>
    <cik0002058261:NoncurrentPrepaidExpenses
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001780"
      unitRef="KRW">38114000</cik0002058261:NoncurrentPrepaidExpenses>
    <cik0002058261:NoncurrentPrepaidExpenses
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001781"
      unitRef="KRW">79693000</cik0002058261:NoncurrentPrepaidExpenses>
    <cik0002058261:Asset
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001783"
      unitRef="KRW">175265000</cik0002058261:Asset>
    <cik0002058261:Asset
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001784"
      unitRef="KRW">137393000</cik0002058261:Asset>
    <ifrs-full:DisclosureOfFinancialInstrumentsHeldForTradingExplanatory
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact001786">&lt;p id="xdx_80E_eifrs-full--DisclosureOfFinancialInstrumentsHeldForTradingExplanatory_ztFKL1d629lh" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;12. &lt;span id="xdx_82A_zlgaR6y5eONi"&gt;Financial instruments &#x2013; Fair values and risk management&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.25in; text-align: left"&gt;&lt;b&gt;A.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;&lt;b&gt;Accounting classifications and fair values&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The following table shows the carrying amounts and fair values of financial assets and financial liabilities, including their levels in the fair value hierarchy. It does not include fair value information for financial assets and financial liabilities not measured at fair value if the carrying amount is a reasonable approximation of fair value.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The carrying amounts of financial instruments by category as of December&#160;31, 2025 and 2024 are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_891_ecustom--ScheduleOfFinancialAssetsAndLiabilityFairValueTableTextBlock_pn3n3_z2zeYbua9h3k" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Financial Instruments - Fair values and risk management (Details)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_8BB_z3WYvupG3mol" style="display: none"&gt;Schedule of financial assets and liability at fair value&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="22" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Carrying amount&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Fair value&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Level 1&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Level 2&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Level 3&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="22" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; width: 38%"&gt;&lt;b&gt;Financial liabilities at fair value through profit or loss&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 7%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 7%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 7%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 7%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 7%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 7%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Derivative liabilities (*)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#x20a9;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--DerivativeFinancialLiabilities_iI_pn3n3_c20251231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--CarryingAmountMember_fKCop_zOyJIP88qSNk" title="Derivative liabilities"&gt;1,267,801&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--DerivativeFinancialLiabilities_iI_pn3n3_c20251231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--FairValueMember_fKCop_zFxRFI4NnKc9" title="Derivative liabilities"&gt;1,267,801&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--DerivativeFinancialLiabilities_iI_pn3n3_c20251231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--FairValueMember__ifrs-full--ClassesOfAssetsAxis__custom--FinancialAssetsMember__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level1OfFairValueHierarchyMember_fKCop_zgQ4n1SxZ0E" title="Derivative liabilities"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1794"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--DerivativeFinancialLiabilities_iI_pn3n3_c20251231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--FairValueMember__ifrs-full--ClassesOfAssetsAxis__custom--FinancialAssetsMember__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_fKCop_zf8X037cGQui" title="Derivative liabilities"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1796"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--DerivativeFinancialLiabilities_iI_pn3n3_c20251231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--FairValueMember__ifrs-full--ClassesOfAssetsAxis__custom--FinancialAssetsMember__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_fKCop_zgkJk2sYCsI6" title="Derivative liabilities"&gt;1,267,801&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--DerivativeFinancialLiabilities_iI_pn3n3_c20251231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--FairValueMember__ifrs-full--ClassesOfAssetsAxis__custom--FinancialAssetsMember_fKCop_zvNQnaoKqDY" title="Derivative liabilities"&gt;1,267,801&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;div style="width: 25%; margin-left: 0; margin-right: auto"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;(*)&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;Represents the early redemption rights of the issuer and the investor, which are embedded derivatives of bonds with warrants issued to fund the operations.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="22" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Carrying amount&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Fair value&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Level 1&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Level 2&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Level 3&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="22" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; width: 38%"&gt;&lt;b&gt;Financial liabilities at fair value through profit or loss&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 7%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 7%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 7%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 7%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 7%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 7%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Derivative liabilities (*)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#x20a9;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--DerivativeFinancialLiabilities_iI_pn3n3_c20241231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--CarryingAmountMember_fKCop_zbObmBAeZH9" title="Derivative liabilities"&gt;1,473,823&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--DerivativeFinancialLiabilities_iI_pn3n3_c20241231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--FairValueMember_fKCop_zTyCFV0Tzwj7" title="Derivative liabilities"&gt;1,473,823&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--DerivativeFinancialLiabilities_iI_pn3n3_c20241231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--FairValueMember__ifrs-full--ClassesOfAssetsAxis__custom--FinancialAssetsMember__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level1OfFairValueHierarchyMember_fKCop_zxTKTbmX6i46" title="Derivative liabilities"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1806"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--DerivativeFinancialLiabilities_iI_pn3n3_c20241231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--FairValueMember__ifrs-full--ClassesOfAssetsAxis__custom--FinancialAssetsMember__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_fKCop_zr77jOnLAXvc" title="Derivative liabilities"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1808"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--DerivativeFinancialLiabilities_iI_pn3n3_c20241231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--FairValueMember__ifrs-full--ClassesOfAssetsAxis__custom--FinancialAssetsMember__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_fKCop_zR2RgVLpW8q1" title="Derivative liabilities"&gt;1,473,823&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--DerivativeFinancialLiabilities_iI_pn3n3_c20241231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--FairValueMember__ifrs-full--ClassesOfAssetsAxis__custom--FinancialAssetsMember_fKCop_z4jsd29eLW3c" title="Derivative liabilities"&gt;1,473,823&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;div style="width: 25%; margin-left: 0; margin-right: auto"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td id="xdx_F0B_zXlAqp4QpRmj" style="width: 0.25in; text-align: left"&gt;(*)&lt;/td&gt;
    &lt;td id="xdx_F19_zwnj743xQPMi" style="text-align: justify"&gt;Represents the early redemption rights of the issuer and the investor, which are embedded derivatives of bonds with warrants issued to fund the operations.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AC_zj936pMaCtik" style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

















&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.25in; text-align: left"&gt;&lt;b&gt;B.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;&lt;b&gt;Measurement of fair values&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Fair values are categorized into different levels in a fair value hierarchy based on the inputs used in the valuation techniques as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&#x25cf;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;Level 1: quoted prices (unadjusted) in active markets for identical assets or liabilities.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&#x25cf;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;Level 2: all inputs other than quoted prices included in Level 1 that are observable (either directly that is, prices, or indirectly that is, derived from prices) for the asset or liability.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&#x25cf;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;Level 3: unobservable inputs for the asset or liability.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The fair value of financial instruments traded in an active market is determined based on the quoted market price as of the end of the reporting period. If the quoted prices are readily and regularly available through exchanges, sellers, brokers, industry groups, rating agencies, or regulators and such prices represent actual market transactions that occur regularly between independent parties, they are considered active markets.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The fair value of financial instruments that are not traded in an active market is determined using valuation techniques. These valuation techniques use as much market observable information as possible and use the least amount of the entity-specific information. At this time, if all the significant input variables required to measure the fair value are observable, the financial instruments are classified as Level 2.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;If one or more significant input variable is not based on observable market information, the item is included in Level 3.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company recognizes the bond with warrants as financial liabilities measured at amortized cost. Also, The Company recognizes the early redemption rights of the issuer and the bondholders as financial liabilities measured at FVTPL. In addition, the detachable warrants are assessed separately and are classified either as equity instruments when the fixed-for-fixed condition is met, or as derivative liabilities measured at fair value through profit or loss when the equity classification criteria are not met.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Warrants are subsequently reclassified from derivative financial liabilities to equity instruments when the exercise price is determined and the fixed-for-fixed condition is met. On the reclassification date, the derivative warrant liability is remeasured at fair value using the applicable valuation technique, including the Company&#x2019;s credit risk rate, and the resulting amount is transferred to equity. Following reclassification, the warrants are not subsequently remeasured.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company uses various valuation methods to determine the fair value of financial instruments that are not traded in an active market. The valuation methods applied to each derivative financial liability reflects the nature and payoff structure of the underlying instrument. Option-like instruments whose value is significantly affected by the volatility of the Company&#x2019;s equity price are measured using option pricing models such as the Binomial Model, whereas derivative financial liabilities with deterministic cash flows, such as early redemption rights, are measured using the discounted present value method. The fair value of the Company&#x2019;s common share was estimated using the backsolve method, a form of the subject company transaction method, wherein the equity value for a privately held company is derived from a recent transaction in the company&#x2019;s own securities. Early redemption rights recognized as derivative financial liabilities are measured using the discounted present value method. For early redemption rights, the Company applies a discounted cash flow model using a with-and-without approach. Inputs used to such valuation methods include interest rate and risk premium, and the Company performs valuation using the inputs which are consistent with the natures of assets and liabilities measured.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

















&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Assumptions to value the warrants used in level 3 fair value measurements as of December&#160;31, 2025 and 2024 are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89C_ecustom--AssumptionsToValueWarrantsUsedTableTextBlock_pn3n3_zkenpGM44zoc" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Financial Instruments - Fair values and risk management (Details 1)"&gt;
  &lt;tr style="background-color: #FFFFFF"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span id="xdx_8BA_zioSpbp7sBa" style="display: none"&gt;Assumptions to value the warrants used&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: middle; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: middle; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: top; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: middle; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: middle; width: 61%; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: middle; text-align: center; width: 1%; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; vertical-align: bottom; text-align: center; width: 18%"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; text-align: center; width: 2%; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; vertical-align: bottom; text-align: center; width: 18%"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;b&gt;Early redemption rights&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: middle; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: top; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom; padding-left: 0.25in; text-indent: -0.125in"&gt;Risk-adjusted discount&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: middle; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: middle; text-align: center"&gt;&lt;span id="xdx_900_ecustom--RiskadjustedDiscount_iI_pid_c20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zDYKbPQ0cpd5" title="Risk-adjusted discount"&gt;12.60%&lt;/span&gt; ~ &lt;span id="xdx_90A_ecustom--RiskadjustedDiscount_iI_pid_c20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zW2NMTuOfLQb" title="Risk-adjusted discount"&gt;19.80%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: top; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: middle; text-align: center"&gt;&lt;span id="xdx_90E_ecustom--RiskadjustedDiscount_iI_pid_c20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zjNRKoRP36oc" title="Risk-adjusted discount"&gt;14.43%&lt;/span&gt; ~ &lt;span id="xdx_90D_ecustom--RiskadjustedDiscount_iI_pid_c20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zKeztRmbVIn7" title="Risk-adjusted discount"&gt;20.17%&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AD_z8QVQXCMaTCa" style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;Sensitivity analysis of changes in unobservable inputs&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Sensitivity analysis of financial instruments is performed to measure favorable and unfavorable changes in the fair value of financial instruments which are affected by unobservable parameters, using a statistical technique. When the fair value is affected by more than one input parameter, the amounts represent the most favorable or most unfavorable outcome. Level 3 financial instruments subject to sensitivity analysis are derivative financial liabilities consisting of early redemption rights and preemptive rights.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Results of the sensitivity analysis of changes in unobservable inputs as of December&#160;31, 2025 and 2024 are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89E_ecustom--ScheduleOfFinancialAssetsClassifiedFairValueMeasurementsTableTextBlock_pn3n3_zkh3BD3PgTE" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Financial Instruments - Fair values and risk management (Details 2)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span id="xdx_8BF_z6PPQcrKvY9h" style="display: none"&gt;Schedule of fair value measurements&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="14" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;December&#160;31, 2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Profit or loss&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Other comprehensive&lt;br/&gt; income or loss&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Favorable&lt;br/&gt; changes&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Unfavorable&lt;br/&gt; changes&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Favorable&lt;br/&gt; changes&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Unfavorable&lt;br/&gt; changes&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="14" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;b&gt;Financial Liabilities&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Derivative financial liability&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.375in; text-indent: -0.125in"&gt;Early redemption rights (*1)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#x20a9;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_903_ecustom--FavorableChanges_iI_pn3n3_c20251231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--EarlyRedemptionRightsMember__custom--IncomeStatementsLocationAxis__custom--ProfitOrLossMember_fKCoxKQ_____zZASNFlcAYl4" title="Favorable changes"&gt;43,698&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_908_ecustom--UnfavorableChanges_iNI_pn3n3_di_c20251231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--EarlyRedemptionRightsMember__custom--IncomeStatementsLocationAxis__custom--ProfitOrLossMember_fKCoxKQ_____z0o8FVK0KoL" title="Unfavorable changes"&gt;(41,087&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_900_ecustom--FavorableChanges_iI_pn3n3_c20251231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--EarlyRedemptionRightsMember__custom--IncomeStatementsLocationAxis__custom--OtherComprehensiveIncomeOrLossMember_fKCoxKQ_____ziGrVdfvORK7" title="Favorable changes"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1845"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_909_ecustom--UnfavorableChanges_iNI_pn3n3_di_c20251231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--EarlyRedemptionRightsMember__custom--IncomeStatementsLocationAxis__custom--OtherComprehensiveIncomeOrLossMember_fKCoxKQ_____zBHzmn05SbNd" title="Unfavorable changes"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1847"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;div style="width: 25%; margin-left: 0; margin-right: auto"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td id="xdx_F09_znkxQZyd6WXf" style="width: 0.25in; text-align: left"&gt;(*1)&lt;/td&gt;
    &lt;td id="xdx_F1B_zgetYMNGG3gb" style="text-align: justify"&gt;For early redemption rights, changes in fair value are calculated by shifting principal unobservable input parameters such as correlation between risk free discount rates (-1%p~1%p).&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="14" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;December&#160;31, 2024&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Profit or loss&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Other comprehensive&lt;br/&gt; income or loss&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Favorable&lt;br/&gt; changes&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Unfavorable&lt;br/&gt; changes&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Favorable&lt;br/&gt; changes&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Unfavorable&lt;br/&gt; changes&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="14" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;b&gt;Financial Liabilities&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right; width: 9%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right; width: 9%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right; width: 9%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right; width: 9%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; width: 1%"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #FFFFFF"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Derivative financial liability&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.375in; text-indent: -0.125in"&gt;Early redemption rights (*1)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#x20a9;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_902_ecustom--FavorableChanges_iI_pn3n3_c20241231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--EarlyRedemptionRightsMember__custom--IncomeStatementsLocationAxis__custom--ProfitOrLossMember_fKCoxKQ_____zZw5LnrWl5Q6" title="Favorable changes"&gt;62,935&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_902_ecustom--UnfavorableChanges_iNI_pn3n3_di_c20241231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--EarlyRedemptionRightsMember__custom--IncomeStatementsLocationAxis__custom--ProfitOrLossMember_fKCoxKQ_____zhtldpwiZdvg" title="Unfavorable changes"&gt;(60,750&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--FavorableChanges_iI_pn3n3_c20241231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--EarlyRedemptionRightsMember__custom--IncomeStatementsLocationAxis__custom--OtherComprehensiveIncomeOrLossMember_fKCoxKQ_____zhRcGDuDSuF8" title="Favorable changes"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1854"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_ecustom--UnfavorableChanges_iNI_pn3n3_di_c20241231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--EarlyRedemptionRightsMember__custom--IncomeStatementsLocationAxis__custom--OtherComprehensiveIncomeOrLossMember_fKCoxKQ_____z8zRes3jD2ql" title="Unfavorable changes"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1856"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;div style="width: 25%; margin-left: 0; margin-right: auto"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td id="xdx_F0F_zRjduiz0MQhc" style="width: 0.25in; text-align: left"&gt;(*1)&lt;/td&gt;
    &lt;td id="xdx_F1B_z3RGJ1O9Jqmk" style="text-align: justify"&gt;For early redemption rights, changes in fair value are calculated by shifting principal unobservable input parameters such as correlation between risk free discount rates (-1%p~1%p).&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A4_zIriVlzxj6D5" style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Amounts recognized in profit or loss and changes in the fair value of derivative liabilities at fair value through profit or loss are included in Note 22.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

















&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.25in; text-align: left"&gt;&lt;b&gt;C.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;&lt;b&gt;Financial risk management&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company&#x2019;s operating activities expose itself to a variety of financial risks: market risk, credit risk, and liquidity risk from which the Company&#x2019;s risk management program focuses on minimizing any adverse effects on its financial performance. The Company operates financial risk management policies and programs that closely monitor and respond to each risk factor.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 0.5in"&gt;i.&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;Credit risk&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Credit risk is the risk of financial loss to the Company if a counterparty to a financial instrument fails to meet its contractual obligations and arises principally from the Company&#x2019;s loans to borrowers. To manage credit risk, the Company regularly evaluates the creditworthiness of each borrower or counterparty considering the party&#x2019;s collateral provided, past experience, its own trading records, and other factors. Regarding the impairment of financial assets subsequent to initial recognition, the Company recognizes the impairment in respect of loans less the amount of the fair value of the collateral provided in profit or loss at each reporting date. As of December&#160;31, 2025, the Company holds the collateral of 660,000 shares of the Company&#x2019;s common stock pledged as security for amounts of long-term loans receivable. The carrying amount of a financial asset represents the maximum exposure to credit risk.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Long-term refundable deposits included in other non-current financial assets are non-interest-bearing, and therefore the Company measures them at amortized cost. The contractual refund amount is discounted to its present value using a discount rate derived from market yields of unsecured corporate bonds with similar maturities and counterparty credit risk. The resulting discount is amortized over the expected deposit period using the effective interest method.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company&#x2019;s maximum exposure to credit risk as of December&#160;31, 2025 and 2024 is as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--FinancialAssetsAndLiabilitiesExposedToCreditRiskTableTextBlock_zbNzMjnQ26k5" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Financial Instruments - Fair values and risk management (Details 3)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_8B5_zk2c2P9NCtRf" style="display: none"&gt;Financial assets and liabilities exposed to credit risk&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49D_20251231_zGjOroiCH5mc" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49B_20241231_zPlEMGVFnwP1" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2024&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40A_eifrs-full--CashAndCashEquivalents_iI_z8liOm5OmTe3" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Cash and cash equivalents&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;335,814&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;3,662,174&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--CurrentPortionOfLongtermBankDeposits_iI_zLLfEKCY9zvi" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Current portion of long-term bank deposits&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;30,000&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1872"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--ShorttermLoanReceivableRelatedPartiesNet_iI_pn3n3_zi0mfvvzNK59" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Short-term loan receivable &#x2013; related parties, net&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;442,894&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;214,245&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_401_eifrs-full--OtherReceivables_iI_ziYaLCRk7wkk" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Other receivables&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;33,411&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;202,477&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--LongtermBankDeposit_iI_zdrCwGf3tcNa" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Long-term bank deposit&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1880"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;30,000&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--LongtermLoanReceivablesNet_iI_z7hhcfaZbNSf" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Long-term loan receivable, net&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;1,671,780&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;1,917,960&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--LongtermOtherReceivablesNet_iI_zH9P2iM5lIG6" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Long-term other receivables, net&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1886"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;2,065&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_406_eifrs-full--OtherNoncurrentFinancialAssets_iI_z8yybqBjndT3" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Other non-current financial assets&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;525,042&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;473,682&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--TotalCreditRisk_iI_z2cQa6xVOLWd" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; vertical-align: top; padding-left: 0.125in; padding-bottom: 1.25pt"&gt;Total&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;3,038,941&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;6,502,603&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A6_zPQTI6sM0L4e" style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Cash and cash equivalents and current portion of long-term bank deposits are deposited in financial institutions with strong credit ratings.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

















&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 0.5in; text-align: left"&gt;ii.&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;Liquidity risk&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Liquidity risk management includes the maintenance of sufficient cash and marketable securities, the availability of funds from appropriately committed credit lines, and the ability to settle market positions.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Financial liabilities of the Company by maturity according to the remaining period from December&#160;31, 2025 and 2024 to the contractual maturity date are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_890_ecustom--FinancialLiabilitiesOfCompanyByMaturityTableTextBlock_pn3n3_zXKJidu7VOHk" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Financial Instruments - Fair values and risk management (Details 4)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span id="xdx_8B9_zXvGAlfXM5Re" style="display: none"&gt;Financial liabilities of company by maturity&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49A_20251231__ifrs-full--ClassesOfLiabilitiesAxis__ifrs-full--CarryingAmountMember_zShjttWvqxne" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49E_20251231__ifrs-full--ClassesOfLiabilitiesAxis__custom--FinancialLiabilityMember__ifrs-full--MaturityAxis__custom--LessThan3MonthsMember_zBgjT19YnQLc" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_492_20251231__ifrs-full--ClassesOfLiabilitiesAxis__custom--FinancialLiabilityMember__ifrs-full--MaturityAxis__custom--N3Months1YearMember_zBynD50lvAK" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_499_20251231__ifrs-full--ClassesOfLiabilitiesAxis__custom--FinancialLiabilityMember__ifrs-full--MaturityAxis__custom--N1To2YearsMember_zVsONKyGLjQ1" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49D_20251231__ifrs-full--ClassesOfLiabilitiesAxis__custom--FinancialLiabilityMember__ifrs-full--MaturityAxis__custom--N2To5YearsMember_zxZwDL8Lt2D9" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49E_20251231__ifrs-full--ClassesOfLiabilitiesAxis__custom--FinancialLiabilityMember__ifrs-full--MaturityAxis__custom--MoreThan5YearsMember_zOC6RdHeVa9l" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_492_20251231__ifrs-full--ClassesOfLiabilitiesAxis__custom--FinancialLiabilityMember_zbUPt45Clytf" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="26" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;December&#160;31, 2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Carrying&lt;br/&gt;amount&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Less than&lt;br/&gt;3 months&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;3 months&lt;br/&gt;~ 1 year&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;1~2 years&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2~5 years&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;More than&lt;br/&gt;5 years&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="26" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr id="xdx_406_eifrs-full--DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesAbstract_iB_zTEfCuvMVi0k" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;th colspan="31" style="font: 10pt Times New Roman; padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&lt;b&gt;Financial liabilities&lt;/b&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--AccountsPayable_iI_z8iqqqf7voyf" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; width: 28%"&gt;Accounts
    payable &lt;span id="xdx_F44_z5eDmhEwiX85"&gt;(*)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 7%; text-align: right"&gt;1,374,936&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 7%; text-align: right"&gt;1,006,436&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 7%; text-align: right"&gt;368,500&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 7%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1915"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 7%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1916"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 7%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1917"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 7%; text-align: right"&gt;1,374,936&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--BondWithWarrants_iI_zOK6QjdY7kbh" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Bond with warrants&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;4,533,113&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;3,232,801&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;3,000,000&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1923"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1924"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1925"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;6,232,801&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_404_eifrs-full--LeaseLiabilities_iI_zdtdKL5eKo28" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Lease liabilities&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;552,631&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;40,932&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;122,795&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;146,965&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;350,746&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1933"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;661,438&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_405_eifrs-full--FinancialLiabilities_iI_zeJfWslp3gye" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; vertical-align: top; padding-left: 0.125in; padding-bottom: 1.25pt"&gt;Total&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;6,460,680&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;4,280,169&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;3,491,295&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;146,965&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;350,746&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1941"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;8,269,175&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;div style="width: 25%; margin-left: 0; margin-right: auto"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td id="xdx_F08_zVtlsWCeG13" style="width: 0.25in; text-align: left"&gt;(*)&lt;/td&gt;
    &lt;td id="xdx_F11_zedqA1y1q5rd" style="text-align: justify"&gt;Accounts payable that are not financial liabilities are excluded.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49D_20241231__ifrs-full--ClassesOfLiabilitiesAxis__ifrs-full--CarryingAmountMember_zmUx8i1nywPh" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49D_20241231__ifrs-full--ClassesOfLiabilitiesAxis__custom--FinancialLiabilityMember__ifrs-full--MaturityAxis__custom--LessThan3MonthsMember_ztuddTAvPH22" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49E_20241231__ifrs-full--ClassesOfLiabilitiesAxis__custom--FinancialLiabilityMember__ifrs-full--MaturityAxis__custom--N3Months1YearMember_zVyQYCppTweh" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_495_20241231__ifrs-full--ClassesOfLiabilitiesAxis__custom--FinancialLiabilityMember__ifrs-full--MaturityAxis__custom--N1To2YearsMember_zj7Zf0zLKmxk" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49E_20241231__ifrs-full--ClassesOfLiabilitiesAxis__custom--FinancialLiabilityMember__ifrs-full--MaturityAxis__custom--N2To5YearsMember_zYVxiLK14n9a" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_498_20241231__ifrs-full--ClassesOfLiabilitiesAxis__custom--FinancialLiabilityMember__ifrs-full--MaturityAxis__custom--MoreThan5YearsMember_z5fLF8m4zdGc" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49D_20241231__ifrs-full--ClassesOfLiabilitiesAxis__custom--FinancialLiabilityMember_zZCO8DA3ecB5" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="26" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;December&#160;31, 2024&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Carrying&lt;br/&gt;amount&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Less than&lt;br/&gt;3 months&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;3 months&lt;br/&gt;~ 1 year&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;1~2 years&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2~5 years&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;More than&lt;br/&gt;5 years&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="26" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr id="xdx_405_eifrs-full--DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesAbstract_iB_zl0ZMp7T8B72" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;th colspan="31" style="font: 10pt Times New Roman; padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&lt;b&gt;Financial liabilities&lt;/b&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--AccountsPayable_iI_zCrdmqyuX5zk" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; width: 28%"&gt;Accounts
    payable &lt;span id="xdx_F46_z5Cabjx0zWrb"&gt;(*)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 7%; text-align: right"&gt;996,719&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 7%; text-align: right"&gt;504,909&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 7%; text-align: right"&gt;491,810&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 7%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1956"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 7%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1957"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 7%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1958"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 7%; text-align: right"&gt;996,719&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--BondWithWarrants_iI_zYiJJeF5AK5j" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Bond with warrants&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;4,992,962&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;6,648,823&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1963"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1964"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1965"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1966"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;6,648,823&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_404_eifrs-full--LeaseLiabilities_iI_z3AhyD8z8IQc" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Lease liabilities&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;669,032&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;42,602&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;126,605&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;163,206&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;418,494&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;79,086&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;829,993&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--FinancialLiabilities_iI_znzSLTkHb2L3" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; vertical-align: top; padding-left: 0.125in; padding-bottom: 1.25pt"&gt;Total&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;6,658,713&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;7,196,334&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;618,415&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;163,206&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;418,494&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;79,086&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;8,475,535&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;div style="width: 25%; margin-left: 0; margin-right: auto"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td id="xdx_F0A_zVHLVRDiogJj" style="width: 0.25in; text-align: left"&gt;(*)&lt;/td&gt;
    &lt;td id="xdx_F1B_z0z6rzODzJm7" style="text-align: justify"&gt;Accounts payable that are not financial liabilities are excluded.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A0_zoeW5k1rfJx9" style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 0.5in; text-align: left"&gt;iii.&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;Market risk&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company is exposed to foreign exchange risk arising from cash equivalents denominated in USD.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

















&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Financial assets and liabilities exposed to foreign currency risk as of December&#160;31, 2025 and 2024 are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_892_ecustom--FinancialAssetsAndLiabilitiesExposedToForeignCurrencyRiskTableTextBlock_z7IonPb9QfOl" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Financial Instruments - Fair values and risk management (Details 5)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&lt;span id="xdx_8B1_zi3rGEfOn4v9" style="display: none"&gt;Financial assets and liabilities exposed to foreign currency risk&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Assets in&lt;br/&gt; foreign&lt;br/&gt; currency&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Assets in&lt;br/&gt; Korean won&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(Individual amounts in each foreign currency)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;USD&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_901_ecustom--AssetsInForeignCurrency_iI_pn3n3_uUSD_c20251231_zTYcrB0FlwI3" title="Assets in foreign currency"&gt;41,258&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--FinancialAsset_iI_pn3n3_c20251231_z4QxPtbZeV82" title="Assets"&gt;59,201&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2024&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Assets in&lt;br/&gt; foreign&lt;br/&gt; currency&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Assets in&lt;br/&gt; Korean won&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(Individual amounts in each foreign currency)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;USD&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--AssetsInForeignCurrency_iI_pn3n3_uUSD_c20241231_zChCsK9LYBXb" title="Assets in foreign currency"&gt;39,877&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_901_ecustom--FinancialAsset_iI_pn3n3_c20241231_z2cZJgSTIuWk" title="Assets"&gt;58,619&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AD_zw59I2DBLnhi" style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company measures foreign exchange risk as a 10% fluctuation in the exchange rate of each foreign currency, which reflects the management&#x2019;s assessment of the risk of exchange rate fluctuation that can reasonably occur. The impact of a 10% fluctuation in foreign currency exchange rates on the Company&#x2019;s profit or loss (before income tax effects) for the year ended December&#160;31, 2025 and 2024 is as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89F_ecustom--ImpactOfFluctuationInForeignCurrencyExchangeRatesTableTextBlock_pn3n3_zRBjCnu3qWla" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Financial Instruments - Fair values and risk management (Details 6)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&lt;span id="xdx_8B8_zx4BGmQ5eFJ2" style="display: none"&gt;Impact of fluctuation in foreign currency exchange rates&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="font: 10pt Times New Roman; text-align: center"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="font: 10pt Times New Roman; text-align: center"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="font: 10pt Times New Roman; text-align: center"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="font: 10pt Times New Roman; text-align: center"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2024&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Increased&#160;by&lt;br/&gt; 10%&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Decreased&#160;by&lt;br/&gt; 10%&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Increased&#160;by&lt;br/&gt; 10%&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Decreased&#160;by&lt;br/&gt; 10%&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="14" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Discount rate&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_909_ecustom--DiscountRateIncreased_pn3n3_c20250101__20251231_z4jIYFfto9Qj" title="Discount rate increased by 10%"&gt;5,920&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_905_ecustom--DiscountRateDecreased_iN_pn3n3_di_c20250101__20251231_zVPjCyvvgDx5" title="Discount rate decreased by 10%"&gt;(5,920&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--DiscountRateIncreased_pn3n3_c20240101__20241231_zQ7R1JE5zZXh" title="Discount rate increased by 10%"&gt;5,862&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_909_ecustom--DiscountRateDecreased_iN_pn3n3_di_c20240101__20241231_zcpJz1mvOT4b" title="Discount rate decreased by 10%"&gt;(5,862&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AB_zqtHWk4MR06a" style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The sensitivity analysis is based on monetary assets and liabilities denominated in foreign currencies other than the functional currency as of the end of the reporting period.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

















</ifrs-full:DisclosureOfFinancialInstrumentsHeldForTradingExplanatory>
    <cik0002058261:ScheduleOfFinancialAssetsAndLiabilityFairValueTableTextBlock
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact001788">&lt;table cellpadding="0" cellspacing="0" id="xdx_891_ecustom--ScheduleOfFinancialAssetsAndLiabilityFairValueTableTextBlock_pn3n3_z2zeYbua9h3k" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Financial Instruments - Fair values and risk management (Details)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_8BB_z3WYvupG3mol" style="display: none"&gt;Schedule of financial assets and liability at fair value&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="22" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Carrying amount&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Fair value&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Level 1&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Level 2&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Level 3&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="22" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; width: 38%"&gt;&lt;b&gt;Financial liabilities at fair value through profit or loss&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 7%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 7%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 7%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 7%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 7%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 7%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Derivative liabilities (*)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#x20a9;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--DerivativeFinancialLiabilities_iI_pn3n3_c20251231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--CarryingAmountMember_fKCop_zOyJIP88qSNk" title="Derivative liabilities"&gt;1,267,801&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--DerivativeFinancialLiabilities_iI_pn3n3_c20251231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--FairValueMember_fKCop_zFxRFI4NnKc9" title="Derivative liabilities"&gt;1,267,801&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--DerivativeFinancialLiabilities_iI_pn3n3_c20251231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--FairValueMember__ifrs-full--ClassesOfAssetsAxis__custom--FinancialAssetsMember__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level1OfFairValueHierarchyMember_fKCop_zgQ4n1SxZ0E" title="Derivative liabilities"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1794"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--DerivativeFinancialLiabilities_iI_pn3n3_c20251231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--FairValueMember__ifrs-full--ClassesOfAssetsAxis__custom--FinancialAssetsMember__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_fKCop_zf8X037cGQui" title="Derivative liabilities"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1796"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--DerivativeFinancialLiabilities_iI_pn3n3_c20251231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--FairValueMember__ifrs-full--ClassesOfAssetsAxis__custom--FinancialAssetsMember__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_fKCop_zgkJk2sYCsI6" title="Derivative liabilities"&gt;1,267,801&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--DerivativeFinancialLiabilities_iI_pn3n3_c20251231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--FairValueMember__ifrs-full--ClassesOfAssetsAxis__custom--FinancialAssetsMember_fKCop_zvNQnaoKqDY" title="Derivative liabilities"&gt;1,267,801&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;div style="width: 25%; margin-left: 0; margin-right: auto"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;(*)&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;Represents the early redemption rights of the issuer and the investor, which are embedded derivatives of bonds with warrants issued to fund the operations.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="22" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Carrying amount&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Fair value&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Level 1&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Level 2&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Level 3&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="22" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; width: 38%"&gt;&lt;b&gt;Financial liabilities at fair value through profit or loss&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 7%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 7%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 7%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 7%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 7%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 7%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Derivative liabilities (*)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#x20a9;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--DerivativeFinancialLiabilities_iI_pn3n3_c20241231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--CarryingAmountMember_fKCop_zbObmBAeZH9" title="Derivative liabilities"&gt;1,473,823&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--DerivativeFinancialLiabilities_iI_pn3n3_c20241231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--FairValueMember_fKCop_zTyCFV0Tzwj7" title="Derivative liabilities"&gt;1,473,823&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--DerivativeFinancialLiabilities_iI_pn3n3_c20241231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--FairValueMember__ifrs-full--ClassesOfAssetsAxis__custom--FinancialAssetsMember__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level1OfFairValueHierarchyMember_fKCop_zxTKTbmX6i46" title="Derivative liabilities"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1806"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--DerivativeFinancialLiabilities_iI_pn3n3_c20241231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--FairValueMember__ifrs-full--ClassesOfAssetsAxis__custom--FinancialAssetsMember__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_fKCop_zr77jOnLAXvc" title="Derivative liabilities"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1808"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--DerivativeFinancialLiabilities_iI_pn3n3_c20241231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--FairValueMember__ifrs-full--ClassesOfAssetsAxis__custom--FinancialAssetsMember__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_fKCop_zR2RgVLpW8q1" title="Derivative liabilities"&gt;1,473,823&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--DerivativeFinancialLiabilities_iI_pn3n3_c20241231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--FairValueMember__ifrs-full--ClassesOfAssetsAxis__custom--FinancialAssetsMember_fKCop_z4jsd29eLW3c" title="Derivative liabilities"&gt;1,473,823&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;div style="width: 25%; margin-left: 0; margin-right: auto"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td id="xdx_F0B_zXlAqp4QpRmj" style="width: 0.25in; text-align: left"&gt;(*)&lt;/td&gt;
    &lt;td id="xdx_F19_zwnj743xQPMi" style="text-align: justify"&gt;Represents the early redemption rights of the issuer and the investor, which are embedded derivatives of bonds with warrants issued to fund the operations.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:ScheduleOfFinancialAssetsAndLiabilityFairValueTableTextBlock>
    <ifrs-full:DerivativeFinancialLiabilities
      contextRef="AsOf2025-12-31_ifrs-full_CarryingAmountMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001790"
      unitRef="KRW">1267801000</ifrs-full:DerivativeFinancialLiabilities>
    <ifrs-full:DerivativeFinancialLiabilities
      contextRef="AsOf2025-12-31_custom_FairValueMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001792"
      unitRef="KRW">1267801000</ifrs-full:DerivativeFinancialLiabilities>
    <ifrs-full:DerivativeFinancialLiabilities
      contextRef="AsOf2025-12-31_custom_FairValueMember_custom_FinancialAssetsMember_ifrs-full_Level3OfFairValueHierarchyMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001798"
      unitRef="KRW">1267801000</ifrs-full:DerivativeFinancialLiabilities>
    <ifrs-full:DerivativeFinancialLiabilities
      contextRef="AsOf2025-12-31_custom_FairValueMember_custom_FinancialAssetsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001800"
      unitRef="KRW">1267801000</ifrs-full:DerivativeFinancialLiabilities>
    <ifrs-full:DerivativeFinancialLiabilities
      contextRef="AsOf2024-12-31_ifrs-full_CarryingAmountMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001802"
      unitRef="KRW">1473823000</ifrs-full:DerivativeFinancialLiabilities>
    <ifrs-full:DerivativeFinancialLiabilities
      contextRef="AsOf2024-12-31_custom_FairValueMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001804"
      unitRef="KRW">1473823000</ifrs-full:DerivativeFinancialLiabilities>
    <ifrs-full:DerivativeFinancialLiabilities
      contextRef="AsOf2024-12-31_custom_FairValueMember_custom_FinancialAssetsMember_ifrs-full_Level3OfFairValueHierarchyMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001810"
      unitRef="KRW">1473823000</ifrs-full:DerivativeFinancialLiabilities>
    <ifrs-full:DerivativeFinancialLiabilities
      contextRef="AsOf2024-12-31_custom_FairValueMember_custom_FinancialAssetsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001812"
      unitRef="KRW">1473823000</ifrs-full:DerivativeFinancialLiabilities>
    <cik0002058261:AssumptionsToValueWarrantsUsedTableTextBlock
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact001829">&lt;table cellpadding="0" cellspacing="0" id="xdx_89C_ecustom--AssumptionsToValueWarrantsUsedTableTextBlock_pn3n3_zkenpGM44zoc" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Financial Instruments - Fair values and risk management (Details 1)"&gt;
  &lt;tr style="background-color: #FFFFFF"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span id="xdx_8BA_zioSpbp7sBa" style="display: none"&gt;Assumptions to value the warrants used&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: middle; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: middle; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: top; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: middle; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: middle; width: 61%; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: middle; text-align: center; width: 1%; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; vertical-align: bottom; text-align: center; width: 18%"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; text-align: center; width: 2%; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; vertical-align: bottom; text-align: center; width: 18%"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;b&gt;Early redemption rights&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: middle; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: top; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom; padding-left: 0.25in; text-indent: -0.125in"&gt;Risk-adjusted discount&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: middle; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: middle; text-align: center"&gt;&lt;span id="xdx_900_ecustom--RiskadjustedDiscount_iI_pid_c20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zDYKbPQ0cpd5" title="Risk-adjusted discount"&gt;12.60%&lt;/span&gt; ~ &lt;span id="xdx_90A_ecustom--RiskadjustedDiscount_iI_pid_c20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zW2NMTuOfLQb" title="Risk-adjusted discount"&gt;19.80%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: top; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: middle; text-align: center"&gt;&lt;span id="xdx_90E_ecustom--RiskadjustedDiscount_iI_pid_c20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zjNRKoRP36oc" title="Risk-adjusted discount"&gt;14.43%&lt;/span&gt; ~ &lt;span id="xdx_90D_ecustom--RiskadjustedDiscount_iI_pid_c20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zKeztRmbVIn7" title="Risk-adjusted discount"&gt;20.17%&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:AssumptionsToValueWarrantsUsedTableTextBlock>
    <cik0002058261:RiskadjustedDiscount
      contextRef="AsOf2025-12-31_ifrs-full_Level3OfFairValueHierarchyMember_ifrs-full_BottomOfRangeMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact001831"
      unitRef="Pure">0.1260</cik0002058261:RiskadjustedDiscount>
    <cik0002058261:RiskadjustedDiscount
      contextRef="AsOf2025-12-31_ifrs-full_Level3OfFairValueHierarchyMember_ifrs-full_TopOfRangeMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact001833"
      unitRef="Pure">0.1980</cik0002058261:RiskadjustedDiscount>
    <cik0002058261:RiskadjustedDiscount
      contextRef="AsOf2024-12-31_ifrs-full_Level3OfFairValueHierarchyMember_ifrs-full_BottomOfRangeMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact001835"
      unitRef="Pure">0.1443</cik0002058261:RiskadjustedDiscount>
    <cik0002058261:RiskadjustedDiscount
      contextRef="AsOf2024-12-31_ifrs-full_Level3OfFairValueHierarchyMember_ifrs-full_TopOfRangeMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact001837"
      unitRef="Pure">0.2017</cik0002058261:RiskadjustedDiscount>
    <cik0002058261:ScheduleOfFinancialAssetsClassifiedFairValueMeasurementsTableTextBlock
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact001839">&lt;table cellpadding="0" cellspacing="0" id="xdx_89E_ecustom--ScheduleOfFinancialAssetsClassifiedFairValueMeasurementsTableTextBlock_pn3n3_zkh3BD3PgTE" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Financial Instruments - Fair values and risk management (Details 2)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span id="xdx_8BF_z6PPQcrKvY9h" style="display: none"&gt;Schedule of fair value measurements&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="14" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;December&#160;31, 2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Profit or loss&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Other comprehensive&lt;br/&gt; income or loss&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Favorable&lt;br/&gt; changes&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Unfavorable&lt;br/&gt; changes&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Favorable&lt;br/&gt; changes&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Unfavorable&lt;br/&gt; changes&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="14" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;b&gt;Financial Liabilities&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Derivative financial liability&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.375in; text-indent: -0.125in"&gt;Early redemption rights (*1)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#x20a9;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_903_ecustom--FavorableChanges_iI_pn3n3_c20251231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--EarlyRedemptionRightsMember__custom--IncomeStatementsLocationAxis__custom--ProfitOrLossMember_fKCoxKQ_____zZASNFlcAYl4" title="Favorable changes"&gt;43,698&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_908_ecustom--UnfavorableChanges_iNI_pn3n3_di_c20251231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--EarlyRedemptionRightsMember__custom--IncomeStatementsLocationAxis__custom--ProfitOrLossMember_fKCoxKQ_____z0o8FVK0KoL" title="Unfavorable changes"&gt;(41,087&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_900_ecustom--FavorableChanges_iI_pn3n3_c20251231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--EarlyRedemptionRightsMember__custom--IncomeStatementsLocationAxis__custom--OtherComprehensiveIncomeOrLossMember_fKCoxKQ_____ziGrVdfvORK7" title="Favorable changes"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1845"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_909_ecustom--UnfavorableChanges_iNI_pn3n3_di_c20251231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--EarlyRedemptionRightsMember__custom--IncomeStatementsLocationAxis__custom--OtherComprehensiveIncomeOrLossMember_fKCoxKQ_____zBHzmn05SbNd" title="Unfavorable changes"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1847"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;div style="width: 25%; margin-left: 0; margin-right: auto"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td id="xdx_F09_znkxQZyd6WXf" style="width: 0.25in; text-align: left"&gt;(*1)&lt;/td&gt;
    &lt;td id="xdx_F1B_zgetYMNGG3gb" style="text-align: justify"&gt;For early redemption rights, changes in fair value are calculated by shifting principal unobservable input parameters such as correlation between risk free discount rates (-1%p~1%p).&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="14" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;December&#160;31, 2024&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Profit or loss&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Other comprehensive&lt;br/&gt; income or loss&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Favorable&lt;br/&gt; changes&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Unfavorable&lt;br/&gt; changes&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Favorable&lt;br/&gt; changes&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Unfavorable&lt;br/&gt; changes&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="14" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;b&gt;Financial Liabilities&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right; width: 9%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right; width: 9%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right; width: 9%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right; width: 9%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; width: 1%"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #FFFFFF"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Derivative financial liability&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.375in; text-indent: -0.125in"&gt;Early redemption rights (*1)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#x20a9;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_902_ecustom--FavorableChanges_iI_pn3n3_c20241231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--EarlyRedemptionRightsMember__custom--IncomeStatementsLocationAxis__custom--ProfitOrLossMember_fKCoxKQ_____zZw5LnrWl5Q6" title="Favorable changes"&gt;62,935&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_902_ecustom--UnfavorableChanges_iNI_pn3n3_di_c20241231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--EarlyRedemptionRightsMember__custom--IncomeStatementsLocationAxis__custom--ProfitOrLossMember_fKCoxKQ_____zhtldpwiZdvg" title="Unfavorable changes"&gt;(60,750&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--FavorableChanges_iI_pn3n3_c20241231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--EarlyRedemptionRightsMember__custom--IncomeStatementsLocationAxis__custom--OtherComprehensiveIncomeOrLossMember_fKCoxKQ_____zhRcGDuDSuF8" title="Favorable changes"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1854"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_ecustom--UnfavorableChanges_iNI_pn3n3_di_c20241231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--EarlyRedemptionRightsMember__custom--IncomeStatementsLocationAxis__custom--OtherComprehensiveIncomeOrLossMember_fKCoxKQ_____z8zRes3jD2ql" title="Unfavorable changes"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1856"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;div style="width: 25%; margin-left: 0; margin-right: auto"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td id="xdx_F0F_zRjduiz0MQhc" style="width: 0.25in; text-align: left"&gt;(*1)&lt;/td&gt;
    &lt;td id="xdx_F1B_z3RGJ1O9Jqmk" style="text-align: justify"&gt;For early redemption rights, changes in fair value are calculated by shifting principal unobservable input parameters such as correlation between risk free discount rates (-1%p~1%p).&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:ScheduleOfFinancialAssetsClassifiedFairValueMeasurementsTableTextBlock>
    <cik0002058261:FavorableChanges
      contextRef="AsOf2025-12-31_custom_EarlyRedemptionRightsMember_custom_ProfitOrLossMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001841"
      unitRef="KRW">43698000</cik0002058261:FavorableChanges>
    <cik0002058261:UnfavorableChanges
      contextRef="AsOf2025-12-31_custom_EarlyRedemptionRightsMember_custom_ProfitOrLossMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001843"
      unitRef="KRW">41087000</cik0002058261:UnfavorableChanges>
    <cik0002058261:FavorableChanges
      contextRef="AsOf2024-12-31_custom_EarlyRedemptionRightsMember_custom_ProfitOrLossMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001850"
      unitRef="KRW">62935000</cik0002058261:FavorableChanges>
    <cik0002058261:UnfavorableChanges
      contextRef="AsOf2024-12-31_custom_EarlyRedemptionRightsMember_custom_ProfitOrLossMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001852"
      unitRef="KRW">60750000</cik0002058261:UnfavorableChanges>
    <cik0002058261:FinancialAssetsAndLiabilitiesExposedToCreditRiskTableTextBlock
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact001866">&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--FinancialAssetsAndLiabilitiesExposedToCreditRiskTableTextBlock_zbNzMjnQ26k5" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Financial Instruments - Fair values and risk management (Details 3)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_8B5_zk2c2P9NCtRf" style="display: none"&gt;Financial assets and liabilities exposed to credit risk&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49D_20251231_zGjOroiCH5mc" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49B_20241231_zPlEMGVFnwP1" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2024&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40A_eifrs-full--CashAndCashEquivalents_iI_z8liOm5OmTe3" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Cash and cash equivalents&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;335,814&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;3,662,174&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--CurrentPortionOfLongtermBankDeposits_iI_zLLfEKCY9zvi" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Current portion of long-term bank deposits&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;30,000&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1872"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--ShorttermLoanReceivableRelatedPartiesNet_iI_pn3n3_zi0mfvvzNK59" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Short-term loan receivable &#x2013; related parties, net&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;442,894&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;214,245&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_401_eifrs-full--OtherReceivables_iI_ziYaLCRk7wkk" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Other receivables&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;33,411&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;202,477&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--LongtermBankDeposit_iI_zdrCwGf3tcNa" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Long-term bank deposit&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1880"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;30,000&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--LongtermLoanReceivablesNet_iI_z7hhcfaZbNSf" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Long-term loan receivable, net&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;1,671,780&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;1,917,960&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--LongtermOtherReceivablesNet_iI_zH9P2iM5lIG6" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Long-term other receivables, net&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1886"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;2,065&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_406_eifrs-full--OtherNoncurrentFinancialAssets_iI_z8yybqBjndT3" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Other non-current financial assets&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;525,042&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;473,682&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--TotalCreditRisk_iI_z2cQa6xVOLWd" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; vertical-align: top; padding-left: 0.125in; padding-bottom: 1.25pt"&gt;Total&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;3,038,941&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;6,502,603&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:FinancialAssetsAndLiabilitiesExposedToCreditRiskTableTextBlock>
    <ifrs-full:CashAndCashEquivalents
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001868"
      unitRef="KRW">335814000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001869"
      unitRef="KRW">3662174000</ifrs-full:CashAndCashEquivalents>
    <cik0002058261:CurrentPortionOfLongtermBankDeposits
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001871"
      unitRef="KRW">30000000</cik0002058261:CurrentPortionOfLongtermBankDeposits>
    <cik0002058261:ShorttermLoanReceivableRelatedPartiesNet
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001874"
      unitRef="KRW">442894000</cik0002058261:ShorttermLoanReceivableRelatedPartiesNet>
    <cik0002058261:ShorttermLoanReceivableRelatedPartiesNet
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001875"
      unitRef="KRW">214245000</cik0002058261:ShorttermLoanReceivableRelatedPartiesNet>
    <ifrs-full:OtherReceivables
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001877"
      unitRef="KRW">33411000</ifrs-full:OtherReceivables>
    <ifrs-full:OtherReceivables
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001878"
      unitRef="KRW">202477000</ifrs-full:OtherReceivables>
    <cik0002058261:LongtermBankDeposit
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001881"
      unitRef="KRW">30000000</cik0002058261:LongtermBankDeposit>
    <cik0002058261:LongtermLoanReceivablesNet
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001883"
      unitRef="KRW">1671780000</cik0002058261:LongtermLoanReceivablesNet>
    <cik0002058261:LongtermLoanReceivablesNet
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001884"
      unitRef="KRW">1917960000</cik0002058261:LongtermLoanReceivablesNet>
    <cik0002058261:LongtermOtherReceivablesNet
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001887"
      unitRef="KRW">2065000</cik0002058261:LongtermOtherReceivablesNet>
    <ifrs-full:OtherNoncurrentFinancialAssets
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001889"
      unitRef="KRW">525042000</ifrs-full:OtherNoncurrentFinancialAssets>
    <ifrs-full:OtherNoncurrentFinancialAssets
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001890"
      unitRef="KRW">473682000</ifrs-full:OtherNoncurrentFinancialAssets>
    <cik0002058261:TotalCreditRisk
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001892"
      unitRef="KRW">3038941000</cik0002058261:TotalCreditRisk>
    <cik0002058261:TotalCreditRisk
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001893"
      unitRef="KRW">6502603000</cik0002058261:TotalCreditRisk>
    <cik0002058261:FinancialLiabilitiesOfCompanyByMaturityTableTextBlock
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact001902">&lt;table cellpadding="0" cellspacing="0" id="xdx_890_ecustom--FinancialLiabilitiesOfCompanyByMaturityTableTextBlock_pn3n3_zXKJidu7VOHk" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Financial Instruments - Fair values and risk management (Details 4)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span id="xdx_8B9_zXvGAlfXM5Re" style="display: none"&gt;Financial liabilities of company by maturity&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49A_20251231__ifrs-full--ClassesOfLiabilitiesAxis__ifrs-full--CarryingAmountMember_zShjttWvqxne" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49E_20251231__ifrs-full--ClassesOfLiabilitiesAxis__custom--FinancialLiabilityMember__ifrs-full--MaturityAxis__custom--LessThan3MonthsMember_zBgjT19YnQLc" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_492_20251231__ifrs-full--ClassesOfLiabilitiesAxis__custom--FinancialLiabilityMember__ifrs-full--MaturityAxis__custom--N3Months1YearMember_zBynD50lvAK" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_499_20251231__ifrs-full--ClassesOfLiabilitiesAxis__custom--FinancialLiabilityMember__ifrs-full--MaturityAxis__custom--N1To2YearsMember_zVsONKyGLjQ1" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49D_20251231__ifrs-full--ClassesOfLiabilitiesAxis__custom--FinancialLiabilityMember__ifrs-full--MaturityAxis__custom--N2To5YearsMember_zxZwDL8Lt2D9" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49E_20251231__ifrs-full--ClassesOfLiabilitiesAxis__custom--FinancialLiabilityMember__ifrs-full--MaturityAxis__custom--MoreThan5YearsMember_zOC6RdHeVa9l" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_492_20251231__ifrs-full--ClassesOfLiabilitiesAxis__custom--FinancialLiabilityMember_zbUPt45Clytf" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="26" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;December&#160;31, 2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Carrying&lt;br/&gt;amount&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Less than&lt;br/&gt;3 months&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;3 months&lt;br/&gt;~ 1 year&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;1~2 years&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2~5 years&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;More than&lt;br/&gt;5 years&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="26" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr id="xdx_406_eifrs-full--DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesAbstract_iB_zTEfCuvMVi0k" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;th colspan="31" style="font: 10pt Times New Roman; padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&lt;b&gt;Financial liabilities&lt;/b&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--AccountsPayable_iI_z8iqqqf7voyf" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; width: 28%"&gt;Accounts
    payable &lt;span id="xdx_F44_z5eDmhEwiX85"&gt;(*)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 7%; text-align: right"&gt;1,374,936&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 7%; text-align: right"&gt;1,006,436&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 7%; text-align: right"&gt;368,500&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 7%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1915"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 7%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1916"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 7%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1917"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 7%; text-align: right"&gt;1,374,936&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--BondWithWarrants_iI_zOK6QjdY7kbh" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Bond with warrants&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;4,533,113&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;3,232,801&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;3,000,000&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1923"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1924"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1925"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;6,232,801&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_404_eifrs-full--LeaseLiabilities_iI_zdtdKL5eKo28" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Lease liabilities&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;552,631&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;40,932&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;122,795&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;146,965&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;350,746&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1933"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;661,438&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_405_eifrs-full--FinancialLiabilities_iI_zeJfWslp3gye" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; vertical-align: top; padding-left: 0.125in; padding-bottom: 1.25pt"&gt;Total&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;6,460,680&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;4,280,169&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;3,491,295&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;146,965&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;350,746&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1941"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;8,269,175&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;div style="width: 25%; margin-left: 0; margin-right: auto"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td id="xdx_F08_zVtlsWCeG13" style="width: 0.25in; text-align: left"&gt;(*)&lt;/td&gt;
    &lt;td id="xdx_F11_zedqA1y1q5rd" style="text-align: justify"&gt;Accounts payable that are not financial liabilities are excluded.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49D_20241231__ifrs-full--ClassesOfLiabilitiesAxis__ifrs-full--CarryingAmountMember_zmUx8i1nywPh" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49D_20241231__ifrs-full--ClassesOfLiabilitiesAxis__custom--FinancialLiabilityMember__ifrs-full--MaturityAxis__custom--LessThan3MonthsMember_ztuddTAvPH22" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49E_20241231__ifrs-full--ClassesOfLiabilitiesAxis__custom--FinancialLiabilityMember__ifrs-full--MaturityAxis__custom--N3Months1YearMember_zVyQYCppTweh" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_495_20241231__ifrs-full--ClassesOfLiabilitiesAxis__custom--FinancialLiabilityMember__ifrs-full--MaturityAxis__custom--N1To2YearsMember_zj7Zf0zLKmxk" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49E_20241231__ifrs-full--ClassesOfLiabilitiesAxis__custom--FinancialLiabilityMember__ifrs-full--MaturityAxis__custom--N2To5YearsMember_zYVxiLK14n9a" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_498_20241231__ifrs-full--ClassesOfLiabilitiesAxis__custom--FinancialLiabilityMember__ifrs-full--MaturityAxis__custom--MoreThan5YearsMember_z5fLF8m4zdGc" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49D_20241231__ifrs-full--ClassesOfLiabilitiesAxis__custom--FinancialLiabilityMember_zZCO8DA3ecB5" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="26" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;December&#160;31, 2024&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Carrying&lt;br/&gt;amount&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Less than&lt;br/&gt;3 months&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;3 months&lt;br/&gt;~ 1 year&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;1~2 years&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2~5 years&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;More than&lt;br/&gt;5 years&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="26" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr id="xdx_405_eifrs-full--DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesAbstract_iB_zl0ZMp7T8B72" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;th colspan="31" style="font: 10pt Times New Roman; padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&lt;b&gt;Financial liabilities&lt;/b&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--AccountsPayable_iI_zCrdmqyuX5zk" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; width: 28%"&gt;Accounts
    payable &lt;span id="xdx_F46_z5Cabjx0zWrb"&gt;(*)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 7%; text-align: right"&gt;996,719&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 7%; text-align: right"&gt;504,909&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 7%; text-align: right"&gt;491,810&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 7%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1956"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 7%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1957"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 7%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1958"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 7%; text-align: right"&gt;996,719&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--BondWithWarrants_iI_zYiJJeF5AK5j" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Bond with warrants&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;4,992,962&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;6,648,823&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1963"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1964"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1965"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1966"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;6,648,823&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_404_eifrs-full--LeaseLiabilities_iI_z3AhyD8z8IQc" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Lease liabilities&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;669,032&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;42,602&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;126,605&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;163,206&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;418,494&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;79,086&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;829,993&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--FinancialLiabilities_iI_znzSLTkHb2L3" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; vertical-align: top; padding-left: 0.125in; padding-bottom: 1.25pt"&gt;Total&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;6,658,713&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;7,196,334&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;618,415&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;163,206&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;418,494&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;79,086&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;8,475,535&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;div style="width: 25%; margin-left: 0; margin-right: auto"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td id="xdx_F0A_zVHLVRDiogJj" style="width: 0.25in; text-align: left"&gt;(*)&lt;/td&gt;
    &lt;td id="xdx_F1B_z0z6rzODzJm7" style="text-align: justify"&gt;Accounts payable that are not financial liabilities are excluded.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:FinancialLiabilitiesOfCompanyByMaturityTableTextBlock>
    <cik0002058261:AccountsPayable
      contextRef="AsOf2025-12-31_ifrs-full_CarryingAmountMember_custom_CubebioCo.Ltd.Member273615343"
      decimals="-3"
      id="Fact001912"
      unitRef="KRW">1374936000</cik0002058261:AccountsPayable>
    <cik0002058261:AccountsPayable
      contextRef="AsOf2025-12-31_custom_FinancialLiabilityMember_custom_LessThan3MonthsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001913"
      unitRef="KRW">1006436000</cik0002058261:AccountsPayable>
    <cik0002058261:AccountsPayable
      contextRef="AsOf2025-12-31_custom_FinancialLiabilityMember_custom_N3Months1YearMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001914"
      unitRef="KRW">368500000</cik0002058261:AccountsPayable>
    <cik0002058261:AccountsPayable
      contextRef="AsOf2025-12-31_custom_FinancialLiabilityMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001918"
      unitRef="KRW">1374936000</cik0002058261:AccountsPayable>
    <cik0002058261:BondWithWarrants
      contextRef="AsOf2025-12-31_ifrs-full_CarryingAmountMember_custom_CubebioCo.Ltd.Member273615343"
      decimals="-3"
      id="Fact001920"
      unitRef="KRW">4533113000</cik0002058261:BondWithWarrants>
    <cik0002058261:BondWithWarrants
      contextRef="AsOf2025-12-31_custom_FinancialLiabilityMember_custom_LessThan3MonthsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001921"
      unitRef="KRW">3232801000</cik0002058261:BondWithWarrants>
    <cik0002058261:BondWithWarrants
      contextRef="AsOf2025-12-31_custom_FinancialLiabilityMember_custom_N3Months1YearMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001922"
      unitRef="KRW">3000000000</cik0002058261:BondWithWarrants>
    <cik0002058261:BondWithWarrants
      contextRef="AsOf2025-12-31_custom_FinancialLiabilityMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001926"
      unitRef="KRW">6232801000</cik0002058261:BondWithWarrants>
    <ifrs-full:LeaseLiabilities
      contextRef="AsOf2025-12-31_ifrs-full_CarryingAmountMember_custom_CubebioCo.Ltd.Member273615343"
      decimals="-3"
      id="Fact001928"
      unitRef="KRW">552631000</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="AsOf2025-12-31_custom_FinancialLiabilityMember_custom_LessThan3MonthsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001929"
      unitRef="KRW">40932000</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="AsOf2025-12-31_custom_FinancialLiabilityMember_custom_N3Months1YearMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001930"
      unitRef="KRW">122795000</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="AsOf2025-12-31_custom_FinancialLiabilityMember_custom_N1To2YearsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001931"
      unitRef="KRW">146965000</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="AsOf2025-12-31_custom_FinancialLiabilityMember_custom_N2To5YearsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001932"
      unitRef="KRW">350746000</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="AsOf2025-12-31_custom_FinancialLiabilityMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001934"
      unitRef="KRW">661438000</ifrs-full:LeaseLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2025-12-31_ifrs-full_CarryingAmountMember_custom_CubebioCo.Ltd.Member273615343"
      decimals="-3"
      id="Fact001936"
      unitRef="KRW">6460680000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2025-12-31_custom_FinancialLiabilityMember_custom_LessThan3MonthsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001937"
      unitRef="KRW">4280169000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2025-12-31_custom_FinancialLiabilityMember_custom_N3Months1YearMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001938"
      unitRef="KRW">3491295000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2025-12-31_custom_FinancialLiabilityMember_custom_N1To2YearsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001939"
      unitRef="KRW">146965000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2025-12-31_custom_FinancialLiabilityMember_custom_N2To5YearsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001940"
      unitRef="KRW">350746000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2025-12-31_custom_FinancialLiabilityMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001942"
      unitRef="KRW">8269175000</ifrs-full:FinancialLiabilities>
    <cik0002058261:AccountsPayable
      contextRef="AsOf2024-12-31_ifrs-full_CarryingAmountMember_custom_CubebioCo.Ltd.Member273615390"
      decimals="-3"
      id="Fact001953"
      unitRef="KRW">996719000</cik0002058261:AccountsPayable>
    <cik0002058261:AccountsPayable
      contextRef="AsOf2024-12-31_custom_FinancialLiabilityMember_custom_LessThan3MonthsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001954"
      unitRef="KRW">504909000</cik0002058261:AccountsPayable>
    <cik0002058261:AccountsPayable
      contextRef="AsOf2024-12-31_custom_FinancialLiabilityMember_custom_N3Months1YearMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001955"
      unitRef="KRW">491810000</cik0002058261:AccountsPayable>
    <cik0002058261:AccountsPayable
      contextRef="AsOf2024-12-31_custom_FinancialLiabilityMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001959"
      unitRef="KRW">996719000</cik0002058261:AccountsPayable>
    <cik0002058261:BondWithWarrants
      contextRef="AsOf2024-12-31_ifrs-full_CarryingAmountMember_custom_CubebioCo.Ltd.Member273615390"
      decimals="-3"
      id="Fact001961"
      unitRef="KRW">4992962000</cik0002058261:BondWithWarrants>
    <cik0002058261:BondWithWarrants
      contextRef="AsOf2024-12-31_custom_FinancialLiabilityMember_custom_LessThan3MonthsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001962"
      unitRef="KRW">6648823000</cik0002058261:BondWithWarrants>
    <cik0002058261:BondWithWarrants
      contextRef="AsOf2024-12-31_custom_FinancialLiabilityMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001967"
      unitRef="KRW">6648823000</cik0002058261:BondWithWarrants>
    <ifrs-full:LeaseLiabilities
      contextRef="AsOf2024-12-31_ifrs-full_CarryingAmountMember_custom_CubebioCo.Ltd.Member273615390"
      decimals="-3"
      id="Fact001969"
      unitRef="KRW">669032000</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="AsOf2024-12-31_custom_FinancialLiabilityMember_custom_LessThan3MonthsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001970"
      unitRef="KRW">42602000</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="AsOf2024-12-31_custom_FinancialLiabilityMember_custom_N3Months1YearMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001971"
      unitRef="KRW">126605000</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="AsOf2024-12-31_custom_FinancialLiabilityMember_custom_N1To2YearsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001972"
      unitRef="KRW">163206000</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="AsOf2024-12-31_custom_FinancialLiabilityMember_custom_N2To5YearsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001973"
      unitRef="KRW">418494000</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="AsOf2024-12-31_custom_FinancialLiabilityMember_custom_MoreThan5YearsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001974"
      unitRef="KRW">79086000</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="AsOf2024-12-31_custom_FinancialLiabilityMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001975"
      unitRef="KRW">829993000</ifrs-full:LeaseLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2024-12-31_ifrs-full_CarryingAmountMember_custom_CubebioCo.Ltd.Member273615390"
      decimals="-3"
      id="Fact001977"
      unitRef="KRW">6658713000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2024-12-31_custom_FinancialLiabilityMember_custom_LessThan3MonthsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001978"
      unitRef="KRW">7196334000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2024-12-31_custom_FinancialLiabilityMember_custom_N3Months1YearMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001979"
      unitRef="KRW">618415000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2024-12-31_custom_FinancialLiabilityMember_custom_N1To2YearsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001980"
      unitRef="KRW">163206000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2024-12-31_custom_FinancialLiabilityMember_custom_N2To5YearsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001981"
      unitRef="KRW">418494000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2024-12-31_custom_FinancialLiabilityMember_custom_MoreThan5YearsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001982"
      unitRef="KRW">79086000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2024-12-31_custom_FinancialLiabilityMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001983"
      unitRef="KRW">8475535000</ifrs-full:FinancialLiabilities>
    <cik0002058261:FinancialAssetsAndLiabilitiesExposedToForeignCurrencyRiskTableTextBlock
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact001993">&lt;table cellpadding="0" cellspacing="0" id="xdx_892_ecustom--FinancialAssetsAndLiabilitiesExposedToForeignCurrencyRiskTableTextBlock_z7IonPb9QfOl" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Financial Instruments - Fair values and risk management (Details 5)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&lt;span id="xdx_8B1_zi3rGEfOn4v9" style="display: none"&gt;Financial assets and liabilities exposed to foreign currency risk&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Assets in&lt;br/&gt; foreign&lt;br/&gt; currency&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Assets in&lt;br/&gt; Korean won&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(Individual amounts in each foreign currency)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;USD&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_901_ecustom--AssetsInForeignCurrency_iI_pn3n3_uUSD_c20251231_zTYcrB0FlwI3" title="Assets in foreign currency"&gt;41,258&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--FinancialAsset_iI_pn3n3_c20251231_z4QxPtbZeV82" title="Assets"&gt;59,201&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2024&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Assets in&lt;br/&gt; foreign&lt;br/&gt; currency&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Assets in&lt;br/&gt; Korean won&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(Individual amounts in each foreign currency)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;USD&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--AssetsInForeignCurrency_iI_pn3n3_uUSD_c20241231_zChCsK9LYBXb" title="Assets in foreign currency"&gt;39,877&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_901_ecustom--FinancialAsset_iI_pn3n3_c20241231_z2cZJgSTIuWk" title="Assets"&gt;58,619&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:FinancialAssetsAndLiabilitiesExposedToForeignCurrencyRiskTableTextBlock>
    <cik0002058261:AssetsInForeignCurrency
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001995"
      unitRef="USD">41258000</cik0002058261:AssetsInForeignCurrency>
    <cik0002058261:FinancialAsset
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001997"
      unitRef="KRW">59201000</cik0002058261:FinancialAsset>
    <cik0002058261:AssetsInForeignCurrency
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact001999"
      unitRef="USD">39877000</cik0002058261:AssetsInForeignCurrency>
    <cik0002058261:FinancialAsset
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002001"
      unitRef="KRW">58619000</cik0002058261:FinancialAsset>
    <cik0002058261:ImpactOfFluctuationInForeignCurrencyExchangeRatesTableTextBlock
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact002003">&lt;table cellpadding="0" cellspacing="0" id="xdx_89F_ecustom--ImpactOfFluctuationInForeignCurrencyExchangeRatesTableTextBlock_pn3n3_zRBjCnu3qWla" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Financial Instruments - Fair values and risk management (Details 6)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&lt;span id="xdx_8B8_zx4BGmQ5eFJ2" style="display: none"&gt;Impact of fluctuation in foreign currency exchange rates&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="font: 10pt Times New Roman; text-align: center"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="font: 10pt Times New Roman; text-align: center"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="font: 10pt Times New Roman; text-align: center"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="font: 10pt Times New Roman; text-align: center"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2024&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Increased&#160;by&lt;br/&gt; 10%&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Decreased&#160;by&lt;br/&gt; 10%&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Increased&#160;by&lt;br/&gt; 10%&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Decreased&#160;by&lt;br/&gt; 10%&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="14" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Discount rate&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_909_ecustom--DiscountRateIncreased_pn3n3_c20250101__20251231_z4jIYFfto9Qj" title="Discount rate increased by 10%"&gt;5,920&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_905_ecustom--DiscountRateDecreased_iN_pn3n3_di_c20250101__20251231_zVPjCyvvgDx5" title="Discount rate decreased by 10%"&gt;(5,920&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--DiscountRateIncreased_pn3n3_c20240101__20241231_zQ7R1JE5zZXh" title="Discount rate increased by 10%"&gt;5,862&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_909_ecustom--DiscountRateDecreased_iN_pn3n3_di_c20240101__20241231_zcpJz1mvOT4b" title="Discount rate decreased by 10%"&gt;(5,862&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:ImpactOfFluctuationInForeignCurrencyExchangeRatesTableTextBlock>
    <cik0002058261:DiscountRateIncreased
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002005"
      unitRef="KRW">5920000</cik0002058261:DiscountRateIncreased>
    <cik0002058261:DiscountRateDecreased
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002007"
      unitRef="KRW">5920000</cik0002058261:DiscountRateDecreased>
    <cik0002058261:DiscountRateIncreased
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002009"
      unitRef="KRW">5862000</cik0002058261:DiscountRateIncreased>
    <cik0002058261:DiscountRateDecreased
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002011"
      unitRef="KRW">5862000</cik0002058261:DiscountRateDecreased>
    <cik0002058261:PropertyAndEquipmentTextBlock
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact002020">&lt;p id="xdx_806_ecustom--PropertyAndEquipmentTextBlock_zBXNrQArExSa" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;13. &lt;span id="xdx_826_zrdC6OCuRA7k"&gt;Property and equipment&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.25in; text-align: left"&gt;&lt;b&gt;A.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;&lt;b&gt;Reconciliation of carrying amount&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Details of property and equipment as of December&#160;31, 2025 and 2024 are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89F_eifrs-full--DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_pn3n3_z52F8yj76da1" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Property and equipment (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: #FFFFFF"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span id="xdx_8B2_zJUEmYIS5Dr5" style="display: none"&gt;Schedule of property plant and equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; text-align: center; padding-left: 0.125in; padding-bottom: 1pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 1pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 1pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="14" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;December&#160;31, 2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 1pt; text-indent: -0.125in; padding-left: 0.125in"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 1pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 1pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Cost&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Accumulated&lt;br/&gt;depreciation&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Accumulated&lt;br/&gt;impairment&lt;br/&gt; losses&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Carrying&lt;br/&gt;Amount&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; text-align: center"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="13" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Machinery&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right; width: 9%"&gt;&lt;span id="xdx_903_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CostMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndEquipmentsMember_z7vBAC5v1fJd" title="Property, plant and equipment"&gt;745,246&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right; width: 9%"&gt;&lt;span id="xdx_904_ecustom--AccumulatedDepreciation_iNI_pn3n3_di_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndEquipmentsMember_ziAZ1Dn1AQx6" title="Accumulated depreciation"&gt;(444,954&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; width: 1%"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right; width: 9%"&gt;&lt;span id="xdx_904_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndEquipmentsMember_zr3y9sSZXksf" title="Property, plant and equipment"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2028"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right; width: 9%"&gt;&lt;span id="xdx_906_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndEquipmentsMember_zPwCuJmA91gc" title="Property, plant and equipment"&gt;300,292&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; width: 1%"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #FFFFFF"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Vehicles&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CostMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MotorVehiclesMember_zGez5sysFt69" title="Property, plant and equipment"&gt;64,547&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_909_ecustom--AccumulatedDepreciation_iNI_pn3n3_di_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MotorVehiclesMember_zhw3PMDg1Kqd"&gt;(25,104&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MotorVehiclesMember_ze38202f1Ar4" title="Property, plant and equipment"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2035"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MotorVehiclesMember_zQ7nTN4Qlnhk" title="Property, plant and equipment"&gt;39,443&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Office equipment&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CostMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OfficeAndOtherEquipmentMember_zQ2pgxbzuqIc" title="Property, plant and equipment"&gt;65,768&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_901_ecustom--AccumulatedDepreciation_iNI_pn3n3_di_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OfficeAndOtherEquipmentMember_zPSRxOTYhlRg"&gt;(61,458&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OfficeAndOtherEquipmentMember_zzKoPDwiz7F7" title="Property, plant and equipment"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2042"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OfficeAndOtherEquipmentMember_zh6IIELtQkJj" title="Property, plant and equipment"&gt;4,310&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #FFFFFF"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Furniture and fixtures&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CostMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndFixtureMember_zu9l0R3yAjNk" title="Property, plant and equipment"&gt;287,040&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--AccumulatedDepreciation_iNI_pn3n3_di_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndFixtureMember_zhtoOxEXyBjb"&gt;(287,030&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndFixtureMember_zyTe8ay6xpI7" title="Property, plant and equipment"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2049"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndFixtureMember_zQXP2sHLGGpg" title="Property, plant and equipment"&gt;10&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-left: 0.125in; text-align: center; padding-bottom: 1.25pt"&gt;Total&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CostMember_z7sQaqWiUvI5" title="Property, plant and equipment"&gt;1,162,601&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--AccumulatedDepreciation_iNI_pn3n3_di_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember_z1icTm1jsLVb"&gt;(818,546&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedImpairmentMember_zKEcCZXzvsai" title="Property, plant and equipment"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2056"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20251231_zyliZfR1eNm" title="Property, plant and equipment"&gt;344,055&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom; background-color: #FFFFFF"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;December&#160;31, 2024&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 1pt; text-indent: -0.125in; padding-left: 0.125in"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 1pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 1pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Cost&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Accumulated&lt;br/&gt;depreciation&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Accumulated&lt;br/&gt;impairment&lt;br/&gt; losses&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Carrying&lt;br/&gt;Amount&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; text-align: center"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="13" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Machinery&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right; width: 9%"&gt;&lt;span id="xdx_90E_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CostMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndEquipmentsMember_zze5XniJT4eh" title="Property, plant and equipment"&gt;1,848,286&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right; width: 9%"&gt;&lt;span id="xdx_903_ecustom--AccumulatedDepreciation_iNI_pn3n3_di_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndEquipmentsMember_zSnE77crPl8l" title="Accumulated depreciation"&gt;(887,341&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; width: 1%"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right; width: 9%"&gt;&lt;span id="xdx_90C_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndEquipmentsMember_zVr8b6K6EN49" title="Property, plant and equipment"&gt;(601,792&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; width: 1%"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right; width: 9%"&gt;&lt;span id="xdx_90D_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndEquipmentsMember_zfENP02FVghi" title="Property, plant and equipment"&gt;359,153&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; width: 1%"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Vehicles&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CostMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MotorVehiclesMember_zAtQATDPpqM2" title="Property, plant and equipment"&gt;64,547&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_ecustom--AccumulatedDepreciation_iNI_pn3n3_di_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MotorVehiclesMember_zUYN8hM6TsU9" title="Accumulated depreciation"&gt;(12,195&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MotorVehiclesMember_zhbIiVzWQfH8" title="Property, plant and equipment"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2072"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MotorVehiclesMember_zcIunbiM58v" title="Property, plant and equipment"&gt;52,352&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Office equipment&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CostMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OfficeAndOtherEquipmentMember_zFochRHyVATh" title="Property, plant and equipment"&gt;65,768&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_902_ecustom--AccumulatedDepreciation_iNI_pn3n3_di_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OfficeAndOtherEquipmentMember_zqhyss9seyJ"&gt;(56,447&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OfficeAndOtherEquipmentMember_zOcNnDgs2aj9" title="Property, plant and equipment"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2079"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OfficeAndOtherEquipmentMember_ztcE3zfKjPWf" title="Property, plant and equipment"&gt;9,321&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Furniture and fixtures&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CostMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndFixtureMember_zVjfBYN6l2d8" title="Property, plant and equipment"&gt;287,040&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_902_ecustom--AccumulatedDepreciation_iNI_pn3n3_di_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndFixtureMember_zgNEbD5wMba9"&gt;(287,030&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndFixtureMember_z1IDsB89n9mh" title="Property, plant and equipment"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2086"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndFixtureMember_z2OwxvK4ChPh" title="Property, plant and equipment"&gt;10&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-left: 0.125in; text-align: center; padding-bottom: 1.25pt"&gt;Total&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CostMember_zoqGlbYisB36" title="Property, plant and equipment"&gt;2,265,641&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_901_ecustom--AccumulatedDepreciation_iNI_pn3n3_di_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember_zKJhVglPISP7"&gt;(1,243,013&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedImpairmentMember_zJ2ttgPF57Kd" title="Property, plant and equipment"&gt;(601,792&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20241231_zA0LHUCUOgE" title="Property, plant and equipment"&gt;420,836&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AE_zzJwg7GHoQo3" style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Details of the changes in property and equipment for the year ended December&#160;31, 2025 and 2024 are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_896_ecustom--PropertyAndEquipmentTableTextBlock_pn3n3_zBhnxABuuzR" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Property and equipment (Details 1)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span id="xdx_8BE_zJqH4WD1S8G8" style="display: none"&gt;Schedule of changes in property and equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_499_20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember_z8WfukocMmkd" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_491_20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_zJGUK07zNQrc" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_498_20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OfficeAndOtherEquipmentMember_z47ZYZyKs5X5" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_493_20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndFixtureMember_z1wHKDeSbCv5" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49D_20250101__20251231_zHzZdagdxXRk" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="18" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Machinery&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Vehicles&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Office equipment&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Furniture and fixture&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="18" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr id="xdx_406_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_z9ZnAtPD1Ux" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Beginning balance&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;359,153&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;52,352&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;9,321&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;10&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;420,836&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--AcquisitionsCost_zVYACHEToFde" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Acquisitions&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;7,960&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2106"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2107"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2108"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;7,960&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_404_eifrs-full--DepreciationInvestmentProperty_iN_di_zXMJNzSyBXdh" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Depreciation&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;(66,821&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;(12,909&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;(5,011&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2114"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;(84,741&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_407_eifrs-full--ImpairmentLoss_iN_di_zSvExHY7wEZ" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Impairment loss&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2120"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2121"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--Disposals_zvxCr34ro0Rh" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Disposals /Removals&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2126"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2127"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_401_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_z3OMotXvEref" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.25pt"&gt;Ending balance&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;300,292&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;39,443&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;4,310&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;10&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;344,055&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49E_20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember_zrJbjBgCj3B2" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_494_20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_zmKy07NG9oZ6" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_499_20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OfficeAndOtherEquipmentMember_zAGj6StGKeE8" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_496_20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndFixtureMember_zSdqmrMMds4i" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49A_20240101__20241231_zsKFo9EbIxM7" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="18" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Machinery&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Vehicles&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Office equipment&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Furniture and fixture&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="18" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_zHXbAdhNpssl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Beginning balance&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right; width: 9%"&gt;1,115,413&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right; width: 9%"&gt;23,435&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right; width: 9%"&gt;13,060&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right; width: 9%"&gt;10&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right; width: 9%"&gt;1,151,918&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; width: 1%"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--AcquisitionsCost_zMh9Ksa6xcl1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Acquisitions&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;36,870&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;35,851&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;1,494&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2144"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;74,215&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--DepreciationInvestmentProperty_iN_di_zGMpNJuneNk1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Depreciation&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;(185,266&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;(6,934&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;(5,232&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2150"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;(197,432&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40A_eifrs-full--ImpairmentLoss_iN_di_zACLCcVUtSY7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Impairment loss&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;(601,791&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2154"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2155"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2156"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;(601,791&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--Disposals_zpPFsL9m9Il" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Disposals /Removals&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;(6,073&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2160"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;(1&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2162"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;(6,074&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_406_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_zScVrXAlxAo2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.25pt"&gt;Ending balance&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;359,153&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;52,352&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;9,321&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;10&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;420,836&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AF_zCAo4LmkXBN1" style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;







&lt;p style="font: 10pt Times New Roman, Times, serif; margin: 0px; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;









&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The classification of depreciation expenses in the statements of comprehensive income for the years ended December&#160;31, 2025 and 2024 is as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89C_ecustom--ClassificationOfDepreciationExpensesTableTextBlock_pn3n3_znYVrh2RjFXj" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Property and equipment (Details 2)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 0.5pt"&gt;&lt;span id="xdx_8B2_z6Odkig3XVv7" style="display: none"&gt;Schedule of classification of depreciation expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Selling, general and administrative expenses&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--DepreciationAndAmortisationExpense_pn3n3_c20250101__20251231__custom--IncomeStatementLocationsAxis__custom--SellingGeneralAndAdministrativesExpensesMember_zvmwRx299Mj1" title="Depreciation expenses"&gt;84,741&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--DepreciationAndAmortisationExpense_pn3n3_c20240101__20241231__custom--IncomeStatementLocationsAxis__custom--SellingGeneralAndAdministrativesExpensesMember_zxhVcnrRya67" title="Depreciation expenses"&gt;197,432&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

</cik0002058261:PropertyAndEquipmentTextBlock>
    <ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact002022">&lt;table cellpadding="0" cellspacing="0" id="xdx_89F_eifrs-full--DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_pn3n3_z52F8yj76da1" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Property and equipment (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: #FFFFFF"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span id="xdx_8B2_zJUEmYIS5Dr5" style="display: none"&gt;Schedule of property plant and equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; text-align: center; padding-left: 0.125in; padding-bottom: 1pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 1pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 1pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="14" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;December&#160;31, 2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 1pt; text-indent: -0.125in; padding-left: 0.125in"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 1pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 1pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Cost&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Accumulated&lt;br/&gt;depreciation&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Accumulated&lt;br/&gt;impairment&lt;br/&gt; losses&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Carrying&lt;br/&gt;Amount&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; text-align: center"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="13" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Machinery&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right; width: 9%"&gt;&lt;span id="xdx_903_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CostMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndEquipmentsMember_z7vBAC5v1fJd" title="Property, plant and equipment"&gt;745,246&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right; width: 9%"&gt;&lt;span id="xdx_904_ecustom--AccumulatedDepreciation_iNI_pn3n3_di_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndEquipmentsMember_ziAZ1Dn1AQx6" title="Accumulated depreciation"&gt;(444,954&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; width: 1%"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right; width: 9%"&gt;&lt;span id="xdx_904_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndEquipmentsMember_zr3y9sSZXksf" title="Property, plant and equipment"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2028"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right; width: 9%"&gt;&lt;span id="xdx_906_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndEquipmentsMember_zPwCuJmA91gc" title="Property, plant and equipment"&gt;300,292&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; width: 1%"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #FFFFFF"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Vehicles&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CostMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MotorVehiclesMember_zGez5sysFt69" title="Property, plant and equipment"&gt;64,547&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_909_ecustom--AccumulatedDepreciation_iNI_pn3n3_di_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MotorVehiclesMember_zhw3PMDg1Kqd"&gt;(25,104&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MotorVehiclesMember_ze38202f1Ar4" title="Property, plant and equipment"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2035"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MotorVehiclesMember_zQ7nTN4Qlnhk" title="Property, plant and equipment"&gt;39,443&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Office equipment&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CostMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OfficeAndOtherEquipmentMember_zQ2pgxbzuqIc" title="Property, plant and equipment"&gt;65,768&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_901_ecustom--AccumulatedDepreciation_iNI_pn3n3_di_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OfficeAndOtherEquipmentMember_zPSRxOTYhlRg"&gt;(61,458&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OfficeAndOtherEquipmentMember_zzKoPDwiz7F7" title="Property, plant and equipment"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2042"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OfficeAndOtherEquipmentMember_zh6IIELtQkJj" title="Property, plant and equipment"&gt;4,310&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #FFFFFF"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Furniture and fixtures&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CostMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndFixtureMember_zu9l0R3yAjNk" title="Property, plant and equipment"&gt;287,040&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--AccumulatedDepreciation_iNI_pn3n3_di_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndFixtureMember_zhtoOxEXyBjb"&gt;(287,030&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndFixtureMember_zyTe8ay6xpI7" title="Property, plant and equipment"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2049"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndFixtureMember_zQXP2sHLGGpg" title="Property, plant and equipment"&gt;10&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-left: 0.125in; text-align: center; padding-bottom: 1.25pt"&gt;Total&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CostMember_z7sQaqWiUvI5" title="Property, plant and equipment"&gt;1,162,601&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--AccumulatedDepreciation_iNI_pn3n3_di_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember_z1icTm1jsLVb"&gt;(818,546&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedImpairmentMember_zKEcCZXzvsai" title="Property, plant and equipment"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2056"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20251231_zyliZfR1eNm" title="Property, plant and equipment"&gt;344,055&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom; background-color: #FFFFFF"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;December&#160;31, 2024&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 1pt; text-indent: -0.125in; padding-left: 0.125in"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 1pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 1pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Cost&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Accumulated&lt;br/&gt;depreciation&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Accumulated&lt;br/&gt;impairment&lt;br/&gt; losses&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Carrying&lt;br/&gt;Amount&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; text-align: center"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="13" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Machinery&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right; width: 9%"&gt;&lt;span id="xdx_90E_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CostMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndEquipmentsMember_zze5XniJT4eh" title="Property, plant and equipment"&gt;1,848,286&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right; width: 9%"&gt;&lt;span id="xdx_903_ecustom--AccumulatedDepreciation_iNI_pn3n3_di_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndEquipmentsMember_zSnE77crPl8l" title="Accumulated depreciation"&gt;(887,341&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; width: 1%"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right; width: 9%"&gt;&lt;span id="xdx_90C_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndEquipmentsMember_zVr8b6K6EN49" title="Property, plant and equipment"&gt;(601,792&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; width: 1%"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right; width: 9%"&gt;&lt;span id="xdx_90D_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndEquipmentsMember_zfENP02FVghi" title="Property, plant and equipment"&gt;359,153&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; width: 1%"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Vehicles&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CostMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MotorVehiclesMember_zAtQATDPpqM2" title="Property, plant and equipment"&gt;64,547&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_ecustom--AccumulatedDepreciation_iNI_pn3n3_di_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MotorVehiclesMember_zUYN8hM6TsU9" title="Accumulated depreciation"&gt;(12,195&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MotorVehiclesMember_zhbIiVzWQfH8" title="Property, plant and equipment"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2072"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MotorVehiclesMember_zcIunbiM58v" title="Property, plant and equipment"&gt;52,352&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Office equipment&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CostMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OfficeAndOtherEquipmentMember_zFochRHyVATh" title="Property, plant and equipment"&gt;65,768&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_902_ecustom--AccumulatedDepreciation_iNI_pn3n3_di_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OfficeAndOtherEquipmentMember_zqhyss9seyJ"&gt;(56,447&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OfficeAndOtherEquipmentMember_zOcNnDgs2aj9" title="Property, plant and equipment"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2079"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OfficeAndOtherEquipmentMember_ztcE3zfKjPWf" title="Property, plant and equipment"&gt;9,321&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Furniture and fixtures&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CostMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndFixtureMember_zVjfBYN6l2d8" title="Property, plant and equipment"&gt;287,040&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_902_ecustom--AccumulatedDepreciation_iNI_pn3n3_di_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndFixtureMember_zgNEbD5wMba9"&gt;(287,030&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndFixtureMember_z1IDsB89n9mh" title="Property, plant and equipment"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2086"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndFixtureMember_z2OwxvK4ChPh" title="Property, plant and equipment"&gt;10&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-left: 0.125in; text-align: center; padding-bottom: 1.25pt"&gt;Total&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CostMember_zoqGlbYisB36" title="Property, plant and equipment"&gt;2,265,641&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_901_ecustom--AccumulatedDepreciation_iNI_pn3n3_di_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember_zKJhVglPISP7"&gt;(1,243,013&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedImpairmentMember_zJ2ttgPF57Kd" title="Property, plant and equipment"&gt;(601,792&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20241231_zA0LHUCUOgE" title="Property, plant and equipment"&gt;420,836&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2025-12-31_custom_CostMember_custom_MachineryAndEquipmentsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002024"
      unitRef="KRW">745246000</ifrs-full:PropertyPlantAndEquipment>
    <cik0002058261:AccumulatedDepreciation
      contextRef="AsOf2025-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_custom_MachineryAndEquipmentsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002026"
      unitRef="KRW">444954000</cik0002058261:AccumulatedDepreciation>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2025-12-31_custom_MachineryAndEquipmentsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002030"
      unitRef="KRW">300292000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2025-12-31_custom_CostMember_ifrs-full_MotorVehiclesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002032"
      unitRef="KRW">64547000</ifrs-full:PropertyPlantAndEquipment>
    <cik0002058261:AccumulatedDepreciation
      contextRef="AsOf2025-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_MotorVehiclesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002033"
      unitRef="KRW">25104000</cik0002058261:AccumulatedDepreciation>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2025-12-31_ifrs-full_MotorVehiclesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002037"
      unitRef="KRW">39443000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2025-12-31_custom_CostMember_custom_OfficeAndOtherEquipmentMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002039"
      unitRef="KRW">65768000</ifrs-full:PropertyPlantAndEquipment>
    <cik0002058261:AccumulatedDepreciation
      contextRef="AsOf2025-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_custom_OfficeAndOtherEquipmentMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002040"
      unitRef="KRW">61458000</cik0002058261:AccumulatedDepreciation>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2025-12-31_custom_OfficeAndOtherEquipmentMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002044"
      unitRef="KRW">4310000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2025-12-31_custom_CostMember_custom_FurnitureAndFixtureMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002046"
      unitRef="KRW">287040000</ifrs-full:PropertyPlantAndEquipment>
    <cik0002058261:AccumulatedDepreciation
      contextRef="AsOf2025-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_custom_FurnitureAndFixtureMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002047"
      unitRef="KRW">287030000</cik0002058261:AccumulatedDepreciation>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2025-12-31_custom_FurnitureAndFixtureMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002051"
      unitRef="KRW">10000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2025-12-31_custom_CostMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002053"
      unitRef="KRW">1162601000</ifrs-full:PropertyPlantAndEquipment>
    <cik0002058261:AccumulatedDepreciation
      contextRef="AsOf2025-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002054"
      unitRef="KRW">818546000</cik0002058261:AccumulatedDepreciation>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002058"
      unitRef="KRW">344055000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2024-12-31_custom_CostMember_custom_MachineryAndEquipmentsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002060"
      unitRef="KRW">1848286000</ifrs-full:PropertyPlantAndEquipment>
    <cik0002058261:AccumulatedDepreciation
      contextRef="AsOf2024-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_custom_MachineryAndEquipmentsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002062"
      unitRef="KRW">887341000</cik0002058261:AccumulatedDepreciation>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2024-12-31_ifrs-full_AccumulatedImpairmentMember_custom_MachineryAndEquipmentsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002064"
      unitRef="KRW">-601792000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2024-12-31_custom_MachineryAndEquipmentsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002066"
      unitRef="KRW">359153000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2024-12-31_custom_CostMember_ifrs-full_MotorVehiclesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002068"
      unitRef="KRW">64547000</ifrs-full:PropertyPlantAndEquipment>
    <cik0002058261:AccumulatedDepreciation
      contextRef="AsOf2024-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_MotorVehiclesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002070"
      unitRef="KRW">12195000</cik0002058261:AccumulatedDepreciation>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2024-12-31_ifrs-full_MotorVehiclesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002074"
      unitRef="KRW">52352000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2024-12-31_custom_CostMember_custom_OfficeAndOtherEquipmentMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002076"
      unitRef="KRW">65768000</ifrs-full:PropertyPlantAndEquipment>
    <cik0002058261:AccumulatedDepreciation
      contextRef="AsOf2024-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_custom_OfficeAndOtherEquipmentMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002077"
      unitRef="KRW">56447000</cik0002058261:AccumulatedDepreciation>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2024-12-31_custom_OfficeAndOtherEquipmentMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002081"
      unitRef="KRW">9321000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2024-12-31_custom_CostMember_custom_FurnitureAndFixtureMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002083"
      unitRef="KRW">287040000</ifrs-full:PropertyPlantAndEquipment>
    <cik0002058261:AccumulatedDepreciation
      contextRef="AsOf2024-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_custom_FurnitureAndFixtureMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002084"
      unitRef="KRW">287030000</cik0002058261:AccumulatedDepreciation>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2024-12-31_custom_FurnitureAndFixtureMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002088"
      unitRef="KRW">10000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2024-12-31_custom_CostMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002090"
      unitRef="KRW">2265641000</ifrs-full:PropertyPlantAndEquipment>
    <cik0002058261:AccumulatedDepreciation
      contextRef="AsOf2024-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002091"
      unitRef="KRW">1243013000</cik0002058261:AccumulatedDepreciation>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2024-12-31_ifrs-full_AccumulatedImpairmentMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002093"
      unitRef="KRW">-601792000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002095"
      unitRef="KRW">420836000</ifrs-full:PropertyPlantAndEquipment>
    <cik0002058261:PropertyAndEquipmentTableTextBlock
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact002097">&lt;table cellpadding="0" cellspacing="0" id="xdx_896_ecustom--PropertyAndEquipmentTableTextBlock_pn3n3_zBhnxABuuzR" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Property and equipment (Details 1)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span id="xdx_8BE_zJqH4WD1S8G8" style="display: none"&gt;Schedule of changes in property and equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_499_20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember_z8WfukocMmkd" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_491_20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_zJGUK07zNQrc" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_498_20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OfficeAndOtherEquipmentMember_z47ZYZyKs5X5" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_493_20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndFixtureMember_z1wHKDeSbCv5" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49D_20250101__20251231_zHzZdagdxXRk" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="18" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Machinery&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Vehicles&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Office equipment&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Furniture and fixture&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="18" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr id="xdx_406_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_z9ZnAtPD1Ux" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Beginning balance&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;359,153&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;52,352&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;9,321&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;10&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;420,836&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--AcquisitionsCost_zVYACHEToFde" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Acquisitions&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;7,960&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2106"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2107"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2108"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;7,960&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_404_eifrs-full--DepreciationInvestmentProperty_iN_di_zXMJNzSyBXdh" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Depreciation&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;(66,821&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;(12,909&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;(5,011&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2114"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;(84,741&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_407_eifrs-full--ImpairmentLoss_iN_di_zSvExHY7wEZ" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Impairment loss&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2120"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2121"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--Disposals_zvxCr34ro0Rh" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Disposals /Removals&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2126"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2127"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_401_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_z3OMotXvEref" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.25pt"&gt;Ending balance&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;300,292&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;39,443&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;4,310&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;10&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;344,055&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49E_20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember_zrJbjBgCj3B2" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_494_20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_zmKy07NG9oZ6" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_499_20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OfficeAndOtherEquipmentMember_zAGj6StGKeE8" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_496_20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndFixtureMember_zSdqmrMMds4i" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49A_20240101__20241231_zsKFo9EbIxM7" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="18" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Machinery&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Vehicles&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Office equipment&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Furniture and fixture&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="18" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_zHXbAdhNpssl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Beginning balance&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right; width: 9%"&gt;1,115,413&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right; width: 9%"&gt;23,435&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right; width: 9%"&gt;13,060&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right; width: 9%"&gt;10&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right; width: 9%"&gt;1,151,918&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; width: 1%"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--AcquisitionsCost_zMh9Ksa6xcl1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Acquisitions&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;36,870&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;35,851&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;1,494&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2144"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;74,215&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--DepreciationInvestmentProperty_iN_di_zGMpNJuneNk1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Depreciation&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;(185,266&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;(6,934&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;(5,232&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2150"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;(197,432&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40A_eifrs-full--ImpairmentLoss_iN_di_zACLCcVUtSY7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Impairment loss&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;(601,791&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2154"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2155"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2156"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;(601,791&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--Disposals_zpPFsL9m9Il" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Disposals /Removals&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;(6,073&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2160"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;(1&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2162"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;(6,074&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_406_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_zScVrXAlxAo2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.25pt"&gt;Ending balance&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;359,153&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;52,352&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;9,321&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;10&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;420,836&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:PropertyAndEquipmentTableTextBlock>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2024-12-31_ifrs-full_MachineryMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002099"
      unitRef="KRW">359153000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2024-12-31_ifrs-full_VehiclesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002100"
      unitRef="KRW">52352000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2024-12-31_custom_OfficeAndOtherEquipmentMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002101"
      unitRef="KRW">9321000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2024-12-31_custom_FurnitureAndFixtureMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002102"
      unitRef="KRW">10000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002103"
      unitRef="KRW">420836000</ifrs-full:PropertyPlantAndEquipment>
    <cik0002058261:AcquisitionsCost
      contextRef="From2025-01-012025-12-31_ifrs-full_MachineryMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002105"
      unitRef="KRW">7960000</cik0002058261:AcquisitionsCost>
    <cik0002058261:AcquisitionsCost
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002109"
      unitRef="KRW">7960000</cik0002058261:AcquisitionsCost>
    <ifrs-full:DepreciationInvestmentProperty
      contextRef="From2025-01-012025-12-31_ifrs-full_MachineryMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002111"
      unitRef="KRW">66821000</ifrs-full:DepreciationInvestmentProperty>
    <ifrs-full:DepreciationInvestmentProperty
      contextRef="From2025-01-012025-12-31_ifrs-full_VehiclesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002112"
      unitRef="KRW">12909000</ifrs-full:DepreciationInvestmentProperty>
    <ifrs-full:DepreciationInvestmentProperty
      contextRef="From2025-01-012025-12-31_custom_OfficeAndOtherEquipmentMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002113"
      unitRef="KRW">5011000</ifrs-full:DepreciationInvestmentProperty>
    <ifrs-full:DepreciationInvestmentProperty
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002115"
      unitRef="KRW">84741000</ifrs-full:DepreciationInvestmentProperty>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2025-12-31_ifrs-full_MachineryMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002129"
      unitRef="KRW">300292000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2025-12-31_ifrs-full_VehiclesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002130"
      unitRef="KRW">39443000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2025-12-31_custom_OfficeAndOtherEquipmentMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002131"
      unitRef="KRW">4310000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2025-12-31_custom_FurnitureAndFixtureMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002132"
      unitRef="KRW">10000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002133"
      unitRef="KRW">344055000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2023-12-31_ifrs-full_MachineryMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002135"
      unitRef="KRW">1115413000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2023-12-31_ifrs-full_VehiclesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002136"
      unitRef="KRW">23435000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2023-12-31_custom_OfficeAndOtherEquipmentMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002137"
      unitRef="KRW">13060000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2023-12-31_custom_FurnitureAndFixtureMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002138"
      unitRef="KRW">10000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2023-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002139"
      unitRef="KRW">1151918000</ifrs-full:PropertyPlantAndEquipment>
    <cik0002058261:AcquisitionsCost
      contextRef="From2024-01-012024-12-31_ifrs-full_MachineryMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002141"
      unitRef="KRW">36870000</cik0002058261:AcquisitionsCost>
    <cik0002058261:AcquisitionsCost
      contextRef="From2024-01-012024-12-31_ifrs-full_VehiclesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002142"
      unitRef="KRW">35851000</cik0002058261:AcquisitionsCost>
    <cik0002058261:AcquisitionsCost
      contextRef="From2024-01-012024-12-31_custom_OfficeAndOtherEquipmentMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002143"
      unitRef="KRW">1494000</cik0002058261:AcquisitionsCost>
    <cik0002058261:AcquisitionsCost
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002145"
      unitRef="KRW">74215000</cik0002058261:AcquisitionsCost>
    <ifrs-full:DepreciationInvestmentProperty
      contextRef="From2024-01-012024-12-31_ifrs-full_MachineryMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002147"
      unitRef="KRW">185266000</ifrs-full:DepreciationInvestmentProperty>
    <ifrs-full:DepreciationInvestmentProperty
      contextRef="From2024-01-012024-12-31_ifrs-full_VehiclesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002148"
      unitRef="KRW">6934000</ifrs-full:DepreciationInvestmentProperty>
    <ifrs-full:DepreciationInvestmentProperty
      contextRef="From2024-01-012024-12-31_custom_OfficeAndOtherEquipmentMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002149"
      unitRef="KRW">5232000</ifrs-full:DepreciationInvestmentProperty>
    <ifrs-full:DepreciationInvestmentProperty
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002151"
      unitRef="KRW">197432000</ifrs-full:DepreciationInvestmentProperty>
    <ifrs-full:ImpairmentLoss
      contextRef="From2024-01-012024-12-31_ifrs-full_MachineryMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002153"
      unitRef="KRW">601791000</ifrs-full:ImpairmentLoss>
    <ifrs-full:ImpairmentLoss
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002157"
      unitRef="KRW">601791000</ifrs-full:ImpairmentLoss>
    <cik0002058261:Disposals
      contextRef="From2024-01-012024-12-31_ifrs-full_MachineryMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002159"
      unitRef="KRW">-6073000</cik0002058261:Disposals>
    <cik0002058261:Disposals
      contextRef="From2024-01-012024-12-31_custom_OfficeAndOtherEquipmentMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002161"
      unitRef="KRW">-1000</cik0002058261:Disposals>
    <cik0002058261:Disposals
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002163"
      unitRef="KRW">-6074000</cik0002058261:Disposals>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2024-12-31_ifrs-full_MachineryMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002165"
      unitRef="KRW">359153000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2024-12-31_ifrs-full_VehiclesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002166"
      unitRef="KRW">52352000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2024-12-31_custom_OfficeAndOtherEquipmentMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002167"
      unitRef="KRW">9321000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2024-12-31_custom_FurnitureAndFixtureMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002168"
      unitRef="KRW">10000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002169"
      unitRef="KRW">420836000</ifrs-full:PropertyPlantAndEquipment>
    <cik0002058261:ClassificationOfDepreciationExpensesTableTextBlock
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact002177">&lt;table cellpadding="0" cellspacing="0" id="xdx_89C_ecustom--ClassificationOfDepreciationExpensesTableTextBlock_pn3n3_znYVrh2RjFXj" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Property and equipment (Details 2)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 0.5pt"&gt;&lt;span id="xdx_8B2_z6Odkig3XVv7" style="display: none"&gt;Schedule of classification of depreciation expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Selling, general and administrative expenses&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--DepreciationAndAmortisationExpense_pn3n3_c20250101__20251231__custom--IncomeStatementLocationsAxis__custom--SellingGeneralAndAdministrativesExpensesMember_zvmwRx299Mj1" title="Depreciation expenses"&gt;84,741&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--DepreciationAndAmortisationExpense_pn3n3_c20240101__20241231__custom--IncomeStatementLocationsAxis__custom--SellingGeneralAndAdministrativesExpensesMember_zxhVcnrRya67" title="Depreciation expenses"&gt;197,432&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

</cik0002058261:ClassificationOfDepreciationExpensesTableTextBlock>
    <ifrs-full:DepreciationAndAmortisationExpense
      contextRef="From2025-01-012025-12-31_custom_SellingGeneralAndAdministrativesExpensesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002179"
      unitRef="KRW">84741000</ifrs-full:DepreciationAndAmortisationExpense>
    <ifrs-full:DepreciationAndAmortisationExpense
      contextRef="From2024-01-012024-12-31_custom_SellingGeneralAndAdministrativesExpensesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002181"
      unitRef="KRW">197432000</ifrs-full:DepreciationAndAmortisationExpense>
    <cik0002058261:DisclosureOfLeaseExplanatory
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact002183">&lt;p id="xdx_804_ecustom--DisclosureOfLeaseExplanatory_zaEKYmRa5CD9" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;14. &lt;span id="xdx_82E_zVaTrLw6gR5b"&gt;Leases&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company leases buildings and vehicles. The leases typically run for a period of 2 to 10 years, with an option to renew or terminate the lease after that date. The Company also leases water purifiers, copy machines, and others with contract terms of one to three years. These leases are short-term and/or leases of low-value items. Information about leases for which the Company is a lessee is presented below.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.25in; text-align: left"&gt;&lt;b&gt;A.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;&lt;b&gt;Right-of-use assets&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Right-of-use assets related to leased properties are presented as property and equipment.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Details of right-of-use assets and lease liabilities recognized in the statements of financial position as of December&#160;31, 2025 and 2024 are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_897_ecustom--DisclosureOfQuantitativeInformationAboutRightOfUseAssetsLeaseLiabilitiesTextBlock_pn3n3_zWbZgt9JZGhj" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Leases (Details)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&lt;span id="xdx_8BD_zwArNd6zlP94" style="display: none"&gt;Schedule of right-of-use assets&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2024&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&lt;b&gt;Right-of-use assets (Book value)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Building&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#x20a9;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--AcquisitionsThroughBusinessCombinationsRightofuseAssets_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_zmWUx5avZ30k" title="Right-of-use assets (Book value)"&gt;1,146,698&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--AcquisitionsThroughBusinessCombinationsRightofuseAssets_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_z1UyT7aIYvPc" title="Right-of-use assets (Book value)"&gt;1,145,750&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;Vehicles&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--AcquisitionsThroughBusinessCombinationsRightofuseAssets_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_zIUWaA3R9ezg" title="Right-of-use assets (Book value)"&gt;44,399&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--AcquisitionsThroughBusinessCombinationsRightofuseAssets_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_zq9oK00beyA1" title="Right-of-use assets (Book value)"&gt;44,399&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-left: 0.125in; text-align: center; vertical-align: top; padding-bottom: 1.25pt"&gt;Total&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--AcquisitionsThroughBusinessCombinationsRightofuseAssets_pn3n3_c20250101__20251231_zobiovjp2ouc" title="Right-of-use assets (Book value)"&gt;1,191,097&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--AcquisitionsThroughBusinessCombinationsRightofuseAssets_pn3n3_c20240101__20241231_zP0eOmV3ptbh" title="Right-of-use assets (Book value)"&gt;1,190,149&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2024&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&lt;b&gt;Right-of-use assets (Accumulated depreciation)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Building&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#x20a9;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--RightofuseAssetsAccumulatedDepreciation_iN_pn3n3_di_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_zsUm6fWMhdyc" title="Right-of-use assets (Accumulated depreciation)"&gt;(652,250&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_901_ecustom--RightofuseAssetsAccumulatedDepreciation_iN_pn3n3_di_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_zCAXRGvrGyr2" title="Right-of-use assets (Accumulated depreciation)"&gt;(523,282&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;Vehicles&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--RightofuseAssetsAccumulatedDepreciation_iN_pn3n3_di_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_zwIfefJRGyM4" title="Right-of-use assets (Accumulated depreciation)"&gt;(26,354&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_909_ecustom--RightofuseAssetsAccumulatedDepreciation_iN_pn3n3_di_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_zjxD1kD37ayb" title="Right-of-use assets (Accumulated depreciation)"&gt;(17,473&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-left: 0.125in; text-align: center; vertical-align: top; padding-bottom: 1.25pt"&gt;Total&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_900_ecustom--RightofuseAssetsAccumulatedDepreciation_iN_pn3n3_di_c20250101__20251231_zLCEKAn2UKu1" title="Right-of-use assets (Accumulated depreciation)"&gt;(678,604&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_902_ecustom--RightofuseAssetsAccumulatedDepreciation_iN_pn3n3_di_c20240101__20241231_z3Z0bGWmPPzl" title="Right-of-use assets (Accumulated depreciation)"&gt;(540,755&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&lt;b&gt;Right-of-use assets (Net book value)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Building&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#x20a9;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--AdditionsToRightofuseAssets_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_zzFELdjvwNQ5" title="Right-of-use assets (Net book value)"&gt;494,448&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--AdditionsToRightofuseAssets_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_zMSLK89PL3Tg" title="Right-of-use assets (Net book value)"&gt;622,468&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;Vehicles&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--AdditionsToRightofuseAssets_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_zZ9gAuAkbb5" title="Right-of-use assets (Net book value)"&gt;18,045&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--AdditionsToRightofuseAssets_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_zLFs775jEkZ5" title="Right-of-use assets (Net book value)"&gt;26,926&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-left: 0.125in; text-align: center; vertical-align: top; padding-bottom: 1.25pt"&gt;Total&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--AdditionsToRightofuseAssets_pn3n3_c20250101__20251231_zPL4A6ZPOfR6" title="Right-of-use assets (Net book value)"&gt;512,493&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--AdditionsToRightofuseAssets_pn3n3_c20240101__20241231_zMp7TJgSVSJj" title="Right-of-use assets (Net book value)"&gt;649,394&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A5_zX9lQmRqPfij" style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

















&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Changes in right-of-use assets for the years ended December&#160;31, 2025 and 2024 are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_898_ecustom--DisclosureOfReconcileOpeningAndEndingBalanceOfLeaseLiabilitiesTextBlock_pn3n3_zQojhmZ13Qjh" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Leases (Details 1)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span id="xdx_8BC_zu8Ekia3jHg2" style="display: none"&gt;Changes in right-of-use assets&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49F_20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_z5xHPPBEFI7c" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49E_20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_zeJ2v8j8SwZ5" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_498_20250101__20251231_zx8irqqZ17ef" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="10" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Building&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Vehicles&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="10" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40C_eifrs-full--RightofuseAssets_iS_pn3n3_zQvL5gXkTt15" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Balance as of January&#160;1, 2025&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;622,468&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;26,926&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;649,394&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--Depreciations_iN_di_z8aQ0x7MtdP6" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Depreciation&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;(128,967&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;(8,881&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;(137,848&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--LeaseReassessments_zEUBUdPtnYXd" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Lease reassessment&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;947&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2241"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;947&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_401_eifrs-full--RightofuseAssets_iE_pn3n3_zy9lNUVqojoe" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.25pt"&gt;Balance as of December&#160;31, 2025&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;494,448&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;18,045&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;512,493&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_495_20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_zqUrZLtShP1k" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_492_20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_zMY8UCPalKhd" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_491_20240101__20241231_ztoaLEDBlww1" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="10" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Building&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Vehicles&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="10" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr id="xdx_408_eifrs-full--RightofuseAssets_iS_pn3n3_zoRCA1k1GlKj" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Balance as of January&#160;1, 2024&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;750,037&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;35,805&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;785,842&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--Depreciations_iN_di_zWBcXKo7xE2k" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Depreciation&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;(129,607&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;(8,879&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;(138,486&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--LeaseReassessments_zArzhtki7822" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Lease reassessment&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;2,038&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2257"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;2,038&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_402_eifrs-full--RightofuseAssets_iE_pn3n3_zYcmRLRE56L1" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.25pt"&gt;Balance as of December&#160;31, 2024&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;622,468&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;26,926&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;649,394&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A6_zeAMrHym16Bd" style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.25in; text-align: left"&gt;&lt;b&gt;B.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;&lt;b&gt;Lease liabilities&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 0.5in; text-align: left"&gt;i.&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;Significant judgements and key assumptions&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;In applying the Company&#x2019;s accounting policies for leases, management applies judgment in assessing the lease term and determining the appropriate discount rate. For the leases outstanding as of December&#160;31, 2025, the incremental borrowing rates applied range from 8.392% to 10.997%, depending on the lease term, commencement date, and type of underlying asset. The lease terms applied to individual lease contracts range from 3 to 10 years. As of December&#160;31, 2025, the weighted-average remaining lease term was approximately 4.36 years, calculated based on the carrying amounts of lease liabilities.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 0.5in; text-align: left"&gt;ii.&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;Changes in lease liabilities&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Changes in lease liabilities for the years ended December&#160;31, 2025 and 2024 are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_891_ecustom--ChangesInLeaseLiabilitiesTableTextBlock_pn3n3_zNtMVPBqz5s3" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Leases (Details 2)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.25in; text-align: left; vertical-align: top"&gt;&lt;span id="xdx_8B5_zO67YD8Nye44" style="display: none"&gt;Changes in lease liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&lt;b&gt;Balance as of January&#160;1&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--LeaseLiabilities_iS_pn3n3_c20250101__20251231_zVVpzk8xADu6" title="Balance at beginning"&gt;669,032&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--LeaseLiabilities_iS_pn3n3_c20240101__20241231_zDgJdh7BB0df" title="Balance at beginning"&gt;776,385&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.25in; text-align: left; vertical-align: top"&gt;New leases&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--NewLeases_pn3n3_c20250101__20251231_zW6PDKrMnVs5" title="New leases"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2270"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_903_ecustom--NewLeases_pn3n3_c20240101__20241231_zTEKjRpoWlp4" title="New leases"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2272"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.25in; text-align: left; vertical-align: top"&gt;Interest expense&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--InterestExpenseLease_pn3n3_c20250101__20251231_zFXlUUZOIJLh" title="Interest expense"&gt;52,261&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_903_ecustom--InterestExpenseLease_pn3n3_c20240101__20241231_zpbUlIJbS4V8" title="Interest expense"&gt;62,090&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.25in; text-align: left; vertical-align: top"&gt;Payment of lease liabilities&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_907_ecustom--PaymentOfLeaseLiabilities_iN_pn3n3_di_c20250101__20251231_z5xwzT2T3zV3" title="Payment of lease liabilities"&gt;(169,609&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_ecustom--PaymentOfLeaseLiabilities_iN_pn3n3_di_c20240101__20241231_zwCHO3GErPz" title="Payment of lease liabilities"&gt;(171,481&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.25in; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;Lease reassessment&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_901_ecustom--LeaseReassessment_pn3n3_c20250101__20251231_zhddbBtLx4ua" title="Lease reassessment"&gt;947&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_905_ecustom--LeaseReassessment_pn3n3_c20240101__20241231_z5D7fDA9rPe" title="Lease reassessment"&gt;2,038&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;&lt;b&gt;Balance as of December&#160;31&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--LeaseLiabilities_iE_pn3n3_c20250101__20251231_z7GbrtxcAP2l" title="Balance at ending"&gt;552,631&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--LeaseLiabilities_iE_pn3n3_c20240101__20241231_zjDA4UcbPG9h" title="Balance at ending"&gt;669,032&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.25in; text-align: left; vertical-align: top"&gt;Current portion&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--CurrentLeaseLiabilities_iI_pn3n3_c20251231_zuIGiyU2IdT5" title="Current portion"&gt;122,626&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--CurrentLeaseLiabilities_iI_pn3n3_c20241231_zwDs9VlbOW1b" title="Current portion"&gt;117,351&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.25in; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;Non-current portion&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--NoncurrentLeaseLiabilities_iI_pn3n3_c20251231_zdP90PAhw41" title="Non-current portion"&gt;430,005&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--NoncurrentLeaseLiabilities_iI_pn3n3_c20241231_zPwJdHg6Jtb3" title="Non-current portion"&gt;551,681&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top; padding-bottom: 1.25pt"&gt;&lt;b&gt;Total lease liabilities&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--LeaseLiabilities_iI_pn3n3_c20251231_zexnN4YMmBz" title="Total lease liabilities"&gt;552,631&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--LeaseLiabilities_iI_pn3n3_c20241231_zW5WbrsEkmLj" title="Total lease liabilities"&gt;669,032&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A8_zmUiyPTlLuGf" style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

















&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 0.5in; text-align: left"&gt;iii.&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;Maturity analysis of lease liabilities(undiscounted)&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Undiscounted lease payments as of December&#160;31, 2025 by remaining maturity through the end of the lease term, are as follows. The undiscounted lease payments are reconciled to the lease liabilities recognized in the statement of financial position as of December&#160;31, 2025:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--UndiscountedLeasePaymentsTableTextBlock_pn3n3_zscXzlykxZ84" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Leases (Details 3)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td id="xdx_8BA_zOcPs63PhMec" style="font: 10pt Times New Roman; display: none; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Undiscounted lease payments&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_494_20250101__20251231_zPKIyBnz6li7" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--Within1Year_i_pn3n" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Within 1 year&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;163,727&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--Between1And5Years_i_pn3n" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Between 1 and 5 years&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;497,711&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--Over5Years_i_pn3n" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Over 5 years&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2315"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--TotalLeasePayments_i_pn3n" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; vertical-align: top; padding-left: 0.125in; padding-bottom: 0.5pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;661,438&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--LessImputedInterest_iN_pn3n3_di_z6NV5Kp6piud" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;b&gt;Less: imputed interest&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;(108,807&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--LeaseLiabilitity_i_pn3n" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.25pt"&gt;&lt;b&gt;Lease liabilities&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;552,631&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AE_zzrrZh8wFNr8" style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.25in; text-align: left"&gt;&lt;b&gt;C.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;&lt;b&gt;Amounts recognized in profit or loss&lt;/b&gt;&#173;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Amounts recognized in profit or loss for the years ended December&#160;31, 2025 and 2024 are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_899_eifrs-full--DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory_pn3n3_zNKWUXnhn5q" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Leases (Details 4)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&lt;span id="xdx_8BE_zb5QGvSANtvg" style="display: none"&gt;Schedule of lease-related expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_497_20250101__20251231_zFmOmiG2KfF7" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_490_20240101__20241231_zOaBBARIKexj" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--InterestExpenseOnLeaseLiabilities_i_pn3n" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Interest expense relating to lease liabilities (included in finance cost)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;52,261&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;62,090&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--ExpenseRelatingToShorttermLeases_i_pn3n" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Expense relating to short-term leases&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;1,200&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;9,648&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40F_eifrs-full--ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed_i_pn3n" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Expense relating to leases of low-value assets&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;7,481&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;5,183&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.25in; text-align: left"&gt;&lt;b&gt;D.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;&lt;b&gt;Cash outflows for leases&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Cash outflows for leases for the years ended December&#160;31, 2025 and 2024 are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_891_ecustom--CashOutflowsForLeasesTableTextBlock_pn3n3_zHnnOqNNEW1g" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Leases (Details 5)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&lt;span id="xdx_8BB_zm4yECe5oAje" style="display: none"&gt;Cash outflows for leases&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_497_20250101__20251231_zmeXDuQrIONa" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_490_20240101__20241231_zsuA5yV9uE0k" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--CashOutflowsForPrincipalRepaymentsOfLeaseLiabilities_i_pn3n" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Cash outflows for principal repayments of lease liabilities&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;117,348&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;109,391&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--CashOutflowsForInterestPaidOnLeaseLiabilities_i_pn3n" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Cash outflows for interest paid on lease liabilities&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;52,261&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;62,090&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--CashOutflowsForPaymentsForShorttermLease_i_pn3n" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Cash outflows for payments for short-term lease&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;1,200&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;9,648&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--CashOutflowsForPaymentsForLeasesOfLowvalueAssets_z1uyXnjsK1Ml" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;Cash outflows for payments for leases of low-value assets&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;7,481&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;5,183&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--CashOutflowForLeases_ztrAAOqL16q1" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-left: 0.125in; text-align: center; vertical-align: top; padding-bottom: 1.25pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;178,290&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;186,312&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A6_z1ERqBlp1Cm3" style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

















&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.25in; text-align: left"&gt;&lt;b&gt;E.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;&lt;b&gt;Extension options&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Some property leases contain extension options exercisable by the Company. Where practicable, the Company seeks to include extension options in new leases to provide operational flexibility. The extension options held are exercisable only by the Company and not by the lessors. The Company assesses at the lease commencement date whether it is reasonably certain to exercise the extension options. The Company reassesses whether it is reasonably certain to exercise the options if there is a significant event or significant changes in circumstances within its control. Extension options primarily relate to &#x201c;building leases&#x201d; and do not have a material impact on the measurement of the Company&#x2019;s right-of-use assets and lease liabilities as of December&#160;31, 2025.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

</cik0002058261:DisclosureOfLeaseExplanatory>
    <cik0002058261:DisclosureOfQuantitativeInformationAboutRightOfUseAssetsLeaseLiabilitiesTextBlock
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact002185">&lt;table cellpadding="0" cellspacing="0" id="xdx_897_ecustom--DisclosureOfQuantitativeInformationAboutRightOfUseAssetsLeaseLiabilitiesTextBlock_pn3n3_zWbZgt9JZGhj" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Leases (Details)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&lt;span id="xdx_8BD_zwArNd6zlP94" style="display: none"&gt;Schedule of right-of-use assets&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2024&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&lt;b&gt;Right-of-use assets (Book value)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Building&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#x20a9;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--AcquisitionsThroughBusinessCombinationsRightofuseAssets_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_zmWUx5avZ30k" title="Right-of-use assets (Book value)"&gt;1,146,698&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--AcquisitionsThroughBusinessCombinationsRightofuseAssets_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_z1UyT7aIYvPc" title="Right-of-use assets (Book value)"&gt;1,145,750&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;Vehicles&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--AcquisitionsThroughBusinessCombinationsRightofuseAssets_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_zIUWaA3R9ezg" title="Right-of-use assets (Book value)"&gt;44,399&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--AcquisitionsThroughBusinessCombinationsRightofuseAssets_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_zq9oK00beyA1" title="Right-of-use assets (Book value)"&gt;44,399&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-left: 0.125in; text-align: center; vertical-align: top; padding-bottom: 1.25pt"&gt;Total&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--AcquisitionsThroughBusinessCombinationsRightofuseAssets_pn3n3_c20250101__20251231_zobiovjp2ouc" title="Right-of-use assets (Book value)"&gt;1,191,097&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--AcquisitionsThroughBusinessCombinationsRightofuseAssets_pn3n3_c20240101__20241231_zP0eOmV3ptbh" title="Right-of-use assets (Book value)"&gt;1,190,149&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2024&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&lt;b&gt;Right-of-use assets (Accumulated depreciation)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Building&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#x20a9;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--RightofuseAssetsAccumulatedDepreciation_iN_pn3n3_di_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_zsUm6fWMhdyc" title="Right-of-use assets (Accumulated depreciation)"&gt;(652,250&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_901_ecustom--RightofuseAssetsAccumulatedDepreciation_iN_pn3n3_di_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_zCAXRGvrGyr2" title="Right-of-use assets (Accumulated depreciation)"&gt;(523,282&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;Vehicles&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--RightofuseAssetsAccumulatedDepreciation_iN_pn3n3_di_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_zwIfefJRGyM4" title="Right-of-use assets (Accumulated depreciation)"&gt;(26,354&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_909_ecustom--RightofuseAssetsAccumulatedDepreciation_iN_pn3n3_di_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_zjxD1kD37ayb" title="Right-of-use assets (Accumulated depreciation)"&gt;(17,473&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-left: 0.125in; text-align: center; vertical-align: top; padding-bottom: 1.25pt"&gt;Total&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_900_ecustom--RightofuseAssetsAccumulatedDepreciation_iN_pn3n3_di_c20250101__20251231_zLCEKAn2UKu1" title="Right-of-use assets (Accumulated depreciation)"&gt;(678,604&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_902_ecustom--RightofuseAssetsAccumulatedDepreciation_iN_pn3n3_di_c20240101__20241231_z3Z0bGWmPPzl" title="Right-of-use assets (Accumulated depreciation)"&gt;(540,755&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&lt;b&gt;Right-of-use assets (Net book value)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Building&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#x20a9;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--AdditionsToRightofuseAssets_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_zzFELdjvwNQ5" title="Right-of-use assets (Net book value)"&gt;494,448&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--AdditionsToRightofuseAssets_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_zMSLK89PL3Tg" title="Right-of-use assets (Net book value)"&gt;622,468&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;Vehicles&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--AdditionsToRightofuseAssets_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_zZ9gAuAkbb5" title="Right-of-use assets (Net book value)"&gt;18,045&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--AdditionsToRightofuseAssets_pn3n3_c20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_zLFs775jEkZ5" title="Right-of-use assets (Net book value)"&gt;26,926&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-left: 0.125in; text-align: center; vertical-align: top; padding-bottom: 1.25pt"&gt;Total&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--AdditionsToRightofuseAssets_pn3n3_c20250101__20251231_zPL4A6ZPOfR6" title="Right-of-use assets (Net book value)"&gt;512,493&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--AdditionsToRightofuseAssets_pn3n3_c20240101__20241231_zMp7TJgSVSJj" title="Right-of-use assets (Net book value)"&gt;649,394&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:DisclosureOfQuantitativeInformationAboutRightOfUseAssetsLeaseLiabilitiesTextBlock>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsRightofuseAssets
      contextRef="From2025-01-012025-12-31_ifrs-full_BuildingsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002187"
      unitRef="KRW">1146698000</ifrs-full:AcquisitionsThroughBusinessCombinationsRightofuseAssets>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsRightofuseAssets
      contextRef="From2024-01-012024-12-31_ifrs-full_BuildingsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002189"
      unitRef="KRW">1145750000</ifrs-full:AcquisitionsThroughBusinessCombinationsRightofuseAssets>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsRightofuseAssets
      contextRef="From2025-01-012025-12-31_ifrs-full_VehiclesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002191"
      unitRef="KRW">44399000</ifrs-full:AcquisitionsThroughBusinessCombinationsRightofuseAssets>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsRightofuseAssets
      contextRef="From2024-01-012024-12-31_ifrs-full_VehiclesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002193"
      unitRef="KRW">44399000</ifrs-full:AcquisitionsThroughBusinessCombinationsRightofuseAssets>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsRightofuseAssets
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002195"
      unitRef="KRW">1191097000</ifrs-full:AcquisitionsThroughBusinessCombinationsRightofuseAssets>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsRightofuseAssets
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002197"
      unitRef="KRW">1190149000</ifrs-full:AcquisitionsThroughBusinessCombinationsRightofuseAssets>
    <cik0002058261:RightofuseAssetsAccumulatedDepreciation
      contextRef="From2025-01-012025-12-31_ifrs-full_BuildingsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002199"
      unitRef="KRW">652250000</cik0002058261:RightofuseAssetsAccumulatedDepreciation>
    <cik0002058261:RightofuseAssetsAccumulatedDepreciation
      contextRef="From2024-01-012024-12-31_ifrs-full_BuildingsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002201"
      unitRef="KRW">523282000</cik0002058261:RightofuseAssetsAccumulatedDepreciation>
    <cik0002058261:RightofuseAssetsAccumulatedDepreciation
      contextRef="From2025-01-012025-12-31_ifrs-full_VehiclesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002203"
      unitRef="KRW">26354000</cik0002058261:RightofuseAssetsAccumulatedDepreciation>
    <cik0002058261:RightofuseAssetsAccumulatedDepreciation
      contextRef="From2024-01-012024-12-31_ifrs-full_VehiclesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002205"
      unitRef="KRW">17473000</cik0002058261:RightofuseAssetsAccumulatedDepreciation>
    <cik0002058261:RightofuseAssetsAccumulatedDepreciation
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002207"
      unitRef="KRW">678604000</cik0002058261:RightofuseAssetsAccumulatedDepreciation>
    <cik0002058261:RightofuseAssetsAccumulatedDepreciation
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002209"
      unitRef="KRW">540755000</cik0002058261:RightofuseAssetsAccumulatedDepreciation>
    <ifrs-full:AdditionsToRightofuseAssets
      contextRef="From2025-01-012025-12-31_ifrs-full_BuildingsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002211"
      unitRef="KRW">494448000</ifrs-full:AdditionsToRightofuseAssets>
    <ifrs-full:AdditionsToRightofuseAssets
      contextRef="From2024-01-012024-12-31_ifrs-full_BuildingsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002213"
      unitRef="KRW">622468000</ifrs-full:AdditionsToRightofuseAssets>
    <ifrs-full:AdditionsToRightofuseAssets
      contextRef="From2025-01-012025-12-31_ifrs-full_VehiclesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002215"
      unitRef="KRW">18045000</ifrs-full:AdditionsToRightofuseAssets>
    <ifrs-full:AdditionsToRightofuseAssets
      contextRef="From2024-01-012024-12-31_ifrs-full_VehiclesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002217"
      unitRef="KRW">26926000</ifrs-full:AdditionsToRightofuseAssets>
    <ifrs-full:AdditionsToRightofuseAssets
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002219"
      unitRef="KRW">512493000</ifrs-full:AdditionsToRightofuseAssets>
    <ifrs-full:AdditionsToRightofuseAssets
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002221"
      unitRef="KRW">649394000</ifrs-full:AdditionsToRightofuseAssets>
    <cik0002058261:DisclosureOfReconcileOpeningAndEndingBalanceOfLeaseLiabilitiesTextBlock
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact002230">&lt;table cellpadding="0" cellspacing="0" id="xdx_898_ecustom--DisclosureOfReconcileOpeningAndEndingBalanceOfLeaseLiabilitiesTextBlock_pn3n3_zQojhmZ13Qjh" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Leases (Details 1)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span id="xdx_8BC_zu8Ekia3jHg2" style="display: none"&gt;Changes in right-of-use assets&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49F_20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_z5xHPPBEFI7c" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49E_20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_zeJ2v8j8SwZ5" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_498_20250101__20251231_zx8irqqZ17ef" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="10" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Building&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Vehicles&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="10" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40C_eifrs-full--RightofuseAssets_iS_pn3n3_zQvL5gXkTt15" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Balance as of January&#160;1, 2025&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;622,468&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;26,926&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;649,394&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--Depreciations_iN_di_z8aQ0x7MtdP6" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Depreciation&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;(128,967&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;(8,881&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;(137,848&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--LeaseReassessments_zEUBUdPtnYXd" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Lease reassessment&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;947&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2241"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;947&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_401_eifrs-full--RightofuseAssets_iE_pn3n3_zy9lNUVqojoe" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.25pt"&gt;Balance as of December&#160;31, 2025&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;494,448&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;18,045&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;512,493&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_495_20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_zqUrZLtShP1k" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_492_20240101__20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_zMY8UCPalKhd" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_491_20240101__20241231_ztoaLEDBlww1" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="10" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Building&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Vehicles&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="10" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr id="xdx_408_eifrs-full--RightofuseAssets_iS_pn3n3_zoRCA1k1GlKj" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Balance as of January&#160;1, 2024&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;750,037&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;35,805&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;785,842&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--Depreciations_iN_di_zWBcXKo7xE2k" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Depreciation&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;(129,607&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;(8,879&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;(138,486&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--LeaseReassessments_zArzhtki7822" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Lease reassessment&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;2,038&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2257"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;2,038&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_402_eifrs-full--RightofuseAssets_iE_pn3n3_zYcmRLRE56L1" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.25pt"&gt;Balance as of December&#160;31, 2024&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;622,468&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;26,926&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;649,394&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:DisclosureOfReconcileOpeningAndEndingBalanceOfLeaseLiabilitiesTextBlock>
    <ifrs-full:RightofuseAssets
      contextRef="AsOf2024-12-31_ifrs-full_BuildingsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002232"
      unitRef="KRW">622468000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="AsOf2024-12-31_ifrs-full_VehiclesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002233"
      unitRef="KRW">26926000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002234"
      unitRef="KRW">649394000</ifrs-full:RightofuseAssets>
    <cik0002058261:Depreciations
      contextRef="From2025-01-012025-12-31_ifrs-full_BuildingsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002236"
      unitRef="KRW">128967000</cik0002058261:Depreciations>
    <cik0002058261:Depreciations
      contextRef="From2025-01-012025-12-31_ifrs-full_VehiclesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002237"
      unitRef="KRW">8881000</cik0002058261:Depreciations>
    <cik0002058261:Depreciations
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002238"
      unitRef="KRW">137848000</cik0002058261:Depreciations>
    <cik0002058261:LeaseReassessments
      contextRef="From2025-01-012025-12-31_ifrs-full_BuildingsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002240"
      unitRef="KRW">947000</cik0002058261:LeaseReassessments>
    <cik0002058261:LeaseReassessments
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002242"
      unitRef="KRW">947000</cik0002058261:LeaseReassessments>
    <ifrs-full:RightofuseAssets
      contextRef="AsOf2025-12-31_ifrs-full_BuildingsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002244"
      unitRef="KRW">494448000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="AsOf2025-12-31_ifrs-full_VehiclesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002245"
      unitRef="KRW">18045000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002246"
      unitRef="KRW">512493000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="AsOf2023-12-31_ifrs-full_BuildingsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002248"
      unitRef="KRW">750037000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="AsOf2023-12-31_ifrs-full_VehiclesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002249"
      unitRef="KRW">35805000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="AsOf2023-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002250"
      unitRef="KRW">785842000</ifrs-full:RightofuseAssets>
    <cik0002058261:Depreciations
      contextRef="From2024-01-012024-12-31_ifrs-full_BuildingsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002252"
      unitRef="KRW">129607000</cik0002058261:Depreciations>
    <cik0002058261:Depreciations
      contextRef="From2024-01-012024-12-31_ifrs-full_VehiclesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002253"
      unitRef="KRW">8879000</cik0002058261:Depreciations>
    <cik0002058261:Depreciations
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002254"
      unitRef="KRW">138486000</cik0002058261:Depreciations>
    <cik0002058261:LeaseReassessments
      contextRef="From2024-01-012024-12-31_ifrs-full_BuildingsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002256"
      unitRef="KRW">2038000</cik0002058261:LeaseReassessments>
    <cik0002058261:LeaseReassessments
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002258"
      unitRef="KRW">2038000</cik0002058261:LeaseReassessments>
    <ifrs-full:RightofuseAssets
      contextRef="AsOf2024-12-31_ifrs-full_BuildingsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002260"
      unitRef="KRW">622468000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="AsOf2024-12-31_ifrs-full_VehiclesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002261"
      unitRef="KRW">26926000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002262"
      unitRef="KRW">649394000</ifrs-full:RightofuseAssets>
    <cik0002058261:ChangesInLeaseLiabilitiesTableTextBlock
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact002264">&lt;table cellpadding="0" cellspacing="0" id="xdx_891_ecustom--ChangesInLeaseLiabilitiesTableTextBlock_pn3n3_zNtMVPBqz5s3" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Leases (Details 2)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.25in; text-align: left; vertical-align: top"&gt;&lt;span id="xdx_8B5_zO67YD8Nye44" style="display: none"&gt;Changes in lease liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&lt;b&gt;Balance as of January&#160;1&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--LeaseLiabilities_iS_pn3n3_c20250101__20251231_zVVpzk8xADu6" title="Balance at beginning"&gt;669,032&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--LeaseLiabilities_iS_pn3n3_c20240101__20241231_zDgJdh7BB0df" title="Balance at beginning"&gt;776,385&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.25in; text-align: left; vertical-align: top"&gt;New leases&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--NewLeases_pn3n3_c20250101__20251231_zW6PDKrMnVs5" title="New leases"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2270"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_903_ecustom--NewLeases_pn3n3_c20240101__20241231_zTEKjRpoWlp4" title="New leases"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2272"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.25in; text-align: left; vertical-align: top"&gt;Interest expense&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--InterestExpenseLease_pn3n3_c20250101__20251231_zFXlUUZOIJLh" title="Interest expense"&gt;52,261&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_903_ecustom--InterestExpenseLease_pn3n3_c20240101__20241231_zpbUlIJbS4V8" title="Interest expense"&gt;62,090&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.25in; text-align: left; vertical-align: top"&gt;Payment of lease liabilities&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_907_ecustom--PaymentOfLeaseLiabilities_iN_pn3n3_di_c20250101__20251231_z5xwzT2T3zV3" title="Payment of lease liabilities"&gt;(169,609&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_ecustom--PaymentOfLeaseLiabilities_iN_pn3n3_di_c20240101__20241231_zwCHO3GErPz" title="Payment of lease liabilities"&gt;(171,481&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.25in; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;Lease reassessment&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_901_ecustom--LeaseReassessment_pn3n3_c20250101__20251231_zhddbBtLx4ua" title="Lease reassessment"&gt;947&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_905_ecustom--LeaseReassessment_pn3n3_c20240101__20241231_z5D7fDA9rPe" title="Lease reassessment"&gt;2,038&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;&lt;b&gt;Balance as of December&#160;31&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--LeaseLiabilities_iE_pn3n3_c20250101__20251231_z7GbrtxcAP2l" title="Balance at ending"&gt;552,631&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--LeaseLiabilities_iE_pn3n3_c20240101__20241231_zjDA4UcbPG9h" title="Balance at ending"&gt;669,032&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.25in; text-align: left; vertical-align: top"&gt;Current portion&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--CurrentLeaseLiabilities_iI_pn3n3_c20251231_zuIGiyU2IdT5" title="Current portion"&gt;122,626&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--CurrentLeaseLiabilities_iI_pn3n3_c20241231_zwDs9VlbOW1b" title="Current portion"&gt;117,351&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.25in; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;Non-current portion&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--NoncurrentLeaseLiabilities_iI_pn3n3_c20251231_zdP90PAhw41" title="Non-current portion"&gt;430,005&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--NoncurrentLeaseLiabilities_iI_pn3n3_c20241231_zPwJdHg6Jtb3" title="Non-current portion"&gt;551,681&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top; padding-bottom: 1.25pt"&gt;&lt;b&gt;Total lease liabilities&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--LeaseLiabilities_iI_pn3n3_c20251231_zexnN4YMmBz" title="Total lease liabilities"&gt;552,631&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--LeaseLiabilities_iI_pn3n3_c20241231_zW5WbrsEkmLj" title="Total lease liabilities"&gt;669,032&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:ChangesInLeaseLiabilitiesTableTextBlock>
    <ifrs-full:LeaseLiabilities
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002266"
      unitRef="KRW">669032000</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="AsOf2023-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002268"
      unitRef="KRW">776385000</ifrs-full:LeaseLiabilities>
    <cik0002058261:InterestExpenseLease
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002274"
      unitRef="KRW">52261000</cik0002058261:InterestExpenseLease>
    <cik0002058261:InterestExpenseLease
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002276"
      unitRef="KRW">62090000</cik0002058261:InterestExpenseLease>
    <cik0002058261:PaymentOfLeaseLiabilities
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002278"
      unitRef="KRW">169609000</cik0002058261:PaymentOfLeaseLiabilities>
    <cik0002058261:PaymentOfLeaseLiabilities
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002280"
      unitRef="KRW">171481000</cik0002058261:PaymentOfLeaseLiabilities>
    <cik0002058261:LeaseReassessment
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002282"
      unitRef="KRW">947000</cik0002058261:LeaseReassessment>
    <cik0002058261:LeaseReassessment
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002284"
      unitRef="KRW">2038000</cik0002058261:LeaseReassessment>
    <ifrs-full:LeaseLiabilities
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002286"
      unitRef="KRW">552631000</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002288"
      unitRef="KRW">669032000</ifrs-full:LeaseLiabilities>
    <ifrs-full:CurrentLeaseLiabilities
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002290"
      unitRef="KRW">122626000</ifrs-full:CurrentLeaseLiabilities>
    <ifrs-full:CurrentLeaseLiabilities
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002292"
      unitRef="KRW">117351000</ifrs-full:CurrentLeaseLiabilities>
    <ifrs-full:NoncurrentLeaseLiabilities
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002294"
      unitRef="KRW">430005000</ifrs-full:NoncurrentLeaseLiabilities>
    <ifrs-full:NoncurrentLeaseLiabilities
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002296"
      unitRef="KRW">551681000</ifrs-full:NoncurrentLeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002298"
      unitRef="KRW">552631000</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002300"
      unitRef="KRW">669032000</ifrs-full:LeaseLiabilities>
    <cik0002058261:UndiscountedLeasePaymentsTableTextBlock
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact002309">&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--UndiscountedLeasePaymentsTableTextBlock_pn3n3_zscXzlykxZ84" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Leases (Details 3)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td id="xdx_8BA_zOcPs63PhMec" style="font: 10pt Times New Roman; display: none; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Undiscounted lease payments&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_494_20250101__20251231_zPKIyBnz6li7" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--Within1Year_i_pn3n" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Within 1 year&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;163,727&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--Between1And5Years_i_pn3n" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Between 1 and 5 years&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;497,711&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--Over5Years_i_pn3n" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Over 5 years&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2315"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--TotalLeasePayments_i_pn3n" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; vertical-align: top; padding-left: 0.125in; padding-bottom: 0.5pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;661,438&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--LessImputedInterest_iN_pn3n3_di_z6NV5Kp6piud" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;b&gt;Less: imputed interest&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;(108,807&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--LeaseLiabilitity_i_pn3n" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.25pt"&gt;&lt;b&gt;Lease liabilities&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;552,631&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:UndiscountedLeasePaymentsTableTextBlock>
    <cik0002058261:Within1Year
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002311"
      unitRef="KRW">163727000</cik0002058261:Within1Year>
    <cik0002058261:Between1And5Years
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002313"
      unitRef="KRW">497711000</cik0002058261:Between1And5Years>
    <cik0002058261:TotalLeasePayments
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002317"
      unitRef="KRW">661438000</cik0002058261:TotalLeasePayments>
    <cik0002058261:LessImputedInterest
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002319"
      unitRef="KRW">108807000</cik0002058261:LessImputedInterest>
    <cik0002058261:LeaseLiabilitity
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002321"
      unitRef="KRW">552631000</cik0002058261:LeaseLiabilitity>
    <ifrs-full:DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact002323">&lt;table cellpadding="0" cellspacing="0" id="xdx_899_eifrs-full--DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory_pn3n3_zNKWUXnhn5q" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Leases (Details 4)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&lt;span id="xdx_8BE_zb5QGvSANtvg" style="display: none"&gt;Schedule of lease-related expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_497_20250101__20251231_zFmOmiG2KfF7" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_490_20240101__20241231_zOaBBARIKexj" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--InterestExpenseOnLeaseLiabilities_i_pn3n" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Interest expense relating to lease liabilities (included in finance cost)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;52,261&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;62,090&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--ExpenseRelatingToShorttermLeases_i_pn3n" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Expense relating to short-term leases&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;1,200&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;9,648&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40F_eifrs-full--ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed_i_pn3n" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Expense relating to leases of low-value assets&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;7,481&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;5,183&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.25in; text-align: left"&gt;&lt;b&gt;D.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;&lt;b&gt;Cash outflows for leases&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Cash outflows for leases for the years ended December&#160;31, 2025 and 2024 are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_891_ecustom--CashOutflowsForLeasesTableTextBlock_pn3n3_zHnnOqNNEW1g" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Leases (Details 5)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&lt;span id="xdx_8BB_zm4yECe5oAje" style="display: none"&gt;Cash outflows for leases&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_497_20250101__20251231_zmeXDuQrIONa" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_490_20240101__20241231_zsuA5yV9uE0k" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--CashOutflowsForPrincipalRepaymentsOfLeaseLiabilities_i_pn3n" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Cash outflows for principal repayments of lease liabilities&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;117,348&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;109,391&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--CashOutflowsForInterestPaidOnLeaseLiabilities_i_pn3n" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Cash outflows for interest paid on lease liabilities&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;52,261&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;62,090&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--CashOutflowsForPaymentsForShorttermLease_i_pn3n" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Cash outflows for payments for short-term lease&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;1,200&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;9,648&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--CashOutflowsForPaymentsForLeasesOfLowvalueAssets_z1uyXnjsK1Ml" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;Cash outflows for payments for leases of low-value assets&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;7,481&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;5,183&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--CashOutflowForLeases_ztrAAOqL16q1" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-left: 0.125in; text-align: center; vertical-align: top; padding-bottom: 1.25pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;178,290&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;186,312&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</ifrs-full:DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory>
    <ifrs-full:InterestExpenseOnLeaseLiabilities
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002325"
      unitRef="KRW">52261000</ifrs-full:InterestExpenseOnLeaseLiabilities>
    <ifrs-full:InterestExpenseOnLeaseLiabilities
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002326"
      unitRef="KRW">62090000</ifrs-full:InterestExpenseOnLeaseLiabilities>
    <cik0002058261:ExpenseRelatingToShorttermLeases
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002328"
      unitRef="KRW">1200000</cik0002058261:ExpenseRelatingToShorttermLeases>
    <cik0002058261:ExpenseRelatingToShorttermLeases
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002329"
      unitRef="KRW">9648000</cik0002058261:ExpenseRelatingToShorttermLeases>
    <ifrs-full:ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002331"
      unitRef="KRW">7481000</ifrs-full:ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed>
    <ifrs-full:ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002332"
      unitRef="KRW">5183000</ifrs-full:ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed>
    <cik0002058261:CashOutflowsForLeasesTableTextBlock
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact002334">&lt;table cellpadding="0" cellspacing="0" id="xdx_891_ecustom--CashOutflowsForLeasesTableTextBlock_pn3n3_zHnnOqNNEW1g" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Leases (Details 5)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&lt;span id="xdx_8BB_zm4yECe5oAje" style="display: none"&gt;Cash outflows for leases&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_497_20250101__20251231_zmeXDuQrIONa" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_490_20240101__20241231_zsuA5yV9uE0k" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--CashOutflowsForPrincipalRepaymentsOfLeaseLiabilities_i_pn3n" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Cash outflows for principal repayments of lease liabilities&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;117,348&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;109,391&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--CashOutflowsForInterestPaidOnLeaseLiabilities_i_pn3n" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Cash outflows for interest paid on lease liabilities&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;52,261&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;62,090&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--CashOutflowsForPaymentsForShorttermLease_i_pn3n" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Cash outflows for payments for short-term lease&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;1,200&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;9,648&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--CashOutflowsForPaymentsForLeasesOfLowvalueAssets_z1uyXnjsK1Ml" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;Cash outflows for payments for leases of low-value assets&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;7,481&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;5,183&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--CashOutflowForLeases_ztrAAOqL16q1" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-left: 0.125in; text-align: center; vertical-align: top; padding-bottom: 1.25pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;178,290&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;186,312&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:CashOutflowsForLeasesTableTextBlock>
    <cik0002058261:CashOutflowsForPrincipalRepaymentsOfLeaseLiabilities
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002336"
      unitRef="KRW">117348000</cik0002058261:CashOutflowsForPrincipalRepaymentsOfLeaseLiabilities>
    <cik0002058261:CashOutflowsForPrincipalRepaymentsOfLeaseLiabilities
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002337"
      unitRef="KRW">109391000</cik0002058261:CashOutflowsForPrincipalRepaymentsOfLeaseLiabilities>
    <cik0002058261:CashOutflowsForInterestPaidOnLeaseLiabilities
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002339"
      unitRef="KRW">52261000</cik0002058261:CashOutflowsForInterestPaidOnLeaseLiabilities>
    <cik0002058261:CashOutflowsForInterestPaidOnLeaseLiabilities
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002340"
      unitRef="KRW">62090000</cik0002058261:CashOutflowsForInterestPaidOnLeaseLiabilities>
    <cik0002058261:CashOutflowsForPaymentsForShorttermLease
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002342"
      unitRef="KRW">1200000</cik0002058261:CashOutflowsForPaymentsForShorttermLease>
    <cik0002058261:CashOutflowsForPaymentsForShorttermLease
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002343"
      unitRef="KRW">9648000</cik0002058261:CashOutflowsForPaymentsForShorttermLease>
    <cik0002058261:CashOutflowsForPaymentsForLeasesOfLowvalueAssets
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002345"
      unitRef="KRW">7481000</cik0002058261:CashOutflowsForPaymentsForLeasesOfLowvalueAssets>
    <cik0002058261:CashOutflowsForPaymentsForLeasesOfLowvalueAssets
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002346"
      unitRef="KRW">5183000</cik0002058261:CashOutflowsForPaymentsForLeasesOfLowvalueAssets>
    <ifrs-full:CashOutflowForLeases
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002348"
      unitRef="KRW">178290000</ifrs-full:CashOutflowForLeases>
    <ifrs-full:CashOutflowForLeases
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002349"
      unitRef="KRW">186312000</ifrs-full:CashOutflowForLeases>
    <cik0002058261:IntangibleAssetsTextBlock
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact002358">&lt;p id="xdx_809_ecustom--IntangibleAssetsTextBlock_zjuOeTzRmMN6" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;15. &lt;span id="xdx_825_zaMOg7Zxm4M3"&gt;Intangible assets&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.25in; text-align: left"&gt;&lt;b&gt;A.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;&lt;b&gt;Reconciliation of carrying amount&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Details of intangible assets as of December&#160;31, 2025 and 2024 are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89E_ecustom--IntangibleAssetsTableTextBlock_pn3n3_zsoQ90ZMdRT3" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Intangible assets (Details)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&lt;span id="xdx_8BB_zdFgqxZJp8Ue" style="display: none"&gt;Schedule of intangible assets&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="10" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;December&#160;31, 2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Acquisition&lt;br/&gt; price&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Accumulated&lt;br/&gt; amortization&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Book&lt;br/&gt; amount&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="10" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Software&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--IntangibleAssetsOtherThanGoodwill_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AcquisitionPriceMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_zvF2Q41Wun7h" title="Intangible assets"&gt;10,564&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_900_ecustom--AccumulatedAmortization_iNI_pn3n3_di_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedAmortisationMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_zUmC2xpY1Oq" title="Accumulated amortization"&gt;(9,537&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--IntangibleAssetsOtherThanGoodwill_iI_pn3n3_c20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_zBpcDQDG5vmh" title="Intangible assets"&gt;1,027&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Patents&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--IntangibleAssetsOtherThanGoodwill_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AcquisitionPriceMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--PatentMember_z709FW6GLCw4" title="Intangible assets"&gt;349,730&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_ecustom--AccumulatedAmortization_iNI_pn3n3_di_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedAmortisationMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--PatentMember_zgDahydgsP7e"&gt;(346,901&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--IntangibleAssetsOtherThanGoodwill_iI_pn3n3_c20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--PatentMember_zpZcVLHDcup8" title="Intangible assets"&gt;2,829&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;Brand&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--IntangibleAssetsOtherThanGoodwill_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AcquisitionPriceMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--BrandMember_zhOT5hJ9rls8" title="Intangible assets"&gt;10,585&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_909_ecustom--AccumulatedAmortization_iNI_pn3n3_di_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedAmortisationMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--BrandMember_zVb232pjRfe7"&gt;(9,199&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--IntangibleAssetsOtherThanGoodwill_iI_pn3n3_c20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--BrandMember_zX2uik9HqrNf" title="Intangible assets"&gt;1,386&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-left: 0.125in; text-align: center; vertical-align: top; padding-bottom: 1.25pt"&gt;Total&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--IntangibleAssetsOtherThanGoodwill_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AcquisitionPriceMember_zslqyLz3AeV5" title="Intangible assets"&gt;370,879&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_900_ecustom--AccumulatedAmortization_iNI_pn3n3_di_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedAmortisationMember_zmLAacSJKsu2"&gt;(365,637&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--IntangibleAssetsOtherThanGoodwill_iI_pn3n3_c20251231_zA2pLkXOpaJl" title="Intangible assets"&gt;5,242&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="10" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;December&#160;31, 2024&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Cost&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Accumulated&lt;br/&gt; amortization&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Carrying&lt;br/&gt; amount&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="10" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Software&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--IntangibleAssetsOtherThanGoodwill_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CostMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_zFGFoulEhyEa" title="Intangible assets"&gt;10,564&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_902_ecustom--AccumulatedAmortization_iNI_pn3n3_di_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedAmortisationMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_zJ1gTS6cXYSh"&gt;(9,024&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--IntangibleAssetsOtherThanGoodwill_iI_pn3n3_c20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--CostMember_zLgU3ilWP9vb" title="Intangible assets"&gt;1,540&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Patents&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--IntangibleAssetsOtherThanGoodwill_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CostMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--PatentMember_z3h5qUEvFdF4" title="Intangible assets"&gt;349,730&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--AccumulatedAmortization_iNI_pn3n3_di_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedAmortisationMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--PatentMember_zz89zesuPH4c"&gt;(345,264&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--IntangibleAssetsOtherThanGoodwill_iI_pn3n3_c20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--PatentMember_zqjUzt6RObi" title="Intangible assets"&gt;4,466&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;Brand&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--IntangibleAssetsOtherThanGoodwill_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CostMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--BrandMember_znHUgtsmDEvc" title="Intangible assets"&gt;9,048&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--AccumulatedAmortization_iNI_pn3n3_di_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedAmortisationMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--BrandMember_zVnls8q1uH4a"&gt;(9,045&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--IntangibleAssetsOtherThanGoodwill_iI_pn3n3_c20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--BrandMember_zoR1EzDWXnoj" title="Intangible assets"&gt;3&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-left: 0.125in; text-align: center; vertical-align: top; padding-bottom: 1.25pt"&gt;Total&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--IntangibleAssetsOtherThanGoodwill_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CostMember_z4yjffVSePL8" title="Intangible assets"&gt;369,342&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_901_ecustom--AccumulatedAmortization_iNI_pn3n3_di_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedAmortisationMember_zHik818M4RGc"&gt;(363,333&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--IntangibleAssetsOtherThanGoodwill_iI_pn3n3_c20241231_zN9tYZFyE1M2" title="Intangible assets"&gt;6,009&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AF_zxO8vuvMK5W4" style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Details of the changes in intangible assets for the years ended December&#160;31, 2025 and 2024 are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89C_ecustom--ChangesInIntangibleAssetsTableTextBlock_pn3n3_zO6dYIvPVeYe" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Intangible assets (Details 1)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&lt;span id="xdx_8B4_zOPLeXtQA651" style="display: none"&gt;Schedule of changes on intangible assets&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_498_20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_zotqNGtANr7a" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_490_20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--PatentMember_zQoYl9gYTWB5" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49E_20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--BrandMember_zWDSBPlFZ0D5" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_497_20250101__20251231_zZTTLIO6BKmi" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="14" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Software&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Patents&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Brand&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="14" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr id="xdx_408_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_z9wmDv00MDx8" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Beginning balance&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;1,540&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;4,466&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;3&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;6,009&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40F_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_i_pn3n" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Acquisitions&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2410"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2411"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;1,536&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;1,536&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40A_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_iN_di_zt9xFrKy9iRb" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;Amortization&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;(513&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;(1,637&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;(153&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;(2,303&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_407_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_zU5q4ZPGOeej" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top; padding-bottom: 1.25pt"&gt;Ending balance&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;1,027&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;2,829&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;1,386&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;5,242&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

















&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_498_20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_zd6kIojyj5Cg" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_492_20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--PatentMember_zrgRGdX6yiW7" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49A_20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--BrandMember_zI28CPNA1Jt3" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_492_20240101__20241231_zqpl5rv8J7u9" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="14" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Software&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Patents&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Brand&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="14" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr id="xdx_403_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_zfrNZ5KGPuQ4" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Beginning balance&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;2,052&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;6,714&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;3&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;8,769&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_403_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_iN_di_z49MUKSkUGli" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Amortization&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;(512&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;(2,248&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2439"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;(2,760&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40A_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_zMuRkpQTiwZ1" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.25pt"&gt;Ending balance&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;1,540&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;4,466&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;3&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;6,009&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A6_zk11VvAO6ubj" style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.25in; text-align: left"&gt;&lt;b&gt;B.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;&lt;b&gt;Amortization&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;For the years ended December&#160;31, 2025 and 2024, amortization expense totaling Korean won &lt;span id="xdx_907_ecustom--AmortizationExpense_pn3n3_c20250101__20251231_zVOVqY3jfZ" title="Amortization expense"&gt;2,303&lt;/span&gt; and &lt;span id="xdx_905_ecustom--AmortizationExpense_pn3n3_c20240101__20241231_z8Ky2cm1yhH7" title="Amortization expense"&gt;2,760&lt;/span&gt; thousand was recognized within selling, general and administrative expenses in the statements of comprehensive income.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.25in; text-align: left"&gt;&lt;b&gt;C.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;&lt;b&gt;Research and development cost&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company recognized total research and development costs of Korean won &lt;span id="xdx_90C_ecustom--ResearchAndDevelopmentCost_pn3n3_c20250101__20251231_zHlIewNfkal9" title="Research and development cost"&gt;777,685&lt;/span&gt; and &lt;span id="xdx_90B_ecustom--ResearchAndDevelopmentCost_pn3n3_c20240101__20241231_z4jgzwHqW1sf" title="Research and development cost"&gt;1,007,139&lt;/span&gt; thousand for the years ended December&#160;31, 2025 and 2024.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

</cik0002058261:IntangibleAssetsTextBlock>
    <cik0002058261:IntangibleAssetsTableTextBlock
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact002360">&lt;table cellpadding="0" cellspacing="0" id="xdx_89E_ecustom--IntangibleAssetsTableTextBlock_pn3n3_zsoQ90ZMdRT3" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Intangible assets (Details)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&lt;span id="xdx_8BB_zdFgqxZJp8Ue" style="display: none"&gt;Schedule of intangible assets&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="10" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;December&#160;31, 2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Acquisition&lt;br/&gt; price&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Accumulated&lt;br/&gt; amortization&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Book&lt;br/&gt; amount&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="10" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Software&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--IntangibleAssetsOtherThanGoodwill_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AcquisitionPriceMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_zvF2Q41Wun7h" title="Intangible assets"&gt;10,564&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_900_ecustom--AccumulatedAmortization_iNI_pn3n3_di_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedAmortisationMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_zUmC2xpY1Oq" title="Accumulated amortization"&gt;(9,537&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--IntangibleAssetsOtherThanGoodwill_iI_pn3n3_c20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_zBpcDQDG5vmh" title="Intangible assets"&gt;1,027&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Patents&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--IntangibleAssetsOtherThanGoodwill_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AcquisitionPriceMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--PatentMember_z709FW6GLCw4" title="Intangible assets"&gt;349,730&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_ecustom--AccumulatedAmortization_iNI_pn3n3_di_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedAmortisationMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--PatentMember_zgDahydgsP7e"&gt;(346,901&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--IntangibleAssetsOtherThanGoodwill_iI_pn3n3_c20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--PatentMember_zpZcVLHDcup8" title="Intangible assets"&gt;2,829&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;Brand&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--IntangibleAssetsOtherThanGoodwill_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AcquisitionPriceMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--BrandMember_zhOT5hJ9rls8" title="Intangible assets"&gt;10,585&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_909_ecustom--AccumulatedAmortization_iNI_pn3n3_di_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedAmortisationMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--BrandMember_zVb232pjRfe7"&gt;(9,199&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--IntangibleAssetsOtherThanGoodwill_iI_pn3n3_c20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--BrandMember_zX2uik9HqrNf" title="Intangible assets"&gt;1,386&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-left: 0.125in; text-align: center; vertical-align: top; padding-bottom: 1.25pt"&gt;Total&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--IntangibleAssetsOtherThanGoodwill_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AcquisitionPriceMember_zslqyLz3AeV5" title="Intangible assets"&gt;370,879&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_900_ecustom--AccumulatedAmortization_iNI_pn3n3_di_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedAmortisationMember_zmLAacSJKsu2"&gt;(365,637&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--IntangibleAssetsOtherThanGoodwill_iI_pn3n3_c20251231_zA2pLkXOpaJl" title="Intangible assets"&gt;5,242&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="10" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;December&#160;31, 2024&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Cost&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Accumulated&lt;br/&gt; amortization&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Carrying&lt;br/&gt; amount&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="10" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Software&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--IntangibleAssetsOtherThanGoodwill_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CostMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_zFGFoulEhyEa" title="Intangible assets"&gt;10,564&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_902_ecustom--AccumulatedAmortization_iNI_pn3n3_di_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedAmortisationMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_zJ1gTS6cXYSh"&gt;(9,024&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--IntangibleAssetsOtherThanGoodwill_iI_pn3n3_c20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--CostMember_zLgU3ilWP9vb" title="Intangible assets"&gt;1,540&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Patents&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--IntangibleAssetsOtherThanGoodwill_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CostMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--PatentMember_z3h5qUEvFdF4" title="Intangible assets"&gt;349,730&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--AccumulatedAmortization_iNI_pn3n3_di_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedAmortisationMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--PatentMember_zz89zesuPH4c"&gt;(345,264&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--IntangibleAssetsOtherThanGoodwill_iI_pn3n3_c20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--PatentMember_zqjUzt6RObi" title="Intangible assets"&gt;4,466&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;Brand&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--IntangibleAssetsOtherThanGoodwill_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CostMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--BrandMember_znHUgtsmDEvc" title="Intangible assets"&gt;9,048&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--AccumulatedAmortization_iNI_pn3n3_di_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedAmortisationMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--BrandMember_zVnls8q1uH4a"&gt;(9,045&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--IntangibleAssetsOtherThanGoodwill_iI_pn3n3_c20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--BrandMember_zoR1EzDWXnoj" title="Intangible assets"&gt;3&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-left: 0.125in; text-align: center; vertical-align: top; padding-bottom: 1.25pt"&gt;Total&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--IntangibleAssetsOtherThanGoodwill_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CostMember_z4yjffVSePL8" title="Intangible assets"&gt;369,342&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_901_ecustom--AccumulatedAmortization_iNI_pn3n3_di_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedAmortisationMember_zHik818M4RGc"&gt;(363,333&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--IntangibleAssetsOtherThanGoodwill_iI_pn3n3_c20241231_zN9tYZFyE1M2" title="Intangible assets"&gt;6,009&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:IntangibleAssetsTableTextBlock>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="AsOf2025-12-31_custom_AcquisitionPriceMember_ifrs-full_ComputerSoftwareMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002362"
      unitRef="KRW">10564000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <cik0002058261:AccumulatedAmortization
      contextRef="AsOf2025-12-31_custom_AccumulatedAmortisationMember_ifrs-full_ComputerSoftwareMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002364"
      unitRef="KRW">9537000</cik0002058261:AccumulatedAmortization>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="AsOf2025-12-31_ifrs-full_ComputerSoftwareMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002366"
      unitRef="KRW">1027000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="AsOf2025-12-31_custom_AcquisitionPriceMember_custom_PatentMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002368"
      unitRef="KRW">349730000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <cik0002058261:AccumulatedAmortization
      contextRef="AsOf2025-12-31_custom_AccumulatedAmortisationMember_custom_PatentMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002369"
      unitRef="KRW">346901000</cik0002058261:AccumulatedAmortization>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="AsOf2025-12-31_custom_PatentMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002371"
      unitRef="KRW">2829000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="AsOf2025-12-31_custom_AcquisitionPriceMember_custom_BrandMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002373"
      unitRef="KRW">10585000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <cik0002058261:AccumulatedAmortization
      contextRef="AsOf2025-12-31_custom_AccumulatedAmortisationMember_custom_BrandMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002374"
      unitRef="KRW">9199000</cik0002058261:AccumulatedAmortization>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="AsOf2025-12-31_custom_BrandMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002376"
      unitRef="KRW">1386000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="AsOf2025-12-31_custom_AcquisitionPriceMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002378"
      unitRef="KRW">370879000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <cik0002058261:AccumulatedAmortization
      contextRef="AsOf2025-12-31_custom_AccumulatedAmortisationMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002379"
      unitRef="KRW">365637000</cik0002058261:AccumulatedAmortization>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002381"
      unitRef="KRW">5242000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="AsOf2024-12-31_custom_CostMember_ifrs-full_ComputerSoftwareMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002383"
      unitRef="KRW">10564000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <cik0002058261:AccumulatedAmortization
      contextRef="AsOf2024-12-31_custom_AccumulatedAmortisationMember_ifrs-full_ComputerSoftwareMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002384"
      unitRef="KRW">9024000</cik0002058261:AccumulatedAmortization>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="AsOf2024-12-31_custom_CostMember_custom_CubebioCo.Ltd.Member273618875"
      decimals="-3"
      id="Fact002386"
      unitRef="KRW">1540000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="AsOf2024-12-31_custom_CostMember_custom_PatentMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002388"
      unitRef="KRW">349730000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <cik0002058261:AccumulatedAmortization
      contextRef="AsOf2024-12-31_custom_AccumulatedAmortisationMember_custom_PatentMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002389"
      unitRef="KRW">345264000</cik0002058261:AccumulatedAmortization>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="AsOf2024-12-31_custom_PatentMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002391"
      unitRef="KRW">4466000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="AsOf2024-12-31_custom_CostMember_custom_BrandMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002393"
      unitRef="KRW">9048000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <cik0002058261:AccumulatedAmortization
      contextRef="AsOf2024-12-31_custom_AccumulatedAmortisationMember_custom_BrandMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002394"
      unitRef="KRW">9045000</cik0002058261:AccumulatedAmortization>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="AsOf2024-12-31_custom_BrandMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002396"
      unitRef="KRW">3000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="AsOf2024-12-31_custom_CostMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002398"
      unitRef="KRW">369342000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <cik0002058261:AccumulatedAmortization
      contextRef="AsOf2024-12-31_custom_AccumulatedAmortisationMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002399"
      unitRef="KRW">363333000</cik0002058261:AccumulatedAmortization>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002401"
      unitRef="KRW">6009000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <cik0002058261:ChangesInIntangibleAssetsTableTextBlock
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact002403">&lt;table cellpadding="0" cellspacing="0" id="xdx_89C_ecustom--ChangesInIntangibleAssetsTableTextBlock_pn3n3_zO6dYIvPVeYe" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Intangible assets (Details 1)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&lt;span id="xdx_8B4_zOPLeXtQA651" style="display: none"&gt;Schedule of changes on intangible assets&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_498_20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_zotqNGtANr7a" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_490_20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--PatentMember_zQoYl9gYTWB5" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49E_20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--BrandMember_zWDSBPlFZ0D5" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_497_20250101__20251231_zZTTLIO6BKmi" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="14" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Software&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Patents&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Brand&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="14" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr id="xdx_408_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_z9wmDv00MDx8" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Beginning balance&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;1,540&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;4,466&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;3&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;6,009&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40F_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_i_pn3n" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Acquisitions&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2410"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2411"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;1,536&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;1,536&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40A_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_iN_di_zt9xFrKy9iRb" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;Amortization&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;(513&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;(1,637&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;(153&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;(2,303&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_407_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_zU5q4ZPGOeej" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top; padding-bottom: 1.25pt"&gt;Ending balance&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;1,027&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;2,829&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;1,386&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;5,242&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

















&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_498_20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_zd6kIojyj5Cg" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_492_20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--PatentMember_zrgRGdX6yiW7" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49A_20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--BrandMember_zI28CPNA1Jt3" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_492_20240101__20241231_zqpl5rv8J7u9" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="14" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Software&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Patents&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Brand&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="14" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr id="xdx_403_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_zfrNZ5KGPuQ4" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Beginning balance&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;2,052&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;6,714&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;3&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;8,769&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_403_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_iN_di_z49MUKSkUGli" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Amortization&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;(512&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;(2,248&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2439"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;(2,760&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40A_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_zMuRkpQTiwZ1" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.25pt"&gt;Ending balance&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;1,540&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;4,466&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;3&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;6,009&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:ChangesInIntangibleAssetsTableTextBlock>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2024-12-31_ifrs-full_ComputerSoftwareMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002405"
      unitRef="KRW">1540000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2024-12-31_custom_PatentMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002406"
      unitRef="KRW">4466000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2024-12-31_custom_BrandMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002407"
      unitRef="KRW">3000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002408"
      unitRef="KRW">6009000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="From2025-01-012025-12-31_custom_BrandMember_custom_CubebioCo.Ltd.Member273619093"
      decimals="-3"
      id="Fact002412"
      unitRef="KRW">1536000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002413"
      unitRef="KRW">1536000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2025-01-012025-12-31_ifrs-full_ComputerSoftwareMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002415"
      unitRef="KRW">513000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2025-01-012025-12-31_custom_PatentMember_custom_CubebioCo.Ltd.Member273619093"
      decimals="-3"
      id="Fact002416"
      unitRef="KRW">1637000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2025-01-012025-12-31_custom_BrandMember_custom_CubebioCo.Ltd.Member273619093"
      decimals="-3"
      id="Fact002417"
      unitRef="KRW">153000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002418"
      unitRef="KRW">2303000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2025-12-31_ifrs-full_ComputerSoftwareMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002420"
      unitRef="KRW">1027000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2025-12-31_custom_PatentMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002421"
      unitRef="KRW">2829000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2025-12-31_custom_BrandMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002422"
      unitRef="KRW">1386000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002423"
      unitRef="KRW">5242000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2023-12-31_ifrs-full_ComputerSoftwareMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002432"
      unitRef="KRW">2052000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2023-12-31_custom_PatentMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002433"
      unitRef="KRW">6714000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2023-12-31_custom_BrandMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002434"
      unitRef="KRW">3000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2023-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002435"
      unitRef="KRW">8769000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2024-01-012024-12-31_ifrs-full_ComputerSoftwareMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002437"
      unitRef="KRW">512000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2024-01-012024-12-31_custom_PatentMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002438"
      unitRef="KRW">2248000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002440"
      unitRef="KRW">2760000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2024-12-31_ifrs-full_ComputerSoftwareMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002442"
      unitRef="KRW">1540000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2024-12-31_custom_PatentMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002443"
      unitRef="KRW">4466000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2024-12-31_custom_BrandMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002444"
      unitRef="KRW">3000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002445"
      unitRef="KRW">6009000</ifrs-full:IntangibleAssetsAndGoodwill>
    <cik0002058261:AmortizationExpense
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002447"
      unitRef="KRW">2303000</cik0002058261:AmortizationExpense>
    <cik0002058261:AmortizationExpense
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002449"
      unitRef="KRW">2760000</cik0002058261:AmortizationExpense>
    <cik0002058261:ResearchAndDevelopmentCost
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002451"
      unitRef="KRW">777685000</cik0002058261:ResearchAndDevelopmentCost>
    <cik0002058261:ResearchAndDevelopmentCost
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002453"
      unitRef="KRW">1007139000</cik0002058261:ResearchAndDevelopmentCost>
    <cik0002058261:DeferredTransactionCostSponsorSharePurchaseTextBlock
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact002455">&lt;p id="xdx_803_ecustom--DeferredTransactionCostSponsorSharePurchaseTextBlock_zQoKOb8mPKC8" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;16. &lt;span id="xdx_82F_zVLfF9E72KD7"&gt;Deferred transaction cost &#x2013; Sponsor share purchase&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Details of deferred transaction cost as of December&#160;31, 2025 and 2024 are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_890_ecustom--DetailsOfDeferredTransactionCostTableTextBlock_pn3n3_zg32Wi7XqS3f" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Deferred transaction cost - Sponsor share purchase (Details)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_8BE_zB1BgkFbuRe9" style="display: none"&gt;Details of deferred transaction cost&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2024&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;b&gt;Current&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Deferred transaction cost (*)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#x20a9;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_903_ecustom--DeferredTransactionCost_iI_pn3n3_c20251231_fKCop_zoMEmADMYfua" title="Deferred transaction cost"&gt;2,393,915&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_908_ecustom--DeferredTransactionCost_iI_pn3n3_c20241231_fKCop_zgRRuThbQw62" title="Deferred transaction cost"&gt;1,025,730&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;div style="width: 25%; margin-left: 0; margin-right: auto"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td id="xdx_F0F_zFrREiEjrOrf" style="width: 0.25in; text-align: left"&gt;(*)&lt;/td&gt;
    &lt;td id="xdx_F18_zq06uUoAmVhl" style="text-align: justify"&gt;The deferred balance includes the non-refundable amount paid to Mountain Crest Global Holdings LLC (the &#x201c;Sponsor&#x201d;) to purchase 300,000 founder shares, which will subsequently be transitioned into the Pubco ordinary shares upon completion of the Business Combination. The shares will be transferred at the closing of the business combination and the deferred balances will be charged against equity via treasury shares.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A1_zujlZ8I2sUOa" style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;As of December&#160;31, 2025 and 2024,
the Company had deferred $1.7 &lt;span id="xdx_906_ecustom--DeferredTransactionCost_iI_pn3n3_c20251231_zBQSwuCZqt88" style="display: none" title="Deferred transaction cost"&gt;2,393,915&lt;/span&gt;
million and $0.75 &lt;span id="xdx_90D_ecustom--DeferredTransactionCost_iI_pn3n3_c20241231_zQebOjseHY8h" style="display: none" title="Deferred transaction cost"&gt;1,025,730&lt;/span&gt; million, respectively, in transaction costs directly associated with the ongoing Business
Combination.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

</cik0002058261:DeferredTransactionCostSponsorSharePurchaseTextBlock>
    <cik0002058261:DetailsOfDeferredTransactionCostTableTextBlock
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact002457">&lt;table cellpadding="0" cellspacing="0" id="xdx_890_ecustom--DetailsOfDeferredTransactionCostTableTextBlock_pn3n3_zg32Wi7XqS3f" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Deferred transaction cost - Sponsor share purchase (Details)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_8BE_zB1BgkFbuRe9" style="display: none"&gt;Details of deferred transaction cost&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2024&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;b&gt;Current&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Deferred transaction cost (*)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#x20a9;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_903_ecustom--DeferredTransactionCost_iI_pn3n3_c20251231_fKCop_zoMEmADMYfua" title="Deferred transaction cost"&gt;2,393,915&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_908_ecustom--DeferredTransactionCost_iI_pn3n3_c20241231_fKCop_zgRRuThbQw62" title="Deferred transaction cost"&gt;1,025,730&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;div style="width: 25%; margin-left: 0; margin-right: auto"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td id="xdx_F0F_zFrREiEjrOrf" style="width: 0.25in; text-align: left"&gt;(*)&lt;/td&gt;
    &lt;td id="xdx_F18_zq06uUoAmVhl" style="text-align: justify"&gt;The deferred balance includes the non-refundable amount paid to Mountain Crest Global Holdings LLC (the &#x201c;Sponsor&#x201d;) to purchase 300,000 founder shares, which will subsequently be transitioned into the Pubco ordinary shares upon completion of the Business Combination. The shares will be transferred at the closing of the business combination and the deferred balances will be charged against equity via treasury shares.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:DetailsOfDeferredTransactionCostTableTextBlock>
    <cik0002058261:DeferredTransactionCost
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002459"
      unitRef="KRW">2393915000</cik0002058261:DeferredTransactionCost>
    <cik0002058261:DeferredTransactionCost
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002461"
      unitRef="KRW">1025730000</cik0002058261:DeferredTransactionCost>
    <cik0002058261:DeferredTransactionCost
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002464"
      unitRef="KRW">2393915000</cik0002058261:DeferredTransactionCost>
    <cik0002058261:DeferredTransactionCost
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002466"
      unitRef="KRW">1025730000</cik0002058261:DeferredTransactionCost>
    <cik0002058261:IncomeTaxesTextBlock
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact002468">&lt;p id="xdx_804_ecustom--IncomeTaxesTextBlock_zDeSVjUa3qAh" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;17. &lt;span id="xdx_829_zpAZFTj97h71"&gt;Income taxes&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.25in; text-align: left"&gt;&lt;b&gt;A.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;&lt;b&gt;Amounts recognized in profit or loss and other comprehensive income&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The total income tax expense recognized in profit or loss and other comprehensive income for the years ended December&#160;31, 2025 and 2024 was nil. This results from a current tax expense of nil and no movement in deferred tax assets or liabilities arising from temporary differences, as the Company did not have any transactions recognized in other comprehensive income during the year.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

















&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.25in; text-align: left"&gt;&lt;b&gt;B.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;&lt;b&gt;Reconciliation between income tax (credit) expense and accounting loss:&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89A_ecustom--ScheduleOfEffectivesIncomeTaxRateReconciliationTableTextBlock_pn3n3_zFK8flzLext" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Income taxes (Details)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_8B5_zyZTNaVkOeSh" style="display: none"&gt;Schedule of effective tax rate&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_497_20250101__20251231_ziH1DKAWmmGf" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_494_20240101__20241231_ztsq6c3SDG9c" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr id="xdx_400_eifrs-full--ProfitLossBeforeTax_zUSPEyMslCGi" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Loss before income tax&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;(6,141,476&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;(8,065,334&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--TaxAtStatutoryIncomeTaxRate_zxmFGnt2WMCd" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Tax at the statutory income tax rate&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;(608,006&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;(798,468&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--AdjustmentsAbstract_iB_zOTdKZC0dr59" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;b&gt;Adjustments:&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_405_eifrs-full--TaxEffectOfRevenuesExemptFromTaxation2011_iN_di_zCEcan6cSID8" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Tax-exempt income&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;(36,427&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;(13,673&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--ExpensesNotDeductibleForTaxPurposes_zc6pMPidO3K5" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Expenses not deductible for tax purposes&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;215,761&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;374,340&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--ChangesInUnrecognizedTemporaryDifference_zErWgRLdLj68" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Changes in unrecognized temporary difference&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;125,382&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;683,633&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_404_eifrs-full--OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome_zCngAKGeyzci" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Other&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;303,290&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;(245,832&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40D_eifrs-full--IncomeTaxExpenseContinuingOperations_zeDzxxspdkLa" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1.25pt"&gt;Income tax expenses&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2500"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2501"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--AverageEffectiveTaxRate_pid_dp_zQ1QaeThhbfj" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;b&gt;Effective
    income tax rate &lt;span id="xdx_F4B_zZTobCUfNrHa"&gt;(*)&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;0.0&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;0.0&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;div style="width: 25%; margin-left: 0; margin-right: auto"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td id="xdx_F03_zFxJk7uuPiul" style="width: 0.25in; text-align: left"&gt;(*)&lt;/td&gt;
    &lt;td id="xdx_F1E_zOo5Zt04TSui" style="text-align: justify"&gt;The effective tax rate is not calculated as the Company incurred a loss before income taxes for the years ended December&#160;31, 2025 and 2024.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A5_zhJ2APWBuwMg" style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.25in; text-align: left"&gt;&lt;b&gt;C.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;&lt;b&gt;Movement in deferred tax balances&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 0.5in; text-align: left"&gt;i.&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;Movement in deferred tax balances for the year ended December&#160;31, 2025&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_899_ecustom--ScheduleOfDeferredTaxBalanceTableTextBlock_pn3n3_zK69QbIXuIxj" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Income taxes (Details 1)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: #FFFFFF"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_8BF_zysJIPU52Xlh" style="display: none"&gt;Schedule of deferred tax balances&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="10" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Tax effect&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Beginning&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Increase&lt;br/&gt; (decrease)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Ending&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="10" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Impairment Losses on Intangible Assets&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right; width: 9%"&gt;&lt;span id="xdx_902_ecustom--MovementInDeferredTaxBalances_iS_pn3n3_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ImpairmentLossesOnIntangibleAssetsMember_zrBRjPkurnMj" title="Beginning"&gt;198,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right; width: 9%"&gt;&lt;span id="xdx_902_ecustom--MovementInDeferredTaxBalancesIncreaseDecrease_pn3n3_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ImpairmentLossesOnIntangibleAssetsMember_zvE27AEaZQQ4" title="Increase (decrease)"&gt;8,009&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right; width: 9%"&gt;&lt;span id="xdx_904_ecustom--MovementInDeferredTaxBalances_iE_pn3n3_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ImpairmentLossesOnIntangibleAssetsMember_zIUT9CcdHSVi" title="Ending"&gt;206,009&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; width: 1%"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #FFFFFF"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Allowance for doubtful accounts&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_ecustom--MovementInDeferredTaxBalances_iS_pn3n3_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--AllowanceForDoubtfulAccountsMember_zSVJ1zUzAeH7" title="Beginning"&gt;236,570&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_909_ecustom--MovementInDeferredTaxBalancesIncreaseDecrease_pn3n3_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--AllowanceForDoubtfulAccountsMember_zZcL3yRKCinc" title="Increase (decrease)"&gt;(110,216&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_905_ecustom--MovementInDeferredTaxBalances_iE_pn3n3_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--AllowanceForDoubtfulAccountsMember_z6pWx5ffgrKh" title="Ending"&gt;126,354&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Lease liabilities&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_ecustom--MovementInDeferredTaxBalances_iS_pn3n3_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__ifrs-full--LeaseLiabilitiesMember_zN4O5RpRESNl" title="Beginning"&gt;66,234&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_903_ecustom--MovementInDeferredTaxBalancesIncreaseDecrease_pn3n3_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__ifrs-full--LeaseLiabilitiesMember_zO52sM0pOvoe" title="Increase (decrease)"&gt;(11,524&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_901_ecustom--MovementInDeferredTaxBalances_iE_pn3n3_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__ifrs-full--LeaseLiabilitiesMember_zFn6fOKQOshe" title="Ending"&gt;54,710&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #FFFFFF"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Property and equipment&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--MovementInDeferredTaxBalances_iS_pn3n3_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--PropertyAndEquipmentMember_z7EeA4yGyzpl" title="Beginning"&gt;(6,265&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--MovementInDeferredTaxBalancesIncreaseDecrease_pn3n3_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--PropertyAndEquipmentMember_zZWTnmcK57Zf" title="Increase (decrease)"&gt;(44,292&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_906_ecustom--MovementInDeferredTaxBalances_iE_pn3n3_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--PropertyAndEquipmentMember_zU5yVk8XuqCi" title="Ending"&gt;(50,557&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Bond with warrants, net&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--MovementInDeferredTaxBalances_iS_pn3n3_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--BondWithWarrantsNetMember_zyYTxtqs8lye" title="Beginning"&gt;(163,930&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--MovementInDeferredTaxBalancesIncreaseDecrease_pn3n3_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--BondWithWarrantsNetMember_zFVxU1dyKooh" title="Increase (decrease)"&gt;(4,339&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--MovementInDeferredTaxBalances_iE_pn3n3_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--BondWithWarrantsNetMember_zpQ9FKyEG2B4" title="Ending"&gt;(168,269&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #FFFFFF"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Leasehold deposit receivables&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_909_ecustom--MovementInDeferredTaxBalances_iS_pn3n3_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--LeaseholdDepositReceivablesMember_zWQnMPBMrB4" title="Beginning"&gt;7,278&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_907_ecustom--MovementInDeferredTaxBalancesIncreaseDecrease_pn3n3_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--LeaseholdDepositReceivablesMember_znTyabAFEqY8" title="Increase (decrease)"&gt;(1,145&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--MovementInDeferredTaxBalances_iE_pn3n3_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--LeaseholdDepositReceivablesMember_z6DgGG9g3nRl" title="Ending"&gt;6,133&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Defined benefit liabilities&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_909_ecustom--MovementInDeferredTaxBalances_iS_pn3n3_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--DefinedBenefitLiabilitiesMember_zG7yoqo2UIDi" title="Beginning"&gt;94,072&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_901_ecustom--MovementInDeferredTaxBalancesIncreaseDecrease_pn3n3_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--DefinedBenefitLiabilitiesMember_zFpRqO1Orfhi" title="Increase (decrease)"&gt;3,031&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_909_ecustom--MovementInDeferredTaxBalances_iE_pn3n3_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--DefinedBenefitLiabilitiesMember_zREAsFAKJmVl" title="Ending"&gt;97,103&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #FFFFFF"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Derivative liabilities&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_ecustom--MovementInDeferredTaxBalances_iS_pn3n3_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--DerivativeLiabilitiesMember_ztSgVW3Rybrc" title="Beginning"&gt;145,908&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_903_ecustom--MovementInDeferredTaxBalancesIncreaseDecrease_pn3n3_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--DerivativeLiabilitiesMember_zec8lg7ZRN7" title="Increase (decrease)"&gt;(20,396&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_900_ecustom--MovementInDeferredTaxBalances_iE_pn3n3_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--DerivativeLiabilitiesMember_zhGnJqKI5Xpc" title="Ending"&gt;125,512&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Accrued expenses&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_907_ecustom--MovementInDeferredTaxBalances_iS_pn3n3_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--AccruedExpensesMember_zhw48Sc9Snj5" title="Beginning"&gt;(6,092&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_909_ecustom--MovementInDeferredTaxBalancesIncreaseDecrease_pn3n3_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--AccruedExpensesMember_z7CH4oc3KPf7" title="Increase (decrease)"&gt;(1,270&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--MovementInDeferredTaxBalances_iE_pn3n3_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--AccruedExpensesMember_zuMdBXlEGoV4" title="Ending"&gt;(7,362&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #FFFFFF"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Accrued income&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_906_ecustom--MovementInDeferredTaxBalances_iS_pn3n3_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--AccruedIncomeMember_zSeOKHCKKGf" title="Beginning"&gt;(18,219&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_905_ecustom--MovementInDeferredTaxBalancesIncreaseDecrease_pn3n3_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--AccruedIncomeMember_z2ds9wtV0iFf" title="Increase (decrease)"&gt;(10,536&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_900_ecustom--MovementInDeferredTaxBalances_iE_pn3n3_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--AccruedIncomeMember_zTuUklEAdi3l" title="Ending"&gt;(28,755&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Inventories, net&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--MovementInDeferredTaxBalances_iS_pn3n3_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--InventoriesNetMember_zvZiEYdlPjWi" title="Beginning"&gt;25,372&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_901_ecustom--MovementInDeferredTaxBalancesIncreaseDecrease_pn3n3_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--InventoriesNetMember_zoQbtbdkjgI5" title="Increase (decrease)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2571"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--MovementInDeferredTaxBalances_iE_pn3n3_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--InventoriesNetMember_za5U2CLD98xf" title="Ending"&gt;25,372&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #FFFFFF"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Provisions for restoration&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_906_ecustom--MovementInDeferredTaxBalances_iS_pn3n3_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ProvisionsForRestorationMember_zG4dsCP97FJd" title="Beginning"&gt;4,786&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_900_ecustom--MovementInDeferredTaxBalancesIncreaseDecrease_pn3n3_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ProvisionsForRestorationMember_zTjQh9d1QmJ9" title="Increase (decrease)"&gt;31&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_902_ecustom--MovementInDeferredTaxBalances_iE_pn3n3_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ProvisionsForRestorationMember_zV0WQRAdVi3b" title="Ending"&gt;4,817&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Others&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--MovementInDeferredTaxBalances_iS_pn3n3_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--OthersMember_zRfUDeYspzsj" title="Beginning"&gt;13,499&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--MovementInDeferredTaxBalancesIncreaseDecrease_pn3n3_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--OthersMember_zNHWKoNtsfF3" title="Increase (decrease)"&gt;(4,106&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_ecustom--MovementInDeferredTaxBalances_iE_pn3n3_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--OthersMember_zv4sbnffKcM9" title="Ending"&gt;9,393&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #FFFFFF"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; vertical-align: top; padding-left: 0.125in; padding-bottom: 1.25pt"&gt;Total&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_908_ecustom--MovementInDeferredTaxBalances_iS_pn3n3_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TotalMember_zVxiomHPkTV" title="Beginning"&gt;597,213&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--MovementInDeferredTaxBalancesIncreaseDecrease_pn3n3_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TotalMember_zcT77bh66Jy" title="Increase (decrease)"&gt;(196,753&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_900_ecustom--MovementInDeferredTaxBalances_iE_pn3n3_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TotalMember_zvVtIO1HzVLi" title="Ending"&gt;400,460&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Loss carried forward&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#x20a9;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_906_ecustom--MovementInDeferredTaxBalances_iS_pn3n3_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--LossCarriedForwardMember_z95jDKfZgfZi" title="Beginning"&gt;3,402,320&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--MovementInDeferredTaxBalancesIncreaseDecrease_pn3n3_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--LossCarriedForwardMember_zlsk5L4Sih1c" title="Increase (decrease)"&gt;378,738&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--MovementInDeferredTaxBalances_iE_pn3n3_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--LossCarriedForwardMember_zVWnRtd7BA52" title="Ending"&gt;3,781,058&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #FFFFFF"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Carryover tax credit&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_902_ecustom--MovementInDeferredTaxBalances_iS_pn3n3_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--CarryoverTaxCreditMember_zr21eDvZe7Hc" title="Beginning"&gt;526,463&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_907_ecustom--MovementInDeferredTaxBalancesIncreaseDecrease_pn3n3_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--CarryoverTaxCreditMember_zM2cb1f7lSyc" title="Increase (decrease)"&gt;(56,604&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_909_ecustom--MovementInDeferredTaxBalances_iE_pn3n3_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--CarryoverTaxCreditMember_zWd15Zf8FQ9j" title="Ending"&gt;469,859&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Unrecognized deferred tax assets&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_905_ecustom--MovementInDeferredTaxBalances_iS_pn3n3_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--UnrecognizedDeferredTaxLiabilitiesMember_zGotGAcRMfv1" title="Beginning"&gt;(4,525,996&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--MovementInDeferredTaxBalancesIncreaseDecrease_pn3n3_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--UnrecognizedDeferredTaxLiabilitiesMember_zO1vBe8fzpze" title="Increase (decrease)"&gt;(125,381&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--MovementInDeferredTaxBalances_iE_pn3n3_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--UnrecognizedDeferredTaxLiabilitiesMember_zVbDSSkHuEhb" title="Ending"&gt;(4,651,377&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #FFFFFF"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.25pt"&gt;Deferred tax assets (liabilities)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--MovementInDeferredTaxBalances_iS_pn3n3_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--DeferredTaxAssetsMember_zpDwR5mKIME5" title="Beginning"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2611"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_901_ecustom--MovementInDeferredTaxBalancesIncreaseDecrease_pn3n3_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--DeferredTaxAssetsMember_zKC2GNi7QIC1" title="Increase (decrease)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2613"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--MovementInDeferredTaxBalances_iE_pn3n3_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--DeferredTaxAssetsMember_zWBKybiqr2Ca" title="Ending"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2615"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

















&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 0.5in; text-align: left"&gt;ii.&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;Movement in deferred tax balances for the year ended December&#160;31, 2024&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="10" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Tax effect&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Beginning&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Increase&lt;br/&gt; (decrease)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Ending&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="10" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Impairment Losses on Intangible Assets&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_902_ecustom--MovementInDeferredTaxBalances_iS_pn3n3_c20240101__20241231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ImpairmentLossesOnIntangibleAssetsMember_za4MZxewOcbi" title="Beginning"&gt;198,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_908_ecustom--MovementInDeferredTaxBalancesIncreaseDecrease_pn3n3_c20240101__20241231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ImpairmentLossesOnIntangibleAssetsMember_zq7gUck8jKmh" title="Increase (decrease)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2626"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_900_ecustom--MovementInDeferredTaxBalances_iE_pn3n3_c20240101__20241231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ImpairmentLossesOnIntangibleAssetsMember_zwvFsb2uTfya" title="Ending"&gt;198,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Allowance for doubtful accounts&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--MovementInDeferredTaxBalances_iS_pn3n3_c20240101__20241231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--AllowanceForDoubtfulAccountsMember_zuWmYX2WWDD9" title="Beginning"&gt;282,093&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--MovementInDeferredTaxBalancesIncreaseDecrease_pn3n3_c20240101__20241231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--AllowanceForDoubtfulAccountsMember_z0iOCxZqsWCa" title="Increase (decrease)"&gt;(45,523&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_907_ecustom--MovementInDeferredTaxBalances_iE_pn3n3_c20240101__20241231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--AllowanceForDoubtfulAccountsMember_zwAzUOfbW7ke" title="Ending"&gt;236,570&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Lease liabilities&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--MovementInDeferredTaxBalances_iS_pn3n3_c20240101__20241231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__ifrs-full--LeaseLiabilitiesMember_zmoMr2r4dpSd" title="Beginning"&gt;76,862&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_908_ecustom--MovementInDeferredTaxBalancesIncreaseDecrease_pn3n3_c20240101__20241231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__ifrs-full--LeaseLiabilitiesMember_zeJiC3sO8ZU1" title="Increase (decrease)"&gt;(10,628&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_907_ecustom--MovementInDeferredTaxBalances_iE_pn3n3_c20240101__20241231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__ifrs-full--LeaseLiabilitiesMember_zU5nCTBEBIc1" title="Ending"&gt;66,234&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Property and equipment&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--MovementInDeferredTaxBalances_iS_pn3n3_c20240101__20241231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--PropertyAndEquipmentMember_z2H9Io0mhXN9" title="Beginning"&gt;(77,619&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--MovementInDeferredTaxBalancesIncreaseDecrease_pn3n3_c20240101__20241231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--PropertyAndEquipmentMember_zJdFuDYvFQ5i" title="Increase (decrease)"&gt;71,354&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--MovementInDeferredTaxBalances_iE_pn3n3_c20240101__20241231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--PropertyAndEquipmentMember_zNK5SmCp7uPi" title="Ending"&gt;(6,265&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Bond with warrants, net&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--MovementInDeferredTaxBalances_iS_pn3n3_c20240101__20241231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--BondWithWarrantsNetMember_zZU0xYhI2ZDf" title="Beginning"&gt;(273,033&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--MovementInDeferredTaxBalancesIncreaseDecrease_pn3n3_c20240101__20241231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--BondWithWarrantsNetMember_zsXHe0lapJA8" title="Increase (decrease)"&gt;109,103&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--MovementInDeferredTaxBalances_iE_pn3n3_c20240101__20241231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--BondWithWarrantsNetMember_zn9iBYsjkXla" title="Ending"&gt;(163,930&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Leasehold deposit receivables&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_901_ecustom--MovementInDeferredTaxBalances_iS_pn3n3_c20240101__20241231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--LeaseholdDepositReceivablesMember_z6DTwoKZelod" title="Beginning"&gt;5,828&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_903_ecustom--MovementInDeferredTaxBalancesIncreaseDecrease_pn3n3_c20240101__20241231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--LeaseholdDepositReceivablesMember_zEz44euI29P6" title="Increase (decrease)"&gt;1,450&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_906_ecustom--MovementInDeferredTaxBalances_iE_pn3n3_c20240101__20241231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--LeaseholdDepositReceivablesMember_zwo4ORMpRdw3" title="Ending"&gt;7,278&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Defined benefit liabilities&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--MovementInDeferredTaxBalances_iS_pn3n3_c20240101__20241231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--DefinedBenefitLiabilitiesMember_zNJQjxQpxNXe" title="Beginning"&gt;71,120&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_902_ecustom--MovementInDeferredTaxBalancesIncreaseDecrease_pn3n3_c20240101__20241231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--DefinedBenefitLiabilitiesMember_zwtu2cZzHDJc" title="Increase (decrease)"&gt;22,952&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_902_ecustom--MovementInDeferredTaxBalances_iE_pn3n3_c20240101__20241231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--DefinedBenefitLiabilitiesMember_zcJiVbYL30Y6" title="Ending"&gt;94,072&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Derivative liabilities&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_ecustom--MovementInDeferredTaxBalances_iS_pn3n3_c20240101__20241231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--DerivativeLiabilitiesMember_z8t8BcZiuLX6" title="Beginning"&gt;213,102&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_ecustom--MovementInDeferredTaxBalancesIncreaseDecrease_pn3n3_c20240101__20241231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--DerivativeLiabilitiesMember_zyZkfKYFm9N2" title="Increase (decrease)"&gt;(67,194&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_903_ecustom--MovementInDeferredTaxBalances_iE_pn3n3_c20240101__20241231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--DerivativeLiabilitiesMember_z4AUcm3ufXW2" title="Ending"&gt;145,908&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Accrued expenses&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_901_ecustom--MovementInDeferredTaxBalances_iS_pn3n3_c20240101__20241231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--AccruedExpensesMember_z1tpANDpJAwj" title="Beginning"&gt;4,132&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_907_ecustom--MovementInDeferredTaxBalancesIncreaseDecrease_pn3n3_c20240101__20241231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--AccruedExpensesMember_zH5CrInmdfPj" title="Increase (decrease)"&gt;(10,224&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_ecustom--MovementInDeferredTaxBalances_iE_pn3n3_c20240101__20241231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--AccruedExpensesMember_zzWYLkW7WYaf" title="Ending"&gt;(6,092&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Accrued income&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_903_ecustom--MovementInDeferredTaxBalances_iS_pn3n3_c20240101__20241231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--AccruedIncomeMember_z8Nwi8jPQnpd" title="Beginning"&gt;(9,587&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_ecustom--MovementInDeferredTaxBalancesIncreaseDecrease_pn3n3_c20240101__20241231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--AccruedIncomeMember_zL6kuzco0wWe" title="Increase (decrease)"&gt;(8,632&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_905_ecustom--MovementInDeferredTaxBalances_iE_pn3n3_c20240101__20241231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--AccruedIncomeMember_z1KUFFPzehRd" title="Ending"&gt;(18,219&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Inventories, net&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_ecustom--MovementInDeferredTaxBalances_iS_pn3n3_c20240101__20241231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--InventoriesNetMember_zxgyEgjsoWjh" title="Beginning"&gt;25,372&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--MovementInDeferredTaxBalancesIncreaseDecrease_pn3n3_c20240101__20241231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--InventoriesNetMember_zp2HgsqFmgyj" title="Increase (decrease)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2686"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_903_ecustom--MovementInDeferredTaxBalances_iE_pn3n3_c20240101__20241231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--InventoriesNetMember_z6bPHxMdHiQb" title="Ending"&gt;25,372&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Provisions for restoration&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--MovementInDeferredTaxBalances_iS_pn3n3_c20240101__20241231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ProvisionsForRestorationMember_zIpQBxO7jOMf" title="Beginning"&gt;4,753&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_900_ecustom--MovementInDeferredTaxBalancesIncreaseDecrease_pn3n3_c20240101__20241231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ProvisionsForRestorationMember_zHXGHDrHPY07" title="Increase (decrease)"&gt;33&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--MovementInDeferredTaxBalances_iE_pn3n3_c20240101__20241231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ProvisionsForRestorationMember_zPXOvvcnWd8" title="Ending"&gt;4,786&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Others&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--MovementInDeferredTaxBalances_iS_pn3n3_c20240101__20241231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--OthersMember_z33w2Sk8v3A6" title="Beginning"&gt;17,197&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_903_ecustom--MovementInDeferredTaxBalancesIncreaseDecrease_pn3n3_c20240101__20241231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--OthersMember_zmRAjds8grWk" title="Increase (decrease)"&gt;(3,698&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_903_ecustom--MovementInDeferredTaxBalances_iE_pn3n3_c20240101__20241231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--OthersMember_zFGiE9df9PB3" title="Ending"&gt;13,499&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; vertical-align: top; padding-left: 0.125in; padding-bottom: 1.25pt"&gt;Total&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--MovementInDeferredTaxBalances_iS_pn3n3_c20240101__20241231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TotalMember_zWXZJfmC6Irc" title="Beginning"&gt;538,220&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_908_ecustom--MovementInDeferredTaxBalancesIncreaseDecrease_pn3n3_c20240101__20241231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TotalMember_z9K4YgWz3JU3" title="Increase (decrease)"&gt;58,993&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--MovementInDeferredTaxBalances_iE_pn3n3_c20240101__20241231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TotalMember_zxjKo8sCZ0fg" title="Ending"&gt;597,213&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Loss carried forward&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#x20a9;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--MovementInDeferredTaxBalances_iS_pn3n3_c20240101__20241231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--LossCarriedForwardMember_zRJ2JDFHIGCl" title="Beginning"&gt;2,893,763&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_906_ecustom--MovementInDeferredTaxBalancesIncreaseDecrease_pn3n3_c20240101__20241231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--LossCarriedForwardMember_zGU6U8yPWK48" title="Increase (decrease)"&gt;508,557&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_909_ecustom--MovementInDeferredTaxBalances_iE_pn3n3_c20240101__20241231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--LossCarriedForwardMember_z0ZgEROkoqWj" title="Ending"&gt;3,402,320&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Carryover tax credit&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--MovementInDeferredTaxBalances_iS_pn3n3_c20240101__20241231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--CarryoverTaxCreditMember_zPzHdxlpfiF7" title="Beginning"&gt;410,379&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_907_ecustom--MovementInDeferredTaxBalancesIncreaseDecrease_pn3n3_c20240101__20241231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--CarryoverTaxCreditMember_zJ1qJLicDF9k" title="Increase (decrease)"&gt;116,084&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--MovementInDeferredTaxBalances_iE_pn3n3_c20240101__20241231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--CarryoverTaxCreditMember_zvrc3XeT0O79" title="Ending"&gt;526,463&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Unrecognized deferred tax assets&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_909_ecustom--MovementInDeferredTaxBalances_iS_pn3n3_c20240101__20241231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--UnrecognizedDeferredTaxLiabilitiesMember_zz0Bj8rrTiKg" title="Beginning"&gt;(3,842,362&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_903_ecustom--MovementInDeferredTaxBalancesIncreaseDecrease_pn3n3_c20240101__20241231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--UnrecognizedDeferredTaxLiabilitiesMember_zHYn96IcvH8e" title="Increase (decrease)"&gt;(683,634&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_905_ecustom--MovementInDeferredTaxBalances_iE_pn3n3_c20240101__20241231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--UnrecognizedDeferredTaxLiabilitiesMember_z7vBOpMsRRz9" title="Ending"&gt;(4,525,996&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.25pt"&gt;Deferred tax assets (liabilities)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--MovementInDeferredTaxBalances_iS_pn3n3_c20240101__20241231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--DeferredTaxAssetsMember_zdVbmJ6w2w2c" title="Beginning"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2726"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_909_ecustom--MovementInDeferredTaxBalancesIncreaseDecrease_pn3n3_c20240101__20241231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--DeferredTaxAssetsMember_zIXvEAGVbdOa" title="Increase (decrease)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2728"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_909_ecustom--MovementInDeferredTaxBalances_iE_pn3n3_c20240101__20241231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--DeferredTaxAssetsMember_z4L0kJdVjsX2" title="Ending"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2730"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A7_zK0Fi0oiGPL5" style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.25in; text-align: left"&gt;&lt;b&gt;D.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;&lt;b&gt;Deferred assets (liabilities)&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 0.5in; text-align: left"&gt;i.&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;Details of unrecognized deferred income tax assets as of December&#160;31, 2025 and 2024 are as follows:&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89B_ecustom--DetailsOfUnrecognizedDeferredIncomeTaxAssetsTableTextBlock_pn3n3_zvUYbM6oC0Mk" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Income taxes (Details 2)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_8BC_zPRmgppmbJQ8" style="display: none"&gt;Details of unrecognized deferred income tax assets&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_496_20250101__20251231_zQp1uf8gR3Oi" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_498_20240101__20241231_zhU91iKd1Z0k" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2024&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--UnrecognizedTemporaryDifference_zlrt59HpmObd" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Unrecognized temporary difference&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;400,460&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;597,213&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--TaxLossCarryforwards_zQ3aDsArE74" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Loss carried forward&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;3,781,058&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;3,402,320&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--TaxCreditCarryforwards_z7Ma0SxXLFJl" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Carryover tax credit&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;469,859&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;526,463&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--DeferredIncomeTaxAssets_zuWGO8qUAu63" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; vertical-align: top; padding-left: 0.125in; padding-bottom: 1.25pt"&gt;Total&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;4,651,377&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;4,525,996&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A5_zxCm8aFIDgQ" style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

















&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 0.5in; text-align: left"&gt;ii.&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;Details of unused loss carried forward and unused carryover tax credit that are not recognized as deferred income tax assets as of December&#160;31, 2025 are as follows:&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_892_ecustom--SummaryOfUnusedTaxLossCarryforwardsTableTextBlock_pn3n3_zC5FCtlcDZ6e" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Income taxes (Details 3)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_8BD_zuZ5rVKoHnu7" style="display: none"&gt;Schedule of unused tax loss carryforwards&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&lt;b&gt;Year of expiration&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Unused&lt;br/&gt; loss carried&lt;br/&gt; forward&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Unused&lt;br/&gt; carryover&lt;br/&gt; tax credit&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;2026&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised_iI_pn3n3_c20251231__custom--TaxExpirationPeriodAxis__custom--TaxPeriodTwoThousandAndTwentySixMember_zFX2yLKcHEX7" title="Unused loss carried forward"&gt;722,024&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--UnusedTaxCreditsForWhichNoDeferredTaxAssetRecognised_iI_pn3n3_c20251231__custom--TaxExpirationPeriodAxis__custom--TaxPeriodTwoThousandAndTwentySixMember_zqvb7Cp0EzC6" title="Unused tax credit carryforwards"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2757"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;2027&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised_iI_pn3n3_c20251231__custom--TaxExpirationPeriodAxis__custom--TaxPeriodTwoThousandAndTwentySevenMember_zz98Ko0GeEjh" title="Unused loss carried forward"&gt;292,098&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--UnusedTaxCreditsForWhichNoDeferredTaxAssetRecognised_iI_pn3n3_c20251231__custom--TaxExpirationPeriodAxis__custom--TaxPeriodTwoThousandAndTwentySevenMember_z8xgezMbPUDj" title="Unused tax credit carryforwards"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2761"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;2028&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised_iI_pn3n3_c20251231__custom--TaxExpirationPeriodAxis__custom--TaxPeriodTwoThousandAndTwentyEightMember_z2pwzysZyml3" title="Unused loss carried forward"&gt;319,426&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--UnusedTaxCreditsForWhichNoDeferredTaxAssetRecognised_iI_pn3n3_c20251231__custom--TaxExpirationPeriodAxis__custom--TaxPeriodTwoThousandAndTwentyEightMember_zhPv64YLqfMl" title="Unused tax credit carryforwards"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2765"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;2029&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised_iI_pn3n3_c20251231__custom--TaxExpirationPeriodAxis__custom--TaxPeriodTwoThousandAndTwentyNineMember_zHBcZDHRFZlb" title="Unused loss carried forward"&gt;383,584&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--UnusedTaxCreditsForWhichNoDeferredTaxAssetRecognised_iI_pn3n3_c20251231__custom--TaxExpirationPeriodAxis__custom--TaxPeriodTwoThousandAndTwentyNineMember_zm0bBHPabJ8h" title="Unused tax credit carryforwards"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2769"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;2030&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised_iI_pn3n3_c20251231__custom--TaxExpirationPeriodAxis__custom--TaxPeriodTwoThousandAndThirtyMember_zux3Mvurwb0c" title="Unused loss carried forward"&gt;49,670&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--UnusedTaxCreditsForWhichNoDeferredTaxAssetRecognised_iI_pn3n3_c20251231__custom--TaxExpirationPeriodAxis__custom--TaxPeriodTwoThousandAndThirtyMember_z0gYZJzlGBpi" title="Unused tax credit carryforwards"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2773"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;2031&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised_iI_pn3n3_c20251231__custom--TaxExpirationPeriodAxis__custom--TaxPeriodTwoThousandAndThirtyOneMember_z0Y4HuEy3T1f" title="Unused loss carried forward"&gt;281,727&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--UnusedTaxCreditsForWhichNoDeferredTaxAssetRecognised_iI_pn3n3_c20251231__custom--TaxExpirationPeriodAxis__custom--TaxPeriodTwoThousandAndThirtyOneMember_zPFRWo95c4Hi" title="Unused tax credit carryforwards"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2777"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;After 2031&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised_iI_pn3n3_c20251231__custom--TaxExpirationPeriodAxis__custom--After2031Member_zOwngCmOYhK6" title="Unused loss carried forward"&gt;1,732,529&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--UnusedTaxCreditsForWhichNoDeferredTaxAssetRecognised_iI_pn3n3_c20251231__custom--TaxExpirationPeriodAxis__custom--After2031Member_ztzaoUeXMsZ7" title="Unused tax credit carryforwards"&gt;469,859&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; vertical-align: top; padding-left: 0.125in; padding-bottom: 1.25pt"&gt;Total&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised_iI_pn3n3_c20251231_zTmYQ354Qtw8" title="Unused loss carried forward"&gt;3,781,058&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--UnusedTaxCreditsForWhichNoDeferredTaxAssetRecognised_iI_pn3n3_c20251231_zvrv12AKzO1b" title="Unused tax credit carryforwards"&gt;469,859&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A3_zZsAK6kpz9U1" style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 0.5in; text-align: left"&gt;iii.&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;The timing of recovery of deferred tax assets and liabilities as of December&#160;31, 2025 and 2024 are as follows:&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89B_ecustom--RecoveryOfDeferredTaxAssetsAndLiabilitiesDisclosureTableTextBlock_pn3n3_zxEHczQHVIs7" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Income taxes (Details 4)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span id="xdx_8B5_zMUwBbKHfMb7" style="display: none"&gt;Schedule of recovery of deferred tax assets and liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2024&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Deferred tax assets&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;- Deferred tax assets to be recovered after more than 12 months&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#x20a9;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--DeferredTaxAsset_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zYdcCs3YY261" title="Deferred tax assets"&gt;4,574,362&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--DeferredTaxAsset_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zlPQQfrYjcni" title="Deferred tax assets"&gt;4,305,986&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;- Deferred tax assets to be recovered within 12 months&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--DeferredTaxAsset_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember_zSF8LjHcRdtl" title="Deferred tax assets"&gt;324,775&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--DeferredTaxAsset_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember_zBCHkNbuEGK2" title="Deferred tax assets"&gt;468,181&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; vertical-align: top; padding-left: 0.125in; padding-bottom: 0.5pt"&gt;Sub-total&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_908_ecustom--DeferredTaxAsset_iI_pn3n3_c20251231_zf6ptkHl2qEl" title="Deferred tax assets"&gt;4,899,137&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_909_ecustom--DeferredTaxAsset_iI_pn3n3_c20241231_z7hgHjze6u9k" title="Deferred tax assets"&gt;4,774,167&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Deferred tax liabilities&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;- Deferred tax liabilities to be recovered after more than 12 months&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--DeferredTaxLiabilitiess_iNI_pn3n3_di_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zk7b3NDy6HY1" title="Deferred tax liabilities"&gt;(75,235&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_ecustom--DeferredTaxLiabilitiess_iNI_pn3n3_di_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zJ0UdrJhBcrl" title="Deferred tax liabilities"&gt;(81,256&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;- Deferred tax liabilities to be recovered within 12 months&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--DeferredTaxLiabilitiess_iNI_pn3n3_di_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember_z29dNSzTg4i8" title="Deferred tax liabilities"&gt;(172,525&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_901_ecustom--DeferredTaxLiabilitiess_iNI_pn3n3_di_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember_zcrsMrqmxQKa" title="Deferred tax liabilities"&gt;(166,915&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; vertical-align: top; padding-left: 0.125in; padding-bottom: 0.5pt"&gt;Sub-total&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--DeferredTaxLiabilitiess_iNI_pn3n3_di_c20251231_zK24EHx7zAGh" title="Deferred tax liabilities"&gt;(247,760&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_906_ecustom--DeferredTaxLiabilitiess_iNI_pn3n3_di_c20241231_zDEaiDB13Mvb" title="Deferred tax liabilities"&gt;(248,171&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Unrecognized deferred tax assets&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--UnrecognizedDeferredTaxAssets_iNI_pn3n3_di_c20251231_zP8xzsCTVaCe" title="Unrecognized deferred tax assets"&gt;(4,651,377&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_902_ecustom--UnrecognizedDeferredTaxAssets_iNI_pn3n3_di_c20241231_zCEnpalcgnBl" title="Unrecognized deferred tax assets"&gt;(4,525,996&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.25pt"&gt;Deferred tax assets (liabilities), net&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--NetDeferredTaxLiabilities_iI_pn3n3_c20251231_zzPfA0x1iCr7" title="Deferred tax assets (liabilities), net"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2817"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--NetDeferredTaxLiabilities_iI_pn3n3_c20241231_zCys0ggSFaMc" title="Deferred tax assets (liabilities), net"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2819"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AA_zCAN4G8hvch1" style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

</cik0002058261:IncomeTaxesTextBlock>
    <cik0002058261:ScheduleOfEffectivesIncomeTaxRateReconciliationTableTextBlock
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact002477">&lt;table cellpadding="0" cellspacing="0" id="xdx_89A_ecustom--ScheduleOfEffectivesIncomeTaxRateReconciliationTableTextBlock_pn3n3_zFK8flzLext" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Income taxes (Details)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_8B5_zyZTNaVkOeSh" style="display: none"&gt;Schedule of effective tax rate&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_497_20250101__20251231_ziH1DKAWmmGf" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_494_20240101__20241231_ztsq6c3SDG9c" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr id="xdx_400_eifrs-full--ProfitLossBeforeTax_zUSPEyMslCGi" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Loss before income tax&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;(6,141,476&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;(8,065,334&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--TaxAtStatutoryIncomeTaxRate_zxmFGnt2WMCd" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Tax at the statutory income tax rate&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;(608,006&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;(798,468&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--AdjustmentsAbstract_iB_zOTdKZC0dr59" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;b&gt;Adjustments:&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_405_eifrs-full--TaxEffectOfRevenuesExemptFromTaxation2011_iN_di_zCEcan6cSID8" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Tax-exempt income&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;(36,427&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;(13,673&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--ExpensesNotDeductibleForTaxPurposes_zc6pMPidO3K5" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Expenses not deductible for tax purposes&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;215,761&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;374,340&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--ChangesInUnrecognizedTemporaryDifference_zErWgRLdLj68" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Changes in unrecognized temporary difference&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;125,382&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;683,633&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_404_eifrs-full--OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome_zCngAKGeyzci" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Other&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;303,290&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;(245,832&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40D_eifrs-full--IncomeTaxExpenseContinuingOperations_zeDzxxspdkLa" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1.25pt"&gt;Income tax expenses&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2500"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2501"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--AverageEffectiveTaxRate_pid_dp_zQ1QaeThhbfj" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;b&gt;Effective
    income tax rate &lt;span id="xdx_F4B_zZTobCUfNrHa"&gt;(*)&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;0.0&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;0.0&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;div style="width: 25%; margin-left: 0; margin-right: auto"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td id="xdx_F03_zFxJk7uuPiul" style="width: 0.25in; text-align: left"&gt;(*)&lt;/td&gt;
    &lt;td id="xdx_F1E_zOo5Zt04TSui" style="text-align: justify"&gt;The effective tax rate is not calculated as the Company incurred a loss before income taxes for the years ended December&#160;31, 2025 and 2024.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:ScheduleOfEffectivesIncomeTaxRateReconciliationTableTextBlock>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002479"
      unitRef="KRW">-6141476000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002480"
      unitRef="KRW">-8065334000</ifrs-full:ProfitLossBeforeTax>
    <cik0002058261:TaxAtStatutoryIncomeTaxRate
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002482"
      unitRef="KRW">-608006000</cik0002058261:TaxAtStatutoryIncomeTaxRate>
    <cik0002058261:TaxAtStatutoryIncomeTaxRate
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002483"
      unitRef="KRW">-798468000</cik0002058261:TaxAtStatutoryIncomeTaxRate>
    <ifrs-full:TaxEffectOfRevenuesExemptFromTaxation2011
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002488"
      unitRef="KRW">36427000</ifrs-full:TaxEffectOfRevenuesExemptFromTaxation2011>
    <ifrs-full:TaxEffectOfRevenuesExemptFromTaxation2011
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002489"
      unitRef="KRW">13673000</ifrs-full:TaxEffectOfRevenuesExemptFromTaxation2011>
    <cik0002058261:ExpensesNotDeductibleForTaxPurposes
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002491"
      unitRef="KRW">215761000</cik0002058261:ExpensesNotDeductibleForTaxPurposes>
    <cik0002058261:ExpensesNotDeductibleForTaxPurposes
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002492"
      unitRef="KRW">374340000</cik0002058261:ExpensesNotDeductibleForTaxPurposes>
    <cik0002058261:ChangesInUnrecognizedTemporaryDifference
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002494"
      unitRef="KRW">125382000</cik0002058261:ChangesInUnrecognizedTemporaryDifference>
    <cik0002058261:ChangesInUnrecognizedTemporaryDifference
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002495"
      unitRef="KRW">683633000</cik0002058261:ChangesInUnrecognizedTemporaryDifference>
    <ifrs-full:OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002497"
      unitRef="KRW">303290000</ifrs-full:OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome>
    <ifrs-full:OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002498"
      unitRef="KRW">-245832000</ifrs-full:OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome>
    <ifrs-full:AverageEffectiveTaxRate
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact002503"
      unitRef="Pure">0.000</ifrs-full:AverageEffectiveTaxRate>
    <ifrs-full:AverageEffectiveTaxRate
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact002504"
      unitRef="Pure">0.000</ifrs-full:AverageEffectiveTaxRate>
    <cik0002058261:ScheduleOfDeferredTaxBalanceTableTextBlock
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact002507">&lt;table cellpadding="0" cellspacing="0" id="xdx_899_ecustom--ScheduleOfDeferredTaxBalanceTableTextBlock_pn3n3_zK69QbIXuIxj" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Income taxes (Details 1)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: #FFFFFF"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_8BF_zysJIPU52Xlh" style="display: none"&gt;Schedule of deferred tax balances&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="10" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Tax effect&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Beginning&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Increase&lt;br/&gt; (decrease)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Ending&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="10" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Impairment Losses on Intangible Assets&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right; width: 9%"&gt;&lt;span id="xdx_902_ecustom--MovementInDeferredTaxBalances_iS_pn3n3_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ImpairmentLossesOnIntangibleAssetsMember_zrBRjPkurnMj" title="Beginning"&gt;198,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right; width: 9%"&gt;&lt;span id="xdx_902_ecustom--MovementInDeferredTaxBalancesIncreaseDecrease_pn3n3_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ImpairmentLossesOnIntangibleAssetsMember_zvE27AEaZQQ4" title="Increase (decrease)"&gt;8,009&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right; width: 9%"&gt;&lt;span id="xdx_904_ecustom--MovementInDeferredTaxBalances_iE_pn3n3_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ImpairmentLossesOnIntangibleAssetsMember_zIUT9CcdHSVi" title="Ending"&gt;206,009&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; width: 1%"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #FFFFFF"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Allowance for doubtful accounts&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_ecustom--MovementInDeferredTaxBalances_iS_pn3n3_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--AllowanceForDoubtfulAccountsMember_zSVJ1zUzAeH7" title="Beginning"&gt;236,570&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_909_ecustom--MovementInDeferredTaxBalancesIncreaseDecrease_pn3n3_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--AllowanceForDoubtfulAccountsMember_zZcL3yRKCinc" title="Increase (decrease)"&gt;(110,216&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_905_ecustom--MovementInDeferredTaxBalances_iE_pn3n3_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--AllowanceForDoubtfulAccountsMember_z6pWx5ffgrKh" title="Ending"&gt;126,354&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Lease liabilities&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_ecustom--MovementInDeferredTaxBalances_iS_pn3n3_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__ifrs-full--LeaseLiabilitiesMember_zN4O5RpRESNl" title="Beginning"&gt;66,234&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_903_ecustom--MovementInDeferredTaxBalancesIncreaseDecrease_pn3n3_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__ifrs-full--LeaseLiabilitiesMember_zO52sM0pOvoe" title="Increase (decrease)"&gt;(11,524&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_901_ecustom--MovementInDeferredTaxBalances_iE_pn3n3_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__ifrs-full--LeaseLiabilitiesMember_zFn6fOKQOshe" title="Ending"&gt;54,710&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #FFFFFF"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Property and equipment&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--MovementInDeferredTaxBalances_iS_pn3n3_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--PropertyAndEquipmentMember_z7EeA4yGyzpl" title="Beginning"&gt;(6,265&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--MovementInDeferredTaxBalancesIncreaseDecrease_pn3n3_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--PropertyAndEquipmentMember_zZWTnmcK57Zf" title="Increase (decrease)"&gt;(44,292&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_906_ecustom--MovementInDeferredTaxBalances_iE_pn3n3_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--PropertyAndEquipmentMember_zU5yVk8XuqCi" title="Ending"&gt;(50,557&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Bond with warrants, net&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--MovementInDeferredTaxBalances_iS_pn3n3_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--BondWithWarrantsNetMember_zyYTxtqs8lye" title="Beginning"&gt;(163,930&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--MovementInDeferredTaxBalancesIncreaseDecrease_pn3n3_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--BondWithWarrantsNetMember_zFVxU1dyKooh" title="Increase (decrease)"&gt;(4,339&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--MovementInDeferredTaxBalances_iE_pn3n3_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--BondWithWarrantsNetMember_zpQ9FKyEG2B4" title="Ending"&gt;(168,269&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #FFFFFF"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Leasehold deposit receivables&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_909_ecustom--MovementInDeferredTaxBalances_iS_pn3n3_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--LeaseholdDepositReceivablesMember_zWQnMPBMrB4" title="Beginning"&gt;7,278&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_907_ecustom--MovementInDeferredTaxBalancesIncreaseDecrease_pn3n3_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--LeaseholdDepositReceivablesMember_znTyabAFEqY8" title="Increase (decrease)"&gt;(1,145&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--MovementInDeferredTaxBalances_iE_pn3n3_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--LeaseholdDepositReceivablesMember_z6DgGG9g3nRl" title="Ending"&gt;6,133&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Defined benefit liabilities&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_909_ecustom--MovementInDeferredTaxBalances_iS_pn3n3_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--DefinedBenefitLiabilitiesMember_zG7yoqo2UIDi" title="Beginning"&gt;94,072&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_901_ecustom--MovementInDeferredTaxBalancesIncreaseDecrease_pn3n3_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--DefinedBenefitLiabilitiesMember_zFpRqO1Orfhi" title="Increase (decrease)"&gt;3,031&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_909_ecustom--MovementInDeferredTaxBalances_iE_pn3n3_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--DefinedBenefitLiabilitiesMember_zREAsFAKJmVl" title="Ending"&gt;97,103&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #FFFFFF"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Derivative liabilities&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_ecustom--MovementInDeferredTaxBalances_iS_pn3n3_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--DerivativeLiabilitiesMember_ztSgVW3Rybrc" title="Beginning"&gt;145,908&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_903_ecustom--MovementInDeferredTaxBalancesIncreaseDecrease_pn3n3_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--DerivativeLiabilitiesMember_zec8lg7ZRN7" title="Increase (decrease)"&gt;(20,396&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_900_ecustom--MovementInDeferredTaxBalances_iE_pn3n3_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--DerivativeLiabilitiesMember_zhGnJqKI5Xpc" title="Ending"&gt;125,512&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Accrued expenses&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_907_ecustom--MovementInDeferredTaxBalances_iS_pn3n3_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--AccruedExpensesMember_zhw48Sc9Snj5" title="Beginning"&gt;(6,092&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_909_ecustom--MovementInDeferredTaxBalancesIncreaseDecrease_pn3n3_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--AccruedExpensesMember_z7CH4oc3KPf7" title="Increase (decrease)"&gt;(1,270&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--MovementInDeferredTaxBalances_iE_pn3n3_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--AccruedExpensesMember_zuMdBXlEGoV4" title="Ending"&gt;(7,362&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #FFFFFF"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Accrued income&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_906_ecustom--MovementInDeferredTaxBalances_iS_pn3n3_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--AccruedIncomeMember_zSeOKHCKKGf" title="Beginning"&gt;(18,219&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_905_ecustom--MovementInDeferredTaxBalancesIncreaseDecrease_pn3n3_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--AccruedIncomeMember_z2ds9wtV0iFf" title="Increase (decrease)"&gt;(10,536&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_900_ecustom--MovementInDeferredTaxBalances_iE_pn3n3_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--AccruedIncomeMember_zTuUklEAdi3l" title="Ending"&gt;(28,755&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Inventories, net&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--MovementInDeferredTaxBalances_iS_pn3n3_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--InventoriesNetMember_zvZiEYdlPjWi" title="Beginning"&gt;25,372&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_901_ecustom--MovementInDeferredTaxBalancesIncreaseDecrease_pn3n3_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--InventoriesNetMember_zoQbtbdkjgI5" title="Increase (decrease)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2571"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--MovementInDeferredTaxBalances_iE_pn3n3_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--InventoriesNetMember_za5U2CLD98xf" title="Ending"&gt;25,372&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #FFFFFF"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Provisions for restoration&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_906_ecustom--MovementInDeferredTaxBalances_iS_pn3n3_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ProvisionsForRestorationMember_zG4dsCP97FJd" title="Beginning"&gt;4,786&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_900_ecustom--MovementInDeferredTaxBalancesIncreaseDecrease_pn3n3_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ProvisionsForRestorationMember_zTjQh9d1QmJ9" title="Increase (decrease)"&gt;31&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_902_ecustom--MovementInDeferredTaxBalances_iE_pn3n3_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ProvisionsForRestorationMember_zV0WQRAdVi3b" title="Ending"&gt;4,817&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Others&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--MovementInDeferredTaxBalances_iS_pn3n3_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--OthersMember_zRfUDeYspzsj" title="Beginning"&gt;13,499&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--MovementInDeferredTaxBalancesIncreaseDecrease_pn3n3_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--OthersMember_zNHWKoNtsfF3" title="Increase (decrease)"&gt;(4,106&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_ecustom--MovementInDeferredTaxBalances_iE_pn3n3_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--OthersMember_zv4sbnffKcM9" title="Ending"&gt;9,393&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #FFFFFF"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; vertical-align: top; padding-left: 0.125in; padding-bottom: 1.25pt"&gt;Total&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_908_ecustom--MovementInDeferredTaxBalances_iS_pn3n3_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TotalMember_zVxiomHPkTV" title="Beginning"&gt;597,213&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--MovementInDeferredTaxBalancesIncreaseDecrease_pn3n3_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TotalMember_zcT77bh66Jy" title="Increase (decrease)"&gt;(196,753&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_900_ecustom--MovementInDeferredTaxBalances_iE_pn3n3_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TotalMember_zvVtIO1HzVLi" title="Ending"&gt;400,460&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Loss carried forward&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#x20a9;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_906_ecustom--MovementInDeferredTaxBalances_iS_pn3n3_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--LossCarriedForwardMember_z95jDKfZgfZi" title="Beginning"&gt;3,402,320&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--MovementInDeferredTaxBalancesIncreaseDecrease_pn3n3_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--LossCarriedForwardMember_zlsk5L4Sih1c" title="Increase (decrease)"&gt;378,738&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--MovementInDeferredTaxBalances_iE_pn3n3_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--LossCarriedForwardMember_zVWnRtd7BA52" title="Ending"&gt;3,781,058&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #FFFFFF"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Carryover tax credit&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_902_ecustom--MovementInDeferredTaxBalances_iS_pn3n3_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--CarryoverTaxCreditMember_zr21eDvZe7Hc" title="Beginning"&gt;526,463&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_907_ecustom--MovementInDeferredTaxBalancesIncreaseDecrease_pn3n3_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--CarryoverTaxCreditMember_zM2cb1f7lSyc" title="Increase (decrease)"&gt;(56,604&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_909_ecustom--MovementInDeferredTaxBalances_iE_pn3n3_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--CarryoverTaxCreditMember_zWd15Zf8FQ9j" title="Ending"&gt;469,859&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Unrecognized deferred tax assets&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_905_ecustom--MovementInDeferredTaxBalances_iS_pn3n3_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--UnrecognizedDeferredTaxLiabilitiesMember_zGotGAcRMfv1" title="Beginning"&gt;(4,525,996&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--MovementInDeferredTaxBalancesIncreaseDecrease_pn3n3_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--UnrecognizedDeferredTaxLiabilitiesMember_zO1vBe8fzpze" title="Increase (decrease)"&gt;(125,381&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--MovementInDeferredTaxBalances_iE_pn3n3_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--UnrecognizedDeferredTaxLiabilitiesMember_zVbDSSkHuEhb" title="Ending"&gt;(4,651,377&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #FFFFFF"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.25pt"&gt;Deferred tax assets (liabilities)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--MovementInDeferredTaxBalances_iS_pn3n3_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--DeferredTaxAssetsMember_zpDwR5mKIME5" title="Beginning"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2611"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_901_ecustom--MovementInDeferredTaxBalancesIncreaseDecrease_pn3n3_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--DeferredTaxAssetsMember_zKC2GNi7QIC1" title="Increase (decrease)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2613"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--MovementInDeferredTaxBalances_iE_pn3n3_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--DeferredTaxAssetsMember_zWBKybiqr2Ca" title="Ending"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2615"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

















&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 0.5in; text-align: left"&gt;ii.&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;Movement in deferred tax balances for the year ended December&#160;31, 2024&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="10" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Tax effect&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Beginning&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Increase&lt;br/&gt; (decrease)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Ending&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="10" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Impairment Losses on Intangible Assets&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_902_ecustom--MovementInDeferredTaxBalances_iS_pn3n3_c20240101__20241231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ImpairmentLossesOnIntangibleAssetsMember_za4MZxewOcbi" title="Beginning"&gt;198,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_908_ecustom--MovementInDeferredTaxBalancesIncreaseDecrease_pn3n3_c20240101__20241231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ImpairmentLossesOnIntangibleAssetsMember_zq7gUck8jKmh" title="Increase (decrease)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2626"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_900_ecustom--MovementInDeferredTaxBalances_iE_pn3n3_c20240101__20241231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ImpairmentLossesOnIntangibleAssetsMember_zwvFsb2uTfya" title="Ending"&gt;198,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Allowance for doubtful accounts&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--MovementInDeferredTaxBalances_iS_pn3n3_c20240101__20241231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--AllowanceForDoubtfulAccountsMember_zuWmYX2WWDD9" title="Beginning"&gt;282,093&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--MovementInDeferredTaxBalancesIncreaseDecrease_pn3n3_c20240101__20241231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--AllowanceForDoubtfulAccountsMember_z0iOCxZqsWCa" title="Increase (decrease)"&gt;(45,523&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_907_ecustom--MovementInDeferredTaxBalances_iE_pn3n3_c20240101__20241231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--AllowanceForDoubtfulAccountsMember_zwAzUOfbW7ke" title="Ending"&gt;236,570&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Lease liabilities&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--MovementInDeferredTaxBalances_iS_pn3n3_c20240101__20241231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__ifrs-full--LeaseLiabilitiesMember_zmoMr2r4dpSd" title="Beginning"&gt;76,862&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_908_ecustom--MovementInDeferredTaxBalancesIncreaseDecrease_pn3n3_c20240101__20241231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__ifrs-full--LeaseLiabilitiesMember_zeJiC3sO8ZU1" title="Increase (decrease)"&gt;(10,628&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_907_ecustom--MovementInDeferredTaxBalances_iE_pn3n3_c20240101__20241231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__ifrs-full--LeaseLiabilitiesMember_zU5nCTBEBIc1" title="Ending"&gt;66,234&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Property and equipment&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--MovementInDeferredTaxBalances_iS_pn3n3_c20240101__20241231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--PropertyAndEquipmentMember_z2H9Io0mhXN9" title="Beginning"&gt;(77,619&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--MovementInDeferredTaxBalancesIncreaseDecrease_pn3n3_c20240101__20241231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--PropertyAndEquipmentMember_zJdFuDYvFQ5i" title="Increase (decrease)"&gt;71,354&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--MovementInDeferredTaxBalances_iE_pn3n3_c20240101__20241231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--PropertyAndEquipmentMember_zNK5SmCp7uPi" title="Ending"&gt;(6,265&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Bond with warrants, net&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--MovementInDeferredTaxBalances_iS_pn3n3_c20240101__20241231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--BondWithWarrantsNetMember_zZU0xYhI2ZDf" title="Beginning"&gt;(273,033&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--MovementInDeferredTaxBalancesIncreaseDecrease_pn3n3_c20240101__20241231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--BondWithWarrantsNetMember_zsXHe0lapJA8" title="Increase (decrease)"&gt;109,103&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--MovementInDeferredTaxBalances_iE_pn3n3_c20240101__20241231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--BondWithWarrantsNetMember_zn9iBYsjkXla" title="Ending"&gt;(163,930&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Leasehold deposit receivables&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_901_ecustom--MovementInDeferredTaxBalances_iS_pn3n3_c20240101__20241231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--LeaseholdDepositReceivablesMember_z6DTwoKZelod" title="Beginning"&gt;5,828&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_903_ecustom--MovementInDeferredTaxBalancesIncreaseDecrease_pn3n3_c20240101__20241231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--LeaseholdDepositReceivablesMember_zEz44euI29P6" title="Increase (decrease)"&gt;1,450&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_906_ecustom--MovementInDeferredTaxBalances_iE_pn3n3_c20240101__20241231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--LeaseholdDepositReceivablesMember_zwo4ORMpRdw3" title="Ending"&gt;7,278&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Defined benefit liabilities&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--MovementInDeferredTaxBalances_iS_pn3n3_c20240101__20241231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--DefinedBenefitLiabilitiesMember_zNJQjxQpxNXe" title="Beginning"&gt;71,120&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_902_ecustom--MovementInDeferredTaxBalancesIncreaseDecrease_pn3n3_c20240101__20241231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--DefinedBenefitLiabilitiesMember_zwtu2cZzHDJc" title="Increase (decrease)"&gt;22,952&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_902_ecustom--MovementInDeferredTaxBalances_iE_pn3n3_c20240101__20241231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--DefinedBenefitLiabilitiesMember_zcJiVbYL30Y6" title="Ending"&gt;94,072&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Derivative liabilities&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_ecustom--MovementInDeferredTaxBalances_iS_pn3n3_c20240101__20241231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--DerivativeLiabilitiesMember_z8t8BcZiuLX6" title="Beginning"&gt;213,102&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_ecustom--MovementInDeferredTaxBalancesIncreaseDecrease_pn3n3_c20240101__20241231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--DerivativeLiabilitiesMember_zyZkfKYFm9N2" title="Increase (decrease)"&gt;(67,194&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_903_ecustom--MovementInDeferredTaxBalances_iE_pn3n3_c20240101__20241231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--DerivativeLiabilitiesMember_z4AUcm3ufXW2" title="Ending"&gt;145,908&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Accrued expenses&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_901_ecustom--MovementInDeferredTaxBalances_iS_pn3n3_c20240101__20241231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--AccruedExpensesMember_z1tpANDpJAwj" title="Beginning"&gt;4,132&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_907_ecustom--MovementInDeferredTaxBalancesIncreaseDecrease_pn3n3_c20240101__20241231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--AccruedExpensesMember_zH5CrInmdfPj" title="Increase (decrease)"&gt;(10,224&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_ecustom--MovementInDeferredTaxBalances_iE_pn3n3_c20240101__20241231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--AccruedExpensesMember_zzWYLkW7WYaf" title="Ending"&gt;(6,092&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Accrued income&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_903_ecustom--MovementInDeferredTaxBalances_iS_pn3n3_c20240101__20241231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--AccruedIncomeMember_z8Nwi8jPQnpd" title="Beginning"&gt;(9,587&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_ecustom--MovementInDeferredTaxBalancesIncreaseDecrease_pn3n3_c20240101__20241231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--AccruedIncomeMember_zL6kuzco0wWe" title="Increase (decrease)"&gt;(8,632&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_905_ecustom--MovementInDeferredTaxBalances_iE_pn3n3_c20240101__20241231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--AccruedIncomeMember_z1KUFFPzehRd" title="Ending"&gt;(18,219&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Inventories, net&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_ecustom--MovementInDeferredTaxBalances_iS_pn3n3_c20240101__20241231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--InventoriesNetMember_zxgyEgjsoWjh" title="Beginning"&gt;25,372&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--MovementInDeferredTaxBalancesIncreaseDecrease_pn3n3_c20240101__20241231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--InventoriesNetMember_zp2HgsqFmgyj" title="Increase (decrease)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2686"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_903_ecustom--MovementInDeferredTaxBalances_iE_pn3n3_c20240101__20241231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--InventoriesNetMember_z6bPHxMdHiQb" title="Ending"&gt;25,372&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Provisions for restoration&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--MovementInDeferredTaxBalances_iS_pn3n3_c20240101__20241231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ProvisionsForRestorationMember_zIpQBxO7jOMf" title="Beginning"&gt;4,753&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_900_ecustom--MovementInDeferredTaxBalancesIncreaseDecrease_pn3n3_c20240101__20241231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ProvisionsForRestorationMember_zHXGHDrHPY07" title="Increase (decrease)"&gt;33&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--MovementInDeferredTaxBalances_iE_pn3n3_c20240101__20241231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ProvisionsForRestorationMember_zPXOvvcnWd8" title="Ending"&gt;4,786&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Others&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--MovementInDeferredTaxBalances_iS_pn3n3_c20240101__20241231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--OthersMember_z33w2Sk8v3A6" title="Beginning"&gt;17,197&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_903_ecustom--MovementInDeferredTaxBalancesIncreaseDecrease_pn3n3_c20240101__20241231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--OthersMember_zmRAjds8grWk" title="Increase (decrease)"&gt;(3,698&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_903_ecustom--MovementInDeferredTaxBalances_iE_pn3n3_c20240101__20241231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--OthersMember_zFGiE9df9PB3" title="Ending"&gt;13,499&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; vertical-align: top; padding-left: 0.125in; padding-bottom: 1.25pt"&gt;Total&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--MovementInDeferredTaxBalances_iS_pn3n3_c20240101__20241231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TotalMember_zWXZJfmC6Irc" title="Beginning"&gt;538,220&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_908_ecustom--MovementInDeferredTaxBalancesIncreaseDecrease_pn3n3_c20240101__20241231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TotalMember_z9K4YgWz3JU3" title="Increase (decrease)"&gt;58,993&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--MovementInDeferredTaxBalances_iE_pn3n3_c20240101__20241231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TotalMember_zxjKo8sCZ0fg" title="Ending"&gt;597,213&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Loss carried forward&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#x20a9;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--MovementInDeferredTaxBalances_iS_pn3n3_c20240101__20241231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--LossCarriedForwardMember_zRJ2JDFHIGCl" title="Beginning"&gt;2,893,763&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_906_ecustom--MovementInDeferredTaxBalancesIncreaseDecrease_pn3n3_c20240101__20241231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--LossCarriedForwardMember_zGU6U8yPWK48" title="Increase (decrease)"&gt;508,557&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_909_ecustom--MovementInDeferredTaxBalances_iE_pn3n3_c20240101__20241231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--LossCarriedForwardMember_z0ZgEROkoqWj" title="Ending"&gt;3,402,320&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Carryover tax credit&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--MovementInDeferredTaxBalances_iS_pn3n3_c20240101__20241231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--CarryoverTaxCreditMember_zPzHdxlpfiF7" title="Beginning"&gt;410,379&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_907_ecustom--MovementInDeferredTaxBalancesIncreaseDecrease_pn3n3_c20240101__20241231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--CarryoverTaxCreditMember_zJ1qJLicDF9k" title="Increase (decrease)"&gt;116,084&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--MovementInDeferredTaxBalances_iE_pn3n3_c20240101__20241231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--CarryoverTaxCreditMember_zvrc3XeT0O79" title="Ending"&gt;526,463&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Unrecognized deferred tax assets&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_909_ecustom--MovementInDeferredTaxBalances_iS_pn3n3_c20240101__20241231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--UnrecognizedDeferredTaxLiabilitiesMember_zz0Bj8rrTiKg" title="Beginning"&gt;(3,842,362&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_903_ecustom--MovementInDeferredTaxBalancesIncreaseDecrease_pn3n3_c20240101__20241231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--UnrecognizedDeferredTaxLiabilitiesMember_zHYn96IcvH8e" title="Increase (decrease)"&gt;(683,634&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_905_ecustom--MovementInDeferredTaxBalances_iE_pn3n3_c20240101__20241231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--UnrecognizedDeferredTaxLiabilitiesMember_z7vBOpMsRRz9" title="Ending"&gt;(4,525,996&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.25pt"&gt;Deferred tax assets (liabilities)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--MovementInDeferredTaxBalances_iS_pn3n3_c20240101__20241231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--DeferredTaxAssetsMember_zdVbmJ6w2w2c" title="Beginning"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2726"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_909_ecustom--MovementInDeferredTaxBalancesIncreaseDecrease_pn3n3_c20240101__20241231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--DeferredTaxAssetsMember_zIXvEAGVbdOa" title="Increase (decrease)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2728"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_909_ecustom--MovementInDeferredTaxBalances_iE_pn3n3_c20240101__20241231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--DeferredTaxAssetsMember_z4L0kJdVjsX2" title="Ending"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2730"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:ScheduleOfDeferredTaxBalanceTableTextBlock>
    <cik0002058261:MovementInDeferredTaxBalances
      contextRef="AsOf2024-12-31_custom_ImpairmentLossesOnIntangibleAssetsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002509"
      unitRef="KRW">198000000</cik0002058261:MovementInDeferredTaxBalances>
    <cik0002058261:MovementInDeferredTaxBalancesIncreaseDecrease
      contextRef="From2025-01-012025-12-31_custom_ImpairmentLossesOnIntangibleAssetsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002511"
      unitRef="KRW">8009000</cik0002058261:MovementInDeferredTaxBalancesIncreaseDecrease>
    <cik0002058261:MovementInDeferredTaxBalances
      contextRef="AsOf2025-12-31_custom_ImpairmentLossesOnIntangibleAssetsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002513"
      unitRef="KRW">206009000</cik0002058261:MovementInDeferredTaxBalances>
    <cik0002058261:MovementInDeferredTaxBalances
      contextRef="AsOf2024-12-31_custom_AllowanceForDoubtfulAccountsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002515"
      unitRef="KRW">236570000</cik0002058261:MovementInDeferredTaxBalances>
    <cik0002058261:MovementInDeferredTaxBalancesIncreaseDecrease
      contextRef="From2025-01-012025-12-31_custom_AllowanceForDoubtfulAccountsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002517"
      unitRef="KRW">-110216000</cik0002058261:MovementInDeferredTaxBalancesIncreaseDecrease>
    <cik0002058261:MovementInDeferredTaxBalances
      contextRef="AsOf2025-12-31_custom_AllowanceForDoubtfulAccountsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002519"
      unitRef="KRW">126354000</cik0002058261:MovementInDeferredTaxBalances>
    <cik0002058261:MovementInDeferredTaxBalances
      contextRef="AsOf2024-12-31_ifrs-full_LeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002521"
      unitRef="KRW">66234000</cik0002058261:MovementInDeferredTaxBalances>
    <cik0002058261:MovementInDeferredTaxBalancesIncreaseDecrease
      contextRef="From2025-01-012025-12-31_ifrs-full_LeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002523"
      unitRef="KRW">-11524000</cik0002058261:MovementInDeferredTaxBalancesIncreaseDecrease>
    <cik0002058261:MovementInDeferredTaxBalances
      contextRef="AsOf2025-12-31_ifrs-full_LeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002525"
      unitRef="KRW">54710000</cik0002058261:MovementInDeferredTaxBalances>
    <cik0002058261:MovementInDeferredTaxBalances
      contextRef="AsOf2024-12-31_custom_PropertyAndEquipmentMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002527"
      unitRef="KRW">-6265000</cik0002058261:MovementInDeferredTaxBalances>
    <cik0002058261:MovementInDeferredTaxBalancesIncreaseDecrease
      contextRef="From2025-01-012025-12-31_custom_PropertyAndEquipmentMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002529"
      unitRef="KRW">-44292000</cik0002058261:MovementInDeferredTaxBalancesIncreaseDecrease>
    <cik0002058261:MovementInDeferredTaxBalances
      contextRef="AsOf2025-12-31_custom_PropertyAndEquipmentMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002531"
      unitRef="KRW">-50557000</cik0002058261:MovementInDeferredTaxBalances>
    <cik0002058261:MovementInDeferredTaxBalances
      contextRef="AsOf2024-12-31_custom_BondWithWarrantsNetMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002533"
      unitRef="KRW">-163930000</cik0002058261:MovementInDeferredTaxBalances>
    <cik0002058261:MovementInDeferredTaxBalancesIncreaseDecrease
      contextRef="From2025-01-012025-12-31_custom_BondWithWarrantsNetMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002535"
      unitRef="KRW">-4339000</cik0002058261:MovementInDeferredTaxBalancesIncreaseDecrease>
    <cik0002058261:MovementInDeferredTaxBalances
      contextRef="AsOf2025-12-31_custom_BondWithWarrantsNetMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002537"
      unitRef="KRW">-168269000</cik0002058261:MovementInDeferredTaxBalances>
    <cik0002058261:MovementInDeferredTaxBalances
      contextRef="AsOf2024-12-31_custom_LeaseholdDepositReceivablesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002539"
      unitRef="KRW">7278000</cik0002058261:MovementInDeferredTaxBalances>
    <cik0002058261:MovementInDeferredTaxBalancesIncreaseDecrease
      contextRef="From2025-01-012025-12-31_custom_LeaseholdDepositReceivablesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002541"
      unitRef="KRW">-1145000</cik0002058261:MovementInDeferredTaxBalancesIncreaseDecrease>
    <cik0002058261:MovementInDeferredTaxBalances
      contextRef="AsOf2025-12-31_custom_LeaseholdDepositReceivablesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002543"
      unitRef="KRW">6133000</cik0002058261:MovementInDeferredTaxBalances>
    <cik0002058261:MovementInDeferredTaxBalances
      contextRef="AsOf2024-12-31_custom_DefinedBenefitLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002545"
      unitRef="KRW">94072000</cik0002058261:MovementInDeferredTaxBalances>
    <cik0002058261:MovementInDeferredTaxBalancesIncreaseDecrease
      contextRef="From2025-01-012025-12-31_custom_DefinedBenefitLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002547"
      unitRef="KRW">3031000</cik0002058261:MovementInDeferredTaxBalancesIncreaseDecrease>
    <cik0002058261:MovementInDeferredTaxBalances
      contextRef="AsOf2025-12-31_custom_DefinedBenefitLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002549"
      unitRef="KRW">97103000</cik0002058261:MovementInDeferredTaxBalances>
    <cik0002058261:MovementInDeferredTaxBalances
      contextRef="AsOf2024-12-31_custom_DerivativeLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002551"
      unitRef="KRW">145908000</cik0002058261:MovementInDeferredTaxBalances>
    <cik0002058261:MovementInDeferredTaxBalancesIncreaseDecrease
      contextRef="From2025-01-012025-12-31_custom_DerivativeLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002553"
      unitRef="KRW">-20396000</cik0002058261:MovementInDeferredTaxBalancesIncreaseDecrease>
    <cik0002058261:MovementInDeferredTaxBalances
      contextRef="AsOf2025-12-31_custom_DerivativeLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002555"
      unitRef="KRW">125512000</cik0002058261:MovementInDeferredTaxBalances>
    <cik0002058261:MovementInDeferredTaxBalances
      contextRef="AsOf2024-12-31_custom_AccruedExpensesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002557"
      unitRef="KRW">-6092000</cik0002058261:MovementInDeferredTaxBalances>
    <cik0002058261:MovementInDeferredTaxBalancesIncreaseDecrease
      contextRef="From2025-01-012025-12-31_custom_AccruedExpensesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002559"
      unitRef="KRW">-1270000</cik0002058261:MovementInDeferredTaxBalancesIncreaseDecrease>
    <cik0002058261:MovementInDeferredTaxBalances
      contextRef="AsOf2025-12-31_custom_AccruedExpensesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002561"
      unitRef="KRW">-7362000</cik0002058261:MovementInDeferredTaxBalances>
    <cik0002058261:MovementInDeferredTaxBalances
      contextRef="AsOf2024-12-31_custom_AccruedIncomeMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002563"
      unitRef="KRW">-18219000</cik0002058261:MovementInDeferredTaxBalances>
    <cik0002058261:MovementInDeferredTaxBalancesIncreaseDecrease
      contextRef="From2025-01-012025-12-31_custom_AccruedIncomeMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002565"
      unitRef="KRW">-10536000</cik0002058261:MovementInDeferredTaxBalancesIncreaseDecrease>
    <cik0002058261:MovementInDeferredTaxBalances
      contextRef="AsOf2025-12-31_custom_AccruedIncomeMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002567"
      unitRef="KRW">-28755000</cik0002058261:MovementInDeferredTaxBalances>
    <cik0002058261:MovementInDeferredTaxBalances
      contextRef="AsOf2024-12-31_custom_InventoriesNetMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002569"
      unitRef="KRW">25372000</cik0002058261:MovementInDeferredTaxBalances>
    <cik0002058261:MovementInDeferredTaxBalances
      contextRef="AsOf2025-12-31_custom_InventoriesNetMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002573"
      unitRef="KRW">25372000</cik0002058261:MovementInDeferredTaxBalances>
    <cik0002058261:MovementInDeferredTaxBalances
      contextRef="AsOf2024-12-31_custom_ProvisionsForRestorationMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002575"
      unitRef="KRW">4786000</cik0002058261:MovementInDeferredTaxBalances>
    <cik0002058261:MovementInDeferredTaxBalancesIncreaseDecrease
      contextRef="From2025-01-012025-12-31_custom_ProvisionsForRestorationMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002577"
      unitRef="KRW">31000</cik0002058261:MovementInDeferredTaxBalancesIncreaseDecrease>
    <cik0002058261:MovementInDeferredTaxBalances
      contextRef="AsOf2025-12-31_custom_ProvisionsForRestorationMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002579"
      unitRef="KRW">4817000</cik0002058261:MovementInDeferredTaxBalances>
    <cik0002058261:MovementInDeferredTaxBalances
      contextRef="AsOf2024-12-31_custom_OthersMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002581"
      unitRef="KRW">13499000</cik0002058261:MovementInDeferredTaxBalances>
    <cik0002058261:MovementInDeferredTaxBalancesIncreaseDecrease
      contextRef="From2025-01-012025-12-31_custom_OthersMember_custom_CubebioCo.Ltd.Member273621031"
      decimals="-3"
      id="Fact002583"
      unitRef="KRW">-4106000</cik0002058261:MovementInDeferredTaxBalancesIncreaseDecrease>
    <cik0002058261:MovementInDeferredTaxBalances
      contextRef="AsOf2025-12-31_custom_OthersMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002585"
      unitRef="KRW">9393000</cik0002058261:MovementInDeferredTaxBalances>
    <cik0002058261:MovementInDeferredTaxBalances
      contextRef="AsOf2024-12-31_custom_TotalMember_custom_CubebioCo.Ltd.Member273621031"
      decimals="-3"
      id="Fact002587"
      unitRef="KRW">597213000</cik0002058261:MovementInDeferredTaxBalances>
    <cik0002058261:MovementInDeferredTaxBalancesIncreaseDecrease
      contextRef="From2025-01-012025-12-31_custom_TotalMember_custom_CubebioCo.Ltd.Member273621046"
      decimals="-3"
      id="Fact002589"
      unitRef="KRW">-196753000</cik0002058261:MovementInDeferredTaxBalancesIncreaseDecrease>
    <cik0002058261:MovementInDeferredTaxBalances
      contextRef="AsOf2025-12-31_custom_TotalMember_custom_CubebioCo.Ltd.Member273621046"
      decimals="-3"
      id="Fact002591"
      unitRef="KRW">400460000</cik0002058261:MovementInDeferredTaxBalances>
    <cik0002058261:MovementInDeferredTaxBalances
      contextRef="AsOf2024-12-31_custom_LossCarriedForwardMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002593"
      unitRef="KRW">3402320000</cik0002058261:MovementInDeferredTaxBalances>
    <cik0002058261:MovementInDeferredTaxBalancesIncreaseDecrease
      contextRef="From2025-01-012025-12-31_custom_LossCarriedForwardMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002595"
      unitRef="KRW">378738000</cik0002058261:MovementInDeferredTaxBalancesIncreaseDecrease>
    <cik0002058261:MovementInDeferredTaxBalances
      contextRef="AsOf2025-12-31_custom_LossCarriedForwardMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002597"
      unitRef="KRW">3781058000</cik0002058261:MovementInDeferredTaxBalances>
    <cik0002058261:MovementInDeferredTaxBalances
      contextRef="AsOf2024-12-31_custom_CarryoverTaxCreditMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002599"
      unitRef="KRW">526463000</cik0002058261:MovementInDeferredTaxBalances>
    <cik0002058261:MovementInDeferredTaxBalancesIncreaseDecrease
      contextRef="From2025-01-012025-12-31_custom_CarryoverTaxCreditMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002601"
      unitRef="KRW">-56604000</cik0002058261:MovementInDeferredTaxBalancesIncreaseDecrease>
    <cik0002058261:MovementInDeferredTaxBalances
      contextRef="AsOf2025-12-31_custom_CarryoverTaxCreditMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002603"
      unitRef="KRW">469859000</cik0002058261:MovementInDeferredTaxBalances>
    <cik0002058261:MovementInDeferredTaxBalances
      contextRef="AsOf2024-12-31_custom_UnrecognizedDeferredTaxLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002605"
      unitRef="KRW">-4525996000</cik0002058261:MovementInDeferredTaxBalances>
    <cik0002058261:MovementInDeferredTaxBalancesIncreaseDecrease
      contextRef="From2025-01-012025-12-31_custom_UnrecognizedDeferredTaxLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002607"
      unitRef="KRW">-125381000</cik0002058261:MovementInDeferredTaxBalancesIncreaseDecrease>
    <cik0002058261:MovementInDeferredTaxBalances
      contextRef="AsOf2025-12-31_custom_UnrecognizedDeferredTaxLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002609"
      unitRef="KRW">-4651377000</cik0002058261:MovementInDeferredTaxBalances>
    <cik0002058261:MovementInDeferredTaxBalances
      contextRef="AsOf2023-12-31_custom_ImpairmentLossesOnIntangibleAssetsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002624"
      unitRef="KRW">198000000</cik0002058261:MovementInDeferredTaxBalances>
    <cik0002058261:MovementInDeferredTaxBalances
      contextRef="AsOf2024-12-31_custom_ImpairmentLossesOnIntangibleAssetsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002628"
      unitRef="KRW">198000000</cik0002058261:MovementInDeferredTaxBalances>
    <cik0002058261:MovementInDeferredTaxBalances
      contextRef="AsOf2023-12-31_custom_AllowanceForDoubtfulAccountsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002630"
      unitRef="KRW">282093000</cik0002058261:MovementInDeferredTaxBalances>
    <cik0002058261:MovementInDeferredTaxBalancesIncreaseDecrease
      contextRef="From2024-01-012024-12-31_custom_AllowanceForDoubtfulAccountsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002632"
      unitRef="KRW">-45523000</cik0002058261:MovementInDeferredTaxBalancesIncreaseDecrease>
    <cik0002058261:MovementInDeferredTaxBalances
      contextRef="AsOf2024-12-31_custom_AllowanceForDoubtfulAccountsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002634"
      unitRef="KRW">236570000</cik0002058261:MovementInDeferredTaxBalances>
    <cik0002058261:MovementInDeferredTaxBalances
      contextRef="AsOf2023-12-31_ifrs-full_LeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002636"
      unitRef="KRW">76862000</cik0002058261:MovementInDeferredTaxBalances>
    <cik0002058261:MovementInDeferredTaxBalancesIncreaseDecrease
      contextRef="From2024-01-012024-12-31_ifrs-full_LeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002638"
      unitRef="KRW">-10628000</cik0002058261:MovementInDeferredTaxBalancesIncreaseDecrease>
    <cik0002058261:MovementInDeferredTaxBalances
      contextRef="AsOf2024-12-31_ifrs-full_LeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002640"
      unitRef="KRW">66234000</cik0002058261:MovementInDeferredTaxBalances>
    <cik0002058261:MovementInDeferredTaxBalances
      contextRef="AsOf2023-12-31_custom_PropertyAndEquipmentMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002642"
      unitRef="KRW">-77619000</cik0002058261:MovementInDeferredTaxBalances>
    <cik0002058261:MovementInDeferredTaxBalancesIncreaseDecrease
      contextRef="From2024-01-012024-12-31_custom_PropertyAndEquipmentMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002644"
      unitRef="KRW">71354000</cik0002058261:MovementInDeferredTaxBalancesIncreaseDecrease>
    <cik0002058261:MovementInDeferredTaxBalances
      contextRef="AsOf2024-12-31_custom_PropertyAndEquipmentMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002646"
      unitRef="KRW">-6265000</cik0002058261:MovementInDeferredTaxBalances>
    <cik0002058261:MovementInDeferredTaxBalances
      contextRef="AsOf2023-12-31_custom_BondWithWarrantsNetMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002648"
      unitRef="KRW">-273033000</cik0002058261:MovementInDeferredTaxBalances>
    <cik0002058261:MovementInDeferredTaxBalancesIncreaseDecrease
      contextRef="From2024-01-012024-12-31_custom_BondWithWarrantsNetMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002650"
      unitRef="KRW">109103000</cik0002058261:MovementInDeferredTaxBalancesIncreaseDecrease>
    <cik0002058261:MovementInDeferredTaxBalances
      contextRef="AsOf2024-12-31_custom_BondWithWarrantsNetMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002652"
      unitRef="KRW">-163930000</cik0002058261:MovementInDeferredTaxBalances>
    <cik0002058261:MovementInDeferredTaxBalances
      contextRef="AsOf2023-12-31_custom_LeaseholdDepositReceivablesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002654"
      unitRef="KRW">5828000</cik0002058261:MovementInDeferredTaxBalances>
    <cik0002058261:MovementInDeferredTaxBalancesIncreaseDecrease
      contextRef="From2024-01-012024-12-31_custom_LeaseholdDepositReceivablesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002656"
      unitRef="KRW">1450000</cik0002058261:MovementInDeferredTaxBalancesIncreaseDecrease>
    <cik0002058261:MovementInDeferredTaxBalances
      contextRef="AsOf2024-12-31_custom_LeaseholdDepositReceivablesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002658"
      unitRef="KRW">7278000</cik0002058261:MovementInDeferredTaxBalances>
    <cik0002058261:MovementInDeferredTaxBalances
      contextRef="AsOf2023-12-31_custom_DefinedBenefitLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002660"
      unitRef="KRW">71120000</cik0002058261:MovementInDeferredTaxBalances>
    <cik0002058261:MovementInDeferredTaxBalancesIncreaseDecrease
      contextRef="From2024-01-012024-12-31_custom_DefinedBenefitLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002662"
      unitRef="KRW">22952000</cik0002058261:MovementInDeferredTaxBalancesIncreaseDecrease>
    <cik0002058261:MovementInDeferredTaxBalances
      contextRef="AsOf2024-12-31_custom_DefinedBenefitLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002664"
      unitRef="KRW">94072000</cik0002058261:MovementInDeferredTaxBalances>
    <cik0002058261:MovementInDeferredTaxBalances
      contextRef="AsOf2023-12-31_custom_DerivativeLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002666"
      unitRef="KRW">213102000</cik0002058261:MovementInDeferredTaxBalances>
    <cik0002058261:MovementInDeferredTaxBalancesIncreaseDecrease
      contextRef="From2024-01-012024-12-31_custom_DerivativeLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002668"
      unitRef="KRW">-67194000</cik0002058261:MovementInDeferredTaxBalancesIncreaseDecrease>
    <cik0002058261:MovementInDeferredTaxBalances
      contextRef="AsOf2024-12-31_custom_DerivativeLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002670"
      unitRef="KRW">145908000</cik0002058261:MovementInDeferredTaxBalances>
    <cik0002058261:MovementInDeferredTaxBalances
      contextRef="AsOf2023-12-31_custom_AccruedExpensesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002672"
      unitRef="KRW">4132000</cik0002058261:MovementInDeferredTaxBalances>
    <cik0002058261:MovementInDeferredTaxBalancesIncreaseDecrease
      contextRef="From2024-01-012024-12-31_custom_AccruedExpensesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002674"
      unitRef="KRW">-10224000</cik0002058261:MovementInDeferredTaxBalancesIncreaseDecrease>
    <cik0002058261:MovementInDeferredTaxBalances
      contextRef="AsOf2024-12-31_custom_AccruedExpensesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002676"
      unitRef="KRW">-6092000</cik0002058261:MovementInDeferredTaxBalances>
    <cik0002058261:MovementInDeferredTaxBalances
      contextRef="AsOf2023-12-31_custom_AccruedIncomeMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002678"
      unitRef="KRW">-9587000</cik0002058261:MovementInDeferredTaxBalances>
    <cik0002058261:MovementInDeferredTaxBalancesIncreaseDecrease
      contextRef="From2024-01-012024-12-31_custom_AccruedIncomeMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002680"
      unitRef="KRW">-8632000</cik0002058261:MovementInDeferredTaxBalancesIncreaseDecrease>
    <cik0002058261:MovementInDeferredTaxBalances
      contextRef="AsOf2024-12-31_custom_AccruedIncomeMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002682"
      unitRef="KRW">-18219000</cik0002058261:MovementInDeferredTaxBalances>
    <cik0002058261:MovementInDeferredTaxBalances
      contextRef="AsOf2023-12-31_custom_InventoriesNetMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002684"
      unitRef="KRW">25372000</cik0002058261:MovementInDeferredTaxBalances>
    <cik0002058261:MovementInDeferredTaxBalances
      contextRef="AsOf2024-12-31_custom_InventoriesNetMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002688"
      unitRef="KRW">25372000</cik0002058261:MovementInDeferredTaxBalances>
    <cik0002058261:MovementInDeferredTaxBalances
      contextRef="AsOf2023-12-31_custom_ProvisionsForRestorationMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002690"
      unitRef="KRW">4753000</cik0002058261:MovementInDeferredTaxBalances>
    <cik0002058261:MovementInDeferredTaxBalancesIncreaseDecrease
      contextRef="From2024-01-012024-12-31_custom_ProvisionsForRestorationMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002692"
      unitRef="KRW">33000</cik0002058261:MovementInDeferredTaxBalancesIncreaseDecrease>
    <cik0002058261:MovementInDeferredTaxBalances
      contextRef="AsOf2024-12-31_custom_ProvisionsForRestorationMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002694"
      unitRef="KRW">4786000</cik0002058261:MovementInDeferredTaxBalances>
    <cik0002058261:MovementInDeferredTaxBalances
      contextRef="AsOf2023-12-31_custom_OthersMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002696"
      unitRef="KRW">17197000</cik0002058261:MovementInDeferredTaxBalances>
    <cik0002058261:MovementInDeferredTaxBalancesIncreaseDecrease
      contextRef="From2024-01-012024-12-31_custom_OthersMember_custom_CubebioCo.Ltd.Member273621437"
      decimals="-3"
      id="Fact002698"
      unitRef="KRW">-3698000</cik0002058261:MovementInDeferredTaxBalancesIncreaseDecrease>
    <cik0002058261:MovementInDeferredTaxBalances
      contextRef="AsOf2024-12-31_custom_OthersMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002700"
      unitRef="KRW">13499000</cik0002058261:MovementInDeferredTaxBalances>
    <cik0002058261:MovementInDeferredTaxBalances
      contextRef="AsOf2023-12-31_custom_TotalMember_custom_CubebioCo.Ltd.Member273621437"
      decimals="-3"
      id="Fact002702"
      unitRef="KRW">538220000</cik0002058261:MovementInDeferredTaxBalances>
    <cik0002058261:MovementInDeferredTaxBalancesIncreaseDecrease
      contextRef="From2024-01-012024-12-31_custom_TotalMember_custom_CubebioCo.Ltd.Member273621453"
      decimals="-3"
      id="Fact002704"
      unitRef="KRW">58993000</cik0002058261:MovementInDeferredTaxBalancesIncreaseDecrease>
    <cik0002058261:MovementInDeferredTaxBalances
      contextRef="AsOf2024-12-31_custom_TotalMember_custom_CubebioCo.Ltd.Member273621031"
      decimals="-3"
      id="Fact002706"
      unitRef="KRW">597213000</cik0002058261:MovementInDeferredTaxBalances>
    <cik0002058261:MovementInDeferredTaxBalances
      contextRef="AsOf2023-12-31_custom_LossCarriedForwardMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002708"
      unitRef="KRW">2893763000</cik0002058261:MovementInDeferredTaxBalances>
    <cik0002058261:MovementInDeferredTaxBalancesIncreaseDecrease
      contextRef="From2024-01-012024-12-31_custom_LossCarriedForwardMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002710"
      unitRef="KRW">508557000</cik0002058261:MovementInDeferredTaxBalancesIncreaseDecrease>
    <cik0002058261:MovementInDeferredTaxBalances
      contextRef="AsOf2024-12-31_custom_LossCarriedForwardMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002712"
      unitRef="KRW">3402320000</cik0002058261:MovementInDeferredTaxBalances>
    <cik0002058261:MovementInDeferredTaxBalances
      contextRef="AsOf2023-12-31_custom_CarryoverTaxCreditMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002714"
      unitRef="KRW">410379000</cik0002058261:MovementInDeferredTaxBalances>
    <cik0002058261:MovementInDeferredTaxBalancesIncreaseDecrease
      contextRef="From2024-01-012024-12-31_custom_CarryoverTaxCreditMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002716"
      unitRef="KRW">116084000</cik0002058261:MovementInDeferredTaxBalancesIncreaseDecrease>
    <cik0002058261:MovementInDeferredTaxBalances
      contextRef="AsOf2024-12-31_custom_CarryoverTaxCreditMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002718"
      unitRef="KRW">526463000</cik0002058261:MovementInDeferredTaxBalances>
    <cik0002058261:MovementInDeferredTaxBalances
      contextRef="AsOf2023-12-31_custom_UnrecognizedDeferredTaxLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002720"
      unitRef="KRW">-3842362000</cik0002058261:MovementInDeferredTaxBalances>
    <cik0002058261:MovementInDeferredTaxBalancesIncreaseDecrease
      contextRef="From2024-01-012024-12-31_custom_UnrecognizedDeferredTaxLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002722"
      unitRef="KRW">-683634000</cik0002058261:MovementInDeferredTaxBalancesIncreaseDecrease>
    <cik0002058261:MovementInDeferredTaxBalances
      contextRef="AsOf2024-12-31_custom_UnrecognizedDeferredTaxLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002724"
      unitRef="KRW">-4525996000</cik0002058261:MovementInDeferredTaxBalances>
    <cik0002058261:DetailsOfUnrecognizedDeferredIncomeTaxAssetsTableTextBlock
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact002732">&lt;table cellpadding="0" cellspacing="0" id="xdx_89B_ecustom--DetailsOfUnrecognizedDeferredIncomeTaxAssetsTableTextBlock_pn3n3_zvUYbM6oC0Mk" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Income taxes (Details 2)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_8BC_zPRmgppmbJQ8" style="display: none"&gt;Details of unrecognized deferred income tax assets&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_496_20250101__20251231_zQp1uf8gR3Oi" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_498_20240101__20241231_zhU91iKd1Z0k" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2024&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--UnrecognizedTemporaryDifference_zlrt59HpmObd" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Unrecognized temporary difference&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;400,460&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;597,213&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--TaxLossCarryforwards_zQ3aDsArE74" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Loss carried forward&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;3,781,058&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;3,402,320&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--TaxCreditCarryforwards_z7Ma0SxXLFJl" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Carryover tax credit&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;469,859&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;526,463&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--DeferredIncomeTaxAssets_zuWGO8qUAu63" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; vertical-align: top; padding-left: 0.125in; padding-bottom: 1.25pt"&gt;Total&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;4,651,377&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;4,525,996&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:DetailsOfUnrecognizedDeferredIncomeTaxAssetsTableTextBlock>
    <cik0002058261:UnrecognizedTemporaryDifference
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002734"
      unitRef="KRW">400460000</cik0002058261:UnrecognizedTemporaryDifference>
    <cik0002058261:UnrecognizedTemporaryDifference
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002735"
      unitRef="KRW">597213000</cik0002058261:UnrecognizedTemporaryDifference>
    <cik0002058261:TaxLossCarryforwards
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002737"
      unitRef="KRW">3781058000</cik0002058261:TaxLossCarryforwards>
    <cik0002058261:TaxLossCarryforwards
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002738"
      unitRef="KRW">3402320000</cik0002058261:TaxLossCarryforwards>
    <cik0002058261:TaxCreditCarryforwards
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002740"
      unitRef="KRW">469859000</cik0002058261:TaxCreditCarryforwards>
    <cik0002058261:TaxCreditCarryforwards
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002741"
      unitRef="KRW">526463000</cik0002058261:TaxCreditCarryforwards>
    <cik0002058261:DeferredIncomeTaxAssets
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002743"
      unitRef="KRW">4651377000</cik0002058261:DeferredIncomeTaxAssets>
    <cik0002058261:DeferredIncomeTaxAssets
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002744"
      unitRef="KRW">4525996000</cik0002058261:DeferredIncomeTaxAssets>
    <cik0002058261:SummaryOfUnusedTaxLossCarryforwardsTableTextBlock
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact002753">&lt;table cellpadding="0" cellspacing="0" id="xdx_892_ecustom--SummaryOfUnusedTaxLossCarryforwardsTableTextBlock_pn3n3_zC5FCtlcDZ6e" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Income taxes (Details 3)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_8BD_zuZ5rVKoHnu7" style="display: none"&gt;Schedule of unused tax loss carryforwards&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&lt;b&gt;Year of expiration&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Unused&lt;br/&gt; loss carried&lt;br/&gt; forward&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Unused&lt;br/&gt; carryover&lt;br/&gt; tax credit&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;2026&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised_iI_pn3n3_c20251231__custom--TaxExpirationPeriodAxis__custom--TaxPeriodTwoThousandAndTwentySixMember_zFX2yLKcHEX7" title="Unused loss carried forward"&gt;722,024&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--UnusedTaxCreditsForWhichNoDeferredTaxAssetRecognised_iI_pn3n3_c20251231__custom--TaxExpirationPeriodAxis__custom--TaxPeriodTwoThousandAndTwentySixMember_zqvb7Cp0EzC6" title="Unused tax credit carryforwards"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2757"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;2027&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised_iI_pn3n3_c20251231__custom--TaxExpirationPeriodAxis__custom--TaxPeriodTwoThousandAndTwentySevenMember_zz98Ko0GeEjh" title="Unused loss carried forward"&gt;292,098&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--UnusedTaxCreditsForWhichNoDeferredTaxAssetRecognised_iI_pn3n3_c20251231__custom--TaxExpirationPeriodAxis__custom--TaxPeriodTwoThousandAndTwentySevenMember_z8xgezMbPUDj" title="Unused tax credit carryforwards"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2761"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;2028&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised_iI_pn3n3_c20251231__custom--TaxExpirationPeriodAxis__custom--TaxPeriodTwoThousandAndTwentyEightMember_z2pwzysZyml3" title="Unused loss carried forward"&gt;319,426&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--UnusedTaxCreditsForWhichNoDeferredTaxAssetRecognised_iI_pn3n3_c20251231__custom--TaxExpirationPeriodAxis__custom--TaxPeriodTwoThousandAndTwentyEightMember_zhPv64YLqfMl" title="Unused tax credit carryforwards"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2765"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;2029&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised_iI_pn3n3_c20251231__custom--TaxExpirationPeriodAxis__custom--TaxPeriodTwoThousandAndTwentyNineMember_zHBcZDHRFZlb" title="Unused loss carried forward"&gt;383,584&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--UnusedTaxCreditsForWhichNoDeferredTaxAssetRecognised_iI_pn3n3_c20251231__custom--TaxExpirationPeriodAxis__custom--TaxPeriodTwoThousandAndTwentyNineMember_zm0bBHPabJ8h" title="Unused tax credit carryforwards"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2769"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;2030&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised_iI_pn3n3_c20251231__custom--TaxExpirationPeriodAxis__custom--TaxPeriodTwoThousandAndThirtyMember_zux3Mvurwb0c" title="Unused loss carried forward"&gt;49,670&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--UnusedTaxCreditsForWhichNoDeferredTaxAssetRecognised_iI_pn3n3_c20251231__custom--TaxExpirationPeriodAxis__custom--TaxPeriodTwoThousandAndThirtyMember_z0gYZJzlGBpi" title="Unused tax credit carryforwards"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2773"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;2031&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised_iI_pn3n3_c20251231__custom--TaxExpirationPeriodAxis__custom--TaxPeriodTwoThousandAndThirtyOneMember_z0Y4HuEy3T1f" title="Unused loss carried forward"&gt;281,727&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--UnusedTaxCreditsForWhichNoDeferredTaxAssetRecognised_iI_pn3n3_c20251231__custom--TaxExpirationPeriodAxis__custom--TaxPeriodTwoThousandAndThirtyOneMember_zPFRWo95c4Hi" title="Unused tax credit carryforwards"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2777"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;After 2031&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised_iI_pn3n3_c20251231__custom--TaxExpirationPeriodAxis__custom--After2031Member_zOwngCmOYhK6" title="Unused loss carried forward"&gt;1,732,529&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--UnusedTaxCreditsForWhichNoDeferredTaxAssetRecognised_iI_pn3n3_c20251231__custom--TaxExpirationPeriodAxis__custom--After2031Member_ztzaoUeXMsZ7" title="Unused tax credit carryforwards"&gt;469,859&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; vertical-align: top; padding-left: 0.125in; padding-bottom: 1.25pt"&gt;Total&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised_iI_pn3n3_c20251231_zTmYQ354Qtw8" title="Unused loss carried forward"&gt;3,781,058&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--UnusedTaxCreditsForWhichNoDeferredTaxAssetRecognised_iI_pn3n3_c20251231_zvrv12AKzO1b" title="Unused tax credit carryforwards"&gt;469,859&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:SummaryOfUnusedTaxLossCarryforwardsTableTextBlock>
    <ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised
      contextRef="AsOf2025-12-31_custom_TaxPeriodTwoThousandAndTwentySixMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002755"
      unitRef="KRW">722024000</ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised>
    <ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised
      contextRef="AsOf2025-12-31_custom_TaxPeriodTwoThousandAndTwentySevenMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002759"
      unitRef="KRW">292098000</ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised>
    <ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised
      contextRef="AsOf2025-12-31_custom_TaxPeriodTwoThousandAndTwentyEightMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002763"
      unitRef="KRW">319426000</ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised>
    <ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised
      contextRef="AsOf2025-12-31_custom_TaxPeriodTwoThousandAndTwentyNineMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002767"
      unitRef="KRW">383584000</ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised>
    <ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised
      contextRef="AsOf2025-12-31_custom_TaxPeriodTwoThousandAndThirtyMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002771"
      unitRef="KRW">49670000</ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised>
    <ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised
      contextRef="AsOf2025-12-31_custom_TaxPeriodTwoThousandAndThirtyOneMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002775"
      unitRef="KRW">281727000</ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised>
    <ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised
      contextRef="AsOf2025-12-31_custom_After2031Member_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002779"
      unitRef="KRW">1732529000</ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised>
    <ifrs-full:UnusedTaxCreditsForWhichNoDeferredTaxAssetRecognised
      contextRef="AsOf2025-12-31_custom_After2031Member_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002781"
      unitRef="KRW">469859000</ifrs-full:UnusedTaxCreditsForWhichNoDeferredTaxAssetRecognised>
    <ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002783"
      unitRef="KRW">3781058000</ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised>
    <ifrs-full:UnusedTaxCreditsForWhichNoDeferredTaxAssetRecognised
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002785"
      unitRef="KRW">469859000</ifrs-full:UnusedTaxCreditsForWhichNoDeferredTaxAssetRecognised>
    <cik0002058261:RecoveryOfDeferredTaxAssetsAndLiabilitiesDisclosureTableTextBlock
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact002787">&lt;table cellpadding="0" cellspacing="0" id="xdx_89B_ecustom--RecoveryOfDeferredTaxAssetsAndLiabilitiesDisclosureTableTextBlock_pn3n3_zxEHczQHVIs7" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Income taxes (Details 4)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span id="xdx_8B5_zMUwBbKHfMb7" style="display: none"&gt;Schedule of recovery of deferred tax assets and liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2024&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Deferred tax assets&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;- Deferred tax assets to be recovered after more than 12 months&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#x20a9;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--DeferredTaxAsset_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zYdcCs3YY261" title="Deferred tax assets"&gt;4,574,362&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--DeferredTaxAsset_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zlPQQfrYjcni" title="Deferred tax assets"&gt;4,305,986&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;- Deferred tax assets to be recovered within 12 months&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--DeferredTaxAsset_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember_zSF8LjHcRdtl" title="Deferred tax assets"&gt;324,775&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--DeferredTaxAsset_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember_zBCHkNbuEGK2" title="Deferred tax assets"&gt;468,181&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; vertical-align: top; padding-left: 0.125in; padding-bottom: 0.5pt"&gt;Sub-total&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_908_ecustom--DeferredTaxAsset_iI_pn3n3_c20251231_zf6ptkHl2qEl" title="Deferred tax assets"&gt;4,899,137&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_909_ecustom--DeferredTaxAsset_iI_pn3n3_c20241231_z7hgHjze6u9k" title="Deferred tax assets"&gt;4,774,167&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Deferred tax liabilities&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;- Deferred tax liabilities to be recovered after more than 12 months&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--DeferredTaxLiabilitiess_iNI_pn3n3_di_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zk7b3NDy6HY1" title="Deferred tax liabilities"&gt;(75,235&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_ecustom--DeferredTaxLiabilitiess_iNI_pn3n3_di_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zJ0UdrJhBcrl" title="Deferred tax liabilities"&gt;(81,256&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;- Deferred tax liabilities to be recovered within 12 months&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--DeferredTaxLiabilitiess_iNI_pn3n3_di_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember_z29dNSzTg4i8" title="Deferred tax liabilities"&gt;(172,525&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_901_ecustom--DeferredTaxLiabilitiess_iNI_pn3n3_di_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember_zcrsMrqmxQKa" title="Deferred tax liabilities"&gt;(166,915&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; vertical-align: top; padding-left: 0.125in; padding-bottom: 0.5pt"&gt;Sub-total&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--DeferredTaxLiabilitiess_iNI_pn3n3_di_c20251231_zK24EHx7zAGh" title="Deferred tax liabilities"&gt;(247,760&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_906_ecustom--DeferredTaxLiabilitiess_iNI_pn3n3_di_c20241231_zDEaiDB13Mvb" title="Deferred tax liabilities"&gt;(248,171&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Unrecognized deferred tax assets&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--UnrecognizedDeferredTaxAssets_iNI_pn3n3_di_c20251231_zP8xzsCTVaCe" title="Unrecognized deferred tax assets"&gt;(4,651,377&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_902_ecustom--UnrecognizedDeferredTaxAssets_iNI_pn3n3_di_c20241231_zCEnpalcgnBl" title="Unrecognized deferred tax assets"&gt;(4,525,996&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.25pt"&gt;Deferred tax assets (liabilities), net&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--NetDeferredTaxLiabilities_iI_pn3n3_c20251231_zzPfA0x1iCr7" title="Deferred tax assets (liabilities), net"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2817"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--NetDeferredTaxLiabilities_iI_pn3n3_c20241231_zCys0ggSFaMc" title="Deferred tax assets (liabilities), net"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2819"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:RecoveryOfDeferredTaxAssetsAndLiabilitiesDisclosureTableTextBlock>
    <cik0002058261:DeferredTaxAsset
      contextRef="AsOf2025-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_NotLaterThanOneYearMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002789"
      unitRef="KRW">4574362000</cik0002058261:DeferredTaxAsset>
    <cik0002058261:DeferredTaxAsset
      contextRef="AsOf2024-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_NotLaterThanOneYearMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002791"
      unitRef="KRW">4305986000</cik0002058261:DeferredTaxAsset>
    <cik0002058261:DeferredTaxAsset
      contextRef="AsOf2025-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LaterThanOneYearMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002793"
      unitRef="KRW">324775000</cik0002058261:DeferredTaxAsset>
    <cik0002058261:DeferredTaxAsset
      contextRef="AsOf2024-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LaterThanOneYearMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002795"
      unitRef="KRW">468181000</cik0002058261:DeferredTaxAsset>
    <cik0002058261:DeferredTaxAsset
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002797"
      unitRef="KRW">4899137000</cik0002058261:DeferredTaxAsset>
    <cik0002058261:DeferredTaxAsset
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002799"
      unitRef="KRW">4774167000</cik0002058261:DeferredTaxAsset>
    <cik0002058261:DeferredTaxLiabilitiess
      contextRef="AsOf2025-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_NotLaterThanOneYearMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002801"
      unitRef="KRW">75235000</cik0002058261:DeferredTaxLiabilitiess>
    <cik0002058261:DeferredTaxLiabilitiess
      contextRef="AsOf2024-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_NotLaterThanOneYearMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002803"
      unitRef="KRW">81256000</cik0002058261:DeferredTaxLiabilitiess>
    <cik0002058261:DeferredTaxLiabilitiess
      contextRef="AsOf2025-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LaterThanOneYearMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002805"
      unitRef="KRW">172525000</cik0002058261:DeferredTaxLiabilitiess>
    <cik0002058261:DeferredTaxLiabilitiess
      contextRef="AsOf2024-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LaterThanOneYearMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002807"
      unitRef="KRW">166915000</cik0002058261:DeferredTaxLiabilitiess>
    <cik0002058261:DeferredTaxLiabilitiess
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002809"
      unitRef="KRW">247760000</cik0002058261:DeferredTaxLiabilitiess>
    <cik0002058261:DeferredTaxLiabilitiess
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002811"
      unitRef="KRW">248171000</cik0002058261:DeferredTaxLiabilitiess>
    <cik0002058261:UnrecognizedDeferredTaxAssets
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002813"
      unitRef="KRW">4651377000</cik0002058261:UnrecognizedDeferredTaxAssets>
    <cik0002058261:UnrecognizedDeferredTaxAssets
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002815"
      unitRef="KRW">4525996000</cik0002058261:UnrecognizedDeferredTaxAssets>
    <ifrs-full:DisclosureOfEarningsPerShareExplanatory
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact002821">&lt;p id="xdx_800_eifrs-full--DisclosureOfEarningsPerShareExplanatory_zWgmoLyxZuYa" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;18. &lt;span id="xdx_82A_zdBC8GP0PB92"&gt;Loss per share&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.25in; text-align: left"&gt;&lt;b&gt;A.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;&lt;b&gt;Basic loss per share&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The calculation of basic EPS has been based on the following loss attributable to ordinary shareholders and the weighted-average number of ordinary shares outstanding.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

















&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 0.5in; text-align: left"&gt;i.&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;Loss attributable to ordinary shareholders (basic)&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_898_ecustom--ScheduleOfLossAttributableToOrdinaryShareholdersTableTaxBlock_z2E5TRWmTMbg" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Loss per share (Details)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span id="xdx_8B2_zHvrsX2tlHqe" style="display: none"&gt;Schedule of Loss attributable to ordinary shareholders (basic)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Loss for the year&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--ProfitLossAttributableToOwnersOfParent_pn3n3_c20250101__20251231_zE4LhgRDWBwd" title="Loss for the year"&gt;(6,141,476&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--ProfitLossAttributableToOwnersOfParent_pn3n3_c20240101__20241231_zaKicY9RVg1k" title="Loss for the year"&gt;(8,065,334&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Loss attributable to ordinary shareholders&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#x20a9;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--LossAttributableToOrdinaryShareholders_pn3n3_c20250101__20251231_z2uOSDm92gMa" title="Loss attributable to ordinary shareholders"&gt;(6,141,476&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_901_ecustom--LossAttributableToOrdinaryShareholders_pn3n3_c20240101__20241231_zrQcnzZkoAkd" title="Loss attributable to ordinary shareholders"&gt;(8,065,334&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AB_zuKxTsTYhH0l" style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 0.5in; text-align: left"&gt;ii.&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;Weighted-average number of ordinary shares (basic)&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_892_ecustom--WeightedAverageNumberOfOrdinarySharesTableTaxBlock_pn3n3_zOrtyDomjeC3" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Loss per share (Details 1)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span id="xdx_8B6_za6O7A2P2o0d" style="display: none"&gt;Schedule of Weighted-average number of ordinary shares (basic)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_497_20250101__20251231_zK2pqVar034a" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49F_20240101__20241231_zX3BSn7A7hDd" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In number of shares)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_403_eifrs-full--IncreaseDecreaseInNumberOfOrdinarySharesIssued_pid_zSxkY0jTf8Xk" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Number of ordinary shares issued at January&#160;1&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;48,361,075&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;42,716,210&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--ShareOptionsExercised_pid_zGXFv7VcmDg1" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Share options exercised&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2845"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;1,324,220&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--BondWithWarrantsExercised_pid_zkxSbkITyuel" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Bond with warrants exercised&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;217,441&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;734,268&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--AcquisitionOfTreasuryShares_pid_zm1y9fO5Wv2b" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Acquisition of treasury shares&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;52,055&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;450,821&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_404_eifrs-full--WeightedAverageShares_pid_zVdnsKbApsM8" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.25pt"&gt;Weighted-average number of ordinary shares at December&#160;31&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;48,630,571&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;45,225,519&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A9_zmcRbMF2Ik79" style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.25in; text-align: left"&gt;&lt;b&gt;B.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;&lt;b&gt;Anti-diluted loss per share&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Diluted loss per share is not different from basic earnings per share as there are no dilution effects of potential ordinary shares for the years ended December&#160;31, 2025 and 2024.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Details of potential ordinary shares with no dilution effects are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_895_ecustom--ScheduleOfAntidilutiveEarningsPerShareTableTextBlock_pn3n3_zCwZN2lceJ5e" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Loss per share (Details 2)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span id="xdx_8BF_zBcwjyr7pL4d" style="display: none"&gt;Schedule of anti-dilutive shares&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In Korean&#160;won and number of shares)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;b&gt;Share option&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Exercise price&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#x20a9;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented_pid_c20250101__20251231__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--ShareOptionExercisePriceMember_z4zRSxNLxHK5" title="Anti-dilutive shares"&gt;500&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented_pid_c20240101__20241231__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--ShareOptionExercisePriceMember_zXhjY5IVjCah" title="Anti-dilutive shares"&gt;500&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Potential ordinary share&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented_pid_c20250101__20251231__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--ShareOptionPotentialOrdinaryShareMember_zRNTbtlZ9me2" title="Anti-dilutive shares"&gt;640,160&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented_pid_c20240101__20241231__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--ShareOptionPotentialOrdinaryShareMember_zE0wuHXcCi9f" title="Anti-dilutive shares"&gt;640,160&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;b&gt;Bonds with Warrants&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Exercise price&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#x20a9;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented_pid_c20250101__20251231__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--BondsWithWarrantsExercisePriceMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zALjtNy7FQWf" title="Anti-dilutive shares"&gt;3,000&lt;/span&gt;&#160;~&#160;&lt;span id="xdx_90E_eifrs-full--NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented_pid_c20250101__20251231__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--BondsWithWarrantsExercisePriceMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zDWp68tosyW1" title="Anti-dilutive shares"&gt;4,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented_pid_c20240101__20241231__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--BondsWithWarrantsExercisePriceMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zStUy7z9qVTc" title="Anti-dilutive shares"&gt;2,500&lt;/span&gt;&#x202f;~&#160;&lt;span id="xdx_909_eifrs-full--NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented_pid_c20240101__20241231__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--BondsWithWarrantsExercisePriceMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zefNOJgmTkHh" title="Anti-dilutive shares"&gt;4,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Potential ordinary share (*)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented_pid_c20250101__20251231__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--BondsWithWarrantsPotentialOrdinaryShareMember_fKCop_zXf0fgbPbwPf" title="Anti-dilutive shares"&gt;13,480,002&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented_pid_c20240101__20241231__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--BondsWithWarrantsPotentialOrdinaryShareMember_fKCop_zhzqanD63ehe" title="Anti-dilutive shares"&gt;11,757,336&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;div style="width: 25%; margin-left: 0; margin-right: auto"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td id="xdx_F09_zWB91yvZyt8j" style="width: 0.25in; text-align: left"&gt;(*)&lt;/td&gt;
    &lt;td id="xdx_F1E_zgs0AAjZp0Wc" style="text-align: justify"&gt;As of December&#160;31, 2025, the exercise period for 1,000,000 shares of the 21st series bonds with warrants had not yet commenced.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A2_zEqWvuygGaM" style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.25in; text-align: left"&gt;&lt;b&gt;C.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;&lt;b&gt;Losses per share&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_895_ecustom--ScheduleOfEarningsPerShareBasicTableTaxBlock_pn3n3_zzIct1n4khQc" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Loss per share (Details 3)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&lt;span id="xdx_8B1_zUQSDzEPSQtk" style="display: none"&gt;Schedule of losses per share&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="font: 10pt Times New Roman; text-align: center"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="font: 10pt Times New Roman; text-align: center"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Basic losses per share&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--BasicEarningsLossPerShare_pid_c20250101__20251231_z6g581ldF1kk" title="Basic losses per share"&gt;(126&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--BasicEarningsLossPerShare_pid_c20240101__20241231_zlqFeFZ5XRU7" title="Basic losses per share"&gt;(178&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AA_zYyfme0hVpef" style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

















</ifrs-full:DisclosureOfEarningsPerShareExplanatory>
    <cik0002058261:ScheduleOfLossAttributableToOrdinaryShareholdersTableTaxBlock
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact002830">&lt;table cellpadding="0" cellspacing="0" id="xdx_898_ecustom--ScheduleOfLossAttributableToOrdinaryShareholdersTableTaxBlock_z2E5TRWmTMbg" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Loss per share (Details)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span id="xdx_8B2_zHvrsX2tlHqe" style="display: none"&gt;Schedule of Loss attributable to ordinary shareholders (basic)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Loss for the year&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--ProfitLossAttributableToOwnersOfParent_pn3n3_c20250101__20251231_zE4LhgRDWBwd" title="Loss for the year"&gt;(6,141,476&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--ProfitLossAttributableToOwnersOfParent_pn3n3_c20240101__20241231_zaKicY9RVg1k" title="Loss for the year"&gt;(8,065,334&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Loss attributable to ordinary shareholders&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#x20a9;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--LossAttributableToOrdinaryShareholders_pn3n3_c20250101__20251231_z2uOSDm92gMa" title="Loss attributable to ordinary shareholders"&gt;(6,141,476&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_901_ecustom--LossAttributableToOrdinaryShareholders_pn3n3_c20240101__20241231_zrQcnzZkoAkd" title="Loss attributable to ordinary shareholders"&gt;(8,065,334&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:ScheduleOfLossAttributableToOrdinaryShareholdersTableTaxBlock>
    <ifrs-full:ProfitLossAttributableToOwnersOfParent
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002832"
      unitRef="KRW">-6141476000</ifrs-full:ProfitLossAttributableToOwnersOfParent>
    <ifrs-full:ProfitLossAttributableToOwnersOfParent
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002834"
      unitRef="KRW">-8065334000</ifrs-full:ProfitLossAttributableToOwnersOfParent>
    <cik0002058261:LossAttributableToOrdinaryShareholders
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002836"
      unitRef="KRW">-6141476000</cik0002058261:LossAttributableToOrdinaryShareholders>
    <cik0002058261:LossAttributableToOrdinaryShareholders
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002838"
      unitRef="KRW">-8065334000</cik0002058261:LossAttributableToOrdinaryShareholders>
    <cik0002058261:WeightedAverageNumberOfOrdinarySharesTableTaxBlock
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact002840">&lt;table cellpadding="0" cellspacing="0" id="xdx_892_ecustom--WeightedAverageNumberOfOrdinarySharesTableTaxBlock_pn3n3_zOrtyDomjeC3" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Loss per share (Details 1)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span id="xdx_8B6_za6O7A2P2o0d" style="display: none"&gt;Schedule of Weighted-average number of ordinary shares (basic)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_497_20250101__20251231_zK2pqVar034a" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49F_20240101__20241231_zX3BSn7A7hDd" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In number of shares)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_403_eifrs-full--IncreaseDecreaseInNumberOfOrdinarySharesIssued_pid_zSxkY0jTf8Xk" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Number of ordinary shares issued at January&#160;1&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;48,361,075&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;42,716,210&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--ShareOptionsExercised_pid_zGXFv7VcmDg1" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Share options exercised&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2845"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;1,324,220&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--BondWithWarrantsExercised_pid_zkxSbkITyuel" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Bond with warrants exercised&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;217,441&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;734,268&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--AcquisitionOfTreasuryShares_pid_zm1y9fO5Wv2b" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Acquisition of treasury shares&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;52,055&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;450,821&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_404_eifrs-full--WeightedAverageShares_pid_zVdnsKbApsM8" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.25pt"&gt;Weighted-average number of ordinary shares at December&#160;31&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;48,630,571&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;45,225,519&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:WeightedAverageNumberOfOrdinarySharesTableTaxBlock>
    <ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact002842"
      unitRef="Shares">48361075</ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued>
    <ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact002843"
      unitRef="Shares">42716210</ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued>
    <cik0002058261:ShareOptionsExercised
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact002846"
      unitRef="Shares">1324220</cik0002058261:ShareOptionsExercised>
    <cik0002058261:BondWithWarrantsExercised
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact002848"
      unitRef="Shares">217441</cik0002058261:BondWithWarrantsExercised>
    <cik0002058261:BondWithWarrantsExercised
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact002849"
      unitRef="Shares">734268</cik0002058261:BondWithWarrantsExercised>
    <cik0002058261:AcquisitionOfTreasuryShares
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact002851"
      unitRef="Shares">52055</cik0002058261:AcquisitionOfTreasuryShares>
    <cik0002058261:AcquisitionOfTreasuryShares
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact002852"
      unitRef="Shares">450821</cik0002058261:AcquisitionOfTreasuryShares>
    <ifrs-full:WeightedAverageShares
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact002854"
      unitRef="Shares">48630571</ifrs-full:WeightedAverageShares>
    <ifrs-full:WeightedAverageShares
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact002855"
      unitRef="Shares">45225519</ifrs-full:WeightedAverageShares>
    <cik0002058261:ScheduleOfAntidilutiveEarningsPerShareTableTextBlock
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact002857">&lt;table cellpadding="0" cellspacing="0" id="xdx_895_ecustom--ScheduleOfAntidilutiveEarningsPerShareTableTextBlock_pn3n3_zCwZN2lceJ5e" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Loss per share (Details 2)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span id="xdx_8BF_zBcwjyr7pL4d" style="display: none"&gt;Schedule of anti-dilutive shares&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In Korean&#160;won and number of shares)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;b&gt;Share option&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Exercise price&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#x20a9;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented_pid_c20250101__20251231__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--ShareOptionExercisePriceMember_z4zRSxNLxHK5" title="Anti-dilutive shares"&gt;500&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented_pid_c20240101__20241231__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--ShareOptionExercisePriceMember_zXhjY5IVjCah" title="Anti-dilutive shares"&gt;500&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Potential ordinary share&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented_pid_c20250101__20251231__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--ShareOptionPotentialOrdinaryShareMember_zRNTbtlZ9me2" title="Anti-dilutive shares"&gt;640,160&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented_pid_c20240101__20241231__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--ShareOptionPotentialOrdinaryShareMember_zE0wuHXcCi9f" title="Anti-dilutive shares"&gt;640,160&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;b&gt;Bonds with Warrants&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Exercise price&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#x20a9;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented_pid_c20250101__20251231__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--BondsWithWarrantsExercisePriceMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zALjtNy7FQWf" title="Anti-dilutive shares"&gt;3,000&lt;/span&gt;&#160;~&#160;&lt;span id="xdx_90E_eifrs-full--NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented_pid_c20250101__20251231__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--BondsWithWarrantsExercisePriceMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zDWp68tosyW1" title="Anti-dilutive shares"&gt;4,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented_pid_c20240101__20241231__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--BondsWithWarrantsExercisePriceMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zStUy7z9qVTc" title="Anti-dilutive shares"&gt;2,500&lt;/span&gt;&#x202f;~&#160;&lt;span id="xdx_909_eifrs-full--NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented_pid_c20240101__20241231__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--BondsWithWarrantsExercisePriceMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zefNOJgmTkHh" title="Anti-dilutive shares"&gt;4,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Potential ordinary share (*)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented_pid_c20250101__20251231__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--BondsWithWarrantsPotentialOrdinaryShareMember_fKCop_zXf0fgbPbwPf" title="Anti-dilutive shares"&gt;13,480,002&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented_pid_c20240101__20241231__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--BondsWithWarrantsPotentialOrdinaryShareMember_fKCop_zhzqanD63ehe" title="Anti-dilutive shares"&gt;11,757,336&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;div style="width: 25%; margin-left: 0; margin-right: auto"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td id="xdx_F09_zWB91yvZyt8j" style="width: 0.25in; text-align: left"&gt;(*)&lt;/td&gt;
    &lt;td id="xdx_F1E_zgs0AAjZp0Wc" style="text-align: justify"&gt;As of December&#160;31, 2025, the exercise period for 1,000,000 shares of the 21st series bonds with warrants had not yet commenced.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:ScheduleOfAntidilutiveEarningsPerShareTableTextBlock>
    <ifrs-full:NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented
      contextRef="From2025-01-012025-12-31_custom_ShareOptionExercisePriceMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact002859"
      unitRef="Shares">500</ifrs-full:NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented>
    <ifrs-full:NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented
      contextRef="From2024-01-012024-12-31_custom_ShareOptionExercisePriceMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact002861"
      unitRef="Shares">500</ifrs-full:NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented>
    <ifrs-full:NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented
      contextRef="From2025-01-012025-12-31_custom_ShareOptionPotentialOrdinaryShareMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact002863"
      unitRef="Shares">640160</ifrs-full:NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented>
    <ifrs-full:NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented
      contextRef="From2024-01-012024-12-31_custom_ShareOptionPotentialOrdinaryShareMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact002865"
      unitRef="Shares">640160</ifrs-full:NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented>
    <ifrs-full:NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented
      contextRef="From2025-01-012025-12-31_custom_BondsWithWarrantsExercisePriceMember_ifrs-full_BottomOfRangeMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact002867"
      unitRef="Shares">3000</ifrs-full:NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented>
    <ifrs-full:NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented
      contextRef="From2025-01-012025-12-31_custom_BondsWithWarrantsExercisePriceMember_ifrs-full_TopOfRangeMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact002869"
      unitRef="Shares">4000</ifrs-full:NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented>
    <ifrs-full:NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented
      contextRef="From2024-01-012024-12-31_custom_BondsWithWarrantsExercisePriceMember_ifrs-full_BottomOfRangeMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact002871"
      unitRef="Shares">2500</ifrs-full:NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented>
    <ifrs-full:NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented
      contextRef="From2024-01-012024-12-31_custom_BondsWithWarrantsExercisePriceMember_ifrs-full_TopOfRangeMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact002873"
      unitRef="Shares">4000</ifrs-full:NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented>
    <ifrs-full:NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented
      contextRef="From2025-01-012025-12-31_custom_BondsWithWarrantsPotentialOrdinaryShareMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact002875"
      unitRef="Shares">13480002</ifrs-full:NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented>
    <ifrs-full:NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented
      contextRef="From2024-01-012024-12-31_custom_BondsWithWarrantsPotentialOrdinaryShareMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact002877"
      unitRef="Shares">11757336</ifrs-full:NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented>
    <cik0002058261:ScheduleOfEarningsPerShareBasicTableTaxBlock
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact002880">&lt;table cellpadding="0" cellspacing="0" id="xdx_895_ecustom--ScheduleOfEarningsPerShareBasicTableTaxBlock_pn3n3_zzIct1n4khQc" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Loss per share (Details 3)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&lt;span id="xdx_8B1_zUQSDzEPSQtk" style="display: none"&gt;Schedule of losses per share&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="font: 10pt Times New Roman; text-align: center"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="font: 10pt Times New Roman; text-align: center"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Basic losses per share&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--BasicEarningsLossPerShare_pid_c20250101__20251231_z6g581ldF1kk" title="Basic losses per share"&gt;(126&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--BasicEarningsLossPerShare_pid_c20240101__20241231_zlqFeFZ5XRU7" title="Basic losses per share"&gt;(178&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:ScheduleOfEarningsPerShareBasicTableTaxBlock>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact002882"
      unitRef="KRWShares">-126</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact002884"
      unitRef="KRWShares">-178</ifrs-full:BasicEarningsLossPerShare>
    <cik0002058261:AccountsPayableTextBlock
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact002893">&lt;p id="xdx_801_ecustom--AccountsPayableTextBlock_zE2wMDB48jFf" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;19. &lt;span id="xdx_827_zkxTfoqorWjl"&gt;Accounts payable&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Accounts payables as of December&#160;31, 2025 and 2024 are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_899_ecustom--ScheduleOfAccountsPayablesTableTextBlock_pn3n3_zPfYPDPGLZwa" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Accounts payables (Details)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span id="xdx_8B6_zd1EHDSJG4v2" style="display: none"&gt;Schedule of accounts payables&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49E_20251231_zFcuXdVXqo7k" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_491_20241231_zzJdm6IV5y1k" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2025&lt;span id="xdx_F57_zz32GwJOOifk"&gt;(*)&lt;/span&gt;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2024&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Current&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--OtherPayablesCurrent_iI_pn3n3_z507dUqhaBR" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Other payables&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#x20a9;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;3,508,878&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;1,209,694&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--AccruedExpenses_iI_pn3n3_zfbFFlfUE52i" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Accrued expenses&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;44,171&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;45,108&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--AccountsPayablesCurrent_iI_pn3n3_zkh0BDhdNjO6" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; vertical-align: top; padding-left: 0.125in; padding-bottom: 1.25pt"&gt;Total&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;3,553,049&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;1,254,802&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;div style="width: 25%; margin-left: 0; margin-right: auto"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td id="xdx_F08_zMYcjukPMCU4" style="width: 0.25in; text-align: left"&gt;(*)&lt;/td&gt;
    &lt;td id="xdx_F1D_z1Y67rqum5Og" style="text-align: justify"&gt;Other payables consist primarily of professional service payable, credit card payables, and refundable deposit for disposal of treasury shares of Korean won of 2,110,000 thousand.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AA_zEtEmO0ZkRVd" style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

</cik0002058261:AccountsPayableTextBlock>
    <cik0002058261:ScheduleOfAccountsPayablesTableTextBlock
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact002895">&lt;table cellpadding="0" cellspacing="0" id="xdx_899_ecustom--ScheduleOfAccountsPayablesTableTextBlock_pn3n3_zPfYPDPGLZwa" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Accounts payables (Details)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span id="xdx_8B6_zd1EHDSJG4v2" style="display: none"&gt;Schedule of accounts payables&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49E_20251231_zFcuXdVXqo7k" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_491_20241231_zzJdm6IV5y1k" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2025&lt;span id="xdx_F57_zz32GwJOOifk"&gt;(*)&lt;/span&gt;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2024&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Current&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--OtherPayablesCurrent_iI_pn3n3_z507dUqhaBR" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Other payables&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#x20a9;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;3,508,878&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;1,209,694&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--AccruedExpenses_iI_pn3n3_zfbFFlfUE52i" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Accrued expenses&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;44,171&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;45,108&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--AccountsPayablesCurrent_iI_pn3n3_zkh0BDhdNjO6" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; vertical-align: top; padding-left: 0.125in; padding-bottom: 1.25pt"&gt;Total&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;3,553,049&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;1,254,802&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;div style="width: 25%; margin-left: 0; margin-right: auto"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td id="xdx_F08_zMYcjukPMCU4" style="width: 0.25in; text-align: left"&gt;(*)&lt;/td&gt;
    &lt;td id="xdx_F1D_z1Y67rqum5Og" style="text-align: justify"&gt;Other payables consist primarily of professional service payable, credit card payables, and refundable deposit for disposal of treasury shares of Korean won of 2,110,000 thousand.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:ScheduleOfAccountsPayablesTableTextBlock>
    <cik0002058261:OtherPayablesCurrent
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002897"
      unitRef="KRW">3508878000</cik0002058261:OtherPayablesCurrent>
    <cik0002058261:OtherPayablesCurrent
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002898"
      unitRef="KRW">1209694000</cik0002058261:OtherPayablesCurrent>
    <cik0002058261:AccruedExpenses
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002900"
      unitRef="KRW">44171000</cik0002058261:AccruedExpenses>
    <cik0002058261:AccruedExpenses
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002901"
      unitRef="KRW">45108000</cik0002058261:AccruedExpenses>
    <cik0002058261:AccountsPayablesCurrent
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002903"
      unitRef="KRW">3553049000</cik0002058261:AccountsPayablesCurrent>
    <cik0002058261:AccountsPayablesCurrent
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002904"
      unitRef="KRW">1254802000</cik0002058261:AccountsPayablesCurrent>
    <cik0002058261:ProvisionsTextBlock
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact002907">&lt;p id="xdx_80F_ecustom--ProvisionsTextBlock_zfFbdcdvcdwe" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;20. &lt;span id="xdx_824_zCsp06b6Usk2"&gt;Provisions&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Details of provisions for the years ended December&#160;31, 2025 and 2024 are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_889_ecustom--ScheduleOfLossForProvisionsTableTextBlock_pn3n3_zE3aSh6kv832" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Provisions (Details)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span id="xdx_8B0_zkjTmADl7vX3" style="display: none"&gt;Schedule of provisions&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_493_20250101__20251231__ifrs-full--ClassesOfProvisionsAxis__custom--BuildingRestorationMember_zMeTLOZxgKcg" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_491_20240101__20241231__ifrs-full--ClassesOfProvisionsAxis__custom--BuildingRestorationMember_zSUdK1h89Bag" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;b&gt;Building restoration&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_408_eifrs-full--Provisions_iS_pn3n3_z7KwyDmOmGgh" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Beginning of the year&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#x20a9;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;48,341&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;48,024&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_403_eifrs-full--InterestExpense_i_pn3n" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Interest expense&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;317&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;317&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40D_eifrs-full--Provisions_iE_pn3n3_zCWTRgPlINMl" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 2.5pt"&gt;Ending of the year&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;48,658&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;48,341&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The provision for building restoration relates mainly to buildings that were leased during 2023. The provision has been estimated based on historical data associated with similar buildings.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

</cik0002058261:ProvisionsTextBlock>
    <cik0002058261:ScheduleOfLossForProvisionsTableTextBlock
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact002909">&lt;table cellpadding="0" cellspacing="0" id="xdx_889_ecustom--ScheduleOfLossForProvisionsTableTextBlock_pn3n3_zE3aSh6kv832" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Provisions (Details)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span id="xdx_8B0_zkjTmADl7vX3" style="display: none"&gt;Schedule of provisions&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_493_20250101__20251231__ifrs-full--ClassesOfProvisionsAxis__custom--BuildingRestorationMember_zMeTLOZxgKcg" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_491_20240101__20241231__ifrs-full--ClassesOfProvisionsAxis__custom--BuildingRestorationMember_zSUdK1h89Bag" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;b&gt;Building restoration&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_408_eifrs-full--Provisions_iS_pn3n3_z7KwyDmOmGgh" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Beginning of the year&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#x20a9;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;48,341&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;48,024&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_403_eifrs-full--InterestExpense_i_pn3n" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Interest expense&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;317&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;317&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40D_eifrs-full--Provisions_iE_pn3n3_zCWTRgPlINMl" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 2.5pt"&gt;Ending of the year&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;48,658&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;48,341&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;</cik0002058261:ScheduleOfLossForProvisionsTableTextBlock>
    <ifrs-full:Provisions
      contextRef="AsOf2024-12-31_custom_BuildingRestorationMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002911"
      unitRef="KRW">48341000</ifrs-full:Provisions>
    <ifrs-full:Provisions
      contextRef="AsOf2023-12-31_custom_BuildingRestorationMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002912"
      unitRef="KRW">48024000</ifrs-full:Provisions>
    <ifrs-full:InterestExpense
      contextRef="From2025-01-012025-12-31_custom_BuildingRestorationMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002914"
      unitRef="KRW">317000</ifrs-full:InterestExpense>
    <ifrs-full:InterestExpense
      contextRef="From2024-01-012024-12-31_custom_BuildingRestorationMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002915"
      unitRef="KRW">317000</ifrs-full:InterestExpense>
    <ifrs-full:Provisions
      contextRef="AsOf2025-12-31_custom_BuildingRestorationMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002917"
      unitRef="KRW">48658000</ifrs-full:Provisions>
    <ifrs-full:Provisions
      contextRef="AsOf2024-12-31_custom_BuildingRestorationMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002918"
      unitRef="KRW">48341000</ifrs-full:Provisions>
    <ifrs-full:DisclosureOfEmployeeBenefitsExplanatory
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact002920">&lt;p id="xdx_805_eifrs-full--DisclosureOfEmployeeBenefitsExplanatory_zKjOGwXRCZWf" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;21. &lt;span id="xdx_822_zWRjokqxW90h"&gt;Employee benefits&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Details of defined benefit liability recognized as of December&#160;31, 2025 and 2024 are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_897_ecustom--EmployeeBenefitsLiabilityRecognizedTableTextBlock_pn3n3_zUCjkRsTbBU4" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Employee benefits (Details)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&lt;span id="xdx_8BE_zOIRk8RIVzFi" style="display: none"&gt;Schedule of employee benefits liability recognized&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="font: 10pt Times New Roman; text-align: center"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="font: 10pt Times New Roman; text-align: center"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2024&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Defined benefit liability&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--NetDefinedBenefitLiability_iI_pn3n3_c20251231_z5id5rAQwTa6" title="Defined benefit liability"&gt;980,841&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_900_ecustom--NetDefinedBenefitLiability_iI_pn3n3_c20241231_zLXPvQ5P1J34" title="Defined benefit liability"&gt;950,220&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A7_z2kBSbxltbN6" style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company operates defined benefit plans as a retirement pension scheme. Defined benefit plans expose the Company to actuarial risks, such as longevity risk, currency risk, interest rate risk, and market (investment) risk.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

















&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.25in; text-align: left"&gt;&lt;b&gt;A.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;&lt;b&gt;Movement in net defined benefit (liability) asset&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Details of the reconciliation from the opening balances to the closing balances for the net defined benefit liability and its components for the years ended December&#160;31, 2025 and 2024 are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_899_ecustom--ScheduleOfReconciliationFromTheOpeningBalancesTableTextBlock_pn3n3_zWALQr4pLMm7" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Employee benefits (Details 1)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_8BF_zIn1PwwBwO4f" style="display: none"&gt;Schedule of reconciliation from the opening balances&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_492_20250101__20251231__ifrs-full--DefinedBenefitPlansAxis__custom--DefinedBenefitObligationMember_zJ1wF1YfVYj2" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49A_20240101__20241231__ifrs-full--DefinedBenefitPlansAxis__custom--DefinedBenefitObligationMember_zhYKM4ySGIs3" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_496_20250101__20251231__ifrs-full--DefinedBenefitPlansAxis__custom--FairValueOfPlanAssetsMember_zCnRWqAvHXB5" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_497_20240101__20241231__ifrs-full--DefinedBenefitPlansAxis__custom--FairValueOfPlanAssetsMember_zWltetMhSdGa" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49D_20250101__20251231__ifrs-full--DefinedBenefitPlansAxis__custom--NetDefinedBenefitLiabilitiesMember_zmcos47gVaFl" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49E_20240101__20241231__ifrs-full--DefinedBenefitPlansAxis__custom--NetDefinedBenefitLiabilitiesMember_zlswl4ihokSh" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Defined benefit&lt;br/&gt; obligation&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Fair value of&lt;br/&gt; plan assets&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Net defined&lt;br/&gt; Benefit liabilities&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="22" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--DefinedBenefitObligation_iS_pn3n3_zZTNFCYO3b16" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; width: 38%"&gt;&lt;b&gt;Balance at 1 January&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 7%; text-align: right"&gt;950,220&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 7%; text-align: right"&gt;718,383&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 7%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2939"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 7%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2940"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 7%; text-align: right"&gt;950,220&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 7%; text-align: right"&gt;718,383&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--IncludedInProfitOrLossAbstract_i" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;b&gt;Included in profit or loss&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;-&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;-&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_403_eifrs-full--CurrentServiceCostDefinedBenefitPlans_i_pn3n" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Current service cost&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;201,808&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;180,690&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2953"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2954"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;201,808&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;180,690&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40D_eifrs-full--InterestExpenseDefinedBenefitPlans_i_pn3n" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Interest expense&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;36,339&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;31,575&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2960"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2961"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;36,339&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;31,575&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--IncludedInProfitOrLoss_i_pn3n" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; vertical-align: top; padding-left: 0.125in; padding-bottom: 0.5pt"&gt;Subtotal&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;238,147&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;212,265&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2967"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2968"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;238,147&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;212,265&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--IncludedInOciAbstract_i" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;b&gt;Included in OCI&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;-&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;-&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--RemeasurementLossgain_i01_pn3n3_zoBwNzNzkoEd" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Remeasurement loss(gain)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2981"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2982"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--DemographicAssumption_i01N_pn3n3_di_zJD7jDrFkSUe" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;- Demographic assumption&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2986"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;(1,425&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2988"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2989"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2990"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;(1,425&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--FinancialAssumption_i01N_pn3n3_di_zQXn2NvLL507" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;- Financial assumption&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;(30,017&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;77,394&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2995"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2996"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;(30,017&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;77,394&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--AdjustmentBasedOnExperience_i01N_pn3n3_di_zu2rKcvroG9b" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;- Adjustment based on experience&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;(22,104&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;51,884&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3002"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3003"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;(22,104&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;51,884&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_403_eifrs-full--GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset_i_pn3n" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; vertical-align: top; padding-left: 0.125in; padding-bottom: 0.5pt"&gt;Subtotal&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;(52,121&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;127,853&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3009"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3010"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;(52,121&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;127,853&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--OtherAbstract_i" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;&lt;b&gt;Other&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;-&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;-&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--GainsOnSettlement_i01N_pn3n3_di_zMy2SouCkK93" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Gains on settlement&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;(48,663&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;(3,653&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3023"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3024"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;(48,663&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;(3,653&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40F_eifrs-full--BenefitsPaidOrPayable_i01N_pn3n3_di_zkDv6SKcPavd" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Benefits paid&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;(106,742&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;(104,628&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3030"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3031"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;(106,742&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;(104,628&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--DefinedBenefitObligation_iE_pn3n3_zkgTOCxw99M6" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.25pt"&gt;&lt;b&gt;Balance at 31 December&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;980,841&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;950,220&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3037"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3038"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;980,841&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;950,220&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A9_zetWnxVZm2Je" style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.25in; text-align: left"&gt;&lt;b&gt;B.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;&lt;b&gt;Plan assets&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;There are no contributions funded to its defined benefit plans as of December&#160;31, 2025 and 2024.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.25in; text-align: left"&gt;&lt;b&gt;C.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;&lt;b&gt;Defined benefit obligation&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 0.5in; text-align: left"&gt;i.&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;Actuarial assumptions&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Details of actuarial assumptions used for the years ended December&#160;31, 2025 and 2024 are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--ScheduleOfActuarialAssumptionsTaBleTextBlock_pn3n3_zuayEfNk3858" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Employee benefits (Details 2)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_8B1_zd200HC6VZr2" style="display: none"&gt;Schedule of actuarial assumptions&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Discount rate&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountsRate_iI_pid_dp_c20251231_zIaXRDSPn7ya" title="Discount rate"&gt;4.36&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_900_ecustom--DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountsRate_iI_pid_dp_c20241231_zYzBVZdr7cIe" title="Discount rate"&gt;3.98&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Future salary growth&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--FutureSalaryGrowth_iI_pid_dp_c20251231_zRQsOi9q97Gc" title="Future salary growth"&gt;3.00&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--FutureSalaryGrowth_iI_pid_dp_c20241231_zCgJRNyPMqXj" title="Future salary growth"&gt;3.00&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AD_zxUQpb2ppJJ5" style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Assumptions regarding future longevity and standard salary scale have been based on data issued by Korea Insurance Development Institute.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;As of December&#160;31, 2025, the weighted average duration of the defined benefit obligation was 8.45 years.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

















&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 0.5in; text-align: left"&gt;ii.&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;Sensitivity analysis&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company measures the risk of actuarial assumption changes as a 1% fluctuation in the discount rate and future salary growth rate of the amounts of the defined benefit obligation, which reflects the management&#x2019;s assessment of the risk of actuarial assumption fluctuation that can reasonably occur. The impact of a 1% fluctuation in discount rates and future salary growth rates on the Company&#x2019;s defined benefit obligation as of December&#160;31, 2025 and 2024 are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0 0 0 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89A_ecustom--ScheduleOfDefinedBenefitObligationTableTextBlock_pn3n3_zs8vk3USKZW8" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Employee benefits (Details 3)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: #FFFFFF"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_8B9_zMthZ2qjoBg" style="display: none"&gt;Schedule of defined benefit obligation&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2024&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Increased&#160;by&lt;br/&gt; 1%&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Decreased&#160;by&lt;br/&gt; 1%&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Increased&#160;by&lt;br/&gt; 1%&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Decreased&#160;by&lt;br/&gt; 1%&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="14" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Discount rate&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right; width: 9%"&gt;&lt;span id="xdx_90C_ecustom--DiscountRateIncrease_pn3n3_c20250101__20251231_zNBtXmFR3sa4" title="Discount rate Increased by 1%"&gt;(73,191&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; width: 1%"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right; width: 9%"&gt;&lt;span id="xdx_905_ecustom--DiscountRateDecrease_pn3n3_c20250101__20251231_z82R25C1sJ3g" title="Discount rate Decreased by 1%"&gt;84,609&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right; width: 9%"&gt;&lt;span id="xdx_90D_ecustom--DiscountRateIncrease_pn3n3_c20240101__20241231_zoFzGM77MIl9" title="Discount rate Increased by 1%"&gt;(70,838&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; width: 1%"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right; width: 9%"&gt;&lt;span id="xdx_903_ecustom--DiscountRateDecrease_pn3n3_c20240101__20241231_zNpxcLh5VoR2" title="Discount rate Decreased by 1%"&gt;81,873&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; width: 1%"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #FFFFFF"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Future salary growth&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_906_ecustom--FutureSalaryGrowthIncreased_pn3n3_c20250101__20251231_zdmKmdADCiy3" title="Future salary growth Increased by 1%"&gt;85,026&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_903_ecustom--FutureSalaryGrowthDecreased_pn3n3_c20250101__20251231_zUNXbyDhDjJ4" title="Future salary growth Decreased by 1%"&gt;(74,839&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_903_ecustom--FutureSalaryGrowthIncreased_pn3n3_c20240101__20241231_zMEynPMkBAkb" title="Future salary growth Increased by 1%"&gt;81,953&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_903_ecustom--FutureSalaryGrowthDecreased_pn3n3_c20240101__20241231_zDe4eYszGnU" title="Future salary growth Decreased by 1%"&gt;(72,186&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AE_zy43uLl1PJwh" style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Although the analysis does not take account of the full distribution of cash flows expected under the plan, it does provide an approximation of the sensitivity of the shown assumptions.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

</ifrs-full:DisclosureOfEmployeeBenefitsExplanatory>
    <cik0002058261:EmployeeBenefitsLiabilityRecognizedTableTextBlock
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact002922">&lt;table cellpadding="0" cellspacing="0" id="xdx_897_ecustom--EmployeeBenefitsLiabilityRecognizedTableTextBlock_pn3n3_zUCjkRsTbBU4" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Employee benefits (Details)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&lt;span id="xdx_8BE_zOIRk8RIVzFi" style="display: none"&gt;Schedule of employee benefits liability recognized&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="font: 10pt Times New Roman; text-align: center"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="font: 10pt Times New Roman; text-align: center"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2024&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Defined benefit liability&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--NetDefinedBenefitLiability_iI_pn3n3_c20251231_z5id5rAQwTa6" title="Defined benefit liability"&gt;980,841&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_900_ecustom--NetDefinedBenefitLiability_iI_pn3n3_c20241231_zLXPvQ5P1J34" title="Defined benefit liability"&gt;950,220&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:EmployeeBenefitsLiabilityRecognizedTableTextBlock>
    <cik0002058261:NetDefinedBenefitLiability
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002924"
      unitRef="KRW">980841000</cik0002058261:NetDefinedBenefitLiability>
    <cik0002058261:NetDefinedBenefitLiability
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002926"
      unitRef="KRW">950220000</cik0002058261:NetDefinedBenefitLiability>
    <cik0002058261:ScheduleOfReconciliationFromTheOpeningBalancesTableTextBlock
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact002935">&lt;table cellpadding="0" cellspacing="0" id="xdx_899_ecustom--ScheduleOfReconciliationFromTheOpeningBalancesTableTextBlock_pn3n3_zWALQr4pLMm7" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Employee benefits (Details 1)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_8BF_zIn1PwwBwO4f" style="display: none"&gt;Schedule of reconciliation from the opening balances&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_492_20250101__20251231__ifrs-full--DefinedBenefitPlansAxis__custom--DefinedBenefitObligationMember_zJ1wF1YfVYj2" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49A_20240101__20241231__ifrs-full--DefinedBenefitPlansAxis__custom--DefinedBenefitObligationMember_zhYKM4ySGIs3" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_496_20250101__20251231__ifrs-full--DefinedBenefitPlansAxis__custom--FairValueOfPlanAssetsMember_zCnRWqAvHXB5" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_497_20240101__20241231__ifrs-full--DefinedBenefitPlansAxis__custom--FairValueOfPlanAssetsMember_zWltetMhSdGa" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49D_20250101__20251231__ifrs-full--DefinedBenefitPlansAxis__custom--NetDefinedBenefitLiabilitiesMember_zmcos47gVaFl" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49E_20240101__20241231__ifrs-full--DefinedBenefitPlansAxis__custom--NetDefinedBenefitLiabilitiesMember_zlswl4ihokSh" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Defined benefit&lt;br/&gt; obligation&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Fair value of&lt;br/&gt; plan assets&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Net defined&lt;br/&gt; Benefit liabilities&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="22" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--DefinedBenefitObligation_iS_pn3n3_zZTNFCYO3b16" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; width: 38%"&gt;&lt;b&gt;Balance at 1 January&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 7%; text-align: right"&gt;950,220&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 7%; text-align: right"&gt;718,383&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 7%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2939"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 7%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2940"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 7%; text-align: right"&gt;950,220&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 7%; text-align: right"&gt;718,383&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--IncludedInProfitOrLossAbstract_i" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;b&gt;Included in profit or loss&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;-&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;-&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_403_eifrs-full--CurrentServiceCostDefinedBenefitPlans_i_pn3n" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Current service cost&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;201,808&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;180,690&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2953"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2954"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;201,808&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;180,690&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40D_eifrs-full--InterestExpenseDefinedBenefitPlans_i_pn3n" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Interest expense&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;36,339&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;31,575&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2960"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2961"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;36,339&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;31,575&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--IncludedInProfitOrLoss_i_pn3n" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; vertical-align: top; padding-left: 0.125in; padding-bottom: 0.5pt"&gt;Subtotal&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;238,147&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;212,265&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2967"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2968"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;238,147&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;212,265&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--IncludedInOciAbstract_i" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;b&gt;Included in OCI&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;-&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;-&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--RemeasurementLossgain_i01_pn3n3_zoBwNzNzkoEd" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Remeasurement loss(gain)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2981"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2982"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--DemographicAssumption_i01N_pn3n3_di_zJD7jDrFkSUe" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;- Demographic assumption&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2986"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;(1,425&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2988"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2989"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2990"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;(1,425&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--FinancialAssumption_i01N_pn3n3_di_zQXn2NvLL507" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;- Financial assumption&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;(30,017&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;77,394&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2995"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2996"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;(30,017&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;77,394&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--AdjustmentBasedOnExperience_i01N_pn3n3_di_zu2rKcvroG9b" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;- Adjustment based on experience&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;(22,104&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;51,884&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3002"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3003"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;(22,104&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;51,884&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_403_eifrs-full--GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset_i_pn3n" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; vertical-align: top; padding-left: 0.125in; padding-bottom: 0.5pt"&gt;Subtotal&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;(52,121&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;127,853&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3009"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3010"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;(52,121&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;127,853&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--OtherAbstract_i" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;&lt;b&gt;Other&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;-&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;-&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--GainsOnSettlement_i01N_pn3n3_di_zMy2SouCkK93" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Gains on settlement&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;(48,663&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;(3,653&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3023"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3024"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;(48,663&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;(3,653&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40F_eifrs-full--BenefitsPaidOrPayable_i01N_pn3n3_di_zkDv6SKcPavd" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Benefits paid&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;(106,742&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;(104,628&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3030"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3031"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;(106,742&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;(104,628&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--DefinedBenefitObligation_iE_pn3n3_zkgTOCxw99M6" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.25pt"&gt;&lt;b&gt;Balance at 31 December&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;980,841&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;950,220&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3037"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3038"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;980,841&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;950,220&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:ScheduleOfReconciliationFromTheOpeningBalancesTableTextBlock>
    <cik0002058261:DefinedBenefitObligation
      contextRef="AsOf2024-12-31_custom_DefinedBenefitObligationMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002937"
      unitRef="KRW">950220000</cik0002058261:DefinedBenefitObligation>
    <cik0002058261:DefinedBenefitObligation
      contextRef="AsOf2023-12-31_custom_DefinedBenefitObligationMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002938"
      unitRef="KRW">718383000</cik0002058261:DefinedBenefitObligation>
    <cik0002058261:DefinedBenefitObligation
      contextRef="AsOf2024-12-31_custom_NetDefinedBenefitLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002941"
      unitRef="KRW">950220000</cik0002058261:DefinedBenefitObligation>
    <cik0002058261:DefinedBenefitObligation
      contextRef="AsOf2023-12-31_custom_NetDefinedBenefitLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002942"
      unitRef="KRW">718383000</cik0002058261:DefinedBenefitObligation>
    <ifrs-full:CurrentServiceCostDefinedBenefitPlans
      contextRef="From2025-01-012025-12-31_custom_DefinedBenefitObligationMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002951"
      unitRef="KRW">201808000</ifrs-full:CurrentServiceCostDefinedBenefitPlans>
    <ifrs-full:CurrentServiceCostDefinedBenefitPlans
      contextRef="From2024-01-012024-12-31_custom_DefinedBenefitObligationMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002952"
      unitRef="KRW">180690000</ifrs-full:CurrentServiceCostDefinedBenefitPlans>
    <ifrs-full:CurrentServiceCostDefinedBenefitPlans
      contextRef="From2025-01-012025-12-31_custom_NetDefinedBenefitLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002955"
      unitRef="KRW">201808000</ifrs-full:CurrentServiceCostDefinedBenefitPlans>
    <ifrs-full:CurrentServiceCostDefinedBenefitPlans
      contextRef="From2024-01-012024-12-31_custom_NetDefinedBenefitLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002956"
      unitRef="KRW">180690000</ifrs-full:CurrentServiceCostDefinedBenefitPlans>
    <ifrs-full:InterestExpenseDefinedBenefitPlans
      contextRef="From2025-01-012025-12-31_custom_DefinedBenefitObligationMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002958"
      unitRef="KRW">36339000</ifrs-full:InterestExpenseDefinedBenefitPlans>
    <ifrs-full:InterestExpenseDefinedBenefitPlans
      contextRef="From2024-01-012024-12-31_custom_DefinedBenefitObligationMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002959"
      unitRef="KRW">31575000</ifrs-full:InterestExpenseDefinedBenefitPlans>
    <ifrs-full:InterestExpenseDefinedBenefitPlans
      contextRef="From2025-01-012025-12-31_custom_NetDefinedBenefitLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002962"
      unitRef="KRW">36339000</ifrs-full:InterestExpenseDefinedBenefitPlans>
    <ifrs-full:InterestExpenseDefinedBenefitPlans
      contextRef="From2024-01-012024-12-31_custom_NetDefinedBenefitLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002963"
      unitRef="KRW">31575000</ifrs-full:InterestExpenseDefinedBenefitPlans>
    <cik0002058261:IncludedInProfitOrLoss
      contextRef="From2025-01-012025-12-31_custom_DefinedBenefitObligationMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002965"
      unitRef="KRW">238147000</cik0002058261:IncludedInProfitOrLoss>
    <cik0002058261:IncludedInProfitOrLoss
      contextRef="From2024-01-012024-12-31_custom_DefinedBenefitObligationMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002966"
      unitRef="KRW">212265000</cik0002058261:IncludedInProfitOrLoss>
    <cik0002058261:IncludedInProfitOrLoss
      contextRef="From2025-01-012025-12-31_custom_NetDefinedBenefitLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002969"
      unitRef="KRW">238147000</cik0002058261:IncludedInProfitOrLoss>
    <cik0002058261:IncludedInProfitOrLoss
      contextRef="From2024-01-012024-12-31_custom_NetDefinedBenefitLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002970"
      unitRef="KRW">212265000</cik0002058261:IncludedInProfitOrLoss>
    <cik0002058261:DemographicAssumption
      contextRef="From2024-01-012024-12-31_custom_DefinedBenefitObligationMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002987"
      unitRef="KRW">1425000</cik0002058261:DemographicAssumption>
    <cik0002058261:DemographicAssumption
      contextRef="From2024-01-012024-12-31_custom_NetDefinedBenefitLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002991"
      unitRef="KRW">1425000</cik0002058261:DemographicAssumption>
    <cik0002058261:FinancialAssumption
      contextRef="From2025-01-012025-12-31_custom_DefinedBenefitObligationMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002993"
      unitRef="KRW">30017000</cik0002058261:FinancialAssumption>
    <cik0002058261:FinancialAssumption
      contextRef="From2024-01-012024-12-31_custom_DefinedBenefitObligationMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002994"
      unitRef="KRW">-77394000</cik0002058261:FinancialAssumption>
    <cik0002058261:FinancialAssumption
      contextRef="From2025-01-012025-12-31_custom_NetDefinedBenefitLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002997"
      unitRef="KRW">30017000</cik0002058261:FinancialAssumption>
    <cik0002058261:FinancialAssumption
      contextRef="From2024-01-012024-12-31_custom_NetDefinedBenefitLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact002998"
      unitRef="KRW">-77394000</cik0002058261:FinancialAssumption>
    <cik0002058261:AdjustmentBasedOnExperience
      contextRef="From2025-01-012025-12-31_custom_DefinedBenefitObligationMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003000"
      unitRef="KRW">22104000</cik0002058261:AdjustmentBasedOnExperience>
    <cik0002058261:AdjustmentBasedOnExperience
      contextRef="From2024-01-012024-12-31_custom_DefinedBenefitObligationMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003001"
      unitRef="KRW">-51884000</cik0002058261:AdjustmentBasedOnExperience>
    <cik0002058261:AdjustmentBasedOnExperience
      contextRef="From2025-01-012025-12-31_custom_NetDefinedBenefitLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003004"
      unitRef="KRW">22104000</cik0002058261:AdjustmentBasedOnExperience>
    <cik0002058261:AdjustmentBasedOnExperience
      contextRef="From2024-01-012024-12-31_custom_NetDefinedBenefitLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003005"
      unitRef="KRW">-51884000</cik0002058261:AdjustmentBasedOnExperience>
    <ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset
      contextRef="From2025-01-012025-12-31_custom_DefinedBenefitObligationMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003007"
      unitRef="KRW">-52121000</ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset>
    <ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset
      contextRef="From2024-01-012024-12-31_custom_DefinedBenefitObligationMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003008"
      unitRef="KRW">127853000</ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset>
    <ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset
      contextRef="From2025-01-012025-12-31_custom_NetDefinedBenefitLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003011"
      unitRef="KRW">-52121000</ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset>
    <ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset
      contextRef="From2024-01-012024-12-31_custom_NetDefinedBenefitLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003012"
      unitRef="KRW">127853000</ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset>
    <cik0002058261:GainsOnSettlement
      contextRef="From2025-01-012025-12-31_custom_DefinedBenefitObligationMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003021"
      unitRef="KRW">48663000</cik0002058261:GainsOnSettlement>
    <cik0002058261:GainsOnSettlement
      contextRef="From2024-01-012024-12-31_custom_DefinedBenefitObligationMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003022"
      unitRef="KRW">3653000</cik0002058261:GainsOnSettlement>
    <cik0002058261:GainsOnSettlement
      contextRef="From2025-01-012025-12-31_custom_NetDefinedBenefitLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003025"
      unitRef="KRW">48663000</cik0002058261:GainsOnSettlement>
    <cik0002058261:GainsOnSettlement
      contextRef="From2024-01-012024-12-31_custom_NetDefinedBenefitLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003026"
      unitRef="KRW">3653000</cik0002058261:GainsOnSettlement>
    <ifrs-full:BenefitsPaidOrPayable
      contextRef="From2025-01-012025-12-31_custom_DefinedBenefitObligationMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003028"
      unitRef="KRW">106742000</ifrs-full:BenefitsPaidOrPayable>
    <ifrs-full:BenefitsPaidOrPayable
      contextRef="From2024-01-012024-12-31_custom_DefinedBenefitObligationMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003029"
      unitRef="KRW">104628000</ifrs-full:BenefitsPaidOrPayable>
    <ifrs-full:BenefitsPaidOrPayable
      contextRef="From2025-01-012025-12-31_custom_NetDefinedBenefitLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003032"
      unitRef="KRW">106742000</ifrs-full:BenefitsPaidOrPayable>
    <ifrs-full:BenefitsPaidOrPayable
      contextRef="From2024-01-012024-12-31_custom_NetDefinedBenefitLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003033"
      unitRef="KRW">104628000</ifrs-full:BenefitsPaidOrPayable>
    <cik0002058261:DefinedBenefitObligation
      contextRef="AsOf2025-12-31_custom_DefinedBenefitObligationMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003035"
      unitRef="KRW">980841000</cik0002058261:DefinedBenefitObligation>
    <cik0002058261:DefinedBenefitObligation
      contextRef="AsOf2024-12-31_custom_DefinedBenefitObligationMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003036"
      unitRef="KRW">950220000</cik0002058261:DefinedBenefitObligation>
    <cik0002058261:DefinedBenefitObligation
      contextRef="AsOf2025-12-31_custom_NetDefinedBenefitLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003039"
      unitRef="KRW">980841000</cik0002058261:DefinedBenefitObligation>
    <cik0002058261:DefinedBenefitObligation
      contextRef="AsOf2024-12-31_custom_NetDefinedBenefitLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003040"
      unitRef="KRW">950220000</cik0002058261:DefinedBenefitObligation>
    <cik0002058261:ScheduleOfActuarialAssumptionsTaBleTextBlock
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact003042">&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--ScheduleOfActuarialAssumptionsTaBleTextBlock_pn3n3_zuayEfNk3858" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Employee benefits (Details 2)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_8B1_zd200HC6VZr2" style="display: none"&gt;Schedule of actuarial assumptions&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Discount rate&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountsRate_iI_pid_dp_c20251231_zIaXRDSPn7ya" title="Discount rate"&gt;4.36&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_900_ecustom--DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountsRate_iI_pid_dp_c20241231_zYzBVZdr7cIe" title="Discount rate"&gt;3.98&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Future salary growth&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--FutureSalaryGrowth_iI_pid_dp_c20251231_zRQsOi9q97Gc" title="Future salary growth"&gt;3.00&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--FutureSalaryGrowth_iI_pid_dp_c20241231_zCgJRNyPMqXj" title="Future salary growth"&gt;3.00&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:ScheduleOfActuarialAssumptionsTaBleTextBlock>
    <cik0002058261:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountsRate
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact003044"
      unitRef="Pure">0.0436</cik0002058261:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountsRate>
    <cik0002058261:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountsRate
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact003046"
      unitRef="Pure">0.0398</cik0002058261:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountsRate>
    <cik0002058261:FutureSalaryGrowth
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact003048"
      unitRef="Pure">0.0300</cik0002058261:FutureSalaryGrowth>
    <cik0002058261:FutureSalaryGrowth
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact003050"
      unitRef="Pure">0.0300</cik0002058261:FutureSalaryGrowth>
    <cik0002058261:ScheduleOfDefinedBenefitObligationTableTextBlock
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact003059">&lt;table cellpadding="0" cellspacing="0" id="xdx_89A_ecustom--ScheduleOfDefinedBenefitObligationTableTextBlock_pn3n3_zs8vk3USKZW8" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Employee benefits (Details 3)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: #FFFFFF"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_8B9_zMthZ2qjoBg" style="display: none"&gt;Schedule of defined benefit obligation&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2024&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Increased&#160;by&lt;br/&gt; 1%&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Decreased&#160;by&lt;br/&gt; 1%&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Increased&#160;by&lt;br/&gt; 1%&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Decreased&#160;by&lt;br/&gt; 1%&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="14" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Discount rate&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right; width: 9%"&gt;&lt;span id="xdx_90C_ecustom--DiscountRateIncrease_pn3n3_c20250101__20251231_zNBtXmFR3sa4" title="Discount rate Increased by 1%"&gt;(73,191&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; width: 1%"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right; width: 9%"&gt;&lt;span id="xdx_905_ecustom--DiscountRateDecrease_pn3n3_c20250101__20251231_z82R25C1sJ3g" title="Discount rate Decreased by 1%"&gt;84,609&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right; width: 9%"&gt;&lt;span id="xdx_90D_ecustom--DiscountRateIncrease_pn3n3_c20240101__20241231_zoFzGM77MIl9" title="Discount rate Increased by 1%"&gt;(70,838&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; width: 1%"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right; width: 9%"&gt;&lt;span id="xdx_903_ecustom--DiscountRateDecrease_pn3n3_c20240101__20241231_zNpxcLh5VoR2" title="Discount rate Decreased by 1%"&gt;81,873&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; width: 1%"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #FFFFFF"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Future salary growth&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_906_ecustom--FutureSalaryGrowthIncreased_pn3n3_c20250101__20251231_zdmKmdADCiy3" title="Future salary growth Increased by 1%"&gt;85,026&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_903_ecustom--FutureSalaryGrowthDecreased_pn3n3_c20250101__20251231_zUNXbyDhDjJ4" title="Future salary growth Decreased by 1%"&gt;(74,839&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_903_ecustom--FutureSalaryGrowthIncreased_pn3n3_c20240101__20241231_zMEynPMkBAkb" title="Future salary growth Increased by 1%"&gt;81,953&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_903_ecustom--FutureSalaryGrowthDecreased_pn3n3_c20240101__20241231_zDe4eYszGnU" title="Future salary growth Decreased by 1%"&gt;(72,186&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:ScheduleOfDefinedBenefitObligationTableTextBlock>
    <cik0002058261:DiscountRateIncrease
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003061"
      unitRef="KRW">-73191000</cik0002058261:DiscountRateIncrease>
    <cik0002058261:DiscountRateDecrease
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003063"
      unitRef="KRW">84609000</cik0002058261:DiscountRateDecrease>
    <cik0002058261:DiscountRateIncrease
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003065"
      unitRef="KRW">-70838000</cik0002058261:DiscountRateIncrease>
    <cik0002058261:DiscountRateDecrease
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003067"
      unitRef="KRW">81873000</cik0002058261:DiscountRateDecrease>
    <cik0002058261:FutureSalaryGrowthIncreased
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003069"
      unitRef="KRW">85026000</cik0002058261:FutureSalaryGrowthIncreased>
    <cik0002058261:FutureSalaryGrowthDecreased
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003071"
      unitRef="KRW">-74839000</cik0002058261:FutureSalaryGrowthDecreased>
    <cik0002058261:FutureSalaryGrowthIncreased
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003073"
      unitRef="KRW">81953000</cik0002058261:FutureSalaryGrowthIncreased>
    <cik0002058261:FutureSalaryGrowthDecreased
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003075"
      unitRef="KRW">-72186000</cik0002058261:FutureSalaryGrowthDecreased>
    <cik0002058261:BondWithWarrantsAndDerivativeInstrumentsTextBlock
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact003077">&lt;p id="xdx_807_ecustom--BondWithWarrantsAndDerivativeInstrumentsTextBlock_z6i8BfMRIaAg" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;22. &lt;span id="xdx_822_zkMRRaDuJZmh"&gt;Bond with warrants and derivative instruments&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Details of principal of bonds issued and outstanding as of December&#160;31, 2025 and 2024 are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89A_ecustom--DetailsOfPrincipalOfBondsIssuedAndOutstandingTableTextBlock_pn3n3_zxkgoyGEwp3d" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Bond with warrants and derivative instruments (Details)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span id="xdx_8BD_zacs6Ct3hN5b" style="display: none"&gt;Details of principal of bonds issued and outstanding&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2024&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;b&gt;Bond with warrants&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;12&lt;sup&gt;th&lt;/sup&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--BondsIssued_iI_pn3n3_c20251231__ifrs-full--BorrowingsByNameAxis__custom--N12thBondWithWarrantsMember_zyY8xc3DJef3" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3081"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--BondsIssued_iI_pn3n3_c20241231__ifrs-full--BorrowingsByNameAxis__custom--N12thBondWithWarrantsMember_zpZgbbnADl0a" title="Total"&gt;800,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;13&lt;sup&gt;th&lt;/sup&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--BondsIssued_iI_pn3n3_c20251231__ifrs-full--BorrowingsByNameAxis__custom--N13thBondWithWarrantsMember_zFrYJ6vDTo6c" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3085"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--BondsIssued_iI_pn3n3_c20241231__ifrs-full--BorrowingsByNameAxis__custom--N13thBondWithWarrantsMember_zENMImIMoNZf" title="Total"&gt;495,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;14&lt;sup&gt;th&lt;/sup&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--BondsIssued_iI_pn3n3_c20251231__ifrs-full--BorrowingsByNameAxis__custom--N14thBondWithWarrantsMember_zWxDRYcHrIC3" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3089"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--BondsIssued_iI_pn3n3_c20241231__ifrs-full--BorrowingsByNameAxis__custom--N14thBondWithWarrantsMember_zJedUi79vCU1" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3091"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;15&lt;sup&gt;th&lt;/sup&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--BondsIssued_iI_pn3n3_c20251231__ifrs-full--BorrowingsByNameAxis__custom--N15thBondWithWarrantsMember_zsvLNqzTz74f" title="Total"&gt;1,365,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--BondsIssued_iI_pn3n3_c20241231__ifrs-full--BorrowingsByNameAxis__custom--N15thBondWithWarrantsMember_zRxv3eqzD8N3" title="Total"&gt;1,380,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;18&lt;sup&gt;th&lt;/sup&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--BondsIssued_iI_pn3n3_c20251231__ifrs-full--BorrowingsByNameAxis__custom--N18thBondWithWarrantsMember_zrsrVlAoPokf" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3097"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--BondsIssued_iI_pn3n3_c20241231__ifrs-full--BorrowingsByNameAxis__custom--N18thBondWithWarrantsMember_zDg80RhoRGNk" title="Total"&gt;2,500,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;20&lt;sup&gt;th&lt;/sup&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--BondsIssued_iI_pn3n3_c20251231__ifrs-full--BorrowingsByNameAxis__custom--N20thBondWithWarrantsMember_zgiWBnAmPl8h" title="Total"&gt;600,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--BondsIssued_iI_pn3n3_c20241231__ifrs-full--BorrowingsByNameAxis__custom--N20thBondWithWarrantsMember_z2Bex6M4B8Wk" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3103"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;21&lt;sup&gt;st&lt;/sup&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--BondsIssued_iI_pn3n3_c20251231__ifrs-full--BorrowingsByNameAxis__custom--N21stBondWithWarrantsMember_zPNj6xGfB2Ij" title="Total"&gt;3,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--BondsIssued_iI_pn3n3_c20241231__ifrs-full--BorrowingsByNameAxis__custom--N21stBondWithWarrantsMember_znp7RE2iXBtc" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3107"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; vertical-align: top; padding-left: 0.25in; padding-bottom: 1.25pt"&gt;Total&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--BondsIssued_iI_pn3n3_c20251231_zIbDCx7WHXMk" title="Total"&gt;4,965,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--BondsIssued_iI_pn3n3_c20241231_zTASmFxlSMM3" title="Total"&gt;5,175,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AA_zTwa0veTYkc6" style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

















&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Details of the changes in principal of bonds for the years ended December&#160;31, 2025 are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89F_ecustom--DetailsOfChangesInPrincipalOfBondsTableTextBlock_pn3n3_zHbHtVXUQjL3" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Bond with warrants and derivative instruments (Details 1)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left; vertical-align: top"&gt;&lt;span id="xdx_8BE_zcb0YHkckRr6" style="display: none"&gt;Details of changes in principal of bonds&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_495_20250401__20250630__ifrs-full--BorrowingsByNameAxis__custom--N12thBondWithWarrantsMember_zgfBdS3p0L6k" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49C_20250401__20250630__ifrs-full--BorrowingsByNameAxis__custom--N13thBondWithWarrantsMember_zAmJVrAVnVfd" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49E_20250401__20250630__ifrs-full--BorrowingsByNameAxis__custom--N15thBondWithWarrantsMember_zCHXgpgQL3h4" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_497_20250401__20250630__ifrs-full--BorrowingsByNameAxis__custom--N18thBondWithWarrantsMember_z6tpyX01fxye" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_496_20250401__20250630__ifrs-full--BorrowingsByNameAxis__custom--N19thBondWithWarrantsMember_zuyJxqVYGcNf" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_496_20250401__20250630__ifrs-full--BorrowingsByNameAxis__custom--N20thBondWithWarrantsMember_zOG42Zq83eGh" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_493_20250401__20250630__ifrs-full--BorrowingsByNameAxis__custom--N21stBondWithWarrantsMember_zNTNazhOu2G5" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49F_20250401__20250630_z9QSRMDYMus5" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;th style="text-align: left; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;12&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;13&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;15&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;18&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;19&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;20&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;21&lt;sup&gt;st&lt;/sup&gt;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;th style="text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="30" style="text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr id="xdx_400_eifrs-full--BondsIssued_iS_pn3n3_zIsE1mbYxQ0b" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; vertical-align: top"&gt;&lt;b&gt;Balance as of January&#160;1&lt;/b&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 5%"&gt;800,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 5%"&gt;495,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 5%"&gt;1,380,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 5%"&gt;2,500,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 5%"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3126"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 5%"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3127"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 5%"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3128"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 5%"&gt;5,175,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_402_eifrs-full--ShareIssueRelatedCost_i_pn3n" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left; vertical-align: top"&gt;Issuance&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3131"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3132"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3133"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3134"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;2,000,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;4,200,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;3,000,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;9,200,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--EarlyRedemption_i_pn3n" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left; vertical-align: top"&gt;Early redemption&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3140"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3141"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3142"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(2,500,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(2,000,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(3,600,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3146"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(8,100,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--RedemptionAtMaturity_i_pn3n" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left; vertical-align: top"&gt;Redemption at maturity&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3149"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(5,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3151"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3152"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3153"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3154"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3155"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(5,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--SettledThroughDebttoequitySwap_i_pn3n" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;Settled through
    debt-to-equity swap &lt;span id="xdx_F48_zCtI8nRmkOT6"&gt;(*)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(800,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(490,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(15,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3161"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3162"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3163"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3164"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(1,305,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; padding-bottom: 0.5pt"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_409_eifrs-full--BondsIssued_iE_pn3n3_zW0cvxXW5Kc" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; vertical-align: top; padding-bottom: 1.25pt"&gt;&lt;b&gt;Balance at 31 December&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3167"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3168"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,365,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3170"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3171"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;600,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;3,000,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;4,965,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;div style="width: 25%; margin-left: 0; margin-right: auto"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td id="xdx_F07_zE5qrYoVhEhg" style="width: 0.25in; text-align: left"&gt;(*)&lt;/td&gt;
    &lt;td id="xdx_F1F_zZSXn1tPPKo7" style="text-align: justify"&gt;During the period, the detachable warrants were exercised through debt-to-equity swap (non-cash settlement). The amounts presented under &#x201c;Settled through debt-to-equity swap&#x201d; relate solely to warrants exercised through the non-cash settlement method, whereby bond principal was settled through conversion. Accordingly, no cash inflows arose from the transactions reflected in this table during the period. As a result of the exercise of warrants through non-cash settlement during the period, 320,000 ordinary shares were issued in connection with the 12th series, and 196,000 ordinary shares were issued in connection with the 13th series, and 5,000 ordinary shares were issued in connection with the 15th series.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Details of the changes in principal of bonds for the year ended December&#160;31, 2024 are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_498_20240401__20240630__ifrs-full--BorrowingsByNameAxis__custom--N12thBondWithWarrantsMember_zuOc2kBQnGZd" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_497_20240401__20240630__ifrs-full--BorrowingsByNameAxis__custom--N13thBondWithWarrantsMember_zh6HruupIVUi" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_499_20240401__20240630__ifrs-full--BorrowingsByNameAxis__custom--N14thBondWithWarrantsMember_z1PMYHa7eug2" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49D_20240401__20240630__ifrs-full--BorrowingsByNameAxis__custom--N15thBondWithWarrantsMember_zFaEQrSn1FR7" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_496_20240401__20240630__ifrs-full--BorrowingsByNameAxis__custom--N17thBondWithWarrantsMember_zkzRqrbJoo5f" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49D_20240401__20240630__ifrs-full--BorrowingsByNameAxis__custom--N18thBondWithWarrantsMember_zV4tysEuN35g" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_495_20240401__20240630_zlvWR9dTpysg" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;th style="text-align: left; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;12&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;13&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;14&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;15&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;17&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;18&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;th style="text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="26" style="text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr id="xdx_407_eifrs-full--BondsIssued_iS_pn3n3_z5FEqGhkaeL5" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; vertical-align: top"&gt;&lt;b&gt;Balance as of January&#160;1&lt;/b&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 5%"&gt;800,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 5%"&gt;3,855,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 5%"&gt;750,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 5%"&gt;2,180,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 5%"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3181"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 5%"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3182"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 5%"&gt;7,585,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_403_eifrs-full--ShareIssueRelatedCost_z4z1lz3Vv5Ce" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left; vertical-align: top"&gt;Issuance&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3185"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3186"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3187"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3188"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;2,000,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;2,500,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;4,500,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--EarlyRedemption_zjfFYqVvjPha" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left; vertical-align: top"&gt;Early redemption&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3193"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3194"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(750,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3196"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(2,000,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3198"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(2,750,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--SettledThroughDebttoequitySwap_zxXxw3xNrZz8" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;Settled through
    debt-to-equity swap &lt;span id="xdx_F49_z8aJcOvulmSg"&gt;(*)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3201"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(3,360,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3203"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(800,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3205"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3206"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(4,160,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; padding-bottom: 0.5pt"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_400_eifrs-full--BondsIssued_iE_pn3n3_zu4toycP8r0h" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; vertical-align: top; padding-bottom: 1.25pt"&gt;&lt;b&gt;Balance at 31 December&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;800,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;495,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3211"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,380,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3213"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;2,500,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;5,175,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;div style="width: 25%; margin-left: 0; margin-right: auto"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td id="xdx_F0E_zRFKkaK0HoOh" style="width: 0.25in; text-align: left"&gt;(*)&lt;/td&gt;
    &lt;td id="xdx_F13_zfdAx1eIjCZg" style="text-align: justify"&gt;During the period, the detachable warrants were exercised through two methods: cash settlement and debt-to-equity swap (non-cash settlement). The amounts presented under &#x201c;Settled through debt-to-equity swap&#x201d; relate solely to warrants exercised through the non-cash settlement method, whereby bond principal was settled through conversion. Accordingly, no cash inflows arose from the transactions reflected in this table during the period. As a result of the exercise of warrants through non-cash settlement during the period, 1,344,000 ordinary shares were issued in connection with the 13th series, and 266,665 ordinary shares were issued in connection with the 15th series. In addition, as a result of the exercise of warrants through cash settlement during the period, 14,000 ordinary shares were issued in connection with the 13th series and 1,000,000 ordinary shares in connection with the 16th series, for which the related bonds had been fully settled prior to the warrant exercise. The Company recognized increases in share capital equal to the number of shares exercised multiplied by par value, and in share premium equal to the number of shares exercised multiplied by the excess of the exercise price over par value.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A9_zT7jbVxh1QK1" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

















&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Changes in the fair value of derivative liabilities embedded in each series of bonds with warrants that were recognized in profit or loss for the year ended December&#160;31, 2025 are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_890_ecustom--ChangesInFairValueOfDerivativeLiabilitiesTableTextBlock_pn3n3_zWkpLg9IGCbg" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Bond with warrants and derivative instruments (Details 2)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left; vertical-align: top"&gt;&lt;span id="xdx_8B4_zjyAzPthIMCd" style="display: none"&gt;Changes in fair value of derivative liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_494_20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N12thBondWithWarrantsMember_zeNaJJfiT3Z4" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49B_20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N13thBondWithWarrantsMember_zaZ9ojvJpCI3" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_490_20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N15thBondWithWarrantsMember_zTVwg32KH8la" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49C_20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N18thBondWithWarrantsMember_zKBKqIdWsRLe" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_494_20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N19thBondWithWarrantsMember_zV7ppuSxr2x5" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_497_20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N20thBondWithWarrantsMember_zuioPpKZIbBf" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49D_20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N21stBondWithWarrantsMember_zsjeNvZ60Ie8" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49D_20250101__20251231_ze2VVOBmbAla" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;th style="text-align: left; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;12&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;13&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;15&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;18&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;19&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;20&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;21&lt;sup&gt;st&lt;/sup&gt;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;th style="text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="30" style="text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr id="xdx_407_eifrs-full--DerivativeFinancialLiabilities_iS_pn3n3_zWe9vmHOVQE8" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; vertical-align: top"&gt;&lt;b&gt;Balance at January&#160;1&lt;/b&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 5%"&gt;66,240&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 5%"&gt;53,263&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 5%"&gt;337,179&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 5%"&gt;1,017,141&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 5%"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3231"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 5%"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3232"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 5%"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3233"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 5%"&gt;1,473,823&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--Issuance_ztxABeGeU0Re" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left; vertical-align: top"&gt;Issuance&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3236"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3237"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3238"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3239"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;824,174&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;1,719,885&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;916,475&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;3,460,534&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--Redemption_zhbufSrQKcO3" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left; vertical-align: top"&gt;Redemption&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3245"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3246"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3247"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(1,011,875&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(775,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(1,408,200&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3251"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(3,195,075&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--LossesGainsOnValuationOfDerivatives_ztcbFRFfi6Y5" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left; vertical-align: top"&gt;Losses (gains) on valuation of derivatives&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(57,920&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(47,163&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(217,414&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(5,266&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(49,174&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(84,485&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;6,281&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(455,141&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--DerecognizedUponBondSettlement_zuJGail3AmFh" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;Derecognized upon bond settlement&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(8,320&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(6,100&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(1,920&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3266"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3267"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3268"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3269"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(16,340&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; padding-bottom: 0.5pt"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_407_eifrs-full--DerivativeFinancialLiabilities_iE_pn3n3_z0OMla9e632h" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; vertical-align: top; padding-bottom: 1.25pt"&gt;&lt;b&gt;Balance at December&#160;31&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3272"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3273"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;117,845&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3275"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3276"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;227,200&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;922,756&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,267,801&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Changes in the fair value of derivative liabilities embedded in each series of bonds with warrants that were recognized in profit or loss for the year ended December&#160;31, 2024 are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49F_20240101__20241231__ifrs-full--BorrowingsByNameAxis__custom--N12thBondWithWarrantsMember_z1RaMidDJcRk" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_497_20240101__20241231__ifrs-full--BorrowingsByNameAxis__custom--N13thBondWithWarrantsMember_zwEEI2urY3Hl" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_493_20240101__20241231__ifrs-full--BorrowingsByNameAxis__custom--N14thBondWithWarrantsMember_z0iPy5nQjFla" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49C_20240101__20241231__ifrs-full--BorrowingsByNameAxis__custom--N15thBondWithWarrantsMember_zcHVEVZVss4b" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_498_20240101__20241231__ifrs-full--BorrowingsByNameAxis__custom--N17thBondWithWarrantsMember_zM8Ye9RLfO6i" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_496_20240101__20241231__ifrs-full--BorrowingsByNameAxis__custom--N18thBondWithWarrantsMember_zEtJgzi0Xjo3" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_495_20240101__20241231_zcSVr54X3EI4" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;12&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;13&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;14&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;15&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;17&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;18&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="26" style="text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr id="xdx_403_eifrs-full--DerivativeFinancialLiabilities_iS_pn3n3_zv1tkTNcWuah" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;b&gt;Balance at January&#160;1&lt;/b&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 5%"&gt;208,960&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 5%"&gt;963,391&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 5%"&gt;281,400&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 5%"&gt;698,795&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 5%"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3285"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 5%"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3286"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 5%"&gt;2,152,546&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; width: 1%"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--Issuance_zdtPUYWF7Fm3" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Issuance&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3289"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3290"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3291"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3292"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;802,198&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;1,021,266&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;1,823,464&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--Redemption_zih3OT5bd3ok" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Redemption&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3297"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3298"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(195,900&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3300"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(808,000&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3302"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(1,003,900&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--LossesGainsOnValuationOfDerivatives_zgbnITk4nOZ6" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Losses (gains) on valuation of derivatives&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(142,720&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(322,128&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(85,500&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(119,164&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;5,802&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(4,125&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(667,835&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--DerecognizedUponBondSettlement_zyFTPAX4SJ1c" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Derecognized upon bond settlement&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3313"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(588,000&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3315"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(242,452&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3317"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3318"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(830,452&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--DerivativeFinancialLiabilities_iE_pn3n3_z5WJOCpX7ktg" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.25pt"&gt;&lt;b&gt;Balance at December&#160;31&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;66,240&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;53,263&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3323"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;337,179&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3325"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,017,141&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,473,823&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AB_zgVa7Q62ZPb3" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

















&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Details of the bonds with detachable warrants issued by the Company, including those outstanding as of December&#160;31, 2024 and fully settled or redeemed during the year ended December&#160;31, 2025, are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--DetailsOfBondsWithDetachableWarrantsIssuedTableTextBlock_pn3n3_zeT28csOKxP1" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Bond with warrants and derivative instruments (Details 3)"&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&lt;span id="xdx_8B6_zAXglBmwepTl" style="display: none"&gt;Details of bonds with detachable warrants issued&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;th style="border-bottom: Black 1pt solid; text-indent: -0.125in; padding-left: 0.125in; text-align: center"&gt;&lt;b&gt;Series&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;11&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;12&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;13&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; width: 18%; vertical-align: top"&gt;Type&lt;/td&gt;
    &lt;td style="width: 2%; text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; width: 24%; vertical-align: top"&gt;&lt;span id="xdx_904_ecustom--Type_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N11thDetachableWarrantsBondsMember_zhDFbCywbyJ9" title="Type"&gt;Detachable Warrants bonds&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 2%; text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; width: 26%; vertical-align: top"&gt;&lt;span id="xdx_90F_ecustom--Type_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N12thDetachableWarrantsBondsMember_zKpkpTIp58Ak" title="Type"&gt;Detachable Warrants bonds&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 2%; text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; width: 26%; vertical-align: top"&gt;&lt;span id="xdx_904_ecustom--Type_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N13thDetachableWarrantsBondsMember_zQ0WRA4Gm5V7" title="Type"&gt;Detachable Warrants bonds&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"&gt;Issuance amount&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;span id="xdx_903_ecustom--IssuanceAmount_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N11thDetachableWarrantsBondsMember_pp0p" title="Issuance amount"&gt;1,500,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;span id="xdx_900_ecustom--IssuanceAmount_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N12thDetachableWarrantsBondsMember_pp0p" title="Issuance amount"&gt;800,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;span id="xdx_901_ecustom--IssuanceAmount_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N13thDetachableWarrantsBondsMember_pp0p" title="Issuance amount"&gt;4,000,000,000&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Coupon rate (%)&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&lt;span id="xdx_90B_ecustom--CouponRate_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N11thDetachableWarrantsBondsMember_pd" title="Coupon rate (%)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3350"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&lt;span id="xdx_90A_ecustom--CouponRate_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N12thDetachableWarrantsBondsMember_pd" title="Coupon rate (%)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3352"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&lt;span id="xdx_90D_ecustom--CouponRate_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N13thDetachableWarrantsBondsMember_pd" title="Coupon rate (%)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3354"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Yield to maturity (%)&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&lt;span id="xdx_900_ecustom--YieldToMaturity_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N11thDetachableWarrantsBondsMember_pd" title="Yield to maturity (%)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3356"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&lt;span id="xdx_907_ecustom--YieldToMaturity_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N12thDetachableWarrantsBondsMember_pd" title="Yield to maturity (%)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3358"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&lt;span id="xdx_906_ecustom--YieldToMaturity_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N13thDetachableWarrantsBondsMember_pd" title="Yield to maturity (%)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3360"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Issuance date&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&lt;span id="xdx_909_ecustom--IssuanceDate_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N11thDetachableWarrantsBondsMember_zzPyCzDZepU8" title="Issuance date"&gt;March&#160;2022&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&lt;span id="xdx_900_ecustom--IssuanceDate_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N12thDetachableWarrantsBondsMember_zYxyim6os2ij" title="Issuance date"&gt;August&#160;2022&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&lt;span id="xdx_90C_ecustom--IssuanceDate_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N13thDetachableWarrantsBondsMember_znnLmwLBk4nc" title="Issuance date"&gt;October&#160;2022&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Maturity date&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&lt;span id="xdx_90A_ecustom--MaturityDate_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N11thDetachableWarrantsBondsMember_zURYfez6m5U8" title="Maturity date"&gt;March&#160;2025&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&lt;span id="xdx_902_ecustom--MaturityDate_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N12thDetachableWarrantsBondsMember_zoOMbBcc1Fsc" title="Maturity date"&gt;August&#160;2025&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&lt;span id="xdx_904_ecustom--MaturityDate_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N13thDetachableWarrantsBondsMember_zpChta9N9cUh" title="Maturity date"&gt;October&#160;2025&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Principal redemption&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--PrincipalRedemption_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N11thDetachableWarrantsBondsMember_zSKP6Ixs0fl1" style="text-align: justify; vertical-align: top" title="Principal redemption"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;1. Redemption at maturity:&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Redeemed on the maturity date, at their outstanding principal amount, which has not been early redeemed&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;2. Early redemption:&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company has a right to redeem before maturity (call option) or the bondholders have a right to require the Company to redeem before maturity (put option). Upon exercise of each option, the outstanding principal amount is to be redeemed.&lt;/p&gt; &lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--PrincipalRedemption_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N12thDetachableWarrantsBondsMember_zQR4GKn4dRu6" style="text-align: justify; vertical-align: top" title="Principal redemption"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;1. Redemption at maturity:&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Redeemed on the maturity date, at their outstanding principal amount, which has not been early redeemed&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;2. Early redemption:&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company has a right to redeem before maturity (call option) or the bondholders have a right to require the Company to redeem before maturity (put option). Upon exercise of each option, the outstanding principal amount is to be redeemed.&lt;/p&gt; &lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--PrincipalRedemption_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N13thDetachableWarrantsBondsMember_zjdEjFlnB4s4" style="text-align: justify; vertical-align: top" title="Principal redemption"&gt;
        &lt;p style="text-align: justify; margin-top: 0; margin-bottom: 0"&gt;1. Redemption at maturity:&lt;br/&gt;Redeemed on the maturity date, at their outstanding principal amount, which has not been early redeemed&lt;/p&gt;
        &lt;p style="text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;
        &lt;p style="text-align: justify; margin-top: 0; margin-bottom: 0"&gt;2. Early redemption:&lt;br/&gt;The Company has a right to redeem before maturity (call option) or the bondholders have a right to require the Company to redeem before maturity (put option). Upon exercise of each option, the outstanding principal amount is to be redeemed.&lt;/p&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"&gt;Exercise Price (*)&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--ExercisePrice_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N11thDetachableWarrantsBondsMember_fKCop_zRrHtxmApku9" style="vertical-align: top; text-align: justify" title="Exercise Price"&gt;&#x20a9;4,000 per common share&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--ExercisePrice_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N12thDetachableWarrantsBondsMember_fKCop_zONrGvpUIkDa" style="vertical-align: top; text-align: justify" title="Exercise Price"&gt;&#x20a9;2,500 per common share (Subject to adjustment based on revenue at a specific point in time)&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--ExercisePrice_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N13thDetachableWarrantsBondsMember_fKCop_zvJaim6Ep2lb" style="vertical-align: top; text-align: justify" title="Exercise Price"&gt;&#x20a9;2,500 per common share&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Exercise period&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--ExercisePeriod_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N11thDetachableWarrantsBondsMember_zbKETHtHByjl" style="text-align: justify; vertical-align: top" title="Exercise period"&gt;September&#160;2022 ~ January&#160;2025&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--ExercisePeriod_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N12thDetachableWarrantsBondsMember_zXn6PlpJ2JL7" style="text-align: justify; vertical-align: top" title="Exercise period"&gt;February&#160;2023 ~ July&#160;2025&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--ExercisePeriod_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N13thDetachableWarrantsBondsMember_z3wSezbbpaEi" style="text-align: justify; vertical-align: top" title="Exercise period"&gt;February&#160;2023 ~ September&#160;2025&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; margin-left: 0.125in; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;Redemption at the Option of the issuer (Call option)&lt;/p&gt; &lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--RedemptionAtOptionOfIssuerCallOption_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N11thDetachableWarrantsBondsMember_zx56MWaUJnV8" style="vertical-align: top; text-align: justify" title="Redemption at the Option of the issuer (Call option)"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The bonds are early redeemable by the Company in full or partial on March&#160;7, 2023, 12 months from the issuance, or every three months after.&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;In the event of early redemption, the principal amount shall be paid.&lt;/p&gt; &lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--RedemptionAtOptionOfIssuerCallOption_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N12thDetachableWarrantsBondsMember_zvczg27XOLyd" style="vertical-align: top; text-align: justify" title="Redemption at the Option of the issuer (Call option)"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The bonds are early redeemable by the Company in full or partial on August&#160;7, 2023, 12 months from the issuance, or every three months after.&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;In the event of early redemption, the principal amount shall be paid.&lt;/p&gt; &lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--RedemptionAtOptionOfIssuerCallOption_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N13thDetachableWarrantsBondsMember_z7P5lo54raPi" style="vertical-align: top; text-align: justify" title="Redemption at the Option of the issuer (Call option)"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The bonds are early redeemable by the Company in full or partial on April&#160;16, 2024, 18 months from the issuance, or every three months after.&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;In the event of early redemption, the principal amount shall be paid.&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

















&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr&gt;
    &lt;th style="border-bottom: black 1pt solid; text-indent: -0.125in; padding-left: 0.125in; text-align: center"&gt;&lt;b&gt;Series&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;b&gt;11&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;b&gt;12&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;b&gt;13&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; vertical-align: top; width: 18%"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; margin-left: 0.125in; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;Redemption at the option of the bond holders (Put option)&lt;/p&gt; &lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--RedemptionAtOptionOfBondHoldersPutOption_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N11thDetachableWarrantsBondsMember_z8QXIbNDZEHe" style="text-align: justify; vertical-align: top; width: 24%" title="Redemption at the option of the bond holders (Put option)"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The bonds are early redeemable by the Company in full or partial on March&#160;7, 2023, 12 months from the issuance, or every three months after.&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;In the event of early redemption, the principal amount shall be paid.&lt;/p&gt; &lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--RedemptionAtOptionOfBondHoldersPutOption_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N12thDetachableWarrantsBondsMember_zP4iQnc7En53" style="text-align: justify; vertical-align: top; width: 26%" title="Redemption at the option of the bond holders (Put option)"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The bonds are early redeemable by the Company in full or partial on August&#160;7, 2023, 12 months from the issuance, or every three months after.&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;In the event of early redemption, the principal amount shall be paid.&lt;/p&gt; &lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--RedemptionAtOptionOfBondHoldersPutOption_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N13thDetachableWarrantsBondsMember_zzzzqwcRlPXc" style="text-align: justify; vertical-align: top; width: 26%" title="Redemption at the option of the bond holders (Put option)"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The bonds are early redeemable by the Company in full or partial on April&#160;16, 2024, 18 months from the issuance, or every three months after.&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;In the event of early redemption, the principal amount shall be paid.&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Early redemption rights accounting treatment&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--EarlyRedemptionRightsAccountingTreatment_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N11thDetachableWarrantsBondsMember_zWKUYZPQi815" style="text-align: justify; vertical-align: top" title="Early redemption rights accounting treatment"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The early redemption right is separated from the host debt instrument as an embedded derivative and accounted for separately.&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The separated embedded derivative is measured at fair value through profit or loss (FVTPL).&lt;/p&gt; &lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--EarlyRedemptionRightsAccountingTreatment_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N12thDetachableWarrantsBondsMember_zVr38xoKfeh1" style="text-align: justify; vertical-align: top" title="Early redemption rights accounting treatment"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The early redemption right is separated from the host debt instrument as an embedded derivative and accounted for separately.&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The separated embedded derivative is measured at fair value through profit or loss (FVTPL).&lt;/p&gt; &lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--EarlyRedemptionRightsAccountingTreatment_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N13thDetachableWarrantsBondsMember_z0Vwu4igLOxe" style="text-align: justify; vertical-align: top" title="Early redemption rights accounting treatment"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The early redemption right is separated from the host debt instrument as an embedded derivative and accounted for separately.&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The separated embedded derivative is measured at fair value through profit or loss (FVTPL).&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; margin-left: 0.125in; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;Classification of Warrants&lt;/p&gt; &lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--ClassificationOfWarrants_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N11thDetachableWarrantsBondsMember_zD2EXdTexiR8" style="text-align: justify; vertical-align: top" title="Classification of Warrants"&gt;The warrants were classified as equity instruments at the date of issuance, as it satisfied the fixed-for-fixed condition.&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--ClassificationOfWarrants_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N12thDetachableWarrantsBondsMember_z0xox6PIxRE9" style="text-align: justify; vertical-align: top" title="Classification of Warrants"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Upon initial recognition, the warrants were classified as derivative financial liabilities as the fixed-for-fixed condition was not met at the inception date.&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Subsequently, following the determination of the exercise price, the warrants were reclassified as equity instruments.&lt;/p&gt; &lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--ClassificationOfWarrants_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N13thDetachableWarrantsBondsMember_zLljbFVqWl07" style="text-align: justify; vertical-align: top" title="Classification of Warrants"&gt;The warrants were classified as equity instruments at the date of issuance, as it satisfied the fixed-for-fixed condition.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;div style="width: 25%; margin-left: 0; margin-right: auto"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td id="xdx_F03_zPXJTX6PxBDb" style="width: 0.25in; text-align: left"&gt;(*)&lt;/td&gt;
    &lt;td id="xdx_F19_z0WpqFeTfeMh" style="text-align: justify"&gt;The exercise price for the 12th series was finalized in February&#160;2023.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

















&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Details of the bonds with detachable warrants issued by the Company, including those outstanding as of December&#160;31, 2024 and fully settled or redeemed during the year ended December&#160;31, 2025, are as follows: (Continued)&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-indent: -0.125in; padding-left: 0.125in; text-align: center; vertical-align: bottom"&gt;&lt;b&gt;Series&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: bottom; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"&gt;&lt;b&gt;14&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: bottom; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"&gt;&lt;b&gt;15&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: bottom; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"&gt;&lt;b&gt;16&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; width: 18%; vertical-align: top"&gt;Type&lt;/td&gt;
    &lt;td style="width: 2%; text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; width: 24%; vertical-align: top"&gt;&lt;span id="xdx_903_ecustom--Type_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N14thDetachableWarrantsBondsMember_zOUaNBJiFOs9" title="Type"&gt;Detachable Warrants bonds&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 2%; text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; width: 26%; vertical-align: top"&gt;&lt;span id="xdx_90F_ecustom--Type_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N15thDetachableWarrantsBondsMember_zXv5jGfvWIRd" title="Type"&gt;Detachable Warrants bonds&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 2%; text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; width: 26%; vertical-align: top"&gt;&lt;span id="xdx_90A_ecustom--Type_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N16thDetachableWarrantsBondsMember_zlc0Fi1zSI4d" title="Type"&gt;Detachable Warrants bonds&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"&gt;Issuance amount&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;span id="xdx_90E_ecustom--IssuanceAmount_pp0d_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N14thDetachableWarrantsBondsMember_zushMSDXlDrf" title="Issuance amount"&gt;750,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;span id="xdx_90E_ecustom--IssuanceAmount_pp0d_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N15thDetachableWarrantsBondsMember_zgySc6hf8rEh" title="Issuance amount"&gt;2,180,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;span id="xdx_909_ecustom--IssuanceAmount_pp0d_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N16thDetachableWarrantsBondsMember_zgy7zBi4JCQg" title="Issuance amount"&gt;30,000,000,000&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Coupon rate (%)&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&lt;span id="xdx_900_ecustom--CouponRate_pid_dp_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N14thDetachableWarrantsBondsMember_zmCqFWssjRfa" title="Coupon rate (%)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3443"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt; &lt;span id="xdx_904_ecustom--CouponRate_pid_dp_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N15thDetachableWarrantsBondsMember_zFbUMOdsRjJd" title="Coupon rate (%)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3445"&gt;-&lt;/span&gt; &lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&lt;span id="xdx_90F_ecustom--CouponRate_pid_dp_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N16thDetachableWarrantsBondsMember_zMdJKobK6eh1" title="Coupon rate (%)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3447"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Yield to maturity (%)&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&lt;span id="xdx_903_ecustom--YieldToMaturity_pid_dp_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N14thDetachableWarrantsBondsMember_zqqlqP1fcmCe" title="Yield to maturity (%)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3449"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&lt;span id="xdx_90E_ecustom--YieldToMaturity_pid_dp_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N15thDetachableWarrantsBondsMember_zzCGmMSgVvR8" title="Yield to maturity (%)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3451"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;Annual simple interest &lt;span id="xdx_903_ecustom--YieldToMaturity_pid_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N16thDetachableWarrantsBondsMember_z60vWd1vIOvk" title="Yield to maturity (%)"&gt;3.9%&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Issuance date&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&lt;span id="xdx_902_ecustom--IssuanceDate_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N14thDetachableWarrantsBondsMember_zExU9dCwuJT5" title="Issuance date"&gt;April&#160;2023&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&lt;span id="xdx_90E_ecustom--IssuanceDate_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N15thDetachableWarrantsBondsMember_zPwO8LzvH5xi" title="Issuance date"&gt;August&#160;2023&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&lt;span id="xdx_90E_ecustom--IssuanceDate_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N16thDetachableWarrantsBondsMember_zZXQOO0UMQH8" title="Issuance date"&gt;September&#160;2023&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Maturity date&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&lt;span id="xdx_900_ecustom--MaturityDate_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N14thDetachableWarrantsBondsMember_ze8lLkpjvqeb" title="Maturity date"&gt;April&#160;2026&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&lt;span id="xdx_906_ecustom--MaturityDate_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N15thDetachableWarrantsBondsMember_z4D6SAbIrRG2" title="Maturity date"&gt;August&#160;2026&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&lt;span id="xdx_902_ecustom--MaturityDate_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N16thDetachableWarrantsBondsMember_zS2NnUmLG0Ki" title="Maturity date"&gt;September&#160;2028&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Principal redemption&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--PrincipalRedemption_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N14thDetachableWarrantsBondsMember_zsaD4G4jAyZb" style="text-align: justify; vertical-align: top" title="Principal redemption"&gt;
        &lt;p style="text-align: justify; margin-top: 0; margin-bottom: 0"&gt;1. Redemption at maturity:&lt;br/&gt;Redeemed on the maturity date, at their outstanding principal amount, which has not been early redeemed&lt;/p&gt;
        &lt;p style="text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;
        &lt;p style="text-align: justify; margin-top: 0; margin-bottom: 0"&gt;2. Early redemption:&lt;br/&gt;The Company has a right to redeem before maturity (call option) or the bondholders have a right to require the Company to redeem before maturity (put option). Upon exercise of each option, the outstanding principal amount is to be redeemed.&lt;/p&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--PrincipalRedemption_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N15thDetachableWarrantsBondsMember_zUZw0c5K4oeh" style="text-align: justify; vertical-align: top" title="Principal redemption"&gt;
        &lt;p style="text-align: justify; margin-top: 0; margin-bottom: 0"&gt;1. Redemption at maturity:&lt;br/&gt;Redeemed on the maturity date, at their outstanding principal amount, which has not been early redeemed&lt;/p&gt;
        &lt;p style="text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;
        &lt;p style="text-align: justify; margin-top: 0; margin-bottom: 0"&gt;2. Early redemption:&lt;br/&gt;The Company has a right to redeem before maturity (call option) or the bondholders have a right to require the Company to redeem before maturity (put option). Upon exercise of each option, the outstanding principal amount is to be redeemed.&lt;/p&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--PrincipalRedemption_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N16thDetachableWarrantsBondsMember_z16ZYiCsVfz7" style="text-align: justify; vertical-align: top" title="Principal redemption"&gt;
        &lt;p style="text-align: justify; margin-top: 0; margin-bottom: 0"&gt;1. Redemption at maturity:&lt;br/&gt;Redeemed on the maturity date, at their outstanding principal amount, which has not been early redeemed&lt;/p&gt;
        &lt;p style="text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;
        &lt;p style="text-align: justify; margin-top: 0; margin-bottom: 0"&gt;2. Early redemption:&lt;/p&gt;
        &lt;p style="text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company has a right to redeem before maturity (call option) or the bondholders have a right to require the Company to redeem before maturity (put option). At exercise of each option, the outstanding principal amount together with accrued but unpaid interest are to be redeemed.&lt;/p&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"&gt;Exercise Price&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--ExercisePrice_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N14thDetachableWarrantsBondsMember_fKCop_zZYpeISQoZHh" style="vertical-align: top; text-align: justify" title="Exercise Price"&gt;&#x20a9;2,500 per common share&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--ExercisePrice_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N15thDetachableWarrantsBondsMember_fKCop_zh6VLi2Dm0od" style="vertical-align: top; text-align: justify" title="Exercise Price"&gt;&#x20a9;3,000 per common share&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--ExercisePrice_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N16thDetachableWarrantsBondsMember_fKCop_zfndxRjbNvD9" style="vertical-align: top; text-align: justify" title="Exercise Price"&gt;&#x20a9;3,000 per common share&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Exercise period&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--ExercisePeriod_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N14thDetachableWarrantsBondsMember_z0QO1gzjWOH4" style="text-align: justify; vertical-align: top" title="Exercise period"&gt;August&#160;2023 ~ November&#160;2025&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--ExercisePeriod_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N15thDetachableWarrantsBondsMember_z52I4OMYNcPb" style="text-align: justify; vertical-align: top" title="Exercise period"&gt;November&#160;2023 ~ July&#160;2026&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--ExercisePeriod_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N16thDetachableWarrantsBondsMember_zTNaBiWKVSD4" style="text-align: justify; vertical-align: top" title="Exercise period"&gt;October&#160;2023 ~ August&#160;2028&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

















&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr&gt;
    &lt;td style="border-bottom: black 1pt solid; text-indent: -0.125in; padding-left: 0.125in; text-align: center; vertical-align: bottom; width: 18%"&gt;&lt;b&gt;Series&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: bottom; padding-bottom: 0.5pt; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: center; vertical-align: bottom; width: 24%"&gt;&lt;b&gt;14&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: bottom; padding-bottom: 0.5pt; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: center; vertical-align: bottom; width: 26%"&gt;&lt;b&gt;15&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: bottom; padding-bottom: 0.5pt; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: center; vertical-align: bottom; width: 26%"&gt;&lt;b&gt;16&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; margin-left: 0.125in; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;Redemption at the Option of the issuer (Call option)&lt;/p&gt; &lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--RedemptionAtOptionOfIssuerCallOption_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N14thDetachableWarrantsBondsMember_zyzKA9yJ3MO6" style="vertical-align: top; text-align: justify" title="Redemption at the Option of the issuer (Call option)"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The bonds are early redeemable by the Company in full or partial on August&#160;7, 2023 or every three months after.&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;In the event of early redemption, the principal amount shall be paid.&lt;/p&gt; &lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--RedemptionAtOptionOfIssuerCallOption_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N15thDetachableWarrantsBondsMember_zBElWtX9BiP7" style="vertical-align: top; text-align: justify" title="Redemption at the Option of the issuer (Call option)"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The bonds are early redeemable by the Company in full or partial on August&#160;18, 2024 or every three months after.&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;In the event of early redemption, the principal amount shall be paid.&lt;/p&gt; &lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--RedemptionAtOptionOfIssuerCallOption_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N16thDetachableWarrantsBondsMember_zpglmB0RV2vc" style="vertical-align: top; text-align: justify" title="Redemption at the Option of the issuer (Call option)"&gt;The bonds are early redeemable by the Company in full or partial on November&#160;20, 2023, 2 months from the issuance, or every three months after.&lt;br/&gt;&lt;br/&gt;In the event of early redemption, the principal amount shall be payable.&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; margin-left: 0.125in; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;Redemption at the option of the bond holders (Put option)&lt;/p&gt; &lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--RedemptionAtOptionOfBondHoldersPutOption_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N14thDetachableWarrantsBondsMember_zCgrbUQAue05" style="vertical-align: top; text-align: justify" title="Redemption at the option of the bond holders (Put option)"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The bonds are early redeemable by the Company in full or partial on August&#160;7, 2023 or every three months after.&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;In the event of early redemption, the principal amount shall be paid.&lt;/p&gt; &lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--RedemptionAtOptionOfBondHoldersPutOption_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N15thDetachableWarrantsBondsMember_zOxXW9AbpTj8" style="vertical-align: top; text-align: justify" title="Redemption at the option of the bond holders (Put option)"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The bonds are early redeemable by the Company in full or partial on August&#160;18, 2024 or every three months after.&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;In the event of early redemption, the principal amount shall be paid.&lt;/p&gt; &lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--RedemptionAtOptionOfBondHoldersPutOption_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N16thDetachableWarrantsBondsMember_zbfEjdiXZ3H9" style="vertical-align: top; text-align: justify" title="Redemption at the option of the bond holders (Put option)"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The bonds are early redeemable by the Company in full or partial on November&#160;20, 2023, which is three months from the issuance date, or at any time thereafter.&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;In the event of early redemption, the principal amount shall be paid.&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"&gt;Early redemption rights accounting treatment&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--EarlyRedemptionRightsAccountingTreatment_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N14thDetachableWarrantsBondsMember_zhUzGlU5bK41" style="vertical-align: top; text-align: justify" title="Early redemption rights accounting treatment"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The early redemption right is separated from the host debt instrument as an embedded derivative and accounted for separately.&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The separated embedded derivative is measured at fair value through profit or loss (FVTPL).&lt;/p&gt; &lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--EarlyRedemptionRightsAccountingTreatment_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N15thDetachableWarrantsBondsMember_zmfA7h4HmO5d" style="vertical-align: top; text-align: justify" title="Early redemption rights accounting treatment"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The early redemption right is separated from the host debt instrument as an embedded derivative and accounted for separately.&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The separated embedded derivative is measured at fair value through profit or loss (FVTPL).&lt;/p&gt; &lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--EarlyRedemptionRightsAccountingTreatment_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N16thDetachableWarrantsBondsMember_zVDwxoEIiSd7" style="vertical-align: top; text-align: justify" title="Early redemption rights accounting treatment"&gt;The bonds are early redeemable by the Company in full or partial on November&#160;20, 2024, 2 months from the issuance, or every three months after.&lt;br/&gt;&lt;br/&gt;In the event of early redemption, the principal amount shall be payable.&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; margin-left: 0.125in; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;Classification of Warrants&lt;/p&gt; &lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--ClassificationOfWarrants_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N14thDetachableWarrantsBondsMember_zXRSPsJhUxH2" style="text-align: justify; vertical-align: top" title="Classification of Warrants"&gt;The warrants were classified as equity instruments at the date of issuance, as it satisfied the fixed-for-fixed condition.&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--ClassificationOfWarrants_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N15thDetachableWarrantsBondsMember_zfeJiG3d1HB9" style="text-align: justify; vertical-align: top" title="Classification of Warrants"&gt;The warrants were classified as equity instruments at the date of issuance, as it satisfied the fixed-for-fixed condition.&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--ClassificationOfWarrants_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N16thDetachableWarrantsBondsMember_zRiNICIE7oj7" style="text-align: justify; vertical-align: top" title="Classification of Warrants"&gt;The warrants were classified as equity instruments at the date of issuance, as it satisfied the fixed-for-fixed condition.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

















&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Details of the bonds with detachable warrants issued by the Company, including those outstanding as of December&#160;31, 2024 and fully settled or redeemed during the year ended December&#160;31, 2025, are as follows: (Continued)&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr&gt;
    &lt;th style="border-bottom: Black 1pt solid; text-indent: -0.125in; padding-left: 0.125in; text-align: center; vertical-align: bottom"&gt;&lt;b&gt;Series&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; vertical-align: bottom; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"&gt;&lt;b&gt;17&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; vertical-align: bottom; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"&gt;&lt;b&gt;18&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; vertical-align: bottom; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"&gt;&lt;b&gt;19&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; width: 18%; vertical-align: top"&gt;Type&lt;/td&gt;
    &lt;td style="text-align: justify; width: 2%; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; width: 24%; vertical-align: top"&gt;&lt;span id="xdx_90C_ecustom--Type_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N17thDetachableWarrantsBondsMember_zfM6jHVXSbo6" title="Type"&gt;Detachable Warrants bonds&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; width: 2%; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; width: 26%; vertical-align: top"&gt;&lt;span id="xdx_904_ecustom--Type_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N18thDetachableWarrantsBondsMember_zwBeoblX1gs1" title="Type"&gt;Detachable Warrants bonds&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; width: 2%; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; width: 26%; vertical-align: top"&gt;&lt;span id="xdx_90F_ecustom--Type_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N19thDetachableWarrantsBondsMember_z4sPLWh7Nu1" title="Type"&gt;Detachable Warrants bonds&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Issuance amount&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&lt;span id="xdx_905_ecustom--IssuanceAmount_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N17thDetachableWarrantsBondsMember_pp0p" title="Issuance amount"&gt;2,000,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&lt;span id="xdx_90A_ecustom--IssuanceAmount_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N18thDetachableWarrantsBondsMember_pp0p" title="Issuance amount"&gt;2,500,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&lt;span id="xdx_90B_ecustom--IssuanceAmount_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N19thDetachableWarrantsBondsMember_pp0p" title="Issuance amount"&gt;2,000,000,000&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Coupon rate (%)&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&lt;span id="xdx_900_ecustom--CouponRate_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N17thDetachableWarrantsBondsMember_pd" title="Coupon rate (%)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3535"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&lt;span id="xdx_901_ecustom--CouponRate_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N18thDetachableWarrantsBondsMember_pd" title="Coupon rate (%)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3537"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&lt;span id="xdx_902_ecustom--CouponRate_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N19thDetachableWarrantsBondsMember_pd" title="Coupon rate (%)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3539"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Yield to maturity (%)&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&lt;span id="xdx_90A_ecustom--YieldToMaturity_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N17thDetachableWarrantsBondsMember_pd" title="Yield to maturity (%)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3541"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&lt;span id="xdx_909_ecustom--YieldToMaturity_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N18thDetachableWarrantsBondsMember_pd" title="Yield to maturity (%)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3543"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&lt;span id="xdx_908_ecustom--YieldToMaturity_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N19thDetachableWarrantsBondsMember_pd" title="Yield to maturity (%)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3545"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Issuance date&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&lt;span id="xdx_908_ecustom--IssuanceDate_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N17thDetachableWarrantsBondsMember_zfDg2XMS8DU1" title="Issuance date"&gt;July&#160;2024&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&lt;span id="xdx_905_ecustom--IssuanceDate_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N18thDetachableWarrantsBondsMember_zC0nPeNi1zEf" title="Issuance date"&gt;November&#160;2024&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&lt;span id="xdx_907_ecustom--IssuanceDate_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N19thDetachableWarrantsBondsMember_zEbpnkWBlXVj" title="Issuance date"&gt;February&#160;2025&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Maturity date&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&lt;span id="xdx_90C_ecustom--MaturityDate_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N17thDetachableWarrantsBondsMember_zXwqV2CzBIL9" title="Maturity date"&gt;July&#160;2027&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&lt;span id="xdx_900_ecustom--MaturityDate_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N18thDetachableWarrantsBondsMember_zPLsxm7TsMG8" title="Maturity date"&gt;November&#160;2027&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&lt;span id="xdx_902_ecustom--MaturityDate_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N19thDetachableWarrantsBondsMember_zyXKfZxRQ459" title="Maturity date"&gt;February&#160;2028&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Principal redemption&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--PrincipalRedemption_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N17thDetachableWarrantsBondsMember_zK4aZFWF9mz3" style="text-align: justify; vertical-align: top" title="Principal redemption"&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1. Redemption at maturity:&lt;br/&gt;Redeemed on the maturity date, at their outstanding principal amount, which has not been early redeemed&lt;/span&gt;
        &lt;p style="text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2. Early redemption:&lt;br/&gt;The Company has a right to redeem before maturity (call option) or the bondholders have a right to require the Company to redeem before maturity (put option). At exercise of each option, the outstanding principal amount together with accrued but unpaid interest are to be redeemed.&lt;/span&gt; &lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--PrincipalRedemption_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N18thDetachableWarrantsBondsMember_z6MciEF7Wxx5" style="text-align: justify; vertical-align: top" title="Principal redemption"&gt;
        &lt;p style="text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1. Redemption at maturity:&lt;br/&gt;Redeemed on the maturity date, at their outstanding principal amount, which has not been early redeemed&lt;/span&gt;&lt;/p&gt;
        &lt;p style="text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2. Early redemption:&lt;br/&gt;The Company has a right to redeem before maturity (call option) or the bondholders have a right to require the Company to redeem before maturity (put option). Upon exercise of each option, the outstanding principal amount is to be redeemed.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--PrincipalRedemption_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N19thDetachableWarrantsBondsMember_zYtuCoTyOdnf" style="text-align: justify; vertical-align: top" title="Principal redemption"&gt;
        &lt;p style="text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1. Redemption at maturity:&lt;br/&gt;Redeemed on the maturity date, at their outstanding principal amount, which has not been early redeemed&lt;/span&gt;&lt;/p&gt;
        &lt;p style="text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2. Early redemption:&lt;br/&gt;The Company has a right to redeem before maturity (call option) or the bondholders have a right to require the Company to redeem before maturity (put option). Upon exercise of each option, the outstanding principal amount is to be redeemed.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Exercise Price&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--ExercisePrice_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N17thDetachableWarrantsBondsMember_fKCop_z6pvdjDIN9jk" style="text-align: justify; vertical-align: top" title="Exercise Price"&gt;&#x20a9;4,000 per common share&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--ExercisePrice_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N18thDetachableWarrantsBondsMember_fKCop_zM7bMUKYeTd9" style="text-align: justify; vertical-align: top" title="Exercise Price"&gt;&#x20a9;4,000 per common share&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--ExercisePrice_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N19thDetachableWarrantsBondsMember_fKCop_zDUR1RD7Rfkg" style="text-align: justify; vertical-align: top" title="Exercise Price"&gt;&#x20a9;4,000 per common share&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Exercise period&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--ExercisePeriod_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N17thDetachableWarrantsBondsMember_z1Etxz76FYM1" style="text-align: justify; vertical-align: top" title="Exercise period"&gt;November&#160;2024 ~ June&#160;2027&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--ExercisePeriod_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N18thDetachableWarrantsBondsMember_zv6SSsM2HvC" style="text-align: justify; vertical-align: top" title="Exercise period"&gt;February&#160;2025 ~ November&#160;2027&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--ExercisePeriod_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N19thDetachableWarrantsBondsMember_zBvoYMQ3UkF5" style="text-align: justify; vertical-align: top" title="Exercise period"&gt;May&#160;2025 ~ January&#160;2028&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

















&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr&gt;
    &lt;th style="border-bottom: black 1pt solid; text-align: center; vertical-align: bottom"&gt;&lt;b&gt;Series&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; vertical-align: bottom; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="border-bottom: black 1pt solid; text-align: center; vertical-align: bottom"&gt;&lt;b&gt;17&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; vertical-align: bottom; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="border-bottom: black 1pt solid; text-align: center; vertical-align: bottom"&gt;&lt;b&gt;18&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; vertical-align: bottom; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="border-bottom: black 1pt solid; text-align: center; vertical-align: bottom"&gt;&lt;b&gt;19&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; vertical-align: top; width: 18%"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; margin-left: 0.125in; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;Redemption at the Option of the issuer (Call option)&lt;/p&gt; &lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--RedemptionAtOptionOfIssuerCallOption_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N17thDetachableWarrantsBondsMember_zYkViDIbQBr8" style="text-align: justify; vertical-align: top; width: 24%" title="Redemption at the Option of the issuer (Call option)"&gt;The bonds are early redeemable by the Company in full or partial on November&#160;2, 2024 or every three months after.&lt;br/&gt;&lt;br/&gt;In the event of early redemption, the principal amount shall be payable.&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--RedemptionAtOptionOfIssuerCallOption_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N18thDetachableWarrantsBondsMember_z4E8ulaMDdPf" style="text-align: justify; vertical-align: top; width: 26%" title="Redemption at the Option of the issuer (Call option)"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The bonds are early redeemable by the Company in full or partial on February&#160;7, 2025, which is three months from the issuance date, or at any time thereafter.&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;In the event of early redemption, the principal amount shall be paid.&lt;/p&gt; &lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--RedemptionAtOptionOfIssuerCallOption_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N19thDetachableWarrantsBondsMember_zh6wTvWThLT4" style="text-align: justify; vertical-align: top; width: 26%" title="Redemption at the Option of the issuer (Call option)"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The bonds are early redeemable by the Company in full or partial on May&#160;17, 2025, which is three months from the issuance date, or at any time thereafter.&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;In the event of early redemption, the principal amount shall be paid.&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; vertical-align: top; width: 18%"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; margin-left: 0.125in; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;Redemption at the option of the bond holders (Put option)&lt;/p&gt; &lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--RedemptionAtOptionOfBondHoldersPutOption_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N17thDetachableWarrantsBondsMember_zo3D8CbKEble" style="text-align: justify; vertical-align: top; width: 24%" title="Redemption at the option of the bond holders (Put option)"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;The bonds are early redeemable by the Company in full or partial on November&#160;18, 2026, which is one year from the issuance date, or at any time thereafter.&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;In the event of early redemption, the principal amount shall be paid.&lt;/p&gt; &lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--RedemptionAtOptionOfBondHoldersPutOption_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N18thDetachableWarrantsBondsMember_zEVi1D5VEvLl" style="text-align: justify; vertical-align: top; width: 26%" title="Redemption at the option of the bond holders (Put option)"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;The bonds are early redeemable by the Company in full or partial on February&#160;7, 2025, which is three months from the issuance date, or at any time thereafter.&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;In the event of early redemption, the principal amount shall be paid.&lt;/p&gt; &lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--RedemptionAtOptionOfBondHoldersPutOption_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N19thDetachableWarrantsBondsMember_zWEbdtrOKMh2" style="text-align: justify; vertical-align: top; width: 26%" title="Redemption at the option of the bond holders (Put option)"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;The bonds are early redeemable by the Company in full or partial on May&#160;17, 2025, which is three months from the issuance date, or at any time thereafter.&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;In the event of early redemption, the principal amount shall be paid.&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Early redemption rights accounting treatment&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--EarlyRedemptionRightsAccountingTreatment_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N17thDetachableWarrantsBondsMember_z00WQyM8lDqh" style="text-align: justify; vertical-align: top" title="Early redemption rights accounting treatment"&gt;
        &lt;p style="margin-top: 0pt; text-align: justify; margin-bottom: 0pt"&gt;The bonds are early redeemable by the Company in full or partial on November&#160;2, 2024 or every four months after.&lt;/p&gt;
        &lt;p style="margin-top: 0pt; text-align: justify; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;
        &lt;p style="margin-top: 0pt; text-align: justify; margin-bottom: 0pt"&gt;In the event of early redemption, the principal amount shall be payable.&lt;/p&gt; &lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--EarlyRedemptionRightsAccountingTreatment_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N18thDetachableWarrantsBondsMember_z3xfNAtky7q9" style="text-align: justify; vertical-align: top" title="Early redemption rights accounting treatment"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;The early redemption right is separated from the host debt instrument as an embedded derivative and accounted for separately.&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;The separated embedded derivative is measured at fair value through profit or loss (FVTPL).&lt;/p&gt; &lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--EarlyRedemptionRightsAccountingTreatment_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N19thDetachableWarrantsBondsMember_zV6pAq8T4TY4" style="text-align: justify; vertical-align: top" title="Early redemption rights accounting treatment"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;The early redemption right is separated from the host debt instrument as an embedded derivative and accounted for separately.&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;The separated embedded derivative is measured at fair value through profit or loss (FVTPL).&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; margin-left: 0.125in; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;Classification of Warrants&lt;/p&gt; &lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--ClassificationOfWarrants_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N17thDetachableWarrantsBondsMember_znKO0TtcXPS9" style="text-align: justify; vertical-align: top" title="Classification of Warrants"&gt;The warrants were classified as equity instruments at the date of issuance, as it satisfied the fixed-for-fixed condition.&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--ClassificationOfWarrants_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N18thDetachableWarrantsBondsMember_z1Y5BTnfrTu5" style="text-align: justify; vertical-align: top" title="Classification of Warrants"&gt;The warrants were classified as equity instruments at the date of issuance, as it satisfied the fixed-for-fixed condition.&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--ClassificationOfWarrants_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N19thDetachableWarrantsBondsMember_zFsQ0FfEXEPe" style="text-align: justify; vertical-align: top" title="Classification of Warrants"&gt;The warrants were classified as equity instruments at the date of issuance, as it satisfied the fixed-for-fixed condition.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

















&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Details of the bonds with detachable warrants issued by the Company, including those outstanding as of December&#160;31, 2024 and fully settled or redeemed during the year ended December&#160;31, 2025, are as follows: (Continued)&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr&gt;
    &lt;th style="border-bottom: Black 1pt solid; text-indent: -0.125in; padding-left: 0.125in; vertical-align: bottom; text-align: center"&gt;&lt;b&gt;Series&lt;/b&gt;&lt;/th&gt;
    &lt;th style="vertical-align: top; text-align: center; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"&gt;&lt;b&gt;20&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"&gt;&lt;b&gt;21&lt;sup&gt;st&lt;/sup&gt;&lt;/b&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; width: 18%; vertical-align: top"&gt;Type&lt;/td&gt;
    &lt;td style="text-align: justify; width: 2%; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; width: 39%; vertical-align: top"&gt;&lt;span id="xdx_90E_ecustom--Type_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N20thDetachableWarrantsBondsMember_z3IEAWayVZBd" title="Type"&gt;Detachable Warrants bonds&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 2%; text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; width: 39%; vertical-align: top"&gt;&lt;span id="xdx_90B_ecustom--Type_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N21stDetachableWarrantsBondsMember_zX8ijeAHzhk1" title="Type"&gt;Detachable Warrants bonds&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Issuance amount&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&lt;span id="xdx_903_ecustom--IssuanceAmount_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N20thDetachableWarrantsBondsMember_pp0p" title="Issuance amount"&gt;4,200,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&lt;span id="xdx_900_ecustom--IssuanceAmount_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N21stDetachableWarrantsBondsMember_pp0p" title="Issuance amount"&gt;3,000,000,000&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Coupon rate (%)&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&lt;span id="xdx_90B_ecustom--CouponRate_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N20thDetachableWarrantsBondsMember_pd" title="Coupon rate (%)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3623"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&lt;span id="xdx_90A_ecustom--CouponRate_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N21stDetachableWarrantsBondsMember_pd" title="Coupon rate (%)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3625"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Yield to maturity (%)&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&lt;span id="xdx_900_ecustom--YieldToMaturity_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N20thDetachableWarrantsBondsMember_pd" title="Yield to maturity (%)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3627"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&lt;span id="xdx_907_ecustom--YieldToMaturity_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N21stDetachableWarrantsBondsMember_pd" title="Yield to maturity (%)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3629"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Issuance date&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&lt;span id="xdx_901_ecustom--IssuanceDate_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N20thDetachableWarrantsBondsMember_zuDhSL280X39" title="Issuance date"&gt;July&#160;2025&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&lt;span id="xdx_909_ecustom--IssuanceDate_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N21stDetachableWarrantsBondsMember_zMMIGwBVNCz4" title="Issuance date"&gt;November&#160;2025&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Maturity date&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&lt;span id="xdx_90D_ecustom--MaturityDate_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N20thDetachableWarrantsBondsMember_zpiM8r5mciHa" title="Maturity date"&gt;July&#160;2028&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&lt;span id="xdx_90E_ecustom--MaturityDate_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N21stDetachableWarrantsBondsMember_zsce4H2hTMCg" title="Maturity date"&gt;November&#160;2028&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Principal redemption&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--PrincipalRedemption_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N20thDetachableWarrantsBondsMember_zHGOG8qMKgla" style="text-align: justify; vertical-align: top" title="Principal redemption"&gt;
        &lt;p style="text-align: justify; margin-top: 0; margin-bottom: 0"&gt;1. Redemption at maturity:&lt;br/&gt;Redeemed on the maturity date, at their outstanding principal amount, which has not been early redeemed&lt;/p&gt;
        &lt;p style="text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;
        &lt;p style="text-align: justify; margin-top: 0; margin-bottom: 0"&gt;2. Early redemption:&lt;br/&gt;The Company has a right to redeem before maturity (call option) or the bondholders have a right to require the Company to redeem before maturity (put option). Upon exercise of each option, the outstanding principal amount is to be redeemed.&lt;/p&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--PrincipalRedemption_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N21stDetachableWarrantsBondsMember_zBNX4uqLXDD8" style="text-align: justify; vertical-align: top" title="Principal redemption"&gt;
        &lt;p style="text-align: justify; margin-top: 0; margin-bottom: 0"&gt;1. Redemption at maturity:&lt;br/&gt;Redeemed on the maturity date, at their outstanding principal amount, which has not been early redeemed&lt;/p&gt;
        &lt;p style="text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;
        &lt;p style="text-align: justify; margin-top: 0; margin-bottom: 0"&gt;2. Early redemption:&lt;br/&gt;The Company has a right to redeem before maturity (call option) or the bondholders have a right to require the Company to redeem before maturity (put option). Upon exercise of each option, the outstanding principal amount is to be redeemed.&lt;/p&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Exercise Price&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--ExercisePrice_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N20thDetachableWarrantsBondsMember_fKCop_z2A3m8hlIST5" style="text-align: justify; vertical-align: top" title="Exercise Price"&gt;&#x20a9;3,000 per common share&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--ExercisePrice_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N21stDetachableWarrantsBondsMember_fKCop_zOOH80F0xHf1" style="text-align: justify; vertical-align: top" title="Exercise Price"&gt;&#x20a9;3,000 per common share&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Exercise period&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--ExercisePeriod_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N20thDetachableWarrantsBondsMember_zOxKygngQHEk" style="text-align: justify; vertical-align: top" title="Exercise period"&gt;October&#160;2025 ~ June&#160;2028&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--ExercisePeriod_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N21stDetachableWarrantsBondsMember_z3kpRL8LppGi" style="text-align: justify; vertical-align: top" title="Exercise period"&gt;February&#160;2026 ~ October&#160;2028&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; margin-left: 0.125in; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;Redemption at the Option of the issuer (Call option)&lt;/p&gt; &lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--RedemptionAtOptionOfIssuerCallOption_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N20thDetachableWarrantsBondsMember_zXjKM3bmGqsb" style="text-align: justify; vertical-align: top" title="Redemption at the Option of the issuer (Call option)"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The bonds are early redeemable by the Company in full or partial on October&#160;2, 2025, which is three months from the issuance date, or at any time thereafter.&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;In the event of early redemption, the principal amount shall be paid.&lt;/p&gt; &lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--RedemptionAtOptionOfIssuerCallOption_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N21stDetachableWarrantsBondsMember_zEPwnGN3g0F6" style="text-align: justify; vertical-align: top" title="Redemption at the Option of the issuer (Call option)"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The bonds are early redeemable by the Company in full or partial on November&#160;18, 2026, which is one year from the issuance date, or at any time thereafter.&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;In the event of early redemption, the principal amount shall be paid.&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; margin-left: 0.125in; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;Redemption at the option of the bond holders (Put option)&lt;/p&gt; &lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--RedemptionAtOptionOfBondHoldersPutOption_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N20thDetachableWarrantsBondsMember_z0ZUFe117iOg" style="text-align: justify; vertical-align: top" title="Redemption at the option of the bond holders (Put option)"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The bonds are early redeemable by the Company in full or partial on October&#160;2, 2025, which is three months from the issuance date, or at any time thereafter.&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;In the event of early redemption, the principal amount shall be paid.&lt;/p&gt; &lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--RedemptionAtOptionOfBondHoldersPutOption_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N21stDetachableWarrantsBondsMember_znjfpCtu8Rma" style="text-align: justify; vertical-align: top" title="Redemption at the option of the bond holders (Put option)"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The bonds are early redeemable by the Company in full or partial on November&#160;18, 2026, which is one year from the issuance date, or at any time thereafter.&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;In the event of early redemption, the principal amount shall be paid.&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Early redemption rights accounting treatment&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--EarlyRedemptionRightsAccountingTreatment_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N20thDetachableWarrantsBondsMember_zOAbmkQPl8i" style="text-align: justify; vertical-align: top" title="Early redemption rights accounting treatment"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The early redemption right is separated from the host debt instrument as an embedded derivative and accounted for separately.&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The separated embedded derivative is measured at fair value through profit or loss (FVTPL).&lt;/p&gt; &lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--EarlyRedemptionRightsAccountingTreatment_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N21stDetachableWarrantsBondsMember_ztDofVPUyyc3" style="text-align: justify; vertical-align: top" title="Early redemption rights accounting treatment"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The early redemption right is separated from the host debt instrument as an embedded derivative and accounted for separately.&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The separated embedded derivative is measured at fair value through profit or loss (FVTPL).&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; margin-left: 0.125in; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;Classification of Warrants&lt;/p&gt; &lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--ClassificationOfWarrants_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N20thDetachableWarrantsBondsMember_zUXDU4GzO1ha" style="text-align: justify; vertical-align: top" title="Classification of Warrants"&gt;The warrants were classified as equity instruments at the date of issuance, as it satisfied the fixed-for-fixed condition.&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--ClassificationOfWarrants_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N21stDetachableWarrantsBondsMember_z99NkiWGIgFi" style="text-align: justify; vertical-align: top" title="Classification of Warrants"&gt;The warrants were classified as equity instruments at the date of issuance, as it satisfied the fixed-for-fixed condition.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AE_zA45VRUXx03" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;















&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

</cik0002058261:BondWithWarrantsAndDerivativeInstrumentsTextBlock>
    <cik0002058261:DetailsOfPrincipalOfBondsIssuedAndOutstandingTableTextBlock
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact003079">&lt;table cellpadding="0" cellspacing="0" id="xdx_89A_ecustom--DetailsOfPrincipalOfBondsIssuedAndOutstandingTableTextBlock_pn3n3_zxkgoyGEwp3d" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Bond with warrants and derivative instruments (Details)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span id="xdx_8BD_zacs6Ct3hN5b" style="display: none"&gt;Details of principal of bonds issued and outstanding&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2024&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;b&gt;Bond with warrants&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;12&lt;sup&gt;th&lt;/sup&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--BondsIssued_iI_pn3n3_c20251231__ifrs-full--BorrowingsByNameAxis__custom--N12thBondWithWarrantsMember_zyY8xc3DJef3" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3081"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--BondsIssued_iI_pn3n3_c20241231__ifrs-full--BorrowingsByNameAxis__custom--N12thBondWithWarrantsMember_zpZgbbnADl0a" title="Total"&gt;800,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;13&lt;sup&gt;th&lt;/sup&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--BondsIssued_iI_pn3n3_c20251231__ifrs-full--BorrowingsByNameAxis__custom--N13thBondWithWarrantsMember_zFrYJ6vDTo6c" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3085"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--BondsIssued_iI_pn3n3_c20241231__ifrs-full--BorrowingsByNameAxis__custom--N13thBondWithWarrantsMember_zENMImIMoNZf" title="Total"&gt;495,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;14&lt;sup&gt;th&lt;/sup&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--BondsIssued_iI_pn3n3_c20251231__ifrs-full--BorrowingsByNameAxis__custom--N14thBondWithWarrantsMember_zWxDRYcHrIC3" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3089"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--BondsIssued_iI_pn3n3_c20241231__ifrs-full--BorrowingsByNameAxis__custom--N14thBondWithWarrantsMember_zJedUi79vCU1" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3091"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;15&lt;sup&gt;th&lt;/sup&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--BondsIssued_iI_pn3n3_c20251231__ifrs-full--BorrowingsByNameAxis__custom--N15thBondWithWarrantsMember_zsvLNqzTz74f" title="Total"&gt;1,365,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--BondsIssued_iI_pn3n3_c20241231__ifrs-full--BorrowingsByNameAxis__custom--N15thBondWithWarrantsMember_zRxv3eqzD8N3" title="Total"&gt;1,380,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;18&lt;sup&gt;th&lt;/sup&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--BondsIssued_iI_pn3n3_c20251231__ifrs-full--BorrowingsByNameAxis__custom--N18thBondWithWarrantsMember_zrsrVlAoPokf" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3097"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--BondsIssued_iI_pn3n3_c20241231__ifrs-full--BorrowingsByNameAxis__custom--N18thBondWithWarrantsMember_zDg80RhoRGNk" title="Total"&gt;2,500,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;20&lt;sup&gt;th&lt;/sup&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--BondsIssued_iI_pn3n3_c20251231__ifrs-full--BorrowingsByNameAxis__custom--N20thBondWithWarrantsMember_zgiWBnAmPl8h" title="Total"&gt;600,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--BondsIssued_iI_pn3n3_c20241231__ifrs-full--BorrowingsByNameAxis__custom--N20thBondWithWarrantsMember_z2Bex6M4B8Wk" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3103"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;21&lt;sup&gt;st&lt;/sup&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--BondsIssued_iI_pn3n3_c20251231__ifrs-full--BorrowingsByNameAxis__custom--N21stBondWithWarrantsMember_zPNj6xGfB2Ij" title="Total"&gt;3,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--BondsIssued_iI_pn3n3_c20241231__ifrs-full--BorrowingsByNameAxis__custom--N21stBondWithWarrantsMember_znp7RE2iXBtc" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3107"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; vertical-align: top; padding-left: 0.25in; padding-bottom: 1.25pt"&gt;Total&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--BondsIssued_iI_pn3n3_c20251231_zIbDCx7WHXMk" title="Total"&gt;4,965,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--BondsIssued_iI_pn3n3_c20241231_zTASmFxlSMM3" title="Total"&gt;5,175,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:DetailsOfPrincipalOfBondsIssuedAndOutstandingTableTextBlock>
    <ifrs-full:BondsIssued
      contextRef="AsOf2024-12-31_custom_N12thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003083"
      unitRef="KRW">800000000</ifrs-full:BondsIssued>
    <ifrs-full:BondsIssued
      contextRef="AsOf2024-12-31_custom_N13thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003087"
      unitRef="KRW">495000000</ifrs-full:BondsIssued>
    <ifrs-full:BondsIssued
      contextRef="AsOf2025-12-31_custom_N15thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003093"
      unitRef="KRW">1365000000</ifrs-full:BondsIssued>
    <ifrs-full:BondsIssued
      contextRef="AsOf2024-12-31_custom_N15thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003095"
      unitRef="KRW">1380000000</ifrs-full:BondsIssued>
    <ifrs-full:BondsIssued
      contextRef="AsOf2024-12-31_custom_N18thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003099"
      unitRef="KRW">2500000000</ifrs-full:BondsIssued>
    <ifrs-full:BondsIssued
      contextRef="AsOf2025-12-31_custom_N20thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003101"
      unitRef="KRW">600000000</ifrs-full:BondsIssued>
    <ifrs-full:BondsIssued
      contextRef="AsOf2025-12-31_custom_N21stBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003105"
      unitRef="KRW">3000000000</ifrs-full:BondsIssued>
    <ifrs-full:BondsIssued
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003109"
      unitRef="KRW">4965000000</ifrs-full:BondsIssued>
    <ifrs-full:BondsIssued
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003111"
      unitRef="KRW">5175000000</ifrs-full:BondsIssued>
    <cik0002058261:DetailsOfChangesInPrincipalOfBondsTableTextBlock
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact003120">&lt;table cellpadding="0" cellspacing="0" id="xdx_89F_ecustom--DetailsOfChangesInPrincipalOfBondsTableTextBlock_pn3n3_zHbHtVXUQjL3" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Bond with warrants and derivative instruments (Details 1)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left; vertical-align: top"&gt;&lt;span id="xdx_8BE_zcb0YHkckRr6" style="display: none"&gt;Details of changes in principal of bonds&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_495_20250401__20250630__ifrs-full--BorrowingsByNameAxis__custom--N12thBondWithWarrantsMember_zgfBdS3p0L6k" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49C_20250401__20250630__ifrs-full--BorrowingsByNameAxis__custom--N13thBondWithWarrantsMember_zAmJVrAVnVfd" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49E_20250401__20250630__ifrs-full--BorrowingsByNameAxis__custom--N15thBondWithWarrantsMember_zCHXgpgQL3h4" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_497_20250401__20250630__ifrs-full--BorrowingsByNameAxis__custom--N18thBondWithWarrantsMember_z6tpyX01fxye" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_496_20250401__20250630__ifrs-full--BorrowingsByNameAxis__custom--N19thBondWithWarrantsMember_zuyJxqVYGcNf" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_496_20250401__20250630__ifrs-full--BorrowingsByNameAxis__custom--N20thBondWithWarrantsMember_zOG42Zq83eGh" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_493_20250401__20250630__ifrs-full--BorrowingsByNameAxis__custom--N21stBondWithWarrantsMember_zNTNazhOu2G5" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49F_20250401__20250630_z9QSRMDYMus5" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;th style="text-align: left; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;12&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;13&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;15&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;18&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;19&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;20&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;21&lt;sup&gt;st&lt;/sup&gt;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;th style="text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="30" style="text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr id="xdx_400_eifrs-full--BondsIssued_iS_pn3n3_zIsE1mbYxQ0b" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; vertical-align: top"&gt;&lt;b&gt;Balance as of January&#160;1&lt;/b&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 5%"&gt;800,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 5%"&gt;495,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 5%"&gt;1,380,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 5%"&gt;2,500,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 5%"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3126"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 5%"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3127"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 5%"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3128"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 5%"&gt;5,175,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_402_eifrs-full--ShareIssueRelatedCost_i_pn3n" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left; vertical-align: top"&gt;Issuance&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3131"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3132"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3133"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3134"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;2,000,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;4,200,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;3,000,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;9,200,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--EarlyRedemption_i_pn3n" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left; vertical-align: top"&gt;Early redemption&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3140"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3141"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3142"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(2,500,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(2,000,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(3,600,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3146"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(8,100,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--RedemptionAtMaturity_i_pn3n" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left; vertical-align: top"&gt;Redemption at maturity&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3149"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(5,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3151"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3152"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3153"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3154"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3155"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(5,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--SettledThroughDebttoequitySwap_i_pn3n" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;Settled through
    debt-to-equity swap &lt;span id="xdx_F48_zCtI8nRmkOT6"&gt;(*)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(800,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(490,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(15,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3161"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3162"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3163"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3164"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(1,305,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; padding-bottom: 0.5pt"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_409_eifrs-full--BondsIssued_iE_pn3n3_zW0cvxXW5Kc" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; vertical-align: top; padding-bottom: 1.25pt"&gt;&lt;b&gt;Balance at 31 December&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3167"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3168"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,365,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3170"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3171"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;600,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;3,000,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;4,965,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;div style="width: 25%; margin-left: 0; margin-right: auto"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td id="xdx_F07_zE5qrYoVhEhg" style="width: 0.25in; text-align: left"&gt;(*)&lt;/td&gt;
    &lt;td id="xdx_F1F_zZSXn1tPPKo7" style="text-align: justify"&gt;During the period, the detachable warrants were exercised through debt-to-equity swap (non-cash settlement). The amounts presented under &#x201c;Settled through debt-to-equity swap&#x201d; relate solely to warrants exercised through the non-cash settlement method, whereby bond principal was settled through conversion. Accordingly, no cash inflows arose from the transactions reflected in this table during the period. As a result of the exercise of warrants through non-cash settlement during the period, 320,000 ordinary shares were issued in connection with the 12th series, and 196,000 ordinary shares were issued in connection with the 13th series, and 5,000 ordinary shares were issued in connection with the 15th series.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Details of the changes in principal of bonds for the year ended December&#160;31, 2024 are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_498_20240401__20240630__ifrs-full--BorrowingsByNameAxis__custom--N12thBondWithWarrantsMember_zuOc2kBQnGZd" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_497_20240401__20240630__ifrs-full--BorrowingsByNameAxis__custom--N13thBondWithWarrantsMember_zh6HruupIVUi" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_499_20240401__20240630__ifrs-full--BorrowingsByNameAxis__custom--N14thBondWithWarrantsMember_z1PMYHa7eug2" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49D_20240401__20240630__ifrs-full--BorrowingsByNameAxis__custom--N15thBondWithWarrantsMember_zFaEQrSn1FR7" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_496_20240401__20240630__ifrs-full--BorrowingsByNameAxis__custom--N17thBondWithWarrantsMember_zkzRqrbJoo5f" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49D_20240401__20240630__ifrs-full--BorrowingsByNameAxis__custom--N18thBondWithWarrantsMember_zV4tysEuN35g" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_495_20240401__20240630_zlvWR9dTpysg" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;th style="text-align: left; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;12&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;13&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;14&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;15&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;17&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;18&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;th style="text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="26" style="text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr id="xdx_407_eifrs-full--BondsIssued_iS_pn3n3_z5FEqGhkaeL5" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; vertical-align: top"&gt;&lt;b&gt;Balance as of January&#160;1&lt;/b&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 5%"&gt;800,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 5%"&gt;3,855,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 5%"&gt;750,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 5%"&gt;2,180,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 5%"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3181"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 5%"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3182"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 5%"&gt;7,585,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_403_eifrs-full--ShareIssueRelatedCost_z4z1lz3Vv5Ce" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left; vertical-align: top"&gt;Issuance&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3185"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3186"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3187"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3188"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;2,000,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;2,500,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;4,500,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--EarlyRedemption_zjfFYqVvjPha" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left; vertical-align: top"&gt;Early redemption&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3193"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3194"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(750,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3196"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(2,000,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3198"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(2,750,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--SettledThroughDebttoequitySwap_zxXxw3xNrZz8" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;Settled through
    debt-to-equity swap &lt;span id="xdx_F49_z8aJcOvulmSg"&gt;(*)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3201"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(3,360,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3203"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(800,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3205"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3206"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(4,160,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; padding-bottom: 0.5pt"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_400_eifrs-full--BondsIssued_iE_pn3n3_zu4toycP8r0h" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; vertical-align: top; padding-bottom: 1.25pt"&gt;&lt;b&gt;Balance at 31 December&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;800,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;495,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3211"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,380,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3213"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;2,500,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;5,175,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;div style="width: 25%; margin-left: 0; margin-right: auto"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td id="xdx_F0E_zRFKkaK0HoOh" style="width: 0.25in; text-align: left"&gt;(*)&lt;/td&gt;
    &lt;td id="xdx_F13_zfdAx1eIjCZg" style="text-align: justify"&gt;During the period, the detachable warrants were exercised through two methods: cash settlement and debt-to-equity swap (non-cash settlement). The amounts presented under &#x201c;Settled through debt-to-equity swap&#x201d; relate solely to warrants exercised through the non-cash settlement method, whereby bond principal was settled through conversion. Accordingly, no cash inflows arose from the transactions reflected in this table during the period. As a result of the exercise of warrants through non-cash settlement during the period, 1,344,000 ordinary shares were issued in connection with the 13th series, and 266,665 ordinary shares were issued in connection with the 15th series. In addition, as a result of the exercise of warrants through cash settlement during the period, 14,000 ordinary shares were issued in connection with the 13th series and 1,000,000 ordinary shares in connection with the 16th series, for which the related bonds had been fully settled prior to the warrant exercise. The Company recognized increases in share capital equal to the number of shares exercised multiplied by par value, and in share premium equal to the number of shares exercised multiplied by the excess of the exercise price over par value.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:DetailsOfChangesInPrincipalOfBondsTableTextBlock>
    <ifrs-full:BondsIssued
      contextRef="AsOf2025-03-31_custom_N12thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003122"
      unitRef="KRW">800000000</ifrs-full:BondsIssued>
    <ifrs-full:BondsIssued
      contextRef="AsOf2025-03-31_custom_N13thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003123"
      unitRef="KRW">495000000</ifrs-full:BondsIssued>
    <ifrs-full:BondsIssued
      contextRef="AsOf2025-03-31_custom_N15thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003124"
      unitRef="KRW">1380000000</ifrs-full:BondsIssued>
    <ifrs-full:BondsIssued
      contextRef="AsOf2025-03-31_custom_N18thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003125"
      unitRef="KRW">2500000000</ifrs-full:BondsIssued>
    <ifrs-full:BondsIssued
      contextRef="AsOf2025-03-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003129"
      unitRef="KRW">5175000000</ifrs-full:BondsIssued>
    <ifrs-full:ShareIssueRelatedCost
      contextRef="From2025-04-012025-06-30_custom_N19thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003135"
      unitRef="KRW">2000000000</ifrs-full:ShareIssueRelatedCost>
    <ifrs-full:ShareIssueRelatedCost
      contextRef="From2025-04-012025-06-30_custom_N20thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003136"
      unitRef="KRW">4200000000</ifrs-full:ShareIssueRelatedCost>
    <ifrs-full:ShareIssueRelatedCost
      contextRef="From2025-04-012025-06-30_custom_N21stBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003137"
      unitRef="KRW">3000000000</ifrs-full:ShareIssueRelatedCost>
    <ifrs-full:ShareIssueRelatedCost
      contextRef="From2025-04-012025-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003138"
      unitRef="KRW">9200000000</ifrs-full:ShareIssueRelatedCost>
    <cik0002058261:EarlyRedemption
      contextRef="From2025-04-012025-06-30_custom_N18thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003143"
      unitRef="KRW">-2500000000</cik0002058261:EarlyRedemption>
    <cik0002058261:EarlyRedemption
      contextRef="From2025-04-012025-06-30_custom_N19thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003144"
      unitRef="KRW">-2000000000</cik0002058261:EarlyRedemption>
    <cik0002058261:EarlyRedemption
      contextRef="From2025-04-012025-06-30_custom_N20thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003145"
      unitRef="KRW">-3600000000</cik0002058261:EarlyRedemption>
    <cik0002058261:EarlyRedemption
      contextRef="From2025-04-012025-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003147"
      unitRef="KRW">-8100000000</cik0002058261:EarlyRedemption>
    <cik0002058261:RedemptionAtMaturity
      contextRef="From2025-04-012025-06-30_custom_N13thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003150"
      unitRef="KRW">-5000000</cik0002058261:RedemptionAtMaturity>
    <cik0002058261:RedemptionAtMaturity
      contextRef="From2025-04-012025-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003156"
      unitRef="KRW">-5000000</cik0002058261:RedemptionAtMaturity>
    <cik0002058261:SettledThroughDebttoequitySwap
      contextRef="From2025-04-012025-06-30_custom_N12thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003158"
      unitRef="KRW">-800000000</cik0002058261:SettledThroughDebttoequitySwap>
    <cik0002058261:SettledThroughDebttoequitySwap
      contextRef="From2025-04-012025-06-30_custom_N13thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003159"
      unitRef="KRW">-490000000</cik0002058261:SettledThroughDebttoequitySwap>
    <cik0002058261:SettledThroughDebttoequitySwap
      contextRef="From2025-04-012025-06-30_custom_N15thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003160"
      unitRef="KRW">-15000000</cik0002058261:SettledThroughDebttoequitySwap>
    <cik0002058261:SettledThroughDebttoequitySwap
      contextRef="From2025-04-012025-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003165"
      unitRef="KRW">-1305000000</cik0002058261:SettledThroughDebttoequitySwap>
    <ifrs-full:BondsIssued
      contextRef="AsOf2025-06-30_custom_N15thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003169"
      unitRef="KRW">1365000000</ifrs-full:BondsIssued>
    <ifrs-full:BondsIssued
      contextRef="AsOf2025-06-30_custom_N20thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003172"
      unitRef="KRW">600000000</ifrs-full:BondsIssued>
    <ifrs-full:BondsIssued
      contextRef="AsOf2025-06-30_custom_N21stBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003173"
      unitRef="KRW">3000000000</ifrs-full:BondsIssued>
    <ifrs-full:BondsIssued
      contextRef="AsOf2025-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003174"
      unitRef="KRW">4965000000</ifrs-full:BondsIssued>
    <ifrs-full:BondsIssued
      contextRef="AsOf2024-03-31_custom_N12thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003177"
      unitRef="KRW">800000000</ifrs-full:BondsIssued>
    <ifrs-full:BondsIssued
      contextRef="AsOf2024-03-31_custom_N13thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003178"
      unitRef="KRW">3855000000</ifrs-full:BondsIssued>
    <ifrs-full:BondsIssued
      contextRef="AsOf2024-03-31_custom_N14thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003179"
      unitRef="KRW">750000000</ifrs-full:BondsIssued>
    <ifrs-full:BondsIssued
      contextRef="AsOf2024-03-31_custom_N15thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003180"
      unitRef="KRW">2180000000</ifrs-full:BondsIssued>
    <ifrs-full:BondsIssued
      contextRef="AsOf2024-03-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003183"
      unitRef="KRW">7585000000</ifrs-full:BondsIssued>
    <ifrs-full:ShareIssueRelatedCost
      contextRef="From2024-04-012024-06-30_custom_N17thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003189"
      unitRef="KRW">2000000000</ifrs-full:ShareIssueRelatedCost>
    <ifrs-full:ShareIssueRelatedCost
      contextRef="From2024-04-012024-06-30_custom_N18thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003190"
      unitRef="KRW">2500000000</ifrs-full:ShareIssueRelatedCost>
    <ifrs-full:ShareIssueRelatedCost
      contextRef="From2024-04-012024-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003191"
      unitRef="KRW">4500000000</ifrs-full:ShareIssueRelatedCost>
    <cik0002058261:EarlyRedemption
      contextRef="From2024-04-012024-06-30_custom_N14thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003195"
      unitRef="KRW">-750000000</cik0002058261:EarlyRedemption>
    <cik0002058261:EarlyRedemption
      contextRef="From2024-04-012024-06-30_custom_N17thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003197"
      unitRef="KRW">-2000000000</cik0002058261:EarlyRedemption>
    <cik0002058261:EarlyRedemption
      contextRef="From2024-04-012024-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003199"
      unitRef="KRW">-2750000000</cik0002058261:EarlyRedemption>
    <cik0002058261:SettledThroughDebttoequitySwap
      contextRef="From2024-04-012024-06-30_custom_N13thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003202"
      unitRef="KRW">-3360000000</cik0002058261:SettledThroughDebttoequitySwap>
    <cik0002058261:SettledThroughDebttoequitySwap
      contextRef="From2024-04-012024-06-30_custom_N15thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003204"
      unitRef="KRW">-800000000</cik0002058261:SettledThroughDebttoequitySwap>
    <cik0002058261:SettledThroughDebttoequitySwap
      contextRef="From2024-04-012024-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003207"
      unitRef="KRW">-4160000000</cik0002058261:SettledThroughDebttoequitySwap>
    <ifrs-full:BondsIssued
      contextRef="AsOf2024-06-30_custom_N12thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003209"
      unitRef="KRW">800000000</ifrs-full:BondsIssued>
    <ifrs-full:BondsIssued
      contextRef="AsOf2024-06-30_custom_N13thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003210"
      unitRef="KRW">495000000</ifrs-full:BondsIssued>
    <ifrs-full:BondsIssued
      contextRef="AsOf2024-06-30_custom_N15thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003212"
      unitRef="KRW">1380000000</ifrs-full:BondsIssued>
    <ifrs-full:BondsIssued
      contextRef="AsOf2024-06-30_custom_N18thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003214"
      unitRef="KRW">2500000000</ifrs-full:BondsIssued>
    <ifrs-full:BondsIssued
      contextRef="AsOf2024-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003215"
      unitRef="KRW">5175000000</ifrs-full:BondsIssued>
    <cik0002058261:ChangesInFairValueOfDerivativeLiabilitiesTableTextBlock
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact003225">&lt;table cellpadding="0" cellspacing="0" id="xdx_890_ecustom--ChangesInFairValueOfDerivativeLiabilitiesTableTextBlock_pn3n3_zWkpLg9IGCbg" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Bond with warrants and derivative instruments (Details 2)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left; vertical-align: top"&gt;&lt;span id="xdx_8B4_zjyAzPthIMCd" style="display: none"&gt;Changes in fair value of derivative liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_494_20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N12thBondWithWarrantsMember_zeNaJJfiT3Z4" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49B_20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N13thBondWithWarrantsMember_zaZ9ojvJpCI3" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_490_20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N15thBondWithWarrantsMember_zTVwg32KH8la" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49C_20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N18thBondWithWarrantsMember_zKBKqIdWsRLe" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_494_20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N19thBondWithWarrantsMember_zV7ppuSxr2x5" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_497_20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N20thBondWithWarrantsMember_zuioPpKZIbBf" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49D_20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N21stBondWithWarrantsMember_zsjeNvZ60Ie8" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49D_20250101__20251231_ze2VVOBmbAla" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;th style="text-align: left; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;12&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;13&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;15&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;18&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;19&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;20&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;21&lt;sup&gt;st&lt;/sup&gt;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;th style="text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="30" style="text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr id="xdx_407_eifrs-full--DerivativeFinancialLiabilities_iS_pn3n3_zWe9vmHOVQE8" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; vertical-align: top"&gt;&lt;b&gt;Balance at January&#160;1&lt;/b&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 5%"&gt;66,240&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 5%"&gt;53,263&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 5%"&gt;337,179&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 5%"&gt;1,017,141&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 5%"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3231"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 5%"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3232"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 5%"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3233"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 5%"&gt;1,473,823&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--Issuance_ztxABeGeU0Re" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left; vertical-align: top"&gt;Issuance&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3236"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3237"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3238"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3239"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;824,174&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;1,719,885&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;916,475&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;3,460,534&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--Redemption_zhbufSrQKcO3" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left; vertical-align: top"&gt;Redemption&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3245"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3246"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3247"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(1,011,875&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(775,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(1,408,200&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3251"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(3,195,075&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--LossesGainsOnValuationOfDerivatives_ztcbFRFfi6Y5" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left; vertical-align: top"&gt;Losses (gains) on valuation of derivatives&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(57,920&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(47,163&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(217,414&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(5,266&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(49,174&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(84,485&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;6,281&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(455,141&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--DerecognizedUponBondSettlement_zuJGail3AmFh" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;Derecognized upon bond settlement&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(8,320&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(6,100&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(1,920&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3266"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3267"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3268"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3269"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(16,340&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; padding-bottom: 0.5pt"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_407_eifrs-full--DerivativeFinancialLiabilities_iE_pn3n3_z0OMla9e632h" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; vertical-align: top; padding-bottom: 1.25pt"&gt;&lt;b&gt;Balance at December&#160;31&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3272"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3273"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;117,845&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3275"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3276"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;227,200&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;922,756&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,267,801&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Changes in the fair value of derivative liabilities embedded in each series of bonds with warrants that were recognized in profit or loss for the year ended December&#160;31, 2024 are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49F_20240101__20241231__ifrs-full--BorrowingsByNameAxis__custom--N12thBondWithWarrantsMember_z1RaMidDJcRk" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_497_20240101__20241231__ifrs-full--BorrowingsByNameAxis__custom--N13thBondWithWarrantsMember_zwEEI2urY3Hl" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_493_20240101__20241231__ifrs-full--BorrowingsByNameAxis__custom--N14thBondWithWarrantsMember_z0iPy5nQjFla" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49C_20240101__20241231__ifrs-full--BorrowingsByNameAxis__custom--N15thBondWithWarrantsMember_zcHVEVZVss4b" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_498_20240101__20241231__ifrs-full--BorrowingsByNameAxis__custom--N17thBondWithWarrantsMember_zM8Ye9RLfO6i" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_496_20240101__20241231__ifrs-full--BorrowingsByNameAxis__custom--N18thBondWithWarrantsMember_zEtJgzi0Xjo3" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_495_20240101__20241231_zcSVr54X3EI4" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;12&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;13&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;14&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;15&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;17&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;18&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="26" style="text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr id="xdx_403_eifrs-full--DerivativeFinancialLiabilities_iS_pn3n3_zv1tkTNcWuah" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;b&gt;Balance at January&#160;1&lt;/b&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 5%"&gt;208,960&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 5%"&gt;963,391&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 5%"&gt;281,400&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 5%"&gt;698,795&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 5%"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3285"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 5%"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3286"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 5%"&gt;2,152,546&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; width: 1%"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--Issuance_zdtPUYWF7Fm3" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Issuance&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3289"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3290"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3291"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3292"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;802,198&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;1,021,266&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;1,823,464&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--Redemption_zih3OT5bd3ok" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Redemption&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3297"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3298"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(195,900&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3300"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(808,000&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3302"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(1,003,900&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--LossesGainsOnValuationOfDerivatives_zgbnITk4nOZ6" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Losses (gains) on valuation of derivatives&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(142,720&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(322,128&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(85,500&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(119,164&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;5,802&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(4,125&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(667,835&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--DerecognizedUponBondSettlement_zyFTPAX4SJ1c" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Derecognized upon bond settlement&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3313"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(588,000&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3315"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(242,452&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3317"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3318"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(830,452&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--DerivativeFinancialLiabilities_iE_pn3n3_z5WJOCpX7ktg" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.25pt"&gt;&lt;b&gt;Balance at December&#160;31&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;66,240&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;53,263&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3323"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;337,179&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3325"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,017,141&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,473,823&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:ChangesInFairValueOfDerivativeLiabilitiesTableTextBlock>
    <ifrs-full:DerivativeFinancialLiabilities
      contextRef="AsOf2024-12-31_custom_N12thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003227"
      unitRef="KRW">66240000</ifrs-full:DerivativeFinancialLiabilities>
    <ifrs-full:DerivativeFinancialLiabilities
      contextRef="AsOf2024-12-31_custom_N13thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003228"
      unitRef="KRW">53263000</ifrs-full:DerivativeFinancialLiabilities>
    <ifrs-full:DerivativeFinancialLiabilities
      contextRef="AsOf2024-12-31_custom_N15thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003229"
      unitRef="KRW">337179000</ifrs-full:DerivativeFinancialLiabilities>
    <ifrs-full:DerivativeFinancialLiabilities
      contextRef="AsOf2024-12-31_custom_N18thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003230"
      unitRef="KRW">1017141000</ifrs-full:DerivativeFinancialLiabilities>
    <ifrs-full:DerivativeFinancialLiabilities
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003234"
      unitRef="KRW">1473823000</ifrs-full:DerivativeFinancialLiabilities>
    <cik0002058261:Issuance
      contextRef="From2025-01-012025-12-31_custom_N19thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003240"
      unitRef="KRW">824174000</cik0002058261:Issuance>
    <cik0002058261:Issuance
      contextRef="From2025-01-012025-12-31_custom_N20thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003241"
      unitRef="KRW">1719885000</cik0002058261:Issuance>
    <cik0002058261:Issuance
      contextRef="From2025-01-012025-12-31_custom_N21stBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003242"
      unitRef="KRW">916475000</cik0002058261:Issuance>
    <cik0002058261:Issuance
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003243"
      unitRef="KRW">3460534000</cik0002058261:Issuance>
    <cik0002058261:Redemption
      contextRef="From2025-01-012025-12-31_custom_N18thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003248"
      unitRef="KRW">-1011875000</cik0002058261:Redemption>
    <cik0002058261:Redemption
      contextRef="From2025-01-012025-12-31_custom_N19thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003249"
      unitRef="KRW">-775000000</cik0002058261:Redemption>
    <cik0002058261:Redemption
      contextRef="From2025-01-012025-12-31_custom_N20thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003250"
      unitRef="KRW">-1408200000</cik0002058261:Redemption>
    <cik0002058261:Redemption
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003252"
      unitRef="KRW">-3195075000</cik0002058261:Redemption>
    <cik0002058261:LossesGainsOnValuationOfDerivatives
      contextRef="From2025-01-012025-12-31_custom_N12thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003254"
      unitRef="KRW">-57920000</cik0002058261:LossesGainsOnValuationOfDerivatives>
    <cik0002058261:LossesGainsOnValuationOfDerivatives
      contextRef="From2025-01-012025-12-31_custom_N13thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003255"
      unitRef="KRW">-47163000</cik0002058261:LossesGainsOnValuationOfDerivatives>
    <cik0002058261:LossesGainsOnValuationOfDerivatives
      contextRef="From2025-01-012025-12-31_custom_N15thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003256"
      unitRef="KRW">-217414000</cik0002058261:LossesGainsOnValuationOfDerivatives>
    <cik0002058261:LossesGainsOnValuationOfDerivatives
      contextRef="From2025-01-012025-12-31_custom_N18thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003257"
      unitRef="KRW">-5266000</cik0002058261:LossesGainsOnValuationOfDerivatives>
    <cik0002058261:LossesGainsOnValuationOfDerivatives
      contextRef="From2025-01-012025-12-31_custom_N19thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003258"
      unitRef="KRW">-49174000</cik0002058261:LossesGainsOnValuationOfDerivatives>
    <cik0002058261:LossesGainsOnValuationOfDerivatives
      contextRef="From2025-01-012025-12-31_custom_N20thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003259"
      unitRef="KRW">-84485000</cik0002058261:LossesGainsOnValuationOfDerivatives>
    <cik0002058261:LossesGainsOnValuationOfDerivatives
      contextRef="From2025-01-012025-12-31_custom_N21stBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003260"
      unitRef="KRW">6281000</cik0002058261:LossesGainsOnValuationOfDerivatives>
    <cik0002058261:LossesGainsOnValuationOfDerivatives
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003261"
      unitRef="KRW">-455141000</cik0002058261:LossesGainsOnValuationOfDerivatives>
    <cik0002058261:DerecognizedUponBondSettlement
      contextRef="From2025-01-012025-12-31_custom_N12thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003263"
      unitRef="KRW">-8320000</cik0002058261:DerecognizedUponBondSettlement>
    <cik0002058261:DerecognizedUponBondSettlement
      contextRef="From2025-01-012025-12-31_custom_N13thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003264"
      unitRef="KRW">-6100000</cik0002058261:DerecognizedUponBondSettlement>
    <cik0002058261:DerecognizedUponBondSettlement
      contextRef="From2025-01-012025-12-31_custom_N15thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003265"
      unitRef="KRW">-1920000</cik0002058261:DerecognizedUponBondSettlement>
    <cik0002058261:DerecognizedUponBondSettlement
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003270"
      unitRef="KRW">-16340000</cik0002058261:DerecognizedUponBondSettlement>
    <ifrs-full:DerivativeFinancialLiabilities
      contextRef="AsOf2025-12-31_custom_N15thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003274"
      unitRef="KRW">117845000</ifrs-full:DerivativeFinancialLiabilities>
    <ifrs-full:DerivativeFinancialLiabilities
      contextRef="AsOf2025-12-31_custom_N20thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003277"
      unitRef="KRW">227200000</ifrs-full:DerivativeFinancialLiabilities>
    <ifrs-full:DerivativeFinancialLiabilities
      contextRef="AsOf2025-12-31_custom_N21stBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003278"
      unitRef="KRW">922756000</ifrs-full:DerivativeFinancialLiabilities>
    <ifrs-full:DerivativeFinancialLiabilities
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003279"
      unitRef="KRW">1267801000</ifrs-full:DerivativeFinancialLiabilities>
    <ifrs-full:DerivativeFinancialLiabilities
      contextRef="AsOf2023-12-31_custom_N12thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003281"
      unitRef="KRW">208960000</ifrs-full:DerivativeFinancialLiabilities>
    <ifrs-full:DerivativeFinancialLiabilities
      contextRef="AsOf2023-12-31_custom_N13thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003282"
      unitRef="KRW">963391000</ifrs-full:DerivativeFinancialLiabilities>
    <ifrs-full:DerivativeFinancialLiabilities
      contextRef="AsOf2023-12-31_custom_N14thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003283"
      unitRef="KRW">281400000</ifrs-full:DerivativeFinancialLiabilities>
    <ifrs-full:DerivativeFinancialLiabilities
      contextRef="AsOf2023-12-31_custom_N15thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003284"
      unitRef="KRW">698795000</ifrs-full:DerivativeFinancialLiabilities>
    <ifrs-full:DerivativeFinancialLiabilities
      contextRef="AsOf2023-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003287"
      unitRef="KRW">2152546000</ifrs-full:DerivativeFinancialLiabilities>
    <cik0002058261:Issuance
      contextRef="From2024-01-012024-12-31_custom_N17thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003293"
      unitRef="KRW">802198000</cik0002058261:Issuance>
    <cik0002058261:Issuance
      contextRef="From2024-01-012024-12-31_custom_N18thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003294"
      unitRef="KRW">1021266000</cik0002058261:Issuance>
    <cik0002058261:Issuance
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003295"
      unitRef="KRW">1823464000</cik0002058261:Issuance>
    <cik0002058261:Redemption
      contextRef="From2024-01-012024-12-31_custom_N14thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003299"
      unitRef="KRW">-195900000</cik0002058261:Redemption>
    <cik0002058261:Redemption
      contextRef="From2024-01-012024-12-31_custom_N17thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003301"
      unitRef="KRW">-808000000</cik0002058261:Redemption>
    <cik0002058261:Redemption
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003303"
      unitRef="KRW">-1003900000</cik0002058261:Redemption>
    <cik0002058261:LossesGainsOnValuationOfDerivatives
      contextRef="From2024-01-012024-12-31_custom_N12thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003305"
      unitRef="KRW">-142720000</cik0002058261:LossesGainsOnValuationOfDerivatives>
    <cik0002058261:LossesGainsOnValuationOfDerivatives
      contextRef="From2024-01-012024-12-31_custom_N13thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003306"
      unitRef="KRW">-322128000</cik0002058261:LossesGainsOnValuationOfDerivatives>
    <cik0002058261:LossesGainsOnValuationOfDerivatives
      contextRef="From2024-01-012024-12-31_custom_N14thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003307"
      unitRef="KRW">-85500000</cik0002058261:LossesGainsOnValuationOfDerivatives>
    <cik0002058261:LossesGainsOnValuationOfDerivatives
      contextRef="From2024-01-012024-12-31_custom_N15thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003308"
      unitRef="KRW">-119164000</cik0002058261:LossesGainsOnValuationOfDerivatives>
    <cik0002058261:LossesGainsOnValuationOfDerivatives
      contextRef="From2024-01-012024-12-31_custom_N17thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003309"
      unitRef="KRW">5802000</cik0002058261:LossesGainsOnValuationOfDerivatives>
    <cik0002058261:LossesGainsOnValuationOfDerivatives
      contextRef="From2024-01-012024-12-31_custom_N18thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003310"
      unitRef="KRW">-4125000</cik0002058261:LossesGainsOnValuationOfDerivatives>
    <cik0002058261:LossesGainsOnValuationOfDerivatives
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003311"
      unitRef="KRW">-667835000</cik0002058261:LossesGainsOnValuationOfDerivatives>
    <cik0002058261:DerecognizedUponBondSettlement
      contextRef="From2024-01-012024-12-31_custom_N13thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003314"
      unitRef="KRW">-588000000</cik0002058261:DerecognizedUponBondSettlement>
    <cik0002058261:DerecognizedUponBondSettlement
      contextRef="From2024-01-012024-12-31_custom_N15thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003316"
      unitRef="KRW">-242452000</cik0002058261:DerecognizedUponBondSettlement>
    <cik0002058261:DerecognizedUponBondSettlement
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003319"
      unitRef="KRW">-830452000</cik0002058261:DerecognizedUponBondSettlement>
    <ifrs-full:DerivativeFinancialLiabilities
      contextRef="AsOf2024-12-31_custom_N12thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003321"
      unitRef="KRW">66240000</ifrs-full:DerivativeFinancialLiabilities>
    <ifrs-full:DerivativeFinancialLiabilities
      contextRef="AsOf2024-12-31_custom_N13thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003322"
      unitRef="KRW">53263000</ifrs-full:DerivativeFinancialLiabilities>
    <ifrs-full:DerivativeFinancialLiabilities
      contextRef="AsOf2024-12-31_custom_N15thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003324"
      unitRef="KRW">337179000</ifrs-full:DerivativeFinancialLiabilities>
    <ifrs-full:DerivativeFinancialLiabilities
      contextRef="AsOf2024-12-31_custom_N18thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003326"
      unitRef="KRW">1017141000</ifrs-full:DerivativeFinancialLiabilities>
    <ifrs-full:DerivativeFinancialLiabilities
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003327"
      unitRef="KRW">1473823000</ifrs-full:DerivativeFinancialLiabilities>
    <cik0002058261:DetailsOfBondsWithDetachableWarrantsIssuedTableTextBlock
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact003336">&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--DetailsOfBondsWithDetachableWarrantsIssuedTableTextBlock_pn3n3_zeT28csOKxP1" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Bond with warrants and derivative instruments (Details 3)"&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&lt;span id="xdx_8B6_zAXglBmwepTl" style="display: none"&gt;Details of bonds with detachable warrants issued&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;th style="border-bottom: Black 1pt solid; text-indent: -0.125in; padding-left: 0.125in; text-align: center"&gt;&lt;b&gt;Series&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;11&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;12&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;13&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; width: 18%; vertical-align: top"&gt;Type&lt;/td&gt;
    &lt;td style="width: 2%; text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; width: 24%; vertical-align: top"&gt;&lt;span id="xdx_904_ecustom--Type_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N11thDetachableWarrantsBondsMember_zhDFbCywbyJ9" title="Type"&gt;Detachable Warrants bonds&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 2%; text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; width: 26%; vertical-align: top"&gt;&lt;span id="xdx_90F_ecustom--Type_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N12thDetachableWarrantsBondsMember_zKpkpTIp58Ak" title="Type"&gt;Detachable Warrants bonds&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 2%; text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; width: 26%; vertical-align: top"&gt;&lt;span id="xdx_904_ecustom--Type_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N13thDetachableWarrantsBondsMember_zQ0WRA4Gm5V7" title="Type"&gt;Detachable Warrants bonds&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"&gt;Issuance amount&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;span id="xdx_903_ecustom--IssuanceAmount_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N11thDetachableWarrantsBondsMember_pp0p" title="Issuance amount"&gt;1,500,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;span id="xdx_900_ecustom--IssuanceAmount_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N12thDetachableWarrantsBondsMember_pp0p" title="Issuance amount"&gt;800,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;span id="xdx_901_ecustom--IssuanceAmount_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N13thDetachableWarrantsBondsMember_pp0p" title="Issuance amount"&gt;4,000,000,000&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Coupon rate (%)&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&lt;span id="xdx_90B_ecustom--CouponRate_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N11thDetachableWarrantsBondsMember_pd" title="Coupon rate (%)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3350"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&lt;span id="xdx_90A_ecustom--CouponRate_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N12thDetachableWarrantsBondsMember_pd" title="Coupon rate (%)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3352"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&lt;span id="xdx_90D_ecustom--CouponRate_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N13thDetachableWarrantsBondsMember_pd" title="Coupon rate (%)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3354"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Yield to maturity (%)&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&lt;span id="xdx_900_ecustom--YieldToMaturity_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N11thDetachableWarrantsBondsMember_pd" title="Yield to maturity (%)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3356"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&lt;span id="xdx_907_ecustom--YieldToMaturity_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N12thDetachableWarrantsBondsMember_pd" title="Yield to maturity (%)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3358"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&lt;span id="xdx_906_ecustom--YieldToMaturity_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N13thDetachableWarrantsBondsMember_pd" title="Yield to maturity (%)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3360"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Issuance date&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&lt;span id="xdx_909_ecustom--IssuanceDate_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N11thDetachableWarrantsBondsMember_zzPyCzDZepU8" title="Issuance date"&gt;March&#160;2022&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&lt;span id="xdx_900_ecustom--IssuanceDate_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N12thDetachableWarrantsBondsMember_zYxyim6os2ij" title="Issuance date"&gt;August&#160;2022&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&lt;span id="xdx_90C_ecustom--IssuanceDate_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N13thDetachableWarrantsBondsMember_znnLmwLBk4nc" title="Issuance date"&gt;October&#160;2022&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Maturity date&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&lt;span id="xdx_90A_ecustom--MaturityDate_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N11thDetachableWarrantsBondsMember_zURYfez6m5U8" title="Maturity date"&gt;March&#160;2025&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&lt;span id="xdx_902_ecustom--MaturityDate_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N12thDetachableWarrantsBondsMember_zoOMbBcc1Fsc" title="Maturity date"&gt;August&#160;2025&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&lt;span id="xdx_904_ecustom--MaturityDate_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N13thDetachableWarrantsBondsMember_zpChta9N9cUh" title="Maturity date"&gt;October&#160;2025&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Principal redemption&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--PrincipalRedemption_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N11thDetachableWarrantsBondsMember_zSKP6Ixs0fl1" style="text-align: justify; vertical-align: top" title="Principal redemption"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;1. Redemption at maturity:&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Redeemed on the maturity date, at their outstanding principal amount, which has not been early redeemed&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;2. Early redemption:&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company has a right to redeem before maturity (call option) or the bondholders have a right to require the Company to redeem before maturity (put option). Upon exercise of each option, the outstanding principal amount is to be redeemed.&lt;/p&gt; &lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--PrincipalRedemption_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N12thDetachableWarrantsBondsMember_zQR4GKn4dRu6" style="text-align: justify; vertical-align: top" title="Principal redemption"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;1. Redemption at maturity:&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Redeemed on the maturity date, at their outstanding principal amount, which has not been early redeemed&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;2. Early redemption:&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company has a right to redeem before maturity (call option) or the bondholders have a right to require the Company to redeem before maturity (put option). Upon exercise of each option, the outstanding principal amount is to be redeemed.&lt;/p&gt; &lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--PrincipalRedemption_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N13thDetachableWarrantsBondsMember_zjdEjFlnB4s4" style="text-align: justify; vertical-align: top" title="Principal redemption"&gt;
        &lt;p style="text-align: justify; margin-top: 0; margin-bottom: 0"&gt;1. Redemption at maturity:&lt;br/&gt;Redeemed on the maturity date, at their outstanding principal amount, which has not been early redeemed&lt;/p&gt;
        &lt;p style="text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;
        &lt;p style="text-align: justify; margin-top: 0; margin-bottom: 0"&gt;2. Early redemption:&lt;br/&gt;The Company has a right to redeem before maturity (call option) or the bondholders have a right to require the Company to redeem before maturity (put option). Upon exercise of each option, the outstanding principal amount is to be redeemed.&lt;/p&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"&gt;Exercise Price (*)&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--ExercisePrice_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N11thDetachableWarrantsBondsMember_fKCop_zRrHtxmApku9" style="vertical-align: top; text-align: justify" title="Exercise Price"&gt;&#x20a9;4,000 per common share&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--ExercisePrice_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N12thDetachableWarrantsBondsMember_fKCop_zONrGvpUIkDa" style="vertical-align: top; text-align: justify" title="Exercise Price"&gt;&#x20a9;2,500 per common share (Subject to adjustment based on revenue at a specific point in time)&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--ExercisePrice_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N13thDetachableWarrantsBondsMember_fKCop_zvJaim6Ep2lb" style="vertical-align: top; text-align: justify" title="Exercise Price"&gt;&#x20a9;2,500 per common share&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Exercise period&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--ExercisePeriod_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N11thDetachableWarrantsBondsMember_zbKETHtHByjl" style="text-align: justify; vertical-align: top" title="Exercise period"&gt;September&#160;2022 ~ January&#160;2025&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--ExercisePeriod_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N12thDetachableWarrantsBondsMember_zXn6PlpJ2JL7" style="text-align: justify; vertical-align: top" title="Exercise period"&gt;February&#160;2023 ~ July&#160;2025&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--ExercisePeriod_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N13thDetachableWarrantsBondsMember_z3wSezbbpaEi" style="text-align: justify; vertical-align: top" title="Exercise period"&gt;February&#160;2023 ~ September&#160;2025&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; margin-left: 0.125in; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;Redemption at the Option of the issuer (Call option)&lt;/p&gt; &lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--RedemptionAtOptionOfIssuerCallOption_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N11thDetachableWarrantsBondsMember_zx56MWaUJnV8" style="vertical-align: top; text-align: justify" title="Redemption at the Option of the issuer (Call option)"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The bonds are early redeemable by the Company in full or partial on March&#160;7, 2023, 12 months from the issuance, or every three months after.&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;In the event of early redemption, the principal amount shall be paid.&lt;/p&gt; &lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--RedemptionAtOptionOfIssuerCallOption_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N12thDetachableWarrantsBondsMember_zvczg27XOLyd" style="vertical-align: top; text-align: justify" title="Redemption at the Option of the issuer (Call option)"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The bonds are early redeemable by the Company in full or partial on August&#160;7, 2023, 12 months from the issuance, or every three months after.&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;In the event of early redemption, the principal amount shall be paid.&lt;/p&gt; &lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--RedemptionAtOptionOfIssuerCallOption_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N13thDetachableWarrantsBondsMember_z7P5lo54raPi" style="vertical-align: top; text-align: justify" title="Redemption at the Option of the issuer (Call option)"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The bonds are early redeemable by the Company in full or partial on April&#160;16, 2024, 18 months from the issuance, or every three months after.&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;In the event of early redemption, the principal amount shall be paid.&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

















&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr&gt;
    &lt;th style="border-bottom: black 1pt solid; text-indent: -0.125in; padding-left: 0.125in; text-align: center"&gt;&lt;b&gt;Series&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;b&gt;11&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;b&gt;12&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;b&gt;13&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; vertical-align: top; width: 18%"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; margin-left: 0.125in; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;Redemption at the option of the bond holders (Put option)&lt;/p&gt; &lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--RedemptionAtOptionOfBondHoldersPutOption_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N11thDetachableWarrantsBondsMember_z8QXIbNDZEHe" style="text-align: justify; vertical-align: top; width: 24%" title="Redemption at the option of the bond holders (Put option)"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The bonds are early redeemable by the Company in full or partial on March&#160;7, 2023, 12 months from the issuance, or every three months after.&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;In the event of early redemption, the principal amount shall be paid.&lt;/p&gt; &lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--RedemptionAtOptionOfBondHoldersPutOption_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N12thDetachableWarrantsBondsMember_zP4iQnc7En53" style="text-align: justify; vertical-align: top; width: 26%" title="Redemption at the option of the bond holders (Put option)"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The bonds are early redeemable by the Company in full or partial on August&#160;7, 2023, 12 months from the issuance, or every three months after.&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;In the event of early redemption, the principal amount shall be paid.&lt;/p&gt; &lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--RedemptionAtOptionOfBondHoldersPutOption_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N13thDetachableWarrantsBondsMember_zzzzqwcRlPXc" style="text-align: justify; vertical-align: top; width: 26%" title="Redemption at the option of the bond holders (Put option)"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The bonds are early redeemable by the Company in full or partial on April&#160;16, 2024, 18 months from the issuance, or every three months after.&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;In the event of early redemption, the principal amount shall be paid.&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Early redemption rights accounting treatment&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--EarlyRedemptionRightsAccountingTreatment_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N11thDetachableWarrantsBondsMember_zWKUYZPQi815" style="text-align: justify; vertical-align: top" title="Early redemption rights accounting treatment"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The early redemption right is separated from the host debt instrument as an embedded derivative and accounted for separately.&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The separated embedded derivative is measured at fair value through profit or loss (FVTPL).&lt;/p&gt; &lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--EarlyRedemptionRightsAccountingTreatment_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N12thDetachableWarrantsBondsMember_zVr38xoKfeh1" style="text-align: justify; vertical-align: top" title="Early redemption rights accounting treatment"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The early redemption right is separated from the host debt instrument as an embedded derivative and accounted for separately.&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The separated embedded derivative is measured at fair value through profit or loss (FVTPL).&lt;/p&gt; &lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--EarlyRedemptionRightsAccountingTreatment_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N13thDetachableWarrantsBondsMember_z0Vwu4igLOxe" style="text-align: justify; vertical-align: top" title="Early redemption rights accounting treatment"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The early redemption right is separated from the host debt instrument as an embedded derivative and accounted for separately.&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The separated embedded derivative is measured at fair value through profit or loss (FVTPL).&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; margin-left: 0.125in; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;Classification of Warrants&lt;/p&gt; &lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--ClassificationOfWarrants_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N11thDetachableWarrantsBondsMember_zD2EXdTexiR8" style="text-align: justify; vertical-align: top" title="Classification of Warrants"&gt;The warrants were classified as equity instruments at the date of issuance, as it satisfied the fixed-for-fixed condition.&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--ClassificationOfWarrants_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N12thDetachableWarrantsBondsMember_z0xox6PIxRE9" style="text-align: justify; vertical-align: top" title="Classification of Warrants"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Upon initial recognition, the warrants were classified as derivative financial liabilities as the fixed-for-fixed condition was not met at the inception date.&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Subsequently, following the determination of the exercise price, the warrants were reclassified as equity instruments.&lt;/p&gt; &lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--ClassificationOfWarrants_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N13thDetachableWarrantsBondsMember_zLljbFVqWl07" style="text-align: justify; vertical-align: top" title="Classification of Warrants"&gt;The warrants were classified as equity instruments at the date of issuance, as it satisfied the fixed-for-fixed condition.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;div style="width: 25%; margin-left: 0; margin-right: auto"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td id="xdx_F03_zPXJTX6PxBDb" style="width: 0.25in; text-align: left"&gt;(*)&lt;/td&gt;
    &lt;td id="xdx_F19_z0WpqFeTfeMh" style="text-align: justify"&gt;The exercise price for the 12th series was finalized in February&#160;2023.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

















&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Details of the bonds with detachable warrants issued by the Company, including those outstanding as of December&#160;31, 2024 and fully settled or redeemed during the year ended December&#160;31, 2025, are as follows: (Continued)&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-indent: -0.125in; padding-left: 0.125in; text-align: center; vertical-align: bottom"&gt;&lt;b&gt;Series&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: bottom; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"&gt;&lt;b&gt;14&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: bottom; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"&gt;&lt;b&gt;15&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: bottom; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"&gt;&lt;b&gt;16&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; width: 18%; vertical-align: top"&gt;Type&lt;/td&gt;
    &lt;td style="width: 2%; text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; width: 24%; vertical-align: top"&gt;&lt;span id="xdx_903_ecustom--Type_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N14thDetachableWarrantsBondsMember_zOUaNBJiFOs9" title="Type"&gt;Detachable Warrants bonds&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 2%; text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; width: 26%; vertical-align: top"&gt;&lt;span id="xdx_90F_ecustom--Type_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N15thDetachableWarrantsBondsMember_zXv5jGfvWIRd" title="Type"&gt;Detachable Warrants bonds&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 2%; text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; width: 26%; vertical-align: top"&gt;&lt;span id="xdx_90A_ecustom--Type_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N16thDetachableWarrantsBondsMember_zlc0Fi1zSI4d" title="Type"&gt;Detachable Warrants bonds&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"&gt;Issuance amount&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;span id="xdx_90E_ecustom--IssuanceAmount_pp0d_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N14thDetachableWarrantsBondsMember_zushMSDXlDrf" title="Issuance amount"&gt;750,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;span id="xdx_90E_ecustom--IssuanceAmount_pp0d_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N15thDetachableWarrantsBondsMember_zgySc6hf8rEh" title="Issuance amount"&gt;2,180,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;span id="xdx_909_ecustom--IssuanceAmount_pp0d_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N16thDetachableWarrantsBondsMember_zgy7zBi4JCQg" title="Issuance amount"&gt;30,000,000,000&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Coupon rate (%)&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&lt;span id="xdx_900_ecustom--CouponRate_pid_dp_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N14thDetachableWarrantsBondsMember_zmCqFWssjRfa" title="Coupon rate (%)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3443"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt; &lt;span id="xdx_904_ecustom--CouponRate_pid_dp_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N15thDetachableWarrantsBondsMember_zFbUMOdsRjJd" title="Coupon rate (%)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3445"&gt;-&lt;/span&gt; &lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&lt;span id="xdx_90F_ecustom--CouponRate_pid_dp_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N16thDetachableWarrantsBondsMember_zMdJKobK6eh1" title="Coupon rate (%)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3447"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Yield to maturity (%)&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&lt;span id="xdx_903_ecustom--YieldToMaturity_pid_dp_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N14thDetachableWarrantsBondsMember_zqqlqP1fcmCe" title="Yield to maturity (%)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3449"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&lt;span id="xdx_90E_ecustom--YieldToMaturity_pid_dp_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N15thDetachableWarrantsBondsMember_zzCGmMSgVvR8" title="Yield to maturity (%)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3451"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;Annual simple interest &lt;span id="xdx_903_ecustom--YieldToMaturity_pid_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N16thDetachableWarrantsBondsMember_z60vWd1vIOvk" title="Yield to maturity (%)"&gt;3.9%&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Issuance date&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&lt;span id="xdx_902_ecustom--IssuanceDate_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N14thDetachableWarrantsBondsMember_zExU9dCwuJT5" title="Issuance date"&gt;April&#160;2023&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&lt;span id="xdx_90E_ecustom--IssuanceDate_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N15thDetachableWarrantsBondsMember_zPwO8LzvH5xi" title="Issuance date"&gt;August&#160;2023&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&lt;span id="xdx_90E_ecustom--IssuanceDate_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N16thDetachableWarrantsBondsMember_zZXQOO0UMQH8" title="Issuance date"&gt;September&#160;2023&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Maturity date&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&lt;span id="xdx_900_ecustom--MaturityDate_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N14thDetachableWarrantsBondsMember_ze8lLkpjvqeb" title="Maturity date"&gt;April&#160;2026&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&lt;span id="xdx_906_ecustom--MaturityDate_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N15thDetachableWarrantsBondsMember_z4D6SAbIrRG2" title="Maturity date"&gt;August&#160;2026&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&lt;span id="xdx_902_ecustom--MaturityDate_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N16thDetachableWarrantsBondsMember_zS2NnUmLG0Ki" title="Maturity date"&gt;September&#160;2028&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Principal redemption&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--PrincipalRedemption_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N14thDetachableWarrantsBondsMember_zsaD4G4jAyZb" style="text-align: justify; vertical-align: top" title="Principal redemption"&gt;
        &lt;p style="text-align: justify; margin-top: 0; margin-bottom: 0"&gt;1. Redemption at maturity:&lt;br/&gt;Redeemed on the maturity date, at their outstanding principal amount, which has not been early redeemed&lt;/p&gt;
        &lt;p style="text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;
        &lt;p style="text-align: justify; margin-top: 0; margin-bottom: 0"&gt;2. Early redemption:&lt;br/&gt;The Company has a right to redeem before maturity (call option) or the bondholders have a right to require the Company to redeem before maturity (put option). Upon exercise of each option, the outstanding principal amount is to be redeemed.&lt;/p&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--PrincipalRedemption_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N15thDetachableWarrantsBondsMember_zUZw0c5K4oeh" style="text-align: justify; vertical-align: top" title="Principal redemption"&gt;
        &lt;p style="text-align: justify; margin-top: 0; margin-bottom: 0"&gt;1. Redemption at maturity:&lt;br/&gt;Redeemed on the maturity date, at their outstanding principal amount, which has not been early redeemed&lt;/p&gt;
        &lt;p style="text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;
        &lt;p style="text-align: justify; margin-top: 0; margin-bottom: 0"&gt;2. Early redemption:&lt;br/&gt;The Company has a right to redeem before maturity (call option) or the bondholders have a right to require the Company to redeem before maturity (put option). Upon exercise of each option, the outstanding principal amount is to be redeemed.&lt;/p&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--PrincipalRedemption_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N16thDetachableWarrantsBondsMember_z16ZYiCsVfz7" style="text-align: justify; vertical-align: top" title="Principal redemption"&gt;
        &lt;p style="text-align: justify; margin-top: 0; margin-bottom: 0"&gt;1. Redemption at maturity:&lt;br/&gt;Redeemed on the maturity date, at their outstanding principal amount, which has not been early redeemed&lt;/p&gt;
        &lt;p style="text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;
        &lt;p style="text-align: justify; margin-top: 0; margin-bottom: 0"&gt;2. Early redemption:&lt;/p&gt;
        &lt;p style="text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company has a right to redeem before maturity (call option) or the bondholders have a right to require the Company to redeem before maturity (put option). At exercise of each option, the outstanding principal amount together with accrued but unpaid interest are to be redeemed.&lt;/p&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"&gt;Exercise Price&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--ExercisePrice_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N14thDetachableWarrantsBondsMember_fKCop_zZYpeISQoZHh" style="vertical-align: top; text-align: justify" title="Exercise Price"&gt;&#x20a9;2,500 per common share&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--ExercisePrice_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N15thDetachableWarrantsBondsMember_fKCop_zh6VLi2Dm0od" style="vertical-align: top; text-align: justify" title="Exercise Price"&gt;&#x20a9;3,000 per common share&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--ExercisePrice_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N16thDetachableWarrantsBondsMember_fKCop_zfndxRjbNvD9" style="vertical-align: top; text-align: justify" title="Exercise Price"&gt;&#x20a9;3,000 per common share&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Exercise period&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--ExercisePeriod_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N14thDetachableWarrantsBondsMember_z0QO1gzjWOH4" style="text-align: justify; vertical-align: top" title="Exercise period"&gt;August&#160;2023 ~ November&#160;2025&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--ExercisePeriod_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N15thDetachableWarrantsBondsMember_z52I4OMYNcPb" style="text-align: justify; vertical-align: top" title="Exercise period"&gt;November&#160;2023 ~ July&#160;2026&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--ExercisePeriod_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N16thDetachableWarrantsBondsMember_zTNaBiWKVSD4" style="text-align: justify; vertical-align: top" title="Exercise period"&gt;October&#160;2023 ~ August&#160;2028&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

















&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr&gt;
    &lt;td style="border-bottom: black 1pt solid; text-indent: -0.125in; padding-left: 0.125in; text-align: center; vertical-align: bottom; width: 18%"&gt;&lt;b&gt;Series&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: bottom; padding-bottom: 0.5pt; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: center; vertical-align: bottom; width: 24%"&gt;&lt;b&gt;14&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: bottom; padding-bottom: 0.5pt; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: center; vertical-align: bottom; width: 26%"&gt;&lt;b&gt;15&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: bottom; padding-bottom: 0.5pt; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: center; vertical-align: bottom; width: 26%"&gt;&lt;b&gt;16&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; margin-left: 0.125in; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;Redemption at the Option of the issuer (Call option)&lt;/p&gt; &lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--RedemptionAtOptionOfIssuerCallOption_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N14thDetachableWarrantsBondsMember_zyzKA9yJ3MO6" style="vertical-align: top; text-align: justify" title="Redemption at the Option of the issuer (Call option)"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The bonds are early redeemable by the Company in full or partial on August&#160;7, 2023 or every three months after.&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;In the event of early redemption, the principal amount shall be paid.&lt;/p&gt; &lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--RedemptionAtOptionOfIssuerCallOption_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N15thDetachableWarrantsBondsMember_zBElWtX9BiP7" style="vertical-align: top; text-align: justify" title="Redemption at the Option of the issuer (Call option)"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The bonds are early redeemable by the Company in full or partial on August&#160;18, 2024 or every three months after.&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;In the event of early redemption, the principal amount shall be paid.&lt;/p&gt; &lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--RedemptionAtOptionOfIssuerCallOption_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N16thDetachableWarrantsBondsMember_zpglmB0RV2vc" style="vertical-align: top; text-align: justify" title="Redemption at the Option of the issuer (Call option)"&gt;The bonds are early redeemable by the Company in full or partial on November&#160;20, 2023, 2 months from the issuance, or every three months after.&lt;br/&gt;&lt;br/&gt;In the event of early redemption, the principal amount shall be payable.&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; margin-left: 0.125in; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;Redemption at the option of the bond holders (Put option)&lt;/p&gt; &lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--RedemptionAtOptionOfBondHoldersPutOption_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N14thDetachableWarrantsBondsMember_zCgrbUQAue05" style="vertical-align: top; text-align: justify" title="Redemption at the option of the bond holders (Put option)"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The bonds are early redeemable by the Company in full or partial on August&#160;7, 2023 or every three months after.&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;In the event of early redemption, the principal amount shall be paid.&lt;/p&gt; &lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--RedemptionAtOptionOfBondHoldersPutOption_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N15thDetachableWarrantsBondsMember_zOxXW9AbpTj8" style="vertical-align: top; text-align: justify" title="Redemption at the option of the bond holders (Put option)"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The bonds are early redeemable by the Company in full or partial on August&#160;18, 2024 or every three months after.&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;In the event of early redemption, the principal amount shall be paid.&lt;/p&gt; &lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--RedemptionAtOptionOfBondHoldersPutOption_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N16thDetachableWarrantsBondsMember_zbfEjdiXZ3H9" style="vertical-align: top; text-align: justify" title="Redemption at the option of the bond holders (Put option)"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The bonds are early redeemable by the Company in full or partial on November&#160;20, 2023, which is three months from the issuance date, or at any time thereafter.&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;In the event of early redemption, the principal amount shall be paid.&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"&gt;Early redemption rights accounting treatment&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--EarlyRedemptionRightsAccountingTreatment_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N14thDetachableWarrantsBondsMember_zhUzGlU5bK41" style="vertical-align: top; text-align: justify" title="Early redemption rights accounting treatment"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The early redemption right is separated from the host debt instrument as an embedded derivative and accounted for separately.&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The separated embedded derivative is measured at fair value through profit or loss (FVTPL).&lt;/p&gt; &lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--EarlyRedemptionRightsAccountingTreatment_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N15thDetachableWarrantsBondsMember_zmfA7h4HmO5d" style="vertical-align: top; text-align: justify" title="Early redemption rights accounting treatment"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The early redemption right is separated from the host debt instrument as an embedded derivative and accounted for separately.&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The separated embedded derivative is measured at fair value through profit or loss (FVTPL).&lt;/p&gt; &lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--EarlyRedemptionRightsAccountingTreatment_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N16thDetachableWarrantsBondsMember_zVDwxoEIiSd7" style="vertical-align: top; text-align: justify" title="Early redemption rights accounting treatment"&gt;The bonds are early redeemable by the Company in full or partial on November&#160;20, 2024, 2 months from the issuance, or every three months after.&lt;br/&gt;&lt;br/&gt;In the event of early redemption, the principal amount shall be payable.&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; margin-left: 0.125in; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;Classification of Warrants&lt;/p&gt; &lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--ClassificationOfWarrants_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N14thDetachableWarrantsBondsMember_zXRSPsJhUxH2" style="text-align: justify; vertical-align: top" title="Classification of Warrants"&gt;The warrants were classified as equity instruments at the date of issuance, as it satisfied the fixed-for-fixed condition.&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--ClassificationOfWarrants_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N15thDetachableWarrantsBondsMember_zfeJiG3d1HB9" style="text-align: justify; vertical-align: top" title="Classification of Warrants"&gt;The warrants were classified as equity instruments at the date of issuance, as it satisfied the fixed-for-fixed condition.&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--ClassificationOfWarrants_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N16thDetachableWarrantsBondsMember_zRiNICIE7oj7" style="text-align: justify; vertical-align: top" title="Classification of Warrants"&gt;The warrants were classified as equity instruments at the date of issuance, as it satisfied the fixed-for-fixed condition.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

















&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Details of the bonds with detachable warrants issued by the Company, including those outstanding as of December&#160;31, 2024 and fully settled or redeemed during the year ended December&#160;31, 2025, are as follows: (Continued)&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr&gt;
    &lt;th style="border-bottom: Black 1pt solid; text-indent: -0.125in; padding-left: 0.125in; text-align: center; vertical-align: bottom"&gt;&lt;b&gt;Series&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; vertical-align: bottom; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"&gt;&lt;b&gt;17&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; vertical-align: bottom; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"&gt;&lt;b&gt;18&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; vertical-align: bottom; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"&gt;&lt;b&gt;19&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; width: 18%; vertical-align: top"&gt;Type&lt;/td&gt;
    &lt;td style="text-align: justify; width: 2%; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; width: 24%; vertical-align: top"&gt;&lt;span id="xdx_90C_ecustom--Type_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N17thDetachableWarrantsBondsMember_zfM6jHVXSbo6" title="Type"&gt;Detachable Warrants bonds&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; width: 2%; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; width: 26%; vertical-align: top"&gt;&lt;span id="xdx_904_ecustom--Type_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N18thDetachableWarrantsBondsMember_zwBeoblX1gs1" title="Type"&gt;Detachable Warrants bonds&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; width: 2%; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; width: 26%; vertical-align: top"&gt;&lt;span id="xdx_90F_ecustom--Type_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N19thDetachableWarrantsBondsMember_z4sPLWh7Nu1" title="Type"&gt;Detachable Warrants bonds&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Issuance amount&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&lt;span id="xdx_905_ecustom--IssuanceAmount_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N17thDetachableWarrantsBondsMember_pp0p" title="Issuance amount"&gt;2,000,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&lt;span id="xdx_90A_ecustom--IssuanceAmount_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N18thDetachableWarrantsBondsMember_pp0p" title="Issuance amount"&gt;2,500,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&lt;span id="xdx_90B_ecustom--IssuanceAmount_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N19thDetachableWarrantsBondsMember_pp0p" title="Issuance amount"&gt;2,000,000,000&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Coupon rate (%)&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&lt;span id="xdx_900_ecustom--CouponRate_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N17thDetachableWarrantsBondsMember_pd" title="Coupon rate (%)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3535"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&lt;span id="xdx_901_ecustom--CouponRate_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N18thDetachableWarrantsBondsMember_pd" title="Coupon rate (%)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3537"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&lt;span id="xdx_902_ecustom--CouponRate_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N19thDetachableWarrantsBondsMember_pd" title="Coupon rate (%)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3539"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Yield to maturity (%)&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&lt;span id="xdx_90A_ecustom--YieldToMaturity_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N17thDetachableWarrantsBondsMember_pd" title="Yield to maturity (%)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3541"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&lt;span id="xdx_909_ecustom--YieldToMaturity_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N18thDetachableWarrantsBondsMember_pd" title="Yield to maturity (%)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3543"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&lt;span id="xdx_908_ecustom--YieldToMaturity_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N19thDetachableWarrantsBondsMember_pd" title="Yield to maturity (%)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3545"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Issuance date&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&lt;span id="xdx_908_ecustom--IssuanceDate_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N17thDetachableWarrantsBondsMember_zfDg2XMS8DU1" title="Issuance date"&gt;July&#160;2024&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&lt;span id="xdx_905_ecustom--IssuanceDate_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N18thDetachableWarrantsBondsMember_zC0nPeNi1zEf" title="Issuance date"&gt;November&#160;2024&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&lt;span id="xdx_907_ecustom--IssuanceDate_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N19thDetachableWarrantsBondsMember_zEbpnkWBlXVj" title="Issuance date"&gt;February&#160;2025&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Maturity date&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&lt;span id="xdx_90C_ecustom--MaturityDate_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N17thDetachableWarrantsBondsMember_zXwqV2CzBIL9" title="Maturity date"&gt;July&#160;2027&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&lt;span id="xdx_900_ecustom--MaturityDate_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N18thDetachableWarrantsBondsMember_zPLsxm7TsMG8" title="Maturity date"&gt;November&#160;2027&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&lt;span id="xdx_902_ecustom--MaturityDate_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N19thDetachableWarrantsBondsMember_zyXKfZxRQ459" title="Maturity date"&gt;February&#160;2028&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Principal redemption&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--PrincipalRedemption_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N17thDetachableWarrantsBondsMember_zK4aZFWF9mz3" style="text-align: justify; vertical-align: top" title="Principal redemption"&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1. Redemption at maturity:&lt;br/&gt;Redeemed on the maturity date, at their outstanding principal amount, which has not been early redeemed&lt;/span&gt;
        &lt;p style="text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2. Early redemption:&lt;br/&gt;The Company has a right to redeem before maturity (call option) or the bondholders have a right to require the Company to redeem before maturity (put option). At exercise of each option, the outstanding principal amount together with accrued but unpaid interest are to be redeemed.&lt;/span&gt; &lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--PrincipalRedemption_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N18thDetachableWarrantsBondsMember_z6MciEF7Wxx5" style="text-align: justify; vertical-align: top" title="Principal redemption"&gt;
        &lt;p style="text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1. Redemption at maturity:&lt;br/&gt;Redeemed on the maturity date, at their outstanding principal amount, which has not been early redeemed&lt;/span&gt;&lt;/p&gt;
        &lt;p style="text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2. Early redemption:&lt;br/&gt;The Company has a right to redeem before maturity (call option) or the bondholders have a right to require the Company to redeem before maturity (put option). Upon exercise of each option, the outstanding principal amount is to be redeemed.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--PrincipalRedemption_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N19thDetachableWarrantsBondsMember_zYtuCoTyOdnf" style="text-align: justify; vertical-align: top" title="Principal redemption"&gt;
        &lt;p style="text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1. Redemption at maturity:&lt;br/&gt;Redeemed on the maturity date, at their outstanding principal amount, which has not been early redeemed&lt;/span&gt;&lt;/p&gt;
        &lt;p style="text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2. Early redemption:&lt;br/&gt;The Company has a right to redeem before maturity (call option) or the bondholders have a right to require the Company to redeem before maturity (put option). Upon exercise of each option, the outstanding principal amount is to be redeemed.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Exercise Price&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--ExercisePrice_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N17thDetachableWarrantsBondsMember_fKCop_z6pvdjDIN9jk" style="text-align: justify; vertical-align: top" title="Exercise Price"&gt;&#x20a9;4,000 per common share&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--ExercisePrice_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N18thDetachableWarrantsBondsMember_fKCop_zM7bMUKYeTd9" style="text-align: justify; vertical-align: top" title="Exercise Price"&gt;&#x20a9;4,000 per common share&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--ExercisePrice_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N19thDetachableWarrantsBondsMember_fKCop_zDUR1RD7Rfkg" style="text-align: justify; vertical-align: top" title="Exercise Price"&gt;&#x20a9;4,000 per common share&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Exercise period&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--ExercisePeriod_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N17thDetachableWarrantsBondsMember_z1Etxz76FYM1" style="text-align: justify; vertical-align: top" title="Exercise period"&gt;November&#160;2024 ~ June&#160;2027&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--ExercisePeriod_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N18thDetachableWarrantsBondsMember_zv6SSsM2HvC" style="text-align: justify; vertical-align: top" title="Exercise period"&gt;February&#160;2025 ~ November&#160;2027&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--ExercisePeriod_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N19thDetachableWarrantsBondsMember_zBvoYMQ3UkF5" style="text-align: justify; vertical-align: top" title="Exercise period"&gt;May&#160;2025 ~ January&#160;2028&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

















&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr&gt;
    &lt;th style="border-bottom: black 1pt solid; text-align: center; vertical-align: bottom"&gt;&lt;b&gt;Series&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; vertical-align: bottom; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="border-bottom: black 1pt solid; text-align: center; vertical-align: bottom"&gt;&lt;b&gt;17&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; vertical-align: bottom; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="border-bottom: black 1pt solid; text-align: center; vertical-align: bottom"&gt;&lt;b&gt;18&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; vertical-align: bottom; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="border-bottom: black 1pt solid; text-align: center; vertical-align: bottom"&gt;&lt;b&gt;19&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; vertical-align: top; width: 18%"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; margin-left: 0.125in; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;Redemption at the Option of the issuer (Call option)&lt;/p&gt; &lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--RedemptionAtOptionOfIssuerCallOption_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N17thDetachableWarrantsBondsMember_zYkViDIbQBr8" style="text-align: justify; vertical-align: top; width: 24%" title="Redemption at the Option of the issuer (Call option)"&gt;The bonds are early redeemable by the Company in full or partial on November&#160;2, 2024 or every three months after.&lt;br/&gt;&lt;br/&gt;In the event of early redemption, the principal amount shall be payable.&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--RedemptionAtOptionOfIssuerCallOption_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N18thDetachableWarrantsBondsMember_z4E8ulaMDdPf" style="text-align: justify; vertical-align: top; width: 26%" title="Redemption at the Option of the issuer (Call option)"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The bonds are early redeemable by the Company in full or partial on February&#160;7, 2025, which is three months from the issuance date, or at any time thereafter.&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;In the event of early redemption, the principal amount shall be paid.&lt;/p&gt; &lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--RedemptionAtOptionOfIssuerCallOption_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N19thDetachableWarrantsBondsMember_zh6wTvWThLT4" style="text-align: justify; vertical-align: top; width: 26%" title="Redemption at the Option of the issuer (Call option)"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The bonds are early redeemable by the Company in full or partial on May&#160;17, 2025, which is three months from the issuance date, or at any time thereafter.&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;In the event of early redemption, the principal amount shall be paid.&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; vertical-align: top; width: 18%"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; margin-left: 0.125in; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;Redemption at the option of the bond holders (Put option)&lt;/p&gt; &lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--RedemptionAtOptionOfBondHoldersPutOption_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N17thDetachableWarrantsBondsMember_zo3D8CbKEble" style="text-align: justify; vertical-align: top; width: 24%" title="Redemption at the option of the bond holders (Put option)"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;The bonds are early redeemable by the Company in full or partial on November&#160;18, 2026, which is one year from the issuance date, or at any time thereafter.&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;In the event of early redemption, the principal amount shall be paid.&lt;/p&gt; &lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--RedemptionAtOptionOfBondHoldersPutOption_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N18thDetachableWarrantsBondsMember_zEVi1D5VEvLl" style="text-align: justify; vertical-align: top; width: 26%" title="Redemption at the option of the bond holders (Put option)"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;The bonds are early redeemable by the Company in full or partial on February&#160;7, 2025, which is three months from the issuance date, or at any time thereafter.&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;In the event of early redemption, the principal amount shall be paid.&lt;/p&gt; &lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--RedemptionAtOptionOfBondHoldersPutOption_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N19thDetachableWarrantsBondsMember_zWEbdtrOKMh2" style="text-align: justify; vertical-align: top; width: 26%" title="Redemption at the option of the bond holders (Put option)"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;The bonds are early redeemable by the Company in full or partial on May&#160;17, 2025, which is three months from the issuance date, or at any time thereafter.&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;In the event of early redemption, the principal amount shall be paid.&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Early redemption rights accounting treatment&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--EarlyRedemptionRightsAccountingTreatment_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N17thDetachableWarrantsBondsMember_z00WQyM8lDqh" style="text-align: justify; vertical-align: top" title="Early redemption rights accounting treatment"&gt;
        &lt;p style="margin-top: 0pt; text-align: justify; margin-bottom: 0pt"&gt;The bonds are early redeemable by the Company in full or partial on November&#160;2, 2024 or every four months after.&lt;/p&gt;
        &lt;p style="margin-top: 0pt; text-align: justify; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;
        &lt;p style="margin-top: 0pt; text-align: justify; margin-bottom: 0pt"&gt;In the event of early redemption, the principal amount shall be payable.&lt;/p&gt; &lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--EarlyRedemptionRightsAccountingTreatment_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N18thDetachableWarrantsBondsMember_z3xfNAtky7q9" style="text-align: justify; vertical-align: top" title="Early redemption rights accounting treatment"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;The early redemption right is separated from the host debt instrument as an embedded derivative and accounted for separately.&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;The separated embedded derivative is measured at fair value through profit or loss (FVTPL).&lt;/p&gt; &lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--EarlyRedemptionRightsAccountingTreatment_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N19thDetachableWarrantsBondsMember_zV6pAq8T4TY4" style="text-align: justify; vertical-align: top" title="Early redemption rights accounting treatment"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;The early redemption right is separated from the host debt instrument as an embedded derivative and accounted for separately.&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;The separated embedded derivative is measured at fair value through profit or loss (FVTPL).&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; margin-left: 0.125in; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;Classification of Warrants&lt;/p&gt; &lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--ClassificationOfWarrants_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N17thDetachableWarrantsBondsMember_znKO0TtcXPS9" style="text-align: justify; vertical-align: top" title="Classification of Warrants"&gt;The warrants were classified as equity instruments at the date of issuance, as it satisfied the fixed-for-fixed condition.&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--ClassificationOfWarrants_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N18thDetachableWarrantsBondsMember_z1Y5BTnfrTu5" style="text-align: justify; vertical-align: top" title="Classification of Warrants"&gt;The warrants were classified as equity instruments at the date of issuance, as it satisfied the fixed-for-fixed condition.&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--ClassificationOfWarrants_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N19thDetachableWarrantsBondsMember_zFsQ0FfEXEPe" style="text-align: justify; vertical-align: top" title="Classification of Warrants"&gt;The warrants were classified as equity instruments at the date of issuance, as it satisfied the fixed-for-fixed condition.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

















&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Details of the bonds with detachable warrants issued by the Company, including those outstanding as of December&#160;31, 2024 and fully settled or redeemed during the year ended December&#160;31, 2025, are as follows: (Continued)&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr&gt;
    &lt;th style="border-bottom: Black 1pt solid; text-indent: -0.125in; padding-left: 0.125in; vertical-align: bottom; text-align: center"&gt;&lt;b&gt;Series&lt;/b&gt;&lt;/th&gt;
    &lt;th style="vertical-align: top; text-align: center; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"&gt;&lt;b&gt;20&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"&gt;&lt;b&gt;21&lt;sup&gt;st&lt;/sup&gt;&lt;/b&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; width: 18%; vertical-align: top"&gt;Type&lt;/td&gt;
    &lt;td style="text-align: justify; width: 2%; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; width: 39%; vertical-align: top"&gt;&lt;span id="xdx_90E_ecustom--Type_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N20thDetachableWarrantsBondsMember_z3IEAWayVZBd" title="Type"&gt;Detachable Warrants bonds&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 2%; text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; width: 39%; vertical-align: top"&gt;&lt;span id="xdx_90B_ecustom--Type_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N21stDetachableWarrantsBondsMember_zX8ijeAHzhk1" title="Type"&gt;Detachable Warrants bonds&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Issuance amount&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&lt;span id="xdx_903_ecustom--IssuanceAmount_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N20thDetachableWarrantsBondsMember_pp0p" title="Issuance amount"&gt;4,200,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&lt;span id="xdx_900_ecustom--IssuanceAmount_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N21stDetachableWarrantsBondsMember_pp0p" title="Issuance amount"&gt;3,000,000,000&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Coupon rate (%)&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&lt;span id="xdx_90B_ecustom--CouponRate_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N20thDetachableWarrantsBondsMember_pd" title="Coupon rate (%)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3623"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&lt;span id="xdx_90A_ecustom--CouponRate_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N21stDetachableWarrantsBondsMember_pd" title="Coupon rate (%)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3625"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Yield to maturity (%)&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&lt;span id="xdx_900_ecustom--YieldToMaturity_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N20thDetachableWarrantsBondsMember_pd" title="Yield to maturity (%)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3627"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&lt;span id="xdx_907_ecustom--YieldToMaturity_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N21stDetachableWarrantsBondsMember_pd" title="Yield to maturity (%)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3629"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Issuance date&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&lt;span id="xdx_901_ecustom--IssuanceDate_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N20thDetachableWarrantsBondsMember_zuDhSL280X39" title="Issuance date"&gt;July&#160;2025&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&lt;span id="xdx_909_ecustom--IssuanceDate_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N21stDetachableWarrantsBondsMember_zMMIGwBVNCz4" title="Issuance date"&gt;November&#160;2025&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Maturity date&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&lt;span id="xdx_90D_ecustom--MaturityDate_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N20thDetachableWarrantsBondsMember_zpiM8r5mciHa" title="Maturity date"&gt;July&#160;2028&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&lt;span id="xdx_90E_ecustom--MaturityDate_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N21stDetachableWarrantsBondsMember_zsce4H2hTMCg" title="Maturity date"&gt;November&#160;2028&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Principal redemption&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--PrincipalRedemption_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N20thDetachableWarrantsBondsMember_zHGOG8qMKgla" style="text-align: justify; vertical-align: top" title="Principal redemption"&gt;
        &lt;p style="text-align: justify; margin-top: 0; margin-bottom: 0"&gt;1. Redemption at maturity:&lt;br/&gt;Redeemed on the maturity date, at their outstanding principal amount, which has not been early redeemed&lt;/p&gt;
        &lt;p style="text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;
        &lt;p style="text-align: justify; margin-top: 0; margin-bottom: 0"&gt;2. Early redemption:&lt;br/&gt;The Company has a right to redeem before maturity (call option) or the bondholders have a right to require the Company to redeem before maturity (put option). Upon exercise of each option, the outstanding principal amount is to be redeemed.&lt;/p&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--PrincipalRedemption_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N21stDetachableWarrantsBondsMember_zBNX4uqLXDD8" style="text-align: justify; vertical-align: top" title="Principal redemption"&gt;
        &lt;p style="text-align: justify; margin-top: 0; margin-bottom: 0"&gt;1. Redemption at maturity:&lt;br/&gt;Redeemed on the maturity date, at their outstanding principal amount, which has not been early redeemed&lt;/p&gt;
        &lt;p style="text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;
        &lt;p style="text-align: justify; margin-top: 0; margin-bottom: 0"&gt;2. Early redemption:&lt;br/&gt;The Company has a right to redeem before maturity (call option) or the bondholders have a right to require the Company to redeem before maturity (put option). Upon exercise of each option, the outstanding principal amount is to be redeemed.&lt;/p&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Exercise Price&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--ExercisePrice_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N20thDetachableWarrantsBondsMember_fKCop_z2A3m8hlIST5" style="text-align: justify; vertical-align: top" title="Exercise Price"&gt;&#x20a9;3,000 per common share&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--ExercisePrice_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N21stDetachableWarrantsBondsMember_fKCop_zOOH80F0xHf1" style="text-align: justify; vertical-align: top" title="Exercise Price"&gt;&#x20a9;3,000 per common share&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Exercise period&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--ExercisePeriod_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N20thDetachableWarrantsBondsMember_zOxKygngQHEk" style="text-align: justify; vertical-align: top" title="Exercise period"&gt;October&#160;2025 ~ June&#160;2028&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--ExercisePeriod_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N21stDetachableWarrantsBondsMember_z3kpRL8LppGi" style="text-align: justify; vertical-align: top" title="Exercise period"&gt;February&#160;2026 ~ October&#160;2028&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; margin-left: 0.125in; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;Redemption at the Option of the issuer (Call option)&lt;/p&gt; &lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--RedemptionAtOptionOfIssuerCallOption_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N20thDetachableWarrantsBondsMember_zXjKM3bmGqsb" style="text-align: justify; vertical-align: top" title="Redemption at the Option of the issuer (Call option)"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The bonds are early redeemable by the Company in full or partial on October&#160;2, 2025, which is three months from the issuance date, or at any time thereafter.&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;In the event of early redemption, the principal amount shall be paid.&lt;/p&gt; &lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--RedemptionAtOptionOfIssuerCallOption_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N21stDetachableWarrantsBondsMember_zEPwnGN3g0F6" style="text-align: justify; vertical-align: top" title="Redemption at the Option of the issuer (Call option)"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The bonds are early redeemable by the Company in full or partial on November&#160;18, 2026, which is one year from the issuance date, or at any time thereafter.&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;In the event of early redemption, the principal amount shall be paid.&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; margin-left: 0.125in; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;Redemption at the option of the bond holders (Put option)&lt;/p&gt; &lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--RedemptionAtOptionOfBondHoldersPutOption_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N20thDetachableWarrantsBondsMember_z0ZUFe117iOg" style="text-align: justify; vertical-align: top" title="Redemption at the option of the bond holders (Put option)"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The bonds are early redeemable by the Company in full or partial on October&#160;2, 2025, which is three months from the issuance date, or at any time thereafter.&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;In the event of early redemption, the principal amount shall be paid.&lt;/p&gt; &lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--RedemptionAtOptionOfBondHoldersPutOption_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N21stDetachableWarrantsBondsMember_znjfpCtu8Rma" style="text-align: justify; vertical-align: top" title="Redemption at the option of the bond holders (Put option)"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The bonds are early redeemable by the Company in full or partial on November&#160;18, 2026, which is one year from the issuance date, or at any time thereafter.&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;In the event of early redemption, the principal amount shall be paid.&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Early redemption rights accounting treatment&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--EarlyRedemptionRightsAccountingTreatment_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N20thDetachableWarrantsBondsMember_zOAbmkQPl8i" style="text-align: justify; vertical-align: top" title="Early redemption rights accounting treatment"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The early redemption right is separated from the host debt instrument as an embedded derivative and accounted for separately.&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The separated embedded derivative is measured at fair value through profit or loss (FVTPL).&lt;/p&gt; &lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--EarlyRedemptionRightsAccountingTreatment_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N21stDetachableWarrantsBondsMember_ztDofVPUyyc3" style="text-align: justify; vertical-align: top" title="Early redemption rights accounting treatment"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The early redemption right is separated from the host debt instrument as an embedded derivative and accounted for separately.&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The separated embedded derivative is measured at fair value through profit or loss (FVTPL).&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; margin-left: 0.125in; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;Classification of Warrants&lt;/p&gt; &lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--ClassificationOfWarrants_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N20thDetachableWarrantsBondsMember_zUXDU4GzO1ha" style="text-align: justify; vertical-align: top" title="Classification of Warrants"&gt;The warrants were classified as equity instruments at the date of issuance, as it satisfied the fixed-for-fixed condition.&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--ClassificationOfWarrants_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--N21stDetachableWarrantsBondsMember_z99NkiWGIgFi" style="text-align: justify; vertical-align: top" title="Classification of Warrants"&gt;The warrants were classified as equity instruments at the date of issuance, as it satisfied the fixed-for-fixed condition.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:DetailsOfBondsWithDetachableWarrantsIssuedTableTextBlock>
    <cik0002058261:Type
      contextRef="From2025-01-012025-12-31_custom_N11thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact003338">Detachable Warrants bonds</cik0002058261:Type>
    <cik0002058261:Type
      contextRef="From2025-01-012025-12-31_custom_N12thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact003340">Detachable Warrants bonds</cik0002058261:Type>
    <cik0002058261:Type
      contextRef="From2025-01-012025-12-31_custom_N13thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact003342">Detachable Warrants bonds</cik0002058261:Type>
    <cik0002058261:IssuanceAmount
      contextRef="From2025-01-012025-12-31_custom_N11thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      decimals="0"
      id="Fact003344"
      unitRef="KRW">1500000000</cik0002058261:IssuanceAmount>
    <cik0002058261:IssuanceAmount
      contextRef="From2025-01-012025-12-31_custom_N12thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      decimals="0"
      id="Fact003346"
      unitRef="KRW">800000000</cik0002058261:IssuanceAmount>
    <cik0002058261:IssuanceAmount
      contextRef="From2025-01-012025-12-31_custom_N13thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      decimals="0"
      id="Fact003348"
      unitRef="KRW">4000000000</cik0002058261:IssuanceAmount>
    <cik0002058261:IssuanceDate
      contextRef="From2025-01-012025-12-31_custom_N11thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact003362">March&#160;2022</cik0002058261:IssuanceDate>
    <cik0002058261:IssuanceDate
      contextRef="From2025-01-012025-12-31_custom_N12thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact003364">August&#160;2022</cik0002058261:IssuanceDate>
    <cik0002058261:IssuanceDate
      contextRef="From2025-01-012025-12-31_custom_N13thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact003366">October&#160;2022</cik0002058261:IssuanceDate>
    <cik0002058261:MaturityDate
      contextRef="From2025-01-012025-12-31_custom_N11thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact003368">March&#160;2025</cik0002058261:MaturityDate>
    <cik0002058261:MaturityDate
      contextRef="From2025-01-012025-12-31_custom_N12thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact003370">August&#160;2025</cik0002058261:MaturityDate>
    <cik0002058261:MaturityDate
      contextRef="From2025-01-012025-12-31_custom_N13thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact003372">October&#160;2025</cik0002058261:MaturityDate>
    <cik0002058261:PrincipalRedemption
      contextRef="From2025-01-012025-12-31_custom_N11thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact003374">1. Redemption at maturity:
        Redeemed on the maturity date, at their outstanding principal amount, which has not been early redeemed
        &#160;
        2. Early redemption:
        The Company has a right to redeem before maturity (call option) or the bondholders have a right to require the Company to redeem before maturity (put option). Upon exercise of each option, the outstanding principal amount is to be redeemed.</cik0002058261:PrincipalRedemption>
    <cik0002058261:PrincipalRedemption
      contextRef="From2025-01-012025-12-31_custom_N12thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact003376">1. Redemption at maturity:
        Redeemed on the maturity date, at their outstanding principal amount, which has not been early redeemed
        &#160;
        2. Early redemption:
        The Company has a right to redeem before maturity (call option) or the bondholders have a right to require the Company to redeem before maturity (put option). Upon exercise of each option, the outstanding principal amount is to be redeemed.</cik0002058261:PrincipalRedemption>
    <cik0002058261:PrincipalRedemption
      contextRef="From2025-01-012025-12-31_custom_N13thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact003378">1. Redemption at maturity:Redeemed on the maturity date, at their outstanding principal amount, which has not been early redeemed
        &#160;
        2. Early redemption:The Company has a right to redeem before maturity (call option) or the bondholders have a right to require the Company to redeem before maturity (put option). Upon exercise of each option, the outstanding principal amount is to be redeemed.</cik0002058261:PrincipalRedemption>
    <cik0002058261:ExercisePrice
      contextRef="From2025-01-012025-12-31_custom_N11thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact003380">&#x20a9;4,000 per common share</cik0002058261:ExercisePrice>
    <cik0002058261:ExercisePrice
      contextRef="From2025-01-012025-12-31_custom_N12thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact003382">&#x20a9;2,500 per common share (Subject to adjustment based on revenue at a specific point in time)</cik0002058261:ExercisePrice>
    <cik0002058261:ExercisePrice
      contextRef="From2025-01-012025-12-31_custom_N13thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact003384">&#x20a9;2,500 per common share</cik0002058261:ExercisePrice>
    <cik0002058261:ExercisePeriod
      contextRef="From2025-01-012025-12-31_custom_N11thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact003386">September&#160;2022 ~ January&#160;2025</cik0002058261:ExercisePeriod>
    <cik0002058261:ExercisePeriod
      contextRef="From2025-01-012025-12-31_custom_N12thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact003388">February&#160;2023 ~ July&#160;2025</cik0002058261:ExercisePeriod>
    <cik0002058261:ExercisePeriod
      contextRef="From2025-01-012025-12-31_custom_N13thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact003390">February&#160;2023 ~ September&#160;2025</cik0002058261:ExercisePeriod>
    <cik0002058261:RedemptionAtOptionOfIssuerCallOption
      contextRef="From2025-01-012025-12-31_custom_N11thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact003392">The bonds are early redeemable by the Company in full or partial on March&#160;7, 2023, 12 months from the issuance, or every three months after.
        &#160;
        In the event of early redemption, the principal amount shall be paid.</cik0002058261:RedemptionAtOptionOfIssuerCallOption>
    <cik0002058261:RedemptionAtOptionOfIssuerCallOption
      contextRef="From2025-01-012025-12-31_custom_N12thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact003394">The bonds are early redeemable by the Company in full or partial on August&#160;7, 2023, 12 months from the issuance, or every three months after.
        &#160;
        In the event of early redemption, the principal amount shall be paid.</cik0002058261:RedemptionAtOptionOfIssuerCallOption>
    <cik0002058261:RedemptionAtOptionOfIssuerCallOption
      contextRef="From2025-01-012025-12-31_custom_N13thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact003396">The bonds are early redeemable by the Company in full or partial on April&#160;16, 2024, 18 months from the issuance, or every three months after.
        &#160;
        In the event of early redemption, the principal amount shall be paid.</cik0002058261:RedemptionAtOptionOfIssuerCallOption>
    <cik0002058261:RedemptionAtOptionOfBondHoldersPutOption
      contextRef="From2025-01-012025-12-31_custom_N11thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact003405">The bonds are early redeemable by the Company in full or partial on March&#160;7, 2023, 12 months from the issuance, or every three months after.
        &#160;
        In the event of early redemption, the principal amount shall be paid.</cik0002058261:RedemptionAtOptionOfBondHoldersPutOption>
    <cik0002058261:RedemptionAtOptionOfBondHoldersPutOption
      contextRef="From2025-01-012025-12-31_custom_N12thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact003407">The bonds are early redeemable by the Company in full or partial on August&#160;7, 2023, 12 months from the issuance, or every three months after.
        &#160;
        In the event of early redemption, the principal amount shall be paid.</cik0002058261:RedemptionAtOptionOfBondHoldersPutOption>
    <cik0002058261:RedemptionAtOptionOfBondHoldersPutOption
      contextRef="From2025-01-012025-12-31_custom_N13thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact003409">The bonds are early redeemable by the Company in full or partial on April&#160;16, 2024, 18 months from the issuance, or every three months after.
        &#160;
        In the event of early redemption, the principal amount shall be paid.</cik0002058261:RedemptionAtOptionOfBondHoldersPutOption>
    <cik0002058261:EarlyRedemptionRightsAccountingTreatment
      contextRef="From2025-01-012025-12-31_custom_N11thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact003411">The early redemption right is separated from the host debt instrument as an embedded derivative and accounted for separately.
        &#160;
        The separated embedded derivative is measured at fair value through profit or loss (FVTPL).</cik0002058261:EarlyRedemptionRightsAccountingTreatment>
    <cik0002058261:EarlyRedemptionRightsAccountingTreatment
      contextRef="From2025-01-012025-12-31_custom_N12thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact003413">The early redemption right is separated from the host debt instrument as an embedded derivative and accounted for separately.
        &#160;
        The separated embedded derivative is measured at fair value through profit or loss (FVTPL).</cik0002058261:EarlyRedemptionRightsAccountingTreatment>
    <cik0002058261:EarlyRedemptionRightsAccountingTreatment
      contextRef="From2025-01-012025-12-31_custom_N13thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact003415">The early redemption right is separated from the host debt instrument as an embedded derivative and accounted for separately.
        &#160;
        The separated embedded derivative is measured at fair value through profit or loss (FVTPL).</cik0002058261:EarlyRedemptionRightsAccountingTreatment>
    <cik0002058261:ClassificationOfWarrants
      contextRef="From2025-01-012025-12-31_custom_N11thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact003417">The warrants were classified as equity instruments at the date of issuance, as it satisfied the fixed-for-fixed condition.</cik0002058261:ClassificationOfWarrants>
    <cik0002058261:ClassificationOfWarrants
      contextRef="From2025-01-012025-12-31_custom_N12thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact003419">Upon initial recognition, the warrants were classified as derivative financial liabilities as the fixed-for-fixed condition was not met at the inception date.
        &#160;
        Subsequently, following the determination of the exercise price, the warrants were reclassified as equity instruments.</cik0002058261:ClassificationOfWarrants>
    <cik0002058261:ClassificationOfWarrants
      contextRef="From2025-01-012025-12-31_custom_N13thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact003421">The warrants were classified as equity instruments at the date of issuance, as it satisfied the fixed-for-fixed condition.</cik0002058261:ClassificationOfWarrants>
    <cik0002058261:Type
      contextRef="From2025-01-012025-12-31_custom_N14thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact003431">Detachable Warrants bonds</cik0002058261:Type>
    <cik0002058261:Type
      contextRef="From2025-01-012025-12-31_custom_N15thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact003433">Detachable Warrants bonds</cik0002058261:Type>
    <cik0002058261:Type
      contextRef="From2025-01-012025-12-31_custom_N16thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact003435">Detachable Warrants bonds</cik0002058261:Type>
    <cik0002058261:IssuanceAmount
      contextRef="From2025-01-012025-12-31_custom_N14thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      decimals="0"
      id="Fact003437"
      unitRef="KRW">750000000</cik0002058261:IssuanceAmount>
    <cik0002058261:IssuanceAmount
      contextRef="From2025-01-012025-12-31_custom_N15thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      decimals="0"
      id="Fact003439"
      unitRef="KRW">2180000000</cik0002058261:IssuanceAmount>
    <cik0002058261:IssuanceAmount
      contextRef="From2025-01-012025-12-31_custom_N16thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      decimals="0"
      id="Fact003441"
      unitRef="KRW">30000000000</cik0002058261:IssuanceAmount>
    <cik0002058261:YieldToMaturity
      contextRef="From2025-01-012025-12-31_custom_N16thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact003453"
      unitRef="Pure">0.039</cik0002058261:YieldToMaturity>
    <cik0002058261:IssuanceDate
      contextRef="From2025-01-012025-12-31_custom_N14thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact003455">April&#160;2023</cik0002058261:IssuanceDate>
    <cik0002058261:IssuanceDate
      contextRef="From2025-01-012025-12-31_custom_N15thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact003457">August&#160;2023</cik0002058261:IssuanceDate>
    <cik0002058261:IssuanceDate
      contextRef="From2025-01-012025-12-31_custom_N16thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact003459">September&#160;2023</cik0002058261:IssuanceDate>
    <cik0002058261:MaturityDate
      contextRef="From2025-01-012025-12-31_custom_N14thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact003461">April&#160;2026</cik0002058261:MaturityDate>
    <cik0002058261:MaturityDate
      contextRef="From2025-01-012025-12-31_custom_N15thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact003463">August&#160;2026</cik0002058261:MaturityDate>
    <cik0002058261:MaturityDate
      contextRef="From2025-01-012025-12-31_custom_N16thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact003465">September&#160;2028</cik0002058261:MaturityDate>
    <cik0002058261:PrincipalRedemption
      contextRef="From2025-01-012025-12-31_custom_N14thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact003467">1. Redemption at maturity:Redeemed on the maturity date, at their outstanding principal amount, which has not been early redeemed
        &#160;
        2. Early redemption:The Company has a right to redeem before maturity (call option) or the bondholders have a right to require the Company to redeem before maturity (put option). Upon exercise of each option, the outstanding principal amount is to be redeemed.</cik0002058261:PrincipalRedemption>
    <cik0002058261:PrincipalRedemption
      contextRef="From2025-01-012025-12-31_custom_N15thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact003469">1. Redemption at maturity:Redeemed on the maturity date, at their outstanding principal amount, which has not been early redeemed
        &#160;
        2. Early redemption:The Company has a right to redeem before maturity (call option) or the bondholders have a right to require the Company to redeem before maturity (put option). Upon exercise of each option, the outstanding principal amount is to be redeemed.</cik0002058261:PrincipalRedemption>
    <cik0002058261:PrincipalRedemption
      contextRef="From2025-01-012025-12-31_custom_N16thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact003471">1. Redemption at maturity:Redeemed on the maturity date, at their outstanding principal amount, which has not been early redeemed
        &#160;
        2. Early redemption:
        The Company has a right to redeem before maturity (call option) or the bondholders have a right to require the Company to redeem before maturity (put option). At exercise of each option, the outstanding principal amount together with accrued but unpaid interest are to be redeemed.</cik0002058261:PrincipalRedemption>
    <cik0002058261:ExercisePrice
      contextRef="From2025-01-012025-12-31_custom_N14thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact003473">&#x20a9;2,500 per common share</cik0002058261:ExercisePrice>
    <cik0002058261:ExercisePrice
      contextRef="From2025-01-012025-12-31_custom_N15thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact003475">&#x20a9;3,000 per common share</cik0002058261:ExercisePrice>
    <cik0002058261:ExercisePrice
      contextRef="From2025-01-012025-12-31_custom_N16thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact003477">&#x20a9;3,000 per common share</cik0002058261:ExercisePrice>
    <cik0002058261:ExercisePeriod
      contextRef="From2025-01-012025-12-31_custom_N14thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact003479">August&#160;2023 ~ November&#160;2025</cik0002058261:ExercisePeriod>
    <cik0002058261:ExercisePeriod
      contextRef="From2025-01-012025-12-31_custom_N15thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact003481">November&#160;2023 ~ July&#160;2026</cik0002058261:ExercisePeriod>
    <cik0002058261:ExercisePeriod
      contextRef="From2025-01-012025-12-31_custom_N16thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact003483">October&#160;2023 ~ August&#160;2028</cik0002058261:ExercisePeriod>
    <cik0002058261:RedemptionAtOptionOfIssuerCallOption
      contextRef="From2025-01-012025-12-31_custom_N14thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact003492">The bonds are early redeemable by the Company in full or partial on August&#160;7, 2023 or every three months after.
        &#160;
        In the event of early redemption, the principal amount shall be paid.</cik0002058261:RedemptionAtOptionOfIssuerCallOption>
    <cik0002058261:RedemptionAtOptionOfIssuerCallOption
      contextRef="From2025-01-012025-12-31_custom_N15thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact003494">The bonds are early redeemable by the Company in full or partial on August&#160;18, 2024 or every three months after.
        &#160;
        In the event of early redemption, the principal amount shall be paid.</cik0002058261:RedemptionAtOptionOfIssuerCallOption>
    <cik0002058261:RedemptionAtOptionOfIssuerCallOption
      contextRef="From2025-01-012025-12-31_custom_N16thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact003496">The bonds are early redeemable by the Company in full or partial on November&#160;20, 2023, 2 months from the issuance, or every three months after.In the event of early redemption, the principal amount shall be payable.</cik0002058261:RedemptionAtOptionOfIssuerCallOption>
    <cik0002058261:RedemptionAtOptionOfBondHoldersPutOption
      contextRef="From2025-01-012025-12-31_custom_N14thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact003498">The bonds are early redeemable by the Company in full or partial on August&#160;7, 2023 or every three months after.
        &#160;
        In the event of early redemption, the principal amount shall be paid.</cik0002058261:RedemptionAtOptionOfBondHoldersPutOption>
    <cik0002058261:RedemptionAtOptionOfBondHoldersPutOption
      contextRef="From2025-01-012025-12-31_custom_N15thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact003500">The bonds are early redeemable by the Company in full or partial on August&#160;18, 2024 or every three months after.
        &#160;
        In the event of early redemption, the principal amount shall be paid.</cik0002058261:RedemptionAtOptionOfBondHoldersPutOption>
    <cik0002058261:RedemptionAtOptionOfBondHoldersPutOption
      contextRef="From2025-01-012025-12-31_custom_N16thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact003502">The bonds are early redeemable by the Company in full or partial on November&#160;20, 2023, which is three months from the issuance date, or at any time thereafter.
        &#160;
        In the event of early redemption, the principal amount shall be paid.</cik0002058261:RedemptionAtOptionOfBondHoldersPutOption>
    <cik0002058261:EarlyRedemptionRightsAccountingTreatment
      contextRef="From2025-01-012025-12-31_custom_N14thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact003504">The early redemption right is separated from the host debt instrument as an embedded derivative and accounted for separately.
        &#160;
        The separated embedded derivative is measured at fair value through profit or loss (FVTPL).</cik0002058261:EarlyRedemptionRightsAccountingTreatment>
    <cik0002058261:EarlyRedemptionRightsAccountingTreatment
      contextRef="From2025-01-012025-12-31_custom_N15thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact003506">The early redemption right is separated from the host debt instrument as an embedded derivative and accounted for separately.
        &#160;
        The separated embedded derivative is measured at fair value through profit or loss (FVTPL).</cik0002058261:EarlyRedemptionRightsAccountingTreatment>
    <cik0002058261:EarlyRedemptionRightsAccountingTreatment
      contextRef="From2025-01-012025-12-31_custom_N16thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact003508">The bonds are early redeemable by the Company in full or partial on November&#160;20, 2024, 2 months from the issuance, or every three months after.In the event of early redemption, the principal amount shall be payable.</cik0002058261:EarlyRedemptionRightsAccountingTreatment>
    <cik0002058261:ClassificationOfWarrants
      contextRef="From2025-01-012025-12-31_custom_N14thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact003510">The warrants were classified as equity instruments at the date of issuance, as it satisfied the fixed-for-fixed condition.</cik0002058261:ClassificationOfWarrants>
    <cik0002058261:ClassificationOfWarrants
      contextRef="From2025-01-012025-12-31_custom_N15thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact003512">The warrants were classified as equity instruments at the date of issuance, as it satisfied the fixed-for-fixed condition.</cik0002058261:ClassificationOfWarrants>
    <cik0002058261:ClassificationOfWarrants
      contextRef="From2025-01-012025-12-31_custom_N16thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact003514">The warrants were classified as equity instruments at the date of issuance, as it satisfied the fixed-for-fixed condition.</cik0002058261:ClassificationOfWarrants>
    <cik0002058261:Type
      contextRef="From2025-01-012025-12-31_custom_N17thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact003523">Detachable Warrants bonds</cik0002058261:Type>
    <cik0002058261:Type
      contextRef="From2025-01-012025-12-31_custom_N18thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact003525">Detachable Warrants bonds</cik0002058261:Type>
    <cik0002058261:Type
      contextRef="From2025-01-012025-12-31_custom_N19thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact003527">Detachable Warrants bonds</cik0002058261:Type>
    <cik0002058261:IssuanceAmount
      contextRef="From2025-01-012025-12-31_custom_N17thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      decimals="0"
      id="Fact003529"
      unitRef="KRW">2000000000</cik0002058261:IssuanceAmount>
    <cik0002058261:IssuanceAmount
      contextRef="From2025-01-012025-12-31_custom_N18thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      decimals="0"
      id="Fact003531"
      unitRef="KRW">2500000000</cik0002058261:IssuanceAmount>
    <cik0002058261:IssuanceAmount
      contextRef="From2025-01-012025-12-31_custom_N19thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      decimals="0"
      id="Fact003533"
      unitRef="KRW">2000000000</cik0002058261:IssuanceAmount>
    <cik0002058261:IssuanceDate
      contextRef="From2025-01-012025-12-31_custom_N17thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact003547">July&#160;2024</cik0002058261:IssuanceDate>
    <cik0002058261:IssuanceDate
      contextRef="From2025-01-012025-12-31_custom_N18thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact003549">November&#160;2024</cik0002058261:IssuanceDate>
    <cik0002058261:IssuanceDate
      contextRef="From2025-01-012025-12-31_custom_N19thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact003551">February&#160;2025</cik0002058261:IssuanceDate>
    <cik0002058261:MaturityDate
      contextRef="From2025-01-012025-12-31_custom_N17thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact003553">July&#160;2027</cik0002058261:MaturityDate>
    <cik0002058261:MaturityDate
      contextRef="From2025-01-012025-12-31_custom_N18thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact003555">November&#160;2027</cik0002058261:MaturityDate>
    <cik0002058261:MaturityDate
      contextRef="From2025-01-012025-12-31_custom_N19thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact003557">February&#160;2028</cik0002058261:MaturityDate>
    <cik0002058261:PrincipalRedemption
      contextRef="From2025-01-012025-12-31_custom_N17thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact003559">1. Redemption at maturity:Redeemed on the maturity date, at their outstanding principal amount, which has not been early redeemed
        &#160; 2. Early redemption:The Company has a right to redeem before maturity (call option) or the bondholders have a right to require the Company to redeem before maturity (put option). At exercise of each option, the outstanding principal amount together with accrued but unpaid interest are to be redeemed.</cik0002058261:PrincipalRedemption>
    <cik0002058261:PrincipalRedemption
      contextRef="From2025-01-012025-12-31_custom_N18thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact003561">1. Redemption at maturity:Redeemed on the maturity date, at their outstanding principal amount, which has not been early redeemed
        &#160;
        2. Early redemption:The Company has a right to redeem before maturity (call option) or the bondholders have a right to require the Company to redeem before maturity (put option). Upon exercise of each option, the outstanding principal amount is to be redeemed.</cik0002058261:PrincipalRedemption>
    <cik0002058261:PrincipalRedemption
      contextRef="From2025-01-012025-12-31_custom_N19thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact003563">1. Redemption at maturity:Redeemed on the maturity date, at their outstanding principal amount, which has not been early redeemed
        &#160;
        2. Early redemption:The Company has a right to redeem before maturity (call option) or the bondholders have a right to require the Company to redeem before maturity (put option). Upon exercise of each option, the outstanding principal amount is to be redeemed.</cik0002058261:PrincipalRedemption>
    <cik0002058261:ExercisePrice
      contextRef="From2025-01-012025-12-31_custom_N17thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact003565">&#x20a9;4,000 per common share</cik0002058261:ExercisePrice>
    <cik0002058261:ExercisePrice
      contextRef="From2025-01-012025-12-31_custom_N18thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact003567">&#x20a9;4,000 per common share</cik0002058261:ExercisePrice>
    <cik0002058261:ExercisePrice
      contextRef="From2025-01-012025-12-31_custom_N19thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact003569">&#x20a9;4,000 per common share</cik0002058261:ExercisePrice>
    <cik0002058261:ExercisePeriod
      contextRef="From2025-01-012025-12-31_custom_N17thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact003571">November&#160;2024 ~ June&#160;2027</cik0002058261:ExercisePeriod>
    <cik0002058261:ExercisePeriod
      contextRef="From2025-01-012025-12-31_custom_N18thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact003573">February&#160;2025 ~ November&#160;2027</cik0002058261:ExercisePeriod>
    <cik0002058261:ExercisePeriod
      contextRef="From2025-01-012025-12-31_custom_N19thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact003575">May&#160;2025 ~ January&#160;2028</cik0002058261:ExercisePeriod>
    <cik0002058261:RedemptionAtOptionOfIssuerCallOption
      contextRef="From2025-01-012025-12-31_custom_N17thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact003584">The bonds are early redeemable by the Company in full or partial on November&#160;2, 2024 or every three months after.In the event of early redemption, the principal amount shall be payable.</cik0002058261:RedemptionAtOptionOfIssuerCallOption>
    <cik0002058261:RedemptionAtOptionOfIssuerCallOption
      contextRef="From2025-01-012025-12-31_custom_N18thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact003586">The bonds are early redeemable by the Company in full or partial on February&#160;7, 2025, which is three months from the issuance date, or at any time thereafter.
        &#160;
        In the event of early redemption, the principal amount shall be paid.</cik0002058261:RedemptionAtOptionOfIssuerCallOption>
    <cik0002058261:RedemptionAtOptionOfIssuerCallOption
      contextRef="From2025-01-012025-12-31_custom_N19thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact003588">The bonds are early redeemable by the Company in full or partial on May&#160;17, 2025, which is three months from the issuance date, or at any time thereafter.
        &#160;
        In the event of early redemption, the principal amount shall be paid.</cik0002058261:RedemptionAtOptionOfIssuerCallOption>
    <cik0002058261:RedemptionAtOptionOfBondHoldersPutOption
      contextRef="From2025-01-012025-12-31_custom_N17thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact003590">The bonds are early redeemable by the Company in full or partial on November&#160;18, 2026, which is one year from the issuance date, or at any time thereafter.
        &#160;
        In the event of early redemption, the principal amount shall be paid.</cik0002058261:RedemptionAtOptionOfBondHoldersPutOption>
    <cik0002058261:RedemptionAtOptionOfBondHoldersPutOption
      contextRef="From2025-01-012025-12-31_custom_N18thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact003592">The bonds are early redeemable by the Company in full or partial on February&#160;7, 2025, which is three months from the issuance date, or at any time thereafter.
        &#160;
        In the event of early redemption, the principal amount shall be paid.</cik0002058261:RedemptionAtOptionOfBondHoldersPutOption>
    <cik0002058261:RedemptionAtOptionOfBondHoldersPutOption
      contextRef="From2025-01-012025-12-31_custom_N19thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact003594">The bonds are early redeemable by the Company in full or partial on May&#160;17, 2025, which is three months from the issuance date, or at any time thereafter.
        &#160;
        In the event of early redemption, the principal amount shall be paid.</cik0002058261:RedemptionAtOptionOfBondHoldersPutOption>
    <cik0002058261:EarlyRedemptionRightsAccountingTreatment
      contextRef="From2025-01-012025-12-31_custom_N17thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact003596">The bonds are early redeemable by the Company in full or partial on November&#160;2, 2024 or every four months after.
        &#160;
        In the event of early redemption, the principal amount shall be payable.</cik0002058261:EarlyRedemptionRightsAccountingTreatment>
    <cik0002058261:EarlyRedemptionRightsAccountingTreatment
      contextRef="From2025-01-012025-12-31_custom_N18thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact003598">The early redemption right is separated from the host debt instrument as an embedded derivative and accounted for separately.
        &#160;
        The separated embedded derivative is measured at fair value through profit or loss (FVTPL).</cik0002058261:EarlyRedemptionRightsAccountingTreatment>
    <cik0002058261:EarlyRedemptionRightsAccountingTreatment
      contextRef="From2025-01-012025-12-31_custom_N19thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact003600">The early redemption right is separated from the host debt instrument as an embedded derivative and accounted for separately.
        &#160;
        The separated embedded derivative is measured at fair value through profit or loss (FVTPL).</cik0002058261:EarlyRedemptionRightsAccountingTreatment>
    <cik0002058261:ClassificationOfWarrants
      contextRef="From2025-01-012025-12-31_custom_N17thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact003602">The warrants were classified as equity instruments at the date of issuance, as it satisfied the fixed-for-fixed condition.</cik0002058261:ClassificationOfWarrants>
    <cik0002058261:ClassificationOfWarrants
      contextRef="From2025-01-012025-12-31_custom_N18thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact003604">The warrants were classified as equity instruments at the date of issuance, as it satisfied the fixed-for-fixed condition.</cik0002058261:ClassificationOfWarrants>
    <cik0002058261:ClassificationOfWarrants
      contextRef="From2025-01-012025-12-31_custom_N19thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact003606">The warrants were classified as equity instruments at the date of issuance, as it satisfied the fixed-for-fixed condition.</cik0002058261:ClassificationOfWarrants>
    <cik0002058261:Type
      contextRef="From2025-01-012025-12-31_custom_N20thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact003615">Detachable Warrants bonds</cik0002058261:Type>
    <cik0002058261:Type
      contextRef="From2025-01-012025-12-31_custom_N21stDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact003617">Detachable Warrants bonds</cik0002058261:Type>
    <cik0002058261:IssuanceAmount
      contextRef="From2025-01-012025-12-31_custom_N20thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      decimals="0"
      id="Fact003619"
      unitRef="KRW">4200000000</cik0002058261:IssuanceAmount>
    <cik0002058261:IssuanceAmount
      contextRef="From2025-01-012025-12-31_custom_N21stDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      decimals="0"
      id="Fact003621"
      unitRef="KRW">3000000000</cik0002058261:IssuanceAmount>
    <cik0002058261:IssuanceDate
      contextRef="From2025-01-012025-12-31_custom_N20thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact003631">July&#160;2025</cik0002058261:IssuanceDate>
    <cik0002058261:IssuanceDate
      contextRef="From2025-01-012025-12-31_custom_N21stDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact003633">November&#160;2025</cik0002058261:IssuanceDate>
    <cik0002058261:MaturityDate
      contextRef="From2025-01-012025-12-31_custom_N20thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact003635">July&#160;2028</cik0002058261:MaturityDate>
    <cik0002058261:MaturityDate
      contextRef="From2025-01-012025-12-31_custom_N21stDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact003637">November&#160;2028</cik0002058261:MaturityDate>
    <cik0002058261:PrincipalRedemption
      contextRef="From2025-01-012025-12-31_custom_N20thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact003639">1. Redemption at maturity:Redeemed on the maturity date, at their outstanding principal amount, which has not been early redeemed
        &#160;
        2. Early redemption:The Company has a right to redeem before maturity (call option) or the bondholders have a right to require the Company to redeem before maturity (put option). Upon exercise of each option, the outstanding principal amount is to be redeemed.</cik0002058261:PrincipalRedemption>
    <cik0002058261:PrincipalRedemption
      contextRef="From2025-01-012025-12-31_custom_N21stDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact003641">1. Redemption at maturity:Redeemed on the maturity date, at their outstanding principal amount, which has not been early redeemed
        &#160;
        2. Early redemption:The Company has a right to redeem before maturity (call option) or the bondholders have a right to require the Company to redeem before maturity (put option). Upon exercise of each option, the outstanding principal amount is to be redeemed.</cik0002058261:PrincipalRedemption>
    <cik0002058261:ExercisePrice
      contextRef="From2025-01-012025-12-31_custom_N20thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact003643">&#x20a9;3,000 per common share</cik0002058261:ExercisePrice>
    <cik0002058261:ExercisePrice
      contextRef="From2025-01-012025-12-31_custom_N21stDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact003645">&#x20a9;3,000 per common share</cik0002058261:ExercisePrice>
    <cik0002058261:ExercisePeriod
      contextRef="From2025-01-012025-12-31_custom_N20thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact003647">October&#160;2025 ~ June&#160;2028</cik0002058261:ExercisePeriod>
    <cik0002058261:ExercisePeriod
      contextRef="From2025-01-012025-12-31_custom_N21stDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact003649">February&#160;2026 ~ October&#160;2028</cik0002058261:ExercisePeriod>
    <cik0002058261:RedemptionAtOptionOfIssuerCallOption
      contextRef="From2025-01-012025-12-31_custom_N20thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact003651">The bonds are early redeemable by the Company in full or partial on October&#160;2, 2025, which is three months from the issuance date, or at any time thereafter.
        &#160;
        In the event of early redemption, the principal amount shall be paid.</cik0002058261:RedemptionAtOptionOfIssuerCallOption>
    <cik0002058261:RedemptionAtOptionOfIssuerCallOption
      contextRef="From2025-01-012025-12-31_custom_N21stDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact003653">The bonds are early redeemable by the Company in full or partial on November&#160;18, 2026, which is one year from the issuance date, or at any time thereafter.
        &#160;
        In the event of early redemption, the principal amount shall be paid.</cik0002058261:RedemptionAtOptionOfIssuerCallOption>
    <cik0002058261:RedemptionAtOptionOfBondHoldersPutOption
      contextRef="From2025-01-012025-12-31_custom_N20thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact003655">The bonds are early redeemable by the Company in full or partial on October&#160;2, 2025, which is three months from the issuance date, or at any time thereafter.
        &#160;
        In the event of early redemption, the principal amount shall be paid.</cik0002058261:RedemptionAtOptionOfBondHoldersPutOption>
    <cik0002058261:RedemptionAtOptionOfBondHoldersPutOption
      contextRef="From2025-01-012025-12-31_custom_N21stDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact003657">The bonds are early redeemable by the Company in full or partial on November&#160;18, 2026, which is one year from the issuance date, or at any time thereafter.
        &#160;
        In the event of early redemption, the principal amount shall be paid.</cik0002058261:RedemptionAtOptionOfBondHoldersPutOption>
    <cik0002058261:EarlyRedemptionRightsAccountingTreatment
      contextRef="From2025-01-012025-12-31_custom_N20thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact003659">The early redemption right is separated from the host debt instrument as an embedded derivative and accounted for separately.
        &#160;
        The separated embedded derivative is measured at fair value through profit or loss (FVTPL).</cik0002058261:EarlyRedemptionRightsAccountingTreatment>
    <cik0002058261:EarlyRedemptionRightsAccountingTreatment
      contextRef="From2025-01-012025-12-31_custom_N21stDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact003661">The early redemption right is separated from the host debt instrument as an embedded derivative and accounted for separately.
        &#160;
        The separated embedded derivative is measured at fair value through profit or loss (FVTPL).</cik0002058261:EarlyRedemptionRightsAccountingTreatment>
    <cik0002058261:ClassificationOfWarrants
      contextRef="From2025-01-012025-12-31_custom_N20thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact003663">The warrants were classified as equity instruments at the date of issuance, as it satisfied the fixed-for-fixed condition.</cik0002058261:ClassificationOfWarrants>
    <cik0002058261:ClassificationOfWarrants
      contextRef="From2025-01-012025-12-31_custom_N21stDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact003665">The warrants were classified as equity instruments at the date of issuance, as it satisfied the fixed-for-fixed condition.</cik0002058261:ClassificationOfWarrants>
    <cik0002058261:FinancialInstrumentsByCategoryTextBlock
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact003673">&lt;p id="xdx_807_ecustom--FinancialInstrumentsByCategoryTextBlock_zIBecZVZ74Ic" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;23. &lt;span id="xdx_828_ziaa4lfVfMOl"&gt;Financial instruments by category&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The carrying amounts of financial instruments by category as of December&#160;31, 2025 and 2024 are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89F_ecustom--FinancialInstrumentsByCategoryTableTextBlock_pn3n3_zrWVfFqFOv65" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Financial instruments by category (Details)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_8BF_zStDePhGKs08" style="display: none"&gt;Schedule of financial instruments by category&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2024&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;b&gt;Financial assets at amortized cost&lt;/b&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Cash and cash equivalents&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#x20a9;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--FinancialAssets_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--CashAndCashEquivalentMember_z1PTeZwZcfO8" title="Total"&gt;335,814&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--FinancialAssets_iI_pn3n3_c20241231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--CashAndCashEquivalentMember_zqVjxFxjcTn9" title="Total"&gt;3,662,174&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Current portion of long-term bank deposit&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--FinancialAssets_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--CurrentPortionOfLongTermBankDepositMember_zsKlwnCpdSl4" title="Total"&gt;30,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--FinancialAssets_iI_pn3n3_c20241231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--CurrentPortionOfLongTermBankDepositMember_z6Wozu5LwXEf" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3683"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Short-term loan receivable, net&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--FinancialAssets_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--ShortTermLoanReceivableNetMember_zzf5niIkJxGf" title="Total"&gt;442,894&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--FinancialAssets_iI_pn3n3_c20241231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--ShortTermLoanReceivableNetMember_zspMsIOFhJFi" title="Total"&gt;214,245&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Other receivables&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--FinancialAssets_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--OtherReceivablesMember_zX79AdIIsOLc" title="Total"&gt;33,411&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--FinancialAssets_iI_pn3n3_c20241231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--OtherReceivablesMember_zSJaWVXUkp8e" title="Total"&gt;202,477&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Long-term bank deposit&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--FinancialAssets_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--LongtermBankDepositMember_z1MW14wsTDN" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3693"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--FinancialAssets_iI_pn3n3_c20241231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--LongtermBankDepositMember_zfKYSDhi2Ysf" title="Total"&gt;30,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Long-term loan receivable, net&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--FinancialAssets_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--LongTermLoanReceivableNetMember_zOemGbQPgt43" title="Total"&gt;1,671,780&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--FinancialAssets_iI_pn3n3_c20241231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--LongTermLoanReceivableNetMember_zICpdC3JuZOi" title="Total"&gt;1,917,960&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Long-term other receivables, net&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--FinancialAssets_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--LongTermOtherReceivablesNetMember_z0dlPBYSdpEl" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3701"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--FinancialAssets_iI_pn3n3_c20241231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--LongTermOtherReceivablesNetMember_zWN928mfr4A7" title="Total"&gt;2,065&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Other non-current financial assets&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--FinancialAssets_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--OtherNoncurrentFinancialAssetsMember_zzwdvJtSEBl1" title="Total"&gt;525,042&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--FinancialAssets_iI_pn3n3_c20241231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--OtherNoncurrentFinancialAssetsMember_zlhUl0y9OhE2" title="Total"&gt;473,682&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: center; vertical-align: top; padding-bottom: 1.25pt"&gt;Total&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--FinancialAssets_iI_pn3n3_c20251231_zG1dkzWnuFJ9" title="Total"&gt;3,038,941&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--FinancialAssets_iI_pn3n3_c20241231_ze1McHhmo0Ij" title="Total"&gt;6,502,603&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2024&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;b&gt;Financial liabilities at amortized cost&lt;/b&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Accounts payable - other (*)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#x20a9;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--FinancialLiabilities_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableOtherMember_z9K4CD23kRil" title="Total"&gt;1,374,936&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--FinancialLiabilities_iI_pn3n3_c20241231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableOtherMember_zi2NiS49RQK6" title="Total"&gt;996,719&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Bond with warrants, net&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--FinancialLiabilities_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--BondWithWarrantsNetMember_zrFTjpJPz9hf" title="Total"&gt;3,265,312&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--FinancialLiabilities_iI_pn3n3_c20241231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--BondWithWarrantsNetMember_zqHWmBVAoyt9" title="Total"&gt;3,519,139&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Lease liabilities&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--FinancialLiabilities_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--LeaseLiabilitiesMember_zmIPzdLk7LIc" title="Total"&gt;552,631&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--FinancialLiabilities_iI_pn3n3_c20241231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--LeaseLiabilitiesMember_zvkxptYBMR66" title="Total"&gt;669,032&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;b&gt;Financial liabilities at fair value through profit or loss&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Derivative liabilities&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--FinancialLiabilities_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--DerivativeLiabilitiesMember_zrag0ZzCEznj" title="Total"&gt;1,267,801&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--FinancialLiabilities_iI_pn3n3_c20241231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--DerivativeLiabilitiesMember_zat5BTO355vc" title="Total"&gt;1,473,823&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: center; vertical-align: top; padding-bottom: 1.25pt"&gt;Total&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--FinancialLiabilities_iI_pn3n3_c20251231_zhUKAajC1ueh" title="Total"&gt;6,460,680&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--FinancialLiabilities_iI_pn3n3_c20241231_zrKGVC1NrsWg" title="Total"&gt;6,658,713&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;div style="width: 25%; margin-left: 0; margin-right: auto"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;(*)&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;Accounts payable that are not financial liabilities are excluded.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A3_zFDILfUFlObf" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The net gains and losses by category of financial instruments for the years ended December&#160;31, 2025 and 2024 are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89F_ecustom--ScheduleOfNetGainsAndLossesByCategoryOfFinancialInstrumentsTableTextBlock_pn3n3_zyUOgxhSGR8k" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Financial instruments by category (Details 1)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_8B5_zAMszRD6X3E4" style="display: none"&gt;Schedule of net gains and losses by category of financial instruments&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="18" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Financial&lt;br/&gt;assets at&lt;br/&gt;amortized cost&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Financial&lt;br/&gt;assets at fair&lt;br/&gt;value through other&lt;br/&gt;comprehensive&lt;br/&gt;income&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Financial&lt;br/&gt;liabilities at&lt;br/&gt;amortized cost&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Financial&lt;br/&gt;liabilities at&lt;br/&gt;fair value through&lt;br/&gt;profit or loss&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="18" style="text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Interest income&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--AdjustmentsForInterestIncome_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostCategoryMember_zHG9LkHaEChg" title="Interest income"&gt;230,557&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--AdjustmentsForInterestIncome_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember_zcundiybxh8j" title="Interest income"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3737"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--AdjustmentsForInterestIncome_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember_zayXXu5lSPgh" title="Interest income"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3739"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--AdjustmentsForInterestIncome_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember_zSpDuZ86Zw0k" title="Interest income"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3741"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--AdjustmentsForInterestIncome_pn3n3_c20250101__20251231_zwd7t2GpdC9h" title="Interest income"&gt;230,557&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Interest expense&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--InterestExpense_iN_pn3n3_di_c20250101__20251231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostCategoryMember_z0d3BxDY1aXk" title="Interest expense"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3745"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--InterestExpense_iN_pn3n3_di_c20250101__20251231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember_zfPx19XNStCb" title="Interest expense"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3747"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--InterestExpense_iN_pn3n3_di_c20250101__20251231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember_zX9GSayueFDg" title="Interest expense"&gt;(798,128&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--InterestExpense_iN_pn3n3_di_c20250101__20251231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember_zmtlT2dUS5ve" title="Interest expense"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3751"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--InterestExpense_iN_pn3n3_di_c20250101__20251231_ziLJbnpXoL2g" title="Interest expense"&gt;(798,128&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Foreign currency differences&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostCategoryMember_zon7pY8B9dS3" title="Foreign currency differences"&gt;4,205&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember_zt5K5WZXBOje" title="Foreign currency differences"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3757"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember_zZJoZ3QZ0fU7" title="Foreign currency differences"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3759"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember_zOAZ5nGLYCp7" title="Foreign currency differences"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3761"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_pn3n3_c20250101__20251231_zioYSWM21Rpk" title="Foreign currency differences"&gt;4,205&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Gain on valuation&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_909_ecustom--GainOnValuation_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostCategoryMember_zYy18UefvHg2" title="Gain on valuation"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3765"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_ecustom--GainOnValuation_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember_zzxuQmORSML9" title="Gain on valuation"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3767"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_907_ecustom--GainOnValuation_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember_z6rD8lL9pD33" title="Gain on valuation"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3769"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_ecustom--GainOnValuation_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember_zzkmZSPKO0ul" title="Gain on valuation"&gt;455,141&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_ecustom--GainOnValuation_pn3n3_c20250101__20251231_zrnUiz9gVY3e" title="Gain on valuation"&gt;455,141&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Loss on bond redemption&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--LossOnBondRedemption_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostCategoryMember_z98qZvwotsJ7" title="Loss on bond redemption"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3775"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_908_ecustom--LossOnBondRedemption_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember_zC3UExIxXTU1" title="Loss on bond redemption"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3777"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_907_ecustom--LossOnBondRedemption_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember_zYjlW41Q3AP" title="Loss on bond redemption"&gt;(69,890&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_904_ecustom--LossOnBondRedemption_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember_zysPr2abCff1" title="Loss on bond redemption"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3781"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_900_ecustom--LossOnBondRedemption_pn3n3_c20250101__20251231_zmmAZmNXTrag" title="Loss on bond redemption"&gt;(69,890&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: center; vertical-align: top; padding-left: 0.25in; padding-bottom: 1.25pt"&gt;Total&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--Total_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostCategoryMember_zUQoRV23TAzk" title="Total"&gt;234,762&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_907_ecustom--Total_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember_zaoWdC6Rjr92" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3787"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--Total_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember_ztWolM84mWhl" title="Total"&gt;(868,018&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_908_ecustom--Total_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember_zZxIbMuYcDDc" title="Total"&gt;455,141&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_909_ecustom--Total_pn3n3_c20250101__20251231_ztjOQpgUBdQh" title="Total"&gt;(178,115&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

















&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="18" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Financial&lt;br/&gt;assets at&lt;br/&gt;amortized cost&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Financial&lt;br/&gt;assets at fair&lt;br/&gt;value through other&lt;br/&gt;comprehensive&lt;br/&gt;income&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Financial&lt;br/&gt;liabilities at&lt;br/&gt;amortized cost&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Financial&lt;br/&gt;liabilities at&lt;br/&gt;fair value through&lt;br/&gt;profit or loss&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="18" style="text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Interest income&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--AdjustmentsForInterestIncome_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostCategoryMember_zSJbwZqNJBLi" title="Interest income"&gt;193,012&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--AdjustmentsForInterestIncome_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember_zkmuLJooPNhi" title="Interest income"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3804"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--AdjustmentsForInterestIncome_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember_z5zmySGUDCrd" title="Interest income"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3806"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--AdjustmentsForInterestIncome_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember_zq9aVWxWJWga" title="Interest income"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3808"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--AdjustmentsForInterestIncome_pn3n3_c20240101__20241231_zMQSSDkrOLI6" title="Interest income"&gt;193,012&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Interest expense&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--InterestExpense_iN_pn3n3_di_c20240101__20241231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostCategoryMember_z6wjsyegcbU7" title="Interest expense"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3812"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--InterestExpense_iN_pn3n3_di_c20240101__20241231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember_zDDLgB1c2fQ9" title="Interest expense"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3814"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--InterestExpense_iN_pn3n3_di_c20240101__20241231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember_zVF8Zp2C3Rth" title="Interest expense"&gt;(988,178&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--InterestExpense_iN_pn3n3_di_c20240101__20241231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember_z3iMCG8pgnLf" title="Interest expense"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3818"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--InterestExpense_iN_pn3n3_di_c20240101__20241231_zCgpMAxv32p7" title="Interest expense"&gt;(988,178&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Foreign currency differences&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostCategoryMember_zHAcK934EAEf" title="Foreign currency differences"&gt;8,501&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember_zLHiIgRjNn61" title="Foreign currency differences"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3824"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember_zUXOXbk5smJ1" title="Foreign currency differences"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3826"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember_zZ1Vxny3Lrya" title="Foreign currency differences"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3828"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_pn3n3_c20240101__20241231_z6IouEbio3U3" title="Foreign currency differences"&gt;8,501&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Gain on valuation&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_ecustom--GainOnValuation_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostCategoryMember_zwqIORXTZiM4" title="Gain on valuation"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3832"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_909_ecustom--GainOnValuation_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember_zsjH51ABC6F9" title="Gain on valuation"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3834"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_ecustom--GainOnValuation_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember_ztkangsN0kzk" title="Gain on valuation"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3836"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_906_ecustom--GainOnValuation_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember_z4kvFwaKQHL9" title="Gain on valuation"&gt;667,835&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_902_ecustom--GainOnValuation_pn3n3_c20240101__20241231_z8YYW3m7VYol" title="Gain on valuation"&gt;667,835&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Loss on bond redemption&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--LossOnBondRedemption_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostCategoryMember_zprSjPFaGQLl" title="Loss on bond redemption"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3842"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_903_ecustom--LossOnBondRedemption_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember_zlrXB7md2GH1" title="Loss on bond redemption"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3844"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_903_ecustom--LossOnBondRedemption_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember_zszJUNGE4Cie" title="Loss on bond redemption"&gt;(283,780&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_900_ecustom--LossOnBondRedemption_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember_z6FHaf04tInf" title="Loss on bond redemption"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3848"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--LossOnBondRedemption_pn3n3_c20240101__20241231_zMh7fySrCALk" title="Loss on bond redemption"&gt;(283,780&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: center; vertical-align: top; padding-left: 0.25in; padding-bottom: 1.25pt"&gt;Total&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--Total_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostCategoryMember_zUy4mXXaKqql" title="Total"&gt;201,513&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--Total_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember_zK1v6n8PoBZh" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3854"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_904_ecustom--Total_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember_zEqqItfEGvz5" title="Total"&gt;(1,271,958&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_901_ecustom--Total_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember_zN1edK1ikTDa" title="Total"&gt;667,835&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_903_ecustom--Total_pn3n3_c20240101__20241231_zmwIABcw3Idg" title="Total"&gt;(402,610&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AC_z9fAR124Q183" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

</cik0002058261:FinancialInstrumentsByCategoryTextBlock>
    <cik0002058261:FinancialInstrumentsByCategoryTableTextBlock
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact003675">&lt;table cellpadding="0" cellspacing="0" id="xdx_89F_ecustom--FinancialInstrumentsByCategoryTableTextBlock_pn3n3_zrWVfFqFOv65" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Financial instruments by category (Details)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_8BF_zStDePhGKs08" style="display: none"&gt;Schedule of financial instruments by category&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2024&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;b&gt;Financial assets at amortized cost&lt;/b&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Cash and cash equivalents&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#x20a9;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--FinancialAssets_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--CashAndCashEquivalentMember_z1PTeZwZcfO8" title="Total"&gt;335,814&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--FinancialAssets_iI_pn3n3_c20241231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--CashAndCashEquivalentMember_zqVjxFxjcTn9" title="Total"&gt;3,662,174&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Current portion of long-term bank deposit&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--FinancialAssets_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--CurrentPortionOfLongTermBankDepositMember_zsKlwnCpdSl4" title="Total"&gt;30,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--FinancialAssets_iI_pn3n3_c20241231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--CurrentPortionOfLongTermBankDepositMember_z6Wozu5LwXEf" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3683"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Short-term loan receivable, net&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--FinancialAssets_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--ShortTermLoanReceivableNetMember_zzf5niIkJxGf" title="Total"&gt;442,894&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--FinancialAssets_iI_pn3n3_c20241231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--ShortTermLoanReceivableNetMember_zspMsIOFhJFi" title="Total"&gt;214,245&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Other receivables&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--FinancialAssets_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--OtherReceivablesMember_zX79AdIIsOLc" title="Total"&gt;33,411&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--FinancialAssets_iI_pn3n3_c20241231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--OtherReceivablesMember_zSJaWVXUkp8e" title="Total"&gt;202,477&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Long-term bank deposit&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--FinancialAssets_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--LongtermBankDepositMember_z1MW14wsTDN" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3693"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--FinancialAssets_iI_pn3n3_c20241231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--LongtermBankDepositMember_zfKYSDhi2Ysf" title="Total"&gt;30,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Long-term loan receivable, net&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--FinancialAssets_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--LongTermLoanReceivableNetMember_zOemGbQPgt43" title="Total"&gt;1,671,780&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--FinancialAssets_iI_pn3n3_c20241231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--LongTermLoanReceivableNetMember_zICpdC3JuZOi" title="Total"&gt;1,917,960&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Long-term other receivables, net&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--FinancialAssets_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--LongTermOtherReceivablesNetMember_z0dlPBYSdpEl" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3701"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--FinancialAssets_iI_pn3n3_c20241231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--LongTermOtherReceivablesNetMember_zWN928mfr4A7" title="Total"&gt;2,065&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Other non-current financial assets&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--FinancialAssets_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--OtherNoncurrentFinancialAssetsMember_zzwdvJtSEBl1" title="Total"&gt;525,042&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--FinancialAssets_iI_pn3n3_c20241231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--OtherNoncurrentFinancialAssetsMember_zlhUl0y9OhE2" title="Total"&gt;473,682&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: center; vertical-align: top; padding-bottom: 1.25pt"&gt;Total&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--FinancialAssets_iI_pn3n3_c20251231_zG1dkzWnuFJ9" title="Total"&gt;3,038,941&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--FinancialAssets_iI_pn3n3_c20241231_ze1McHhmo0Ij" title="Total"&gt;6,502,603&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2024&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;b&gt;Financial liabilities at amortized cost&lt;/b&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Accounts payable - other (*)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#x20a9;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--FinancialLiabilities_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableOtherMember_z9K4CD23kRil" title="Total"&gt;1,374,936&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--FinancialLiabilities_iI_pn3n3_c20241231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableOtherMember_zi2NiS49RQK6" title="Total"&gt;996,719&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Bond with warrants, net&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--FinancialLiabilities_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--BondWithWarrantsNetMember_zrFTjpJPz9hf" title="Total"&gt;3,265,312&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--FinancialLiabilities_iI_pn3n3_c20241231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--BondWithWarrantsNetMember_zqHWmBVAoyt9" title="Total"&gt;3,519,139&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Lease liabilities&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--FinancialLiabilities_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--LeaseLiabilitiesMember_zmIPzdLk7LIc" title="Total"&gt;552,631&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--FinancialLiabilities_iI_pn3n3_c20241231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--LeaseLiabilitiesMember_zvkxptYBMR66" title="Total"&gt;669,032&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;b&gt;Financial liabilities at fair value through profit or loss&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Derivative liabilities&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--FinancialLiabilities_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--DerivativeLiabilitiesMember_zrag0ZzCEznj" title="Total"&gt;1,267,801&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--FinancialLiabilities_iI_pn3n3_c20241231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--DerivativeLiabilitiesMember_zat5BTO355vc" title="Total"&gt;1,473,823&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: center; vertical-align: top; padding-bottom: 1.25pt"&gt;Total&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--FinancialLiabilities_iI_pn3n3_c20251231_zhUKAajC1ueh" title="Total"&gt;6,460,680&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--FinancialLiabilities_iI_pn3n3_c20241231_zrKGVC1NrsWg" title="Total"&gt;6,658,713&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;div style="width: 25%; margin-left: 0; margin-right: auto"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;(*)&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;Accounts payable that are not financial liabilities are excluded.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:FinancialInstrumentsByCategoryTableTextBlock>
    <ifrs-full:FinancialAssets
      contextRef="AsOf2025-12-31_custom_CashAndCashEquivalentMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003677"
      unitRef="KRW">335814000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="AsOf2024-12-31_custom_CashAndCashEquivalentMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003679"
      unitRef="KRW">3662174000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="AsOf2025-12-31_custom_CurrentPortionOfLongTermBankDepositMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003681"
      unitRef="KRW">30000000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="AsOf2025-12-31_custom_ShortTermLoanReceivableNetMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003685"
      unitRef="KRW">442894000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="AsOf2024-12-31_custom_ShortTermLoanReceivableNetMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003687"
      unitRef="KRW">214245000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="AsOf2025-12-31_custom_OtherReceivablesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003689"
      unitRef="KRW">33411000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="AsOf2024-12-31_custom_OtherReceivablesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003691"
      unitRef="KRW">202477000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="AsOf2024-12-31_custom_LongtermBankDepositMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003695"
      unitRef="KRW">30000000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="AsOf2025-12-31_custom_LongTermLoanReceivableNetMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003697"
      unitRef="KRW">1671780000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="AsOf2024-12-31_custom_LongTermLoanReceivableNetMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003699"
      unitRef="KRW">1917960000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="AsOf2024-12-31_custom_LongTermOtherReceivablesNetMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003703"
      unitRef="KRW">2065000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="AsOf2025-12-31_custom_OtherNoncurrentFinancialAssetsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003705"
      unitRef="KRW">525042000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="AsOf2024-12-31_custom_OtherNoncurrentFinancialAssetsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003707"
      unitRef="KRW">473682000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003709"
      unitRef="KRW">3038941000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003711"
      unitRef="KRW">6502603000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2025-12-31_custom_AccountsPayableOtherMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003713"
      unitRef="KRW">1374936000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2024-12-31_custom_AccountsPayableOtherMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003715"
      unitRef="KRW">996719000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2025-12-31_custom_BondWithWarrantsNetMember_custom_CubebioCo.Ltd.Member273629718"
      decimals="-3"
      id="Fact003717"
      unitRef="KRW">3265312000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2024-12-31_custom_BondWithWarrantsNetMember_custom_CubebioCo.Ltd.Member273629718"
      decimals="-3"
      id="Fact003719"
      unitRef="KRW">3519139000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2025-12-31_ifrs-full_LeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member273629718"
      decimals="-3"
      id="Fact003721"
      unitRef="KRW">552631000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2024-12-31_ifrs-full_LeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member273629734"
      decimals="-3"
      id="Fact003723"
      unitRef="KRW">669032000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2025-12-31_custom_DerivativeLiabilitiesMember_custom_CubebioCo.Ltd.Member273629734"
      decimals="-3"
      id="Fact003725"
      unitRef="KRW">1267801000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2024-12-31_custom_DerivativeLiabilitiesMember_custom_CubebioCo.Ltd.Member273629750"
      decimals="-3"
      id="Fact003727"
      unitRef="KRW">1473823000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003729"
      unitRef="KRW">6460680000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003731"
      unitRef="KRW">6658713000</ifrs-full:FinancialLiabilities>
    <cik0002058261:ScheduleOfNetGainsAndLossesByCategoryOfFinancialInstrumentsTableTextBlock
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact003733">&lt;table cellpadding="0" cellspacing="0" id="xdx_89F_ecustom--ScheduleOfNetGainsAndLossesByCategoryOfFinancialInstrumentsTableTextBlock_pn3n3_zyUOgxhSGR8k" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Financial instruments by category (Details 1)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_8B5_zAMszRD6X3E4" style="display: none"&gt;Schedule of net gains and losses by category of financial instruments&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="18" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Financial&lt;br/&gt;assets at&lt;br/&gt;amortized cost&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Financial&lt;br/&gt;assets at fair&lt;br/&gt;value through other&lt;br/&gt;comprehensive&lt;br/&gt;income&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Financial&lt;br/&gt;liabilities at&lt;br/&gt;amortized cost&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Financial&lt;br/&gt;liabilities at&lt;br/&gt;fair value through&lt;br/&gt;profit or loss&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="18" style="text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Interest income&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--AdjustmentsForInterestIncome_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostCategoryMember_zHG9LkHaEChg" title="Interest income"&gt;230,557&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--AdjustmentsForInterestIncome_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember_zcundiybxh8j" title="Interest income"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3737"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--AdjustmentsForInterestIncome_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember_zayXXu5lSPgh" title="Interest income"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3739"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--AdjustmentsForInterestIncome_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember_zSpDuZ86Zw0k" title="Interest income"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3741"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--AdjustmentsForInterestIncome_pn3n3_c20250101__20251231_zwd7t2GpdC9h" title="Interest income"&gt;230,557&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Interest expense&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--InterestExpense_iN_pn3n3_di_c20250101__20251231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostCategoryMember_z0d3BxDY1aXk" title="Interest expense"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3745"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--InterestExpense_iN_pn3n3_di_c20250101__20251231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember_zfPx19XNStCb" title="Interest expense"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3747"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--InterestExpense_iN_pn3n3_di_c20250101__20251231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember_zX9GSayueFDg" title="Interest expense"&gt;(798,128&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--InterestExpense_iN_pn3n3_di_c20250101__20251231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember_zmtlT2dUS5ve" title="Interest expense"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3751"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--InterestExpense_iN_pn3n3_di_c20250101__20251231_ziLJbnpXoL2g" title="Interest expense"&gt;(798,128&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Foreign currency differences&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostCategoryMember_zon7pY8B9dS3" title="Foreign currency differences"&gt;4,205&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember_zt5K5WZXBOje" title="Foreign currency differences"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3757"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember_zZJoZ3QZ0fU7" title="Foreign currency differences"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3759"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember_zOAZ5nGLYCp7" title="Foreign currency differences"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3761"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_pn3n3_c20250101__20251231_zioYSWM21Rpk" title="Foreign currency differences"&gt;4,205&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Gain on valuation&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_909_ecustom--GainOnValuation_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostCategoryMember_zYy18UefvHg2" title="Gain on valuation"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3765"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_ecustom--GainOnValuation_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember_zzxuQmORSML9" title="Gain on valuation"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3767"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_907_ecustom--GainOnValuation_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember_z6rD8lL9pD33" title="Gain on valuation"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3769"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_ecustom--GainOnValuation_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember_zzkmZSPKO0ul" title="Gain on valuation"&gt;455,141&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_ecustom--GainOnValuation_pn3n3_c20250101__20251231_zrnUiz9gVY3e" title="Gain on valuation"&gt;455,141&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Loss on bond redemption&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--LossOnBondRedemption_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostCategoryMember_z98qZvwotsJ7" title="Loss on bond redemption"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3775"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_908_ecustom--LossOnBondRedemption_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember_zC3UExIxXTU1" title="Loss on bond redemption"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3777"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_907_ecustom--LossOnBondRedemption_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember_zYjlW41Q3AP" title="Loss on bond redemption"&gt;(69,890&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_904_ecustom--LossOnBondRedemption_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember_zysPr2abCff1" title="Loss on bond redemption"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3781"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_900_ecustom--LossOnBondRedemption_pn3n3_c20250101__20251231_zmmAZmNXTrag" title="Loss on bond redemption"&gt;(69,890&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: center; vertical-align: top; padding-left: 0.25in; padding-bottom: 1.25pt"&gt;Total&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--Total_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostCategoryMember_zUQoRV23TAzk" title="Total"&gt;234,762&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_907_ecustom--Total_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember_zaoWdC6Rjr92" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3787"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--Total_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember_ztWolM84mWhl" title="Total"&gt;(868,018&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_908_ecustom--Total_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember_zZxIbMuYcDDc" title="Total"&gt;455,141&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_909_ecustom--Total_pn3n3_c20250101__20251231_ztjOQpgUBdQh" title="Total"&gt;(178,115&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

















&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="18" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Financial&lt;br/&gt;assets at&lt;br/&gt;amortized cost&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Financial&lt;br/&gt;assets at fair&lt;br/&gt;value through other&lt;br/&gt;comprehensive&lt;br/&gt;income&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Financial&lt;br/&gt;liabilities at&lt;br/&gt;amortized cost&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Financial&lt;br/&gt;liabilities at&lt;br/&gt;fair value through&lt;br/&gt;profit or loss&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="18" style="text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Interest income&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--AdjustmentsForInterestIncome_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostCategoryMember_zSJbwZqNJBLi" title="Interest income"&gt;193,012&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--AdjustmentsForInterestIncome_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember_zkmuLJooPNhi" title="Interest income"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3804"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--AdjustmentsForInterestIncome_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember_z5zmySGUDCrd" title="Interest income"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3806"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--AdjustmentsForInterestIncome_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember_zq9aVWxWJWga" title="Interest income"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3808"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--AdjustmentsForInterestIncome_pn3n3_c20240101__20241231_zMQSSDkrOLI6" title="Interest income"&gt;193,012&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Interest expense&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--InterestExpense_iN_pn3n3_di_c20240101__20241231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostCategoryMember_z6wjsyegcbU7" title="Interest expense"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3812"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--InterestExpense_iN_pn3n3_di_c20240101__20241231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember_zDDLgB1c2fQ9" title="Interest expense"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3814"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--InterestExpense_iN_pn3n3_di_c20240101__20241231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember_zVF8Zp2C3Rth" title="Interest expense"&gt;(988,178&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--InterestExpense_iN_pn3n3_di_c20240101__20241231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember_z3iMCG8pgnLf" title="Interest expense"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3818"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--InterestExpense_iN_pn3n3_di_c20240101__20241231_zCgpMAxv32p7" title="Interest expense"&gt;(988,178&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Foreign currency differences&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostCategoryMember_zHAcK934EAEf" title="Foreign currency differences"&gt;8,501&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember_zLHiIgRjNn61" title="Foreign currency differences"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3824"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember_zUXOXbk5smJ1" title="Foreign currency differences"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3826"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember_zZ1Vxny3Lrya" title="Foreign currency differences"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3828"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_pn3n3_c20240101__20241231_z6IouEbio3U3" title="Foreign currency differences"&gt;8,501&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Gain on valuation&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_ecustom--GainOnValuation_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostCategoryMember_zwqIORXTZiM4" title="Gain on valuation"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3832"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_909_ecustom--GainOnValuation_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember_zsjH51ABC6F9" title="Gain on valuation"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3834"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_ecustom--GainOnValuation_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember_ztkangsN0kzk" title="Gain on valuation"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3836"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_906_ecustom--GainOnValuation_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember_z4kvFwaKQHL9" title="Gain on valuation"&gt;667,835&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_902_ecustom--GainOnValuation_pn3n3_c20240101__20241231_z8YYW3m7VYol" title="Gain on valuation"&gt;667,835&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Loss on bond redemption&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--LossOnBondRedemption_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostCategoryMember_zprSjPFaGQLl" title="Loss on bond redemption"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3842"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_903_ecustom--LossOnBondRedemption_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember_zlrXB7md2GH1" title="Loss on bond redemption"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3844"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_903_ecustom--LossOnBondRedemption_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember_zszJUNGE4Cie" title="Loss on bond redemption"&gt;(283,780&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_900_ecustom--LossOnBondRedemption_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember_z6FHaf04tInf" title="Loss on bond redemption"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3848"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--LossOnBondRedemption_pn3n3_c20240101__20241231_zMh7fySrCALk" title="Loss on bond redemption"&gt;(283,780&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: center; vertical-align: top; padding-left: 0.25in; padding-bottom: 1.25pt"&gt;Total&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--Total_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostCategoryMember_zUy4mXXaKqql" title="Total"&gt;201,513&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--Total_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember_zK1v6n8PoBZh" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3854"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_904_ecustom--Total_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember_zEqqItfEGvz5" title="Total"&gt;(1,271,958&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_901_ecustom--Total_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember_zN1edK1ikTDa" title="Total"&gt;667,835&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_903_ecustom--Total_pn3n3_c20240101__20241231_zmwIABcw3Idg" title="Total"&gt;(402,610&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:ScheduleOfNetGainsAndLossesByCategoryOfFinancialInstrumentsTableTextBlock>
    <ifrs-full:AdjustmentsForInterestIncome
      contextRef="From2025-01-012025-12-31_ifrs-full_FinancialAssetsAtAmortisedCostCategoryMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003735"
      unitRef="KRW">230557000</ifrs-full:AdjustmentsForInterestIncome>
    <ifrs-full:AdjustmentsForInterestIncome
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003743"
      unitRef="KRW">230557000</ifrs-full:AdjustmentsForInterestIncome>
    <ifrs-full:InterestExpense
      contextRef="From2025-01-012025-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostCategoryMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003749"
      unitRef="KRW">798128000</ifrs-full:InterestExpense>
    <ifrs-full:InterestExpense
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003753"
      unitRef="KRW">798128000</ifrs-full:InterestExpense>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss
      contextRef="From2025-01-012025-12-31_ifrs-full_FinancialAssetsAtAmortisedCostCategoryMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003755"
      unitRef="KRW">4205000</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003763"
      unitRef="KRW">4205000</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss>
    <cik0002058261:GainOnValuation
      contextRef="From2025-01-012025-12-31_ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003771"
      unitRef="KRW">455141000</cik0002058261:GainOnValuation>
    <cik0002058261:GainOnValuation
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003773"
      unitRef="KRW">455141000</cik0002058261:GainOnValuation>
    <cik0002058261:LossOnBondRedemption
      contextRef="From2025-01-012025-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostCategoryMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003779"
      unitRef="KRW">-69890000</cik0002058261:LossOnBondRedemption>
    <cik0002058261:LossOnBondRedemption
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003783"
      unitRef="KRW">-69890000</cik0002058261:LossOnBondRedemption>
    <cik0002058261:Total
      contextRef="From2025-01-012025-12-31_ifrs-full_FinancialAssetsAtAmortisedCostCategoryMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003785"
      unitRef="KRW">234762000</cik0002058261:Total>
    <cik0002058261:Total
      contextRef="From2025-01-012025-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostCategoryMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003789"
      unitRef="KRW">-868018000</cik0002058261:Total>
    <cik0002058261:Total
      contextRef="From2025-01-012025-12-31_ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003791"
      unitRef="KRW">455141000</cik0002058261:Total>
    <cik0002058261:Total
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003793"
      unitRef="KRW">-178115000</cik0002058261:Total>
    <ifrs-full:AdjustmentsForInterestIncome
      contextRef="From2024-01-012024-12-31_ifrs-full_FinancialAssetsAtAmortisedCostCategoryMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003802"
      unitRef="KRW">193012000</ifrs-full:AdjustmentsForInterestIncome>
    <ifrs-full:AdjustmentsForInterestIncome
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003810"
      unitRef="KRW">193012000</ifrs-full:AdjustmentsForInterestIncome>
    <ifrs-full:InterestExpense
      contextRef="From2024-01-012024-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostCategoryMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003816"
      unitRef="KRW">988178000</ifrs-full:InterestExpense>
    <ifrs-full:InterestExpense
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003820"
      unitRef="KRW">988178000</ifrs-full:InterestExpense>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss
      contextRef="From2024-01-012024-12-31_ifrs-full_FinancialAssetsAtAmortisedCostCategoryMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003822"
      unitRef="KRW">8501000</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003830"
      unitRef="KRW">8501000</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss>
    <cik0002058261:GainOnValuation
      contextRef="From2024-01-012024-12-31_ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003838"
      unitRef="KRW">667835000</cik0002058261:GainOnValuation>
    <cik0002058261:GainOnValuation
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003840"
      unitRef="KRW">667835000</cik0002058261:GainOnValuation>
    <cik0002058261:LossOnBondRedemption
      contextRef="From2024-01-012024-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostCategoryMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003846"
      unitRef="KRW">-283780000</cik0002058261:LossOnBondRedemption>
    <cik0002058261:LossOnBondRedemption
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003850"
      unitRef="KRW">-283780000</cik0002058261:LossOnBondRedemption>
    <cik0002058261:Total
      contextRef="From2024-01-012024-12-31_ifrs-full_FinancialAssetsAtAmortisedCostCategoryMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003852"
      unitRef="KRW">201513000</cik0002058261:Total>
    <cik0002058261:Total
      contextRef="From2024-01-012024-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostCategoryMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003856"
      unitRef="KRW">-1271958000</cik0002058261:Total>
    <cik0002058261:Total
      contextRef="From2024-01-012024-12-31_ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003858"
      unitRef="KRW">667835000</cik0002058261:Total>
    <cik0002058261:Total
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003860"
      unitRef="KRW">-402610000</cik0002058261:Total>
    <cik0002058261:CapitalAndReservesTextBlock
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact003862">&lt;p id="xdx_805_ecustom--CapitalAndReservesTextBlock_z5pwWWXjdnha" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;24. &lt;span id="xdx_82B_zL1ViZXYOZZ4"&gt;Capital and reserves&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;A.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;b&gt;Share capital&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Details of share capital as of December&#160;31, 2025 and 2024 are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_892_ecustom--ScheduleOfShareCapitalTableTextBlock_pn3n3_zRt9hFZaZerc" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Capital and reserves (Details)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_8B9_zMTJ5V8w9zfj" style="display: none"&gt;Schedule of share capital&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_498_20251231_zMtyUMee46h2" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_492_20241231_zYHnQtbWBFyk" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2024&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="text-align: center"&gt;&lt;b&gt;(In Korean&#160;won and number of shares)&lt;/b&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--NumberOfAuthorizedShares_iI_pd" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Number of authorized shares&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;1,000,000,000&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;1,000,000,000&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40A_eifrs-full--ParValuePerShare_iI_pd" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Value per share&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#x20a9;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;500&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;500&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40E_eifrs-full--NumberOfSharesIssued_iI_pd" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Number of shares issued&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;52,815,475&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;52,294,475&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--CommonShares_iI_pp0p" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Common shares&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#x20a9;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;26,407,737,500&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;26,147,237,500&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AF_zCysEXBMZwSl" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Holders of these shares are entitled to dividends as declared from time to time and are entitled to one vote per share at the general meetings of the Company.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;B.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;b&gt;Other components of equity&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 0.5in; text-align: left"&gt;i.&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;Details of other components of equity, net of taxes, as of December&#160;31, 2025 and 2024 are as follows:&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_898_ecustom--DetailsOfOtherComponentsOfEquityNetOfTaxesTableTextBlock_pn3n3_z1q8fReH3AXd" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Capital and reserves (Details 1)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span id="xdx_8B4_zM35p8D0wigg" style="display: none"&gt;Details of other components of equity, net of taxes&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_492_20251231_zIugGxD8VBQk" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_494_20241231_zk4B4SudriA1" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2024&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--OtherReservesAbstract_iB_znyovSzEo857" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Other reserves&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--EmployeeShareOptions_i01I_z6DpMLcCbAH7" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Employee share options&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;724,661&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;724,661&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_407_eifrs-full--TreasuryShares_iNI_di_zFu3d9qqsra4" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Treasury shares&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(1,414,953&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(1,451,864&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--Subtotal_iI_zkR9I3du39td" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: center; vertical-align: top; padding-bottom: 0.5pt"&gt;Subtotal&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(690,292&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(727,203&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_401_eifrs-full--OtherComprehensiveIncomeAbstract_iB_zESHLJbRQky1" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Other comprehensive income&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_406_eifrs-full--ReserveOfRemeasurementsOfDefinedBenefitPlans_iI_zD5V9s5qPGDk" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Remeasurements of defined benefit liability&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;125,654&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;73,533&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--OtherComprehensiveIncomeSubtotal_iI_pn3n3_za02PI9Up9Tl" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: center; vertical-align: top; padding-bottom: 0.5pt"&gt;Subtotal&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;125,654&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;73,533&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--SharePremiumAndOtherComponentsOfEquity_iI_zrA6pCfysStl" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: center; vertical-align: top; padding-bottom: 1.25pt"&gt;Total&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(564,638&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(653,670&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A0_zPGxXFn1ZVxj" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

















&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 0.5in; text-align: left"&gt;ii.&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;Changes in other components of equity for the years ended December&#160;31, 2025 and 2024 are as follows:&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_898_ecustom--ChangesInOtherComponentsOfEquityTableTextBlock_pn3n3_zbTklROglTw7" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Capital and reserves (Details 2)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span id="xdx_8BA_zc88Aja7Mwwi" style="display: none"&gt;Changes in other components of equity&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Remeasurements&lt;br/&gt; of defined&lt;br/&gt;benefit liability&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Employee share&lt;br/&gt;options&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Treasury&lt;br/&gt;shares&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="14" style="text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Balance as of January&#160;1, 2024&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--OtherEquity_iS_pn3n3_c20240101__20241231__ifrs-full--ComponentsOfEquityAxis__custom--RemeasurementsOfDefinedBenefitLiabilityMember_zCFN8Etfb8x4" title="Balance at beginning"&gt;201,386&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--OtherEquity_iS_pn3n3_c20240101__20241231__ifrs-full--ComponentsOfEquityAxis__custom--EmployeeShareOptionMember_zUyMfI2meEr8" title="Balance at beginning"&gt;3,149,428&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_907_ecustom--OtherEquity_iS_pn3n3_c20240101__20241231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--TreasurySharesMember_zw2dr9gFNFha" title="Balance at beginning"&gt;(1,808,647&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_905_ecustom--OtherEquity_iS_pn3n3_c20240101__20241231_zYZI5NY7CuMd" title="Balance at beginning"&gt;1,542,167&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Changes, net of taxes&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_ecustom--ChangesNetOfTaxes_iN_pn3n3_di_c20240101__20241231__ifrs-full--ComponentsOfEquityAxis__custom--RemeasurementsOfDefinedBenefitLiabilityMember_zWDwBU8b9ESd" title="Changes, net of taxes"&gt;(127,853&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_903_ecustom--ChangesNetOfTaxes_iN_pn3n3_di_c20240101__20241231__ifrs-full--ComponentsOfEquityAxis__custom--EmployeeShareOptionMember_zBCeYYhVSu0f" title="Changes, net of taxes"&gt;(2,424,767&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_901_ecustom--ChangesNetOfTaxes_iN_pn3n3_di_c20240101__20241231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--TreasurySharesMember_zUHDDhf7kdNk" title="Changes, net of taxes"&gt;356,783&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_909_ecustom--ChangesNetOfTaxes_iN_pn3n3_di_c20240101__20241231_z2N6Q5ORx6W9" title="Changes, net of taxes"&gt;(2,195,837&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Balance as of December&#160;31, 2024&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#x20a9;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_ecustom--OtherEquity_iS_pn3n3_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__custom--RemeasurementsOfDefinedBenefitLiabilityMember_zTh9nQnjFoz1" title="Balance at beginning"&gt;73,533&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_901_ecustom--OtherEquity_iS_pn3n3_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__custom--EmployeeShareOptionMember_zjQ5zDxpvbed" title="Balance at beginning"&gt;724,661&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_ecustom--OtherEquity_iS_pn3n3_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--TreasurySharesMember_zJoXimIffWPb" title="Balance at beginning"&gt;(1,451,864&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_905_ecustom--OtherEquity_iS_pn3n3_c20250101__20251231_zNJrSFuvHl8f" title="Balance at beginning"&gt;(653,670&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Changes, net of taxes&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_902_ecustom--ChangesNetOfTaxes_iN_pn3n3_di_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__custom--RemeasurementsOfDefinedBenefitLiabilityMember_z0RgC7uLgTsd" title="Changes, net of taxes"&gt;52,121&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--ChangesNetOfTaxes_iN_pn3n3_di_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__custom--EmployeeShareOptionMember_ziTrX8tDpPsf" title="Changes, net of taxes"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3939"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_905_ecustom--ChangesNetOfTaxes_iN_pn3n3_di_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--TreasurySharesMember_za9u83YxGw1e" title="Changes, net of taxes"&gt;36,911&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_905_ecustom--ChangesNetOfTaxes_iN_pn3n3_di_c20250101__20251231_zUL1eAVDwM35" title="Changes, net of taxes"&gt;89,032&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.25pt"&gt;Balance as of December&#160;31, 2025&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_905_ecustom--OtherEquity_iE_pn3n3_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__custom--RemeasurementsOfDefinedBenefitLiabilityMember_zKlz3LnoSaKe" title="Balance at ending"&gt;125,654&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_909_ecustom--OtherEquity_iE_pn3n3_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__custom--EmployeeShareOptionMember_zj5dMwwCdXrj" title="Balance at ending"&gt;724,661&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--OtherEquity_iE_pn3n3_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--TreasurySharesMember_zKo8QN1a4GN6" title="Balance at ending"&gt;(1,414,953&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_902_ecustom--OtherEquity_iE_pn3n3_c20250101__20251231_zqCG4IlDa723" title="Balance at ending"&gt;(564,638&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AF_zAOszExG3FId" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 0.5in; text-align: left"&gt;iii.&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;Details of treasury shares for the years ended December&#160;31, 2025 and 2024 are as follows:&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--ScheduleOfTreasurySharesTableTextBlock_pn3n3_zarL9z7T53n4" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Capital and reserves (Details 3)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;&lt;span id="xdx_8BA_zToYyKXbw7dd" style="display: none"&gt;Schedule of treasury shares&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Number of&lt;br/&gt;shares&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Carrying&lt;br/&gt;amount&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Number&#160;of&lt;br/&gt;shares&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Carrying&lt;br/&gt;amount&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="14" style="text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Beginning balance&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--NumberOfSharesOutstanding_iS_pid_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--TreasurySharesMember_zPAHs8NOGmC2" title="Number of shares at beginning balance"&gt;3,933,400&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_902_ecustom--CarryingAmounts_iS_pn3n3_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--TreasurySharesMember_zkP6vzA6HUF3" title="Carrying amount at beginning balance"&gt;1,451,864&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--NumberOfSharesOutstanding_iS_pid_c20240101__20241231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--TreasurySharesMember_z63hL4Ec4r3" title="Number of shares at beginning balance"&gt;4,900,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--CarryingAmounts_iS_pn3n3_c20240101__20241231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--TreasurySharesMember_zH7tVrMTttZ" title="Carrying amount at beginning balance"&gt;1,808,647&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Disposal (*)&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--DisposalShares_pid_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--TreasurySharesMember_fKCop_zAqgsYamJeB5" title="Disposal, shares"&gt;100,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--DisposalCarryingAmount_pn3n3_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--TreasurySharesMember_fKCop_z5vb0BxRPWqi" title="Disposal, carrying amount"&gt;36,911&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_909_ecustom--DisposalShares_pid_c20240101__20241231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--TreasurySharesMember_fKCop_zbeDrJvVNMKg" title="Disposal, shares"&gt;966,600&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--DisposalCarryingAmount_pn3n3_c20240101__20241231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--TreasurySharesMember_fKCop_z3NlGwsyjZo" title="Disposal, carrying amount"&gt;356,783&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.25pt"&gt;Ending balance&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--NumberOfSharesOutstanding_iE_pid_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--TreasurySharesMember_zDkxKuPLx9Wg" title="Number of shares at ending balance"&gt;3,833,400&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_902_ecustom--CarryingAmounts_iE_pn3n3_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--TreasurySharesMember_zyfKhAWSNeWl" title="Carrying amount at ending balance"&gt;1,414,953&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--NumberOfSharesOutstanding_iE_pid_c20240101__20241231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--TreasurySharesMember_zd7MtRoCks37" title="Number of shares at ending balance"&gt;3,933,400&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_902_ecustom--CarryingAmounts_iE_pn3n3_c20240101__20241231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--TreasurySharesMember_z8sT3NfMsJ7f" title="Carrying amount at ending balance"&gt;1,451,864&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;div style="width: 25%; margin-left: 0; margin-right: auto"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td id="xdx_F02_zGYuMNWv2gqk" style="width: 0.25in; text-align: left"&gt;(*)&lt;/td&gt;
    &lt;td id="xdx_F18_zNsNRjGcIHU3" style="text-align: justify"&gt;The Company disposed of treasury shares at per-share prices ranging from Korean won 2,000 to Korean won 5,000.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A3_z3LyozqmtCIl" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

</cik0002058261:CapitalAndReservesTextBlock>
    <cik0002058261:ScheduleOfShareCapitalTableTextBlock
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact003864">&lt;table cellpadding="0" cellspacing="0" id="xdx_892_ecustom--ScheduleOfShareCapitalTableTextBlock_pn3n3_zRt9hFZaZerc" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Capital and reserves (Details)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_8B9_zMTJ5V8w9zfj" style="display: none"&gt;Schedule of share capital&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_498_20251231_zMtyUMee46h2" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_492_20241231_zYHnQtbWBFyk" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2024&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="text-align: center"&gt;&lt;b&gt;(In Korean&#160;won and number of shares)&lt;/b&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--NumberOfAuthorizedShares_iI_pd" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Number of authorized shares&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;1,000,000,000&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;1,000,000,000&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40A_eifrs-full--ParValuePerShare_iI_pd" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Value per share&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#x20a9;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;500&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;500&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40E_eifrs-full--NumberOfSharesIssued_iI_pd" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Number of shares issued&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;52,815,475&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;52,294,475&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--CommonShares_iI_pp0p" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Common shares&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#x20a9;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;26,407,737,500&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;26,147,237,500&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:ScheduleOfShareCapitalTableTextBlock>
    <cik0002058261:NumberOfAuthorizedShares
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact003866"
      unitRef="Shares">1000000000</cik0002058261:NumberOfAuthorizedShares>
    <cik0002058261:NumberOfAuthorizedShares
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact003867"
      unitRef="Shares">1000000000</cik0002058261:NumberOfAuthorizedShares>
    <ifrs-full:ParValuePerShare
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact003869"
      unitRef="KRWShares">500</ifrs-full:ParValuePerShare>
    <ifrs-full:ParValuePerShare
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact003870"
      unitRef="KRWShares">500</ifrs-full:ParValuePerShare>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact003872"
      unitRef="Shares">52815475</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact003873"
      unitRef="Shares">52294475</ifrs-full:NumberOfSharesIssued>
    <cik0002058261:CommonShares
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="0"
      id="Fact003875"
      unitRef="KRW">26407737500</cik0002058261:CommonShares>
    <cik0002058261:CommonShares
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="0"
      id="Fact003876"
      unitRef="KRW">26147237500</cik0002058261:CommonShares>
    <cik0002058261:DetailsOfOtherComponentsOfEquityNetOfTaxesTableTextBlock
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact003878">&lt;table cellpadding="0" cellspacing="0" id="xdx_898_ecustom--DetailsOfOtherComponentsOfEquityNetOfTaxesTableTextBlock_pn3n3_z1q8fReH3AXd" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Capital and reserves (Details 1)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span id="xdx_8B4_zM35p8D0wigg" style="display: none"&gt;Details of other components of equity, net of taxes&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_492_20251231_zIugGxD8VBQk" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_494_20241231_zk4B4SudriA1" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2024&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--OtherReservesAbstract_iB_znyovSzEo857" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Other reserves&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--EmployeeShareOptions_i01I_z6DpMLcCbAH7" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Employee share options&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;724,661&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;724,661&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_407_eifrs-full--TreasuryShares_iNI_di_zFu3d9qqsra4" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Treasury shares&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(1,414,953&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(1,451,864&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--Subtotal_iI_zkR9I3du39td" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: center; vertical-align: top; padding-bottom: 0.5pt"&gt;Subtotal&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(690,292&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(727,203&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_401_eifrs-full--OtherComprehensiveIncomeAbstract_iB_zESHLJbRQky1" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Other comprehensive income&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_406_eifrs-full--ReserveOfRemeasurementsOfDefinedBenefitPlans_iI_zD5V9s5qPGDk" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Remeasurements of defined benefit liability&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;125,654&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;73,533&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--OtherComprehensiveIncomeSubtotal_iI_pn3n3_za02PI9Up9Tl" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: center; vertical-align: top; padding-bottom: 0.5pt"&gt;Subtotal&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;125,654&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;73,533&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--SharePremiumAndOtherComponentsOfEquity_iI_zrA6pCfysStl" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: center; vertical-align: top; padding-bottom: 1.25pt"&gt;Total&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(564,638&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(653,670&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:DetailsOfOtherComponentsOfEquityNetOfTaxesTableTextBlock>
    <cik0002058261:EmployeeShareOptions
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003883"
      unitRef="KRW">724661000</cik0002058261:EmployeeShareOptions>
    <cik0002058261:EmployeeShareOptions
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003884"
      unitRef="KRW">724661000</cik0002058261:EmployeeShareOptions>
    <ifrs-full:TreasuryShares
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003886"
      unitRef="KRW">1414953000</ifrs-full:TreasuryShares>
    <ifrs-full:TreasuryShares
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003887"
      unitRef="KRW">1451864000</ifrs-full:TreasuryShares>
    <cik0002058261:Subtotal
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003889"
      unitRef="KRW">-690292000</cik0002058261:Subtotal>
    <cik0002058261:Subtotal
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003890"
      unitRef="KRW">-727203000</cik0002058261:Subtotal>
    <ifrs-full:ReserveOfRemeasurementsOfDefinedBenefitPlans
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003895"
      unitRef="KRW">125654000</ifrs-full:ReserveOfRemeasurementsOfDefinedBenefitPlans>
    <ifrs-full:ReserveOfRemeasurementsOfDefinedBenefitPlans
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003896"
      unitRef="KRW">73533000</ifrs-full:ReserveOfRemeasurementsOfDefinedBenefitPlans>
    <cik0002058261:OtherComprehensiveIncomeSubtotal
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003898"
      unitRef="KRW">125654000</cik0002058261:OtherComprehensiveIncomeSubtotal>
    <cik0002058261:OtherComprehensiveIncomeSubtotal
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003899"
      unitRef="KRW">73533000</cik0002058261:OtherComprehensiveIncomeSubtotal>
    <cik0002058261:SharePremiumAndOtherComponentsOfEquity
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003901"
      unitRef="KRW">-564638000</cik0002058261:SharePremiumAndOtherComponentsOfEquity>
    <cik0002058261:SharePremiumAndOtherComponentsOfEquity
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003902"
      unitRef="KRW">-653670000</cik0002058261:SharePremiumAndOtherComponentsOfEquity>
    <cik0002058261:ChangesInOtherComponentsOfEquityTableTextBlock
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact003911">&lt;table cellpadding="0" cellspacing="0" id="xdx_898_ecustom--ChangesInOtherComponentsOfEquityTableTextBlock_pn3n3_zbTklROglTw7" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Capital and reserves (Details 2)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span id="xdx_8BA_zc88Aja7Mwwi" style="display: none"&gt;Changes in other components of equity&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Remeasurements&lt;br/&gt; of defined&lt;br/&gt;benefit liability&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Employee share&lt;br/&gt;options&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Treasury&lt;br/&gt;shares&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="14" style="text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Balance as of January&#160;1, 2024&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--OtherEquity_iS_pn3n3_c20240101__20241231__ifrs-full--ComponentsOfEquityAxis__custom--RemeasurementsOfDefinedBenefitLiabilityMember_zCFN8Etfb8x4" title="Balance at beginning"&gt;201,386&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--OtherEquity_iS_pn3n3_c20240101__20241231__ifrs-full--ComponentsOfEquityAxis__custom--EmployeeShareOptionMember_zUyMfI2meEr8" title="Balance at beginning"&gt;3,149,428&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_907_ecustom--OtherEquity_iS_pn3n3_c20240101__20241231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--TreasurySharesMember_zw2dr9gFNFha" title="Balance at beginning"&gt;(1,808,647&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_905_ecustom--OtherEquity_iS_pn3n3_c20240101__20241231_zYZI5NY7CuMd" title="Balance at beginning"&gt;1,542,167&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Changes, net of taxes&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_ecustom--ChangesNetOfTaxes_iN_pn3n3_di_c20240101__20241231__ifrs-full--ComponentsOfEquityAxis__custom--RemeasurementsOfDefinedBenefitLiabilityMember_zWDwBU8b9ESd" title="Changes, net of taxes"&gt;(127,853&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_903_ecustom--ChangesNetOfTaxes_iN_pn3n3_di_c20240101__20241231__ifrs-full--ComponentsOfEquityAxis__custom--EmployeeShareOptionMember_zBCeYYhVSu0f" title="Changes, net of taxes"&gt;(2,424,767&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_901_ecustom--ChangesNetOfTaxes_iN_pn3n3_di_c20240101__20241231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--TreasurySharesMember_zUHDDhf7kdNk" title="Changes, net of taxes"&gt;356,783&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_909_ecustom--ChangesNetOfTaxes_iN_pn3n3_di_c20240101__20241231_z2N6Q5ORx6W9" title="Changes, net of taxes"&gt;(2,195,837&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Balance as of December&#160;31, 2024&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#x20a9;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_ecustom--OtherEquity_iS_pn3n3_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__custom--RemeasurementsOfDefinedBenefitLiabilityMember_zTh9nQnjFoz1" title="Balance at beginning"&gt;73,533&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_901_ecustom--OtherEquity_iS_pn3n3_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__custom--EmployeeShareOptionMember_zjQ5zDxpvbed" title="Balance at beginning"&gt;724,661&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_ecustom--OtherEquity_iS_pn3n3_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--TreasurySharesMember_zJoXimIffWPb" title="Balance at beginning"&gt;(1,451,864&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_905_ecustom--OtherEquity_iS_pn3n3_c20250101__20251231_zNJrSFuvHl8f" title="Balance at beginning"&gt;(653,670&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Changes, net of taxes&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_902_ecustom--ChangesNetOfTaxes_iN_pn3n3_di_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__custom--RemeasurementsOfDefinedBenefitLiabilityMember_z0RgC7uLgTsd" title="Changes, net of taxes"&gt;52,121&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--ChangesNetOfTaxes_iN_pn3n3_di_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__custom--EmployeeShareOptionMember_ziTrX8tDpPsf" title="Changes, net of taxes"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3939"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_905_ecustom--ChangesNetOfTaxes_iN_pn3n3_di_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--TreasurySharesMember_za9u83YxGw1e" title="Changes, net of taxes"&gt;36,911&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_905_ecustom--ChangesNetOfTaxes_iN_pn3n3_di_c20250101__20251231_zUL1eAVDwM35" title="Changes, net of taxes"&gt;89,032&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.25pt"&gt;Balance as of December&#160;31, 2025&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_905_ecustom--OtherEquity_iE_pn3n3_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__custom--RemeasurementsOfDefinedBenefitLiabilityMember_zKlz3LnoSaKe" title="Balance at ending"&gt;125,654&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_909_ecustom--OtherEquity_iE_pn3n3_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__custom--EmployeeShareOptionMember_zj5dMwwCdXrj" title="Balance at ending"&gt;724,661&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--OtherEquity_iE_pn3n3_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--TreasurySharesMember_zKo8QN1a4GN6" title="Balance at ending"&gt;(1,414,953&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_902_ecustom--OtherEquity_iE_pn3n3_c20250101__20251231_zqCG4IlDa723" title="Balance at ending"&gt;(564,638&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:ChangesInOtherComponentsOfEquityTableTextBlock>
    <cik0002058261:OtherEquity
      contextRef="AsOf2023-12-31_custom_RemeasurementsOfDefinedBenefitLiabilityMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003913"
      unitRef="KRW">201386000</cik0002058261:OtherEquity>
    <cik0002058261:OtherEquity
      contextRef="AsOf2023-12-31_custom_EmployeeShareOptionMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003915"
      unitRef="KRW">3149428000</cik0002058261:OtherEquity>
    <cik0002058261:OtherEquity
      contextRef="AsOf2023-12-31_ifrs-full_TreasurySharesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003917"
      unitRef="KRW">-1808647000</cik0002058261:OtherEquity>
    <cik0002058261:OtherEquity
      contextRef="AsOf2023-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003919"
      unitRef="KRW">1542167000</cik0002058261:OtherEquity>
    <cik0002058261:ChangesNetOfTaxes
      contextRef="From2024-01-012024-12-31_custom_RemeasurementsOfDefinedBenefitLiabilityMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003921"
      unitRef="KRW">127853000</cik0002058261:ChangesNetOfTaxes>
    <cik0002058261:ChangesNetOfTaxes
      contextRef="From2024-01-012024-12-31_custom_EmployeeShareOptionMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003923"
      unitRef="KRW">2424767000</cik0002058261:ChangesNetOfTaxes>
    <cik0002058261:ChangesNetOfTaxes
      contextRef="From2024-01-012024-12-31_ifrs-full_TreasurySharesMember_custom_CubebioCo.Ltd.Member273631421"
      decimals="-3"
      id="Fact003925"
      unitRef="KRW">-356783000</cik0002058261:ChangesNetOfTaxes>
    <cik0002058261:ChangesNetOfTaxes
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003927"
      unitRef="KRW">2195837000</cik0002058261:ChangesNetOfTaxes>
    <cik0002058261:OtherEquity
      contextRef="AsOf2024-12-31_custom_RemeasurementsOfDefinedBenefitLiabilityMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003929"
      unitRef="KRW">73533000</cik0002058261:OtherEquity>
    <cik0002058261:OtherEquity
      contextRef="AsOf2024-12-31_custom_EmployeeShareOptionMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003931"
      unitRef="KRW">724661000</cik0002058261:OtherEquity>
    <cik0002058261:OtherEquity
      contextRef="AsOf2024-12-31_ifrs-full_TreasurySharesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003933"
      unitRef="KRW">-1451864000</cik0002058261:OtherEquity>
    <cik0002058261:OtherEquity
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003935"
      unitRef="KRW">-653670000</cik0002058261:OtherEquity>
    <cik0002058261:ChangesNetOfTaxes
      contextRef="From2025-01-012025-12-31_custom_RemeasurementsOfDefinedBenefitLiabilityMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003937"
      unitRef="KRW">-52121000</cik0002058261:ChangesNetOfTaxes>
    <cik0002058261:ChangesNetOfTaxes
      contextRef="From2025-01-012025-12-31_ifrs-full_TreasurySharesMember_custom_CubebioCo.Ltd.Member273631453"
      decimals="-3"
      id="Fact003941"
      unitRef="KRW">-36911000</cik0002058261:ChangesNetOfTaxes>
    <cik0002058261:ChangesNetOfTaxes
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003943"
      unitRef="KRW">-89032000</cik0002058261:ChangesNetOfTaxes>
    <cik0002058261:OtherEquity
      contextRef="AsOf2025-12-31_custom_RemeasurementsOfDefinedBenefitLiabilityMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003945"
      unitRef="KRW">125654000</cik0002058261:OtherEquity>
    <cik0002058261:OtherEquity
      contextRef="AsOf2025-12-31_custom_EmployeeShareOptionMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003947"
      unitRef="KRW">724661000</cik0002058261:OtherEquity>
    <cik0002058261:OtherEquity
      contextRef="AsOf2025-12-31_ifrs-full_TreasurySharesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003949"
      unitRef="KRW">-1414953000</cik0002058261:OtherEquity>
    <cik0002058261:OtherEquity
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003951"
      unitRef="KRW">-564638000</cik0002058261:OtherEquity>
    <cik0002058261:ScheduleOfTreasurySharesTableTextBlock
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact003953">&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--ScheduleOfTreasurySharesTableTextBlock_pn3n3_zarL9z7T53n4" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Capital and reserves (Details 3)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;&lt;span id="xdx_8BA_zToYyKXbw7dd" style="display: none"&gt;Schedule of treasury shares&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Number of&lt;br/&gt;shares&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Carrying&lt;br/&gt;amount&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Number&#160;of&lt;br/&gt;shares&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Carrying&lt;br/&gt;amount&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="14" style="text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Beginning balance&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--NumberOfSharesOutstanding_iS_pid_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--TreasurySharesMember_zPAHs8NOGmC2" title="Number of shares at beginning balance"&gt;3,933,400&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_902_ecustom--CarryingAmounts_iS_pn3n3_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--TreasurySharesMember_zkP6vzA6HUF3" title="Carrying amount at beginning balance"&gt;1,451,864&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--NumberOfSharesOutstanding_iS_pid_c20240101__20241231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--TreasurySharesMember_z63hL4Ec4r3" title="Number of shares at beginning balance"&gt;4,900,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--CarryingAmounts_iS_pn3n3_c20240101__20241231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--TreasurySharesMember_zH7tVrMTttZ" title="Carrying amount at beginning balance"&gt;1,808,647&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Disposal (*)&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--DisposalShares_pid_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--TreasurySharesMember_fKCop_zAqgsYamJeB5" title="Disposal, shares"&gt;100,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--DisposalCarryingAmount_pn3n3_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--TreasurySharesMember_fKCop_z5vb0BxRPWqi" title="Disposal, carrying amount"&gt;36,911&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_909_ecustom--DisposalShares_pid_c20240101__20241231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--TreasurySharesMember_fKCop_zbeDrJvVNMKg" title="Disposal, shares"&gt;966,600&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--DisposalCarryingAmount_pn3n3_c20240101__20241231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--TreasurySharesMember_fKCop_z3NlGwsyjZo" title="Disposal, carrying amount"&gt;356,783&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.25pt"&gt;Ending balance&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--NumberOfSharesOutstanding_iE_pid_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--TreasurySharesMember_zDkxKuPLx9Wg" title="Number of shares at ending balance"&gt;3,833,400&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_902_ecustom--CarryingAmounts_iE_pn3n3_c20250101__20251231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--TreasurySharesMember_zyfKhAWSNeWl" title="Carrying amount at ending balance"&gt;1,414,953&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--NumberOfSharesOutstanding_iE_pid_c20240101__20241231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--TreasurySharesMember_zd7MtRoCks37" title="Number of shares at ending balance"&gt;3,933,400&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_902_ecustom--CarryingAmounts_iE_pn3n3_c20240101__20241231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--TreasurySharesMember_z8sT3NfMsJ7f" title="Carrying amount at ending balance"&gt;1,451,864&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;div style="width: 25%; margin-left: 0; margin-right: auto"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td id="xdx_F02_zGYuMNWv2gqk" style="width: 0.25in; text-align: left"&gt;(*)&lt;/td&gt;
    &lt;td id="xdx_F18_zNsNRjGcIHU3" style="text-align: justify"&gt;The Company disposed of treasury shares at per-share prices ranging from Korean won 2,000 to Korean won 5,000.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:ScheduleOfTreasurySharesTableTextBlock>
    <ifrs-full:NumberOfSharesOutstanding
      contextRef="AsOf2024-12-31_ifrs-full_TreasurySharesMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact003955"
      unitRef="Shares">3933400</ifrs-full:NumberOfSharesOutstanding>
    <cik0002058261:CarryingAmounts
      contextRef="AsOf2024-12-31_ifrs-full_TreasurySharesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003957"
      unitRef="KRW">1451864000</cik0002058261:CarryingAmounts>
    <ifrs-full:NumberOfSharesOutstanding
      contextRef="AsOf2023-12-31_ifrs-full_TreasurySharesMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact003959"
      unitRef="Shares">4900000</ifrs-full:NumberOfSharesOutstanding>
    <cik0002058261:CarryingAmounts
      contextRef="AsOf2023-12-31_ifrs-full_TreasurySharesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003961"
      unitRef="KRW">1808647000</cik0002058261:CarryingAmounts>
    <cik0002058261:DisposalShares
      contextRef="From2025-01-012025-12-31_ifrs-full_TreasurySharesMember_custom_CubebioCo.Ltd.Member273631453"
      decimals="INF"
      id="Fact003963"
      unitRef="Shares">100000</cik0002058261:DisposalShares>
    <cik0002058261:DisposalCarryingAmount
      contextRef="From2025-01-012025-12-31_ifrs-full_TreasurySharesMember_custom_CubebioCo.Ltd.Member273631453"
      decimals="-3"
      id="Fact003965"
      unitRef="KRW">36911000</cik0002058261:DisposalCarryingAmount>
    <cik0002058261:DisposalShares
      contextRef="From2024-01-012024-12-31_ifrs-full_TreasurySharesMember_custom_CubebioCo.Ltd.Member273631421"
      decimals="INF"
      id="Fact003967"
      unitRef="Shares">966600</cik0002058261:DisposalShares>
    <cik0002058261:DisposalCarryingAmount
      contextRef="From2024-01-012024-12-31_ifrs-full_TreasurySharesMember_custom_CubebioCo.Ltd.Member273631421"
      decimals="-3"
      id="Fact003969"
      unitRef="KRW">356783000</cik0002058261:DisposalCarryingAmount>
    <ifrs-full:NumberOfSharesOutstanding
      contextRef="AsOf2025-12-31_ifrs-full_TreasurySharesMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact003971"
      unitRef="Shares">3833400</ifrs-full:NumberOfSharesOutstanding>
    <cik0002058261:CarryingAmounts
      contextRef="AsOf2025-12-31_ifrs-full_TreasurySharesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003973"
      unitRef="KRW">1414953000</cik0002058261:CarryingAmounts>
    <ifrs-full:NumberOfSharesOutstanding
      contextRef="AsOf2024-12-31_ifrs-full_TreasurySharesMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact003975"
      unitRef="Shares">3933400</ifrs-full:NumberOfSharesOutstanding>
    <cik0002058261:CarryingAmounts
      contextRef="AsOf2024-12-31_ifrs-full_TreasurySharesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003977"
      unitRef="KRW">1451864000</cik0002058261:CarryingAmounts>
    <cik0002058261:CapitalManagementTextBlock
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact003980">&lt;p id="xdx_802_ecustom--CapitalManagementTextBlock_z6cXRrAYN3N7" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;25. &lt;span id="xdx_826_z4HdJNyAKwhb"&gt;Capital management&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company&#x2019;s policy is to maintain a strong capital base to uphold investor, creditor, and market confidence and to sustain future development of the business. The Company monitors capital using a ratio of &#x2018;net debt&#x2019; to &#x2018;total equity&#x2019;. Net debt is calculated as total liabilities (as shown in the statement of financial position) less cash and cash equivalents. The Company&#x2019;s net debt to adjusted equity ratio as of December&#160;31, 2025 and 2024 is as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89A_ecustom--ScheduleOfNetDebtToAdjustedEquityRatioOfEquityTableTextBlock_pn3n3_zV846EqM5gSl" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Capital management (Details)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_8B9_zJylJ9T9xRN3" style="display: none"&gt;Schedule of net debt to adjusted equity ratio&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_495_20251231_zNLB4LRDW3Pb" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_497_20241231_zZGaRv2Xlf2b" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2024&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--TotalLiabilities_iI_pn3n3_zVUVMmYzbZib" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Total liabilities&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;9,668,292&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;7,915,357&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--LessCashAndCashEquivalents_iNI_pn3n3_di_zJCeOSCiiWw6" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Less: Cash and cash equivalents&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(335,814&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(3,662,174&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_408_eifrs-full--NetDebt_iI_pn3n3_zEEusMDsg8cd" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Net debt&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;9,332,478&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;4,253,183&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--Equities_iI_pn3n3_zn4uYvD7aEIc" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.25pt"&gt;Total equity&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(3,198,381&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;826,608&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--NetDebtToEquityRatio_iI_pid_dp_z8NcZo8fPzX9" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Net debt to total equity ratio &lt;span id="xdx_F4F_zyJ7Jz4F8048"&gt;(*)&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3996"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;5.15&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;div style="width: 25%; margin-left: 0; margin-right: auto"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td id="xdx_F03_zJrO3nR2BWL4" style="width: 0.25in; text-align: left"&gt;(*)&lt;/td&gt;
    &lt;td id="xdx_F1F_zeUu8hVZQpX3" style="text-align: justify"&gt;Net debt to total equity ratio is not calculated as total equity is negative.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A1_zy0XuFOPQJV7" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

















</cik0002058261:CapitalManagementTextBlock>
    <cik0002058261:ScheduleOfNetDebtToAdjustedEquityRatioOfEquityTableTextBlock
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact003982">&lt;table cellpadding="0" cellspacing="0" id="xdx_89A_ecustom--ScheduleOfNetDebtToAdjustedEquityRatioOfEquityTableTextBlock_pn3n3_zV846EqM5gSl" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Capital management (Details)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_8B9_zJylJ9T9xRN3" style="display: none"&gt;Schedule of net debt to adjusted equity ratio&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_495_20251231_zNLB4LRDW3Pb" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_497_20241231_zZGaRv2Xlf2b" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2024&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--TotalLiabilities_iI_pn3n3_zVUVMmYzbZib" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Total liabilities&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;9,668,292&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;7,915,357&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--LessCashAndCashEquivalents_iNI_pn3n3_di_zJCeOSCiiWw6" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Less: Cash and cash equivalents&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(335,814&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(3,662,174&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_408_eifrs-full--NetDebt_iI_pn3n3_zEEusMDsg8cd" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Net debt&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;9,332,478&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;4,253,183&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--Equities_iI_pn3n3_zn4uYvD7aEIc" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.25pt"&gt;Total equity&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(3,198,381&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;826,608&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--NetDebtToEquityRatio_iI_pid_dp_z8NcZo8fPzX9" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Net debt to total equity ratio &lt;span id="xdx_F4F_zyJ7Jz4F8048"&gt;(*)&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3996"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;5.15&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;div style="width: 25%; margin-left: 0; margin-right: auto"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td id="xdx_F03_zJrO3nR2BWL4" style="width: 0.25in; text-align: left"&gt;(*)&lt;/td&gt;
    &lt;td id="xdx_F1F_zeUu8hVZQpX3" style="text-align: justify"&gt;Net debt to total equity ratio is not calculated as total equity is negative.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:ScheduleOfNetDebtToAdjustedEquityRatioOfEquityTableTextBlock>
    <cik0002058261:TotalLiabilities
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003984"
      unitRef="KRW">9668292000</cik0002058261:TotalLiabilities>
    <cik0002058261:TotalLiabilities
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003985"
      unitRef="KRW">7915357000</cik0002058261:TotalLiabilities>
    <cik0002058261:LessCashAndCashEquivalents
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003987"
      unitRef="KRW">335814000</cik0002058261:LessCashAndCashEquivalents>
    <cik0002058261:LessCashAndCashEquivalents
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003988"
      unitRef="KRW">3662174000</cik0002058261:LessCashAndCashEquivalents>
    <ifrs-full:NetDebt
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003990"
      unitRef="KRW">9332478000</ifrs-full:NetDebt>
    <ifrs-full:NetDebt
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003991"
      unitRef="KRW">4253183000</ifrs-full:NetDebt>
    <cik0002058261:Equities
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003993"
      unitRef="KRW">-3198381000</cik0002058261:Equities>
    <cik0002058261:Equities
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact003994"
      unitRef="KRW">826608000</cik0002058261:Equities>
    <cik0002058261:NetDebtToEquityRatio
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact003997"
      unitRef="Pure">0.0515</cik0002058261:NetDebtToEquityRatio>
    <cik0002058261:ShareBasedPaymentArrangementsTextBlock
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact004007">&lt;p id="xdx_807_ecustom--ShareBasedPaymentArrangementsTextBlock_zgt44Er5jgch" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;26. &lt;span id="xdx_827_zW6Hu4vWd6de"&gt;Share-based payment arrangements&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;A.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;b&gt;Description of share-based payment arrangements&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;As of December&#160;31, 2025, the Company had the following share-based payment arrangements. On October&#160;1, 2015, June&#160;29, 2016 and June&#160;15, 2020, the Company established share option plans that entitle key management personnel, employees, and non-employees to purchase shares in the Company. Under these plans, holders of vested options are entitled to purchase shares at the exercise price agreed upon at the grant date.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The key terms and conditions related to the grants under these plans are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89B_ecustom--ScheduleOfShareOptionPlanTableTextBlock_pn3n3_zNtKIqjZszZ7" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Share-based payment arrangements (Details)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_8B8_zKE5RVhahXpa" style="display: none"&gt;Schedule of share option plan&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;b&gt;Grant date&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Number of&lt;br/&gt;instruments&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Vesting&lt;br/&gt;conditions&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Contractual&lt;br/&gt;life of options&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Type&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Underlying&lt;br/&gt;assets&lt;/b&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; width: 29%"&gt;As of October&#160;1, 2015 (*1)&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 7%"&gt;&lt;span id="xdx_907_ecustom--NumberOfInstruments_pid_c20150929__20151001_fKCoxKQ_____zWuXMRmc0lG8" title="Number of instruments"&gt;9,500,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: top; width: 18%"&gt;&lt;span id="xdx_90F_ecustom--VestingCondition_c20150929__20151001_fKCoxKQ_____zPqDdqRmCsxg" title="Vesting condition"&gt;2 years&#x2019; service from grant date&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: top; width: 8%"&gt;&lt;span id="xdx_907_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20150929__20151001_fKCoxKQ_____zAbavgwwXAk1" title="Contractual life of options"&gt;9&lt;/span&gt; years&lt;/td&gt;
    &lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: top; width: 10%"&gt;&lt;span id="xdx_90F_ecustom--Type_c20150929__20151001_fKCoxKQ_____z1gdJtYewV0f" title="Type"&gt;Equity-settled&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: top; width: 18%"&gt;&lt;span id="xdx_904_ecustom--UnderlyingAssets_c20150929__20151001_fKCoxKQ_____zc3lVnivDW8f" title="Underlying assets"&gt;CUBEBIO&#160;Co., Ltd.&#x2019;s ordinary shares&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;As of June&#160;29, 2016 (*2)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_907_ecustom--NumberOfInstruments_pid_c20160601__20160629_fKCoyKQ_____zxQQV3r2djOk" title="Number of instruments"&gt;85,638&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: top"&gt;&lt;span id="xdx_90F_ecustom--VestingCondition_c20160601__20160629_fKCoyKQ_____zwyDmR5jcN96" title="Vesting condition"&gt;2 years&#x2019; service from grant date&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: top"&gt;&lt;span id="xdx_903_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20160601__20160629_fKCoyKQ_____zn92VemdCpUl" title="Contractual life of options"&gt;9&lt;/span&gt; years&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: top"&gt;&lt;span id="xdx_90D_ecustom--Type_c20160601__20160629_fKCoyKQ_____z3DmmUn86hA5" title="Type"&gt;Equity-settled&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: top"&gt;&lt;span id="xdx_900_ecustom--UnderlyingAssets_c20160601__20160629_fKCoyKQ_____zrzKjlris1Xi" title="Underlying  assets"&gt;CUBEBIO&#160;Co., Ltd.&#x2019;s ordinary shares&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;As of June&#160;15, 2020&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--NumberOfInstruments_pid_c20200601__20200615_zUUA5rRX4Eyb" title="Number of instruments"&gt;7,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: top; padding-bottom: 0.5pt"&gt;&lt;span id="xdx_905_ecustom--VestingCondition_c20200601__20200615_zdrDNZUjKZnd" title="Vesting condition"&gt;2 years&#x2019; service from grant date&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: top; padding-bottom: 0.5pt"&gt;&lt;span id="xdx_901_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20200601__20200615_zJcdU32ba4U2" title="Contractual life of options"&gt;7&lt;/span&gt; years&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: top; padding-bottom: 0.5pt"&gt;&lt;span id="xdx_900_ecustom--Type_c20200601__20200615_z99otGHxHAW7" title="Type"&gt;Equity-settled&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: top; padding-bottom: 0.5pt"&gt;&lt;span id="xdx_90F_ecustom--UnderlyingAssets_c20200601__20200615_zeotma84Cet1" title="Underlying  assets"&gt;CUBEBIO&#160;Co., Ltd.&#x2019;s ordinary shares&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.25pt"&gt;&lt;b&gt;Total share options&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_903_ecustom--NumberOfInstruments_pid_c20250101__20251231_z2HqCpKT1G9b" title="Number of instruments"&gt;16,585,638&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;div style="width: 25%; margin-left: 0; margin-right: auto"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td id="xdx_F0F_zG1k9xmLENT3" style="width: 0.25in; text-align: left"&gt;(*1)&lt;/td&gt;
    &lt;td id="xdx_F1F_ze6IthfPPOKk" style="text-align: justify"&gt;The options granted as of October&#160;1, 2015 have been fully vested. Certain of these options were exercised, and the remaining options expired upon reaching the end of their contractual life. As of December&#160;31, 2025, there were no exercisable options outstanding related to this grant&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td id="xdx_F00_z4TvkVwuxcSc" style="text-align: left"&gt;(*2)&lt;/td&gt;
    &lt;td id="xdx_F15_zCjlksCZOtke" style="text-align: justify"&gt;The options granted as of June&#160;29, 2016 have been fully vested and exercised. As of December&#160;31, 2025, there were no exercisable options outstanding related to this grant.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AC_zbBI81qzqlQ7" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;B.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;b&gt;Measurement of fair value&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The fair value of the employee share options granted as of June&#160;15, 2020 has been measured using a binomial model. The inputs used in the measurement of the fair values at the grant date of the equity-settled share-based payment plans are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_892_ecustom--ScheduleOfShareOptionGrantTableTextBlock_pn3n3_zKFGgnpSz0f" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Share-based payment arrangements (Details 1)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; vertical-align: top"&gt;&lt;span id="xdx_8B5_zNAFmbTFkQPc" style="display: none"&gt;Schedule of share option grant&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;th style="border-bottom: Black 1pt solid; padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&lt;b&gt;Share option plan (equity-settled)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;June 15,&lt;br/&gt; 2020&lt;/b&gt;&lt;/th&gt;
    &lt;th style="white-space: nowrap; text-align: center; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;th style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center"&gt;&#160;&lt;/th&gt;
    &lt;th style="text-align: center"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="text-align: center"&gt;&lt;b&gt;(In Korean won and number of shares)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="white-space: nowrap; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; vertical-align: top"&gt;Fair value of option&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--WeightedAverageFairValueAtMeasurementDateShareOptionsGranted_iI_pn3n3_c20200615__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ShareOptionPlanEquitySettledMember_zK68EtdKUtSh" title="Fair value of option"&gt;1,132&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; vertical-align: top"&gt;Share price&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#x20a9;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--WeightedAverageSharePrice2019_pid_c20200601__20200615__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ShareOptionPlanEquitySettledMember_zM1Bn5cZkgG2" title="Share price"&gt;1,412&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; vertical-align: top"&gt;Exercise price&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#x20a9;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--ProceedsFromExerciseOfOptions_pn3n3_c20200601__20200615__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ShareOptionPlanEquitySettledMember_zk0W5vRkPnn4" title="Exercise price"&gt;500&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; vertical-align: top"&gt;Risk - free interest rate (based on government bonds)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20200601__20200615__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ShareOptionPlanEquitySettledMember_zBRR3ux8sMU2" title="Risk- free interest rate (based on government bonds)"&gt;3.89&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;%&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; vertical-align: top"&gt;Volatility (*)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20200601__20200615__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ShareOptionPlanEquitySettledMember_fKCop_zbJ8EO1L9IAl" title="Volatility"&gt;83.78&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;%&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; vertical-align: top"&gt;Expected term (years)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--DescriptionOfOptionLifeShareOptionsGranted_dtY_uDecimal_c20200601__20200615__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ShareOptionPlanEquitySettledMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zEemuD2Dezic" title="Expected term (years)"&gt;4&lt;/span&gt; ~ &lt;span id="xdx_908_eifrs-full--DescriptionOfOptionLifeShareOptionsGranted_dtY_uDecimal_c20200601__20200615__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ShareOptionPlanEquitySettledMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zmUPXBA7rKEg" title="Expected term (years)"&gt;5&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; vertical-align: top"&gt;Expected dividend&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20200601__20200615__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ShareOptionPlanEquitySettledMember_zzx8HObCJpCe" title="Expected dividend"&gt;0&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;%&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;div style="width: 25%; margin-left: 0; margin-right: auto"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td id="xdx_F02_znMoA4d0Y1Rl" style="width: 0.25in; text-align: left"&gt;(*)&lt;/td&gt;
    &lt;td id="xdx_F12_zHATehfTxaJ9" style="text-align: justify"&gt;Volatility has been calculated based on an evaluation of the historical volatility of other companies&#x2019; share prices, which are listed in KOSDAQ, particularly over the historical period commensurate with the prior year.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AF_z9n7ZClMSTxe" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

















&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;C.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;b&gt;Reconciliation of outstanding share options&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;The number and exercise prices of share options under the share option plan for the years ended December&#160;31, 2025 and 2024 are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89E_ecustom--ReconciliationofoutstandingshareOptionsTableTextBlock_pn3n3_zamffOwlU3p9" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Share-based payment arrangements (Details 2)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_8B0_zAcLUTfjgJXk" style="display: none"&gt;Schedule of reconciliation of outstanding share options&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="8" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="8" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&lt;b&gt;Share option plan (equity-settled)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Number&#160;of&lt;br/&gt;options&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Exercise&lt;br/&gt;price(*)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Number&#160;of&lt;br/&gt;options&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Exercise&lt;br/&gt;price(*)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="18" style="text-align: center"&gt;&lt;b&gt;(In Korean Won and number of options)&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; width: 48%"&gt;Outstanding at January&#160;1&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_uShares_c20250101__20251231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ShareOptionPlanEquitySettledMember_zXiBuCUQTID5" title="Number of options, outstanding at beginning"&gt;640,160&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iS_pid_c20250101__20251231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ShareOptionPlanEquitySettledMember_fKCop_z9OoENfBGE49" title="Exercise price, at beginning"&gt;500&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_uShares_c20240101__20241231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ShareOptionPlanEquitySettledMember_znDz4jDULUM8" title="Number of options, outstanding at beginning"&gt;3,893,760&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iS_pid_c20240101__20241231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ShareOptionPlanEquitySettledMember_fKCop_zVMOgJva64D5" title="Exercise price, at beginning"&gt;500&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Expired during the year&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement_iN_pid_di_uShares_c20250101__20251231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ShareOptionPlanEquitySettledMember_z5e9lTg5Hzc5" title="Expired during the year"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4081"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;-&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement_iN_pid_di_uShares_c20240101__20241231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ShareOptionPlanEquitySettledMember_zbZn5AfsXNUi" title="Expired during the year"&gt;(1,200,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019_pid_c20240101__20241231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ShareOptionPlanEquitySettledMember_fKCop_znXI1hAYSyO4" title="Exercise price, Expired"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4085"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Exercised during the year&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement_iN_pid_di_uShares_c20250101__20251231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ShareOptionPlanEquitySettledMember_zh09EWzxm7Oe" title="Expired during the year"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4087"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;-&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pid_di_uShares_c20240101__20241231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ShareOptionPlanEquitySettledMember_zQT1Pnt6LQh4" title="Exercised during the year"&gt;(2,053,600&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_c20240101__20241231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ShareOptionPlanEquitySettledMember_fKCop_zoXVuxtpP4c7" title="Exercise price, Exercised"&gt;500&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Outstanding at December&#160;31&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_uShares_c20250101__20251231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ShareOptionPlanEquitySettledMember_zwPo3Eogweq2" title="Number of options, outstanding at end"&gt;640,160&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iE_pid_c20250101__20251231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ShareOptionPlanEquitySettledMember_fKCop_z4ftxrwKqAhc" title="Exercise price, at end"&gt;500&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_uShares_c20240101__20241231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ShareOptionPlanEquitySettledMember_z2CEzf6VYTXe" title="Number of options, outstanding at end"&gt;640,160&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iE_pid_c20240101__20241231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ShareOptionPlanEquitySettledMember_fKCop_z4NMEPnkKbs9" title="Exercise price, at end"&gt;500&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.25pt"&gt;Exercisable at December&#160;31&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pid_uShares_c20251231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ShareOptionPlanEquitySettledMember_zZM8si4whtgi" title="Number of options, exercisable"&gt;640,160&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pid_c20251231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ShareOptionPlanEquitySettledMember_fKCop_zHTuXkutiXP8" title="Exercise price"&gt;500&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pid_uShares_c20241231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ShareOptionPlanEquitySettledMember_zrmVzfMMxe69" title="Number of options, exercisable"&gt;640,160&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pid_c20241231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ShareOptionPlanEquitySettledMember_fKCop_zUDmJSGqFThg" title="Exercise price"&gt;500&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;div style="width: 25%; margin-left: 0; margin-right: auto"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td id="xdx_F01_zPQRibdbH0E7" style="width: 0.25in; text-align: left"&gt;(*)&lt;/td&gt;
    &lt;td id="xdx_F1A_zQVxZdPscNrc" style="text-align: justify"&gt;Weighted average exercise price per share.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A5_zrIZYa3GTqTa" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

</cik0002058261:ShareBasedPaymentArrangementsTextBlock>
    <cik0002058261:ScheduleOfShareOptionPlanTableTextBlock
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact004009">&lt;table cellpadding="0" cellspacing="0" id="xdx_89B_ecustom--ScheduleOfShareOptionPlanTableTextBlock_pn3n3_zNtKIqjZszZ7" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Share-based payment arrangements (Details)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_8B8_zKE5RVhahXpa" style="display: none"&gt;Schedule of share option plan&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;b&gt;Grant date&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Number of&lt;br/&gt;instruments&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Vesting&lt;br/&gt;conditions&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Contractual&lt;br/&gt;life of options&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Type&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Underlying&lt;br/&gt;assets&lt;/b&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; width: 29%"&gt;As of October&#160;1, 2015 (*1)&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 7%"&gt;&lt;span id="xdx_907_ecustom--NumberOfInstruments_pid_c20150929__20151001_fKCoxKQ_____zWuXMRmc0lG8" title="Number of instruments"&gt;9,500,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: top; width: 18%"&gt;&lt;span id="xdx_90F_ecustom--VestingCondition_c20150929__20151001_fKCoxKQ_____zPqDdqRmCsxg" title="Vesting condition"&gt;2 years&#x2019; service from grant date&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: top; width: 8%"&gt;&lt;span id="xdx_907_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20150929__20151001_fKCoxKQ_____zAbavgwwXAk1" title="Contractual life of options"&gt;9&lt;/span&gt; years&lt;/td&gt;
    &lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: top; width: 10%"&gt;&lt;span id="xdx_90F_ecustom--Type_c20150929__20151001_fKCoxKQ_____z1gdJtYewV0f" title="Type"&gt;Equity-settled&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: top; width: 18%"&gt;&lt;span id="xdx_904_ecustom--UnderlyingAssets_c20150929__20151001_fKCoxKQ_____zc3lVnivDW8f" title="Underlying assets"&gt;CUBEBIO&#160;Co., Ltd.&#x2019;s ordinary shares&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;As of June&#160;29, 2016 (*2)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_907_ecustom--NumberOfInstruments_pid_c20160601__20160629_fKCoyKQ_____zxQQV3r2djOk" title="Number of instruments"&gt;85,638&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: top"&gt;&lt;span id="xdx_90F_ecustom--VestingCondition_c20160601__20160629_fKCoyKQ_____zwyDmR5jcN96" title="Vesting condition"&gt;2 years&#x2019; service from grant date&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: top"&gt;&lt;span id="xdx_903_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20160601__20160629_fKCoyKQ_____zn92VemdCpUl" title="Contractual life of options"&gt;9&lt;/span&gt; years&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: top"&gt;&lt;span id="xdx_90D_ecustom--Type_c20160601__20160629_fKCoyKQ_____z3DmmUn86hA5" title="Type"&gt;Equity-settled&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: top"&gt;&lt;span id="xdx_900_ecustom--UnderlyingAssets_c20160601__20160629_fKCoyKQ_____zrzKjlris1Xi" title="Underlying  assets"&gt;CUBEBIO&#160;Co., Ltd.&#x2019;s ordinary shares&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;As of June&#160;15, 2020&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--NumberOfInstruments_pid_c20200601__20200615_zUUA5rRX4Eyb" title="Number of instruments"&gt;7,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: top; padding-bottom: 0.5pt"&gt;&lt;span id="xdx_905_ecustom--VestingCondition_c20200601__20200615_zdrDNZUjKZnd" title="Vesting condition"&gt;2 years&#x2019; service from grant date&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: top; padding-bottom: 0.5pt"&gt;&lt;span id="xdx_901_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20200601__20200615_zJcdU32ba4U2" title="Contractual life of options"&gt;7&lt;/span&gt; years&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: top; padding-bottom: 0.5pt"&gt;&lt;span id="xdx_900_ecustom--Type_c20200601__20200615_z99otGHxHAW7" title="Type"&gt;Equity-settled&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: top; padding-bottom: 0.5pt"&gt;&lt;span id="xdx_90F_ecustom--UnderlyingAssets_c20200601__20200615_zeotma84Cet1" title="Underlying  assets"&gt;CUBEBIO&#160;Co., Ltd.&#x2019;s ordinary shares&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.25pt"&gt;&lt;b&gt;Total share options&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_903_ecustom--NumberOfInstruments_pid_c20250101__20251231_z2HqCpKT1G9b" title="Number of instruments"&gt;16,585,638&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;div style="width: 25%; margin-left: 0; margin-right: auto"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td id="xdx_F0F_zG1k9xmLENT3" style="width: 0.25in; text-align: left"&gt;(*1)&lt;/td&gt;
    &lt;td id="xdx_F1F_ze6IthfPPOKk" style="text-align: justify"&gt;The options granted as of October&#160;1, 2015 have been fully vested. Certain of these options were exercised, and the remaining options expired upon reaching the end of their contractual life. As of December&#160;31, 2025, there were no exercisable options outstanding related to this grant&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td id="xdx_F00_z4TvkVwuxcSc" style="text-align: left"&gt;(*2)&lt;/td&gt;
    &lt;td id="xdx_F15_zCjlksCZOtke" style="text-align: justify"&gt;The options granted as of June&#160;29, 2016 have been fully vested and exercised. As of December&#160;31, 2025, there were no exercisable options outstanding related to this grant.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:ScheduleOfShareOptionPlanTableTextBlock>
    <cik0002058261:NumberOfInstruments
      contextRef="From2015-09-292015-10-01_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact004011"
      unitRef="Shares">9500000</cik0002058261:NumberOfInstruments>
    <cik0002058261:VestingCondition
      contextRef="From2015-09-292015-10-01_custom_CubebioCo.Ltd.Member"
      id="Fact004013">2 years&#x2019; service from grant date</cik0002058261:VestingCondition>
    <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019
      contextRef="From2015-09-292015-10-01_custom_CubebioCo.Ltd.Member"
      id="Fact004015">P9Y</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
    <cik0002058261:Type
      contextRef="From2015-09-292015-10-01_custom_CubebioCo.Ltd.Member"
      id="Fact004017">Equity-settled</cik0002058261:Type>
    <cik0002058261:UnderlyingAssets
      contextRef="From2015-09-292015-10-01_custom_CubebioCo.Ltd.Member"
      id="Fact004019">CUBEBIO&#160;Co., Ltd.&#x2019;s ordinary shares</cik0002058261:UnderlyingAssets>
    <cik0002058261:NumberOfInstruments
      contextRef="From2016-06-012016-06-29_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact004021"
      unitRef="Shares">85638</cik0002058261:NumberOfInstruments>
    <cik0002058261:VestingCondition
      contextRef="From2016-06-012016-06-29_custom_CubebioCo.Ltd.Member"
      id="Fact004023">2 years&#x2019; service from grant date</cik0002058261:VestingCondition>
    <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019
      contextRef="From2016-06-012016-06-29_custom_CubebioCo.Ltd.Member"
      id="Fact004025">P9Y</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
    <cik0002058261:Type
      contextRef="From2016-06-012016-06-29_custom_CubebioCo.Ltd.Member"
      id="Fact004027">Equity-settled</cik0002058261:Type>
    <cik0002058261:UnderlyingAssets
      contextRef="From2016-06-012016-06-29_custom_CubebioCo.Ltd.Member"
      id="Fact004029">CUBEBIO&#160;Co., Ltd.&#x2019;s ordinary shares</cik0002058261:UnderlyingAssets>
    <cik0002058261:NumberOfInstruments
      contextRef="From2020-06-012020-06-15_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact004031"
      unitRef="Shares">7000000</cik0002058261:NumberOfInstruments>
    <cik0002058261:VestingCondition
      contextRef="From2020-06-012020-06-15_custom_CubebioCo.Ltd.Member"
      id="Fact004033">2 years&#x2019; service from grant date</cik0002058261:VestingCondition>
    <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019
      contextRef="From2020-06-012020-06-15_custom_CubebioCo.Ltd.Member"
      id="Fact004035">P7Y</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
    <cik0002058261:Type
      contextRef="From2020-06-012020-06-15_custom_CubebioCo.Ltd.Member"
      id="Fact004037">Equity-settled</cik0002058261:Type>
    <cik0002058261:UnderlyingAssets
      contextRef="From2020-06-012020-06-15_custom_CubebioCo.Ltd.Member"
      id="Fact004039">CUBEBIO&#160;Co., Ltd.&#x2019;s ordinary shares</cik0002058261:UnderlyingAssets>
    <cik0002058261:NumberOfInstruments
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact004041"
      unitRef="Shares">16585638</cik0002058261:NumberOfInstruments>
    <cik0002058261:ScheduleOfShareOptionGrantTableTextBlock
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact004045">&lt;table cellpadding="0" cellspacing="0" id="xdx_892_ecustom--ScheduleOfShareOptionGrantTableTextBlock_pn3n3_zKFGgnpSz0f" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Share-based payment arrangements (Details 1)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; vertical-align: top"&gt;&lt;span id="xdx_8B5_zNAFmbTFkQPc" style="display: none"&gt;Schedule of share option grant&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;th style="border-bottom: Black 1pt solid; padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&lt;b&gt;Share option plan (equity-settled)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;June 15,&lt;br/&gt; 2020&lt;/b&gt;&lt;/th&gt;
    &lt;th style="white-space: nowrap; text-align: center; padding-bottom: 0.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;th style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt;
    &lt;th style="text-align: center"&gt;&#160;&lt;/th&gt;
    &lt;th style="text-align: center"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="text-align: center"&gt;&lt;b&gt;(In Korean won and number of shares)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="white-space: nowrap; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; vertical-align: top"&gt;Fair value of option&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--WeightedAverageFairValueAtMeasurementDateShareOptionsGranted_iI_pn3n3_c20200615__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ShareOptionPlanEquitySettledMember_zK68EtdKUtSh" title="Fair value of option"&gt;1,132&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; vertical-align: top"&gt;Share price&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#x20a9;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--WeightedAverageSharePrice2019_pid_c20200601__20200615__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ShareOptionPlanEquitySettledMember_zM1Bn5cZkgG2" title="Share price"&gt;1,412&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; vertical-align: top"&gt;Exercise price&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#x20a9;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--ProceedsFromExerciseOfOptions_pn3n3_c20200601__20200615__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ShareOptionPlanEquitySettledMember_zk0W5vRkPnn4" title="Exercise price"&gt;500&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; vertical-align: top"&gt;Risk - free interest rate (based on government bonds)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20200601__20200615__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ShareOptionPlanEquitySettledMember_zBRR3ux8sMU2" title="Risk- free interest rate (based on government bonds)"&gt;3.89&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;%&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; vertical-align: top"&gt;Volatility (*)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20200601__20200615__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ShareOptionPlanEquitySettledMember_fKCop_zbJ8EO1L9IAl" title="Volatility"&gt;83.78&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;%&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; vertical-align: top"&gt;Expected term (years)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--DescriptionOfOptionLifeShareOptionsGranted_dtY_uDecimal_c20200601__20200615__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ShareOptionPlanEquitySettledMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zEemuD2Dezic" title="Expected term (years)"&gt;4&lt;/span&gt; ~ &lt;span id="xdx_908_eifrs-full--DescriptionOfOptionLifeShareOptionsGranted_dtY_uDecimal_c20200601__20200615__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ShareOptionPlanEquitySettledMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zmUPXBA7rKEg" title="Expected term (years)"&gt;5&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; vertical-align: top"&gt;Expected dividend&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20200601__20200615__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ShareOptionPlanEquitySettledMember_zzx8HObCJpCe" title="Expected dividend"&gt;0&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;%&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;div style="width: 25%; margin-left: 0; margin-right: auto"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td id="xdx_F02_znMoA4d0Y1Rl" style="width: 0.25in; text-align: left"&gt;(*)&lt;/td&gt;
    &lt;td id="xdx_F12_zHATehfTxaJ9" style="text-align: justify"&gt;Volatility has been calculated based on an evaluation of the historical volatility of other companies&#x2019; share prices, which are listed in KOSDAQ, particularly over the historical period commensurate with the prior year.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:ScheduleOfShareOptionGrantTableTextBlock>
    <ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted
      contextRef="AsOf2020-06-15_custom_ShareOptionPlanEquitySettledMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004047"
      unitRef="KRW">1132000</ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted>
    <ifrs-full:WeightedAverageSharePrice2019
      contextRef="From2020-06-012020-06-15_custom_ShareOptionPlanEquitySettledMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact004049"
      unitRef="KRWShares">1412</ifrs-full:WeightedAverageSharePrice2019>
    <ifrs-full:ProceedsFromExerciseOfOptions
      contextRef="From2020-06-012020-06-15_custom_ShareOptionPlanEquitySettledMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004051"
      unitRef="KRW">500000</ifrs-full:ProceedsFromExerciseOfOptions>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="From2020-06-012020-06-15_custom_ShareOptionPlanEquitySettledMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact004053"
      unitRef="Pure">0.0389</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="From2020-06-012020-06-15_custom_ShareOptionPlanEquitySettledMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact004055"
      unitRef="Pure">0.8378</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfOptionLifeShareOptionsGranted
      contextRef="From2020-06-012020-06-15_custom_ShareOptionPlanEquitySettledMember_ifrs-full_BottomOfRangeMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004057"
      unitRef="Decimal">4000</ifrs-full:DescriptionOfOptionLifeShareOptionsGranted>
    <ifrs-full:DescriptionOfOptionLifeShareOptionsGranted
      contextRef="From2020-06-012020-06-15_custom_ShareOptionPlanEquitySettledMember_ifrs-full_TopOfRangeMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004059"
      unitRef="Decimal">5000</ifrs-full:DescriptionOfOptionLifeShareOptionsGranted>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="From2020-06-012020-06-15_custom_ShareOptionPlanEquitySettledMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact004061"
      unitRef="Pure">0</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <cik0002058261:ReconciliationofoutstandingshareOptionsTableTextBlock
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact004071">&lt;table cellpadding="0" cellspacing="0" id="xdx_89E_ecustom--ReconciliationofoutstandingshareOptionsTableTextBlock_pn3n3_zamffOwlU3p9" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Share-based payment arrangements (Details 2)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_8B0_zAcLUTfjgJXk" style="display: none"&gt;Schedule of reconciliation of outstanding share options&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="8" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="8" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&lt;b&gt;Share option plan (equity-settled)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Number&#160;of&lt;br/&gt;options&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Exercise&lt;br/&gt;price(*)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Number&#160;of&lt;br/&gt;options&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Exercise&lt;br/&gt;price(*)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="18" style="text-align: center"&gt;&lt;b&gt;(In Korean Won and number of options)&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; width: 48%"&gt;Outstanding at January&#160;1&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_uShares_c20250101__20251231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ShareOptionPlanEquitySettledMember_zXiBuCUQTID5" title="Number of options, outstanding at beginning"&gt;640,160&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iS_pid_c20250101__20251231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ShareOptionPlanEquitySettledMember_fKCop_z9OoENfBGE49" title="Exercise price, at beginning"&gt;500&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_uShares_c20240101__20241231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ShareOptionPlanEquitySettledMember_znDz4jDULUM8" title="Number of options, outstanding at beginning"&gt;3,893,760&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iS_pid_c20240101__20241231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ShareOptionPlanEquitySettledMember_fKCop_zVMOgJva64D5" title="Exercise price, at beginning"&gt;500&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Expired during the year&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement_iN_pid_di_uShares_c20250101__20251231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ShareOptionPlanEquitySettledMember_z5e9lTg5Hzc5" title="Expired during the year"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4081"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;-&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement_iN_pid_di_uShares_c20240101__20241231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ShareOptionPlanEquitySettledMember_zbZn5AfsXNUi" title="Expired during the year"&gt;(1,200,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019_pid_c20240101__20241231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ShareOptionPlanEquitySettledMember_fKCop_znXI1hAYSyO4" title="Exercise price, Expired"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4085"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Exercised during the year&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement_iN_pid_di_uShares_c20250101__20251231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ShareOptionPlanEquitySettledMember_zh09EWzxm7Oe" title="Expired during the year"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4087"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;-&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pid_di_uShares_c20240101__20241231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ShareOptionPlanEquitySettledMember_zQT1Pnt6LQh4" title="Exercised during the year"&gt;(2,053,600&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_c20240101__20241231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ShareOptionPlanEquitySettledMember_fKCop_zoXVuxtpP4c7" title="Exercise price, Exercised"&gt;500&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Outstanding at December&#160;31&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_uShares_c20250101__20251231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ShareOptionPlanEquitySettledMember_zwPo3Eogweq2" title="Number of options, outstanding at end"&gt;640,160&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iE_pid_c20250101__20251231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ShareOptionPlanEquitySettledMember_fKCop_z4ftxrwKqAhc" title="Exercise price, at end"&gt;500&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_uShares_c20240101__20241231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ShareOptionPlanEquitySettledMember_z2CEzf6VYTXe" title="Number of options, outstanding at end"&gt;640,160&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iE_pid_c20240101__20241231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ShareOptionPlanEquitySettledMember_fKCop_z4NMEPnkKbs9" title="Exercise price, at end"&gt;500&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.25pt"&gt;Exercisable at December&#160;31&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pid_uShares_c20251231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ShareOptionPlanEquitySettledMember_zZM8si4whtgi" title="Number of options, exercisable"&gt;640,160&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pid_c20251231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ShareOptionPlanEquitySettledMember_fKCop_zHTuXkutiXP8" title="Exercise price"&gt;500&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pid_uShares_c20241231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ShareOptionPlanEquitySettledMember_zrmVzfMMxe69" title="Number of options, exercisable"&gt;640,160&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pid_c20241231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ShareOptionPlanEquitySettledMember_fKCop_zUDmJSGqFThg" title="Exercise price"&gt;500&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;div style="width: 25%; margin-left: 0; margin-right: auto"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td id="xdx_F01_zPQRibdbH0E7" style="width: 0.25in; text-align: left"&gt;(*)&lt;/td&gt;
    &lt;td id="xdx_F1A_zQVxZdPscNrc" style="text-align: justify"&gt;Weighted average exercise price per share.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:ReconciliationofoutstandingshareOptionsTableTextBlock>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2024-12-31_custom_ShareOptionPlanEquitySettledMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact004073"
      unitRef="Shares">640160</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="AsOf2024-12-31_custom_ShareOptionPlanEquitySettledMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact004075"
      unitRef="KRWShares">500</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2023-12-31_custom_ShareOptionPlanEquitySettledMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact004077"
      unitRef="Shares">3893760</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="AsOf2023-12-31_custom_ShareOptionPlanEquitySettledMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact004079"
      unitRef="KRWShares">500</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement
      contextRef="From2024-01-012024-12-31_custom_ShareOptionPlanEquitySettledMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact004083"
      unitRef="Shares">1200000</ifrs-full:NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement
      contextRef="From2024-01-012024-12-31_custom_ShareOptionPlanEquitySettledMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact004089"
      unitRef="Shares">2053600</ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="From2024-01-012024-12-31_custom_ShareOptionPlanEquitySettledMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact004091"
      unitRef="KRWShares">500</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2025-12-31_custom_ShareOptionPlanEquitySettledMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact004093"
      unitRef="Shares">640160</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="AsOf2025-12-31_custom_ShareOptionPlanEquitySettledMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact004095"
      unitRef="KRWShares">500</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2024-12-31_custom_ShareOptionPlanEquitySettledMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact004097"
      unitRef="Shares">640160</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="AsOf2024-12-31_custom_ShareOptionPlanEquitySettledMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact004099"
      unitRef="KRWShares">500</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement
      contextRef="AsOf2025-12-31_custom_ShareOptionPlanEquitySettledMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact004101"
      unitRef="Shares">640160</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
    <cik0002058261:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement
      contextRef="AsOf2025-12-31_custom_ShareOptionPlanEquitySettledMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact004103"
      unitRef="Shares">500</cik0002058261:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement
      contextRef="AsOf2024-12-31_custom_ShareOptionPlanEquitySettledMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact004105"
      unitRef="Shares">640160</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
    <cik0002058261:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement
      contextRef="AsOf2024-12-31_custom_ShareOptionPlanEquitySettledMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact004107"
      unitRef="Shares">500</cik0002058261:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement>
    <cik0002058261:IncomeAndExpensesTextBlock
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact004110">&lt;p id="xdx_802_ecustom--IncomeAndExpensesTextBlock_z69I3A4omGik" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;27. &lt;span id="xdx_82E_zE7vezfVcVKj"&gt;Income and expenses&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;A.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;b&gt;Other income&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Details of other income for the years ended December&#160;31, 2025 and 2024 are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_898_ecustom--OtherIncomeDisclosureTableTextBlock_pn3n3_zwivPy1YT20f" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Income and Expenses (Details)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_8B6_z9LkhcmwI4M6" style="display: none"&gt;Schedule of other income&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49B_20250101__20251231_zbU7umwdIbs2" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49B_20240101__20241231_zQENimHcSQgk" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--MiscellaneousIncome_maOIzZmD_zIM8F01R9rv4" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Miscellaneous income&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;191,076&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;30,359&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40D_eifrs-full--GainsOnDisposalsOfPropertyPlantAndEquipment_maOIzZmD_zBrH5XYSAUjg" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Gains on disposal of property and equipment&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4117"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;5,616&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--ReversalOfAllowanceForDoubtfulAccount_maOIzZmD_zMSNDp23i38i" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Reversal of allowance for doubtful accounts&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4120"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;489,720&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_409_eifrs-full--OtherIncome_iT_pn3n3_mtOIzZmD_zBrzF3khT5x3" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: center; vertical-align: top; padding-bottom: 1.25pt"&gt;Total&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;191,076&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;525,695&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AE_z2bOlqfiMPqa" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;B.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;b&gt;Other expenses&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Details of other expenses for the years ended December&#160;31, 2025 and 2024 are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_893_ecustom--OtherExpenseDisclosureTableTextBlock_pn3n3_zFBeXmi1z6jg" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Income and Expenses (Details 1)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_8B4_zzmzH5dbfElj" style="display: none"&gt;Schedule of other expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49B_20250101__20251231_zIa62rXlxOrk" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49B_20240101__20241231_zZVPuNEdHLwl" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--OtherBadDebtExpensesIncome_maCzhGd_msTOEzIna_zMOnM8TNG6E4" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Other bad debt expenses&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;341,816&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;71,412&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--LossesOnDisposalOfPropertyAndEquipment_maCzhGd_maTOEzIna_zK4ijXkQsiI" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Losses on disposal of property and equipment&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4131"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;4,172&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--ImpairmentLossOnPropertyAndEquipment_maTOEzIna_z8uHxgZnMHak" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Impairment losses on property and equipment&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4134"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;601,792&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--MiscellaneousExpenses_maCzhGd_maTOEzIna_zLaCzEMr4Vd3" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Miscellaneous expenses&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;31,562&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;63&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--TotalOtherExpenses_iT_mtTOEzIna_zCRtbVTG1qP2" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: center; vertical-align: top; padding-bottom: 1.25pt"&gt;Total&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;373,378&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;677,439&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A9_z5t375ijHZw9" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

















&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;C.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;b&gt;Expenses by nature&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Details of the classification of expenses by nature for the years ended December&#160;31, 2025 and 2024 are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_880_ecustom--ScheduleOfOtherExpensesClassificationTableTextBlock_pn3n3_zZxv0yOb6pTg" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Income and Expenses (Details 2)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_8BC_zwhSTTOIE8Fa" style="display: none"&gt;Schedule of other expenses classification&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_494_20250101__20251231_zA7R5qf88vKh" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_497_20240101__20241231_zzCDlfFKEyC6" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--EmployeeBenefit_maCzesb_zJVwKTA1fvT5" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Employee benefits&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;2,448,384&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;2,339,937&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40F_eifrs-full--AdjustmentsForDepreciationExpense_maCzesb_zWwK3Nzw0jq3" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Depreciation&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;222,589&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;335,918&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40E_eifrs-full--AdjustmentsForAmortisationExpense_maCzesb_z4q8aOdtPeif" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Amortization of intangible assets&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;2,303&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;2,760&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--RdExpenses_maCzesb_zxVKk58DkRfg" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;R&amp;amp;D expenses&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;595,593&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;773,354&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--ProfessionalServiceFee_maCzesb_ziRDfygr6Jzh" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Professional service fee&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;1,239,895&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;3,704,337&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--Rent_maCzesb_zdMkKoCuSRXc" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Rent&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;1,291&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;763&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--SuppliesExpenses_maCzesb_zl4HtklHEWjc" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Supplies&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;6,305&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;4,624&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--WaterAndFuelExpenses_maCzesb_zPzIOYSZuFY2" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Water and fuel expenses&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;86,087&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;83,126&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_408_eifrs-full--TransportationExpense_maCzesb_zcqp0aLE2wgf" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Transportation&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;148,522&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;12,251&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--BuildingMaintenance_maCzesb_zM32MYqYpn36" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Building maintenance&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;55,592&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;54,864&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--OtherExpense_maCzesb_zJz2uMHoTLz8" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Other expenses&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;974,497&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;137,153&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_402_eifrs-full--OtherExpenseByNature_iT_mtCzesb_zMQBiHoUnbZ3" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: center; vertical-align: top; padding-bottom: 1.25pt"&gt;Total&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;5,781,058&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;7,449,087&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AE_z4DeonVhwfQ3" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

</cik0002058261:IncomeAndExpensesTextBlock>
    <cik0002058261:OtherIncomeDisclosureTableTextBlock
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact004112">&lt;table cellpadding="0" cellspacing="0" id="xdx_898_ecustom--OtherIncomeDisclosureTableTextBlock_pn3n3_zwivPy1YT20f" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Income and Expenses (Details)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_8B6_z9LkhcmwI4M6" style="display: none"&gt;Schedule of other income&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49B_20250101__20251231_zbU7umwdIbs2" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49B_20240101__20241231_zQENimHcSQgk" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--MiscellaneousIncome_maOIzZmD_zIM8F01R9rv4" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Miscellaneous income&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;191,076&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;30,359&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40D_eifrs-full--GainsOnDisposalsOfPropertyPlantAndEquipment_maOIzZmD_zBrH5XYSAUjg" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Gains on disposal of property and equipment&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4117"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;5,616&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--ReversalOfAllowanceForDoubtfulAccount_maOIzZmD_zMSNDp23i38i" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Reversal of allowance for doubtful accounts&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4120"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;489,720&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_409_eifrs-full--OtherIncome_iT_pn3n3_mtOIzZmD_zBrzF3khT5x3" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: center; vertical-align: top; padding-bottom: 1.25pt"&gt;Total&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;191,076&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;525,695&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:OtherIncomeDisclosureTableTextBlock>
    <cik0002058261:MiscellaneousIncome
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004114"
      unitRef="KRW">191076000</cik0002058261:MiscellaneousIncome>
    <cik0002058261:MiscellaneousIncome
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004115"
      unitRef="KRW">30359000</cik0002058261:MiscellaneousIncome>
    <ifrs-full:GainsOnDisposalsOfPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004118"
      unitRef="KRW">5616000</ifrs-full:GainsOnDisposalsOfPropertyPlantAndEquipment>
    <cik0002058261:ReversalOfAllowanceForDoubtfulAccount
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004121"
      unitRef="KRW">489720000</cik0002058261:ReversalOfAllowanceForDoubtfulAccount>
    <ifrs-full:OtherIncome
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004123"
      unitRef="KRW">191076000</ifrs-full:OtherIncome>
    <ifrs-full:OtherIncome
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004124"
      unitRef="KRW">525695000</ifrs-full:OtherIncome>
    <cik0002058261:OtherExpenseDisclosureTableTextBlock
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact004126">&lt;table cellpadding="0" cellspacing="0" id="xdx_893_ecustom--OtherExpenseDisclosureTableTextBlock_pn3n3_zFBeXmi1z6jg" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Income and Expenses (Details 1)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_8B4_zzmzH5dbfElj" style="display: none"&gt;Schedule of other expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49B_20250101__20251231_zIa62rXlxOrk" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49B_20240101__20241231_zZVPuNEdHLwl" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--OtherBadDebtExpensesIncome_maCzhGd_msTOEzIna_zMOnM8TNG6E4" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Other bad debt expenses&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;341,816&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;71,412&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--LossesOnDisposalOfPropertyAndEquipment_maCzhGd_maTOEzIna_zK4ijXkQsiI" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Losses on disposal of property and equipment&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4131"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;4,172&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--ImpairmentLossOnPropertyAndEquipment_maTOEzIna_z8uHxgZnMHak" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Impairment losses on property and equipment&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4134"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;601,792&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--MiscellaneousExpenses_maCzhGd_maTOEzIna_zLaCzEMr4Vd3" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Miscellaneous expenses&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;31,562&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;63&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--TotalOtherExpenses_iT_mtTOEzIna_zCRtbVTG1qP2" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: center; vertical-align: top; padding-bottom: 1.25pt"&gt;Total&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;373,378&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;677,439&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:OtherExpenseDisclosureTableTextBlock>
    <cik0002058261:OtherBadDebtExpensesIncome
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004128"
      unitRef="KRW">341816000</cik0002058261:OtherBadDebtExpensesIncome>
    <cik0002058261:OtherBadDebtExpensesIncome
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004129"
      unitRef="KRW">71412000</cik0002058261:OtherBadDebtExpensesIncome>
    <cik0002058261:LossesOnDisposalOfPropertyAndEquipment
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004132"
      unitRef="KRW">4172000</cik0002058261:LossesOnDisposalOfPropertyAndEquipment>
    <cik0002058261:ImpairmentLossOnPropertyAndEquipment
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004135"
      unitRef="KRW">601792000</cik0002058261:ImpairmentLossOnPropertyAndEquipment>
    <cik0002058261:MiscellaneousExpenses
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004137"
      unitRef="KRW">31562000</cik0002058261:MiscellaneousExpenses>
    <cik0002058261:MiscellaneousExpenses
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004138"
      unitRef="KRW">63000</cik0002058261:MiscellaneousExpenses>
    <cik0002058261:TotalOtherExpenses
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004140"
      unitRef="KRW">373378000</cik0002058261:TotalOtherExpenses>
    <cik0002058261:TotalOtherExpenses
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004141"
      unitRef="KRW">677439000</cik0002058261:TotalOtherExpenses>
    <cik0002058261:ScheduleOfOtherExpensesClassificationTableTextBlock
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact004150">&lt;table cellpadding="0" cellspacing="0" id="xdx_880_ecustom--ScheduleOfOtherExpensesClassificationTableTextBlock_pn3n3_zZxv0yOb6pTg" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Income and Expenses (Details 2)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_8BC_zwhSTTOIE8Fa" style="display: none"&gt;Schedule of other expenses classification&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_494_20250101__20251231_zA7R5qf88vKh" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_497_20240101__20241231_zzCDlfFKEyC6" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--EmployeeBenefit_maCzesb_zJVwKTA1fvT5" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Employee benefits&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;2,448,384&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;2,339,937&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40F_eifrs-full--AdjustmentsForDepreciationExpense_maCzesb_zWwK3Nzw0jq3" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Depreciation&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;222,589&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;335,918&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40E_eifrs-full--AdjustmentsForAmortisationExpense_maCzesb_z4q8aOdtPeif" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Amortization of intangible assets&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;2,303&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;2,760&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--RdExpenses_maCzesb_zxVKk58DkRfg" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;R&amp;amp;D expenses&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;595,593&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;773,354&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--ProfessionalServiceFee_maCzesb_ziRDfygr6Jzh" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Professional service fee&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;1,239,895&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;3,704,337&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--Rent_maCzesb_zdMkKoCuSRXc" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Rent&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;1,291&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;763&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--SuppliesExpenses_maCzesb_zl4HtklHEWjc" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Supplies&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;6,305&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;4,624&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--WaterAndFuelExpenses_maCzesb_zPzIOYSZuFY2" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Water and fuel expenses&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;86,087&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;83,126&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_408_eifrs-full--TransportationExpense_maCzesb_zcqp0aLE2wgf" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Transportation&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;148,522&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;12,251&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--BuildingMaintenance_maCzesb_zM32MYqYpn36" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Building maintenance&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;55,592&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;54,864&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--OtherExpense_maCzesb_zJz2uMHoTLz8" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Other expenses&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;974,497&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;137,153&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_402_eifrs-full--OtherExpenseByNature_iT_mtCzesb_zMQBiHoUnbZ3" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: center; vertical-align: top; padding-bottom: 1.25pt"&gt;Total&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;5,781,058&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;7,449,087&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;</cik0002058261:ScheduleOfOtherExpensesClassificationTableTextBlock>
    <cik0002058261:EmployeeBenefit
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004152"
      unitRef="KRW">2448384000</cik0002058261:EmployeeBenefit>
    <cik0002058261:EmployeeBenefit
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004153"
      unitRef="KRW">2339937000</cik0002058261:EmployeeBenefit>
    <ifrs-full:AdjustmentsForDepreciationExpense
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004155"
      unitRef="KRW">222589000</ifrs-full:AdjustmentsForDepreciationExpense>
    <ifrs-full:AdjustmentsForDepreciationExpense
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004156"
      unitRef="KRW">335918000</ifrs-full:AdjustmentsForDepreciationExpense>
    <ifrs-full:AdjustmentsForAmortisationExpense
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004158"
      unitRef="KRW">2303000</ifrs-full:AdjustmentsForAmortisationExpense>
    <ifrs-full:AdjustmentsForAmortisationExpense
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004159"
      unitRef="KRW">2760000</ifrs-full:AdjustmentsForAmortisationExpense>
    <cik0002058261:RdExpenses
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004161"
      unitRef="KRW">595593000</cik0002058261:RdExpenses>
    <cik0002058261:RdExpenses
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004162"
      unitRef="KRW">773354000</cik0002058261:RdExpenses>
    <cik0002058261:ProfessionalServiceFee
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004164"
      unitRef="KRW">1239895000</cik0002058261:ProfessionalServiceFee>
    <cik0002058261:ProfessionalServiceFee
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004165"
      unitRef="KRW">3704337000</cik0002058261:ProfessionalServiceFee>
    <cik0002058261:Rent
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004167"
      unitRef="KRW">1291000</cik0002058261:Rent>
    <cik0002058261:Rent
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004168"
      unitRef="KRW">763000</cik0002058261:Rent>
    <cik0002058261:SuppliesExpenses
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004170"
      unitRef="KRW">6305000</cik0002058261:SuppliesExpenses>
    <cik0002058261:SuppliesExpenses
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004171"
      unitRef="KRW">4624000</cik0002058261:SuppliesExpenses>
    <cik0002058261:WaterAndFuelExpenses
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004173"
      unitRef="KRW">86087000</cik0002058261:WaterAndFuelExpenses>
    <cik0002058261:WaterAndFuelExpenses
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004174"
      unitRef="KRW">83126000</cik0002058261:WaterAndFuelExpenses>
    <ifrs-full:TransportationExpense
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004176"
      unitRef="KRW">148522000</ifrs-full:TransportationExpense>
    <ifrs-full:TransportationExpense
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004177"
      unitRef="KRW">12251000</ifrs-full:TransportationExpense>
    <cik0002058261:BuildingMaintenance
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004179"
      unitRef="KRW">55592000</cik0002058261:BuildingMaintenance>
    <cik0002058261:BuildingMaintenance
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004180"
      unitRef="KRW">54864000</cik0002058261:BuildingMaintenance>
    <cik0002058261:OtherExpense
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004182"
      unitRef="KRW">974497000</cik0002058261:OtherExpense>
    <cik0002058261:OtherExpense
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004183"
      unitRef="KRW">137153000</cik0002058261:OtherExpense>
    <ifrs-full:OtherExpenseByNature
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004185"
      unitRef="KRW">5781058000</ifrs-full:OtherExpenseByNature>
    <ifrs-full:OtherExpenseByNature
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004186"
      unitRef="KRW">7449087000</ifrs-full:OtherExpenseByNature>
    <cik0002058261:FinanceIncomeAndCostsTextBlock
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact004188">&lt;p id="xdx_806_ecustom--FinanceIncomeAndCostsTextBlock_zNbF8ChtUWCd" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;28. &lt;span id="xdx_82D_zFzH0Jr2VhM1"&gt;Finance income and costs&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Details of finance income and costs for the years ended December&#160;31, 2025 and 2024 are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_88A_ecustom--FinanceIncomeAndCostsTableTextBlock_pn3n3_zdL8KetIZgeh" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Finance income and costs (Details)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span id="xdx_8B4_zQxo4kievPGd" style="display: none"&gt;Schedule of finance income and costs&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_494_20250101__20251231_zENXsRBEaJy" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_497_20240101__20241231_zijOfjalR1S9" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--FinanceIncomeAbstract_iB_zu7qhVsGZXZj" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;b&gt;Finance income&lt;/b&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--InterestIncome_i01_zrrkv7t2kjQ" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Interest income&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#x20a9;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;230,557&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;193,012&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--ForeignExchangeGains_i01_zLTy1u3LQpy8" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Foreign exchange gains&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4198"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;693&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--GainsOnForeignCurrencyTranslation_i01_zrYJVOplqdAd" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Gains on foreign currency translation&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;6,350&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;9,162&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--GainsOnValuationOfDerivatives_i01N_di_zaSpsKX5ipQj" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Gains on valuation of derivatives&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;461,422&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;673,637&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--AdjustmentsForFinanceIncome_i01_zEh0HVnx3urf" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: center; vertical-align: top; padding-bottom: 1.25pt"&gt;Total&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;698,329&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;876,504&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--FinanceCostsAbstract_iB_zRJIAck338C" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;b&gt;Finance costs&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_407_eifrs-full--AdjustmentsForInterestExpense_i01_zfvhkkIq9oe3" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Interest expenses&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#x20a9;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;798,129&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;1,050,584&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--ForeignExchangeLosses_i01_zH60ssxU5pj" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Foreign exchange losses&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4216"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;180&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--LossesOnForeignCurrencyTranslation_i01_zNdLF874iPEe" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Losses on foreign currency translation&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;2,145&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;661&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--LossesOnBondRedemption_i01_zOUQBvFyyMUi" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Losses on bond redemption&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;69,890&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;283,780&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--LossesOnValuationOfDerivatives_i01_zfZsFq7uDKU6" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Losses on valuation of derivatives&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;6,281&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;5,802&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_402_eifrs-full--FinanceCosts_i01_zkSHBBLOuIF2" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: center; vertical-align: top; padding-bottom: 1.25pt"&gt;Total&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;876,445&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,341,007&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

















</cik0002058261:FinanceIncomeAndCostsTextBlock>
    <cik0002058261:FinanceIncomeAndCostsTableTextBlock
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact004190">&lt;table cellpadding="0" cellspacing="0" id="xdx_88A_ecustom--FinanceIncomeAndCostsTableTextBlock_pn3n3_zdL8KetIZgeh" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Finance income and costs (Details)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span id="xdx_8B4_zQxo4kievPGd" style="display: none"&gt;Schedule of finance income and costs&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_494_20250101__20251231_zENXsRBEaJy" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_497_20240101__20241231_zijOfjalR1S9" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--FinanceIncomeAbstract_iB_zu7qhVsGZXZj" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;b&gt;Finance income&lt;/b&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--InterestIncome_i01_zrrkv7t2kjQ" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Interest income&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#x20a9;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;230,557&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;193,012&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--ForeignExchangeGains_i01_zLTy1u3LQpy8" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Foreign exchange gains&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4198"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;693&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--GainsOnForeignCurrencyTranslation_i01_zrYJVOplqdAd" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Gains on foreign currency translation&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;6,350&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;9,162&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--GainsOnValuationOfDerivatives_i01N_di_zaSpsKX5ipQj" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Gains on valuation of derivatives&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;461,422&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;673,637&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--AdjustmentsForFinanceIncome_i01_zEh0HVnx3urf" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: center; vertical-align: top; padding-bottom: 1.25pt"&gt;Total&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;698,329&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;876,504&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--FinanceCostsAbstract_iB_zRJIAck338C" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;b&gt;Finance costs&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_407_eifrs-full--AdjustmentsForInterestExpense_i01_zfvhkkIq9oe3" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Interest expenses&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#x20a9;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;798,129&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;1,050,584&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--ForeignExchangeLosses_i01_zH60ssxU5pj" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Foreign exchange losses&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4216"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;180&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--LossesOnForeignCurrencyTranslation_i01_zNdLF874iPEe" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Losses on foreign currency translation&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;2,145&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;661&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--LossesOnBondRedemption_i01_zOUQBvFyyMUi" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Losses on bond redemption&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;69,890&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;283,780&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--LossesOnValuationOfDerivatives_i01_zfZsFq7uDKU6" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Losses on valuation of derivatives&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;6,281&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;5,802&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_402_eifrs-full--FinanceCosts_i01_zkSHBBLOuIF2" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: center; vertical-align: top; padding-bottom: 1.25pt"&gt;Total&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;876,445&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,341,007&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;</cik0002058261:FinanceIncomeAndCostsTableTextBlock>
    <cik0002058261:InterestIncome
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004195"
      unitRef="KRW">230557000</cik0002058261:InterestIncome>
    <cik0002058261:InterestIncome
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004196"
      unitRef="KRW">193012000</cik0002058261:InterestIncome>
    <cik0002058261:ForeignExchangeGains
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004199"
      unitRef="KRW">693000</cik0002058261:ForeignExchangeGains>
    <cik0002058261:GainsOnForeignCurrencyTranslation
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004201"
      unitRef="KRW">6350000</cik0002058261:GainsOnForeignCurrencyTranslation>
    <cik0002058261:GainsOnForeignCurrencyTranslation
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004202"
      unitRef="KRW">9162000</cik0002058261:GainsOnForeignCurrencyTranslation>
    <cik0002058261:GainsOnValuationOfDerivatives
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004204"
      unitRef="KRW">-461422000</cik0002058261:GainsOnValuationOfDerivatives>
    <cik0002058261:GainsOnValuationOfDerivatives
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004205"
      unitRef="KRW">-673637000</cik0002058261:GainsOnValuationOfDerivatives>
    <ifrs-full:AdjustmentsForFinanceIncome
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004207"
      unitRef="KRW">698329000</ifrs-full:AdjustmentsForFinanceIncome>
    <ifrs-full:AdjustmentsForFinanceIncome
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004208"
      unitRef="KRW">876504000</ifrs-full:AdjustmentsForFinanceIncome>
    <ifrs-full:AdjustmentsForInterestExpense
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004213"
      unitRef="KRW">798129000</ifrs-full:AdjustmentsForInterestExpense>
    <ifrs-full:AdjustmentsForInterestExpense
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004214"
      unitRef="KRW">1050584000</ifrs-full:AdjustmentsForInterestExpense>
    <cik0002058261:ForeignExchangeLosses
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004217"
      unitRef="KRW">180000</cik0002058261:ForeignExchangeLosses>
    <cik0002058261:LossesOnForeignCurrencyTranslation
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004219"
      unitRef="KRW">2145000</cik0002058261:LossesOnForeignCurrencyTranslation>
    <cik0002058261:LossesOnForeignCurrencyTranslation
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004220"
      unitRef="KRW">661000</cik0002058261:LossesOnForeignCurrencyTranslation>
    <cik0002058261:LossesOnBondRedemption
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004222"
      unitRef="KRW">69890000</cik0002058261:LossesOnBondRedemption>
    <cik0002058261:LossesOnBondRedemption
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004223"
      unitRef="KRW">283780000</cik0002058261:LossesOnBondRedemption>
    <cik0002058261:LossesOnValuationOfDerivatives
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004225"
      unitRef="KRW">6281000</cik0002058261:LossesOnValuationOfDerivatives>
    <cik0002058261:LossesOnValuationOfDerivatives
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004226"
      unitRef="KRW">5802000</cik0002058261:LossesOnValuationOfDerivatives>
    <ifrs-full:FinanceCosts
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004228"
      unitRef="KRW">876445000</ifrs-full:FinanceCosts>
    <ifrs-full:FinanceCosts
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004229"
      unitRef="KRW">1341007000</ifrs-full:FinanceCosts>
    <ifrs-full:DisclosureOfRelatedPartyExplanatory
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact004238">&lt;p id="xdx_805_eifrs-full--DisclosureOfRelatedPartyExplanatory_zXGGCaHVe4Ob" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;29. &lt;span id="xdx_82B_zYtGG9e0Ed88"&gt;Related parties&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;A.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;b&gt;Transactions with related parties&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Details of transactions with related parties for the years ended December&#160;31, 2025 and 2024 are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_898_ecustom--ScheduleOfTransactionWithRelatedPartiesTableTextBlock_ziggoMlEHU3k" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Related parties (Details 2)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_8B1_z0zPSB1H4x24" style="display: none"&gt;Schedule of transaction with related parties&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="border-bottom: Black 0.5pt solid; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2"&gt;&lt;b&gt;Interest&lt;/b&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="text-align: center"&gt;&lt;b&gt;Interest&lt;/b&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="text-align: center"&gt;&lt;b&gt;Interest&lt;/b&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="text-align: center"&gt;&lt;b&gt;Interest&lt;/b&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;b&gt;Related party&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Name of entity&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 0.5pt solid; text-align: center"&gt;&lt;b&gt;income&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;expenses&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;income&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;expenses&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th style="text-align: center"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th style="text-align: center"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="13" style="text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; width: 36%"&gt;&lt;span id="xdx_907_ecustom--RelatedParty_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--WellCoreMember_zmsiheyakQ22" title="Related party"&gt;Entity that has significant influence over the Company&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 20%; vertical-align: top"&gt;&lt;span id="xdx_90E_eifrs-full--NameOfParentEntity_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--WellCoreMember_fKCoxKQ_____zD1hh9mTsoSk" title="Name of entity"&gt;Well Core&lt;/span&gt;(*1)&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 7%"&gt;&lt;span id="xdx_902_ecustom--InterestIncome_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--WellCoreMember_zYKOZlYx2PPh" title="Interest income"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4246"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 7%"&gt;&lt;span id="xdx_90B_ecustom--InterestExpenses_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--WellCoreMember_z512Si1YwELl" title="Interest expenses"&gt;783&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 7%"&gt;&lt;span id="xdx_904_ecustom--InterestIncome_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--WellCoreMember_zUCV0tZYIAkl" title="Interest income"&gt;567&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 7%"&gt;&lt;span id="xdx_90A_ecustom--InterestExpenses_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--WellCoreMember_zI1gJUOUoEY3" title="Interest expenses"&gt;3,882&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; width: 1%"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_900_ecustom--RelatedParty_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--DongsungDAndCMember_zbj7bWJu19Fg" title="Related party"&gt;Entities controlled by Key Management Personnel&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;&lt;span id="xdx_901_eifrs-full--NameOfParentEntity_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--DongsungDAndCMember_fKCoyKQ_____zZOrjG5nUfC8" title="Name of entity"&gt;Dongsung D&amp;amp;C&lt;/span&gt;(*2)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_904_ecustom--InterestIncome_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--DongsungDAndCMember_zQIbps6CYq2g" title="Interest income"&gt;1,296&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_ecustom--InterestExpenses_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--DongsungDAndCMember_zxgzu1xEJOhk" title="Interest expenses"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4260"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_902_ecustom--InterestIncome_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--DongsungDAndCMember_zQh6jTokOYxj" title="Interest income"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4262"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_904_ecustom--InterestExpenses_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--DongsungDAndCMember_zmFoDWCtNWSi" title="Interest expenses"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4264"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_908_ecustom--RelatedParty_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubeBioHoldingsLtdMember_ziwRolKbthEk" title="Related party"&gt;Entities controlled by Key Management Personnel&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;&lt;span id="xdx_909_eifrs-full--NameOfParentEntity_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubeBioHoldingsLtdMember_zdIEdZWBQVx1" title="Name of entity"&gt;CubeBio Holdings., Ltd.&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_904_ecustom--InterestIncome_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubeBioHoldingsLtdMember_zjDHP4nI4Vnk" title="Interest income"&gt;1,980&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_907_ecustom--InterestExpenses_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubeBioHoldingsLtdMember_zG8ubHf9aSi7" title="Interest expenses"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4272"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_904_ecustom--InterestIncome_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubeBioHoldingsLtdMember_zky8DyungVA2" title="Interest income"&gt;550&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_905_ecustom--InterestExpenses_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubeBioHoldingsLtdMember_znpNs8ppM7ii" title="Interest expenses"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4276"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_90B_ecustom--RelatedParty_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--JaeMyungKimMember_zl0KhzWRjzR4" title="Related party"&gt;Key management personnel&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;&lt;span id="xdx_904_eifrs-full--NameOfParentEntity_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--JaeMyungKimMember_zucCDGJIN46g" title="Name of entity"&gt;Jae Myung Kim&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_ecustom--InterestIncome_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--JaeMyungKimMember_z6YwLAkH2d2i" title="Interest income"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4282"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_901_ecustom--InterestExpenses_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--JaeMyungKimMember_zDXZ51rBOhX6" title="Interest expenses"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4284"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_ecustom--InterestIncome_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--JaeMyungKimMember_zxYxH3ryny37" title="Interest income"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4286"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_902_ecustom--InterestExpenses_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--JaeMyungKimMember_zTks6lEY2yj8" title="Interest expenses"&gt;62,234&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_908_ecustom--RelatedParty_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--NohBinParkNohBinParkMember_ztGAGHIz10ua" title="Related party"&gt;Key management personnel&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;&lt;span id="xdx_90F_eifrs-full--NameOfParentEntity_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--NohBinParkNohBinParkMember_ze6ieTJGdQe4" title="Name of entity"&gt;Noh Bin Park&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_ecustom--InterestIncome_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--NohBinParkNohBinParkMember_zWtx6N8RfuD8" title="Interest income"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4294"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_901_ecustom--InterestExpenses_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--NohBinParkNohBinParkMember_zdqYmzGTcFmc" title="Interest expenses"&gt;2,060&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_901_ecustom--InterestIncome_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--NohBinParkNohBinParkMember_z5qrs1PsDPW8" title="Interest income"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4298"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_904_ecustom--InterestExpenses_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--NohBinParkNohBinParkMember_z4IEM2xAXIql" title="Interest expenses"&gt;3,358&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_90A_ecustom--RelatedParty_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--HoSungHanMember_z6C14FkkdwT7" title="Related party"&gt;Key management personnel&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;&lt;span id="xdx_904_eifrs-full--NameOfParentEntity_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--HoSungHanMember_z85u4cLPEEH5" title="Name of entity"&gt;Ho Sung Han&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_ecustom--InterestIncome_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--HoSungHanMember_zSMCrRUZVURd" title="Interest income"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4306"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_902_ecustom--InterestExpenses_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--HoSungHanMember_zqhynREMG2P8" title="Interest expenses"&gt;2,171&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_909_ecustom--InterestIncome_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--HoSungHanMember_zS5Aq2RFi8Id" title="Interest income"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4310"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_900_ecustom--InterestExpenses_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--HoSungHanMember_zVLXrgcj3v58" title="Interest expenses"&gt;2,519&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_906_ecustom--RelatedParty_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember_zyd8AgpUNeZg" title="Related party"&gt;Key management personnel&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;&lt;span id="xdx_90D_eifrs-full--NameOfParentEntity_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember_zdRMyBhT94m1" title="Name of entity"&gt;Eun Jong Choi&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_ecustom--InterestIncome_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember_zOEJVT4o9rHb" title="Interest income"&gt;6,440&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_907_ecustom--InterestExpenses_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember_zA4S7WUmlXQj" title="Interest expenses"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4320"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_903_ecustom--InterestIncome_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember_zHCAEOQ53pu2" title="Interest income"&gt;23,257&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_906_ecustom--InterestExpenses_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember_zd90v2ppz3zb" title="Interest expenses"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4324"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_904_ecustom--RelatedParty_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--SeYoonKimMember_zRruRxX4Aewl" title="Related party"&gt;Other related party&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;&lt;span id="xdx_909_eifrs-full--NameOfParentEntity_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--SeYoonKimMember_z032IfPWDwfl" title="Name of entity"&gt;Se Yoon Kim&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_ecustom--InterestIncome_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--SeYoonKimMember_zjJVuTLFjoQ7" title="Interest income"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4330"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_904_ecustom--InterestExpenses_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--SeYoonKimMember_zvtUUgPuOrPb" title="Interest expenses"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4332"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_900_ecustom--InterestIncome_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--SeYoonKimMember_zTa5T22XQK9g" title="Interest income"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4334"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_ecustom--InterestExpenses_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--SeYoonKimMember_zlBI7B0sJlv1" title="Interest expenses"&gt;16,594&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_906_ecustom--RelatedParty_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--GyungHaYuMember_ztFyfG7jepvi" title="Related party"&gt;Other related party&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;&lt;span id="xdx_903_eifrs-full--NameOfParentEntity_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--GyungHaYuMember_zcDoMpm4Tb0a" title="Name of entity"&gt;Gyung Ha Yu&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_903_ecustom--InterestIncome_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--GyungHaYuMember_zAStHCyHZ3q" title="Interest income"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4342"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_909_ecustom--InterestExpenses_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--GyungHaYuMember_zGtHxSGffyC4" title="Interest expenses"&gt;1,775&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_904_ecustom--InterestIncome_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--GyungHaYuMember_zgHT4SS4M5h" title="Interest income"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4346"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_ecustom--InterestExpenses_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--GyungHaYuMember_zpIPJEqSoLSh" title="Interest expenses"&gt;2,068&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;&lt;span id="xdx_901_ecustom--RelatedParty_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--JungGonKimMember_zTchPHSBnsWc" title="Related party"&gt;Other related party&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;&lt;span id="xdx_904_eifrs-full--NameOfParentEntity_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--JungGonKimMember_zfGmwKAWOORi" title="Name of entity"&gt;Jung Gon Kim&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_903_ecustom--InterestIncome_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--JungGonKimMember_z1Cv3s1a2QBk" title="Interest income"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4354"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_906_ecustom--InterestExpenses_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--JungGonKimMember_z4xXwG78JHYd" title="Interest expenses"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4356"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--InterestIncome_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--JungGonKimMember_zcpmyOQGI5pd" title="Interest income"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4358"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_906_ecustom--InterestExpenses_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--JungGonKimMember_zAKWjTnohq7l" title="Interest expenses"&gt;231,172&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td colspan="3" style="text-align: center; padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;
    &lt;td style="text-align: right; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_908_ecustom--InterestIncome_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember_ztrK0Vq7JNrk" title="Interest income"&gt;9,716&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_908_ecustom--InterestExpenses_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember_z9Pu5pXUJ4ml" title="Interest expenses"&gt;6,789&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--InterestIncome_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember_z7VAUhfhJJbl" title="Interest income"&gt;24,374&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--InterestExpenses_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember_zJi3Rjwht0Y9" title="Interest expenses"&gt;321,827&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;div style="width: 25%; margin-left: 0; margin-right: auto"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td id="xdx_F09_zV0xfx0N3lYk" style="width: 0.25in; text-align: left"&gt;(*1)&lt;/td&gt;
    &lt;td id="xdx_F11_zcBzs1WP5v97" style="text-align: justify"&gt;Well Core Co., Ltd. (&#x201c;Well Core&#x201d;) is an entity that has significant influence over the Company.&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td id="xdx_F0F_zpWW1m2ULLYe" style="text-align: left"&gt;(*2)&lt;/td&gt;
    &lt;td id="xdx_F10_zx0z1Hu5QJK" style="text-align: justify"&gt;Dongsung D&amp;amp;C., Ltd. (&#x201c;Dongsung D&amp;amp;C&#x201d;) was identified as a related party because it is controlled by a member of the Company&#x2019;s key management personnel.&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="text-align: left"&gt;(*3)&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;CubeBio Holdings., Ltd. (&#x201c;CubeBio Holdings&#x201d;) was recognized as entities controlled by key management personnel, as Eun Jong Choi, a key management personnel of the Company, has control over CubeBio Holdings., Ltd.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A8_z14PDCGcQRBg" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;B.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;b&gt;Account balances with related parties&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Details of receivables and payables account balances with related parties as of December&#160;31, 2025 and 2024 are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89E_ecustom--ScheduleOfPayablesAndReceivablesRelatedPartiesTableTextBlock_pn3n3_zJxFCeVqXYv4" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Related parties (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span id="xdx_8B5_zr6kkc5rpXcd" style="display: none"&gt;Schedule of receivables and payables account balances&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December&#160;31,&lt;br/&gt; 2025&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December&#160;31,&lt;br/&gt; 2024&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;Related party&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Name of entity&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Payables&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Receivables&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Payables&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Receivables&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; width: 36%; text-align: left"&gt;Entities controlled by Key Management Personnel&lt;/td&gt;
    &lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 20%; text-align: left"&gt;Dongsung D&amp;amp;C&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 7%; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--TradeAndOtherPayables_iI_pn3n3_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--DongsungDAndCMember_zl676w7dGMZf" title="Payables"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4374"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 7%; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--OtherReceivable_iI_pn3n3_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--DongsungDAndCMember_zKCrH3KlaSh2" title="Receivables"&gt;221,295&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 7%; text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--TradeAndOtherPayables_iI_pn3n3_c20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--DongsungDAndCMember_zoYET1v2Ptj7" title="Payables"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4378"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 7%; text-align: right"&gt;&lt;span id="xdx_907_ecustom--OtherReceivable_iI_pn3n3_c20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--DongsungDAndCMember_zTJnOxT7FZfl" title="Receivables"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4380"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Entities controlled by Key Management Personnel&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;CubeBio Holdings., Ltd.&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--TradeAndOtherPayables_iI_pn3n3_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubeBioHoldingsLtdMember_zbnK3AeLWLoa" title="Payables"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4382"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_909_ecustom--OtherReceivable_iI_pn3n3_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubeBioHoldingsLtdMember_z2NjaBu6D6ef" title="Receivables"&gt;45,564&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--TradeAndOtherPayables_iI_pn3n3_c20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubeBioHoldingsLtdMember_z0DdWQQS8Pjb" title="Payables"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4386"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_ecustom--OtherReceivable_iI_pn3n3_c20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubeBioHoldingsLtdMember_zl78TAc7Rg1i" title="Receivables"&gt;44,650&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Key management personnel&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;Eun Jong Choi (*)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--OtherPayables_iI_pn3n3_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember_fKCop_zJMRTN5Mnkrf" title="Payables"&gt;24,855&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_906_ecustom--OtherReceivable_iI_pn3n3_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember_fKCop_zkIPahV1BXo9" title="Receivables"&gt;176,035&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--TradeAndOtherPayables_iI_pn3n3_c20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember_fKCop_zi4HZ8WbjjY6" title="Payables"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4394"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_ecustom--OtherReceivable_iI_pn3n3_c20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember_fKCop_zNwdaZsBu4fj" title="Receivables"&gt;169,595&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Key management personnel&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;Noh Bin Park&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--TradeAndOtherPayables_iI_pn3n3_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--NohBinParkMember_z4D1Ue0GdXL3" title="Payables"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4398"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_906_ecustom--OtherReceivable_iI_pn3n3_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--NohBinParkMember_zTqQAlyy1IJ3" title="Receivables"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4400"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--TradeAndOtherPayables_iI_pn3n3_c20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--NohBinParkMember_znJ7nW0sNth5" title="Payables"&gt;16,738&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_904_ecustom--OtherReceivable_iI_pn3n3_c20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--NohBinParkMember_zpvv7yGkHtT7" title="Receivables"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4404"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Key management personnel&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;Ho Sung Han&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--TradeAndOtherPayables_iI_pn3n3_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--HoSungHanMember_zNokjXSd4c73" title="Payables"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4406"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_902_ecustom--OtherReceivable_iI_pn3n3_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--HoSungHanMember_zk1GlaPbRntd" title="Receivables"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4408"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--TradeAndOtherPayables_iI_pn3n3_c20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--HoSungHanMember_zw2GncMUXHRk" title="Payables"&gt;12,553&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_907_ecustom--OtherReceivable_iI_pn3n3_c20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--HoSungHanMember_zOl92pbv0VJ9" title="Receivables"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4412"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Other related party&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;Jung Gon Kim&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--TradeAndOtherPayables_iI_pn3n3_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--JungGonKimMember_zFTzS1rDpbWj" title="Payables"&gt;300,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_904_ecustom--OtherReceivable_iI_pn3n3_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--JungGonKimMember_zWlhvK15yHI2" title="Receivables"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4416"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--TradeAndOtherPayables_iI_pn3n3_c20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--JungGonKimMember_z1xgPLrXZob8" title="Payables"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4418"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_ecustom--OtherReceivable_iI_pn3n3_c20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--JungGonKimMember_zbkLjwCLhtu4" title="Receivables"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4420"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"&gt;Other related party&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Gyung Ha Yu&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--TradeAndOtherPayables_iI_pn3n3_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--GyungHaYuMember_zCk6HSx3ued5" title="Payables"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4422"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_904_ecustom--OtherReceivable_iI_pn3n3_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--GyungHaYuMember_zi8UkbXLEzxj" title="Receivables"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4424"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--TradeAndOtherPayables_iI_pn3n3_c20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--GyungHaYuMember_zoUdwoiLgxT9" title="Payables"&gt;10,478&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_901_ecustom--OtherReceivable_iI_pn3n3_c20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--GyungHaYuMember_z21yTXdZtWVc" title="Receivables"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4428"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; font-weight: bold; text-align: center; padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--TradeAndOtherPayables_iI_pn3n3_c20251231_zr1lMdNvZxxk" title="Payables"&gt;324,855&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_904_ecustom--OtherReceivable_iI_pn3n3_c20251231_zgKl6iCf2J2j" title="Receivables"&gt;442,894&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--TradeAndOtherPayables_iI_pn3n3_c20241231_zFWIxXiMn5Ea" title="Payables"&gt;39,769&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_903_ecustom--OtherReceivable_iI_pn3n3_c20241231_zk9tuMh2UtRj" title="Receivables"&gt;214,245&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;div style="width: 25%; margin-left: 0; margin-right: auto"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td id="xdx_F0D_zkHsJlO7ZCvj" style="width: 0.25in; text-align: left"&gt;(*)&lt;/td&gt;
    &lt;td id="xdx_F16_zYGzWuWueGD" style="text-align: justify"&gt;The Company provided a loan to Eun Jong Choi, the CEO of the Company, who resigned as CEO on January&#160;30, 2026. As of December&#160;31, 2025, compensation payable to the CEO was recorded as other payable and remained unpaid. Pursuant to a mutual agreement between the Company and the CEO, the unpaid compensation is expected to be applied against the outstanding loan receivable from the CEO.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AB_zmsRlYHUH0Qh" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

















&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;C.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;b&gt;Changes in related party balances by account&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Changes in related party balances by accounts for the years ended December 31, 2025 and 2024 are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_895_ecustom--ScheduleOfChangesInRelatedPartyBalancesByAccountTableTextBlock_pn3n3_zO2jKNl8GjSf" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Related parties (Details 1)"&gt;
  &lt;tr style="background-color: White; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_8B5_z9seBLa0KoCb" style="display: none"&gt;Schedule of changes in related party balances by account&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="14" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;b&gt;Related party&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Name of entity&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Account&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Beginning&lt;br/&gt;Balance&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Increase&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Decrease&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Ending&lt;br/&gt;Balance&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th style="text-align: center"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th style="text-align: center"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="14" style="text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; width: 25%"&gt;Entity that has significant influence over the Company&lt;/td&gt;
    &lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top; width: 15%"&gt;Well Core&lt;/td&gt;
    &lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top; width: 15%"&gt;Borrowings&lt;/td&gt;
    &lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 7%"&gt;&lt;span id="xdx_906_ecustom--RelatedPartyBalances_iS_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--WellCoreMember__ifrs-full--BorrowingsByNameAxis__custom--BorrowingMember_zAvwMKRGzoUj" title="Beginning Balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4448"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 7%"&gt;&lt;span id="xdx_900_ecustom--Increase_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--WellCoreMember__ifrs-full--BorrowingsByNameAxis__custom--BorrowingMember_zD9aIOofLcak" title="Increase"&gt;270,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 7%"&gt;&lt;span id="xdx_902_ecustom--Decrease_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--WellCoreMember__ifrs-full--BorrowingsByNameAxis__custom--BorrowingMember_z4yIg0ivNN8c" title="Decrease"&gt;270,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 7%"&gt;&lt;span id="xdx_90C_ecustom--RelatedPartyBalances_iE_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--WellCoreMember__ifrs-full--BorrowingsByNameAxis__custom--BorrowingMember_z39AcLHuc7A8" title="Ending Balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4454"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; width: 1%"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: White; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Entity that has significant influence over the Company&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;Dongsung D&amp;amp;C&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;Short-term loan receivable&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_902_ecustom--RelatedPartyBalances_iS_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--DongsungDAndCMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivableMember_zs3uJBmj85n8" title="Beginning Balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4456"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_ecustom--Increase_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--DongsungDAndCMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivableMember_zEOZeU610upd" title="Increase"&gt;220,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_ecustom--Decrease_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--DongsungDAndCMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivableMember_z0pTrZ8kZq28" title="Decrease"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4460"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_906_ecustom--RelatedPartyBalances_iE_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--DongsungDAndCMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivableMember_zE0mlepOYf4e" title="Ending Balance"&gt;220,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Entity that has significant influence over the Company&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;Dongsung D&amp;amp;C&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;Short-term loan receivable&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_907_ecustom--RelatedPartyBalances_iS_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--DongsungDAndCMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivablesMember_zmhggdOhbpfh" title="Beginning Balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4464"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_902_ecustom--Increase_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--DongsungDAndCMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivablesMember_zOaFmf41R8f2" title="Increase"&gt;1,296&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_ecustom--Decrease_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--DongsungDAndCMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivablesMember_zu44kflQvl9f" title="Decrease"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4468"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_901_ecustom--RelatedPartyBalances_iE_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--DongsungDAndCMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivablesMember_z9naqlVCqnxf" title="Ending Balance"&gt;1,296&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: White; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Key management personnel&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;Eun Jong Choi&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;Short-term loan receivable&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_ecustom--RelatedPartyBalances_iS_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivableMember_zpLEVa8OAMXh" title="Beginning Balance"&gt;140,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_902_ecustom--Increase_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivableMember_zl6gmji0BuXj" title="Increase"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4474"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_902_ecustom--Decrease_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivableMember_zgg6cOpIFYek" title="Decrease"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4476"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_ecustom--RelatedPartyBalances_iE_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivableMember_zcwmIdlX0Ytj" title="Ending Balance"&gt;140,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Key management personnel&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;Eun Jong Choi&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;Short-term loan receivable&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_908_ecustom--RelatedPartyBalances_iS_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivablesMember_zLfkQBV7wzuc" title="Beginning Balance"&gt;29,595&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_909_ecustom--Increase_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivablesMember_z3yCj4tff4C3" title="Increase"&gt;6,440&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_ecustom--Decrease_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivablesMember_zDhu8yxcXCL5" title="Decrease"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4484"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_ecustom--RelatedPartyBalances_iE_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivablesMember_z4ECJItNisRd" title="Ending Balance"&gt;36,035&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: White; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Entities controlled by Key Management Personnel&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;CubeBio Holdings., Ltd.&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;Short-term loan receivable&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_ecustom--RelatedPartyBalances_iS_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubeBioHoldingsLtdMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivableMember_zwZwSZ0pp732" title="Beginning Balance"&gt;44,100&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_902_ecustom--Increase_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubeBioHoldingsLtdMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivableMember_z9lvLDAllBg1" title="Increase"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4490"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_ecustom--Decrease_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubeBioHoldingsLtdMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivableMember_zdYzRJsloCoi" title="Decrease"&gt;1,053&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_ecustom--RelatedPartyBalances_iE_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubeBioHoldingsLtdMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivableMember_zDXnwzKX3CTf" title="Ending Balance"&gt;43,047&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Entities controlled by Key Management Personnel&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;CubeBio Holdings., Ltd.&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;Short-term loan receivable&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_ecustom--RelatedPartyBalances_iS_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubeBioHoldingsLtdMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivablesMember_zXxdfTPrImw4" title="Beginning Balance"&gt;550&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_901_ecustom--Increase_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubeBioHoldingsLtdMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivablesMember_zU5LgnmXl0s" title="Increase"&gt;1,967&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_ecustom--Decrease_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubeBioHoldingsLtdMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivablesMember_zZW3Oq1fXMq8" title="Decrease"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4500"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_ecustom--RelatedPartyBalances_iE_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubeBioHoldingsLtdMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivablesMember_zElx5kxT1U13" title="Ending Balance"&gt;2,517&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: White; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Key management personnel&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;Noh Bin Park&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;Bond with warrants (*1)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_908_ecustom--RelatedPartyBalances_iS_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--NohBinParkMember__ifrs-full--BorrowingsByNameAxis__custom--BondWithWarrantsMember_fKCoxKQ_____zEarbAHSyJ0l" title="Beginning Balance"&gt;20,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_ecustom--Increase_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--NohBinParkMember__ifrs-full--BorrowingsByNameAxis__custom--BondWithWarrantsMember_fKCoxKQ_____z7rGYWh7GN36" title="Increase"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4506"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_ecustom--Decrease_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--NohBinParkMember__ifrs-full--BorrowingsByNameAxis__custom--BondWithWarrantsMember_fKCoxKQ_____z75O2TK8xBWg" title="Decrease"&gt;20,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_904_ecustom--RelatedPartyBalances_iE_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--NohBinParkMember__ifrs-full--BorrowingsByNameAxis__custom--BondWithWarrantsMember_fKCoxKQ_____zsM2Nd9Z0Rrk" title="Ending Balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4510"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Key management personnel&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;Ho Sung Han&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;Bond with warrants (*1)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_ecustom--RelatedPartyBalances_iS_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--HoSungHanMember__ifrs-full--BorrowingsByNameAxis__custom--BondWithWarrantsMember_fKCoxKQ_____zbhrGj7dv5w8" title="Beginning Balance"&gt;15,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_908_ecustom--Increase_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--HoSungHanMember__ifrs-full--BorrowingsByNameAxis__custom--BondWithWarrantsMember_fKCoxKQ_____zxgMu7Kvugn6" title="Increase"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4514"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_902_ecustom--Decrease_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--HoSungHanMember__ifrs-full--BorrowingsByNameAxis__custom--BondWithWarrantsMember_fKCoxKQ_____zDki8moN4iOd" title="Decrease"&gt;15,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_ecustom--RelatedPartyBalances_iE_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--HoSungHanMember__ifrs-full--BorrowingsByNameAxis__custom--BondWithWarrantsMember_fKCoxKQ_____zlEvBjAjigN1" title="Ending Balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4518"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: White; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Other related party&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Jung Gon Kim&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Other payables&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_ecustom--RelatedPartyBalances_iS_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--JungGonKimMember__ifrs-full--BorrowingsByNameAxis__custom--OtherPayablesMember_fKCoxKQ_____z11YrCPnv01f" title="Beginning Balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4520"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90F_ecustom--Increase_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--JungGonKimMember__ifrs-full--BorrowingsByNameAxis__custom--OtherPayablesMember_fKCoxKQ_____z9xMnN56eLyk" title="Increase"&gt;300,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_904_ecustom--Decrease_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--JungGonKimMember__ifrs-full--BorrowingsByNameAxis__custom--OtherPayablesMember_fKCoxKQ_____zkCLHuTRLPl2" title="Decrease"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4524"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90B_ecustom--RelatedPartyBalances_iE_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--JungGonKimMember__ifrs-full--BorrowingsByNameAxis__custom--OtherPayablesMember_zgDfoD4J4UZj" title="Ending Balance"&gt;300,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Other related party&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;Gyung Ha Yu&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;Bond with warrants (*1)&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_902_ecustom--RelatedPartyBalances_iS_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--GyungHaYuMember__ifrs-full--BorrowingsByNameAxis__custom--BondWithWarrantsMember_fKCoxKQ_____zvQkxz7Q2D19" title="Beginning Balance"&gt;15,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--Increase_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--GyungHaYuMember__ifrs-full--BorrowingsByNameAxis__custom--BondWithWarrantsMember_fKCoxKQ_____zzop9rdfo1Gj" title="Increase"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4530"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--Decrease_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--GyungHaYuMember__ifrs-full--BorrowingsByNameAxis__custom--BondWithWarrantsMember_fKCoxKQ_____z65hz57JFwc2" title="Decrease"&gt;15,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_909_ecustom--RelatedPartyBalances_iE_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--GyungHaYuMember__ifrs-full--BorrowingsByNameAxis__custom--BondWithWarrantsMember_fKCoxKQ_____zWJNyy5lLDY6" title="Ending Balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4534"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: White; vertical-align: bottom"&gt;
    &lt;td colspan="5" style="text-align: center; padding-bottom: 1.25pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_902_ecustom--RelatedPartyBalances_iS_pn3n3_c20250101__20251231_zA4sMkoUJpQ2" title="Beginning Balance"&gt;264,245&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_907_ecustom--Increase_pn3n3_c20250101__20251231_zTLQ4M57BeH3" title="Increase"&gt;799,703&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_901_ecustom--Decrease_pn3n3_c20250101__20251231_zASuU3qxOP5l" title="Decrease"&gt;321,053&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_906_ecustom--RelatedPartyBalances_iE_pn3n3_c20250101__20251231_zRq43Jcv1758" title="Ending Balance"&gt;742,895&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;div style="width: 25%; margin-left: 0; margin-right: auto"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td id="xdx_F03_zwvJmLAtYfSf" style="width: 0.25in; text-align: left"&gt;(*1)&lt;/td&gt;
    &lt;td id="xdx_F10_zZCcRnxTF2i7" style="text-align: justify"&gt;The amounts are presented in principal of bonds.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

















&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; vertical-align: top; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; text-align: center; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="14" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left; vertical-align: bottom"&gt;&lt;b&gt;Related party&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; text-align: center; vertical-align: bottom; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; vertical-align: bottom; text-align: center"&gt;&lt;b&gt;Name of entity&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; text-align: center; vertical-align: bottom; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center; vertical-align: bottom"&gt;&lt;b&gt;Account&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; text-align: center; vertical-align: bottom; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center; vertical-align: bottom"&gt;&lt;b&gt;Beginning&lt;br/&gt; Balance&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; text-align: center; vertical-align: bottom; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; text-align: center; vertical-align: bottom; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center; vertical-align: bottom"&gt;&lt;b&gt;Increase&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; text-align: center; vertical-align: bottom; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; text-align: center; vertical-align: bottom; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center; vertical-align: bottom"&gt;&lt;b&gt;Decrease&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; text-align: center; vertical-align: bottom; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; text-align: center; vertical-align: bottom; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center; vertical-align: bottom"&gt;&lt;b&gt;Ending&lt;br/&gt;Balance&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; text-align: center; vertical-align: bottom; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; vertical-align: top"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; text-align: left; vertical-align: top"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; text-align: center"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="14" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; width: 25%"&gt;Entity that has significant influence over the Company&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: top; width: 15%"&gt;Well Core&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; width: 15%"&gt;Short-term loan receivable&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; width: 2%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right; width: 7%"&gt;&lt;span id="xdx_903_ecustom--RelatedPartyBalances_iS_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--WellCoreMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivableMember_zfbeaoJ6Jbmg" title="Beginning Balance"&gt;309,112&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right; width: 7%"&gt;&lt;span id="xdx_906_ecustom--Increase_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--WellCoreMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivableMember_zMaNQLjphUfj" title="Increase"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4554"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right; width: 7%"&gt;&lt;span id="xdx_909_ecustom--Decrease_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--WellCoreMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivableMember_z1FhT9Ev17Ba" title="Decrease"&gt;309,112&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right; width: 7%"&gt;&lt;span id="xdx_90F_ecustom--RelatedPartyBalances_iE_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--WellCoreMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivableMember_zKCNWvxO3ezl" title="Ending Balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4558"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; width: 1%"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Entity that has significant influence over the Company&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: top"&gt;Well Core&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top"&gt;Short-term Borrowings&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--RelatedPartyBalances_iS_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--WellCoreMember__ifrs-full--BorrowingsByNameAxis__ifrs-full--ShorttermBorrowingsMember_zoWQTMBjdftd" title="Beginning Balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4560"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_905_ecustom--Increase_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--WellCoreMember__ifrs-full--BorrowingsByNameAxis__ifrs-full--ShorttermBorrowingsMember_zbAP56BqpAhb" title="Increase"&gt;400,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--Decrease_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--WellCoreMember__ifrs-full--BorrowingsByNameAxis__ifrs-full--ShorttermBorrowingsMember_zK71arjjyBG5" title="Decrease"&gt;400,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_906_ecustom--RelatedPartyBalances_iE_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--WellCoreMember__ifrs-full--BorrowingsByNameAxis__ifrs-full--ShorttermBorrowingsMember_z3K7CXKn2h54" title="Ending Balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4566"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Key management personnel&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: top"&gt;Eun Jong Choi&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top"&gt;Short-term loan receivable&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--RelatedPartyBalances_iS_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivableMember_zUoIUHzsPb7h" title="Beginning Balance"&gt;600,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--Increase_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivableMember_zVLVh7wb3If2" title="Increase"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4570"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--Decrease_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivableMember_z7Kf0CZ2ABZ2" title="Decrease"&gt;460,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--RelatedPartyBalances_iE_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivableMember_zqwrIud50oC5" title="Ending Balance"&gt;140,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Key management personnel&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: top"&gt;Eun Jong Choi&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top"&gt;Short-term loan receivable&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--RelatedPartyBalances_iS_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivablesMember_zkO9chsTmbue" title="Beginning Balance"&gt;6,338&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--Increase_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivablesMember_zhLODttJutJb" title="Increase"&gt;23,257&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_907_ecustom--Decrease_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivablesMember_zoeLJUuWkr4e" title="Decrease"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4580"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--RelatedPartyBalances_iE_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivablesMember_zty8lqtpkTEj" title="Ending Balance"&gt;29,595&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Entities controlled by Key Management Personnel&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: top"&gt;CubeBio Holdings., Ltd.&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top"&gt;Short-term loan receivable&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_909_ecustom--RelatedPartyBalances_iS_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubeBioHoldingsLtdMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivableMember_zhnX7emAH6C2" title="Beginning Balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4584"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_908_ecustom--Increase_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubeBioHoldingsLtdMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivableMember_zyMyI1S3PRL6" title="Increase"&gt;44,100&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--Decrease_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubeBioHoldingsLtdMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivableMember_zXVJEXOjIttk" title="Decrease"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4588"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--RelatedPartyBalances_iE_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubeBioHoldingsLtdMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivableMember_zFoXjORiw9cj" title="Ending Balance"&gt;44,100&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Entities controlled by Key Management Personnel&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: top"&gt;CubeBio Holdings., Ltd.&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top"&gt;Short-term loan receivable&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_ecustom--RelatedPartyBalances_iS_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubeBioHoldingsLtdMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivablesMember_zFkEjpRjhMh5" title="Beginning Balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4592"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_906_ecustom--Increase_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubeBioHoldingsLtdMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivablesMember_zVEpUlP36AKd" title="Increase"&gt;550&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_905_ecustom--Decrease_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubeBioHoldingsLtdMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivablesMember_zdcJzVzwS2Od" title="Decrease"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4596"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_ecustom--RelatedPartyBalances_iE_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubeBioHoldingsLtdMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivablesMember_zZNvSRCaqw7f" title="Ending Balance"&gt;550&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Key management personnel&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: top"&gt;Jae Myung Kim&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top"&gt;Bond with warrants (*1)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_ecustom--RelatedPartyBalances_iS_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--JaeMyungKimMember__ifrs-full--BorrowingsByNameAxis__custom--BondWithWarrantsMember_fKCoxKQ_____zkM9wcuUL2Ja" title="Beginning Balance"&gt;700,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_900_ecustom--Increase_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--JaeMyungKimMember__ifrs-full--BorrowingsByNameAxis__custom--BondWithWarrantsMember_fKCoxKQ_____zbF9LMtfMJfe" title="Increase"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4602"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_900_ecustom--Decrease_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--JaeMyungKimMember__ifrs-full--BorrowingsByNameAxis__custom--BondWithWarrantsMember_fKCoxKQ_____zKicWWGeNxA5" title="Decrease"&gt;700,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_903_ecustom--RelatedPartyBalances_iE_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--JaeMyungKimMember__ifrs-full--BorrowingsByNameAxis__custom--BondWithWarrantsMember_fKCoxKQ_____z0aqZRGX5ib5" title="Ending Balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4606"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Key management personnel&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: top"&gt;Noh Bin Park&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top"&gt;Bond with warrants (*1)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_909_ecustom--RelatedPartyBalances_iS_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--NohBinParkMember__ifrs-full--BorrowingsByNameAxis__custom--BondWithWarrantsMember_fKCoxKQ_____z6XU9rSl0aWa" title="Beginning Balance"&gt;20,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--Increase_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--NohBinParkMember__ifrs-full--BorrowingsByNameAxis__custom--BondWithWarrantsMember_fKCoxKQ_____z9e1HO8p3rEl" title="Increase"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4610"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--Decrease_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--NohBinParkMember__ifrs-full--BorrowingsByNameAxis__custom--BondWithWarrantsMember_fKCoxKQ_____z9eQ2uRd0Bi4" title="Decrease"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4612"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--RelatedPartyBalances_iE_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--NohBinParkMember__ifrs-full--BorrowingsByNameAxis__custom--BondWithWarrantsMember_fKCoxKQ_____zZJjgJPjgeSg" title="Ending Balance"&gt;20,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Key management personnel&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: top"&gt;Ho Sung Han&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top"&gt;Bond with warrants (*1)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_903_ecustom--RelatedPartyBalances_iS_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--HoSungHanMember__ifrs-full--BorrowingsByNameAxis__custom--BondWithWarrantsMember_fKCoxKQ_____zdn3u2wXNHX" title="Beginning Balance"&gt;15,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_905_ecustom--Increase_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--HoSungHanMember__ifrs-full--BorrowingsByNameAxis__custom--BondWithWarrantsMember_fKCoxKQ_____znZGdaLzuP9g" title="Increase"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4618"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_906_ecustom--Decrease_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--HoSungHanMember__ifrs-full--BorrowingsByNameAxis__custom--BondWithWarrantsMember_fKCoxKQ_____z77t95JY9Ywl" title="Decrease"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4620"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--RelatedPartyBalances_iE_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--HoSungHanMember__ifrs-full--BorrowingsByNameAxis__custom--BondWithWarrantsMember_fKCoxKQ_____zN1Cc9VI2YXg" title="Ending Balance"&gt;15,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Other related party&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: top"&gt;Se Yoon Kim&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top"&gt;Bond with warrants (*1)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_901_ecustom--RelatedPartyBalances_iS_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--SeYoonKimMember__ifrs-full--BorrowingsByNameAxis__custom--BondWithWarrantsMember_fKCoxKQ_____zZnCQa8dlQ87" title="Beginning Balance"&gt;210,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_907_ecustom--Increase_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--SeYoonKimMember__ifrs-full--BorrowingsByNameAxis__custom--BondWithWarrantsMember_fKCoxKQ_____zEnUNBZQsbH5" title="Increase"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4626"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_902_ecustom--Decrease_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--SeYoonKimMember__ifrs-full--BorrowingsByNameAxis__custom--BondWithWarrantsMember_fKCoxKQ_____zbM8edzyvzfj" title="Decrease"&gt;210,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_903_ecustom--RelatedPartyBalances_iE_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--SeYoonKimMember__ifrs-full--BorrowingsByNameAxis__custom--BondWithWarrantsMember_fKCoxKQ_____zBxTZFQdcaA8" title="Ending Balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4630"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Other related party&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: top"&gt;Gyung Ha Yu&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top"&gt;Bond with warrants (*1)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--RelatedPartyBalances_iS_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--GyungHaYuMember__ifrs-full--BorrowingsByNameAxis__custom--BondWithWarrantsMember_fKCoxKQ_____ziYrSNqbhc3j" title="Beginning Balance"&gt;15,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--Increase_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--GyungHaYuMember__ifrs-full--BorrowingsByNameAxis__custom--BondWithWarrantsMember_fKCoxKQ_____z2dfjlXBlfyk" title="Increase"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4634"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_ecustom--Decrease_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--GyungHaYuMember__ifrs-full--BorrowingsByNameAxis__custom--BondWithWarrantsMember_fKCoxKQ_____zgkVZ6Q5WmXb" title="Decrease"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4636"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--RelatedPartyBalances_iE_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--GyungHaYuMember__ifrs-full--BorrowingsByNameAxis__custom--BondWithWarrantsMember_fKCoxKQ_____zTOWHqhr8osc" title="Ending Balance"&gt;15,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Other related party&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: top; padding-bottom: 0.5pt"&gt;Jung Gon Kim(*2)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;Bond with warrants (*1)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--RelatedPartyBalances_iS_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--JungGonKimMember__ifrs-full--BorrowingsByNameAxis__custom--BondWithWarrantsMember_fKCoxKSgqMik___zkcNMKjj8AI2" title="Beginning Balance"&gt;2,400,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_907_ecustom--Increase_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--JungGonKimMember__ifrs-full--BorrowingsByNameAxis__custom--BondWithWarrantsMember_fKCoxKSgqMik___zDvee6dPdOt9" title="Increase"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4642"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_900_ecustom--Decrease_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--JungGonKimMember__ifrs-full--BorrowingsByNameAxis__custom--BondWithWarrantsMember_fKCoxKSgqMik___zmqpFE9xNZVd" title="Decrease"&gt;2,400,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--RelatedPartyBalances_iE_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--JungGonKimMember__ifrs-full--BorrowingsByNameAxis__custom--BondWithWarrantsMember_fKCoxKSgqMik___zXiKYnAtIMh1" title="Ending Balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4646"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td colspan="5" style="font: 10pt Times New Roman; text-align: center; padding-bottom: 1.25pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--RelatedPartyBalances_iS_pn3n3_c20240101__20241231_zbQAJAR9G41l" title="Beginning Balance"&gt;4,275,450&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--Increase_pn3n3_c20240101__20241231_zon9hOwK5xVe" title="Increase"&gt;467,907&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--Decrease_pn3n3_c20240101__20241231_zLz0fjUfLw48" title="Decrease"&gt;4,479,112&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--RelatedPartyBalances_iE_pn3n3_c20240101__20241231_zt6SGrkw5ubh" title="Ending Balance"&gt;264,245&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;div style="width: 25%; margin-left: 0; margin-right: auto"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td id="xdx_F08_zQC2bNCBoich" style="font: 10pt Times New Roman; width: 0.35in; text-align: left"&gt;(*1)&lt;/td&gt;
    &lt;td id="xdx_F14_zxxyzTfq9sE8" style="font: 10pt Times New Roman; text-align: justify"&gt;The amounts are presented in principal of bonds.&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;(*2)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;The Company recognized Jung Gon Kim as a related party as Jung Gon Kim is a close family member of Jae Myung Kim, a key management personnel.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A2_zlvgJjypv7Lg" style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.25in; text-align: left"&gt;&lt;b&gt;D.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;&lt;b&gt;Key management personnel compensation&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The compensation for key management personnel for the years ended December&#160;31, 2025 and 2024 are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_897_ecustom--ScheduleOfManagementPersonnelCompensationTableTextBlock_pn3n3_zq7xIEd2Upk3" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Related parties (Details 3)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_8B9_znhKkO0FqmT6" style="display: none"&gt;Schedule of compensation for key management personnel&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_493_20250101__20251231_zKGIrstTuzx7" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49B_20240101__20241231_zjfbUl4ocBpc" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40A_eifrs-full--ShorttermEmployeeBenefitsExpense_zA3P42S32XGa" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Short-term employee benefits&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;453,226&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;402,519&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40A_eifrs-full--PostemploymentBenefitExpenseDefinedBenefitPlans_zPhwJvp6Aa54" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Retirement benefit&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;48,434&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;30,292&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--KeyManagementPersonnelCompensationShorttermEmployeeBenefits_zOv5oA4Nq0qd" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; vertical-align: top; padding-bottom: 1.25pt"&gt;Total&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;501,660&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;432,811&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A6_zYQR51kPaPWh" style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The compensation for the Company&#x2019;s key management personnel includes salaries and contributions to a post-employment defined benefit plan. Executive officers also participate in the Company&#x2019;s share option plan.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

















</ifrs-full:DisclosureOfRelatedPartyExplanatory>
    <cik0002058261:ScheduleOfTransactionWithRelatedPartiesTableTextBlock
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact004240">&lt;table cellpadding="0" cellspacing="0" id="xdx_898_ecustom--ScheduleOfTransactionWithRelatedPartiesTableTextBlock_ziggoMlEHU3k" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Related parties (Details 2)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_8B1_z0zPSB1H4x24" style="display: none"&gt;Schedule of transaction with related parties&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="border-bottom: Black 0.5pt solid; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2"&gt;&lt;b&gt;Interest&lt;/b&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="text-align: center"&gt;&lt;b&gt;Interest&lt;/b&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="text-align: center"&gt;&lt;b&gt;Interest&lt;/b&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="text-align: center"&gt;&lt;b&gt;Interest&lt;/b&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;b&gt;Related party&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Name of entity&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 0.5pt solid; text-align: center"&gt;&lt;b&gt;income&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;expenses&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;income&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;expenses&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th style="text-align: center"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th style="text-align: center"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="13" style="text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; width: 36%"&gt;&lt;span id="xdx_907_ecustom--RelatedParty_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--WellCoreMember_zmsiheyakQ22" title="Related party"&gt;Entity that has significant influence over the Company&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 20%; vertical-align: top"&gt;&lt;span id="xdx_90E_eifrs-full--NameOfParentEntity_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--WellCoreMember_fKCoxKQ_____zD1hh9mTsoSk" title="Name of entity"&gt;Well Core&lt;/span&gt;(*1)&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 7%"&gt;&lt;span id="xdx_902_ecustom--InterestIncome_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--WellCoreMember_zYKOZlYx2PPh" title="Interest income"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4246"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 7%"&gt;&lt;span id="xdx_90B_ecustom--InterestExpenses_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--WellCoreMember_z512Si1YwELl" title="Interest expenses"&gt;783&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 7%"&gt;&lt;span id="xdx_904_ecustom--InterestIncome_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--WellCoreMember_zUCV0tZYIAkl" title="Interest income"&gt;567&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 7%"&gt;&lt;span id="xdx_90A_ecustom--InterestExpenses_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--WellCoreMember_zI1gJUOUoEY3" title="Interest expenses"&gt;3,882&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; width: 1%"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_900_ecustom--RelatedParty_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--DongsungDAndCMember_zbj7bWJu19Fg" title="Related party"&gt;Entities controlled by Key Management Personnel&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;&lt;span id="xdx_901_eifrs-full--NameOfParentEntity_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--DongsungDAndCMember_fKCoyKQ_____zZOrjG5nUfC8" title="Name of entity"&gt;Dongsung D&amp;amp;C&lt;/span&gt;(*2)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_904_ecustom--InterestIncome_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--DongsungDAndCMember_zQIbps6CYq2g" title="Interest income"&gt;1,296&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_ecustom--InterestExpenses_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--DongsungDAndCMember_zxgzu1xEJOhk" title="Interest expenses"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4260"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_902_ecustom--InterestIncome_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--DongsungDAndCMember_zQh6jTokOYxj" title="Interest income"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4262"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_904_ecustom--InterestExpenses_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--DongsungDAndCMember_zmFoDWCtNWSi" title="Interest expenses"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4264"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_908_ecustom--RelatedParty_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubeBioHoldingsLtdMember_ziwRolKbthEk" title="Related party"&gt;Entities controlled by Key Management Personnel&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;&lt;span id="xdx_909_eifrs-full--NameOfParentEntity_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubeBioHoldingsLtdMember_zdIEdZWBQVx1" title="Name of entity"&gt;CubeBio Holdings., Ltd.&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_904_ecustom--InterestIncome_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubeBioHoldingsLtdMember_zjDHP4nI4Vnk" title="Interest income"&gt;1,980&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_907_ecustom--InterestExpenses_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubeBioHoldingsLtdMember_zG8ubHf9aSi7" title="Interest expenses"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4272"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_904_ecustom--InterestIncome_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubeBioHoldingsLtdMember_zky8DyungVA2" title="Interest income"&gt;550&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_905_ecustom--InterestExpenses_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubeBioHoldingsLtdMember_znpNs8ppM7ii" title="Interest expenses"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4276"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_90B_ecustom--RelatedParty_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--JaeMyungKimMember_zl0KhzWRjzR4" title="Related party"&gt;Key management personnel&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;&lt;span id="xdx_904_eifrs-full--NameOfParentEntity_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--JaeMyungKimMember_zucCDGJIN46g" title="Name of entity"&gt;Jae Myung Kim&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_ecustom--InterestIncome_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--JaeMyungKimMember_z6YwLAkH2d2i" title="Interest income"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4282"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_901_ecustom--InterestExpenses_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--JaeMyungKimMember_zDXZ51rBOhX6" title="Interest expenses"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4284"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_ecustom--InterestIncome_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--JaeMyungKimMember_zxYxH3ryny37" title="Interest income"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4286"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_902_ecustom--InterestExpenses_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--JaeMyungKimMember_zTks6lEY2yj8" title="Interest expenses"&gt;62,234&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_908_ecustom--RelatedParty_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--NohBinParkNohBinParkMember_ztGAGHIz10ua" title="Related party"&gt;Key management personnel&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;&lt;span id="xdx_90F_eifrs-full--NameOfParentEntity_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--NohBinParkNohBinParkMember_ze6ieTJGdQe4" title="Name of entity"&gt;Noh Bin Park&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_ecustom--InterestIncome_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--NohBinParkNohBinParkMember_zWtx6N8RfuD8" title="Interest income"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4294"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_901_ecustom--InterestExpenses_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--NohBinParkNohBinParkMember_zdqYmzGTcFmc" title="Interest expenses"&gt;2,060&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_901_ecustom--InterestIncome_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--NohBinParkNohBinParkMember_z5qrs1PsDPW8" title="Interest income"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4298"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_904_ecustom--InterestExpenses_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--NohBinParkNohBinParkMember_z4IEM2xAXIql" title="Interest expenses"&gt;3,358&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_90A_ecustom--RelatedParty_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--HoSungHanMember_z6C14FkkdwT7" title="Related party"&gt;Key management personnel&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;&lt;span id="xdx_904_eifrs-full--NameOfParentEntity_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--HoSungHanMember_z85u4cLPEEH5" title="Name of entity"&gt;Ho Sung Han&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_ecustom--InterestIncome_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--HoSungHanMember_zSMCrRUZVURd" title="Interest income"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4306"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_902_ecustom--InterestExpenses_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--HoSungHanMember_zqhynREMG2P8" title="Interest expenses"&gt;2,171&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_909_ecustom--InterestIncome_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--HoSungHanMember_zS5Aq2RFi8Id" title="Interest income"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4310"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_900_ecustom--InterestExpenses_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--HoSungHanMember_zVLXrgcj3v58" title="Interest expenses"&gt;2,519&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_906_ecustom--RelatedParty_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember_zyd8AgpUNeZg" title="Related party"&gt;Key management personnel&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;&lt;span id="xdx_90D_eifrs-full--NameOfParentEntity_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember_zdRMyBhT94m1" title="Name of entity"&gt;Eun Jong Choi&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_ecustom--InterestIncome_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember_zOEJVT4o9rHb" title="Interest income"&gt;6,440&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_907_ecustom--InterestExpenses_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember_zA4S7WUmlXQj" title="Interest expenses"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4320"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_903_ecustom--InterestIncome_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember_zHCAEOQ53pu2" title="Interest income"&gt;23,257&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_906_ecustom--InterestExpenses_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember_zd90v2ppz3zb" title="Interest expenses"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4324"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_904_ecustom--RelatedParty_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--SeYoonKimMember_zRruRxX4Aewl" title="Related party"&gt;Other related party&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;&lt;span id="xdx_909_eifrs-full--NameOfParentEntity_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--SeYoonKimMember_z032IfPWDwfl" title="Name of entity"&gt;Se Yoon Kim&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_ecustom--InterestIncome_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--SeYoonKimMember_zjJVuTLFjoQ7" title="Interest income"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4330"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_904_ecustom--InterestExpenses_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--SeYoonKimMember_zvtUUgPuOrPb" title="Interest expenses"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4332"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_900_ecustom--InterestIncome_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--SeYoonKimMember_zTa5T22XQK9g" title="Interest income"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4334"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_ecustom--InterestExpenses_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--SeYoonKimMember_zlBI7B0sJlv1" title="Interest expenses"&gt;16,594&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_906_ecustom--RelatedParty_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--GyungHaYuMember_ztFyfG7jepvi" title="Related party"&gt;Other related party&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;&lt;span id="xdx_903_eifrs-full--NameOfParentEntity_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--GyungHaYuMember_zcDoMpm4Tb0a" title="Name of entity"&gt;Gyung Ha Yu&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_903_ecustom--InterestIncome_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--GyungHaYuMember_zAStHCyHZ3q" title="Interest income"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4342"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_909_ecustom--InterestExpenses_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--GyungHaYuMember_zGtHxSGffyC4" title="Interest expenses"&gt;1,775&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_904_ecustom--InterestIncome_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--GyungHaYuMember_zgHT4SS4M5h" title="Interest income"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4346"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_ecustom--InterestExpenses_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--GyungHaYuMember_zpIPJEqSoLSh" title="Interest expenses"&gt;2,068&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;&lt;span id="xdx_901_ecustom--RelatedParty_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--JungGonKimMember_zTchPHSBnsWc" title="Related party"&gt;Other related party&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;&lt;span id="xdx_904_eifrs-full--NameOfParentEntity_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--JungGonKimMember_zfGmwKAWOORi" title="Name of entity"&gt;Jung Gon Kim&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_903_ecustom--InterestIncome_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--JungGonKimMember_z1Cv3s1a2QBk" title="Interest income"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4354"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_906_ecustom--InterestExpenses_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--JungGonKimMember_z4xXwG78JHYd" title="Interest expenses"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4356"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--InterestIncome_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--JungGonKimMember_zcpmyOQGI5pd" title="Interest income"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4358"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_906_ecustom--InterestExpenses_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--JungGonKimMember_zAKWjTnohq7l" title="Interest expenses"&gt;231,172&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td colspan="3" style="text-align: center; padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;
    &lt;td style="text-align: right; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_908_ecustom--InterestIncome_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember_ztrK0Vq7JNrk" title="Interest income"&gt;9,716&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_908_ecustom--InterestExpenses_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember_z9Pu5pXUJ4ml" title="Interest expenses"&gt;6,789&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--InterestIncome_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember_z7VAUhfhJJbl" title="Interest income"&gt;24,374&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--InterestExpenses_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember_zJi3Rjwht0Y9" title="Interest expenses"&gt;321,827&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;div style="width: 25%; margin-left: 0; margin-right: auto"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td id="xdx_F09_zV0xfx0N3lYk" style="width: 0.25in; text-align: left"&gt;(*1)&lt;/td&gt;
    &lt;td id="xdx_F11_zcBzs1WP5v97" style="text-align: justify"&gt;Well Core Co., Ltd. (&#x201c;Well Core&#x201d;) is an entity that has significant influence over the Company.&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td id="xdx_F0F_zpWW1m2ULLYe" style="text-align: left"&gt;(*2)&lt;/td&gt;
    &lt;td id="xdx_F10_zx0z1Hu5QJK" style="text-align: justify"&gt;Dongsung D&amp;amp;C., Ltd. (&#x201c;Dongsung D&amp;amp;C&#x201d;) was identified as a related party because it is controlled by a member of the Company&#x2019;s key management personnel.&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="text-align: left"&gt;(*3)&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;CubeBio Holdings., Ltd. (&#x201c;CubeBio Holdings&#x201d;) was recognized as entities controlled by key management personnel, as Eun Jong Choi, a key management personnel of the Company, has control over CubeBio Holdings., Ltd.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:ScheduleOfTransactionWithRelatedPartiesTableTextBlock>
    <cik0002058261:RelatedParty
      contextRef="From2025-01-012025-12-31_ifrs-full_RelatedPartiesMember_custom_WellCoreMember_custom_CubebioCo.Ltd.Member"
      id="Fact004242">Entity that has significant influence over the Company</cik0002058261:RelatedParty>
    <ifrs-full:NameOfParentEntity
      contextRef="From2025-01-012025-12-31_ifrs-full_RelatedPartiesMember_custom_WellCoreMember_custom_CubebioCo.Ltd.Member"
      id="Fact004244">Well Core</ifrs-full:NameOfParentEntity>
    <cik0002058261:InterestExpenses
      contextRef="From2025-01-012025-12-31_ifrs-full_RelatedPartiesMember_custom_WellCoreMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004248"
      unitRef="KRW">783000</cik0002058261:InterestExpenses>
    <cik0002058261:InterestIncome
      contextRef="From2024-01-012024-12-31_ifrs-full_RelatedPartiesMember_custom_WellCoreMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004250"
      unitRef="KRW">567000</cik0002058261:InterestIncome>
    <cik0002058261:InterestExpenses
      contextRef="From2024-01-012024-12-31_ifrs-full_RelatedPartiesMember_custom_WellCoreMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004252"
      unitRef="KRW">3882000</cik0002058261:InterestExpenses>
    <cik0002058261:RelatedParty
      contextRef="From2025-01-012025-12-31_ifrs-full_RelatedPartiesMember_custom_DongsungDAndCMember_custom_CubebioCo.Ltd.Member"
      id="Fact004254">Entities controlled by Key Management Personnel</cik0002058261:RelatedParty>
    <ifrs-full:NameOfParentEntity
      contextRef="From2025-01-012025-12-31_ifrs-full_RelatedPartiesMember_custom_DongsungDAndCMember_custom_CubebioCo.Ltd.Member"
      id="Fact004256">Dongsung D&amp;C</ifrs-full:NameOfParentEntity>
    <cik0002058261:InterestIncome
      contextRef="From2025-01-012025-12-31_ifrs-full_RelatedPartiesMember_custom_DongsungDAndCMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004258"
      unitRef="KRW">1296000</cik0002058261:InterestIncome>
    <cik0002058261:RelatedParty
      contextRef="From2025-01-012025-12-31_ifrs-full_RelatedPartiesMember_custom_CubeBioHoldingsLtdMember_custom_CubebioCo.Ltd.Member"
      id="Fact004266">Entities controlled by Key Management Personnel</cik0002058261:RelatedParty>
    <ifrs-full:NameOfParentEntity
      contextRef="From2025-01-012025-12-31_ifrs-full_RelatedPartiesMember_custom_CubeBioHoldingsLtdMember_custom_CubebioCo.Ltd.Member"
      id="Fact004268">CubeBio Holdings., Ltd.</ifrs-full:NameOfParentEntity>
    <cik0002058261:InterestIncome
      contextRef="From2025-01-012025-12-31_ifrs-full_RelatedPartiesMember_custom_CubeBioHoldingsLtdMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004270"
      unitRef="KRW">1980000</cik0002058261:InterestIncome>
    <cik0002058261:InterestIncome
      contextRef="From2024-01-012024-12-31_ifrs-full_RelatedPartiesMember_custom_CubeBioHoldingsLtdMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004274"
      unitRef="KRW">550000</cik0002058261:InterestIncome>
    <cik0002058261:RelatedParty
      contextRef="From2025-01-012025-12-31_ifrs-full_RelatedPartiesMember_custom_JaeMyungKimMember_custom_CubebioCo.Ltd.Member"
      id="Fact004278">Key management personnel</cik0002058261:RelatedParty>
    <ifrs-full:NameOfParentEntity
      contextRef="From2025-01-012025-12-31_ifrs-full_RelatedPartiesMember_custom_JaeMyungKimMember_custom_CubebioCo.Ltd.Member"
      id="Fact004280">Jae Myung Kim</ifrs-full:NameOfParentEntity>
    <cik0002058261:InterestExpenses
      contextRef="From2024-01-012024-12-31_ifrs-full_RelatedPartiesMember_custom_JaeMyungKimMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004288"
      unitRef="KRW">62234000</cik0002058261:InterestExpenses>
    <cik0002058261:RelatedParty
      contextRef="From2025-01-012025-12-31_ifrs-full_RelatedPartiesMember_custom_NohBinParkNohBinParkMember_custom_CubebioCo.Ltd.Member"
      id="Fact004290">Key management personnel</cik0002058261:RelatedParty>
    <ifrs-full:NameOfParentEntity
      contextRef="From2025-01-012025-12-31_ifrs-full_RelatedPartiesMember_custom_NohBinParkNohBinParkMember_custom_CubebioCo.Ltd.Member"
      id="Fact004292">Noh Bin Park</ifrs-full:NameOfParentEntity>
    <cik0002058261:InterestExpenses
      contextRef="From2025-01-012025-12-31_ifrs-full_RelatedPartiesMember_custom_NohBinParkNohBinParkMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004296"
      unitRef="KRW">2060000</cik0002058261:InterestExpenses>
    <cik0002058261:InterestExpenses
      contextRef="From2024-01-012024-12-31_ifrs-full_RelatedPartiesMember_custom_NohBinParkNohBinParkMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004300"
      unitRef="KRW">3358000</cik0002058261:InterestExpenses>
    <cik0002058261:RelatedParty
      contextRef="From2025-01-012025-12-31_ifrs-full_RelatedPartiesMember_custom_HoSungHanMember_custom_CubebioCo.Ltd.Member"
      id="Fact004302">Key management personnel</cik0002058261:RelatedParty>
    <ifrs-full:NameOfParentEntity
      contextRef="From2025-01-012025-12-31_ifrs-full_RelatedPartiesMember_custom_HoSungHanMember_custom_CubebioCo.Ltd.Member"
      id="Fact004304">Ho Sung Han</ifrs-full:NameOfParentEntity>
    <cik0002058261:InterestExpenses
      contextRef="From2025-01-012025-12-31_ifrs-full_RelatedPartiesMember_custom_HoSungHanMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004308"
      unitRef="KRW">2171000</cik0002058261:InterestExpenses>
    <cik0002058261:InterestExpenses
      contextRef="From2024-01-012024-12-31_ifrs-full_RelatedPartiesMember_custom_HoSungHanMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004312"
      unitRef="KRW">2519000</cik0002058261:InterestExpenses>
    <cik0002058261:RelatedParty
      contextRef="From2025-01-012025-12-31_ifrs-full_RelatedPartiesMember_custom_EunJongChoiMember_custom_CubebioCo.Ltd.Member"
      id="Fact004314">Key management personnel</cik0002058261:RelatedParty>
    <ifrs-full:NameOfParentEntity
      contextRef="From2025-01-012025-12-31_ifrs-full_RelatedPartiesMember_custom_EunJongChoiMember_custom_CubebioCo.Ltd.Member"
      id="Fact004316">Eun Jong Choi</ifrs-full:NameOfParentEntity>
    <cik0002058261:InterestIncome
      contextRef="From2025-01-012025-12-31_ifrs-full_RelatedPartiesMember_custom_EunJongChoiMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004318"
      unitRef="KRW">6440000</cik0002058261:InterestIncome>
    <cik0002058261:InterestIncome
      contextRef="From2024-01-012024-12-31_ifrs-full_RelatedPartiesMember_custom_EunJongChoiMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004322"
      unitRef="KRW">23257000</cik0002058261:InterestIncome>
    <cik0002058261:RelatedParty
      contextRef="From2025-01-012025-12-31_ifrs-full_RelatedPartiesMember_custom_SeYoonKimMember_custom_CubebioCo.Ltd.Member"
      id="Fact004326">Other related party</cik0002058261:RelatedParty>
    <ifrs-full:NameOfParentEntity
      contextRef="From2025-01-012025-12-31_ifrs-full_RelatedPartiesMember_custom_SeYoonKimMember_custom_CubebioCo.Ltd.Member"
      id="Fact004328">Se Yoon Kim</ifrs-full:NameOfParentEntity>
    <cik0002058261:InterestExpenses
      contextRef="From2024-01-012024-12-31_ifrs-full_RelatedPartiesMember_custom_SeYoonKimMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004336"
      unitRef="KRW">16594000</cik0002058261:InterestExpenses>
    <cik0002058261:RelatedParty
      contextRef="From2025-01-012025-12-31_ifrs-full_RelatedPartiesMember_custom_GyungHaYuMember_custom_CubebioCo.Ltd.Member"
      id="Fact004338">Other related party</cik0002058261:RelatedParty>
    <ifrs-full:NameOfParentEntity
      contextRef="From2025-01-012025-12-31_ifrs-full_RelatedPartiesMember_custom_GyungHaYuMember_custom_CubebioCo.Ltd.Member"
      id="Fact004340">Gyung Ha Yu</ifrs-full:NameOfParentEntity>
    <cik0002058261:InterestExpenses
      contextRef="From2025-01-012025-12-31_ifrs-full_RelatedPartiesMember_custom_GyungHaYuMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004344"
      unitRef="KRW">1775000</cik0002058261:InterestExpenses>
    <cik0002058261:InterestExpenses
      contextRef="From2024-01-012024-12-31_ifrs-full_RelatedPartiesMember_custom_GyungHaYuMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004348"
      unitRef="KRW">2068000</cik0002058261:InterestExpenses>
    <cik0002058261:RelatedParty
      contextRef="From2025-01-012025-12-31_ifrs-full_RelatedPartiesMember_custom_JungGonKimMember_custom_CubebioCo.Ltd.Member"
      id="Fact004350">Other related party</cik0002058261:RelatedParty>
    <ifrs-full:NameOfParentEntity
      contextRef="From2025-01-012025-12-31_ifrs-full_RelatedPartiesMember_custom_JungGonKimMember_custom_CubebioCo.Ltd.Member"
      id="Fact004352">Jung Gon Kim</ifrs-full:NameOfParentEntity>
    <cik0002058261:InterestExpenses
      contextRef="From2024-01-012024-12-31_ifrs-full_RelatedPartiesMember_custom_JungGonKimMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004360"
      unitRef="KRW">231172000</cik0002058261:InterestExpenses>
    <cik0002058261:InterestIncome
      contextRef="From2025-01-012025-12-31_ifrs-full_RelatedPartiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004362"
      unitRef="KRW">9716000</cik0002058261:InterestIncome>
    <cik0002058261:InterestExpenses
      contextRef="From2025-01-012025-12-31_ifrs-full_RelatedPartiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004364"
      unitRef="KRW">6789000</cik0002058261:InterestExpenses>
    <cik0002058261:InterestIncome
      contextRef="From2024-01-012024-12-31_ifrs-full_RelatedPartiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004366"
      unitRef="KRW">24374000</cik0002058261:InterestIncome>
    <cik0002058261:InterestExpenses
      contextRef="From2024-01-012024-12-31_ifrs-full_RelatedPartiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004368"
      unitRef="KRW">321827000</cik0002058261:InterestExpenses>
    <cik0002058261:ScheduleOfPayablesAndReceivablesRelatedPartiesTableTextBlock
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact004372">&lt;table cellpadding="0" cellspacing="0" id="xdx_89E_ecustom--ScheduleOfPayablesAndReceivablesRelatedPartiesTableTextBlock_pn3n3_zJxFCeVqXYv4" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Related parties (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span id="xdx_8B5_zr6kkc5rpXcd" style="display: none"&gt;Schedule of receivables and payables account balances&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December&#160;31,&lt;br/&gt; 2025&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December&#160;31,&lt;br/&gt; 2024&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;Related party&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Name of entity&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Payables&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Receivables&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Payables&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Receivables&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; width: 36%; text-align: left"&gt;Entities controlled by Key Management Personnel&lt;/td&gt;
    &lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 20%; text-align: left"&gt;Dongsung D&amp;amp;C&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 7%; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--TradeAndOtherPayables_iI_pn3n3_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--DongsungDAndCMember_zl676w7dGMZf" title="Payables"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4374"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 7%; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--OtherReceivable_iI_pn3n3_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--DongsungDAndCMember_zKCrH3KlaSh2" title="Receivables"&gt;221,295&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 7%; text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--TradeAndOtherPayables_iI_pn3n3_c20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--DongsungDAndCMember_zoYET1v2Ptj7" title="Payables"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4378"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 7%; text-align: right"&gt;&lt;span id="xdx_907_ecustom--OtherReceivable_iI_pn3n3_c20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--DongsungDAndCMember_zTJnOxT7FZfl" title="Receivables"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4380"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Entities controlled by Key Management Personnel&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;CubeBio Holdings., Ltd.&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--TradeAndOtherPayables_iI_pn3n3_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubeBioHoldingsLtdMember_zbnK3AeLWLoa" title="Payables"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4382"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_909_ecustom--OtherReceivable_iI_pn3n3_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubeBioHoldingsLtdMember_z2NjaBu6D6ef" title="Receivables"&gt;45,564&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--TradeAndOtherPayables_iI_pn3n3_c20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubeBioHoldingsLtdMember_z0DdWQQS8Pjb" title="Payables"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4386"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_ecustom--OtherReceivable_iI_pn3n3_c20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubeBioHoldingsLtdMember_zl78TAc7Rg1i" title="Receivables"&gt;44,650&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Key management personnel&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;Eun Jong Choi (*)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--OtherPayables_iI_pn3n3_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember_fKCop_zJMRTN5Mnkrf" title="Payables"&gt;24,855&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_906_ecustom--OtherReceivable_iI_pn3n3_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember_fKCop_zkIPahV1BXo9" title="Receivables"&gt;176,035&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--TradeAndOtherPayables_iI_pn3n3_c20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember_fKCop_zi4HZ8WbjjY6" title="Payables"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4394"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_ecustom--OtherReceivable_iI_pn3n3_c20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember_fKCop_zNwdaZsBu4fj" title="Receivables"&gt;169,595&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Key management personnel&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;Noh Bin Park&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--TradeAndOtherPayables_iI_pn3n3_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--NohBinParkMember_z4D1Ue0GdXL3" title="Payables"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4398"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_906_ecustom--OtherReceivable_iI_pn3n3_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--NohBinParkMember_zTqQAlyy1IJ3" title="Receivables"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4400"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--TradeAndOtherPayables_iI_pn3n3_c20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--NohBinParkMember_znJ7nW0sNth5" title="Payables"&gt;16,738&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_904_ecustom--OtherReceivable_iI_pn3n3_c20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--NohBinParkMember_zpvv7yGkHtT7" title="Receivables"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4404"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Key management personnel&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;Ho Sung Han&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--TradeAndOtherPayables_iI_pn3n3_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--HoSungHanMember_zNokjXSd4c73" title="Payables"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4406"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_902_ecustom--OtherReceivable_iI_pn3n3_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--HoSungHanMember_zk1GlaPbRntd" title="Receivables"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4408"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--TradeAndOtherPayables_iI_pn3n3_c20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--HoSungHanMember_zw2GncMUXHRk" title="Payables"&gt;12,553&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_907_ecustom--OtherReceivable_iI_pn3n3_c20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--HoSungHanMember_zOl92pbv0VJ9" title="Receivables"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4412"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Other related party&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;Jung Gon Kim&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--TradeAndOtherPayables_iI_pn3n3_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--JungGonKimMember_zFTzS1rDpbWj" title="Payables"&gt;300,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_904_ecustom--OtherReceivable_iI_pn3n3_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--JungGonKimMember_zWlhvK15yHI2" title="Receivables"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4416"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--TradeAndOtherPayables_iI_pn3n3_c20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--JungGonKimMember_z1xgPLrXZob8" title="Payables"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4418"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_ecustom--OtherReceivable_iI_pn3n3_c20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--JungGonKimMember_zbkLjwCLhtu4" title="Receivables"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4420"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"&gt;Other related party&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Gyung Ha Yu&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--TradeAndOtherPayables_iI_pn3n3_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--GyungHaYuMember_zCk6HSx3ued5" title="Payables"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4422"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_904_ecustom--OtherReceivable_iI_pn3n3_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--GyungHaYuMember_zi8UkbXLEzxj" title="Receivables"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4424"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--TradeAndOtherPayables_iI_pn3n3_c20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--GyungHaYuMember_zoUdwoiLgxT9" title="Payables"&gt;10,478&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_901_ecustom--OtherReceivable_iI_pn3n3_c20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--GyungHaYuMember_z21yTXdZtWVc" title="Receivables"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4428"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; font-weight: bold; text-align: center; padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--TradeAndOtherPayables_iI_pn3n3_c20251231_zr1lMdNvZxxk" title="Payables"&gt;324,855&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_904_ecustom--OtherReceivable_iI_pn3n3_c20251231_zgKl6iCf2J2j" title="Receivables"&gt;442,894&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--TradeAndOtherPayables_iI_pn3n3_c20241231_zFWIxXiMn5Ea" title="Payables"&gt;39,769&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_903_ecustom--OtherReceivable_iI_pn3n3_c20241231_zk9tuMh2UtRj" title="Receivables"&gt;214,245&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;div style="width: 25%; margin-left: 0; margin-right: auto"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td id="xdx_F0D_zkHsJlO7ZCvj" style="width: 0.25in; text-align: left"&gt;(*)&lt;/td&gt;
    &lt;td id="xdx_F16_zYGzWuWueGD" style="text-align: justify"&gt;The Company provided a loan to Eun Jong Choi, the CEO of the Company, who resigned as CEO on January&#160;30, 2026. As of December&#160;31, 2025, compensation payable to the CEO was recorded as other payable and remained unpaid. Pursuant to a mutual agreement between the Company and the CEO, the unpaid compensation is expected to be applied against the outstanding loan receivable from the CEO.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:ScheduleOfPayablesAndReceivablesRelatedPartiesTableTextBlock>
    <cik0002058261:OtherReceivable
      contextRef="AsOf2025-12-31_ifrs-full_RelatedPartiesMember_custom_DongsungDAndCMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004376"
      unitRef="KRW">221295000</cik0002058261:OtherReceivable>
    <cik0002058261:OtherReceivable
      contextRef="AsOf2025-12-31_ifrs-full_RelatedPartiesMember_custom_CubeBioHoldingsLtdMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004384"
      unitRef="KRW">45564000</cik0002058261:OtherReceivable>
    <cik0002058261:OtherReceivable
      contextRef="AsOf2024-12-31_ifrs-full_RelatedPartiesMember_custom_CubeBioHoldingsLtdMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004388"
      unitRef="KRW">44650000</cik0002058261:OtherReceivable>
    <ifrs-full:OtherPayables
      contextRef="AsOf2025-12-31_ifrs-full_RelatedPartiesMember_custom_EunJongChoiMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004390"
      unitRef="KRW">24855000</ifrs-full:OtherPayables>
    <cik0002058261:OtherReceivable
      contextRef="AsOf2025-12-31_ifrs-full_RelatedPartiesMember_custom_EunJongChoiMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004392"
      unitRef="KRW">176035000</cik0002058261:OtherReceivable>
    <cik0002058261:OtherReceivable
      contextRef="AsOf2024-12-31_ifrs-full_RelatedPartiesMember_custom_EunJongChoiMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004396"
      unitRef="KRW">169595000</cik0002058261:OtherReceivable>
    <ifrs-full:TradeAndOtherPayables
      contextRef="AsOf2024-12-31_ifrs-full_RelatedPartiesMember_custom_NohBinParkMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004402"
      unitRef="KRW">16738000</ifrs-full:TradeAndOtherPayables>
    <ifrs-full:TradeAndOtherPayables
      contextRef="AsOf2024-12-31_ifrs-full_RelatedPartiesMember_custom_HoSungHanMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004410"
      unitRef="KRW">12553000</ifrs-full:TradeAndOtherPayables>
    <ifrs-full:TradeAndOtherPayables
      contextRef="AsOf2025-12-31_ifrs-full_RelatedPartiesMember_custom_JungGonKimMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004414"
      unitRef="KRW">300000000</ifrs-full:TradeAndOtherPayables>
    <ifrs-full:TradeAndOtherPayables
      contextRef="AsOf2024-12-31_ifrs-full_RelatedPartiesMember_custom_GyungHaYuMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004426"
      unitRef="KRW">10478000</ifrs-full:TradeAndOtherPayables>
    <ifrs-full:TradeAndOtherPayables
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004430"
      unitRef="KRW">324855000</ifrs-full:TradeAndOtherPayables>
    <cik0002058261:OtherReceivable
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004432"
      unitRef="KRW">442894000</cik0002058261:OtherReceivable>
    <ifrs-full:TradeAndOtherPayables
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004434"
      unitRef="KRW">39769000</ifrs-full:TradeAndOtherPayables>
    <cik0002058261:OtherReceivable
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004436"
      unitRef="KRW">214245000</cik0002058261:OtherReceivable>
    <cik0002058261:ScheduleOfChangesInRelatedPartyBalancesByAccountTableTextBlock
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact004446">&lt;table cellpadding="0" cellspacing="0" id="xdx_895_ecustom--ScheduleOfChangesInRelatedPartyBalancesByAccountTableTextBlock_pn3n3_zO2jKNl8GjSf" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Related parties (Details 1)"&gt;
  &lt;tr style="background-color: White; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_8B5_z9seBLa0KoCb" style="display: none"&gt;Schedule of changes in related party balances by account&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="text-align: center; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="14" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;b&gt;Related party&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Name of entity&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Account&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Beginning&lt;br/&gt;Balance&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Increase&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Decrease&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Ending&lt;br/&gt;Balance&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th style="text-align: center"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th style="text-align: center"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="14" style="text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; width: 25%"&gt;Entity that has significant influence over the Company&lt;/td&gt;
    &lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top; width: 15%"&gt;Well Core&lt;/td&gt;
    &lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top; width: 15%"&gt;Borrowings&lt;/td&gt;
    &lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 7%"&gt;&lt;span id="xdx_906_ecustom--RelatedPartyBalances_iS_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--WellCoreMember__ifrs-full--BorrowingsByNameAxis__custom--BorrowingMember_zAvwMKRGzoUj" title="Beginning Balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4448"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 7%"&gt;&lt;span id="xdx_900_ecustom--Increase_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--WellCoreMember__ifrs-full--BorrowingsByNameAxis__custom--BorrowingMember_zD9aIOofLcak" title="Increase"&gt;270,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 7%"&gt;&lt;span id="xdx_902_ecustom--Decrease_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--WellCoreMember__ifrs-full--BorrowingsByNameAxis__custom--BorrowingMember_z4yIg0ivNN8c" title="Decrease"&gt;270,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 7%"&gt;&lt;span id="xdx_90C_ecustom--RelatedPartyBalances_iE_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--WellCoreMember__ifrs-full--BorrowingsByNameAxis__custom--BorrowingMember_z39AcLHuc7A8" title="Ending Balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4454"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; width: 1%"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: White; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Entity that has significant influence over the Company&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;Dongsung D&amp;amp;C&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;Short-term loan receivable&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_902_ecustom--RelatedPartyBalances_iS_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--DongsungDAndCMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivableMember_zs3uJBmj85n8" title="Beginning Balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4456"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_ecustom--Increase_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--DongsungDAndCMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivableMember_zEOZeU610upd" title="Increase"&gt;220,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_ecustom--Decrease_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--DongsungDAndCMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivableMember_z0pTrZ8kZq28" title="Decrease"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4460"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_906_ecustom--RelatedPartyBalances_iE_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--DongsungDAndCMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivableMember_zE0mlepOYf4e" title="Ending Balance"&gt;220,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Entity that has significant influence over the Company&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;Dongsung D&amp;amp;C&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;Short-term loan receivable&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_907_ecustom--RelatedPartyBalances_iS_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--DongsungDAndCMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivablesMember_zmhggdOhbpfh" title="Beginning Balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4464"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_902_ecustom--Increase_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--DongsungDAndCMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivablesMember_zOaFmf41R8f2" title="Increase"&gt;1,296&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_ecustom--Decrease_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--DongsungDAndCMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivablesMember_zu44kflQvl9f" title="Decrease"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4468"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_901_ecustom--RelatedPartyBalances_iE_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--DongsungDAndCMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivablesMember_z9naqlVCqnxf" title="Ending Balance"&gt;1,296&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: White; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Key management personnel&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;Eun Jong Choi&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;Short-term loan receivable&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_ecustom--RelatedPartyBalances_iS_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivableMember_zpLEVa8OAMXh" title="Beginning Balance"&gt;140,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_902_ecustom--Increase_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivableMember_zl6gmji0BuXj" title="Increase"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4474"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_902_ecustom--Decrease_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivableMember_zgg6cOpIFYek" title="Decrease"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4476"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_ecustom--RelatedPartyBalances_iE_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivableMember_zcwmIdlX0Ytj" title="Ending Balance"&gt;140,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Key management personnel&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;Eun Jong Choi&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;Short-term loan receivable&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_908_ecustom--RelatedPartyBalances_iS_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivablesMember_zLfkQBV7wzuc" title="Beginning Balance"&gt;29,595&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_909_ecustom--Increase_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivablesMember_z3yCj4tff4C3" title="Increase"&gt;6,440&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_ecustom--Decrease_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivablesMember_zDhu8yxcXCL5" title="Decrease"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4484"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_ecustom--RelatedPartyBalances_iE_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivablesMember_z4ECJItNisRd" title="Ending Balance"&gt;36,035&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: White; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Entities controlled by Key Management Personnel&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;CubeBio Holdings., Ltd.&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;Short-term loan receivable&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_ecustom--RelatedPartyBalances_iS_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubeBioHoldingsLtdMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivableMember_zwZwSZ0pp732" title="Beginning Balance"&gt;44,100&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_902_ecustom--Increase_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubeBioHoldingsLtdMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivableMember_z9lvLDAllBg1" title="Increase"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4490"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_ecustom--Decrease_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubeBioHoldingsLtdMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivableMember_zdYzRJsloCoi" title="Decrease"&gt;1,053&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_ecustom--RelatedPartyBalances_iE_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubeBioHoldingsLtdMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivableMember_zDXnwzKX3CTf" title="Ending Balance"&gt;43,047&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Entities controlled by Key Management Personnel&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;CubeBio Holdings., Ltd.&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;Short-term loan receivable&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_ecustom--RelatedPartyBalances_iS_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubeBioHoldingsLtdMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivablesMember_zXxdfTPrImw4" title="Beginning Balance"&gt;550&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_901_ecustom--Increase_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubeBioHoldingsLtdMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivablesMember_zU5LgnmXl0s" title="Increase"&gt;1,967&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_ecustom--Decrease_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubeBioHoldingsLtdMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivablesMember_zZW3Oq1fXMq8" title="Decrease"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4500"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_ecustom--RelatedPartyBalances_iE_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubeBioHoldingsLtdMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivablesMember_zElx5kxT1U13" title="Ending Balance"&gt;2,517&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: White; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Key management personnel&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;Noh Bin Park&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;Bond with warrants (*1)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_908_ecustom--RelatedPartyBalances_iS_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--NohBinParkMember__ifrs-full--BorrowingsByNameAxis__custom--BondWithWarrantsMember_fKCoxKQ_____zEarbAHSyJ0l" title="Beginning Balance"&gt;20,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_ecustom--Increase_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--NohBinParkMember__ifrs-full--BorrowingsByNameAxis__custom--BondWithWarrantsMember_fKCoxKQ_____z7rGYWh7GN36" title="Increase"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4506"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_ecustom--Decrease_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--NohBinParkMember__ifrs-full--BorrowingsByNameAxis__custom--BondWithWarrantsMember_fKCoxKQ_____z75O2TK8xBWg" title="Decrease"&gt;20,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_904_ecustom--RelatedPartyBalances_iE_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--NohBinParkMember__ifrs-full--BorrowingsByNameAxis__custom--BondWithWarrantsMember_fKCoxKQ_____zsM2Nd9Z0Rrk" title="Ending Balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4510"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Key management personnel&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;Ho Sung Han&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;Bond with warrants (*1)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_ecustom--RelatedPartyBalances_iS_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--HoSungHanMember__ifrs-full--BorrowingsByNameAxis__custom--BondWithWarrantsMember_fKCoxKQ_____zbhrGj7dv5w8" title="Beginning Balance"&gt;15,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_908_ecustom--Increase_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--HoSungHanMember__ifrs-full--BorrowingsByNameAxis__custom--BondWithWarrantsMember_fKCoxKQ_____zxgMu7Kvugn6" title="Increase"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4514"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_902_ecustom--Decrease_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--HoSungHanMember__ifrs-full--BorrowingsByNameAxis__custom--BondWithWarrantsMember_fKCoxKQ_____zDki8moN4iOd" title="Decrease"&gt;15,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_ecustom--RelatedPartyBalances_iE_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--HoSungHanMember__ifrs-full--BorrowingsByNameAxis__custom--BondWithWarrantsMember_fKCoxKQ_____zlEvBjAjigN1" title="Ending Balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4518"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: White; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Other related party&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Jung Gon Kim&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Other payables&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_ecustom--RelatedPartyBalances_iS_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--JungGonKimMember__ifrs-full--BorrowingsByNameAxis__custom--OtherPayablesMember_fKCoxKQ_____z11YrCPnv01f" title="Beginning Balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4520"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90F_ecustom--Increase_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--JungGonKimMember__ifrs-full--BorrowingsByNameAxis__custom--OtherPayablesMember_fKCoxKQ_____z9xMnN56eLyk" title="Increase"&gt;300,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_904_ecustom--Decrease_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--JungGonKimMember__ifrs-full--BorrowingsByNameAxis__custom--OtherPayablesMember_fKCoxKQ_____zkCLHuTRLPl2" title="Decrease"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4524"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90B_ecustom--RelatedPartyBalances_iE_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--JungGonKimMember__ifrs-full--BorrowingsByNameAxis__custom--OtherPayablesMember_zgDfoD4J4UZj" title="Ending Balance"&gt;300,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Other related party&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;Gyung Ha Yu&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;Bond with warrants (*1)&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_902_ecustom--RelatedPartyBalances_iS_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--GyungHaYuMember__ifrs-full--BorrowingsByNameAxis__custom--BondWithWarrantsMember_fKCoxKQ_____zvQkxz7Q2D19" title="Beginning Balance"&gt;15,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--Increase_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--GyungHaYuMember__ifrs-full--BorrowingsByNameAxis__custom--BondWithWarrantsMember_fKCoxKQ_____zzop9rdfo1Gj" title="Increase"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4530"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--Decrease_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--GyungHaYuMember__ifrs-full--BorrowingsByNameAxis__custom--BondWithWarrantsMember_fKCoxKQ_____z65hz57JFwc2" title="Decrease"&gt;15,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_909_ecustom--RelatedPartyBalances_iE_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--GyungHaYuMember__ifrs-full--BorrowingsByNameAxis__custom--BondWithWarrantsMember_fKCoxKQ_____zWJNyy5lLDY6" title="Ending Balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4534"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: White; vertical-align: bottom"&gt;
    &lt;td colspan="5" style="text-align: center; padding-bottom: 1.25pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_902_ecustom--RelatedPartyBalances_iS_pn3n3_c20250101__20251231_zA4sMkoUJpQ2" title="Beginning Balance"&gt;264,245&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_907_ecustom--Increase_pn3n3_c20250101__20251231_zTLQ4M57BeH3" title="Increase"&gt;799,703&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_901_ecustom--Decrease_pn3n3_c20250101__20251231_zASuU3qxOP5l" title="Decrease"&gt;321,053&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_906_ecustom--RelatedPartyBalances_iE_pn3n3_c20250101__20251231_zRq43Jcv1758" title="Ending Balance"&gt;742,895&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;div style="width: 25%; margin-left: 0; margin-right: auto"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td id="xdx_F03_zwvJmLAtYfSf" style="width: 0.25in; text-align: left"&gt;(*1)&lt;/td&gt;
    &lt;td id="xdx_F10_zZCcRnxTF2i7" style="text-align: justify"&gt;The amounts are presented in principal of bonds.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

















&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; vertical-align: top; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; text-align: center; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="14" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left; vertical-align: bottom"&gt;&lt;b&gt;Related party&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; text-align: center; vertical-align: bottom; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; vertical-align: bottom; text-align: center"&gt;&lt;b&gt;Name of entity&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; text-align: center; vertical-align: bottom; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center; vertical-align: bottom"&gt;&lt;b&gt;Account&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; text-align: center; vertical-align: bottom; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center; vertical-align: bottom"&gt;&lt;b&gt;Beginning&lt;br/&gt; Balance&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; text-align: center; vertical-align: bottom; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; text-align: center; vertical-align: bottom; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center; vertical-align: bottom"&gt;&lt;b&gt;Increase&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; text-align: center; vertical-align: bottom; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; text-align: center; vertical-align: bottom; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center; vertical-align: bottom"&gt;&lt;b&gt;Decrease&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; text-align: center; vertical-align: bottom; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; text-align: center; vertical-align: bottom; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center; vertical-align: bottom"&gt;&lt;b&gt;Ending&lt;br/&gt;Balance&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; text-align: center; vertical-align: bottom; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; vertical-align: top"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; text-align: left; vertical-align: top"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; text-align: center"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="14" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; width: 25%"&gt;Entity that has significant influence over the Company&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: top; width: 15%"&gt;Well Core&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; width: 15%"&gt;Short-term loan receivable&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; width: 2%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right; width: 7%"&gt;&lt;span id="xdx_903_ecustom--RelatedPartyBalances_iS_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--WellCoreMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivableMember_zfbeaoJ6Jbmg" title="Beginning Balance"&gt;309,112&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right; width: 7%"&gt;&lt;span id="xdx_906_ecustom--Increase_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--WellCoreMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivableMember_zMaNQLjphUfj" title="Increase"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4554"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right; width: 7%"&gt;&lt;span id="xdx_909_ecustom--Decrease_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--WellCoreMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivableMember_z1FhT9Ev17Ba" title="Decrease"&gt;309,112&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right; width: 7%"&gt;&lt;span id="xdx_90F_ecustom--RelatedPartyBalances_iE_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--WellCoreMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivableMember_zKCNWvxO3ezl" title="Ending Balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4558"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; width: 1%"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Entity that has significant influence over the Company&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: top"&gt;Well Core&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top"&gt;Short-term Borrowings&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--RelatedPartyBalances_iS_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--WellCoreMember__ifrs-full--BorrowingsByNameAxis__ifrs-full--ShorttermBorrowingsMember_zoWQTMBjdftd" title="Beginning Balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4560"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_905_ecustom--Increase_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--WellCoreMember__ifrs-full--BorrowingsByNameAxis__ifrs-full--ShorttermBorrowingsMember_zbAP56BqpAhb" title="Increase"&gt;400,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--Decrease_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--WellCoreMember__ifrs-full--BorrowingsByNameAxis__ifrs-full--ShorttermBorrowingsMember_zK71arjjyBG5" title="Decrease"&gt;400,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_906_ecustom--RelatedPartyBalances_iE_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--WellCoreMember__ifrs-full--BorrowingsByNameAxis__ifrs-full--ShorttermBorrowingsMember_z3K7CXKn2h54" title="Ending Balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4566"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Key management personnel&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: top"&gt;Eun Jong Choi&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top"&gt;Short-term loan receivable&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--RelatedPartyBalances_iS_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivableMember_zUoIUHzsPb7h" title="Beginning Balance"&gt;600,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--Increase_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivableMember_zVLVh7wb3If2" title="Increase"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4570"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--Decrease_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivableMember_z7Kf0CZ2ABZ2" title="Decrease"&gt;460,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--RelatedPartyBalances_iE_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivableMember_zqwrIud50oC5" title="Ending Balance"&gt;140,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Key management personnel&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: top"&gt;Eun Jong Choi&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top"&gt;Short-term loan receivable&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--RelatedPartyBalances_iS_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivablesMember_zkO9chsTmbue" title="Beginning Balance"&gt;6,338&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--Increase_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivablesMember_zhLODttJutJb" title="Increase"&gt;23,257&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_907_ecustom--Decrease_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivablesMember_zoeLJUuWkr4e" title="Decrease"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4580"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--RelatedPartyBalances_iE_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivablesMember_zty8lqtpkTEj" title="Ending Balance"&gt;29,595&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Entities controlled by Key Management Personnel&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: top"&gt;CubeBio Holdings., Ltd.&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top"&gt;Short-term loan receivable&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_909_ecustom--RelatedPartyBalances_iS_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubeBioHoldingsLtdMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivableMember_zhnX7emAH6C2" title="Beginning Balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4584"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_908_ecustom--Increase_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubeBioHoldingsLtdMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivableMember_zyMyI1S3PRL6" title="Increase"&gt;44,100&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--Decrease_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubeBioHoldingsLtdMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivableMember_zXVJEXOjIttk" title="Decrease"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4588"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--RelatedPartyBalances_iE_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubeBioHoldingsLtdMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivableMember_zFoXjORiw9cj" title="Ending Balance"&gt;44,100&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Entities controlled by Key Management Personnel&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: top"&gt;CubeBio Holdings., Ltd.&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top"&gt;Short-term loan receivable&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_ecustom--RelatedPartyBalances_iS_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubeBioHoldingsLtdMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivablesMember_zFkEjpRjhMh5" title="Beginning Balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4592"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_906_ecustom--Increase_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubeBioHoldingsLtdMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivablesMember_zVEpUlP36AKd" title="Increase"&gt;550&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_905_ecustom--Decrease_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubeBioHoldingsLtdMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivablesMember_zdcJzVzwS2Od" title="Decrease"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4596"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_ecustom--RelatedPartyBalances_iE_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubeBioHoldingsLtdMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivablesMember_zZNvSRCaqw7f" title="Ending Balance"&gt;550&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Key management personnel&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: top"&gt;Jae Myung Kim&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top"&gt;Bond with warrants (*1)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_ecustom--RelatedPartyBalances_iS_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--JaeMyungKimMember__ifrs-full--BorrowingsByNameAxis__custom--BondWithWarrantsMember_fKCoxKQ_____zkM9wcuUL2Ja" title="Beginning Balance"&gt;700,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_900_ecustom--Increase_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--JaeMyungKimMember__ifrs-full--BorrowingsByNameAxis__custom--BondWithWarrantsMember_fKCoxKQ_____zbF9LMtfMJfe" title="Increase"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4602"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_900_ecustom--Decrease_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--JaeMyungKimMember__ifrs-full--BorrowingsByNameAxis__custom--BondWithWarrantsMember_fKCoxKQ_____zKicWWGeNxA5" title="Decrease"&gt;700,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_903_ecustom--RelatedPartyBalances_iE_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--JaeMyungKimMember__ifrs-full--BorrowingsByNameAxis__custom--BondWithWarrantsMember_fKCoxKQ_____z0aqZRGX5ib5" title="Ending Balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4606"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Key management personnel&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: top"&gt;Noh Bin Park&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top"&gt;Bond with warrants (*1)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_909_ecustom--RelatedPartyBalances_iS_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--NohBinParkMember__ifrs-full--BorrowingsByNameAxis__custom--BondWithWarrantsMember_fKCoxKQ_____z6XU9rSl0aWa" title="Beginning Balance"&gt;20,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--Increase_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--NohBinParkMember__ifrs-full--BorrowingsByNameAxis__custom--BondWithWarrantsMember_fKCoxKQ_____z9e1HO8p3rEl" title="Increase"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4610"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--Decrease_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--NohBinParkMember__ifrs-full--BorrowingsByNameAxis__custom--BondWithWarrantsMember_fKCoxKQ_____z9eQ2uRd0Bi4" title="Decrease"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4612"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--RelatedPartyBalances_iE_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--NohBinParkMember__ifrs-full--BorrowingsByNameAxis__custom--BondWithWarrantsMember_fKCoxKQ_____zZJjgJPjgeSg" title="Ending Balance"&gt;20,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Key management personnel&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: top"&gt;Ho Sung Han&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top"&gt;Bond with warrants (*1)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_903_ecustom--RelatedPartyBalances_iS_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--HoSungHanMember__ifrs-full--BorrowingsByNameAxis__custom--BondWithWarrantsMember_fKCoxKQ_____zdn3u2wXNHX" title="Beginning Balance"&gt;15,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_905_ecustom--Increase_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--HoSungHanMember__ifrs-full--BorrowingsByNameAxis__custom--BondWithWarrantsMember_fKCoxKQ_____znZGdaLzuP9g" title="Increase"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4618"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_906_ecustom--Decrease_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--HoSungHanMember__ifrs-full--BorrowingsByNameAxis__custom--BondWithWarrantsMember_fKCoxKQ_____z77t95JY9Ywl" title="Decrease"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4620"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--RelatedPartyBalances_iE_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--HoSungHanMember__ifrs-full--BorrowingsByNameAxis__custom--BondWithWarrantsMember_fKCoxKQ_____zN1Cc9VI2YXg" title="Ending Balance"&gt;15,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Other related party&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: top"&gt;Se Yoon Kim&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top"&gt;Bond with warrants (*1)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_901_ecustom--RelatedPartyBalances_iS_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--SeYoonKimMember__ifrs-full--BorrowingsByNameAxis__custom--BondWithWarrantsMember_fKCoxKQ_____zZnCQa8dlQ87" title="Beginning Balance"&gt;210,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_907_ecustom--Increase_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--SeYoonKimMember__ifrs-full--BorrowingsByNameAxis__custom--BondWithWarrantsMember_fKCoxKQ_____zEnUNBZQsbH5" title="Increase"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4626"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_902_ecustom--Decrease_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--SeYoonKimMember__ifrs-full--BorrowingsByNameAxis__custom--BondWithWarrantsMember_fKCoxKQ_____zbM8edzyvzfj" title="Decrease"&gt;210,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_903_ecustom--RelatedPartyBalances_iE_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--SeYoonKimMember__ifrs-full--BorrowingsByNameAxis__custom--BondWithWarrantsMember_fKCoxKQ_____zBxTZFQdcaA8" title="Ending Balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4630"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Other related party&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: top"&gt;Gyung Ha Yu&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top"&gt;Bond with warrants (*1)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--RelatedPartyBalances_iS_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--GyungHaYuMember__ifrs-full--BorrowingsByNameAxis__custom--BondWithWarrantsMember_fKCoxKQ_____ziYrSNqbhc3j" title="Beginning Balance"&gt;15,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--Increase_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--GyungHaYuMember__ifrs-full--BorrowingsByNameAxis__custom--BondWithWarrantsMember_fKCoxKQ_____z2dfjlXBlfyk" title="Increase"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4634"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_ecustom--Decrease_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--GyungHaYuMember__ifrs-full--BorrowingsByNameAxis__custom--BondWithWarrantsMember_fKCoxKQ_____zgkVZ6Q5WmXb" title="Decrease"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4636"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--RelatedPartyBalances_iE_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--GyungHaYuMember__ifrs-full--BorrowingsByNameAxis__custom--BondWithWarrantsMember_fKCoxKQ_____zTOWHqhr8osc" title="Ending Balance"&gt;15,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Other related party&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: top; padding-bottom: 0.5pt"&gt;Jung Gon Kim(*2)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;Bond with warrants (*1)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--RelatedPartyBalances_iS_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--JungGonKimMember__ifrs-full--BorrowingsByNameAxis__custom--BondWithWarrantsMember_fKCoxKSgqMik___zkcNMKjj8AI2" title="Beginning Balance"&gt;2,400,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_907_ecustom--Increase_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--JungGonKimMember__ifrs-full--BorrowingsByNameAxis__custom--BondWithWarrantsMember_fKCoxKSgqMik___zDvee6dPdOt9" title="Increase"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4642"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_900_ecustom--Decrease_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--JungGonKimMember__ifrs-full--BorrowingsByNameAxis__custom--BondWithWarrantsMember_fKCoxKSgqMik___zmqpFE9xNZVd" title="Decrease"&gt;2,400,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--RelatedPartyBalances_iE_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--JungGonKimMember__ifrs-full--BorrowingsByNameAxis__custom--BondWithWarrantsMember_fKCoxKSgqMik___zXiKYnAtIMh1" title="Ending Balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4646"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td colspan="5" style="font: 10pt Times New Roman; text-align: center; padding-bottom: 1.25pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--RelatedPartyBalances_iS_pn3n3_c20240101__20241231_zbQAJAR9G41l" title="Beginning Balance"&gt;4,275,450&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--Increase_pn3n3_c20240101__20241231_zon9hOwK5xVe" title="Increase"&gt;467,907&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--Decrease_pn3n3_c20240101__20241231_zLz0fjUfLw48" title="Decrease"&gt;4,479,112&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--RelatedPartyBalances_iE_pn3n3_c20240101__20241231_zt6SGrkw5ubh" title="Ending Balance"&gt;264,245&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;div style="width: 25%; margin-left: 0; margin-right: auto"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td id="xdx_F08_zQC2bNCBoich" style="font: 10pt Times New Roman; width: 0.35in; text-align: left"&gt;(*1)&lt;/td&gt;
    &lt;td id="xdx_F14_zxxyzTfq9sE8" style="font: 10pt Times New Roman; text-align: justify"&gt;The amounts are presented in principal of bonds.&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;(*2)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;The Company recognized Jung Gon Kim as a related party as Jung Gon Kim is a close family member of Jae Myung Kim, a key management personnel.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:ScheduleOfChangesInRelatedPartyBalancesByAccountTableTextBlock>
    <cik0002058261:Increase
      contextRef="From2025-01-012025-12-31_ifrs-full_RelatedPartiesMember_custom_WellCoreMember_custom_BorrowingMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004450"
      unitRef="KRW">270000000</cik0002058261:Increase>
    <cik0002058261:Decrease
      contextRef="From2025-01-012025-12-31_ifrs-full_RelatedPartiesMember_custom_WellCoreMember_custom_BorrowingMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004452"
      unitRef="KRW">270000000</cik0002058261:Decrease>
    <cik0002058261:Increase
      contextRef="From2025-01-012025-12-31_ifrs-full_RelatedPartiesMember_custom_DongsungDAndCMember_custom_ShortTermLoanReceivableMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004458"
      unitRef="KRW">220000000</cik0002058261:Increase>
    <cik0002058261:RelatedPartyBalances
      contextRef="AsOf2025-12-31_ifrs-full_RelatedPartiesMember_custom_DongsungDAndCMember_custom_ShortTermLoanReceivableMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004462"
      unitRef="KRW">220000000</cik0002058261:RelatedPartyBalances>
    <cik0002058261:Increase
      contextRef="From2025-01-012025-12-31_ifrs-full_RelatedPartiesMember_custom_DongsungDAndCMember_custom_ShortTermLoanReceivablesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004466"
      unitRef="KRW">1296000</cik0002058261:Increase>
    <cik0002058261:RelatedPartyBalances
      contextRef="AsOf2025-12-31_ifrs-full_RelatedPartiesMember_custom_DongsungDAndCMember_custom_ShortTermLoanReceivablesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004470"
      unitRef="KRW">1296000</cik0002058261:RelatedPartyBalances>
    <cik0002058261:RelatedPartyBalances
      contextRef="AsOf2024-12-31_ifrs-full_RelatedPartiesMember_custom_EunJongChoiMember_custom_ShortTermLoanReceivableMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004472"
      unitRef="KRW">140000000</cik0002058261:RelatedPartyBalances>
    <cik0002058261:RelatedPartyBalances
      contextRef="AsOf2025-12-31_ifrs-full_RelatedPartiesMember_custom_EunJongChoiMember_custom_ShortTermLoanReceivableMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004478"
      unitRef="KRW">140000000</cik0002058261:RelatedPartyBalances>
    <cik0002058261:RelatedPartyBalances
      contextRef="AsOf2024-12-31_ifrs-full_RelatedPartiesMember_custom_EunJongChoiMember_custom_ShortTermLoanReceivablesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004480"
      unitRef="KRW">29595000</cik0002058261:RelatedPartyBalances>
    <cik0002058261:Increase
      contextRef="From2025-01-012025-12-31_ifrs-full_RelatedPartiesMember_custom_EunJongChoiMember_custom_ShortTermLoanReceivablesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004482"
      unitRef="KRW">6440000</cik0002058261:Increase>
    <cik0002058261:RelatedPartyBalances
      contextRef="AsOf2025-12-31_ifrs-full_RelatedPartiesMember_custom_EunJongChoiMember_custom_ShortTermLoanReceivablesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004486"
      unitRef="KRW">36035000</cik0002058261:RelatedPartyBalances>
    <cik0002058261:RelatedPartyBalances
      contextRef="AsOf2024-12-31_ifrs-full_RelatedPartiesMember_custom_CubeBioHoldingsLtdMember_custom_ShortTermLoanReceivableMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004488"
      unitRef="KRW">44100000</cik0002058261:RelatedPartyBalances>
    <cik0002058261:Decrease
      contextRef="From2025-01-012025-12-31_ifrs-full_RelatedPartiesMember_custom_CubeBioHoldingsLtdMember_custom_ShortTermLoanReceivableMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004492"
      unitRef="KRW">1053000</cik0002058261:Decrease>
    <cik0002058261:RelatedPartyBalances
      contextRef="AsOf2025-12-31_ifrs-full_RelatedPartiesMember_custom_CubeBioHoldingsLtdMember_custom_ShortTermLoanReceivableMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004494"
      unitRef="KRW">43047000</cik0002058261:RelatedPartyBalances>
    <cik0002058261:RelatedPartyBalances
      contextRef="AsOf2024-12-31_ifrs-full_RelatedPartiesMember_custom_CubeBioHoldingsLtdMember_custom_ShortTermLoanReceivablesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004496"
      unitRef="KRW">550000</cik0002058261:RelatedPartyBalances>
    <cik0002058261:Increase
      contextRef="From2025-01-012025-12-31_ifrs-full_RelatedPartiesMember_custom_CubeBioHoldingsLtdMember_custom_ShortTermLoanReceivablesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004498"
      unitRef="KRW">1967000</cik0002058261:Increase>
    <cik0002058261:RelatedPartyBalances
      contextRef="AsOf2025-12-31_ifrs-full_RelatedPartiesMember_custom_CubeBioHoldingsLtdMember_custom_ShortTermLoanReceivablesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004502"
      unitRef="KRW">2517000</cik0002058261:RelatedPartyBalances>
    <cik0002058261:RelatedPartyBalances
      contextRef="AsOf2024-12-31_ifrs-full_RelatedPartiesMember_custom_NohBinParkMember_custom_BondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004504"
      unitRef="KRW">20000000</cik0002058261:RelatedPartyBalances>
    <cik0002058261:Decrease
      contextRef="From2025-01-012025-12-31_ifrs-full_RelatedPartiesMember_custom_NohBinParkMember_custom_BondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004508"
      unitRef="KRW">20000000</cik0002058261:Decrease>
    <cik0002058261:RelatedPartyBalances
      contextRef="AsOf2024-12-31_ifrs-full_RelatedPartiesMember_custom_HoSungHanMember_custom_BondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004512"
      unitRef="KRW">15000000</cik0002058261:RelatedPartyBalances>
    <cik0002058261:Decrease
      contextRef="From2025-01-012025-12-31_ifrs-full_RelatedPartiesMember_custom_HoSungHanMember_custom_BondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004516"
      unitRef="KRW">15000000</cik0002058261:Decrease>
    <cik0002058261:Increase
      contextRef="From2025-01-012025-12-31_ifrs-full_RelatedPartiesMember_custom_JungGonKimMember_custom_OtherPayablesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004522"
      unitRef="KRW">300000000</cik0002058261:Increase>
    <cik0002058261:RelatedPartyBalances
      contextRef="AsOf2025-12-31_ifrs-full_RelatedPartiesMember_custom_JungGonKimMember_custom_OtherPayablesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004526"
      unitRef="KRW">300000000</cik0002058261:RelatedPartyBalances>
    <cik0002058261:RelatedPartyBalances
      contextRef="AsOf2024-12-31_ifrs-full_RelatedPartiesMember_custom_GyungHaYuMember_custom_BondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004528"
      unitRef="KRW">15000000</cik0002058261:RelatedPartyBalances>
    <cik0002058261:Decrease
      contextRef="From2025-01-012025-12-31_ifrs-full_RelatedPartiesMember_custom_GyungHaYuMember_custom_BondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004532"
      unitRef="KRW">15000000</cik0002058261:Decrease>
    <cik0002058261:RelatedPartyBalances
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004536"
      unitRef="KRW">264245000</cik0002058261:RelatedPartyBalances>
    <cik0002058261:Increase
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004538"
      unitRef="KRW">799703000</cik0002058261:Increase>
    <cik0002058261:Decrease
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004540"
      unitRef="KRW">321053000</cik0002058261:Decrease>
    <cik0002058261:RelatedPartyBalances
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004542"
      unitRef="KRW">742895000</cik0002058261:RelatedPartyBalances>
    <cik0002058261:RelatedPartyBalances
      contextRef="AsOf2023-12-31_ifrs-full_RelatedPartiesMember_custom_WellCoreMember_custom_ShortTermLoanReceivableMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004552"
      unitRef="KRW">309112000</cik0002058261:RelatedPartyBalances>
    <cik0002058261:Decrease
      contextRef="From2024-01-012024-12-31_ifrs-full_RelatedPartiesMember_custom_WellCoreMember_custom_ShortTermLoanReceivableMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004556"
      unitRef="KRW">309112000</cik0002058261:Decrease>
    <cik0002058261:Increase
      contextRef="From2024-01-012024-12-31_ifrs-full_RelatedPartiesMember_custom_WellCoreMember_ifrs-full_ShorttermBorrowingsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004562"
      unitRef="KRW">400000000</cik0002058261:Increase>
    <cik0002058261:Decrease
      contextRef="From2024-01-012024-12-31_ifrs-full_RelatedPartiesMember_custom_WellCoreMember_ifrs-full_ShorttermBorrowingsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004564"
      unitRef="KRW">400000000</cik0002058261:Decrease>
    <cik0002058261:RelatedPartyBalances
      contextRef="AsOf2023-12-31_ifrs-full_RelatedPartiesMember_custom_EunJongChoiMember_custom_ShortTermLoanReceivableMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004568"
      unitRef="KRW">600000000</cik0002058261:RelatedPartyBalances>
    <cik0002058261:Decrease
      contextRef="From2024-01-012024-12-31_ifrs-full_RelatedPartiesMember_custom_EunJongChoiMember_custom_ShortTermLoanReceivableMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004572"
      unitRef="KRW">460000000</cik0002058261:Decrease>
    <cik0002058261:RelatedPartyBalances
      contextRef="AsOf2024-12-31_ifrs-full_RelatedPartiesMember_custom_EunJongChoiMember_custom_ShortTermLoanReceivableMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004574"
      unitRef="KRW">140000000</cik0002058261:RelatedPartyBalances>
    <cik0002058261:RelatedPartyBalances
      contextRef="AsOf2023-12-31_ifrs-full_RelatedPartiesMember_custom_EunJongChoiMember_custom_ShortTermLoanReceivablesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004576"
      unitRef="KRW">6338000</cik0002058261:RelatedPartyBalances>
    <cik0002058261:Increase
      contextRef="From2024-01-012024-12-31_ifrs-full_RelatedPartiesMember_custom_EunJongChoiMember_custom_ShortTermLoanReceivablesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004578"
      unitRef="KRW">23257000</cik0002058261:Increase>
    <cik0002058261:RelatedPartyBalances
      contextRef="AsOf2024-12-31_ifrs-full_RelatedPartiesMember_custom_EunJongChoiMember_custom_ShortTermLoanReceivablesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004582"
      unitRef="KRW">29595000</cik0002058261:RelatedPartyBalances>
    <cik0002058261:Increase
      contextRef="From2024-01-012024-12-31_ifrs-full_RelatedPartiesMember_custom_CubeBioHoldingsLtdMember_custom_ShortTermLoanReceivableMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004586"
      unitRef="KRW">44100000</cik0002058261:Increase>
    <cik0002058261:RelatedPartyBalances
      contextRef="AsOf2024-12-31_ifrs-full_RelatedPartiesMember_custom_CubeBioHoldingsLtdMember_custom_ShortTermLoanReceivableMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004590"
      unitRef="KRW">44100000</cik0002058261:RelatedPartyBalances>
    <cik0002058261:Increase
      contextRef="From2024-01-012024-12-31_ifrs-full_RelatedPartiesMember_custom_CubeBioHoldingsLtdMember_custom_ShortTermLoanReceivablesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004594"
      unitRef="KRW">550000</cik0002058261:Increase>
    <cik0002058261:RelatedPartyBalances
      contextRef="AsOf2024-12-31_ifrs-full_RelatedPartiesMember_custom_CubeBioHoldingsLtdMember_custom_ShortTermLoanReceivablesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004598"
      unitRef="KRW">550000</cik0002058261:RelatedPartyBalances>
    <cik0002058261:RelatedPartyBalances
      contextRef="AsOf2023-12-31_ifrs-full_RelatedPartiesMember_custom_JaeMyungKimMember_custom_BondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004600"
      unitRef="KRW">700000000</cik0002058261:RelatedPartyBalances>
    <cik0002058261:Decrease
      contextRef="From2024-01-012024-12-31_ifrs-full_RelatedPartiesMember_custom_JaeMyungKimMember_custom_BondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004604"
      unitRef="KRW">700000000</cik0002058261:Decrease>
    <cik0002058261:RelatedPartyBalances
      contextRef="AsOf2023-12-31_ifrs-full_RelatedPartiesMember_custom_NohBinParkMember_custom_BondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004608"
      unitRef="KRW">20000000</cik0002058261:RelatedPartyBalances>
    <cik0002058261:RelatedPartyBalances
      contextRef="AsOf2024-12-31_ifrs-full_RelatedPartiesMember_custom_NohBinParkMember_custom_BondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004614"
      unitRef="KRW">20000000</cik0002058261:RelatedPartyBalances>
    <cik0002058261:RelatedPartyBalances
      contextRef="AsOf2023-12-31_ifrs-full_RelatedPartiesMember_custom_HoSungHanMember_custom_BondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004616"
      unitRef="KRW">15000000</cik0002058261:RelatedPartyBalances>
    <cik0002058261:RelatedPartyBalances
      contextRef="AsOf2024-12-31_ifrs-full_RelatedPartiesMember_custom_HoSungHanMember_custom_BondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004622"
      unitRef="KRW">15000000</cik0002058261:RelatedPartyBalances>
    <cik0002058261:RelatedPartyBalances
      contextRef="AsOf2023-12-31_ifrs-full_RelatedPartiesMember_custom_SeYoonKimMember_custom_BondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004624"
      unitRef="KRW">210000000</cik0002058261:RelatedPartyBalances>
    <cik0002058261:Decrease
      contextRef="From2024-01-012024-12-31_ifrs-full_RelatedPartiesMember_custom_SeYoonKimMember_custom_BondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004628"
      unitRef="KRW">210000000</cik0002058261:Decrease>
    <cik0002058261:RelatedPartyBalances
      contextRef="AsOf2023-12-31_ifrs-full_RelatedPartiesMember_custom_GyungHaYuMember_custom_BondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004632"
      unitRef="KRW">15000000</cik0002058261:RelatedPartyBalances>
    <cik0002058261:RelatedPartyBalances
      contextRef="AsOf2024-12-31_ifrs-full_RelatedPartiesMember_custom_GyungHaYuMember_custom_BondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004638"
      unitRef="KRW">15000000</cik0002058261:RelatedPartyBalances>
    <cik0002058261:RelatedPartyBalances
      contextRef="AsOf2023-12-31_ifrs-full_RelatedPartiesMember_custom_JungGonKimMember_custom_BondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004640"
      unitRef="KRW">2400000000</cik0002058261:RelatedPartyBalances>
    <cik0002058261:Decrease
      contextRef="From2024-01-012024-12-31_ifrs-full_RelatedPartiesMember_custom_JungGonKimMember_custom_BondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004644"
      unitRef="KRW">2400000000</cik0002058261:Decrease>
    <cik0002058261:RelatedPartyBalances
      contextRef="AsOf2023-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004648"
      unitRef="KRW">4275450000</cik0002058261:RelatedPartyBalances>
    <cik0002058261:Increase
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004650"
      unitRef="KRW">467907000</cik0002058261:Increase>
    <cik0002058261:Decrease
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004652"
      unitRef="KRW">4479112000</cik0002058261:Decrease>
    <cik0002058261:RelatedPartyBalances
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004654"
      unitRef="KRW">264245000</cik0002058261:RelatedPartyBalances>
    <cik0002058261:ScheduleOfManagementPersonnelCompensationTableTextBlock
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact004657">&lt;table cellpadding="0" cellspacing="0" id="xdx_897_ecustom--ScheduleOfManagementPersonnelCompensationTableTextBlock_pn3n3_zq7xIEd2Upk3" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Related parties (Details 3)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_8B9_znhKkO0FqmT6" style="display: none"&gt;Schedule of compensation for key management personnel&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_493_20250101__20251231_zKGIrstTuzx7" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49B_20240101__20241231_zjfbUl4ocBpc" style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40A_eifrs-full--ShorttermEmployeeBenefitsExpense_zA3P42S32XGa" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Short-term employee benefits&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;453,226&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;402,519&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40A_eifrs-full--PostemploymentBenefitExpenseDefinedBenefitPlans_zPhwJvp6Aa54" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Retirement benefit&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;48,434&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;30,292&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1pt; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--KeyManagementPersonnelCompensationShorttermEmployeeBenefits_zOv5oA4Nq0qd" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; vertical-align: top; padding-bottom: 1.25pt"&gt;Total&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;501,660&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;432,811&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:ScheduleOfManagementPersonnelCompensationTableTextBlock>
    <ifrs-full:ShorttermEmployeeBenefitsExpense
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004659"
      unitRef="KRW">453226000</ifrs-full:ShorttermEmployeeBenefitsExpense>
    <ifrs-full:ShorttermEmployeeBenefitsExpense
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004660"
      unitRef="KRW">402519000</ifrs-full:ShorttermEmployeeBenefitsExpense>
    <ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004662"
      unitRef="KRW">48434000</ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans>
    <ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004663"
      unitRef="KRW">30292000</ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans>
    <ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004665"
      unitRef="KRW">501660000</ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits>
    <ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004666"
      unitRef="KRW">432811000</ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits>
    <cik0002058261:DisclosureOfCashFlowStatementsExplanatory
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact004675">&lt;p id="xdx_805_ecustom--DisclosureOfCashFlowStatementsExplanatory_zYSGBUOpZO53" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;30. &lt;span id="xdx_82F_zYgQ6GRvZblk"&gt;Statement of cash flows&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.25in; text-align: left"&gt;&lt;b&gt;A.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;&lt;b&gt;Significant non-cash transactions&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Significant non-cash transactions for the years ended December&#160;31, 2025 and 2024 are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89B_ecustom--ScheduleOfSignificantNonCashTransactionsTableTextBlock_pn3n3_zew4tOsTDQJ4" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Statement of Cash flows (Details)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&lt;span id="xdx_8BF_zBwFroYxMGSd" style="display: none"&gt;Schedule of significant non-cash transactions&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="font: 10pt Times New Roman; text-align: center"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="font: 10pt Times New Roman; text-align: center"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Increase in lease liabilities&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_907_ecustom--IncreaseInLeaseLiabilities_pn3n3_c20250101__20251231__ifrs-full--SegmentsAxis__custom--IncomeAndExpensesFromOperatingActivitiesMember_zMqMOWTWU5y2" title="Increase in lease liabilities"&gt;947&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--IncreaseInLeaseLiabilities_pn3n3_c20240101__20241231__ifrs-full--SegmentsAxis__custom--IncomeAndExpensesFromOperatingActivitiesMember_z7gsc5xeNryf" title="Increase in lease liabilities"&gt;2,038&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A9_zsXBokFtc72" style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.25in; text-align: left"&gt;&lt;b&gt;B.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;&lt;b&gt;Movements of liabilities to cash flows arising from financing activities&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The movements of liabilities from cash flows arising from financing activities for the years ended December&#160;31, 2025 and 2024 are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_896_ecustom--ScheduleOfLiabilitiesToCashFlowsArisingFromFinancingActivitiesTableTextBlock_pn3n3_ztmalJXlO9ib" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Statement of Cash flows (Details 1)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span id="xdx_8B5_zmEesIsA81Vg" style="display: none"&gt;Schedule of liabilities to cash flows arising from financing activities&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Current bond&lt;br/&gt; with warrants&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Non-current&lt;br/&gt; bond with&lt;br/&gt; warrants&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Current lease&lt;br/&gt; liabilities&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;
        &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;Non-current&lt;/b&gt;&lt;/p&gt;
        &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;lease liabilities&lt;/b&gt;&lt;/p&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="18" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; width: 38%"&gt;&lt;b&gt;Balance at January&#160;1, 2024&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--Borrowings_iS_pn3n3_c20240101__20241231__ifrs-full--BorrowingsByNameAxis__custom--CurrentBondWithWarrantsMember_zM3QMY3ACV9j" title="Balance at beginning"&gt;4,827,086&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--Borrowings_iS_pn3n3_c20240101__20241231__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentBondWithWarrantsMember_zv88FGP5BYyi" title="Balance at beginning"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4687"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--Borrowings_iS_pn3n3_c20240101__20241231__ifrs-full--BorrowingsByNameAxis__custom--CurrentLeaseLiabilitiesMember_zwdOqqUEGI6c" title="Balance at beginning"&gt;108,627&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--Borrowings_iS_pn3n3_c20240101__20241231__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentLeaseLiabilitiesMember_zKRpEh5mEDri" title="Balance at beginning"&gt;667,758&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--Borrowings_iS_pn3n3_c20240101__20241231_zjM9ptJpYD4e" title="Balance at beginning"&gt;5,603,471&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;b&gt;Changes from financing cash flows&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Proceeds from issuance of bond with warrants&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_ecustom--ProceedsFromIssuanceOfBondWithWarrants_pn3n3_c20240101__20241231__ifrs-full--BorrowingsByNameAxis__custom--CurrentBondWithWarrantsMember_zb8F5DhpimB2" title="Proceeds from issuance of bond with warrants"&gt;4,500,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--ProceedsFromIssuanceOfBondWithWarrants_pn3n3_c20240101__20241231__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentBondWithWarrantsMember_zWwtHaXQ5hv8" title="Proceeds from issuance of bond with warrants"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4697"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_905_ecustom--ProceedsFromIssuanceOfBondWithWarrants_pn3n3_c20240101__20241231__ifrs-full--BorrowingsByNameAxis__custom--CurrentLeaseLiabilitiesMember_zhZTaaQ8kHkl" title="Proceeds from issuance of bond with warrants"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4699"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--ProceedsFromIssuanceOfBondWithWarrants_pn3n3_c20240101__20241231__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentLeaseLiabilitiesMember_zhxHpqlI9269" title="Proceeds from issuance of bond with warrants"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4701"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_906_ecustom--ProceedsFromIssuanceOfBondWithWarrants_pn3n3_c20240101__20241231_zQReFlOF5rbg" title="Proceeds from issuance of bond with warrants"&gt;4,500,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Repayment of bond with warrants&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_900_ecustom--RepaymentOfBondWithWarrants_iN_pn3n3_di_c20240101__20241231__ifrs-full--BorrowingsByNameAxis__custom--CurrentBondWithWarrantsMember_zrN1XCHDHRmd" title="Repayment of bond with warrants"&gt;(2,750,005&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--RepaymentOfBondWithWarrants_iN_pn3n3_di_c20240101__20241231__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentBondWithWarrantsMember_zuumY3VvbIqe" title="Repayment of bond with warrants"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4707"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--RepaymentOfBondWithWarrants_iN_pn3n3_di_c20240101__20241231__ifrs-full--BorrowingsByNameAxis__custom--CurrentLeaseLiabilitiesMember_zUGwsZrVtGjj" title="Repayment of bond with warrants"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4709"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--RepaymentOfBondWithWarrants_iN_pn3n3_di_c20240101__20241231__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentLeaseLiabilitiesMember_z9dNwuzadhKd" title="Repayment of bond with warrants"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4711"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_907_ecustom--RepaymentOfBondWithWarrants_iN_pn3n3_di_c20240101__20241231_zBAJKQgmBuHb" title="Repayment of bond with warrants"&gt;(2,750,005&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Payment of lease liability principal&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_905_ecustom--PaymentOfLeaseLiabilityPrincipal_iN_pn3n3_di_c20240101__20241231__ifrs-full--BorrowingsByNameAxis__custom--CurrentBondWithWarrantsMember_z7WywaRzYIv2" title="Payment of lease liability principal"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4715"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--PaymentOfLeaseLiabilityPrincipal_iN_pn3n3_di_c20240101__20241231__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentBondWithWarrantsMember_zTjxNr3vwBMd" title="Payment of lease liability principal"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4717"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--PaymentOfLeaseLiabilityPrincipal_iN_pn3n3_di_c20240101__20241231__ifrs-full--BorrowingsByNameAxis__custom--CurrentLeaseLiabilitiesMember_z0vSAhBM4x79" title="Payment of lease liability principal"&gt;(109,391&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--PaymentOfLeaseLiabilityPrincipal_iN_pn3n3_di_c20240101__20241231__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentLeaseLiabilitiesMember_zdSR86N90ly3" title="Payment of lease liability principal"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4721"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_909_ecustom--PaymentOfLeaseLiabilityPrincipal_iN_pn3n3_di_c20240101__20241231_zc4Wg7bWeI65" title="Payment of lease liability principal"&gt;(109,391&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; vertical-align: top; padding-bottom: 0.5pt"&gt;Total&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities_pn3n3_c20240101__20241231__ifrs-full--BorrowingsByNameAxis__custom--CurrentBondWithWarrantsMember_zIxbHSEMjL6c" title="Total"&gt;1,749,995&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities_pn3n3_c20240101__20241231__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentBondWithWarrantsMember_zMTwBkRWxTd2" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4727"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities_pn3n3_c20240101__20241231__ifrs-full--BorrowingsByNameAxis__custom--CurrentLeaseLiabilitiesMember_zGx3FpJ1UQA1" title="Total"&gt;(109,391&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities_pn3n3_c20240101__20241231__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentLeaseLiabilitiesMember_zsAo9XCm6eC1" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4731"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities_pn3n3_c20240101__20241231_zsTOJhdS7l0k" title="Total"&gt;1,640,604&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;b&gt;Other changes&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Warrants settled through debt-to-equity swap&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_907_ecustom--WarrantsSettledThroughDebtToEquitySwap_pn3n3_c20240101__20241231__ifrs-full--BorrowingsByNameAxis__custom--CurrentBondWithWarrantsMember_zGfq0HzcxjWl" title="Warrants settled through debt-to-equity swap"&gt;(4,160,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_909_ecustom--WarrantsSettledThroughDebtToEquitySwap_pn3n3_c20240101__20241231__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentBondWithWarrantsMember_zsMko7sA38td" title="Warrants settled through debt-to-equity swap"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4737"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--WarrantsSettledThroughDebtToEquitySwap_pn3n3_c20240101__20241231__ifrs-full--BorrowingsByNameAxis__custom--CurrentLeaseLiabilitiesMember_zTp6Hk90p9af" title="Warrants settled through debt-to-equity swap"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4739"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--WarrantsSettledThroughDebtToEquitySwap_pn3n3_c20240101__20241231__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentLeaseLiabilitiesMember_zusHn6NeFcne" title="Warrants settled through debt-to-equity swap"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4741"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--WarrantsSettledThroughDebtToEquitySwap_pn3n3_c20240101__20241231_zMgjHtdSq4c" title="Warrants settled through debt-to-equity swap"&gt;(4,160,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Other non-cash transactions&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_907_ecustom--OtherNoncashTransactions_pn3n3_c20240101__20241231__ifrs-full--BorrowingsByNameAxis__custom--CurrentBondWithWarrantsMember_zhDsUEkc0BSg" title="Other non-cash transactions"&gt;117,762&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_900_ecustom--OtherNoncashTransactions_pn3n3_c20240101__20241231__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentBondWithWarrantsMember_zGTm4KAmOxOc" title="Other non-cash transactions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4747"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--OtherNoncashTransactions_pn3n3_c20240101__20241231__ifrs-full--BorrowingsByNameAxis__custom--CurrentLeaseLiabilitiesMember_ziE3CRjnHnX8" title="Other non-cash transactions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4749"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_900_ecustom--OtherNoncashTransactions_pn3n3_c20240101__20241231__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentLeaseLiabilitiesMember_zLTHc2cfyeZb" title="Other non-cash transactions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4751"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_905_ecustom--OtherNoncashTransactions_pn3n3_c20240101__20241231_z8VPHwRoNMAg" title="Other non-cash transactions"&gt;117,762&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Lease reassessment&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_901_ecustom--LeaseReassessment_pn3n3_c20240101__20241231__ifrs-full--BorrowingsByNameAxis__custom--CurrentBondWithWarrantsMember_z46iWu83G2kd" title="Lease reassessment"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4755"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--LeaseReassessment_pn3n3_c20240101__20241231__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentBondWithWarrantsMember_z1qv8BE0Dxwg" title="Lease reassessment"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4757"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_905_ecustom--LeaseReassessment_pn3n3_c20240101__20241231__ifrs-full--BorrowingsByNameAxis__custom--CurrentLeaseLiabilitiesMember_zR9p1uqIgzo6" title="Lease reassessment"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4759"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_901_ecustom--LeaseReassessment_pn3n3_c20240101__20241231__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentLeaseLiabilitiesMember_zmKDs90Eo9sd" title="Lease reassessment"&gt;2,038&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_907_ecustom--LeaseReassessment_pn3n3_c20240101__20241231_z0QCI4rMkAyh" title="Lease reassessment"&gt;2,038&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Interest expense&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--OtherInterestExpense_pn3n3_c20240101__20241231__ifrs-full--BorrowingsByNameAxis__custom--CurrentBondWithWarrantsMember_z3ddsUxJtL9" title="Interest expense"&gt;984,296&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_903_ecustom--OtherInterestExpense_pn3n3_c20240101__20241231__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentBondWithWarrantsMember_z1xN3YMm2S85" title="Interest expense"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4767"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_ecustom--OtherInterestExpense_pn3n3_c20240101__20241231__ifrs-full--BorrowingsByNameAxis__custom--CurrentLeaseLiabilitiesMember_zqrWTeascGAe" title="Interest expense"&gt;62,090&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_908_ecustom--OtherInterestExpense_pn3n3_c20240101__20241231__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentLeaseLiabilitiesMember_zfiAIrjl1bs6" title="Interest expense"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4771"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--OtherInterestExpense_pn3n3_c20240101__20241231_zY8O9PYDBWo4" title="Interest expense"&gt;1,046,386&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Interest paid&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20240101__20241231__ifrs-full--BorrowingsByNameAxis__custom--CurrentBondWithWarrantsMember_zN6Muhz9Sl84" title="Interest paid"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4775"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20240101__20241231__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentBondWithWarrantsMember_zO4Oq8wpOwF2" title="Interest paid"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4777"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20240101__20241231__ifrs-full--BorrowingsByNameAxis__custom--CurrentLeaseLiabilitiesMember_zjbI8rWjWGk7" title="Interest paid"&gt;(62,090&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20240101__20241231__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentLeaseLiabilitiesMember_zEoI4jxmu2Pb" title="Interest paid"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4781"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20240101__20241231_ztqqMQ1n8Ttk" title="Interest paid"&gt;(62,090&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Reclassification&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--Reclassification_pn3n3_c20240101__20241231__ifrs-full--BorrowingsByNameAxis__custom--CurrentBondWithWarrantsMember_zmRyXv8lCU2i" title="Reclassification"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4785"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_908_ecustom--Reclassification_pn3n3_c20240101__20241231__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentBondWithWarrantsMember_zXbkSIUEpmne" title="Reclassification"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4787"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_908_ecustom--Reclassification_pn3n3_c20240101__20241231__ifrs-full--BorrowingsByNameAxis__custom--CurrentLeaseLiabilitiesMember_zCNpI8o1g7Z2" title="Reclassification"&gt;118,115&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--Reclassification_pn3n3_c20240101__20241231__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentLeaseLiabilitiesMember_zSCNNSsDuJE3" title="Reclassification"&gt;(118,115&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--Reclassification_pn3n3_c20240101__20241231_zudOjXSxGjGk" title="Reclassification"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4793"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; vertical-align: top; padding-left: 0.125in; padding-bottom: 0.5pt"&gt;Total&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_909_ecustom--TotalOtherChanges_pn3n3_c20240101__20241231__ifrs-full--BorrowingsByNameAxis__custom--CurrentBondWithWarrantsMember_z3vOZVnGe9Da" title="Total"&gt;(3,057,942&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--TotalOtherChanges_pn3n3_c20240101__20241231__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentBondWithWarrantsMember_zlo62YXa9iP9" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4797"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_906_ecustom--TotalOtherChanges_pn3n3_c20240101__20241231__ifrs-full--BorrowingsByNameAxis__custom--CurrentLeaseLiabilitiesMember_zXeI7Jf1O34h" title="Total"&gt;118,115&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--TotalOtherChanges_pn3n3_c20240101__20241231__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentLeaseLiabilitiesMember_zfrs4MsacHzc" title="Total"&gt;(116,077&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_906_ecustom--TotalOtherChanges_pn3n3_c20240101__20241231_z0ZqOzPBKKxa" title="Total"&gt;(3,055,904&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;b&gt;Balance at December&#160;31, 2024&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#x20a9;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--Borrowings_iS_pn3n3_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--CurrentBondWithWarrantsMember_zDxvWoKGp882" title="Balance at beginning"&gt;3,519,139&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--Borrowings_iS_pn3n3_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentBondWithWarrantsMember_z3n1LVMc7xxg" title="Balance at beginning"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4807"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--Borrowings_iS_pn3n3_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--CurrentLeaseLiabilitiesMember_zWfUq7Xk4135" title="Balance at beginning"&gt;117,351&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--Borrowings_iS_pn3n3_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentLeaseLiabilitiesMember_zDH5swqppBy" title="Balance at beginning"&gt;551,681&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--Borrowings_iS_pn3n3_c20250101__20251231_zRvUAhqw4VJe" title="Balance at beginning"&gt;4,188,171&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;b&gt;Changes from financing cash flows&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Proceeds from issuance of bond with warrants&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_905_ecustom--ProceedsFromIssuanceOfBondWithWarrants_pn3n3_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--CurrentBondWithWarrantsMember_ztqqxr2GTx2h" title="Proceeds from issuance of bond with warrants"&gt;9,200,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_900_ecustom--ProceedsFromIssuanceOfBondWithWarrants_pn3n3_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentBondWithWarrantsMember_zbuxUXD9LmR8" title="Proceeds from issuance of bond with warrants"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4817"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--ProceedsFromIssuanceOfBondWithWarrants_pn3n3_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--CurrentLeaseLiabilitiesMember_zBvrImyZKks2" title="Proceeds from issuance of bond with warrants"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4819"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_906_ecustom--ProceedsFromIssuanceOfBondWithWarrants_pn3n3_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentLeaseLiabilitiesMember_z8tFJ1V0f7q2" title="Proceeds from issuance of bond with warrants"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4821"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_905_ecustom--ProceedsFromIssuanceOfBondWithWarrants_pn3n3_c20250101__20251231_zHeoQsPO9EMa" title="Proceeds from issuance of bond with warrants"&gt;9,200,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Repayment of bond with warrants&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_906_ecustom--RepaymentOfBondWithWarrants_iN_pn3n3_di_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--CurrentBondWithWarrantsMember_z3TEO3rQCqSc" title="Repayment of bond with warrants"&gt;(8,105,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_907_ecustom--RepaymentOfBondWithWarrants_iN_pn3n3_di_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentBondWithWarrantsMember_zfNAeD62FWPl" title="Repayment of bond with warrants"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4827"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_903_ecustom--RepaymentOfBondWithWarrants_iN_pn3n3_di_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--CurrentLeaseLiabilitiesMember_zrhavNK45Kh6" title="Repayment of bond with warrants"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4829"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--RepaymentOfBondWithWarrants_iN_pn3n3_di_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentLeaseLiabilitiesMember_z7XQzg4SOvk4" title="Repayment of bond with warrants"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4831"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_906_ecustom--RepaymentOfBondWithWarrants_iN_pn3n3_di_c20250101__20251231_zl75qTJgSpV" title="Repayment of bond with warrants"&gt;(8,105,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Payment of lease liability principal&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_ecustom--PaymentOfLeaseLiabilityPrincipal_iN_pn3n3_di_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--CurrentBondWithWarrantsMember_zPRWakG2oRo1" title="Payment of lease liability principal"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4835"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_903_ecustom--PaymentOfLeaseLiabilityPrincipal_iN_pn3n3_di_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentBondWithWarrantsMember_zJywrijazSX6" title="Payment of lease liability principal"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4837"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_900_ecustom--PaymentOfLeaseLiabilityPrincipal_iN_pn3n3_di_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--CurrentLeaseLiabilitiesMember_zwtNhPOsBP3e" title="Payment of lease liability principal"&gt;(117,348&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_907_ecustom--PaymentOfLeaseLiabilityPrincipal_iN_pn3n3_di_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentLeaseLiabilitiesMember_z0iJavrj9J0g" title="Payment of lease liability principal"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4841"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_900_ecustom--PaymentOfLeaseLiabilityPrincipal_iN_pn3n3_di_c20250101__20251231_zlo1lpQw0wR4" title="Payment of lease liability principal"&gt;(117,348&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; vertical-align: top; padding-bottom: 0.5pt"&gt;Total&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities_pn3n3_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--CurrentBondWithWarrantsMember_zjUlOiUipmy8" title="Total"&gt;1,095,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities_pn3n3_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentBondWithWarrantsMember_zYadv7S7CRFk" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4847"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities_pn3n3_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--CurrentLeaseLiabilitiesMember_zFVS7dF9hnXe" title="Total"&gt;(117,348&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities_pn3n3_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentLeaseLiabilitiesMember_zFG2tH2nupWk" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4851"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities_pn3n3_c20250101__20251231_zOG5vMWvsg05" title="Total"&gt;977,652&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;b&gt;Other changes&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Warrants settled through debt-to-equity swap&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--WarrantsSettledThroughDebtToEquitySwap_pn3n3_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--CurrentBondWithWarrantsMember_znIAoCc0gKtk" title="Warrants settled through debt-to-equity swap"&gt;(1,305,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_900_ecustom--WarrantsSettledThroughDebtToEquitySwap_pn3n3_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentBondWithWarrantsMember_z0lfMvj9AZL1" title="Warrants settled through debt-to-equity swap"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4857"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_907_ecustom--WarrantsSettledThroughDebtToEquitySwap_pn3n3_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--CurrentLeaseLiabilitiesMember_zDB2KrYPvJy2" title="Warrants settled through debt-to-equity swap"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4859"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_905_ecustom--WarrantsSettledThroughDebtToEquitySwap_pn3n3_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentLeaseLiabilitiesMember_zy8212fOotWj" title="Warrants settled through debt-to-equity swap"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4861"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_907_ecustom--WarrantsSettledThroughDebtToEquitySwap_pn3n3_c20250101__20251231_zaWhNDgapaSd" title="Warrants settled through debt-to-equity swap"&gt;(1,305,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Other non-cash transactions&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_900_ecustom--OtherNoncashTransactions_pn3n3_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--CurrentBondWithWarrantsMember_zB26tC31bEVb" title="Other non-cash transactions"&gt;(788,594&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_903_ecustom--OtherNoncashTransactions_pn3n3_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentBondWithWarrantsMember_z6HP8GN0BeQe" title="Other non-cash transactions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4867"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--OtherNoncashTransactions_pn3n3_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--CurrentLeaseLiabilitiesMember_zv0n9t66xKBc" title="Other non-cash transactions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4869"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--OtherNoncashTransactions_pn3n3_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentLeaseLiabilitiesMember_zL1cy9fe6NJ7" title="Other non-cash transactions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4871"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_909_ecustom--OtherNoncashTransactions_pn3n3_c20250101__20251231_zZ7O16zrUBT1" title="Other non-cash transactions"&gt;(788,594&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Lease reassessment&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--LeaseReassessment_pn3n3_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--CurrentBondWithWarrantsMember_zhyAf44upyH4" title="Lease reassessment"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4875"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--LeaseReassessment_pn3n3_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentBondWithWarrantsMember_zUhNGXH2Nre1" title="Lease reassessment"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4877"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_903_ecustom--LeaseReassessment_pn3n3_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--CurrentLeaseLiabilitiesMember_zBrXvdOwMVsl" title="Lease reassessment"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4879"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_ecustom--LeaseReassessment_pn3n3_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentLeaseLiabilitiesMember_zwVFY6D93B2f" title="Lease reassessment"&gt;947&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_900_ecustom--LeaseReassessment_pn3n3_c20250101__20251231_zSxhfq7cNg" title="Lease reassessment"&gt;947&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Interest expense&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_900_ecustom--OtherInterestExpense_pn3n3_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--CurrentBondWithWarrantsMember_zCr28BkExEah" title="Interest expense"&gt;744,767&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_908_ecustom--OtherInterestExpense_pn3n3_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentBondWithWarrantsMember_zOj3zpjHigie" title="Interest expense"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4887"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--OtherInterestExpense_pn3n3_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--CurrentLeaseLiabilitiesMember_znfDVwCJYpVh" title="Interest expense"&gt;52,261&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--OtherInterestExpense_pn3n3_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentLeaseLiabilitiesMember_zwfm4y3rxVSd" title="Interest expense"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4891"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_902_ecustom--OtherInterestExpense_pn3n3_c20250101__20251231_zYYc50dgz3F4" title="Interest expense"&gt;797,028&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Interest paid&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--CurrentBondWithWarrantsMember_ztAwOHxEahJe" title="Interest paid"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4895"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentBondWithWarrantsMember_zkfeNtqYFkw4" title="Interest paid"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4897"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--CurrentLeaseLiabilitiesMember_zbJv4PHTZ2Jb" title="Interest paid"&gt;(52,261&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentLeaseLiabilitiesMember_zZvpLt2rS6S1" title="Interest paid"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4901"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20250101__20251231_zL9VA3LbzH6i" title="Interest paid"&gt;(52,261&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Reclassification&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--Reclassification_pn3n3_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--CurrentBondWithWarrantsMember_zFACSD9CFwvd" title="Reclassification"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4905"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_908_ecustom--Reclassification_pn3n3_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentBondWithWarrantsMember_zEvqpTlcIHY1" title="Reclassification"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4907"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_909_ecustom--Reclassification_pn3n3_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--CurrentLeaseLiabilitiesMember_z3TOxZ7rUFSa" title="Reclassification"&gt;122,623&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_905_ecustom--Reclassification_pn3n3_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentLeaseLiabilitiesMember_zI9X8YXFli2j" title="Reclassification"&gt;(122,623&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_909_ecustom--Reclassification_pn3n3_c20250101__20251231_zvD4FZDcQZ2e" title="Reclassification"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4913"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; vertical-align: top; padding-bottom: 0.5pt"&gt;Total&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--TotalOtherChanges_pn3n3_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--CurrentBondWithWarrantsMember_zjj5y8Go5ryf" title="Total"&gt;(1,348,827&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--TotalOtherChanges_pn3n3_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentBondWithWarrantsMember_zW7wKPi2CKx4" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4917"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_908_ecustom--TotalOtherChanges_pn3n3_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--CurrentLeaseLiabilitiesMember_zdhaA7lNm1A6" title="Total"&gt;122,623&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--TotalOtherChanges_pn3n3_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentLeaseLiabilitiesMember_zVNSD8nZcnK9" title="Total"&gt;(121,676&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_909_ecustom--TotalOtherChanges_pn3n3_c20250101__20251231_zmjwsP42t5X5" title="Total"&gt;(1,347,880&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.25pt"&gt;&lt;b&gt;Balance at December&#160;31, 2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--Borrowings_iE_pn3n3_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--CurrentBondWithWarrantsMember_zoes74TmXnpl" title="Balance at ending"&gt;3,265,312&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--Borrowings_iE_pn3n3_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentBondWithWarrantsMember_zPcLYwa7kRG" title="Balance at ending"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4927"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--Borrowings_iE_pn3n3_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--CurrentLeaseLiabilitiesMember_zUQnqCW0wwI5" title="Balance at ending"&gt;122,626&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--Borrowings_iE_pn3n3_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentLeaseLiabilitiesMember_z1cDvlfzZDY" title="Balance at ending"&gt;430,005&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--Borrowings_iE_pn3n3_c20250101__20251231_zdy0e3rI2qqc" title="Balance at ending"&gt;3,817,943&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A3_zwl8nlC8FxMd" style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

















</cik0002058261:DisclosureOfCashFlowStatementsExplanatory>
    <cik0002058261:ScheduleOfSignificantNonCashTransactionsTableTextBlock
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact004677">&lt;table cellpadding="0" cellspacing="0" id="xdx_89B_ecustom--ScheduleOfSignificantNonCashTransactionsTableTextBlock_pn3n3_zew4tOsTDQJ4" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Statement of Cash flows (Details)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&lt;span id="xdx_8BF_zBwFroYxMGSd" style="display: none"&gt;Schedule of significant non-cash transactions&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="font: 10pt Times New Roman; text-align: center"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="font: 10pt Times New Roman; text-align: center"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Increase in lease liabilities&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_907_ecustom--IncreaseInLeaseLiabilities_pn3n3_c20250101__20251231__ifrs-full--SegmentsAxis__custom--IncomeAndExpensesFromOperatingActivitiesMember_zMqMOWTWU5y2" title="Increase in lease liabilities"&gt;947&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--IncreaseInLeaseLiabilities_pn3n3_c20240101__20241231__ifrs-full--SegmentsAxis__custom--IncomeAndExpensesFromOperatingActivitiesMember_z7gsc5xeNryf" title="Increase in lease liabilities"&gt;2,038&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:ScheduleOfSignificantNonCashTransactionsTableTextBlock>
    <cik0002058261:IncreaseInLeaseLiabilities
      contextRef="From2025-01-012025-12-31_custom_IncomeAndExpensesFromOperatingActivitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004679"
      unitRef="KRW">947000</cik0002058261:IncreaseInLeaseLiabilities>
    <cik0002058261:IncreaseInLeaseLiabilities
      contextRef="From2024-01-012024-12-31_custom_IncomeAndExpensesFromOperatingActivitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004681"
      unitRef="KRW">2038000</cik0002058261:IncreaseInLeaseLiabilities>
    <cik0002058261:ScheduleOfLiabilitiesToCashFlowsArisingFromFinancingActivitiesTableTextBlock
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact004683">&lt;table cellpadding="0" cellspacing="0" id="xdx_896_ecustom--ScheduleOfLiabilitiesToCashFlowsArisingFromFinancingActivitiesTableTextBlock_pn3n3_ztmalJXlO9ib" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Statement of Cash flows (Details 1)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span id="xdx_8B5_zmEesIsA81Vg" style="display: none"&gt;Schedule of liabilities to cash flows arising from financing activities&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Current bond&lt;br/&gt; with warrants&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Non-current&lt;br/&gt; bond with&lt;br/&gt; warrants&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Current lease&lt;br/&gt; liabilities&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;
        &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;Non-current&lt;/b&gt;&lt;/p&gt;
        &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;lease liabilities&lt;/b&gt;&lt;/p&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="18" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; width: 38%"&gt;&lt;b&gt;Balance at January&#160;1, 2024&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--Borrowings_iS_pn3n3_c20240101__20241231__ifrs-full--BorrowingsByNameAxis__custom--CurrentBondWithWarrantsMember_zM3QMY3ACV9j" title="Balance at beginning"&gt;4,827,086&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--Borrowings_iS_pn3n3_c20240101__20241231__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentBondWithWarrantsMember_zv88FGP5BYyi" title="Balance at beginning"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4687"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--Borrowings_iS_pn3n3_c20240101__20241231__ifrs-full--BorrowingsByNameAxis__custom--CurrentLeaseLiabilitiesMember_zwdOqqUEGI6c" title="Balance at beginning"&gt;108,627&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--Borrowings_iS_pn3n3_c20240101__20241231__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentLeaseLiabilitiesMember_zKRpEh5mEDri" title="Balance at beginning"&gt;667,758&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--Borrowings_iS_pn3n3_c20240101__20241231_zjM9ptJpYD4e" title="Balance at beginning"&gt;5,603,471&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;b&gt;Changes from financing cash flows&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Proceeds from issuance of bond with warrants&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_ecustom--ProceedsFromIssuanceOfBondWithWarrants_pn3n3_c20240101__20241231__ifrs-full--BorrowingsByNameAxis__custom--CurrentBondWithWarrantsMember_zb8F5DhpimB2" title="Proceeds from issuance of bond with warrants"&gt;4,500,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--ProceedsFromIssuanceOfBondWithWarrants_pn3n3_c20240101__20241231__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentBondWithWarrantsMember_zWwtHaXQ5hv8" title="Proceeds from issuance of bond with warrants"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4697"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_905_ecustom--ProceedsFromIssuanceOfBondWithWarrants_pn3n3_c20240101__20241231__ifrs-full--BorrowingsByNameAxis__custom--CurrentLeaseLiabilitiesMember_zhZTaaQ8kHkl" title="Proceeds from issuance of bond with warrants"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4699"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--ProceedsFromIssuanceOfBondWithWarrants_pn3n3_c20240101__20241231__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentLeaseLiabilitiesMember_zhxHpqlI9269" title="Proceeds from issuance of bond with warrants"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4701"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_906_ecustom--ProceedsFromIssuanceOfBondWithWarrants_pn3n3_c20240101__20241231_zQReFlOF5rbg" title="Proceeds from issuance of bond with warrants"&gt;4,500,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Repayment of bond with warrants&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_900_ecustom--RepaymentOfBondWithWarrants_iN_pn3n3_di_c20240101__20241231__ifrs-full--BorrowingsByNameAxis__custom--CurrentBondWithWarrantsMember_zrN1XCHDHRmd" title="Repayment of bond with warrants"&gt;(2,750,005&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--RepaymentOfBondWithWarrants_iN_pn3n3_di_c20240101__20241231__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentBondWithWarrantsMember_zuumY3VvbIqe" title="Repayment of bond with warrants"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4707"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--RepaymentOfBondWithWarrants_iN_pn3n3_di_c20240101__20241231__ifrs-full--BorrowingsByNameAxis__custom--CurrentLeaseLiabilitiesMember_zUGwsZrVtGjj" title="Repayment of bond with warrants"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4709"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--RepaymentOfBondWithWarrants_iN_pn3n3_di_c20240101__20241231__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentLeaseLiabilitiesMember_z9dNwuzadhKd" title="Repayment of bond with warrants"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4711"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_907_ecustom--RepaymentOfBondWithWarrants_iN_pn3n3_di_c20240101__20241231_zBAJKQgmBuHb" title="Repayment of bond with warrants"&gt;(2,750,005&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Payment of lease liability principal&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_905_ecustom--PaymentOfLeaseLiabilityPrincipal_iN_pn3n3_di_c20240101__20241231__ifrs-full--BorrowingsByNameAxis__custom--CurrentBondWithWarrantsMember_z7WywaRzYIv2" title="Payment of lease liability principal"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4715"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--PaymentOfLeaseLiabilityPrincipal_iN_pn3n3_di_c20240101__20241231__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentBondWithWarrantsMember_zTjxNr3vwBMd" title="Payment of lease liability principal"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4717"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--PaymentOfLeaseLiabilityPrincipal_iN_pn3n3_di_c20240101__20241231__ifrs-full--BorrowingsByNameAxis__custom--CurrentLeaseLiabilitiesMember_z0vSAhBM4x79" title="Payment of lease liability principal"&gt;(109,391&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--PaymentOfLeaseLiabilityPrincipal_iN_pn3n3_di_c20240101__20241231__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentLeaseLiabilitiesMember_zdSR86N90ly3" title="Payment of lease liability principal"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4721"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_909_ecustom--PaymentOfLeaseLiabilityPrincipal_iN_pn3n3_di_c20240101__20241231_zc4Wg7bWeI65" title="Payment of lease liability principal"&gt;(109,391&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; vertical-align: top; padding-bottom: 0.5pt"&gt;Total&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities_pn3n3_c20240101__20241231__ifrs-full--BorrowingsByNameAxis__custom--CurrentBondWithWarrantsMember_zIxbHSEMjL6c" title="Total"&gt;1,749,995&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities_pn3n3_c20240101__20241231__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentBondWithWarrantsMember_zMTwBkRWxTd2" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4727"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities_pn3n3_c20240101__20241231__ifrs-full--BorrowingsByNameAxis__custom--CurrentLeaseLiabilitiesMember_zGx3FpJ1UQA1" title="Total"&gt;(109,391&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities_pn3n3_c20240101__20241231__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentLeaseLiabilitiesMember_zsAo9XCm6eC1" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4731"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities_pn3n3_c20240101__20241231_zsTOJhdS7l0k" title="Total"&gt;1,640,604&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;b&gt;Other changes&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Warrants settled through debt-to-equity swap&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_907_ecustom--WarrantsSettledThroughDebtToEquitySwap_pn3n3_c20240101__20241231__ifrs-full--BorrowingsByNameAxis__custom--CurrentBondWithWarrantsMember_zGfq0HzcxjWl" title="Warrants settled through debt-to-equity swap"&gt;(4,160,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_909_ecustom--WarrantsSettledThroughDebtToEquitySwap_pn3n3_c20240101__20241231__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentBondWithWarrantsMember_zsMko7sA38td" title="Warrants settled through debt-to-equity swap"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4737"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--WarrantsSettledThroughDebtToEquitySwap_pn3n3_c20240101__20241231__ifrs-full--BorrowingsByNameAxis__custom--CurrentLeaseLiabilitiesMember_zTp6Hk90p9af" title="Warrants settled through debt-to-equity swap"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4739"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--WarrantsSettledThroughDebtToEquitySwap_pn3n3_c20240101__20241231__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentLeaseLiabilitiesMember_zusHn6NeFcne" title="Warrants settled through debt-to-equity swap"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4741"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--WarrantsSettledThroughDebtToEquitySwap_pn3n3_c20240101__20241231_zMgjHtdSq4c" title="Warrants settled through debt-to-equity swap"&gt;(4,160,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Other non-cash transactions&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_907_ecustom--OtherNoncashTransactions_pn3n3_c20240101__20241231__ifrs-full--BorrowingsByNameAxis__custom--CurrentBondWithWarrantsMember_zhDsUEkc0BSg" title="Other non-cash transactions"&gt;117,762&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_900_ecustom--OtherNoncashTransactions_pn3n3_c20240101__20241231__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentBondWithWarrantsMember_zGTm4KAmOxOc" title="Other non-cash transactions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4747"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--OtherNoncashTransactions_pn3n3_c20240101__20241231__ifrs-full--BorrowingsByNameAxis__custom--CurrentLeaseLiabilitiesMember_ziE3CRjnHnX8" title="Other non-cash transactions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4749"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_900_ecustom--OtherNoncashTransactions_pn3n3_c20240101__20241231__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentLeaseLiabilitiesMember_zLTHc2cfyeZb" title="Other non-cash transactions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4751"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_905_ecustom--OtherNoncashTransactions_pn3n3_c20240101__20241231_z8VPHwRoNMAg" title="Other non-cash transactions"&gt;117,762&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Lease reassessment&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_901_ecustom--LeaseReassessment_pn3n3_c20240101__20241231__ifrs-full--BorrowingsByNameAxis__custom--CurrentBondWithWarrantsMember_z46iWu83G2kd" title="Lease reassessment"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4755"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--LeaseReassessment_pn3n3_c20240101__20241231__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentBondWithWarrantsMember_z1qv8BE0Dxwg" title="Lease reassessment"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4757"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_905_ecustom--LeaseReassessment_pn3n3_c20240101__20241231__ifrs-full--BorrowingsByNameAxis__custom--CurrentLeaseLiabilitiesMember_zR9p1uqIgzo6" title="Lease reassessment"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4759"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_901_ecustom--LeaseReassessment_pn3n3_c20240101__20241231__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentLeaseLiabilitiesMember_zmKDs90Eo9sd" title="Lease reassessment"&gt;2,038&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_907_ecustom--LeaseReassessment_pn3n3_c20240101__20241231_z0QCI4rMkAyh" title="Lease reassessment"&gt;2,038&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Interest expense&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--OtherInterestExpense_pn3n3_c20240101__20241231__ifrs-full--BorrowingsByNameAxis__custom--CurrentBondWithWarrantsMember_z3ddsUxJtL9" title="Interest expense"&gt;984,296&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_903_ecustom--OtherInterestExpense_pn3n3_c20240101__20241231__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentBondWithWarrantsMember_z1xN3YMm2S85" title="Interest expense"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4767"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_ecustom--OtherInterestExpense_pn3n3_c20240101__20241231__ifrs-full--BorrowingsByNameAxis__custom--CurrentLeaseLiabilitiesMember_zqrWTeascGAe" title="Interest expense"&gt;62,090&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_908_ecustom--OtherInterestExpense_pn3n3_c20240101__20241231__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentLeaseLiabilitiesMember_zfiAIrjl1bs6" title="Interest expense"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4771"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--OtherInterestExpense_pn3n3_c20240101__20241231_zY8O9PYDBWo4" title="Interest expense"&gt;1,046,386&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Interest paid&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20240101__20241231__ifrs-full--BorrowingsByNameAxis__custom--CurrentBondWithWarrantsMember_zN6Muhz9Sl84" title="Interest paid"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4775"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20240101__20241231__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentBondWithWarrantsMember_zO4Oq8wpOwF2" title="Interest paid"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4777"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20240101__20241231__ifrs-full--BorrowingsByNameAxis__custom--CurrentLeaseLiabilitiesMember_zjbI8rWjWGk7" title="Interest paid"&gt;(62,090&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20240101__20241231__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentLeaseLiabilitiesMember_zEoI4jxmu2Pb" title="Interest paid"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4781"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20240101__20241231_ztqqMQ1n8Ttk" title="Interest paid"&gt;(62,090&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Reclassification&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--Reclassification_pn3n3_c20240101__20241231__ifrs-full--BorrowingsByNameAxis__custom--CurrentBondWithWarrantsMember_zmRyXv8lCU2i" title="Reclassification"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4785"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_908_ecustom--Reclassification_pn3n3_c20240101__20241231__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentBondWithWarrantsMember_zXbkSIUEpmne" title="Reclassification"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4787"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_908_ecustom--Reclassification_pn3n3_c20240101__20241231__ifrs-full--BorrowingsByNameAxis__custom--CurrentLeaseLiabilitiesMember_zCNpI8o1g7Z2" title="Reclassification"&gt;118,115&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--Reclassification_pn3n3_c20240101__20241231__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentLeaseLiabilitiesMember_zSCNNSsDuJE3" title="Reclassification"&gt;(118,115&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--Reclassification_pn3n3_c20240101__20241231_zudOjXSxGjGk" title="Reclassification"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4793"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; vertical-align: top; padding-left: 0.125in; padding-bottom: 0.5pt"&gt;Total&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_909_ecustom--TotalOtherChanges_pn3n3_c20240101__20241231__ifrs-full--BorrowingsByNameAxis__custom--CurrentBondWithWarrantsMember_z3vOZVnGe9Da" title="Total"&gt;(3,057,942&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--TotalOtherChanges_pn3n3_c20240101__20241231__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentBondWithWarrantsMember_zlo62YXa9iP9" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4797"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_906_ecustom--TotalOtherChanges_pn3n3_c20240101__20241231__ifrs-full--BorrowingsByNameAxis__custom--CurrentLeaseLiabilitiesMember_zXeI7Jf1O34h" title="Total"&gt;118,115&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--TotalOtherChanges_pn3n3_c20240101__20241231__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentLeaseLiabilitiesMember_zfrs4MsacHzc" title="Total"&gt;(116,077&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_906_ecustom--TotalOtherChanges_pn3n3_c20240101__20241231_z0ZqOzPBKKxa" title="Total"&gt;(3,055,904&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;b&gt;Balance at December&#160;31, 2024&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#x20a9;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--Borrowings_iS_pn3n3_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--CurrentBondWithWarrantsMember_zDxvWoKGp882" title="Balance at beginning"&gt;3,519,139&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--Borrowings_iS_pn3n3_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentBondWithWarrantsMember_z3n1LVMc7xxg" title="Balance at beginning"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4807"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--Borrowings_iS_pn3n3_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--CurrentLeaseLiabilitiesMember_zWfUq7Xk4135" title="Balance at beginning"&gt;117,351&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--Borrowings_iS_pn3n3_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentLeaseLiabilitiesMember_zDH5swqppBy" title="Balance at beginning"&gt;551,681&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--Borrowings_iS_pn3n3_c20250101__20251231_zRvUAhqw4VJe" title="Balance at beginning"&gt;4,188,171&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;b&gt;Changes from financing cash flows&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Proceeds from issuance of bond with warrants&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_905_ecustom--ProceedsFromIssuanceOfBondWithWarrants_pn3n3_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--CurrentBondWithWarrantsMember_ztqqxr2GTx2h" title="Proceeds from issuance of bond with warrants"&gt;9,200,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_900_ecustom--ProceedsFromIssuanceOfBondWithWarrants_pn3n3_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentBondWithWarrantsMember_zbuxUXD9LmR8" title="Proceeds from issuance of bond with warrants"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4817"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--ProceedsFromIssuanceOfBondWithWarrants_pn3n3_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--CurrentLeaseLiabilitiesMember_zBvrImyZKks2" title="Proceeds from issuance of bond with warrants"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4819"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_906_ecustom--ProceedsFromIssuanceOfBondWithWarrants_pn3n3_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentLeaseLiabilitiesMember_z8tFJ1V0f7q2" title="Proceeds from issuance of bond with warrants"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4821"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_905_ecustom--ProceedsFromIssuanceOfBondWithWarrants_pn3n3_c20250101__20251231_zHeoQsPO9EMa" title="Proceeds from issuance of bond with warrants"&gt;9,200,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Repayment of bond with warrants&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_906_ecustom--RepaymentOfBondWithWarrants_iN_pn3n3_di_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--CurrentBondWithWarrantsMember_z3TEO3rQCqSc" title="Repayment of bond with warrants"&gt;(8,105,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_907_ecustom--RepaymentOfBondWithWarrants_iN_pn3n3_di_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentBondWithWarrantsMember_zfNAeD62FWPl" title="Repayment of bond with warrants"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4827"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_903_ecustom--RepaymentOfBondWithWarrants_iN_pn3n3_di_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--CurrentLeaseLiabilitiesMember_zrhavNK45Kh6" title="Repayment of bond with warrants"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4829"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--RepaymentOfBondWithWarrants_iN_pn3n3_di_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentLeaseLiabilitiesMember_z7XQzg4SOvk4" title="Repayment of bond with warrants"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4831"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_906_ecustom--RepaymentOfBondWithWarrants_iN_pn3n3_di_c20250101__20251231_zl75qTJgSpV" title="Repayment of bond with warrants"&gt;(8,105,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Payment of lease liability principal&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_ecustom--PaymentOfLeaseLiabilityPrincipal_iN_pn3n3_di_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--CurrentBondWithWarrantsMember_zPRWakG2oRo1" title="Payment of lease liability principal"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4835"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_903_ecustom--PaymentOfLeaseLiabilityPrincipal_iN_pn3n3_di_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentBondWithWarrantsMember_zJywrijazSX6" title="Payment of lease liability principal"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4837"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_900_ecustom--PaymentOfLeaseLiabilityPrincipal_iN_pn3n3_di_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--CurrentLeaseLiabilitiesMember_zwtNhPOsBP3e" title="Payment of lease liability principal"&gt;(117,348&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_907_ecustom--PaymentOfLeaseLiabilityPrincipal_iN_pn3n3_di_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentLeaseLiabilitiesMember_z0iJavrj9J0g" title="Payment of lease liability principal"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4841"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_900_ecustom--PaymentOfLeaseLiabilityPrincipal_iN_pn3n3_di_c20250101__20251231_zlo1lpQw0wR4" title="Payment of lease liability principal"&gt;(117,348&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; vertical-align: top; padding-bottom: 0.5pt"&gt;Total&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities_pn3n3_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--CurrentBondWithWarrantsMember_zjUlOiUipmy8" title="Total"&gt;1,095,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities_pn3n3_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentBondWithWarrantsMember_zYadv7S7CRFk" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4847"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities_pn3n3_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--CurrentLeaseLiabilitiesMember_zFVS7dF9hnXe" title="Total"&gt;(117,348&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities_pn3n3_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentLeaseLiabilitiesMember_zFG2tH2nupWk" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4851"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities_pn3n3_c20250101__20251231_zOG5vMWvsg05" title="Total"&gt;977,652&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;b&gt;Other changes&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Warrants settled through debt-to-equity swap&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--WarrantsSettledThroughDebtToEquitySwap_pn3n3_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--CurrentBondWithWarrantsMember_znIAoCc0gKtk" title="Warrants settled through debt-to-equity swap"&gt;(1,305,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_900_ecustom--WarrantsSettledThroughDebtToEquitySwap_pn3n3_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentBondWithWarrantsMember_z0lfMvj9AZL1" title="Warrants settled through debt-to-equity swap"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4857"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_907_ecustom--WarrantsSettledThroughDebtToEquitySwap_pn3n3_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--CurrentLeaseLiabilitiesMember_zDB2KrYPvJy2" title="Warrants settled through debt-to-equity swap"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4859"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_905_ecustom--WarrantsSettledThroughDebtToEquitySwap_pn3n3_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentLeaseLiabilitiesMember_zy8212fOotWj" title="Warrants settled through debt-to-equity swap"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4861"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_907_ecustom--WarrantsSettledThroughDebtToEquitySwap_pn3n3_c20250101__20251231_zaWhNDgapaSd" title="Warrants settled through debt-to-equity swap"&gt;(1,305,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Other non-cash transactions&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_900_ecustom--OtherNoncashTransactions_pn3n3_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--CurrentBondWithWarrantsMember_zB26tC31bEVb" title="Other non-cash transactions"&gt;(788,594&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_903_ecustom--OtherNoncashTransactions_pn3n3_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentBondWithWarrantsMember_z6HP8GN0BeQe" title="Other non-cash transactions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4867"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--OtherNoncashTransactions_pn3n3_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--CurrentLeaseLiabilitiesMember_zv0n9t66xKBc" title="Other non-cash transactions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4869"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--OtherNoncashTransactions_pn3n3_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentLeaseLiabilitiesMember_zL1cy9fe6NJ7" title="Other non-cash transactions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4871"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_909_ecustom--OtherNoncashTransactions_pn3n3_c20250101__20251231_zZ7O16zrUBT1" title="Other non-cash transactions"&gt;(788,594&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Lease reassessment&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--LeaseReassessment_pn3n3_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--CurrentBondWithWarrantsMember_zhyAf44upyH4" title="Lease reassessment"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4875"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--LeaseReassessment_pn3n3_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentBondWithWarrantsMember_zUhNGXH2Nre1" title="Lease reassessment"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4877"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_903_ecustom--LeaseReassessment_pn3n3_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--CurrentLeaseLiabilitiesMember_zBrXvdOwMVsl" title="Lease reassessment"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4879"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_904_ecustom--LeaseReassessment_pn3n3_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentLeaseLiabilitiesMember_zwVFY6D93B2f" title="Lease reassessment"&gt;947&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_900_ecustom--LeaseReassessment_pn3n3_c20250101__20251231_zSxhfq7cNg" title="Lease reassessment"&gt;947&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Interest expense&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_900_ecustom--OtherInterestExpense_pn3n3_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--CurrentBondWithWarrantsMember_zCr28BkExEah" title="Interest expense"&gt;744,767&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_908_ecustom--OtherInterestExpense_pn3n3_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentBondWithWarrantsMember_zOj3zpjHigie" title="Interest expense"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4887"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--OtherInterestExpense_pn3n3_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--CurrentLeaseLiabilitiesMember_znfDVwCJYpVh" title="Interest expense"&gt;52,261&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--OtherInterestExpense_pn3n3_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentLeaseLiabilitiesMember_zwfm4y3rxVSd" title="Interest expense"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4891"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_902_ecustom--OtherInterestExpense_pn3n3_c20250101__20251231_zYYc50dgz3F4" title="Interest expense"&gt;797,028&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Interest paid&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--CurrentBondWithWarrantsMember_ztAwOHxEahJe" title="Interest paid"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4895"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentBondWithWarrantsMember_zkfeNtqYFkw4" title="Interest paid"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4897"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--CurrentLeaseLiabilitiesMember_zbJv4PHTZ2Jb" title="Interest paid"&gt;(52,261&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentLeaseLiabilitiesMember_zZvpLt2rS6S1" title="Interest paid"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4901"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20250101__20251231_zL9VA3LbzH6i" title="Interest paid"&gt;(52,261&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Reclassification&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--Reclassification_pn3n3_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--CurrentBondWithWarrantsMember_zFACSD9CFwvd" title="Reclassification"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4905"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_908_ecustom--Reclassification_pn3n3_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentBondWithWarrantsMember_zEvqpTlcIHY1" title="Reclassification"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4907"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_909_ecustom--Reclassification_pn3n3_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--CurrentLeaseLiabilitiesMember_z3TOxZ7rUFSa" title="Reclassification"&gt;122,623&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_905_ecustom--Reclassification_pn3n3_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentLeaseLiabilitiesMember_zI9X8YXFli2j" title="Reclassification"&gt;(122,623&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_909_ecustom--Reclassification_pn3n3_c20250101__20251231_zvD4FZDcQZ2e" title="Reclassification"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4913"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; vertical-align: top; padding-bottom: 0.5pt"&gt;Total&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--TotalOtherChanges_pn3n3_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--CurrentBondWithWarrantsMember_zjj5y8Go5ryf" title="Total"&gt;(1,348,827&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--TotalOtherChanges_pn3n3_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentBondWithWarrantsMember_zW7wKPi2CKx4" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4917"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_908_ecustom--TotalOtherChanges_pn3n3_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--CurrentLeaseLiabilitiesMember_zdhaA7lNm1A6" title="Total"&gt;122,623&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--TotalOtherChanges_pn3n3_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentLeaseLiabilitiesMember_zVNSD8nZcnK9" title="Total"&gt;(121,676&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_909_ecustom--TotalOtherChanges_pn3n3_c20250101__20251231_zmjwsP42t5X5" title="Total"&gt;(1,347,880&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.25pt"&gt;&lt;b&gt;Balance at December&#160;31, 2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--Borrowings_iE_pn3n3_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--CurrentBondWithWarrantsMember_zoes74TmXnpl" title="Balance at ending"&gt;3,265,312&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--Borrowings_iE_pn3n3_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentBondWithWarrantsMember_zPcLYwa7kRG" title="Balance at ending"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4927"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--Borrowings_iE_pn3n3_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--CurrentLeaseLiabilitiesMember_zUQnqCW0wwI5" title="Balance at ending"&gt;122,626&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--Borrowings_iE_pn3n3_c20250101__20251231__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentLeaseLiabilitiesMember_z1cDvlfzZDY" title="Balance at ending"&gt;430,005&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--Borrowings_iE_pn3n3_c20250101__20251231_zdy0e3rI2qqc" title="Balance at ending"&gt;3,817,943&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:ScheduleOfLiabilitiesToCashFlowsArisingFromFinancingActivitiesTableTextBlock>
    <ifrs-full:Borrowings
      contextRef="AsOf2023-12-31_custom_CurrentBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004685"
      unitRef="KRW">4827086000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="AsOf2023-12-31_custom_CurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004689"
      unitRef="KRW">108627000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="AsOf2023-12-31_custom_NonCurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004691"
      unitRef="KRW">667758000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="AsOf2023-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004693"
      unitRef="KRW">5603471000</ifrs-full:Borrowings>
    <cik0002058261:ProceedsFromIssuanceOfBondWithWarrants
      contextRef="From2024-01-012024-12-31_custom_CurrentBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004695"
      unitRef="KRW">4500000000</cik0002058261:ProceedsFromIssuanceOfBondWithWarrants>
    <cik0002058261:ProceedsFromIssuanceOfBondWithWarrants
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004703"
      unitRef="KRW">4500000000</cik0002058261:ProceedsFromIssuanceOfBondWithWarrants>
    <cik0002058261:RepaymentOfBondWithWarrants
      contextRef="From2024-01-012024-12-31_custom_CurrentBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004705"
      unitRef="KRW">2750005000</cik0002058261:RepaymentOfBondWithWarrants>
    <cik0002058261:RepaymentOfBondWithWarrants
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004713"
      unitRef="KRW">2750005000</cik0002058261:RepaymentOfBondWithWarrants>
    <cik0002058261:PaymentOfLeaseLiabilityPrincipal
      contextRef="From2024-01-012024-12-31_custom_CurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004719"
      unitRef="KRW">109391000</cik0002058261:PaymentOfLeaseLiabilityPrincipal>
    <cik0002058261:PaymentOfLeaseLiabilityPrincipal
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004723"
      unitRef="KRW">109391000</cik0002058261:PaymentOfLeaseLiabilityPrincipal>
    <ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities
      contextRef="From2024-01-012024-12-31_custom_CurrentBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004725"
      unitRef="KRW">1749995000</ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities>
    <ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities
      contextRef="From2024-01-012024-12-31_custom_CurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004729"
      unitRef="KRW">-109391000</ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities>
    <ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004733"
      unitRef="KRW">1640604000</ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities>
    <cik0002058261:WarrantsSettledThroughDebtToEquitySwap
      contextRef="From2024-01-012024-12-31_custom_CurrentBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004735"
      unitRef="KRW">-4160000000</cik0002058261:WarrantsSettledThroughDebtToEquitySwap>
    <cik0002058261:WarrantsSettledThroughDebtToEquitySwap
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004743"
      unitRef="KRW">-4160000000</cik0002058261:WarrantsSettledThroughDebtToEquitySwap>
    <cik0002058261:OtherNoncashTransactions
      contextRef="From2024-01-012024-12-31_custom_CurrentBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004745"
      unitRef="KRW">117762000</cik0002058261:OtherNoncashTransactions>
    <cik0002058261:OtherNoncashTransactions
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004753"
      unitRef="KRW">117762000</cik0002058261:OtherNoncashTransactions>
    <cik0002058261:LeaseReassessment
      contextRef="From2024-01-012024-12-31_custom_NonCurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004761"
      unitRef="KRW">2038000</cik0002058261:LeaseReassessment>
    <cik0002058261:LeaseReassessment
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004763"
      unitRef="KRW">2038000</cik0002058261:LeaseReassessment>
    <cik0002058261:OtherInterestExpense
      contextRef="From2024-01-012024-12-31_custom_CurrentBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004765"
      unitRef="KRW">984296000</cik0002058261:OtherInterestExpense>
    <cik0002058261:OtherInterestExpense
      contextRef="From2024-01-012024-12-31_custom_CurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004769"
      unitRef="KRW">62090000</cik0002058261:OtherInterestExpense>
    <cik0002058261:OtherInterestExpense
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004773"
      unitRef="KRW">1046386000</cik0002058261:OtherInterestExpense>
    <ifrs-full:InterestPaidClassifiedAsFinancingActivities
      contextRef="From2024-01-012024-12-31_custom_CurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004779"
      unitRef="KRW">62090000</ifrs-full:InterestPaidClassifiedAsFinancingActivities>
    <ifrs-full:InterestPaidClassifiedAsFinancingActivities
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004783"
      unitRef="KRW">62090000</ifrs-full:InterestPaidClassifiedAsFinancingActivities>
    <cik0002058261:Reclassification
      contextRef="From2024-01-012024-12-31_custom_CurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004789"
      unitRef="KRW">118115000</cik0002058261:Reclassification>
    <cik0002058261:Reclassification
      contextRef="From2024-01-012024-12-31_custom_NonCurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004791"
      unitRef="KRW">-118115000</cik0002058261:Reclassification>
    <cik0002058261:TotalOtherChanges
      contextRef="From2024-01-012024-12-31_custom_CurrentBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004795"
      unitRef="KRW">-3057942000</cik0002058261:TotalOtherChanges>
    <cik0002058261:TotalOtherChanges
      contextRef="From2024-01-012024-12-31_custom_CurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004799"
      unitRef="KRW">118115000</cik0002058261:TotalOtherChanges>
    <cik0002058261:TotalOtherChanges
      contextRef="From2024-01-012024-12-31_custom_NonCurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004801"
      unitRef="KRW">-116077000</cik0002058261:TotalOtherChanges>
    <cik0002058261:TotalOtherChanges
      contextRef="From2024-01-012024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004803"
      unitRef="KRW">-3055904000</cik0002058261:TotalOtherChanges>
    <ifrs-full:Borrowings
      contextRef="AsOf2024-12-31_custom_CurrentBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004805"
      unitRef="KRW">3519139000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="AsOf2024-12-31_custom_CurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004809"
      unitRef="KRW">117351000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="AsOf2024-12-31_custom_NonCurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004811"
      unitRef="KRW">551681000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004813"
      unitRef="KRW">4188171000</ifrs-full:Borrowings>
    <cik0002058261:ProceedsFromIssuanceOfBondWithWarrants
      contextRef="From2025-01-012025-12-31_custom_CurrentBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004815"
      unitRef="KRW">9200000000</cik0002058261:ProceedsFromIssuanceOfBondWithWarrants>
    <cik0002058261:ProceedsFromIssuanceOfBondWithWarrants
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004823"
      unitRef="KRW">9200000000</cik0002058261:ProceedsFromIssuanceOfBondWithWarrants>
    <cik0002058261:RepaymentOfBondWithWarrants
      contextRef="From2025-01-012025-12-31_custom_CurrentBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004825"
      unitRef="KRW">8105000000</cik0002058261:RepaymentOfBondWithWarrants>
    <cik0002058261:RepaymentOfBondWithWarrants
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004833"
      unitRef="KRW">8105000000</cik0002058261:RepaymentOfBondWithWarrants>
    <cik0002058261:PaymentOfLeaseLiabilityPrincipal
      contextRef="From2025-01-012025-12-31_custom_CurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004839"
      unitRef="KRW">117348000</cik0002058261:PaymentOfLeaseLiabilityPrincipal>
    <cik0002058261:PaymentOfLeaseLiabilityPrincipal
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004843"
      unitRef="KRW">117348000</cik0002058261:PaymentOfLeaseLiabilityPrincipal>
    <ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities
      contextRef="From2025-01-012025-12-31_custom_CurrentBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004845"
      unitRef="KRW">1095000000</ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities>
    <ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities
      contextRef="From2025-01-012025-12-31_custom_CurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004849"
      unitRef="KRW">-117348000</ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities>
    <ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004853"
      unitRef="KRW">977652000</ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities>
    <cik0002058261:WarrantsSettledThroughDebtToEquitySwap
      contextRef="From2025-01-012025-12-31_custom_CurrentBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004855"
      unitRef="KRW">-1305000000</cik0002058261:WarrantsSettledThroughDebtToEquitySwap>
    <cik0002058261:WarrantsSettledThroughDebtToEquitySwap
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004863"
      unitRef="KRW">-1305000000</cik0002058261:WarrantsSettledThroughDebtToEquitySwap>
    <cik0002058261:OtherNoncashTransactions
      contextRef="From2025-01-012025-12-31_custom_CurrentBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004865"
      unitRef="KRW">-788594000</cik0002058261:OtherNoncashTransactions>
    <cik0002058261:OtherNoncashTransactions
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004873"
      unitRef="KRW">-788594000</cik0002058261:OtherNoncashTransactions>
    <cik0002058261:LeaseReassessment
      contextRef="From2025-01-012025-12-31_custom_NonCurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004881"
      unitRef="KRW">947000</cik0002058261:LeaseReassessment>
    <cik0002058261:LeaseReassessment
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004883"
      unitRef="KRW">947000</cik0002058261:LeaseReassessment>
    <cik0002058261:OtherInterestExpense
      contextRef="From2025-01-012025-12-31_custom_CurrentBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004885"
      unitRef="KRW">744767000</cik0002058261:OtherInterestExpense>
    <cik0002058261:OtherInterestExpense
      contextRef="From2025-01-012025-12-31_custom_CurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004889"
      unitRef="KRW">52261000</cik0002058261:OtherInterestExpense>
    <cik0002058261:OtherInterestExpense
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004893"
      unitRef="KRW">797028000</cik0002058261:OtherInterestExpense>
    <ifrs-full:InterestPaidClassifiedAsFinancingActivities
      contextRef="From2025-01-012025-12-31_custom_CurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004899"
      unitRef="KRW">52261000</ifrs-full:InterestPaidClassifiedAsFinancingActivities>
    <ifrs-full:InterestPaidClassifiedAsFinancingActivities
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004903"
      unitRef="KRW">52261000</ifrs-full:InterestPaidClassifiedAsFinancingActivities>
    <cik0002058261:Reclassification
      contextRef="From2025-01-012025-12-31_custom_CurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004909"
      unitRef="KRW">122623000</cik0002058261:Reclassification>
    <cik0002058261:Reclassification
      contextRef="From2025-01-012025-12-31_custom_NonCurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004911"
      unitRef="KRW">-122623000</cik0002058261:Reclassification>
    <cik0002058261:TotalOtherChanges
      contextRef="From2025-01-012025-12-31_custom_CurrentBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004915"
      unitRef="KRW">-1348827000</cik0002058261:TotalOtherChanges>
    <cik0002058261:TotalOtherChanges
      contextRef="From2025-01-012025-12-31_custom_CurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004919"
      unitRef="KRW">122623000</cik0002058261:TotalOtherChanges>
    <cik0002058261:TotalOtherChanges
      contextRef="From2025-01-012025-12-31_custom_NonCurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004921"
      unitRef="KRW">-121676000</cik0002058261:TotalOtherChanges>
    <cik0002058261:TotalOtherChanges
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004923"
      unitRef="KRW">-1347880000</cik0002058261:TotalOtherChanges>
    <ifrs-full:Borrowings
      contextRef="AsOf2025-12-31_custom_CurrentBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004925"
      unitRef="KRW">3265312000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="AsOf2025-12-31_custom_CurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004929"
      unitRef="KRW">122626000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="AsOf2025-12-31_custom_NonCurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004931"
      unitRef="KRW">430005000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004933"
      unitRef="KRW">3817943000</ifrs-full:Borrowings>
    <ifrs-full:DisclosureOfCommitmentsExplanatory
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact004942">&lt;p id="xdx_80A_eifrs-full--DisclosureOfCommitmentsExplanatory_zxmYylbu8Dh7" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;31. &lt;span id="xdx_829_zu4RQOy2Guaf"&gt;Commitments and contingencies&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.25in; text-align: left"&gt;&lt;b&gt;A.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;&lt;b&gt;Litigation&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company&#x2019;s pending lawsuit as a defendant as of December&#160;31, 2025 is as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_895_ecustom--ScheduleOfLitigationTableTextBlock_pn3n3_zyViBHAGfk0j" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Commitments and contingencies (Details)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; text-align: left"&gt;&lt;span id="xdx_8B4_z6lSY3z5rwK9" style="display: none"&gt;Schedule of litigation&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; text-align: center; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; text-align: center; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; text-align: center; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; text-align: center; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; vertical-align: bottom; text-align: left"&gt;&lt;b&gt;Court&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; text-align: center; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; vertical-align: bottom; text-align: center"&gt;&lt;b&gt;Plaintiff&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; text-align: center; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; vertical-align: bottom; text-align: center"&gt;&lt;b&gt;Description&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; text-align: center; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; vertical-align: bottom; text-align: center"&gt;&lt;b&gt;Claim amount&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; text-align: center; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; vertical-align: bottom; text-align: center"&gt;&lt;b&gt;Status&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="7" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top; width: 25%"&gt;Seoul Central District Court&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 15%; text-align: center; vertical-align: top"&gt;Individuals&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 15%; text-align: center; vertical-align: top"&gt;Damages&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 15%; text-align: center"&gt;&lt;span id="xdx_90E_ecustom--ClaimAmount_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--ShortTermFinancialInstrumentsMember_zrt4SnYxTxs" title="Claim amount"&gt;4,600,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: center; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 26%; text-align: left; vertical-align: top"&gt;The case has been pending since 2025.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AB_z7vRtuNuqKK5" style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The case, filed on July 11, 2025, relates to claims for damages and contractual penalties asserted against the Company and three current or former key management personnel, in connection with the plaintiffs&#x2019; acquisition of the Company&#x2019;s shares and bonds with warrants. The Company has assessed that an unfavorable outcome is not probable and, accordingly, no provision has been recognized; furthermore, due to inherent uncertainties in the litigation, the Company is unable to reliably estimate the amount of any potential loss at this time. Based on the information currently available, including advice from legal counsel, the Company has determined that an outflow of resources embodying economic benefits is not probable.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.25in; text-align: left"&gt;&lt;b&gt;B.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;&lt;b&gt;Significant Commitments&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Significant commitments the Company has entered into with financial institutions and others as of December&#160;31, 2025 and 2024 are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89C_ecustom--ScheduleOfSignificantCommitmentsTableTextBlock_pn3n3_zkxmSOCtz5Me" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Commitments and contingencies (Details 1)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;&lt;span id="xdx_8B3_zwFJZefJ136f" style="display: none"&gt;Schedule of significant commitments&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; text-align: left; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 0.5pt; vertical-align: top"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; text-align: center; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt; 2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left; vertical-align: bottom"&gt;&lt;b&gt;Financial institutions&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Categories&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Credit limit&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Borrowings&lt;br/&gt; amount&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; text-align: center"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top; width: 36%"&gt;KYOBO Securities Co., Ltd.&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 36%; text-align: left; vertical-align: top"&gt;Operation fund&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_907_ecustom--CreditLimit_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinancialInstitutionsMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--KYOBOSecuritiesCoLtdMember_z4SJEzMt1Q41" title="Credit limit"&gt;40,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_909_ecustom--BorrowingsAmount_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinancialInstitutionsMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--KYOBOSecuritiesCoLtdMember_zPjvI2v5VH39" title="Borrowings amount"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4952"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;Shinhan Card Co., Ltd.&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;Revolving credit (*)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--CreditLimit_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinancialInstitutionsMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ShinhanCardCoLtdMember_fKCop_z0sM8xAPcuGg" title="Credit limit"&gt;30,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--BorrowingsAmount_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinancialInstitutionsMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ShinhanCardCoLtdMember_fKCop_zKcVhhYDRe1a" title="Borrowings amount"&gt;21,069&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td colspan="3" style="font: 10pt Times New Roman; text-align: center; padding-bottom: 1.25pt"&gt;Total&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_905_ecustom--CreditLimit_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinancialInstitutionsMember_zdMuxagIJ7H3" title="Credit limit"&gt;70,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_905_ecustom--BorrowingsAmount_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinancialInstitutionsMember_zlg5LnO0U0ma" title="Borrowings amount"&gt;21,069&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;div style="width: 25%"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0in"&gt;&lt;/td&gt;
    &lt;td id="xdx_F0B_z09C09bSkIMk" style="width: 0.25in; text-align: left"&gt;(*)&lt;/td&gt;
    &lt;td id="xdx_F1F_znhX0yz8NqKk" style="text-align: justify"&gt;The Company provides current portion of long-term bank deposit as collateral for the borrowing.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; text-align: left; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 0.5pt; vertical-align: top"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; text-align: center; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt; 2024&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left; vertical-align: bottom"&gt;&lt;b&gt;Financial institutions&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Categories&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Credit limit&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Borrowings&lt;br/&gt; amount&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; text-align: center"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top; width: 36%"&gt;KYOBO Securities Co., Ltd.&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 36%; text-align: left; vertical-align: top"&gt;Operation fund&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--CreditLimit_iI_pn3n3_c20241231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinancialInstitutionsMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--KYOBOSecuritiesCoLtdMember_z4pl2tVix0md" title="Credit limit"&gt;40,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_901_ecustom--BorrowingsAmount_iI_pn3n3_c20241231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinancialInstitutionsMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--KYOBOSecuritiesCoLtdMember_z5fahrSNc1N" title="Borrowings amount"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4965"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;Shinhan Card Co., Ltd.&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;Revolving credit (*)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_905_ecustom--CreditLimit_iI_pn3n3_c20241231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinancialInstitutionsMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ShinhanCardCoLtdMember_fKCop_zhQD349DH7p" title="Credit limit"&gt;30,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_900_ecustom--BorrowingsAmount_iI_pn3n3_c20241231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinancialInstitutionsMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ShinhanCardCoLtdMember_fKCop_zQ5c9dAPCVo6" title="Borrowings amount"&gt;22,614&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td colspan="3" style="font: 10pt Times New Roman; text-align: center; padding-bottom: 1.25pt"&gt;Total&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_906_ecustom--CreditLimit_iI_pn3n3_c20241231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinancialInstitutionsMember_za2w75iXJ3Nc" title="Credit limit"&gt;70,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_908_ecustom--BorrowingsAmount_iI_pn3n3_c20241231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinancialInstitutionsMember_zUwWTIQqsrcg" title="Borrowings amount"&gt;22,614&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;div style="width: 25%"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0in"&gt;&lt;/td&gt;
    &lt;td id="xdx_F01_zQiaBkdCLG43" style="width: 0.25in; text-align: left"&gt;(*)&lt;/td&gt;
    &lt;td id="xdx_F17_ztLLx7lLQvDg" style="text-align: justify"&gt;The Company provides Long-term bank deposit as collateral for the borrowing.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A3_zn4rrGgsc0b2" style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

















&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman; width: 0.25in; text-align: left"&gt;&lt;b&gt;C.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: justify"&gt;&lt;b&gt;List of assets provided as collateral&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The list of assets that the Company provided as collateral as of December&#160;31, 2025 and 2024 are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_898_ecustom--ScheduleOfAssetsProvidedAsCollateralTableTextBlock_pn3n3_zWH84Zd1pAy5" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Commitments and contingencies (Details 2)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: bottom; font-weight: bold; text-align: left"&gt;&lt;span id="xdx_8B5_zj6yqCOXditb" style="display: none"&gt;Schedule of assets provided as collateral&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: left"&gt;Account&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Counterparty receiving the collateral&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;usage restrictions&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2025&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center"&gt;(In thousands of Korean won)&lt;/td&gt;
    &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; width: 25%; text-align: left"&gt;Current portion of long-term bank deposit&lt;/td&gt;
    &lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; width: 22%; text-align: left"&gt;Shinhan Card Co., Ltd&lt;/td&gt;
    &lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; width: 24%; text-align: left"&gt;Provided as collateral for revolving credit&lt;/td&gt;
    &lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_904_ecustom--ListOfAssetsProvidedAsCollateral_iI_pn3n3_c20251231_zMTgmZ8Wrna3" title="List of assets provided as collateral"&gt;30,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--ListOfAssetsProvidedAsCollateral_iI_pn3n3_c20241231_zSbWV1oJmXR2" title="List of assets provided as collateral"&gt;30,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A4_zUo3oJiIdN4e" style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

</ifrs-full:DisclosureOfCommitmentsExplanatory>
    <cik0002058261:ScheduleOfLitigationTableTextBlock
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact004944">&lt;table cellpadding="0" cellspacing="0" id="xdx_895_ecustom--ScheduleOfLitigationTableTextBlock_pn3n3_zyViBHAGfk0j" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Commitments and contingencies (Details)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; text-align: left"&gt;&lt;span id="xdx_8B4_z6lSY3z5rwK9" style="display: none"&gt;Schedule of litigation&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; text-align: center; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; text-align: center; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; text-align: center; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; text-align: center; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; vertical-align: bottom; text-align: left"&gt;&lt;b&gt;Court&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; text-align: center; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; vertical-align: bottom; text-align: center"&gt;&lt;b&gt;Plaintiff&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; text-align: center; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; vertical-align: bottom; text-align: center"&gt;&lt;b&gt;Description&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; text-align: center; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; vertical-align: bottom; text-align: center"&gt;&lt;b&gt;Claim amount&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: bottom; text-align: center; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; vertical-align: bottom; text-align: center"&gt;&lt;b&gt;Status&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="7" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top; width: 25%"&gt;Seoul Central District Court&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 15%; text-align: center; vertical-align: top"&gt;Individuals&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 15%; text-align: center; vertical-align: top"&gt;Damages&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: center; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 15%; text-align: center"&gt;&lt;span id="xdx_90E_ecustom--ClaimAmount_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--ShortTermFinancialInstrumentsMember_zrt4SnYxTxs" title="Claim amount"&gt;4,600,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: center; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 26%; text-align: left; vertical-align: top"&gt;The case has been pending since 2025.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:ScheduleOfLitigationTableTextBlock>
    <cik0002058261:ClaimAmount
      contextRef="AsOf2025-12-31_custom_ShortTermFinancialInstrumentsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004946"
      unitRef="KRW">4600000000</cik0002058261:ClaimAmount>
    <cik0002058261:ScheduleOfSignificantCommitmentsTableTextBlock
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact004948">&lt;table cellpadding="0" cellspacing="0" id="xdx_89C_ecustom--ScheduleOfSignificantCommitmentsTableTextBlock_pn3n3_zkxmSOCtz5Me" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Commitments and contingencies (Details 1)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;&lt;span id="xdx_8B3_zwFJZefJ136f" style="display: none"&gt;Schedule of significant commitments&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; text-align: left; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 0.5pt; vertical-align: top"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; text-align: center; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt; 2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left; vertical-align: bottom"&gt;&lt;b&gt;Financial institutions&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Categories&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Credit limit&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Borrowings&lt;br/&gt; amount&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; text-align: center"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top; width: 36%"&gt;KYOBO Securities Co., Ltd.&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 36%; text-align: left; vertical-align: top"&gt;Operation fund&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_907_ecustom--CreditLimit_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinancialInstitutionsMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--KYOBOSecuritiesCoLtdMember_z4SJEzMt1Q41" title="Credit limit"&gt;40,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_909_ecustom--BorrowingsAmount_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinancialInstitutionsMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--KYOBOSecuritiesCoLtdMember_zPjvI2v5VH39" title="Borrowings amount"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4952"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;Shinhan Card Co., Ltd.&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;Revolving credit (*)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--CreditLimit_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinancialInstitutionsMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ShinhanCardCoLtdMember_fKCop_z0sM8xAPcuGg" title="Credit limit"&gt;30,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--BorrowingsAmount_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinancialInstitutionsMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ShinhanCardCoLtdMember_fKCop_zKcVhhYDRe1a" title="Borrowings amount"&gt;21,069&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td colspan="3" style="font: 10pt Times New Roman; text-align: center; padding-bottom: 1.25pt"&gt;Total&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_905_ecustom--CreditLimit_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinancialInstitutionsMember_zdMuxagIJ7H3" title="Credit limit"&gt;70,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_905_ecustom--BorrowingsAmount_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinancialInstitutionsMember_zlg5LnO0U0ma" title="Borrowings amount"&gt;21,069&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;div style="width: 25%"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0in"&gt;&lt;/td&gt;
    &lt;td id="xdx_F0B_z09C09bSkIMk" style="width: 0.25in; text-align: left"&gt;(*)&lt;/td&gt;
    &lt;td id="xdx_F1F_znhX0yz8NqKk" style="text-align: justify"&gt;The Company provides current portion of long-term bank deposit as collateral for the borrowing.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; text-align: left; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 0.5pt; vertical-align: top"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; text-align: center; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt; 2024&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left; vertical-align: bottom"&gt;&lt;b&gt;Financial institutions&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Categories&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Credit limit&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;Borrowings&lt;br/&gt; amount&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman; text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman; text-align: center"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="font: 10pt Times New Roman; text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top; width: 36%"&gt;KYOBO Securities Co., Ltd.&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 36%; text-align: left; vertical-align: top"&gt;Operation fund&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--CreditLimit_iI_pn3n3_c20241231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinancialInstitutionsMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--KYOBOSecuritiesCoLtdMember_z4pl2tVix0md" title="Credit limit"&gt;40,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 9%; text-align: right"&gt;&lt;span id="xdx_901_ecustom--BorrowingsAmount_iI_pn3n3_c20241231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinancialInstitutionsMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--KYOBOSecuritiesCoLtdMember_z5fahrSNc1N" title="Borrowings amount"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4965"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;Shinhan Card Co., Ltd.&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;Revolving credit (*)&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_905_ecustom--CreditLimit_iI_pn3n3_c20241231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinancialInstitutionsMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ShinhanCardCoLtdMember_fKCop_zhQD349DH7p" title="Credit limit"&gt;30,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_900_ecustom--BorrowingsAmount_iI_pn3n3_c20241231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinancialInstitutionsMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ShinhanCardCoLtdMember_fKCop_zQ5c9dAPCVo6" title="Borrowings amount"&gt;22,614&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td colspan="3" style="font: 10pt Times New Roman; text-align: center; padding-bottom: 1.25pt"&gt;Total&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_906_ecustom--CreditLimit_iI_pn3n3_c20241231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinancialInstitutionsMember_za2w75iXJ3Nc" title="Credit limit"&gt;70,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman; text-align: right"&gt;&lt;span id="xdx_908_ecustom--BorrowingsAmount_iI_pn3n3_c20241231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinancialInstitutionsMember_zUwWTIQqsrcg" title="Borrowings amount"&gt;22,614&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;div style="width: 25%"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0in"&gt;&lt;/td&gt;
    &lt;td id="xdx_F01_zQiaBkdCLG43" style="width: 0.25in; text-align: left"&gt;(*)&lt;/td&gt;
    &lt;td id="xdx_F17_ztLLx7lLQvDg" style="text-align: justify"&gt;The Company provides Long-term bank deposit as collateral for the borrowing.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:ScheduleOfSignificantCommitmentsTableTextBlock>
    <cik0002058261:CreditLimit
      contextRef="AsOf2025-12-31_custom_FinancialInstitutionsMember_custom_KYOBOSecuritiesCoLtdMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004950"
      unitRef="KRW">40000000</cik0002058261:CreditLimit>
    <cik0002058261:CreditLimit
      contextRef="AsOf2025-12-31_custom_FinancialInstitutionsMember_custom_ShinhanCardCoLtdMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004954"
      unitRef="KRW">30000000</cik0002058261:CreditLimit>
    <cik0002058261:BorrowingsAmount
      contextRef="AsOf2025-12-31_custom_FinancialInstitutionsMember_custom_ShinhanCardCoLtdMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004956"
      unitRef="KRW">21069000</cik0002058261:BorrowingsAmount>
    <cik0002058261:CreditLimit
      contextRef="AsOf2025-12-31_custom_FinancialInstitutionsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004958"
      unitRef="KRW">70000000</cik0002058261:CreditLimit>
    <cik0002058261:BorrowingsAmount
      contextRef="AsOf2025-12-31_custom_FinancialInstitutionsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004960"
      unitRef="KRW">21069000</cik0002058261:BorrowingsAmount>
    <cik0002058261:CreditLimit
      contextRef="AsOf2024-12-31_custom_FinancialInstitutionsMember_custom_KYOBOSecuritiesCoLtdMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004963"
      unitRef="KRW">40000000</cik0002058261:CreditLimit>
    <cik0002058261:CreditLimit
      contextRef="AsOf2024-12-31_custom_FinancialInstitutionsMember_custom_ShinhanCardCoLtdMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004967"
      unitRef="KRW">30000000</cik0002058261:CreditLimit>
    <cik0002058261:BorrowingsAmount
      contextRef="AsOf2024-12-31_custom_FinancialInstitutionsMember_custom_ShinhanCardCoLtdMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004969"
      unitRef="KRW">22614000</cik0002058261:BorrowingsAmount>
    <cik0002058261:CreditLimit
      contextRef="AsOf2024-12-31_custom_FinancialInstitutionsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004971"
      unitRef="KRW">70000000</cik0002058261:CreditLimit>
    <cik0002058261:BorrowingsAmount
      contextRef="AsOf2024-12-31_custom_FinancialInstitutionsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004973"
      unitRef="KRW">22614000</cik0002058261:BorrowingsAmount>
    <cik0002058261:ScheduleOfAssetsProvidedAsCollateralTableTextBlock
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact004983">&lt;table cellpadding="0" cellspacing="0" id="xdx_898_ecustom--ScheduleOfAssetsProvidedAsCollateralTableTextBlock_pn3n3_zWH84Zd1pAy5" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Commitments and contingencies (Details 2)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: bottom; font-weight: bold; text-align: left"&gt;&lt;span id="xdx_8B5_zj6yqCOXditb" style="display: none"&gt;Schedule of assets provided as collateral&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: left"&gt;Account&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Counterparty receiving the collateral&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;usage restrictions&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2025&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center"&gt;(In thousands of Korean won)&lt;/td&gt;
    &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; width: 25%; text-align: left"&gt;Current portion of long-term bank deposit&lt;/td&gt;
    &lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; width: 22%; text-align: left"&gt;Shinhan Card Co., Ltd&lt;/td&gt;
    &lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; width: 24%; text-align: left"&gt;Provided as collateral for revolving credit&lt;/td&gt;
    &lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_904_ecustom--ListOfAssetsProvidedAsCollateral_iI_pn3n3_c20251231_zMTgmZ8Wrna3" title="List of assets provided as collateral"&gt;30,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--ListOfAssetsProvidedAsCollateral_iI_pn3n3_c20241231_zSbWV1oJmXR2" title="List of assets provided as collateral"&gt;30,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:ScheduleOfAssetsProvidedAsCollateralTableTextBlock>
    <cik0002058261:ListOfAssetsProvidedAsCollateral
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004985"
      unitRef="KRW">30000000</cik0002058261:ListOfAssetsProvidedAsCollateral>
    <cik0002058261:ListOfAssetsProvidedAsCollateral
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004987"
      unitRef="KRW">30000000</cik0002058261:ListOfAssetsProvidedAsCollateral>
    <cik0002058261:GoingConcernsTextBlock
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact004989">&lt;p id="xdx_807_ecustom--GoingConcernsTextBlock_zq8dwhiFgBnf" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;32. &lt;span id="xdx_829_zLSVvpOSL1je"&gt;Going concerns&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company has negative working capital of Korean Won &lt;span id="xdx_90F_ecustom--NegativeWorkingCapital_iI_pn3n3_c20251231_z6SfX1ZVPaDj" title="Negative working capital"&gt;7,229,518&lt;/span&gt; thousand as of December 31, 2025, and incurred significant losses and operating cash outflows during the year then ended. The net loss was Korean won &lt;span id="xdx_907_eifrs-full--ProfitLoss_iN_pn3n3_di_c20250101__20251231_zXugjr89Hj0f" title="Net loss"&gt;6,141,476&lt;/span&gt; thousand for the year ended December 31, 2025. For the year ended December 31, 2025, the Company had negative cash flows from operations of Korean won &lt;span id="xdx_904_eifrs-full--CashFlowsFromUsedInOperatingActivities_iN_pn3n3_di_c20250101__20251231_zcn3JrQb2qKj" title="Negative cash flows from operations"&gt;4,965,996&lt;/span&gt; thousand. As of December 31, 2025, the Company&#x2019;s accumulated deficit was Korean won &lt;span id="xdx_907_eifrs-full--RetainedEarnings_iNI_pn3n3_di_c20251231_zQdOB5ZeAXl" title="Accumulated deficit"&gt;75,558,054&lt;/span&gt; thousand. The Company has funded its operations to date through equity and debt financing and had cash and cash equivalents of Korean won &lt;span id="xdx_908_eifrs-full--CashAndCashEquivalents_iI_pn3n3_c20251231_zbdlPxBGaAV8" title="Cash and cash equivalents"&gt;335,814&lt;/span&gt; thousand as of December 31, 2025. The Company monitors its cash flow projections on a current basis and takes active measures to obtain the funding it requires to continue its operations. However, these cash flow projections are subject to various uncertainties concerning their fulfilment, such as the ability to generate revenues by attracting and expanding its customer base and completing additional financing. The Company expects to fund operations using cash on hand and raising additional proceeds from issuing bonds with warrants. There are no assurances, however, that the Company will be able to generate the revenue necessary to support its cost structure or that it will be successful in obtaining the level of financing necessary for its operations. These conditions raise substantial doubt about the Company&#x2019;s ability to continue as a going concern. These financial statements have been prepared assuming that the Company will continue as a going concern and do not include any adjustments that might result from the outcome of this uncertainty.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</cik0002058261:GoingConcernsTextBlock>
    <cik0002058261:NegativeWorkingCapital
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004991"
      unitRef="KRW">7229518000</cik0002058261:NegativeWorkingCapital>
    <ifrs-full:ProfitLoss
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004993"
      unitRef="KRW">-6141476000</ifrs-full:ProfitLoss>
    <ifrs-full:CashFlowsFromUsedInOperatingActivities
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004995"
      unitRef="KRW">-4965996000</ifrs-full:CashFlowsFromUsedInOperatingActivities>
    <ifrs-full:RetainedEarnings
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004997"
      unitRef="KRW">-75558054000</ifrs-full:RetainedEarnings>
    <ifrs-full:CashAndCashEquivalents
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact004999"
      unitRef="KRW">335814000</ifrs-full:CashAndCashEquivalents>
    <cik0002058261:DisclosureOfEventAfterReportingPeriodExplanatory
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      id="Fact005001">&lt;p id="xdx_807_ecustom--DisclosureOfEventAfterReportingPeriodExplanatory_zC7wTcecTNbg" style="font: 10pt Times New Roman; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;33. &lt;span id="xdx_82D_zQfg56AWTJ3a"&gt;Subsequent events&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to July&#160;10, 2026, the date when the financial statements were available to be issued. Based upon the review, other than as disclosed below or elsewhere, the Company did not identify any subsequent events that would have required adjustments or disclosure in the financial statements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Subsequent to December 31, 2025, in connection with treasury share disposal agreement entered into with a related party during the year ended December 31, 2025, the Company received proceeds of Korean won &lt;span id="xdx_907_eifrs-full--ProceedsFromSaleOrIssueOfTreasuryShares_pn3n3_c20260101__20260111_zJnF3jouPbui" title="Proceeds from treasury shares"&gt;1,000,000&lt;/span&gt; thousand on January 12, 2026 and proceeds of Korean won &lt;span id="xdx_901_eifrs-full--ProceedsFromSaleOrIssueOfTreasuryShares_pn3n3_c20260101__20260112_zM9letTlsCj8" title="Proceeds from treasury shares"&gt;600,000&lt;/span&gt; thousand on January 13, 2026, for aggregate proceeds of Korean won &lt;span id="xdx_90E_eifrs-full--ProceedsFromSaleOrIssueOfTreasuryShares_c20260101__20260113_pn3n" title="Proceeds from treasury shares"&gt;1,600,000&lt;/span&gt; received as of the date of issuance of these financial statements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On January 12, 2026, 20&lt;sup&gt;th&lt;/sup&gt; series of bonds with warrants in the amount of Korean won &lt;span id="xdx_900_ecustom--BondsWithWarrantsEarlyRedeemedUponExercise_pn3n3_c20260101__20260112__ifrs-full--BorrowingsByNameAxis__custom--N20thBondWithWarrantsMember_zHFTKShu8pT9" title="Bonds with warrants early redeemed upon exercise"&gt;600,000&lt;/span&gt; thousand was early redeemed upon the exercise of early redemption right by the holder of the 20&lt;sup&gt;th&lt;/sup&gt; series of bonds with warrants.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

















&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On January 30, 2026, Eun Jong Choi resigned as Chief Executive Officer, and Jae Myung Kim was appointed as the new Chief Executive Officer.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On February 24, 2026, the Company refunded Korean won &lt;span id="xdx_90E_ecustom--TreasuryShareRefunded_pn3n3_c20260201__20260224_zDQzjH8H7aad" title="Treasury share refunded"&gt;810,000&lt;/span&gt; thousand previously received in connection with a treasury share disposal transaction following the cancellation of the related agreement.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On March 27, 2026, Well Core Co., Ltd. loaned Korean Won &lt;span id="xdx_90A_eifrs-full--LoansAndAdvances_iI_pn3n3_c20260327__ifrs-full--CounterpartiesAxis__custom--WellCoreCoLtdMember_zajm8Yq1Qqu2" title="Loan"&gt;1,000,000&lt;/span&gt; thousand. The loan is for a term of 3 months and bears interest at the rate of &lt;span id="xdx_907_eifrs-full--BorrowingsInterestRate_iI_pid_c20260327__ifrs-full--CounterpartiesAxis__custom--WellCoreCoLtdMember_zMN76IZoa7Xc" title="Interest rate"&gt;4.6%&lt;/span&gt; per annum. The proceeds of the loan will be used to fund the operations of the Company. On June 26, 2026, the maturity date of the loan from Well Core was extended to July 31, 2026.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On March 31, 2026, the Company entered into a stock purchase agreement with Mountain Crest Global Holdings LLC to acquire &lt;span id="xdx_906_ecustom--NumberOfSharesAcquired_pid_c20260301__20260331__ifrs-full--CounterpartiesAxis__custom--WellCoreCoLtdMember_zZSdG3lEp9Oi" title="Number of shares acquired"&gt;125,000&lt;/span&gt; shares of common stock of Mountain Crest. Under the agreement, the Company agreed to purchase the shares for an aggregate consideration of $&lt;span id="xdx_90E_ecustom--AggregateConsideration_pn3n3_c20260301__20260331__ifrs-full--CounterpartiesAxis__custom--WellCoreCoLtdMember_zdKFYDgxufz4" title="Aggregate consideration"&gt;500,000&lt;/span&gt;, of which $100,000 was remitted to Mountain Crest Global Holdings LLC on May 29&lt;sup&gt;th&lt;/sup&gt;, 2026.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On April 10, 2026, the &lt;span id="xdx_90C_ecustom--BondIssuanceDescription_c20260401__20260410__ifrs-full--BorrowingsByNameAxis__custom--N22ndBondWithWarrantsMember_zXv2u86HUyf4"&gt;Company
entered into an agreement with a related party for the issuance of the 22&lt;sup&gt;nd&lt;/sup&gt; series of bonds with warrants for the amount of
Korean won 20,000,000 thousand to fund its operation. As of the date of issuance of these financial statements, the Company had received
aggregate proceeds of Korean won 1,280,000 thousand under the agreement.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On May 18, 2026, the Company entered into a loan agreement with Dongsung D&amp;amp;C and provided a loan of Korean won &lt;span id="xdx_90B_eifrs-full--LoansAndAdvances_iI_pn3n3_c20260518__ifrs-full--CounterpartiesAxis__custom--DongsungDAndCMember_zBDCqoRqISMe" title="Loan"&gt;100,000&lt;/span&gt; thousand. The loan is for a term of 1 year and bears interest at the rate of &lt;span id="xdx_90C_eifrs-full--BorrowingsInterestRate_iI_pid_c20260518__ifrs-full--CounterpartiesAxis__custom--DongsungDAndCMember_zdmTN7JABb95" title="Interest rate"&gt;4.6%&lt;/span&gt; per annum.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Subsequent to December 31, 2025, the Company suspended its collaboration with Effibar CDS Private Limited under the exclusive sales and marketing agreement executed in December 2024 and no longer expects to pursue product sales in India through such arrangement. The prepayments of Korean won &lt;span id="xdx_90F_eifrs-full--Prepayments_iI_pn3n3_c20260518__ifrs-full--CounterpartiesAxis__custom--EffibarCDSPrivateLimitedMember_zzvU7YdSblmf" title="Prepayments"&gt;83,673&lt;/span&gt; thousand related to Effibar primarily consisted of marketing and promotional expenses and did not represent investments in, or contributions to, the venture arrangement.&lt;/p&gt;

</cik0002058261:DisclosureOfEventAfterReportingPeriodExplanatory>
    <ifrs-full:ProceedsFromSaleOrIssueOfTreasuryShares
      contextRef="From2026-01-012026-01-11_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005003"
      unitRef="KRW">1000000000</ifrs-full:ProceedsFromSaleOrIssueOfTreasuryShares>
    <ifrs-full:ProceedsFromSaleOrIssueOfTreasuryShares
      contextRef="From2026-01-012026-01-12_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005005"
      unitRef="KRW">600000000</ifrs-full:ProceedsFromSaleOrIssueOfTreasuryShares>
    <ifrs-full:ProceedsFromSaleOrIssueOfTreasuryShares
      contextRef="From2026-01-012026-01-13_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005007"
      unitRef="KRW">1600000</ifrs-full:ProceedsFromSaleOrIssueOfTreasuryShares>
    <cik0002058261:BondsWithWarrantsEarlyRedeemedUponExercise
      contextRef="From2026-01-012026-01-12_custom_N20thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005009"
      unitRef="KRW">600000000</cik0002058261:BondsWithWarrantsEarlyRedeemedUponExercise>
    <cik0002058261:TreasuryShareRefunded
      contextRef="From2026-02-012026-02-24_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005018"
      unitRef="KRW">810000000</cik0002058261:TreasuryShareRefunded>
    <ifrs-full:LoansAndAdvances
      contextRef="AsOf2026-03-27_custom_WellCoreCoLtdMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005020"
      unitRef="KRW">1000000000</ifrs-full:LoansAndAdvances>
    <ifrs-full:BorrowingsInterestRate
      contextRef="AsOf2026-03-27_custom_WellCoreCoLtdMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact005022"
      unitRef="Pure">0.046</ifrs-full:BorrowingsInterestRate>
    <cik0002058261:NumberOfSharesAcquired
      contextRef="From2026-03-012026-03-31_custom_WellCoreCoLtdMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact005024"
      unitRef="Shares">125000</cik0002058261:NumberOfSharesAcquired>
    <cik0002058261:AggregateConsideration
      contextRef="From2026-03-012026-03-31_custom_WellCoreCoLtdMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005026"
      unitRef="KRW">500000000</cik0002058261:AggregateConsideration>
    <cik0002058261:BondIssuanceDescription
      contextRef="From2026-04-012026-04-10_custom_N22ndBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="Fact005027">Company
entered into an agreement with a related party for the issuance of the 22nd series of bonds with warrants for the amount of
Korean won 20,000,000 thousand to fund its operation. As of the date of issuance of these financial statements, the Company had received
aggregate proceeds of Korean won 1,280,000 thousand under the agreement.</cik0002058261:BondIssuanceDescription>
    <ifrs-full:LoansAndAdvances
      contextRef="AsOf2026-05-18_custom_DongsungDAndCMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005029"
      unitRef="KRW">100000000</ifrs-full:LoansAndAdvances>
    <ifrs-full:BorrowingsInterestRate
      contextRef="AsOf2026-05-18_custom_DongsungDAndCMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact005031"
      unitRef="Pure">0.046</ifrs-full:BorrowingsInterestRate>
    <ifrs-full:Prepayments
      contextRef="AsOf2026-05-18_custom_EffibarCDSPrivateLimitedMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005033"
      unitRef="KRW">83673000</ifrs-full:Prepayments>
    <ifrs-full:CashAndCashEquivalents
      contextRef="AsOf2026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005038"
      unitRef="KRW">312427000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005039"
      unitRef="KRW">335814000</ifrs-full:CashAndCashEquivalents>
    <cik0002058261:CurrentPortionOfLongtermBankDeposit
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005042"
      unitRef="KRW">30000000</cik0002058261:CurrentPortionOfLongtermBankDeposit>
    <cik0002058261:ShorttermFinancialInstruments
      contextRef="AsOf2026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005044"
      unitRef="KRW">561944000</cik0002058261:ShorttermFinancialInstruments>
    <cik0002058261:ShorttermFinancialInstruments
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005045"
      unitRef="KRW">442894000</cik0002058261:ShorttermFinancialInstruments>
    <ifrs-full:OtherReceivables
      contextRef="AsOf2026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005047"
      unitRef="KRW">27250000</ifrs-full:OtherReceivables>
    <ifrs-full:OtherReceivables
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005048"
      unitRef="KRW">33411000</ifrs-full:OtherReceivables>
    <ifrs-full:OtherCurrentAssets
      contextRef="AsOf2026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005050"
      unitRef="KRW">127528000</ifrs-full:OtherCurrentAssets>
    <ifrs-full:OtherCurrentAssets
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005051"
      unitRef="KRW">137151000</ifrs-full:OtherCurrentAssets>
    <ifrs-full:CurrentAssets
      contextRef="AsOf2026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005053"
      unitRef="KRW">1029149000</ifrs-full:CurrentAssets>
    <ifrs-full:CurrentAssets
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005054"
      unitRef="KRW">979270000</ifrs-full:CurrentAssets>
    <cik0002058261:LongtermBankDeposit
      contextRef="AsOf2026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005056"
      unitRef="KRW">30000000</cik0002058261:LongtermBankDeposit>
    <cik0002058261:LongtermLoanReceivablesNet
      contextRef="AsOf2026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005059"
      unitRef="KRW">1958880000</cik0002058261:LongtermLoanReceivablesNet>
    <cik0002058261:LongtermLoanReceivablesNet
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005060"
      unitRef="KRW">1671780000</cik0002058261:LongtermLoanReceivablesNet>
    <ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets
      contextRef="AsOf2026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005062"
      unitRef="KRW">303611000</ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005063"
      unitRef="KRW">344055000</ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="AsOf2026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005065"
      unitRef="KRW">434170000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005066"
      unitRef="KRW">512493000</ifrs-full:RightofuseAssets>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="AsOf2026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005068"
      unitRef="KRW">4075000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005069"
      unitRef="KRW">5242000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:OtherNoncurrentFinancialAssets
      contextRef="AsOf2026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005071"
      unitRef="KRW">519945000</ifrs-full:OtherNoncurrentFinancialAssets>
    <ifrs-full:OtherNoncurrentFinancialAssets
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005072"
      unitRef="KRW">525042000</ifrs-full:OtherNoncurrentFinancialAssets>
    <cik0002058261:LongtermOtherReceivablesNet
      contextRef="AsOf2026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005074"
      unitRef="KRW">398000</cik0002058261:LongtermOtherReceivablesNet>
    <cik0002058261:DeferredTransactionCostsSponsorSharePurchase
      contextRef="AsOf2026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005077"
      unitRef="KRW">2545885000</cik0002058261:DeferredTransactionCostsSponsorSharePurchase>
    <cik0002058261:DeferredTransactionCostsSponsorSharePurchase
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005078"
      unitRef="KRW">2393915000</cik0002058261:DeferredTransactionCostsSponsorSharePurchase>
    <ifrs-full:OtherNoncurrentAssets
      contextRef="AsOf2026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005080"
      unitRef="KRW">17325000</ifrs-full:OtherNoncurrentAssets>
    <ifrs-full:OtherNoncurrentAssets
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005081"
      unitRef="KRW">38114000</ifrs-full:OtherNoncurrentAssets>
    <ifrs-full:NoncurrentAssets
      contextRef="AsOf2026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005083"
      unitRef="KRW">5814289000</ifrs-full:NoncurrentAssets>
    <ifrs-full:NoncurrentAssets
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005084"
      unitRef="KRW">5490641000</ifrs-full:NoncurrentAssets>
    <ifrs-full:Assets
      contextRef="AsOf2026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005086"
      unitRef="KRW">6843438000</ifrs-full:Assets>
    <ifrs-full:Assets
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005087"
      unitRef="KRW">6469911000</ifrs-full:Assets>
    <cik0002058261:AccountsPayableOtherRelatedPartiesNet
      contextRef="AsOf2026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005092"
      unitRef="KRW">3269591000</cik0002058261:AccountsPayableOtherRelatedPartiesNet>
    <cik0002058261:AccountsPayableOtherRelatedPartiesNet
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005093"
      unitRef="KRW">324855000</cik0002058261:AccountsPayableOtherRelatedPartiesNet>
    <cik0002058261:AccountsPayableOtherNonrelatedPartiesNet
      contextRef="AsOf2026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005095"
      unitRef="KRW">2866494000</cik0002058261:AccountsPayableOtherNonrelatedPartiesNet>
    <cik0002058261:AccountsPayableOtherNonrelatedPartiesNet
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005096"
      unitRef="KRW">3228194000</cik0002058261:AccountsPayableOtherNonrelatedPartiesNet>
    <cik0002058261:BondWithWarrantsRelatedPartiesNet
      contextRef="AsOf2026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005098"
      unitRef="KRW">1000000000</cik0002058261:BondWithWarrantsRelatedPartiesNet>
    <cik0002058261:BondWithWarrantsNonrelatedPartiesNet
      contextRef="AsOf2026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005101"
      unitRef="KRW">3209760000</cik0002058261:BondWithWarrantsNonrelatedPartiesNet>
    <cik0002058261:BondWithWarrantsNonrelatedPartiesNet
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005102"
      unitRef="KRW">3265312000</cik0002058261:BondWithWarrantsNonrelatedPartiesNet>
    <ifrs-full:DerivativeFinancialLiabilities
      contextRef="AsOf2026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005104"
      unitRef="KRW">979969000</ifrs-full:DerivativeFinancialLiabilities>
    <ifrs-full:DerivativeFinancialLiabilities
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005105"
      unitRef="KRW">1267801000</ifrs-full:DerivativeFinancialLiabilities>
    <ifrs-full:CurrentLeaseLiabilities
      contextRef="AsOf2026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005107"
      unitRef="KRW">108706000</ifrs-full:CurrentLeaseLiabilities>
    <ifrs-full:CurrentLeaseLiabilities
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005108"
      unitRef="KRW">122626000</ifrs-full:CurrentLeaseLiabilities>
    <ifrs-full:CurrentLiabilities
      contextRef="AsOf2026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005110"
      unitRef="KRW">11434520000</ifrs-full:CurrentLiabilities>
    <ifrs-full:CurrentLiabilities
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005111"
      unitRef="KRW">8208788000</ifrs-full:CurrentLiabilities>
    <ifrs-full:CurrentRecognisedLiabilitiesDefinedBenefitPlan
      contextRef="AsOf2026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005113"
      unitRef="KRW">903565000</ifrs-full:CurrentRecognisedLiabilitiesDefinedBenefitPlan>
    <ifrs-full:CurrentRecognisedLiabilitiesDefinedBenefitPlan
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005114"
      unitRef="KRW">980841000</ifrs-full:CurrentRecognisedLiabilitiesDefinedBenefitPlan>
    <cik0002058261:OtherNoncurrentProvisions
      contextRef="AsOf2026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005116"
      unitRef="KRW">48817000</cik0002058261:OtherNoncurrentProvisions>
    <cik0002058261:OtherNoncurrentProvisions
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005117"
      unitRef="KRW">48658000</cik0002058261:OtherNoncurrentProvisions>
    <cik0002058261:NoncurrentLeasesLiabilities
      contextRef="AsOf2026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005119"
      unitRef="KRW">371079000</cik0002058261:NoncurrentLeasesLiabilities>
    <cik0002058261:NoncurrentLeasesLiabilities
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005120"
      unitRef="KRW">430005000</cik0002058261:NoncurrentLeasesLiabilities>
    <ifrs-full:NoncurrentLiabilities
      contextRef="AsOf2026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005122"
      unitRef="KRW">1323461000</ifrs-full:NoncurrentLiabilities>
    <ifrs-full:NoncurrentLiabilities
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005123"
      unitRef="KRW">1459504000</ifrs-full:NoncurrentLiabilities>
    <ifrs-full:Liabilities
      contextRef="AsOf2026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005125"
      unitRef="KRW">12757981000</ifrs-full:Liabilities>
    <ifrs-full:Liabilities
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005126"
      unitRef="KRW">9668292000</ifrs-full:Liabilities>
    <cik0002058261:ShareCapital
      contextRef="AsOf2026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005131"
      unitRef="KRW">26407738000</cik0002058261:ShareCapital>
    <cik0002058261:ShareCapital
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005132"
      unitRef="KRW">26407738000</cik0002058261:ShareCapital>
    <ifrs-full:SharePremium
      contextRef="AsOf2026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005134"
      unitRef="KRW">46679809000</ifrs-full:SharePremium>
    <ifrs-full:SharePremium
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005135"
      unitRef="KRW">46566573000</ifrs-full:SharePremium>
    <cik0002058261:ShareSubscriptionReceivable
      contextRef="AsOf2026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005137"
      unitRef="KRW">-50000000</cik0002058261:ShareSubscriptionReceivable>
    <cik0002058261:ShareSubscriptionReceivable
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005138"
      unitRef="KRW">-50000000</cik0002058261:ShareSubscriptionReceivable>
    <ifrs-full:OtherReserves
      contextRef="AsOf2026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005140"
      unitRef="KRW">-675527000</ifrs-full:OtherReserves>
    <ifrs-full:OtherReserves
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005141"
      unitRef="KRW">-690292000</ifrs-full:OtherReserves>
    <ifrs-full:AccumulatedOtherComprehensiveIncome
      contextRef="AsOf2026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005143"
      unitRef="KRW">279386000</ifrs-full:AccumulatedOtherComprehensiveIncome>
    <ifrs-full:AccumulatedOtherComprehensiveIncome
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005144"
      unitRef="KRW">125654000</ifrs-full:AccumulatedOtherComprehensiveIncome>
    <ifrs-full:RetainedEarnings
      contextRef="AsOf2026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005146"
      unitRef="KRW">-78555949000</ifrs-full:RetainedEarnings>
    <ifrs-full:RetainedEarnings
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005147"
      unitRef="KRW">-75558054000</ifrs-full:RetainedEarnings>
    <ifrs-full:Equity
      contextRef="AsOf2026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005149"
      unitRef="KRW">-5914543000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005150"
      unitRef="KRW">-3198381000</ifrs-full:Equity>
    <ifrs-full:EquityAndLiabilities
      contextRef="AsOf2026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005152"
      unitRef="KRW">6843438000</ifrs-full:EquityAndLiabilities>
    <ifrs-full:EquityAndLiabilities
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005153"
      unitRef="KRW">6469911000</ifrs-full:EquityAndLiabilities>
    <ifrs-full:SellingGeneralAndAdministrativeExpense
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005170"
      unitRef="KRW">-2965749000</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <ifrs-full:SellingGeneralAndAdministrativeExpense
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005171"
      unitRef="KRW">-3350674000</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <ifrs-full:OtherIncome
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005173"
      unitRef="KRW">290384000</ifrs-full:OtherIncome>
    <ifrs-full:OtherIncome
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005174"
      unitRef="KRW">685000</ifrs-full:OtherIncome>
    <ifrs-full:OtherExpenseByFunction
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005176"
      unitRef="KRW">83262000</ifrs-full:OtherExpenseByFunction>
    <ifrs-full:OtherExpenseByFunction
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005177"
      unitRef="KRW">93828000</ifrs-full:OtherExpenseByFunction>
    <ifrs-full:ProfitLossFromContinuingOperations
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005179"
      unitRef="KRW">-2758627000</ifrs-full:ProfitLossFromContinuingOperations>
    <ifrs-full:ProfitLossFromContinuingOperations
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005180"
      unitRef="KRW">-3443817000</ifrs-full:ProfitLossFromContinuingOperations>
    <ifrs-full:FinanceIncome
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005182"
      unitRef="KRW">235798000</ifrs-full:FinanceIncome>
    <ifrs-full:FinanceIncome
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005183"
      unitRef="KRW">450881000</ifrs-full:FinanceIncome>
    <cik0002058261:FinanceIncomeRelatedParties
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005185"
      unitRef="KRW">9961000</cik0002058261:FinanceIncomeRelatedParties>
    <cik0002058261:FinanceIncomeRelatedParties
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005186"
      unitRef="KRW">4122000</cik0002058261:FinanceIncomeRelatedParties>
    <cik0002058261:FinanceIncomeNonrelatedParties
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005188"
      unitRef="KRW">225837000</cik0002058261:FinanceIncomeNonrelatedParties>
    <cik0002058261:FinanceIncomeNonrelatedParties
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005189"
      unitRef="KRW">446759000</cik0002058261:FinanceIncomeNonrelatedParties>
    <ifrs-full:FinanceCosts
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005191"
      unitRef="KRW">475066000</ifrs-full:FinanceCosts>
    <ifrs-full:FinanceCosts
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005192"
      unitRef="KRW">407245000</ifrs-full:FinanceCosts>
    <cik0002058261:FinanceCostsRelatedParties
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005194"
      unitRef="KRW">-11973000</cik0002058261:FinanceCostsRelatedParties>
    <cik0002058261:FinanceCostsRelatedParties
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005195"
      unitRef="KRW">-4509000</cik0002058261:FinanceCostsRelatedParties>
    <cik0002058261:FinanceCostsNonrelatedParties
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005197"
      unitRef="KRW">-463093000</cik0002058261:FinanceCostsNonrelatedParties>
    <cik0002058261:FinanceCostsNonrelatedParties
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005198"
      unitRef="KRW">-402736000</cik0002058261:FinanceCostsNonrelatedParties>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005200"
      unitRef="KRW">-2997895000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005201"
      unitRef="KRW">-3400181000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:ProfitLoss
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005206"
      unitRef="KRW">-2997895000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005207"
      unitRef="KRW">-3400181000</ifrs-full:ProfitLoss>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005212"
      unitRef="KRW">-2844163000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005213"
      unitRef="KRW">-3374120000</ifrs-full:OtherComprehensiveIncome>
    <cik0002058261:EarningsPerShareInKoreanWonAbstract
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      id="Fact005215">(61</cik0002058261:EarningsPerShareInKoreanWonAbstract>
    <cik0002058261:EarningsPerShareInKoreanWonAbstract
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      id="Fact005216">(70</cik0002058261:EarningsPerShareInKoreanWonAbstract>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact005218"
      unitRef="KRWShares">-61</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact005219"
      unitRef="KRWShares">-70</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact005221"
      unitRef="KRWShares">-61</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact005222"
      unitRef="KRWShares">-70</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:EquityAttributableToOwnersOfParent
      contextRef="AsOf2024-12-31_custom_ShareCapitalMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005224"
      unitRef="KRW">26147238000</ifrs-full:EquityAttributableToOwnersOfParent>
    <ifrs-full:EquityAttributableToOwnersOfParent
      contextRef="AsOf2024-12-31_ifrs-full_SharePremiumMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005225"
      unitRef="KRW">44749618000</ifrs-full:EquityAttributableToOwnersOfParent>
    <ifrs-full:EquityAttributableToOwnersOfParent
      contextRef="AsOf2024-12-31_ifrs-full_OtherReservesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005227"
      unitRef="KRW">-727203000</ifrs-full:EquityAttributableToOwnersOfParent>
    <ifrs-full:EquityAttributableToOwnersOfParent
      contextRef="AsOf2024-12-31_ifrs-full_AccumulatedOtherComprehensiveIncomeMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005228"
      unitRef="KRW">73533000</ifrs-full:EquityAttributableToOwnersOfParent>
    <ifrs-full:EquityAttributableToOwnersOfParent
      contextRef="AsOf2024-12-31_ifrs-full_RetainedEarningsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005229"
      unitRef="KRW">-69416578000</ifrs-full:EquityAttributableToOwnersOfParent>
    <ifrs-full:EquityAttributableToOwnersOfParent
      contextRef="AsOf2024-12-31_custom_TotalMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005230"
      unitRef="KRW">826608000</ifrs-full:EquityAttributableToOwnersOfParent>
    <cik0002058261:ProfitLossFromContinuingOperation
      contextRef="From2025-01-012025-06-30_ifrs-full_RetainedEarningsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005245"
      unitRef="KRW">-3400181000</cik0002058261:ProfitLossFromContinuingOperation>
    <cik0002058261:ProfitLossFromContinuingOperation
      contextRef="From2025-01-012025-06-30_custom_TotalMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005246"
      unitRef="KRW">-3400181000</cik0002058261:ProfitLossFromContinuingOperation>
    <cik0002058261:RemeasurementOfDefinedBenefitLiabilitie
      contextRef="From2025-01-012025-06-30_ifrs-full_AccumulatedOtherComprehensiveIncomeMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005252"
      unitRef="KRW">26061000</cik0002058261:RemeasurementOfDefinedBenefitLiabilitie>
    <cik0002058261:RemeasurementOfDefinedBenefitLiabilitie
      contextRef="From2025-01-012025-06-30_custom_TotalMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005254"
      unitRef="KRW">26061000</cik0002058261:RemeasurementOfDefinedBenefitLiabilitie>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2025-01-012025-06-30_ifrs-full_AccumulatedOtherComprehensiveIncomeMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005260"
      unitRef="KRW">26061000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2025-01-012025-06-30_ifrs-full_RetainedEarningsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005261"
      unitRef="KRW">-3400181000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2025-01-012025-06-30_custom_TotalMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005262"
      unitRef="KRW">-3374120000</ifrs-full:ComprehensiveIncome>
    <cik0002058261:IssuanceOfBondWithWarrants
      contextRef="From2025-01-012025-06-30_ifrs-full_SharePremiumMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005273"
      unitRef="KRW">61326000</cik0002058261:IssuanceOfBondWithWarrants>
    <cik0002058261:IssuanceOfBondWithWarrants
      contextRef="From2025-01-012025-06-30_custom_TotalMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005278"
      unitRef="KRW">61326000</cik0002058261:IssuanceOfBondWithWarrants>
    <cik0002058261:DisposalOfTreasuryShares
      contextRef="From2025-01-012025-06-30_ifrs-full_SharePremiumMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005281"
      unitRef="KRW">163089000</cik0002058261:DisposalOfTreasuryShares>
    <cik0002058261:DisposalOfTreasuryShares
      contextRef="From2025-01-012025-06-30_custom_ShareSubscriptionReceivableMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005282"
      unitRef="KRW">-100000000</cik0002058261:DisposalOfTreasuryShares>
    <cik0002058261:DisposalOfTreasuryShares
      contextRef="From2025-01-012025-06-30_ifrs-full_OtherReservesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005283"
      unitRef="KRW">36911000</cik0002058261:DisposalOfTreasuryShares>
    <cik0002058261:DisposalOfTreasuryShares
      contextRef="From2025-01-012025-06-30_custom_TotalMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005286"
      unitRef="KRW">100000000</cik0002058261:DisposalOfTreasuryShares>
    <ifrs-full:EquityAttributableToOwnersOfParent
      contextRef="AsOf2025-06-30_custom_ShareCapitalMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005288"
      unitRef="KRW">26147238000</ifrs-full:EquityAttributableToOwnersOfParent>
    <ifrs-full:EquityAttributableToOwnersOfParent
      contextRef="AsOf2025-06-30_ifrs-full_SharePremiumMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005289"
      unitRef="KRW">44974033000</ifrs-full:EquityAttributableToOwnersOfParent>
    <ifrs-full:EquityAttributableToOwnersOfParent
      contextRef="AsOf2025-06-30_custom_ShareSubscriptionReceivableMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005290"
      unitRef="KRW">-100000000</ifrs-full:EquityAttributableToOwnersOfParent>
    <ifrs-full:EquityAttributableToOwnersOfParent
      contextRef="AsOf2025-06-30_ifrs-full_OtherReservesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005291"
      unitRef="KRW">-690292000</ifrs-full:EquityAttributableToOwnersOfParent>
    <ifrs-full:EquityAttributableToOwnersOfParent
      contextRef="AsOf2025-06-30_ifrs-full_AccumulatedOtherComprehensiveIncomeMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005292"
      unitRef="KRW">99594000</ifrs-full:EquityAttributableToOwnersOfParent>
    <ifrs-full:EquityAttributableToOwnersOfParent
      contextRef="AsOf2025-06-30_ifrs-full_RetainedEarningsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005293"
      unitRef="KRW">-72816759000</ifrs-full:EquityAttributableToOwnersOfParent>
    <ifrs-full:EquityAttributableToOwnersOfParent
      contextRef="AsOf2025-06-30_custom_TotalMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005294"
      unitRef="KRW">-2386186000</ifrs-full:EquityAttributableToOwnersOfParent>
    <ifrs-full:EquityAttributableToOwnersOfParent
      contextRef="AsOf2025-12-31_custom_ShareCapitalMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005296"
      unitRef="KRW">26407738000</ifrs-full:EquityAttributableToOwnersOfParent>
    <ifrs-full:EquityAttributableToOwnersOfParent
      contextRef="AsOf2025-12-31_ifrs-full_SharePremiumMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005297"
      unitRef="KRW">46566573000</ifrs-full:EquityAttributableToOwnersOfParent>
    <ifrs-full:EquityAttributableToOwnersOfParent
      contextRef="AsOf2025-12-31_custom_ShareSubscriptionReceivableMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005298"
      unitRef="KRW">-50000000</ifrs-full:EquityAttributableToOwnersOfParent>
    <ifrs-full:EquityAttributableToOwnersOfParent
      contextRef="AsOf2025-12-31_ifrs-full_OtherReservesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005299"
      unitRef="KRW">-690292000</ifrs-full:EquityAttributableToOwnersOfParent>
    <ifrs-full:EquityAttributableToOwnersOfParent
      contextRef="AsOf2025-12-31_ifrs-full_AccumulatedOtherComprehensiveIncomeMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005300"
      unitRef="KRW">125654000</ifrs-full:EquityAttributableToOwnersOfParent>
    <ifrs-full:EquityAttributableToOwnersOfParent
      contextRef="AsOf2025-12-31_ifrs-full_RetainedEarningsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005301"
      unitRef="KRW">-75558054000</ifrs-full:EquityAttributableToOwnersOfParent>
    <ifrs-full:EquityAttributableToOwnersOfParent
      contextRef="AsOf2025-12-31_custom_TotalMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005302"
      unitRef="KRW">-3198381000</ifrs-full:EquityAttributableToOwnersOfParent>
    <cik0002058261:ProfitLossFromContinuingOperation
      contextRef="From2026-01-012026-06-30_ifrs-full_RetainedEarningsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005317"
      unitRef="KRW">-2997895000</cik0002058261:ProfitLossFromContinuingOperation>
    <cik0002058261:ProfitLossFromContinuingOperation
      contextRef="From2026-01-012026-06-30_custom_TotalMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005318"
      unitRef="KRW">-2997895000</cik0002058261:ProfitLossFromContinuingOperation>
    <cik0002058261:RemeasurementOfDefinedBenefitLiabilitie
      contextRef="From2026-01-012026-06-30_ifrs-full_AccumulatedOtherComprehensiveIncomeMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005324"
      unitRef="KRW">153732000</cik0002058261:RemeasurementOfDefinedBenefitLiabilitie>
    <cik0002058261:RemeasurementOfDefinedBenefitLiabilitie
      contextRef="From2026-01-012026-06-30_custom_TotalMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005326"
      unitRef="KRW">153732000</cik0002058261:RemeasurementOfDefinedBenefitLiabilitie>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2026-01-012026-06-30_ifrs-full_AccumulatedOtherComprehensiveIncomeMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005332"
      unitRef="KRW">153732000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2026-01-012026-06-30_ifrs-full_RetainedEarningsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005333"
      unitRef="KRW">-2997895000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2026-01-012026-06-30_custom_TotalMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005334"
      unitRef="KRW">-2844163000</ifrs-full:ComprehensiveIncome>
    <cik0002058261:DisposalOfTreasuryShares
      contextRef="From2026-01-012026-06-30_ifrs-full_SharePremiumMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005345"
      unitRef="KRW">113236000</cik0002058261:DisposalOfTreasuryShares>
    <cik0002058261:DisposalOfTreasuryShares
      contextRef="From2026-01-012026-06-30_ifrs-full_OtherReservesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005347"
      unitRef="KRW">14765000</cik0002058261:DisposalOfTreasuryShares>
    <cik0002058261:DisposalOfTreasuryShares
      contextRef="From2026-01-012026-06-30_custom_TotalMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005350"
      unitRef="KRW">128001000</cik0002058261:DisposalOfTreasuryShares>
    <ifrs-full:EquityAttributableToOwnersOfParent
      contextRef="AsOf2026-06-30_custom_ShareCapitalMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005352"
      unitRef="KRW">26407738000</ifrs-full:EquityAttributableToOwnersOfParent>
    <ifrs-full:EquityAttributableToOwnersOfParent
      contextRef="AsOf2026-06-30_ifrs-full_SharePremiumMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005353"
      unitRef="KRW">46679809000</ifrs-full:EquityAttributableToOwnersOfParent>
    <ifrs-full:EquityAttributableToOwnersOfParent
      contextRef="AsOf2026-06-30_custom_ShareSubscriptionReceivableMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005354"
      unitRef="KRW">-50000000</ifrs-full:EquityAttributableToOwnersOfParent>
    <ifrs-full:EquityAttributableToOwnersOfParent
      contextRef="AsOf2026-06-30_ifrs-full_OtherReservesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005355"
      unitRef="KRW">-675527000</ifrs-full:EquityAttributableToOwnersOfParent>
    <ifrs-full:EquityAttributableToOwnersOfParent
      contextRef="AsOf2026-06-30_ifrs-full_AccumulatedOtherComprehensiveIncomeMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005356"
      unitRef="KRW">279386000</ifrs-full:EquityAttributableToOwnersOfParent>
    <ifrs-full:EquityAttributableToOwnersOfParent
      contextRef="AsOf2026-06-30_ifrs-full_RetainedEarningsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005357"
      unitRef="KRW">-78555949000</ifrs-full:EquityAttributableToOwnersOfParent>
    <ifrs-full:EquityAttributableToOwnersOfParent
      contextRef="AsOf2026-06-30_custom_TotalMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005358"
      unitRef="KRW">-5914543000</ifrs-full:EquityAttributableToOwnersOfParent>
    <ifrs-full:ProfitLoss
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005363"
      unitRef="KRW">-2997895000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005364"
      unitRef="KRW">-3400181000</ifrs-full:ProfitLoss>
    <ifrs-full:InterestReceivedClassifiedAsOperatingActivities
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005369"
      unitRef="KRW">29499000</ifrs-full:InterestReceivedClassifiedAsOperatingActivities>
    <ifrs-full:InterestReceivedClassifiedAsOperatingActivities
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005370"
      unitRef="KRW">49281000</ifrs-full:InterestReceivedClassifiedAsOperatingActivities>
    <ifrs-full:InterestPaidClassifiedAsOperatingActivities
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005372"
      unitRef="KRW">21678000</ifrs-full:InterestPaidClassifiedAsOperatingActivities>
    <ifrs-full:InterestPaidClassifiedAsOperatingActivities
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005373"
      unitRef="KRW">27316000</ifrs-full:InterestPaidClassifiedAsOperatingActivities>
    <ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005375"
      unitRef="KRW">-9688000</ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities>
    <ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005376"
      unitRef="KRW">-5874000</ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities>
    <ifrs-full:CashFlowsFromUsedInOperatingActivities
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005378"
      unitRef="KRW">-2345678000</ifrs-full:CashFlowsFromUsedInOperatingActivities>
    <ifrs-full:CashFlowsFromUsedInOperatingActivities
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005379"
      unitRef="KRW">-2934045000</ifrs-full:CashFlowsFromUsedInOperatingActivities>
    <cik0002058261:LoansAdvanceToRelatedParty
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005384"
      unitRef="KRW">105290000</cik0002058261:LoansAdvanceToRelatedParty>
    <cik0002058261:LoanRepaymentsReceived
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005387"
      unitRef="KRW">35722000</cik0002058261:LoanRepaymentsReceived>
    <cik0002058261:ProceedFromDisposalOfPropertyPlantAndEquipment
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005390"
      unitRef="KRW">1500000</cik0002058261:ProceedFromDisposalOfPropertyPlantAndEquipment>
    <ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005394"
      unitRef="KRW">7960000</ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
    <ifrs-full:CashFlowsFromUsedInInvestingActivities
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005396"
      unitRef="KRW">-68068000</ifrs-full:CashFlowsFromUsedInInvestingActivities>
    <ifrs-full:CashFlowsFromUsedInInvestingActivities
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005397"
      unitRef="KRW">-7960000</ifrs-full:CashFlowsFromUsedInInvestingActivities>
    <cik0002058261:RepaymentOfShorttermBorrowings
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005402"
      unitRef="KRW">-1000000000</cik0002058261:RepaymentOfShorttermBorrowings>
    <cik0002058261:RepaymentOfShorttermBorrowings
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005403"
      unitRef="KRW">-270000000</cik0002058261:RepaymentOfShorttermBorrowings>
    <cik0002058261:ProceedsFromIssuanceOfBondWithWarrants
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005406"
      unitRef="KRW">2000000000</cik0002058261:ProceedsFromIssuanceOfBondWithWarrants>
    <cik0002058261:DisposalOfTreasuryShares
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005408"
      unitRef="KRW">128000000</cik0002058261:DisposalOfTreasuryShares>
    <cik0002058261:DisposalOfTreasuryShares
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005409"
      unitRef="KRW">100000000</cik0002058261:DisposalOfTreasuryShares>
    <cik0002058261:RepaymentOfLeaseLiabilities
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005411"
      unitRef="KRW">56773000</cik0002058261:RepaymentOfLeaseLiabilities>
    <cik0002058261:RepaymentOfLeaseLiabilities
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005412"
      unitRef="KRW">58029000</cik0002058261:RepaymentOfLeaseLiabilities>
    <cik0002058261:RepaymentOfIssuanceOfBondWithWarrants
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005414"
      unitRef="KRW">600000000</cik0002058261:RepaymentOfIssuanceOfBondWithWarrants>
    <cik0002058261:RepaymentOfIssuanceOfBondWithWarrants
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005415"
      unitRef="KRW">2500000000</cik0002058261:RepaymentOfIssuanceOfBondWithWarrants>
    <cik0002058261:PaymentOfOfferingCost
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005417"
      unitRef="KRW">151970000</cik0002058261:PaymentOfOfferingCost>
    <cik0002058261:PaymentOfOfferingCost
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005418"
      unitRef="KRW">515585000</cik0002058261:PaymentOfOfferingCost>
    <cik0002058261:ProceedsFromTreasuryStocksDisposedWithRefundObligation
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005420"
      unitRef="KRW">2070000000</cik0002058261:ProceedsFromTreasuryStocksDisposedWithRefundObligation>
    <ifrs-full:CashFlowsFromUsedInFinancingActivities
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005423"
      unitRef="KRW">2389257000</ifrs-full:CashFlowsFromUsedInFinancingActivities>
    <ifrs-full:CashFlowsFromUsedInFinancingActivities
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005424"
      unitRef="KRW">-703614000</ifrs-full:CashFlowsFromUsedInFinancingActivities>
    <ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005426"
      unitRef="KRW">1102000</ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents>
    <ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005427"
      unitRef="KRW">-1080000</ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005429"
      unitRef="KRW">-24489000</ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005430"
      unitRef="KRW">-3645619000</ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges>
    <ifrs-full:CashAndCashEquivalents
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005432"
      unitRef="KRW">335814000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005433"
      unitRef="KRW">3662174000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="AsOf2026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005435"
      unitRef="KRW">312427000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="AsOf2025-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005436"
      unitRef="KRW">15475000</ifrs-full:CashAndCashEquivalents>
    <cik0002058261:ReportingEntityTextBlock
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      id="Fact005438">&lt;p id="xdx_807_ecustom--ReportingEntityTextBlock_z9G6r3snJKll" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;1. Reporting entity&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;The Company&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;CubeBio Co., Ltd. (the &#x201c;Company&#x201d;) was incorporated in November 2011 and the Company&#x2019;s registered office is at 9, Digital-ro 10-gil, Geumcheon-gu, Seoul, Republic of Korea. The Company primarily engages in discovering, designing, developing, manufacturing, and selling in-vitro diagnostics using liquid biopsies for strategic cancer treatment.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company&#x2019;s major shareholders and their respective percentage of ownership as of June&#160;30, 2026 and December&#160;31, 2025 are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_880_ecustom--ScheduleOfMajorShareholdersAndTheirRespectivePercentageOfOwnershipTableTextBlock_pn3n3_zJevhu2XGK97" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Reporting entity (Details)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_8B7_z7lvw0YBWDv2" style="display: none"&gt;Schedule of major shareholders and their respective percentage of ownership&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;June&#160;30,&lt;br/&gt;2026&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Number of&lt;br/&gt;shares&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Ownership&lt;br/&gt;(%)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Number of&lt;br/&gt;shares&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Ownership&lt;br/&gt;(%)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Well Core Co., Ltd.&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_904_ecustom--NumberOfShares_c20260101__20260630__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--WellCoreCoLtdMember_pd" title="Number of shares"&gt;12,110,698&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_c20260101__20260630__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--WellCoreCoLtdMember_zXnp78ugfLg1" title="Ownership (%)"&gt;22.93&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--NumberOfShares_c20250101__20250630__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--WellCoreCoLtdMember_pd" title="Number of shares"&gt;12,110,698&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_c20250101__20250630__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--WellCoreCoLtdMember_zYkyK5QPzBKa" title="Ownership (%)"&gt;22.93&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Treasury shares&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_908_ecustom--NumberOfShares_c20260101__20260630__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__ifrs-full--TreasurySharesMember_pd" title="Number of shares"&gt;3,793,400&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_c20260101__20260630__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__ifrs-full--TreasurySharesMember_z8cf6cEgf1Ue" title="Ownership (%)"&gt;7.18&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;%&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_ecustom--NumberOfShares_c20250101__20250630__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__ifrs-full--TreasurySharesMember_pd" title="Number of shares"&gt;3,833,400&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_c20250101__20250630__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__ifrs-full--TreasurySharesMember_zGzenuCnNpre" title="Ownership (%)"&gt;7.26&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;%&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Others&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_901_ecustom--NumberOfShares_c20260101__20260630__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--OthersMember_pd" title="Number of shares"&gt;36,911,377&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_c20260101__20260630__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--OthersMember_zpFLDkzuUNul" title="Ownership (%)"&gt;69.89&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;%&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_903_ecustom--NumberOfShares_c20250101__20250630__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--OthersMember_pd" title="Number of shares"&gt;36,871,377&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_c20250101__20250630__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--OthersMember_zm42SoXmQwml" title="Ownership (%)"&gt;69.81&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;%&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: center; vertical-align: top; padding-bottom: 1.25pt"&gt;Total&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--NumberOfShares_c20260101__20260630_pd" title="Number of shares"&gt;52,815,475&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_c20260101__20260630_zA5p7I0Kwfx4" title="Ownership (%)"&gt;100.00&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;%&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_908_ecustom--NumberOfShares_c20250101__20250630_pd" title="Number of shares"&gt;52,815,475&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_c20250101__20250630_zcFW1wZcW1Hk" title="Ownership (%)"&gt;100.00&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;%&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

</cik0002058261:ReportingEntityTextBlock>
    <cik0002058261:ScheduleOfMajorShareholdersAndTheirRespectivePercentageOfOwnershipTableTextBlock
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      id="Fact005440">&lt;table cellpadding="0" cellspacing="0" id="xdx_880_ecustom--ScheduleOfMajorShareholdersAndTheirRespectivePercentageOfOwnershipTableTextBlock_pn3n3_zJevhu2XGK97" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Reporting entity (Details)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_8B7_z7lvw0YBWDv2" style="display: none"&gt;Schedule of major shareholders and their respective percentage of ownership&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;June&#160;30,&lt;br/&gt;2026&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Number of&lt;br/&gt;shares&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Ownership&lt;br/&gt;(%)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Number of&lt;br/&gt;shares&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Ownership&lt;br/&gt;(%)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Well Core Co., Ltd.&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_904_ecustom--NumberOfShares_c20260101__20260630__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--WellCoreCoLtdMember_pd" title="Number of shares"&gt;12,110,698&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_c20260101__20260630__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--WellCoreCoLtdMember_zXnp78ugfLg1" title="Ownership (%)"&gt;22.93&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--NumberOfShares_c20250101__20250630__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--WellCoreCoLtdMember_pd" title="Number of shares"&gt;12,110,698&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_c20250101__20250630__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--WellCoreCoLtdMember_zYkyK5QPzBKa" title="Ownership (%)"&gt;22.93&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;%&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Treasury shares&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_908_ecustom--NumberOfShares_c20260101__20260630__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__ifrs-full--TreasurySharesMember_pd" title="Number of shares"&gt;3,793,400&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_c20260101__20260630__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__ifrs-full--TreasurySharesMember_z8cf6cEgf1Ue" title="Ownership (%)"&gt;7.18&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;%&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_ecustom--NumberOfShares_c20250101__20250630__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__ifrs-full--TreasurySharesMember_pd" title="Number of shares"&gt;3,833,400&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_c20250101__20250630__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__ifrs-full--TreasurySharesMember_zGzenuCnNpre" title="Ownership (%)"&gt;7.26&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;%&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Others&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_901_ecustom--NumberOfShares_c20260101__20260630__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--OthersMember_pd" title="Number of shares"&gt;36,911,377&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_c20260101__20260630__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--OthersMember_zpFLDkzuUNul" title="Ownership (%)"&gt;69.89&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;%&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_903_ecustom--NumberOfShares_c20250101__20250630__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--OthersMember_pd" title="Number of shares"&gt;36,871,377&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_c20250101__20250630__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--OthersMember_zm42SoXmQwml" title="Ownership (%)"&gt;69.81&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;%&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: center; vertical-align: top; padding-bottom: 1.25pt"&gt;Total&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--NumberOfShares_c20260101__20260630_pd" title="Number of shares"&gt;52,815,475&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_c20260101__20260630_zA5p7I0Kwfx4" title="Ownership (%)"&gt;100.00&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;%&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_908_ecustom--NumberOfShares_c20250101__20250630_pd" title="Number of shares"&gt;52,815,475&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_c20250101__20250630_zcFW1wZcW1Hk" title="Ownership (%)"&gt;100.00&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;%&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;</cik0002058261:ScheduleOfMajorShareholdersAndTheirRespectivePercentageOfOwnershipTableTextBlock>
    <cik0002058261:NumberOfShares
      contextRef="From2026-01-012026-06-30_custom_WellCoreCoLtdMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact005442"
      unitRef="Shares">12110698</cik0002058261:NumberOfShares>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="From2026-01-012026-06-30_custom_WellCoreCoLtdMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact005444"
      unitRef="Pure">0.2293</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <cik0002058261:NumberOfShares
      contextRef="From2025-01-012025-06-30_custom_WellCoreCoLtdMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact005446"
      unitRef="Shares">12110698</cik0002058261:NumberOfShares>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="From2025-01-012025-06-30_custom_WellCoreCoLtdMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact005448"
      unitRef="Pure">0.2293</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <cik0002058261:NumberOfShares
      contextRef="From2026-01-012026-06-30_ifrs-full_TreasurySharesMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact005450"
      unitRef="Shares">3793400</cik0002058261:NumberOfShares>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="From2026-01-012026-06-30_ifrs-full_TreasurySharesMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact005452"
      unitRef="Pure">0.0718</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <cik0002058261:NumberOfShares
      contextRef="From2025-01-012025-06-30_ifrs-full_TreasurySharesMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact005454"
      unitRef="Shares">3833400</cik0002058261:NumberOfShares>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="From2025-01-012025-06-30_ifrs-full_TreasurySharesMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact005456"
      unitRef="Pure">0.0726</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <cik0002058261:NumberOfShares
      contextRef="From2026-01-012026-06-30_custom_OthersMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact005458"
      unitRef="Shares">36911377</cik0002058261:NumberOfShares>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="From2026-01-012026-06-30_custom_OthersMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact005460"
      unitRef="Pure">0.6989</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <cik0002058261:NumberOfShares
      contextRef="From2025-01-012025-06-30_custom_OthersMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact005462"
      unitRef="Shares">36871377</cik0002058261:NumberOfShares>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="From2025-01-012025-06-30_custom_OthersMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact005464"
      unitRef="Pure">0.6981</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <cik0002058261:NumberOfShares
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact005466"
      unitRef="Shares">52815475</cik0002058261:NumberOfShares>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact005468"
      unitRef="Pure">1.0000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <cik0002058261:NumberOfShares
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact005470"
      unitRef="Shares">52815475</cik0002058261:NumberOfShares>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact005472"
      unitRef="Pure">1.0000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <cik0002058261:BasisOfPreparationTextBlock
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      id="Fact005474">&lt;p id="xdx_801_ecustom--BasisOfPreparationTextBlock_zkFoK2YxszN9" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;2. &lt;span id="xdx_82E_z5BQObZgG1x7"&gt;Basis of Presentation and Material Accounting Policies&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p id="xdx_84B_ecustom--BasisOfAccountingPolicyPolicyTextBlock_zPjHUjHifun8" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;A.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_869_zhdK4x4xdmo4"&gt;Basis of Presentation&lt;/span&gt;&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;These unaudited interim condensed financial statements have been prepared in accordance with International Financial Reporting Standards as issued by International Accounting Standards Board (&#x201c;IFRS&#x201d;).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;These unaudited interim condensed financial statements for the six months ended June&#160;30, 2026 have been prepared in accordance with IAS 34&#160;&lt;i&gt;Interim Financial Reporting&lt;/i&gt;, and should be read in conjunction with the Company&#x2019;s last annual financial statements as at and for the year ended December&#160;31, 2025 (&#x201c;last annual financial statements&#x201d;). They do not include all of the information and disclosures required by IFRS Accounting Standards for a complete set of annual financial statements, and certain information and note disclosures normally included in audited annual financial statements prepared in accordance with IFRS Accounting Standards have been condensed or omitted as permitted by the rules and regulations of the U.S. Securities and Exchange Commission (the &#x201c;SEC&#x201d;) applicable to interim financial statements of foreign private issuers. Accordingly, these unaudited interim condensed financial statements should be read in conjunction with the audited financial statements of the Company as at and for the year ended December&#160;31, 2025. However, selected explanatory notes are included to explain events and transactions that are significant to an understanding of the changes in the Company&#x2019;s financial position and performance since the last annual financial statements.&lt;/p&gt;

&lt;p id="xdx_842_ecustom--MaterialAccountingPoliciesPolicyTextBlock_zkIAIlEigIOe" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;B.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_860_z3CPTmFaThIk"&gt;Material Accounting Policies&lt;/span&gt;&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Material accounting policies and methods of computation used in the preparation of the unaudited interim condensed financial statements are consistent with those of the last annual financial statements for the year ended December&#160;31, 2025, except for the changes described below.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

















&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;New and amended standards or interpretations adopted by the Company.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company applied the following amended standards for June&#160;30, 2026 reporting period.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;Amendments to IFRS 9 and IFRS 7 &#x2013; Amendments to the Classification and Measurement of Financial Instruments&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;-&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;The amendments clarify the requirements for the timing of recognition and derecognition of some financial assets and liabilities, with a new exception for some financial liabilities settled through an electronic cash transfer system.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;-&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;The amendments clarify and add further guidance for assessing whether a financial asset meets the solely payments of principal and interest (SPPI) criterion.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;-&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;The amendments add new disclosures for certain instruments with contractual terms that can change cash flows.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;-&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;The amendments make updates to the disclosures for equity instruments designated at fair value through other comprehensive income.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Effective for annual periods beginning on or after 1 January&#160;2026, with earlier application permitted. The adoption of the amendments does not have a significant impact on the Company&#x2019;s unaudited interim condensed financial statements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;Annual Improvements &#x2013; Volume 11&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;These amendments are part of the Annual Improvements to IFRS Accounting Standards. Annual improvements are limited to changes that either clarify the wording in an Accounting Standard or correct relatively minor unintended consequences, oversights or conflicts between the requirements in the IFRS Accounting Standards.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&lt;i&gt;-&lt;/i&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;i&gt;IFRS 1, &#x2018;First-time Adoption of International Financial Reporting Standards&#x2019;&lt;/i&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&lt;i&gt;-&lt;/i&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;i&gt;IFRS 7, &#x2018;Financial Instruments: Disclosures&#x2019; and its accompanying Guidance on implementing IFRS 7&lt;/i&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&lt;i&gt;-&lt;/i&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;i&gt;IFRS 9, &#x2018;Financial Instruments&#x2019;&lt;/i&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&lt;i&gt;-&lt;/i&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;i&gt;IFRS 10, &#x2018;Consolidated Financial Statements&#x2019;; and&lt;/i&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&lt;i&gt;-&lt;/i&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;i&gt;IAS 7, &#x2018;Statement of Cash Flows&#x2019;.&lt;/i&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Effective for annual periods beginning on or after 1 January&#160;2026, with earlier application permitted. The adoption of the amendments does not have a significant impact on the Company&#x2019;s unaudited interim condensed financial statements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;Amendments to IFRS 9 and IFRS 7 &#x2013; Contracts Referencing Nature-dependent Electricity&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;These amendments change the &#x2018;own use&#x2019; and hedge accounting requirements in IFRS 9 and include targeted disclosure requirements to IFRS 7. These amendments apply only to contracts that expose an entity to variability in the underlying amount of electricity because of source of its generation depends on uncontrollable natural conditions (such as the weather). These are described as &#x2018;contracts referencing nature-dependent electricity&#x2019;. Effective for annual periods beginning on or after 1 January&#160;2026, with earlier application permitted. The adoption of the amendments does not have a significant impact on the Company&#x2019;s unaudited interim condensed financial statements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

















&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 0.5in; text-align: left"&gt;i.&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;New and amended standards or interpretations not yet adopted by the Company&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The following new accounting standards and interpretations have been published but are not mandatory for June&#160;30, 2026 reporting period, and have not been early adopted by the Company.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;IFRS 18, &#x2018;Presentation and Disclosure in Financial Statements&#x2019;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;IFRS 18 is the new Accounting Standard on presentation and disclosure in financial statements, with a focus on updates to the statement of profit or loss. The key new concepts introduced in IFRS 18 relate to:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;-&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;The structure of the statement of profit or loss&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;-&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;Required disclosures in the financial statements for certain profit or loss performance measures that are reported outside an entity&#x2019;s financial statements&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;-&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;Enhanced principles on aggregation and disaggregation which apply to the primary financial statements and notes in general&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Effective for annual periods beginning on or after 1 January&#160;2027, with earlier application permitted. The Company does not expect that these standards have a significant impact on the unaudited interim condensed financial statements.&lt;/p&gt;

&lt;p id="xdx_84C_ecustom--BasisOfMeasurementPolicyTextBlock_z3O4N6cObZF3" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;C.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_861_zOYR0G2au1og"&gt;Basis of measurement&lt;/span&gt;&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;These unaudited interim condensed financial statements have been prepared on a historical cost basis except for the following items, which are measured on an alternative basis at each reporting date.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="background-color: #FFFFFF"&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: left"&gt;&lt;b&gt;Items&lt;/b&gt;&lt;/td&gt;
    &lt;td style="width: 1%; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"&gt;&lt;b&gt;Measurement bases&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF"&gt;
    &lt;td style="text-align: left; vertical-align: bottom; padding-left: 0.125in; text-indent: -0.125in"&gt;Defined benefit liabilities&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center"&gt;Present value&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF"&gt;
    &lt;td style="text-align: left; vertical-align: bottom; padding-left: 0.125in; text-indent: -0.125in"&gt;Financial instruments measured at fair value through profit or loss (&#x201c;FVTPL&#x201d;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center"&gt;Fair value&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_84F_ecustom--ReclassificationPolicyTextBlock_zO5nJ1EblME" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;D.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_867_zppdRVIONvKl"&gt;Reclassification&lt;/span&gt;&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Certain previously reported balances have been reclassified to conform to the current presentation. These reclassifications had no effect on total assets, liabilities, shareholders&#x2019; equity or income as previously reported.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

</cik0002058261:BasisOfPreparationTextBlock>
    <cik0002058261:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      id="Fact005476">&lt;p id="xdx_84B_ecustom--BasisOfAccountingPolicyPolicyTextBlock_zPjHUjHifun8" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;A.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_869_zhdK4x4xdmo4"&gt;Basis of Presentation&lt;/span&gt;&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;These unaudited interim condensed financial statements have been prepared in accordance with International Financial Reporting Standards as issued by International Accounting Standards Board (&#x201c;IFRS&#x201d;).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;These unaudited interim condensed financial statements for the six months ended June&#160;30, 2026 have been prepared in accordance with IAS 34&#160;&lt;i&gt;Interim Financial Reporting&lt;/i&gt;, and should be read in conjunction with the Company&#x2019;s last annual financial statements as at and for the year ended December&#160;31, 2025 (&#x201c;last annual financial statements&#x201d;). They do not include all of the information and disclosures required by IFRS Accounting Standards for a complete set of annual financial statements, and certain information and note disclosures normally included in audited annual financial statements prepared in accordance with IFRS Accounting Standards have been condensed or omitted as permitted by the rules and regulations of the U.S. Securities and Exchange Commission (the &#x201c;SEC&#x201d;) applicable to interim financial statements of foreign private issuers. Accordingly, these unaudited interim condensed financial statements should be read in conjunction with the audited financial statements of the Company as at and for the year ended December&#160;31, 2025. However, selected explanatory notes are included to explain events and transactions that are significant to an understanding of the changes in the Company&#x2019;s financial position and performance since the last annual financial statements.&lt;/p&gt;

</cik0002058261:BasisOfAccountingPolicyPolicyTextBlock>
    <cik0002058261:MaterialAccountingPoliciesPolicyTextBlock
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      id="Fact005478">&lt;p id="xdx_842_ecustom--MaterialAccountingPoliciesPolicyTextBlock_zkIAIlEigIOe" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;B.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_860_z3CPTmFaThIk"&gt;Material Accounting Policies&lt;/span&gt;&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Material accounting policies and methods of computation used in the preparation of the unaudited interim condensed financial statements are consistent with those of the last annual financial statements for the year ended December&#160;31, 2025, except for the changes described below.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

















&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;New and amended standards or interpretations adopted by the Company.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company applied the following amended standards for June&#160;30, 2026 reporting period.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;Amendments to IFRS 9 and IFRS 7 &#x2013; Amendments to the Classification and Measurement of Financial Instruments&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;-&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;The amendments clarify the requirements for the timing of recognition and derecognition of some financial assets and liabilities, with a new exception for some financial liabilities settled through an electronic cash transfer system.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;-&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;The amendments clarify and add further guidance for assessing whether a financial asset meets the solely payments of principal and interest (SPPI) criterion.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;-&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;The amendments add new disclosures for certain instruments with contractual terms that can change cash flows.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;-&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;The amendments make updates to the disclosures for equity instruments designated at fair value through other comprehensive income.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Effective for annual periods beginning on or after 1 January&#160;2026, with earlier application permitted. The adoption of the amendments does not have a significant impact on the Company&#x2019;s unaudited interim condensed financial statements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;Annual Improvements &#x2013; Volume 11&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;These amendments are part of the Annual Improvements to IFRS Accounting Standards. Annual improvements are limited to changes that either clarify the wording in an Accounting Standard or correct relatively minor unintended consequences, oversights or conflicts between the requirements in the IFRS Accounting Standards.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&lt;i&gt;-&lt;/i&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;i&gt;IFRS 1, &#x2018;First-time Adoption of International Financial Reporting Standards&#x2019;&lt;/i&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&lt;i&gt;-&lt;/i&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;i&gt;IFRS 7, &#x2018;Financial Instruments: Disclosures&#x2019; and its accompanying Guidance on implementing IFRS 7&lt;/i&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&lt;i&gt;-&lt;/i&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;i&gt;IFRS 9, &#x2018;Financial Instruments&#x2019;&lt;/i&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&lt;i&gt;-&lt;/i&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;i&gt;IFRS 10, &#x2018;Consolidated Financial Statements&#x2019;; and&lt;/i&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&lt;i&gt;-&lt;/i&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;i&gt;IAS 7, &#x2018;Statement of Cash Flows&#x2019;.&lt;/i&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Effective for annual periods beginning on or after 1 January&#160;2026, with earlier application permitted. The adoption of the amendments does not have a significant impact on the Company&#x2019;s unaudited interim condensed financial statements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;Amendments to IFRS 9 and IFRS 7 &#x2013; Contracts Referencing Nature-dependent Electricity&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;These amendments change the &#x2018;own use&#x2019; and hedge accounting requirements in IFRS 9 and include targeted disclosure requirements to IFRS 7. These amendments apply only to contracts that expose an entity to variability in the underlying amount of electricity because of source of its generation depends on uncontrollable natural conditions (such as the weather). These are described as &#x2018;contracts referencing nature-dependent electricity&#x2019;. Effective for annual periods beginning on or after 1 January&#160;2026, with earlier application permitted. The adoption of the amendments does not have a significant impact on the Company&#x2019;s unaudited interim condensed financial statements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

















&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 0.5in; text-align: left"&gt;i.&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;New and amended standards or interpretations not yet adopted by the Company&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The following new accounting standards and interpretations have been published but are not mandatory for June&#160;30, 2026 reporting period, and have not been early adopted by the Company.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;IFRS 18, &#x2018;Presentation and Disclosure in Financial Statements&#x2019;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;IFRS 18 is the new Accounting Standard on presentation and disclosure in financial statements, with a focus on updates to the statement of profit or loss. The key new concepts introduced in IFRS 18 relate to:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;-&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;The structure of the statement of profit or loss&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;-&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;Required disclosures in the financial statements for certain profit or loss performance measures that are reported outside an entity&#x2019;s financial statements&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;-&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;Enhanced principles on aggregation and disaggregation which apply to the primary financial statements and notes in general&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Effective for annual periods beginning on or after 1 January&#160;2027, with earlier application permitted. The Company does not expect that these standards have a significant impact on the unaudited interim condensed financial statements.&lt;/p&gt;

</cik0002058261:MaterialAccountingPoliciesPolicyTextBlock>
    <cik0002058261:BasisOfMeasurementPolicyTextBlock
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      id="Fact005494">&lt;p id="xdx_84C_ecustom--BasisOfMeasurementPolicyTextBlock_z3O4N6cObZF3" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;C.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_861_zOYR0G2au1og"&gt;Basis of measurement&lt;/span&gt;&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;These unaudited interim condensed financial statements have been prepared on a historical cost basis except for the following items, which are measured on an alternative basis at each reporting date.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="background-color: #FFFFFF"&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: left"&gt;&lt;b&gt;Items&lt;/b&gt;&lt;/td&gt;
    &lt;td style="width: 1%; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"&gt;&lt;b&gt;Measurement bases&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF"&gt;
    &lt;td style="text-align: left; vertical-align: bottom; padding-left: 0.125in; text-indent: -0.125in"&gt;Defined benefit liabilities&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center"&gt;Present value&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF"&gt;
    &lt;td style="text-align: left; vertical-align: bottom; padding-left: 0.125in; text-indent: -0.125in"&gt;Financial instruments measured at fair value through profit or loss (&#x201c;FVTPL&#x201d;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center"&gt;Fair value&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:BasisOfMeasurementPolicyTextBlock>
    <cik0002058261:ReclassificationPolicyTextBlock
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      id="Fact005496">&lt;p id="xdx_84F_ecustom--ReclassificationPolicyTextBlock_zO5nJ1EblME" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;D.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_867_zppdRVIONvKl"&gt;Reclassification&lt;/span&gt;&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Certain previously reported balances have been reclassified to conform to the current presentation. These reclassifications had no effect on total assets, liabilities, shareholders&#x2019; equity or income as previously reported.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

</cik0002058261:ReclassificationPolicyTextBlock>
    <cik0002058261:FunctionalAndPresentationCurrencyTextBlock
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      id="Fact005498">&lt;p id="xdx_80A_ecustom--FunctionalAndPresentationCurrencyTextBlock_zdx37F0CGtud" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;3. &lt;span id="xdx_825_zzy4g1QoWqf6"&gt;Functional and presentation currency&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;These unaudited interim condensed financial statements are presented in Korean Won, which is the Company&#x2019;s functional currency.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

</cik0002058261:FunctionalAndPresentationCurrencyTextBlock>
    <cik0002058261:UseOfJudgementsAndEstimatesTextBlock
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      id="Fact005500">&lt;p id="xdx_80C_ecustom--UseOfJudgementsAndEstimatesTextBlock_zEBGxXXcEpjd" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;4. &lt;span id="xdx_82D_zcfMrDxfE21b"&gt;Use of judgements and estimates&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;In preparing these unaudited interim condensed financial statements, management has made judgements and estimates that affect the application of the Company&#x2019;s accounting policies and the reported amounts of assets, liabilities, income, and expenses. Actual results may differ from these estimates.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to estimates are recognized prospectively.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

















&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;A.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;b&gt;Judgements&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Information about judgements made in applying accounting policies that have the most significant effects on the amounts recognized in the unaudited interim condensed financial statements is included in the following notes:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Note 10(A): lease term: whether the Company is reasonably certain to exercise extension options.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;B.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;b&gt;Assumptions and estimation uncertainties&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 0.5in; text-align: left"&gt;i.&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;Estimation uncertainties&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Information about assumptions and estimation uncertainties at the reporting date that have a significant risk of resulting in material adjustments to the carrying amounts of assets and liabilities within the next financial year is as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company establishes additional current tax liabilities for income taxes when, despite the belief that tax positions are fully supportable, there remain positions that do not meet the minimum probability threshold, which is a tax position that is more likely than not to be sustained upon examination by the applicable taxation authority. The impact of current tax liabilities for uncertain tax positions, as well as the related net interest and penalties, is included in income taxes in the statements of operations.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 0.5in; text-align: left"&gt;ii.&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;Measurement of fair values&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;A number of the Company&#x2019;s accounting policies and disclosures require the measurement of fair values for financial assets and liabilities.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;When measuring the fair value of financial instruments measured at FVTPL, the Company uses observable market data as far as possible. Fair values are categorized into different levels in a fair value hierarchy based on the inputs used in the valuation techniques as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&#x25cf;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;Level 1: quoted prices (unadjusted) in active markets for identical assets or liabilities.&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#x25cf;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;Level 2: inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly (i.e., as prices) or indirectly (i.e., derived from prices).&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#x25cf;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;Level 3: inputs for the asset or liability that are not based on observable market data (unobservable inputs).&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;If the inputs used to measure the fair value of an asset or a liability fall into different levels of the fair value hierarchy, then the fair value measurement is categorized in its entirety in the same level of the fair value hierarchy as the lowest level input that is significant to the entire measurement.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company recognizes transfers between levels of the fair value hierarchy at the end of the reporting period during which the change has occurred.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Further information about the assumptions made in measuring fair values is included in the following notes:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&#x25cf;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;Note 19: Bond with warrants and derivative instruments;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#x25cf;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;Note 8(B): Financial instruments;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#x25cf;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;Note 24(B): Share-based payment arrangements.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

















</cik0002058261:UseOfJudgementsAndEstimatesTextBlock>
    <cik0002058261:OperatingSegmentsTextBlock
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      id="Fact005516">&lt;p id="xdx_806_ecustom--OperatingSegmentsTextBlock_zwxwQWNAiQCd" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;5. &lt;span id="xdx_827_znzoyFExQsW7"&gt;Operating segments&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;A.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;b&gt;Basis for segmentation&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company&#x2019;s operating segments have been identified as a single business unit, by which the Company currently engages in discovering and developing in-vitro diagnostics products for cancers.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company&#x2019;s chief executive officer reviews the internal management reports of the business at least annually.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;B.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;b&gt;Information about reportable segments&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Information related to the reportable segment is set out below. Segment operating profit is used to measure performance because management believes that this information is the most relevant for evaluating the results of the segment relative to other entities that operate in the same industry.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The segment information for the six-month periods ended June&#160;30, 2026 and 2025 is as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_88C_ecustom--DisclosureOfOperatingSegmentsExplanatoryTableTextBlock_pn3n3_zj2yXECQyyoa" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Operating segments (Details)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_8BC_zepc6drYMct7" style="display: none"&gt;Schedule of segment information&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_495_20260101__20260630_zbFQRMWqC4l6" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_492_20250101__20250630_zN8YTJOHtNz9" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;June&#160;30,&lt;br/&gt;2026&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;June&#160;30,&lt;br/&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--SegmentRevenue_zHkKILCCmR2l" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Segment revenue&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5520"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5521"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--DepreciationAmortization_zsVUCW693H18" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Depreciation/Amortization&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(103,485&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(121,250&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--SegmentOperatingProfitloss_zOYWQ0nDwLC3" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Segment operating loss&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(2,758,627&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(3,443,817&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--SegmentLoss_zzFTXyhlT1ba" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Segment loss for the period&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(2,997,895&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(3,400,181&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;C.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;b&gt;Geographic information&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company is managed and operated in Seoul, South Korea. In presenting the geographic information, non-current assets are based on the geographic location of the Company&#x2019;s operations.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

</cik0002058261:OperatingSegmentsTextBlock>
    <cik0002058261:DisclosureOfOperatingSegmentsExplanatoryTableTextBlock
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      id="Fact005518">&lt;table cellpadding="0" cellspacing="0" id="xdx_88C_ecustom--DisclosureOfOperatingSegmentsExplanatoryTableTextBlock_pn3n3_zj2yXECQyyoa" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Operating segments (Details)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_8BC_zepc6drYMct7" style="display: none"&gt;Schedule of segment information&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_495_20260101__20260630_zbFQRMWqC4l6" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_492_20250101__20250630_zN8YTJOHtNz9" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;June&#160;30,&lt;br/&gt;2026&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;June&#160;30,&lt;br/&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--SegmentRevenue_zHkKILCCmR2l" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Segment revenue&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5520"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5521"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--DepreciationAmortization_zsVUCW693H18" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Depreciation/Amortization&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(103,485&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(121,250&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--SegmentOperatingProfitloss_zOYWQ0nDwLC3" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Segment operating loss&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(2,758,627&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(3,443,817&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--SegmentLoss_zzFTXyhlT1ba" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Segment loss for the period&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(2,997,895&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(3,400,181&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;</cik0002058261:DisclosureOfOperatingSegmentsExplanatoryTableTextBlock>
    <cik0002058261:DepreciationAmortization
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005523"
      unitRef="KRW">-103485000</cik0002058261:DepreciationAmortization>
    <cik0002058261:DepreciationAmortization
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005524"
      unitRef="KRW">-121250000</cik0002058261:DepreciationAmortization>
    <cik0002058261:SegmentOperatingProfitloss
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005526"
      unitRef="KRW">-2758627000</cik0002058261:SegmentOperatingProfitloss>
    <cik0002058261:SegmentOperatingProfitloss
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005527"
      unitRef="KRW">-3443817000</cik0002058261:SegmentOperatingProfitloss>
    <cik0002058261:SegmentLoss
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005529"
      unitRef="KRW">-2997895000</cik0002058261:SegmentLoss>
    <cik0002058261:SegmentLoss
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005530"
      unitRef="KRW">-3400181000</cik0002058261:SegmentLoss>
    <ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      id="Fact005532">&lt;p id="xdx_808_eifrs-full--DisclosureOfCashAndCashEquivalentsExplanatory_zKy3O79k3K2b" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;6. &lt;span id="xdx_82D_z0kmBwq5okdi"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Cash and cash equivalents as of June&#160;30, 2026 and December&#160;31, 2025 are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89F_ecustom--ScheduleOfRestrictedCashAndCashEquivalentsTableTextBlock_pn3n3_z8otFHBjszIe" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Cash and cash equivalents (Details)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;&lt;span id="xdx_8BF_zr8ykUWudJx8" style="display: none"&gt;Schedule of cash and cash equivalents&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49B_20260630_zJWupUut0O8b" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_490_20251231_zYInG4vFRkF6" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;June&#160;30,&lt;br/&gt;2026&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr id="xdx_408_eifrs-full--BalancesWithBanks_iI_zPvIXE5d2lpk" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Deposit in banks&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;296,399&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;322,177&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--ForeignCurrencyDepositInBanks_iI_zXCPGvVNtygh" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Foreign currency deposit in banks&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;16,028&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;13,637&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_409_eifrs-full--CashAndCashEquivalents_iI_zQeuOSwUKhC2" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: center; vertical-align: top; padding-bottom: 1.25pt"&gt;Total&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;312,427&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;335,814&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company doesn&#x2019;t have any restricted cash and cash equivalents as of June&#160;30, 2026 and December&#160;31 2025.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

















</ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory>
    <cik0002058261:ScheduleOfRestrictedCashAndCashEquivalentsTableTextBlock
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      id="Fact005534">&lt;table cellpadding="0" cellspacing="0" id="xdx_89F_ecustom--ScheduleOfRestrictedCashAndCashEquivalentsTableTextBlock_pn3n3_z8otFHBjszIe" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Cash and cash equivalents (Details)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;&lt;span id="xdx_8BF_zr8ykUWudJx8" style="display: none"&gt;Schedule of cash and cash equivalents&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49B_20260630_zJWupUut0O8b" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_490_20251231_zYInG4vFRkF6" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;June&#160;30,&lt;br/&gt;2026&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr id="xdx_408_eifrs-full--BalancesWithBanks_iI_zPvIXE5d2lpk" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Deposit in banks&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;296,399&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;322,177&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--ForeignCurrencyDepositInBanks_iI_zXCPGvVNtygh" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Foreign currency deposit in banks&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;16,028&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;13,637&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_409_eifrs-full--CashAndCashEquivalents_iI_zQeuOSwUKhC2" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: center; vertical-align: top; padding-bottom: 1.25pt"&gt;Total&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;312,427&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;335,814&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company doesn&#x2019;t have any restricted cash and cash equivalents as of June&#160;30, 2026 and December&#160;31 2025.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

















</cik0002058261:ScheduleOfRestrictedCashAndCashEquivalentsTableTextBlock>
    <ifrs-full:BalancesWithBanks
      contextRef="AsOf2026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005536"
      unitRef="KRW">296399000</ifrs-full:BalancesWithBanks>
    <ifrs-full:BalancesWithBanks
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005537"
      unitRef="KRW">322177000</ifrs-full:BalancesWithBanks>
    <cik0002058261:ForeignCurrencyDepositInBanks
      contextRef="AsOf2026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005539"
      unitRef="KRW">16028000</cik0002058261:ForeignCurrencyDepositInBanks>
    <cik0002058261:ForeignCurrencyDepositInBanks
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005540"
      unitRef="KRW">13637000</cik0002058261:ForeignCurrencyDepositInBanks>
    <ifrs-full:CashAndCashEquivalents
      contextRef="AsOf2026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005542"
      unitRef="KRW">312427000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005543"
      unitRef="KRW">335814000</ifrs-full:CashAndCashEquivalents>
    <cik0002058261:LoansReceivablesTextBlock
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      id="Fact005552">&lt;p id="xdx_80E_ecustom--LoansReceivablesTextBlock_zneY9GGtIpY1" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;7. &lt;span id="xdx_829_zCvs4e4f2AL1"&gt;Loans receivables&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;A.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;b&gt;Terms and collection schedule&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The terms and conditions of outstanding loans as of June&#160;30, 2026 and December&#160;31, 2025 are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_891_ecustom--ScheduleOfTermsAndConditionTableTextBlock_pn3n3_zej6mMwU5Sii" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Loans receivables (Details)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span id="xdx_8BF_zEmBGu4maync" style="display: none"&gt;Schedule of terms and condition&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;June&#160;30,&lt;br/&gt;2026&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td colspan="9" style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Currency&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Nominal&lt;br/&gt;interest rate&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Maturity&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Face value&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Carrying&lt;br/&gt;amount&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Face value&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Carrying&lt;br/&gt;amount&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;b&gt;Short-term loans, net&lt;/b&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 10%; text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 10%; text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Eun Jong Choi (*1)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: top"&gt;KRW&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_901_ecustom--NominalInterestRate_pid_dp_c20260101__20260630__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--EunJongChoiMember_fKCoxKQ_____zJRVKMKKe6wf" title="Nominal interest rate"&gt;4.60&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;%&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: top"&gt;&lt;span id="xdx_90E_ecustom--Maturity_pp0d_c20260101__20260630__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--EunJongChoiMember_zcpQQCSDXSdb" title="Maturity"&gt;31-Dec-26&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_907_ecustom--FaceValue_pn3n3_c20260101__20260630__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--EunJongChoiMember_fKCoxKQ_____zPGYqRYoPJM5" title="Face value"&gt;100,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_ecustom--CarryingAmount_pn3n3_c20260101__20260630__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--EunJongChoiMember_fKCoxKQ_____zcZvYpEXLg6j" title="Carrying amount"&gt;128,021&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_906_ecustom--FaceValue_pn3n3_c20250101__20250630__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--EunJongChoiMember_fKCoxKQ_____zcUY7j6fuzi8" title="Face value"&gt;100,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_906_ecustom--CarryingAmount_pn3n3_c20250101__20250630__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--EunJongChoiMember_fKCoxKQ_____zqMrTB3Kxzcb" title="Carrying amount"&gt;125,739&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Eun Jong Choi (*1)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: top"&gt;KRW&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_909_ecustom--NominalInterestRate_pid_dp_c20260101__20260630__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--EunJongChoi1Member_fKCoxKQ_____zd1m9TKViDsa" title="Nominal interest rate"&gt;4.60&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;%&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: top"&gt;&lt;span id="xdx_902_ecustom--Maturity_pp0d_c20260101__20260630__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--EunJongChoi1Member_zMP3521kx6s3" title="Maturity"&gt;31-Dec-26&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_909_ecustom--FaceValue_pn3n3_c20260101__20260630__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--EunJongChoi1Member_fKCoxKQ_____zKwjmpTrr3ya" title="Face value"&gt;40,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_902_ecustom--CarryingAmount_pn3n3_c20260101__20260630__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--EunJongChoi1Member_fKCoxKQ_____zzrvADpwBl3a" title="Carrying amount"&gt;51,208&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_ecustom--FaceValue_pn3n3_c20250101__20250630__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--EunJongChoi1Member_fKCoxKQ_____z61GSL5kGct" title="Face value"&gt;40,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_ecustom--CarryingAmount_pn3n3_c20250101__20250630__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--EunJongChoi1Member_fKCoxKQ_____zyqEeqKg6Vn4" title="Carrying amount"&gt;50,296&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;CubeBio Holdings., Ltd. (*2)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: top"&gt;KRW&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_900_ecustom--NominalInterestRate_pid_dp_c20260101__20260630__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--CubeBioHoldingsLtdMember_fKCoyKQ_____zJ5H2ZOWtDMa" title="Nominal interest rate"&gt;4.60&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;%&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: top"&gt;&lt;span id="xdx_907_ecustom--Maturity_pp0d_c20260101__20260630__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--CubeBioHoldingsLtdMember_zu8Lruo8zFta" title="Maturity"&gt;24-Sep-26&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_ecustom--FaceValue_pn3n3_c20260101__20260630__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--CubeBioHoldingsLtdMember_fKCoyKQ_____zgap5n4OC3vf" title="Face value"&gt;46,245&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_905_ecustom--CarryingAmount_pn3n3_c20260101__20260630__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--CubeBioHoldingsLtdMember_fKCoyKQ_____zB2YDZrk4wac" title="Carrying amount"&gt;50,048&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_902_ecustom--FaceValue_pn3n3_c20250101__20250630__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--CubeBioHoldingsLtdMember_fKCoyKQ_____zFjlLDW99bd5" title="Face value"&gt;43,047&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_900_ecustom--CarryingAmount_pn3n3_c20250101__20250630__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--CubeBioHoldingsLtdMember_fKCoyKQ_____zCUNbl3Ny50g" title="Carrying amount"&gt;45,564&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;CubeBio Holdings., Ltd. (*2)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: top"&gt;KRW&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_901_ecustom--NominalInterestRate_pid_dp_c20260101__20260630__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--CubeBioHoldingsLtd1Member_fKCoyKQ_____z6qKWvJNHgn1" title="Nominal interest rate"&gt;4.60&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;%&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: top"&gt;&lt;span id="xdx_909_ecustom--Maturity_pp0d_c20260101__20260630__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--CubeBioHoldingsLtd1Member_zlcZBzQKTdI3" title="Maturity"&gt;28-Jan-27&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_903_ecustom--FaceValue_pn3n3_c20260101__20260630__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--CubeBioHoldingsLtd1Member_fKCoyKQ_____zTaw4lku3qxa" title="Face value"&gt;5,704&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_908_ecustom--CarryingAmount_pn3n3_c20260101__20260630__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--CubeBioHoldingsLtd1Member_fKCoyKQ_____zq0xbu9lZCQ6" title="Carrying amount"&gt;5,811&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_905_ecustom--FaceValue_pn3n3_c20250101__20250630__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--CubeBioHoldingsLtd1Member_fKCoyKQ_____z8PfMOrvhUw7" title="Face value"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5600"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_ecustom--CarryingAmount_pn3n3_c20250101__20250630__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--CubeBioHoldingsLtd1Member_fKCoyKQ_____z0PdTgWS6wTa" title="Carrying amount"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5602"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Dongsung D&amp;amp;C (*3)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: top"&gt;KRW&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_905_ecustom--NominalInterestRate_pid_dp_c20260101__20260630__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--DongsungDAndCMember_fKCozKQ_____zNzVLGHaZc29" title="Nominal interest rate"&gt;4.60&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;%&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: top"&gt;&lt;span id="xdx_904_ecustom--Maturity_pp0d_c20260101__20260630__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--DongsungDAndCMember_zhyouTWQZenb" title="Maturity"&gt;04-Nov-26&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_ecustom--FaceValue_pn3n3_c20260101__20260630__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--DongsungDAndCMember_fKCozKQ_____zBoFcuH0LKJf" title="Face value"&gt;220,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_ecustom--CarryingAmount_pn3n3_c20260101__20260630__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--DongsungDAndCMember_fKCozKQ_____ziug095lQHP" title="Carrying amount"&gt;226,314&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_902_ecustom--FaceValue_pn3n3_c20250101__20250630__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--DongsungDAndCMember_fKCozKQ_____zhKnHZw1l0v4" title="Face value"&gt;220,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_ecustom--CarryingAmount_pn3n3_c20250101__20250630__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--DongsungDAndCMember_fKCozKQ_____zCInFgTVSgoj" title="Carrying amount"&gt;221,295&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Dongsung D&amp;amp;C (*3)&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: top; padding-bottom: 0.5pt"&gt;KRW&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; padding-bottom: 0.5pt"&gt;&lt;span id="xdx_90B_ecustom--NominalInterestRate_pid_dp_c20260101__20260630__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--DongsungDAndC1Member_fKCozKQ_____zyWOOddPmh6j" title="Nominal interest rate"&gt;4.60&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;%&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: top; padding-bottom: 0.5pt"&gt;&lt;span id="xdx_907_ecustom--Maturity_pp0d_c20260101__20260630__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--DongsungDAndC1Member_zcXWYQ151349" title="Maturity"&gt;17-May-27&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_906_ecustom--FaceValue_pn3n3_c20260101__20260630__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--DongsungDAndC1Member_fKCozKQ_____zR57TO1qWrU7" title="Face value"&gt;100,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_906_ecustom--CarryingAmount_pn3n3_c20260101__20260630__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--DongsungDAndC1Member_fKCozKQ_____zrJJewh4puJi" title="Carrying amount"&gt;100,542&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_901_ecustom--FaceValue_pn3n3_c20250101__20250630__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--DongsungDAndC1Member_fKCozKQ_____zDOh9gTxcry7" title="Face value"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5624"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_909_ecustom--CarryingAmount_pn3n3_c20250101__20250630__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--DongsungDAndC1Member_fKCozKQ_____zQzZzuHFyxTa" title="Carrying amount"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5626"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: center; padding-bottom: 0.5pt"&gt;&lt;b&gt;Subtotal&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="7" style="text-align: center; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_906_ecustom--FaceValue_pn3n3_c20260101__20260630__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--SubtotalMember_zPI5E1s6xHNk" title="Face value"&gt;511,949&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_906_ecustom--CarryingAmount_pn3n3_c20260101__20260630__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--SubtotalMember_zcVxWmBDXQO8" title="Carrying amount"&gt;561,944&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_906_ecustom--FaceValue_pn3n3_c20250101__20250630__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--SubtotalMember_zAUCskO17eVd" title="Face value"&gt;403,047&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_908_ecustom--CarryingAmount_pn3n3_c20250101__20250630__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--SubtotalMember_zblWvFoIbX9b" title="Carrying amount"&gt;442,894&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;b&gt;Long-term loans, net&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Magium Corp. (*4)&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: top; padding-bottom: 0.5pt"&gt;KRW&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; padding-bottom: 0.5pt"&gt;&lt;span id="xdx_90E_ecustom--NominalInterestRate_pid_dp_c20260101__20260630__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--MagiumCorpMember_fKCo0KQ_____zc3rm98zKjAj" title="Nominal interest rate"&gt;5.00&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;%&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: top; padding-bottom: 0.5pt"&gt;&lt;span id="xdx_908_ecustom--Maturity_pp0d_c20260101__20260630__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--MagiumCorpMember_zzlVssOzVP7a" title="Maturity"&gt;31-Mar-27&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_908_ecustom--FaceValue_pn3n3_c20260101__20260630__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--MagiumCorpMember_fKCo0KQ_____zPxPqEmM7aVi" title="Face value"&gt;2,300,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--CarryingAmount_pn3n3_c20260101__20260630__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--MagiumCorpMember_fKCo0KQ_____zAHbf38yRYUl" title="Carrying amount"&gt;1,958,880&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_905_ecustom--FaceValue_pn3n3_c20250101__20250630__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--MagiumCorpMember_fKCo0KQ_____zMJmzLKCxHOh" title="Face value"&gt;2,300,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--CarryingAmount_pn3n3_c20250101__20250630__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--MagiumCorpMember_fKCo0KQ_____zSqVjKosCEY4" title="Carrying amount"&gt;1,671,780&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: center; padding-bottom: 1.25pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="7" style="text-align: center; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--FaceValue_pn3n3_c20260101__20260630_zCnMy2NtrH15" title="Face value"&gt;2,811,949&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--CarryingAmount_pn3n3_c20260101__20260630_zK2ieqkCDaxl" title="Carrying amount"&gt;2,520,824&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_907_ecustom--FaceValue_pn3n3_c20250101__20250630_zNlTn6ZVo61a" title="Face value"&gt;2,703,047&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--CarryingAmount_pn3n3_c20250101__20250630_zObSnr6Xa4gd" title="Carrying amount"&gt;2,114,674&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;div style="width: 25%; margin-left: 0; margin-right: auto"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.35in; text-align: left"&gt;&lt;span id="xdx_F01_zq8kk39UQem4"&gt;(*1)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_F1A_zQ9vf6oBVYhd"&gt;The loan to Eun Jong Choi is a related party transaction.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_F02_zHkcMFC0dw3j"&gt;(*2)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_F18_zks8iFxAUXza"&gt;The loan to CubeBio Holdings Ltd. is denominated in USD&#160;33,700 and presented in Korean won for reporting purposes. It is a related party transaction.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_F06_zgoV1Cx2lxu1"&gt;(*3)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_F1C_zC7tfFXWDArh"&gt;The loan to Dongsung D&amp;amp;C is denominated in KRW 320,000,000 and presented in Korean won for reporting purposes. The loan to Dongsung D&amp;amp;C is a related party transaction.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_F0E_zQiLv5LlR2k1"&gt;(*4)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_F1F_zVtds3U5Ox2c"&gt;The loan was classified as long-term as it is not expected to be recovered within 12 months after the June&#160;30, 2026 reporting period. In March&#160;2026, the maturity date of the loan was extended to March&#160;31, 2027, and the Company intends to further extend the maturity by one year in March&#160;2027.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AC_zU7gFTnuUeW4" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

















&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;B.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;b&gt;Details of allowance for impairment&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Changes in the allowance for impairment of loans for the year ended June&#160;30, 2026 are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89C_ecustom--ChangesInLossAllowanceForExpectedCreditLossesOnLoanReceivablesTableTextBlock_pn3n3_zxQcdFr25cv6" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Loans receivables (Details 1)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_8BD_zwOGpkEFk9ca" style="display: none"&gt;Changes in loss allowance for expected credit losses on loan receivables&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49A_20260101__20260630_zTivSAPxD6xd" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;June&#160;30,&lt;br/&gt;2026&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;b&gt;Short-term loans, net&lt;/b&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--ShortTermLoanReceivable_iS_zfIpivaBdd85" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Beginning of the year&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#x20a9;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5669"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--WriteoffOfAllowanceForDoubtfulAccounts_zl48rgANvVec" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Write-off of allowance for doubtful accounts&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5671"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--ReclassificationOfLongtermToShortterm_zfUYLc0Nnh02" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Reclassification of long-term to short-term&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5673"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--ShortTermLoanReceivable_iE_zuupt3uvTRa8" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Ending of the year&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5675"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;b&gt;Long-term loans receivable, net&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--LongtermLoanReceivableNet_iS_zvjzfGq7HKQ7" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Beginning of the year&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#x20a9;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;628,220&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--OtherBadDebtExpenses_zxpdanQltS07" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Other bad debt expenses&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5679"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--ReversalOfAllowanceForDoubtfulAccounts_zrcHClF0ku79" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Reversal of allowance for doubtful accounts&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(287,100&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--LongtermLoanReceivableNet_iE_zw1K9ooiXnIe" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Ending of the period&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;341,120&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;b&gt;Long-term Accrued interest income&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--LongTermAccruedInterestIncome_iS_zcxtHtAAQ9gj" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Beginning of the year&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#x20a9;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;247,458&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--LongTermAccruedInterestIncomeOtherBadDebtExpenses_i_pp0p" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Other bad debt expenses&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;65,379&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--LongTermAccruedInterestIncome_iE_zvQFaT2tbKU3" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Ending of the period&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;312,837&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A0_z8Smc46VLIdb" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

</cik0002058261:LoansReceivablesTextBlock>
    <cik0002058261:ScheduleOfTermsAndConditionTableTextBlock
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      id="Fact005554">&lt;table cellpadding="0" cellspacing="0" id="xdx_891_ecustom--ScheduleOfTermsAndConditionTableTextBlock_pn3n3_zej6mMwU5Sii" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Loans receivables (Details)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span id="xdx_8BF_zEmBGu4maync" style="display: none"&gt;Schedule of terms and condition&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;June&#160;30,&lt;br/&gt;2026&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td colspan="9" style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Currency&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Nominal&lt;br/&gt;interest rate&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Maturity&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Face value&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Carrying&lt;br/&gt;amount&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Face value&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Carrying&lt;br/&gt;amount&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;b&gt;Short-term loans, net&lt;/b&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 10%; text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 10%; text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Eun Jong Choi (*1)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: top"&gt;KRW&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_901_ecustom--NominalInterestRate_pid_dp_c20260101__20260630__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--EunJongChoiMember_fKCoxKQ_____zJRVKMKKe6wf" title="Nominal interest rate"&gt;4.60&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;%&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: top"&gt;&lt;span id="xdx_90E_ecustom--Maturity_pp0d_c20260101__20260630__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--EunJongChoiMember_zcpQQCSDXSdb" title="Maturity"&gt;31-Dec-26&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_907_ecustom--FaceValue_pn3n3_c20260101__20260630__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--EunJongChoiMember_fKCoxKQ_____zPGYqRYoPJM5" title="Face value"&gt;100,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_ecustom--CarryingAmount_pn3n3_c20260101__20260630__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--EunJongChoiMember_fKCoxKQ_____zcZvYpEXLg6j" title="Carrying amount"&gt;128,021&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_906_ecustom--FaceValue_pn3n3_c20250101__20250630__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--EunJongChoiMember_fKCoxKQ_____zcUY7j6fuzi8" title="Face value"&gt;100,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_906_ecustom--CarryingAmount_pn3n3_c20250101__20250630__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--EunJongChoiMember_fKCoxKQ_____zqMrTB3Kxzcb" title="Carrying amount"&gt;125,739&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Eun Jong Choi (*1)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: top"&gt;KRW&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_909_ecustom--NominalInterestRate_pid_dp_c20260101__20260630__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--EunJongChoi1Member_fKCoxKQ_____zd1m9TKViDsa" title="Nominal interest rate"&gt;4.60&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;%&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: top"&gt;&lt;span id="xdx_902_ecustom--Maturity_pp0d_c20260101__20260630__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--EunJongChoi1Member_zMP3521kx6s3" title="Maturity"&gt;31-Dec-26&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_909_ecustom--FaceValue_pn3n3_c20260101__20260630__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--EunJongChoi1Member_fKCoxKQ_____zKwjmpTrr3ya" title="Face value"&gt;40,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_902_ecustom--CarryingAmount_pn3n3_c20260101__20260630__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--EunJongChoi1Member_fKCoxKQ_____zzrvADpwBl3a" title="Carrying amount"&gt;51,208&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_ecustom--FaceValue_pn3n3_c20250101__20250630__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--EunJongChoi1Member_fKCoxKQ_____z61GSL5kGct" title="Face value"&gt;40,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_ecustom--CarryingAmount_pn3n3_c20250101__20250630__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--EunJongChoi1Member_fKCoxKQ_____zyqEeqKg6Vn4" title="Carrying amount"&gt;50,296&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;CubeBio Holdings., Ltd. (*2)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: top"&gt;KRW&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_900_ecustom--NominalInterestRate_pid_dp_c20260101__20260630__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--CubeBioHoldingsLtdMember_fKCoyKQ_____zJ5H2ZOWtDMa" title="Nominal interest rate"&gt;4.60&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;%&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: top"&gt;&lt;span id="xdx_907_ecustom--Maturity_pp0d_c20260101__20260630__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--CubeBioHoldingsLtdMember_zu8Lruo8zFta" title="Maturity"&gt;24-Sep-26&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_ecustom--FaceValue_pn3n3_c20260101__20260630__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--CubeBioHoldingsLtdMember_fKCoyKQ_____zgap5n4OC3vf" title="Face value"&gt;46,245&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_905_ecustom--CarryingAmount_pn3n3_c20260101__20260630__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--CubeBioHoldingsLtdMember_fKCoyKQ_____zB2YDZrk4wac" title="Carrying amount"&gt;50,048&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_902_ecustom--FaceValue_pn3n3_c20250101__20250630__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--CubeBioHoldingsLtdMember_fKCoyKQ_____zFjlLDW99bd5" title="Face value"&gt;43,047&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_900_ecustom--CarryingAmount_pn3n3_c20250101__20250630__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--CubeBioHoldingsLtdMember_fKCoyKQ_____zCUNbl3Ny50g" title="Carrying amount"&gt;45,564&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;CubeBio Holdings., Ltd. (*2)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: top"&gt;KRW&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_901_ecustom--NominalInterestRate_pid_dp_c20260101__20260630__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--CubeBioHoldingsLtd1Member_fKCoyKQ_____z6qKWvJNHgn1" title="Nominal interest rate"&gt;4.60&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;%&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: top"&gt;&lt;span id="xdx_909_ecustom--Maturity_pp0d_c20260101__20260630__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--CubeBioHoldingsLtd1Member_zlcZBzQKTdI3" title="Maturity"&gt;28-Jan-27&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_903_ecustom--FaceValue_pn3n3_c20260101__20260630__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--CubeBioHoldingsLtd1Member_fKCoyKQ_____zTaw4lku3qxa" title="Face value"&gt;5,704&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_908_ecustom--CarryingAmount_pn3n3_c20260101__20260630__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--CubeBioHoldingsLtd1Member_fKCoyKQ_____zq0xbu9lZCQ6" title="Carrying amount"&gt;5,811&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_905_ecustom--FaceValue_pn3n3_c20250101__20250630__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--CubeBioHoldingsLtd1Member_fKCoyKQ_____z8PfMOrvhUw7" title="Face value"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5600"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_ecustom--CarryingAmount_pn3n3_c20250101__20250630__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--CubeBioHoldingsLtd1Member_fKCoyKQ_____z0PdTgWS6wTa" title="Carrying amount"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5602"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Dongsung D&amp;amp;C (*3)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: top"&gt;KRW&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_905_ecustom--NominalInterestRate_pid_dp_c20260101__20260630__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--DongsungDAndCMember_fKCozKQ_____zNzVLGHaZc29" title="Nominal interest rate"&gt;4.60&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;%&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: top"&gt;&lt;span id="xdx_904_ecustom--Maturity_pp0d_c20260101__20260630__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--DongsungDAndCMember_zhyouTWQZenb" title="Maturity"&gt;04-Nov-26&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_ecustom--FaceValue_pn3n3_c20260101__20260630__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--DongsungDAndCMember_fKCozKQ_____zBoFcuH0LKJf" title="Face value"&gt;220,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_ecustom--CarryingAmount_pn3n3_c20260101__20260630__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--DongsungDAndCMember_fKCozKQ_____ziug095lQHP" title="Carrying amount"&gt;226,314&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_902_ecustom--FaceValue_pn3n3_c20250101__20250630__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--DongsungDAndCMember_fKCozKQ_____zhKnHZw1l0v4" title="Face value"&gt;220,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_ecustom--CarryingAmount_pn3n3_c20250101__20250630__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--DongsungDAndCMember_fKCozKQ_____zCInFgTVSgoj" title="Carrying amount"&gt;221,295&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Dongsung D&amp;amp;C (*3)&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: top; padding-bottom: 0.5pt"&gt;KRW&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; padding-bottom: 0.5pt"&gt;&lt;span id="xdx_90B_ecustom--NominalInterestRate_pid_dp_c20260101__20260630__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--DongsungDAndC1Member_fKCozKQ_____zyWOOddPmh6j" title="Nominal interest rate"&gt;4.60&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;%&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: top; padding-bottom: 0.5pt"&gt;&lt;span id="xdx_907_ecustom--Maturity_pp0d_c20260101__20260630__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--DongsungDAndC1Member_zcXWYQ151349" title="Maturity"&gt;17-May-27&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_906_ecustom--FaceValue_pn3n3_c20260101__20260630__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--DongsungDAndC1Member_fKCozKQ_____zR57TO1qWrU7" title="Face value"&gt;100,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_906_ecustom--CarryingAmount_pn3n3_c20260101__20260630__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--DongsungDAndC1Member_fKCozKQ_____zrJJewh4puJi" title="Carrying amount"&gt;100,542&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_901_ecustom--FaceValue_pn3n3_c20250101__20250630__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--DongsungDAndC1Member_fKCozKQ_____zDOh9gTxcry7" title="Face value"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5624"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_909_ecustom--CarryingAmount_pn3n3_c20250101__20250630__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--DongsungDAndC1Member_fKCozKQ_____zQzZzuHFyxTa" title="Carrying amount"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5626"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: center; padding-bottom: 0.5pt"&gt;&lt;b&gt;Subtotal&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="7" style="text-align: center; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_906_ecustom--FaceValue_pn3n3_c20260101__20260630__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--SubtotalMember_zPI5E1s6xHNk" title="Face value"&gt;511,949&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_906_ecustom--CarryingAmount_pn3n3_c20260101__20260630__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--SubtotalMember_zcVxWmBDXQO8" title="Carrying amount"&gt;561,944&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_906_ecustom--FaceValue_pn3n3_c20250101__20250630__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--SubtotalMember_zAUCskO17eVd" title="Face value"&gt;403,047&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_908_ecustom--CarryingAmount_pn3n3_c20250101__20250630__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--SubtotalMember_zblWvFoIbX9b" title="Carrying amount"&gt;442,894&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;b&gt;Long-term loans, net&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Magium Corp. (*4)&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: top; padding-bottom: 0.5pt"&gt;KRW&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; padding-bottom: 0.5pt"&gt;&lt;span id="xdx_90E_ecustom--NominalInterestRate_pid_dp_c20260101__20260630__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--MagiumCorpMember_fKCo0KQ_____zc3rm98zKjAj" title="Nominal interest rate"&gt;5.00&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;%&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: top; padding-bottom: 0.5pt"&gt;&lt;span id="xdx_908_ecustom--Maturity_pp0d_c20260101__20260630__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--MagiumCorpMember_zzlVssOzVP7a" title="Maturity"&gt;31-Mar-27&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_908_ecustom--FaceValue_pn3n3_c20260101__20260630__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--MagiumCorpMember_fKCo0KQ_____zPxPqEmM7aVi" title="Face value"&gt;2,300,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--CarryingAmount_pn3n3_c20260101__20260630__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--MagiumCorpMember_fKCo0KQ_____zAHbf38yRYUl" title="Carrying amount"&gt;1,958,880&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_905_ecustom--FaceValue_pn3n3_c20250101__20250630__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--MagiumCorpMember_fKCo0KQ_____zMJmzLKCxHOh" title="Face value"&gt;2,300,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--CarryingAmount_pn3n3_c20250101__20250630__ifrs-full--ClassesOfAcquiredReceivablesAxis__custom--MagiumCorpMember_fKCo0KQ_____zSqVjKosCEY4" title="Carrying amount"&gt;1,671,780&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: center; padding-bottom: 1.25pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="7" style="text-align: center; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--FaceValue_pn3n3_c20260101__20260630_zCnMy2NtrH15" title="Face value"&gt;2,811,949&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--CarryingAmount_pn3n3_c20260101__20260630_zK2ieqkCDaxl" title="Carrying amount"&gt;2,520,824&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_907_ecustom--FaceValue_pn3n3_c20250101__20250630_zNlTn6ZVo61a" title="Face value"&gt;2,703,047&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--CarryingAmount_pn3n3_c20250101__20250630_zObSnr6Xa4gd" title="Carrying amount"&gt;2,114,674&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;div style="width: 25%; margin-left: 0; margin-right: auto"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.35in; text-align: left"&gt;&lt;span id="xdx_F01_zq8kk39UQem4"&gt;(*1)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_F1A_zQ9vf6oBVYhd"&gt;The loan to Eun Jong Choi is a related party transaction.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_F02_zHkcMFC0dw3j"&gt;(*2)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_F18_zks8iFxAUXza"&gt;The loan to CubeBio Holdings Ltd. is denominated in USD&#160;33,700 and presented in Korean won for reporting purposes. It is a related party transaction.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_F06_zgoV1Cx2lxu1"&gt;(*3)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_F1C_zC7tfFXWDArh"&gt;The loan to Dongsung D&amp;amp;C is denominated in KRW 320,000,000 and presented in Korean won for reporting purposes. The loan to Dongsung D&amp;amp;C is a related party transaction.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_F0E_zQiLv5LlR2k1"&gt;(*4)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_F1F_zVtds3U5Ox2c"&gt;The loan was classified as long-term as it is not expected to be recovered within 12 months after the June&#160;30, 2026 reporting period. In March&#160;2026, the maturity date of the loan was extended to March&#160;31, 2027, and the Company intends to further extend the maturity by one year in March&#160;2027.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:ScheduleOfTermsAndConditionTableTextBlock>
    <cik0002058261:NominalInterestRate
      contextRef="From2026-01-012026-06-30_custom_EunJongChoiMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact005556"
      unitRef="Pure">0.0460</cik0002058261:NominalInterestRate>
    <cik0002058261:Maturity
      contextRef="From2026-01-012026-06-30_custom_EunJongChoiMember_custom_CubebioCo.Ltd.Member"
      id="Fact005558">2026-12-31</cik0002058261:Maturity>
    <cik0002058261:FaceValue
      contextRef="From2026-01-012026-06-30_custom_EunJongChoiMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005560"
      unitRef="KRW">100000000</cik0002058261:FaceValue>
    <cik0002058261:CarryingAmount
      contextRef="From2026-01-012026-06-30_custom_EunJongChoiMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005562"
      unitRef="KRW">128021000</cik0002058261:CarryingAmount>
    <cik0002058261:FaceValue
      contextRef="From2025-01-012025-06-30_custom_EunJongChoiMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005564"
      unitRef="KRW">100000000</cik0002058261:FaceValue>
    <cik0002058261:CarryingAmount
      contextRef="From2025-01-012025-06-30_custom_EunJongChoiMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005566"
      unitRef="KRW">125739000</cik0002058261:CarryingAmount>
    <cik0002058261:NominalInterestRate
      contextRef="From2026-01-012026-06-30_custom_EunJongChoi1Member_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact005568"
      unitRef="Pure">0.0460</cik0002058261:NominalInterestRate>
    <cik0002058261:Maturity
      contextRef="From2026-01-012026-06-30_custom_EunJongChoi1Member_custom_CubebioCo.Ltd.Member"
      id="Fact005570">2026-12-31</cik0002058261:Maturity>
    <cik0002058261:FaceValue
      contextRef="From2026-01-012026-06-30_custom_EunJongChoi1Member_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005572"
      unitRef="KRW">40000000</cik0002058261:FaceValue>
    <cik0002058261:CarryingAmount
      contextRef="From2026-01-012026-06-30_custom_EunJongChoi1Member_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005574"
      unitRef="KRW">51208000</cik0002058261:CarryingAmount>
    <cik0002058261:FaceValue
      contextRef="From2025-01-012025-06-30_custom_EunJongChoi1Member_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005576"
      unitRef="KRW">40000000</cik0002058261:FaceValue>
    <cik0002058261:CarryingAmount
      contextRef="From2025-01-012025-06-30_custom_EunJongChoi1Member_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005578"
      unitRef="KRW">50296000</cik0002058261:CarryingAmount>
    <cik0002058261:NominalInterestRate
      contextRef="From2026-01-012026-06-30_custom_CubeBioHoldingsLtdMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact005580"
      unitRef="Pure">0.0460</cik0002058261:NominalInterestRate>
    <cik0002058261:Maturity
      contextRef="From2026-01-012026-06-30_custom_CubeBioHoldingsLtdMember_custom_CubebioCo.Ltd.Member"
      id="Fact005582">2026-09-24</cik0002058261:Maturity>
    <cik0002058261:FaceValue
      contextRef="From2026-01-012026-06-30_custom_CubeBioHoldingsLtdMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005584"
      unitRef="KRW">46245000</cik0002058261:FaceValue>
    <cik0002058261:CarryingAmount
      contextRef="From2026-01-012026-06-30_custom_CubeBioHoldingsLtdMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005586"
      unitRef="KRW">50048000</cik0002058261:CarryingAmount>
    <cik0002058261:FaceValue
      contextRef="From2025-01-012025-06-30_custom_CubeBioHoldingsLtdMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005588"
      unitRef="KRW">43047000</cik0002058261:FaceValue>
    <cik0002058261:CarryingAmount
      contextRef="From2025-01-012025-06-30_custom_CubeBioHoldingsLtdMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005590"
      unitRef="KRW">45564000</cik0002058261:CarryingAmount>
    <cik0002058261:NominalInterestRate
      contextRef="From2026-01-012026-06-30_custom_CubeBioHoldingsLtd1Member_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact005592"
      unitRef="Pure">0.0460</cik0002058261:NominalInterestRate>
    <cik0002058261:Maturity
      contextRef="From2026-01-012026-06-30_custom_CubeBioHoldingsLtd1Member_custom_CubebioCo.Ltd.Member"
      id="Fact005594">2027-01-28</cik0002058261:Maturity>
    <cik0002058261:FaceValue
      contextRef="From2026-01-012026-06-30_custom_CubeBioHoldingsLtd1Member_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005596"
      unitRef="KRW">5704000</cik0002058261:FaceValue>
    <cik0002058261:CarryingAmount
      contextRef="From2026-01-012026-06-30_custom_CubeBioHoldingsLtd1Member_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005598"
      unitRef="KRW">5811000</cik0002058261:CarryingAmount>
    <cik0002058261:NominalInterestRate
      contextRef="From2026-01-012026-06-30_custom_DongsungDAndCMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact005604"
      unitRef="Pure">0.0460</cik0002058261:NominalInterestRate>
    <cik0002058261:Maturity
      contextRef="From2026-01-012026-06-30_custom_DongsungDAndCMember_custom_CubebioCo.Ltd.Member"
      id="Fact005606">2026-11-04</cik0002058261:Maturity>
    <cik0002058261:FaceValue
      contextRef="From2026-01-012026-06-30_custom_DongsungDAndCMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005608"
      unitRef="KRW">220000000</cik0002058261:FaceValue>
    <cik0002058261:CarryingAmount
      contextRef="From2026-01-012026-06-30_custom_DongsungDAndCMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005610"
      unitRef="KRW">226314000</cik0002058261:CarryingAmount>
    <cik0002058261:FaceValue
      contextRef="From2025-01-012025-06-30_custom_DongsungDAndCMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005612"
      unitRef="KRW">220000000</cik0002058261:FaceValue>
    <cik0002058261:CarryingAmount
      contextRef="From2025-01-012025-06-30_custom_DongsungDAndCMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005614"
      unitRef="KRW">221295000</cik0002058261:CarryingAmount>
    <cik0002058261:NominalInterestRate
      contextRef="From2026-01-012026-06-30_custom_DongsungDAndC1Member_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact005616"
      unitRef="Pure">0.0460</cik0002058261:NominalInterestRate>
    <cik0002058261:Maturity
      contextRef="From2026-01-012026-06-30_custom_DongsungDAndC1Member_custom_CubebioCo.Ltd.Member"
      id="Fact005618">2027-05-17</cik0002058261:Maturity>
    <cik0002058261:FaceValue
      contextRef="From2026-01-012026-06-30_custom_DongsungDAndC1Member_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005620"
      unitRef="KRW">100000000</cik0002058261:FaceValue>
    <cik0002058261:CarryingAmount
      contextRef="From2026-01-012026-06-30_custom_DongsungDAndC1Member_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005622"
      unitRef="KRW">100542000</cik0002058261:CarryingAmount>
    <cik0002058261:FaceValue
      contextRef="From2026-01-012026-06-30_custom_SubtotalMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005628"
      unitRef="KRW">511949000</cik0002058261:FaceValue>
    <cik0002058261:CarryingAmount
      contextRef="From2026-01-012026-06-30_custom_SubtotalMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005630"
      unitRef="KRW">561944000</cik0002058261:CarryingAmount>
    <cik0002058261:FaceValue
      contextRef="From2025-01-012025-06-30_custom_SubtotalMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005632"
      unitRef="KRW">403047000</cik0002058261:FaceValue>
    <cik0002058261:CarryingAmount
      contextRef="From2025-01-012025-06-30_custom_SubtotalMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005634"
      unitRef="KRW">442894000</cik0002058261:CarryingAmount>
    <cik0002058261:NominalInterestRate
      contextRef="From2026-01-012026-06-30_custom_MagiumCorpMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact005636"
      unitRef="Pure">0.0500</cik0002058261:NominalInterestRate>
    <cik0002058261:Maturity
      contextRef="From2026-01-012026-06-30_custom_MagiumCorpMember_custom_CubebioCo.Ltd.Member"
      id="Fact005638">2027-03-31</cik0002058261:Maturity>
    <cik0002058261:FaceValue
      contextRef="From2026-01-012026-06-30_custom_MagiumCorpMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005640"
      unitRef="KRW">2300000000</cik0002058261:FaceValue>
    <cik0002058261:CarryingAmount
      contextRef="From2026-01-012026-06-30_custom_MagiumCorpMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005642"
      unitRef="KRW">1958880000</cik0002058261:CarryingAmount>
    <cik0002058261:FaceValue
      contextRef="From2025-01-012025-06-30_custom_MagiumCorpMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005644"
      unitRef="KRW">2300000000</cik0002058261:FaceValue>
    <cik0002058261:CarryingAmount
      contextRef="From2025-01-012025-06-30_custom_MagiumCorpMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005646"
      unitRef="KRW">1671780000</cik0002058261:CarryingAmount>
    <cik0002058261:FaceValue
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005648"
      unitRef="KRW">2811949000</cik0002058261:FaceValue>
    <cik0002058261:CarryingAmount
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005650"
      unitRef="KRW">2520824000</cik0002058261:CarryingAmount>
    <cik0002058261:FaceValue
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005652"
      unitRef="KRW">2703047000</cik0002058261:FaceValue>
    <cik0002058261:CarryingAmount
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005654"
      unitRef="KRW">2114674000</cik0002058261:CarryingAmount>
    <cik0002058261:ChangesInLossAllowanceForExpectedCreditLossesOnLoanReceivablesTableTextBlock
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      id="Fact005667">&lt;table cellpadding="0" cellspacing="0" id="xdx_89C_ecustom--ChangesInLossAllowanceForExpectedCreditLossesOnLoanReceivablesTableTextBlock_pn3n3_zxQcdFr25cv6" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Loans receivables (Details 1)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_8BD_zwOGpkEFk9ca" style="display: none"&gt;Changes in loss allowance for expected credit losses on loan receivables&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49A_20260101__20260630_zTivSAPxD6xd" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;June&#160;30,&lt;br/&gt;2026&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;b&gt;Short-term loans, net&lt;/b&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--ShortTermLoanReceivable_iS_zfIpivaBdd85" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Beginning of the year&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#x20a9;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5669"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--WriteoffOfAllowanceForDoubtfulAccounts_zl48rgANvVec" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Write-off of allowance for doubtful accounts&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5671"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--ReclassificationOfLongtermToShortterm_zfUYLc0Nnh02" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Reclassification of long-term to short-term&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5673"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--ShortTermLoanReceivable_iE_zuupt3uvTRa8" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Ending of the year&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5675"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;b&gt;Long-term loans receivable, net&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--LongtermLoanReceivableNet_iS_zvjzfGq7HKQ7" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Beginning of the year&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#x20a9;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;628,220&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--OtherBadDebtExpenses_zxpdanQltS07" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Other bad debt expenses&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5679"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--ReversalOfAllowanceForDoubtfulAccounts_zrcHClF0ku79" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Reversal of allowance for doubtful accounts&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(287,100&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--LongtermLoanReceivableNet_iE_zw1K9ooiXnIe" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Ending of the period&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;341,120&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;b&gt;Long-term Accrued interest income&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--LongTermAccruedInterestIncome_iS_zcxtHtAAQ9gj" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Beginning of the year&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#x20a9;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;247,458&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--LongTermAccruedInterestIncomeOtherBadDebtExpenses_i_pp0p" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Other bad debt expenses&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;65,379&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--LongTermAccruedInterestIncome_iE_zvQFaT2tbKU3" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Ending of the period&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;312,837&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:ChangesInLossAllowanceForExpectedCreditLossesOnLoanReceivablesTableTextBlock>
    <cik0002058261:LongtermLoanReceivableNet
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005677"
      unitRef="KRW">628220000</cik0002058261:LongtermLoanReceivableNet>
    <cik0002058261:ReversalOfAllowanceForDoubtfulAccounts
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005681"
      unitRef="KRW">-287100000</cik0002058261:ReversalOfAllowanceForDoubtfulAccounts>
    <cik0002058261:LongtermLoanReceivableNet
      contextRef="AsOf2026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005683"
      unitRef="KRW">341120000</cik0002058261:LongtermLoanReceivableNet>
    <cik0002058261:LongTermAccruedInterestIncome
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005685"
      unitRef="KRW">247458000</cik0002058261:LongTermAccruedInterestIncome>
    <cik0002058261:LongTermAccruedInterestIncomeOtherBadDebtExpenses
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005687"
      unitRef="KRW">65379000</cik0002058261:LongTermAccruedInterestIncomeOtherBadDebtExpenses>
    <cik0002058261:LongTermAccruedInterestIncome
      contextRef="AsOf2026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005689"
      unitRef="KRW">312837000</cik0002058261:LongTermAccruedInterestIncome>
    <cik0002058261:FinancialInstrumentsDisclosureTextBlock
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      id="Fact005691">&lt;p id="xdx_800_ecustom--FinancialInstrumentsDisclosureTextBlock_zVLAXCM9mkYc" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;8. &lt;span id="xdx_82E_z9OIzMjhXIc6"&gt;Financial instruments &#x2013; Fair values and risk management&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;A.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;b&gt;Accounting classifications and fair values&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The following table shows the carrying amounts and fair values of financial assets and financial liabilities, including their levels in the fair value hierarchy. It does not include fair value information for financial assets and financial liabilities not measured at fair value if the carrying amount is a reasonable approximation of fair value.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The carrying amounts of financial instruments by category as of June&#160;30, 2026 are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--ScheduleOfFinancialAssetsAndLiabilityFairValueTableTextBlock_pn3n3_zpz1M3emh4V3" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Financial Instruments - Fair values and risk management (Details)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_8BE_zhV3w7pa7MG8" style="display: none"&gt;Schedule of financial assets and liability at fair value&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Carrying amount&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Fair value&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Level 1&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Level 2&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Level 3&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="22" style="text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;b&gt;Financial liabilities at fair value&lt;br/&gt;through profit or loss&lt;/b&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Derivative liabilities (*)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#x20a9;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--DerivativeFinancialLiabilities_iI_pn3n3_c20260630__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--CarryingAmountMember_fKCop_z55SJfYZCgHj" title="Derivative liabilities"&gt;979,969&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--DerivativeFinancialLiabilities_iI_pn3n3_c20260630__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--FairValueMember_fKCop_zHlHvnGVB0rd" title="Derivative liabilities"&gt;979,969&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--DerivativeFinancialLiabilities_iI_pn3n3_c20260630__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--FairValueMember__ifrs-full--ClassesOfLiabilitiesAxis__custom--FinancialLiabilityMember__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level1OfFairValueHierarchyMember_fKCop_zvO04tZLN5b6" title="Derivative liabilities"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5699"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--DerivativeFinancialLiabilities_iI_pn3n3_c20260630__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--FairValueMember__ifrs-full--ClassesOfLiabilitiesAxis__custom--FinancialLiabilityMember__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_fKCop_zjtc8YsTHivc" title="Derivative liabilities"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5701"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--DerivativeFinancialLiabilities_iI_pn3n3_c20260630__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--FairValueMember__ifrs-full--ClassesOfLiabilitiesAxis__custom--FinancialLiabilityMember__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_fKCop_zG9PYRHAUxJ5" title="Derivative liabilities"&gt;979,969&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--DerivativeFinancialLiabilities_iI_pn3n3_c20260630__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--FairValueMember__ifrs-full--ClassesOfLiabilitiesAxis__custom--FinancialLiabilityMember_fKCop_zzFRHjPROW5d" title="Derivative liabilities"&gt;979,969&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;div style="width: 25%; margin-left: 0; margin-right: auto"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&lt;span id="xdx_F0C_zEgPUVfDmRH3"&gt;(*)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_F14_zshWVacOZfUi"&gt;Represents the early redemption rights of the issuer and the investor, which are embedded derivatives of bonds with warrants issued to fund the operations.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

















&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The carrying amounts of financial instruments by category as of December&#160;31, 2025 are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Carrying amount&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Fair value&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Level 1&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Level 2&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Level 3&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="22" style="text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;b&gt;Financial liabilities at fair value through profit or loss&lt;/b&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Derivative liabilities (*)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#x20a9;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--DerivativeFinancialLiabilities_iI_pn3n3_c20251231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--CarryingAmountMember_fKCop_zq7EiFQWpU7h" title="Derivative liabilities"&gt;1,267,801&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--DerivativeFinancialLiabilities_iI_pn3n3_c20251231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--FairValueMember_fKCop_zEM7n0KRvK46" title="Derivative liabilities"&gt;1,267,801&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--DerivativeFinancialLiabilities_iI_pn3n3_c20251231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--FairValueMember__ifrs-full--ClassesOfAssetsAxis__custom--FinancialAssetsMember__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level1OfFairValueHierarchyMember_fKCop_zBDsFTmA86s" title="Derivative liabilities"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5719"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--DerivativeFinancialLiabilities_iI_pn3n3_c20251231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--FairValueMember__ifrs-full--ClassesOfAssetsAxis__custom--FinancialAssetsMember__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_fKCop_zwzmobkThlV3" title="Derivative liabilities"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5721"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--DerivativeFinancialLiabilities_iI_pn3n3_c20251231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--FairValueMember__ifrs-full--ClassesOfAssetsAxis__custom--FinancialAssetsMember__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_fKCop_zn9kg5EAIFRa" title="Derivative liabilities"&gt;1,267,801&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--DerivativeFinancialLiabilities_iI_pn3n3_c20251231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--FairValueMember__ifrs-full--ClassesOfAssetsAxis__custom--FinancialAssetsMember_fKCop_zfx1tRKIkys8" title="Derivative liabilities"&gt;1,267,801&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;div style="width: 25%; margin-left: 0; margin-right: auto"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&lt;span id="xdx_F09_ztDfVTCHk6Ch"&gt;(*)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_F1C_zi13JfyI4o21"&gt;Represents the early redemption rights of the issuer and the investor, which are embedded derivatives of bonds with warrants issued to fund the operations.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A2_zbz8C5e53j44" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;B.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;b&gt;Measurement of fair values&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Fair values are categorized into different levels in a fair value hierarchy based on the inputs used in the valuation techniques as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 0.25in"&gt;&#x25cf;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;Level 1: quoted prices (unadjusted) in active markets for identical assets or liabilities.&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#x25cf;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;Level 2: all inputs other than quoted prices included in Level 1 that are observable (either directly that is, prices, or indirectly that is, derived from prices) for the asset or liability.&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#x25cf;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;Level 3: unobservable inputs for the asset or liability.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The fair value of financial instruments traded in an active market is determined based on the quoted market price as of the end of the reporting period. If the quoted prices are readily and regularly available through exchanges, sellers, brokers, industry groups, rating agencies, or regulators and such prices represent actual market transactions that occur regularly between independent parties, they are considered active markets.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The fair value of financial instruments that are not traded in an active market is determined using valuation techniques. These valuation techniques use as much market observable information as possible and use the least amount of the entity-specific information. At this time, if all the significant input variables required to measure the fair value are observable, the financial instruments are classified as Level 2.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;If one or more significant input variable is not based on observable market information, the item is included in Level 3.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company recognizes the bond with warrants as financial liabilities measured at amortized cost. Also, The Company recognizes the early redemption rights of the issuer and the bondholders as financial liabilities measured at FVTPL. In addition, the detachable warrants are assessed separately and are classified either as equity instruments when the fixed-for-fixed condition is met, or as derivative liabilities measured at fair value through profit or loss when the equity classification criteria are not met.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Warrants are subsequently reclassified from derivative financial liabilities to equity instruments when the exercise price is determined and the fixed-for-fixed condition is met. On the reclassification date, the derivative warrant liability is remeasured at fair value using the applicable valuation technique, including the Company&#x2019;s credit risk rate, and the resulting amount is transferred to equity. Following reclassification, the warrants are not subsequently remeasured.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

















&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company uses various valuation methods to determine the fair value of financial instruments that are not traded in an active market. The valuation methods applied to each derivative financial liability reflects the nature and payoff structure of the underlying instrument. Option-like instruments whose value is significantly affected by the volatility of the Company&#x2019;s equity price are measured using option pricing models such as the Binomial Model, whereas derivative financial liabilities with deterministic cash flows, such as early redemption rights, are measured using the discounted present value method. The fair value of the Company&#x2019;s common share was estimated using the backsolve method, a form of the subject company transaction method, wherein the equity value for a privately held company is derived from a recent transaction in the company&#x2019;s own securities. Early redemption rights recognized as derivative financial liabilities are measured using the discounted present value method. For early redemption rights, the Company applies a discounted cash flow model using a with-and-without approach. Inputs used to such valuation methods include interest rate and risk premium, and the Company performs valuation using the inputs which are consistent with the natures of assets and liabilities measured.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Assumptions to value the warrants used in level 3 fair value measurements as of June&#160;30, 2026 and December&#160;31, 2025 are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89B_ecustom--AssumptionsToValueWarrantsUsedTableTextBlock_pn3n3_zD7AG3pvpVm7" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Financial Instruments - Fair values and risk management (Details 1)"&gt;
  &lt;tr style="background-color: #FFFFFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left; vertical-align: bottom"&gt;&lt;span id="xdx_8BC_zE5x7wOZ2Cl6" style="display: none"&gt;Assumptions to value the warrants used&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF"&gt;
    &lt;td style="text-align: left; vertical-align: middle; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center; width: 1%; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center; width: 18%"&gt;&lt;b&gt;2026&lt;/b&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: center; width: 2%; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center; width: 18%"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF"&gt;
    &lt;td style="text-align: left; vertical-align: bottom; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;b&gt;Early redemption rights&lt;/b&gt;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left; vertical-align: bottom"&gt;Risk-adjusted discount rate&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center"&gt;&lt;span id="xdx_901_ecustom--RiskadjustedDiscount_iI_pid_dp_c20260630__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_z7MWl9P1sVEf" title="Risk-adjusted discount"&gt;15.23%&lt;/span&gt;~&lt;span id="xdx_90C_ecustom--RiskadjustedDiscount_iI_pid_dp_c20260630__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zT56aTe6TTxa" title="Risk-adjusted discount"&gt;22.17%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center"&gt;&lt;span id="xdx_90F_ecustom--RiskadjustedDiscount_iI_pid_dp_c20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_ziJJCrX4hzRg" title="Risk-adjusted discount"&gt;12.60%&lt;/span&gt;~&lt;span id="xdx_907_ecustom--RiskadjustedDiscount_iI_pid_dp_c20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zmqeuoF0UBdh" title="Risk-adjusted discount"&gt;19.80%&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AB_z202ZZPnQTH1" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;Sensitivity analysis of changes in unobservable inputs&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Sensitivity analysis of financial instruments is performed to measure favorable and unfavorable changes in the fair value of financial instruments which are affected by unobservable parameters, using a statistical technique. When the fair value is affected by more than one input parameter, the amounts represent the most favorable or most unfavorable outcome. Level 3 financial instruments subject to sensitivity analysis are derivative financial liabilities consisting of early redemption rights and preemptive rights.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Results of the sensitivity analysis of changes in unobservable inputs as of June&#160;30, 2026 and December&#160;31, 2025 are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89C_ecustom--ScheduleOfSignificantUnobservableInputsTableTextBlock_pn3n3_zW01UqcAzn7c" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Financial Instruments - Fair values and risk management (Details 1)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span id="xdx_8BA_zybJrCwoi9Kc" style="display: none"&gt;Schedule
    of significant unobservable inputs&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="14" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;June&#160;30, 2026&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Profit or loss&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Other comprehensive&lt;br/&gt; income or loss&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Favorable&lt;br/&gt; changes&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Unfavorable&lt;br/&gt; changes&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Favorable&lt;br/&gt; changes&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Unfavorable&lt;br/&gt; changes&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="14" style="text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;b&gt;Financial Liabilities&lt;/b&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Derivative financial liability&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.375in; text-indent: -0.125in"&gt;Early redemption rights (*1)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#x20a9;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_902_ecustom--FavorableChanges_iI_pn3n3_c20260630__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--EarlyRedemptionRightsMember__custom--IncomeStatementsLocationAxis__custom--ProfitOrLossMember_fKCoxKQ_____zAsfZHsmLK29" title="Favorable changes"&gt;27,311&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_901_ecustom--UnfavorableChanges_iNI_pn3n3_di_c20260630__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--EarlyRedemptionRightsMember__custom--IncomeStatementsLocationAxis__custom--ProfitOrLossMember_fKCoxKQ_____zI285Pt6OsSg" title="Unfavorable changes"&gt;(26,418&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_907_ecustom--FavorableChanges_iI_pn3n3_c20260630__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--EarlyRedemptionRightsMember__custom--IncomeStatementsLocationAxis__custom--OtherComprehensiveIncomeOrLossMember_fKCoxKQ_____zCXwqFYcJKJd" title="Favorable changes"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5751"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_906_ecustom--UnfavorableChanges_iNI_pn3n3_di_c20260630__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--EarlyRedemptionRightsMember__custom--IncomeStatementsLocationAxis__custom--OtherComprehensiveIncomeOrLossMember_fKCoxKQ_____z0OmLG6bWfMk" title="Unfavorable changes"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5753"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;div style="width: 25%; margin-left: 0; margin-right: auto"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.35in; text-align: left"&gt;&lt;span id="xdx_F02_zof4iTJCXYWf"&gt;(*1)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_F17_zXWqM5JZCwGk"&gt;For early redemption rights, changes in fair value are calculated by shifting principal unobservable input parameters such as correlation between risk-adjusted discount rates (-1%p~1%p).&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

















&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="14" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;December&#160;31, 2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Profit or loss&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;
        &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;Other comprehensive&lt;/b&gt;&lt;/p&gt;
        &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;income or loss&lt;/b&gt;&lt;/p&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Favorable&lt;br/&gt; changes&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Unfavorable&lt;br/&gt; changes&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;
        &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;Favorable&lt;/b&gt;&lt;/p&gt;
        &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;changes&lt;/b&gt;&lt;/p&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Unfavorable&lt;br/&gt; changes&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="14" style="text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;b&gt;Financial Liabilities&lt;/b&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Derivative financial liability&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.375in; text-indent: -0.125in"&gt;Early redemption rights (*1)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#x20a9;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_ecustom--FavorableChanges_iI_pn3n3_c20251231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--EarlyRedemptionRightsMember__custom--IncomeStatementsLocationAxis__custom--ProfitOrLossMember_fKCoxKQ_____zlJh1UgymTI4" title="Favorable changes"&gt;43,698&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_904_ecustom--UnfavorableChanges_iNI_pn3n3_di_c20251231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--EarlyRedemptionRightsMember__custom--IncomeStatementsLocationAxis__custom--ProfitOrLossMember_fKCoxKQ_____zg0eO2rvcHDe" title="Unfavorable changes"&gt;(41,087&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_900_ecustom--FavorableChanges_iI_pn3n3_c20251231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--EarlyRedemptionRightsMember__custom--IncomeStatementsLocationAxis__custom--OtherComprehensiveIncomeOrLossMember_fKCoxKQ_____zoU252a74LC3" title="Favorable changes"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5767"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_909_ecustom--UnfavorableChanges_iNI_pn3n3_di_c20251231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--EarlyRedemptionRightsMember__custom--IncomeStatementsLocationAxis__custom--OtherComprehensiveIncomeOrLossMember_fKCoxKQ_____zM20PvCNkgF6" title="Unfavorable changes"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5769"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;div style="width: 25%; margin-left: 0; margin-right: auto"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td id="xdx_F04_zjsLkMfdAWi9" style="width: 0.35in; text-align: left"&gt;(*1)&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_F1F_ziAE5OuNgLXh"&gt;For early redemption rights, changes in fair value are calculated by shifting principal unobservable input parameters such as correlation between risk-adjusted discount rates (-1%p~1%p).&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AD_z9cKOXGZpzj3" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Amounts recognized in profit or loss and changes in the fair value of derivative liabilities at fair value through profit or loss are included in Note&#160;21.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

</cik0002058261:FinancialInstrumentsDisclosureTextBlock>
    <cik0002058261:ScheduleOfFinancialAssetsAndLiabilityFairValueTableTextBlock
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      id="Fact005693">&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--ScheduleOfFinancialAssetsAndLiabilityFairValueTableTextBlock_pn3n3_zpz1M3emh4V3" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Financial Instruments - Fair values and risk management (Details)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_8BE_zhV3w7pa7MG8" style="display: none"&gt;Schedule of financial assets and liability at fair value&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Carrying amount&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Fair value&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Level 1&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Level 2&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Level 3&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="22" style="text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;b&gt;Financial liabilities at fair value&lt;br/&gt;through profit or loss&lt;/b&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Derivative liabilities (*)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#x20a9;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--DerivativeFinancialLiabilities_iI_pn3n3_c20260630__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--CarryingAmountMember_fKCop_z55SJfYZCgHj" title="Derivative liabilities"&gt;979,969&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--DerivativeFinancialLiabilities_iI_pn3n3_c20260630__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--FairValueMember_fKCop_zHlHvnGVB0rd" title="Derivative liabilities"&gt;979,969&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--DerivativeFinancialLiabilities_iI_pn3n3_c20260630__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--FairValueMember__ifrs-full--ClassesOfLiabilitiesAxis__custom--FinancialLiabilityMember__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level1OfFairValueHierarchyMember_fKCop_zvO04tZLN5b6" title="Derivative liabilities"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5699"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--DerivativeFinancialLiabilities_iI_pn3n3_c20260630__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--FairValueMember__ifrs-full--ClassesOfLiabilitiesAxis__custom--FinancialLiabilityMember__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_fKCop_zjtc8YsTHivc" title="Derivative liabilities"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5701"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--DerivativeFinancialLiabilities_iI_pn3n3_c20260630__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--FairValueMember__ifrs-full--ClassesOfLiabilitiesAxis__custom--FinancialLiabilityMember__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_fKCop_zG9PYRHAUxJ5" title="Derivative liabilities"&gt;979,969&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--DerivativeFinancialLiabilities_iI_pn3n3_c20260630__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--FairValueMember__ifrs-full--ClassesOfLiabilitiesAxis__custom--FinancialLiabilityMember_fKCop_zzFRHjPROW5d" title="Derivative liabilities"&gt;979,969&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;div style="width: 25%; margin-left: 0; margin-right: auto"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&lt;span id="xdx_F0C_zEgPUVfDmRH3"&gt;(*)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_F14_zshWVacOZfUi"&gt;Represents the early redemption rights of the issuer and the investor, which are embedded derivatives of bonds with warrants issued to fund the operations.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

















&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The carrying amounts of financial instruments by category as of December&#160;31, 2025 are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Carrying amount&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Fair value&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Level 1&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Level 2&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Level 3&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="22" style="text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;b&gt;Financial liabilities at fair value through profit or loss&lt;/b&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Derivative liabilities (*)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#x20a9;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--DerivativeFinancialLiabilities_iI_pn3n3_c20251231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--CarryingAmountMember_fKCop_zq7EiFQWpU7h" title="Derivative liabilities"&gt;1,267,801&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--DerivativeFinancialLiabilities_iI_pn3n3_c20251231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--FairValueMember_fKCop_zEM7n0KRvK46" title="Derivative liabilities"&gt;1,267,801&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--DerivativeFinancialLiabilities_iI_pn3n3_c20251231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--FairValueMember__ifrs-full--ClassesOfAssetsAxis__custom--FinancialAssetsMember__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level1OfFairValueHierarchyMember_fKCop_zBDsFTmA86s" title="Derivative liabilities"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5719"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--DerivativeFinancialLiabilities_iI_pn3n3_c20251231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--FairValueMember__ifrs-full--ClassesOfAssetsAxis__custom--FinancialAssetsMember__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_fKCop_zwzmobkThlV3" title="Derivative liabilities"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5721"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--DerivativeFinancialLiabilities_iI_pn3n3_c20251231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--FairValueMember__ifrs-full--ClassesOfAssetsAxis__custom--FinancialAssetsMember__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_fKCop_zn9kg5EAIFRa" title="Derivative liabilities"&gt;1,267,801&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--DerivativeFinancialLiabilities_iI_pn3n3_c20251231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--FairValueMember__ifrs-full--ClassesOfAssetsAxis__custom--FinancialAssetsMember_fKCop_zfx1tRKIkys8" title="Derivative liabilities"&gt;1,267,801&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;div style="width: 25%; margin-left: 0; margin-right: auto"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&lt;span id="xdx_F09_ztDfVTCHk6Ch"&gt;(*)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_F1C_zi13JfyI4o21"&gt;Represents the early redemption rights of the issuer and the investor, which are embedded derivatives of bonds with warrants issued to fund the operations.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:ScheduleOfFinancialAssetsAndLiabilityFairValueTableTextBlock>
    <ifrs-full:DerivativeFinancialLiabilities
      contextRef="AsOf2026-06-30_ifrs-full_CarryingAmountMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005695"
      unitRef="KRW">979969000</ifrs-full:DerivativeFinancialLiabilities>
    <ifrs-full:DerivativeFinancialLiabilities
      contextRef="AsOf2026-06-30_custom_FairValueMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005697"
      unitRef="KRW">979969000</ifrs-full:DerivativeFinancialLiabilities>
    <ifrs-full:DerivativeFinancialLiabilities
      contextRef="AsOf2026-06-30_custom_FairValueMember_custom_FinancialLiabilityMember_ifrs-full_Level3OfFairValueHierarchyMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005703"
      unitRef="KRW">979969000</ifrs-full:DerivativeFinancialLiabilities>
    <ifrs-full:DerivativeFinancialLiabilities
      contextRef="AsOf2026-06-30_custom_FairValueMember_custom_FinancialLiabilityMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005705"
      unitRef="KRW">979969000</ifrs-full:DerivativeFinancialLiabilities>
    <ifrs-full:DerivativeFinancialLiabilities
      contextRef="AsOf2025-12-31_ifrs-full_CarryingAmountMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005715"
      unitRef="KRW">1267801000</ifrs-full:DerivativeFinancialLiabilities>
    <ifrs-full:DerivativeFinancialLiabilities
      contextRef="AsOf2025-12-31_custom_FairValueMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005717"
      unitRef="KRW">1267801000</ifrs-full:DerivativeFinancialLiabilities>
    <ifrs-full:DerivativeFinancialLiabilities
      contextRef="AsOf2025-12-31_custom_FairValueMember_custom_FinancialAssetsMember_ifrs-full_Level3OfFairValueHierarchyMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005723"
      unitRef="KRW">1267801000</ifrs-full:DerivativeFinancialLiabilities>
    <ifrs-full:DerivativeFinancialLiabilities
      contextRef="AsOf2025-12-31_custom_FairValueMember_custom_FinancialAssetsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005725"
      unitRef="KRW">1267801000</ifrs-full:DerivativeFinancialLiabilities>
    <cik0002058261:AssumptionsToValueWarrantsUsedTableTextBlock
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      id="Fact005735">&lt;table cellpadding="0" cellspacing="0" id="xdx_89B_ecustom--AssumptionsToValueWarrantsUsedTableTextBlock_pn3n3_zD7AG3pvpVm7" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Financial Instruments - Fair values and risk management (Details 1)"&gt;
  &lt;tr style="background-color: #FFFFFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left; vertical-align: bottom"&gt;&lt;span id="xdx_8BC_zE5x7wOZ2Cl6" style="display: none"&gt;Assumptions to value the warrants used&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF"&gt;
    &lt;td style="text-align: left; vertical-align: middle; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center; width: 1%; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center; width: 18%"&gt;&lt;b&gt;2026&lt;/b&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: center; width: 2%; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center; width: 18%"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF"&gt;
    &lt;td style="text-align: left; vertical-align: bottom; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;b&gt;Early redemption rights&lt;/b&gt;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left; vertical-align: bottom"&gt;Risk-adjusted discount rate&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center"&gt;&lt;span id="xdx_901_ecustom--RiskadjustedDiscount_iI_pid_dp_c20260630__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_z7MWl9P1sVEf" title="Risk-adjusted discount"&gt;15.23%&lt;/span&gt;~&lt;span id="xdx_90C_ecustom--RiskadjustedDiscount_iI_pid_dp_c20260630__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zT56aTe6TTxa" title="Risk-adjusted discount"&gt;22.17%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center"&gt;&lt;span id="xdx_90F_ecustom--RiskadjustedDiscount_iI_pid_dp_c20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_ziJJCrX4hzRg" title="Risk-adjusted discount"&gt;12.60%&lt;/span&gt;~&lt;span id="xdx_907_ecustom--RiskadjustedDiscount_iI_pid_dp_c20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zmqeuoF0UBdh" title="Risk-adjusted discount"&gt;19.80%&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:AssumptionsToValueWarrantsUsedTableTextBlock>
    <cik0002058261:RiskadjustedDiscount
      contextRef="AsOf2026-06-30_ifrs-full_Level3OfFairValueHierarchyMember_ifrs-full_BottomOfRangeMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact005737"
      unitRef="Pure">0.1523</cik0002058261:RiskadjustedDiscount>
    <cik0002058261:RiskadjustedDiscount
      contextRef="AsOf2026-06-30_ifrs-full_Level3OfFairValueHierarchyMember_ifrs-full_TopOfRangeMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact005739"
      unitRef="Pure">0.2217</cik0002058261:RiskadjustedDiscount>
    <cik0002058261:RiskadjustedDiscount
      contextRef="AsOf2025-12-31_ifrs-full_Level3OfFairValueHierarchyMember_ifrs-full_BottomOfRangeMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact005741"
      unitRef="Pure">0.1260</cik0002058261:RiskadjustedDiscount>
    <cik0002058261:RiskadjustedDiscount
      contextRef="AsOf2025-12-31_ifrs-full_Level3OfFairValueHierarchyMember_ifrs-full_TopOfRangeMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact005743"
      unitRef="Pure">0.1980</cik0002058261:RiskadjustedDiscount>
    <cik0002058261:ScheduleOfSignificantUnobservableInputsTableTextBlock
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      id="Fact005745">&lt;table cellpadding="0" cellspacing="0" id="xdx_89C_ecustom--ScheduleOfSignificantUnobservableInputsTableTextBlock_pn3n3_zW01UqcAzn7c" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Financial Instruments - Fair values and risk management (Details 1)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span id="xdx_8BA_zybJrCwoi9Kc" style="display: none"&gt;Schedule
    of significant unobservable inputs&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="14" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;June&#160;30, 2026&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Profit or loss&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Other comprehensive&lt;br/&gt; income or loss&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Favorable&lt;br/&gt; changes&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Unfavorable&lt;br/&gt; changes&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Favorable&lt;br/&gt; changes&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Unfavorable&lt;br/&gt; changes&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="14" style="text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;b&gt;Financial Liabilities&lt;/b&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Derivative financial liability&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.375in; text-indent: -0.125in"&gt;Early redemption rights (*1)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#x20a9;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_902_ecustom--FavorableChanges_iI_pn3n3_c20260630__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--EarlyRedemptionRightsMember__custom--IncomeStatementsLocationAxis__custom--ProfitOrLossMember_fKCoxKQ_____zAsfZHsmLK29" title="Favorable changes"&gt;27,311&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_901_ecustom--UnfavorableChanges_iNI_pn3n3_di_c20260630__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--EarlyRedemptionRightsMember__custom--IncomeStatementsLocationAxis__custom--ProfitOrLossMember_fKCoxKQ_____zI285Pt6OsSg" title="Unfavorable changes"&gt;(26,418&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_907_ecustom--FavorableChanges_iI_pn3n3_c20260630__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--EarlyRedemptionRightsMember__custom--IncomeStatementsLocationAxis__custom--OtherComprehensiveIncomeOrLossMember_fKCoxKQ_____zCXwqFYcJKJd" title="Favorable changes"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5751"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_906_ecustom--UnfavorableChanges_iNI_pn3n3_di_c20260630__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--EarlyRedemptionRightsMember__custom--IncomeStatementsLocationAxis__custom--OtherComprehensiveIncomeOrLossMember_fKCoxKQ_____z0OmLG6bWfMk" title="Unfavorable changes"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5753"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;div style="width: 25%; margin-left: 0; margin-right: auto"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.35in; text-align: left"&gt;&lt;span id="xdx_F02_zof4iTJCXYWf"&gt;(*1)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_F17_zXWqM5JZCwGk"&gt;For early redemption rights, changes in fair value are calculated by shifting principal unobservable input parameters such as correlation between risk-adjusted discount rates (-1%p~1%p).&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

















&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="14" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;December&#160;31, 2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Profit or loss&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;
        &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;Other comprehensive&lt;/b&gt;&lt;/p&gt;
        &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;income or loss&lt;/b&gt;&lt;/p&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Favorable&lt;br/&gt; changes&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Unfavorable&lt;br/&gt; changes&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;
        &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;Favorable&lt;/b&gt;&lt;/p&gt;
        &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;changes&lt;/b&gt;&lt;/p&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Unfavorable&lt;br/&gt; changes&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="14" style="text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;b&gt;Financial Liabilities&lt;/b&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Derivative financial liability&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.375in; text-indent: -0.125in"&gt;Early redemption rights (*1)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#x20a9;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_ecustom--FavorableChanges_iI_pn3n3_c20251231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--EarlyRedemptionRightsMember__custom--IncomeStatementsLocationAxis__custom--ProfitOrLossMember_fKCoxKQ_____zlJh1UgymTI4" title="Favorable changes"&gt;43,698&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_904_ecustom--UnfavorableChanges_iNI_pn3n3_di_c20251231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--EarlyRedemptionRightsMember__custom--IncomeStatementsLocationAxis__custom--ProfitOrLossMember_fKCoxKQ_____zg0eO2rvcHDe" title="Unfavorable changes"&gt;(41,087&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_900_ecustom--FavorableChanges_iI_pn3n3_c20251231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--EarlyRedemptionRightsMember__custom--IncomeStatementsLocationAxis__custom--OtherComprehensiveIncomeOrLossMember_fKCoxKQ_____zoU252a74LC3" title="Favorable changes"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5767"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_909_ecustom--UnfavorableChanges_iNI_pn3n3_di_c20251231__ifrs-full--CategoriesOfFinancialAssetsAxis__custom--EarlyRedemptionRightsMember__custom--IncomeStatementsLocationAxis__custom--OtherComprehensiveIncomeOrLossMember_fKCoxKQ_____zM20PvCNkgF6" title="Unfavorable changes"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5769"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;div style="width: 25%; margin-left: 0; margin-right: auto"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td id="xdx_F04_zjsLkMfdAWi9" style="width: 0.35in; text-align: left"&gt;(*1)&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_F1F_ziAE5OuNgLXh"&gt;For early redemption rights, changes in fair value are calculated by shifting principal unobservable input parameters such as correlation between risk-adjusted discount rates (-1%p~1%p).&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:ScheduleOfSignificantUnobservableInputsTableTextBlock>
    <cik0002058261:FavorableChanges
      contextRef="AsOf2026-06-30_custom_EarlyRedemptionRightsMember_custom_ProfitOrLossMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005747"
      unitRef="KRW">27311000</cik0002058261:FavorableChanges>
    <cik0002058261:UnfavorableChanges
      contextRef="AsOf2026-06-30_custom_EarlyRedemptionRightsMember_custom_ProfitOrLossMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005749"
      unitRef="KRW">26418000</cik0002058261:UnfavorableChanges>
    <cik0002058261:FavorableChanges
      contextRef="AsOf2025-12-31_custom_EarlyRedemptionRightsMember_custom_ProfitOrLossMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005763"
      unitRef="KRW">43698000</cik0002058261:FavorableChanges>
    <cik0002058261:UnfavorableChanges
      contextRef="AsOf2025-12-31_custom_EarlyRedemptionRightsMember_custom_ProfitOrLossMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005765"
      unitRef="KRW">41087000</cik0002058261:UnfavorableChanges>
    <cik0002058261:PropertyPlantAndEquipmentDisclosureTextBlock
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      id="Fact005772">&lt;p id="xdx_809_ecustom--PropertyPlantAndEquipmentDisclosureTextBlock_zDf8dQ4wzhj3" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;9. &lt;span id="xdx_825_zNHU8Rjo0I95"&gt;Property and equipment&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;A.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;b&gt;Reconciliation of carrying amount&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Details of property and equipment as of June&#160;30, 2026 and December&#160;31, 2025 are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89F_eifrs-full--DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_pn3n3_z0yxuBiZeIxk" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Property and equipment (Details)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&lt;span id="xdx_8B1_zVwNFHj1BJPb" style="display: none"&gt;Schedule of property plant and equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="14" style="border-bottom: Black 0.5pt solid; text-align: center"&gt;&lt;b&gt;June&#160;30, 2026&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-bottom: 1pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 1pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 1pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 1pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Cost&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 1pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 1pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Accumulated&lt;br/&gt;depreciation&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 1pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 1pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Accumulated&lt;br/&gt;impairment losses&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 1pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 1pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Carrying&lt;br/&gt;Amount&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 1pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th style="text-align: center"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="13" style="text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Machinery&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20260630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CostMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndEquipmentsMember_zUA4yQsukTz7" title="Property, plant and equipment"&gt;736,246&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_908_ecustom--AccumulatedDepreciation_iNI_pn3n3_di_c20260630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndEquipmentsMember_zhztR4R1lJz1"&gt;(468,587&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20260630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndEquipmentsMember_zThniTNGNBR5" title="Property, plant and equipment"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5779"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20260630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndEquipmentsMember_zHK3o9Y35YY2" title="Property, plant and equipment"&gt;267,659&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Vehicles&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20260630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CostMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MotorVehiclesMember_zvI8dkqLy8Gg" title="Property, plant and equipment"&gt;64,547&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_ecustom--AccumulatedDepreciation_iNI_pn3n3_di_c20260630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MotorVehiclesMember_ztMDj5n4VpT7"&gt;(31,559&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20260630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MotorVehiclesMember_zNiQWgPszwR7" title="Property, plant and equipment"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5786"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20260630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MotorVehiclesMember_zD81JYS5q8u3" title="Property, plant and equipment"&gt;32,988&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Office equipment&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20260630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CostMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OfficeAndOtherEquipmentMember_zFm5GbNpxLmd" title="Property, plant and equipment"&gt;65,768&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_903_ecustom--AccumulatedDepreciation_iNI_pn3n3_di_c20260630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OfficeAndOtherEquipmentMember_zj6btiTPenkd"&gt;(62,814&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20260630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OfficeAndOtherEquipmentMember_zT6LzBEmEes9" title="Property, plant and equipment"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5793"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20260630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OfficeAndOtherEquipmentMember_zopwxvuC8jl" title="Property, plant and equipment"&gt;2,954&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 0.5pt"&gt;Furniture and fixtures&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20260630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CostMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndFixtureMember_zeE5Ev2bC3x9" title="Property, plant and equipment"&gt;287,040&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_908_ecustom--AccumulatedDepreciation_iNI_pn3n3_di_c20260630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndFixtureMember_zm7Fx3fTQcUf"&gt;(287,030&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20260630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndFixtureMember_zsPRYWP2AStg" title="Property, plant and equipment"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5800"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20260630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndFixtureMember_z6pFfUZTc672" title="Property, plant and equipment"&gt;10&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: center; padding-bottom: 1.25pt"&gt;Total&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20260630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CostMember_zqEf6AC71NF5" title="Property, plant and equipment"&gt;1,153,601&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_902_ecustom--AccumulatedDepreciation_iNI_pn3n3_di_c20260630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember_z6fO8LvqiOP8" title="Accumulated depreciation"&gt;(849,990&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20260630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedImpairmentMember_zBack4qMhxX4" title="Property, plant and equipment"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5808"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20260630_zPWA8pgz8g96" title="Property, plant and equipment"&gt;303,611&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"&gt;&lt;b&gt;December&#160;31, 2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-bottom: 1pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 1pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 1pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 1pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Cost&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 1pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 1pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Accumulated&lt;br/&gt;depreciation&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 1pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 1pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Accumulated&lt;br/&gt;impairment losses&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 1pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 1pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Carrying&lt;br/&gt;Amount&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 1pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th style="text-align: center"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="13" style="text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Machinery&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#x20a9;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CostMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndEquipmentsMember_zyiWPUI5qEg4" title="Property, plant and equipment"&gt;745,246&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_901_ecustom--AccumulatedDepreciation_iNI_pn3n3_di_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndEquipmentsMember_zUVQMnw6218g"&gt;(444,954&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndEquipmentsMember_zeckTwZWrKxi" title="Property, plant and equipment"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5815"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndEquipmentsMember_zh9cauhPiHW" title="Property, plant and equipment"&gt;300,292&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: White; vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Vehicles&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CostMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MotorVehiclesMember_zCwpPT18THPg" title="Property, plant and equipment"&gt;64,547&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_ecustom--AccumulatedDepreciation_iNI_pn3n3_di_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MotorVehiclesMember_ztAWPoDRigJh"&gt;(25,104&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MotorVehiclesMember_znYOs3N8aMX" title="Property, plant and equipment"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5822"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MotorVehiclesMember_zWHCa2kiF8T7" title="Property, plant and equipment"&gt;39,443&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Office equipment&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 9%"&gt;&lt;span id="xdx_90F_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CostMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OfficeAndOtherEquipmentMember_zKfRfiqZyx7h" title="Property, plant and equipment"&gt;65,768&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 9%"&gt;&lt;span id="xdx_90F_ecustom--AccumulatedDepreciation_iNI_pn3n3_di_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OfficeAndOtherEquipmentMember_zfVpyHK8mXfk"&gt;(61,458&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; width: 1%"&gt;)&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 9%"&gt;&lt;span id="xdx_906_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OfficeAndOtherEquipmentMember_zbZ76LyrY1Ze" title="Property, plant and equipment"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5829"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 9%"&gt;&lt;span id="xdx_906_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OfficeAndOtherEquipmentMember_zRZmXv7YsYN1" title="Property, plant and equipment"&gt;4,310&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; width: 1%"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: White; vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 0.5pt"&gt;Furniture and fixtures&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CostMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndFixtureMember_zjtuGkXXOFPe" title="Property, plant and equipment"&gt;287,040&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--AccumulatedDepreciation_iNI_pn3n3_di_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndFixtureMember_zd8ZclXPT2v4"&gt;(287,030&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndFixtureMember_zWXjJbEqAPPj" title="Property, plant and equipment"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5836"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndFixtureMember_zHISJzFHDn8l" title="Property, plant and equipment"&gt;10&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;
    &lt;td style="text-align: center; padding-bottom: 1.25pt"&gt;Total&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CostMember_zm6m9qpOnJce" title="Property, plant and equipment"&gt;1,162,601&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_909_ecustom--AccumulatedDepreciation_iNI_pn3n3_di_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember_zyi8KYecHlge"&gt;(818,546&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedImpairmentMember_zVDlruzw60b" title="Property, plant and equipment"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5843"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20251231_zE6NcmUg4Gt" title="Property, plant and equipment"&gt;344,055&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A4_zclNEN8WKxA7" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

















&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Details of the changes in property and equipment for the six-month periods ended June&#160;30, 2026 and 2025 are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_892_ecustom--PropertyAndEquipmentTableTextBlock_pn3n3_z2JXAN2VvCTh" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Property and equipment (Details 1)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left; vertical-align: top"&gt;&lt;span id="xdx_8B1_zC4ZXU8vlZp1" style="display: none"&gt;Schedule of changes in property and equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="18" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Six-month period ended June&#160;30, 2026&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Machinery&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Vehicles&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Office equipment&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Furniture and fixture&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="18" style="text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Beginning balance&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20260101__20260630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember_z4ErVpXgu25a" title="Balance at beginning"&gt;300,292&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20260101__20260630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_zmbOhDZocPJe" title="Balance at beginning"&gt;39,443&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20260101__20260630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OfficeAndOtherEquipmentMember_zWxiHSYewXa8" title="Balance at beginning"&gt;4,310&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20260101__20260630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndFixtureMember_zwKJzUWntodj" title="Balance at beginning"&gt;10&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20260101__20260630_zZCFJTnFJ4sg" title="Balance at beginning"&gt;344,055&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left; vertical-align: top"&gt;Depreciation&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--DepreciationInvestmentProperty_iN_pn3n3_di_c20260101__20260630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember_ziODggiEgKA3" title="Depreciation"&gt;(32,258&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--DepreciationInvestmentProperty_iN_pn3n3_di_c20260101__20260630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_zKW2a9tsbOC1" title="Depreciation"&gt;(6,455&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--DepreciationInvestmentProperty_iN_pn3n3_di_c20260101__20260630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OfficeAndOtherEquipmentMember_zX2YaJejBSIa" title="Depreciation"&gt;(1,356&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--DepreciationInvestmentProperty_iN_pn3n3_di_c20260101__20260630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndFixtureMember_zPoDwRRHvqGg" title="Depreciation"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5872"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--DepreciationInvestmentProperty_iN_pn3n3_di_c20260101__20260630_z2AoWemtdBB6" title="Depreciation"&gt;(40,069&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;Disposals/Removals&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_900_ecustom--Disposals_pn3n3_c20260101__20260630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember_z3HYDFrzMQ4i" title="Disposals /Removals"&gt;(375&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_902_ecustom--Disposals_pn3n3_c20260101__20260630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_zmGtgVIBOktc" title="Disposals /Removals"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5878"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span title="Disposals /Removals"&gt;&lt;span id="xdx_909_ecustom--Disposals_pn3n3_c20260101__20260630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OfficeAndOtherEquipmentMember_z61f2k0Lkkmc" title="Disposals /Removals"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5880"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_908_ecustom--Disposals_pn3n3_c20260101__20260630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndFixtureMember_zEu4LLKkNNig" title="Disposals /Removals"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5882"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--Disposals_pn3n3_c20260101__20260630_z4JLkO8pD778" title="Disposals /Removals"&gt;(375&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;Ending balance&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20260101__20260630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember_z84zBdDAjAme" title="Balance at Ending"&gt;267,659&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20260101__20260630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_zte5usrbkQx" title="Balance at Ending"&gt;32,988&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20260101__20260630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OfficeAndOtherEquipmentMember_zdAEhItEIBDi" title="Balance at Ending"&gt;2,954&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20260101__20260630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndFixtureMember_zESnvKMHllfj" title="Balance at Ending"&gt;10&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20260101__20260630_zWPWew8oXlWg" title="Balance at Ending"&gt;303,611&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="18" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Six-month period ended June&#160;30, 2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Machinery&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Vehicles&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Office equipment&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Furniture and fixture&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="18" style="text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Beginning balance&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20250101__20250630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember_zAPEPy6Yrd1e" title="Balance at beginning"&gt;359,153&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20250101__20250630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_zuN5Y0BBFBg7" title="Balance at beginning"&gt;52,352&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20250101__20250630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OfficeAndOtherEquipmentMember_zWMhAIBVvbzb" title="Balance at beginning"&gt;9,321&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20250101__20250630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndFixtureMember_z79czUrCP6E3" title="Balance at beginning"&gt;10&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20250101__20250630_zxi4bqrEBp8i" title="Balance at beginning"&gt;420,836&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left; vertical-align: top"&gt;Acquisitions&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_905_ecustom--AcquisitionsCost_pn3n3_c20250101__20250630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember_zEo4L3IGaWI5" title="Acquisitions"&gt;7,960&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_900_ecustom--AcquisitionsCost_pn3n3_c20250101__20250630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_zIz96TfZN3J1" title="Acquisitions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5908"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_905_ecustom--AcquisitionsCost_pn3n3_c20250101__20250630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OfficeAndOtherEquipmentMember_zY4v3eI4jnAe" title="Acquisitions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5910"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_905_ecustom--AcquisitionsCost_pn3n3_c20250101__20250630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndFixtureMember_z7LFUcVstCJk" title="Acquisitions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5912"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_ecustom--AcquisitionsCost_pn3n3_c20250101__20250630_zaihik3paqm5" title="Acquisitions"&gt;7,960&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;Depreciation&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--DepreciationInvestmentProperty_iN_pn3n3_di_c20250101__20250630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember_zATIYRctZoP2" title="Depreciation"&gt;(41,726&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--DepreciationInvestmentProperty_iN_pn3n3_di_c20250101__20250630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_z2lFzDYQm7P9" title="Depreciation"&gt;(6,455&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--DepreciationInvestmentProperty_iN_pn3n3_di_c20250101__20250630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OfficeAndOtherEquipmentMember_zmF0BZ0ekE03" title="Depreciation"&gt;(2,725&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--DepreciationInvestmentProperty_iN_pn3n3_di_c20250101__20250630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndFixtureMember_zfuMUbtgV1ub" title="Depreciation"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5922"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--DepreciationInvestmentProperty_iN_pn3n3_di_c20250101__20250630_zRdclbj0Tv0l" title="Depreciation"&gt;(50,906&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;Ending balance&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20250101__20250630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember_znKItpK53U31" title="Balance at Ending"&gt;325,387&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20250101__20250630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_zWBA7PpcLYu7" title="Balance at Ending"&gt;45,897&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20250101__20250630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OfficeAndOtherEquipmentMember_z0lLaHjSGMg9" title="Balance at Ending"&gt;6,596&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20250101__20250630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndFixtureMember_z7fAEKnjboOk" title="Balance at Ending"&gt;10&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20250101__20250630_zTOTxtsDNf2g" title="Balance at Ending"&gt;377,890&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A4_zN8RHYAPPxy" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The classification of depreciation expenses in the statements of comprehensive income for the six-month periods ended June&#160;30, 2026 and 2025 is as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89C_ecustom--ClassificationOfDepreciationExpensesTableTextBlock_pn3n3_zvUH0NmOYaJ1" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Property and equipment (Details 2)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;&lt;span id="xdx_8BC_zuzlwAfDDsi1" style="display: none"&gt;Schedule of classification of depreciation expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Six-month&lt;br/&gt; period ended&lt;br/&gt;June&#160;30,&lt;br/&gt;2026&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Six-month&lt;br/&gt; period ended&lt;br/&gt;June&#160;30,&lt;br/&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Selling, general and administrative expenses&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--DepreciationAndAmortisationExpense_pn3n3_c20260101__20260630__custom--IncomeStatementLocationsAxis__custom--SellingGeneralAndAdministrativesExpensesMember_z3SNJYKdVQw8" title="Depreciation expenses"&gt;7,611&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--DepreciationAndAmortisationExpense_pn3n3_c20250101__20250630__custom--IncomeStatementLocationsAxis__custom--SellingGeneralAndAdministrativesExpensesMember_zg7M0Jt5uEs7" title="Depreciation expenses"&gt;7,811&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Research and development costs&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--DepreciationAndAmortisationExpense_pn3n3_c20260101__20260630__custom--IncomeStatementLocationsAxis__custom--ResearchAndDevelopmentCostsMember_ziUmppHEkb34" title="Depreciation expenses"&gt;32,458&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--DepreciationAndAmortisationExpense_pn3n3_c20250101__20250630__custom--IncomeStatementLocationsAxis__custom--ResearchAndDevelopmentCostsMember_zySMRdmSSXo7" title="Depreciation expenses"&gt;43,095&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: center; vertical-align: top; padding-bottom: 1.25pt"&gt;Total&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--DepreciationAndAmortisationExpense_pn3n3_c20260101__20260630_zmiJK6rGSAeh" title="Depreciation expenses"&gt;40,069&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--DepreciationAndAmortisationExpense_pn3n3_c20250101__20250630_zBSFkEoEwNq6" title="Depreciation expenses"&gt;50,906&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A0_zHBYKW6t69Ok" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

</cik0002058261:PropertyPlantAndEquipmentDisclosureTextBlock>
    <ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      id="Fact005774">&lt;table cellpadding="0" cellspacing="0" id="xdx_89F_eifrs-full--DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_pn3n3_z0yxuBiZeIxk" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Property and equipment (Details)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&lt;span id="xdx_8B1_zVwNFHj1BJPb" style="display: none"&gt;Schedule of property plant and equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="14" style="border-bottom: Black 0.5pt solid; text-align: center"&gt;&lt;b&gt;June&#160;30, 2026&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-bottom: 1pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 1pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 1pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 1pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Cost&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 1pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 1pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Accumulated&lt;br/&gt;depreciation&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 1pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 1pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Accumulated&lt;br/&gt;impairment losses&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 1pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 1pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Carrying&lt;br/&gt;Amount&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 1pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th style="text-align: center"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="13" style="text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Machinery&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20260630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CostMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndEquipmentsMember_zUA4yQsukTz7" title="Property, plant and equipment"&gt;736,246&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_908_ecustom--AccumulatedDepreciation_iNI_pn3n3_di_c20260630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndEquipmentsMember_zhztR4R1lJz1"&gt;(468,587&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20260630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndEquipmentsMember_zThniTNGNBR5" title="Property, plant and equipment"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5779"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20260630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndEquipmentsMember_zHK3o9Y35YY2" title="Property, plant and equipment"&gt;267,659&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Vehicles&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20260630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CostMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MotorVehiclesMember_zvI8dkqLy8Gg" title="Property, plant and equipment"&gt;64,547&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_ecustom--AccumulatedDepreciation_iNI_pn3n3_di_c20260630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MotorVehiclesMember_ztMDj5n4VpT7"&gt;(31,559&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20260630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MotorVehiclesMember_zNiQWgPszwR7" title="Property, plant and equipment"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5786"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20260630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MotorVehiclesMember_zD81JYS5q8u3" title="Property, plant and equipment"&gt;32,988&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Office equipment&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20260630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CostMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OfficeAndOtherEquipmentMember_zFm5GbNpxLmd" title="Property, plant and equipment"&gt;65,768&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_903_ecustom--AccumulatedDepreciation_iNI_pn3n3_di_c20260630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OfficeAndOtherEquipmentMember_zj6btiTPenkd"&gt;(62,814&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20260630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OfficeAndOtherEquipmentMember_zT6LzBEmEes9" title="Property, plant and equipment"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5793"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20260630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OfficeAndOtherEquipmentMember_zopwxvuC8jl" title="Property, plant and equipment"&gt;2,954&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 0.5pt"&gt;Furniture and fixtures&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20260630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CostMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndFixtureMember_zeE5Ev2bC3x9" title="Property, plant and equipment"&gt;287,040&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_908_ecustom--AccumulatedDepreciation_iNI_pn3n3_di_c20260630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndFixtureMember_zm7Fx3fTQcUf"&gt;(287,030&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20260630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndFixtureMember_zsPRYWP2AStg" title="Property, plant and equipment"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5800"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20260630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndFixtureMember_z6pFfUZTc672" title="Property, plant and equipment"&gt;10&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: center; padding-bottom: 1.25pt"&gt;Total&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20260630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CostMember_zqEf6AC71NF5" title="Property, plant and equipment"&gt;1,153,601&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_902_ecustom--AccumulatedDepreciation_iNI_pn3n3_di_c20260630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember_z6fO8LvqiOP8" title="Accumulated depreciation"&gt;(849,990&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20260630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedImpairmentMember_zBack4qMhxX4" title="Property, plant and equipment"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5808"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20260630_zPWA8pgz8g96" title="Property, plant and equipment"&gt;303,611&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"&gt;&lt;b&gt;December&#160;31, 2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-bottom: 1pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 1pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 1pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 1pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Cost&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 1pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 1pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Accumulated&lt;br/&gt;depreciation&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 1pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 1pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Accumulated&lt;br/&gt;impairment losses&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 1pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 1pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Carrying&lt;br/&gt;Amount&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 1pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th style="text-align: center"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="13" style="text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Machinery&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#x20a9;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CostMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndEquipmentsMember_zyiWPUI5qEg4" title="Property, plant and equipment"&gt;745,246&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_901_ecustom--AccumulatedDepreciation_iNI_pn3n3_di_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndEquipmentsMember_zUVQMnw6218g"&gt;(444,954&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndEquipmentsMember_zeckTwZWrKxi" title="Property, plant and equipment"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5815"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndEquipmentsMember_zh9cauhPiHW" title="Property, plant and equipment"&gt;300,292&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: White; vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Vehicles&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CostMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MotorVehiclesMember_zCwpPT18THPg" title="Property, plant and equipment"&gt;64,547&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_ecustom--AccumulatedDepreciation_iNI_pn3n3_di_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MotorVehiclesMember_ztAWPoDRigJh"&gt;(25,104&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MotorVehiclesMember_znYOs3N8aMX" title="Property, plant and equipment"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5822"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MotorVehiclesMember_zWHCa2kiF8T7" title="Property, plant and equipment"&gt;39,443&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Office equipment&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 9%"&gt;&lt;span id="xdx_90F_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CostMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OfficeAndOtherEquipmentMember_zKfRfiqZyx7h" title="Property, plant and equipment"&gt;65,768&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 9%"&gt;&lt;span id="xdx_90F_ecustom--AccumulatedDepreciation_iNI_pn3n3_di_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OfficeAndOtherEquipmentMember_zfVpyHK8mXfk"&gt;(61,458&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; width: 1%"&gt;)&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 9%"&gt;&lt;span id="xdx_906_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OfficeAndOtherEquipmentMember_zbZ76LyrY1Ze" title="Property, plant and equipment"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5829"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 9%"&gt;&lt;span id="xdx_906_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OfficeAndOtherEquipmentMember_zRZmXv7YsYN1" title="Property, plant and equipment"&gt;4,310&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; width: 1%"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: White; vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 0.5pt"&gt;Furniture and fixtures&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CostMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndFixtureMember_zjtuGkXXOFPe" title="Property, plant and equipment"&gt;287,040&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--AccumulatedDepreciation_iNI_pn3n3_di_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndFixtureMember_zd8ZclXPT2v4"&gt;(287,030&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndFixtureMember_zWXjJbEqAPPj" title="Property, plant and equipment"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5836"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndFixtureMember_zHISJzFHDn8l" title="Property, plant and equipment"&gt;10&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;
    &lt;td style="text-align: center; padding-bottom: 1.25pt"&gt;Total&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CostMember_zm6m9qpOnJce" title="Property, plant and equipment"&gt;1,162,601&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_909_ecustom--AccumulatedDepreciation_iNI_pn3n3_di_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember_zyi8KYecHlge"&gt;(818,546&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedImpairmentMember_zVDlruzw60b" title="Property, plant and equipment"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5843"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--PropertyPlantAndEquipment_iI_pn3n3_c20251231_zE6NcmUg4Gt" title="Property, plant and equipment"&gt;344,055&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2026-06-30_custom_CostMember_custom_MachineryAndEquipmentsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005776"
      unitRef="KRW">736246000</ifrs-full:PropertyPlantAndEquipment>
    <cik0002058261:AccumulatedDepreciation
      contextRef="AsOf2026-06-30_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_custom_MachineryAndEquipmentsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005777"
      unitRef="KRW">468587000</cik0002058261:AccumulatedDepreciation>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2026-06-30_custom_MachineryAndEquipmentsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005781"
      unitRef="KRW">267659000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2026-06-30_custom_CostMember_ifrs-full_MotorVehiclesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005783"
      unitRef="KRW">64547000</ifrs-full:PropertyPlantAndEquipment>
    <cik0002058261:AccumulatedDepreciation
      contextRef="AsOf2026-06-30_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_MotorVehiclesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005784"
      unitRef="KRW">31559000</cik0002058261:AccumulatedDepreciation>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2026-06-30_ifrs-full_MotorVehiclesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005788"
      unitRef="KRW">32988000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2026-06-30_custom_CostMember_custom_OfficeAndOtherEquipmentMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005790"
      unitRef="KRW">65768000</ifrs-full:PropertyPlantAndEquipment>
    <cik0002058261:AccumulatedDepreciation
      contextRef="AsOf2026-06-30_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_custom_OfficeAndOtherEquipmentMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005791"
      unitRef="KRW">62814000</cik0002058261:AccumulatedDepreciation>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2026-06-30_custom_OfficeAndOtherEquipmentMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005795"
      unitRef="KRW">2954000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2026-06-30_custom_CostMember_custom_FurnitureAndFixtureMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005797"
      unitRef="KRW">287040000</ifrs-full:PropertyPlantAndEquipment>
    <cik0002058261:AccumulatedDepreciation
      contextRef="AsOf2026-06-30_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_custom_FurnitureAndFixtureMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005798"
      unitRef="KRW">287030000</cik0002058261:AccumulatedDepreciation>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2026-06-30_custom_FurnitureAndFixtureMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005802"
      unitRef="KRW">10000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2026-06-30_custom_CostMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005804"
      unitRef="KRW">1153601000</ifrs-full:PropertyPlantAndEquipment>
    <cik0002058261:AccumulatedDepreciation
      contextRef="AsOf2026-06-30_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005806"
      unitRef="KRW">849990000</cik0002058261:AccumulatedDepreciation>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005810"
      unitRef="KRW">303611000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2025-12-31_custom_CostMember_custom_MachineryAndEquipmentsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005812"
      unitRef="KRW">745246000</ifrs-full:PropertyPlantAndEquipment>
    <cik0002058261:AccumulatedDepreciation
      contextRef="AsOf2025-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_custom_MachineryAndEquipmentsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005813"
      unitRef="KRW">444954000</cik0002058261:AccumulatedDepreciation>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2025-12-31_custom_MachineryAndEquipmentsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005817"
      unitRef="KRW">300292000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2025-12-31_custom_CostMember_ifrs-full_MotorVehiclesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005819"
      unitRef="KRW">64547000</ifrs-full:PropertyPlantAndEquipment>
    <cik0002058261:AccumulatedDepreciation
      contextRef="AsOf2025-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_MotorVehiclesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005820"
      unitRef="KRW">25104000</cik0002058261:AccumulatedDepreciation>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2025-12-31_ifrs-full_MotorVehiclesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005824"
      unitRef="KRW">39443000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2025-12-31_custom_CostMember_custom_OfficeAndOtherEquipmentMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005826"
      unitRef="KRW">65768000</ifrs-full:PropertyPlantAndEquipment>
    <cik0002058261:AccumulatedDepreciation
      contextRef="AsOf2025-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_custom_OfficeAndOtherEquipmentMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005827"
      unitRef="KRW">61458000</cik0002058261:AccumulatedDepreciation>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2025-12-31_custom_OfficeAndOtherEquipmentMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005831"
      unitRef="KRW">4310000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2025-12-31_custom_CostMember_custom_FurnitureAndFixtureMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005833"
      unitRef="KRW">287040000</ifrs-full:PropertyPlantAndEquipment>
    <cik0002058261:AccumulatedDepreciation
      contextRef="AsOf2025-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_custom_FurnitureAndFixtureMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005834"
      unitRef="KRW">287030000</cik0002058261:AccumulatedDepreciation>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2025-12-31_custom_FurnitureAndFixtureMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005838"
      unitRef="KRW">10000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2025-12-31_custom_CostMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005840"
      unitRef="KRW">1162601000</ifrs-full:PropertyPlantAndEquipment>
    <cik0002058261:AccumulatedDepreciation
      contextRef="AsOf2025-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005841"
      unitRef="KRW">818546000</cik0002058261:AccumulatedDepreciation>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005845"
      unitRef="KRW">344055000</ifrs-full:PropertyPlantAndEquipment>
    <cik0002058261:PropertyAndEquipmentTableTextBlock
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      id="Fact005854">&lt;table cellpadding="0" cellspacing="0" id="xdx_892_ecustom--PropertyAndEquipmentTableTextBlock_pn3n3_z2JXAN2VvCTh" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Property and equipment (Details 1)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left; vertical-align: top"&gt;&lt;span id="xdx_8B1_zC4ZXU8vlZp1" style="display: none"&gt;Schedule of changes in property and equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="18" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Six-month period ended June&#160;30, 2026&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Machinery&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Vehicles&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Office equipment&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Furniture and fixture&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="18" style="text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Beginning balance&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20260101__20260630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember_z4ErVpXgu25a" title="Balance at beginning"&gt;300,292&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20260101__20260630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_zmbOhDZocPJe" title="Balance at beginning"&gt;39,443&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20260101__20260630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OfficeAndOtherEquipmentMember_zWxiHSYewXa8" title="Balance at beginning"&gt;4,310&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20260101__20260630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndFixtureMember_zwKJzUWntodj" title="Balance at beginning"&gt;10&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20260101__20260630_zZCFJTnFJ4sg" title="Balance at beginning"&gt;344,055&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left; vertical-align: top"&gt;Depreciation&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--DepreciationInvestmentProperty_iN_pn3n3_di_c20260101__20260630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember_ziODggiEgKA3" title="Depreciation"&gt;(32,258&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--DepreciationInvestmentProperty_iN_pn3n3_di_c20260101__20260630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_zKW2a9tsbOC1" title="Depreciation"&gt;(6,455&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--DepreciationInvestmentProperty_iN_pn3n3_di_c20260101__20260630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OfficeAndOtherEquipmentMember_zX2YaJejBSIa" title="Depreciation"&gt;(1,356&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--DepreciationInvestmentProperty_iN_pn3n3_di_c20260101__20260630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndFixtureMember_zPoDwRRHvqGg" title="Depreciation"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5872"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--DepreciationInvestmentProperty_iN_pn3n3_di_c20260101__20260630_z2AoWemtdBB6" title="Depreciation"&gt;(40,069&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;Disposals/Removals&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_900_ecustom--Disposals_pn3n3_c20260101__20260630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember_z3HYDFrzMQ4i" title="Disposals /Removals"&gt;(375&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_902_ecustom--Disposals_pn3n3_c20260101__20260630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_zmGtgVIBOktc" title="Disposals /Removals"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5878"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span title="Disposals /Removals"&gt;&lt;span id="xdx_909_ecustom--Disposals_pn3n3_c20260101__20260630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OfficeAndOtherEquipmentMember_z61f2k0Lkkmc" title="Disposals /Removals"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5880"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_908_ecustom--Disposals_pn3n3_c20260101__20260630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndFixtureMember_zEu4LLKkNNig" title="Disposals /Removals"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5882"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--Disposals_pn3n3_c20260101__20260630_z4JLkO8pD778" title="Disposals /Removals"&gt;(375&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;Ending balance&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20260101__20260630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember_z84zBdDAjAme" title="Balance at Ending"&gt;267,659&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20260101__20260630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_zte5usrbkQx" title="Balance at Ending"&gt;32,988&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20260101__20260630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OfficeAndOtherEquipmentMember_zdAEhItEIBDi" title="Balance at Ending"&gt;2,954&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20260101__20260630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndFixtureMember_zESnvKMHllfj" title="Balance at Ending"&gt;10&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20260101__20260630_zWPWew8oXlWg" title="Balance at Ending"&gt;303,611&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="18" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Six-month period ended June&#160;30, 2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Machinery&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Vehicles&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Office equipment&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Furniture and fixture&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="18" style="text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Beginning balance&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20250101__20250630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember_zAPEPy6Yrd1e" title="Balance at beginning"&gt;359,153&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20250101__20250630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_zuN5Y0BBFBg7" title="Balance at beginning"&gt;52,352&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20250101__20250630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OfficeAndOtherEquipmentMember_zWMhAIBVvbzb" title="Balance at beginning"&gt;9,321&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20250101__20250630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndFixtureMember_z79czUrCP6E3" title="Balance at beginning"&gt;10&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20250101__20250630_zxi4bqrEBp8i" title="Balance at beginning"&gt;420,836&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left; vertical-align: top"&gt;Acquisitions&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_905_ecustom--AcquisitionsCost_pn3n3_c20250101__20250630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember_zEo4L3IGaWI5" title="Acquisitions"&gt;7,960&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_900_ecustom--AcquisitionsCost_pn3n3_c20250101__20250630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_zIz96TfZN3J1" title="Acquisitions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5908"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_905_ecustom--AcquisitionsCost_pn3n3_c20250101__20250630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OfficeAndOtherEquipmentMember_zY4v3eI4jnAe" title="Acquisitions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5910"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_905_ecustom--AcquisitionsCost_pn3n3_c20250101__20250630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndFixtureMember_z7LFUcVstCJk" title="Acquisitions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5912"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_ecustom--AcquisitionsCost_pn3n3_c20250101__20250630_zaihik3paqm5" title="Acquisitions"&gt;7,960&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;Depreciation&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--DepreciationInvestmentProperty_iN_pn3n3_di_c20250101__20250630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember_zATIYRctZoP2" title="Depreciation"&gt;(41,726&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--DepreciationInvestmentProperty_iN_pn3n3_di_c20250101__20250630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_z2lFzDYQm7P9" title="Depreciation"&gt;(6,455&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--DepreciationInvestmentProperty_iN_pn3n3_di_c20250101__20250630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OfficeAndOtherEquipmentMember_zmF0BZ0ekE03" title="Depreciation"&gt;(2,725&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--DepreciationInvestmentProperty_iN_pn3n3_di_c20250101__20250630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndFixtureMember_zfuMUbtgV1ub" title="Depreciation"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5922"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--DepreciationInvestmentProperty_iN_pn3n3_di_c20250101__20250630_zRdclbj0Tv0l" title="Depreciation"&gt;(50,906&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;Ending balance&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20250101__20250630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember_znKItpK53U31" title="Balance at Ending"&gt;325,387&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20250101__20250630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_zWBA7PpcLYu7" title="Balance at Ending"&gt;45,897&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20250101__20250630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--OfficeAndOtherEquipmentMember_z0lLaHjSGMg9" title="Balance at Ending"&gt;6,596&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20250101__20250630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndFixtureMember_z7fAEKnjboOk" title="Balance at Ending"&gt;10&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20250101__20250630_zTOTxtsDNf2g" title="Balance at Ending"&gt;377,890&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:PropertyAndEquipmentTableTextBlock>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2025-12-31_ifrs-full_MachineryMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005856"
      unitRef="KRW">300292000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2025-12-31_ifrs-full_VehiclesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005858"
      unitRef="KRW">39443000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2025-12-31_custom_OfficeAndOtherEquipmentMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005860"
      unitRef="KRW">4310000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2025-12-31_custom_FurnitureAndFixtureMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005862"
      unitRef="KRW">10000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005864"
      unitRef="KRW">344055000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:DepreciationInvestmentProperty
      contextRef="From2026-01-012026-06-30_ifrs-full_MachineryMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005866"
      unitRef="KRW">32258000</ifrs-full:DepreciationInvestmentProperty>
    <ifrs-full:DepreciationInvestmentProperty
      contextRef="From2026-01-012026-06-30_ifrs-full_VehiclesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005868"
      unitRef="KRW">6455000</ifrs-full:DepreciationInvestmentProperty>
    <ifrs-full:DepreciationInvestmentProperty
      contextRef="From2026-01-012026-06-30_custom_OfficeAndOtherEquipmentMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005870"
      unitRef="KRW">1356000</ifrs-full:DepreciationInvestmentProperty>
    <ifrs-full:DepreciationInvestmentProperty
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005874"
      unitRef="KRW">40069000</ifrs-full:DepreciationInvestmentProperty>
    <cik0002058261:Disposals
      contextRef="From2026-01-012026-06-30_ifrs-full_MachineryMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005876"
      unitRef="KRW">-375000</cik0002058261:Disposals>
    <cik0002058261:Disposals
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005884"
      unitRef="KRW">-375000</cik0002058261:Disposals>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2026-06-30_ifrs-full_MachineryMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005886"
      unitRef="KRW">267659000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2026-06-30_ifrs-full_VehiclesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005888"
      unitRef="KRW">32988000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2026-06-30_custom_OfficeAndOtherEquipmentMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005890"
      unitRef="KRW">2954000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2026-06-30_custom_FurnitureAndFixtureMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005892"
      unitRef="KRW">10000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005894"
      unitRef="KRW">303611000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2024-12-31_ifrs-full_MachineryMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005896"
      unitRef="KRW">359153000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2024-12-31_ifrs-full_VehiclesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005898"
      unitRef="KRW">52352000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2024-12-31_custom_OfficeAndOtherEquipmentMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005900"
      unitRef="KRW">9321000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2024-12-31_custom_FurnitureAndFixtureMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005902"
      unitRef="KRW">10000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005904"
      unitRef="KRW">420836000</ifrs-full:PropertyPlantAndEquipment>
    <cik0002058261:AcquisitionsCost
      contextRef="From2025-01-012025-06-30_ifrs-full_MachineryMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005906"
      unitRef="KRW">7960000</cik0002058261:AcquisitionsCost>
    <cik0002058261:AcquisitionsCost
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005914"
      unitRef="KRW">7960000</cik0002058261:AcquisitionsCost>
    <ifrs-full:DepreciationInvestmentProperty
      contextRef="From2025-01-012025-06-30_ifrs-full_MachineryMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005916"
      unitRef="KRW">41726000</ifrs-full:DepreciationInvestmentProperty>
    <ifrs-full:DepreciationInvestmentProperty
      contextRef="From2025-01-012025-06-30_ifrs-full_VehiclesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005918"
      unitRef="KRW">6455000</ifrs-full:DepreciationInvestmentProperty>
    <ifrs-full:DepreciationInvestmentProperty
      contextRef="From2025-01-012025-06-30_custom_OfficeAndOtherEquipmentMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005920"
      unitRef="KRW">2725000</ifrs-full:DepreciationInvestmentProperty>
    <ifrs-full:DepreciationInvestmentProperty
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005924"
      unitRef="KRW">50906000</ifrs-full:DepreciationInvestmentProperty>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2025-06-30_ifrs-full_MachineryMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005926"
      unitRef="KRW">325387000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2025-06-30_ifrs-full_VehiclesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005928"
      unitRef="KRW">45897000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2025-06-30_custom_OfficeAndOtherEquipmentMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005930"
      unitRef="KRW">6596000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2025-06-30_custom_FurnitureAndFixtureMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005932"
      unitRef="KRW">10000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2025-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005934"
      unitRef="KRW">377890000</ifrs-full:PropertyPlantAndEquipment>
    <cik0002058261:ClassificationOfDepreciationExpensesTableTextBlock
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      id="Fact005936">&lt;table cellpadding="0" cellspacing="0" id="xdx_89C_ecustom--ClassificationOfDepreciationExpensesTableTextBlock_pn3n3_zvUH0NmOYaJ1" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Property and equipment (Details 2)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;&lt;span id="xdx_8BC_zuzlwAfDDsi1" style="display: none"&gt;Schedule of classification of depreciation expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Six-month&lt;br/&gt; period ended&lt;br/&gt;June&#160;30,&lt;br/&gt;2026&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Six-month&lt;br/&gt; period ended&lt;br/&gt;June&#160;30,&lt;br/&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Selling, general and administrative expenses&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--DepreciationAndAmortisationExpense_pn3n3_c20260101__20260630__custom--IncomeStatementLocationsAxis__custom--SellingGeneralAndAdministrativesExpensesMember_z3SNJYKdVQw8" title="Depreciation expenses"&gt;7,611&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--DepreciationAndAmortisationExpense_pn3n3_c20250101__20250630__custom--IncomeStatementLocationsAxis__custom--SellingGeneralAndAdministrativesExpensesMember_zg7M0Jt5uEs7" title="Depreciation expenses"&gt;7,811&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Research and development costs&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--DepreciationAndAmortisationExpense_pn3n3_c20260101__20260630__custom--IncomeStatementLocationsAxis__custom--ResearchAndDevelopmentCostsMember_ziUmppHEkb34" title="Depreciation expenses"&gt;32,458&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--DepreciationAndAmortisationExpense_pn3n3_c20250101__20250630__custom--IncomeStatementLocationsAxis__custom--ResearchAndDevelopmentCostsMember_zySMRdmSSXo7" title="Depreciation expenses"&gt;43,095&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: center; vertical-align: top; padding-bottom: 1.25pt"&gt;Total&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--DepreciationAndAmortisationExpense_pn3n3_c20260101__20260630_zmiJK6rGSAeh" title="Depreciation expenses"&gt;40,069&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--DepreciationAndAmortisationExpense_pn3n3_c20250101__20250630_zBSFkEoEwNq6" title="Depreciation expenses"&gt;50,906&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:ClassificationOfDepreciationExpensesTableTextBlock>
    <ifrs-full:DepreciationAndAmortisationExpense
      contextRef="From2026-01-012026-06-30_custom_SellingGeneralAndAdministrativesExpensesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005938"
      unitRef="KRW">7611000</ifrs-full:DepreciationAndAmortisationExpense>
    <ifrs-full:DepreciationAndAmortisationExpense
      contextRef="From2025-01-012025-06-30_custom_SellingGeneralAndAdministrativesExpensesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005940"
      unitRef="KRW">7811000</ifrs-full:DepreciationAndAmortisationExpense>
    <ifrs-full:DepreciationAndAmortisationExpense
      contextRef="From2026-01-012026-06-30_custom_ResearchAndDevelopmentCostsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005942"
      unitRef="KRW">32458000</ifrs-full:DepreciationAndAmortisationExpense>
    <ifrs-full:DepreciationAndAmortisationExpense
      contextRef="From2025-01-012025-06-30_custom_ResearchAndDevelopmentCostsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005944"
      unitRef="KRW">43095000</ifrs-full:DepreciationAndAmortisationExpense>
    <ifrs-full:DepreciationAndAmortisationExpense
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005946"
      unitRef="KRW">40069000</ifrs-full:DepreciationAndAmortisationExpense>
    <ifrs-full:DepreciationAndAmortisationExpense
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005948"
      unitRef="KRW">50906000</ifrs-full:DepreciationAndAmortisationExpense>
    <cik0002058261:DisclosureOfLeaseExplanatory
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      id="Fact005950">&lt;p id="xdx_802_ecustom--DisclosureOfLeaseExplanatory_ztJU8mskRDUd" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;10. &lt;span id="xdx_82D_zfgDL7yrPenl"&gt;Leases&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company leases buildings and vehicles. The leases typically run for a period of 2 to 10 years with an option to renew or terminate the lease after that date. The Company also leases water purifiers, copy machines and others with contract terms of one to three years. These leases are short-term and/or leases of low-value items. Information about leases for which the Company is a lessee is presented below.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;A.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;b&gt;Right-of-use assets&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Right-of-use assets related to leased are presented as property and equipment.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Details of right-of-use assets and lease liabilities recognized in the statements of financial position as of June&#160;30, 2026 and December&#160;31, 2025 are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_894_ecustom--DisclosureOfQuantitativeInformationAboutRightOfUseAssetsLeaseLiabilitiesTextBlock_pn3n3_zyRkcC3m2W6c" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Leases (Details)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_8B2_zURzU50rmEF2" style="display: none"&gt;Schedule of right-of-use assets&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="text-align: center"&gt;&lt;b&gt;June&#160;30,&lt;/b&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;/b&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;2026&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;b&gt;Right-of-use assets (book value)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Building&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--AcquisitionsThroughBusinessCombinationsRightofuseAssets_pn3n3_c20260101__20260630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_zxdi0s37kO81" title="Right-of-use assets (Book value)"&gt;1,034,917&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--AcquisitionsThroughBusinessCombinationsRightofuseAssets_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_zIjUuKv9v3il" title="Right-of-use assets (Book value)"&gt;1,146,698&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Vehicles&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--AcquisitionsThroughBusinessCombinationsRightofuseAssets_pn3n3_c20260101__20260630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_z0eB26G189Xf" title="Right-of-use assets (Book value)"&gt;44,399&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--AcquisitionsThroughBusinessCombinationsRightofuseAssets_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_zCZRCe6JD7i5" title="Right-of-use assets (Book value)"&gt;44,399&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: center; vertical-align: top; padding-bottom: 1.25pt"&gt;Total&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--AcquisitionsThroughBusinessCombinationsRightofuseAssets_pn3n3_c20260101__20260630_zkx1ouuQlkw5" title="Right-of-use assets (Book value)"&gt;1,079,316&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--AcquisitionsThroughBusinessCombinationsRightofuseAssets_pn3n3_c20250101__20251231_zb1TBz4xuTS8" title="Right-of-use assets (Book value)"&gt;1,191,097&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

















&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="text-align: center"&gt;&lt;b&gt;June&#160;30,&lt;/b&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;/b&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;2026&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;b&gt;Right-of-use assets (Accumulated depreciation)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Building&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_902_ecustom--RightofuseAssetsAccumulatedDepreciation_iN_pn3n3_di_c20260101__20260630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_zHwqCW4utBG" title="Right-of-use assets (Accumulated depreciation)"&gt;(614,361&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_903_ecustom--RightofuseAssetsAccumulatedDepreciation_iN_pn3n3_di_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_zDlD8aWADHB5" title="Right-of-use assets (Accumulated depreciation)"&gt;(652,250&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Vehicles&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_907_ecustom--RightofuseAssetsAccumulatedDepreciation_iN_pn3n3_di_c20260101__20260630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_zT089mQRlAzb" title="Right-of-use assets (Accumulated depreciation)"&gt;(30,785&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_904_ecustom--RightofuseAssetsAccumulatedDepreciation_iN_pn3n3_di_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_zGX1FRF8APN5" title="Right-of-use assets (Accumulated depreciation)"&gt;(26,354&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: center; vertical-align: top; padding-bottom: 1.25pt"&gt;Total&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--RightofuseAssetsAccumulatedDepreciation_iN_pn3n3_di_c20260101__20260630_zB7SPv3ZqdXe" title="Right-of-use assets (Accumulated depreciation)"&gt;(645,146&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--RightofuseAssetsAccumulatedDepreciation_iN_pn3n3_di_c20250101__20251231_zuc7Xl16TYcj" title="Right-of-use assets (Accumulated depreciation)"&gt;(678,604&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="text-align: center"&gt;&lt;b&gt;June&#160;30,&lt;/b&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;/b&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;2026&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;b&gt;Right-of-use assets (Net book value)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Building&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#x20a9;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--AdditionsToRightofuseAssets_pn3n3_c20260101__20260630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_zEn7dhffDN3d" title="Right-of-use assets (Net book value)"&gt;420,556&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--AdditionsToRightofuseAssets_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_zMwhIb1xm1g1" title="Right-of-use assets (Net book value)"&gt;494,448&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Vehicles&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--AdditionsToRightofuseAssets_pn3n3_c20260101__20260630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_zpe4koRLC6l4" title="Right-of-use assets (Net book value)"&gt;13,614&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--AdditionsToRightofuseAssets_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_zRCKdehfF7wh" title="Right-of-use assets (Net book value)"&gt;18,045&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: center; vertical-align: top; padding-bottom: 1.25pt"&gt;Total&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--AdditionsToRightofuseAssets_pn3n3_c20260101__20260630_zII6fVO1BDhb" title="Right-of-use assets (Net book value)"&gt;434,170&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--AdditionsToRightofuseAssets_pn3n3_c20250101__20251231_zW0nJy0YOvb6" title="Right-of-use assets (Net book value)"&gt;512,493&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AB_zX3MfQ2PYdeg" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Changes in right-of-use assets for the six-month periods ended June&#160;30, 2026 and 2025 are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_890_ecustom--DisclosureOfReconcileOpeningAndEndingBalanceOfLeaseLiabilitiesTextBlock_pn3n3_z4JNkcMm6zfh" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Leases (Details 1)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left; vertical-align: top"&gt;&lt;span id="xdx_8BA_zL3rhJhfuE9a" style="display: none"&gt;Changes in right-of-use assets&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="10" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Six-month period ended&lt;br/&gt; June&#160;30,&#160;2026&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Building&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Vehicles&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="10" style="text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Balance as of January&#160;1, 2026&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--RightofuseAssets_iS_pn3n3_c20260101__20260630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_zebQvEazLsu7" title="Balance at beginning"&gt;494,448&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--RightofuseAssets_iS_pn3n3_c20260101__20260630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_zeMfiTQx9hQ4" title="Balance at beginning"&gt;18,045&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--RightofuseAssets_iS_pn3n3_c20260101__20260630_z1S4ZOYy79l7" title="Balance at beginning"&gt;512,493&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left; vertical-align: top"&gt;Depreciation&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_908_ecustom--Depreciations_iN_pn3n3_di_c20260101__20260630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_zm5CXCphLkAg" title="Depreciation"&gt;(57,818&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_905_ecustom--Depreciations_iN_pn3n3_di_c20260101__20260630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_z6dlpkRkyJR1" title="Depreciation"&gt;(4,431&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_906_ecustom--Depreciations_iN_pn3n3_di_c20260101__20260630_ztYWp9NuHQu7" title="Depreciation"&gt;(62,249&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;Lease reassessment&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--LeaseReassessments_pn3n3_c20260101__20260630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_zdaJnVQldFG" title="Lease reassessment"&gt;(16,074&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--LeaseReassessments_pn3n3_c20260101__20260630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_zIjn5fjIRKYc" title="Lease reassessment"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6013"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--LeaseReassessments_pn3n3_c20260101__20260630_z9NK471GXpEj" title="Lease reassessment"&gt;(16,074&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;Balance as of June&#160;30, 2026&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--RightofuseAssets_iE_pn3n3_c20260101__20260630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_z1WnZr7F0Zj5" title="Balance at ending"&gt;420,556&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--RightofuseAssets_iE_pn3n3_c20260101__20260630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_z53AjB1XHbFb" title="Balance at ending"&gt;13,614&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--RightofuseAssets_iE_pn3n3_c20260101__20260630_zJbIpUbg7qAh" title="Balance at ending"&gt;434,170&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="10" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Six-month period ended&lt;br/&gt; June&#160;30,&#160;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Building&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Vehicles&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="10" style="text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Balance as of January&#160;1, 2025&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--RightofuseAssets_iS_pn3n3_c20250101__20250630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_zM1hsxdNRzSb" title="Balance at beginning"&gt;622,468&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--RightofuseAssets_iS_pn3n3_c20250101__20250630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_zgcnLDyEeLD4" title="Balance at beginning"&gt;26,926&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--RightofuseAssets_iS_pn3n3_c20250101__20250630_zuckKqWv3H93" title="Balance at beginning"&gt;649,394&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left; vertical-align: top"&gt;Depreciation&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_904_ecustom--Depreciations_iN_pn3n3_di_c20250101__20250630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_zrPHqaP4A9h7" title="Depreciation"&gt;(64,776&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_901_ecustom--Depreciations_iN_pn3n3_di_c20250101__20250630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_zsAwa8624xi4" title="Depreciation"&gt;(4,432&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_ecustom--Depreciations_iN_pn3n3_di_c20250101__20250630_zJVdrvbfujq1" title="Depreciation"&gt;(69,208&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left; vertical-align: top"&gt;Acquisitions&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_904_ecustom--Acquisitions_iP3custom--Depreciations_pn3n3_c20250101__20250630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_zbOYpdIygnDh" title="Acquisitions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6035"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_ecustom--Acquisitions_pn3n3_c20250101__20250630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_zj9C8gyBmlF5" title="Acquisitions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6037"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_907_ecustom--Acquisitions_pn3n3_c20250101__20250630_z4CVCduLdfca" title="Acquisitions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6039"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;Lease reassessment&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--LeaseReassessments_pn3n3_c20250101__20250630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_zWGUXUlOyiSj" title="Lease reassessment"&gt;947&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_909_ecustom--LeaseReassessments_pn3n3_c20250101__20250630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_zekTzdAr3wj1" title="Lease reassessment"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6043"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--LeaseReassessments_pn3n3_c20250101__20250630_zIWEcy1RAuvc" title="Lease reassessment"&gt;947&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;Balance as of June&#160;30, 2025&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--RightofuseAssets_iE_pn3n3_c20250101__20250630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_zUK5EXiiVxX5" title="Balance at ending"&gt;558,639&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--RightofuseAssets_iE_pn3n3_c20250101__20250630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_zTJLsxLDhUj8" title="Balance at ending"&gt;22,494&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--RightofuseAssets_iE_pn3n3_c20250101__20250630_zcfwfSPYcRRg" title="Balance at ending"&gt;581,133&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A6_zEuYRsEwBevd" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

















&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;B.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;b&gt;Lease liabilities&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Changes in lease liabilities for the six-month period ended June&#160;30, 2026 are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_892_ecustom--ChangesInLeaseLiabilitiesTableTextBlock_pn3n3_zUXHWFmaiZEa" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Leases (Details 2)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span id="xdx_8BF_zSINyLD7LAh" style="display: none"&gt;Changes in lease liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Six-month&lt;br/&gt; period ended &lt;br/&gt;June&#160;30,&lt;br/&gt;2026&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Balance as of January&#160;1&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--LeaseLiabilities_iS_pn3n3_c20260101__20260630_zpdDltBvw4H3" title="Balance at beginning"&gt;552,631&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;New leases&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_ecustom--NewLeases_pn3n3_c20260101__20260630_ziDrPzYTLmfd" title="New leases"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6064"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Interest expense&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_908_ecustom--InterestExpenseLease_pn3n3_c20260101__20260630_zwgLuO15A2z9" title="Interest expense"&gt;21,678&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Payment of lease liabilities&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_902_ecustom--PaymentOfLeaseLiabilities_iN_pn3n3_di_c20260101__20260630_zRW59LTiZHN4" title="Payment of lease liabilities"&gt;(78,451&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Lease reassessment&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--LeaseReassessment_pn3n3_c20260101__20260630_zR98ngcxUN64" title="Lease reassessment"&gt;(16,073&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Balance as of June&#160;30&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--LeaseLiabilities_iE_pn3n3_c20260101__20260630_zuHDfxSF327g" title="Balance at ending"&gt;479,785&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A2_zqUDinxVUIge" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;C.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;b&gt;Amounts recognized in profit or loss&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Amounts recognized in profit or loss for the six-month periods ended June&#160;30, 2026 and 2025 are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_891_eifrs-full--DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory_pn3n3_zbWmxvCqWCz" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Leases (Details 4)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_8B0_zpRyvR2ZSnQj" style="display: none"&gt;Schedule of lease-related expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_498_20260101__20260630_ztFSxJeuyJ7" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_493_20250101__20250630_z41pTFeL3Vy5" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Six-month&lt;br/&gt; period ended&lt;br/&gt;June&#160;30,&lt;br/&gt;2026&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Six-month&lt;br/&gt; period ended &lt;br/&gt;June&#160;30,&lt;br/&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr id="xdx_405_eifrs-full--InterestExpenseOnLeaseLiabilities_zNFB5SgKjAP2" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Interest expense relating to lease liabilities (included in finance cost)&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;21,678&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;27,316&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--ExpenseRelatingToShorttermLeases_zid0DVnA2hjf" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Expense relating to short-term leases&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;3,600&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6080"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40A_eifrs-full--ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed_zNfgC29Qqd66" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Expense relating to leases of low-value assets&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;3,847&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;3,672&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A6_zAJANUhNKuN8" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;D.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;b&gt;Amounts recognized in statement of cash flows&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Amounts recognized in statements of cash flows for the six-month periods ended June&#160;30, 2026 and 2025 are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_893_ecustom--CashOutflowsForLeasesTableTextBlock_pn3n3_zxeGcZo32ege" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Leases (Details 5)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_8BB_zsFVKdOtlA92" style="display: none"&gt;Cash outflows for leases&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_494_20260101__20260630_z92gzrHQD1za" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_498_20250101__20250630_zc8c6AHJrAN3" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Six-month&lt;br/&gt; period ended&lt;br/&gt;June&#160;30,&lt;br/&gt;2026&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Six-month&lt;br/&gt; period ended &lt;br/&gt;June&#160;30,&lt;br/&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--CashOutflowsFromPaymentOfLeaseLiabilitiesPrincipal_zMbwD6DmXk0e" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Cash outflows from payment of lease liabilities principal&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;56,773&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;58,029&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--CashOutflowsFromLeaseLiabilitiesInterestPaid_zyFyJhtQO2Ki" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Cash outflows from lease liabilities interest paid&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;21,678&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;27,316&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--CashOutflowsForPaymentsForShorttermLease_zPHe1Eq36aM1" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Cash outflows due to short-term leases&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;3,600&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6094"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--CashOutflowForLeases_zPuPexF4r0O3" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Cash outflows due to leases of low-value assets&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;3,847&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;3,672&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--TotalAmountRecognised_zXCdBNXwCNGi" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: center; vertical-align: top; padding-bottom: 1.25pt"&gt;Total&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;85,898&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;89,017&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A9_zW1oyikVl3I8" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

















&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;E.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;b&gt;Extension options&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Some property leases contain extension options exercisable by the Company. Where practicable, the Company seeks to include extension options in new leases to provide operational flexibility. The extension options held are exercisable only by the Company and not by the lessors. The Company assesses at the lease commencement date whether it is reasonably certain to exercise the extension options. The Company reassesses whether it is reasonably certain to exercise the options if there is a significant event or significant changes in circumstances within its control. Extension options primarily relate to &#x201c;building leases&#x201d; and do not have a material impact on the measurement of the Company&#x2019;s right-of-use assets and lease liabilities as of June&#160;30, 2026.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

</cik0002058261:DisclosureOfLeaseExplanatory>
    <cik0002058261:DisclosureOfQuantitativeInformationAboutRightOfUseAssetsLeaseLiabilitiesTextBlock
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      id="Fact005952">&lt;table cellpadding="0" cellspacing="0" id="xdx_894_ecustom--DisclosureOfQuantitativeInformationAboutRightOfUseAssetsLeaseLiabilitiesTextBlock_pn3n3_zyRkcC3m2W6c" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Leases (Details)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_8B2_zURzU50rmEF2" style="display: none"&gt;Schedule of right-of-use assets&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="text-align: center"&gt;&lt;b&gt;June&#160;30,&lt;/b&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;/b&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;2026&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;b&gt;Right-of-use assets (book value)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Building&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--AcquisitionsThroughBusinessCombinationsRightofuseAssets_pn3n3_c20260101__20260630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_zxdi0s37kO81" title="Right-of-use assets (Book value)"&gt;1,034,917&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--AcquisitionsThroughBusinessCombinationsRightofuseAssets_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_zIjUuKv9v3il" title="Right-of-use assets (Book value)"&gt;1,146,698&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Vehicles&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--AcquisitionsThroughBusinessCombinationsRightofuseAssets_pn3n3_c20260101__20260630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_z0eB26G189Xf" title="Right-of-use assets (Book value)"&gt;44,399&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--AcquisitionsThroughBusinessCombinationsRightofuseAssets_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_zCZRCe6JD7i5" title="Right-of-use assets (Book value)"&gt;44,399&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: center; vertical-align: top; padding-bottom: 1.25pt"&gt;Total&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--AcquisitionsThroughBusinessCombinationsRightofuseAssets_pn3n3_c20260101__20260630_zkx1ouuQlkw5" title="Right-of-use assets (Book value)"&gt;1,079,316&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--AcquisitionsThroughBusinessCombinationsRightofuseAssets_pn3n3_c20250101__20251231_zb1TBz4xuTS8" title="Right-of-use assets (Book value)"&gt;1,191,097&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

















&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="text-align: center"&gt;&lt;b&gt;June&#160;30,&lt;/b&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;/b&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;2026&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;b&gt;Right-of-use assets (Accumulated depreciation)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Building&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_902_ecustom--RightofuseAssetsAccumulatedDepreciation_iN_pn3n3_di_c20260101__20260630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_zHwqCW4utBG" title="Right-of-use assets (Accumulated depreciation)"&gt;(614,361&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_903_ecustom--RightofuseAssetsAccumulatedDepreciation_iN_pn3n3_di_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_zDlD8aWADHB5" title="Right-of-use assets (Accumulated depreciation)"&gt;(652,250&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Vehicles&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_907_ecustom--RightofuseAssetsAccumulatedDepreciation_iN_pn3n3_di_c20260101__20260630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_zT089mQRlAzb" title="Right-of-use assets (Accumulated depreciation)"&gt;(30,785&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_904_ecustom--RightofuseAssetsAccumulatedDepreciation_iN_pn3n3_di_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_zGX1FRF8APN5" title="Right-of-use assets (Accumulated depreciation)"&gt;(26,354&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: center; vertical-align: top; padding-bottom: 1.25pt"&gt;Total&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--RightofuseAssetsAccumulatedDepreciation_iN_pn3n3_di_c20260101__20260630_zB7SPv3ZqdXe" title="Right-of-use assets (Accumulated depreciation)"&gt;(645,146&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--RightofuseAssetsAccumulatedDepreciation_iN_pn3n3_di_c20250101__20251231_zuc7Xl16TYcj" title="Right-of-use assets (Accumulated depreciation)"&gt;(678,604&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="text-align: center"&gt;&lt;b&gt;June&#160;30,&lt;/b&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;/b&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;2026&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;b&gt;Right-of-use assets (Net book value)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Building&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#x20a9;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--AdditionsToRightofuseAssets_pn3n3_c20260101__20260630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_zEn7dhffDN3d" title="Right-of-use assets (Net book value)"&gt;420,556&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--AdditionsToRightofuseAssets_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_zMwhIb1xm1g1" title="Right-of-use assets (Net book value)"&gt;494,448&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Vehicles&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--AdditionsToRightofuseAssets_pn3n3_c20260101__20260630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_zpe4koRLC6l4" title="Right-of-use assets (Net book value)"&gt;13,614&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--AdditionsToRightofuseAssets_pn3n3_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_zRCKdehfF7wh" title="Right-of-use assets (Net book value)"&gt;18,045&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: center; vertical-align: top; padding-bottom: 1.25pt"&gt;Total&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--AdditionsToRightofuseAssets_pn3n3_c20260101__20260630_zII6fVO1BDhb" title="Right-of-use assets (Net book value)"&gt;434,170&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--AdditionsToRightofuseAssets_pn3n3_c20250101__20251231_zW0nJy0YOvb6" title="Right-of-use assets (Net book value)"&gt;512,493&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:DisclosureOfQuantitativeInformationAboutRightOfUseAssetsLeaseLiabilitiesTextBlock>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsRightofuseAssets
      contextRef="From2026-01-012026-06-30_ifrs-full_BuildingsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005954"
      unitRef="KRW">1034917000</ifrs-full:AcquisitionsThroughBusinessCombinationsRightofuseAssets>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsRightofuseAssets
      contextRef="From2025-01-012025-12-31_ifrs-full_BuildingsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005956"
      unitRef="KRW">1146698000</ifrs-full:AcquisitionsThroughBusinessCombinationsRightofuseAssets>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsRightofuseAssets
      contextRef="From2026-01-012026-06-30_ifrs-full_VehiclesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005958"
      unitRef="KRW">44399000</ifrs-full:AcquisitionsThroughBusinessCombinationsRightofuseAssets>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsRightofuseAssets
      contextRef="From2025-01-012025-12-31_ifrs-full_VehiclesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005960"
      unitRef="KRW">44399000</ifrs-full:AcquisitionsThroughBusinessCombinationsRightofuseAssets>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsRightofuseAssets
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005962"
      unitRef="KRW">1079316000</ifrs-full:AcquisitionsThroughBusinessCombinationsRightofuseAssets>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsRightofuseAssets
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005964"
      unitRef="KRW">1191097000</ifrs-full:AcquisitionsThroughBusinessCombinationsRightofuseAssets>
    <cik0002058261:RightofuseAssetsAccumulatedDepreciation
      contextRef="From2026-01-012026-06-30_ifrs-full_BuildingsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005973"
      unitRef="KRW">614361000</cik0002058261:RightofuseAssetsAccumulatedDepreciation>
    <cik0002058261:RightofuseAssetsAccumulatedDepreciation
      contextRef="From2025-01-012025-12-31_ifrs-full_BuildingsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005975"
      unitRef="KRW">652250000</cik0002058261:RightofuseAssetsAccumulatedDepreciation>
    <cik0002058261:RightofuseAssetsAccumulatedDepreciation
      contextRef="From2026-01-012026-06-30_ifrs-full_VehiclesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005977"
      unitRef="KRW">30785000</cik0002058261:RightofuseAssetsAccumulatedDepreciation>
    <cik0002058261:RightofuseAssetsAccumulatedDepreciation
      contextRef="From2025-01-012025-12-31_ifrs-full_VehiclesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005979"
      unitRef="KRW">26354000</cik0002058261:RightofuseAssetsAccumulatedDepreciation>
    <cik0002058261:RightofuseAssetsAccumulatedDepreciation
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005981"
      unitRef="KRW">645146000</cik0002058261:RightofuseAssetsAccumulatedDepreciation>
    <cik0002058261:RightofuseAssetsAccumulatedDepreciation
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005983"
      unitRef="KRW">678604000</cik0002058261:RightofuseAssetsAccumulatedDepreciation>
    <ifrs-full:AdditionsToRightofuseAssets
      contextRef="From2026-01-012026-06-30_ifrs-full_BuildingsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005985"
      unitRef="KRW">420556000</ifrs-full:AdditionsToRightofuseAssets>
    <ifrs-full:AdditionsToRightofuseAssets
      contextRef="From2025-01-012025-12-31_ifrs-full_BuildingsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005987"
      unitRef="KRW">494448000</ifrs-full:AdditionsToRightofuseAssets>
    <ifrs-full:AdditionsToRightofuseAssets
      contextRef="From2026-01-012026-06-30_ifrs-full_VehiclesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005989"
      unitRef="KRW">13614000</ifrs-full:AdditionsToRightofuseAssets>
    <ifrs-full:AdditionsToRightofuseAssets
      contextRef="From2025-01-012025-12-31_ifrs-full_VehiclesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005991"
      unitRef="KRW">18045000</ifrs-full:AdditionsToRightofuseAssets>
    <ifrs-full:AdditionsToRightofuseAssets
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005993"
      unitRef="KRW">434170000</ifrs-full:AdditionsToRightofuseAssets>
    <ifrs-full:AdditionsToRightofuseAssets
      contextRef="From2025-01-012025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005995"
      unitRef="KRW">512493000</ifrs-full:AdditionsToRightofuseAssets>
    <cik0002058261:DisclosureOfReconcileOpeningAndEndingBalanceOfLeaseLiabilitiesTextBlock
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      id="Fact005997">&lt;table cellpadding="0" cellspacing="0" id="xdx_890_ecustom--DisclosureOfReconcileOpeningAndEndingBalanceOfLeaseLiabilitiesTextBlock_pn3n3_z4JNkcMm6zfh" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Leases (Details 1)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left; vertical-align: top"&gt;&lt;span id="xdx_8BA_zL3rhJhfuE9a" style="display: none"&gt;Changes in right-of-use assets&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="10" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Six-month period ended&lt;br/&gt; June&#160;30,&#160;2026&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Building&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Vehicles&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="10" style="text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Balance as of January&#160;1, 2026&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--RightofuseAssets_iS_pn3n3_c20260101__20260630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_zebQvEazLsu7" title="Balance at beginning"&gt;494,448&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--RightofuseAssets_iS_pn3n3_c20260101__20260630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_zeMfiTQx9hQ4" title="Balance at beginning"&gt;18,045&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--RightofuseAssets_iS_pn3n3_c20260101__20260630_z1S4ZOYy79l7" title="Balance at beginning"&gt;512,493&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left; vertical-align: top"&gt;Depreciation&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_908_ecustom--Depreciations_iN_pn3n3_di_c20260101__20260630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_zm5CXCphLkAg" title="Depreciation"&gt;(57,818&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_905_ecustom--Depreciations_iN_pn3n3_di_c20260101__20260630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_z6dlpkRkyJR1" title="Depreciation"&gt;(4,431&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_906_ecustom--Depreciations_iN_pn3n3_di_c20260101__20260630_ztYWp9NuHQu7" title="Depreciation"&gt;(62,249&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;Lease reassessment&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--LeaseReassessments_pn3n3_c20260101__20260630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_zdaJnVQldFG" title="Lease reassessment"&gt;(16,074&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--LeaseReassessments_pn3n3_c20260101__20260630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_zIjn5fjIRKYc" title="Lease reassessment"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6013"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--LeaseReassessments_pn3n3_c20260101__20260630_z9NK471GXpEj" title="Lease reassessment"&gt;(16,074&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;Balance as of June&#160;30, 2026&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--RightofuseAssets_iE_pn3n3_c20260101__20260630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_z1WnZr7F0Zj5" title="Balance at ending"&gt;420,556&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--RightofuseAssets_iE_pn3n3_c20260101__20260630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_z53AjB1XHbFb" title="Balance at ending"&gt;13,614&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--RightofuseAssets_iE_pn3n3_c20260101__20260630_zJbIpUbg7qAh" title="Balance at ending"&gt;434,170&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="10" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Six-month period ended&lt;br/&gt; June&#160;30,&#160;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Building&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Vehicles&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="10" style="text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Balance as of January&#160;1, 2025&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--RightofuseAssets_iS_pn3n3_c20250101__20250630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_zM1hsxdNRzSb" title="Balance at beginning"&gt;622,468&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--RightofuseAssets_iS_pn3n3_c20250101__20250630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_zgcnLDyEeLD4" title="Balance at beginning"&gt;26,926&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--RightofuseAssets_iS_pn3n3_c20250101__20250630_zuckKqWv3H93" title="Balance at beginning"&gt;649,394&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left; vertical-align: top"&gt;Depreciation&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_904_ecustom--Depreciations_iN_pn3n3_di_c20250101__20250630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_zrPHqaP4A9h7" title="Depreciation"&gt;(64,776&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_901_ecustom--Depreciations_iN_pn3n3_di_c20250101__20250630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_zsAwa8624xi4" title="Depreciation"&gt;(4,432&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_ecustom--Depreciations_iN_pn3n3_di_c20250101__20250630_zJVdrvbfujq1" title="Depreciation"&gt;(69,208&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left; vertical-align: top"&gt;Acquisitions&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_904_ecustom--Acquisitions_iP3custom--Depreciations_pn3n3_c20250101__20250630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_zbOYpdIygnDh" title="Acquisitions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6035"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_ecustom--Acquisitions_pn3n3_c20250101__20250630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_zj9C8gyBmlF5" title="Acquisitions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6037"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_907_ecustom--Acquisitions_pn3n3_c20250101__20250630_z4CVCduLdfca" title="Acquisitions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6039"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;Lease reassessment&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--LeaseReassessments_pn3n3_c20250101__20250630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_zWGUXUlOyiSj" title="Lease reassessment"&gt;947&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_909_ecustom--LeaseReassessments_pn3n3_c20250101__20250630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_zekTzdAr3wj1" title="Lease reassessment"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6043"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--LeaseReassessments_pn3n3_c20250101__20250630_zIWEcy1RAuvc" title="Lease reassessment"&gt;947&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;Balance as of June&#160;30, 2025&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--RightofuseAssets_iE_pn3n3_c20250101__20250630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_zUK5EXiiVxX5" title="Balance at ending"&gt;558,639&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--RightofuseAssets_iE_pn3n3_c20250101__20250630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_zTJLsxLDhUj8" title="Balance at ending"&gt;22,494&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--RightofuseAssets_iE_pn3n3_c20250101__20250630_zcfwfSPYcRRg" title="Balance at ending"&gt;581,133&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:DisclosureOfReconcileOpeningAndEndingBalanceOfLeaseLiabilitiesTextBlock>
    <ifrs-full:RightofuseAssets
      contextRef="AsOf2025-12-31_ifrs-full_BuildingsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact005999"
      unitRef="KRW">494448000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="AsOf2025-12-31_ifrs-full_VehiclesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006001"
      unitRef="KRW">18045000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006003"
      unitRef="KRW">512493000</ifrs-full:RightofuseAssets>
    <cik0002058261:Depreciations
      contextRef="From2026-01-012026-06-30_ifrs-full_BuildingsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006005"
      unitRef="KRW">57818000</cik0002058261:Depreciations>
    <cik0002058261:Depreciations
      contextRef="From2026-01-012026-06-30_ifrs-full_VehiclesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006007"
      unitRef="KRW">4431000</cik0002058261:Depreciations>
    <cik0002058261:Depreciations
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006009"
      unitRef="KRW">62249000</cik0002058261:Depreciations>
    <cik0002058261:LeaseReassessments
      contextRef="From2026-01-012026-06-30_ifrs-full_BuildingsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006011"
      unitRef="KRW">-16074000</cik0002058261:LeaseReassessments>
    <cik0002058261:LeaseReassessments
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006015"
      unitRef="KRW">-16074000</cik0002058261:LeaseReassessments>
    <ifrs-full:RightofuseAssets
      contextRef="AsOf2026-06-30_ifrs-full_BuildingsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006017"
      unitRef="KRW">420556000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="AsOf2026-06-30_ifrs-full_VehiclesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006019"
      unitRef="KRW">13614000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="AsOf2026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006021"
      unitRef="KRW">434170000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="AsOf2024-12-31_ifrs-full_BuildingsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006023"
      unitRef="KRW">622468000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="AsOf2024-12-31_ifrs-full_VehiclesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006025"
      unitRef="KRW">26926000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006027"
      unitRef="KRW">649394000</ifrs-full:RightofuseAssets>
    <cik0002058261:Depreciations
      contextRef="From2025-01-012025-06-30_ifrs-full_BuildingsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006029"
      unitRef="KRW">64776000</cik0002058261:Depreciations>
    <cik0002058261:Depreciations
      contextRef="From2025-01-012025-06-30_ifrs-full_VehiclesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006031"
      unitRef="KRW">4432000</cik0002058261:Depreciations>
    <cik0002058261:Depreciations
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006033"
      unitRef="KRW">69208000</cik0002058261:Depreciations>
    <cik0002058261:LeaseReassessments
      contextRef="From2025-01-012025-06-30_ifrs-full_BuildingsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006041"
      unitRef="KRW">947000</cik0002058261:LeaseReassessments>
    <cik0002058261:LeaseReassessments
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006045"
      unitRef="KRW">947000</cik0002058261:LeaseReassessments>
    <ifrs-full:RightofuseAssets
      contextRef="AsOf2025-06-30_ifrs-full_BuildingsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006047"
      unitRef="KRW">558639000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="AsOf2025-06-30_ifrs-full_VehiclesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006049"
      unitRef="KRW">22494000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="AsOf2025-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006051"
      unitRef="KRW">581133000</ifrs-full:RightofuseAssets>
    <cik0002058261:ChangesInLeaseLiabilitiesTableTextBlock
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      id="Fact006060">&lt;table cellpadding="0" cellspacing="0" id="xdx_892_ecustom--ChangesInLeaseLiabilitiesTableTextBlock_pn3n3_zUXHWFmaiZEa" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Leases (Details 2)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span id="xdx_8BF_zSINyLD7LAh" style="display: none"&gt;Changes in lease liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Six-month&lt;br/&gt; period ended &lt;br/&gt;June&#160;30,&lt;br/&gt;2026&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Balance as of January&#160;1&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--LeaseLiabilities_iS_pn3n3_c20260101__20260630_zpdDltBvw4H3" title="Balance at beginning"&gt;552,631&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;New leases&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_ecustom--NewLeases_pn3n3_c20260101__20260630_ziDrPzYTLmfd" title="New leases"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6064"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Interest expense&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_908_ecustom--InterestExpenseLease_pn3n3_c20260101__20260630_zwgLuO15A2z9" title="Interest expense"&gt;21,678&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Payment of lease liabilities&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_902_ecustom--PaymentOfLeaseLiabilities_iN_pn3n3_di_c20260101__20260630_zRW59LTiZHN4" title="Payment of lease liabilities"&gt;(78,451&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Lease reassessment&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--LeaseReassessment_pn3n3_c20260101__20260630_zR98ngcxUN64" title="Lease reassessment"&gt;(16,073&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Balance as of June&#160;30&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--LeaseLiabilities_iE_pn3n3_c20260101__20260630_zuHDfxSF327g" title="Balance at ending"&gt;479,785&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:ChangesInLeaseLiabilitiesTableTextBlock>
    <ifrs-full:LeaseLiabilities
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006062"
      unitRef="KRW">552631000</ifrs-full:LeaseLiabilities>
    <cik0002058261:InterestExpenseLease
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006066"
      unitRef="KRW">21678000</cik0002058261:InterestExpenseLease>
    <cik0002058261:PaymentOfLeaseLiabilities
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006068"
      unitRef="KRW">78451000</cik0002058261:PaymentOfLeaseLiabilities>
    <cik0002058261:LeaseReassessment
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006070"
      unitRef="KRW">-16073000</cik0002058261:LeaseReassessment>
    <ifrs-full:LeaseLiabilities
      contextRef="AsOf2026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006072"
      unitRef="KRW">479785000</ifrs-full:LeaseLiabilities>
    <ifrs-full:DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      id="Fact006074">&lt;table cellpadding="0" cellspacing="0" id="xdx_891_eifrs-full--DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory_pn3n3_zbWmxvCqWCz" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Leases (Details 4)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_8B0_zpRyvR2ZSnQj" style="display: none"&gt;Schedule of lease-related expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_498_20260101__20260630_ztFSxJeuyJ7" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_493_20250101__20250630_z41pTFeL3Vy5" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Six-month&lt;br/&gt; period ended&lt;br/&gt;June&#160;30,&lt;br/&gt;2026&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Six-month&lt;br/&gt; period ended &lt;br/&gt;June&#160;30,&lt;br/&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr id="xdx_405_eifrs-full--InterestExpenseOnLeaseLiabilities_zNFB5SgKjAP2" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Interest expense relating to lease liabilities (included in finance cost)&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;21,678&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;27,316&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--ExpenseRelatingToShorttermLeases_zid0DVnA2hjf" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Expense relating to short-term leases&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;3,600&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6080"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40A_eifrs-full--ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed_zNfgC29Qqd66" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Expense relating to leases of low-value assets&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;3,847&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;3,672&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</ifrs-full:DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory>
    <ifrs-full:InterestExpenseOnLeaseLiabilities
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006076"
      unitRef="KRW">21678000</ifrs-full:InterestExpenseOnLeaseLiabilities>
    <ifrs-full:InterestExpenseOnLeaseLiabilities
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006077"
      unitRef="KRW">27316000</ifrs-full:InterestExpenseOnLeaseLiabilities>
    <cik0002058261:ExpenseRelatingToShorttermLeases
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006079"
      unitRef="KRW">3600000</cik0002058261:ExpenseRelatingToShorttermLeases>
    <ifrs-full:ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006082"
      unitRef="KRW">3847000</ifrs-full:ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed>
    <ifrs-full:ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006083"
      unitRef="KRW">3672000</ifrs-full:ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed>
    <cik0002058261:CashOutflowsForLeasesTableTextBlock
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      id="Fact006085">&lt;table cellpadding="0" cellspacing="0" id="xdx_893_ecustom--CashOutflowsForLeasesTableTextBlock_pn3n3_zxeGcZo32ege" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Leases (Details 5)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_8BB_zsFVKdOtlA92" style="display: none"&gt;Cash outflows for leases&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_494_20260101__20260630_z92gzrHQD1za" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_498_20250101__20250630_zc8c6AHJrAN3" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Six-month&lt;br/&gt; period ended&lt;br/&gt;June&#160;30,&lt;br/&gt;2026&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Six-month&lt;br/&gt; period ended &lt;br/&gt;June&#160;30,&lt;br/&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--CashOutflowsFromPaymentOfLeaseLiabilitiesPrincipal_zMbwD6DmXk0e" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Cash outflows from payment of lease liabilities principal&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;56,773&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;58,029&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--CashOutflowsFromLeaseLiabilitiesInterestPaid_zyFyJhtQO2Ki" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Cash outflows from lease liabilities interest paid&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;21,678&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;27,316&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--CashOutflowsForPaymentsForShorttermLease_zPHe1Eq36aM1" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Cash outflows due to short-term leases&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;3,600&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6094"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--CashOutflowForLeases_zPuPexF4r0O3" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Cash outflows due to leases of low-value assets&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;3,847&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;3,672&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--TotalAmountRecognised_zXCdBNXwCNGi" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: center; vertical-align: top; padding-bottom: 1.25pt"&gt;Total&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;85,898&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;89,017&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:CashOutflowsForLeasesTableTextBlock>
    <cik0002058261:CashOutflowsFromPaymentOfLeaseLiabilitiesPrincipal
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006087"
      unitRef="KRW">56773000</cik0002058261:CashOutflowsFromPaymentOfLeaseLiabilitiesPrincipal>
    <cik0002058261:CashOutflowsFromPaymentOfLeaseLiabilitiesPrincipal
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006088"
      unitRef="KRW">58029000</cik0002058261:CashOutflowsFromPaymentOfLeaseLiabilitiesPrincipal>
    <cik0002058261:CashOutflowsFromLeaseLiabilitiesInterestPaid
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006090"
      unitRef="KRW">21678000</cik0002058261:CashOutflowsFromLeaseLiabilitiesInterestPaid>
    <cik0002058261:CashOutflowsFromLeaseLiabilitiesInterestPaid
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006091"
      unitRef="KRW">27316000</cik0002058261:CashOutflowsFromLeaseLiabilitiesInterestPaid>
    <cik0002058261:CashOutflowsForPaymentsForShorttermLease
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006093"
      unitRef="KRW">3600000</cik0002058261:CashOutflowsForPaymentsForShorttermLease>
    <ifrs-full:CashOutflowForLeases
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006096"
      unitRef="KRW">3847000</ifrs-full:CashOutflowForLeases>
    <ifrs-full:CashOutflowForLeases
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006097"
      unitRef="KRW">3672000</ifrs-full:CashOutflowForLeases>
    <cik0002058261:TotalAmountRecognised
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006099"
      unitRef="KRW">85898000</cik0002058261:TotalAmountRecognised>
    <cik0002058261:TotalAmountRecognised
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006100"
      unitRef="KRW">89017000</cik0002058261:TotalAmountRecognised>
    <cik0002058261:IntangibleAssetsTextBlock
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      id="Fact006109">&lt;p id="xdx_807_ecustom--IntangibleAssetsTextBlock_zrwOgXiLMSXa" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;11. &lt;span id="xdx_825_zTkbVkV8H8eh"&gt;Intangible assets&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;A.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;b&gt;Details of the changes in intangible assets&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Details of the changes in intangible assets for the six-month periods ended June&#160;30, 2026 and 2025 are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_890_ecustom--ChangesInIntangibleAssetsTableTextBlock_pn3n3_zcgd3e2bSddh" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Intangible assets (Details 1)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span id="xdx_8B6_z2Fj72gKvsWb" style="display: none"&gt;Schedule of changes on intangible assets&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="14" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Six-month period ended June&#160;30, 2026&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Software&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Patents&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Brand&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="14" style="text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;Beginning balance&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20260101__20260630__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_zWhHlzEgLFPg" title="Beginning balance"&gt;1,027&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20260101__20260630__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--PatentMember_zw23Jr4uPOlc" title="Beginning balance"&gt;2,829&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20260101__20260630__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--BrandMember_zcRz7RwQTcBi" title="Beginning balance"&gt;1,386&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20260101__20260630_zpFKSR5UOV1b" title="Beginning balance"&gt;5,242&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Acquisitions&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20260101__20260630__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_zadLEs8WhQ82" title="Acquisition"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6121"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20260101__20260630__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--PatentMember_zRQpWe2yRMX1" title="Acquisition"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6123"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20260101__20260630__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--BrandMember_zQ9LFbl1988" title="Acquisition"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6125"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20260101__20260630_zn0HmdSaaCc8" title="Acquisition"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6127"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Amortization&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_iN_pn3n3_di_c20260101__20260630__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_zr8iyKh48NYb" title="Amortization"&gt;(256&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_iN_pn3n3_di_c20260101__20260630__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--PatentMember_z0TqsobfU1e5" title="Amortization"&gt;(757&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_iN_pn3n3_di_c20260101__20260630__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--BrandMember_zpEB2S13pf3c" title="Amortization"&gt;(154&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_iN_pn3n3_di_c20260101__20260630_zYfnvfoHRazb" title="Amortization"&gt;(1,167&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;Ending balance&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20260101__20260630__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_zHmqFcj2gXZa" title="Ending balance"&gt;771&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20260101__20260630__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--PatentMember_zJLBlh2mDb2i" title="Ending balance"&gt;2,072&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20260101__20260630__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--BrandMember_zhtjJ1MSiOk3" title="Ending balance"&gt;1,232&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20260101__20260630_zBRaGHkzXfRj" title="Ending balance"&gt;4,075&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="14" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Six-month period ended June&#160;30, 2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Software&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Patents&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Brand&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="14" style="text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;Beginning balance&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20250630__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_zUHgqn6bDw25" title="Beginning balance"&gt;1,540&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20250630__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--PatentMember_zWkQlEBxC9D3" title="Beginning balance"&gt;4,466&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20250630__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--BrandMember_zCjbyNTPvzEa" title="Beginning balance"&gt;3&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20250630_zNn3ZMr66X94" title="Beginning balance"&gt;6,009&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Acquisitions&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20250101__20250630__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_zGLN2FUm6h96" title="Acquisition"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6153"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20250101__20250630__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--PatentMember_zCvLZMuSijJ5" title="Acquisition"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6155"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20250101__20250630__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--BrandMember_zLpr1phGOAp2" title="Acquisition"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6157"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20250101__20250630_zk8NzKyr6mz3" title="Acquisition"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6159"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Amortization&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_iN_pn3n3_di_c20250101__20250630__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_zkMvt7LyQCo1" title="Amortization"&gt;(256&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_iN_pn3n3_di_c20250101__20250630__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--PatentMember_zP7eqfoZV6G1" title="Amortization"&gt;(880&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_iN_pn3n3_di_c20250101__20250630__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--BrandMember_zh0SsPWx2h97" title="Amortization"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6165"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_iN_pn3n3_di_c20250101__20250630_zBwkivFXP6bc" title="Amortization"&gt;(1,136&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;Ending balance&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20250630__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_zWu9LrYV6hU3" title="Ending balance"&gt;1,284&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20250630__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--PatentMember_zIlnW0nbtira" title="Ending balance"&gt;3,586&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20250630__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--BrandMember_zMX3Hrh7Ju3f" title="Ending balance"&gt;3&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20250630_zQ6LWQjf0dq1" title="Ending balance"&gt;4,873&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A5_z37h0jy4ixAb" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;B.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;b&gt;Amortization&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The classification of amortization in the statements of comprehensive income for the six-month periods ended June&#160;30, 2026 and 2025 is as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89F_ecustom--ClassificationOfAmortizationTableTextBlock_pn3n3_z7MH7MQoYfR4" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Intangible assets (Details 2)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;&lt;span id="xdx_8B9_zstIQMqbqoGi" style="display: none"&gt;Schedule of classification of amortization expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;
        &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;Six-month&lt;br/&gt; period ended&lt;br/&gt;June&#160;30,&lt;br/&gt;2026&lt;/b&gt;&lt;/p&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Six-month&lt;br/&gt; period ended&lt;br/&gt;June&#160;30,&lt;br/&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Selling, general and administrative expenses&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--AmortizationExpense_pn3n3_c20260101__20260630__custom--IncomeStatementLocationsAxis__custom--SellingGeneralAndAdministrativesExpensesMember_zkEnI5Qm4Uba" title="Amortization expense"&gt;256&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--AmortizationExpense_pn3n3_c20250101__20250630__custom--IncomeStatementLocationsAxis__custom--SellingGeneralAndAdministrativesExpensesMember_zZZHU6T4DAXe" title="Amortization expense"&gt;256&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Research and development costs&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_903_ecustom--AmortizationExpense_pn3n3_c20260101__20260630__custom--IncomeStatementLocationsAxis__custom--ResearchAndDevelopmentCostsMember_zfKDqXyx0Ocl" title="Amortization expense"&gt;911&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--AmortizationExpense_pn3n3_c20250101__20250630__custom--IncomeStatementLocationsAxis__custom--ResearchAndDevelopmentCostsMember_zoEwBG0EoVMf" title="Amortization expense"&gt;880&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: center; vertical-align: top; padding-bottom: 1.25pt"&gt;Total&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_908_ecustom--AmortizationExpense_pn3n3_c20260101__20260630_z7YsxT4YiAE3" title="Amortization expense"&gt;1,167&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--AmortizationExpense_pn3n3_c20250101__20250630_zCaxWB0Ixwtj" title="Amortization expense"&gt;1,136&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A2_znsU8jiNKfs" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

















&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;C.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;b&gt;Research and development expense&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The Company recognized total research and development costs of Korean Won 181,078 thousand for six-month periods ended June&#160;30, 2026 and Korean won 521,798 thousand for six-month periods ended June&#160;30, 2025&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

</cik0002058261:IntangibleAssetsTextBlock>
    <cik0002058261:ChangesInIntangibleAssetsTableTextBlock
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      id="Fact006111">&lt;table cellpadding="0" cellspacing="0" id="xdx_890_ecustom--ChangesInIntangibleAssetsTableTextBlock_pn3n3_zcgd3e2bSddh" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Intangible assets (Details 1)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span id="xdx_8B6_z2Fj72gKvsWb" style="display: none"&gt;Schedule of changes on intangible assets&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="14" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Six-month period ended June&#160;30, 2026&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Software&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Patents&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Brand&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="14" style="text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;Beginning balance&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20260101__20260630__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_zWhHlzEgLFPg" title="Beginning balance"&gt;1,027&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20260101__20260630__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--PatentMember_zw23Jr4uPOlc" title="Beginning balance"&gt;2,829&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20260101__20260630__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--BrandMember_zcRz7RwQTcBi" title="Beginning balance"&gt;1,386&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20260101__20260630_zpFKSR5UOV1b" title="Beginning balance"&gt;5,242&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Acquisitions&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20260101__20260630__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_zadLEs8WhQ82" title="Acquisition"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6121"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20260101__20260630__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--PatentMember_zRQpWe2yRMX1" title="Acquisition"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6123"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20260101__20260630__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--BrandMember_zQ9LFbl1988" title="Acquisition"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6125"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20260101__20260630_zn0HmdSaaCc8" title="Acquisition"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6127"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Amortization&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_iN_pn3n3_di_c20260101__20260630__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_zr8iyKh48NYb" title="Amortization"&gt;(256&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_iN_pn3n3_di_c20260101__20260630__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--PatentMember_z0TqsobfU1e5" title="Amortization"&gt;(757&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_iN_pn3n3_di_c20260101__20260630__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--BrandMember_zpEB2S13pf3c" title="Amortization"&gt;(154&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_iN_pn3n3_di_c20260101__20260630_zYfnvfoHRazb" title="Amortization"&gt;(1,167&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;Ending balance&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20260101__20260630__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_zHmqFcj2gXZa" title="Ending balance"&gt;771&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20260101__20260630__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--PatentMember_zJLBlh2mDb2i" title="Ending balance"&gt;2,072&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20260101__20260630__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--BrandMember_zhtjJ1MSiOk3" title="Ending balance"&gt;1,232&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20260101__20260630_zBRaGHkzXfRj" title="Ending balance"&gt;4,075&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="14" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Six-month period ended June&#160;30, 2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Software&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Patents&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Brand&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="14" style="text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;Beginning balance&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20250630__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_zUHgqn6bDw25" title="Beginning balance"&gt;1,540&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20250630__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--PatentMember_zWkQlEBxC9D3" title="Beginning balance"&gt;4,466&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20250630__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--BrandMember_zCjbyNTPvzEa" title="Beginning balance"&gt;3&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20250630_zNn3ZMr66X94" title="Beginning balance"&gt;6,009&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Acquisitions&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20250101__20250630__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_zGLN2FUm6h96" title="Acquisition"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6153"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20250101__20250630__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--PatentMember_zCvLZMuSijJ5" title="Acquisition"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6155"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20250101__20250630__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--BrandMember_zLpr1phGOAp2" title="Acquisition"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6157"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20250101__20250630_zk8NzKyr6mz3" title="Acquisition"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6159"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Amortization&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_iN_pn3n3_di_c20250101__20250630__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_zkMvt7LyQCo1" title="Amortization"&gt;(256&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_iN_pn3n3_di_c20250101__20250630__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--PatentMember_zP7eqfoZV6G1" title="Amortization"&gt;(880&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_iN_pn3n3_di_c20250101__20250630__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--BrandMember_zh0SsPWx2h97" title="Amortization"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6165"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_iN_pn3n3_di_c20250101__20250630_zBwkivFXP6bc" title="Amortization"&gt;(1,136&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;Ending balance&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20250630__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_zWu9LrYV6hU3" title="Ending balance"&gt;1,284&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20250630__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--PatentMember_zIlnW0nbtira" title="Ending balance"&gt;3,586&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20250630__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--BrandMember_zMX3Hrh7Ju3f" title="Ending balance"&gt;3&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20250630_zQ6LWQjf0dq1" title="Ending balance"&gt;4,873&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:ChangesInIntangibleAssetsTableTextBlock>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2025-12-31_ifrs-full_ComputerSoftwareMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006113"
      unitRef="KRW">1027000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2025-12-31_custom_PatentMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006115"
      unitRef="KRW">2829000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2025-12-31_custom_BrandMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006117"
      unitRef="KRW">1386000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006119"
      unitRef="KRW">5242000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2026-01-012026-06-30_ifrs-full_ComputerSoftwareMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006129"
      unitRef="KRW">256000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2026-01-012026-06-30_custom_PatentMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006131"
      unitRef="KRW">757000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2026-01-012026-06-30_custom_BrandMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006133"
      unitRef="KRW">154000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006135"
      unitRef="KRW">1167000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2026-06-30_ifrs-full_ComputerSoftwareMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006137"
      unitRef="KRW">771000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2026-06-30_custom_PatentMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006139"
      unitRef="KRW">2072000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2026-06-30_custom_BrandMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006141"
      unitRef="KRW">1232000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006143"
      unitRef="KRW">4075000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2024-12-31_ifrs-full_ComputerSoftwareMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006145"
      unitRef="KRW">1540000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2024-12-31_custom_PatentMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006147"
      unitRef="KRW">4466000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2024-12-31_custom_BrandMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006149"
      unitRef="KRW">3000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006151"
      unitRef="KRW">6009000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2025-01-012025-06-30_ifrs-full_ComputerSoftwareMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006161"
      unitRef="KRW">256000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2025-01-012025-06-30_custom_PatentMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006163"
      unitRef="KRW">880000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006167"
      unitRef="KRW">1136000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2025-06-30_ifrs-full_ComputerSoftwareMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006169"
      unitRef="KRW">1284000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2025-06-30_custom_PatentMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006171"
      unitRef="KRW">3586000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2025-06-30_custom_BrandMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006173"
      unitRef="KRW">3000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2025-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006175"
      unitRef="KRW">4873000</ifrs-full:IntangibleAssetsAndGoodwill>
    <cik0002058261:ClassificationOfAmortizationTableTextBlock
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      id="Fact006177">&lt;table cellpadding="0" cellspacing="0" id="xdx_89F_ecustom--ClassificationOfAmortizationTableTextBlock_pn3n3_z7MH7MQoYfR4" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Intangible assets (Details 2)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;&lt;span id="xdx_8B9_zstIQMqbqoGi" style="display: none"&gt;Schedule of classification of amortization expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;
        &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;Six-month&lt;br/&gt; period ended&lt;br/&gt;June&#160;30,&lt;br/&gt;2026&lt;/b&gt;&lt;/p&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Six-month&lt;br/&gt; period ended&lt;br/&gt;June&#160;30,&lt;br/&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Selling, general and administrative expenses&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--AmortizationExpense_pn3n3_c20260101__20260630__custom--IncomeStatementLocationsAxis__custom--SellingGeneralAndAdministrativesExpensesMember_zkEnI5Qm4Uba" title="Amortization expense"&gt;256&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--AmortizationExpense_pn3n3_c20250101__20250630__custom--IncomeStatementLocationsAxis__custom--SellingGeneralAndAdministrativesExpensesMember_zZZHU6T4DAXe" title="Amortization expense"&gt;256&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Research and development costs&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_903_ecustom--AmortizationExpense_pn3n3_c20260101__20260630__custom--IncomeStatementLocationsAxis__custom--ResearchAndDevelopmentCostsMember_zfKDqXyx0Ocl" title="Amortization expense"&gt;911&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--AmortizationExpense_pn3n3_c20250101__20250630__custom--IncomeStatementLocationsAxis__custom--ResearchAndDevelopmentCostsMember_zoEwBG0EoVMf" title="Amortization expense"&gt;880&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: center; vertical-align: top; padding-bottom: 1.25pt"&gt;Total&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_908_ecustom--AmortizationExpense_pn3n3_c20260101__20260630_z7YsxT4YiAE3" title="Amortization expense"&gt;1,167&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--AmortizationExpense_pn3n3_c20250101__20250630_zCaxWB0Ixwtj" title="Amortization expense"&gt;1,136&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:ClassificationOfAmortizationTableTextBlock>
    <cik0002058261:AmortizationExpense
      contextRef="From2026-01-012026-06-30_custom_SellingGeneralAndAdministrativesExpensesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006179"
      unitRef="KRW">256000</cik0002058261:AmortizationExpense>
    <cik0002058261:AmortizationExpense
      contextRef="From2025-01-012025-06-30_custom_SellingGeneralAndAdministrativesExpensesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006181"
      unitRef="KRW">256000</cik0002058261:AmortizationExpense>
    <cik0002058261:AmortizationExpense
      contextRef="From2026-01-012026-06-30_custom_ResearchAndDevelopmentCostsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006183"
      unitRef="KRW">911000</cik0002058261:AmortizationExpense>
    <cik0002058261:AmortizationExpense
      contextRef="From2025-01-012025-06-30_custom_ResearchAndDevelopmentCostsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006185"
      unitRef="KRW">880000</cik0002058261:AmortizationExpense>
    <cik0002058261:AmortizationExpense
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006187"
      unitRef="KRW">1167000</cik0002058261:AmortizationExpense>
    <cik0002058261:AmortizationExpense
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006189"
      unitRef="KRW">1136000</cik0002058261:AmortizationExpense>
    <cik0002058261:DeferredTransactionCostSponsorSharePurchaseTextBlock
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      id="Fact006198">&lt;p id="xdx_807_ecustom--DeferredTransactionCostSponsorSharePurchaseTextBlock_zWqXthRB5d8i" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;12. &lt;span id="xdx_822_z1mIfQ0wt61g"&gt;Deferred transaction costs &#x2013; Sponsor share purchase&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Details of deferred transaction costs as of June&#160;30, 2026 and December&#160;31, 2025 are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89A_ecustom--DetailsOfDeferredTransactionCostTableTextBlock_pn3n3_zdUiaYUYYUvf" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Deferred transaction cost - Sponsor share purchase (Details)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_8BE_zs4IoiiWaCT6" style="display: none"&gt;Schedule of deferred transaction cost&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;June&#160;30,&lt;br/&gt;2026&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;b&gt;Non-Current&lt;/b&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Deferred transaction costs (*)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#x20a9;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_907_ecustom--DeferredTransactionCost_iI_pn3n3_c20260630_fKCop_zUxYClfZ6gWl" title="Deferred transaction cost"&gt;2,545,885&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_ecustom--DeferredTransactionCost_iI_pn3n3_c20251231_fKCop_z61Z0eTY0LEl" title="Deferred transaction cost"&gt;2,393,915&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;div style="width: 25%; margin-left: 0; margin-right: auto"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&lt;span id="xdx_F00_zrgsR6SDoZu8"&gt;(*)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_F17_zSG8Y2a1CXih"&gt;The deferred balance includes the non-refundable amount paid to Mountain Crest Global Holdings LLC (the &#x201c;Sponsor&#x201d;) to purchase 325,000 founder shares, which will subsequently be transitioned into the Pubco ordinary shares upon completion of the Business Combination. The shares will be transferred at the closing of the business combination and the deferred balances will be charged against equity via treasury shares.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AB_zyYdsFJP2Dae" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;As
of June&#160;30, 2026 and December&#160;31, 2025, the Company had deferred $1.8 &lt;span id="xdx_904_ecustom--DeferredTransactionCost_iI_pn3n3_c20260630_zW1WJmc7aKd6" style="display: none" title="Deferred transaction cost"&gt;2,545,885&lt;/span&gt; million and $1.7 &lt;span id="xdx_909_ecustom--DeferredTransactionCost_iI_pn3n3_c20251231_zh3nwEGmvBf4" style="display: none" title="Deferred transaction cost"&gt;2,393,915&lt;/span&gt; million,
respectively, in transaction costs directly associated with the ongoing Business Combination.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

</cik0002058261:DeferredTransactionCostSponsorSharePurchaseTextBlock>
    <cik0002058261:DetailsOfDeferredTransactionCostTableTextBlock
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      id="Fact006200">&lt;table cellpadding="0" cellspacing="0" id="xdx_89A_ecustom--DetailsOfDeferredTransactionCostTableTextBlock_pn3n3_zdUiaYUYYUvf" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Deferred transaction cost - Sponsor share purchase (Details)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_8BE_zs4IoiiWaCT6" style="display: none"&gt;Schedule of deferred transaction cost&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;June&#160;30,&lt;br/&gt;2026&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;b&gt;Non-Current&lt;/b&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Deferred transaction costs (*)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#x20a9;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_907_ecustom--DeferredTransactionCost_iI_pn3n3_c20260630_fKCop_zUxYClfZ6gWl" title="Deferred transaction cost"&gt;2,545,885&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_ecustom--DeferredTransactionCost_iI_pn3n3_c20251231_fKCop_z61Z0eTY0LEl" title="Deferred transaction cost"&gt;2,393,915&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;div style="width: 25%; margin-left: 0; margin-right: auto"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&lt;span id="xdx_F00_zrgsR6SDoZu8"&gt;(*)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_F17_zSG8Y2a1CXih"&gt;The deferred balance includes the non-refundable amount paid to Mountain Crest Global Holdings LLC (the &#x201c;Sponsor&#x201d;) to purchase 325,000 founder shares, which will subsequently be transitioned into the Pubco ordinary shares upon completion of the Business Combination. The shares will be transferred at the closing of the business combination and the deferred balances will be charged against equity via treasury shares.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:DetailsOfDeferredTransactionCostTableTextBlock>
    <cik0002058261:DeferredTransactionCost
      contextRef="AsOf2026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006202"
      unitRef="KRW">2545885000</cik0002058261:DeferredTransactionCost>
    <cik0002058261:DeferredTransactionCost
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006204"
      unitRef="KRW">2393915000</cik0002058261:DeferredTransactionCost>
    <cik0002058261:DeferredTransactionCost
      contextRef="AsOf2026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006207"
      unitRef="KRW">2545885000</cik0002058261:DeferredTransactionCost>
    <cik0002058261:DeferredTransactionCost
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006209"
      unitRef="KRW">2393915000</cik0002058261:DeferredTransactionCost>
    <cik0002058261:IncomeTaxesTextBlock
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      id="Fact006211">&lt;p id="xdx_809_ecustom--IncomeTaxesTextBlock_zfuUEBT3hra2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;13. &lt;span id="xdx_823_z9OiAiWUKTbj"&gt;Income taxes&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Income tax expense is recognized based on management&#x2019;s best estimate of the average annual effective income tax rate expected for the full financial year, multiplied by the pre-tax income of the interim reporting period. No discrete tax items were recognized during the six months ended June&#160;30, 2026 and 2025.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;For the six months ended June&#160;30, 2026 and 2025, the Company&#x2019;s effective tax rate was &lt;span id="xdx_90D_eifrs-full--AverageEffectiveTaxRate_pid_c20260101__20260630_zZMF81eDrfv6" title="Effective income tax rate"&gt;&lt;span id="xdx_904_eifrs-full--AverageEffectiveTaxRate_pid_c20250101__20250630_zA8FUJCjJkXf" title="Effective income tax rate"&gt;0.0%&lt;/span&gt;&lt;/span&gt;. The effective income tax rate differs significantly from the statutory tax rate applicable to the Company primarily due to the full recognition of valuation allowances of deferred tax assets and temporary differences incurred during the period.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

</cik0002058261:IncomeTaxesTextBlock>
    <ifrs-full:AverageEffectiveTaxRate
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact006213"
      unitRef="Pure">0.000</ifrs-full:AverageEffectiveTaxRate>
    <ifrs-full:AverageEffectiveTaxRate
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact006215"
      unitRef="Pure">0.000</ifrs-full:AverageEffectiveTaxRate>
    <ifrs-full:DisclosureOfEarningsPerShareExplanatory
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      id="Fact006217">&lt;p id="xdx_807_eifrs-full--DisclosureOfEarningsPerShareExplanatory_zQz2n6DGuVWh" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;14. &lt;span id="xdx_826_zKzjU7vjwYy1"&gt;Loss per share&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;A.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;b&gt;Basic loss per share&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The calculation of basic EPS has been based on the following loss attributable to ordinary shareholders and the weighted-average number of ordinary shares outstanding.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 0.5in; text-align: left"&gt;i.&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;Loss attributable to ordinary shareholders (basic)&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89A_ecustom--ScheduleOfLossAttributableToOrdinaryShareholdersTableTaxBlock_pn3n3_zJpsYBEJe1Zh" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Loss per share (Details)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;&lt;span id="xdx_8B0_zMGX4UwGdnrf" style="display: none"&gt;Schedule of loss attributable to ordinary shareholders&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_492_20260101__20260630_zcl9wFGWe7Q7" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_493_20250101__20250630_zlIbm91Opkm8" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Six-month&lt;br/&gt; period ended&lt;br/&gt;June&#160;30,&lt;br/&gt;2026&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Six-month&lt;br/&gt; period ended&lt;br/&gt; June&#160;30,&lt;br/&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="text-align: center"&gt;&lt;b&gt;(In thousands of Korean Won)&lt;/b&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr id="xdx_407_eifrs-full--ProfitLossAttributableToOwnersOfParent_i_pn3n" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Loss for the period&lt;/td&gt;
    &lt;td style="width: 1%; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; padding-bottom: 0.5pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 9%; text-align: right"&gt;(2,997,895&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="width: 1%; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 9%; text-align: right"&gt;(3,400,181&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--LossAttributableToOrdinaryShareholders_i_pn3n" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Loss attributable to ordinary shareholders&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(2,997,895&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(3,400,181&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AD_z3ReEQ4FiyM9" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

















&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 0.5in; text-align: left"&gt;ii.&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;Weighted-average number of ordinary shares (basic)&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_891_ecustom--WeightedAverageNumberOfOrdinarySharesTableTaxBlock_pn3n3_zbae8atfAGCl" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Loss per share (Details 1)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;&lt;span id="xdx_8BE_zZfAFmtCsbg1" style="display: none"&gt;Schedule of weighted-average number of ordinary shares&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_493_20260101__20260630_zX1N5NO4Gdui" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_493_20250101__20250630_zZTVMVPFPmil" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Six-month&lt;br/&gt; period ended&lt;br/&gt; June&#160;30,&lt;br/&gt;2026&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Six-month&lt;br/&gt; period ended&lt;br/&gt; June&#160;30,&lt;br/&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center"&gt;&lt;b&gt;(In number of shares)&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_409_eifrs-full--IncreaseDecreaseInNumberOfOrdinarySharesIssued_pid_z7UokzTfnFNj" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Number of ordinary shares issued at January&#160;1&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;48,982,075&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;48,361,075&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--DisposalOfTreasuryShare_iP3ifrs-full--IncreaseDecreaseInNumberOfOrdinarySharesIssued_pid_zJKjaMBJthhe" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;Disposal of treasury shares&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,326&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;2,762&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_403_eifrs-full--WeightedAverageShares_pid_zLbNqd8ORqcl" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top; padding-bottom: 2.5pt"&gt;Weighted-average number of ordinary shares at June&#160;30&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;48,983,401&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;48,363,837&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A1_zbOCEI9jd2bf" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;B.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;b&gt;Anti-diluted loss per share&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Diluted loss per share is not different from basic loss per share as there are no dilution effects of potential ordinary shares for the six-month periods ended June&#160;30, 2026 and 2025.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Details of potential ordinary shares with no dilution effects are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_899_ecustom--ScheduleOfPotentialOrdinaryTableTaxBlock_pn3n3_zs1l5tO8jpW8" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Loss per share (Details 2)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left; vertical-align: top"&gt;&lt;span id="xdx_8B0_zlsoF1xhQL68" style="display: none"&gt;Schedule
    of potential ordinary shares&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Six-month&lt;br/&gt; period ended&lt;br/&gt;June&#160;30,&lt;br/&gt;2026&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Six-month&lt;br/&gt; period ended&lt;br/&gt;June&#160;30,&lt;br/&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="text-align: center"&gt;&lt;b&gt;(In Korean&#160;won and number of shares)&lt;/b&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&lt;b&gt;Stock option&lt;/b&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 12%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 12%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left; vertical-align: top"&gt;Exercise price&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#x20a9;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented_pid_c20260101__20260630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--ShareOptionExercisePriceMember_zbevnXy3dg28" title="Anti-dilutive shares"&gt;500&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented_pid_c20250101__20250630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--ShareOptionExercisePriceMember_zBaiTw8tsNOi" title="Anti-dilutive shares"&gt;500&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left; vertical-align: top"&gt;Potential ordinary share&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented_pid_c20260101__20260630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--ShareOptionPotentialOrdinaryShareMember_zJKTBWNedhp6" title="Anti-dilutive shares"&gt;640,160&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented_pid_c20250101__20250630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--ShareOptionPotentialOrdinaryShareMember_zJeRlF1Dfy4f" title="Anti-dilutive shares"&gt;640,160&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&lt;b&gt;Bonds with Warrants&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left; vertical-align: top"&gt;Exercise price&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#x20a9;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented_pid_c20260101__20260630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--BondsWithWarrantsExercisePriceMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zdintkxMYrj4" title="Anti-dilutive shares"&gt;2,500&lt;/span&gt; ~ &lt;span id="xdx_90F_eifrs-full--NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented_pid_c20260101__20260630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--BondsWithWarrantsExercisePriceMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zWVFEJ65bcab" title="Anti-dilutive shares"&gt;4,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented_pid_c20250101__20250630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--BondsWithWarrantsExercisePriceMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zHsJ8SZzj2n7" title="Anti-dilutive shares"&gt;2,500&lt;/span&gt; ~ &lt;span id="xdx_90B_eifrs-full--NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented_pid_c20250101__20250630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--BondsWithWarrantsExercisePriceMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zONb84YOMJEj" title="Anti-dilutive shares"&gt;4,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left; vertical-align: top"&gt;Potential ordinary share&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented_pid_c20260101__20260630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--BondsWithWarrantsPotentialOrdinaryShareMember_z23gjtSP2bm5" title="Anti-dilutive shares"&gt;13,480,002&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented_pid_c20250101__20250630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--BondsWithWarrantsPotentialOrdinaryShareMember_zH1JSvuogAug" title="Anti-dilutive shares"&gt;11,903,002&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AD_zVsgDV6Itlrd" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;C.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;b&gt;Losses per share&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89B_ecustom--ScheduleOfEarningsPerShareBasicTableTaxBlock_pn3n3_zkohzpaMnwle" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Loss per share (Details 3)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&lt;span id="xdx_8B8_zhWTo7yFL3yf" style="display: none"&gt;Schedule of losses per share&lt;/span&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" id="xdx_498_20260101__20260630_zNcljqHzYIt5" style="text-align: center"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" id="xdx_49B_20250101__20250630_zBUKMd5QOMx3" style="text-align: center"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Six-month&lt;br/&gt; period ended&lt;br/&gt;June&#160;30,&lt;br/&gt;2026&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Six-month&lt;br/&gt; period ended&lt;br/&gt;June&#160;30,&lt;br/&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="text-align: center"&gt;&lt;b&gt;(In Korean Won)&lt;/b&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40A_eifrs-full--BasicEarningsLossPerShare_pid_zGt3Q7V7WKx6" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Basic losses per share&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;(61&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;(70&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A9_zINJ7LMwFfQf" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

















</ifrs-full:DisclosureOfEarningsPerShareExplanatory>
    <cik0002058261:ScheduleOfLossAttributableToOrdinaryShareholdersTableTaxBlock
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      id="Fact006219">&lt;table cellpadding="0" cellspacing="0" id="xdx_89A_ecustom--ScheduleOfLossAttributableToOrdinaryShareholdersTableTaxBlock_pn3n3_zJpsYBEJe1Zh" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Loss per share (Details)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;&lt;span id="xdx_8B0_zMGX4UwGdnrf" style="display: none"&gt;Schedule of loss attributable to ordinary shareholders&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_492_20260101__20260630_zcl9wFGWe7Q7" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_493_20250101__20250630_zlIbm91Opkm8" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Six-month&lt;br/&gt; period ended&lt;br/&gt;June&#160;30,&lt;br/&gt;2026&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Six-month&lt;br/&gt; period ended&lt;br/&gt; June&#160;30,&lt;br/&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="text-align: center"&gt;&lt;b&gt;(In thousands of Korean Won)&lt;/b&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr id="xdx_407_eifrs-full--ProfitLossAttributableToOwnersOfParent_i_pn3n" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Loss for the period&lt;/td&gt;
    &lt;td style="width: 1%; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; padding-bottom: 0.5pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 9%; text-align: right"&gt;(2,997,895&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="width: 1%; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 9%; text-align: right"&gt;(3,400,181&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--LossAttributableToOrdinaryShareholders_i_pn3n" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Loss attributable to ordinary shareholders&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(2,997,895&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(3,400,181&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:ScheduleOfLossAttributableToOrdinaryShareholdersTableTaxBlock>
    <ifrs-full:ProfitLossAttributableToOwnersOfParent
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006221"
      unitRef="KRW">-2997895000</ifrs-full:ProfitLossAttributableToOwnersOfParent>
    <ifrs-full:ProfitLossAttributableToOwnersOfParent
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006222"
      unitRef="KRW">-3400181000</ifrs-full:ProfitLossAttributableToOwnersOfParent>
    <cik0002058261:LossAttributableToOrdinaryShareholders
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006224"
      unitRef="KRW">-2997895000</cik0002058261:LossAttributableToOrdinaryShareholders>
    <cik0002058261:LossAttributableToOrdinaryShareholders
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006225"
      unitRef="KRW">-3400181000</cik0002058261:LossAttributableToOrdinaryShareholders>
    <cik0002058261:WeightedAverageNumberOfOrdinarySharesTableTaxBlock
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      id="Fact006234">&lt;table cellpadding="0" cellspacing="0" id="xdx_891_ecustom--WeightedAverageNumberOfOrdinarySharesTableTaxBlock_pn3n3_zbae8atfAGCl" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Loss per share (Details 1)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;&lt;span id="xdx_8BE_zZfAFmtCsbg1" style="display: none"&gt;Schedule of weighted-average number of ordinary shares&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_493_20260101__20260630_zX1N5NO4Gdui" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_493_20250101__20250630_zZTVMVPFPmil" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Six-month&lt;br/&gt; period ended&lt;br/&gt; June&#160;30,&lt;br/&gt;2026&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Six-month&lt;br/&gt; period ended&lt;br/&gt; June&#160;30,&lt;br/&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center"&gt;&lt;b&gt;(In number of shares)&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_409_eifrs-full--IncreaseDecreaseInNumberOfOrdinarySharesIssued_pid_z7UokzTfnFNj" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Number of ordinary shares issued at January&#160;1&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;48,982,075&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;48,361,075&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--DisposalOfTreasuryShare_iP3ifrs-full--IncreaseDecreaseInNumberOfOrdinarySharesIssued_pid_zJKjaMBJthhe" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;Disposal of treasury shares&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,326&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;2,762&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_403_eifrs-full--WeightedAverageShares_pid_zLbNqd8ORqcl" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top; padding-bottom: 2.5pt"&gt;Weighted-average number of ordinary shares at June&#160;30&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;48,983,401&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;48,363,837&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:WeightedAverageNumberOfOrdinarySharesTableTaxBlock>
    <ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact006236"
      unitRef="Shares">48982075</ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued>
    <ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact006237"
      unitRef="Shares">48361075</ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued>
    <cik0002058261:DisposalOfTreasuryShare
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact006239"
      unitRef="Shares">1326</cik0002058261:DisposalOfTreasuryShare>
    <cik0002058261:DisposalOfTreasuryShare
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact006240"
      unitRef="Shares">2762</cik0002058261:DisposalOfTreasuryShare>
    <ifrs-full:WeightedAverageShares
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact006242"
      unitRef="Shares">48983401</ifrs-full:WeightedAverageShares>
    <ifrs-full:WeightedAverageShares
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact006243"
      unitRef="Shares">48363837</ifrs-full:WeightedAverageShares>
    <cik0002058261:ScheduleOfPotentialOrdinaryTableTaxBlock
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      id="Fact006245">&lt;table cellpadding="0" cellspacing="0" id="xdx_899_ecustom--ScheduleOfPotentialOrdinaryTableTaxBlock_pn3n3_zs1l5tO8jpW8" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Loss per share (Details 2)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left; vertical-align: top"&gt;&lt;span id="xdx_8B0_zlsoF1xhQL68" style="display: none"&gt;Schedule
    of potential ordinary shares&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Six-month&lt;br/&gt; period ended&lt;br/&gt;June&#160;30,&lt;br/&gt;2026&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Six-month&lt;br/&gt; period ended&lt;br/&gt;June&#160;30,&lt;br/&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="text-align: center"&gt;&lt;b&gt;(In Korean&#160;won and number of shares)&lt;/b&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&lt;b&gt;Stock option&lt;/b&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 12%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 12%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left; vertical-align: top"&gt;Exercise price&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#x20a9;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented_pid_c20260101__20260630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--ShareOptionExercisePriceMember_zbevnXy3dg28" title="Anti-dilutive shares"&gt;500&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented_pid_c20250101__20250630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--ShareOptionExercisePriceMember_zBaiTw8tsNOi" title="Anti-dilutive shares"&gt;500&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left; vertical-align: top"&gt;Potential ordinary share&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented_pid_c20260101__20260630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--ShareOptionPotentialOrdinaryShareMember_zJKTBWNedhp6" title="Anti-dilutive shares"&gt;640,160&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented_pid_c20250101__20250630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--ShareOptionPotentialOrdinaryShareMember_zJeRlF1Dfy4f" title="Anti-dilutive shares"&gt;640,160&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&lt;b&gt;Bonds with Warrants&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left; vertical-align: top"&gt;Exercise price&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#x20a9;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented_pid_c20260101__20260630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--BondsWithWarrantsExercisePriceMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zdintkxMYrj4" title="Anti-dilutive shares"&gt;2,500&lt;/span&gt; ~ &lt;span id="xdx_90F_eifrs-full--NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented_pid_c20260101__20260630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--BondsWithWarrantsExercisePriceMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zWVFEJ65bcab" title="Anti-dilutive shares"&gt;4,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented_pid_c20250101__20250630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--BondsWithWarrantsExercisePriceMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zHsJ8SZzj2n7" title="Anti-dilutive shares"&gt;2,500&lt;/span&gt; ~ &lt;span id="xdx_90B_eifrs-full--NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented_pid_c20250101__20250630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--BondsWithWarrantsExercisePriceMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zONb84YOMJEj" title="Anti-dilutive shares"&gt;4,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left; vertical-align: top"&gt;Potential ordinary share&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented_pid_c20260101__20260630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--BondsWithWarrantsPotentialOrdinaryShareMember_z23gjtSP2bm5" title="Anti-dilutive shares"&gt;13,480,002&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented_pid_c20250101__20250630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--BondsWithWarrantsPotentialOrdinaryShareMember_zH1JSvuogAug" title="Anti-dilutive shares"&gt;11,903,002&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:ScheduleOfPotentialOrdinaryTableTaxBlock>
    <ifrs-full:NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented
      contextRef="From2026-01-012026-06-30_custom_ShareOptionExercisePriceMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact006247"
      unitRef="Shares">500</ifrs-full:NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented>
    <ifrs-full:NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented
      contextRef="From2025-01-012025-06-30_custom_ShareOptionExercisePriceMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact006249"
      unitRef="Shares">500</ifrs-full:NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented>
    <ifrs-full:NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented
      contextRef="From2026-01-012026-06-30_custom_ShareOptionPotentialOrdinaryShareMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact006251"
      unitRef="Shares">640160</ifrs-full:NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented>
    <ifrs-full:NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented
      contextRef="From2025-01-012025-06-30_custom_ShareOptionPotentialOrdinaryShareMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact006253"
      unitRef="Shares">640160</ifrs-full:NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented>
    <ifrs-full:NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented
      contextRef="From2026-01-012026-06-30_custom_BondsWithWarrantsExercisePriceMember_ifrs-full_BottomOfRangeMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact006255"
      unitRef="Shares">2500</ifrs-full:NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented>
    <ifrs-full:NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented
      contextRef="From2026-01-012026-06-30_custom_BondsWithWarrantsExercisePriceMember_ifrs-full_TopOfRangeMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact006257"
      unitRef="Shares">4000</ifrs-full:NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented>
    <ifrs-full:NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented
      contextRef="From2025-01-012025-06-30_custom_BondsWithWarrantsExercisePriceMember_ifrs-full_BottomOfRangeMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact006259"
      unitRef="Shares">2500</ifrs-full:NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented>
    <ifrs-full:NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented
      contextRef="From2025-01-012025-06-30_custom_BondsWithWarrantsExercisePriceMember_ifrs-full_TopOfRangeMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact006261"
      unitRef="Shares">4000</ifrs-full:NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented>
    <ifrs-full:NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented
      contextRef="From2026-01-012026-06-30_custom_BondsWithWarrantsPotentialOrdinaryShareMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact006263"
      unitRef="Shares">13480002</ifrs-full:NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented>
    <ifrs-full:NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented
      contextRef="From2025-01-012025-06-30_custom_BondsWithWarrantsPotentialOrdinaryShareMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact006265"
      unitRef="Shares">11903002</ifrs-full:NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented>
    <cik0002058261:ScheduleOfEarningsPerShareBasicTableTaxBlock
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      id="Fact006267">&lt;table cellpadding="0" cellspacing="0" id="xdx_89B_ecustom--ScheduleOfEarningsPerShareBasicTableTaxBlock_pn3n3_zkohzpaMnwle" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Loss per share (Details 3)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&lt;span id="xdx_8B8_zhWTo7yFL3yf" style="display: none"&gt;Schedule of losses per share&lt;/span&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" id="xdx_498_20260101__20260630_zNcljqHzYIt5" style="text-align: center"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" id="xdx_49B_20250101__20250630_zBUKMd5QOMx3" style="text-align: center"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Six-month&lt;br/&gt; period ended&lt;br/&gt;June&#160;30,&lt;br/&gt;2026&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Six-month&lt;br/&gt; period ended&lt;br/&gt;June&#160;30,&lt;br/&gt;2025&lt;/b&gt;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="text-align: center"&gt;&lt;b&gt;(In Korean Won)&lt;/b&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40A_eifrs-full--BasicEarningsLossPerShare_pid_zGt3Q7V7WKx6" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Basic losses per share&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;(61&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;(70&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:ScheduleOfEarningsPerShareBasicTableTaxBlock>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact006269"
      unitRef="KRWShares">-61</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact006270"
      unitRef="KRWShares">-70</ifrs-full:BasicEarningsLossPerShare>
    <cik0002058261:AccountsPayableTextBlock
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      id="Fact006279">&lt;p id="xdx_80A_ecustom--AccountsPayableTextBlock_zwDCH6WzA7Mb" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;15. &lt;span id="xdx_82B_zYZ6ig8irBa"&gt;Accounts payable&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;Details of accounts payable recognized as of June&#160;30, 2026 and December&#160;31, 2025 are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89A_ecustom--ScheduleOfAccountsPayablesTableTextBlock_pn3n3_ztmiCXqVZpcj" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Accounts payables (Details)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span id="xdx_8B0_zUGYrHgXzU8" style="display: none"&gt;Schedule of accounts payables&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;June&#160;30,&lt;br/&gt;2026&lt;/b&gt;(*)&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2025&lt;/b&gt;(*)&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;Current&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Other payables&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#x20a9;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_905_ecustom--OtherPayablesCurrent_iI_pn3n3_c20260630_fKCop_zlfSMuAGw4Dl" title="Other payables"&gt;6,057,410&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_ecustom--OtherPayablesCurrent_iI_pn3n3_c20251231_fKCop_zblw947i64u7" title="Other payables"&gt;3,508,878&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Accrued expenses&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--AccruedExpenses_iI_pn3n3_c20260630_fKCop_zL9ALJhZ2xk9" title="Accrued expenses"&gt;78,675&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_901_ecustom--AccruedExpenses_iI_pn3n3_c20251231_fKCop_zrTABu0Op1g" title="Accrued expenses"&gt;44,171&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: center; vertical-align: top; padding-bottom: 1.25pt"&gt;Total&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_906_ecustom--AccountsPayablesCurrent_iI_pn3n3_c20260630_fKCop_z5ztwfr27ul5" title="Total"&gt;6,136,085&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_908_ecustom--AccountsPayablesCurrent_iI_pn3n3_c20251231_fKCop_zjmc9jyRSqZd" title="Total"&gt;3,553,049&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;div style="width: 25%; margin-left: 0; margin-right: auto"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&lt;span id="xdx_F03_zzoqJBH6Aoie"&gt;(*)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_F1D_z20ijIu3miih"&gt;Other payables consist primarily of professional service payable, credit card payables, and refundable deposit for disposal of treasury shares of Korean won 4,180,000 and 2,110,000 thousand as of June&#160;30, 2026 and December&#160;31, 2025, respectively.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AF_ziYR0TDXRiCd" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

</cik0002058261:AccountsPayableTextBlock>
    <cik0002058261:ScheduleOfAccountsPayablesTableTextBlock
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      id="Fact006281">&lt;table cellpadding="0" cellspacing="0" id="xdx_89A_ecustom--ScheduleOfAccountsPayablesTableTextBlock_pn3n3_ztmiCXqVZpcj" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Accounts payables (Details)"&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span id="xdx_8B0_zUGYrHgXzU8" style="display: none"&gt;Schedule of accounts payables&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;June&#160;30,&lt;br/&gt;2026&lt;/b&gt;(*)&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2025&lt;/b&gt;(*)&lt;/th&gt;
    &lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="text-align: center"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;Current&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;Other payables&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#x20a9;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_905_ecustom--OtherPayablesCurrent_iI_pn3n3_c20260630_fKCop_zlfSMuAGw4Dl" title="Other payables"&gt;6,057,410&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_ecustom--OtherPayablesCurrent_iI_pn3n3_c20251231_fKCop_zblw947i64u7" title="Other payables"&gt;3,508,878&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Accrued expenses&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--AccruedExpenses_iI_pn3n3_c20260630_fKCop_zL9ALJhZ2xk9" title="Accrued expenses"&gt;78,675&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_901_ecustom--AccruedExpenses_iI_pn3n3_c20251231_fKCop_zrTABu0Op1g" title="Accrued expenses"&gt;44,171&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="text-align: center; vertical-align: top; padding-bottom: 1.25pt"&gt;Total&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#x20a9;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_906_ecustom--AccountsPayablesCurrent_iI_pn3n3_c20260630_fKCop_z5ztwfr27ul5" title="Total"&gt;6,136,085&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_908_ecustom--AccountsPayablesCurrent_iI_pn3n3_c20251231_fKCop_zjmc9jyRSqZd" title="Total"&gt;3,553,049&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;div style="width: 25%; margin-left: 0; margin-right: auto"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&lt;span id="xdx_F03_zzoqJBH6Aoie"&gt;(*)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_F1D_z20ijIu3miih"&gt;Other payables consist primarily of professional service payable, credit card payables, and refundable deposit for disposal of treasury shares of Korean won 4,180,000 and 2,110,000 thousand as of June&#160;30, 2026 and December&#160;31, 2025, respectively.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:ScheduleOfAccountsPayablesTableTextBlock>
    <cik0002058261:OtherPayablesCurrent
      contextRef="AsOf2026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006283"
      unitRef="KRW">6057410000</cik0002058261:OtherPayablesCurrent>
    <cik0002058261:OtherPayablesCurrent
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006285"
      unitRef="KRW">3508878000</cik0002058261:OtherPayablesCurrent>
    <cik0002058261:AccruedExpenses
      contextRef="AsOf2026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006287"
      unitRef="KRW">78675000</cik0002058261:AccruedExpenses>
    <cik0002058261:AccruedExpenses
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006289"
      unitRef="KRW">44171000</cik0002058261:AccruedExpenses>
    <cik0002058261:AccountsPayablesCurrent
      contextRef="AsOf2026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006291"
      unitRef="KRW">6136085000</cik0002058261:AccountsPayablesCurrent>
    <cik0002058261:AccountsPayablesCurrent
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006293"
      unitRef="KRW">3553049000</cik0002058261:AccountsPayablesCurrent>
    <cik0002058261:ProvisionsTextBlock
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      id="Fact006296">&lt;p id="xdx_809_ecustom--ProvisionsTextBlock_zTVRKqugANee" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;16. &lt;span id="xdx_82E_zVhrOd3Klcqi"&gt;Provisions&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Details of provisions for the six-month periods ended June&#160;30, 2026 and 2025 are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_887_ecustom--ScheduleOfLossForProvisionsTableTextBlock_pn3n3_zMj8ykBoYu8f" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Provisions (Details)"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span id="xdx_8B2_zuOTaNTQ7DH7" style="display: none"&gt;Schedule of provisions&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Six-month&lt;br/&gt;period ended&lt;br/&gt;June&#160;30,&lt;br/&gt;2026&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Six-month&lt;br/&gt;period ended&lt;br/&gt;June&#160;30,&lt;br/&gt;2025&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="6" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;(In thousands of Korean Won)&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Building restoration&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Beginning of the period&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90A_eifrs-full--Provisions_iS_pn3n3_c20260101__20260630__ifrs-full--ClassesOfProvisionsAxis__custom--BuildingRestorationMember_zrEjOqt6RTv1" title="Beginning of the year"&gt;48,658&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90F_eifrs-full--Provisions_iS_pn3n3_c20250101__20250630__ifrs-full--ClassesOfProvisionsAxis__custom--BuildingRestorationMember_zLShiUPaHBJ1" title="Beginning of the year"&gt;48,341&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_907_eifrs-full--InterestExpense_pn3n3_c20260101__20260630__ifrs-full--ClassesOfProvisionsAxis__custom--BuildingRestorationMember_zsJKO6g0xqi3" title="Interest expense"&gt;159&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_907_eifrs-full--InterestExpense_pn3n3_c20250101__20250630__ifrs-full--ClassesOfProvisionsAxis__custom--BuildingRestorationMember_zOeFwfCUo4Qj" title="Interest expense"&gt;158&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Ending of the period&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90F_eifrs-full--Provisions_iE_pn3n3_c20260101__20260630__ifrs-full--ClassesOfProvisionsAxis__custom--BuildingRestorationMember_zflvqmlLj4Bj" title="Ending of the year"&gt;48,817&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90F_eifrs-full--Provisions_iE_pn3n3_c20250101__20250630__ifrs-full--ClassesOfProvisionsAxis__custom--BuildingRestorationMember_z80LLhaFrBE6" title="Ending of the year"&gt;48,499&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The provision for building restoration relates mainly to buildings leased during the six-month periods ended June&#160;30, 2026 and 2025. The provision has been estimated based on historical data associated with similar buildings.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</cik0002058261:ProvisionsTextBlock>
    <cik0002058261:ScheduleOfLossForProvisionsTableTextBlock
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      id="Fact006298">&lt;table cellpadding="0" cellspacing="0" id="xdx_887_ecustom--ScheduleOfLossForProvisionsTableTextBlock_pn3n3_zMj8ykBoYu8f" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Provisions (Details)"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span id="xdx_8B2_zuOTaNTQ7DH7" style="display: none"&gt;Schedule of provisions&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Six-month&lt;br/&gt;period ended&lt;br/&gt;June&#160;30,&lt;br/&gt;2026&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Six-month&lt;br/&gt;period ended&lt;br/&gt;June&#160;30,&lt;br/&gt;2025&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="6" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;(In thousands of Korean Won)&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Building restoration&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Beginning of the period&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90A_eifrs-full--Provisions_iS_pn3n3_c20260101__20260630__ifrs-full--ClassesOfProvisionsAxis__custom--BuildingRestorationMember_zrEjOqt6RTv1" title="Beginning of the year"&gt;48,658&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90F_eifrs-full--Provisions_iS_pn3n3_c20250101__20250630__ifrs-full--ClassesOfProvisionsAxis__custom--BuildingRestorationMember_zLShiUPaHBJ1" title="Beginning of the year"&gt;48,341&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_907_eifrs-full--InterestExpense_pn3n3_c20260101__20260630__ifrs-full--ClassesOfProvisionsAxis__custom--BuildingRestorationMember_zsJKO6g0xqi3" title="Interest expense"&gt;159&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_907_eifrs-full--InterestExpense_pn3n3_c20250101__20250630__ifrs-full--ClassesOfProvisionsAxis__custom--BuildingRestorationMember_zOeFwfCUo4Qj" title="Interest expense"&gt;158&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Ending of the period&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90F_eifrs-full--Provisions_iE_pn3n3_c20260101__20260630__ifrs-full--ClassesOfProvisionsAxis__custom--BuildingRestorationMember_zflvqmlLj4Bj" title="Ending of the year"&gt;48,817&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90F_eifrs-full--Provisions_iE_pn3n3_c20250101__20250630__ifrs-full--ClassesOfProvisionsAxis__custom--BuildingRestorationMember_z80LLhaFrBE6" title="Ending of the year"&gt;48,499&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;</cik0002058261:ScheduleOfLossForProvisionsTableTextBlock>
    <ifrs-full:Provisions
      contextRef="AsOf2025-12-31_custom_BuildingRestorationMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006300"
      unitRef="KRW">48658000</ifrs-full:Provisions>
    <ifrs-full:Provisions
      contextRef="AsOf2024-12-31_custom_BuildingRestorationMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006302"
      unitRef="KRW">48341000</ifrs-full:Provisions>
    <ifrs-full:InterestExpense
      contextRef="From2026-01-012026-06-30_custom_BuildingRestorationMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006304"
      unitRef="KRW">159000</ifrs-full:InterestExpense>
    <ifrs-full:InterestExpense
      contextRef="From2025-01-012025-06-30_custom_BuildingRestorationMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006306"
      unitRef="KRW">158000</ifrs-full:InterestExpense>
    <ifrs-full:Provisions
      contextRef="AsOf2026-06-30_custom_BuildingRestorationMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006308"
      unitRef="KRW">48817000</ifrs-full:Provisions>
    <ifrs-full:Provisions
      contextRef="AsOf2025-06-30_custom_BuildingRestorationMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006310"
      unitRef="KRW">48499000</ifrs-full:Provisions>
    <ifrs-full:DisclosureOfEmployeeBenefitsExplanatory
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      id="Fact006312">&lt;p id="xdx_809_eifrs-full--DisclosureOfEmployeeBenefitsExplanatory_zsbcetGLCf86" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;17. &lt;span id="xdx_822_zm5BSQq5Cgqj"&gt;Employee benefits&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Details of defined benefit liability recognized as of June&#160;30, 2026 and December&#160;31, 2025 are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_895_ecustom--EmployeeBenefitsLiabilityRecognizedTableTextBlock_pn3n3_zc9BKmdvFVH3" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Employee benefits (Details)"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span id="xdx_8BA_zzqprZklcka2" style="display: none"&gt;Schedule of employee benefits liability recognized&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20260630_zMcO9hh60as1" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49D_20251231_zRK9nMebuHHc" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;June&#160;30,&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;December&#160;31,&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;2026&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--NetDefinedBenefitLiability_iI_pn3n3_zgkRcZCtWbSi" style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Defined benefit liability&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;903,565&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;980,841&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AD_zcg6uSj5g0Fa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The Company operates defined benefit plans as a retirement pension scheme. Defined benefit plans expose the Company to actuarial risks, such as longevity risk, currency risk, interest rate risk, and market (investment) risk.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

















&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;A.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Movement in net defined benefit (liability) asset&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Details of the reconciliation from the opening balances to the closing balances for the net defined benefit liability and its components for the six-month period ended June&#160;30, 2026 are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--ScheduleOfReconciliationFromTheOpeningBalancesTableTextBlock_pn3n3_zO23QlRfVVxd" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Employee benefits (Details 1)"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_8B7_zUh0yQypDfTf" style="display: none"&gt;Schedule of reconciliation from the opening balances&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49F_20260101__20260630__ifrs-full--DefinedBenefitPlansAxis__custom--DefinedBenefitObligationMember_ziAzL4agLNy1" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49F_20260101__20260630__ifrs-full--DefinedBenefitPlansAxis__custom--FairValueOfPlanAssetsMember_zLWd9IdV31A" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49C_20260101__20260630__ifrs-full--DefinedBenefitPlansAxis__custom--NetDefinedBenefitLiabilitiesMember_zwz7i28t1eb6" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Defined benefit&lt;br/&gt;obligation&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Fair value of&lt;br/&gt;plan assets&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Net defined&lt;br/&gt;Benefit liabilities&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;June&#160;30, &lt;br/&gt;2026&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;June&#160;30, &lt;br/&gt;2026&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;June&#160;30, &lt;br/&gt;2026&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="10" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--DefinedBenefitObligation_iS_pn3n3_zDEM39WrvCCc" style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Balance at 1 January&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 9%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;980,841&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 9%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6329"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 9%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;980,841&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--IncludedInProfitOrLossAbstract_iB_zshQO1nP5ti2" style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Included in profit or loss&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40D_eifrs-full--CurrentServiceCostDefinedBenefitPlans_pn3n3_zxbx0miDDGBj" style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Current service cost&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;96,415&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6337"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;96,415&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_405_eifrs-full--InterestExpenseDefinedBenefitPlans_pn3n3_z8kb1YohsSr7" style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;20,642&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6341"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;20,642&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--IncludedInProfitOrLoss_pn3n3_z6zqeXoZhzX3" style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;117,057&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6345"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;117,057&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--IncludedInOciAbstract_iB_zC3mR7YYR6yh" style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Included in OCI&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--RemeasurementLossgain_i01_pn3n3_zw4ZRbHUigB" style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Remeasurement losses(gains)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--DemographicAssumption_i01N_pn3n3_di_zzMhpq1RNXp" style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;- Demographic assumption&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6356"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6357"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6358"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--FinancialAssumption_i01N_pn3n3_di_zZOIg8roMAO9" style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;- Financial assumption&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(53,297&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6361"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(53,297&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--AdjustmentBasedOnExperience_i01N_pn3n3_di_zT8Isf4uNSM2" style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;- Adjustment based on experience&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(100,435&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6365"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(100,435&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40D_eifrs-full--GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset_pn3n3_zipwVaYFs6P4" style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(153,732&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6369"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(153,732&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--OtherAbstract_iB_zjgRyZ1fOF4e" style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Other&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--InterimSettlement_i01N_pn3n3_di_zjWDBtthm7Nl" style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;- Interim Settlement&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6376"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6377"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6378"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_409_eifrs-full--BenefitsPaidOrPayable_i01N_pn3n3_di_zzZMAU4eK8lj" style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Benefits paid&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(40,601&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6381"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(40,601&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--OtherSubtotal_i01N_pn3n3_di_z11NRq3St9vk" style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(40,601&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6385"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(40,601&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--DefinedBenefitObligation_iE_pn3n3_z9u7GvfTQ2j" style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Balance at 30 June&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;903,565&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6389"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;903,565&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A5_zos81bXxDrZe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;B.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Plan assets&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;There are no contributions funded to its defined benefit plans as of June&#160;30, 2026 and December&#160;31, 2025.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;

</ifrs-full:DisclosureOfEmployeeBenefitsExplanatory>
    <cik0002058261:EmployeeBenefitsLiabilityRecognizedTableTextBlock
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      id="Fact006314">&lt;table cellpadding="0" cellspacing="0" id="xdx_895_ecustom--EmployeeBenefitsLiabilityRecognizedTableTextBlock_pn3n3_zc9BKmdvFVH3" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Employee benefits (Details)"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span id="xdx_8BA_zzqprZklcka2" style="display: none"&gt;Schedule of employee benefits liability recognized&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20260630_zMcO9hh60as1" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49D_20251231_zRK9nMebuHHc" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;June&#160;30,&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;December&#160;31,&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;2026&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--NetDefinedBenefitLiability_iI_pn3n3_zgkRcZCtWbSi" style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Defined benefit liability&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;903,565&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;980,841&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:EmployeeBenefitsLiabilityRecognizedTableTextBlock>
    <cik0002058261:NetDefinedBenefitLiability
      contextRef="AsOf2026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006316"
      unitRef="KRW">903565000</cik0002058261:NetDefinedBenefitLiability>
    <cik0002058261:NetDefinedBenefitLiability
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006317"
      unitRef="KRW">980841000</cik0002058261:NetDefinedBenefitLiability>
    <cik0002058261:ScheduleOfReconciliationFromTheOpeningBalancesTableTextBlock
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      id="Fact006326">&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--ScheduleOfReconciliationFromTheOpeningBalancesTableTextBlock_pn3n3_zO23QlRfVVxd" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Employee benefits (Details 1)"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_8B7_zUh0yQypDfTf" style="display: none"&gt;Schedule of reconciliation from the opening balances&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49F_20260101__20260630__ifrs-full--DefinedBenefitPlansAxis__custom--DefinedBenefitObligationMember_ziAzL4agLNy1" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49F_20260101__20260630__ifrs-full--DefinedBenefitPlansAxis__custom--FairValueOfPlanAssetsMember_zLWd9IdV31A" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49C_20260101__20260630__ifrs-full--DefinedBenefitPlansAxis__custom--NetDefinedBenefitLiabilitiesMember_zwz7i28t1eb6" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Defined benefit&lt;br/&gt;obligation&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Fair value of&lt;br/&gt;plan assets&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Net defined&lt;br/&gt;Benefit liabilities&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;June&#160;30, &lt;br/&gt;2026&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;June&#160;30, &lt;br/&gt;2026&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;June&#160;30, &lt;br/&gt;2026&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="10" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--DefinedBenefitObligation_iS_pn3n3_zDEM39WrvCCc" style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Balance at 1 January&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 9%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;980,841&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 9%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6329"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 9%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;980,841&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--IncludedInProfitOrLossAbstract_iB_zshQO1nP5ti2" style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Included in profit or loss&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40D_eifrs-full--CurrentServiceCostDefinedBenefitPlans_pn3n3_zxbx0miDDGBj" style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Current service cost&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;96,415&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6337"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;96,415&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_405_eifrs-full--InterestExpenseDefinedBenefitPlans_pn3n3_z8kb1YohsSr7" style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;20,642&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6341"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;20,642&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--IncludedInProfitOrLoss_pn3n3_z6zqeXoZhzX3" style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;117,057&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6345"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;117,057&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--IncludedInOciAbstract_iB_zC3mR7YYR6yh" style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Included in OCI&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--RemeasurementLossgain_i01_pn3n3_zw4ZRbHUigB" style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Remeasurement losses(gains)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--DemographicAssumption_i01N_pn3n3_di_zzMhpq1RNXp" style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;- Demographic assumption&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6356"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6357"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6358"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--FinancialAssumption_i01N_pn3n3_di_zZOIg8roMAO9" style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;- Financial assumption&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(53,297&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6361"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(53,297&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--AdjustmentBasedOnExperience_i01N_pn3n3_di_zT8Isf4uNSM2" style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;- Adjustment based on experience&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(100,435&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6365"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(100,435&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40D_eifrs-full--GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset_pn3n3_zipwVaYFs6P4" style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(153,732&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6369"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(153,732&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--OtherAbstract_iB_zjgRyZ1fOF4e" style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Other&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--InterimSettlement_i01N_pn3n3_di_zjWDBtthm7Nl" style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;- Interim Settlement&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6376"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6377"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6378"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_409_eifrs-full--BenefitsPaidOrPayable_i01N_pn3n3_di_zzZMAU4eK8lj" style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Benefits paid&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(40,601&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6381"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(40,601&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--OtherSubtotal_i01N_pn3n3_di_z11NRq3St9vk" style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(40,601&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6385"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(40,601&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--DefinedBenefitObligation_iE_pn3n3_z9u7GvfTQ2j" style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Balance at 30 June&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;903,565&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6389"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;903,565&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:ScheduleOfReconciliationFromTheOpeningBalancesTableTextBlock>
    <cik0002058261:DefinedBenefitObligation
      contextRef="AsOf2025-12-31_custom_DefinedBenefitObligationMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006328"
      unitRef="KRW">980841000</cik0002058261:DefinedBenefitObligation>
    <cik0002058261:DefinedBenefitObligation
      contextRef="AsOf2025-12-31_custom_NetDefinedBenefitLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006330"
      unitRef="KRW">980841000</cik0002058261:DefinedBenefitObligation>
    <ifrs-full:CurrentServiceCostDefinedBenefitPlans
      contextRef="From2026-01-012026-06-30_custom_DefinedBenefitObligationMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006336"
      unitRef="KRW">96415000</ifrs-full:CurrentServiceCostDefinedBenefitPlans>
    <ifrs-full:CurrentServiceCostDefinedBenefitPlans
      contextRef="From2026-01-012026-06-30_custom_NetDefinedBenefitLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006338"
      unitRef="KRW">96415000</ifrs-full:CurrentServiceCostDefinedBenefitPlans>
    <ifrs-full:InterestExpenseDefinedBenefitPlans
      contextRef="From2026-01-012026-06-30_custom_DefinedBenefitObligationMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006340"
      unitRef="KRW">20642000</ifrs-full:InterestExpenseDefinedBenefitPlans>
    <ifrs-full:InterestExpenseDefinedBenefitPlans
      contextRef="From2026-01-012026-06-30_custom_NetDefinedBenefitLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006342"
      unitRef="KRW">20642000</ifrs-full:InterestExpenseDefinedBenefitPlans>
    <cik0002058261:IncludedInProfitOrLoss
      contextRef="From2026-01-012026-06-30_custom_DefinedBenefitObligationMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006344"
      unitRef="KRW">117057000</cik0002058261:IncludedInProfitOrLoss>
    <cik0002058261:IncludedInProfitOrLoss
      contextRef="From2026-01-012026-06-30_custom_NetDefinedBenefitLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006346"
      unitRef="KRW">117057000</cik0002058261:IncludedInProfitOrLoss>
    <cik0002058261:FinancialAssumption
      contextRef="From2026-01-012026-06-30_custom_DefinedBenefitObligationMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006360"
      unitRef="KRW">53297000</cik0002058261:FinancialAssumption>
    <cik0002058261:FinancialAssumption
      contextRef="From2026-01-012026-06-30_custom_NetDefinedBenefitLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006362"
      unitRef="KRW">53297000</cik0002058261:FinancialAssumption>
    <cik0002058261:AdjustmentBasedOnExperience
      contextRef="From2026-01-012026-06-30_custom_DefinedBenefitObligationMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006364"
      unitRef="KRW">100435000</cik0002058261:AdjustmentBasedOnExperience>
    <cik0002058261:AdjustmentBasedOnExperience
      contextRef="From2026-01-012026-06-30_custom_NetDefinedBenefitLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006366"
      unitRef="KRW">100435000</cik0002058261:AdjustmentBasedOnExperience>
    <ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset
      contextRef="From2026-01-012026-06-30_custom_DefinedBenefitObligationMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006368"
      unitRef="KRW">-153732000</ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset>
    <ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset
      contextRef="From2026-01-012026-06-30_custom_NetDefinedBenefitLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006370"
      unitRef="KRW">-153732000</ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset>
    <ifrs-full:BenefitsPaidOrPayable
      contextRef="From2026-01-012026-06-30_custom_DefinedBenefitObligationMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006380"
      unitRef="KRW">40601000</ifrs-full:BenefitsPaidOrPayable>
    <ifrs-full:BenefitsPaidOrPayable
      contextRef="From2026-01-012026-06-30_custom_NetDefinedBenefitLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006382"
      unitRef="KRW">40601000</ifrs-full:BenefitsPaidOrPayable>
    <cik0002058261:OtherSubtotal
      contextRef="From2026-01-012026-06-30_custom_DefinedBenefitObligationMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006384"
      unitRef="KRW">40601000</cik0002058261:OtherSubtotal>
    <cik0002058261:OtherSubtotal
      contextRef="From2026-01-012026-06-30_custom_NetDefinedBenefitLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006386"
      unitRef="KRW">40601000</cik0002058261:OtherSubtotal>
    <cik0002058261:DefinedBenefitObligation
      contextRef="AsOf2026-06-30_custom_DefinedBenefitObligationMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006388"
      unitRef="KRW">903565000</cik0002058261:DefinedBenefitObligation>
    <cik0002058261:DefinedBenefitObligation
      contextRef="AsOf2026-06-30_custom_NetDefinedBenefitLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006390"
      unitRef="KRW">903565000</cik0002058261:DefinedBenefitObligation>
    <cik0002058261:SubordinatedBorrowingsDisclosureTextBlock
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      id="Fact006392">&lt;p id="xdx_808_ecustom--SubordinatedBorrowingsDisclosureTextBlock_z0Y8oISxo7T1" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;18. &lt;span id="xdx_822_zp0kUZ1rE0ma"&gt;Borrowings&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; color: #212529"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Details of borrowing as of June&#160;30, 2026 and December&#160;31, 2025 are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89C_ecustom--ScheduleOfBorrowingTableTaxBlock_pn3n3_zMFcwHiacUP6" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Borrowings (Details)"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: #FFFFFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.25in; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;&lt;span id="xdx_8BC_zzh79HAN6VSi" style="display: none"&gt;Schedule of borrowing&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Amount&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Currency&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Nominal&lt;br/&gt;interest rate&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Maturity&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;June&#160;30,&lt;br/&gt;2026&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2025&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="6" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Short-term borrowings&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: #FFFFFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.25in; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Well Core Co., Ltd. (*)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top; width: 10%; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;KRW&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 9%; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_902_eifrs-full--BorrowingsInterestRate_iI_pid_dp_c20260630__ifrs-full--CounterpartiesAxis__custom--WellCoreMember_fKCop_zBZBCr5wrFda" title="Nominal interest rate"&gt;4.60&lt;/span&gt;&lt;/span&gt;%&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; width: 1%; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top; width: 10%; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90A_ecustom--Maturity_c20260101__20260630__ifrs-full--CounterpartiesAxis__custom--WellCoreMember_fKCop_zymm6suacbYk" title="Maturity"&gt;31-Jul-26&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; width: 9%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_907_eifrs-full--ShorttermBorrowings_iI_pn3n3_c20260630__ifrs-full--CounterpartiesAxis__custom--WellCoreMember_fKCop_z7JJG6w48tSb" title="Amount"&gt;1,000,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; width: 1%; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; width: 9%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_907_eifrs-full--ShorttermBorrowings_iI_pn3n3_c20251231__ifrs-full--CounterpartiesAxis__custom--WellCoreMember_fKCop_z4k5Ot0NKvK6" title="Amount"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6402"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; width: 1%; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td colspan="8" style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_909_eifrs-full--ShorttermBorrowings_iI_pn3n3_c20260630_fKCop_zZNxUYpFYDTc" title="Amount"&gt;1,000,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90C_eifrs-full--ShorttermBorrowings_iI_pn3n3_c20251231_fKCop_zQqyT9ry8nmc" title="Amount"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6406"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;div style="margin: 0pt auto 0pt 0; font-family: Times New Roman, Times, Serif; width: 25%"&gt;&lt;div style="border-top: Black 1pt solid; font: 1pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"&gt;&lt;span id="xdx_F05_z8DgA0oUDYRf" style="font-family: Times New Roman, Times, Serif"&gt;(*)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F17_zmq8PUEEDhI4" style="font-family: Times New Roman, Times, Serif"&gt;The borrowing from Well Core Co., Ltd is a related party transaction.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A9_zNuhG42RZPNi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

















</cik0002058261:SubordinatedBorrowingsDisclosureTextBlock>
    <cik0002058261:ScheduleOfBorrowingTableTaxBlock
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      id="Fact006394">&lt;table cellpadding="0" cellspacing="0" id="xdx_89C_ecustom--ScheduleOfBorrowingTableTaxBlock_pn3n3_zMFcwHiacUP6" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Borrowings (Details)"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: #FFFFFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.25in; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;&lt;span id="xdx_8BC_zzh79HAN6VSi" style="display: none"&gt;Schedule of borrowing&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Amount&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Currency&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Nominal&lt;br/&gt;interest rate&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Maturity&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;June&#160;30,&lt;br/&gt;2026&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2025&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="6" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Short-term borrowings&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: #FFFFFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.25in; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Well Core Co., Ltd. (*)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top; width: 10%; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;KRW&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 9%; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_902_eifrs-full--BorrowingsInterestRate_iI_pid_dp_c20260630__ifrs-full--CounterpartiesAxis__custom--WellCoreMember_fKCop_zBZBCr5wrFda" title="Nominal interest rate"&gt;4.60&lt;/span&gt;&lt;/span&gt;%&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; width: 1%; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top; width: 10%; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90A_ecustom--Maturity_c20260101__20260630__ifrs-full--CounterpartiesAxis__custom--WellCoreMember_fKCop_zymm6suacbYk" title="Maturity"&gt;31-Jul-26&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; width: 9%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_907_eifrs-full--ShorttermBorrowings_iI_pn3n3_c20260630__ifrs-full--CounterpartiesAxis__custom--WellCoreMember_fKCop_z7JJG6w48tSb" title="Amount"&gt;1,000,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; width: 1%; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; width: 9%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_907_eifrs-full--ShorttermBorrowings_iI_pn3n3_c20251231__ifrs-full--CounterpartiesAxis__custom--WellCoreMember_fKCop_z4k5Ot0NKvK6" title="Amount"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6402"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; width: 1%; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td colspan="8" style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_909_eifrs-full--ShorttermBorrowings_iI_pn3n3_c20260630_fKCop_zZNxUYpFYDTc" title="Amount"&gt;1,000,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90C_eifrs-full--ShorttermBorrowings_iI_pn3n3_c20251231_fKCop_zQqyT9ry8nmc" title="Amount"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6406"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;div style="margin: 0pt auto 0pt 0; font-family: Times New Roman, Times, Serif; width: 25%"&gt;&lt;div style="border-top: Black 1pt solid; font: 1pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"&gt;&lt;span id="xdx_F05_z8DgA0oUDYRf" style="font-family: Times New Roman, Times, Serif"&gt;(*)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F17_zmq8PUEEDhI4" style="font-family: Times New Roman, Times, Serif"&gt;The borrowing from Well Core Co., Ltd is a related party transaction.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:ScheduleOfBorrowingTableTaxBlock>
    <ifrs-full:BorrowingsInterestRate
      contextRef="AsOf2026-06-30_custom_WellCoreMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact006396"
      unitRef="Pure">0.0460</ifrs-full:BorrowingsInterestRate>
    <cik0002058261:Maturity
      contextRef="From2026-01-012026-06-30_custom_WellCoreMember_custom_CubebioCo.Ltd.Member"
      id="Fact006398">2026-07-31</cik0002058261:Maturity>
    <ifrs-full:ShorttermBorrowings
      contextRef="AsOf2026-06-30_custom_WellCoreMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006400"
      unitRef="KRW">1000000000</ifrs-full:ShorttermBorrowings>
    <ifrs-full:ShorttermBorrowings
      contextRef="AsOf2026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006404"
      unitRef="KRW">1000000000</ifrs-full:ShorttermBorrowings>
    <cik0002058261:BondWithWarrantsAndDerivativeInstrumentsTextBlock
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      id="Fact006416">&lt;p id="xdx_802_ecustom--BondWithWarrantsAndDerivativeInstrumentsTextBlock_zFM3WNhLVS72" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;19. &lt;span id="xdx_82B_zTzegtZXNefj"&gt;Bond with warrants and derivative instruments&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Details of principal of bonds issued and outstanding as of June&#160;30, 2026 and December&#160;31, 2025 are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_891_ecustom--DetailsOfPrincipalOfBondsIssuedAndOutstandingTableTextBlock_pn3n3_zCf4yxbTEyb7" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Bond with warrants and derivative instruments (Details)"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span id="xdx_8B7_zsLodsfKk5h5" style="display: none"&gt;Details of principal of bonds issued and outstanding&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;June&#160;30,&lt;br/&gt;2026&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2025&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="6" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Bond with warrants&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;15&lt;sup&gt;th&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_909_eifrs-full--BondsIssued_iI_pn3n3_c20260630__ifrs-full--BorrowingsByNameAxis__custom--N15thBondWithWarrantsMember_ziCYFvJZttjl" title="Total"&gt;1,365,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90B_eifrs-full--BondsIssued_iI_pn3n3_c20251231__ifrs-full--BorrowingsByNameAxis__custom--N15thBondWithWarrantsMember_zEWo8rKBsVHj" title="Total"&gt;1,365,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;20&lt;sup&gt;th&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90F_eifrs-full--BondsIssued_iI_pn3n3_c20260630__ifrs-full--BorrowingsByNameAxis__custom--N20thBondWithWarrantsMember_zOLoNMVRlyzd" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6424"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_905_eifrs-full--BondsIssued_iI_pn3n3_c20251231__ifrs-full--BorrowingsByNameAxis__custom--N20thBondWithWarrantsMember_zyX69Z9asOjd" title="Total"&gt;600,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;21&lt;sup&gt;st&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90F_eifrs-full--BondsIssued_iI_pn3n3_c20260630__ifrs-full--BorrowingsByNameAxis__custom--N21stBondWithWarrantsMember_zsudoGgdwLs4" title="Total"&gt;3,000,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_905_eifrs-full--BondsIssued_iI_pn3n3_c20251231__ifrs-full--BorrowingsByNameAxis__custom--N21stBondWithWarrantsMember_z08EDygTUjpd" title="Total"&gt;3,000,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90E_eifrs-full--BondsIssued_iI_pn3n3_c20260630_z1IZI6Fu49y5" title="Total"&gt;4,365,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_903_eifrs-full--BondsIssued_iI_pn3n3_c20251231_ze6o7ICAVMWl" title="Total"&gt;4,965,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AC_zrUEvH1R3Kyb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Details of the face value of bonds with warrants, the related warrants adjustment and the resulting carrying amount as of June&#160;30, 2026 and December&#160;31, 2025 are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--DetailsOfChangesInFaceValueOfBondsWithWarrantsTableTextBlock_zGXa5PVQDqYh" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Bond with warrants and derivative instruments (Details 4)"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: #FFFFFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;&lt;span id="xdx_8B6_zLIMiWjknKM" style="display: none"&gt;Details of face value of bonds with warrants&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;June&#160;30,&lt;br/&gt;2026&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2025&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="6" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Bond with warrants&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 9%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,365,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 9%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,965,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: #FFFFFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Warrants adjustment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(1,155,240&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(1,699,688&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,209,760&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,265,312&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AD_zPk4XgRTwy9l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Details of the changes in principal of bonds for the period ended June&#160;30, 2026 are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_895_ecustom--DetailsOfChangesInPrincipalOfBondsTableTextBlock_zbFlGIQJEMs4" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Bond with warrants and derivative instruments (Details 1)"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span id="xdx_8B1_zDSMHrSqeT1e" style="display: none"&gt;&lt;span&gt;Details of changes in principal of bonds&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;15&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;20&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;21&lt;sup&gt;st&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="14" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Balance as of January&#160;1&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_906_eifrs-full--BondsIssued_iS_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N15thBondWithWarrantsMember_z79EnqYI0nI" title="Balance at beginning"&gt;1,365,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_905_eifrs-full--BondsIssued_iS_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N20thBondWithWarrantsMember_zVoIvygRfo0h" title="Balance at beginning"&gt;600,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90B_eifrs-full--BondsIssued_iS_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N21stDetachableWarrantsBondsMember_zXlHGKB3BN19" title="Balance at beginning"&gt;3,000,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_903_eifrs-full--BondsIssued_iS_pn3n3_c20260101__20260630_zN6wCnilGQjc" title="Balance at beginning"&gt;4,965,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Issuance&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90C_eifrs-full--ShareIssueRelatedCost_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N15thBondWithWarrantsMember_zIvdT1xIhXB7" title="Issuance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6448"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_901_eifrs-full--ShareIssueRelatedCost_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N20thBondWithWarrantsMember_zRLWJ4WTu35l" title="Issuance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6450"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90D_eifrs-full--ShareIssueRelatedCost_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N21stDetachableWarrantsBondsMember_zapaiG0tsAog" title="Issuance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6452"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_907_eifrs-full--ShareIssueRelatedCost_pn3n3_c20260101__20260630_z350ZGNMHA2c" title="Issuance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6454"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Early redemption&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90C_ecustom--EarlyRedemption_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N15thBondWithWarrantsMember_zZxCk1xJ5ly9" title="Early redemption"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6456"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_909_ecustom--EarlyRedemption_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N20thBondWithWarrantsMember_zbBpm6qHqbk1" title="Early redemption"&gt;(600,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_900_ecustom--EarlyRedemption_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N21stDetachableWarrantsBondsMember_z0VlFcxjXFpg" title="Early redemption"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6460"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_900_ecustom--EarlyRedemption_pn3n3_c20260101__20260630_zNLGjXNXDLD5" title="Early redemption"&gt;(600,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Balance at June&#160;30&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90F_eifrs-full--BondsIssued_iE_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N15thBondWithWarrantsMember_zncfAmfP4v14" title="Balance at end"&gt;1,365,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_902_eifrs-full--BondsIssued_iE_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N20thBondWithWarrantsMember_zlykjhHy5Fv8" title="Balance at end"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6466"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_908_eifrs-full--BondsIssued_iE_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N21stDetachableWarrantsBondsMember_zMCvJooVAxwi" title="Balance at end"&gt;3,000,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90A_eifrs-full--BondsIssued_iE_pn3n3_c20260101__20260630_zngkfVkMVAsb" title="Balance at end"&gt;4,365,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AF_z63lvwDyeLs7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Changes in the fair value of derivative liabilities embedded in each series of bonds with warrants that were recognized in profit or loss for the period ended June&#160;30, 2026 are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_897_ecustom--ChangesInFairValueOfDerivativeLiabilitiesTableTextBlock_pn3n3_ztllKT0R67p8" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Bond with warrants and derivative instruments (Details 2)"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: #FFFFFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span id="xdx_8BC_zRRs9ONB215f" style="display: none"&gt;Changes in fair value of derivative liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;15&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;20&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;21&lt;sup&gt;st&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="14" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Balance at January&#160;1&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 9%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90E_eifrs-full--DerivativeFinancialLiabilities_iS_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N15thBondWithWarrantsMember_zayh2av8YXMf" title="Balance at beginning"&gt;117,845&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 9%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_904_eifrs-full--DerivativeFinancialLiabilities_iS_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N20thBondWithWarrantsMember_z7orqUAQtM63" title="Balance at beginning"&gt;227,200&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 9%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90D_eifrs-full--DerivativeFinancialLiabilities_iS_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N21stBondWithWarrantsMember_zVueB0OqZxQh" title="Balance at beginning"&gt;922,756&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 9%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_902_eifrs-full--DerivativeFinancialLiabilities_iS_pn3n3_c20260101__20260630_zDT2ejeH8xub" title="Balance at beginning"&gt;1,267,801&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: #FFFFFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Issuance&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_903_ecustom--Issuance_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N15thBondWithWarrantsMember_zZTBdxZcS639" title="Issuance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6482"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90B_ecustom--Issuance_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N20thBondWithWarrantsMember_zIP4CuYeamD6" title="Issuance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6484"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90E_ecustom--Issuance_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N21stBondWithWarrantsMember_zfnVfmoeJuc5" title="Issuance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6486"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90A_ecustom--Issuance_pn3n3_c20260101__20260630_zXeCab4zB9wg" title="Issuance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6488"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Redemption&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_903_ecustom--Redemption_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N15thBondWithWarrantsMember_z8XNl89qxuP" title="Redemption"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6490"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90D_ecustom--Redemption_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N20thBondWithWarrantsMember_z3d1C5qCydEe" title="Redemption"&gt;(227,200&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_905_ecustom--Redemption_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N21stBondWithWarrantsMember_zrJ0yBSxYzx2" title="Redemption"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6494"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_905_ecustom--Redemption_pn3n3_c20260101__20260630_z9dLldTDfnj8" title="Redemption"&gt;(227,200&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: #FFFFFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Losses (gains) on valuation of derivatives&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_900_ecustom--LossesGainsOnValuationOfDerivatives_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N15thBondWithWarrantsMember_z4RBNZgYxDsi" title="Losses (gains) on valuation of derivatives"&gt;(117,845&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_904_ecustom--LossesGainsOnValuationOfDerivatives_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N20thBondWithWarrantsMember_zcJehPxrdkBh" title="Losses (gains) on valuation of derivatives"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6500"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_909_ecustom--LossesGainsOnValuationOfDerivatives_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N21stBondWithWarrantsMember_zmZJHx1mY5q8" title="Losses (gains) on valuation of derivatives"&gt;57,213&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90F_ecustom--LossesGainsOnValuationOfDerivatives_pn3n3_c20260101__20260630_zaxhWuhfp8Eb" title="Losses (gains) on valuation of derivatives"&gt;(60,632&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Balance at June&#160;30&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90A_eifrs-full--DerivativeFinancialLiabilities_iE_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N15thBondWithWarrantsMember_zcwPYydGbH5k" title="Balance at end"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6506"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_902_eifrs-full--DerivativeFinancialLiabilities_iE_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N20thBondWithWarrantsMember_zMYcRevKFtxg" title="Balance at end"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6508"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90C_eifrs-full--DerivativeFinancialLiabilities_iE_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N21stBondWithWarrantsMember_zKelxM1naz06" title="Balance at end"&gt;979,969&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_904_eifrs-full--DerivativeFinancialLiabilities_iE_pn3n3_c20260101__20260630_zDr0RLIbeHe9" title="Balance at end"&gt;979,969&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AF_zx6X3etLOKy6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

















&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Details of the bonds with detachable warrants issued by the Company, including those for which either the bonds or the detachable warrants were outstanding as of June&#160;30, 2026 or December&#160;31, 2025, or were settled, redeemed, exercised or expired during the six-month periods ended June&#160;30, 2026 and 2025, are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_895_ecustom--DetailsOfBondsWithDetachableWarrantsIssuedTableTextBlock_pn3n3_zZB8I8bnVlId" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Bond with warrants and derivative instruments (Details 3)"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_8BE_zXtu2a4RTNYa" style="display: none"&gt;Details of bonds with detachable warrants issued&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;th style="border-bottom: #000000 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Series&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;11&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;12&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;13&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top; width: 18%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Type&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top; width: 24%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90C_ecustom--Type_pp0d_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N11thDetachableWarrantsBondsMember_zALEvUpL6FB3" title="Type"&gt;Detachable Warrants bonds&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top; width: 26%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_904_ecustom--Type_pp0d_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N12thDetachableWarrantsBondsMember_z2rjqv5vqQii" title="Type"&gt;Detachable Warrants bonds&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top; width: 26%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_903_ecustom--Type_pp0d_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N13thDetachableWarrantsBondsMember_zLju8Hu7Yu1i" title="Type"&gt;Detachable Warrants bonds&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Issuance amount&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_907_ecustom--IssuanceAmount_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N11thDetachableWarrantsBondsMember_pp0p" title="Issuance amount"&gt;1,500,000,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_904_ecustom--IssuanceAmount_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N12thDetachableWarrantsBondsMember_pp0p" title="Issuance amount"&gt;800,000,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_905_ecustom--IssuanceAmount_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N13thDetachableWarrantsBondsMember_pp0p" title="Issuance amount"&gt;4,000,000,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Coupon rate (%)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90F_ecustom--CouponRate_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N11thDetachableWarrantsBondsMember_pd" title="Coupon rate (%)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6535"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90E_ecustom--CouponRate_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N12thDetachableWarrantsBondsMember_pd" title="Coupon rate (%)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6537"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_900_ecustom--CouponRate_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N13thDetachableWarrantsBondsMember_pd" title="Coupon rate (%)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6539"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Yield to maturity (%)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_904_ecustom--YieldToMaturity_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N11thDetachableWarrantsBondsMember_pd" title="Yield to maturity (%)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6541"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90B_ecustom--YieldToMaturity_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N12thDetachableWarrantsBondsMember_pd" title="Yield to maturity (%)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6543"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90A_ecustom--YieldToMaturity_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N13thDetachableWarrantsBondsMember_pd" title="Yield to maturity (%)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6545"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Issuance date&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_908_ecustom--IssuanceDate_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N11thDetachableWarrantsBondsMember_zaLBmSlN0qI6" title="Issuance date"&gt;March&#160;2022&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_903_ecustom--IssuanceDate_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N12thDetachableWarrantsBondsMember_z7O6mxeAJTHh" title="Issuance date"&gt;August&#160;2022&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_909_ecustom--IssuanceDate_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N13thDetachableWarrantsBondsMember_zYn7hd5HGpTd" title="Issuance date"&gt;October&#160;2022&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Maturity date&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90E_ecustom--MaturityDate_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N11thDetachableWarrantsBondsMember_zGwq5gc39eSh" title="Maturity date"&gt;March&#160;2025&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90B_ecustom--MaturityDate_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N12thDetachableWarrantsBondsMember_zzCKzcqda9nc" title="Maturity date"&gt;August&#160;2025&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_907_ecustom--MaturityDate_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N13thDetachableWarrantsBondsMember_zNzgQZPlurdk" title="Maturity date"&gt;October&#160;2025&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Principal redemption&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--PrincipalRedemption_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N11thDetachableWarrantsBondsMember_zicNDnQnAzq2" style="font-family: Times New Roman, Times, Serif; text-align: justify; vertical-align: top" title="Principal redemption"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1. Redemption at maturity:&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Redeemed on the maturity date, at their outstanding principal amount, which has not been early redeemed&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2. Early redemption:&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The Company has a right to redeem before maturity (call option) or the bondholders have a right to require the Company to redeem before maturity (put option). Upon exercise of each option, the outstanding principal amount is to be redeemed.&lt;/span&gt;&lt;/p&gt; &lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--PrincipalRedemption_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N12thDetachableWarrantsBondsMember_zm3z16MoMgjl" style="font-family: Times New Roman, Times, Serif; text-align: justify; vertical-align: top" title="Principal redemption"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1. Redemption at maturity:&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Redeemed on the maturity date, at their outstanding principal amount, which has not been early redeemed&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2. Early redemption:&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The Company has a right to redeem before maturity (call option) or the bondholders have a right to require the Company to redeem before maturity (put option). Upon exercise of each option, the outstanding principal amount is to be redeemed.&lt;/span&gt;&lt;/p&gt; &lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--PrincipalRedemption_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N13thDetachableWarrantsBondsMember_zipSBUABRB21" style="font-family: Times New Roman, Times, Serif; text-align: justify; vertical-align: top" title="Principal redemption"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1. Redemption at maturity:&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Redeemed on the maturity date, at their outstanding principal amount, which has not been early redeemed&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-top: 0pt; font-family: Times New Roman, Times, Serif; text-align: justify; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2. Early redemption:&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The Company has a right to redeem before maturity (call option) or the bondholders have a right to require the Company to redeem before maturity (put option). Upon exercise of each option, the outstanding principal amount is to be redeemed.&lt;/span&gt;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Exercise Price (*)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--ExercisePrice_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N11thDetachableWarrantsBondsMember_fKCop_zr5C50dBdpe5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;4,000 per common share&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--ExercisePrice_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N12thDetachableWarrantsBondsMember_fKCop_z6anD8o6JjY5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;2,500 per common share (Subject to adjustment based on revenue at a specific point in time)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--ExercisePrice_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N13thDetachableWarrantsBondsMember_fKCop_zK9T3WliWP2e" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;2,500 per common share&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Exercise period&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--ExercisePeriod_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N11thDetachableWarrantsBondsMember_zrRno5xHwws2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top" title="Exercise period"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;September&#160;2022 ~ January&#160;2025&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--ExercisePeriod_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N12thDetachableWarrantsBondsMember_zG0ciOT1WLge" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top" title="Exercise period"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;February&#160;2023 ~ July&#160;2025&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--ExercisePeriod_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N13thDetachableWarrantsBondsMember_zuBNxVIII6d6" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top" title="Exercise period"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;February&#160;2023 ~ September&#160;2025&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Redemption at the Option of the issuer (Call option)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--RedemptionAtOptionOfIssuerCallOption_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N11thDetachableWarrantsBondsMember_zmR81kzjQZoa" style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify" title="Redemption at the Option of the issuer (Call option)"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The bonds are early redeemable by the Company in full or partial on March&#160;7, 2023, 12 months from the issuance, or every three months after.&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In the event of early redemption, the principal amount shall be paid.&lt;/span&gt;&lt;/p&gt; &lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--RedemptionAtOptionOfIssuerCallOption_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N12thDetachableWarrantsBondsMember_zpWEewmw3ec7" style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify" title="Redemption at the Option of the issuer (Call option)"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The bonds are early redeemable by the Company in full or partial on August&#160;7, 2023, 12 months from the issuance, or every three months after.&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In the event of early redemption, the principal amount shall be paid.&lt;/span&gt;&lt;/p&gt; &lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--RedemptionAtOptionOfIssuerCallOption_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N13thDetachableWarrantsBondsMember_z4tHm4IoTx92" style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify" title="Redemption at the Option of the issuer (Call option)"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The bonds are early redeemable by the Company in full or partial on April&#160;16, 2024, 18 months from the issuance, or every three months after.&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In the event of early redemption, the principal amount shall be paid.&lt;/span&gt;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

















&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif"&gt;
    &lt;th style="border-bottom: #000000 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Series&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;11&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;12&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;13&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-family: Times New Roman, Times, Serif; text-align: left; vertical-align: top; width: 18%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Redemption at the option of the bond holders (Put option)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--RedemptionAtOptionOfBondHoldersPutOption_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N11thDetachableWarrantsBondsMember_zv5wYa5vv6d" style="font-family: Times New Roman, Times, Serif; text-align: justify; vertical-align: top; width: 24%" title="Redemption at the option of the bond holders (Put option)"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The bonds are early redeemable by the Company in full or partial on March&#160;7, 2023, 12 months from the issuance, or every three months after.&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In the event of early redemption, the principal amount shall be paid.&lt;/span&gt;&lt;/p&gt; &lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--RedemptionAtOptionOfBondHoldersPutOption_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N12thDetachableWarrantsBondsMember_ziQiLfF0mAc" style="font-family: Times New Roman, Times, Serif; text-align: justify; vertical-align: top; width: 26%" title="Redemption at the option of the bond holders (Put option)"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The bonds are early redeemable by the Company in full or partial on August&#160;7, 2023, 12 months from the issuance, or every three months after.&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In the event of early redemption, the principal amount shall be paid.&lt;/span&gt;&lt;/p&gt; &lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--RedemptionAtOptionOfBondHoldersPutOption_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N13thDetachableWarrantsBondsMember_zh2UHnNkC0Ga" style="font-family: Times New Roman, Times, Serif; text-align: justify; vertical-align: top; width: 26%" title="Redemption at the option of the bond holders (Put option)"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The bonds are early redeemable by the Company in full or partial on April&#160;16, 2024, 18 months from the issuance, or every three months after.&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In the event of early redemption, the principal amount shall be paid.&lt;/span&gt;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Early redemption rights accounting treatment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--EarlyRedemptionRightsAccountingTreatment_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N11thDetachableWarrantsBondsMember_zexfKIRf5NP4" style="font-family: Times New Roman, Times, Serif; text-align: justify; vertical-align: top" title="Early redemption rights accounting treatment"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The early redemption right is separated from the host debt instrument as an embedded derivative and accounted for separately.&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The separated embedded derivative is measured at fair value through profit or loss (FVTPL).&lt;/span&gt;&lt;/p&gt; &lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--EarlyRedemptionRightsAccountingTreatment_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N12thDetachableWarrantsBondsMember_zYlAHWqMCVql" style="font-family: Times New Roman, Times, Serif; text-align: justify; vertical-align: top" title="Early redemption rights accounting treatment"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The early redemption right is separated from the host debt instrument as an embedded derivative and accounted for separately.&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The separated embedded derivative is measured at fair value through profit or loss (FVTPL).&lt;/span&gt;&lt;/p&gt; &lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--EarlyRedemptionRightsAccountingTreatment_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N13thDetachableWarrantsBondsMember_zbDhQjpcCrp8" style="font-family: Times New Roman, Times, Serif; text-align: justify; vertical-align: top" title="Early redemption rights accounting treatment"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The early redemption right is separated from the host debt instrument as an embedded derivative and accounted for separately.&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The separated embedded derivative is measured at fair value through profit or loss (FVTPL).&lt;/span&gt;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-family: Times New Roman, Times, Serif; text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Classification of Warrants&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--ClassificationOfWarrants_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N11thDetachableWarrantsBondsMember_zQAAw5NxLFG5" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top" title="Classification of Warrants"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The warrants were classified as equity instruments at the date of issuance, as it satisfied the fixed-for-fixed condition.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--ClassificationOfWarrants_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N12thDetachableWarrantsBondsMember_zXCNRf31QrWd" style="font-family: Times New Roman, Times, Serif; text-align: justify; vertical-align: top" title="Classification of Warrants"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Upon initial recognition, the warrants were classified as derivative financial liabilities as the fixed-for-fixed condition was not met at the inception date.&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Subsequently, following the determination of the exercise price, the warrants were reclassified as equity instruments.&lt;/span&gt;&lt;/p&gt; &lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--ClassificationOfWarrants_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N13thDetachableWarrantsBondsMember_zO3jEVCL8ZP4" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top" title="Classification of Warrants"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The warrants were classified as equity instruments at the date of issuance, as it satisfied the fixed-for-fixed condition.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;div style="margin: 0pt auto 0pt 0; font-family: Times New Roman, Times, Serif; width: 25%"&gt;&lt;div style="border-top: Black 1pt solid; font: 1pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"&gt;&lt;span id="xdx_F03_z6BWhPGRAlR9" style="font-family: Times New Roman, Times, Serif"&gt;(*)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F14_zuPVmPsZuKMg" style="font-family: Times New Roman, Times, Serif"&gt;The exercise price for the 12th series was finalized in February&#160;2023.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

















&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Details of the bonds with detachable warrants issued by the Company, including those for which either the bonds or the detachable warrants were outstanding as of June&#160;30, 2026 or December&#160;31, 2025, or were settled, redeemed, exercised or expired during the six-month periods ended June&#160;30, 2026 and 2025, are as follows: (Continued)&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;th style="border-bottom: #000000 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Series&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;14&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;15&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;16&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; width: 18%; vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Type&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 24%; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_906_ecustom--Type_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N14thDetachableWarrantsBondsMember_zSQiTHqESQ3i" title="Type"&gt;Detachable Warrants bonds&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 26%; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90C_ecustom--Type_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N15thDetachableWarrantsBondsMember_zL4aM9Qf6CKh" title="Type"&gt;Detachable Warrants bonds&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 26%; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_908_ecustom--Type_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N16thDetachableWarrantsBondsMember_z8vd0a4YRsg6" title="Type"&gt;Detachable Warrants bonds&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Issuance amount&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90F_ecustom--IssuanceAmount_pp0d_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N14thDetachableWarrantsBondsMember_zH4oeIleHUIc" title="Issuance amount"&gt;750,000,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_903_ecustom--IssuanceAmount_pp0d_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N15thDetachableWarrantsBondsMember_zJCbGzq00217" title="Issuance amount"&gt;2,180,000,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_900_ecustom--IssuanceAmount_pp0d_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N16thDetachableWarrantsBondsMember_zNHNhP037ieg" title="Issuance amount"&gt;30,000,000,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Coupon rate (%)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_900_ecustom--CouponRate_pid_dp_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N14thDetachableWarrantsBondsMember_zeDn6SgYRcQ8" title="Coupon rate (%)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6628"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90D_ecustom--CouponRate_pid_dp_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N15thDetachableWarrantsBondsMember_z16xegI33vXb" title="Coupon rate (%)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6630"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90C_ecustom--CouponRate_pid_dp_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N16thDetachableWarrantsBondsMember_zLEYJBUBsE16" title="Coupon rate (%)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6632"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Yield to maturity (%)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90F_ecustom--YieldToMaturity_pid_dp_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N14thDetachableWarrantsBondsMember_z4LyAHkUKKe7" title="Yield to maturity (%)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6634"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_906_ecustom--YieldToMaturity_pid_dp_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N15thDetachableWarrantsBondsMember_zIxy2PHOdjNb" title="Yield to maturity (%)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6636"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Annual simple interest &lt;span id="xdx_904_ecustom--YieldToMaturity_pid_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N16thDetachableWarrantsBondsMember_z6Lt9XrOS57e" title="Yield to maturity (%)"&gt;3.9%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Issuance date&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_902_ecustom--IssuanceDate_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N14thDetachableWarrantsBondsMember_zwaL3bIpUHd" title="Issuance date"&gt;April&#160;2023&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_903_ecustom--IssuanceDate_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N15thDetachableWarrantsBondsMember_zhSbKoUIdZdi" title="Issuance date"&gt;August&#160;2023&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_908_ecustom--IssuanceDate_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N16thDetachableWarrantsBondsMember_z7IrKrbykpN9" title="Issuance date"&gt;September&#160;2023&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Maturity date&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_906_ecustom--MaturityDate_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N14thDetachableWarrantsBondsMember_zxaUBr73xj0c" title="Maturity date"&gt;April&#160;2026&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_908_ecustom--MaturityDate_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N15thDetachableWarrantsBondsMember_zGilGuEmH0R2" title="Maturity date"&gt;August&#160;2026&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_908_ecustom--MaturityDate_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N16thDetachableWarrantsBondsMember_zjlABjucdTs2" title="Maturity date"&gt;September&#160;2028&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Principal redemption&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--PrincipalRedemption_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N14thDetachableWarrantsBondsMember_zvoJPZt60Z72" style="font-family: Times New Roman, Times, Serif; text-align: justify; vertical-align: top" title="Principal redemption"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1. Redemption at maturity:&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Redeemed on the maturity date, at their outstanding principal amount, which has not been early redeemed&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-top: 0pt; font-family: Times New Roman, Times, Serif; text-align: justify; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2. Early redemption:&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The Company has a right to redeem before maturity (call option) or the bondholders have a right to require the Company to redeem before maturity (put option). Upon exercise of each option, the outstanding principal amount is to be redeemed.&lt;/span&gt;&lt;/p&gt; &lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--PrincipalRedemption_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N15thDetachableWarrantsBondsMember_z9DCqVcfGW38" style="font-family: Times New Roman, Times, Serif; text-align: justify; vertical-align: top" title="Principal redemption"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1. Redemption at maturity:&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Redeemed on the maturity date, at their outstanding principal amount, which has not been early redeemed&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-top: 0pt; font-family: Times New Roman, Times, Serif; text-align: justify; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2. Early redemption:&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The Company has a right to redeem before maturity (call option) or the bondholders have a right to require the Company to redeem before maturity (put option). Upon exercise of each option, the outstanding principal amount is to be redeemed.&lt;/span&gt;&lt;/p&gt; &lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--PrincipalRedemption_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N16thDetachableWarrantsBondsMember_z2UsXlkY4GW1" style="font-family: Times New Roman, Times, Serif; text-align: justify; vertical-align: top" title="Principal redemption"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1. Redemption at maturity:&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Redeemed on the maturity date, at their outstanding principal amount, which has not been early redeemed&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-top: 0pt; font-family: Times New Roman, Times, Serif; text-align: justify; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2. Early redemption:&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The Company has a right to redeem before maturity (call option) or the bondholders have a right to require the Company to redeem before maturity (put option). At exercise of each option, the outstanding principal amount together with accrued but unpaid interest are to be redeemed.&lt;/span&gt;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Exercise Price&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--ExercisePrice_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N14thDetachableWarrantsBondsMember_fKCop_zyhBaKxbHKih" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;2,500 per common share&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--ExercisePrice_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N15thDetachableWarrantsBondsMember_fKCop_zUwfwFxHhBUa" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;3,000 per common share&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--ExercisePrice_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N16thDetachableWarrantsBondsMember_fKCop_z4AoWwzts2ab" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;3,000 per common share&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Exercise period&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--ExercisePeriod_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N14thDetachableWarrantsBondsMember_zfP3F0l67ci" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top" title="Exercise period"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;August&#160;2023 ~ November&#160;2025&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--ExercisePeriod_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N15thDetachableWarrantsBondsMember_z4cBFDPvfAw6" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top" title="Exercise period"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;November&#160;2023 ~ July&#160;2026&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--ExercisePeriod_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N16thDetachableWarrantsBondsMember_zGPNlDCa2eC8" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top" title="Exercise period"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;October&#160;2023 ~ August&#160;2028&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Redemption at the Option of the issuer (Call option)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--RedemptionAtOptionOfIssuerCallOption_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N14thDetachableWarrantsBondsMember_zU9nnIUezbR9" style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify" title="Redemption at the Option of the issuer (Call option)"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The bonds are early redeemable by the Company in full or partial on August&#160;7, 2023 or every three months after.&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In the event of early redemption, the principal amount shall be paid.&lt;/span&gt;&lt;/p&gt; &lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--RedemptionAtOptionOfIssuerCallOption_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N15thDetachableWarrantsBondsMember_zjWuU4rd4vTc" style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify" title="Redemption at the Option of the issuer (Call option)"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The bonds are early redeemable by the Company in full or partial on August&#160;18, 2024 or every three months after.&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In the event of early redemption, the principal amount shall be paid.&lt;/span&gt;&lt;/p&gt; &lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--RedemptionAtOptionOfIssuerCallOption_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N16thDetachableWarrantsBondsMember_zcT54HzePOo9" style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify" title="Redemption at the Option of the issuer (Call option)"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The bonds are early redeemable by the Company in full or partial on November&#160;20, 2023, which is 2 months from the issuance date, or at any time thereafter.&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In the event of early redemption, the principal amount shall be paid.&lt;/span&gt;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

















&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif"&gt;
    &lt;th style="border-bottom: #000000 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Series&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;14&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;15&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;16&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: left; width: 18%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Redemption at the option of the bond holders (Put option)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--RedemptionAtOptionOfBondHoldersPutOption_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N14thDetachableWarrantsBondsMember_ziQKN3hjUhNe" style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify; width: 24%" title="Redemption at the option of the bond holders (Put option)"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The bonds are early redeemable by the Company in full or partial on August&#160;7, 2023 or every three months after.&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In the event of early redemption, the principal amount shall be paid.&lt;/span&gt;&lt;/p&gt; &lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--RedemptionAtOptionOfBondHoldersPutOption_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N15thDetachableWarrantsBondsMember_zdVyLMVOeJ0g" style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify; width: 26%" title="Redemption at the option of the bond holders (Put option)"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The bonds are early redeemable by the Company in full or partial on August&#160;18, 2024 or every three months after.&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In the event of early redemption, the principal amount shall be paid.&lt;/span&gt;&lt;/p&gt; &lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--RedemptionAtOptionOfBondHoldersPutOption_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N16thDetachableWarrantsBondsMember_zj9F9Kll08Ac" style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify; width: 26%" title="Redemption at the option of the bond holders (Put option)"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The bonds are early redeemable by the Company in full or partial on November&#160;20, 2023, which is 2 months from the issuance date, or at any time thereafter.&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In the event of early redemption, the principal amount shall be paid.&lt;/span&gt;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Early redemption rights accounting treatment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--EarlyRedemptionRightsAccountingTreatment_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N14thDetachableWarrantsBondsMember_zpjD34jf0cbh" style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify" title="Early redemption rights accounting treatment"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The early redemption right is separated from the host debt instrument as an embedded derivative and accounted for separately.&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The separated embedded derivative is measured at fair value through profit or loss (FVTPL).&lt;/span&gt;&lt;/p&gt; &lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--EarlyRedemptionRightsAccountingTreatment_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N15thDetachableWarrantsBondsMember_zmzFww6g2OY4" style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify" title="Early redemption rights accounting treatment"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The early redemption right is separated from the host debt instrument as an embedded derivative and accounted for separately.&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The separated embedded derivative is measured at fair value through profit or loss (FVTPL).&lt;/span&gt;&lt;/p&gt; &lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--EarlyRedemptionRightsAccountingTreatment_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N16thDetachableWarrantsBondsMember_zs32aXKZoQG2" style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify" title="Early redemption rights accounting treatment"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The early redemption right is separated from the host debt instrument as an embedded derivative and accounted for separately.&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The separated embedded derivative is measured at fair value through profit or loss (FVTPL).&lt;/span&gt;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Classification of Warrants&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--ClassificationOfWarrants_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N14thDetachableWarrantsBondsMember_zonAEcYls9sg" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top" title="Classification of Warrants"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The warrants were classified as equity instruments at the date of issuance, as it satisfied the fixed-for-fixed condition.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--ClassificationOfWarrants_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N15thDetachableWarrantsBondsMember_zrRnTbNIJtSj" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top" title="Classification of Warrants"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The warrants were classified as equity instruments at the date of issuance, as it satisfied the fixed-for-fixed condition.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--ClassificationOfWarrants_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N16thDetachableWarrantsBondsMember_z6If5ogPPjOk" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top" title="Classification of Warrants"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The warrants were classified as equity instruments at the date of issuance, as it satisfied the fixed-for-fixed condition.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Details of the bonds with detachable warrants issued by the Company, including those for which either the bonds or the detachable warrants were outstanding as of June&#160;30, 2026 or December&#160;31, 2025, or were settled, redeemed, exercised or expired during the six-month periods ended June&#160;30, 2026 and 2025, are as follows: (Continued)&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif"&gt;
    &lt;th style="border-bottom: #000000 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Series&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="border-bottom: #000000 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;17&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="border-bottom: #000000 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;18&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="border-bottom: #000000 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;19&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; width: 18%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Type&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top; width: 24%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_903_ecustom--Type_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N17thDetachableWarrantsBondsMember_zbY0H3Gzrcll" title="Type"&gt;Detachable Warrants bonds&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top; width: 26%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_905_ecustom--Type_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N18thDetachableWarrantsBondsMember_zKNgqkdorTTa" title="Type"&gt;Detachable Warrants bonds&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top; width: 26%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_906_ecustom--Type_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N19thDetachableWarrantsBondsMember_zbJ6SSC2O317" title="Type"&gt;Detachable Warrants bonds&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Issuance amount&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_901_ecustom--IssuanceAmount_pp0d_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N17thDetachableWarrantsBondsMember_zEQbaak7rJQj" title="Issuance amount"&gt;2,000,000,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_902_ecustom--IssuanceAmount_pp0d_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N18thDetachableWarrantsBondsMember_zIntfFcKqoH3" title="Issuance amount"&gt;2,500,000,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90F_ecustom--IssuanceAmount_pp0d_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N19thDetachableWarrantsBondsMember_zcTEBJwgGYr6" title="Issuance amount"&gt;2,000,000,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Coupon rate (%)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90A_ecustom--CouponRate_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N17thDetachableWarrantsBondsMember_zk0xyHu1tqM4" title="Coupon rate (%)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6713"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_905_ecustom--CouponRate_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N18thDetachableWarrantsBondsMember_zMv1j06oqd49" title="Coupon rate (%)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6715"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_903_ecustom--CouponRate_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N19thDetachableWarrantsBondsMember_zajVEKBGBNcc" title="Coupon rate (%)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6717"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Yield to maturity (%)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_904_ecustom--YieldToMaturity_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N17thDetachableWarrantsBondsMember_zyUZ5xagBT6j" title="Yield to maturity (%)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6719"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_901_ecustom--YieldToMaturity_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N18thDetachableWarrantsBondsMember_zuBtI1ipfScc" title="Yield to maturity (%)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6721"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_905_ecustom--YieldToMaturity_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N19thDetachableWarrantsBondsMember_zdiyDUsnRuV5" title="Yield to maturity (%)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6723"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Issuance date&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_901_ecustom--IssuanceDate_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N17thDetachableWarrantsBondsMember_zS1pYrjXQDP4" title="Issuance date"&gt;July&#160;2024&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_901_ecustom--IssuanceDate_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N18thDetachableWarrantsBondsMember_zl7Kgo9ETPc" title="Issuance date"&gt;November&#160;2024&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_903_ecustom--IssuanceDate_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N19thDetachableWarrantsBondsMember_z09yAHAwJwf1" title="Issuance date"&gt;February&#160;2025&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Maturity date&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90F_ecustom--MaturityDate_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N17thDetachableWarrantsBondsMember_z94ytJChTUo8" title="Maturity date"&gt;July&#160;2027&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_903_ecustom--MaturityDate_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N18thDetachableWarrantsBondsMember_zIdP2HnYMOr4" title="Maturity date"&gt;November&#160;2027&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_906_ecustom--MaturityDate_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N19thDetachableWarrantsBondsMember_z4RBvOxXDwq" title="Maturity date"&gt;February&#160;2028&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

















&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif"&gt;
    &lt;th style="border-bottom: rgb(0, 0, 0) 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Series&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="border-bottom: rgb(0, 0, 0) 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;17&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="border-bottom: rgb(0, 0, 0) 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;18&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="border-bottom: rgb(0, 0, 0) 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;19&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top; width: 18%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Principal redemption&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--PrincipalRedemption_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N17thDetachableWarrantsBondsMember_zeBrOObWKgH2" style="font-family: Times New Roman, Times, Serif; text-align: justify; vertical-align: top; width: 24%" title="Principal redemption"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1. Redemption at maturity:&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Redeemed on the maturity date, at their outstanding principal amount, which has not been early redeemed&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2. Early redemption:&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The Company has a right to redeem before maturity (call option) or the bondholders have a right to require the Company to redeem before maturity (put option). At exercise of each option, the outstanding principal amount together with accrued but unpaid interest are to be redeemed.&lt;/span&gt;&lt;/p&gt; &lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--PrincipalRedemption_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N18thDetachableWarrantsBondsMember_zwxwmp2Y6WS6" style="font-family: Times New Roman, Times, Serif; text-align: justify; vertical-align: top; width: 26%" title="Principal redemption"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1. Redemption at maturity:&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Redeemed on the maturity date, at their outstanding principal amount, which has not been early redeemed&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-top: 0pt; font-family: Times New Roman, Times, Serif; text-align: justify; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2. Early redemption:&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The Company has a right to redeem before maturity (call option) or the bondholders have a right to require the Company to redeem before maturity (put option). Upon exercise of each option, the outstanding principal amount is to be redeemed.&lt;/span&gt;&lt;/p&gt; &lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--PrincipalRedemption_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N19thDetachableWarrantsBondsMember_zNF7bXOWUAS7" style="font-family: Times New Roman, Times, Serif; text-align: justify; vertical-align: top; width: 26%" title="Principal redemption"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1. Redemption at maturity:&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Redeemed on the maturity date, at their outstanding principal amount, which has not been early redeemed&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-top: 0pt; font-family: Times New Roman, Times, Serif; text-align: justify; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2. Early redemption:&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The Company has a right to redeem before maturity (call option) or the bondholders have a right to require the Company to redeem before maturity (put option). Upon exercise of each option, the outstanding principal amount is to be redeemed.&lt;/span&gt;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Exercise Price&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--ExercisePrice_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N17thDetachableWarrantsBondsMember_fKCop_znyXttFLu982" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;4,000 per common share&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--ExercisePrice_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N18thDetachableWarrantsBondsMember_fKCop_zV7we2vfKSH8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;4,000 per common share&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--ExercisePrice_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N19thDetachableWarrantsBondsMember_fKCop_zqcJvZJxUfwl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;4,000 per common share&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Exercise period&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--ExercisePeriod_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N17thDetachableWarrantsBondsMember_zg5UEGpgFdNd" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top" title="Exercise period"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;November&#160;2024 ~ June&#160;2027&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--ExercisePeriod_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N18thDetachableWarrantsBondsMember_zvASne47zFkd" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top" title="Exercise period"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;February&#160;2025 ~ November&#160;2027&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--ExercisePeriod_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N19thDetachableWarrantsBondsMember_zCdkCZIhbp95" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top" title="Exercise period"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;May&#160;2025 ~ January&#160;2028&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Redemption at the Option of the issuer (Call option)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--RedemptionAtOptionOfIssuerCallOption_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N17thDetachableWarrantsBondsMember_zR1xhzGi8zzg" style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify" title="Redemption at the Option of the issuer (Call option)"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The bonds are early redeemable by the Company in full or partial on November&#160;2, 2024, which is four months from the issuance date, or at any time thereafter.&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In the event of early redemption, the principal amount shall be paid.&lt;/span&gt;&lt;/p&gt; &lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--RedemptionAtOptionOfIssuerCallOption_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N18thDetachableWarrantsBondsMember_z3eaLtz7Zqy4" style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify" title="Redemption at the Option of the issuer (Call option)"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The bonds are early redeemable by the Company in full or partial on February&#160;7, 2025, which is three months from the issuance date, or at any time thereafter.&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In the event of early redemption, the principal amount shall be paid.&lt;/span&gt;&lt;/p&gt; &lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--RedemptionAtOptionOfIssuerCallOption_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N19thDetachableWarrantsBondsMember_zABMjObvfjhb" style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify" title="Redemption at the Option of the issuer (Call option)"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The bonds are early redeemable by the Company in full or partial on May&#160;17, 2025, which is three months from the issuance date, or at any time thereafter.&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In the event of early redemption, the principal amount shall be paid.&lt;/span&gt;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Redemption at the option of the bond holders (Put option)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--RedemptionAtOptionOfBondHoldersPutOption_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N17thDetachableWarrantsBondsMember_zezgb3RphUni" style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify" title="Redemption at the option of the bond holders (Put option)"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The bonds are early redeemable by the Company in full or partial on November&#160;2, 2024, which is four months from the issuance date, or at any time thereafter.&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In the event of early redemption, the principal amount shall be paid.&lt;/span&gt;&lt;/p&gt; &lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--RedemptionAtOptionOfBondHoldersPutOption_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N18thDetachableWarrantsBondsMember_ze3w6zqdkd4g" style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify" title="Redemption at the option of the bond holders (Put option)"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The bonds are early redeemable by the Company in full or partial on February&#160;7, 2025, which is three months from the issuance date, or at any time thereafter.&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In the event of early redemption, the principal amount shall be paid.&lt;/span&gt;&lt;/p&gt; &lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--RedemptionAtOptionOfBondHoldersPutOption_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N19thDetachableWarrantsBondsMember_z2v8D36K62Xd" style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify" title="Redemption at the option of the bond holders (Put option)"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The bonds are early redeemable by the Company in full or partial on May&#160;17, 2025, which is three months from the issuance date, or at any time thereafter.&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In the event of early redemption, the principal amount shall be paid.&lt;/span&gt;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

















&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif"&gt;
    &lt;th style="border-bottom: rgb(0, 0, 0) 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Series&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="border-bottom: rgb(0, 0, 0) 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;17&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="border-bottom: rgb(0, 0, 0) 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;18&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="border-bottom: rgb(0, 0, 0) 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;19&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left; width: 18%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Early redemption rights accounting treatment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--EarlyRedemptionRightsAccountingTreatment_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N17thDetachableWarrantsBondsMember_zmZmwE0pi0Q4" style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify; width: 24%" title="Early redemption rights accounting treatment"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The early redemption right is separated from the host debt instrument as an embedded derivative and accounted for separately.&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The separated embedded derivative is measured at fair value through profit or loss (FVTPL).&lt;/span&gt;&lt;/p&gt; &lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--EarlyRedemptionRightsAccountingTreatment_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N18thDetachableWarrantsBondsMember_zJ3giSDvAW5h" style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify; width: 26%" title="Early redemption rights accounting treatment"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The early redemption right is separated from the host debt instrument as an embedded derivative and accounted for separately.&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The separated embedded derivative is measured at fair value through profit or loss (FVTPL).&lt;/span&gt;&lt;/p&gt; &lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--EarlyRedemptionRightsAccountingTreatment_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N19thDetachableWarrantsBondsMember_zzcpGNuHEHx8" style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify; width: 26%" title="Early redemption rights accounting treatment"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The early redemption right is separated from the host debt instrument as an embedded derivative and accounted for separately.&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The separated embedded derivative is measured at fair value through profit or loss (FVTPL).&lt;/span&gt;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Classification of Warrants&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--ClassificationOfWarrants_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N17thDetachableWarrantsBondsMember_zrOYTzlfLG16" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top" title="Classification of Warrants"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The warrants were classified as equity instruments at the date of issuance, as it satisfied the fixed-for-fixed condition.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--ClassificationOfWarrants_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N18thDetachableWarrantsBondsMember_zXX3EKMjPLUh" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top" title="Classification of Warrants"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The warrants were classified as equity instruments at the date of issuance, as it satisfied the fixed-for-fixed condition.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--ClassificationOfWarrants_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N19thDetachableWarrantsBondsMember_zczB5Pd5ZLo4" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top" title="Classification of Warrants"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The warrants were classified as equity instruments at the date of issuance, as it satisfied the fixed-for-fixed condition.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Details of the bonds with detachable warrants issued by the Company, including those for which either the bonds or the detachable warrants were outstanding as of June&#160;30, 2026 or December&#160;31, 2025, or were settled, redeemed, exercised or expired during the six-month periods ended June&#160;30, 2026 and 2025, are as follows: (Continued)&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif"&gt;
    &lt;th style="border-bottom: #000000 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Series&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="border-bottom: #000000 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;20&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="border-bottom: #000000 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;21&lt;sup&gt;st&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; width: 18%; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Type&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; width: 39%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_909_ecustom--Type_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N20thDetachableWarrantsBondsMember_zW8yO7rmAR69" title="Type"&gt;Detachable Warrants bonds&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; width: 39%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90F_ecustom--Type_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N21stDetachableWarrantsBondsMember_zOncBpFoga6l" title="Type"&gt;Detachable Warrants bonds&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Issuance amount&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90D_ecustom--IssuanceAmount_pp0d_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N20thDetachableWarrantsBondsMember_z4QHVjB6Udll" title="Issuance amount"&gt;4,200,000,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90E_ecustom--IssuanceAmount_pp0d_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N21stDetachableWarrantsBondsMember_zVd9BUxBLNY8" title="Issuance amount"&gt;3,000,000,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Coupon rate (%)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90E_ecustom--CouponRate_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N20thDetachableWarrantsBondsMember_zoUwVmKB7z2f" title="Coupon rate (%)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6801"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_907_ecustom--CouponRate_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N21stDetachableWarrantsBondsMember_zj7TVGqwN75" title="Coupon rate (%)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6803"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Yield to maturity (%)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90A_ecustom--YieldToMaturity_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N20thDetachableWarrantsBondsMember_zoCeEFeJrV0c" title="Yield to maturity (%)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6805"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90D_ecustom--YieldToMaturity_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N21stDetachableWarrantsBondsMember_zarS4WGzmvdj" title="Yield to maturity (%)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6807"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Issuance date&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90E_ecustom--IssuanceDate_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N20thDetachableWarrantsBondsMember_zjMT4vYPGlfe" title="Issuance date"&gt;July&#160;2025&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_904_ecustom--IssuanceDate_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N21stDetachableWarrantsBondsMember_z3xzwmsWxhni" title="Issuance date"&gt;November&#160;2025&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Maturity date&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90F_ecustom--MaturityDate_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N20thDetachableWarrantsBondsMember_zbcb0E97Rr18" title="Maturity date"&gt;July&#160;2028&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_904_ecustom--MaturityDate_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N21stDetachableWarrantsBondsMember_zMuqRmBcsF9e" title="Maturity date"&gt;November&#160;2028&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Principal redemption&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--PrincipalRedemption_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N20thDetachableWarrantsBondsMember_zcdFuqRgdjb8" style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify" title="Principal redemption"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1. Redemption at maturity:&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Redeemed on the maturity date, at their outstanding principal amount, which has not been early redeemed&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-top: 0pt; font-family: Times New Roman, Times, Serif; text-align: justify; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2. Early redemption:&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The Company has a right to redeem before maturity (call option) or the bondholders have a right to require the Company to redeem before maturity (put option). Upon exercise of each option, the outstanding principal amount is to be redeemed.&lt;/span&gt;&lt;/p&gt; &lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--PrincipalRedemption_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N21stDetachableWarrantsBondsMember_zwqcPY5xOali" style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify" title="Principal redemption"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1. Redemption at maturity:&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Redeemed on the maturity date, at their outstanding principal amount, which has not been early redeemed&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-top: 0pt; font-family: Times New Roman, Times, Serif; text-align: justify; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2. Early redemption:&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The Company has a right to redeem before maturity (call option) or the bondholders have a right to require the Company to redeem before maturity (put option). Upon exercise of each option, the outstanding principal amount is to be redeemed.&lt;/span&gt;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: middle; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Exercise Price&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--ExercisePrice_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N20thDetachableWarrantsBondsMember_fKCop_zfBKSlrXQBzd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;3,000 per common share&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--ExercisePrice_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N21stDetachableWarrantsBondsMember_fKCop_ztbAAXa1Tip3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;3,000 per common share&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

















&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;th style="border-bottom: rgb(0, 0, 0) 1pt solid; font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; vertical-align: bottom; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Series&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="border-bottom: rgb(0, 0, 0) 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;20&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="border-bottom: rgb(0, 0, 0) 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;21&lt;sup&gt;st&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top; width: 18%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exercise period&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--ExercisePeriod_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N20thDetachableWarrantsBondsMember_zgHiQE7vCBHa" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; width: 39%" title="Exercise period"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;October&#160;2025 ~ June&#160;2028&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--ExercisePeriod_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N21stDetachableWarrantsBondsMember_zDBhiVWTj5Aa" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; width: 39%" title="Exercise period"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;February&#160;2026 ~ October&#160;2028&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: #FFFFFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Redemption at the Option of the issuer (Call option)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--RedemptionAtOptionOfIssuerCallOption_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N20thDetachableWarrantsBondsMember_zxdOeRxAYEw5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify" title="Redemption at the Option of the issuer (Call option)"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The bonds are early redeemable by the Company in full or partial on October&#160;2, 2025, which is three months from the issuance date, or at any time thereafter.&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In the event of early redemption, the principal amount shall be paid.&lt;/span&gt;&lt;/p&gt; &lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--RedemptionAtOptionOfIssuerCallOption_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N21stDetachableWarrantsBondsMember_zEiWWNzjuj2l" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify" title="Redemption at the Option of the issuer (Call option)"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The bonds are early redeemable by the Company in full or partial on November&#160;18, 2026, which is one year from the issuance date, or at any time thereafter.&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In the event of early redemption, the principal amount shall be paid.&lt;/span&gt;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: #FFFFFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Redemption at the option of the bond holders (Put option)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--RedemptionAtOptionOfBondHoldersPutOption_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N20thDetachableWarrantsBondsMember_zVBpWZ3kc9Ub" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify" title="Redemption at the option of the bond holders (Put option)"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The bonds are early redeemable by the Company in full or partial on October&#160;2, 2025, which is three months from the issuance date, or at any time thereafter.&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In the event of early redemption, the principal amount shall be paid.&lt;/span&gt;&lt;/p&gt; &lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--RedemptionAtOptionOfBondHoldersPutOption_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N21stDetachableWarrantsBondsMember_zPieEmlD0HZi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify" title="Redemption at the option of the bond holders (Put option)"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The bonds are early redeemable by the Company in full or partial on November&#160;18, 2026, which is one year from the issuance date, or at any time thereafter.&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In the event of early redemption, the principal amount shall be paid.&lt;/span&gt;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: #FFFFFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Early redemption rights accounting treatment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--EarlyRedemptionRightsAccountingTreatment_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N20thDetachableWarrantsBondsMember_z0dE96gIBFFc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify" title="Early redemption rights accounting treatment"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The early redemption right is separated from the host debt instrument as an embedded derivative and accounted for separately.&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The separated embedded derivative is measured at fair value through profit or loss (FVTPL).&lt;/span&gt;&lt;/p&gt; &lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--EarlyRedemptionRightsAccountingTreatment_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N21stDetachableWarrantsBondsMember_ztTGTcuJG6u7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify" title="Early redemption rights accounting treatment"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The early redemption right is separated from the host debt instrument as an embedded derivative and accounted for separately.&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The separated embedded derivative is measured at fair value through profit or loss (FVTPL).&lt;/span&gt;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: #FFFFFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Classification of Warrants&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--ClassificationOfWarrants_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N20thDetachableWarrantsBondsMember_ziqWl3WQZxP5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify" title="Classification of Warrants"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The warrants were classified as equity instruments at the date of issuance, as it satisfied the fixed-for-fixed condition.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--ClassificationOfWarrants_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N21stDetachableWarrantsBondsMember_z9Q1jDjd70o3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify" title="Classification of Warrants"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The warrants were classified as equity instruments at the date of issuance, as it satisfied the fixed-for-fixed condition.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A1_zzlJpE97J4f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

















</cik0002058261:BondWithWarrantsAndDerivativeInstrumentsTextBlock>
    <cik0002058261:DetailsOfPrincipalOfBondsIssuedAndOutstandingTableTextBlock
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      id="Fact006418">&lt;table cellpadding="0" cellspacing="0" id="xdx_891_ecustom--DetailsOfPrincipalOfBondsIssuedAndOutstandingTableTextBlock_pn3n3_zCf4yxbTEyb7" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Bond with warrants and derivative instruments (Details)"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span id="xdx_8B7_zsLodsfKk5h5" style="display: none"&gt;Details of principal of bonds issued and outstanding&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;June&#160;30,&lt;br/&gt;2026&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2025&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="6" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Bond with warrants&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;15&lt;sup&gt;th&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_909_eifrs-full--BondsIssued_iI_pn3n3_c20260630__ifrs-full--BorrowingsByNameAxis__custom--N15thBondWithWarrantsMember_ziCYFvJZttjl" title="Total"&gt;1,365,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90B_eifrs-full--BondsIssued_iI_pn3n3_c20251231__ifrs-full--BorrowingsByNameAxis__custom--N15thBondWithWarrantsMember_zEWo8rKBsVHj" title="Total"&gt;1,365,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;20&lt;sup&gt;th&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90F_eifrs-full--BondsIssued_iI_pn3n3_c20260630__ifrs-full--BorrowingsByNameAxis__custom--N20thBondWithWarrantsMember_zOLoNMVRlyzd" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6424"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_905_eifrs-full--BondsIssued_iI_pn3n3_c20251231__ifrs-full--BorrowingsByNameAxis__custom--N20thBondWithWarrantsMember_zyX69Z9asOjd" title="Total"&gt;600,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;21&lt;sup&gt;st&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90F_eifrs-full--BondsIssued_iI_pn3n3_c20260630__ifrs-full--BorrowingsByNameAxis__custom--N21stBondWithWarrantsMember_zsudoGgdwLs4" title="Total"&gt;3,000,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_905_eifrs-full--BondsIssued_iI_pn3n3_c20251231__ifrs-full--BorrowingsByNameAxis__custom--N21stBondWithWarrantsMember_z08EDygTUjpd" title="Total"&gt;3,000,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90E_eifrs-full--BondsIssued_iI_pn3n3_c20260630_z1IZI6Fu49y5" title="Total"&gt;4,365,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_903_eifrs-full--BondsIssued_iI_pn3n3_c20251231_ze6o7ICAVMWl" title="Total"&gt;4,965,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:DetailsOfPrincipalOfBondsIssuedAndOutstandingTableTextBlock>
    <ifrs-full:BondsIssued
      contextRef="AsOf2026-06-30_custom_N15thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006420"
      unitRef="KRW">1365000000</ifrs-full:BondsIssued>
    <ifrs-full:BondsIssued
      contextRef="AsOf2025-12-31_custom_N15thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006422"
      unitRef="KRW">1365000000</ifrs-full:BondsIssued>
    <ifrs-full:BondsIssued
      contextRef="AsOf2025-12-31_custom_N20thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006426"
      unitRef="KRW">600000000</ifrs-full:BondsIssued>
    <ifrs-full:BondsIssued
      contextRef="AsOf2026-06-30_custom_N21stBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006428"
      unitRef="KRW">3000000000</ifrs-full:BondsIssued>
    <ifrs-full:BondsIssued
      contextRef="AsOf2025-12-31_custom_N21stBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006430"
      unitRef="KRW">3000000000</ifrs-full:BondsIssued>
    <ifrs-full:BondsIssued
      contextRef="AsOf2026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006432"
      unitRef="KRW">4365000000</ifrs-full:BondsIssued>
    <ifrs-full:BondsIssued
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006434"
      unitRef="KRW">4965000000</ifrs-full:BondsIssued>
    <cik0002058261:DetailsOfChangesInFaceValueOfBondsWithWarrantsTableTextBlock
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      id="Fact006436">&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--DetailsOfChangesInFaceValueOfBondsWithWarrantsTableTextBlock_zGXa5PVQDqYh" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Bond with warrants and derivative instruments (Details 4)"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: #FFFFFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;&lt;span id="xdx_8B6_zLIMiWjknKM" style="display: none"&gt;Details of face value of bonds with warrants&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;June&#160;30,&lt;br/&gt;2026&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2025&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="6" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Bond with warrants&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 9%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,365,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 9%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,965,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: #FFFFFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Warrants adjustment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(1,155,240&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(1,699,688&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,209,760&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,265,312&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:DetailsOfChangesInFaceValueOfBondsWithWarrantsTableTextBlock>
    <cik0002058261:DetailsOfChangesInPrincipalOfBondsTableTextBlock
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      id="Fact006438">&lt;table cellpadding="0" cellspacing="0" id="xdx_895_ecustom--DetailsOfChangesInPrincipalOfBondsTableTextBlock_zbFlGIQJEMs4" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Bond with warrants and derivative instruments (Details 1)"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span id="xdx_8B1_zDSMHrSqeT1e" style="display: none"&gt;&lt;span&gt;Details of changes in principal of bonds&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;15&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;20&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;21&lt;sup&gt;st&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="14" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Balance as of January&#160;1&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_906_eifrs-full--BondsIssued_iS_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N15thBondWithWarrantsMember_z79EnqYI0nI" title="Balance at beginning"&gt;1,365,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_905_eifrs-full--BondsIssued_iS_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N20thBondWithWarrantsMember_zVoIvygRfo0h" title="Balance at beginning"&gt;600,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90B_eifrs-full--BondsIssued_iS_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N21stDetachableWarrantsBondsMember_zXlHGKB3BN19" title="Balance at beginning"&gt;3,000,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_903_eifrs-full--BondsIssued_iS_pn3n3_c20260101__20260630_zN6wCnilGQjc" title="Balance at beginning"&gt;4,965,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Issuance&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90C_eifrs-full--ShareIssueRelatedCost_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N15thBondWithWarrantsMember_zIvdT1xIhXB7" title="Issuance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6448"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_901_eifrs-full--ShareIssueRelatedCost_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N20thBondWithWarrantsMember_zRLWJ4WTu35l" title="Issuance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6450"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90D_eifrs-full--ShareIssueRelatedCost_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N21stDetachableWarrantsBondsMember_zapaiG0tsAog" title="Issuance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6452"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_907_eifrs-full--ShareIssueRelatedCost_pn3n3_c20260101__20260630_z350ZGNMHA2c" title="Issuance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6454"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Early redemption&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90C_ecustom--EarlyRedemption_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N15thBondWithWarrantsMember_zZxCk1xJ5ly9" title="Early redemption"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6456"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_909_ecustom--EarlyRedemption_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N20thBondWithWarrantsMember_zbBpm6qHqbk1" title="Early redemption"&gt;(600,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_900_ecustom--EarlyRedemption_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N21stDetachableWarrantsBondsMember_z0VlFcxjXFpg" title="Early redemption"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6460"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_900_ecustom--EarlyRedemption_pn3n3_c20260101__20260630_zNLGjXNXDLD5" title="Early redemption"&gt;(600,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Balance at June&#160;30&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90F_eifrs-full--BondsIssued_iE_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N15thBondWithWarrantsMember_zncfAmfP4v14" title="Balance at end"&gt;1,365,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_902_eifrs-full--BondsIssued_iE_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N20thBondWithWarrantsMember_zlykjhHy5Fv8" title="Balance at end"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6466"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_908_eifrs-full--BondsIssued_iE_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N21stDetachableWarrantsBondsMember_zMCvJooVAxwi" title="Balance at end"&gt;3,000,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90A_eifrs-full--BondsIssued_iE_pn3n3_c20260101__20260630_zngkfVkMVAsb" title="Balance at end"&gt;4,365,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:DetailsOfChangesInPrincipalOfBondsTableTextBlock>
    <ifrs-full:BondsIssued
      contextRef="AsOf2025-12-31_custom_N15thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006440"
      unitRef="KRW">1365000000</ifrs-full:BondsIssued>
    <ifrs-full:BondsIssued
      contextRef="AsOf2025-12-31_custom_N20thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006442"
      unitRef="KRW">600000000</ifrs-full:BondsIssued>
    <ifrs-full:BondsIssued
      contextRef="AsOf2025-12-31_custom_N21stDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006444"
      unitRef="KRW">3000000000</ifrs-full:BondsIssued>
    <ifrs-full:BondsIssued
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006446"
      unitRef="KRW">4965000000</ifrs-full:BondsIssued>
    <cik0002058261:EarlyRedemption
      contextRef="From2026-01-012026-06-30_custom_N20thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006458"
      unitRef="KRW">-600000000</cik0002058261:EarlyRedemption>
    <cik0002058261:EarlyRedemption
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006462"
      unitRef="KRW">-600000000</cik0002058261:EarlyRedemption>
    <ifrs-full:BondsIssued
      contextRef="AsOf2026-06-30_custom_N15thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006464"
      unitRef="KRW">1365000000</ifrs-full:BondsIssued>
    <ifrs-full:BondsIssued
      contextRef="AsOf2026-06-30_custom_N21stDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006468"
      unitRef="KRW">3000000000</ifrs-full:BondsIssued>
    <ifrs-full:BondsIssued
      contextRef="AsOf2026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006470"
      unitRef="KRW">4365000000</ifrs-full:BondsIssued>
    <cik0002058261:ChangesInFairValueOfDerivativeLiabilitiesTableTextBlock
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      id="Fact006472">&lt;table cellpadding="0" cellspacing="0" id="xdx_897_ecustom--ChangesInFairValueOfDerivativeLiabilitiesTableTextBlock_pn3n3_ztllKT0R67p8" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Bond with warrants and derivative instruments (Details 2)"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: #FFFFFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span id="xdx_8BC_zRRs9ONB215f" style="display: none"&gt;Changes in fair value of derivative liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;15&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;20&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;21&lt;sup&gt;st&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="14" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Balance at January&#160;1&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 9%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90E_eifrs-full--DerivativeFinancialLiabilities_iS_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N15thBondWithWarrantsMember_zayh2av8YXMf" title="Balance at beginning"&gt;117,845&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 9%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_904_eifrs-full--DerivativeFinancialLiabilities_iS_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N20thBondWithWarrantsMember_z7orqUAQtM63" title="Balance at beginning"&gt;227,200&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 9%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90D_eifrs-full--DerivativeFinancialLiabilities_iS_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N21stBondWithWarrantsMember_zVueB0OqZxQh" title="Balance at beginning"&gt;922,756&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 9%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_902_eifrs-full--DerivativeFinancialLiabilities_iS_pn3n3_c20260101__20260630_zDT2ejeH8xub" title="Balance at beginning"&gt;1,267,801&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: #FFFFFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Issuance&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_903_ecustom--Issuance_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N15thBondWithWarrantsMember_zZTBdxZcS639" title="Issuance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6482"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90B_ecustom--Issuance_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N20thBondWithWarrantsMember_zIP4CuYeamD6" title="Issuance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6484"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90E_ecustom--Issuance_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N21stBondWithWarrantsMember_zfnVfmoeJuc5" title="Issuance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6486"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90A_ecustom--Issuance_pn3n3_c20260101__20260630_zXeCab4zB9wg" title="Issuance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6488"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Redemption&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_903_ecustom--Redemption_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N15thBondWithWarrantsMember_z8XNl89qxuP" title="Redemption"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6490"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90D_ecustom--Redemption_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N20thBondWithWarrantsMember_z3d1C5qCydEe" title="Redemption"&gt;(227,200&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_905_ecustom--Redemption_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N21stBondWithWarrantsMember_zrJ0yBSxYzx2" title="Redemption"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6494"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_905_ecustom--Redemption_pn3n3_c20260101__20260630_z9dLldTDfnj8" title="Redemption"&gt;(227,200&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: #FFFFFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Losses (gains) on valuation of derivatives&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_900_ecustom--LossesGainsOnValuationOfDerivatives_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N15thBondWithWarrantsMember_z4RBNZgYxDsi" title="Losses (gains) on valuation of derivatives"&gt;(117,845&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_904_ecustom--LossesGainsOnValuationOfDerivatives_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N20thBondWithWarrantsMember_zcJehPxrdkBh" title="Losses (gains) on valuation of derivatives"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6500"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_909_ecustom--LossesGainsOnValuationOfDerivatives_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N21stBondWithWarrantsMember_zmZJHx1mY5q8" title="Losses (gains) on valuation of derivatives"&gt;57,213&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90F_ecustom--LossesGainsOnValuationOfDerivatives_pn3n3_c20260101__20260630_zaxhWuhfp8Eb" title="Losses (gains) on valuation of derivatives"&gt;(60,632&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Balance at June&#160;30&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90A_eifrs-full--DerivativeFinancialLiabilities_iE_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N15thBondWithWarrantsMember_zcwPYydGbH5k" title="Balance at end"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6506"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_902_eifrs-full--DerivativeFinancialLiabilities_iE_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N20thBondWithWarrantsMember_zMYcRevKFtxg" title="Balance at end"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6508"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90C_eifrs-full--DerivativeFinancialLiabilities_iE_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N21stBondWithWarrantsMember_zKelxM1naz06" title="Balance at end"&gt;979,969&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_904_eifrs-full--DerivativeFinancialLiabilities_iE_pn3n3_c20260101__20260630_zDr0RLIbeHe9" title="Balance at end"&gt;979,969&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:ChangesInFairValueOfDerivativeLiabilitiesTableTextBlock>
    <ifrs-full:DerivativeFinancialLiabilities
      contextRef="AsOf2025-12-31_custom_N15thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006474"
      unitRef="KRW">117845000</ifrs-full:DerivativeFinancialLiabilities>
    <ifrs-full:DerivativeFinancialLiabilities
      contextRef="AsOf2025-12-31_custom_N20thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006476"
      unitRef="KRW">227200000</ifrs-full:DerivativeFinancialLiabilities>
    <ifrs-full:DerivativeFinancialLiabilities
      contextRef="AsOf2025-12-31_custom_N21stBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006478"
      unitRef="KRW">922756000</ifrs-full:DerivativeFinancialLiabilities>
    <ifrs-full:DerivativeFinancialLiabilities
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006480"
      unitRef="KRW">1267801000</ifrs-full:DerivativeFinancialLiabilities>
    <cik0002058261:Redemption
      contextRef="From2026-01-012026-06-30_custom_N20thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006492"
      unitRef="KRW">-227200000</cik0002058261:Redemption>
    <cik0002058261:Redemption
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006496"
      unitRef="KRW">-227200000</cik0002058261:Redemption>
    <cik0002058261:LossesGainsOnValuationOfDerivatives
      contextRef="From2026-01-012026-06-30_custom_N15thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006498"
      unitRef="KRW">-117845000</cik0002058261:LossesGainsOnValuationOfDerivatives>
    <cik0002058261:LossesGainsOnValuationOfDerivatives
      contextRef="From2026-01-012026-06-30_custom_N21stBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006502"
      unitRef="KRW">57213000</cik0002058261:LossesGainsOnValuationOfDerivatives>
    <cik0002058261:LossesGainsOnValuationOfDerivatives
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006504"
      unitRef="KRW">-60632000</cik0002058261:LossesGainsOnValuationOfDerivatives>
    <ifrs-full:DerivativeFinancialLiabilities
      contextRef="AsOf2026-06-30_custom_N21stBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006510"
      unitRef="KRW">979969000</ifrs-full:DerivativeFinancialLiabilities>
    <ifrs-full:DerivativeFinancialLiabilities
      contextRef="AsOf2026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006512"
      unitRef="KRW">979969000</ifrs-full:DerivativeFinancialLiabilities>
    <cik0002058261:DetailsOfBondsWithDetachableWarrantsIssuedTableTextBlock
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      id="Fact006521">&lt;table cellpadding="0" cellspacing="0" id="xdx_895_ecustom--DetailsOfBondsWithDetachableWarrantsIssuedTableTextBlock_pn3n3_zZB8I8bnVlId" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Bond with warrants and derivative instruments (Details 3)"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_8BE_zXtu2a4RTNYa" style="display: none"&gt;Details of bonds with detachable warrants issued&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;th style="border-bottom: #000000 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Series&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;11&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;12&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;13&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top; width: 18%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Type&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top; width: 24%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90C_ecustom--Type_pp0d_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N11thDetachableWarrantsBondsMember_zALEvUpL6FB3" title="Type"&gt;Detachable Warrants bonds&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top; width: 26%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_904_ecustom--Type_pp0d_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N12thDetachableWarrantsBondsMember_z2rjqv5vqQii" title="Type"&gt;Detachable Warrants bonds&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top; width: 26%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_903_ecustom--Type_pp0d_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N13thDetachableWarrantsBondsMember_zLju8Hu7Yu1i" title="Type"&gt;Detachable Warrants bonds&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Issuance amount&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_907_ecustom--IssuanceAmount_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N11thDetachableWarrantsBondsMember_pp0p" title="Issuance amount"&gt;1,500,000,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_904_ecustom--IssuanceAmount_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N12thDetachableWarrantsBondsMember_pp0p" title="Issuance amount"&gt;800,000,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_905_ecustom--IssuanceAmount_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N13thDetachableWarrantsBondsMember_pp0p" title="Issuance amount"&gt;4,000,000,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Coupon rate (%)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90F_ecustom--CouponRate_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N11thDetachableWarrantsBondsMember_pd" title="Coupon rate (%)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6535"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90E_ecustom--CouponRate_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N12thDetachableWarrantsBondsMember_pd" title="Coupon rate (%)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6537"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_900_ecustom--CouponRate_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N13thDetachableWarrantsBondsMember_pd" title="Coupon rate (%)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6539"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Yield to maturity (%)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_904_ecustom--YieldToMaturity_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N11thDetachableWarrantsBondsMember_pd" title="Yield to maturity (%)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6541"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90B_ecustom--YieldToMaturity_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N12thDetachableWarrantsBondsMember_pd" title="Yield to maturity (%)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6543"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90A_ecustom--YieldToMaturity_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N13thDetachableWarrantsBondsMember_pd" title="Yield to maturity (%)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6545"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Issuance date&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_908_ecustom--IssuanceDate_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N11thDetachableWarrantsBondsMember_zaLBmSlN0qI6" title="Issuance date"&gt;March&#160;2022&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_903_ecustom--IssuanceDate_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N12thDetachableWarrantsBondsMember_z7O6mxeAJTHh" title="Issuance date"&gt;August&#160;2022&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_909_ecustom--IssuanceDate_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N13thDetachableWarrantsBondsMember_zYn7hd5HGpTd" title="Issuance date"&gt;October&#160;2022&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Maturity date&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90E_ecustom--MaturityDate_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N11thDetachableWarrantsBondsMember_zGwq5gc39eSh" title="Maturity date"&gt;March&#160;2025&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90B_ecustom--MaturityDate_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N12thDetachableWarrantsBondsMember_zzCKzcqda9nc" title="Maturity date"&gt;August&#160;2025&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_907_ecustom--MaturityDate_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N13thDetachableWarrantsBondsMember_zNzgQZPlurdk" title="Maturity date"&gt;October&#160;2025&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Principal redemption&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--PrincipalRedemption_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N11thDetachableWarrantsBondsMember_zicNDnQnAzq2" style="font-family: Times New Roman, Times, Serif; text-align: justify; vertical-align: top" title="Principal redemption"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1. Redemption at maturity:&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Redeemed on the maturity date, at their outstanding principal amount, which has not been early redeemed&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2. Early redemption:&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The Company has a right to redeem before maturity (call option) or the bondholders have a right to require the Company to redeem before maturity (put option). Upon exercise of each option, the outstanding principal amount is to be redeemed.&lt;/span&gt;&lt;/p&gt; &lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--PrincipalRedemption_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N12thDetachableWarrantsBondsMember_zm3z16MoMgjl" style="font-family: Times New Roman, Times, Serif; text-align: justify; vertical-align: top" title="Principal redemption"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1. Redemption at maturity:&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Redeemed on the maturity date, at their outstanding principal amount, which has not been early redeemed&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2. Early redemption:&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The Company has a right to redeem before maturity (call option) or the bondholders have a right to require the Company to redeem before maturity (put option). Upon exercise of each option, the outstanding principal amount is to be redeemed.&lt;/span&gt;&lt;/p&gt; &lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--PrincipalRedemption_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N13thDetachableWarrantsBondsMember_zipSBUABRB21" style="font-family: Times New Roman, Times, Serif; text-align: justify; vertical-align: top" title="Principal redemption"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1. Redemption at maturity:&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Redeemed on the maturity date, at their outstanding principal amount, which has not been early redeemed&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-top: 0pt; font-family: Times New Roman, Times, Serif; text-align: justify; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2. Early redemption:&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The Company has a right to redeem before maturity (call option) or the bondholders have a right to require the Company to redeem before maturity (put option). Upon exercise of each option, the outstanding principal amount is to be redeemed.&lt;/span&gt;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Exercise Price (*)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--ExercisePrice_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N11thDetachableWarrantsBondsMember_fKCop_zr5C50dBdpe5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;4,000 per common share&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--ExercisePrice_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N12thDetachableWarrantsBondsMember_fKCop_z6anD8o6JjY5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;2,500 per common share (Subject to adjustment based on revenue at a specific point in time)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--ExercisePrice_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N13thDetachableWarrantsBondsMember_fKCop_zK9T3WliWP2e" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;2,500 per common share&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Exercise period&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--ExercisePeriod_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N11thDetachableWarrantsBondsMember_zrRno5xHwws2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top" title="Exercise period"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;September&#160;2022 ~ January&#160;2025&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--ExercisePeriod_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N12thDetachableWarrantsBondsMember_zG0ciOT1WLge" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top" title="Exercise period"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;February&#160;2023 ~ July&#160;2025&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--ExercisePeriod_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N13thDetachableWarrantsBondsMember_zuBNxVIII6d6" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top" title="Exercise period"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;February&#160;2023 ~ September&#160;2025&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Redemption at the Option of the issuer (Call option)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--RedemptionAtOptionOfIssuerCallOption_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N11thDetachableWarrantsBondsMember_zmR81kzjQZoa" style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify" title="Redemption at the Option of the issuer (Call option)"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The bonds are early redeemable by the Company in full or partial on March&#160;7, 2023, 12 months from the issuance, or every three months after.&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In the event of early redemption, the principal amount shall be paid.&lt;/span&gt;&lt;/p&gt; &lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--RedemptionAtOptionOfIssuerCallOption_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N12thDetachableWarrantsBondsMember_zpWEewmw3ec7" style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify" title="Redemption at the Option of the issuer (Call option)"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The bonds are early redeemable by the Company in full or partial on August&#160;7, 2023, 12 months from the issuance, or every three months after.&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In the event of early redemption, the principal amount shall be paid.&lt;/span&gt;&lt;/p&gt; &lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--RedemptionAtOptionOfIssuerCallOption_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N13thDetachableWarrantsBondsMember_z4tHm4IoTx92" style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify" title="Redemption at the Option of the issuer (Call option)"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The bonds are early redeemable by the Company in full or partial on April&#160;16, 2024, 18 months from the issuance, or every three months after.&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In the event of early redemption, the principal amount shall be paid.&lt;/span&gt;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

















&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif"&gt;
    &lt;th style="border-bottom: #000000 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Series&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;11&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;12&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;13&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-family: Times New Roman, Times, Serif; text-align: left; vertical-align: top; width: 18%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Redemption at the option of the bond holders (Put option)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--RedemptionAtOptionOfBondHoldersPutOption_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N11thDetachableWarrantsBondsMember_zv5wYa5vv6d" style="font-family: Times New Roman, Times, Serif; text-align: justify; vertical-align: top; width: 24%" title="Redemption at the option of the bond holders (Put option)"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The bonds are early redeemable by the Company in full or partial on March&#160;7, 2023, 12 months from the issuance, or every three months after.&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In the event of early redemption, the principal amount shall be paid.&lt;/span&gt;&lt;/p&gt; &lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--RedemptionAtOptionOfBondHoldersPutOption_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N12thDetachableWarrantsBondsMember_ziQiLfF0mAc" style="font-family: Times New Roman, Times, Serif; text-align: justify; vertical-align: top; width: 26%" title="Redemption at the option of the bond holders (Put option)"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The bonds are early redeemable by the Company in full or partial on August&#160;7, 2023, 12 months from the issuance, or every three months after.&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In the event of early redemption, the principal amount shall be paid.&lt;/span&gt;&lt;/p&gt; &lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--RedemptionAtOptionOfBondHoldersPutOption_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N13thDetachableWarrantsBondsMember_zh2UHnNkC0Ga" style="font-family: Times New Roman, Times, Serif; text-align: justify; vertical-align: top; width: 26%" title="Redemption at the option of the bond holders (Put option)"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The bonds are early redeemable by the Company in full or partial on April&#160;16, 2024, 18 months from the issuance, or every three months after.&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In the event of early redemption, the principal amount shall be paid.&lt;/span&gt;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Early redemption rights accounting treatment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--EarlyRedemptionRightsAccountingTreatment_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N11thDetachableWarrantsBondsMember_zexfKIRf5NP4" style="font-family: Times New Roman, Times, Serif; text-align: justify; vertical-align: top" title="Early redemption rights accounting treatment"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The early redemption right is separated from the host debt instrument as an embedded derivative and accounted for separately.&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The separated embedded derivative is measured at fair value through profit or loss (FVTPL).&lt;/span&gt;&lt;/p&gt; &lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--EarlyRedemptionRightsAccountingTreatment_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N12thDetachableWarrantsBondsMember_zYlAHWqMCVql" style="font-family: Times New Roman, Times, Serif; text-align: justify; vertical-align: top" title="Early redemption rights accounting treatment"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The early redemption right is separated from the host debt instrument as an embedded derivative and accounted for separately.&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The separated embedded derivative is measured at fair value through profit or loss (FVTPL).&lt;/span&gt;&lt;/p&gt; &lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--EarlyRedemptionRightsAccountingTreatment_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N13thDetachableWarrantsBondsMember_zbDhQjpcCrp8" style="font-family: Times New Roman, Times, Serif; text-align: justify; vertical-align: top" title="Early redemption rights accounting treatment"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The early redemption right is separated from the host debt instrument as an embedded derivative and accounted for separately.&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The separated embedded derivative is measured at fair value through profit or loss (FVTPL).&lt;/span&gt;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-family: Times New Roman, Times, Serif; text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Classification of Warrants&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--ClassificationOfWarrants_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N11thDetachableWarrantsBondsMember_zQAAw5NxLFG5" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top" title="Classification of Warrants"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The warrants were classified as equity instruments at the date of issuance, as it satisfied the fixed-for-fixed condition.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--ClassificationOfWarrants_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N12thDetachableWarrantsBondsMember_zXCNRf31QrWd" style="font-family: Times New Roman, Times, Serif; text-align: justify; vertical-align: top" title="Classification of Warrants"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Upon initial recognition, the warrants were classified as derivative financial liabilities as the fixed-for-fixed condition was not met at the inception date.&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Subsequently, following the determination of the exercise price, the warrants were reclassified as equity instruments.&lt;/span&gt;&lt;/p&gt; &lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--ClassificationOfWarrants_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N13thDetachableWarrantsBondsMember_zO3jEVCL8ZP4" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top" title="Classification of Warrants"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The warrants were classified as equity instruments at the date of issuance, as it satisfied the fixed-for-fixed condition.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;div style="margin: 0pt auto 0pt 0; font-family: Times New Roman, Times, Serif; width: 25%"&gt;&lt;div style="border-top: Black 1pt solid; font: 1pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"&gt;&lt;span id="xdx_F03_z6BWhPGRAlR9" style="font-family: Times New Roman, Times, Serif"&gt;(*)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F14_zuPVmPsZuKMg" style="font-family: Times New Roman, Times, Serif"&gt;The exercise price for the 12th series was finalized in February&#160;2023.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

















&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Details of the bonds with detachable warrants issued by the Company, including those for which either the bonds or the detachable warrants were outstanding as of June&#160;30, 2026 or December&#160;31, 2025, or were settled, redeemed, exercised or expired during the six-month periods ended June&#160;30, 2026 and 2025, are as follows: (Continued)&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;th style="border-bottom: #000000 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Series&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;14&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;15&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;16&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; width: 18%; vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Type&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 24%; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_906_ecustom--Type_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N14thDetachableWarrantsBondsMember_zSQiTHqESQ3i" title="Type"&gt;Detachable Warrants bonds&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 26%; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90C_ecustom--Type_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N15thDetachableWarrantsBondsMember_zL4aM9Qf6CKh" title="Type"&gt;Detachable Warrants bonds&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 26%; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_908_ecustom--Type_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N16thDetachableWarrantsBondsMember_z8vd0a4YRsg6" title="Type"&gt;Detachable Warrants bonds&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Issuance amount&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90F_ecustom--IssuanceAmount_pp0d_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N14thDetachableWarrantsBondsMember_zH4oeIleHUIc" title="Issuance amount"&gt;750,000,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_903_ecustom--IssuanceAmount_pp0d_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N15thDetachableWarrantsBondsMember_zJCbGzq00217" title="Issuance amount"&gt;2,180,000,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_900_ecustom--IssuanceAmount_pp0d_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N16thDetachableWarrantsBondsMember_zNHNhP037ieg" title="Issuance amount"&gt;30,000,000,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Coupon rate (%)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_900_ecustom--CouponRate_pid_dp_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N14thDetachableWarrantsBondsMember_zeDn6SgYRcQ8" title="Coupon rate (%)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6628"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90D_ecustom--CouponRate_pid_dp_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N15thDetachableWarrantsBondsMember_z16xegI33vXb" title="Coupon rate (%)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6630"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90C_ecustom--CouponRate_pid_dp_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N16thDetachableWarrantsBondsMember_zLEYJBUBsE16" title="Coupon rate (%)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6632"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Yield to maturity (%)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90F_ecustom--YieldToMaturity_pid_dp_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N14thDetachableWarrantsBondsMember_z4LyAHkUKKe7" title="Yield to maturity (%)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6634"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_906_ecustom--YieldToMaturity_pid_dp_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N15thDetachableWarrantsBondsMember_zIxy2PHOdjNb" title="Yield to maturity (%)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6636"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Annual simple interest &lt;span id="xdx_904_ecustom--YieldToMaturity_pid_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N16thDetachableWarrantsBondsMember_z6Lt9XrOS57e" title="Yield to maturity (%)"&gt;3.9%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Issuance date&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_902_ecustom--IssuanceDate_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N14thDetachableWarrantsBondsMember_zwaL3bIpUHd" title="Issuance date"&gt;April&#160;2023&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_903_ecustom--IssuanceDate_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N15thDetachableWarrantsBondsMember_zhSbKoUIdZdi" title="Issuance date"&gt;August&#160;2023&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_908_ecustom--IssuanceDate_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N16thDetachableWarrantsBondsMember_z7IrKrbykpN9" title="Issuance date"&gt;September&#160;2023&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Maturity date&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_906_ecustom--MaturityDate_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N14thDetachableWarrantsBondsMember_zxaUBr73xj0c" title="Maturity date"&gt;April&#160;2026&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_908_ecustom--MaturityDate_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N15thDetachableWarrantsBondsMember_zGilGuEmH0R2" title="Maturity date"&gt;August&#160;2026&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_908_ecustom--MaturityDate_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N16thDetachableWarrantsBondsMember_zjlABjucdTs2" title="Maturity date"&gt;September&#160;2028&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Principal redemption&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--PrincipalRedemption_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N14thDetachableWarrantsBondsMember_zvoJPZt60Z72" style="font-family: Times New Roman, Times, Serif; text-align: justify; vertical-align: top" title="Principal redemption"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1. Redemption at maturity:&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Redeemed on the maturity date, at their outstanding principal amount, which has not been early redeemed&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-top: 0pt; font-family: Times New Roman, Times, Serif; text-align: justify; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2. Early redemption:&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The Company has a right to redeem before maturity (call option) or the bondholders have a right to require the Company to redeem before maturity (put option). Upon exercise of each option, the outstanding principal amount is to be redeemed.&lt;/span&gt;&lt;/p&gt; &lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--PrincipalRedemption_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N15thDetachableWarrantsBondsMember_z9DCqVcfGW38" style="font-family: Times New Roman, Times, Serif; text-align: justify; vertical-align: top" title="Principal redemption"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1. Redemption at maturity:&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Redeemed on the maturity date, at their outstanding principal amount, which has not been early redeemed&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-top: 0pt; font-family: Times New Roman, Times, Serif; text-align: justify; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2. Early redemption:&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The Company has a right to redeem before maturity (call option) or the bondholders have a right to require the Company to redeem before maturity (put option). Upon exercise of each option, the outstanding principal amount is to be redeemed.&lt;/span&gt;&lt;/p&gt; &lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--PrincipalRedemption_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N16thDetachableWarrantsBondsMember_z2UsXlkY4GW1" style="font-family: Times New Roman, Times, Serif; text-align: justify; vertical-align: top" title="Principal redemption"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1. Redemption at maturity:&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Redeemed on the maturity date, at their outstanding principal amount, which has not been early redeemed&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-top: 0pt; font-family: Times New Roman, Times, Serif; text-align: justify; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2. Early redemption:&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The Company has a right to redeem before maturity (call option) or the bondholders have a right to require the Company to redeem before maturity (put option). At exercise of each option, the outstanding principal amount together with accrued but unpaid interest are to be redeemed.&lt;/span&gt;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Exercise Price&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--ExercisePrice_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N14thDetachableWarrantsBondsMember_fKCop_zyhBaKxbHKih" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;2,500 per common share&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--ExercisePrice_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N15thDetachableWarrantsBondsMember_fKCop_zUwfwFxHhBUa" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;3,000 per common share&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--ExercisePrice_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N16thDetachableWarrantsBondsMember_fKCop_z4AoWwzts2ab" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;3,000 per common share&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Exercise period&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--ExercisePeriod_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N14thDetachableWarrantsBondsMember_zfP3F0l67ci" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top" title="Exercise period"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;August&#160;2023 ~ November&#160;2025&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--ExercisePeriod_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N15thDetachableWarrantsBondsMember_z4cBFDPvfAw6" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top" title="Exercise period"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;November&#160;2023 ~ July&#160;2026&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--ExercisePeriod_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N16thDetachableWarrantsBondsMember_zGPNlDCa2eC8" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top" title="Exercise period"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;October&#160;2023 ~ August&#160;2028&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Redemption at the Option of the issuer (Call option)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--RedemptionAtOptionOfIssuerCallOption_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N14thDetachableWarrantsBondsMember_zU9nnIUezbR9" style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify" title="Redemption at the Option of the issuer (Call option)"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The bonds are early redeemable by the Company in full or partial on August&#160;7, 2023 or every three months after.&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In the event of early redemption, the principal amount shall be paid.&lt;/span&gt;&lt;/p&gt; &lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--RedemptionAtOptionOfIssuerCallOption_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N15thDetachableWarrantsBondsMember_zjWuU4rd4vTc" style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify" title="Redemption at the Option of the issuer (Call option)"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The bonds are early redeemable by the Company in full or partial on August&#160;18, 2024 or every three months after.&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In the event of early redemption, the principal amount shall be paid.&lt;/span&gt;&lt;/p&gt; &lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--RedemptionAtOptionOfIssuerCallOption_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N16thDetachableWarrantsBondsMember_zcT54HzePOo9" style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify" title="Redemption at the Option of the issuer (Call option)"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The bonds are early redeemable by the Company in full or partial on November&#160;20, 2023, which is 2 months from the issuance date, or at any time thereafter.&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In the event of early redemption, the principal amount shall be paid.&lt;/span&gt;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

















&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif"&gt;
    &lt;th style="border-bottom: #000000 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Series&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;14&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;15&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;16&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: left; width: 18%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Redemption at the option of the bond holders (Put option)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--RedemptionAtOptionOfBondHoldersPutOption_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N14thDetachableWarrantsBondsMember_ziQKN3hjUhNe" style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify; width: 24%" title="Redemption at the option of the bond holders (Put option)"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The bonds are early redeemable by the Company in full or partial on August&#160;7, 2023 or every three months after.&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In the event of early redemption, the principal amount shall be paid.&lt;/span&gt;&lt;/p&gt; &lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--RedemptionAtOptionOfBondHoldersPutOption_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N15thDetachableWarrantsBondsMember_zdVyLMVOeJ0g" style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify; width: 26%" title="Redemption at the option of the bond holders (Put option)"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The bonds are early redeemable by the Company in full or partial on August&#160;18, 2024 or every three months after.&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In the event of early redemption, the principal amount shall be paid.&lt;/span&gt;&lt;/p&gt; &lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--RedemptionAtOptionOfBondHoldersPutOption_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N16thDetachableWarrantsBondsMember_zj9F9Kll08Ac" style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify; width: 26%" title="Redemption at the option of the bond holders (Put option)"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The bonds are early redeemable by the Company in full or partial on November&#160;20, 2023, which is 2 months from the issuance date, or at any time thereafter.&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In the event of early redemption, the principal amount shall be paid.&lt;/span&gt;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Early redemption rights accounting treatment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--EarlyRedemptionRightsAccountingTreatment_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N14thDetachableWarrantsBondsMember_zpjD34jf0cbh" style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify" title="Early redemption rights accounting treatment"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The early redemption right is separated from the host debt instrument as an embedded derivative and accounted for separately.&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The separated embedded derivative is measured at fair value through profit or loss (FVTPL).&lt;/span&gt;&lt;/p&gt; &lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--EarlyRedemptionRightsAccountingTreatment_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N15thDetachableWarrantsBondsMember_zmzFww6g2OY4" style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify" title="Early redemption rights accounting treatment"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The early redemption right is separated from the host debt instrument as an embedded derivative and accounted for separately.&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The separated embedded derivative is measured at fair value through profit or loss (FVTPL).&lt;/span&gt;&lt;/p&gt; &lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--EarlyRedemptionRightsAccountingTreatment_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N16thDetachableWarrantsBondsMember_zs32aXKZoQG2" style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify" title="Early redemption rights accounting treatment"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The early redemption right is separated from the host debt instrument as an embedded derivative and accounted for separately.&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The separated embedded derivative is measured at fair value through profit or loss (FVTPL).&lt;/span&gt;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Classification of Warrants&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--ClassificationOfWarrants_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N14thDetachableWarrantsBondsMember_zonAEcYls9sg" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top" title="Classification of Warrants"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The warrants were classified as equity instruments at the date of issuance, as it satisfied the fixed-for-fixed condition.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--ClassificationOfWarrants_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N15thDetachableWarrantsBondsMember_zrRnTbNIJtSj" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top" title="Classification of Warrants"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The warrants were classified as equity instruments at the date of issuance, as it satisfied the fixed-for-fixed condition.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--ClassificationOfWarrants_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N16thDetachableWarrantsBondsMember_z6If5ogPPjOk" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top" title="Classification of Warrants"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The warrants were classified as equity instruments at the date of issuance, as it satisfied the fixed-for-fixed condition.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Details of the bonds with detachable warrants issued by the Company, including those for which either the bonds or the detachable warrants were outstanding as of June&#160;30, 2026 or December&#160;31, 2025, or were settled, redeemed, exercised or expired during the six-month periods ended June&#160;30, 2026 and 2025, are as follows: (Continued)&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif"&gt;
    &lt;th style="border-bottom: #000000 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Series&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="border-bottom: #000000 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;17&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="border-bottom: #000000 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;18&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="border-bottom: #000000 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;19&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; width: 18%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Type&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top; width: 24%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_903_ecustom--Type_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N17thDetachableWarrantsBondsMember_zbY0H3Gzrcll" title="Type"&gt;Detachable Warrants bonds&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top; width: 26%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_905_ecustom--Type_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N18thDetachableWarrantsBondsMember_zKNgqkdorTTa" title="Type"&gt;Detachable Warrants bonds&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top; width: 26%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_906_ecustom--Type_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N19thDetachableWarrantsBondsMember_zbJ6SSC2O317" title="Type"&gt;Detachable Warrants bonds&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Issuance amount&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_901_ecustom--IssuanceAmount_pp0d_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N17thDetachableWarrantsBondsMember_zEQbaak7rJQj" title="Issuance amount"&gt;2,000,000,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_902_ecustom--IssuanceAmount_pp0d_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N18thDetachableWarrantsBondsMember_zIntfFcKqoH3" title="Issuance amount"&gt;2,500,000,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90F_ecustom--IssuanceAmount_pp0d_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N19thDetachableWarrantsBondsMember_zcTEBJwgGYr6" title="Issuance amount"&gt;2,000,000,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Coupon rate (%)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90A_ecustom--CouponRate_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N17thDetachableWarrantsBondsMember_zk0xyHu1tqM4" title="Coupon rate (%)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6713"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_905_ecustom--CouponRate_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N18thDetachableWarrantsBondsMember_zMv1j06oqd49" title="Coupon rate (%)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6715"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_903_ecustom--CouponRate_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N19thDetachableWarrantsBondsMember_zajVEKBGBNcc" title="Coupon rate (%)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6717"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Yield to maturity (%)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_904_ecustom--YieldToMaturity_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N17thDetachableWarrantsBondsMember_zyUZ5xagBT6j" title="Yield to maturity (%)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6719"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_901_ecustom--YieldToMaturity_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N18thDetachableWarrantsBondsMember_zuBtI1ipfScc" title="Yield to maturity (%)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6721"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_905_ecustom--YieldToMaturity_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N19thDetachableWarrantsBondsMember_zdiyDUsnRuV5" title="Yield to maturity (%)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6723"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Issuance date&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_901_ecustom--IssuanceDate_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N17thDetachableWarrantsBondsMember_zS1pYrjXQDP4" title="Issuance date"&gt;July&#160;2024&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_901_ecustom--IssuanceDate_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N18thDetachableWarrantsBondsMember_zl7Kgo9ETPc" title="Issuance date"&gt;November&#160;2024&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_903_ecustom--IssuanceDate_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N19thDetachableWarrantsBondsMember_z09yAHAwJwf1" title="Issuance date"&gt;February&#160;2025&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Maturity date&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90F_ecustom--MaturityDate_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N17thDetachableWarrantsBondsMember_z94ytJChTUo8" title="Maturity date"&gt;July&#160;2027&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_903_ecustom--MaturityDate_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N18thDetachableWarrantsBondsMember_zIdP2HnYMOr4" title="Maturity date"&gt;November&#160;2027&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_906_ecustom--MaturityDate_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N19thDetachableWarrantsBondsMember_z4RBvOxXDwq" title="Maturity date"&gt;February&#160;2028&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

















&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif"&gt;
    &lt;th style="border-bottom: rgb(0, 0, 0) 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Series&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="border-bottom: rgb(0, 0, 0) 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;17&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="border-bottom: rgb(0, 0, 0) 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;18&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="border-bottom: rgb(0, 0, 0) 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;19&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top; width: 18%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Principal redemption&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--PrincipalRedemption_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N17thDetachableWarrantsBondsMember_zeBrOObWKgH2" style="font-family: Times New Roman, Times, Serif; text-align: justify; vertical-align: top; width: 24%" title="Principal redemption"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1. Redemption at maturity:&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Redeemed on the maturity date, at their outstanding principal amount, which has not been early redeemed&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2. Early redemption:&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The Company has a right to redeem before maturity (call option) or the bondholders have a right to require the Company to redeem before maturity (put option). At exercise of each option, the outstanding principal amount together with accrued but unpaid interest are to be redeemed.&lt;/span&gt;&lt;/p&gt; &lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--PrincipalRedemption_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N18thDetachableWarrantsBondsMember_zwxwmp2Y6WS6" style="font-family: Times New Roman, Times, Serif; text-align: justify; vertical-align: top; width: 26%" title="Principal redemption"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1. Redemption at maturity:&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Redeemed on the maturity date, at their outstanding principal amount, which has not been early redeemed&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-top: 0pt; font-family: Times New Roman, Times, Serif; text-align: justify; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2. Early redemption:&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The Company has a right to redeem before maturity (call option) or the bondholders have a right to require the Company to redeem before maturity (put option). Upon exercise of each option, the outstanding principal amount is to be redeemed.&lt;/span&gt;&lt;/p&gt; &lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--PrincipalRedemption_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N19thDetachableWarrantsBondsMember_zNF7bXOWUAS7" style="font-family: Times New Roman, Times, Serif; text-align: justify; vertical-align: top; width: 26%" title="Principal redemption"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1. Redemption at maturity:&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Redeemed on the maturity date, at their outstanding principal amount, which has not been early redeemed&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-top: 0pt; font-family: Times New Roman, Times, Serif; text-align: justify; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2. Early redemption:&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The Company has a right to redeem before maturity (call option) or the bondholders have a right to require the Company to redeem before maturity (put option). Upon exercise of each option, the outstanding principal amount is to be redeemed.&lt;/span&gt;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Exercise Price&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--ExercisePrice_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N17thDetachableWarrantsBondsMember_fKCop_znyXttFLu982" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;4,000 per common share&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--ExercisePrice_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N18thDetachableWarrantsBondsMember_fKCop_zV7we2vfKSH8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;4,000 per common share&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--ExercisePrice_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N19thDetachableWarrantsBondsMember_fKCop_zqcJvZJxUfwl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;4,000 per common share&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Exercise period&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--ExercisePeriod_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N17thDetachableWarrantsBondsMember_zg5UEGpgFdNd" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top" title="Exercise period"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;November&#160;2024 ~ June&#160;2027&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--ExercisePeriod_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N18thDetachableWarrantsBondsMember_zvASne47zFkd" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top" title="Exercise period"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;February&#160;2025 ~ November&#160;2027&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--ExercisePeriod_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N19thDetachableWarrantsBondsMember_zCdkCZIhbp95" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top" title="Exercise period"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;May&#160;2025 ~ January&#160;2028&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Redemption at the Option of the issuer (Call option)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--RedemptionAtOptionOfIssuerCallOption_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N17thDetachableWarrantsBondsMember_zR1xhzGi8zzg" style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify" title="Redemption at the Option of the issuer (Call option)"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The bonds are early redeemable by the Company in full or partial on November&#160;2, 2024, which is four months from the issuance date, or at any time thereafter.&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In the event of early redemption, the principal amount shall be paid.&lt;/span&gt;&lt;/p&gt; &lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--RedemptionAtOptionOfIssuerCallOption_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N18thDetachableWarrantsBondsMember_z3eaLtz7Zqy4" style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify" title="Redemption at the Option of the issuer (Call option)"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The bonds are early redeemable by the Company in full or partial on February&#160;7, 2025, which is three months from the issuance date, or at any time thereafter.&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In the event of early redemption, the principal amount shall be paid.&lt;/span&gt;&lt;/p&gt; &lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--RedemptionAtOptionOfIssuerCallOption_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N19thDetachableWarrantsBondsMember_zABMjObvfjhb" style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify" title="Redemption at the Option of the issuer (Call option)"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The bonds are early redeemable by the Company in full or partial on May&#160;17, 2025, which is three months from the issuance date, or at any time thereafter.&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In the event of early redemption, the principal amount shall be paid.&lt;/span&gt;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Redemption at the option of the bond holders (Put option)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--RedemptionAtOptionOfBondHoldersPutOption_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N17thDetachableWarrantsBondsMember_zezgb3RphUni" style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify" title="Redemption at the option of the bond holders (Put option)"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The bonds are early redeemable by the Company in full or partial on November&#160;2, 2024, which is four months from the issuance date, or at any time thereafter.&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In the event of early redemption, the principal amount shall be paid.&lt;/span&gt;&lt;/p&gt; &lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--RedemptionAtOptionOfBondHoldersPutOption_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N18thDetachableWarrantsBondsMember_ze3w6zqdkd4g" style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify" title="Redemption at the option of the bond holders (Put option)"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The bonds are early redeemable by the Company in full or partial on February&#160;7, 2025, which is three months from the issuance date, or at any time thereafter.&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In the event of early redemption, the principal amount shall be paid.&lt;/span&gt;&lt;/p&gt; &lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--RedemptionAtOptionOfBondHoldersPutOption_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N19thDetachableWarrantsBondsMember_z2v8D36K62Xd" style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify" title="Redemption at the option of the bond holders (Put option)"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The bonds are early redeemable by the Company in full or partial on May&#160;17, 2025, which is three months from the issuance date, or at any time thereafter.&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In the event of early redemption, the principal amount shall be paid.&lt;/span&gt;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

















&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif"&gt;
    &lt;th style="border-bottom: rgb(0, 0, 0) 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Series&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="border-bottom: rgb(0, 0, 0) 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;17&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="border-bottom: rgb(0, 0, 0) 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;18&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="border-bottom: rgb(0, 0, 0) 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;19&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left; width: 18%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Early redemption rights accounting treatment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--EarlyRedemptionRightsAccountingTreatment_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N17thDetachableWarrantsBondsMember_zmZmwE0pi0Q4" style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify; width: 24%" title="Early redemption rights accounting treatment"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The early redemption right is separated from the host debt instrument as an embedded derivative and accounted for separately.&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The separated embedded derivative is measured at fair value through profit or loss (FVTPL).&lt;/span&gt;&lt;/p&gt; &lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--EarlyRedemptionRightsAccountingTreatment_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N18thDetachableWarrantsBondsMember_zJ3giSDvAW5h" style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify; width: 26%" title="Early redemption rights accounting treatment"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The early redemption right is separated from the host debt instrument as an embedded derivative and accounted for separately.&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The separated embedded derivative is measured at fair value through profit or loss (FVTPL).&lt;/span&gt;&lt;/p&gt; &lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--EarlyRedemptionRightsAccountingTreatment_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N19thDetachableWarrantsBondsMember_zzcpGNuHEHx8" style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify; width: 26%" title="Early redemption rights accounting treatment"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The early redemption right is separated from the host debt instrument as an embedded derivative and accounted for separately.&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The separated embedded derivative is measured at fair value through profit or loss (FVTPL).&lt;/span&gt;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Classification of Warrants&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--ClassificationOfWarrants_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N17thDetachableWarrantsBondsMember_zrOYTzlfLG16" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top" title="Classification of Warrants"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The warrants were classified as equity instruments at the date of issuance, as it satisfied the fixed-for-fixed condition.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--ClassificationOfWarrants_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N18thDetachableWarrantsBondsMember_zXX3EKMjPLUh" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top" title="Classification of Warrants"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The warrants were classified as equity instruments at the date of issuance, as it satisfied the fixed-for-fixed condition.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--ClassificationOfWarrants_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N19thDetachableWarrantsBondsMember_zczB5Pd5ZLo4" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top" title="Classification of Warrants"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The warrants were classified as equity instruments at the date of issuance, as it satisfied the fixed-for-fixed condition.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Details of the bonds with detachable warrants issued by the Company, including those for which either the bonds or the detachable warrants were outstanding as of June&#160;30, 2026 or December&#160;31, 2025, or were settled, redeemed, exercised or expired during the six-month periods ended June&#160;30, 2026 and 2025, are as follows: (Continued)&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif"&gt;
    &lt;th style="border-bottom: #000000 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Series&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="border-bottom: #000000 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;20&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="border-bottom: #000000 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;21&lt;sup&gt;st&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; width: 18%; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Type&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; width: 39%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_909_ecustom--Type_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N20thDetachableWarrantsBondsMember_zW8yO7rmAR69" title="Type"&gt;Detachable Warrants bonds&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; width: 39%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90F_ecustom--Type_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N21stDetachableWarrantsBondsMember_zOncBpFoga6l" title="Type"&gt;Detachable Warrants bonds&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Issuance amount&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90D_ecustom--IssuanceAmount_pp0d_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N20thDetachableWarrantsBondsMember_z4QHVjB6Udll" title="Issuance amount"&gt;4,200,000,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90E_ecustom--IssuanceAmount_pp0d_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N21stDetachableWarrantsBondsMember_zVd9BUxBLNY8" title="Issuance amount"&gt;3,000,000,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Coupon rate (%)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90E_ecustom--CouponRate_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N20thDetachableWarrantsBondsMember_zoUwVmKB7z2f" title="Coupon rate (%)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6801"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_907_ecustom--CouponRate_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N21stDetachableWarrantsBondsMember_zj7TVGqwN75" title="Coupon rate (%)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6803"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Yield to maturity (%)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90A_ecustom--YieldToMaturity_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N20thDetachableWarrantsBondsMember_zoCeEFeJrV0c" title="Yield to maturity (%)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6805"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90D_ecustom--YieldToMaturity_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N21stDetachableWarrantsBondsMember_zarS4WGzmvdj" title="Yield to maturity (%)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6807"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Issuance date&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90E_ecustom--IssuanceDate_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N20thDetachableWarrantsBondsMember_zjMT4vYPGlfe" title="Issuance date"&gt;July&#160;2025&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_904_ecustom--IssuanceDate_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N21stDetachableWarrantsBondsMember_z3xzwmsWxhni" title="Issuance date"&gt;November&#160;2025&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Maturity date&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90F_ecustom--MaturityDate_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N20thDetachableWarrantsBondsMember_zbcb0E97Rr18" title="Maturity date"&gt;July&#160;2028&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_904_ecustom--MaturityDate_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N21stDetachableWarrantsBondsMember_zMuqRmBcsF9e" title="Maturity date"&gt;November&#160;2028&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Principal redemption&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--PrincipalRedemption_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N20thDetachableWarrantsBondsMember_zcdFuqRgdjb8" style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify" title="Principal redemption"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1. Redemption at maturity:&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Redeemed on the maturity date, at their outstanding principal amount, which has not been early redeemed&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-top: 0pt; font-family: Times New Roman, Times, Serif; text-align: justify; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2. Early redemption:&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The Company has a right to redeem before maturity (call option) or the bondholders have a right to require the Company to redeem before maturity (put option). Upon exercise of each option, the outstanding principal amount is to be redeemed.&lt;/span&gt;&lt;/p&gt; &lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--PrincipalRedemption_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N21stDetachableWarrantsBondsMember_zwqcPY5xOali" style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify" title="Principal redemption"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1. Redemption at maturity:&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Redeemed on the maturity date, at their outstanding principal amount, which has not been early redeemed&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-top: 0pt; font-family: Times New Roman, Times, Serif; text-align: justify; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2. Early redemption:&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The Company has a right to redeem before maturity (call option) or the bondholders have a right to require the Company to redeem before maturity (put option). Upon exercise of each option, the outstanding principal amount is to be redeemed.&lt;/span&gt;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: middle; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Exercise Price&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--ExercisePrice_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N20thDetachableWarrantsBondsMember_fKCop_zfBKSlrXQBzd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;3,000 per common share&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--ExercisePrice_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N21stDetachableWarrantsBondsMember_fKCop_ztbAAXa1Tip3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;3,000 per common share&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

















&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;th style="border-bottom: rgb(0, 0, 0) 1pt solid; font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; vertical-align: bottom; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Series&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="border-bottom: rgb(0, 0, 0) 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;20&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="border-bottom: rgb(0, 0, 0) 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;21&lt;sup&gt;st&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top; width: 18%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exercise period&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--ExercisePeriod_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N20thDetachableWarrantsBondsMember_zgHiQE7vCBHa" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; width: 39%" title="Exercise period"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;October&#160;2025 ~ June&#160;2028&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--ExercisePeriod_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N21stDetachableWarrantsBondsMember_zDBhiVWTj5Aa" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; width: 39%" title="Exercise period"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;February&#160;2026 ~ October&#160;2028&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: #FFFFFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Redemption at the Option of the issuer (Call option)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--RedemptionAtOptionOfIssuerCallOption_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N20thDetachableWarrantsBondsMember_zxdOeRxAYEw5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify" title="Redemption at the Option of the issuer (Call option)"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The bonds are early redeemable by the Company in full or partial on October&#160;2, 2025, which is three months from the issuance date, or at any time thereafter.&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In the event of early redemption, the principal amount shall be paid.&lt;/span&gt;&lt;/p&gt; &lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--RedemptionAtOptionOfIssuerCallOption_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N21stDetachableWarrantsBondsMember_zEiWWNzjuj2l" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify" title="Redemption at the Option of the issuer (Call option)"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The bonds are early redeemable by the Company in full or partial on November&#160;18, 2026, which is one year from the issuance date, or at any time thereafter.&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In the event of early redemption, the principal amount shall be paid.&lt;/span&gt;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: #FFFFFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Redemption at the option of the bond holders (Put option)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--RedemptionAtOptionOfBondHoldersPutOption_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N20thDetachableWarrantsBondsMember_zVBpWZ3kc9Ub" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify" title="Redemption at the option of the bond holders (Put option)"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The bonds are early redeemable by the Company in full or partial on October&#160;2, 2025, which is three months from the issuance date, or at any time thereafter.&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In the event of early redemption, the principal amount shall be paid.&lt;/span&gt;&lt;/p&gt; &lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--RedemptionAtOptionOfBondHoldersPutOption_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N21stDetachableWarrantsBondsMember_zPieEmlD0HZi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify" title="Redemption at the option of the bond holders (Put option)"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The bonds are early redeemable by the Company in full or partial on November&#160;18, 2026, which is one year from the issuance date, or at any time thereafter.&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In the event of early redemption, the principal amount shall be paid.&lt;/span&gt;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: #FFFFFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Early redemption rights accounting treatment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--EarlyRedemptionRightsAccountingTreatment_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N20thDetachableWarrantsBondsMember_z0dE96gIBFFc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify" title="Early redemption rights accounting treatment"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The early redemption right is separated from the host debt instrument as an embedded derivative and accounted for separately.&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The separated embedded derivative is measured at fair value through profit or loss (FVTPL).&lt;/span&gt;&lt;/p&gt; &lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--EarlyRedemptionRightsAccountingTreatment_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N21stDetachableWarrantsBondsMember_ztTGTcuJG6u7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify" title="Early redemption rights accounting treatment"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The early redemption right is separated from the host debt instrument as an embedded derivative and accounted for separately.&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The separated embedded derivative is measured at fair value through profit or loss (FVTPL).&lt;/span&gt;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: #FFFFFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Classification of Warrants&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--ClassificationOfWarrants_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N20thDetachableWarrantsBondsMember_ziqWl3WQZxP5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify" title="Classification of Warrants"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The warrants were classified as equity instruments at the date of issuance, as it satisfied the fixed-for-fixed condition.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--ClassificationOfWarrants_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--N21stDetachableWarrantsBondsMember_z9Q1jDjd70o3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify" title="Classification of Warrants"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The warrants were classified as equity instruments at the date of issuance, as it satisfied the fixed-for-fixed condition.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:DetailsOfBondsWithDetachableWarrantsIssuedTableTextBlock>
    <cik0002058261:Type
      contextRef="From2026-01-012026-06-30_custom_N11thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact006523">Detachable Warrants bonds</cik0002058261:Type>
    <cik0002058261:Type
      contextRef="From2026-01-012026-06-30_custom_N12thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact006525">Detachable Warrants bonds</cik0002058261:Type>
    <cik0002058261:Type
      contextRef="From2026-01-012026-06-30_custom_N13thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact006527">Detachable Warrants bonds</cik0002058261:Type>
    <cik0002058261:IssuanceAmount
      contextRef="From2026-01-012026-06-30_custom_N11thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      decimals="0"
      id="Fact006529"
      unitRef="KRW">1500000000</cik0002058261:IssuanceAmount>
    <cik0002058261:IssuanceAmount
      contextRef="From2026-01-012026-06-30_custom_N12thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      decimals="0"
      id="Fact006531"
      unitRef="KRW">800000000</cik0002058261:IssuanceAmount>
    <cik0002058261:IssuanceAmount
      contextRef="From2026-01-012026-06-30_custom_N13thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      decimals="0"
      id="Fact006533"
      unitRef="KRW">4000000000</cik0002058261:IssuanceAmount>
    <cik0002058261:IssuanceDate
      contextRef="From2026-01-012026-06-30_custom_N11thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact006547">March&#160;2022</cik0002058261:IssuanceDate>
    <cik0002058261:IssuanceDate
      contextRef="From2026-01-012026-06-30_custom_N12thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact006549">August&#160;2022</cik0002058261:IssuanceDate>
    <cik0002058261:IssuanceDate
      contextRef="From2026-01-012026-06-30_custom_N13thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact006551">October&#160;2022</cik0002058261:IssuanceDate>
    <cik0002058261:MaturityDate
      contextRef="From2026-01-012026-06-30_custom_N11thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact006553">March&#160;2025</cik0002058261:MaturityDate>
    <cik0002058261:MaturityDate
      contextRef="From2026-01-012026-06-30_custom_N12thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact006555">August&#160;2025</cik0002058261:MaturityDate>
    <cik0002058261:MaturityDate
      contextRef="From2026-01-012026-06-30_custom_N13thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact006557">October&#160;2025</cik0002058261:MaturityDate>
    <cik0002058261:PrincipalRedemption
      contextRef="From2026-01-012026-06-30_custom_N11thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact006559">1. Redemption at maturity:
        Redeemed on the maturity date, at their outstanding principal amount, which has not been early redeemed
        &#160;
        2. Early redemption:
        The Company has a right to redeem before maturity (call option) or the bondholders have a right to require the Company to redeem before maturity (put option). Upon exercise of each option, the outstanding principal amount is to be redeemed.</cik0002058261:PrincipalRedemption>
    <cik0002058261:PrincipalRedemption
      contextRef="From2026-01-012026-06-30_custom_N12thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact006561">1. Redemption at maturity:
        Redeemed on the maturity date, at their outstanding principal amount, which has not been early redeemed
        &#160;
        2. Early redemption:
        The Company has a right to redeem before maturity (call option) or the bondholders have a right to require the Company to redeem before maturity (put option). Upon exercise of each option, the outstanding principal amount is to be redeemed.</cik0002058261:PrincipalRedemption>
    <cik0002058261:PrincipalRedemption
      contextRef="From2026-01-012026-06-30_custom_N13thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact006563">1. Redemption at maturity:
        Redeemed on the maturity date, at their outstanding principal amount, which has not been early redeemed
        &#160;
        2. Early redemption:
        The Company has a right to redeem before maturity (call option) or the bondholders have a right to require the Company to redeem before maturity (put option). Upon exercise of each option, the outstanding principal amount is to be redeemed.</cik0002058261:PrincipalRedemption>
    <cik0002058261:ExercisePrice
      contextRef="From2026-01-012026-06-30_custom_N11thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact006565">&#x20a9;4,000 per common share</cik0002058261:ExercisePrice>
    <cik0002058261:ExercisePrice
      contextRef="From2026-01-012026-06-30_custom_N12thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact006567">&#x20a9;2,500 per common share (Subject to adjustment based on revenue at a specific point in time)</cik0002058261:ExercisePrice>
    <cik0002058261:ExercisePrice
      contextRef="From2026-01-012026-06-30_custom_N13thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact006569">&#x20a9;2,500 per common share</cik0002058261:ExercisePrice>
    <cik0002058261:ExercisePeriod
      contextRef="From2026-01-012026-06-30_custom_N11thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact006571">September&#160;2022 ~ January&#160;2025</cik0002058261:ExercisePeriod>
    <cik0002058261:ExercisePeriod
      contextRef="From2026-01-012026-06-30_custom_N12thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact006573">February&#160;2023 ~ July&#160;2025</cik0002058261:ExercisePeriod>
    <cik0002058261:ExercisePeriod
      contextRef="From2026-01-012026-06-30_custom_N13thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact006575">February&#160;2023 ~ September&#160;2025</cik0002058261:ExercisePeriod>
    <cik0002058261:RedemptionAtOptionOfIssuerCallOption
      contextRef="From2026-01-012026-06-30_custom_N11thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact006577">The bonds are early redeemable by the Company in full or partial on March&#160;7, 2023, 12 months from the issuance, or every three months after.
        &#160;
        In the event of early redemption, the principal amount shall be paid.</cik0002058261:RedemptionAtOptionOfIssuerCallOption>
    <cik0002058261:RedemptionAtOptionOfIssuerCallOption
      contextRef="From2026-01-012026-06-30_custom_N12thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact006579">The bonds are early redeemable by the Company in full or partial on August&#160;7, 2023, 12 months from the issuance, or every three months after.
        &#160;
        In the event of early redemption, the principal amount shall be paid.</cik0002058261:RedemptionAtOptionOfIssuerCallOption>
    <cik0002058261:RedemptionAtOptionOfIssuerCallOption
      contextRef="From2026-01-012026-06-30_custom_N13thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact006581">The bonds are early redeemable by the Company in full or partial on April&#160;16, 2024, 18 months from the issuance, or every three months after.
        &#160;
        In the event of early redemption, the principal amount shall be paid.</cik0002058261:RedemptionAtOptionOfIssuerCallOption>
    <cik0002058261:RedemptionAtOptionOfBondHoldersPutOption
      contextRef="From2026-01-012026-06-30_custom_N11thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact006590">The bonds are early redeemable by the Company in full or partial on March&#160;7, 2023, 12 months from the issuance, or every three months after.
        &#160;
        In the event of early redemption, the principal amount shall be paid.</cik0002058261:RedemptionAtOptionOfBondHoldersPutOption>
    <cik0002058261:RedemptionAtOptionOfBondHoldersPutOption
      contextRef="From2026-01-012026-06-30_custom_N12thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact006592">The bonds are early redeemable by the Company in full or partial on August&#160;7, 2023, 12 months from the issuance, or every three months after.
        &#160;
        In the event of early redemption, the principal amount shall be paid.</cik0002058261:RedemptionAtOptionOfBondHoldersPutOption>
    <cik0002058261:RedemptionAtOptionOfBondHoldersPutOption
      contextRef="From2026-01-012026-06-30_custom_N13thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact006594">The bonds are early redeemable by the Company in full or partial on April&#160;16, 2024, 18 months from the issuance, or every three months after.
        &#160;
        In the event of early redemption, the principal amount shall be paid.</cik0002058261:RedemptionAtOptionOfBondHoldersPutOption>
    <cik0002058261:EarlyRedemptionRightsAccountingTreatment
      contextRef="From2026-01-012026-06-30_custom_N11thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact006596">The early redemption right is separated from the host debt instrument as an embedded derivative and accounted for separately.
        &#160;
        The separated embedded derivative is measured at fair value through profit or loss (FVTPL).</cik0002058261:EarlyRedemptionRightsAccountingTreatment>
    <cik0002058261:EarlyRedemptionRightsAccountingTreatment
      contextRef="From2026-01-012026-06-30_custom_N12thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact006598">The early redemption right is separated from the host debt instrument as an embedded derivative and accounted for separately.
        &#160;
        The separated embedded derivative is measured at fair value through profit or loss (FVTPL).</cik0002058261:EarlyRedemptionRightsAccountingTreatment>
    <cik0002058261:EarlyRedemptionRightsAccountingTreatment
      contextRef="From2026-01-012026-06-30_custom_N13thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact006600">The early redemption right is separated from the host debt instrument as an embedded derivative and accounted for separately.
        &#160;
        The separated embedded derivative is measured at fair value through profit or loss (FVTPL).</cik0002058261:EarlyRedemptionRightsAccountingTreatment>
    <cik0002058261:ClassificationOfWarrants
      contextRef="From2026-01-012026-06-30_custom_N11thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact006602">The warrants were classified as equity instruments at the date of issuance, as it satisfied the fixed-for-fixed condition.</cik0002058261:ClassificationOfWarrants>
    <cik0002058261:ClassificationOfWarrants
      contextRef="From2026-01-012026-06-30_custom_N12thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact006604">Upon initial recognition, the warrants were classified as derivative financial liabilities as the fixed-for-fixed condition was not met at the inception date.
        &#160;
        Subsequently, following the determination of the exercise price, the warrants were reclassified as equity instruments.</cik0002058261:ClassificationOfWarrants>
    <cik0002058261:ClassificationOfWarrants
      contextRef="From2026-01-012026-06-30_custom_N13thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact006606">The warrants were classified as equity instruments at the date of issuance, as it satisfied the fixed-for-fixed condition.</cik0002058261:ClassificationOfWarrants>
    <cik0002058261:Type
      contextRef="From2026-01-012026-06-30_custom_N14thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact006616">Detachable Warrants bonds</cik0002058261:Type>
    <cik0002058261:Type
      contextRef="From2026-01-012026-06-30_custom_N15thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact006618">Detachable Warrants bonds</cik0002058261:Type>
    <cik0002058261:Type
      contextRef="From2026-01-012026-06-30_custom_N16thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact006620">Detachable Warrants bonds</cik0002058261:Type>
    <cik0002058261:IssuanceAmount
      contextRef="From2026-01-012026-06-30_custom_N14thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      decimals="0"
      id="Fact006622"
      unitRef="KRW">750000000</cik0002058261:IssuanceAmount>
    <cik0002058261:IssuanceAmount
      contextRef="From2026-01-012026-06-30_custom_N15thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      decimals="0"
      id="Fact006624"
      unitRef="KRW">2180000000</cik0002058261:IssuanceAmount>
    <cik0002058261:IssuanceAmount
      contextRef="From2026-01-012026-06-30_custom_N16thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      decimals="0"
      id="Fact006626"
      unitRef="KRW">30000000000</cik0002058261:IssuanceAmount>
    <cik0002058261:YieldToMaturity
      contextRef="From2026-01-012026-06-30_custom_N16thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact006638"
      unitRef="Pure">0.039</cik0002058261:YieldToMaturity>
    <cik0002058261:IssuanceDate
      contextRef="From2026-01-012026-06-30_custom_N14thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact006640">April&#160;2023</cik0002058261:IssuanceDate>
    <cik0002058261:IssuanceDate
      contextRef="From2026-01-012026-06-30_custom_N15thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact006642">August&#160;2023</cik0002058261:IssuanceDate>
    <cik0002058261:IssuanceDate
      contextRef="From2026-01-012026-06-30_custom_N16thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact006644">September&#160;2023</cik0002058261:IssuanceDate>
    <cik0002058261:MaturityDate
      contextRef="From2026-01-012026-06-30_custom_N14thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact006646">April&#160;2026</cik0002058261:MaturityDate>
    <cik0002058261:MaturityDate
      contextRef="From2026-01-012026-06-30_custom_N15thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact006648">August&#160;2026</cik0002058261:MaturityDate>
    <cik0002058261:MaturityDate
      contextRef="From2026-01-012026-06-30_custom_N16thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact006650">September&#160;2028</cik0002058261:MaturityDate>
    <cik0002058261:PrincipalRedemption
      contextRef="From2026-01-012026-06-30_custom_N14thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact006652">1. Redemption at maturity:
        Redeemed on the maturity date, at their outstanding principal amount, which has not been early redeemed
        &#160;
        2. Early redemption:
        The Company has a right to redeem before maturity (call option) or the bondholders have a right to require the Company to redeem before maturity (put option). Upon exercise of each option, the outstanding principal amount is to be redeemed.</cik0002058261:PrincipalRedemption>
    <cik0002058261:PrincipalRedemption
      contextRef="From2026-01-012026-06-30_custom_N15thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact006654">1. Redemption at maturity:
        Redeemed on the maturity date, at their outstanding principal amount, which has not been early redeemed
        &#160;
        2. Early redemption:
        The Company has a right to redeem before maturity (call option) or the bondholders have a right to require the Company to redeem before maturity (put option). Upon exercise of each option, the outstanding principal amount is to be redeemed.</cik0002058261:PrincipalRedemption>
    <cik0002058261:PrincipalRedemption
      contextRef="From2026-01-012026-06-30_custom_N16thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact006656">1. Redemption at maturity:
        Redeemed on the maturity date, at their outstanding principal amount, which has not been early redeemed
        &#160;
        2. Early redemption:
        The Company has a right to redeem before maturity (call option) or the bondholders have a right to require the Company to redeem before maturity (put option). At exercise of each option, the outstanding principal amount together with accrued but unpaid interest are to be redeemed.</cik0002058261:PrincipalRedemption>
    <cik0002058261:ExercisePrice
      contextRef="From2026-01-012026-06-30_custom_N14thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact006658">&#x20a9;2,500 per common share</cik0002058261:ExercisePrice>
    <cik0002058261:ExercisePrice
      contextRef="From2026-01-012026-06-30_custom_N15thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact006660">&#x20a9;3,000 per common share</cik0002058261:ExercisePrice>
    <cik0002058261:ExercisePrice
      contextRef="From2026-01-012026-06-30_custom_N16thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact006662">&#x20a9;3,000 per common share</cik0002058261:ExercisePrice>
    <cik0002058261:ExercisePeriod
      contextRef="From2026-01-012026-06-30_custom_N14thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact006664">August&#160;2023 ~ November&#160;2025</cik0002058261:ExercisePeriod>
    <cik0002058261:ExercisePeriod
      contextRef="From2026-01-012026-06-30_custom_N15thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact006666">November&#160;2023 ~ July&#160;2026</cik0002058261:ExercisePeriod>
    <cik0002058261:ExercisePeriod
      contextRef="From2026-01-012026-06-30_custom_N16thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact006668">October&#160;2023 ~ August&#160;2028</cik0002058261:ExercisePeriod>
    <cik0002058261:RedemptionAtOptionOfIssuerCallOption
      contextRef="From2026-01-012026-06-30_custom_N14thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact006670">The bonds are early redeemable by the Company in full or partial on August&#160;7, 2023 or every three months after.
        &#160;
        In the event of early redemption, the principal amount shall be paid.</cik0002058261:RedemptionAtOptionOfIssuerCallOption>
    <cik0002058261:RedemptionAtOptionOfIssuerCallOption
      contextRef="From2026-01-012026-06-30_custom_N15thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact006672">The bonds are early redeemable by the Company in full or partial on August&#160;18, 2024 or every three months after.
        &#160;
        In the event of early redemption, the principal amount shall be paid.</cik0002058261:RedemptionAtOptionOfIssuerCallOption>
    <cik0002058261:RedemptionAtOptionOfIssuerCallOption
      contextRef="From2026-01-012026-06-30_custom_N16thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact006674">The bonds are early redeemable by the Company in full or partial on November&#160;20, 2023, which is 2 months from the issuance date, or at any time thereafter.
        &#160;
        In the event of early redemption, the principal amount shall be paid.</cik0002058261:RedemptionAtOptionOfIssuerCallOption>
    <cik0002058261:RedemptionAtOptionOfBondHoldersPutOption
      contextRef="From2026-01-012026-06-30_custom_N14thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact006683">The bonds are early redeemable by the Company in full or partial on August&#160;7, 2023 or every three months after.
        &#160;
        In the event of early redemption, the principal amount shall be paid.</cik0002058261:RedemptionAtOptionOfBondHoldersPutOption>
    <cik0002058261:RedemptionAtOptionOfBondHoldersPutOption
      contextRef="From2026-01-012026-06-30_custom_N15thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact006685">The bonds are early redeemable by the Company in full or partial on August&#160;18, 2024 or every three months after.
        &#160;
        In the event of early redemption, the principal amount shall be paid.</cik0002058261:RedemptionAtOptionOfBondHoldersPutOption>
    <cik0002058261:RedemptionAtOptionOfBondHoldersPutOption
      contextRef="From2026-01-012026-06-30_custom_N16thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact006687">The bonds are early redeemable by the Company in full or partial on November&#160;20, 2023, which is 2 months from the issuance date, or at any time thereafter.
        &#160;
        In the event of early redemption, the principal amount shall be paid.</cik0002058261:RedemptionAtOptionOfBondHoldersPutOption>
    <cik0002058261:EarlyRedemptionRightsAccountingTreatment
      contextRef="From2026-01-012026-06-30_custom_N14thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact006689">The early redemption right is separated from the host debt instrument as an embedded derivative and accounted for separately.
        &#160;
        The separated embedded derivative is measured at fair value through profit or loss (FVTPL).</cik0002058261:EarlyRedemptionRightsAccountingTreatment>
    <cik0002058261:EarlyRedemptionRightsAccountingTreatment
      contextRef="From2026-01-012026-06-30_custom_N15thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact006691">The early redemption right is separated from the host debt instrument as an embedded derivative and accounted for separately.
        &#160;
        The separated embedded derivative is measured at fair value through profit or loss (FVTPL).</cik0002058261:EarlyRedemptionRightsAccountingTreatment>
    <cik0002058261:EarlyRedemptionRightsAccountingTreatment
      contextRef="From2026-01-012026-06-30_custom_N16thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact006693">The early redemption right is separated from the host debt instrument as an embedded derivative and accounted for separately.
        &#160;
        The separated embedded derivative is measured at fair value through profit or loss (FVTPL).</cik0002058261:EarlyRedemptionRightsAccountingTreatment>
    <cik0002058261:ClassificationOfWarrants
      contextRef="From2026-01-012026-06-30_custom_N14thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact006695">The warrants were classified as equity instruments at the date of issuance, as it satisfied the fixed-for-fixed condition.</cik0002058261:ClassificationOfWarrants>
    <cik0002058261:ClassificationOfWarrants
      contextRef="From2026-01-012026-06-30_custom_N15thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact006697">The warrants were classified as equity instruments at the date of issuance, as it satisfied the fixed-for-fixed condition.</cik0002058261:ClassificationOfWarrants>
    <cik0002058261:ClassificationOfWarrants
      contextRef="From2026-01-012026-06-30_custom_N16thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact006699">The warrants were classified as equity instruments at the date of issuance, as it satisfied the fixed-for-fixed condition.</cik0002058261:ClassificationOfWarrants>
    <cik0002058261:Type
      contextRef="From2026-01-012026-06-30_custom_N17thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact006701">Detachable Warrants bonds</cik0002058261:Type>
    <cik0002058261:Type
      contextRef="From2026-01-012026-06-30_custom_N18thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact006703">Detachable Warrants bonds</cik0002058261:Type>
    <cik0002058261:Type
      contextRef="From2026-01-012026-06-30_custom_N19thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact006705">Detachable Warrants bonds</cik0002058261:Type>
    <cik0002058261:IssuanceAmount
      contextRef="From2026-01-012026-06-30_custom_N17thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      decimals="0"
      id="Fact006707"
      unitRef="KRW">2000000000</cik0002058261:IssuanceAmount>
    <cik0002058261:IssuanceAmount
      contextRef="From2026-01-012026-06-30_custom_N18thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      decimals="0"
      id="Fact006709"
      unitRef="KRW">2500000000</cik0002058261:IssuanceAmount>
    <cik0002058261:IssuanceAmount
      contextRef="From2026-01-012026-06-30_custom_N19thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      decimals="0"
      id="Fact006711"
      unitRef="KRW">2000000000</cik0002058261:IssuanceAmount>
    <cik0002058261:IssuanceDate
      contextRef="From2026-01-012026-06-30_custom_N17thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact006725">July&#160;2024</cik0002058261:IssuanceDate>
    <cik0002058261:IssuanceDate
      contextRef="From2026-01-012026-06-30_custom_N18thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact006727">November&#160;2024</cik0002058261:IssuanceDate>
    <cik0002058261:IssuanceDate
      contextRef="From2026-01-012026-06-30_custom_N19thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact006729">February&#160;2025</cik0002058261:IssuanceDate>
    <cik0002058261:MaturityDate
      contextRef="From2026-01-012026-06-30_custom_N17thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact006731">July&#160;2027</cik0002058261:MaturityDate>
    <cik0002058261:MaturityDate
      contextRef="From2026-01-012026-06-30_custom_N18thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact006733">November&#160;2027</cik0002058261:MaturityDate>
    <cik0002058261:MaturityDate
      contextRef="From2026-01-012026-06-30_custom_N19thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact006735">February&#160;2028</cik0002058261:MaturityDate>
    <cik0002058261:PrincipalRedemption
      contextRef="From2026-01-012026-06-30_custom_N17thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact006744">1. Redemption at maturity:
        Redeemed on the maturity date, at their outstanding principal amount, which has not been early redeemed
        &#160;
        2. Early redemption:
        The Company has a right to redeem before maturity (call option) or the bondholders have a right to require the Company to redeem before maturity (put option). At exercise of each option, the outstanding principal amount together with accrued but unpaid interest are to be redeemed.</cik0002058261:PrincipalRedemption>
    <cik0002058261:PrincipalRedemption
      contextRef="From2026-01-012026-06-30_custom_N18thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact006746">1. Redemption at maturity:
        Redeemed on the maturity date, at their outstanding principal amount, which has not been early redeemed
        &#160;
        2. Early redemption:
        The Company has a right to redeem before maturity (call option) or the bondholders have a right to require the Company to redeem before maturity (put option). Upon exercise of each option, the outstanding principal amount is to be redeemed.</cik0002058261:PrincipalRedemption>
    <cik0002058261:PrincipalRedemption
      contextRef="From2026-01-012026-06-30_custom_N19thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact006748">1. Redemption at maturity:
        Redeemed on the maturity date, at their outstanding principal amount, which has not been early redeemed
        &#160;
        2. Early redemption:
        The Company has a right to redeem before maturity (call option) or the bondholders have a right to require the Company to redeem before maturity (put option). Upon exercise of each option, the outstanding principal amount is to be redeemed.</cik0002058261:PrincipalRedemption>
    <cik0002058261:ExercisePrice
      contextRef="From2026-01-012026-06-30_custom_N17thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact006750">&#x20a9;4,000 per common share</cik0002058261:ExercisePrice>
    <cik0002058261:ExercisePrice
      contextRef="From2026-01-012026-06-30_custom_N18thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact006752">&#x20a9;4,000 per common share</cik0002058261:ExercisePrice>
    <cik0002058261:ExercisePrice
      contextRef="From2026-01-012026-06-30_custom_N19thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact006754">&#x20a9;4,000 per common share</cik0002058261:ExercisePrice>
    <cik0002058261:ExercisePeriod
      contextRef="From2026-01-012026-06-30_custom_N17thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact006756">November&#160;2024 ~ June&#160;2027</cik0002058261:ExercisePeriod>
    <cik0002058261:ExercisePeriod
      contextRef="From2026-01-012026-06-30_custom_N18thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact006758">February&#160;2025 ~ November&#160;2027</cik0002058261:ExercisePeriod>
    <cik0002058261:ExercisePeriod
      contextRef="From2026-01-012026-06-30_custom_N19thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact006760">May&#160;2025 ~ January&#160;2028</cik0002058261:ExercisePeriod>
    <cik0002058261:RedemptionAtOptionOfIssuerCallOption
      contextRef="From2026-01-012026-06-30_custom_N17thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact006762">The bonds are early redeemable by the Company in full or partial on November&#160;2, 2024, which is four months from the issuance date, or at any time thereafter.
        &#160;
        In the event of early redemption, the principal amount shall be paid.</cik0002058261:RedemptionAtOptionOfIssuerCallOption>
    <cik0002058261:RedemptionAtOptionOfIssuerCallOption
      contextRef="From2026-01-012026-06-30_custom_N18thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact006764">The bonds are early redeemable by the Company in full or partial on February&#160;7, 2025, which is three months from the issuance date, or at any time thereafter.
        &#160;
        In the event of early redemption, the principal amount shall be paid.</cik0002058261:RedemptionAtOptionOfIssuerCallOption>
    <cik0002058261:RedemptionAtOptionOfIssuerCallOption
      contextRef="From2026-01-012026-06-30_custom_N19thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact006766">The bonds are early redeemable by the Company in full or partial on May&#160;17, 2025, which is three months from the issuance date, or at any time thereafter.
        &#160;
        In the event of early redemption, the principal amount shall be paid.</cik0002058261:RedemptionAtOptionOfIssuerCallOption>
    <cik0002058261:RedemptionAtOptionOfBondHoldersPutOption
      contextRef="From2026-01-012026-06-30_custom_N17thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact006768">The bonds are early redeemable by the Company in full or partial on November&#160;2, 2024, which is four months from the issuance date, or at any time thereafter.
        &#160;
        In the event of early redemption, the principal amount shall be paid.</cik0002058261:RedemptionAtOptionOfBondHoldersPutOption>
    <cik0002058261:RedemptionAtOptionOfBondHoldersPutOption
      contextRef="From2026-01-012026-06-30_custom_N18thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact006770">The bonds are early redeemable by the Company in full or partial on February&#160;7, 2025, which is three months from the issuance date, or at any time thereafter.
        &#160;
        In the event of early redemption, the principal amount shall be paid.</cik0002058261:RedemptionAtOptionOfBondHoldersPutOption>
    <cik0002058261:RedemptionAtOptionOfBondHoldersPutOption
      contextRef="From2026-01-012026-06-30_custom_N19thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact006772">The bonds are early redeemable by the Company in full or partial on May&#160;17, 2025, which is three months from the issuance date, or at any time thereafter.
        &#160;
        In the event of early redemption, the principal amount shall be paid.</cik0002058261:RedemptionAtOptionOfBondHoldersPutOption>
    <cik0002058261:EarlyRedemptionRightsAccountingTreatment
      contextRef="From2026-01-012026-06-30_custom_N17thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact006781">The early redemption right is separated from the host debt instrument as an embedded derivative and accounted for separately.
        &#160;
        The separated embedded derivative is measured at fair value through profit or loss (FVTPL).</cik0002058261:EarlyRedemptionRightsAccountingTreatment>
    <cik0002058261:EarlyRedemptionRightsAccountingTreatment
      contextRef="From2026-01-012026-06-30_custom_N18thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact006783">The early redemption right is separated from the host debt instrument as an embedded derivative and accounted for separately.
        &#160;
        The separated embedded derivative is measured at fair value through profit or loss (FVTPL).</cik0002058261:EarlyRedemptionRightsAccountingTreatment>
    <cik0002058261:EarlyRedemptionRightsAccountingTreatment
      contextRef="From2026-01-012026-06-30_custom_N19thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact006785">The early redemption right is separated from the host debt instrument as an embedded derivative and accounted for separately.
        &#160;
        The separated embedded derivative is measured at fair value through profit or loss (FVTPL).</cik0002058261:EarlyRedemptionRightsAccountingTreatment>
    <cik0002058261:ClassificationOfWarrants
      contextRef="From2026-01-012026-06-30_custom_N17thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact006787">The warrants were classified as equity instruments at the date of issuance, as it satisfied the fixed-for-fixed condition.</cik0002058261:ClassificationOfWarrants>
    <cik0002058261:ClassificationOfWarrants
      contextRef="From2026-01-012026-06-30_custom_N18thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact006789">The warrants were classified as equity instruments at the date of issuance, as it satisfied the fixed-for-fixed condition.</cik0002058261:ClassificationOfWarrants>
    <cik0002058261:ClassificationOfWarrants
      contextRef="From2026-01-012026-06-30_custom_N19thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact006791">The warrants were classified as equity instruments at the date of issuance, as it satisfied the fixed-for-fixed condition.</cik0002058261:ClassificationOfWarrants>
    <cik0002058261:Type
      contextRef="From2026-01-012026-06-30_custom_N20thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact006793">Detachable Warrants bonds</cik0002058261:Type>
    <cik0002058261:Type
      contextRef="From2026-01-012026-06-30_custom_N21stDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact006795">Detachable Warrants bonds</cik0002058261:Type>
    <cik0002058261:IssuanceAmount
      contextRef="From2026-01-012026-06-30_custom_N20thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      decimals="0"
      id="Fact006797"
      unitRef="KRW">4200000000</cik0002058261:IssuanceAmount>
    <cik0002058261:IssuanceAmount
      contextRef="From2026-01-012026-06-30_custom_N21stDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      decimals="0"
      id="Fact006799"
      unitRef="KRW">3000000000</cik0002058261:IssuanceAmount>
    <cik0002058261:IssuanceDate
      contextRef="From2026-01-012026-06-30_custom_N20thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact006809">July&#160;2025</cik0002058261:IssuanceDate>
    <cik0002058261:IssuanceDate
      contextRef="From2026-01-012026-06-30_custom_N21stDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact006811">November&#160;2025</cik0002058261:IssuanceDate>
    <cik0002058261:MaturityDate
      contextRef="From2026-01-012026-06-30_custom_N20thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact006813">July&#160;2028</cik0002058261:MaturityDate>
    <cik0002058261:MaturityDate
      contextRef="From2026-01-012026-06-30_custom_N21stDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact006815">November&#160;2028</cik0002058261:MaturityDate>
    <cik0002058261:PrincipalRedemption
      contextRef="From2026-01-012026-06-30_custom_N20thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact006817">1. Redemption at maturity:
        Redeemed on the maturity date, at their outstanding principal amount, which has not been early redeemed
        &#160;
        2. Early redemption:
        The Company has a right to redeem before maturity (call option) or the bondholders have a right to require the Company to redeem before maturity (put option). Upon exercise of each option, the outstanding principal amount is to be redeemed.</cik0002058261:PrincipalRedemption>
    <cik0002058261:PrincipalRedemption
      contextRef="From2026-01-012026-06-30_custom_N21stDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact006819">1. Redemption at maturity:
        Redeemed on the maturity date, at their outstanding principal amount, which has not been early redeemed
        &#160;
        2. Early redemption:
        The Company has a right to redeem before maturity (call option) or the bondholders have a right to require the Company to redeem before maturity (put option). Upon exercise of each option, the outstanding principal amount is to be redeemed.</cik0002058261:PrincipalRedemption>
    <cik0002058261:ExercisePrice
      contextRef="From2026-01-012026-06-30_custom_N20thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact006821">&#x20a9;3,000 per common share</cik0002058261:ExercisePrice>
    <cik0002058261:ExercisePrice
      contextRef="From2026-01-012026-06-30_custom_N21stDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact006823">&#x20a9;3,000 per common share</cik0002058261:ExercisePrice>
    <cik0002058261:ExercisePeriod
      contextRef="From2026-01-012026-06-30_custom_N20thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact006832">October&#160;2025 ~ June&#160;2028</cik0002058261:ExercisePeriod>
    <cik0002058261:ExercisePeriod
      contextRef="From2026-01-012026-06-30_custom_N21stDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact006834">February&#160;2026 ~ October&#160;2028</cik0002058261:ExercisePeriod>
    <cik0002058261:RedemptionAtOptionOfIssuerCallOption
      contextRef="From2026-01-012026-06-30_custom_N20thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact006836">The bonds are early redeemable by the Company in full or partial on October&#160;2, 2025, which is three months from the issuance date, or at any time thereafter.
        &#160;
        In the event of early redemption, the principal amount shall be paid.</cik0002058261:RedemptionAtOptionOfIssuerCallOption>
    <cik0002058261:RedemptionAtOptionOfIssuerCallOption
      contextRef="From2026-01-012026-06-30_custom_N21stDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact006838">The bonds are early redeemable by the Company in full or partial on November&#160;18, 2026, which is one year from the issuance date, or at any time thereafter.
        &#160;
        In the event of early redemption, the principal amount shall be paid.</cik0002058261:RedemptionAtOptionOfIssuerCallOption>
    <cik0002058261:RedemptionAtOptionOfBondHoldersPutOption
      contextRef="From2026-01-012026-06-30_custom_N20thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact006840">The bonds are early redeemable by the Company in full or partial on October&#160;2, 2025, which is three months from the issuance date, or at any time thereafter.
        &#160;
        In the event of early redemption, the principal amount shall be paid.</cik0002058261:RedemptionAtOptionOfBondHoldersPutOption>
    <cik0002058261:RedemptionAtOptionOfBondHoldersPutOption
      contextRef="From2026-01-012026-06-30_custom_N21stDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact006842">The bonds are early redeemable by the Company in full or partial on November&#160;18, 2026, which is one year from the issuance date, or at any time thereafter.
        &#160;
        In the event of early redemption, the principal amount shall be paid.</cik0002058261:RedemptionAtOptionOfBondHoldersPutOption>
    <cik0002058261:EarlyRedemptionRightsAccountingTreatment
      contextRef="From2026-01-012026-06-30_custom_N20thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact006844">The early redemption right is separated from the host debt instrument as an embedded derivative and accounted for separately.
        &#160;
        The separated embedded derivative is measured at fair value through profit or loss (FVTPL).</cik0002058261:EarlyRedemptionRightsAccountingTreatment>
    <cik0002058261:EarlyRedemptionRightsAccountingTreatment
      contextRef="From2026-01-012026-06-30_custom_N21stDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact006846">The early redemption right is separated from the host debt instrument as an embedded derivative and accounted for separately.
        &#160;
        The separated embedded derivative is measured at fair value through profit or loss (FVTPL).</cik0002058261:EarlyRedemptionRightsAccountingTreatment>
    <cik0002058261:ClassificationOfWarrants
      contextRef="From2026-01-012026-06-30_custom_N20thDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact006848">The warrants were classified as equity instruments at the date of issuance, as it satisfied the fixed-for-fixed condition.</cik0002058261:ClassificationOfWarrants>
    <cik0002058261:ClassificationOfWarrants
      contextRef="From2026-01-012026-06-30_custom_N21stDetachableWarrantsBondsMember_custom_CubebioCo.Ltd.Member"
      id="Fact006850">The warrants were classified as equity instruments at the date of issuance, as it satisfied the fixed-for-fixed condition.</cik0002058261:ClassificationOfWarrants>
    <cik0002058261:SellingGeneralAndAdministrativeExpensesTextBlock
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      id="Fact006859">&lt;p id="xdx_801_ecustom--SellingGeneralAndAdministrativeExpensesTextBlock_zUCnpEe04QF2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;20. &lt;span id="xdx_82C_zBAx1nUwksYk"&gt;Selling, general and administrative expenses&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The selling, general and administrative expenses for the six-month periods ended June&#160;30, 2026 and 2025 are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_886_ecustom--ScheduleOfSellingGeneralAndAdministrativeExpensesTableTextBlock_pn3n3_zd7LUkge6cSh" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Selling, general and administrative expenses (Details)"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_8B8_zOGSklL1sjvd" style="display: none"&gt;Schedule of selling, general and administrative expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49C_20260101__20260630_zY9fCZfcrhBb" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49E_20250101__20250630_zZFLHwR6wjfb" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;June&#160;30,&lt;br/&gt;2026&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;June&#160;30,&lt;br/&gt;2025&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="6" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr id="xdx_404_eifrs-full--WagesAndSalaries_maCziY3_zS5JewNf6Spf" style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Salaries&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;986,284&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;991,340&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--SeveranceBenefits_maCziY3_zZ8RlAcGZQX5" style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Severance Benefits&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;102,647&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;98,811&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--FringeBenefit_maCziY3_zhny7R0Ha4Cb" style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Fringe benefit&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;92,300&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;116,869&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_405_eifrs-full--TransportationExpense_maCziY3_z9LMKKpGOHj3" style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Transportation&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,218&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;21,011&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--Entertainment_maCziY3_zPl9gwbpwc0f" style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Entertainment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;224&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;14,327&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_402_eifrs-full--CommunicationExpense_maCziY3_zqaytSdyD0o8" style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Communications&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,109&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,286&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--TaxesDues_maCziY3_zlhlzClCUM44" style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Taxes &amp;amp; dues&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;36,242&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;44,958&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_401_eifrs-full--AdjustmentsForDepreciationExpense_maCziY3_zoGFBE9Rmoak" style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Depreciation&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;67,358&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;39,475&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--Rent_maCziY3_z5LObAAQ4GF5" style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Rent&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,321&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;91&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--RepairsAndMaintenanceExpense_maCziY3_z5yjPHW3IQHj" style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Repairs&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;864&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6891"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_407_eifrs-full--InsuranceExpense_maCziY3_zJE0nMBNetd7" style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Insurance&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;19,789&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;17,709&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--RdExpenses_maCziY3_zstB0AusTgnd" style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;R&amp;amp;D expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;181,078&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;521,798&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--VehicleMaintenance_maCziY3_zwhv6jUtPTpf" style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Vehicle maintenance&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;6,396&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5,839&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--DeliveryPostage_maCziY3_ziq1a9MS8Bqg" style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Delivery &amp;amp; postage&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;656&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,262&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--Education_maCziY3_zB3mW2PRfCSb" style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Education&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;45&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,600&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--BooksSubscription_maCziY3_zw7ybJA9XSte" style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Books &amp;amp; subscription&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;118&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;102&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40C_eifrs-full--AdjustmentsForAmortisationExpense_maCziY3_zOJj4jtI7TZe" style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Amortization&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;256&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;256&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--SuppliesExpenses_maCziY3_zQj1LASjNA9k" style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Supplies&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;10,664&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,098&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--ProfessionalServiceFee_maCziY3_z979ARqxpx4f" style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt; Professional service fee&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,421,852&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;552,288&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--AdvertisingMarketing_maCziY3_ztfKtNtv55Kk" style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Advertising &amp;amp; marketing&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,156&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,517&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--BuildingMaintenance_maCziY3_zZXqR1orZUtj" style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Building Maintenance&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;27,172&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;26,896&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--OtherExpense_maCziY3_z9b6NMajen7" style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Other expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6926"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;883,141&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_405_eifrs-full--OtherExpenseByNature_iT_mtCziY3_zke21GlHwKw6" style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,965,749&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,350,674&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

















</cik0002058261:SellingGeneralAndAdministrativeExpensesTextBlock>
    <cik0002058261:ScheduleOfSellingGeneralAndAdministrativeExpensesTableTextBlock
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      id="Fact006861">&lt;table cellpadding="0" cellspacing="0" id="xdx_886_ecustom--ScheduleOfSellingGeneralAndAdministrativeExpensesTableTextBlock_pn3n3_zd7LUkge6cSh" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Selling, general and administrative expenses (Details)"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_8B8_zOGSklL1sjvd" style="display: none"&gt;Schedule of selling, general and administrative expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49C_20260101__20260630_zY9fCZfcrhBb" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49E_20250101__20250630_zZFLHwR6wjfb" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;June&#160;30,&lt;br/&gt;2026&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;June&#160;30,&lt;br/&gt;2025&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="6" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr id="xdx_404_eifrs-full--WagesAndSalaries_maCziY3_zS5JewNf6Spf" style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Salaries&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;986,284&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;991,340&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--SeveranceBenefits_maCziY3_zZ8RlAcGZQX5" style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Severance Benefits&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;102,647&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;98,811&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--FringeBenefit_maCziY3_zhny7R0Ha4Cb" style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Fringe benefit&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;92,300&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;116,869&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_405_eifrs-full--TransportationExpense_maCziY3_z9LMKKpGOHj3" style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Transportation&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,218&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;21,011&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--Entertainment_maCziY3_zPl9gwbpwc0f" style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Entertainment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;224&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;14,327&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_402_eifrs-full--CommunicationExpense_maCziY3_zqaytSdyD0o8" style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Communications&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,109&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,286&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--TaxesDues_maCziY3_zlhlzClCUM44" style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Taxes &amp;amp; dues&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;36,242&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;44,958&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_401_eifrs-full--AdjustmentsForDepreciationExpense_maCziY3_zoGFBE9Rmoak" style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Depreciation&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;67,358&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;39,475&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--Rent_maCziY3_z5LObAAQ4GF5" style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Rent&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,321&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;91&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--RepairsAndMaintenanceExpense_maCziY3_z5yjPHW3IQHj" style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Repairs&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;864&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6891"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_407_eifrs-full--InsuranceExpense_maCziY3_zJE0nMBNetd7" style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Insurance&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;19,789&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;17,709&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--RdExpenses_maCziY3_zstB0AusTgnd" style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;R&amp;amp;D expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;181,078&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;521,798&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--VehicleMaintenance_maCziY3_zwhv6jUtPTpf" style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Vehicle maintenance&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;6,396&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5,839&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--DeliveryPostage_maCziY3_ziq1a9MS8Bqg" style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Delivery &amp;amp; postage&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;656&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,262&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--Education_maCziY3_zB3mW2PRfCSb" style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Education&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;45&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,600&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--BooksSubscription_maCziY3_zw7ybJA9XSte" style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Books &amp;amp; subscription&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;118&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;102&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40C_eifrs-full--AdjustmentsForAmortisationExpense_maCziY3_zOJj4jtI7TZe" style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Amortization&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;256&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;256&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--SuppliesExpenses_maCziY3_zQj1LASjNA9k" style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Supplies&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;10,664&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,098&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--ProfessionalServiceFee_maCziY3_z979ARqxpx4f" style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt; Professional service fee&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,421,852&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;552,288&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--AdvertisingMarketing_maCziY3_ztfKtNtv55Kk" style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Advertising &amp;amp; marketing&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,156&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,517&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--BuildingMaintenance_maCziY3_zZXqR1orZUtj" style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Building Maintenance&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;27,172&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;26,896&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--OtherExpense_maCziY3_z9b6NMajen7" style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Other expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6926"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;883,141&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_405_eifrs-full--OtherExpenseByNature_iT_mtCziY3_zke21GlHwKw6" style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,965,749&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,350,674&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;</cik0002058261:ScheduleOfSellingGeneralAndAdministrativeExpensesTableTextBlock>
    <ifrs-full:WagesAndSalaries
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006863"
      unitRef="KRW">986284000</ifrs-full:WagesAndSalaries>
    <ifrs-full:WagesAndSalaries
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006864"
      unitRef="KRW">991340000</ifrs-full:WagesAndSalaries>
    <cik0002058261:SeveranceBenefits
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006866"
      unitRef="KRW">102647000</cik0002058261:SeveranceBenefits>
    <cik0002058261:SeveranceBenefits
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006867"
      unitRef="KRW">98811000</cik0002058261:SeveranceBenefits>
    <cik0002058261:FringeBenefit
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006869"
      unitRef="KRW">92300000</cik0002058261:FringeBenefit>
    <cik0002058261:FringeBenefit
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006870"
      unitRef="KRW">116869000</cik0002058261:FringeBenefit>
    <ifrs-full:TransportationExpense
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006872"
      unitRef="KRW">3218000</ifrs-full:TransportationExpense>
    <ifrs-full:TransportationExpense
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006873"
      unitRef="KRW">21011000</ifrs-full:TransportationExpense>
    <cik0002058261:Entertainment
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006875"
      unitRef="KRW">224000</cik0002058261:Entertainment>
    <cik0002058261:Entertainment
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006876"
      unitRef="KRW">14327000</cik0002058261:Entertainment>
    <ifrs-full:CommunicationExpense
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006878"
      unitRef="KRW">2109000</ifrs-full:CommunicationExpense>
    <ifrs-full:CommunicationExpense
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006879"
      unitRef="KRW">2286000</ifrs-full:CommunicationExpense>
    <cik0002058261:TaxesDues
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006881"
      unitRef="KRW">36242000</cik0002058261:TaxesDues>
    <cik0002058261:TaxesDues
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006882"
      unitRef="KRW">44958000</cik0002058261:TaxesDues>
    <ifrs-full:AdjustmentsForDepreciationExpense
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006884"
      unitRef="KRW">67358000</ifrs-full:AdjustmentsForDepreciationExpense>
    <ifrs-full:AdjustmentsForDepreciationExpense
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006885"
      unitRef="KRW">39475000</ifrs-full:AdjustmentsForDepreciationExpense>
    <cik0002058261:Rent
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006887"
      unitRef="KRW">4321000</cik0002058261:Rent>
    <cik0002058261:Rent
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006888"
      unitRef="KRW">91000</cik0002058261:Rent>
    <ifrs-full:RepairsAndMaintenanceExpense
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006890"
      unitRef="KRW">864000</ifrs-full:RepairsAndMaintenanceExpense>
    <ifrs-full:InsuranceExpense
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006893"
      unitRef="KRW">19789000</ifrs-full:InsuranceExpense>
    <ifrs-full:InsuranceExpense
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006894"
      unitRef="KRW">17709000</ifrs-full:InsuranceExpense>
    <cik0002058261:RdExpenses
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006896"
      unitRef="KRW">181078000</cik0002058261:RdExpenses>
    <cik0002058261:RdExpenses
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006897"
      unitRef="KRW">521798000</cik0002058261:RdExpenses>
    <cik0002058261:VehicleMaintenance
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006899"
      unitRef="KRW">6396000</cik0002058261:VehicleMaintenance>
    <cik0002058261:VehicleMaintenance
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006900"
      unitRef="KRW">5839000</cik0002058261:VehicleMaintenance>
    <cik0002058261:DeliveryPostage
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006902"
      unitRef="KRW">656000</cik0002058261:DeliveryPostage>
    <cik0002058261:DeliveryPostage
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006903"
      unitRef="KRW">2262000</cik0002058261:DeliveryPostage>
    <cik0002058261:Education
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006905"
      unitRef="KRW">45000</cik0002058261:Education>
    <cik0002058261:Education
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006906"
      unitRef="KRW">3600000</cik0002058261:Education>
    <cik0002058261:BooksSubscription
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006908"
      unitRef="KRW">118000</cik0002058261:BooksSubscription>
    <cik0002058261:BooksSubscription
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006909"
      unitRef="KRW">102000</cik0002058261:BooksSubscription>
    <ifrs-full:AdjustmentsForAmortisationExpense
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006911"
      unitRef="KRW">256000</ifrs-full:AdjustmentsForAmortisationExpense>
    <ifrs-full:AdjustmentsForAmortisationExpense
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006912"
      unitRef="KRW">256000</ifrs-full:AdjustmentsForAmortisationExpense>
    <cik0002058261:SuppliesExpenses
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006914"
      unitRef="KRW">10664000</cik0002058261:SuppliesExpenses>
    <cik0002058261:SuppliesExpenses
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006915"
      unitRef="KRW">4098000</cik0002058261:SuppliesExpenses>
    <cik0002058261:ProfessionalServiceFee
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006917"
      unitRef="KRW">1421852000</cik0002058261:ProfessionalServiceFee>
    <cik0002058261:ProfessionalServiceFee
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006918"
      unitRef="KRW">552288000</cik0002058261:ProfessionalServiceFee>
    <cik0002058261:AdvertisingMarketing
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006920"
      unitRef="KRW">2156000</cik0002058261:AdvertisingMarketing>
    <cik0002058261:AdvertisingMarketing
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006921"
      unitRef="KRW">3517000</cik0002058261:AdvertisingMarketing>
    <cik0002058261:BuildingMaintenance
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006923"
      unitRef="KRW">27172000</cik0002058261:BuildingMaintenance>
    <cik0002058261:BuildingMaintenance
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006924"
      unitRef="KRW">26896000</cik0002058261:BuildingMaintenance>
    <cik0002058261:OtherExpense
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006927"
      unitRef="KRW">883141000</cik0002058261:OtherExpense>
    <ifrs-full:OtherExpenseByNature
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006929"
      unitRef="KRW">2965749000</ifrs-full:OtherExpenseByNature>
    <ifrs-full:OtherExpenseByNature
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006930"
      unitRef="KRW">3350674000</ifrs-full:OtherExpenseByNature>
    <cik0002058261:FinancialInstrumentsByCategoryTextBlock
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      id="Fact006939">&lt;p id="xdx_805_ecustom--FinancialInstrumentsByCategoryTextBlock_zix5b2RwyZQd" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;21. &lt;span id="xdx_826_zxcIhCfBGUr9"&gt;Financial instruments by category&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The carrying amounts of financial instruments by category as of June&#160;30, 2026 and December&#160;31, 2025 are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_894_ecustom--FinancialInstrumentsByCategoryTableTextBlock_pn3n3_zHYSL3FyZCdb" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Financial instruments by category (Details)"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_8B0_znbMnIL9GB2a" style="display: none"&gt;Schedule of financial instruments by category&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;June&#160;30,&lt;br/&gt;2026&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2025&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="6" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Financial assets at amortized cost&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90E_eifrs-full--FinancialAssets_iI_pn3n3_c20260630__ifrs-full--ClassesOfFinancialAssetsAxis__custom--CashAndCashEquivalentMember_zgTcJYd8Xgp6" title="Total"&gt;312,427&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_902_eifrs-full--FinancialAssets_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--CashAndCashEquivalentMember_zjyxErsK5aVk" title="Total"&gt;335,814&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Current portion of long-term bank deposit&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_903_eifrs-full--FinancialAssets_iI_pn3n3_c20260630__ifrs-full--ClassesOfFinancialAssetsAxis__custom--CurrentPortionOfLongTermBankDepositMember_zpAvnktz32ua" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6947"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90A_eifrs-full--FinancialAssets_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--CurrentPortionOfLongTermBankDepositMember_z53KhKrZKgzk" title="Total"&gt;30,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Short-term loan receivable, net&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90B_eifrs-full--FinancialAssets_iI_pn3n3_c20260630__ifrs-full--ClassesOfFinancialAssetsAxis__custom--ShortTermLoanReceivableNetMember_zpTh1wjJ3Acd" title="Total"&gt;561,944&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90D_eifrs-full--FinancialAssets_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--ShortTermLoanReceivableNetMember_z0hsZfDg13ze" title="Total"&gt;442,894&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Other receivables&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90F_eifrs-full--FinancialAssets_iI_pn3n3_c20260630__ifrs-full--ClassesOfFinancialAssetsAxis__custom--OtherReceivablesMember_z63a29ZyoHX6" title="Total"&gt;27,250&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_909_eifrs-full--FinancialAssets_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--OtherReceivablesMember_zv0RnNCejEUb" title="Total"&gt;33,411&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Long-term bank deposit&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90E_eifrs-full--FinancialAssets_iI_pn3n3_c20260630__ifrs-full--ClassesOfFinancialAssetsAxis__custom--LongtermBankDepositMember_zOFVhcIjYLg7" title="Total"&gt;30,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90F_eifrs-full--FinancialAssets_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--LongtermBankDepositMember_ztBkncs1Aqth" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6961"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Long-term loan receivable, net&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90D_eifrs-full--FinancialAssets_iI_pn3n3_c20260630__ifrs-full--ClassesOfFinancialAssetsAxis__custom--LongTermLoanReceivableNetMember_za04wVPKacTj" title="Total"&gt;1,958,880&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_900_eifrs-full--FinancialAssets_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--LongTermLoanReceivableNetMember_zuZYAzIqFfYa" title="Total"&gt;1,671,780&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Long-term other receivables, net&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90A_eifrs-full--FinancialAssets_iI_pn3n3_c20260630__ifrs-full--ClassesOfFinancialAssetsAxis__custom--LongTermOtherReceivablesNetMember_zIIiiekAYzg1" title="Total"&gt;398&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90F_eifrs-full--FinancialAssets_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--LongTermOtherReceivablesNetMember_z9knDqOl9Gl4" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6969"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Other non-current financial assets&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_901_eifrs-full--FinancialAssets_iI_pn3n3_c20260630__ifrs-full--ClassesOfFinancialAssetsAxis__custom--OtherNoncurrentFinancialAssetsMember_zz6Cr8u0YRi2" title="Total"&gt;519,945&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90D_eifrs-full--FinancialAssets_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--OtherNoncurrentFinancialAssetsMember_zxn1IRL3nnN" title="Total"&gt;525,042&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90E_eifrs-full--FinancialAssets_iI_pn3n3_c20260630_zg8xNDsBKYt1" title="Total"&gt;3,410,844&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_901_eifrs-full--FinancialAssets_iI_pn3n3_c20251231_zqVVuqve7iFg" title="Total"&gt;3,038,941&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;June&#160;30,&lt;br/&gt;2026&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2025&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="6" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td colspan="11" style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Financial liabilities at amortized cost&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Accounts payable - other (*)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_903_eifrs-full--FinancialLiabilities_iI_pn3n3_c20260630__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableOtherMember_fKCop_zzlG3GWENtBe" title="Total"&gt;1,755,551&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_909_eifrs-full--FinancialLiabilities_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableOtherMember_fKCop_zTaCwe3BPbT8" title="Total"&gt;1,374,936&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Bond with warrants&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_901_eifrs-full--FinancialLiabilities_iI_pn3n3_c20260630__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--BondWithWarrantsNetMember_zT3Wa4RkQpSl" title="Total"&gt;3,209,760&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90A_eifrs-full--FinancialLiabilities_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--BondWithWarrantsNetMember_zPI9L8x6hoPk" title="Total"&gt;3,265,312&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Lease liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_904_eifrs-full--FinancialLiabilities_iI_pn3n3_c20260630__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--LeaseLiabilitiesMember_zX8DPzSh0PWd" title="Total"&gt;479,785&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90D_eifrs-full--FinancialLiabilities_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--LeaseLiabilitiesMember_zqKlozNX8Ek" title="Total"&gt;552,631&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Short-term borrowings&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_903_eifrs-full--FinancialLiabilities_iI_pn3n3_c20260630__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--ShorttermBorrowingsMember_zLs3DyrLSXUe" title="Total"&gt;1,000,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_907_eifrs-full--FinancialLiabilities_iI_pn3n3_c20250630__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--ShorttermBorrowingsMember_zRvLSmfGxGGa" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6993"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td colspan="11" style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Financial liabilities at fair value through profit or loss&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Derivative liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_908_eifrs-full--FinancialLiabilities_iI_pn3n3_c20260630__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--DerivativeLiabilitiesMember_zTtvFfse9G28" title="Total"&gt;979,969&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_906_eifrs-full--FinancialLiabilities_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--DerivativeLiabilitiesMember_zTsfjaB3669g" title="Total"&gt;1,267,801&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_907_eifrs-full--FinancialLiabilities_iI_pn3n3_c20260630_zhgAMN9idQRk" title="Total"&gt;7,425,065&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90A_eifrs-full--FinancialLiabilities_iI_pn3n3_c20251231_z4FFiUlnsop1" title="Total"&gt;6,460,680&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;div style="margin: 0pt auto 0pt 0; font-family: Times New Roman, Times, Serif; width: 25%"&gt;&lt;div style="border-top: Black 1pt solid; font: 1pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"&gt;&lt;span id="xdx_F02_z0bzI4CstDe8" style="font-family: Times New Roman, Times, Serif"&gt;(*)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F1A_zzmOrKo9lRgf" style="font-family: Times New Roman, Times, Serif"&gt;Accounts payable that are not financial liabilities are excluded.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A6_z7JlkqqGIN1f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The net gains and losses by category of financial instruments for the six-month periods ended June&#160;30, 2026 and 2025 are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89E_ecustom--ScheduleOfNetGainsAndLossesByCategoryOfFinancialInstrumentsTableTextBlock_pn3n3_zdrd4La139b5" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Financial instruments by category (Details 1)"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_8B5_z2Pp8So6Qs05" style="display: none"&gt;Schedule of net gains and losses by category of financial instruments&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_492_20260101__20260630__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostCategoryMember_zBYWVZ0fULs3" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_495_20260101__20260630__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember_zEmhKnSgmjuj" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49C_20260101__20260630__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember_ztYi1bsaiGw9" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_497_20260101__20260630_ztjzWxlTxiz4" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="14" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Six-month period ended June&#160;30, 2026&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Financial&lt;br/&gt;assets at&lt;br/&gt;amortized cost&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Financial&lt;br/&gt;liabilities at&lt;br/&gt;amortized cost&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Financial&lt;br/&gt;liabilities at&lt;br/&gt;fair value through&lt;br/&gt;profit or loss&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="14" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr id="xdx_400_eifrs-full--AdjustmentsForInterestIncome_pn3n3_zYOYmGGSfnUc" style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Interest income&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;109,493&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7007"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7008"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;109,493&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_403_eifrs-full--InterestExpense_iN_pn3n3_di_z1w1klP4Q6s1" style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Interest expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7011"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(351,045&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7013"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(351,045&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_403_eifrs-full--GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_pn3n3_zIUG2VstDB0j" style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Foreign currency differences&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,899&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(66,795&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7018"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(61,896&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--GainsOnDisposal_iP3ifrs-full--GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_pn3n3_zmQOdISzraw4" style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Gains on disposal&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,560&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7022"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7023"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,560&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--GainOnValuation_pn3n3_zesawrnzMH2b" style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Gains on valuation&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7026"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7027"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;117,845&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;117,845&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--LossesOnRepayment_iP3custom--GainOnValuation_pn3n3_z4r5UMnDAr67" style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Losses on repayment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7031"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(12&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7033"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(12&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--LossesOnValuation_iP3custom--LossesOnRepayment_pn3n3_zRBuSNeEoWic" style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Losses on valuation&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7036"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7037"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(57,213&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(57,213&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--Total_pn3n3_zzoOSKaXbyp8" style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;117,952&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(417,852&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;60,632&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(239,268&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

















&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49F_20250101__20250630__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostCategoryMember_znm1VjuZV2Xe" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49B_20250101__20250630__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember_z6nQHaU6FWX2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_493_20250101__20250630__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember_zwFmH8jXSMU4" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49E_20250101__20250630_zzEZx0pDL5h2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="14" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Six-month period ended June&#160;30, 2025&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Financial&lt;br/&gt;assets at&lt;br/&gt;amortized cost&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Financial&lt;br/&gt;liabilities at&lt;br/&gt;amortized cost&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Financial&lt;br/&gt;liabilities at&lt;br/&gt;fair value through&lt;br/&gt;profit or loss&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="14" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40D_eifrs-full--AdjustmentsForInterestIncome_pn3n3_z6puxZhOwsY5" style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Interest income&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;121,109&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7054"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7055"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;121,109&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_409_eifrs-full--InterestExpense_iN_pn3n3_di_zlLKviMPX095" style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Interest expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7058"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(385,423&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7060"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(385,423&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40A_eifrs-full--GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_pn3n3_z3SwBw30arhl" style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Foreign currency differences&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;20,439&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(4,530&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7065"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;15,909&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--GainOnValuation_pn3n3_zUZqdMyjX9cc" style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Gains on valuation&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7068"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7069"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;309,333&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;309,333&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--LossesOnRepayment_pn3n3_zXUb3IQ570Ga" style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Losses on repayment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7073"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(17,292&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7075"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(17,292&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--Total_pn3n3_zF7Tlx3wuzDj" style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;141,548&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(407,245&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;309,333&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;43,636&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A3_zAvvh3yDOVA8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</cik0002058261:FinancialInstrumentsByCategoryTextBlock>
    <cik0002058261:FinancialInstrumentsByCategoryTableTextBlock
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      id="Fact006941">&lt;table cellpadding="0" cellspacing="0" id="xdx_894_ecustom--FinancialInstrumentsByCategoryTableTextBlock_pn3n3_zHYSL3FyZCdb" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Financial instruments by category (Details)"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_8B0_znbMnIL9GB2a" style="display: none"&gt;Schedule of financial instruments by category&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;June&#160;30,&lt;br/&gt;2026&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2025&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="6" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Financial assets at amortized cost&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90E_eifrs-full--FinancialAssets_iI_pn3n3_c20260630__ifrs-full--ClassesOfFinancialAssetsAxis__custom--CashAndCashEquivalentMember_zgTcJYd8Xgp6" title="Total"&gt;312,427&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_902_eifrs-full--FinancialAssets_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--CashAndCashEquivalentMember_zjyxErsK5aVk" title="Total"&gt;335,814&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Current portion of long-term bank deposit&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_903_eifrs-full--FinancialAssets_iI_pn3n3_c20260630__ifrs-full--ClassesOfFinancialAssetsAxis__custom--CurrentPortionOfLongTermBankDepositMember_zpAvnktz32ua" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6947"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90A_eifrs-full--FinancialAssets_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--CurrentPortionOfLongTermBankDepositMember_z53KhKrZKgzk" title="Total"&gt;30,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Short-term loan receivable, net&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90B_eifrs-full--FinancialAssets_iI_pn3n3_c20260630__ifrs-full--ClassesOfFinancialAssetsAxis__custom--ShortTermLoanReceivableNetMember_zpTh1wjJ3Acd" title="Total"&gt;561,944&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90D_eifrs-full--FinancialAssets_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--ShortTermLoanReceivableNetMember_z0hsZfDg13ze" title="Total"&gt;442,894&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Other receivables&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90F_eifrs-full--FinancialAssets_iI_pn3n3_c20260630__ifrs-full--ClassesOfFinancialAssetsAxis__custom--OtherReceivablesMember_z63a29ZyoHX6" title="Total"&gt;27,250&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_909_eifrs-full--FinancialAssets_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--OtherReceivablesMember_zv0RnNCejEUb" title="Total"&gt;33,411&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Long-term bank deposit&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90E_eifrs-full--FinancialAssets_iI_pn3n3_c20260630__ifrs-full--ClassesOfFinancialAssetsAxis__custom--LongtermBankDepositMember_zOFVhcIjYLg7" title="Total"&gt;30,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90F_eifrs-full--FinancialAssets_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--LongtermBankDepositMember_ztBkncs1Aqth" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6961"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Long-term loan receivable, net&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90D_eifrs-full--FinancialAssets_iI_pn3n3_c20260630__ifrs-full--ClassesOfFinancialAssetsAxis__custom--LongTermLoanReceivableNetMember_za04wVPKacTj" title="Total"&gt;1,958,880&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_900_eifrs-full--FinancialAssets_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--LongTermLoanReceivableNetMember_zuZYAzIqFfYa" title="Total"&gt;1,671,780&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Long-term other receivables, net&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90A_eifrs-full--FinancialAssets_iI_pn3n3_c20260630__ifrs-full--ClassesOfFinancialAssetsAxis__custom--LongTermOtherReceivablesNetMember_zIIiiekAYzg1" title="Total"&gt;398&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90F_eifrs-full--FinancialAssets_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--LongTermOtherReceivablesNetMember_z9knDqOl9Gl4" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6969"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Other non-current financial assets&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_901_eifrs-full--FinancialAssets_iI_pn3n3_c20260630__ifrs-full--ClassesOfFinancialAssetsAxis__custom--OtherNoncurrentFinancialAssetsMember_zz6Cr8u0YRi2" title="Total"&gt;519,945&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90D_eifrs-full--FinancialAssets_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--OtherNoncurrentFinancialAssetsMember_zxn1IRL3nnN" title="Total"&gt;525,042&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90E_eifrs-full--FinancialAssets_iI_pn3n3_c20260630_zg8xNDsBKYt1" title="Total"&gt;3,410,844&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_901_eifrs-full--FinancialAssets_iI_pn3n3_c20251231_zqVVuqve7iFg" title="Total"&gt;3,038,941&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;June&#160;30,&lt;br/&gt;2026&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2025&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="6" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td colspan="11" style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Financial liabilities at amortized cost&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Accounts payable - other (*)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_903_eifrs-full--FinancialLiabilities_iI_pn3n3_c20260630__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableOtherMember_fKCop_zzlG3GWENtBe" title="Total"&gt;1,755,551&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_909_eifrs-full--FinancialLiabilities_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableOtherMember_fKCop_zTaCwe3BPbT8" title="Total"&gt;1,374,936&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Bond with warrants&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_901_eifrs-full--FinancialLiabilities_iI_pn3n3_c20260630__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--BondWithWarrantsNetMember_zT3Wa4RkQpSl" title="Total"&gt;3,209,760&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90A_eifrs-full--FinancialLiabilities_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--BondWithWarrantsNetMember_zPI9L8x6hoPk" title="Total"&gt;3,265,312&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Lease liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_904_eifrs-full--FinancialLiabilities_iI_pn3n3_c20260630__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--LeaseLiabilitiesMember_zX8DPzSh0PWd" title="Total"&gt;479,785&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90D_eifrs-full--FinancialLiabilities_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--LeaseLiabilitiesMember_zqKlozNX8Ek" title="Total"&gt;552,631&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Short-term borrowings&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_903_eifrs-full--FinancialLiabilities_iI_pn3n3_c20260630__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--ShorttermBorrowingsMember_zLs3DyrLSXUe" title="Total"&gt;1,000,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_907_eifrs-full--FinancialLiabilities_iI_pn3n3_c20250630__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--ShorttermBorrowingsMember_zRvLSmfGxGGa" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl6993"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td colspan="11" style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Financial liabilities at fair value through profit or loss&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Derivative liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_908_eifrs-full--FinancialLiabilities_iI_pn3n3_c20260630__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--DerivativeLiabilitiesMember_zTtvFfse9G28" title="Total"&gt;979,969&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_906_eifrs-full--FinancialLiabilities_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--DerivativeLiabilitiesMember_zTsfjaB3669g" title="Total"&gt;1,267,801&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_907_eifrs-full--FinancialLiabilities_iI_pn3n3_c20260630_zhgAMN9idQRk" title="Total"&gt;7,425,065&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90A_eifrs-full--FinancialLiabilities_iI_pn3n3_c20251231_z4FFiUlnsop1" title="Total"&gt;6,460,680&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;div style="margin: 0pt auto 0pt 0; font-family: Times New Roman, Times, Serif; width: 25%"&gt;&lt;div style="border-top: Black 1pt solid; font: 1pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"&gt;&lt;span id="xdx_F02_z0bzI4CstDe8" style="font-family: Times New Roman, Times, Serif"&gt;(*)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F1A_zzmOrKo9lRgf" style="font-family: Times New Roman, Times, Serif"&gt;Accounts payable that are not financial liabilities are excluded.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:FinancialInstrumentsByCategoryTableTextBlock>
    <ifrs-full:FinancialAssets
      contextRef="AsOf2026-06-30_custom_CashAndCashEquivalentMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006943"
      unitRef="KRW">312427000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="AsOf2025-12-31_custom_CashAndCashEquivalentMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006945"
      unitRef="KRW">335814000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="AsOf2025-12-31_custom_CurrentPortionOfLongTermBankDepositMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006949"
      unitRef="KRW">30000000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="AsOf2026-06-30_custom_ShortTermLoanReceivableNetMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006951"
      unitRef="KRW">561944000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="AsOf2025-12-31_custom_ShortTermLoanReceivableNetMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006953"
      unitRef="KRW">442894000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="AsOf2026-06-30_custom_OtherReceivablesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006955"
      unitRef="KRW">27250000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="AsOf2025-12-31_custom_OtherReceivablesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006957"
      unitRef="KRW">33411000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="AsOf2026-06-30_custom_LongtermBankDepositMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006959"
      unitRef="KRW">30000000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="AsOf2026-06-30_custom_LongTermLoanReceivableNetMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006963"
      unitRef="KRW">1958880000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="AsOf2025-12-31_custom_LongTermLoanReceivableNetMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006965"
      unitRef="KRW">1671780000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="AsOf2026-06-30_custom_LongTermOtherReceivablesNetMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006967"
      unitRef="KRW">398000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="AsOf2026-06-30_custom_OtherNoncurrentFinancialAssetsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006971"
      unitRef="KRW">519945000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="AsOf2025-12-31_custom_OtherNoncurrentFinancialAssetsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006973"
      unitRef="KRW">525042000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="AsOf2026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006975"
      unitRef="KRW">3410844000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006977"
      unitRef="KRW">3038941000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2026-06-30_custom_AccountsPayableOtherMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006979"
      unitRef="KRW">1755551000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2025-12-31_custom_AccountsPayableOtherMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006981"
      unitRef="KRW">1374936000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2026-06-30_custom_BondWithWarrantsNetMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006983"
      unitRef="KRW">3209760000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2025-12-31_custom_BondWithWarrantsNetMember_custom_CubebioCo.Ltd.Member273629718"
      decimals="-3"
      id="Fact006985"
      unitRef="KRW">3265312000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2026-06-30_ifrs-full_LeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006987"
      unitRef="KRW">479785000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2025-12-31_ifrs-full_LeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member273629718"
      decimals="-3"
      id="Fact006989"
      unitRef="KRW">552631000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2026-06-30_ifrs-full_ShorttermBorrowingsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006991"
      unitRef="KRW">1000000000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2026-06-30_custom_DerivativeLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006995"
      unitRef="KRW">979969000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2025-12-31_custom_DerivativeLiabilitiesMember_custom_CubebioCo.Ltd.Member273629734"
      decimals="-3"
      id="Fact006997"
      unitRef="KRW">1267801000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact006999"
      unitRef="KRW">7425065000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007001"
      unitRef="KRW">6460680000</ifrs-full:FinancialLiabilities>
    <cik0002058261:ScheduleOfNetGainsAndLossesByCategoryOfFinancialInstrumentsTableTextBlock
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      id="Fact007004">&lt;table cellpadding="0" cellspacing="0" id="xdx_89E_ecustom--ScheduleOfNetGainsAndLossesByCategoryOfFinancialInstrumentsTableTextBlock_pn3n3_zdrd4La139b5" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Financial instruments by category (Details 1)"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_8B5_z2Pp8So6Qs05" style="display: none"&gt;Schedule of net gains and losses by category of financial instruments&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_492_20260101__20260630__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostCategoryMember_zBYWVZ0fULs3" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_495_20260101__20260630__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember_zEmhKnSgmjuj" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49C_20260101__20260630__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember_ztYi1bsaiGw9" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_497_20260101__20260630_ztjzWxlTxiz4" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="14" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Six-month period ended June&#160;30, 2026&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Financial&lt;br/&gt;assets at&lt;br/&gt;amortized cost&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Financial&lt;br/&gt;liabilities at&lt;br/&gt;amortized cost&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Financial&lt;br/&gt;liabilities at&lt;br/&gt;fair value through&lt;br/&gt;profit or loss&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="14" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr id="xdx_400_eifrs-full--AdjustmentsForInterestIncome_pn3n3_zYOYmGGSfnUc" style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Interest income&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;109,493&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7007"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7008"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;109,493&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_403_eifrs-full--InterestExpense_iN_pn3n3_di_z1w1klP4Q6s1" style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Interest expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7011"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(351,045&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7013"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(351,045&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_403_eifrs-full--GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_pn3n3_zIUG2VstDB0j" style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Foreign currency differences&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,899&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(66,795&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7018"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(61,896&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--GainsOnDisposal_iP3ifrs-full--GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_pn3n3_zmQOdISzraw4" style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Gains on disposal&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,560&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7022"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7023"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,560&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--GainOnValuation_pn3n3_zesawrnzMH2b" style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Gains on valuation&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7026"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7027"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;117,845&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;117,845&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--LossesOnRepayment_iP3custom--GainOnValuation_pn3n3_z4r5UMnDAr67" style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Losses on repayment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7031"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(12&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7033"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(12&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--LossesOnValuation_iP3custom--LossesOnRepayment_pn3n3_zRBuSNeEoWic" style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Losses on valuation&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7036"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7037"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(57,213&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(57,213&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--Total_pn3n3_zzoOSKaXbyp8" style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;117,952&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(417,852&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;60,632&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(239,268&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

















&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49F_20250101__20250630__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostCategoryMember_znm1VjuZV2Xe" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49B_20250101__20250630__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember_z6nQHaU6FWX2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_493_20250101__20250630__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember_zwFmH8jXSMU4" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49E_20250101__20250630_zzEZx0pDL5h2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="14" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Six-month period ended June&#160;30, 2025&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Financial&lt;br/&gt;assets at&lt;br/&gt;amortized cost&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Financial&lt;br/&gt;liabilities at&lt;br/&gt;amortized cost&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Financial&lt;br/&gt;liabilities at&lt;br/&gt;fair value through&lt;br/&gt;profit or loss&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="14" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40D_eifrs-full--AdjustmentsForInterestIncome_pn3n3_z6puxZhOwsY5" style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Interest income&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;121,109&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7054"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7055"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;121,109&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_409_eifrs-full--InterestExpense_iN_pn3n3_di_zlLKviMPX095" style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Interest expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7058"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(385,423&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7060"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(385,423&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40A_eifrs-full--GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_pn3n3_z3SwBw30arhl" style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Foreign currency differences&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;20,439&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(4,530&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7065"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;15,909&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--GainOnValuation_pn3n3_zUZqdMyjX9cc" style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Gains on valuation&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7068"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7069"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;309,333&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;309,333&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--LossesOnRepayment_pn3n3_zXUb3IQ570Ga" style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Losses on repayment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7073"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(17,292&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7075"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(17,292&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--Total_pn3n3_zF7Tlx3wuzDj" style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;141,548&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(407,245&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;309,333&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;43,636&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:ScheduleOfNetGainsAndLossesByCategoryOfFinancialInstrumentsTableTextBlock>
    <ifrs-full:AdjustmentsForInterestIncome
      contextRef="From2026-01-012026-06-30_ifrs-full_FinancialAssetsAtAmortisedCostCategoryMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007006"
      unitRef="KRW">109493000</ifrs-full:AdjustmentsForInterestIncome>
    <ifrs-full:AdjustmentsForInterestIncome
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007009"
      unitRef="KRW">109493000</ifrs-full:AdjustmentsForInterestIncome>
    <ifrs-full:InterestExpense
      contextRef="From2026-01-012026-06-30_ifrs-full_FinancialLiabilitiesAtAmortisedCostCategoryMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007012"
      unitRef="KRW">351045000</ifrs-full:InterestExpense>
    <ifrs-full:InterestExpense
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007014"
      unitRef="KRW">351045000</ifrs-full:InterestExpense>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss
      contextRef="From2026-01-012026-06-30_ifrs-full_FinancialAssetsAtAmortisedCostCategoryMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007016"
      unitRef="KRW">4899000</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss
      contextRef="From2026-01-012026-06-30_ifrs-full_FinancialLiabilitiesAtAmortisedCostCategoryMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007017"
      unitRef="KRW">-66795000</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007019"
      unitRef="KRW">-61896000</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss>
    <cik0002058261:GainsOnDisposal
      contextRef="From2026-01-012026-06-30_ifrs-full_FinancialAssetsAtAmortisedCostCategoryMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007021"
      unitRef="KRW">3560000</cik0002058261:GainsOnDisposal>
    <cik0002058261:GainsOnDisposal
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007024"
      unitRef="KRW">3560000</cik0002058261:GainsOnDisposal>
    <cik0002058261:GainOnValuation
      contextRef="From2026-01-012026-06-30_ifrs-full_FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007028"
      unitRef="KRW">117845000</cik0002058261:GainOnValuation>
    <cik0002058261:GainOnValuation
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007029"
      unitRef="KRW">117845000</cik0002058261:GainOnValuation>
    <cik0002058261:LossesOnRepayment
      contextRef="From2026-01-012026-06-30_ifrs-full_FinancialLiabilitiesAtAmortisedCostCategoryMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007032"
      unitRef="KRW">-12000</cik0002058261:LossesOnRepayment>
    <cik0002058261:LossesOnRepayment
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007034"
      unitRef="KRW">-12000</cik0002058261:LossesOnRepayment>
    <cik0002058261:LossesOnValuation
      contextRef="From2026-01-012026-06-30_ifrs-full_FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007038"
      unitRef="KRW">-57213000</cik0002058261:LossesOnValuation>
    <cik0002058261:LossesOnValuation
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007039"
      unitRef="KRW">-57213000</cik0002058261:LossesOnValuation>
    <cik0002058261:Total
      contextRef="From2026-01-012026-06-30_ifrs-full_FinancialAssetsAtAmortisedCostCategoryMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007041"
      unitRef="KRW">117952000</cik0002058261:Total>
    <cik0002058261:Total
      contextRef="From2026-01-012026-06-30_ifrs-full_FinancialLiabilitiesAtAmortisedCostCategoryMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007042"
      unitRef="KRW">-417852000</cik0002058261:Total>
    <cik0002058261:Total
      contextRef="From2026-01-012026-06-30_ifrs-full_FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007043"
      unitRef="KRW">60632000</cik0002058261:Total>
    <cik0002058261:Total
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007044"
      unitRef="KRW">-239268000</cik0002058261:Total>
    <ifrs-full:AdjustmentsForInterestIncome
      contextRef="From2025-01-012025-06-30_ifrs-full_FinancialAssetsAtAmortisedCostCategoryMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007053"
      unitRef="KRW">121109000</ifrs-full:AdjustmentsForInterestIncome>
    <ifrs-full:AdjustmentsForInterestIncome
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007056"
      unitRef="KRW">121109000</ifrs-full:AdjustmentsForInterestIncome>
    <ifrs-full:InterestExpense
      contextRef="From2025-01-012025-06-30_ifrs-full_FinancialLiabilitiesAtAmortisedCostCategoryMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007059"
      unitRef="KRW">385423000</ifrs-full:InterestExpense>
    <ifrs-full:InterestExpense
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007061"
      unitRef="KRW">385423000</ifrs-full:InterestExpense>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss
      contextRef="From2025-01-012025-06-30_ifrs-full_FinancialAssetsAtAmortisedCostCategoryMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007063"
      unitRef="KRW">20439000</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss
      contextRef="From2025-01-012025-06-30_ifrs-full_FinancialLiabilitiesAtAmortisedCostCategoryMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007064"
      unitRef="KRW">-4530000</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007066"
      unitRef="KRW">15909000</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss>
    <cik0002058261:GainOnValuation
      contextRef="From2025-01-012025-06-30_ifrs-full_FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007070"
      unitRef="KRW">309333000</cik0002058261:GainOnValuation>
    <cik0002058261:GainOnValuation
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007071"
      unitRef="KRW">309333000</cik0002058261:GainOnValuation>
    <cik0002058261:LossesOnRepayment
      contextRef="From2025-01-012025-06-30_ifrs-full_FinancialLiabilitiesAtAmortisedCostCategoryMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007074"
      unitRef="KRW">-17292000</cik0002058261:LossesOnRepayment>
    <cik0002058261:LossesOnRepayment
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007076"
      unitRef="KRW">-17292000</cik0002058261:LossesOnRepayment>
    <cik0002058261:Total
      contextRef="From2025-01-012025-06-30_ifrs-full_FinancialAssetsAtAmortisedCostCategoryMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007078"
      unitRef="KRW">141548000</cik0002058261:Total>
    <cik0002058261:Total
      contextRef="From2025-01-012025-06-30_ifrs-full_FinancialLiabilitiesAtAmortisedCostCategoryMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007079"
      unitRef="KRW">-407245000</cik0002058261:Total>
    <cik0002058261:Total
      contextRef="From2025-01-012025-06-30_ifrs-full_FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007080"
      unitRef="KRW">309333000</cik0002058261:Total>
    <cik0002058261:Total
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007081"
      unitRef="KRW">43636000</cik0002058261:Total>
    <cik0002058261:CapitalAndOtherComponentsOfEquityTextBlock
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      id="Fact007083">&lt;p id="xdx_802_ecustom--CapitalAndOtherComponentsOfEquityTextBlock_zisbUcMZa4Dd" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;22. &lt;span id="xdx_82D_zthwEjzlGn39"&gt;Capital and other components of equity&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;A.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Share capital&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Details of share capital as of June&#160;30, 2026 and December&#160;31, 2025 are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_897_ecustom--ScheduleOfShareCapitalTableTextBlock_pn3n3_zz5IcOonx6f1" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Capital and other components of equity (Details)"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_8BA_zu2aSNkzIsIc" style="display: none"&gt;Schedule of share capital&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_496_20260630_zQq449H7j3ue" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_490_20251231_zY23a7yJNep3" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;June&#160;30,&lt;br/&gt;2026&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2025&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="6" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;(In Korean&#160;won and number of shares)&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--NumberOfAuthorizedShares_iI_pid_zJlwP4mYsnaf" style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Number of authorized shares&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,000,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,000,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_400_eifrs-full--ParValuePerShare_iI_pid_z1yvqdodVqj7" style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Value per share&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;500&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;500&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40E_eifrs-full--NumberOfSharesIssued_iI_pid_zwIdEMKVli2b" style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Number of shares issued&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;52,815,475&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;52,815,475&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--CommonShares_iI_pid_zGCfC7d4enA8" style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Common shares&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;26,407,737,500&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;26,407,737,500&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AC_zYxUM9lv8BG9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Holders of these shares are entitled to dividends as declared from time to time and are entitled to one vote per share at the general meetings of the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;B.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Other components of equity&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;i.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Details of other components of equity, net of taxes, as of June&#160;30, 2026 and 2025 are as follows:&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_896_ecustom--DetailsOfOtherComponentsOfEquityNetOfTaxesTableTextBlock_pn3n3_z7Z53daKyw47" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Capital and other components of equity (Details 1)"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span id="xdx_8B5_zNzQo61sBF97" style="display: none"&gt;Details of other components of equity, net of taxes&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" id="xdx_491_20260630_zXuTVEYTrdQd" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;June&#160;30,&lt;br/&gt;2026&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" id="xdx_494_20251231_zmGb0M8sgBb3" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2025&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="6" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--OtherReservesAbstract_iB_zybUKxeFBPW" style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Other reserves&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--EmployeeShareOptions_i01I_pn3n3_zsIs1Q9X32Pg" style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Employee share options&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;724,661&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;724,661&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_400_eifrs-full--TreasuryShares_iNI_pn3n3_di_zkbT0CMcLLNk" style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Treasury shares&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(1,400,188&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(1,414,953&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--Subtotal_iI_pn3n3_zixQ7pTJidJ9" style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(675,527&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(690,292&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_409_eifrs-full--OtherComprehensiveIncomeAbstract_iB_zh4RWJzuSMT5" style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Other comprehensive income&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_409_eifrs-full--ReserveOfRemeasurementsOfDefinedBenefitPlans_iI_pn3n3_zXVuEpQVqIL5" style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Remeasurements of defined benefit liability&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;279,386&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;125,654&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--OtherComprehensiveIncomeSubtotal_iI_pn3n3_zLM6L7ygd9Vf" style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;279,386&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;125,654&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--SharePremiumAndOtherComponentsOfEquity_iI_pn3n3_zLM9juNusfNf" style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(396,141&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(564,638&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A3_zeR3KaRkoRK3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

















&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;ii.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Changes in other components of equity for the periods ended June&#160;30, 2026 and 2025 are as follows:&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_895_ecustom--ChangesInOtherComponentsOfEquityTableTextBlock_pn3n3_zuaq9dgUPTkg" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Capital and other components of equity (Details 2)"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_8BD_zZIMhv81lFak" style="display: none"&gt;Changes in other components of equity&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Remeasurements&lt;br/&gt;of defined&lt;br/&gt;benefit liability&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Employee share&lt;br/&gt;options&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Treasury&lt;br/&gt;shares&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="14" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Balance as of January&#160;1, 2025&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_904_ecustom--OtherEquity_iS_pn3n3_c20250101__20250630__ifrs-full--ComponentsOfEquityAxis__custom--RemeasurementsOfDefinedBenefitLiabilityMember_zr5ngXQGiUrf" title="Balance at beginning"&gt;73,533&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90D_ecustom--OtherEquity_iS_pn3n3_c20250101__20250630__ifrs-full--ComponentsOfEquityAxis__custom--EmployeeShareOptionMember_zMvbrBB4Rwji" title="Balance at beginning"&gt;724,661&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_904_ecustom--OtherEquity_iS_pn3n3_c20250101__20250630__ifrs-full--ComponentsOfEquityAxis__ifrs-full--TreasurySharesMember_zsTR2ZdFtIU2" title="Balance at beginning"&gt;(1,451,864&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90B_ecustom--OtherEquity_iS_pn3n3_c20250101__20250630_zJiF3XtMw2Ua" title="Balance at beginning"&gt;(653,670&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Changes, net of taxes&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_908_ecustom--ChangesNetOfTaxes_iN_pn3n3_di_c20250101__20250630__ifrs-full--ComponentsOfEquityAxis__custom--RemeasurementsOfDefinedBenefitLiabilityMember_zhcdPjyAwIFj" title="Changes, net of taxes"&gt;26,061&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90F_ecustom--ChangesNetOfTaxes_iN_pn3n3_di_c20250101__20250630__ifrs-full--ComponentsOfEquityAxis__custom--EmployeeShareOptionMember_zbgt1amRov28" title="Changes, net of taxes"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7144"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_909_ecustom--ChangesNetOfTaxes_iN_pn3n3_di_c20250101__20250630__ifrs-full--ComponentsOfEquityAxis__ifrs-full--TreasurySharesMember_zFkf411WoMga" title="Changes, net of taxes"&gt;36,911&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_901_ecustom--ChangesNetOfTaxes_iN_pn3n3_di_c20250101__20250630_zJptOIMttiHd" title="Changes, net of taxes"&gt;62,972&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Balance as of June&#160;30, 2025&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90D_ecustom--OtherEquity_iE_pn3n3_c20250101__20250630__ifrs-full--ComponentsOfEquityAxis__custom--RemeasurementsOfDefinedBenefitLiabilityMember_z1c0dDLde5df" title="Balance at ending"&gt;99,594&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_907_ecustom--OtherEquity_iE_pn3n3_c20250101__20250630__ifrs-full--ComponentsOfEquityAxis__custom--EmployeeShareOptionMember_zjr1nk0BVIsf" title="Balance at ending"&gt;724,661&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_907_ecustom--OtherEquity_iE_pn3n3_c20250101__20250630__ifrs-full--ComponentsOfEquityAxis__ifrs-full--TreasurySharesMember_zyCrozuS3ihd" title="Balance at ending"&gt;(1,414,953&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90F_ecustom--OtherEquity_iE_pn3n3_c20250101__20250630_zrhQy4Ha2Mzi" title="Balance at ending"&gt;(590,698&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Balance as of January&#160;1, 2026&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_904_ecustom--OtherEquity_iS_pn3n3_c20260101__20260630__ifrs-full--ComponentsOfEquityAxis__custom--RemeasurementsOfDefinedBenefitLiabilityMember_zOBMQFffkrji" title="Balance at beginning"&gt;125,654&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_901_ecustom--OtherEquity_iS_pn3n3_c20260101__20260630__ifrs-full--ComponentsOfEquityAxis__custom--EmployeeShareOptionMember_zqHuih1A9Cxf" title="Balance at beginning"&gt;724,661&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90E_ecustom--OtherEquity_iS_pn3n3_c20260101__20260630__ifrs-full--ComponentsOfEquityAxis__ifrs-full--TreasurySharesMember_z6EmdjkXZfC9" title="Balance at beginning"&gt;(1,414,953&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90F_ecustom--OtherEquity_iS_pn3n3_c20260101__20260630_zXYVP6NnXKj9" title="Balance at beginning"&gt;(564,638&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Changes, net of taxes&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_903_ecustom--ChangesNetOfTaxes_iN_pn3n3_di_c20260101__20260630__ifrs-full--ComponentsOfEquityAxis__custom--RemeasurementsOfDefinedBenefitLiabilityMember_zpkw7P65fs5a" title="Changes, net of taxes"&gt;153,732&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_909_ecustom--ChangesNetOfTaxes_iN_pn3n3_di_c20260101__20260630__ifrs-full--ComponentsOfEquityAxis__custom--EmployeeShareOptionMember_zajd9JP2Lnnj" title="Changes, net of taxes"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7168"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_903_ecustom--ChangesNetOfTaxes_iN_pn3n3_di_c20260101__20260630__ifrs-full--ComponentsOfEquityAxis__ifrs-full--TreasurySharesMember_zTdVGvZd2rR" title="Changes, net of taxes"&gt;14,765&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90B_ecustom--ChangesNetOfTaxes_iN_pn3n3_di_c20260101__20260630_zq8LalT7c22g" title="Changes, net of taxes"&gt;168,497&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Balance as of June&#160;30, 2026&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90F_ecustom--OtherEquity_iE_pn3n3_c20260101__20260630__ifrs-full--ComponentsOfEquityAxis__custom--RemeasurementsOfDefinedBenefitLiabilityMember_zNJTQnyZYkji" title="Balance at ending"&gt;279,386&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_905_ecustom--OtherEquity_iE_pn3n3_c20260101__20260630__ifrs-full--ComponentsOfEquityAxis__custom--EmployeeShareOptionMember_zKILN2wFDYre" title="Balance at ending"&gt;724,661&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_902_ecustom--OtherEquity_iE_pn3n3_c20260101__20260630__ifrs-full--ComponentsOfEquityAxis__ifrs-full--TreasurySharesMember_zazGbTEMeXg9" title="Balance at ending"&gt;(1,400,188&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_902_ecustom--OtherEquity_iE_pn3n3_c20260101__20260630_zfaauYQU3tYk" title="Balance at ending"&gt;(396,141&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A8_zNK02OyxLjdd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;iii.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Details of treasury shares for the six-month periods ended June&#160;30, 2026 and 2025 are as follows:&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--ScheduleOfTreasurySharesTableTextBlock_pn3n3_zCtTUA0njCs5" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Capital and other components of equity (Details 3)"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span id="xdx_8B2_zB9IL5J3Ouej" style="display: none"&gt;Schedule of treasury shares&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="7" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;June&#160;30,&lt;br/&gt;2026&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="7" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;June&#160;30,&lt;br/&gt;2025&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Number of&lt;br/&gt;shares&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; text-align: right; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Carrying&lt;br/&gt;amount&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Number&lt;br/&gt;of shares&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; text-align: right; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Carrying&lt;br/&gt;amount&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="16" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;(In thousands of Korean won and number of shares)&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 9%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_904_eifrs-full--NumberOfSharesOutstanding_iS_pid_c20260101__20260630__ifrs-full--ComponentsOfEquityAxis__ifrs-full--TreasurySharesMember_zOkWX4o8sfpl" title="Number of shares at beginning balance"&gt;3,833,400&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 9%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90D_ecustom--CarryingAmounts_iS_pn3n3_c20260101__20260630__ifrs-full--ComponentsOfEquityAxis__ifrs-full--TreasurySharesMember_zRljsWbJYsNl" title="Carrying amount at beginning balance"&gt;1,414,953&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 9%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_906_eifrs-full--NumberOfSharesOutstanding_iS_pid_c20250101__20250630__ifrs-full--ComponentsOfEquityAxis__ifrs-full--TreasurySharesMember_zcjJX6P0VLS9" title="Number of shares at beginning balance"&gt;3,933,400&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 9%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_906_ecustom--CarryingAmounts_iS_pn3n3_c20250101__20250630__ifrs-full--ComponentsOfEquityAxis__ifrs-full--TreasurySharesMember_zo1eYKW8Cq5d" title="Carrying amount at beginning balance"&gt;1,451,864&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Acquisition&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_901_ecustom--AcquisitionShares_pid_c20260101__20260630__ifrs-full--ComponentsOfEquityAxis__ifrs-full--TreasurySharesMember_zRLFWnmEc897" title="Acquisition, shares"&gt;0&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90B_ecustom--AcquisitionCarryingAmount_pn3n3_c20260101__20260630__ifrs-full--ComponentsOfEquityAxis__ifrs-full--TreasurySharesMember_zTpo6uWdUT1j" title="Acquisition carrying amount"&gt;0&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_904_ecustom--AcquisitionShares_pid_c20250101__20250630__ifrs-full--ComponentsOfEquityAxis__ifrs-full--TreasurySharesMember_z3gmwWhXBe58" title="Acquisition, shares"&gt;0&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_908_ecustom--AcquisitionCarryingAmount_pn3n3_c20250101__20250630__ifrs-full--ComponentsOfEquityAxis__ifrs-full--TreasurySharesMember_zHNP3yS4goy8" title="Acquisition carrying amount"&gt;0&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Disposal (*)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_909_ecustom--DisposalShares_pid_c20260101__20260630__ifrs-full--ComponentsOfEquityAxis__ifrs-full--TreasurySharesMember_fKCop_zZn8Du5XDLkh" title="Disposal, shares"&gt;40,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: right; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90B_ecustom--DisposalCarryingAmount_pn3n3_c20260101__20260630__ifrs-full--ComponentsOfEquityAxis__ifrs-full--TreasurySharesMember_fKCop_zolXLd5LAfgd" title="Disposal, carrying amount"&gt;14,765&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90F_ecustom--DisposalShares_pid_c20250101__20250630__ifrs-full--ComponentsOfEquityAxis__ifrs-full--TreasurySharesMember_fKCop_zqsPeFj7RW7g" title="Disposal, shares"&gt;100,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: right; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_903_ecustom--DisposalCarryingAmount_pn3n3_c20250101__20250630__ifrs-full--ComponentsOfEquityAxis__ifrs-full--TreasurySharesMember_fKCop_zdWoWCH9yVv7" title="Disposal, carrying amount"&gt;36,911&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90D_eifrs-full--NumberOfSharesOutstanding_iE_pid_c20260101__20260630__ifrs-full--ComponentsOfEquityAxis__ifrs-full--TreasurySharesMember_zP3rF8JlG4M1" title="Number of shares at ending balance"&gt;3,793,400&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90E_ecustom--CarryingAmounts_iE_pn3n3_c20260101__20260630__ifrs-full--ComponentsOfEquityAxis__ifrs-full--TreasurySharesMember_zNs1odOrLduf" title="Carrying amount at ending balance"&gt;1,400,188&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_902_eifrs-full--NumberOfSharesOutstanding_iE_pid_c20250101__20250630__ifrs-full--ComponentsOfEquityAxis__ifrs-full--TreasurySharesMember_zPEkrjaQC5ii" title="Number of shares at ending balance"&gt;3,833,400&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_900_ecustom--CarryingAmounts_iE_pn3n3_c20250101__20250630__ifrs-full--ComponentsOfEquityAxis__ifrs-full--TreasurySharesMember_z2EeAUKH0ZC" title="Carrying amount at ending balance"&gt;1,414,953&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;div style="margin: 0pt auto 0pt 0; font-family: Times New Roman, Times, Serif; width: 25%"&gt;&lt;div style="border-top: Black 1pt solid; font: 1pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"&gt;&lt;span id="xdx_F06_zp4ZuetdeNr4" style="font-family: Times New Roman, Times, Serif"&gt;(*)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F1B_zoFlmRuYkxld" style="font-family: Times New Roman, Times, Serif"&gt;The Company disposed of treasury shares at per-share prices ranging from Korean won 2,000 to Korean won 3,200.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A8_zbmI15hPkxsi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</cik0002058261:CapitalAndOtherComponentsOfEquityTextBlock>
    <cik0002058261:ScheduleOfShareCapitalTableTextBlock
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      id="Fact007085">&lt;table cellpadding="0" cellspacing="0" id="xdx_897_ecustom--ScheduleOfShareCapitalTableTextBlock_pn3n3_zz5IcOonx6f1" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Capital and other components of equity (Details)"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_8BA_zu2aSNkzIsIc" style="display: none"&gt;Schedule of share capital&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_496_20260630_zQq449H7j3ue" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_490_20251231_zY23a7yJNep3" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;June&#160;30,&lt;br/&gt;2026&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2025&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="6" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;(In Korean&#160;won and number of shares)&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--NumberOfAuthorizedShares_iI_pid_zJlwP4mYsnaf" style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Number of authorized shares&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,000,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,000,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_400_eifrs-full--ParValuePerShare_iI_pid_z1yvqdodVqj7" style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Value per share&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;500&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;500&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40E_eifrs-full--NumberOfSharesIssued_iI_pid_zwIdEMKVli2b" style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Number of shares issued&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;52,815,475&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;52,815,475&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--CommonShares_iI_pid_zGCfC7d4enA8" style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Common shares&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;26,407,737,500&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;26,407,737,500&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:ScheduleOfShareCapitalTableTextBlock>
    <cik0002058261:NumberOfAuthorizedShares
      contextRef="AsOf2026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact007087"
      unitRef="Shares">1000000000</cik0002058261:NumberOfAuthorizedShares>
    <cik0002058261:NumberOfAuthorizedShares
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact007088"
      unitRef="Shares">1000000000</cik0002058261:NumberOfAuthorizedShares>
    <ifrs-full:ParValuePerShare
      contextRef="AsOf2026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact007090"
      unitRef="KRWShares">500</ifrs-full:ParValuePerShare>
    <ifrs-full:ParValuePerShare
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact007091"
      unitRef="KRWShares">500</ifrs-full:ParValuePerShare>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact007093"
      unitRef="Shares">52815475</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact007094"
      unitRef="Shares">52815475</ifrs-full:NumberOfSharesIssued>
    <cik0002058261:CommonShares
      contextRef="AsOf2026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact007096"
      unitRef="KRW">26407737500</cik0002058261:CommonShares>
    <cik0002058261:CommonShares
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact007097"
      unitRef="KRW">26407737500</cik0002058261:CommonShares>
    <cik0002058261:DetailsOfOtherComponentsOfEquityNetOfTaxesTableTextBlock
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      id="Fact007099">&lt;table cellpadding="0" cellspacing="0" id="xdx_896_ecustom--DetailsOfOtherComponentsOfEquityNetOfTaxesTableTextBlock_pn3n3_z7Z53daKyw47" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Capital and other components of equity (Details 1)"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span id="xdx_8B5_zNzQo61sBF97" style="display: none"&gt;Details of other components of equity, net of taxes&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" id="xdx_491_20260630_zXuTVEYTrdQd" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;June&#160;30,&lt;br/&gt;2026&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" id="xdx_494_20251231_zmGb0M8sgBb3" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2025&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="6" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--OtherReservesAbstract_iB_zybUKxeFBPW" style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Other reserves&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--EmployeeShareOptions_i01I_pn3n3_zsIs1Q9X32Pg" style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Employee share options&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;724,661&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;724,661&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_400_eifrs-full--TreasuryShares_iNI_pn3n3_di_zkbT0CMcLLNk" style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Treasury shares&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(1,400,188&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(1,414,953&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--Subtotal_iI_pn3n3_zixQ7pTJidJ9" style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(675,527&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(690,292&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_409_eifrs-full--OtherComprehensiveIncomeAbstract_iB_zh4RWJzuSMT5" style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Other comprehensive income&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_409_eifrs-full--ReserveOfRemeasurementsOfDefinedBenefitPlans_iI_pn3n3_zXVuEpQVqIL5" style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Remeasurements of defined benefit liability&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;279,386&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;125,654&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--OtherComprehensiveIncomeSubtotal_iI_pn3n3_zLM6L7ygd9Vf" style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;279,386&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;125,654&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--SharePremiumAndOtherComponentsOfEquity_iI_pn3n3_zLM9juNusfNf" style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(396,141&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(564,638&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:DetailsOfOtherComponentsOfEquityNetOfTaxesTableTextBlock>
    <cik0002058261:EmployeeShareOptions
      contextRef="AsOf2026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007104"
      unitRef="KRW">724661000</cik0002058261:EmployeeShareOptions>
    <cik0002058261:EmployeeShareOptions
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007105"
      unitRef="KRW">724661000</cik0002058261:EmployeeShareOptions>
    <ifrs-full:TreasuryShares
      contextRef="AsOf2026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007107"
      unitRef="KRW">1400188000</ifrs-full:TreasuryShares>
    <ifrs-full:TreasuryShares
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007108"
      unitRef="KRW">1414953000</ifrs-full:TreasuryShares>
    <cik0002058261:Subtotal
      contextRef="AsOf2026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007110"
      unitRef="KRW">-675527000</cik0002058261:Subtotal>
    <cik0002058261:Subtotal
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007111"
      unitRef="KRW">-690292000</cik0002058261:Subtotal>
    <ifrs-full:ReserveOfRemeasurementsOfDefinedBenefitPlans
      contextRef="AsOf2026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007116"
      unitRef="KRW">279386000</ifrs-full:ReserveOfRemeasurementsOfDefinedBenefitPlans>
    <ifrs-full:ReserveOfRemeasurementsOfDefinedBenefitPlans
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007117"
      unitRef="KRW">125654000</ifrs-full:ReserveOfRemeasurementsOfDefinedBenefitPlans>
    <cik0002058261:OtherComprehensiveIncomeSubtotal
      contextRef="AsOf2026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007119"
      unitRef="KRW">279386000</cik0002058261:OtherComprehensiveIncomeSubtotal>
    <cik0002058261:OtherComprehensiveIncomeSubtotal
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007120"
      unitRef="KRW">125654000</cik0002058261:OtherComprehensiveIncomeSubtotal>
    <cik0002058261:SharePremiumAndOtherComponentsOfEquity
      contextRef="AsOf2026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007122"
      unitRef="KRW">-396141000</cik0002058261:SharePremiumAndOtherComponentsOfEquity>
    <cik0002058261:SharePremiumAndOtherComponentsOfEquity
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007123"
      unitRef="KRW">-564638000</cik0002058261:SharePremiumAndOtherComponentsOfEquity>
    <cik0002058261:ChangesInOtherComponentsOfEquityTableTextBlock
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      id="Fact007132">&lt;table cellpadding="0" cellspacing="0" id="xdx_895_ecustom--ChangesInOtherComponentsOfEquityTableTextBlock_pn3n3_zuaq9dgUPTkg" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Capital and other components of equity (Details 2)"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_8BD_zZIMhv81lFak" style="display: none"&gt;Changes in other components of equity&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Remeasurements&lt;br/&gt;of defined&lt;br/&gt;benefit liability&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Employee share&lt;br/&gt;options&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Treasury&lt;br/&gt;shares&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="14" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Balance as of January&#160;1, 2025&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_904_ecustom--OtherEquity_iS_pn3n3_c20250101__20250630__ifrs-full--ComponentsOfEquityAxis__custom--RemeasurementsOfDefinedBenefitLiabilityMember_zr5ngXQGiUrf" title="Balance at beginning"&gt;73,533&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90D_ecustom--OtherEquity_iS_pn3n3_c20250101__20250630__ifrs-full--ComponentsOfEquityAxis__custom--EmployeeShareOptionMember_zMvbrBB4Rwji" title="Balance at beginning"&gt;724,661&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_904_ecustom--OtherEquity_iS_pn3n3_c20250101__20250630__ifrs-full--ComponentsOfEquityAxis__ifrs-full--TreasurySharesMember_zsTR2ZdFtIU2" title="Balance at beginning"&gt;(1,451,864&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90B_ecustom--OtherEquity_iS_pn3n3_c20250101__20250630_zJiF3XtMw2Ua" title="Balance at beginning"&gt;(653,670&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Changes, net of taxes&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_908_ecustom--ChangesNetOfTaxes_iN_pn3n3_di_c20250101__20250630__ifrs-full--ComponentsOfEquityAxis__custom--RemeasurementsOfDefinedBenefitLiabilityMember_zhcdPjyAwIFj" title="Changes, net of taxes"&gt;26,061&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90F_ecustom--ChangesNetOfTaxes_iN_pn3n3_di_c20250101__20250630__ifrs-full--ComponentsOfEquityAxis__custom--EmployeeShareOptionMember_zbgt1amRov28" title="Changes, net of taxes"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7144"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_909_ecustom--ChangesNetOfTaxes_iN_pn3n3_di_c20250101__20250630__ifrs-full--ComponentsOfEquityAxis__ifrs-full--TreasurySharesMember_zFkf411WoMga" title="Changes, net of taxes"&gt;36,911&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_901_ecustom--ChangesNetOfTaxes_iN_pn3n3_di_c20250101__20250630_zJptOIMttiHd" title="Changes, net of taxes"&gt;62,972&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Balance as of June&#160;30, 2025&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90D_ecustom--OtherEquity_iE_pn3n3_c20250101__20250630__ifrs-full--ComponentsOfEquityAxis__custom--RemeasurementsOfDefinedBenefitLiabilityMember_z1c0dDLde5df" title="Balance at ending"&gt;99,594&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_907_ecustom--OtherEquity_iE_pn3n3_c20250101__20250630__ifrs-full--ComponentsOfEquityAxis__custom--EmployeeShareOptionMember_zjr1nk0BVIsf" title="Balance at ending"&gt;724,661&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_907_ecustom--OtherEquity_iE_pn3n3_c20250101__20250630__ifrs-full--ComponentsOfEquityAxis__ifrs-full--TreasurySharesMember_zyCrozuS3ihd" title="Balance at ending"&gt;(1,414,953&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90F_ecustom--OtherEquity_iE_pn3n3_c20250101__20250630_zrhQy4Ha2Mzi" title="Balance at ending"&gt;(590,698&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Balance as of January&#160;1, 2026&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_904_ecustom--OtherEquity_iS_pn3n3_c20260101__20260630__ifrs-full--ComponentsOfEquityAxis__custom--RemeasurementsOfDefinedBenefitLiabilityMember_zOBMQFffkrji" title="Balance at beginning"&gt;125,654&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_901_ecustom--OtherEquity_iS_pn3n3_c20260101__20260630__ifrs-full--ComponentsOfEquityAxis__custom--EmployeeShareOptionMember_zqHuih1A9Cxf" title="Balance at beginning"&gt;724,661&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90E_ecustom--OtherEquity_iS_pn3n3_c20260101__20260630__ifrs-full--ComponentsOfEquityAxis__ifrs-full--TreasurySharesMember_z6EmdjkXZfC9" title="Balance at beginning"&gt;(1,414,953&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90F_ecustom--OtherEquity_iS_pn3n3_c20260101__20260630_zXYVP6NnXKj9" title="Balance at beginning"&gt;(564,638&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Changes, net of taxes&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_903_ecustom--ChangesNetOfTaxes_iN_pn3n3_di_c20260101__20260630__ifrs-full--ComponentsOfEquityAxis__custom--RemeasurementsOfDefinedBenefitLiabilityMember_zpkw7P65fs5a" title="Changes, net of taxes"&gt;153,732&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_909_ecustom--ChangesNetOfTaxes_iN_pn3n3_di_c20260101__20260630__ifrs-full--ComponentsOfEquityAxis__custom--EmployeeShareOptionMember_zajd9JP2Lnnj" title="Changes, net of taxes"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7168"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_903_ecustom--ChangesNetOfTaxes_iN_pn3n3_di_c20260101__20260630__ifrs-full--ComponentsOfEquityAxis__ifrs-full--TreasurySharesMember_zTdVGvZd2rR" title="Changes, net of taxes"&gt;14,765&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90B_ecustom--ChangesNetOfTaxes_iN_pn3n3_di_c20260101__20260630_zq8LalT7c22g" title="Changes, net of taxes"&gt;168,497&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Balance as of June&#160;30, 2026&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90F_ecustom--OtherEquity_iE_pn3n3_c20260101__20260630__ifrs-full--ComponentsOfEquityAxis__custom--RemeasurementsOfDefinedBenefitLiabilityMember_zNJTQnyZYkji" title="Balance at ending"&gt;279,386&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_905_ecustom--OtherEquity_iE_pn3n3_c20260101__20260630__ifrs-full--ComponentsOfEquityAxis__custom--EmployeeShareOptionMember_zKILN2wFDYre" title="Balance at ending"&gt;724,661&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_902_ecustom--OtherEquity_iE_pn3n3_c20260101__20260630__ifrs-full--ComponentsOfEquityAxis__ifrs-full--TreasurySharesMember_zazGbTEMeXg9" title="Balance at ending"&gt;(1,400,188&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_902_ecustom--OtherEquity_iE_pn3n3_c20260101__20260630_zfaauYQU3tYk" title="Balance at ending"&gt;(396,141&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:ChangesInOtherComponentsOfEquityTableTextBlock>
    <cik0002058261:OtherEquity
      contextRef="AsOf2024-12-31_custom_RemeasurementsOfDefinedBenefitLiabilityMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007134"
      unitRef="KRW">73533000</cik0002058261:OtherEquity>
    <cik0002058261:OtherEquity
      contextRef="AsOf2024-12-31_custom_EmployeeShareOptionMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007136"
      unitRef="KRW">724661000</cik0002058261:OtherEquity>
    <cik0002058261:OtherEquity
      contextRef="AsOf2024-12-31_ifrs-full_TreasurySharesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007138"
      unitRef="KRW">-1451864000</cik0002058261:OtherEquity>
    <cik0002058261:OtherEquity
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007140"
      unitRef="KRW">-653670000</cik0002058261:OtherEquity>
    <cik0002058261:ChangesNetOfTaxes
      contextRef="From2025-01-012025-06-30_custom_RemeasurementsOfDefinedBenefitLiabilityMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007142"
      unitRef="KRW">-26061000</cik0002058261:ChangesNetOfTaxes>
    <cik0002058261:ChangesNetOfTaxes
      contextRef="From2025-01-012025-06-30_ifrs-full_TreasurySharesMember_custom_CubebioCo.Ltd.Member273646953"
      decimals="-3"
      id="Fact007146"
      unitRef="KRW">-36911000</cik0002058261:ChangesNetOfTaxes>
    <cik0002058261:ChangesNetOfTaxes
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007148"
      unitRef="KRW">-62972000</cik0002058261:ChangesNetOfTaxes>
    <cik0002058261:OtherEquity
      contextRef="AsOf2025-06-30_custom_RemeasurementsOfDefinedBenefitLiabilityMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007150"
      unitRef="KRW">99594000</cik0002058261:OtherEquity>
    <cik0002058261:OtherEquity
      contextRef="AsOf2025-06-30_custom_EmployeeShareOptionMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007152"
      unitRef="KRW">724661000</cik0002058261:OtherEquity>
    <cik0002058261:OtherEquity
      contextRef="AsOf2025-06-30_ifrs-full_TreasurySharesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007154"
      unitRef="KRW">-1414953000</cik0002058261:OtherEquity>
    <cik0002058261:OtherEquity
      contextRef="AsOf2025-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007156"
      unitRef="KRW">-590698000</cik0002058261:OtherEquity>
    <cik0002058261:OtherEquity
      contextRef="AsOf2025-12-31_custom_RemeasurementsOfDefinedBenefitLiabilityMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007158"
      unitRef="KRW">125654000</cik0002058261:OtherEquity>
    <cik0002058261:OtherEquity
      contextRef="AsOf2025-12-31_custom_EmployeeShareOptionMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007160"
      unitRef="KRW">724661000</cik0002058261:OtherEquity>
    <cik0002058261:OtherEquity
      contextRef="AsOf2025-12-31_ifrs-full_TreasurySharesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007162"
      unitRef="KRW">-1414953000</cik0002058261:OtherEquity>
    <cik0002058261:OtherEquity
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007164"
      unitRef="KRW">-564638000</cik0002058261:OtherEquity>
    <cik0002058261:ChangesNetOfTaxes
      contextRef="From2026-01-012026-06-30_custom_RemeasurementsOfDefinedBenefitLiabilityMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007166"
      unitRef="KRW">-153732000</cik0002058261:ChangesNetOfTaxes>
    <cik0002058261:ChangesNetOfTaxes
      contextRef="From2026-01-012026-06-30_ifrs-full_TreasurySharesMember_custom_CubebioCo.Ltd.Member273647062"
      decimals="-3"
      id="Fact007170"
      unitRef="KRW">-14765000</cik0002058261:ChangesNetOfTaxes>
    <cik0002058261:ChangesNetOfTaxes
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007172"
      unitRef="KRW">-168497000</cik0002058261:ChangesNetOfTaxes>
    <cik0002058261:OtherEquity
      contextRef="AsOf2026-06-30_custom_RemeasurementsOfDefinedBenefitLiabilityMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007174"
      unitRef="KRW">279386000</cik0002058261:OtherEquity>
    <cik0002058261:OtherEquity
      contextRef="AsOf2026-06-30_custom_EmployeeShareOptionMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007176"
      unitRef="KRW">724661000</cik0002058261:OtherEquity>
    <cik0002058261:OtherEquity
      contextRef="AsOf2026-06-30_ifrs-full_TreasurySharesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007178"
      unitRef="KRW">-1400188000</cik0002058261:OtherEquity>
    <cik0002058261:OtherEquity
      contextRef="AsOf2026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007180"
      unitRef="KRW">-396141000</cik0002058261:OtherEquity>
    <cik0002058261:ScheduleOfTreasurySharesTableTextBlock
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      id="Fact007182">&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--ScheduleOfTreasurySharesTableTextBlock_pn3n3_zCtTUA0njCs5" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Capital and other components of equity (Details 3)"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span id="xdx_8B2_zB9IL5J3Ouej" style="display: none"&gt;Schedule of treasury shares&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="7" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;June&#160;30,&lt;br/&gt;2026&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="7" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;June&#160;30,&lt;br/&gt;2025&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Number of&lt;br/&gt;shares&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; text-align: right; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Carrying&lt;br/&gt;amount&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Number&lt;br/&gt;of shares&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; text-align: right; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Carrying&lt;br/&gt;amount&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="16" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;(In thousands of Korean won and number of shares)&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 9%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_904_eifrs-full--NumberOfSharesOutstanding_iS_pid_c20260101__20260630__ifrs-full--ComponentsOfEquityAxis__ifrs-full--TreasurySharesMember_zOkWX4o8sfpl" title="Number of shares at beginning balance"&gt;3,833,400&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 9%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90D_ecustom--CarryingAmounts_iS_pn3n3_c20260101__20260630__ifrs-full--ComponentsOfEquityAxis__ifrs-full--TreasurySharesMember_zRljsWbJYsNl" title="Carrying amount at beginning balance"&gt;1,414,953&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 9%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_906_eifrs-full--NumberOfSharesOutstanding_iS_pid_c20250101__20250630__ifrs-full--ComponentsOfEquityAxis__ifrs-full--TreasurySharesMember_zcjJX6P0VLS9" title="Number of shares at beginning balance"&gt;3,933,400&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 9%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_906_ecustom--CarryingAmounts_iS_pn3n3_c20250101__20250630__ifrs-full--ComponentsOfEquityAxis__ifrs-full--TreasurySharesMember_zo1eYKW8Cq5d" title="Carrying amount at beginning balance"&gt;1,451,864&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Acquisition&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_901_ecustom--AcquisitionShares_pid_c20260101__20260630__ifrs-full--ComponentsOfEquityAxis__ifrs-full--TreasurySharesMember_zRLFWnmEc897" title="Acquisition, shares"&gt;0&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90B_ecustom--AcquisitionCarryingAmount_pn3n3_c20260101__20260630__ifrs-full--ComponentsOfEquityAxis__ifrs-full--TreasurySharesMember_zTpo6uWdUT1j" title="Acquisition carrying amount"&gt;0&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_904_ecustom--AcquisitionShares_pid_c20250101__20250630__ifrs-full--ComponentsOfEquityAxis__ifrs-full--TreasurySharesMember_z3gmwWhXBe58" title="Acquisition, shares"&gt;0&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_908_ecustom--AcquisitionCarryingAmount_pn3n3_c20250101__20250630__ifrs-full--ComponentsOfEquityAxis__ifrs-full--TreasurySharesMember_zHNP3yS4goy8" title="Acquisition carrying amount"&gt;0&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Disposal (*)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_909_ecustom--DisposalShares_pid_c20260101__20260630__ifrs-full--ComponentsOfEquityAxis__ifrs-full--TreasurySharesMember_fKCop_zZn8Du5XDLkh" title="Disposal, shares"&gt;40,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: right; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90B_ecustom--DisposalCarryingAmount_pn3n3_c20260101__20260630__ifrs-full--ComponentsOfEquityAxis__ifrs-full--TreasurySharesMember_fKCop_zolXLd5LAfgd" title="Disposal, carrying amount"&gt;14,765&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90F_ecustom--DisposalShares_pid_c20250101__20250630__ifrs-full--ComponentsOfEquityAxis__ifrs-full--TreasurySharesMember_fKCop_zqsPeFj7RW7g" title="Disposal, shares"&gt;100,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: right; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_903_ecustom--DisposalCarryingAmount_pn3n3_c20250101__20250630__ifrs-full--ComponentsOfEquityAxis__ifrs-full--TreasurySharesMember_fKCop_zdWoWCH9yVv7" title="Disposal, carrying amount"&gt;36,911&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90D_eifrs-full--NumberOfSharesOutstanding_iE_pid_c20260101__20260630__ifrs-full--ComponentsOfEquityAxis__ifrs-full--TreasurySharesMember_zP3rF8JlG4M1" title="Number of shares at ending balance"&gt;3,793,400&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90E_ecustom--CarryingAmounts_iE_pn3n3_c20260101__20260630__ifrs-full--ComponentsOfEquityAxis__ifrs-full--TreasurySharesMember_zNs1odOrLduf" title="Carrying amount at ending balance"&gt;1,400,188&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_902_eifrs-full--NumberOfSharesOutstanding_iE_pid_c20250101__20250630__ifrs-full--ComponentsOfEquityAxis__ifrs-full--TreasurySharesMember_zPEkrjaQC5ii" title="Number of shares at ending balance"&gt;3,833,400&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_900_ecustom--CarryingAmounts_iE_pn3n3_c20250101__20250630__ifrs-full--ComponentsOfEquityAxis__ifrs-full--TreasurySharesMember_z2EeAUKH0ZC" title="Carrying amount at ending balance"&gt;1,414,953&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;div style="margin: 0pt auto 0pt 0; font-family: Times New Roman, Times, Serif; width: 25%"&gt;&lt;div style="border-top: Black 1pt solid; font: 1pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"&gt;&lt;span id="xdx_F06_zp4ZuetdeNr4" style="font-family: Times New Roman, Times, Serif"&gt;(*)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F1B_zoFlmRuYkxld" style="font-family: Times New Roman, Times, Serif"&gt;The Company disposed of treasury shares at per-share prices ranging from Korean won 2,000 to Korean won 3,200.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:ScheduleOfTreasurySharesTableTextBlock>
    <ifrs-full:NumberOfSharesOutstanding
      contextRef="AsOf2025-12-31_ifrs-full_TreasurySharesMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact007184"
      unitRef="Shares">3833400</ifrs-full:NumberOfSharesOutstanding>
    <cik0002058261:CarryingAmounts
      contextRef="AsOf2025-12-31_ifrs-full_TreasurySharesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007186"
      unitRef="KRW">1414953000</cik0002058261:CarryingAmounts>
    <ifrs-full:NumberOfSharesOutstanding
      contextRef="AsOf2024-12-31_ifrs-full_TreasurySharesMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact007188"
      unitRef="Shares">3933400</ifrs-full:NumberOfSharesOutstanding>
    <cik0002058261:CarryingAmounts
      contextRef="AsOf2024-12-31_ifrs-full_TreasurySharesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007190"
      unitRef="KRW">1451864000</cik0002058261:CarryingAmounts>
    <cik0002058261:AcquisitionShares
      contextRef="From2026-01-012026-06-30_ifrs-full_TreasurySharesMember_custom_CubebioCo.Ltd.Member273647062"
      decimals="INF"
      id="Fact007192"
      unitRef="Shares">0</cik0002058261:AcquisitionShares>
    <cik0002058261:AcquisitionCarryingAmount
      contextRef="From2026-01-012026-06-30_ifrs-full_TreasurySharesMember_custom_CubebioCo.Ltd.Member273647062"
      decimals="-3"
      id="Fact007194"
      unitRef="KRW">0</cik0002058261:AcquisitionCarryingAmount>
    <cik0002058261:AcquisitionShares
      contextRef="From2025-01-012025-06-30_ifrs-full_TreasurySharesMember_custom_CubebioCo.Ltd.Member273646953"
      decimals="INF"
      id="Fact007196"
      unitRef="Shares">0</cik0002058261:AcquisitionShares>
    <cik0002058261:AcquisitionCarryingAmount
      contextRef="From2025-01-012025-06-30_ifrs-full_TreasurySharesMember_custom_CubebioCo.Ltd.Member273646953"
      decimals="-3"
      id="Fact007198"
      unitRef="KRW">0</cik0002058261:AcquisitionCarryingAmount>
    <cik0002058261:DisposalShares
      contextRef="From2026-01-012026-06-30_ifrs-full_TreasurySharesMember_custom_CubebioCo.Ltd.Member273647062"
      decimals="INF"
      id="Fact007200"
      unitRef="Shares">40000</cik0002058261:DisposalShares>
    <cik0002058261:DisposalCarryingAmount
      contextRef="From2026-01-012026-06-30_ifrs-full_TreasurySharesMember_custom_CubebioCo.Ltd.Member273647062"
      decimals="-3"
      id="Fact007202"
      unitRef="KRW">14765000</cik0002058261:DisposalCarryingAmount>
    <cik0002058261:DisposalShares
      contextRef="From2025-01-012025-06-30_ifrs-full_TreasurySharesMember_custom_CubebioCo.Ltd.Member273646953"
      decimals="INF"
      id="Fact007204"
      unitRef="Shares">100000</cik0002058261:DisposalShares>
    <cik0002058261:DisposalCarryingAmount
      contextRef="From2025-01-012025-06-30_ifrs-full_TreasurySharesMember_custom_CubebioCo.Ltd.Member273646953"
      decimals="-3"
      id="Fact007206"
      unitRef="KRW">36911000</cik0002058261:DisposalCarryingAmount>
    <ifrs-full:NumberOfSharesOutstanding
      contextRef="AsOf2026-06-30_ifrs-full_TreasurySharesMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact007208"
      unitRef="Shares">3793400</ifrs-full:NumberOfSharesOutstanding>
    <cik0002058261:CarryingAmounts
      contextRef="AsOf2026-06-30_ifrs-full_TreasurySharesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007210"
      unitRef="KRW">1400188000</cik0002058261:CarryingAmounts>
    <ifrs-full:NumberOfSharesOutstanding
      contextRef="AsOf2025-06-30_ifrs-full_TreasurySharesMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact007212"
      unitRef="Shares">3833400</ifrs-full:NumberOfSharesOutstanding>
    <cik0002058261:CarryingAmounts
      contextRef="AsOf2025-06-30_ifrs-full_TreasurySharesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007214"
      unitRef="KRW">1414953000</cik0002058261:CarryingAmounts>
    <cik0002058261:CapitalManagementTextBlock
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      id="Fact007217">&lt;p id="xdx_802_ecustom--CapitalManagementTextBlock_z1aalaNM85d8" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;23. &lt;span id="xdx_823_zq8S503tWB0j"&gt;Capital management&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The Company&#x2019;s policy is to maintain a strong capital base to uphold investor, creditor, and market confidence and to sustain future development of the business. The Company monitors capital using a ratio of &#x2018;net debt&#x2019; to &#x2018;total equity&#x2019;. Net debt is calculated as total liabilities (as shown in the statement of financial position) less cash and cash equivalents. The Company&#x2019;s net debt to adjusted equity ratio as of June&#160;30, 2026 and December&#160;31, 2025 is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_892_ecustom--ScheduleOfNetDebtToAdjustedEquityRatioOfEquityTableTextBlock_pn3n3_ztEY5VAYyTd2" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Capital management (Details)"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_8BA_zMWO1hatjfj9" style="display: none"&gt;Schedule of net debt to adjusted equity ratio&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49C_20260630_zXVgIdQ8EWC5" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_492_20251231_zqlk8VpNcDu9" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;June&#160;30,&lt;br/&gt;2026&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2025&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="6" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--TotalLiabilities_iI_pn3n3_zIYK6UHT2oBk" style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;12,757,981&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;9,668,292&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--LessCashAndCashEquivalents_iNI_pn3n3_di_zZvP1GUoy2ze" style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Less: Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(312,427&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(335,814&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_406_eifrs-full--NetDebt_iI_pn3n3_zM6YhJWu7P57" style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Net debt&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;12,445,554&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;9,332,478&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--Equities_iI_pn3n3_zMpQFSiLD9Ea" style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total equity&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(5,914,543&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(3,198,381&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--NetDebtToEquityRatio_iI_pid_zii4D81Vw0f4" style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Net
    debt to total equity ratio &lt;span id="xdx_F4C_ziA0Zk5OKvPb"&gt;(*)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7233"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7234"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;div style="margin: 0pt auto 0pt 0; font-family: Times New Roman, Times, Serif; width: 25%"&gt;&lt;div style="border-top: Black 1pt solid; font: 1pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"&gt;&lt;span id="xdx_F04_zpjow90JXyL7" style="font-family: Times New Roman, Times, Serif"&gt;(*)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F1E_zx5o3dpt6QDj" style="font-family: Times New Roman, Times, Serif"&gt;Net debt to total equity ratio is not calculated as total equity is negative.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A0_zEGkKzJIbhEb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

















</cik0002058261:CapitalManagementTextBlock>
    <cik0002058261:ScheduleOfNetDebtToAdjustedEquityRatioOfEquityTableTextBlock
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      id="Fact007219">&lt;table cellpadding="0" cellspacing="0" id="xdx_892_ecustom--ScheduleOfNetDebtToAdjustedEquityRatioOfEquityTableTextBlock_pn3n3_ztEY5VAYyTd2" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Capital management (Details)"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_8BA_zMWO1hatjfj9" style="display: none"&gt;Schedule of net debt to adjusted equity ratio&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49C_20260630_zXVgIdQ8EWC5" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_492_20251231_zqlk8VpNcDu9" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;June&#160;30,&lt;br/&gt;2026&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2025&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="6" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--TotalLiabilities_iI_pn3n3_zIYK6UHT2oBk" style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;12,757,981&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;9,668,292&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--LessCashAndCashEquivalents_iNI_pn3n3_di_zZvP1GUoy2ze" style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Less: Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(312,427&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(335,814&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_406_eifrs-full--NetDebt_iI_pn3n3_zM6YhJWu7P57" style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Net debt&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;12,445,554&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;9,332,478&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--Equities_iI_pn3n3_zMpQFSiLD9Ea" style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total equity&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(5,914,543&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(3,198,381&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--NetDebtToEquityRatio_iI_pid_zii4D81Vw0f4" style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Net
    debt to total equity ratio &lt;span id="xdx_F4C_ziA0Zk5OKvPb"&gt;(*)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7233"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7234"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;div style="margin: 0pt auto 0pt 0; font-family: Times New Roman, Times, Serif; width: 25%"&gt;&lt;div style="border-top: Black 1pt solid; font: 1pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"&gt;&lt;span id="xdx_F04_zpjow90JXyL7" style="font-family: Times New Roman, Times, Serif"&gt;(*)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F1E_zx5o3dpt6QDj" style="font-family: Times New Roman, Times, Serif"&gt;Net debt to total equity ratio is not calculated as total equity is negative.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:ScheduleOfNetDebtToAdjustedEquityRatioOfEquityTableTextBlock>
    <cik0002058261:TotalLiabilities
      contextRef="AsOf2026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007221"
      unitRef="KRW">12757981000</cik0002058261:TotalLiabilities>
    <cik0002058261:TotalLiabilities
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007222"
      unitRef="KRW">9668292000</cik0002058261:TotalLiabilities>
    <cik0002058261:LessCashAndCashEquivalents
      contextRef="AsOf2026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007224"
      unitRef="KRW">312427000</cik0002058261:LessCashAndCashEquivalents>
    <cik0002058261:LessCashAndCashEquivalents
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007225"
      unitRef="KRW">335814000</cik0002058261:LessCashAndCashEquivalents>
    <ifrs-full:NetDebt
      contextRef="AsOf2026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007227"
      unitRef="KRW">12445554000</ifrs-full:NetDebt>
    <ifrs-full:NetDebt
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007228"
      unitRef="KRW">9332478000</ifrs-full:NetDebt>
    <cik0002058261:Equities
      contextRef="AsOf2026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007230"
      unitRef="KRW">-5914543000</cik0002058261:Equities>
    <cik0002058261:Equities
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007231"
      unitRef="KRW">-3198381000</cik0002058261:Equities>
    <cik0002058261:ShareBasedPaymentArrangementsTextBlock
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      id="Fact007244">&lt;p id="xdx_808_ecustom--ShareBasedPaymentArrangementsTextBlock_zUeqEcUIgjOd" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;24. &lt;span id="xdx_828_zzK7Fn38ruqd"&gt;Share-based payment arrangements&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;A.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Description of share-based payment arrangements&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;As of June&#160;30, 2026, the Company had the following share-based payment arrangements. On October&#160;1, 2015, June&#160;29, 2016 and June&#160;15, 2020, the Company established share option plans that entitle key management personnel and employees to purchase shares in the Company. Under these plans, holders of vested options are entitled to purchase shares at the exercise price at the grant date. Currently, these plans are limited to key management personnel and employees.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The key terms and conditions related to the grants under these plans are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89B_ecustom--ScheduleOfShareOptionPlanTableTextBlock_pn3n3_zO0Ck6q6uBu2" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Share-based payment arrangements (Details)"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_8B6_zLPxOsga0OK7" style="display: none"&gt;Schedule of share option plan&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Grant date&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Number of&lt;br/&gt;instruments&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Vesting&lt;br/&gt;conditions&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Contractual&lt;br/&gt;life of options&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Type&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Underlying&lt;br/&gt;assets&lt;/b&gt;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;As of October&#160;1, 2015 (*1)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 7%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_909_ecustom--NumberOfInstruments_pid_c20150929__20151001_fKCoxKQ_____z2gj4VE0LQXi" title="Number of instruments"&gt;9,500,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top; width: 18%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_901_ecustom--VestingCondition_c20150929__20151001_fKCoxKQ_____zQ3P6yUHOrEh" title="Vesting condition"&gt;2 years&#x2019; service from grant date&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top; width: 8%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90C_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20150929__20151001_fKCoxKQ_____zeVXdgXiXFdh" title="Contractual life of options"&gt;9&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top; width: 10%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_902_ecustom--Type_c20150929__20151001_fKCoxKQ_____z1KOpt31nz5j" title="Type"&gt;Equity-settled&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top; width: 18%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_907_ecustom--UnderlyingAssets_c20150929__20151001_fKCoxKQ_____zdHKeRBp3Xtd" title="Underlying assets"&gt;CUBEBIO&#160;Co., Ltd.&#x2019;s ordinary shares&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;As of June&#160;29, 2016 (*2)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90C_ecustom--NumberOfInstruments_pid_c20160601__20160629_fKCoyKQ_____z3bYnRt5xcuc" title="Number of instruments"&gt;85,638&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_903_ecustom--VestingCondition_c20160601__20160629_fKCoyKQ_____z4HijUjy3wme" title="Vesting condition"&gt;2 years&#x2019; service from grant date&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90A_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20160601__20160629_fKCoyKQ_____zDe9q0zsLeKb" title="Contractual life of options"&gt;9&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_909_ecustom--Type_c20160601__20160629_fKCoyKQ_____zwAJjgYb2Kzf" title="Type"&gt;Equity-settled&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90C_ecustom--UnderlyingAssets_c20160601__20160629_fKCoyKQ_____zAlEmcjxbPs6" title="Underlying  assets"&gt;CUBEBIO&#160;Co., Ltd.&#x2019;s ordinary shares&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;As of June&#160;15, 2020&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_904_ecustom--NumberOfInstruments_pid_c20200601__20200615_zgMTKU9aSE5k" title="Number of instruments"&gt;7,000,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_908_ecustom--VestingCondition_c20200601__20200615_zbqjNYYxSS51" title="Vesting condition"&gt;2 years&#x2019; service from grant date&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_902_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20200601__20200615_zTt0eirXTHda" title="Contractual life of options"&gt;7&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_908_ecustom--Type_c20200601__20200615_ziQRNmaaVAy9" title="Type"&gt;Equity-settled&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_905_ecustom--UnderlyingAssets_c20200601__20200615_z2CYunEkxbUl" title="Underlying  assets"&gt;CUBEBIO&#160;Co., Ltd.&#x2019;s ordinary shares&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Total share options&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_900_ecustom--NumberOfInstruments_pid_c20260101__20260630_z21mQLSaPCz1" title="Number of instruments"&gt;16,585,638&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;div style="margin: 0pt auto 0pt 0; font-family: Times New Roman, Times, Serif; width: 25%"&gt;&lt;div style="border-top: Black 1pt solid; font: 1pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in; text-align: left"&gt;&lt;span id="xdx_F00_z5o47Nfwt3Jk" style="font-family: Times New Roman, Times, Serif"&gt;(*1)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F18_zDdMfsHjRGEl" style="font-family: Times New Roman, Times, Serif"&gt;The options granted as of October&#160;1, 2015 have been fully vested. Certain of these options were exercised, and the remaining options expired upon reaching the end of their contractual life. As of June&#160;30, 2026, there were no exercisable options outstanding related to this grant.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span id="xdx_F0A_zO1s6K8WlnM8" style="font-family: Times New Roman, Times, Serif"&gt;(*2)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F1C_zymhyHUzB8Te" style="font-family: Times New Roman, Times, Serif"&gt;The options granted as of June&#160;29, 2016 have been fully vested and exercised. As of June&#160;30, 2026, there were no exercisable options outstanding related to this grant.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A8_z8eVl1ssJws" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;B.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Measurement of fair values&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The fair value of the employee share options granted as of June&#160;15, 2020 has been measured using a binomial model. The inputs used in the measurement of the fair values at the grant date of the equity-settled share-based payment plans are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_892_ecustom--ScheduleOfShareOptionGrantTableTextBlock_pn3n3_zVAy0yVZU0gg" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Share-based payment arrangements (Details 1)"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: #FFFFFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_8BC_zE07DketrWzc" style="display: none"&gt;Schedule of share option grant&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;th style="border-bottom: #000000 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Share option plan (equity-settled)&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;June 15,&lt;br/&gt;2020&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;(In Korean Won and number of shares)&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Fair value of option&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 9%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_909_eifrs-full--WeightedAverageFairValueAtMeasurementDateShareOptionsGranted_iI_pn3n3_c20200615__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ShareOptionPlanEquitySettledMember_zTb3n0v9N6id" title="Fair value of option"&gt;1,132&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: #FFFFFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Share price&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90E_eifrs-full--WeightedAverageSharePrice2019_pid_c20200601__20200615__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ShareOptionPlanEquitySettledMember_zgfsZMxmhBKk" title="Share price"&gt;1,412&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Exercise price&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_903_eifrs-full--ProceedsFromExerciseOfOptions_pn3n3_c20200601__20200615__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ShareOptionPlanEquitySettledMember_zz6OqzS0y8j1" title="Exercise price"&gt;500&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: #FFFFFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Risk - free interest rate (based on government bonds)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90C_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20200601__20200615__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ShareOptionPlanEquitySettledMember_zvsBTlIoknhk" title="Risk- free interest rate (based on government bonds)"&gt;3.89&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Volatility (*)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90A_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20200601__20200615__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ShareOptionPlanEquitySettledMember_fKCop_zUZFGut0Ppz2" title="Volatility"&gt;83.78&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: #FFFFFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Expected term (years)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_904_eifrs-full--DescriptionOfOptionLifeShareOptionsGranted_dtY_uDecimal_c20200601__20200615__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ShareOptionPlanEquitySettledMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zYU9yoHL6bdk" title="Expected term (years)"&gt;4&lt;/span&gt; ~ &lt;span id="xdx_908_eifrs-full--DescriptionOfOptionLifeShareOptionsGranted_dtY_uDecimal_c20200601__20200615__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ShareOptionPlanEquitySettledMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zaAl1PshjL54" title="Expected term (years)"&gt;5&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Expected dividend&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90A_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20200601__20200615__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ShareOptionPlanEquitySettledMember_zdCpoyNXzXT2" title="Expected dividend"&gt;0&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;div style="margin: 0pt auto 0pt 0; font-family: Times New Roman, Times, Serif; width: 25%"&gt;&lt;div style="border-top: Black 1pt solid; font: 1pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"&gt;&lt;span id="xdx_F02_zqJ20CQIfdOh" style="font-family: Times New Roman, Times, Serif"&gt;(*)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F16_zwm4k6Z9Fw6c" style="font-family: Times New Roman, Times, Serif"&gt;Volatility has been calculated based on an evaluation of the historical volatility of other companies&#x2019; share prices, which are listed in KOSDAQ, particularly over the historical period commensurate with the prior year.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AA_zu0SpVeuAjLh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

















&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;C.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Reconciliation of outstanding share options&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The number and exercise prices of share options under the share option plan for the periods ended June&#160;30, 2026 and 2025 are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_892_ecustom--ReconciliationofoutstandingshareOptionsTableTextBlock_pn3n3_zqLucsPNzng8" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Share-based payment arrangements (Details 2)"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_8B3_zetecQrmUwtf" style="display: none"&gt;Schedule of reconciliation of outstanding share options&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Six-month&lt;br/&gt;period ended&lt;br/&gt;June&#160;30,&lt;br/&gt;2026&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Six-month&lt;br/&gt;period ended&lt;br/&gt;June&#160;30,&lt;br/&gt;2025&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="border-bottom: #000000 1pt solid; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Share option plan (equity-settled)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Number of&lt;br/&gt;options&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Exercise &lt;br/&gt;Price(*)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Number of&lt;br/&gt;options&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Exercise &lt;br/&gt;Price(*)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="16" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;(In Korean Won and number of options)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Outstanding at January&#160;1&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_903_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_uShares_c20260101__20260630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ShareOptionPlanEquitySettledMember_zAklebGa06X1" title="Number of options, outstanding at beginning"&gt;640,160&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90E_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iS_pid_c20260101__20260630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ShareOptionPlanEquitySettledMember_fKCop_z0XKEeSKw2pc" title="Exercise price, at beginning"&gt;500&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_908_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_uShares_c20250101__20250630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ShareOptionPlanEquitySettledMember_zNOTIAnARcdh" title="Number of options, outstanding at beginning"&gt;640,160&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_902_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iS_pid_c20250101__20250630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ShareOptionPlanEquitySettledMember_fKCop_z1iBVcotJCjj" title="Exercise price, at beginning"&gt;500&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Exercised during the period&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90B_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pid_di_uShares_c20260101__20260630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ShareOptionPlanEquitySettledMember_zlXKhFQpkt62" title="Exercised during the year"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7318"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90B_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_di_uShares_c20250101__20250630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ShareOptionPlanEquitySettledMember_z4MzpmBJTXa7" title="Exercised during the year"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7320"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Outstanding at June&#160;30&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_902_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_uShares_c20260101__20260630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ShareOptionPlanEquitySettledMember_zNVW4IoSxex2" title="Number of options, outstanding at end"&gt;640,160&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90B_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iE_pid_c20260101__20260630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ShareOptionPlanEquitySettledMember_fKCop_zPIj6QoyKF5c" title="Exercise price, at end"&gt;500&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_908_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_uShares_c20250101__20250630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ShareOptionPlanEquitySettledMember_zVRhe4Km6Vqj" title="Number of options, outstanding at end"&gt;640,160&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_904_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iE_pid_c20250101__20250630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ShareOptionPlanEquitySettledMember_fKCop_z4ATWjkpG9X8" title="Exercise price, at end"&gt;500&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Exercisable at June&#160;30&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_903_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pid_uShares_c20260630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ShareOptionPlanEquitySettledMember_zXLIVuhiUQXg" title="Number of options, exercisable"&gt;640,160&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_906_ecustom--WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pid_c20260630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ShareOptionPlanEquitySettledMember_fKCop_zmhHEBM4sHE9" title="Exercise price"&gt;500&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_909_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pid_uShares_c20250630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ShareOptionPlanEquitySettledMember_zxobTHPbaRL5" title="Number of options, exercisable"&gt;640,160&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_908_ecustom--WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pid_c20250630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ShareOptionPlanEquitySettledMember_fKCop_zqgV8nomoh15" title="Exercise price"&gt;500&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;div style="margin: 0pt auto 0pt 0; font-family: Times New Roman, Times, Serif; width: 25%"&gt;&lt;div style="border-top: Black 1pt solid; font: 1pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"&gt;&lt;span id="xdx_F06_z3OkA0mMuY15" style="font-family: Times New Roman, Times, Serif"&gt;(*)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F16_zhHsPR2NQKh5" style="font-family: Times New Roman, Times, Serif"&gt;Weighted average exercise price per share.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AD_zQqAmoXggp7d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</cik0002058261:ShareBasedPaymentArrangementsTextBlock>
    <cik0002058261:ScheduleOfShareOptionPlanTableTextBlock
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      id="Fact007246">&lt;table cellpadding="0" cellspacing="0" id="xdx_89B_ecustom--ScheduleOfShareOptionPlanTableTextBlock_pn3n3_zO0Ck6q6uBu2" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Share-based payment arrangements (Details)"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_8B6_zLPxOsga0OK7" style="display: none"&gt;Schedule of share option plan&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Grant date&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Number of&lt;br/&gt;instruments&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Vesting&lt;br/&gt;conditions&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Contractual&lt;br/&gt;life of options&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Type&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Underlying&lt;br/&gt;assets&lt;/b&gt;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;As of October&#160;1, 2015 (*1)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 7%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_909_ecustom--NumberOfInstruments_pid_c20150929__20151001_fKCoxKQ_____z2gj4VE0LQXi" title="Number of instruments"&gt;9,500,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top; width: 18%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_901_ecustom--VestingCondition_c20150929__20151001_fKCoxKQ_____zQ3P6yUHOrEh" title="Vesting condition"&gt;2 years&#x2019; service from grant date&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top; width: 8%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90C_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20150929__20151001_fKCoxKQ_____zeVXdgXiXFdh" title="Contractual life of options"&gt;9&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top; width: 10%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_902_ecustom--Type_c20150929__20151001_fKCoxKQ_____z1KOpt31nz5j" title="Type"&gt;Equity-settled&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top; width: 18%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_907_ecustom--UnderlyingAssets_c20150929__20151001_fKCoxKQ_____zdHKeRBp3Xtd" title="Underlying assets"&gt;CUBEBIO&#160;Co., Ltd.&#x2019;s ordinary shares&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;As of June&#160;29, 2016 (*2)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90C_ecustom--NumberOfInstruments_pid_c20160601__20160629_fKCoyKQ_____z3bYnRt5xcuc" title="Number of instruments"&gt;85,638&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_903_ecustom--VestingCondition_c20160601__20160629_fKCoyKQ_____z4HijUjy3wme" title="Vesting condition"&gt;2 years&#x2019; service from grant date&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90A_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20160601__20160629_fKCoyKQ_____zDe9q0zsLeKb" title="Contractual life of options"&gt;9&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_909_ecustom--Type_c20160601__20160629_fKCoyKQ_____zwAJjgYb2Kzf" title="Type"&gt;Equity-settled&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90C_ecustom--UnderlyingAssets_c20160601__20160629_fKCoyKQ_____zAlEmcjxbPs6" title="Underlying  assets"&gt;CUBEBIO&#160;Co., Ltd.&#x2019;s ordinary shares&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;As of June&#160;15, 2020&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_904_ecustom--NumberOfInstruments_pid_c20200601__20200615_zgMTKU9aSE5k" title="Number of instruments"&gt;7,000,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_908_ecustom--VestingCondition_c20200601__20200615_zbqjNYYxSS51" title="Vesting condition"&gt;2 years&#x2019; service from grant date&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_902_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20200601__20200615_zTt0eirXTHda" title="Contractual life of options"&gt;7&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_908_ecustom--Type_c20200601__20200615_ziQRNmaaVAy9" title="Type"&gt;Equity-settled&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_905_ecustom--UnderlyingAssets_c20200601__20200615_z2CYunEkxbUl" title="Underlying  assets"&gt;CUBEBIO&#160;Co., Ltd.&#x2019;s ordinary shares&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Total share options&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_900_ecustom--NumberOfInstruments_pid_c20260101__20260630_z21mQLSaPCz1" title="Number of instruments"&gt;16,585,638&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;div style="margin: 0pt auto 0pt 0; font-family: Times New Roman, Times, Serif; width: 25%"&gt;&lt;div style="border-top: Black 1pt solid; font: 1pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in; text-align: left"&gt;&lt;span id="xdx_F00_z5o47Nfwt3Jk" style="font-family: Times New Roman, Times, Serif"&gt;(*1)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F18_zDdMfsHjRGEl" style="font-family: Times New Roman, Times, Serif"&gt;The options granted as of October&#160;1, 2015 have been fully vested. Certain of these options were exercised, and the remaining options expired upon reaching the end of their contractual life. As of June&#160;30, 2026, there were no exercisable options outstanding related to this grant.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span id="xdx_F0A_zO1s6K8WlnM8" style="font-family: Times New Roman, Times, Serif"&gt;(*2)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F1C_zymhyHUzB8Te" style="font-family: Times New Roman, Times, Serif"&gt;The options granted as of June&#160;29, 2016 have been fully vested and exercised. As of June&#160;30, 2026, there were no exercisable options outstanding related to this grant.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:ScheduleOfShareOptionPlanTableTextBlock>
    <cik0002058261:NumberOfInstruments
      contextRef="From2015-09-292015-10-01_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact007248"
      unitRef="Shares">9500000</cik0002058261:NumberOfInstruments>
    <cik0002058261:VestingCondition
      contextRef="From2015-09-292015-10-01_custom_CubebioCo.Ltd.Member"
      id="Fact007250">2 years&#x2019; service from grant date</cik0002058261:VestingCondition>
    <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019
      contextRef="From2015-09-292015-10-01_custom_CubebioCo.Ltd.Member"
      id="Fact007252">P9Y</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
    <cik0002058261:Type
      contextRef="From2015-09-292015-10-01_custom_CubebioCo.Ltd.Member"
      id="Fact007254">Equity-settled</cik0002058261:Type>
    <cik0002058261:UnderlyingAssets
      contextRef="From2015-09-292015-10-01_custom_CubebioCo.Ltd.Member"
      id="Fact007256">CUBEBIO&#160;Co., Ltd.&#x2019;s ordinary shares</cik0002058261:UnderlyingAssets>
    <cik0002058261:NumberOfInstruments
      contextRef="From2016-06-012016-06-29_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact007258"
      unitRef="Shares">85638</cik0002058261:NumberOfInstruments>
    <cik0002058261:VestingCondition
      contextRef="From2016-06-012016-06-29_custom_CubebioCo.Ltd.Member"
      id="Fact007260">2 years&#x2019; service from grant date</cik0002058261:VestingCondition>
    <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019
      contextRef="From2016-06-012016-06-29_custom_CubebioCo.Ltd.Member"
      id="Fact007262">P9Y</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
    <cik0002058261:Type
      contextRef="From2016-06-012016-06-29_custom_CubebioCo.Ltd.Member"
      id="Fact007264">Equity-settled</cik0002058261:Type>
    <cik0002058261:UnderlyingAssets
      contextRef="From2016-06-012016-06-29_custom_CubebioCo.Ltd.Member"
      id="Fact007266">CUBEBIO&#160;Co., Ltd.&#x2019;s ordinary shares</cik0002058261:UnderlyingAssets>
    <cik0002058261:NumberOfInstruments
      contextRef="From2020-06-012020-06-15_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact007268"
      unitRef="Shares">7000000</cik0002058261:NumberOfInstruments>
    <cik0002058261:VestingCondition
      contextRef="From2020-06-012020-06-15_custom_CubebioCo.Ltd.Member"
      id="Fact007270">2 years&#x2019; service from grant date</cik0002058261:VestingCondition>
    <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019
      contextRef="From2020-06-012020-06-15_custom_CubebioCo.Ltd.Member"
      id="Fact007272">P7Y</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
    <cik0002058261:Type
      contextRef="From2020-06-012020-06-15_custom_CubebioCo.Ltd.Member"
      id="Fact007274">Equity-settled</cik0002058261:Type>
    <cik0002058261:UnderlyingAssets
      contextRef="From2020-06-012020-06-15_custom_CubebioCo.Ltd.Member"
      id="Fact007276">CUBEBIO&#160;Co., Ltd.&#x2019;s ordinary shares</cik0002058261:UnderlyingAssets>
    <cik0002058261:NumberOfInstruments
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact007278"
      unitRef="Shares">16585638</cik0002058261:NumberOfInstruments>
    <cik0002058261:ScheduleOfShareOptionGrantTableTextBlock
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      id="Fact007282">&lt;table cellpadding="0" cellspacing="0" id="xdx_892_ecustom--ScheduleOfShareOptionGrantTableTextBlock_pn3n3_zVAy0yVZU0gg" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Share-based payment arrangements (Details 1)"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: #FFFFFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_8BC_zE07DketrWzc" style="display: none"&gt;Schedule of share option grant&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;th style="border-bottom: #000000 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Share option plan (equity-settled)&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;June 15,&lt;br/&gt;2020&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;(In Korean Won and number of shares)&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Fair value of option&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 9%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_909_eifrs-full--WeightedAverageFairValueAtMeasurementDateShareOptionsGranted_iI_pn3n3_c20200615__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ShareOptionPlanEquitySettledMember_zTb3n0v9N6id" title="Fair value of option"&gt;1,132&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: #FFFFFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Share price&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90E_eifrs-full--WeightedAverageSharePrice2019_pid_c20200601__20200615__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ShareOptionPlanEquitySettledMember_zgfsZMxmhBKk" title="Share price"&gt;1,412&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Exercise price&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_903_eifrs-full--ProceedsFromExerciseOfOptions_pn3n3_c20200601__20200615__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ShareOptionPlanEquitySettledMember_zz6OqzS0y8j1" title="Exercise price"&gt;500&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: #FFFFFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Risk - free interest rate (based on government bonds)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90C_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20200601__20200615__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ShareOptionPlanEquitySettledMember_zvsBTlIoknhk" title="Risk- free interest rate (based on government bonds)"&gt;3.89&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Volatility (*)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90A_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20200601__20200615__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ShareOptionPlanEquitySettledMember_fKCop_zUZFGut0Ppz2" title="Volatility"&gt;83.78&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: #FFFFFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Expected term (years)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_904_eifrs-full--DescriptionOfOptionLifeShareOptionsGranted_dtY_uDecimal_c20200601__20200615__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ShareOptionPlanEquitySettledMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zYU9yoHL6bdk" title="Expected term (years)"&gt;4&lt;/span&gt; ~ &lt;span id="xdx_908_eifrs-full--DescriptionOfOptionLifeShareOptionsGranted_dtY_uDecimal_c20200601__20200615__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ShareOptionPlanEquitySettledMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zaAl1PshjL54" title="Expected term (years)"&gt;5&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Expected dividend&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90A_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20200601__20200615__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ShareOptionPlanEquitySettledMember_zdCpoyNXzXT2" title="Expected dividend"&gt;0&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;div style="margin: 0pt auto 0pt 0; font-family: Times New Roman, Times, Serif; width: 25%"&gt;&lt;div style="border-top: Black 1pt solid; font: 1pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"&gt;&lt;span id="xdx_F02_zqJ20CQIfdOh" style="font-family: Times New Roman, Times, Serif"&gt;(*)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F16_zwm4k6Z9Fw6c" style="font-family: Times New Roman, Times, Serif"&gt;Volatility has been calculated based on an evaluation of the historical volatility of other companies&#x2019; share prices, which are listed in KOSDAQ, particularly over the historical period commensurate with the prior year.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:ScheduleOfShareOptionGrantTableTextBlock>
    <ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted
      contextRef="AsOf2020-06-15_custom_ShareOptionPlanEquitySettledMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007284"
      unitRef="KRW">1132000</ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted>
    <ifrs-full:WeightedAverageSharePrice2019
      contextRef="From2020-06-012020-06-15_custom_ShareOptionPlanEquitySettledMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact007286"
      unitRef="KRWShares">1412</ifrs-full:WeightedAverageSharePrice2019>
    <ifrs-full:ProceedsFromExerciseOfOptions
      contextRef="From2020-06-012020-06-15_custom_ShareOptionPlanEquitySettledMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007288"
      unitRef="KRW">500000</ifrs-full:ProceedsFromExerciseOfOptions>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="From2020-06-012020-06-15_custom_ShareOptionPlanEquitySettledMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact007290"
      unitRef="Pure">0.0389</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="From2020-06-012020-06-15_custom_ShareOptionPlanEquitySettledMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact007292"
      unitRef="Pure">0.8378</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfOptionLifeShareOptionsGranted
      contextRef="From2020-06-012020-06-15_custom_ShareOptionPlanEquitySettledMember_ifrs-full_BottomOfRangeMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007294"
      unitRef="Decimal">4000</ifrs-full:DescriptionOfOptionLifeShareOptionsGranted>
    <ifrs-full:DescriptionOfOptionLifeShareOptionsGranted
      contextRef="From2020-06-012020-06-15_custom_ShareOptionPlanEquitySettledMember_ifrs-full_TopOfRangeMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007296"
      unitRef="Decimal">5000</ifrs-full:DescriptionOfOptionLifeShareOptionsGranted>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="From2020-06-012020-06-15_custom_ShareOptionPlanEquitySettledMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact007298"
      unitRef="Pure">0</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <cik0002058261:ReconciliationofoutstandingshareOptionsTableTextBlock
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      id="Fact007308">&lt;table cellpadding="0" cellspacing="0" id="xdx_892_ecustom--ReconciliationofoutstandingshareOptionsTableTextBlock_pn3n3_zqLucsPNzng8" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Share-based payment arrangements (Details 2)"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_8B3_zetecQrmUwtf" style="display: none"&gt;Schedule of reconciliation of outstanding share options&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Six-month&lt;br/&gt;period ended&lt;br/&gt;June&#160;30,&lt;br/&gt;2026&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Six-month&lt;br/&gt;period ended&lt;br/&gt;June&#160;30,&lt;br/&gt;2025&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="border-bottom: #000000 1pt solid; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Share option plan (equity-settled)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Number of&lt;br/&gt;options&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Exercise &lt;br/&gt;Price(*)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Number of&lt;br/&gt;options&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Exercise &lt;br/&gt;Price(*)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="16" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;(In Korean Won and number of options)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Outstanding at January&#160;1&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_903_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_uShares_c20260101__20260630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ShareOptionPlanEquitySettledMember_zAklebGa06X1" title="Number of options, outstanding at beginning"&gt;640,160&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90E_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iS_pid_c20260101__20260630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ShareOptionPlanEquitySettledMember_fKCop_z0XKEeSKw2pc" title="Exercise price, at beginning"&gt;500&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_908_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_uShares_c20250101__20250630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ShareOptionPlanEquitySettledMember_zNOTIAnARcdh" title="Number of options, outstanding at beginning"&gt;640,160&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_902_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iS_pid_c20250101__20250630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ShareOptionPlanEquitySettledMember_fKCop_z1iBVcotJCjj" title="Exercise price, at beginning"&gt;500&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Exercised during the period&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90B_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pid_di_uShares_c20260101__20260630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ShareOptionPlanEquitySettledMember_zlXKhFQpkt62" title="Exercised during the year"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7318"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90B_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_di_uShares_c20250101__20250630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ShareOptionPlanEquitySettledMember_z4MzpmBJTXa7" title="Exercised during the year"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7320"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Outstanding at June&#160;30&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_902_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_uShares_c20260101__20260630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ShareOptionPlanEquitySettledMember_zNVW4IoSxex2" title="Number of options, outstanding at end"&gt;640,160&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90B_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iE_pid_c20260101__20260630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ShareOptionPlanEquitySettledMember_fKCop_zPIj6QoyKF5c" title="Exercise price, at end"&gt;500&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_908_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_uShares_c20250101__20250630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ShareOptionPlanEquitySettledMember_zVRhe4Km6Vqj" title="Number of options, outstanding at end"&gt;640,160&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_904_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iE_pid_c20250101__20250630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ShareOptionPlanEquitySettledMember_fKCop_z4ATWjkpG9X8" title="Exercise price, at end"&gt;500&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Exercisable at June&#160;30&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_903_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pid_uShares_c20260630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ShareOptionPlanEquitySettledMember_zXLIVuhiUQXg" title="Number of options, exercisable"&gt;640,160&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_906_ecustom--WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pid_c20260630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ShareOptionPlanEquitySettledMember_fKCop_zmhHEBM4sHE9" title="Exercise price"&gt;500&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_909_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pid_uShares_c20250630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ShareOptionPlanEquitySettledMember_zxobTHPbaRL5" title="Number of options, exercisable"&gt;640,160&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_908_ecustom--WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pid_c20250630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ShareOptionPlanEquitySettledMember_fKCop_zqgV8nomoh15" title="Exercise price"&gt;500&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;div style="margin: 0pt auto 0pt 0; font-family: Times New Roman, Times, Serif; width: 25%"&gt;&lt;div style="border-top: Black 1pt solid; font: 1pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"&gt;&lt;span id="xdx_F06_z3OkA0mMuY15" style="font-family: Times New Roman, Times, Serif"&gt;(*)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F16_zhHsPR2NQKh5" style="font-family: Times New Roman, Times, Serif"&gt;Weighted average exercise price per share.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:ReconciliationofoutstandingshareOptionsTableTextBlock>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2025-12-31_custom_ShareOptionPlanEquitySettledMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact007310"
      unitRef="Shares">640160</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="AsOf2025-12-31_custom_ShareOptionPlanEquitySettledMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact007312"
      unitRef="KRWShares">500</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2024-12-31_custom_ShareOptionPlanEquitySettledMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact007314"
      unitRef="Shares">640160</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="AsOf2024-12-31_custom_ShareOptionPlanEquitySettledMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact007316"
      unitRef="KRWShares">500</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2026-06-30_custom_ShareOptionPlanEquitySettledMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact007322"
      unitRef="Shares">640160</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="AsOf2026-06-30_custom_ShareOptionPlanEquitySettledMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact007324"
      unitRef="KRWShares">500</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2025-06-30_custom_ShareOptionPlanEquitySettledMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact007326"
      unitRef="Shares">640160</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="AsOf2025-06-30_custom_ShareOptionPlanEquitySettledMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact007328"
      unitRef="KRWShares">500</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement
      contextRef="AsOf2026-06-30_custom_ShareOptionPlanEquitySettledMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact007330"
      unitRef="Shares">640160</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
    <cik0002058261:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement
      contextRef="AsOf2026-06-30_custom_ShareOptionPlanEquitySettledMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact007332"
      unitRef="Shares">500</cik0002058261:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement
      contextRef="AsOf2025-06-30_custom_ShareOptionPlanEquitySettledMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact007334"
      unitRef="Shares">640160</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
    <cik0002058261:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement
      contextRef="AsOf2025-06-30_custom_ShareOptionPlanEquitySettledMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact007336"
      unitRef="Shares">500</cik0002058261:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement>
    <ifrs-full:DisclosureOfRelatedPartyExplanatory
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      id="Fact007339">&lt;p id="xdx_80E_eifrs-full--DisclosureOfRelatedPartyExplanatory_zCeQoeOwWkM6" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;25. &lt;span id="xdx_828_zDDI8MD9LyFc"&gt;Related parties&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;A.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;List of related parties&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;List of related parties that had transactions with the Company for the periods covered by the unaudited interim condensed financial statements as of June&#160;30, 2026 and December&#160;31, 2025 is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Related parties (Details)"&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif"&gt;
    &lt;th style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Relationship&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;June&#160;30,&lt;br/&gt;2026&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2025&lt;/b&gt;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-family: Times New Roman, Times, Serif; vertical-align: top; width: 46%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Entity that has significant influence over the Company (*1)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center; width: 25%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Well Core Co., Ltd. (&#x201c;Well Core&#x201d;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center; width: 25%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Well Core Co., Ltd. (&#x201c;Well Core&#x201d;)&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Entities controlled by Key Management Personnel (*2)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Dongsung D&amp;amp;C Co., Ltd. (&#x201c;Dongsung D&amp;amp;C&#x201d;), CubeBio Holdings., Ltd. (&#x201c;CubeBio Holdings&#x201d;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Dongsung D&amp;amp;C Co., Ltd. (&#x201c;Dongsung D&amp;amp;C&#x201d;), CubeBio Holdings., Ltd. (&#x201c;CubeBio Holdings&#x201d;)&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span title="Related party"&gt;Other related parties&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(*3)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(*3)&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;div style="margin: 0pt auto 0pt 0; font-family: Times New Roman, Times, Serif; width: 25%"&gt;&lt;div style="border-top: Black 1pt solid; font: 1pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(*1)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Well Core Co., Ltd. (&#x201c;Well Core&#x201d;) is an entity that has significant influence over the Company.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(*2)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Dongsung D&amp;amp;C Co., Ltd. (&#x201c;Dongsung D&amp;amp;C&#x201d;) and CubeBio Holdings Co., Ltd. (&#x201c;CubeBio Holdings&#x201d;) are related parties as they are controlled by Yun Woo Choo and Eun Jong Choi, respectively, who are members of the Company&#x2019;s key management personnel.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(*3)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Other related parties include a member of the key management personnel of the reporting entity, a close member of the person&#x2019;s family, and an entity that is controlled or jointly controlled by such person.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

















&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;B.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Transactions with related parties&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Details of transactions with related parties for the six-month periods ended June&#160;30, 2026 and 2025 are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_891_ecustom--ScheduleOfTransactionWithRelatedPartiesTableTextBlock_pn3n3_zruq1RJOrbm6" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Related parties (Details 2)"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&lt;span id="xdx_8BB_zE49IEjpeJq4" style="display: none"&gt;Schedule of transaction with related parties&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 0.5pt; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="6" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: center"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Six-month&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;period ended&lt;br/&gt;June&#160;30,&lt;br/&gt;2026&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Six-month&lt;br/&gt;period ended &lt;br/&gt;June&#160;30,&lt;br/&gt;2025&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Related party&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Name of&lt;br/&gt;entity&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Interest&lt;br/&gt;income&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Interest&lt;br/&gt;expenses&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Interest&lt;br/&gt;income&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Interest&lt;br/&gt;expenses&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="14" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top; width: 36%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90D_ecustom--RelatedParty_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--WellCoreMember_zvbUhmV6uCwf" title="Related party"&gt;Entity that has significant influence over the Company&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; width: 20%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_907_eifrs-full--NameOfParentEntity_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--WellCoreMember_zIfKza3gH2u8" title="Name of entity"&gt;Well Core&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 7%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90D_ecustom--InterestIncome_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--WellCoreMember_zzBqnz7qbwF3" title="Interest income"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7354"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 7%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90E_ecustom--InterestExpenses_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--WellCoreMember_z7R1oYwBn99i" title="Interest expenses"&gt;11,973&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 7%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90F_ecustom--InterestIncome_pn3n3_c20250101__20250630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--WellCoreMember_zJyAFJs2qvTj" title="Interest income"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7358"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 7%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90A_ecustom--InterestExpenses_pn3n3_c20250101__20250630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--WellCoreMember_zVQ8coaEav7i" title="Interest expenses"&gt;715&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90C_ecustom--RelatedParty_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--DongsungDAndCMember_zdwdvWeb16td" title="Related party"&gt;Entities controlled by Key Management Personnel&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90D_eifrs-full--NameOfParentEntity_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--DongsungDAndCMember_zkZN62WgswU5" title="Name of entity"&gt;Dongsung D&amp;amp;C&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_909_ecustom--InterestIncome_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--DongsungDAndCMember_zTr3YPPSuxQd" title="Interest income"&gt;5,560&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_906_ecustom--InterestExpenses_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--DongsungDAndCMember_zCk7egsDFH1a" title="Interest expenses"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7368"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_908_ecustom--InterestIncome_pn3n3_c20250101__20250630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--DongsungDAndCMember_zyu5qO8C5Dg3" title="Interest income"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7370"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90E_ecustom--InterestExpenses_pn3n3_c20250101__20250630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--DongsungDAndCMember_zMw72KV9Ort" title="Interest expenses"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7372"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_901_ecustom--RelatedParty_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubeBioHoldingsLtdMember_z4YpamANFFA2" title="Related party"&gt;Entities controlled by Key Management Personnel&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90B_eifrs-full--NameOfParentEntity_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubeBioHoldingsLtdMember_zg7OJaQebLU1" title="Name of entity"&gt;CubeBio Holdings&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_906_ecustom--InterestIncome_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubeBioHoldingsLtdMember_zSWdirKQ7GRf" title="Interest income"&gt;1,207&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_903_ecustom--InterestExpenses_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubeBioHoldingsLtdMember_z92gAiVYhmX9" title="Interest expenses"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7380"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_901_ecustom--InterestIncome_pn3n3_c20250101__20250630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubeBioHoldingsLtdMember_z7fyfFCjZD2h" title="Interest income"&gt;928&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_904_ecustom--InterestExpenses_pn3n3_c20250101__20250630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubeBioHoldingsLtdMember_zpJ5TCSrSSvg" title="Interest expenses"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7384"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_905_ecustom--RelatedParty_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--JaeMyungKimMember_zAv3Bla5yGN2" title="Related party"&gt;Key management personnel&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90F_eifrs-full--NameOfParentEntity_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--JaeMyungKimMember_zlYmcXtwjjFh" title="Name of entity"&gt;Noh Bin Park&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90E_ecustom--InterestIncome_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--NohBinParkNohBinParkMember_zP4cjHzMsa7" title="Interest income"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7390"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_905_ecustom--InterestExpenses_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--NohBinParkNohBinParkMember_zs3vnOAWHPgl" title="Interest expenses"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7392"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_905_ecustom--InterestIncome_pn3n3_c20250101__20250630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--NohBinParkNohBinParkMember_zetvfIxcqqni" title="Interest income"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7394"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_908_ecustom--InterestExpenses_pn3n3_c20250101__20250630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--NohBinParkNohBinParkMember_z1F0sMxyymB5" title="Interest expenses"&gt;1,472&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_907_ecustom--RelatedParty_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--NohBinParkNohBinParkMember_zAWM7ISgrfT9" title="Related party"&gt;Key management personnel&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_908_eifrs-full--NameOfParentEntity_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--NohBinParkNohBinParkMember_z5fhtPInjB98" title="Name of entity"&gt;Ho Sung Han&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_909_ecustom--InterestIncome_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--HoSungHanMember_z8NrL0OQW7y1" title="Interest income"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7402"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_900_ecustom--InterestExpenses_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--HoSungHanMember_ztECUuZw1KWd" title="Interest expenses"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7404"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_904_ecustom--InterestIncome_pn3n3_c20250101__20250630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--HoSungHanMember_z9MVRmK2wXC9" title="Interest income"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7406"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90D_ecustom--InterestExpenses_pn3n3_c20250101__20250630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--HoSungHanMember_zRv0L5oYiJDg" title="Interest expenses"&gt;1,104&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_906_ecustom--RelatedParty_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--HoSungHanMember_zRGXKXiVww3e" title="Related party"&gt;Key management personnel&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_907_eifrs-full--NameOfParentEntity_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--HoSungHanMember_zUYRO4JTtNq9" title="Name of entity"&gt;Eun Jong Choi&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90D_ecustom--InterestIncome_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember_zOPFOCMIQPo8" title="Interest income"&gt;3,194&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90D_ecustom--InterestExpenses_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember_zjuUgGhiLGz6" title="Interest expenses"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7416"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_906_ecustom--InterestIncome_pn3n3_c20250101__20250630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember_zhalAyW3zNXb" title="Interest income"&gt;3,194&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_904_ecustom--InterestExpenses_pn3n3_c20250101__20250630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember_z89YEcwAFT16" title="Interest expenses"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7420"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_908_ecustom--RelatedParty_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--SeYoonKimMember_zH2ITj2omfRg" title="Related party"&gt;Other related party&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90B_eifrs-full--NameOfParentEntity_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--SeYoonKimMember_zOHjibYzcUoe" title="Name of entity"&gt;Gyung Ha Yu&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_900_ecustom--InterestIncome_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--GyungHaYuMember_zDXezmtqY5c6" title="Interest income"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7426"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90E_ecustom--InterestExpenses_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--GyungHaYuMember_zOZpJKQNUCoe" title="Interest expenses"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7428"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90B_ecustom--InterestIncome_pn3n3_c20250101__20250630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--GyungHaYuMember_ziECN0B1CeXe" title="Interest income"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7430"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90C_ecustom--InterestExpenses_pn3n3_c20250101__20250630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--GyungHaYuMember_zNgCJzlkXld7" title="Interest expenses"&gt;1,218&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_909_ecustom--InterestIncome_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember_z1KHmbr7wEPi" title="Interest income"&gt;9,961&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_901_ecustom--InterestExpenses_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember_zNaSAoP5f5vc" title="Interest expenses"&gt;11,973&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_900_ecustom--InterestIncome_pn3n3_c20250101__20250630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember_zOY21LcNyMVj" title="Interest income"&gt;4,122&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90D_ecustom--InterestExpenses_pn3n3_c20250101__20250630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember_zVzCmlqXaMvg" title="Interest expenses"&gt;4,509&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AB_z9YniWKtREw8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;C.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Account balances with related parties&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Details of receivables and payables account balances with related parties as of June&#160;30, 2026 and December&#160;31, 2025 are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_891_ecustom--ScheduleOfPayablesAndReceivablesRelatedPartiesTableTextBlock_pn3n3_z0uIjWceinX5" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Related parties (Details)"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&lt;span id="xdx_8B2_zHzPse7MFr28" style="display: none"&gt;Schedule of receivables and payables account balances&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;June&#160;30,&lt;br/&gt;2026&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2025&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Related party&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Name of&lt;br/&gt;entity&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Payables&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Receivables&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Payables&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Receivables&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="14" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top; width: 36%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Entity that has significant influence over the Company&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left; width: 20%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Well Core&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 7%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_901_eifrs-full--TradeAndOtherPayables_iI_pn3n3_c20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--WellCoreMember_zoMUJcEndoPa" title="Payables"&gt;1,011,973&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 7%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90E_ecustom--OtherReceivable_iI_pn3n3_c20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--WellCoreMember_zCdqNx8kWOw9" title="Receivables"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7446"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 7%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_909_eifrs-full--TradeAndOtherPayables_iI_pn3n3_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--DongsungDAndCMember_zVYxFTQ1ga62" title="Payables"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7448"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 7%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90E_ecustom--OtherReceivable_iI_pn3n3_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--WellCoreMember_zgKO9DNYEoOa" title="Receivables"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7450"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Entities controlled by Key Management Personnel&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Dongsung D&amp;amp;C&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90B_eifrs-full--TradeAndOtherPayables_iI_pn3n3_c20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--DongsungDAndCMember_zqxvtT74nuPf" title="Payables"&gt;1,280,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_901_ecustom--OtherReceivable_iI_pn3n3_c20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--DongsungDAndCMember_z57iCZVrm4Mj" title="Receivables"&gt;326,856&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_900_eifrs-full--TradeAndOtherPayables_iI_pn3n3_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--DongsungDAndCMember_zHf2iGglBA4c" title="Payables"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7456"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_902_ecustom--OtherReceivable_iI_pn3n3_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--DongsungDAndCMember_zUCVsRxgDTzj" title="Receivables"&gt;221,295&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Entities controlled by Key Management Personnel&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;CubeBio Holdings&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_909_eifrs-full--TradeAndOtherPayables_iI_pn3n3_c20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubeBioHoldingsLtdMember_zspMBieRuKH5" title="Payables"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7460"&gt;-&lt;/span&gt;&lt;/span&gt;&#x3000;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_903_ecustom--OtherReceivable_iI_pn3n3_c20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubeBioHoldingsLtdMember_zJUKvFjrItui" title="Receivables"&gt;55,859&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_909_eifrs-full--TradeAndOtherPayables_iI_pn3n3_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubeBioHoldingsLtdMember_z0BESYs0MR0h" title="Payables"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7464"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_908_ecustom--OtherReceivable_iI_pn3n3_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubeBioHoldingsLtdMember_zZpux4aYSCR" title="Receivables"&gt;45,564&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Key management personnel&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Eun Jong Choi (*)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_909_eifrs-full--TradeAndOtherPayables_iI_pn3n3_c20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember_fKCop_z4YiZS1wOJGb" title="Payables"&gt;5,235&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_907_ecustom--OtherReceivable_iI_pn3n3_c20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember_fKCop_zPfkzJltET48" title="Receivables"&gt;179,229&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_909_eifrs-full--TradeAndOtherPayables_iI_pn3n3_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember_fKCop_zuLg27pqV9l4" title="Payables"&gt;24,855&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90E_ecustom--OtherReceivable_iI_pn3n3_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember_fKCop_za7jEMjwu1Tf" title="Receivables"&gt;176,035&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Key management personnel&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Yun Woo Choo&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90D_eifrs-full--TradeAndOtherPayables_iI_pn3n3_c20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--YunWooChooMember_zrFHUbIfL89j" title="Payables"&gt;72,383&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_904_ecustom--OtherReceivable_iI_pn3n3_c20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--YunWooChooMember_fKCop_zYVEVkZR4Wn2" title="Receivables"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7478"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_901_eifrs-full--TradeAndOtherPayables_iI_pn3n3_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--YunWooChooMember_zHj6xSh8aoL7" title="Payables"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7480"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90B_ecustom--OtherReceivable_iI_pn3n3_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--YunWooChooMember_fKCop_zgM72kKolhtg" title="Receivables"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7482"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Other related party&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Jung Gon Kim&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: #000000 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_907_eifrs-full--TradeAndOtherPayables_iI_pn3n3_c20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--JungGonKimMember_zYXw3Pb4Eeb9" title="Payables"&gt;1,900,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90A_ecustom--OtherReceivable_iI_pn3n3_c20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--JungGonKimMember_zwCp2kVIU621" title="Receivables"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7486"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_905_eifrs-full--TradeAndOtherPayables_iI_pn3n3_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--JungGonKimMember_ztybbBAWxewb" title="Payables"&gt;300,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90B_ecustom--OtherReceivable_iI_pn3n3_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--JungGonKimMember_zQEtMYXu1uwb" title="Receivables"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7490"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_904_eifrs-full--TradeAndOtherPayables_iI_pn3n3_c20260630_zpaXb7N6kmDa" title="Payables"&gt;4,269,591&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_906_ecustom--OtherReceivable_iI_pn3n3_c20260630_z49OQoHiy2L1" title="Receivables"&gt;561,944&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90A_eifrs-full--TradeAndOtherPayables_iI_pn3n3_c20251231_zxGVkoN96k8l" title="Payables"&gt;324,855&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_904_ecustom--OtherReceivable_iI_pn3n3_c20251231_zV5ujuGTnFD1" title="Receivables"&gt;442,894&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;div style="margin: 0pt auto 0pt 0; font-family: Times New Roman, Times, Serif; width: 25%"&gt;&lt;div style="border-top: Black 1pt solid; font: 1pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"&gt;&lt;span id="xdx_F0E_zKCRSO0A9YC8" style="font-family: Times New Roman, Times, Serif"&gt;(*)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F16_zbUA2qKDGDrh" style="font-family: Times New Roman, Times, Serif"&gt;The Company provided a loan to Eun Jong Choi, a director of the Company, who resigned as CEO on January&#160;30, 2026. As of June&#160;30, 2026, compensation payable to the director was recorded as other payable and remained unpaid. Pursuant to a mutual agreement between the Company and the director, the unpaid compensation is expected to be applied against the outstanding loan receivable from the director. As the offsetting has not been executed as of June&#160;30, 2026, the loan receivable and other payable are presented on a gross basis.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A2_zFMJ1hs3Ijv3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

















&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;D.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Financing transactions with related parties&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Details of significant financing transactions with related parties for the six-month periods ended June&#160;30, 2026 and 2025 are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_899_ecustom--ScheduleOfChangesInRelatedPartyBalancesByAccountTableTextBlock_pn3n3_zgkNvPkKX8Ie" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Related parties (Details 1)"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&lt;span id="xdx_8B5_zWBd7yp4EPOg" style="display: none"&gt;Schedule of changes in related party balances by account&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 0.5pt; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="14" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Six-month&lt;br/&gt;period ended&lt;br/&gt;June&#160;30,&lt;br/&gt;2026&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Related party&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Name of&lt;br/&gt;entity&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Account&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Beginning&lt;br/&gt;Balance&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Increase&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Decrease&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Ending&lt;br/&gt;Balance&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="14" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top; width: 25%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Entity that has significant influence over the Company&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; width: 15%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Well Core&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; width: 15%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Borrowings&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 7%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_903_ecustom--RelatedPartyBalances_iS_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--WellCoreMember__ifrs-full--BorrowingsByNameAxis__custom--BorrowingMember_zMGPxEUpUxj6" title="Beginning Balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7510"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 7%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_902_ecustom--Increase_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--WellCoreMember__ifrs-full--BorrowingsByNameAxis__custom--BorrowingMember_zbGO3h2j8JAk" title="Increase"&gt;1,000,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 7%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_902_ecustom--Decrease_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--WellCoreMember__ifrs-full--BorrowingsByNameAxis__custom--BorrowingMember_zSOUEXaBe3A5" title="Decrease"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7514"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 7%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90A_ecustom--RelatedPartyBalances_iE_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--WellCoreMember__ifrs-full--BorrowingsByNameAxis__custom--BorrowingMember_z6cXe138wwW8" title="Ending Balance"&gt;1,000,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Entity that has significant influence over the Company&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Well Core&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Accrued expense&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_904_ecustom--RelatedPartyBalances_iS_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--WellCoreMember__ifrs-full--BorrowingsByNameAxis__custom--AccruedExpenseMember_zWJMh6k5jzJ8" title="Beginning Balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7518"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_908_ecustom--Increase_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--WellCoreMember__ifrs-full--BorrowingsByNameAxis__custom--AccruedExpenseMember_zUebtoKTzsqi" title="Increase"&gt;11,973&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90B_ecustom--Decrease_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--WellCoreMember__ifrs-full--BorrowingsByNameAxis__custom--AccruedExpenseMember_zHh3hkmwhx05" title="Decrease"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7522"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90C_ecustom--RelatedPartyBalances_iE_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--WellCoreMember__ifrs-full--BorrowingsByNameAxis__custom--AccruedExpenseMember_zIisDLGQb2e5" title="Ending Balance"&gt;11,973&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Entities controlled by Key Management Personnel&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Dongsung D&amp;amp;C&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Short-term loan receivable&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_903_ecustom--RelatedPartyBalances_iS_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--DongsungDAndCMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivableMember_zCmCRrS2pQI9" title="Beginning Balance"&gt;220,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_903_ecustom--Increase_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--DongsungDAndCMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivableMember_zk6YpCjHwEYl" title="Increase"&gt;100,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90B_ecustom--Decrease_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--DongsungDAndCMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivableMember_z23OQ7qFK21g" title="Decrease"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7530"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_904_ecustom--RelatedPartyBalances_iE_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--DongsungDAndCMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivableMember_zweoNDcIHcJ9" title="Ending Balance"&gt;320,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Entities controlled by Key Management Personnel&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Dongsung D&amp;amp;C&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Short-term loan receivable&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_903_ecustom--RelatedPartyBalances_iS_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--DongsungDAndCMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivablesMember_zMUCVQQswjLa" title="Beginning Balance"&gt;1,296&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_905_ecustom--Increase_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--DongsungDAndCMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivablesMember_z2uhDBp9Fh1i" title="Increase"&gt;5,560&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90A_ecustom--Decrease_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--DongsungDAndCMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivablesMember_zzLrdJNZe5Jg" title="Decrease"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7538"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90A_ecustom--RelatedPartyBalances_iE_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--DongsungDAndCMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivablesMember_zv76POU9oZN8" title="Ending Balance"&gt;6,856&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Entities controlled by Key Management Personnel&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Dongsung D&amp;amp;C&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Other payables- Advances received for allotment of common shares (*1)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_906_ecustom--RelatedPartyBalances_iS_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--DongsungDAndCMember__ifrs-full--BorrowingsByNameAxis__custom--OtherPayablesAdvancesReceivedForAllotmentOfCommonSharesMember_fKCoxKQ_____zaPD4kcdwvbb" title="Beginning Balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7542"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90D_ecustom--Increase_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--DongsungDAndCMember__ifrs-full--BorrowingsByNameAxis__custom--OtherPayablesAdvancesReceivedForAllotmentOfCommonSharesMember_fKCoxKQ_____zt2Yk8cUca9d" title="Increase"&gt;1,280,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_908_ecustom--Decrease_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--DongsungDAndCMember__ifrs-full--BorrowingsByNameAxis__custom--OtherPayablesAdvancesReceivedForAllotmentOfCommonSharesMember_fKCoxKQ_____zLBwpQ2Usgc5" title="Decrease"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7546"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90E_ecustom--RelatedPartyBalances_iE_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--DongsungDAndCMember__ifrs-full--BorrowingsByNameAxis__custom--OtherPayablesAdvancesReceivedForAllotmentOfCommonSharesMember_fKCoxKQ_____z9nbhc23krB5" title="Ending Balance"&gt;1,280,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Key management personnel&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Eun Jong Choi&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Short-term loan receivable&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_902_ecustom--RelatedPartyBalances_iS_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivableMember_z43X6aVLjO8k" title="Beginning Balance"&gt;140,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_902_ecustom--Increase_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivableMember_zYxKgkX3bH7a" title="Increase"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7552"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_906_ecustom--Decrease_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivableMember_zyEtz432wDY9" title="Decrease"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7554"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_903_ecustom--RelatedPartyBalances_iE_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivableMember_zgCHVKB8H6f4" title="Ending Balance"&gt;140,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Key management personnel&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Eun Jong Choi&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Short-term loan receivable&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_906_ecustom--RelatedPartyBalances_iS_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivablesMember_zncFkspLUGg7" title="Beginning Balance"&gt;36,035&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_901_ecustom--Increase_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivablesMember_zWZaKZm05cX6" title="Increase"&gt;3,194&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_909_ecustom--Decrease_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivablesMember_ze8I3fRWiHN4" title="Decrease"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7562"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_901_ecustom--RelatedPartyBalances_iE_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivablesMember_zGqsKXvncJBh" title="Ending Balance"&gt;39,229&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Entities controlled by Key Management Personnel&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;CubeBio Holdings&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Short-term loan receivable&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_909_ecustom--RelatedPartyBalances_iS_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubeBioHoldingsLtdMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivableMember_zXJyYO7sxkSa" title="Beginning Balance"&gt;43,047&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_908_ecustom--Increase_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubeBioHoldingsLtdMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivableMember_zWTUCbshY1ja" title="Increase"&gt;8,902&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_908_ecustom--Decrease_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubeBioHoldingsLtdMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivableMember_zaaUVYv5IPdc" title="Decrease"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7570"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_907_ecustom--RelatedPartyBalances_iE_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubeBioHoldingsLtdMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivableMember_zplvjJNWXe34" title="Ending Balance"&gt;51,949&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Entities controlled by Key Management Personnel&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;CubeBio Holdings&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Short-term loan receivable&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_900_ecustom--RelatedPartyBalances_iS_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubeBioHoldingsLtdMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivablesMember_zHoRZbY8Xyue" title="Beginning Balance"&gt;2,517&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_900_ecustom--Increase_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubeBioHoldingsLtdMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivablesMember_zXvsoDW1gnI5" title="Increase"&gt;1,393&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_902_ecustom--Decrease_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubeBioHoldingsLtdMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivablesMember_z50szJPBM1v1" title="Decrease"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7578"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90A_ecustom--RelatedPartyBalances_iE_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubeBioHoldingsLtdMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivablesMember_zxGgTfvWvx1k" title="Ending Balance"&gt;3,910&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Other related party&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Jung Gon Kim&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Other payable- Advances received for sale of treasury shares (*2)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90E_ecustom--RelatedPartyBalances_iS_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--JungGonKimMember__ifrs-full--BorrowingsByNameAxis__custom--OtherPayablesMember_fKCoyKQ_____zLRCGFidAcc6" title="Beginning Balance"&gt;300,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_904_ecustom--Increase_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--JungGonKimMember__ifrs-full--BorrowingsByNameAxis__custom--OtherPayablesMember_fKCoyKQ_____zDQc6SHlEJ6h" title="Increase"&gt;1,600,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90F_ecustom--Decrease_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--JungGonKimMember__ifrs-full--BorrowingsByNameAxis__custom--OtherPayablesMember_fKCoyKQ_____zVGS95DHUcC1" title="Decrease"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7586"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_901_ecustom--RelatedPartyBalances_iE_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--JungGonKimMember__ifrs-full--BorrowingsByNameAxis__custom--OtherPayablesMember_fKCoyKQ_____zDw2M5PUgRp1" title="Ending Balance"&gt;1,900,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td colspan="5" style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_904_ecustom--RelatedPartyBalances_iS_pn3n3_c20260101__20260630_z8a8ucfzB4jj" title="Beginning Balance"&gt;742,895&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_906_ecustom--Increase_pn3n3_c20260101__20260630_zkUApNDA1FIj" title="Increase"&gt;4,011,022&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90B_ecustom--Decrease_pn3n3_c20260101__20260630_zsOzvCpcywy1" title="Decrease"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7594"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_903_ecustom--RelatedPartyBalances_iE_pn3n3_c20260101__20260630_zFRgyXbnyo54" title="Ending Balance"&gt;4,753,917&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;div style="margin: 0pt auto 0pt 0; font-family: Times New Roman, Times, Serif; width: 25%"&gt;&lt;div style="border-top: Black 1pt solid; font: 1pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in; text-align: left"&gt;&lt;span id="xdx_F0F_zyMnmUrj7Vl5" style="font-family: Times New Roman, Times, Serif"&gt;(*1)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F11_zj1Mu9a8ADA7" style="font-family: Times New Roman, Times, Serif"&gt;The Company received an advance payment of KRW 1,280,000 thousand from Dongsung D&amp;amp;C in connection with a planned investment, which was recorded within other payables as of June&#160;30, 2026, as no shares had been issued. Subsequent to the reporting date, the transaction was finalized as a third-party allotment of common shares, under which the advance payment will be applied as share subscription proceeds (refer to Note 29).&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span id="xdx_F0C_zpGVjrA1wnxi" style="font-family: Times New Roman, Times, Serif"&gt;(*2)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F1E_zGPMnaVo3za3" style="font-family: Times New Roman, Times, Serif"&gt;On November&#160;4, 2025, the Company entered into an agreement with Jung Gon Kim to dispose of 1,000,000 treasury shares at KRW 3,000 per share, for total consideration of KRW 3,000,000 thousand. The Company received a down payment of KRW 300,000 thousand in the prior year and an interim payment of KRW 1,600,000 thousand during the six-month period ended June&#160;30, 2026. As the shares had not been transferred as of June&#160;30, 2026, the cumulative amount received of KRW 1,900,000 thousand was recorded as other payable.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A3_zQ9YfRspB17j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

















&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;E.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Key management personnel compensation&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The compensation for key management personnel for the six-month periods ended June&#160;30, 2026 and 2025 is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89C_ecustom--ScheduleOfManagementPersonnelCompensationTableTextBlock_pn3n3_zOZpgmCakBgb" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Related parties (Details 3)"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;&lt;span id="xdx_8B6_zfhB3vkFSc84" style="display: none"&gt;Schedule of compensation for key management personnel&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_498_20260101__20260630_zFMVZFUbkpn8" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49B_20250101__20250630_zhb2O3RerXMi" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Six-month&lt;br/&gt;period ended&lt;br/&gt;June&#160;30,&lt;br/&gt;2026&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Six-month&lt;br/&gt;period ended&lt;br/&gt;June&#160;30,&lt;br/&gt;2025&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="6" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr id="xdx_405_eifrs-full--ShorttermEmployeeBenefitsExpense_i_pn3n" style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Short-term employee benefits&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;177,950&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;245,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_403_eifrs-full--PostemploymentBenefitExpenseDefinedBenefitPlans_i_pn3n" style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Retirement benefit&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;18,422&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;23,951&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_406_eifrs-full--KeyManagementPersonnelCompensationShorttermEmployeeBenefits_i_pn3n" style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;196,372&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;268,951&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AA_zRSqcuzhj01g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The compensation for the Company&#x2019;s key management personnel includes salaries and contributions to a post-employment defined benefit plan. Executive officers also participate in the Company&#x2019;s share option plan.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DisclosureOfRelatedPartyExplanatory>
    <cik0002058261:ScheduleOfTransactionWithRelatedPartiesTableTextBlock
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      id="Fact007348">&lt;table cellpadding="0" cellspacing="0" id="xdx_891_ecustom--ScheduleOfTransactionWithRelatedPartiesTableTextBlock_pn3n3_zruq1RJOrbm6" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Related parties (Details 2)"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&lt;span id="xdx_8BB_zE49IEjpeJq4" style="display: none"&gt;Schedule of transaction with related parties&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 0.5pt; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="6" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: center"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Six-month&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;period ended&lt;br/&gt;June&#160;30,&lt;br/&gt;2026&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Six-month&lt;br/&gt;period ended &lt;br/&gt;June&#160;30,&lt;br/&gt;2025&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Related party&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Name of&lt;br/&gt;entity&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Interest&lt;br/&gt;income&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Interest&lt;br/&gt;expenses&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Interest&lt;br/&gt;income&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Interest&lt;br/&gt;expenses&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="14" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top; width: 36%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90D_ecustom--RelatedParty_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--WellCoreMember_zvbUhmV6uCwf" title="Related party"&gt;Entity that has significant influence over the Company&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; width: 20%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_907_eifrs-full--NameOfParentEntity_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--WellCoreMember_zIfKza3gH2u8" title="Name of entity"&gt;Well Core&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 7%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90D_ecustom--InterestIncome_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--WellCoreMember_zzBqnz7qbwF3" title="Interest income"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7354"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 7%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90E_ecustom--InterestExpenses_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--WellCoreMember_z7R1oYwBn99i" title="Interest expenses"&gt;11,973&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 7%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90F_ecustom--InterestIncome_pn3n3_c20250101__20250630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--WellCoreMember_zJyAFJs2qvTj" title="Interest income"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7358"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 7%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90A_ecustom--InterestExpenses_pn3n3_c20250101__20250630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--WellCoreMember_zVQ8coaEav7i" title="Interest expenses"&gt;715&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90C_ecustom--RelatedParty_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--DongsungDAndCMember_zdwdvWeb16td" title="Related party"&gt;Entities controlled by Key Management Personnel&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90D_eifrs-full--NameOfParentEntity_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--DongsungDAndCMember_zkZN62WgswU5" title="Name of entity"&gt;Dongsung D&amp;amp;C&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_909_ecustom--InterestIncome_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--DongsungDAndCMember_zTr3YPPSuxQd" title="Interest income"&gt;5,560&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_906_ecustom--InterestExpenses_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--DongsungDAndCMember_zCk7egsDFH1a" title="Interest expenses"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7368"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_908_ecustom--InterestIncome_pn3n3_c20250101__20250630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--DongsungDAndCMember_zyu5qO8C5Dg3" title="Interest income"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7370"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90E_ecustom--InterestExpenses_pn3n3_c20250101__20250630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--DongsungDAndCMember_zMw72KV9Ort" title="Interest expenses"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7372"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_901_ecustom--RelatedParty_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubeBioHoldingsLtdMember_z4YpamANFFA2" title="Related party"&gt;Entities controlled by Key Management Personnel&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90B_eifrs-full--NameOfParentEntity_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubeBioHoldingsLtdMember_zg7OJaQebLU1" title="Name of entity"&gt;CubeBio Holdings&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_906_ecustom--InterestIncome_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubeBioHoldingsLtdMember_zSWdirKQ7GRf" title="Interest income"&gt;1,207&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_903_ecustom--InterestExpenses_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubeBioHoldingsLtdMember_z92gAiVYhmX9" title="Interest expenses"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7380"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_901_ecustom--InterestIncome_pn3n3_c20250101__20250630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubeBioHoldingsLtdMember_z7fyfFCjZD2h" title="Interest income"&gt;928&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_904_ecustom--InterestExpenses_pn3n3_c20250101__20250630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubeBioHoldingsLtdMember_zpJ5TCSrSSvg" title="Interest expenses"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7384"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_905_ecustom--RelatedParty_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--JaeMyungKimMember_zAv3Bla5yGN2" title="Related party"&gt;Key management personnel&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90F_eifrs-full--NameOfParentEntity_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--JaeMyungKimMember_zlYmcXtwjjFh" title="Name of entity"&gt;Noh Bin Park&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90E_ecustom--InterestIncome_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--NohBinParkNohBinParkMember_zP4cjHzMsa7" title="Interest income"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7390"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_905_ecustom--InterestExpenses_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--NohBinParkNohBinParkMember_zs3vnOAWHPgl" title="Interest expenses"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7392"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_905_ecustom--InterestIncome_pn3n3_c20250101__20250630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--NohBinParkNohBinParkMember_zetvfIxcqqni" title="Interest income"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7394"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_908_ecustom--InterestExpenses_pn3n3_c20250101__20250630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--NohBinParkNohBinParkMember_z1F0sMxyymB5" title="Interest expenses"&gt;1,472&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_907_ecustom--RelatedParty_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--NohBinParkNohBinParkMember_zAWM7ISgrfT9" title="Related party"&gt;Key management personnel&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_908_eifrs-full--NameOfParentEntity_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--NohBinParkNohBinParkMember_z5fhtPInjB98" title="Name of entity"&gt;Ho Sung Han&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_909_ecustom--InterestIncome_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--HoSungHanMember_z8NrL0OQW7y1" title="Interest income"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7402"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_900_ecustom--InterestExpenses_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--HoSungHanMember_ztECUuZw1KWd" title="Interest expenses"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7404"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_904_ecustom--InterestIncome_pn3n3_c20250101__20250630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--HoSungHanMember_z9MVRmK2wXC9" title="Interest income"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7406"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90D_ecustom--InterestExpenses_pn3n3_c20250101__20250630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--HoSungHanMember_zRv0L5oYiJDg" title="Interest expenses"&gt;1,104&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_906_ecustom--RelatedParty_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--HoSungHanMember_zRGXKXiVww3e" title="Related party"&gt;Key management personnel&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_907_eifrs-full--NameOfParentEntity_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--HoSungHanMember_zUYRO4JTtNq9" title="Name of entity"&gt;Eun Jong Choi&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90D_ecustom--InterestIncome_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember_zOPFOCMIQPo8" title="Interest income"&gt;3,194&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90D_ecustom--InterestExpenses_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember_zjuUgGhiLGz6" title="Interest expenses"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7416"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_906_ecustom--InterestIncome_pn3n3_c20250101__20250630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember_zhalAyW3zNXb" title="Interest income"&gt;3,194&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_904_ecustom--InterestExpenses_pn3n3_c20250101__20250630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember_z89YEcwAFT16" title="Interest expenses"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7420"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_908_ecustom--RelatedParty_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--SeYoonKimMember_zH2ITj2omfRg" title="Related party"&gt;Other related party&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90B_eifrs-full--NameOfParentEntity_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--SeYoonKimMember_zOHjibYzcUoe" title="Name of entity"&gt;Gyung Ha Yu&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_900_ecustom--InterestIncome_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--GyungHaYuMember_zDXezmtqY5c6" title="Interest income"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7426"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90E_ecustom--InterestExpenses_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--GyungHaYuMember_zOZpJKQNUCoe" title="Interest expenses"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7428"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90B_ecustom--InterestIncome_pn3n3_c20250101__20250630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--GyungHaYuMember_ziECN0B1CeXe" title="Interest income"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7430"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90C_ecustom--InterestExpenses_pn3n3_c20250101__20250630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--GyungHaYuMember_zNgCJzlkXld7" title="Interest expenses"&gt;1,218&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_909_ecustom--InterestIncome_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember_z1KHmbr7wEPi" title="Interest income"&gt;9,961&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_901_ecustom--InterestExpenses_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember_zNaSAoP5f5vc" title="Interest expenses"&gt;11,973&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_900_ecustom--InterestIncome_pn3n3_c20250101__20250630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember_zOY21LcNyMVj" title="Interest income"&gt;4,122&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90D_ecustom--InterestExpenses_pn3n3_c20250101__20250630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember_zVzCmlqXaMvg" title="Interest expenses"&gt;4,509&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:ScheduleOfTransactionWithRelatedPartiesTableTextBlock>
    <cik0002058261:RelatedParty
      contextRef="From2026-01-012026-06-30_ifrs-full_RelatedPartiesMember_custom_WellCoreMember_custom_CubebioCo.Ltd.Member"
      id="Fact007350">Entity that has significant influence over the Company</cik0002058261:RelatedParty>
    <ifrs-full:NameOfParentEntity
      contextRef="From2026-01-012026-06-30_ifrs-full_RelatedPartiesMember_custom_WellCoreMember_custom_CubebioCo.Ltd.Member"
      id="Fact007352">Well Core</ifrs-full:NameOfParentEntity>
    <cik0002058261:InterestExpenses
      contextRef="From2026-01-012026-06-30_ifrs-full_RelatedPartiesMember_custom_WellCoreMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007356"
      unitRef="KRW">11973000</cik0002058261:InterestExpenses>
    <cik0002058261:InterestExpenses
      contextRef="From2025-01-012025-06-30_ifrs-full_RelatedPartiesMember_custom_WellCoreMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007360"
      unitRef="KRW">715000</cik0002058261:InterestExpenses>
    <cik0002058261:RelatedParty
      contextRef="From2026-01-012026-06-30_ifrs-full_RelatedPartiesMember_custom_DongsungDAndCMember_custom_CubebioCo.Ltd.Member"
      id="Fact007362">Entities controlled by Key Management Personnel</cik0002058261:RelatedParty>
    <ifrs-full:NameOfParentEntity
      contextRef="From2026-01-012026-06-30_ifrs-full_RelatedPartiesMember_custom_DongsungDAndCMember_custom_CubebioCo.Ltd.Member"
      id="Fact007364">Dongsung D&amp;C</ifrs-full:NameOfParentEntity>
    <cik0002058261:InterestIncome
      contextRef="From2026-01-012026-06-30_ifrs-full_RelatedPartiesMember_custom_DongsungDAndCMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007366"
      unitRef="KRW">5560000</cik0002058261:InterestIncome>
    <cik0002058261:RelatedParty
      contextRef="From2026-01-012026-06-30_ifrs-full_RelatedPartiesMember_custom_CubeBioHoldingsLtdMember_custom_CubebioCo.Ltd.Member"
      id="Fact007374">Entities controlled by Key Management Personnel</cik0002058261:RelatedParty>
    <ifrs-full:NameOfParentEntity
      contextRef="From2026-01-012026-06-30_ifrs-full_RelatedPartiesMember_custom_CubeBioHoldingsLtdMember_custom_CubebioCo.Ltd.Member"
      id="Fact007376">CubeBio Holdings</ifrs-full:NameOfParentEntity>
    <cik0002058261:InterestIncome
      contextRef="From2026-01-012026-06-30_ifrs-full_RelatedPartiesMember_custom_CubeBioHoldingsLtdMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007378"
      unitRef="KRW">1207000</cik0002058261:InterestIncome>
    <cik0002058261:InterestIncome
      contextRef="From2025-01-012025-06-30_ifrs-full_RelatedPartiesMember_custom_CubeBioHoldingsLtdMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007382"
      unitRef="KRW">928000</cik0002058261:InterestIncome>
    <cik0002058261:RelatedParty
      contextRef="From2026-01-012026-06-30_ifrs-full_RelatedPartiesMember_custom_JaeMyungKimMember_custom_CubebioCo.Ltd.Member"
      id="Fact007386">Key management personnel</cik0002058261:RelatedParty>
    <ifrs-full:NameOfParentEntity
      contextRef="From2026-01-012026-06-30_ifrs-full_RelatedPartiesMember_custom_JaeMyungKimMember_custom_CubebioCo.Ltd.Member"
      id="Fact007388">Noh Bin Park</ifrs-full:NameOfParentEntity>
    <cik0002058261:InterestExpenses
      contextRef="From2025-01-012025-06-30_ifrs-full_RelatedPartiesMember_custom_NohBinParkNohBinParkMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007396"
      unitRef="KRW">1472000</cik0002058261:InterestExpenses>
    <cik0002058261:RelatedParty
      contextRef="From2026-01-012026-06-30_ifrs-full_RelatedPartiesMember_custom_NohBinParkNohBinParkMember_custom_CubebioCo.Ltd.Member"
      id="Fact007398">Key management personnel</cik0002058261:RelatedParty>
    <ifrs-full:NameOfParentEntity
      contextRef="From2026-01-012026-06-30_ifrs-full_RelatedPartiesMember_custom_NohBinParkNohBinParkMember_custom_CubebioCo.Ltd.Member"
      id="Fact007400">Ho Sung Han</ifrs-full:NameOfParentEntity>
    <cik0002058261:InterestExpenses
      contextRef="From2025-01-012025-06-30_ifrs-full_RelatedPartiesMember_custom_HoSungHanMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007408"
      unitRef="KRW">1104000</cik0002058261:InterestExpenses>
    <cik0002058261:RelatedParty
      contextRef="From2026-01-012026-06-30_ifrs-full_RelatedPartiesMember_custom_HoSungHanMember_custom_CubebioCo.Ltd.Member"
      id="Fact007410">Key management personnel</cik0002058261:RelatedParty>
    <ifrs-full:NameOfParentEntity
      contextRef="From2026-01-012026-06-30_ifrs-full_RelatedPartiesMember_custom_HoSungHanMember_custom_CubebioCo.Ltd.Member"
      id="Fact007412">Eun Jong Choi</ifrs-full:NameOfParentEntity>
    <cik0002058261:InterestIncome
      contextRef="From2026-01-012026-06-30_ifrs-full_RelatedPartiesMember_custom_EunJongChoiMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007414"
      unitRef="KRW">3194000</cik0002058261:InterestIncome>
    <cik0002058261:InterestIncome
      contextRef="From2025-01-012025-06-30_ifrs-full_RelatedPartiesMember_custom_EunJongChoiMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007418"
      unitRef="KRW">3194000</cik0002058261:InterestIncome>
    <cik0002058261:RelatedParty
      contextRef="From2026-01-012026-06-30_ifrs-full_RelatedPartiesMember_custom_SeYoonKimMember_custom_CubebioCo.Ltd.Member"
      id="Fact007422">Other related party</cik0002058261:RelatedParty>
    <ifrs-full:NameOfParentEntity
      contextRef="From2026-01-012026-06-30_ifrs-full_RelatedPartiesMember_custom_SeYoonKimMember_custom_CubebioCo.Ltd.Member"
      id="Fact007424">Gyung Ha Yu</ifrs-full:NameOfParentEntity>
    <cik0002058261:InterestExpenses
      contextRef="From2025-01-012025-06-30_ifrs-full_RelatedPartiesMember_custom_GyungHaYuMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007432"
      unitRef="KRW">1218000</cik0002058261:InterestExpenses>
    <cik0002058261:InterestIncome
      contextRef="From2026-01-012026-06-30_ifrs-full_RelatedPartiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007434"
      unitRef="KRW">9961000</cik0002058261:InterestIncome>
    <cik0002058261:InterestExpenses
      contextRef="From2026-01-012026-06-30_ifrs-full_RelatedPartiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007436"
      unitRef="KRW">11973000</cik0002058261:InterestExpenses>
    <cik0002058261:InterestIncome
      contextRef="From2025-01-012025-06-30_ifrs-full_RelatedPartiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007438"
      unitRef="KRW">4122000</cik0002058261:InterestIncome>
    <cik0002058261:InterestExpenses
      contextRef="From2025-01-012025-06-30_ifrs-full_RelatedPartiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007440"
      unitRef="KRW">4509000</cik0002058261:InterestExpenses>
    <cik0002058261:ScheduleOfPayablesAndReceivablesRelatedPartiesTableTextBlock
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      id="Fact007442">&lt;table cellpadding="0" cellspacing="0" id="xdx_891_ecustom--ScheduleOfPayablesAndReceivablesRelatedPartiesTableTextBlock_pn3n3_z0uIjWceinX5" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Related parties (Details)"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&lt;span id="xdx_8B2_zHzPse7MFr28" style="display: none"&gt;Schedule of receivables and payables account balances&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;June&#160;30,&lt;br/&gt;2026&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2025&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Related party&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Name of&lt;br/&gt;entity&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Payables&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Receivables&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Payables&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Receivables&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="14" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top; width: 36%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Entity that has significant influence over the Company&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left; width: 20%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Well Core&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 7%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_901_eifrs-full--TradeAndOtherPayables_iI_pn3n3_c20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--WellCoreMember_zoMUJcEndoPa" title="Payables"&gt;1,011,973&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 7%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90E_ecustom--OtherReceivable_iI_pn3n3_c20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--WellCoreMember_zCdqNx8kWOw9" title="Receivables"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7446"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 7%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_909_eifrs-full--TradeAndOtherPayables_iI_pn3n3_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--DongsungDAndCMember_zVYxFTQ1ga62" title="Payables"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7448"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 7%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90E_ecustom--OtherReceivable_iI_pn3n3_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--WellCoreMember_zgKO9DNYEoOa" title="Receivables"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7450"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Entities controlled by Key Management Personnel&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Dongsung D&amp;amp;C&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90B_eifrs-full--TradeAndOtherPayables_iI_pn3n3_c20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--DongsungDAndCMember_zqxvtT74nuPf" title="Payables"&gt;1,280,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_901_ecustom--OtherReceivable_iI_pn3n3_c20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--DongsungDAndCMember_z57iCZVrm4Mj" title="Receivables"&gt;326,856&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_900_eifrs-full--TradeAndOtherPayables_iI_pn3n3_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--DongsungDAndCMember_zHf2iGglBA4c" title="Payables"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7456"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_902_ecustom--OtherReceivable_iI_pn3n3_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--DongsungDAndCMember_zUCVsRxgDTzj" title="Receivables"&gt;221,295&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Entities controlled by Key Management Personnel&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;CubeBio Holdings&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_909_eifrs-full--TradeAndOtherPayables_iI_pn3n3_c20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubeBioHoldingsLtdMember_zspMBieRuKH5" title="Payables"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7460"&gt;-&lt;/span&gt;&lt;/span&gt;&#x3000;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_903_ecustom--OtherReceivable_iI_pn3n3_c20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubeBioHoldingsLtdMember_zJUKvFjrItui" title="Receivables"&gt;55,859&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_909_eifrs-full--TradeAndOtherPayables_iI_pn3n3_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubeBioHoldingsLtdMember_z0BESYs0MR0h" title="Payables"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7464"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_908_ecustom--OtherReceivable_iI_pn3n3_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubeBioHoldingsLtdMember_zZpux4aYSCR" title="Receivables"&gt;45,564&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Key management personnel&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Eun Jong Choi (*)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_909_eifrs-full--TradeAndOtherPayables_iI_pn3n3_c20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember_fKCop_z4YiZS1wOJGb" title="Payables"&gt;5,235&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_907_ecustom--OtherReceivable_iI_pn3n3_c20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember_fKCop_zPfkzJltET48" title="Receivables"&gt;179,229&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_909_eifrs-full--TradeAndOtherPayables_iI_pn3n3_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember_fKCop_zuLg27pqV9l4" title="Payables"&gt;24,855&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90E_ecustom--OtherReceivable_iI_pn3n3_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember_fKCop_za7jEMjwu1Tf" title="Receivables"&gt;176,035&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Key management personnel&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Yun Woo Choo&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90D_eifrs-full--TradeAndOtherPayables_iI_pn3n3_c20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--YunWooChooMember_zrFHUbIfL89j" title="Payables"&gt;72,383&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_904_ecustom--OtherReceivable_iI_pn3n3_c20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--YunWooChooMember_fKCop_zYVEVkZR4Wn2" title="Receivables"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7478"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_901_eifrs-full--TradeAndOtherPayables_iI_pn3n3_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--YunWooChooMember_zHj6xSh8aoL7" title="Payables"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7480"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90B_ecustom--OtherReceivable_iI_pn3n3_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--YunWooChooMember_fKCop_zgM72kKolhtg" title="Receivables"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7482"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Other related party&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Jung Gon Kim&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: #000000 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_907_eifrs-full--TradeAndOtherPayables_iI_pn3n3_c20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--JungGonKimMember_zYXw3Pb4Eeb9" title="Payables"&gt;1,900,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90A_ecustom--OtherReceivable_iI_pn3n3_c20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--JungGonKimMember_zwCp2kVIU621" title="Receivables"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7486"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_905_eifrs-full--TradeAndOtherPayables_iI_pn3n3_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--JungGonKimMember_ztybbBAWxewb" title="Payables"&gt;300,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90B_ecustom--OtherReceivable_iI_pn3n3_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--JungGonKimMember_zQEtMYXu1uwb" title="Receivables"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7490"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_904_eifrs-full--TradeAndOtherPayables_iI_pn3n3_c20260630_zpaXb7N6kmDa" title="Payables"&gt;4,269,591&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_906_ecustom--OtherReceivable_iI_pn3n3_c20260630_z49OQoHiy2L1" title="Receivables"&gt;561,944&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90A_eifrs-full--TradeAndOtherPayables_iI_pn3n3_c20251231_zxGVkoN96k8l" title="Payables"&gt;324,855&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_904_ecustom--OtherReceivable_iI_pn3n3_c20251231_zV5ujuGTnFD1" title="Receivables"&gt;442,894&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;div style="margin: 0pt auto 0pt 0; font-family: Times New Roman, Times, Serif; width: 25%"&gt;&lt;div style="border-top: Black 1pt solid; font: 1pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"&gt;&lt;span id="xdx_F0E_zKCRSO0A9YC8" style="font-family: Times New Roman, Times, Serif"&gt;(*)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F16_zbUA2qKDGDrh" style="font-family: Times New Roman, Times, Serif"&gt;The Company provided a loan to Eun Jong Choi, a director of the Company, who resigned as CEO on January&#160;30, 2026. As of June&#160;30, 2026, compensation payable to the director was recorded as other payable and remained unpaid. Pursuant to a mutual agreement between the Company and the director, the unpaid compensation is expected to be applied against the outstanding loan receivable from the director. As the offsetting has not been executed as of June&#160;30, 2026, the loan receivable and other payable are presented on a gross basis.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:ScheduleOfPayablesAndReceivablesRelatedPartiesTableTextBlock>
    <ifrs-full:TradeAndOtherPayables
      contextRef="AsOf2026-06-30_ifrs-full_RelatedPartiesMember_custom_WellCoreMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007444"
      unitRef="KRW">1011973000</ifrs-full:TradeAndOtherPayables>
    <ifrs-full:TradeAndOtherPayables
      contextRef="AsOf2026-06-30_ifrs-full_RelatedPartiesMember_custom_DongsungDAndCMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007452"
      unitRef="KRW">1280000000</ifrs-full:TradeAndOtherPayables>
    <cik0002058261:OtherReceivable
      contextRef="AsOf2026-06-30_ifrs-full_RelatedPartiesMember_custom_DongsungDAndCMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007454"
      unitRef="KRW">326856000</cik0002058261:OtherReceivable>
    <cik0002058261:OtherReceivable
      contextRef="AsOf2025-12-31_ifrs-full_RelatedPartiesMember_custom_DongsungDAndCMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007458"
      unitRef="KRW">221295000</cik0002058261:OtherReceivable>
    <cik0002058261:OtherReceivable
      contextRef="AsOf2026-06-30_ifrs-full_RelatedPartiesMember_custom_CubeBioHoldingsLtdMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007462"
      unitRef="KRW">55859000</cik0002058261:OtherReceivable>
    <cik0002058261:OtherReceivable
      contextRef="AsOf2025-12-31_ifrs-full_RelatedPartiesMember_custom_CubeBioHoldingsLtdMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007466"
      unitRef="KRW">45564000</cik0002058261:OtherReceivable>
    <ifrs-full:TradeAndOtherPayables
      contextRef="AsOf2026-06-30_ifrs-full_RelatedPartiesMember_custom_EunJongChoiMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007468"
      unitRef="KRW">5235000</ifrs-full:TradeAndOtherPayables>
    <cik0002058261:OtherReceivable
      contextRef="AsOf2026-06-30_ifrs-full_RelatedPartiesMember_custom_EunJongChoiMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007470"
      unitRef="KRW">179229000</cik0002058261:OtherReceivable>
    <ifrs-full:TradeAndOtherPayables
      contextRef="AsOf2025-12-31_ifrs-full_RelatedPartiesMember_custom_EunJongChoiMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007472"
      unitRef="KRW">24855000</ifrs-full:TradeAndOtherPayables>
    <cik0002058261:OtherReceivable
      contextRef="AsOf2025-12-31_ifrs-full_RelatedPartiesMember_custom_EunJongChoiMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007474"
      unitRef="KRW">176035000</cik0002058261:OtherReceivable>
    <ifrs-full:TradeAndOtherPayables
      contextRef="AsOf2026-06-30_ifrs-full_RelatedPartiesMember_custom_YunWooChooMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007476"
      unitRef="KRW">72383000</ifrs-full:TradeAndOtherPayables>
    <ifrs-full:TradeAndOtherPayables
      contextRef="AsOf2026-06-30_ifrs-full_RelatedPartiesMember_custom_JungGonKimMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007484"
      unitRef="KRW">1900000000</ifrs-full:TradeAndOtherPayables>
    <ifrs-full:TradeAndOtherPayables
      contextRef="AsOf2025-12-31_ifrs-full_RelatedPartiesMember_custom_JungGonKimMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007488"
      unitRef="KRW">300000000</ifrs-full:TradeAndOtherPayables>
    <ifrs-full:TradeAndOtherPayables
      contextRef="AsOf2026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007492"
      unitRef="KRW">4269591000</ifrs-full:TradeAndOtherPayables>
    <cik0002058261:OtherReceivable
      contextRef="AsOf2026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007494"
      unitRef="KRW">561944000</cik0002058261:OtherReceivable>
    <ifrs-full:TradeAndOtherPayables
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007496"
      unitRef="KRW">324855000</ifrs-full:TradeAndOtherPayables>
    <cik0002058261:OtherReceivable
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007498"
      unitRef="KRW">442894000</cik0002058261:OtherReceivable>
    <cik0002058261:ScheduleOfChangesInRelatedPartyBalancesByAccountTableTextBlock
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      id="Fact007508">&lt;table cellpadding="0" cellspacing="0" id="xdx_899_ecustom--ScheduleOfChangesInRelatedPartyBalancesByAccountTableTextBlock_pn3n3_zgkNvPkKX8Ie" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Related parties (Details 1)"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&lt;span id="xdx_8B5_zWBd7yp4EPOg" style="display: none"&gt;Schedule of changes in related party balances by account&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 0.5pt; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="14" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Six-month&lt;br/&gt;period ended&lt;br/&gt;June&#160;30,&lt;br/&gt;2026&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Related party&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Name of&lt;br/&gt;entity&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Account&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Beginning&lt;br/&gt;Balance&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Increase&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Decrease&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Ending&lt;br/&gt;Balance&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="14" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top; width: 25%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Entity that has significant influence over the Company&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; width: 15%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Well Core&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; width: 15%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Borrowings&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 7%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_903_ecustom--RelatedPartyBalances_iS_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--WellCoreMember__ifrs-full--BorrowingsByNameAxis__custom--BorrowingMember_zMGPxEUpUxj6" title="Beginning Balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7510"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 7%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_902_ecustom--Increase_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--WellCoreMember__ifrs-full--BorrowingsByNameAxis__custom--BorrowingMember_zbGO3h2j8JAk" title="Increase"&gt;1,000,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 7%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_902_ecustom--Decrease_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--WellCoreMember__ifrs-full--BorrowingsByNameAxis__custom--BorrowingMember_zSOUEXaBe3A5" title="Decrease"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7514"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 7%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90A_ecustom--RelatedPartyBalances_iE_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--WellCoreMember__ifrs-full--BorrowingsByNameAxis__custom--BorrowingMember_z6cXe138wwW8" title="Ending Balance"&gt;1,000,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Entity that has significant influence over the Company&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Well Core&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Accrued expense&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_904_ecustom--RelatedPartyBalances_iS_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--WellCoreMember__ifrs-full--BorrowingsByNameAxis__custom--AccruedExpenseMember_zWJMh6k5jzJ8" title="Beginning Balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7518"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_908_ecustom--Increase_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--WellCoreMember__ifrs-full--BorrowingsByNameAxis__custom--AccruedExpenseMember_zUebtoKTzsqi" title="Increase"&gt;11,973&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90B_ecustom--Decrease_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--WellCoreMember__ifrs-full--BorrowingsByNameAxis__custom--AccruedExpenseMember_zHh3hkmwhx05" title="Decrease"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7522"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90C_ecustom--RelatedPartyBalances_iE_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--WellCoreMember__ifrs-full--BorrowingsByNameAxis__custom--AccruedExpenseMember_zIisDLGQb2e5" title="Ending Balance"&gt;11,973&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Entities controlled by Key Management Personnel&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Dongsung D&amp;amp;C&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Short-term loan receivable&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_903_ecustom--RelatedPartyBalances_iS_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--DongsungDAndCMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivableMember_zCmCRrS2pQI9" title="Beginning Balance"&gt;220,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_903_ecustom--Increase_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--DongsungDAndCMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivableMember_zk6YpCjHwEYl" title="Increase"&gt;100,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90B_ecustom--Decrease_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--DongsungDAndCMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivableMember_z23OQ7qFK21g" title="Decrease"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7530"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_904_ecustom--RelatedPartyBalances_iE_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--DongsungDAndCMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivableMember_zweoNDcIHcJ9" title="Ending Balance"&gt;320,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Entities controlled by Key Management Personnel&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Dongsung D&amp;amp;C&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Short-term loan receivable&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_903_ecustom--RelatedPartyBalances_iS_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--DongsungDAndCMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivablesMember_zMUCVQQswjLa" title="Beginning Balance"&gt;1,296&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_905_ecustom--Increase_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--DongsungDAndCMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivablesMember_z2uhDBp9Fh1i" title="Increase"&gt;5,560&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90A_ecustom--Decrease_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--DongsungDAndCMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivablesMember_zzLrdJNZe5Jg" title="Decrease"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7538"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90A_ecustom--RelatedPartyBalances_iE_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--DongsungDAndCMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivablesMember_zv76POU9oZN8" title="Ending Balance"&gt;6,856&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Entities controlled by Key Management Personnel&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Dongsung D&amp;amp;C&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Other payables- Advances received for allotment of common shares (*1)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_906_ecustom--RelatedPartyBalances_iS_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--DongsungDAndCMember__ifrs-full--BorrowingsByNameAxis__custom--OtherPayablesAdvancesReceivedForAllotmentOfCommonSharesMember_fKCoxKQ_____zaPD4kcdwvbb" title="Beginning Balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7542"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90D_ecustom--Increase_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--DongsungDAndCMember__ifrs-full--BorrowingsByNameAxis__custom--OtherPayablesAdvancesReceivedForAllotmentOfCommonSharesMember_fKCoxKQ_____zt2Yk8cUca9d" title="Increase"&gt;1,280,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_908_ecustom--Decrease_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--DongsungDAndCMember__ifrs-full--BorrowingsByNameAxis__custom--OtherPayablesAdvancesReceivedForAllotmentOfCommonSharesMember_fKCoxKQ_____zLBwpQ2Usgc5" title="Decrease"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7546"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90E_ecustom--RelatedPartyBalances_iE_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--DongsungDAndCMember__ifrs-full--BorrowingsByNameAxis__custom--OtherPayablesAdvancesReceivedForAllotmentOfCommonSharesMember_fKCoxKQ_____z9nbhc23krB5" title="Ending Balance"&gt;1,280,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Key management personnel&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Eun Jong Choi&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Short-term loan receivable&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_902_ecustom--RelatedPartyBalances_iS_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivableMember_z43X6aVLjO8k" title="Beginning Balance"&gt;140,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_902_ecustom--Increase_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivableMember_zYxKgkX3bH7a" title="Increase"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7552"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_906_ecustom--Decrease_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivableMember_zyEtz432wDY9" title="Decrease"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7554"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_903_ecustom--RelatedPartyBalances_iE_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivableMember_zgCHVKB8H6f4" title="Ending Balance"&gt;140,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Key management personnel&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Eun Jong Choi&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Short-term loan receivable&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_906_ecustom--RelatedPartyBalances_iS_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivablesMember_zncFkspLUGg7" title="Beginning Balance"&gt;36,035&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_901_ecustom--Increase_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivablesMember_zWZaKZm05cX6" title="Increase"&gt;3,194&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_909_ecustom--Decrease_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivablesMember_ze8I3fRWiHN4" title="Decrease"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7562"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_901_ecustom--RelatedPartyBalances_iE_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--EunJongChoiMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivablesMember_zGqsKXvncJBh" title="Ending Balance"&gt;39,229&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Entities controlled by Key Management Personnel&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;CubeBio Holdings&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Short-term loan receivable&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_909_ecustom--RelatedPartyBalances_iS_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubeBioHoldingsLtdMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivableMember_zXJyYO7sxkSa" title="Beginning Balance"&gt;43,047&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_908_ecustom--Increase_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubeBioHoldingsLtdMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivableMember_zWTUCbshY1ja" title="Increase"&gt;8,902&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_908_ecustom--Decrease_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubeBioHoldingsLtdMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivableMember_zaaUVYv5IPdc" title="Decrease"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7570"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_907_ecustom--RelatedPartyBalances_iE_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubeBioHoldingsLtdMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivableMember_zplvjJNWXe34" title="Ending Balance"&gt;51,949&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Entities controlled by Key Management Personnel&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;CubeBio Holdings&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Short-term loan receivable&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_900_ecustom--RelatedPartyBalances_iS_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubeBioHoldingsLtdMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivablesMember_zHoRZbY8Xyue" title="Beginning Balance"&gt;2,517&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_900_ecustom--Increase_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubeBioHoldingsLtdMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivablesMember_zXvsoDW1gnI5" title="Increase"&gt;1,393&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_902_ecustom--Decrease_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubeBioHoldingsLtdMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivablesMember_z50szJPBM1v1" title="Decrease"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7578"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90A_ecustom--RelatedPartyBalances_iE_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--CubeBioHoldingsLtdMember__ifrs-full--BorrowingsByNameAxis__custom--ShortTermLoanReceivablesMember_zxGgTfvWvx1k" title="Ending Balance"&gt;3,910&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Other related party&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Jung Gon Kim&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Other payable- Advances received for sale of treasury shares (*2)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90E_ecustom--RelatedPartyBalances_iS_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--JungGonKimMember__ifrs-full--BorrowingsByNameAxis__custom--OtherPayablesMember_fKCoyKQ_____zLRCGFidAcc6" title="Beginning Balance"&gt;300,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_904_ecustom--Increase_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--JungGonKimMember__ifrs-full--BorrowingsByNameAxis__custom--OtherPayablesMember_fKCoyKQ_____zDQc6SHlEJ6h" title="Increase"&gt;1,600,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90F_ecustom--Decrease_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--JungGonKimMember__ifrs-full--BorrowingsByNameAxis__custom--OtherPayablesMember_fKCoyKQ_____zVGS95DHUcC1" title="Decrease"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7586"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_901_ecustom--RelatedPartyBalances_iE_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--CounterpartiesAxis__custom--JungGonKimMember__ifrs-full--BorrowingsByNameAxis__custom--OtherPayablesMember_fKCoyKQ_____zDw2M5PUgRp1" title="Ending Balance"&gt;1,900,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td colspan="5" style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_904_ecustom--RelatedPartyBalances_iS_pn3n3_c20260101__20260630_z8a8ucfzB4jj" title="Beginning Balance"&gt;742,895&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_906_ecustom--Increase_pn3n3_c20260101__20260630_zkUApNDA1FIj" title="Increase"&gt;4,011,022&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90B_ecustom--Decrease_pn3n3_c20260101__20260630_zsOzvCpcywy1" title="Decrease"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7594"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_903_ecustom--RelatedPartyBalances_iE_pn3n3_c20260101__20260630_zFRgyXbnyo54" title="Ending Balance"&gt;4,753,917&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;div style="margin: 0pt auto 0pt 0; font-family: Times New Roman, Times, Serif; width: 25%"&gt;&lt;div style="border-top: Black 1pt solid; font: 1pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in; text-align: left"&gt;&lt;span id="xdx_F0F_zyMnmUrj7Vl5" style="font-family: Times New Roman, Times, Serif"&gt;(*1)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F11_zj1Mu9a8ADA7" style="font-family: Times New Roman, Times, Serif"&gt;The Company received an advance payment of KRW 1,280,000 thousand from Dongsung D&amp;amp;C in connection with a planned investment, which was recorded within other payables as of June&#160;30, 2026, as no shares had been issued. Subsequent to the reporting date, the transaction was finalized as a third-party allotment of common shares, under which the advance payment will be applied as share subscription proceeds (refer to Note 29).&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span id="xdx_F0C_zpGVjrA1wnxi" style="font-family: Times New Roman, Times, Serif"&gt;(*2)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F1E_zGPMnaVo3za3" style="font-family: Times New Roman, Times, Serif"&gt;On November&#160;4, 2025, the Company entered into an agreement with Jung Gon Kim to dispose of 1,000,000 treasury shares at KRW 3,000 per share, for total consideration of KRW 3,000,000 thousand. The Company received a down payment of KRW 300,000 thousand in the prior year and an interim payment of KRW 1,600,000 thousand during the six-month period ended June&#160;30, 2026. As the shares had not been transferred as of June&#160;30, 2026, the cumulative amount received of KRW 1,900,000 thousand was recorded as other payable.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:ScheduleOfChangesInRelatedPartyBalancesByAccountTableTextBlock>
    <cik0002058261:Increase
      contextRef="From2026-01-012026-06-30_ifrs-full_RelatedPartiesMember_custom_WellCoreMember_custom_BorrowingMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007512"
      unitRef="KRW">1000000000</cik0002058261:Increase>
    <cik0002058261:RelatedPartyBalances
      contextRef="AsOf2026-06-30_ifrs-full_RelatedPartiesMember_custom_WellCoreMember_custom_BorrowingMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007516"
      unitRef="KRW">1000000000</cik0002058261:RelatedPartyBalances>
    <cik0002058261:Increase
      contextRef="From2026-01-012026-06-30_ifrs-full_RelatedPartiesMember_custom_WellCoreMember_custom_AccruedExpenseMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007520"
      unitRef="KRW">11973000</cik0002058261:Increase>
    <cik0002058261:RelatedPartyBalances
      contextRef="AsOf2026-06-30_ifrs-full_RelatedPartiesMember_custom_WellCoreMember_custom_AccruedExpenseMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007524"
      unitRef="KRW">11973000</cik0002058261:RelatedPartyBalances>
    <cik0002058261:RelatedPartyBalances
      contextRef="AsOf2025-12-31_ifrs-full_RelatedPartiesMember_custom_DongsungDAndCMember_custom_ShortTermLoanReceivableMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007526"
      unitRef="KRW">220000000</cik0002058261:RelatedPartyBalances>
    <cik0002058261:Increase
      contextRef="From2026-01-012026-06-30_ifrs-full_RelatedPartiesMember_custom_DongsungDAndCMember_custom_ShortTermLoanReceivableMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007528"
      unitRef="KRW">100000000</cik0002058261:Increase>
    <cik0002058261:RelatedPartyBalances
      contextRef="AsOf2026-06-30_ifrs-full_RelatedPartiesMember_custom_DongsungDAndCMember_custom_ShortTermLoanReceivableMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007532"
      unitRef="KRW">320000000</cik0002058261:RelatedPartyBalances>
    <cik0002058261:RelatedPartyBalances
      contextRef="AsOf2025-12-31_ifrs-full_RelatedPartiesMember_custom_DongsungDAndCMember_custom_ShortTermLoanReceivablesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007534"
      unitRef="KRW">1296000</cik0002058261:RelatedPartyBalances>
    <cik0002058261:Increase
      contextRef="From2026-01-012026-06-30_ifrs-full_RelatedPartiesMember_custom_DongsungDAndCMember_custom_ShortTermLoanReceivablesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007536"
      unitRef="KRW">5560000</cik0002058261:Increase>
    <cik0002058261:RelatedPartyBalances
      contextRef="AsOf2026-06-30_ifrs-full_RelatedPartiesMember_custom_DongsungDAndCMember_custom_ShortTermLoanReceivablesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007540"
      unitRef="KRW">6856000</cik0002058261:RelatedPartyBalances>
    <cik0002058261:Increase
      contextRef="From2026-01-012026-06-30_ifrs-full_RelatedPartiesMember_custom_DongsungDAndCMember_custom_OtherPayablesAdvancesReceivedForAllotmentOfCommonSharesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007544"
      unitRef="KRW">1280000000</cik0002058261:Increase>
    <cik0002058261:RelatedPartyBalances
      contextRef="AsOf2026-06-30_ifrs-full_RelatedPartiesMember_custom_DongsungDAndCMember_custom_OtherPayablesAdvancesReceivedForAllotmentOfCommonSharesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007548"
      unitRef="KRW">1280000000</cik0002058261:RelatedPartyBalances>
    <cik0002058261:RelatedPartyBalances
      contextRef="AsOf2025-12-31_ifrs-full_RelatedPartiesMember_custom_EunJongChoiMember_custom_ShortTermLoanReceivableMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007550"
      unitRef="KRW">140000000</cik0002058261:RelatedPartyBalances>
    <cik0002058261:RelatedPartyBalances
      contextRef="AsOf2026-06-30_ifrs-full_RelatedPartiesMember_custom_EunJongChoiMember_custom_ShortTermLoanReceivableMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007556"
      unitRef="KRW">140000000</cik0002058261:RelatedPartyBalances>
    <cik0002058261:RelatedPartyBalances
      contextRef="AsOf2025-12-31_ifrs-full_RelatedPartiesMember_custom_EunJongChoiMember_custom_ShortTermLoanReceivablesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007558"
      unitRef="KRW">36035000</cik0002058261:RelatedPartyBalances>
    <cik0002058261:Increase
      contextRef="From2026-01-012026-06-30_ifrs-full_RelatedPartiesMember_custom_EunJongChoiMember_custom_ShortTermLoanReceivablesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007560"
      unitRef="KRW">3194000</cik0002058261:Increase>
    <cik0002058261:RelatedPartyBalances
      contextRef="AsOf2026-06-30_ifrs-full_RelatedPartiesMember_custom_EunJongChoiMember_custom_ShortTermLoanReceivablesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007564"
      unitRef="KRW">39229000</cik0002058261:RelatedPartyBalances>
    <cik0002058261:RelatedPartyBalances
      contextRef="AsOf2025-12-31_ifrs-full_RelatedPartiesMember_custom_CubeBioHoldingsLtdMember_custom_ShortTermLoanReceivableMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007566"
      unitRef="KRW">43047000</cik0002058261:RelatedPartyBalances>
    <cik0002058261:Increase
      contextRef="From2026-01-012026-06-30_ifrs-full_RelatedPartiesMember_custom_CubeBioHoldingsLtdMember_custom_ShortTermLoanReceivableMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007568"
      unitRef="KRW">8902000</cik0002058261:Increase>
    <cik0002058261:RelatedPartyBalances
      contextRef="AsOf2026-06-30_ifrs-full_RelatedPartiesMember_custom_CubeBioHoldingsLtdMember_custom_ShortTermLoanReceivableMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007572"
      unitRef="KRW">51949000</cik0002058261:RelatedPartyBalances>
    <cik0002058261:RelatedPartyBalances
      contextRef="AsOf2025-12-31_ifrs-full_RelatedPartiesMember_custom_CubeBioHoldingsLtdMember_custom_ShortTermLoanReceivablesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007574"
      unitRef="KRW">2517000</cik0002058261:RelatedPartyBalances>
    <cik0002058261:Increase
      contextRef="From2026-01-012026-06-30_ifrs-full_RelatedPartiesMember_custom_CubeBioHoldingsLtdMember_custom_ShortTermLoanReceivablesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007576"
      unitRef="KRW">1393000</cik0002058261:Increase>
    <cik0002058261:RelatedPartyBalances
      contextRef="AsOf2026-06-30_ifrs-full_RelatedPartiesMember_custom_CubeBioHoldingsLtdMember_custom_ShortTermLoanReceivablesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007580"
      unitRef="KRW">3910000</cik0002058261:RelatedPartyBalances>
    <cik0002058261:RelatedPartyBalances
      contextRef="AsOf2025-12-31_ifrs-full_RelatedPartiesMember_custom_JungGonKimMember_custom_OtherPayablesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007582"
      unitRef="KRW">300000000</cik0002058261:RelatedPartyBalances>
    <cik0002058261:Increase
      contextRef="From2026-01-012026-06-30_ifrs-full_RelatedPartiesMember_custom_JungGonKimMember_custom_OtherPayablesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007584"
      unitRef="KRW">1600000000</cik0002058261:Increase>
    <cik0002058261:RelatedPartyBalances
      contextRef="AsOf2026-06-30_ifrs-full_RelatedPartiesMember_custom_JungGonKimMember_custom_OtherPayablesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007588"
      unitRef="KRW">1900000000</cik0002058261:RelatedPartyBalances>
    <cik0002058261:RelatedPartyBalances
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007590"
      unitRef="KRW">742895000</cik0002058261:RelatedPartyBalances>
    <cik0002058261:Increase
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007592"
      unitRef="KRW">4011022000</cik0002058261:Increase>
    <cik0002058261:RelatedPartyBalances
      contextRef="AsOf2026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007596"
      unitRef="KRW">4753917000</cik0002058261:RelatedPartyBalances>
    <cik0002058261:ScheduleOfManagementPersonnelCompensationTableTextBlock
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      id="Fact007607">&lt;table cellpadding="0" cellspacing="0" id="xdx_89C_ecustom--ScheduleOfManagementPersonnelCompensationTableTextBlock_pn3n3_zOZpgmCakBgb" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Related parties (Details 3)"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;&lt;span id="xdx_8B6_zfhB3vkFSc84" style="display: none"&gt;Schedule of compensation for key management personnel&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_498_20260101__20260630_zFMVZFUbkpn8" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49B_20250101__20250630_zhb2O3RerXMi" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Six-month&lt;br/&gt;period ended&lt;br/&gt;June&#160;30,&lt;br/&gt;2026&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Six-month&lt;br/&gt;period ended&lt;br/&gt;June&#160;30,&lt;br/&gt;2025&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="6" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr id="xdx_405_eifrs-full--ShorttermEmployeeBenefitsExpense_i_pn3n" style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Short-term employee benefits&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;177,950&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;245,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_403_eifrs-full--PostemploymentBenefitExpenseDefinedBenefitPlans_i_pn3n" style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Retirement benefit&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;18,422&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;23,951&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_406_eifrs-full--KeyManagementPersonnelCompensationShorttermEmployeeBenefits_i_pn3n" style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;196,372&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;268,951&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:ScheduleOfManagementPersonnelCompensationTableTextBlock>
    <ifrs-full:ShorttermEmployeeBenefitsExpense
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007609"
      unitRef="KRW">177950000</ifrs-full:ShorttermEmployeeBenefitsExpense>
    <ifrs-full:ShorttermEmployeeBenefitsExpense
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007610"
      unitRef="KRW">245000000</ifrs-full:ShorttermEmployeeBenefitsExpense>
    <ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007612"
      unitRef="KRW">18422000</ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans>
    <ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007613"
      unitRef="KRW">23951000</ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans>
    <ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007615"
      unitRef="KRW">196372000</ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits>
    <ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007616"
      unitRef="KRW">268951000</ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits>
    <cik0002058261:DisclosureOfCashFlowStatementsExplanatory
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      id="Fact007618">&lt;p id="xdx_802_ecustom--DisclosureOfCashFlowStatementsExplanatory_zTJcMqcNkDk4" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;26. &lt;span id="xdx_824_zzc3Yb8gpRCd"&gt;Statement of cash flows&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;A.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Cash flows from operating activities&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Details of adjustments for income and expenses from operating activities for the six-month periods ended June&#160;30, 2026 and 2025 are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--ScheduleOfIncomeAndExpensesFromOperatingActivitiesTableTextBlock_pn3n3_z2UJSdods3Ih" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Statement of Cash flows (Details 2)"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span id="xdx_8B3_zObDnUlysDy" style="display: none"&gt;Schedule of income and expenses from operating activities&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_495_20260101__20260630__ifrs-full--SegmentsAxis__custom--IncomeAndExpensesFromOperatingActivitiesMember_zjRpU8ztkoD3" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49A_20250101__20250630__ifrs-full--SegmentsAxis__custom--IncomeAndExpensesFromOperatingActivitiesMember_z6dQQ84d78Xi" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Six-month&lt;br/&gt; period ended&lt;br/&gt;June&#160;30,&lt;br/&gt; 2026&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Six-month&lt;br/&gt; period ended&lt;br/&gt;June&#160;30,&lt;br/&gt; 2025&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="6" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--AdjustmentsForIncomeAndExpensesAbstract_iB_ztg06vdWkDK1" style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Adjustments for income and expenses&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--AdjustmentsForDepreciationExpense_zESlumRSMBWl" style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Depreciation&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;102,318&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;120,114&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40F_eifrs-full--AmortisationExpense_zOeHEMDtFE57" style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Amortization&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,167&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,136&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_402_eifrs-full--ExpenseRecognisedDuringPeriodForBadAndDoubtfulDebtsForRelatedPartyTransaction_zrXIuJOJK4Qg" style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Other bad debt expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;65,379&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;62,266&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--ReversalOfAllowanceForDoubtfulAccounts_zKnXmmSjMg7k" style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Reversal of allowance for doubtful accounts&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(287,100&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7635"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--LossesOnValuationOfDerivatives_zFHFP9hNcf07" style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Losses on valuation of derivatives&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;57,213&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7638"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--GainsOnValuationOfDerivatives_zDxuodMLyEU4" style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Gains on valuation of derivatives&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(117,845&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(309,333&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--LossesOnForeignCurrencyTranslation_zU1jowcF45Sd" style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Losses on foreign currency translation&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;66,412&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,530&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--GainsOnForeignCurrencyTranslation_zdHadhlxkSna" style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Gains on foreign currency translation&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(4,899&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(20,439&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--GainsOnLongtermInvestmentSecurities_zl5TPUTPaCqd" style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Gains on Long-term investment securities&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(3,560&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7650"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--InterestExpenses_z4PmunLjaDJf" style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Interest expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;351,045&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;385,423&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--InterestIncome_zP5YjP6f3Lwl" style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Interest income&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(109,493&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(121,109&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--LossesOnBondRedemption_zbU3foZcEqCc" style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Losses on bond redemption&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;12&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;17,292&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_409_eifrs-full--GainsLossesOnDisposalsOfPropertyPlantAndEquipment_zM0k5xRQRh7i" style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Gains on disposition of property and equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(1,125&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7662"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--SeveranceBenefit_z9NazmL5Dxof" style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Severance benefits&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;117,057&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;119,073&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--Subtotals_zjFPbZMF8A5d" style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;236,581&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;258,953&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--ChangesInAssetsAndLiabilitiesAbstract_iB_zJ4sA8PQVCn1" style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Changes in assets and liabilities&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--AdditionsToNoncurrentAssets_zcfiwgAbEWg4" style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Other non-current assets&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7673"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7674"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--AdjustmentsOfOtherCurrentNonfinancialLiabilities_zaD4I7QbbN1" style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Other current non-financial liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;434,653&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;201,577&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40C_eifrs-full--AdjustmentsForDecreaseIncreaseInTradeAccountReceivable_z2VzZ4hsKsnk" style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Accounts receivable - other, net&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(16,648&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;107,777&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_405_eifrs-full--AdjustmentsForDecreaseIncreaseInPrepaidExpenses_zPU8cnOg5PIj" style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Prepaid expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;21,383&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;25,748&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--AdjustmentsForPrepayments_zJH5EKpDrPU4" style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Prepayments&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(660&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(94,192&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--AdjustmentsForLiabilitiesDueToBenefitsPaid_z5zS4rJKo3E3" style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Liabilities due to benefits paid&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(40,601&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(61,566&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--AdjustmentsForSubtotal_i_pn3n" style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;398,127&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;179,344&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--IncomeAndExpensesFromOperatingActivities_zD2Ykus7uuUj" style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;634,708&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;438,297&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AF_zJr3pNScQ4K1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

















&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;B.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Significant non-cash transactions&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Significant non-cash transactions for the six-month periods ended June&#160;30, 2026 and 2025 are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_897_ecustom--ScheduleOfSignificantNonCashTransactionsTableTextBlock_pn3n3_zvEp4bSvMcP5" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Statement of Cash flows (Details)"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_8B6_zOAUA8FGoUWd" style="display: none"&gt;Schedule of significant non-cash transactions&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49B_20260101__20260630_zNw3Kfh6r76k" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_498_20250101__20250630_z80cPBFextna" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Six-month&lt;br/&gt;period ended&lt;br/&gt;June&#160;30,&lt;br/&gt;2026&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Six-month&lt;br/&gt;period ended &lt;br/&gt;June&#160;30,&lt;br/&gt;2025&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--IncreaseInLeaseLiabilities_i_pn3n" style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Increase in lease liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(16,073&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;947&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--IncreaseInDerivativeLiabilities_i_pn3n" style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Increase in derivative liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(227,213&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(143,667&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A9_zubm7cTkl3r7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;C.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Movements of liabilities to cash flows arising from financing activities&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The movements of liabilities from cash flows arising from financing activities for the six-month periods ended June&#160;30, 2026 and June&#160;30, 2025 are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_896_ecustom--ScheduleOfLiabilitiesToCashFlowsArisingFromFinancingActivitiesTableTextBlock_pn3n3_zmClTvJMYJNe" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Statement of Cash flows (Details 1)"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span id="xdx_8B4_zHdaSW3WcZIe" style="display: none"&gt;Schedule of liabilities to cash flows arising from financing activities&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Current bond&lt;br/&gt;with warrants&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Short-term&lt;br/&gt;borrowings&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Current lease&lt;br/&gt;liabilities&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Non-current&lt;br/&gt; lease liabilities&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="18" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Balance at January&#160;1, 2025&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90A_eifrs-full--Borrowings_iS_pn3n3_c20250101__20250630__ifrs-full--BorrowingsByNameAxis__custom--CurrentBondWithWarrantsMember_zVMihR4kVyX6" title="Balance at beginning"&gt;3,519,139&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90E_eifrs-full--Borrowings_iS_pn3n3_c20250101__20250630__ifrs-full--BorrowingsByNameAxis__ifrs-full--ShorttermBorrowingsMember_zxWseW7KJoKe" title="Balance at beginning"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7716"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_909_eifrs-full--Borrowings_iS_pn3n3_c20250101__20250630__ifrs-full--BorrowingsByNameAxis__custom--CurrentLeaseLiabilitiesMember_zJmuXClacu8d" title="Balance at beginning"&gt;117,351&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_906_eifrs-full--Borrowings_iS_pn3n3_c20250101__20250630__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentLeaseLiabilitiesMember_zEk5e1BXPihf" title="Balance at beginning"&gt;551,681&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_905_eifrs-full--Borrowings_iS_pn3n3_c20250101__20250630_zQBAYJzjdw4i" title="Balance at beginning"&gt;4,188,171&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Changes from financing cash flows&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Proceeds from issuance of bond with warrants&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_908_ecustom--ProceedsFromIssuanceOfBondWithWarrants_pn3n3_c20250101__20250630__ifrs-full--BorrowingsByNameAxis__custom--CurrentBondWithWarrantsMember_znbovtSlHiLb" title="Proceeds from issuance of bond with warrants"&gt;2,000,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_901_ecustom--ProceedsFromIssuanceOfBondWithWarrants_pn3n3_c20250101__20250630__ifrs-full--BorrowingsByNameAxis__ifrs-full--ShorttermBorrowingsMember_zx5YvCGhdvS9" title="Proceeds from issuance of bond with warrants"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7726"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90A_ecustom--ProceedsFromIssuanceOfBondWithWarrants_pn3n3_c20250101__20250630__ifrs-full--BorrowingsByNameAxis__custom--CurrentLeaseLiabilitiesMember_zPSBgXgIqdJf" title="Proceeds from issuance of bond with warrants"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7728"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_902_ecustom--ProceedsFromIssuanceOfBondWithWarrants_pn3n3_c20250101__20250630__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentLeaseLiabilitiesMember_zQBOnW74DS55" title="Proceeds from issuance of bond with warrants"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7730"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90C_ecustom--ProceedsFromIssuanceOfBondWithWarrants_pn3n3_c20250101__20250630_zGwTK51XSEU1" title="Proceeds from issuance of bond with warrants"&gt;2,000,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Repayment of bond with warrants&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_905_ecustom--RepaymentOfBondWithWarrants_iN_pn3n3_di_c20250101__20250630__ifrs-full--BorrowingsByNameAxis__custom--CurrentBondWithWarrantsMember_zKFDwUqX9TU9" title="Repayment of bond with warrants"&gt;(2,500,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_900_ecustom--RepaymentOfBondWithWarrants_iN_pn3n3_di_c20250101__20250630__ifrs-full--BorrowingsByNameAxis__ifrs-full--ShorttermBorrowingsMember_ziMZoClFSrV5" title="Repayment of bond with warrants"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7736"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90B_ecustom--RepaymentOfBondWithWarrants_iN_pn3n3_di_c20250101__20250630__ifrs-full--BorrowingsByNameAxis__custom--CurrentLeaseLiabilitiesMember_zinQeMJ7l14f" title="Repayment of bond with warrants"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7738"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_905_ecustom--RepaymentOfBondWithWarrants_iN_pn3n3_di_c20250101__20250630__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentLeaseLiabilitiesMember_zdd6S6M5dLP2" title="Repayment of bond with warrants"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7740"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_908_ecustom--RepaymentOfBondWithWarrants_iN_pn3n3_di_c20250101__20250630_zvyS1CoSOOGh" title="Repayment of bond with warrants"&gt;(2,500,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Payment of lease liability principal&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_908_ecustom--PaymentOfLeaseLiabilityPrincipal_iN_pn3n3_di_c20250101__20250630__ifrs-full--BorrowingsByNameAxis__custom--CurrentBondWithWarrantsMember_zvhOIKWmOB9i" title="Payment of lease liability principal"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7744"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90B_ecustom--PaymentOfLeaseLiabilityPrincipal_iN_pn3n3_di_c20250101__20250630__ifrs-full--BorrowingsByNameAxis__ifrs-full--ShorttermBorrowingsMember_z6cKIES96Caa" title="Payment of lease liability principal"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7746"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_909_ecustom--PaymentOfLeaseLiabilityPrincipal_iN_pn3n3_di_c20250101__20250630__ifrs-full--BorrowingsByNameAxis__custom--CurrentLeaseLiabilitiesMember_zXCGu0162Doa" title="Payment of lease liability principal"&gt;(58,029&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_907_ecustom--PaymentOfLeaseLiabilityPrincipal_iN_pn3n3_di_c20250101__20250630__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentLeaseLiabilitiesMember_zFvpDmHiTYwc" title="Payment of lease liability principal"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7750"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90D_ecustom--PaymentOfLeaseLiabilityPrincipal_iN_pn3n3_di_c20250101__20250630_zWqyI9ZblAsd" title="Payment of lease liability principal"&gt;(58,029&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_907_eifrs-full--OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities_pn3n3_c20250101__20250630__ifrs-full--BorrowingsByNameAxis__custom--CurrentBondWithWarrantsMember_zMeugt68GmY3" title="Total"&gt;(500,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_907_eifrs-full--OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities_pn3n3_c20250101__20250630__ifrs-full--BorrowingsByNameAxis__ifrs-full--ShorttermBorrowingsMember_zYUEK38TKR67" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7756"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_906_eifrs-full--OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities_pn3n3_c20250101__20250630__ifrs-full--BorrowingsByNameAxis__custom--CurrentLeaseLiabilitiesMember_z3i9EPKA5blh" title="Total"&gt;(58,029&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_902_eifrs-full--OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities_pn3n3_c20250101__20250630__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentLeaseLiabilitiesMember_zR4yECKV7cjf" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7760"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_905_eifrs-full--OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities_pn3n3_c20250101__20250630_zFAG1MUzeon4" title="Total"&gt;(558,029&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Other changes&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Proceeds from Warrants Exercised&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_905_ecustom--ProceedsFromWarrantsExercised_iP3ifrs-full--OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities_pn3n3_c20250101__20250630__ifrs-full--BorrowingsByNameAxis__custom--CurrentBondWithWarrantsMember_z2BdH83j8Oyl" title="Proceeds from Warrants Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7764"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90E_ecustom--ProceedsFromWarrantsExercised_pn3n3_c20250101__20250630__ifrs-full--BorrowingsByNameAxis__ifrs-full--ShorttermBorrowingsMember_zSJ3N2VyX5Mb" title="Proceeds from Warrants Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7766"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90E_ecustom--ProceedsFromWarrantsExercised_pn3n3_c20250101__20250630__ifrs-full--BorrowingsByNameAxis__custom--CurrentLeaseLiabilitiesMember_z8dzrHcldX44" title="Proceeds from Warrants Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7768"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90B_ecustom--ProceedsFromWarrantsExercised_pn3n3_c20250101__20250630__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentLeaseLiabilitiesMember_zdoHvEGCllA6" title="Proceeds from Warrants Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7770"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_904_ecustom--ProceedsFromWarrantsExercised_pn3n3_c20250101__20250630_z2R3YQ52z8ah" title="Proceeds from Warrants Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7772"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Proceeds from borrowings&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_906_eifrs-full--ProceedsFromCurrentBorrowings_iP3custom--ProceedsFromWarrantsExercised_pn3n3_c20250101__20250630__ifrs-full--BorrowingsByNameAxis__custom--CurrentBondWithWarrantsMember_zQModSt8J884" title="Proceeds from borrowings"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7774"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90B_eifrs-full--ProceedsFromCurrentBorrowings_pn3n3_c20250101__20250630__ifrs-full--BorrowingsByNameAxis__ifrs-full--ShorttermBorrowingsMember_zbNfLRKqF0vk" title="Proceeds from borrowings"&gt;270,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_902_eifrs-full--ProceedsFromCurrentBorrowings_pn3n3_c20250101__20250630__ifrs-full--BorrowingsByNameAxis__custom--CurrentLeaseLiabilitiesMember_zc3E3taXaKIb" title="Proceeds from borrowings"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7778"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90D_eifrs-full--ProceedsFromCurrentBorrowings_pn3n3_c20250101__20250630__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentLeaseLiabilitiesMember_z7U4eNm0Y2j4" title="Proceeds from borrowings"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7780"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90A_eifrs-full--ProceedsFromCurrentBorrowings_pn3n3_c20250101__20250630_zCW6JPBTeid7" title="Proceeds from borrowings"&gt;270,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Other non-cash transactions&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_900_ecustom--OtherNoncashTransactions_pn3n3_c20250101__20250630__ifrs-full--BorrowingsByNameAxis__custom--CurrentBondWithWarrantsMember_zoSQl2P3fsy5" title="Other non-cash transactions"&gt;143,667&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90A_ecustom--OtherNoncashTransactions_pn3n3_c20250101__20250630__ifrs-full--BorrowingsByNameAxis__ifrs-full--ShorttermBorrowingsMember_zQkR4eGB18Uh" title="Other non-cash transactions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7786"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_901_ecustom--OtherNoncashTransactions_pn3n3_c20250101__20250630__ifrs-full--BorrowingsByNameAxis__custom--CurrentLeaseLiabilitiesMember_ziCTvgkpYyqe" title="Other non-cash transactions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7788"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_908_ecustom--OtherNoncashTransactions_pn3n3_c20250101__20250630__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentLeaseLiabilitiesMember_zStdfpBDWfLc" title="Other non-cash transactions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7790"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_901_ecustom--OtherNoncashTransactions_pn3n3_c20250101__20250630_z6Z2xKdTGDWk" title="Other non-cash transactions"&gt;143,667&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Lease reassessment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_902_ecustom--LeaseReassessment_pn3n3_c20250101__20250630__ifrs-full--BorrowingsByNameAxis__custom--CurrentBondWithWarrantsMember_zjVhmXa5EAxe" title="Lease reassessment"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7794"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_908_ecustom--LeaseReassessment_pn3n3_c20250101__20250630__ifrs-full--BorrowingsByNameAxis__ifrs-full--ShorttermBorrowingsMember_zzHvGNgSFO53" title="Lease reassessment"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7796"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90B_ecustom--LeaseReassessment_pn3n3_c20250101__20250630__ifrs-full--BorrowingsByNameAxis__custom--CurrentLeaseLiabilitiesMember_zfRET76930F6" title="Lease reassessment"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7798"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_904_ecustom--LeaseReassessment_pn3n3_c20250101__20250630__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentLeaseLiabilitiesMember_zobSyw0zcRbc" title="Lease reassessment"&gt;947&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90F_ecustom--LeaseReassessment_pn3n3_c20250101__20250630_zFlFH00Hiz5c" title="Lease reassessment"&gt;947&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_907_ecustom--OtherInterestExpense_pn3n3_c20250101__20250630__ifrs-full--BorrowingsByNameAxis__custom--CurrentBondWithWarrantsMember_zMowp6oL6Qsj" title="Interest expense"&gt;357,234&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_907_ecustom--OtherInterestExpense_pn3n3_c20250101__20250630__ifrs-full--BorrowingsByNameAxis__ifrs-full--ShorttermBorrowingsMember_zgiapcaFPP5f" title="Interest expense"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7806"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_901_ecustom--OtherInterestExpense_pn3n3_c20250101__20250630__ifrs-full--BorrowingsByNameAxis__custom--CurrentLeaseLiabilitiesMember_zpfsGvN92nKe" title="Interest expense"&gt;27,316&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_904_ecustom--OtherInterestExpense_pn3n3_c20250101__20250630__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentLeaseLiabilitiesMember_zhcweq31YNjk" title="Interest expense"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7810"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_904_ecustom--OtherInterestExpense_pn3n3_c20250101__20250630_zQzPGbBXWyLf" title="Interest expense"&gt;384,550&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Interest paid&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90F_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20250101__20250630__ifrs-full--BorrowingsByNameAxis__custom--CurrentBondWithWarrantsMember_z5QZxxgamW4e" title="Interest paid"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7814"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_906_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20250101__20250630__ifrs-full--BorrowingsByNameAxis__ifrs-full--ShorttermBorrowingsMember_zvuOj4zecMfd" title="Interest paid"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7816"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90E_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20250101__20250630__ifrs-full--BorrowingsByNameAxis__custom--CurrentLeaseLiabilitiesMember_zdBkFHM2UPBd" title="Interest paid"&gt;(27,316&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90B_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20250101__20250630__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentLeaseLiabilitiesMember_z7vuvv3Sr69c" title="Interest paid"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7820"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_905_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20250101__20250630_zc5IXH31k2N3" title="Interest paid"&gt;(27,316&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Reclassification&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_901_ecustom--Reclassification_pn3n3_c20250101__20250630__ifrs-full--BorrowingsByNameAxis__custom--CurrentBondWithWarrantsMember_zhJwgTHdsvma" title="Reclassification"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7824"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90C_ecustom--Reclassification_pn3n3_c20250101__20250630__ifrs-full--BorrowingsByNameAxis__ifrs-full--ShorttermBorrowingsMember_ztaLNQU3ifx3" title="Reclassification"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7826"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_905_ecustom--Reclassification_pn3n3_c20250101__20250630__ifrs-full--BorrowingsByNameAxis__custom--CurrentLeaseLiabilitiesMember_zv24pzk64jqa" title="Reclassification"&gt;60,018&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_907_ecustom--Reclassification_pn3n3_c20250101__20250630__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentLeaseLiabilitiesMember_zXtS8x5FT3Ue" title="Reclassification"&gt;(60,018&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90E_ecustom--Reclassification_pn3n3_c20250101__20250630_zJeBLd0aCfY3" title="Reclassification"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7832"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_908_ecustom--TotalOtherChanges_pn3n3_c20250101__20250630__ifrs-full--BorrowingsByNameAxis__custom--CurrentBondWithWarrantsMember_zEuZKTRccim6" title="Total"&gt;500,901&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90C_ecustom--TotalOtherChanges_pn3n3_c20250101__20250630__ifrs-full--BorrowingsByNameAxis__ifrs-full--ShorttermBorrowingsMember_zl83zWYFAG99" title="Total"&gt;270,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_907_ecustom--TotalOtherChanges_pn3n3_c20250101__20250630__ifrs-full--BorrowingsByNameAxis__custom--CurrentLeaseLiabilitiesMember_zQ6mrR37Ejf" title="Total"&gt;60,018&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_906_ecustom--TotalOtherChanges_pn3n3_c20250101__20250630__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentLeaseLiabilitiesMember_zgLW2Ai2sfbc" title="Total"&gt;(59,071&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_902_ecustom--TotalOtherChanges_pn3n3_c20250101__20250630_zydl39LbaVCh" title="Total"&gt;771,848&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Balance at June&#160;30, 2025&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_901_eifrs-full--Borrowings_iE_pn3n3_c20250101__20250630__ifrs-full--BorrowingsByNameAxis__custom--CurrentBondWithWarrantsMember_zcULdOk5r5Ga" title="Balance at ending"&gt;3,520,040&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_909_eifrs-full--Borrowings_iE_pn3n3_c20250101__20250630__ifrs-full--BorrowingsByNameAxis__ifrs-full--ShorttermBorrowingsMember_zh4w97RA34U" title="Balance at ending"&gt;270,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_908_eifrs-full--Borrowings_iE_pn3n3_c20250101__20250630__ifrs-full--BorrowingsByNameAxis__custom--CurrentLeaseLiabilitiesMember_zurSuevKpc9c" title="Balance at ending"&gt;119,340&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_908_eifrs-full--Borrowings_iE_pn3n3_c20250101__20250630__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentLeaseLiabilitiesMember_zsOwzh0rYW2j" title="Balance at ending"&gt;492,610&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_907_eifrs-full--Borrowings_iE_pn3n3_c20250101__20250630_zYFqCwI6ww53" title="Balance at ending"&gt;4,401,990&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Balance at January&#160;1, 2026&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_902_eifrs-full--Borrowings_iS_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--CurrentBondWithWarrantsMember_zzl5Pp4iila3" title="Balance at beginning"&gt;3,265,312&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90F_eifrs-full--Borrowings_iS_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__ifrs-full--ShorttermBorrowingsMember_zwm91Nejkj66" title="Balance at beginning"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7856"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90E_eifrs-full--Borrowings_iS_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--CurrentLeaseLiabilitiesMember_zvFRUQSO7fJ4" title="Balance at beginning"&gt;122,626&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_901_eifrs-full--Borrowings_iS_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentLeaseLiabilitiesMember_zSvzXQ2TCfNk" title="Balance at beginning"&gt;430,005&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_904_eifrs-full--Borrowings_iS_pn3n3_c20260101__20260630_zBq1tPvdEJS9" title="Balance at beginning"&gt;3,817,943&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Changes from financing cash flows&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Proceeds from issuance of bond with warrants&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90C_ecustom--ProceedsFromIssuanceOfBondWithWarrants_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--CurrentBondWithWarrantsMember_zmsdykMw4oJ9" title="Proceeds from issuance of bond with warrants"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7864"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_908_ecustom--ProceedsFromIssuanceOfBondWithWarrants_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__ifrs-full--ShorttermBorrowingsMember_zJ1LIqv5CtXa" title="Proceeds from issuance of bond with warrants"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7866"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_904_ecustom--ProceedsFromIssuanceOfBondWithWarrants_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--CurrentLeaseLiabilitiesMember_z0QMl1UZchZa" title="Proceeds from issuance of bond with warrants"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7868"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_905_ecustom--ProceedsFromIssuanceOfBondWithWarrants_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentLeaseLiabilitiesMember_zZqYrXihVdvb" title="Proceeds from issuance of bond with warrants"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7870"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_901_ecustom--ProceedsFromIssuanceOfBondWithWarrants_pn3n3_c20260101__20260630_zEDE3Tlxcr3" title="Proceeds from issuance of bond with warrants"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7872"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Repayment of bond with warrants&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90B_ecustom--RepaymentOfBondWithWarrants_iN_pn3n3_di_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--CurrentBondWithWarrantsMember_zewJ1i0gg1Vb" title="Repayment of bond with warrants"&gt;(600,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90D_ecustom--RepaymentOfBondWithWarrants_iN_pn3n3_di_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__ifrs-full--ShorttermBorrowingsMember_zjBkmZz2VOCg" title="Repayment of bond with warrants"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7876"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_900_ecustom--RepaymentOfBondWithWarrants_iN_pn3n3_di_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--CurrentLeaseLiabilitiesMember_zsbPb5ibDxck" title="Repayment of bond with warrants"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7878"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90A_ecustom--RepaymentOfBondWithWarrants_iN_pn3n3_di_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentLeaseLiabilitiesMember_zLVqyqGYuKYa" title="Repayment of bond with warrants"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7880"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_904_ecustom--RepaymentOfBondWithWarrants_iN_pn3n3_di_c20260101__20260630_zqpwzmPCCloe" title="Repayment of bond with warrants"&gt;(600,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Payment of lease liability principal&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90A_ecustom--PaymentOfLeaseLiabilityPrincipal_iN_pn3n3_di_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--CurrentBondWithWarrantsMember_zwxna3qwiIal" title="Payment of lease liability principal"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7884"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_905_ecustom--PaymentOfLeaseLiabilityPrincipal_iN_pn3n3_di_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__ifrs-full--ShorttermBorrowingsMember_z0t1FHBCctP1" title="Payment of lease liability principal"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7886"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_904_ecustom--PaymentOfLeaseLiabilityPrincipal_iN_pn3n3_di_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--CurrentLeaseLiabilitiesMember_zddOdMB7qxUe" title="Payment of lease liability principal"&gt;(56,773&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_909_ecustom--PaymentOfLeaseLiabilityPrincipal_iN_pn3n3_di_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentLeaseLiabilitiesMember_zwxjotJrmQb1" title="Payment of lease liability principal"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7890"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_909_ecustom--PaymentOfLeaseLiabilityPrincipal_iN_pn3n3_di_c20260101__20260630_z9RjDsA8YyRi" title="Payment of lease liability principal"&gt;(56,773&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90D_eifrs-full--OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--CurrentBondWithWarrantsMember_zGx60XxNrgab" title="Total"&gt;(600,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_903_eifrs-full--OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__ifrs-full--ShorttermBorrowingsMember_z6knBMFUhJbb" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7896"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_909_eifrs-full--OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--CurrentLeaseLiabilitiesMember_zrRkt8hfTPsj" title="Total"&gt;(56,773&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90A_eifrs-full--OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentLeaseLiabilitiesMember_z5IKoGPZZom9" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7900"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_901_eifrs-full--OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities_pn3n3_c20260101__20260630_zDCDRmnleVJ3" title="Total"&gt;(656,773&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Other changes&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Proceeds from Warrants Exercised&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_907_ecustom--ProceedsFromWarrantsExercised_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--CurrentBondWithWarrantsMember_zPwsp6KnvEW4" title="Proceeds from Warrants Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7904"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90D_ecustom--ProceedsFromWarrantsExercised_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__ifrs-full--ShorttermBorrowingsMember_zD0bT5iuhEp" title="Proceeds from Warrants Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7906"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90F_ecustom--ProceedsFromWarrantsExercised_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--CurrentLeaseLiabilitiesMember_zeXWhPXO8oml" title="Proceeds from Warrants Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7908"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_906_ecustom--ProceedsFromWarrantsExercised_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentLeaseLiabilitiesMember_ze528FhPAh11" title="Proceeds from Warrants Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7910"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_903_ecustom--ProceedsFromWarrantsExercised_pn3n3_c20260101__20260630_z8BemAo4upNd" title="Proceeds from Warrants Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7912"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Proceeds from borrowings&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_902_eifrs-full--ProceedsFromCurrentBorrowings_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--CurrentBondWithWarrantsMember_zRWA9Hq1smbi" title="Proceeds from borrowings"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7914"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_902_eifrs-full--ProceedsFromCurrentBorrowings_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__ifrs-full--ShorttermBorrowingsMember_ze01eQE3zbq5" title="Proceeds from borrowings"&gt;1,000,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90B_eifrs-full--ProceedsFromCurrentBorrowings_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--CurrentLeaseLiabilitiesMember_zSxdkg0mlpQj" title="Proceeds from borrowings"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7918"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_905_eifrs-full--ProceedsFromCurrentBorrowings_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentLeaseLiabilitiesMember_zP0RengnZU5c" title="Proceeds from borrowings"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7920"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90E_eifrs-full--ProceedsFromCurrentBorrowings_pn3n3_c20260101__20260630_zN3vlPeQJIgf" title="Proceeds from borrowings"&gt;1,000,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Other non-cash transactions&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_909_ecustom--OtherNoncashTransactions_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--CurrentBondWithWarrantsMember_zYVjJqJFElZ1" title="Other non-cash transactions"&gt;227,213&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90C_ecustom--OtherNoncashTransactions_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__ifrs-full--ShorttermBorrowingsMember_zqsEDjy1idA7" title="Other non-cash transactions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7926"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_900_ecustom--OtherNoncashTransactions_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--CurrentLeaseLiabilitiesMember_zd8yA88IUCTc" title="Other non-cash transactions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7928"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_908_ecustom--OtherNoncashTransactions_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentLeaseLiabilitiesMember_zv16hQ8Hs5s8" title="Other non-cash transactions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7930"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90B_ecustom--OtherNoncashTransactions_pn3n3_c20260101__20260630_znufXQBzg8ge" title="Other non-cash transactions"&gt;227,213&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Lease reassessment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_900_ecustom--LeaseReassessment_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--CurrentBondWithWarrantsMember_zlnBOSzQCyZa" title="Lease reassessment"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7934"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90E_ecustom--LeaseReassessment_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__ifrs-full--ShorttermBorrowingsMember_zQqBjilCXska" title="Lease reassessment"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7936"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_900_ecustom--LeaseReassessment_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--CurrentLeaseLiabilitiesMember_z15Iwg2qYWB6" title="Lease reassessment"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7938"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_906_ecustom--LeaseReassessment_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentLeaseLiabilitiesMember_zIh6j7dcXfXk" title="Lease reassessment"&gt;(16,073&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90C_ecustom--LeaseReassessment_pn3n3_c20260101__20260630_z5jZPRUQ9rP7" title="Lease reassessment"&gt;(16,073&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90A_ecustom--OtherInterestExpense_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--CurrentBondWithWarrantsMember_zOf0xN6l19Oi" title="Interest expense"&gt;317,235&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_905_ecustom--OtherInterestExpense_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__ifrs-full--ShorttermBorrowingsMember_zh1IdZI20dTj" title="Interest expense"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7946"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_908_ecustom--OtherInterestExpense_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--CurrentLeaseLiabilitiesMember_zyN0XTrbmmve" title="Interest expense"&gt;21,678&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90F_ecustom--OtherInterestExpense_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentLeaseLiabilitiesMember_zYOpgCmEKb9b" title="Interest expense"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7950"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_900_ecustom--OtherInterestExpense_pn3n3_c20260101__20260630_zWSYpj5jLfMg" title="Interest expense"&gt;338,913&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Interest paid&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_902_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--CurrentBondWithWarrantsMember_zZwuQwibHli4" title="Interest paid"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7954"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_901_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__ifrs-full--ShorttermBorrowingsMember_z4ryPMJBjLCa" title="Interest paid"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7956"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90B_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--CurrentLeaseLiabilitiesMember_zBnZLZSUlAld" title="Interest paid"&gt;(21,678&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_902_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentLeaseLiabilitiesMember_zELyyQ0lqYn8" title="Interest paid"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7960"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_902_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20260101__20260630_zXQK9FIC2LT5" title="Interest paid"&gt;(21,678&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Reclassification&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90B_ecustom--Reclassification_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--CurrentBondWithWarrantsMember_zmx75ssmvnih" title="Reclassification"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7964"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_902_ecustom--Reclassification_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__ifrs-full--ShorttermBorrowingsMember_zChEpeeQJh59" title="Reclassification"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7966"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90B_ecustom--Reclassification_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--CurrentLeaseLiabilitiesMember_zRLQFFfVsH1h" title="Reclassification"&gt;42,853&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_905_ecustom--Reclassification_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentLeaseLiabilitiesMember_zQk03bhSXBZ9" title="Reclassification"&gt;(42,853&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_902_ecustom--Reclassification_pn3n3_c20260101__20260630_zypWJSloopC4" title="Reclassification"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7972"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90F_ecustom--TotalOtherChanges_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--CurrentBondWithWarrantsMember_zZQcqmRq3PD" title="Total"&gt;544,448&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_903_ecustom--TotalOtherChanges_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__ifrs-full--ShorttermBorrowingsMember_zCJZ7V5yLHsj" title="Total"&gt;1,000,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90C_ecustom--TotalOtherChanges_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--CurrentLeaseLiabilitiesMember_zB3ZRP5uKNek" title="Total"&gt;42,853&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_900_ecustom--TotalOtherChanges_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentLeaseLiabilitiesMember_zeHCXZrh6QSi" title="Total"&gt;(58,926&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_906_ecustom--TotalOtherChanges_pn3n3_c20260101__20260630_zyXf1LTPR3Ta" title="Total"&gt;1,528,375&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Balance at June&#160;30, 2026&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_906_eifrs-full--Borrowings_iE_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--CurrentBondWithWarrantsMember_zgBH89unXaE5" title="Balance at ending"&gt;3,209,760&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_902_eifrs-full--Borrowings_iE_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__ifrs-full--ShorttermBorrowingsMember_zHfESlkoZc66" title="Balance at ending"&gt;1,000,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_906_eifrs-full--Borrowings_iE_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--CurrentLeaseLiabilitiesMember_zDGFhEtfZAhh" title="Balance at ending"&gt;108,706&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90F_eifrs-full--Borrowings_iE_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentLeaseLiabilitiesMember_z4UKlpJasxg7" title="Balance at ending"&gt;371,079&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_903_eifrs-full--Borrowings_iE_pn3n3_c20260101__20260630_z8kh8R22To6c" title="Balance at ending"&gt;4,689,545&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A0_z32BjkQvbcdc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

















</cik0002058261:DisclosureOfCashFlowStatementsExplanatory>
    <cik0002058261:ScheduleOfIncomeAndExpensesFromOperatingActivitiesTableTextBlock
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      id="Fact007620">&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--ScheduleOfIncomeAndExpensesFromOperatingActivitiesTableTextBlock_pn3n3_z2UJSdods3Ih" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Statement of Cash flows (Details 2)"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span id="xdx_8B3_zObDnUlysDy" style="display: none"&gt;Schedule of income and expenses from operating activities&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_495_20260101__20260630__ifrs-full--SegmentsAxis__custom--IncomeAndExpensesFromOperatingActivitiesMember_zjRpU8ztkoD3" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49A_20250101__20250630__ifrs-full--SegmentsAxis__custom--IncomeAndExpensesFromOperatingActivitiesMember_z6dQQ84d78Xi" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Six-month&lt;br/&gt; period ended&lt;br/&gt;June&#160;30,&lt;br/&gt; 2026&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Six-month&lt;br/&gt; period ended&lt;br/&gt;June&#160;30,&lt;br/&gt; 2025&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="6" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--AdjustmentsForIncomeAndExpensesAbstract_iB_ztg06vdWkDK1" style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Adjustments for income and expenses&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--AdjustmentsForDepreciationExpense_zESlumRSMBWl" style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Depreciation&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;102,318&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;120,114&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40F_eifrs-full--AmortisationExpense_zOeHEMDtFE57" style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Amortization&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,167&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,136&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_402_eifrs-full--ExpenseRecognisedDuringPeriodForBadAndDoubtfulDebtsForRelatedPartyTransaction_zrXIuJOJK4Qg" style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Other bad debt expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;65,379&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;62,266&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--ReversalOfAllowanceForDoubtfulAccounts_zKnXmmSjMg7k" style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Reversal of allowance for doubtful accounts&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(287,100&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7635"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--LossesOnValuationOfDerivatives_zFHFP9hNcf07" style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Losses on valuation of derivatives&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;57,213&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7638"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--GainsOnValuationOfDerivatives_zDxuodMLyEU4" style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Gains on valuation of derivatives&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(117,845&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(309,333&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--LossesOnForeignCurrencyTranslation_zU1jowcF45Sd" style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Losses on foreign currency translation&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;66,412&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,530&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--GainsOnForeignCurrencyTranslation_zdHadhlxkSna" style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Gains on foreign currency translation&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(4,899&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(20,439&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--GainsOnLongtermInvestmentSecurities_zl5TPUTPaCqd" style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Gains on Long-term investment securities&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(3,560&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7650"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--InterestExpenses_z4PmunLjaDJf" style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Interest expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;351,045&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;385,423&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--InterestIncome_zP5YjP6f3Lwl" style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Interest income&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(109,493&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(121,109&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--LossesOnBondRedemption_zbU3foZcEqCc" style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Losses on bond redemption&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;12&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;17,292&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_409_eifrs-full--GainsLossesOnDisposalsOfPropertyPlantAndEquipment_zM0k5xRQRh7i" style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Gains on disposition of property and equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(1,125&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7662"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--SeveranceBenefit_z9NazmL5Dxof" style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Severance benefits&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;117,057&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;119,073&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--Subtotals_zjFPbZMF8A5d" style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;236,581&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;258,953&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--ChangesInAssetsAndLiabilitiesAbstract_iB_zJ4sA8PQVCn1" style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Changes in assets and liabilities&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--AdditionsToNoncurrentAssets_zcfiwgAbEWg4" style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Other non-current assets&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7673"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7674"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--AdjustmentsOfOtherCurrentNonfinancialLiabilities_zaD4I7QbbN1" style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Other current non-financial liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;434,653&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;201,577&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40C_eifrs-full--AdjustmentsForDecreaseIncreaseInTradeAccountReceivable_z2VzZ4hsKsnk" style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Accounts receivable - other, net&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(16,648&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;107,777&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_405_eifrs-full--AdjustmentsForDecreaseIncreaseInPrepaidExpenses_zPU8cnOg5PIj" style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Prepaid expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;21,383&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;25,748&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--AdjustmentsForPrepayments_zJH5EKpDrPU4" style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Prepayments&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(660&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(94,192&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--AdjustmentsForLiabilitiesDueToBenefitsPaid_z5zS4rJKo3E3" style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Liabilities due to benefits paid&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(40,601&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(61,566&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--AdjustmentsForSubtotal_i_pn3n" style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;398,127&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;179,344&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--IncomeAndExpensesFromOperatingActivities_zD2Ykus7uuUj" style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;634,708&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;438,297&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:ScheduleOfIncomeAndExpensesFromOperatingActivitiesTableTextBlock>
    <ifrs-full:AdjustmentsForDepreciationExpense
      contextRef="From2026-01-012026-06-30_custom_IncomeAndExpensesFromOperatingActivitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007625"
      unitRef="KRW">102318000</ifrs-full:AdjustmentsForDepreciationExpense>
    <ifrs-full:AdjustmentsForDepreciationExpense
      contextRef="From2025-01-012025-06-30_custom_IncomeAndExpensesFromOperatingActivitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007626"
      unitRef="KRW">120114000</ifrs-full:AdjustmentsForDepreciationExpense>
    <ifrs-full:AmortisationExpense
      contextRef="From2026-01-012026-06-30_custom_IncomeAndExpensesFromOperatingActivitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007628"
      unitRef="KRW">1167000</ifrs-full:AmortisationExpense>
    <ifrs-full:AmortisationExpense
      contextRef="From2025-01-012025-06-30_custom_IncomeAndExpensesFromOperatingActivitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007629"
      unitRef="KRW">1136000</ifrs-full:AmortisationExpense>
    <ifrs-full:ExpenseRecognisedDuringPeriodForBadAndDoubtfulDebtsForRelatedPartyTransaction
      contextRef="From2026-01-012026-06-30_custom_IncomeAndExpensesFromOperatingActivitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007631"
      unitRef="KRW">65379000</ifrs-full:ExpenseRecognisedDuringPeriodForBadAndDoubtfulDebtsForRelatedPartyTransaction>
    <ifrs-full:ExpenseRecognisedDuringPeriodForBadAndDoubtfulDebtsForRelatedPartyTransaction
      contextRef="From2025-01-012025-06-30_custom_IncomeAndExpensesFromOperatingActivitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007632"
      unitRef="KRW">62266000</ifrs-full:ExpenseRecognisedDuringPeriodForBadAndDoubtfulDebtsForRelatedPartyTransaction>
    <cik0002058261:ReversalOfAllowanceForDoubtfulAccounts
      contextRef="From2026-01-012026-06-30_custom_IncomeAndExpensesFromOperatingActivitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007634"
      unitRef="KRW">-287100000</cik0002058261:ReversalOfAllowanceForDoubtfulAccounts>
    <cik0002058261:LossesOnValuationOfDerivatives
      contextRef="From2026-01-012026-06-30_custom_IncomeAndExpensesFromOperatingActivitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007637"
      unitRef="KRW">57213000</cik0002058261:LossesOnValuationOfDerivatives>
    <cik0002058261:GainsOnValuationOfDerivatives
      contextRef="From2026-01-012026-06-30_custom_IncomeAndExpensesFromOperatingActivitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007640"
      unitRef="KRW">-117845000</cik0002058261:GainsOnValuationOfDerivatives>
    <cik0002058261:GainsOnValuationOfDerivatives
      contextRef="From2025-01-012025-06-30_custom_IncomeAndExpensesFromOperatingActivitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007641"
      unitRef="KRW">-309333000</cik0002058261:GainsOnValuationOfDerivatives>
    <cik0002058261:LossesOnForeignCurrencyTranslation
      contextRef="From2026-01-012026-06-30_custom_IncomeAndExpensesFromOperatingActivitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007643"
      unitRef="KRW">66412000</cik0002058261:LossesOnForeignCurrencyTranslation>
    <cik0002058261:LossesOnForeignCurrencyTranslation
      contextRef="From2025-01-012025-06-30_custom_IncomeAndExpensesFromOperatingActivitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007644"
      unitRef="KRW">4530000</cik0002058261:LossesOnForeignCurrencyTranslation>
    <cik0002058261:GainsOnForeignCurrencyTranslation
      contextRef="From2026-01-012026-06-30_custom_IncomeAndExpensesFromOperatingActivitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007646"
      unitRef="KRW">-4899000</cik0002058261:GainsOnForeignCurrencyTranslation>
    <cik0002058261:GainsOnForeignCurrencyTranslation
      contextRef="From2025-01-012025-06-30_custom_IncomeAndExpensesFromOperatingActivitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007647"
      unitRef="KRW">-20439000</cik0002058261:GainsOnForeignCurrencyTranslation>
    <cik0002058261:GainsOnLongtermInvestmentSecurities
      contextRef="From2026-01-012026-06-30_custom_IncomeAndExpensesFromOperatingActivitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007649"
      unitRef="KRW">-3560000</cik0002058261:GainsOnLongtermInvestmentSecurities>
    <cik0002058261:InterestExpenses
      contextRef="From2026-01-012026-06-30_custom_IncomeAndExpensesFromOperatingActivitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007652"
      unitRef="KRW">351045000</cik0002058261:InterestExpenses>
    <cik0002058261:InterestExpenses
      contextRef="From2025-01-012025-06-30_custom_IncomeAndExpensesFromOperatingActivitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007653"
      unitRef="KRW">385423000</cik0002058261:InterestExpenses>
    <cik0002058261:InterestIncome
      contextRef="From2026-01-012026-06-30_custom_IncomeAndExpensesFromOperatingActivitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007655"
      unitRef="KRW">-109493000</cik0002058261:InterestIncome>
    <cik0002058261:InterestIncome
      contextRef="From2025-01-012025-06-30_custom_IncomeAndExpensesFromOperatingActivitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007656"
      unitRef="KRW">-121109000</cik0002058261:InterestIncome>
    <cik0002058261:LossesOnBondRedemption
      contextRef="From2026-01-012026-06-30_custom_IncomeAndExpensesFromOperatingActivitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007658"
      unitRef="KRW">12000</cik0002058261:LossesOnBondRedemption>
    <cik0002058261:LossesOnBondRedemption
      contextRef="From2025-01-012025-06-30_custom_IncomeAndExpensesFromOperatingActivitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007659"
      unitRef="KRW">17292000</cik0002058261:LossesOnBondRedemption>
    <ifrs-full:GainsLossesOnDisposalsOfPropertyPlantAndEquipment
      contextRef="From2026-01-012026-06-30_custom_IncomeAndExpensesFromOperatingActivitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007661"
      unitRef="KRW">-1125000</ifrs-full:GainsLossesOnDisposalsOfPropertyPlantAndEquipment>
    <cik0002058261:SeveranceBenefit
      contextRef="From2026-01-012026-06-30_custom_IncomeAndExpensesFromOperatingActivitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007664"
      unitRef="KRW">117057000</cik0002058261:SeveranceBenefit>
    <cik0002058261:SeveranceBenefit
      contextRef="From2025-01-012025-06-30_custom_IncomeAndExpensesFromOperatingActivitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007665"
      unitRef="KRW">119073000</cik0002058261:SeveranceBenefit>
    <cik0002058261:Subtotals
      contextRef="From2026-01-012026-06-30_custom_IncomeAndExpensesFromOperatingActivitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007667"
      unitRef="KRW">236581000</cik0002058261:Subtotals>
    <cik0002058261:Subtotals
      contextRef="From2025-01-012025-06-30_custom_IncomeAndExpensesFromOperatingActivitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007668"
      unitRef="KRW">258953000</cik0002058261:Subtotals>
    <cik0002058261:AdjustmentsOfOtherCurrentNonfinancialLiabilities
      contextRef="From2026-01-012026-06-30_custom_IncomeAndExpensesFromOperatingActivitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007676"
      unitRef="KRW">434653000</cik0002058261:AdjustmentsOfOtherCurrentNonfinancialLiabilities>
    <cik0002058261:AdjustmentsOfOtherCurrentNonfinancialLiabilities
      contextRef="From2025-01-012025-06-30_custom_IncomeAndExpensesFromOperatingActivitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007677"
      unitRef="KRW">201577000</cik0002058261:AdjustmentsOfOtherCurrentNonfinancialLiabilities>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable
      contextRef="From2026-01-012026-06-30_custom_IncomeAndExpensesFromOperatingActivitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007679"
      unitRef="KRW">-16648000</ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable
      contextRef="From2025-01-012025-06-30_custom_IncomeAndExpensesFromOperatingActivitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007680"
      unitRef="KRW">107777000</ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInPrepaidExpenses
      contextRef="From2026-01-012026-06-30_custom_IncomeAndExpensesFromOperatingActivitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007682"
      unitRef="KRW">21383000</ifrs-full:AdjustmentsForDecreaseIncreaseInPrepaidExpenses>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInPrepaidExpenses
      contextRef="From2025-01-012025-06-30_custom_IncomeAndExpensesFromOperatingActivitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007683"
      unitRef="KRW">25748000</ifrs-full:AdjustmentsForDecreaseIncreaseInPrepaidExpenses>
    <cik0002058261:AdjustmentsForPrepayments
      contextRef="From2026-01-012026-06-30_custom_IncomeAndExpensesFromOperatingActivitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007685"
      unitRef="KRW">-660000</cik0002058261:AdjustmentsForPrepayments>
    <cik0002058261:AdjustmentsForPrepayments
      contextRef="From2025-01-012025-06-30_custom_IncomeAndExpensesFromOperatingActivitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007686"
      unitRef="KRW">-94192000</cik0002058261:AdjustmentsForPrepayments>
    <cik0002058261:AdjustmentsForLiabilitiesDueToBenefitsPaid
      contextRef="From2026-01-012026-06-30_custom_IncomeAndExpensesFromOperatingActivitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007688"
      unitRef="KRW">-40601000</cik0002058261:AdjustmentsForLiabilitiesDueToBenefitsPaid>
    <cik0002058261:AdjustmentsForLiabilitiesDueToBenefitsPaid
      contextRef="From2025-01-012025-06-30_custom_IncomeAndExpensesFromOperatingActivitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007689"
      unitRef="KRW">-61566000</cik0002058261:AdjustmentsForLiabilitiesDueToBenefitsPaid>
    <cik0002058261:AdjustmentsForSubtotal
      contextRef="From2026-01-012026-06-30_custom_IncomeAndExpensesFromOperatingActivitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007691"
      unitRef="KRW">398127000</cik0002058261:AdjustmentsForSubtotal>
    <cik0002058261:AdjustmentsForSubtotal
      contextRef="From2025-01-012025-06-30_custom_IncomeAndExpensesFromOperatingActivitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007692"
      unitRef="KRW">179344000</cik0002058261:AdjustmentsForSubtotal>
    <cik0002058261:IncomeAndExpensesFromOperatingActivities
      contextRef="From2026-01-012026-06-30_custom_IncomeAndExpensesFromOperatingActivitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007694"
      unitRef="KRW">634708000</cik0002058261:IncomeAndExpensesFromOperatingActivities>
    <cik0002058261:IncomeAndExpensesFromOperatingActivities
      contextRef="From2025-01-012025-06-30_custom_IncomeAndExpensesFromOperatingActivitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007695"
      unitRef="KRW">438297000</cik0002058261:IncomeAndExpensesFromOperatingActivities>
    <cik0002058261:ScheduleOfSignificantNonCashTransactionsTableTextBlock
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      id="Fact007704">&lt;table cellpadding="0" cellspacing="0" id="xdx_897_ecustom--ScheduleOfSignificantNonCashTransactionsTableTextBlock_pn3n3_zvEp4bSvMcP5" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Statement of Cash flows (Details)"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_8B6_zOAUA8FGoUWd" style="display: none"&gt;Schedule of significant non-cash transactions&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49B_20260101__20260630_zNw3Kfh6r76k" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_498_20250101__20250630_z80cPBFextna" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Six-month&lt;br/&gt;period ended&lt;br/&gt;June&#160;30,&lt;br/&gt;2026&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Six-month&lt;br/&gt;period ended &lt;br/&gt;June&#160;30,&lt;br/&gt;2025&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--IncreaseInLeaseLiabilities_i_pn3n" style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Increase in lease liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(16,073&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;947&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--IncreaseInDerivativeLiabilities_i_pn3n" style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Increase in derivative liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(227,213&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(143,667&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:ScheduleOfSignificantNonCashTransactionsTableTextBlock>
    <cik0002058261:IncreaseInLeaseLiabilities
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007706"
      unitRef="KRW">-16073000</cik0002058261:IncreaseInLeaseLiabilities>
    <cik0002058261:IncreaseInLeaseLiabilities
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007707"
      unitRef="KRW">947000</cik0002058261:IncreaseInLeaseLiabilities>
    <cik0002058261:IncreaseInDerivativeLiabilities
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007709"
      unitRef="KRW">-227213000</cik0002058261:IncreaseInDerivativeLiabilities>
    <cik0002058261:IncreaseInDerivativeLiabilities
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007710"
      unitRef="KRW">-143667000</cik0002058261:IncreaseInDerivativeLiabilities>
    <cik0002058261:ScheduleOfLiabilitiesToCashFlowsArisingFromFinancingActivitiesTableTextBlock
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      id="Fact007712">&lt;table cellpadding="0" cellspacing="0" id="xdx_896_ecustom--ScheduleOfLiabilitiesToCashFlowsArisingFromFinancingActivitiesTableTextBlock_pn3n3_zmClTvJMYJNe" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Statement of Cash flows (Details 1)"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span id="xdx_8B4_zHdaSW3WcZIe" style="display: none"&gt;Schedule of liabilities to cash flows arising from financing activities&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Current bond&lt;br/&gt;with warrants&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Short-term&lt;br/&gt;borrowings&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Current lease&lt;br/&gt;liabilities&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Non-current&lt;br/&gt; lease liabilities&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="18" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Balance at January&#160;1, 2025&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90A_eifrs-full--Borrowings_iS_pn3n3_c20250101__20250630__ifrs-full--BorrowingsByNameAxis__custom--CurrentBondWithWarrantsMember_zVMihR4kVyX6" title="Balance at beginning"&gt;3,519,139&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90E_eifrs-full--Borrowings_iS_pn3n3_c20250101__20250630__ifrs-full--BorrowingsByNameAxis__ifrs-full--ShorttermBorrowingsMember_zxWseW7KJoKe" title="Balance at beginning"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7716"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_909_eifrs-full--Borrowings_iS_pn3n3_c20250101__20250630__ifrs-full--BorrowingsByNameAxis__custom--CurrentLeaseLiabilitiesMember_zJmuXClacu8d" title="Balance at beginning"&gt;117,351&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_906_eifrs-full--Borrowings_iS_pn3n3_c20250101__20250630__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentLeaseLiabilitiesMember_zEk5e1BXPihf" title="Balance at beginning"&gt;551,681&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_905_eifrs-full--Borrowings_iS_pn3n3_c20250101__20250630_zQBAYJzjdw4i" title="Balance at beginning"&gt;4,188,171&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Changes from financing cash flows&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Proceeds from issuance of bond with warrants&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_908_ecustom--ProceedsFromIssuanceOfBondWithWarrants_pn3n3_c20250101__20250630__ifrs-full--BorrowingsByNameAxis__custom--CurrentBondWithWarrantsMember_znbovtSlHiLb" title="Proceeds from issuance of bond with warrants"&gt;2,000,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_901_ecustom--ProceedsFromIssuanceOfBondWithWarrants_pn3n3_c20250101__20250630__ifrs-full--BorrowingsByNameAxis__ifrs-full--ShorttermBorrowingsMember_zx5YvCGhdvS9" title="Proceeds from issuance of bond with warrants"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7726"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90A_ecustom--ProceedsFromIssuanceOfBondWithWarrants_pn3n3_c20250101__20250630__ifrs-full--BorrowingsByNameAxis__custom--CurrentLeaseLiabilitiesMember_zPSBgXgIqdJf" title="Proceeds from issuance of bond with warrants"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7728"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_902_ecustom--ProceedsFromIssuanceOfBondWithWarrants_pn3n3_c20250101__20250630__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentLeaseLiabilitiesMember_zQBOnW74DS55" title="Proceeds from issuance of bond with warrants"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7730"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90C_ecustom--ProceedsFromIssuanceOfBondWithWarrants_pn3n3_c20250101__20250630_zGwTK51XSEU1" title="Proceeds from issuance of bond with warrants"&gt;2,000,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Repayment of bond with warrants&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_905_ecustom--RepaymentOfBondWithWarrants_iN_pn3n3_di_c20250101__20250630__ifrs-full--BorrowingsByNameAxis__custom--CurrentBondWithWarrantsMember_zKFDwUqX9TU9" title="Repayment of bond with warrants"&gt;(2,500,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_900_ecustom--RepaymentOfBondWithWarrants_iN_pn3n3_di_c20250101__20250630__ifrs-full--BorrowingsByNameAxis__ifrs-full--ShorttermBorrowingsMember_ziMZoClFSrV5" title="Repayment of bond with warrants"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7736"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90B_ecustom--RepaymentOfBondWithWarrants_iN_pn3n3_di_c20250101__20250630__ifrs-full--BorrowingsByNameAxis__custom--CurrentLeaseLiabilitiesMember_zinQeMJ7l14f" title="Repayment of bond with warrants"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7738"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_905_ecustom--RepaymentOfBondWithWarrants_iN_pn3n3_di_c20250101__20250630__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentLeaseLiabilitiesMember_zdd6S6M5dLP2" title="Repayment of bond with warrants"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7740"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_908_ecustom--RepaymentOfBondWithWarrants_iN_pn3n3_di_c20250101__20250630_zvyS1CoSOOGh" title="Repayment of bond with warrants"&gt;(2,500,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Payment of lease liability principal&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_908_ecustom--PaymentOfLeaseLiabilityPrincipal_iN_pn3n3_di_c20250101__20250630__ifrs-full--BorrowingsByNameAxis__custom--CurrentBondWithWarrantsMember_zvhOIKWmOB9i" title="Payment of lease liability principal"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7744"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90B_ecustom--PaymentOfLeaseLiabilityPrincipal_iN_pn3n3_di_c20250101__20250630__ifrs-full--BorrowingsByNameAxis__ifrs-full--ShorttermBorrowingsMember_z6cKIES96Caa" title="Payment of lease liability principal"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7746"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_909_ecustom--PaymentOfLeaseLiabilityPrincipal_iN_pn3n3_di_c20250101__20250630__ifrs-full--BorrowingsByNameAxis__custom--CurrentLeaseLiabilitiesMember_zXCGu0162Doa" title="Payment of lease liability principal"&gt;(58,029&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_907_ecustom--PaymentOfLeaseLiabilityPrincipal_iN_pn3n3_di_c20250101__20250630__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentLeaseLiabilitiesMember_zFvpDmHiTYwc" title="Payment of lease liability principal"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7750"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90D_ecustom--PaymentOfLeaseLiabilityPrincipal_iN_pn3n3_di_c20250101__20250630_zWqyI9ZblAsd" title="Payment of lease liability principal"&gt;(58,029&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_907_eifrs-full--OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities_pn3n3_c20250101__20250630__ifrs-full--BorrowingsByNameAxis__custom--CurrentBondWithWarrantsMember_zMeugt68GmY3" title="Total"&gt;(500,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_907_eifrs-full--OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities_pn3n3_c20250101__20250630__ifrs-full--BorrowingsByNameAxis__ifrs-full--ShorttermBorrowingsMember_zYUEK38TKR67" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7756"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_906_eifrs-full--OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities_pn3n3_c20250101__20250630__ifrs-full--BorrowingsByNameAxis__custom--CurrentLeaseLiabilitiesMember_z3i9EPKA5blh" title="Total"&gt;(58,029&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_902_eifrs-full--OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities_pn3n3_c20250101__20250630__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentLeaseLiabilitiesMember_zR4yECKV7cjf" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7760"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_905_eifrs-full--OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities_pn3n3_c20250101__20250630_zFAG1MUzeon4" title="Total"&gt;(558,029&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Other changes&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Proceeds from Warrants Exercised&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_905_ecustom--ProceedsFromWarrantsExercised_iP3ifrs-full--OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities_pn3n3_c20250101__20250630__ifrs-full--BorrowingsByNameAxis__custom--CurrentBondWithWarrantsMember_z2BdH83j8Oyl" title="Proceeds from Warrants Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7764"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90E_ecustom--ProceedsFromWarrantsExercised_pn3n3_c20250101__20250630__ifrs-full--BorrowingsByNameAxis__ifrs-full--ShorttermBorrowingsMember_zSJ3N2VyX5Mb" title="Proceeds from Warrants Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7766"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90E_ecustom--ProceedsFromWarrantsExercised_pn3n3_c20250101__20250630__ifrs-full--BorrowingsByNameAxis__custom--CurrentLeaseLiabilitiesMember_z8dzrHcldX44" title="Proceeds from Warrants Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7768"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90B_ecustom--ProceedsFromWarrantsExercised_pn3n3_c20250101__20250630__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentLeaseLiabilitiesMember_zdoHvEGCllA6" title="Proceeds from Warrants Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7770"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_904_ecustom--ProceedsFromWarrantsExercised_pn3n3_c20250101__20250630_z2R3YQ52z8ah" title="Proceeds from Warrants Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7772"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Proceeds from borrowings&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_906_eifrs-full--ProceedsFromCurrentBorrowings_iP3custom--ProceedsFromWarrantsExercised_pn3n3_c20250101__20250630__ifrs-full--BorrowingsByNameAxis__custom--CurrentBondWithWarrantsMember_zQModSt8J884" title="Proceeds from borrowings"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7774"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90B_eifrs-full--ProceedsFromCurrentBorrowings_pn3n3_c20250101__20250630__ifrs-full--BorrowingsByNameAxis__ifrs-full--ShorttermBorrowingsMember_zbNfLRKqF0vk" title="Proceeds from borrowings"&gt;270,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_902_eifrs-full--ProceedsFromCurrentBorrowings_pn3n3_c20250101__20250630__ifrs-full--BorrowingsByNameAxis__custom--CurrentLeaseLiabilitiesMember_zc3E3taXaKIb" title="Proceeds from borrowings"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7778"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90D_eifrs-full--ProceedsFromCurrentBorrowings_pn3n3_c20250101__20250630__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentLeaseLiabilitiesMember_z7U4eNm0Y2j4" title="Proceeds from borrowings"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7780"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90A_eifrs-full--ProceedsFromCurrentBorrowings_pn3n3_c20250101__20250630_zCW6JPBTeid7" title="Proceeds from borrowings"&gt;270,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Other non-cash transactions&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_900_ecustom--OtherNoncashTransactions_pn3n3_c20250101__20250630__ifrs-full--BorrowingsByNameAxis__custom--CurrentBondWithWarrantsMember_zoSQl2P3fsy5" title="Other non-cash transactions"&gt;143,667&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90A_ecustom--OtherNoncashTransactions_pn3n3_c20250101__20250630__ifrs-full--BorrowingsByNameAxis__ifrs-full--ShorttermBorrowingsMember_zQkR4eGB18Uh" title="Other non-cash transactions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7786"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_901_ecustom--OtherNoncashTransactions_pn3n3_c20250101__20250630__ifrs-full--BorrowingsByNameAxis__custom--CurrentLeaseLiabilitiesMember_ziCTvgkpYyqe" title="Other non-cash transactions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7788"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_908_ecustom--OtherNoncashTransactions_pn3n3_c20250101__20250630__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentLeaseLiabilitiesMember_zStdfpBDWfLc" title="Other non-cash transactions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7790"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_901_ecustom--OtherNoncashTransactions_pn3n3_c20250101__20250630_z6Z2xKdTGDWk" title="Other non-cash transactions"&gt;143,667&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Lease reassessment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_902_ecustom--LeaseReassessment_pn3n3_c20250101__20250630__ifrs-full--BorrowingsByNameAxis__custom--CurrentBondWithWarrantsMember_zjVhmXa5EAxe" title="Lease reassessment"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7794"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_908_ecustom--LeaseReassessment_pn3n3_c20250101__20250630__ifrs-full--BorrowingsByNameAxis__ifrs-full--ShorttermBorrowingsMember_zzHvGNgSFO53" title="Lease reassessment"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7796"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90B_ecustom--LeaseReassessment_pn3n3_c20250101__20250630__ifrs-full--BorrowingsByNameAxis__custom--CurrentLeaseLiabilitiesMember_zfRET76930F6" title="Lease reassessment"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7798"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_904_ecustom--LeaseReassessment_pn3n3_c20250101__20250630__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentLeaseLiabilitiesMember_zobSyw0zcRbc" title="Lease reassessment"&gt;947&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90F_ecustom--LeaseReassessment_pn3n3_c20250101__20250630_zFlFH00Hiz5c" title="Lease reassessment"&gt;947&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_907_ecustom--OtherInterestExpense_pn3n3_c20250101__20250630__ifrs-full--BorrowingsByNameAxis__custom--CurrentBondWithWarrantsMember_zMowp6oL6Qsj" title="Interest expense"&gt;357,234&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_907_ecustom--OtherInterestExpense_pn3n3_c20250101__20250630__ifrs-full--BorrowingsByNameAxis__ifrs-full--ShorttermBorrowingsMember_zgiapcaFPP5f" title="Interest expense"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7806"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_901_ecustom--OtherInterestExpense_pn3n3_c20250101__20250630__ifrs-full--BorrowingsByNameAxis__custom--CurrentLeaseLiabilitiesMember_zpfsGvN92nKe" title="Interest expense"&gt;27,316&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_904_ecustom--OtherInterestExpense_pn3n3_c20250101__20250630__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentLeaseLiabilitiesMember_zhcweq31YNjk" title="Interest expense"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7810"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_904_ecustom--OtherInterestExpense_pn3n3_c20250101__20250630_zQzPGbBXWyLf" title="Interest expense"&gt;384,550&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Interest paid&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90F_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20250101__20250630__ifrs-full--BorrowingsByNameAxis__custom--CurrentBondWithWarrantsMember_z5QZxxgamW4e" title="Interest paid"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7814"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_906_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20250101__20250630__ifrs-full--BorrowingsByNameAxis__ifrs-full--ShorttermBorrowingsMember_zvuOj4zecMfd" title="Interest paid"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7816"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90E_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20250101__20250630__ifrs-full--BorrowingsByNameAxis__custom--CurrentLeaseLiabilitiesMember_zdBkFHM2UPBd" title="Interest paid"&gt;(27,316&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90B_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20250101__20250630__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentLeaseLiabilitiesMember_z7vuvv3Sr69c" title="Interest paid"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7820"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_905_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20250101__20250630_zc5IXH31k2N3" title="Interest paid"&gt;(27,316&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Reclassification&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_901_ecustom--Reclassification_pn3n3_c20250101__20250630__ifrs-full--BorrowingsByNameAxis__custom--CurrentBondWithWarrantsMember_zhJwgTHdsvma" title="Reclassification"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7824"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90C_ecustom--Reclassification_pn3n3_c20250101__20250630__ifrs-full--BorrowingsByNameAxis__ifrs-full--ShorttermBorrowingsMember_ztaLNQU3ifx3" title="Reclassification"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7826"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_905_ecustom--Reclassification_pn3n3_c20250101__20250630__ifrs-full--BorrowingsByNameAxis__custom--CurrentLeaseLiabilitiesMember_zv24pzk64jqa" title="Reclassification"&gt;60,018&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_907_ecustom--Reclassification_pn3n3_c20250101__20250630__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentLeaseLiabilitiesMember_zXtS8x5FT3Ue" title="Reclassification"&gt;(60,018&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90E_ecustom--Reclassification_pn3n3_c20250101__20250630_zJeBLd0aCfY3" title="Reclassification"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7832"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_908_ecustom--TotalOtherChanges_pn3n3_c20250101__20250630__ifrs-full--BorrowingsByNameAxis__custom--CurrentBondWithWarrantsMember_zEuZKTRccim6" title="Total"&gt;500,901&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90C_ecustom--TotalOtherChanges_pn3n3_c20250101__20250630__ifrs-full--BorrowingsByNameAxis__ifrs-full--ShorttermBorrowingsMember_zl83zWYFAG99" title="Total"&gt;270,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_907_ecustom--TotalOtherChanges_pn3n3_c20250101__20250630__ifrs-full--BorrowingsByNameAxis__custom--CurrentLeaseLiabilitiesMember_zQ6mrR37Ejf" title="Total"&gt;60,018&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_906_ecustom--TotalOtherChanges_pn3n3_c20250101__20250630__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentLeaseLiabilitiesMember_zgLW2Ai2sfbc" title="Total"&gt;(59,071&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_902_ecustom--TotalOtherChanges_pn3n3_c20250101__20250630_zydl39LbaVCh" title="Total"&gt;771,848&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Balance at June&#160;30, 2025&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_901_eifrs-full--Borrowings_iE_pn3n3_c20250101__20250630__ifrs-full--BorrowingsByNameAxis__custom--CurrentBondWithWarrantsMember_zcULdOk5r5Ga" title="Balance at ending"&gt;3,520,040&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_909_eifrs-full--Borrowings_iE_pn3n3_c20250101__20250630__ifrs-full--BorrowingsByNameAxis__ifrs-full--ShorttermBorrowingsMember_zh4w97RA34U" title="Balance at ending"&gt;270,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_908_eifrs-full--Borrowings_iE_pn3n3_c20250101__20250630__ifrs-full--BorrowingsByNameAxis__custom--CurrentLeaseLiabilitiesMember_zurSuevKpc9c" title="Balance at ending"&gt;119,340&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_908_eifrs-full--Borrowings_iE_pn3n3_c20250101__20250630__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentLeaseLiabilitiesMember_zsOwzh0rYW2j" title="Balance at ending"&gt;492,610&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_907_eifrs-full--Borrowings_iE_pn3n3_c20250101__20250630_zYFqCwI6ww53" title="Balance at ending"&gt;4,401,990&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Balance at January&#160;1, 2026&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_902_eifrs-full--Borrowings_iS_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--CurrentBondWithWarrantsMember_zzl5Pp4iila3" title="Balance at beginning"&gt;3,265,312&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90F_eifrs-full--Borrowings_iS_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__ifrs-full--ShorttermBorrowingsMember_zwm91Nejkj66" title="Balance at beginning"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7856"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90E_eifrs-full--Borrowings_iS_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--CurrentLeaseLiabilitiesMember_zvFRUQSO7fJ4" title="Balance at beginning"&gt;122,626&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_901_eifrs-full--Borrowings_iS_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentLeaseLiabilitiesMember_zSvzXQ2TCfNk" title="Balance at beginning"&gt;430,005&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_904_eifrs-full--Borrowings_iS_pn3n3_c20260101__20260630_zBq1tPvdEJS9" title="Balance at beginning"&gt;3,817,943&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Changes from financing cash flows&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Proceeds from issuance of bond with warrants&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90C_ecustom--ProceedsFromIssuanceOfBondWithWarrants_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--CurrentBondWithWarrantsMember_zmsdykMw4oJ9" title="Proceeds from issuance of bond with warrants"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7864"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_908_ecustom--ProceedsFromIssuanceOfBondWithWarrants_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__ifrs-full--ShorttermBorrowingsMember_zJ1LIqv5CtXa" title="Proceeds from issuance of bond with warrants"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7866"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_904_ecustom--ProceedsFromIssuanceOfBondWithWarrants_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--CurrentLeaseLiabilitiesMember_z0QMl1UZchZa" title="Proceeds from issuance of bond with warrants"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7868"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_905_ecustom--ProceedsFromIssuanceOfBondWithWarrants_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentLeaseLiabilitiesMember_zZqYrXihVdvb" title="Proceeds from issuance of bond with warrants"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7870"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_901_ecustom--ProceedsFromIssuanceOfBondWithWarrants_pn3n3_c20260101__20260630_zEDE3Tlxcr3" title="Proceeds from issuance of bond with warrants"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7872"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Repayment of bond with warrants&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90B_ecustom--RepaymentOfBondWithWarrants_iN_pn3n3_di_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--CurrentBondWithWarrantsMember_zewJ1i0gg1Vb" title="Repayment of bond with warrants"&gt;(600,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90D_ecustom--RepaymentOfBondWithWarrants_iN_pn3n3_di_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__ifrs-full--ShorttermBorrowingsMember_zjBkmZz2VOCg" title="Repayment of bond with warrants"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7876"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_900_ecustom--RepaymentOfBondWithWarrants_iN_pn3n3_di_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--CurrentLeaseLiabilitiesMember_zsbPb5ibDxck" title="Repayment of bond with warrants"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7878"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90A_ecustom--RepaymentOfBondWithWarrants_iN_pn3n3_di_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentLeaseLiabilitiesMember_zLVqyqGYuKYa" title="Repayment of bond with warrants"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7880"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_904_ecustom--RepaymentOfBondWithWarrants_iN_pn3n3_di_c20260101__20260630_zqpwzmPCCloe" title="Repayment of bond with warrants"&gt;(600,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Payment of lease liability principal&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90A_ecustom--PaymentOfLeaseLiabilityPrincipal_iN_pn3n3_di_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--CurrentBondWithWarrantsMember_zwxna3qwiIal" title="Payment of lease liability principal"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7884"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_905_ecustom--PaymentOfLeaseLiabilityPrincipal_iN_pn3n3_di_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__ifrs-full--ShorttermBorrowingsMember_z0t1FHBCctP1" title="Payment of lease liability principal"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7886"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_904_ecustom--PaymentOfLeaseLiabilityPrincipal_iN_pn3n3_di_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--CurrentLeaseLiabilitiesMember_zddOdMB7qxUe" title="Payment of lease liability principal"&gt;(56,773&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_909_ecustom--PaymentOfLeaseLiabilityPrincipal_iN_pn3n3_di_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentLeaseLiabilitiesMember_zwxjotJrmQb1" title="Payment of lease liability principal"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7890"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_909_ecustom--PaymentOfLeaseLiabilityPrincipal_iN_pn3n3_di_c20260101__20260630_z9RjDsA8YyRi" title="Payment of lease liability principal"&gt;(56,773&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90D_eifrs-full--OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--CurrentBondWithWarrantsMember_zGx60XxNrgab" title="Total"&gt;(600,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_903_eifrs-full--OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__ifrs-full--ShorttermBorrowingsMember_z6knBMFUhJbb" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7896"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_909_eifrs-full--OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--CurrentLeaseLiabilitiesMember_zrRkt8hfTPsj" title="Total"&gt;(56,773&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90A_eifrs-full--OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentLeaseLiabilitiesMember_z5IKoGPZZom9" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7900"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_901_eifrs-full--OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities_pn3n3_c20260101__20260630_zDCDRmnleVJ3" title="Total"&gt;(656,773&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Other changes&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Proceeds from Warrants Exercised&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_907_ecustom--ProceedsFromWarrantsExercised_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--CurrentBondWithWarrantsMember_zPwsp6KnvEW4" title="Proceeds from Warrants Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7904"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90D_ecustom--ProceedsFromWarrantsExercised_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__ifrs-full--ShorttermBorrowingsMember_zD0bT5iuhEp" title="Proceeds from Warrants Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7906"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90F_ecustom--ProceedsFromWarrantsExercised_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--CurrentLeaseLiabilitiesMember_zeXWhPXO8oml" title="Proceeds from Warrants Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7908"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_906_ecustom--ProceedsFromWarrantsExercised_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentLeaseLiabilitiesMember_ze528FhPAh11" title="Proceeds from Warrants Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7910"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_903_ecustom--ProceedsFromWarrantsExercised_pn3n3_c20260101__20260630_z8BemAo4upNd" title="Proceeds from Warrants Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7912"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Proceeds from borrowings&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_902_eifrs-full--ProceedsFromCurrentBorrowings_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--CurrentBondWithWarrantsMember_zRWA9Hq1smbi" title="Proceeds from borrowings"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7914"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_902_eifrs-full--ProceedsFromCurrentBorrowings_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__ifrs-full--ShorttermBorrowingsMember_ze01eQE3zbq5" title="Proceeds from borrowings"&gt;1,000,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90B_eifrs-full--ProceedsFromCurrentBorrowings_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--CurrentLeaseLiabilitiesMember_zSxdkg0mlpQj" title="Proceeds from borrowings"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7918"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_905_eifrs-full--ProceedsFromCurrentBorrowings_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentLeaseLiabilitiesMember_zP0RengnZU5c" title="Proceeds from borrowings"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7920"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90E_eifrs-full--ProceedsFromCurrentBorrowings_pn3n3_c20260101__20260630_zN3vlPeQJIgf" title="Proceeds from borrowings"&gt;1,000,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Other non-cash transactions&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_909_ecustom--OtherNoncashTransactions_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--CurrentBondWithWarrantsMember_zYVjJqJFElZ1" title="Other non-cash transactions"&gt;227,213&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90C_ecustom--OtherNoncashTransactions_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__ifrs-full--ShorttermBorrowingsMember_zqsEDjy1idA7" title="Other non-cash transactions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7926"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_900_ecustom--OtherNoncashTransactions_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--CurrentLeaseLiabilitiesMember_zd8yA88IUCTc" title="Other non-cash transactions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7928"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_908_ecustom--OtherNoncashTransactions_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentLeaseLiabilitiesMember_zv16hQ8Hs5s8" title="Other non-cash transactions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7930"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90B_ecustom--OtherNoncashTransactions_pn3n3_c20260101__20260630_znufXQBzg8ge" title="Other non-cash transactions"&gt;227,213&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Lease reassessment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_900_ecustom--LeaseReassessment_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--CurrentBondWithWarrantsMember_zlnBOSzQCyZa" title="Lease reassessment"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7934"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90E_ecustom--LeaseReassessment_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__ifrs-full--ShorttermBorrowingsMember_zQqBjilCXska" title="Lease reassessment"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7936"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_900_ecustom--LeaseReassessment_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--CurrentLeaseLiabilitiesMember_z15Iwg2qYWB6" title="Lease reassessment"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7938"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_906_ecustom--LeaseReassessment_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentLeaseLiabilitiesMember_zIh6j7dcXfXk" title="Lease reassessment"&gt;(16,073&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90C_ecustom--LeaseReassessment_pn3n3_c20260101__20260630_z5jZPRUQ9rP7" title="Lease reassessment"&gt;(16,073&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90A_ecustom--OtherInterestExpense_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--CurrentBondWithWarrantsMember_zOf0xN6l19Oi" title="Interest expense"&gt;317,235&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_905_ecustom--OtherInterestExpense_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__ifrs-full--ShorttermBorrowingsMember_zh1IdZI20dTj" title="Interest expense"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7946"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_908_ecustom--OtherInterestExpense_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--CurrentLeaseLiabilitiesMember_zyN0XTrbmmve" title="Interest expense"&gt;21,678&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90F_ecustom--OtherInterestExpense_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentLeaseLiabilitiesMember_zYOpgCmEKb9b" title="Interest expense"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7950"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_900_ecustom--OtherInterestExpense_pn3n3_c20260101__20260630_zWSYpj5jLfMg" title="Interest expense"&gt;338,913&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Interest paid&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_902_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--CurrentBondWithWarrantsMember_zZwuQwibHli4" title="Interest paid"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7954"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_901_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__ifrs-full--ShorttermBorrowingsMember_z4ryPMJBjLCa" title="Interest paid"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7956"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90B_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--CurrentLeaseLiabilitiesMember_zBnZLZSUlAld" title="Interest paid"&gt;(21,678&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_902_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentLeaseLiabilitiesMember_zELyyQ0lqYn8" title="Interest paid"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7960"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_902_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20260101__20260630_zXQK9FIC2LT5" title="Interest paid"&gt;(21,678&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Reclassification&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90B_ecustom--Reclassification_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--CurrentBondWithWarrantsMember_zmx75ssmvnih" title="Reclassification"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7964"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_902_ecustom--Reclassification_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__ifrs-full--ShorttermBorrowingsMember_zChEpeeQJh59" title="Reclassification"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7966"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90B_ecustom--Reclassification_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--CurrentLeaseLiabilitiesMember_zRLQFFfVsH1h" title="Reclassification"&gt;42,853&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_905_ecustom--Reclassification_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentLeaseLiabilitiesMember_zQk03bhSXBZ9" title="Reclassification"&gt;(42,853&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_902_ecustom--Reclassification_pn3n3_c20260101__20260630_zypWJSloopC4" title="Reclassification"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl7972"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90F_ecustom--TotalOtherChanges_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--CurrentBondWithWarrantsMember_zZQcqmRq3PD" title="Total"&gt;544,448&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_903_ecustom--TotalOtherChanges_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__ifrs-full--ShorttermBorrowingsMember_zCJZ7V5yLHsj" title="Total"&gt;1,000,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90C_ecustom--TotalOtherChanges_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--CurrentLeaseLiabilitiesMember_zB3ZRP5uKNek" title="Total"&gt;42,853&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_900_ecustom--TotalOtherChanges_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentLeaseLiabilitiesMember_zeHCXZrh6QSi" title="Total"&gt;(58,926&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_906_ecustom--TotalOtherChanges_pn3n3_c20260101__20260630_zyXf1LTPR3Ta" title="Total"&gt;1,528,375&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Balance at June&#160;30, 2026&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_906_eifrs-full--Borrowings_iE_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--CurrentBondWithWarrantsMember_zgBH89unXaE5" title="Balance at ending"&gt;3,209,760&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_902_eifrs-full--Borrowings_iE_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__ifrs-full--ShorttermBorrowingsMember_zHfESlkoZc66" title="Balance at ending"&gt;1,000,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_906_eifrs-full--Borrowings_iE_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--CurrentLeaseLiabilitiesMember_zDGFhEtfZAhh" title="Balance at ending"&gt;108,706&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90F_eifrs-full--Borrowings_iE_pn3n3_c20260101__20260630__ifrs-full--BorrowingsByNameAxis__custom--NonCurrentLeaseLiabilitiesMember_z4UKlpJasxg7" title="Balance at ending"&gt;371,079&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_903_eifrs-full--Borrowings_iE_pn3n3_c20260101__20260630_z8kh8R22To6c" title="Balance at ending"&gt;4,689,545&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:ScheduleOfLiabilitiesToCashFlowsArisingFromFinancingActivitiesTableTextBlock>
    <ifrs-full:Borrowings
      contextRef="AsOf2024-12-31_custom_CurrentBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007714"
      unitRef="KRW">3519139000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="AsOf2024-12-31_custom_CurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007718"
      unitRef="KRW">117351000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="AsOf2024-12-31_custom_NonCurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007720"
      unitRef="KRW">551681000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="AsOf2024-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007722"
      unitRef="KRW">4188171000</ifrs-full:Borrowings>
    <cik0002058261:ProceedsFromIssuanceOfBondWithWarrants
      contextRef="From2025-01-012025-06-30_custom_CurrentBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007724"
      unitRef="KRW">2000000000</cik0002058261:ProceedsFromIssuanceOfBondWithWarrants>
    <cik0002058261:ProceedsFromIssuanceOfBondWithWarrants
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007732"
      unitRef="KRW">2000000000</cik0002058261:ProceedsFromIssuanceOfBondWithWarrants>
    <cik0002058261:RepaymentOfBondWithWarrants
      contextRef="From2025-01-012025-06-30_custom_CurrentBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007734"
      unitRef="KRW">2500000000</cik0002058261:RepaymentOfBondWithWarrants>
    <cik0002058261:RepaymentOfBondWithWarrants
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007742"
      unitRef="KRW">2500000000</cik0002058261:RepaymentOfBondWithWarrants>
    <cik0002058261:PaymentOfLeaseLiabilityPrincipal
      contextRef="From2025-01-012025-06-30_custom_CurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007748"
      unitRef="KRW">58029000</cik0002058261:PaymentOfLeaseLiabilityPrincipal>
    <cik0002058261:PaymentOfLeaseLiabilityPrincipal
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007752"
      unitRef="KRW">58029000</cik0002058261:PaymentOfLeaseLiabilityPrincipal>
    <ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities
      contextRef="From2025-01-012025-06-30_custom_CurrentBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007754"
      unitRef="KRW">-500000000</ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities>
    <ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities
      contextRef="From2025-01-012025-06-30_custom_CurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007758"
      unitRef="KRW">-58029000</ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities>
    <ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007762"
      unitRef="KRW">-558029000</ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities>
    <ifrs-full:ProceedsFromCurrentBorrowings
      contextRef="From2025-01-012025-06-30_ifrs-full_ShorttermBorrowingsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007776"
      unitRef="KRW">270000000</ifrs-full:ProceedsFromCurrentBorrowings>
    <ifrs-full:ProceedsFromCurrentBorrowings
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007782"
      unitRef="KRW">270000000</ifrs-full:ProceedsFromCurrentBorrowings>
    <cik0002058261:OtherNoncashTransactions
      contextRef="From2025-01-012025-06-30_custom_CurrentBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007784"
      unitRef="KRW">143667000</cik0002058261:OtherNoncashTransactions>
    <cik0002058261:OtherNoncashTransactions
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007792"
      unitRef="KRW">143667000</cik0002058261:OtherNoncashTransactions>
    <cik0002058261:LeaseReassessment
      contextRef="From2025-01-012025-06-30_custom_NonCurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007800"
      unitRef="KRW">947000</cik0002058261:LeaseReassessment>
    <cik0002058261:LeaseReassessment
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007802"
      unitRef="KRW">947000</cik0002058261:LeaseReassessment>
    <cik0002058261:OtherInterestExpense
      contextRef="From2025-01-012025-06-30_custom_CurrentBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007804"
      unitRef="KRW">357234000</cik0002058261:OtherInterestExpense>
    <cik0002058261:OtherInterestExpense
      contextRef="From2025-01-012025-06-30_custom_CurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007808"
      unitRef="KRW">27316000</cik0002058261:OtherInterestExpense>
    <cik0002058261:OtherInterestExpense
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007812"
      unitRef="KRW">384550000</cik0002058261:OtherInterestExpense>
    <ifrs-full:InterestPaidClassifiedAsFinancingActivities
      contextRef="From2025-01-012025-06-30_custom_CurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007818"
      unitRef="KRW">27316000</ifrs-full:InterestPaidClassifiedAsFinancingActivities>
    <ifrs-full:InterestPaidClassifiedAsFinancingActivities
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007822"
      unitRef="KRW">27316000</ifrs-full:InterestPaidClassifiedAsFinancingActivities>
    <cik0002058261:Reclassification
      contextRef="From2025-01-012025-06-30_custom_CurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007828"
      unitRef="KRW">60018000</cik0002058261:Reclassification>
    <cik0002058261:Reclassification
      contextRef="From2025-01-012025-06-30_custom_NonCurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007830"
      unitRef="KRW">-60018000</cik0002058261:Reclassification>
    <cik0002058261:TotalOtherChanges
      contextRef="From2025-01-012025-06-30_custom_CurrentBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007834"
      unitRef="KRW">500901000</cik0002058261:TotalOtherChanges>
    <cik0002058261:TotalOtherChanges
      contextRef="From2025-01-012025-06-30_ifrs-full_ShorttermBorrowingsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007836"
      unitRef="KRW">270000000</cik0002058261:TotalOtherChanges>
    <cik0002058261:TotalOtherChanges
      contextRef="From2025-01-012025-06-30_custom_CurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007838"
      unitRef="KRW">60018000</cik0002058261:TotalOtherChanges>
    <cik0002058261:TotalOtherChanges
      contextRef="From2025-01-012025-06-30_custom_NonCurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007840"
      unitRef="KRW">-59071000</cik0002058261:TotalOtherChanges>
    <cik0002058261:TotalOtherChanges
      contextRef="From2025-01-012025-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007842"
      unitRef="KRW">771848000</cik0002058261:TotalOtherChanges>
    <ifrs-full:Borrowings
      contextRef="AsOf2025-06-30_custom_CurrentBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007844"
      unitRef="KRW">3520040000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="AsOf2025-06-30_ifrs-full_ShorttermBorrowingsMember_custom_CubebioCo.Ltd.Member273638953"
      decimals="-3"
      id="Fact007846"
      unitRef="KRW">270000000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="AsOf2025-06-30_custom_CurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007848"
      unitRef="KRW">119340000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="AsOf2025-06-30_custom_NonCurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007850"
      unitRef="KRW">492610000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="AsOf2025-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007852"
      unitRef="KRW">4401990000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="AsOf2025-12-31_custom_CurrentBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007854"
      unitRef="KRW">3265312000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="AsOf2025-12-31_custom_CurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007858"
      unitRef="KRW">122626000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="AsOf2025-12-31_custom_NonCurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007860"
      unitRef="KRW">430005000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007862"
      unitRef="KRW">3817943000</ifrs-full:Borrowings>
    <cik0002058261:RepaymentOfBondWithWarrants
      contextRef="From2026-01-012026-06-30_custom_CurrentBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007874"
      unitRef="KRW">600000000</cik0002058261:RepaymentOfBondWithWarrants>
    <cik0002058261:RepaymentOfBondWithWarrants
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007882"
      unitRef="KRW">600000000</cik0002058261:RepaymentOfBondWithWarrants>
    <cik0002058261:PaymentOfLeaseLiabilityPrincipal
      contextRef="From2026-01-012026-06-30_custom_CurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007888"
      unitRef="KRW">56773000</cik0002058261:PaymentOfLeaseLiabilityPrincipal>
    <cik0002058261:PaymentOfLeaseLiabilityPrincipal
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007892"
      unitRef="KRW">56773000</cik0002058261:PaymentOfLeaseLiabilityPrincipal>
    <ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities
      contextRef="From2026-01-012026-06-30_custom_CurrentBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007894"
      unitRef="KRW">-600000000</ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities>
    <ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities
      contextRef="From2026-01-012026-06-30_custom_CurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007898"
      unitRef="KRW">-56773000</ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities>
    <ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007902"
      unitRef="KRW">-656773000</ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities>
    <ifrs-full:ProceedsFromCurrentBorrowings
      contextRef="From2026-01-012026-06-30_ifrs-full_ShorttermBorrowingsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007916"
      unitRef="KRW">1000000000</ifrs-full:ProceedsFromCurrentBorrowings>
    <ifrs-full:ProceedsFromCurrentBorrowings
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007922"
      unitRef="KRW">1000000000</ifrs-full:ProceedsFromCurrentBorrowings>
    <cik0002058261:OtherNoncashTransactions
      contextRef="From2026-01-012026-06-30_custom_CurrentBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007924"
      unitRef="KRW">227213000</cik0002058261:OtherNoncashTransactions>
    <cik0002058261:OtherNoncashTransactions
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007932"
      unitRef="KRW">227213000</cik0002058261:OtherNoncashTransactions>
    <cik0002058261:LeaseReassessment
      contextRef="From2026-01-012026-06-30_custom_NonCurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007940"
      unitRef="KRW">-16073000</cik0002058261:LeaseReassessment>
    <cik0002058261:LeaseReassessment
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007942"
      unitRef="KRW">-16073000</cik0002058261:LeaseReassessment>
    <cik0002058261:OtherInterestExpense
      contextRef="From2026-01-012026-06-30_custom_CurrentBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007944"
      unitRef="KRW">317235000</cik0002058261:OtherInterestExpense>
    <cik0002058261:OtherInterestExpense
      contextRef="From2026-01-012026-06-30_custom_CurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007948"
      unitRef="KRW">21678000</cik0002058261:OtherInterestExpense>
    <cik0002058261:OtherInterestExpense
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007952"
      unitRef="KRW">338913000</cik0002058261:OtherInterestExpense>
    <ifrs-full:InterestPaidClassifiedAsFinancingActivities
      contextRef="From2026-01-012026-06-30_custom_CurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007958"
      unitRef="KRW">21678000</ifrs-full:InterestPaidClassifiedAsFinancingActivities>
    <ifrs-full:InterestPaidClassifiedAsFinancingActivities
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007962"
      unitRef="KRW">21678000</ifrs-full:InterestPaidClassifiedAsFinancingActivities>
    <cik0002058261:Reclassification
      contextRef="From2026-01-012026-06-30_custom_CurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007968"
      unitRef="KRW">42853000</cik0002058261:Reclassification>
    <cik0002058261:Reclassification
      contextRef="From2026-01-012026-06-30_custom_NonCurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007970"
      unitRef="KRW">-42853000</cik0002058261:Reclassification>
    <cik0002058261:TotalOtherChanges
      contextRef="From2026-01-012026-06-30_custom_CurrentBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007974"
      unitRef="KRW">544448000</cik0002058261:TotalOtherChanges>
    <cik0002058261:TotalOtherChanges
      contextRef="From2026-01-012026-06-30_ifrs-full_ShorttermBorrowingsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007976"
      unitRef="KRW">1000000000</cik0002058261:TotalOtherChanges>
    <cik0002058261:TotalOtherChanges
      contextRef="From2026-01-012026-06-30_custom_CurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007978"
      unitRef="KRW">42853000</cik0002058261:TotalOtherChanges>
    <cik0002058261:TotalOtherChanges
      contextRef="From2026-01-012026-06-30_custom_NonCurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007980"
      unitRef="KRW">-58926000</cik0002058261:TotalOtherChanges>
    <cik0002058261:TotalOtherChanges
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007982"
      unitRef="KRW">1528375000</cik0002058261:TotalOtherChanges>
    <ifrs-full:Borrowings
      contextRef="AsOf2026-06-30_custom_CurrentBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007984"
      unitRef="KRW">3209760000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="AsOf2026-06-30_ifrs-full_ShorttermBorrowingsMember_custom_CubebioCo.Ltd.Member273639125"
      decimals="-3"
      id="Fact007986"
      unitRef="KRW">1000000000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="AsOf2026-06-30_custom_CurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007988"
      unitRef="KRW">108706000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="AsOf2026-06-30_custom_NonCurrentLeaseLiabilitiesMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007990"
      unitRef="KRW">371079000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="AsOf2026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact007992"
      unitRef="KRW">4689545000</ifrs-full:Borrowings>
    <ifrs-full:DisclosureOfCommitmentsExplanatory
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      id="Fact008001">&lt;p id="xdx_800_eifrs-full--DisclosureOfCommitmentsExplanatory_zGrhaKNBwLie" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;27. &lt;span id="xdx_827_zVla8K5dXY9a"&gt;Commitments and contingencies&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;A.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Litigation&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The Company&#x2019;s pending lawsuit as a defendant as of June&#160;30, 2026 is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89E_ecustom--ScheduleOfLitigationTableTextBlock_pn3n3_zOkV2hsTijbe" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Commitments and contingencies (Details)"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"&gt;&lt;span id="xdx_8B6_zjW5d3ZAxAvj" style="display: none"&gt;Schedule of litigation&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;&lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;th style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Court&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Plaintiff&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Description&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Claim amount&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Status&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;&lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="7" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;&lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; width: 30%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Seoul Central District Court&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top; width: 13%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Individuals&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top; width: 13%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Damages&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 13%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_900_ecustom--ClaimAmount_iI_pn3n3_c20260630__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--ShortTermFinancialInstrumentsMember_z53noSSQtnW1" title="Claim amount"&gt;4,600,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; width: 26%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The case has been pending since 2025.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The case, filed on July&#160;11, 2025, relates to claims for damages and contractual penalties asserted against the Company and three current or former key management personnel, in connection with the plaintiffs&#x2019; acquisition of the Company&#x2019;s shares and bonds with warrants. The Company has assessed that an unfavorable outcome is not probable and, accordingly, no provision has been recognized; furthermore, due to inherent uncertainties in the litigation, the Company is unable to reliably estimate the amount of any potential loss at this time. Based on the information currently available, including advice from legal counsel, the Company has determined that an outflow of resources embodying economic benefits is not probable.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;B.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Significant commitments&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Significant commitments the Company has entered into with financial institutions and others as of June&#160;30, 2026 are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_897_ecustom--ScheduleOfSignificantCommitmentsTableTextBlock_pn3n3_zA7kNWAUILu1" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Commitments and contingencies (Details 1)"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;&lt;span id="xdx_8B1_z7wwXhSfkjw1" style="display: none"&gt;Schedule of significant commitments&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Financial institutions&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Categories&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Credit&lt;br/&gt;limit&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Borrowings&lt;br/&gt;amount&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="6" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; width: 36%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;KYOBO Securities Co., Ltd&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; width: 36%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Operation fund&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 9%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90A_ecustom--CreditLimit_iI_pn3n3_c20260630__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinancialInstitutionsMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--KYOBOSecuritiesCoLtdMember_zUd2UfNGYXb8" title="Credit limit"&gt;40,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 9%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90C_ecustom--BorrowingsAmount_iI_pn3n3_c20260630__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinancialInstitutionsMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--KYOBOSecuritiesCoLtdMember_zTmETaFzwRt" title="Borrowings amount"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl8011"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Shinhan Card Co., Ltd.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Revolving credit (*)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_906_ecustom--CreditLimit_iI_pn3n3_c20260630__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinancialInstitutionsMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ShinhanCardCoLtdMember_fKCop_zeGn430ruU7h" title="Credit limit"&gt;30,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90D_ecustom--BorrowingsAmount_iI_pn3n3_c20260630__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinancialInstitutionsMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ShinhanCardCoLtdMember_fKCop_zeoo6wKhaVc5" title="Borrowings amount"&gt;6,241&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_902_ecustom--CreditLimit_iI_pn3n3_c20260630__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinancialInstitutionsMember_z6q0xy34iJdl" title="Credit limit"&gt;70,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90D_ecustom--BorrowingsAmount_iI_pn3n3_c20260630__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinancialInstitutionsMember_zrCDkYEPCBPc" title="Borrowings amount"&gt;6,241&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;div style="margin: 0pt auto 0pt 0; font-family: Times New Roman, Times, Serif; width: 25%"&gt;&lt;div style="border-top: Black 1pt solid; font: 1pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"&gt;&lt;span id="xdx_F0E_zazx5cwPCHK2" style="font-family: Times New Roman, Times, Serif"&gt;(*)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F11_zbMxE5soL8w6" style="font-family: Times New Roman, Times, Serif"&gt;The Company provides long-term bank deposit as collateral for the borrowing.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Significant commitments the Company has entered into with financial institutions and others as of December&#160;31, 2025 are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Financial institutions&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Categories&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Credit&lt;br/&gt;limit&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Borrowings&lt;br/&gt;amount&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="6" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; width: 36%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;KYOBO Securities Co., Ltd&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 36%; text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Operation fund&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_903_ecustom--CreditLimit_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinancialInstitutionsMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--KYOBOSecuritiesCoLtdMember_zgWhRsNytsT5" title="Credit limit"&gt;40,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90A_ecustom--BorrowingsAmount_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinancialInstitutionsMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--KYOBOSecuritiesCoLtdMember_zCaFvEHbmOt6" title="Borrowings amount"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl8024"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Shinhan Card Co., Ltd.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Revolving credit (*)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_901_ecustom--CreditLimit_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinancialInstitutionsMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ShinhanCardCoLtdMember_fKCop_zqBFakLKPa13" title="Credit limit"&gt;30,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90F_ecustom--BorrowingsAmount_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinancialInstitutionsMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ShinhanCardCoLtdMember_fKCop_zgxgpIXHJIZ" title="Borrowings amount"&gt;21,069&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90D_ecustom--CreditLimit_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinancialInstitutionsMember_zlFssu9qu4Q6" title="Credit limit"&gt;70,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90B_ecustom--BorrowingsAmount_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinancialInstitutionsMember_zPWQzw9cr7P6" title="Borrowings amount"&gt;21,069&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;div style="margin: 0pt auto 0pt 0; font-family: Times New Roman, Times, Serif; width: 25%"&gt;&lt;div style="border-top: Black 1pt solid; font: 1pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"&gt;&lt;span id="xdx_F0A_zG3wKSLsb5Qf" style="font-family: Times New Roman, Times, Serif"&gt;(*)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F12_ziOCssDYBUXb" style="font-family: Times New Roman, Times, Serif"&gt;The Company provides current portion of long-term bank deposit as collateral for the borrowing.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A7_z6pM4xnv9I0j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

















&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;C.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;List of assets provided as collateral&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The list of assets that the company provided as collateral as of June&#160;30, 2026 and December&#160;31, 2025 is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_893_ecustom--ScheduleOfAssetsProvidedCollateralTableTextBlock_pn3n3_zLC50AXLyU9b" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Commitments and contingencies (Details 2)"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_8B3_zoNZTO0uv1dc" style="display: none"&gt;Schedule of assets provided as collateral&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/th&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Account&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Counterparty&lt;br/&gt;receiving the collateral&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Usage&lt;br/&gt;restrictions&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;June&#160;30,&lt;br/&gt;2026&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2025&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="6" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; width: 25%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Current portion of long-term bank deposit&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top; width: 22%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Shinhan Card Co.,Ltd&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top; width: 24%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Provided as collateral for revolving credit&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 9%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_907_ecustom--ListOfAssetsProvidedAsCollateral_iI_pn3n3_c20260630_z24gRLUQlYJi" title="List of assets provided as collateral"&gt;30,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 9%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_903_ecustom--ListOfAssetsProvidedAsCollateral_iI_pn3n3_c20251231_z8fL3XrAyND7" title="List of assets provided as collateral"&gt;30,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A9_zeaiAVTGnbV3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DisclosureOfCommitmentsExplanatory>
    <cik0002058261:ScheduleOfLitigationTableTextBlock
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      id="Fact008003">&lt;table cellpadding="0" cellspacing="0" id="xdx_89E_ecustom--ScheduleOfLitigationTableTextBlock_pn3n3_zOkV2hsTijbe" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Commitments and contingencies (Details)"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"&gt;&lt;span id="xdx_8B6_zjW5d3ZAxAvj" style="display: none"&gt;Schedule of litigation&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;&lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;th style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Court&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Plaintiff&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Description&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Claim amount&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Status&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;&lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="7" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th&gt;&#160;&lt;/th&gt;&lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; width: 30%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Seoul Central District Court&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top; width: 13%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Individuals&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top; width: 13%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Damages&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 13%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_900_ecustom--ClaimAmount_iI_pn3n3_c20260630__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--ShortTermFinancialInstrumentsMember_z53noSSQtnW1" title="Claim amount"&gt;4,600,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; width: 26%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The case has been pending since 2025.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The case, filed on July&#160;11, 2025, relates to claims for damages and contractual penalties asserted against the Company and three current or former key management personnel, in connection with the plaintiffs&#x2019; acquisition of the Company&#x2019;s shares and bonds with warrants. The Company has assessed that an unfavorable outcome is not probable and, accordingly, no provision has been recognized; furthermore, due to inherent uncertainties in the litigation, the Company is unable to reliably estimate the amount of any potential loss at this time. Based on the information currently available, including advice from legal counsel, the Company has determined that an outflow of resources embodying economic benefits is not probable.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;B.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Significant commitments&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Significant commitments the Company has entered into with financial institutions and others as of June&#160;30, 2026 are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_897_ecustom--ScheduleOfSignificantCommitmentsTableTextBlock_pn3n3_zA7kNWAUILu1" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Commitments and contingencies (Details 1)"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;&lt;span id="xdx_8B1_z7wwXhSfkjw1" style="display: none"&gt;Schedule of significant commitments&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Financial institutions&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Categories&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Credit&lt;br/&gt;limit&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Borrowings&lt;br/&gt;amount&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="6" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; width: 36%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;KYOBO Securities Co., Ltd&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; width: 36%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Operation fund&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 9%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90A_ecustom--CreditLimit_iI_pn3n3_c20260630__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinancialInstitutionsMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--KYOBOSecuritiesCoLtdMember_zUd2UfNGYXb8" title="Credit limit"&gt;40,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 9%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90C_ecustom--BorrowingsAmount_iI_pn3n3_c20260630__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinancialInstitutionsMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--KYOBOSecuritiesCoLtdMember_zTmETaFzwRt" title="Borrowings amount"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl8011"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Shinhan Card Co., Ltd.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Revolving credit (*)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_906_ecustom--CreditLimit_iI_pn3n3_c20260630__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinancialInstitutionsMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ShinhanCardCoLtdMember_fKCop_zeGn430ruU7h" title="Credit limit"&gt;30,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90D_ecustom--BorrowingsAmount_iI_pn3n3_c20260630__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinancialInstitutionsMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ShinhanCardCoLtdMember_fKCop_zeoo6wKhaVc5" title="Borrowings amount"&gt;6,241&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_902_ecustom--CreditLimit_iI_pn3n3_c20260630__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinancialInstitutionsMember_z6q0xy34iJdl" title="Credit limit"&gt;70,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90D_ecustom--BorrowingsAmount_iI_pn3n3_c20260630__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinancialInstitutionsMember_zrCDkYEPCBPc" title="Borrowings amount"&gt;6,241&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;div style="margin: 0pt auto 0pt 0; font-family: Times New Roman, Times, Serif; width: 25%"&gt;&lt;div style="border-top: Black 1pt solid; font: 1pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"&gt;&lt;span id="xdx_F0E_zazx5cwPCHK2" style="font-family: Times New Roman, Times, Serif"&gt;(*)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F11_zbMxE5soL8w6" style="font-family: Times New Roman, Times, Serif"&gt;The Company provides long-term bank deposit as collateral for the borrowing.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Significant commitments the Company has entered into with financial institutions and others as of December&#160;31, 2025 are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Financial institutions&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Categories&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Credit&lt;br/&gt;limit&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Borrowings&lt;br/&gt;amount&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="6" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; width: 36%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;KYOBO Securities Co., Ltd&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 36%; text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Operation fund&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_903_ecustom--CreditLimit_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinancialInstitutionsMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--KYOBOSecuritiesCoLtdMember_zgWhRsNytsT5" title="Credit limit"&gt;40,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90A_ecustom--BorrowingsAmount_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinancialInstitutionsMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--KYOBOSecuritiesCoLtdMember_zCaFvEHbmOt6" title="Borrowings amount"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl8024"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Shinhan Card Co., Ltd.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Revolving credit (*)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_901_ecustom--CreditLimit_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinancialInstitutionsMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ShinhanCardCoLtdMember_fKCop_zqBFakLKPa13" title="Credit limit"&gt;30,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90F_ecustom--BorrowingsAmount_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinancialInstitutionsMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ShinhanCardCoLtdMember_fKCop_zgxgpIXHJIZ" title="Borrowings amount"&gt;21,069&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90D_ecustom--CreditLimit_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinancialInstitutionsMember_zlFssu9qu4Q6" title="Credit limit"&gt;70,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90B_ecustom--BorrowingsAmount_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinancialInstitutionsMember_zPWQzw9cr7P6" title="Borrowings amount"&gt;21,069&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;div style="margin: 0pt auto 0pt 0; font-family: Times New Roman, Times, Serif; width: 25%"&gt;&lt;div style="border-top: Black 1pt solid; font: 1pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"&gt;&lt;span id="xdx_F0A_zG3wKSLsb5Qf" style="font-family: Times New Roman, Times, Serif"&gt;(*)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F12_ziOCssDYBUXb" style="font-family: Times New Roman, Times, Serif"&gt;The Company provides current portion of long-term bank deposit as collateral for the borrowing.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:ScheduleOfLitigationTableTextBlock>
    <cik0002058261:ClaimAmount
      contextRef="AsOf2026-06-30_custom_ShortTermFinancialInstrumentsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact008005"
      unitRef="KRW">4600000000</cik0002058261:ClaimAmount>
    <cik0002058261:ScheduleOfSignificantCommitmentsTableTextBlock
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      id="Fact008007">&lt;table cellpadding="0" cellspacing="0" id="xdx_897_ecustom--ScheduleOfSignificantCommitmentsTableTextBlock_pn3n3_zA7kNWAUILu1" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Commitments and contingencies (Details 1)"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;&lt;span id="xdx_8B1_z7wwXhSfkjw1" style="display: none"&gt;Schedule of significant commitments&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Financial institutions&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Categories&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Credit&lt;br/&gt;limit&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Borrowings&lt;br/&gt;amount&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="6" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; width: 36%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;KYOBO Securities Co., Ltd&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; width: 36%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Operation fund&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 9%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90A_ecustom--CreditLimit_iI_pn3n3_c20260630__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinancialInstitutionsMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--KYOBOSecuritiesCoLtdMember_zUd2UfNGYXb8" title="Credit limit"&gt;40,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 9%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90C_ecustom--BorrowingsAmount_iI_pn3n3_c20260630__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinancialInstitutionsMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--KYOBOSecuritiesCoLtdMember_zTmETaFzwRt" title="Borrowings amount"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl8011"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Shinhan Card Co., Ltd.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Revolving credit (*)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_906_ecustom--CreditLimit_iI_pn3n3_c20260630__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinancialInstitutionsMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ShinhanCardCoLtdMember_fKCop_zeGn430ruU7h" title="Credit limit"&gt;30,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90D_ecustom--BorrowingsAmount_iI_pn3n3_c20260630__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinancialInstitutionsMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ShinhanCardCoLtdMember_fKCop_zeoo6wKhaVc5" title="Borrowings amount"&gt;6,241&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_902_ecustom--CreditLimit_iI_pn3n3_c20260630__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinancialInstitutionsMember_z6q0xy34iJdl" title="Credit limit"&gt;70,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90D_ecustom--BorrowingsAmount_iI_pn3n3_c20260630__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinancialInstitutionsMember_zrCDkYEPCBPc" title="Borrowings amount"&gt;6,241&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;div style="margin: 0pt auto 0pt 0; font-family: Times New Roman, Times, Serif; width: 25%"&gt;&lt;div style="border-top: Black 1pt solid; font: 1pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"&gt;&lt;span id="xdx_F0E_zazx5cwPCHK2" style="font-family: Times New Roman, Times, Serif"&gt;(*)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F11_zbMxE5soL8w6" style="font-family: Times New Roman, Times, Serif"&gt;The Company provides long-term bank deposit as collateral for the borrowing.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Significant commitments the Company has entered into with financial institutions and others as of December&#160;31, 2025 are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Financial institutions&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Categories&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Credit&lt;br/&gt;limit&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Borrowings&lt;br/&gt;amount&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="6" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; width: 36%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;KYOBO Securities Co., Ltd&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 36%; text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Operation fund&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_903_ecustom--CreditLimit_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinancialInstitutionsMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--KYOBOSecuritiesCoLtdMember_zgWhRsNytsT5" title="Credit limit"&gt;40,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90A_ecustom--BorrowingsAmount_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinancialInstitutionsMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--KYOBOSecuritiesCoLtdMember_zCaFvEHbmOt6" title="Borrowings amount"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl8024"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Shinhan Card Co., Ltd.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Revolving credit (*)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_901_ecustom--CreditLimit_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinancialInstitutionsMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ShinhanCardCoLtdMember_fKCop_zqBFakLKPa13" title="Credit limit"&gt;30,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90F_ecustom--BorrowingsAmount_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinancialInstitutionsMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ShinhanCardCoLtdMember_fKCop_zgxgpIXHJIZ" title="Borrowings amount"&gt;21,069&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x20a9;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90D_ecustom--CreditLimit_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinancialInstitutionsMember_zlFssu9qu4Q6" title="Credit limit"&gt;70,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90B_ecustom--BorrowingsAmount_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--FinancialInstitutionsMember_zPWQzw9cr7P6" title="Borrowings amount"&gt;21,069&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;div style="margin: 0pt auto 0pt 0; font-family: Times New Roman, Times, Serif; width: 25%"&gt;&lt;div style="border-top: Black 1pt solid; font: 1pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"&gt;&lt;span id="xdx_F0A_zG3wKSLsb5Qf" style="font-family: Times New Roman, Times, Serif"&gt;(*)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F12_ziOCssDYBUXb" style="font-family: Times New Roman, Times, Serif"&gt;The Company provides current portion of long-term bank deposit as collateral for the borrowing.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:ScheduleOfSignificantCommitmentsTableTextBlock>
    <cik0002058261:CreditLimit
      contextRef="AsOf2026-06-30_custom_FinancialInstitutionsMember_custom_KYOBOSecuritiesCoLtdMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact008009"
      unitRef="KRW">40000000</cik0002058261:CreditLimit>
    <cik0002058261:CreditLimit
      contextRef="AsOf2026-06-30_custom_FinancialInstitutionsMember_custom_ShinhanCardCoLtdMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact008013"
      unitRef="KRW">30000000</cik0002058261:CreditLimit>
    <cik0002058261:BorrowingsAmount
      contextRef="AsOf2026-06-30_custom_FinancialInstitutionsMember_custom_ShinhanCardCoLtdMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact008015"
      unitRef="KRW">6241000</cik0002058261:BorrowingsAmount>
    <cik0002058261:CreditLimit
      contextRef="AsOf2026-06-30_custom_FinancialInstitutionsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact008017"
      unitRef="KRW">70000000</cik0002058261:CreditLimit>
    <cik0002058261:BorrowingsAmount
      contextRef="AsOf2026-06-30_custom_FinancialInstitutionsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact008019"
      unitRef="KRW">6241000</cik0002058261:BorrowingsAmount>
    <cik0002058261:CreditLimit
      contextRef="AsOf2025-12-31_custom_FinancialInstitutionsMember_custom_KYOBOSecuritiesCoLtdMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact008022"
      unitRef="KRW">40000000</cik0002058261:CreditLimit>
    <cik0002058261:CreditLimit
      contextRef="AsOf2025-12-31_custom_FinancialInstitutionsMember_custom_ShinhanCardCoLtdMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact008026"
      unitRef="KRW">30000000</cik0002058261:CreditLimit>
    <cik0002058261:BorrowingsAmount
      contextRef="AsOf2025-12-31_custom_FinancialInstitutionsMember_custom_ShinhanCardCoLtdMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact008028"
      unitRef="KRW">21069000</cik0002058261:BorrowingsAmount>
    <cik0002058261:CreditLimit
      contextRef="AsOf2025-12-31_custom_FinancialInstitutionsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact008030"
      unitRef="KRW">70000000</cik0002058261:CreditLimit>
    <cik0002058261:BorrowingsAmount
      contextRef="AsOf2025-12-31_custom_FinancialInstitutionsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact008032"
      unitRef="KRW">21069000</cik0002058261:BorrowingsAmount>
    <cik0002058261:ScheduleOfAssetsProvidedCollateralTableTextBlock
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      id="Fact008042">&lt;table cellpadding="0" cellspacing="0" id="xdx_893_ecustom--ScheduleOfAssetsProvidedCollateralTableTextBlock_pn3n3_zLC50AXLyU9b" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Commitments and contingencies (Details 2)"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_8B3_zoNZTO0uv1dc" style="display: none"&gt;Schedule of assets provided as collateral&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/th&gt;
    &lt;th colspan="6" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/th&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Account&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Counterparty&lt;br/&gt;receiving the collateral&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Usage&lt;br/&gt;restrictions&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;June&#160;30,&lt;br/&gt;2026&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2025&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #FFFFFF; vertical-align: bottom"&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt;
    &lt;th colspan="6" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;(In thousands of Korean won)&lt;/b&gt;&lt;/span&gt;&lt;/th&gt;
    &lt;th style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/th&gt; &lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; width: 25%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Current portion of long-term bank deposit&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top; width: 22%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Shinhan Card Co.,Ltd&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top; width: 24%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Provided as collateral for revolving credit&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 9%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_907_ecustom--ListOfAssetsProvidedAsCollateral_iI_pn3n3_c20260630_z24gRLUQlYJi" title="List of assets provided as collateral"&gt;30,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 9%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_903_ecustom--ListOfAssetsProvidedAsCollateral_iI_pn3n3_c20251231_z8fL3XrAyND7" title="List of assets provided as collateral"&gt;30,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cik0002058261:ScheduleOfAssetsProvidedCollateralTableTextBlock>
    <cik0002058261:ListOfAssetsProvidedAsCollateral
      contextRef="AsOf2026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact008044"
      unitRef="KRW">30000000</cik0002058261:ListOfAssetsProvidedAsCollateral>
    <cik0002058261:ListOfAssetsProvidedAsCollateral
      contextRef="AsOf2025-12-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact008046"
      unitRef="KRW">30000000</cik0002058261:ListOfAssetsProvidedAsCollateral>
    <cik0002058261:GoingConcernsTextBlock
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      id="Fact008048">&lt;p id="xdx_806_ecustom--GoingConcernsTextBlock_zCGoiDZis9Kd" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;28. &lt;span id="xdx_822_zMPc9aM0kwEb"&gt;Going concerns&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The Company has incurred significant losses and negative cash flows from operations; net loss was Korean won &lt;span id="xdx_908_eifrs-full--ProfitLoss_iN_pn3n3_di_c20260101__20260630_zPWngEtYnaA6" title="Net loss"&gt;2,997,895&lt;/span&gt; thousand for the period ended June&#160;30, 2026. During the period ended June&#160;30, 2026, the Company had negative cash flows from operations of Korean won &lt;span id="xdx_904_eifrs-full--CashFlowsFromUsedInOperatingActivities_iN_pn3n3_di_c20260101__20260630_z1ffjHSObEp5" title="Negative cash flows from operations"&gt;2,345,678&lt;/span&gt; thousand. As of June&#160;30, 2026, the Company&#x2019;s accumulated deficit was Korean won &lt;span id="xdx_901_eifrs-full--RetainedEarnings_iNI_pn3n3_di_c20260630_zEbpyjHMRsHl" title="Accumulated deficit"&gt;78,555,949&lt;/span&gt; thousand. The Company has funded its operations to date through equity and debt financing and had cash and cash equivalents of Korean won &lt;span id="xdx_903_eifrs-full--CashAndCashEquivalents_iI_pn3n3_c20260630_zugcgzpZ5D34" title="Cash and cash equivalents"&gt;312,427&lt;/span&gt; thousand as of June&#160;30, 2026.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The Company monitors its cash flow projections on a current basis and takes active measures to obtain the funding it requires to continue its operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;However, these cash flow projections are subject to various uncertainties concerning their fulfilment, such as the ability to generate revenues by attracting and expanding its customer base and completing additional financing. The Company expects to fund operations using cash on hand and raising additional proceeds from issuing bonds with warrants and equity offerings. There are no assurances, however, that the Company will be able to generate the revenue necessary to support its cost structure or that it will be successful in obtaining the level of financing necessary for its operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;These conditions raise substantial doubt about the Company&#x2019;s ability to continue as a going concern. These unaudited interim condensed financial statements have been prepared assuming that the Company will continue as a going concern and do not include any adjustments that might result from the outcome of this uncertainty.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</cik0002058261:GoingConcernsTextBlock>
    <ifrs-full:ProfitLoss
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact008050"
      unitRef="KRW">-2997895000</ifrs-full:ProfitLoss>
    <ifrs-full:CashFlowsFromUsedInOperatingActivities
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact008052"
      unitRef="KRW">-2345678000</ifrs-full:CashFlowsFromUsedInOperatingActivities>
    <ifrs-full:RetainedEarnings
      contextRef="AsOf2026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact008054"
      unitRef="KRW">-78555949000</ifrs-full:RetainedEarnings>
    <ifrs-full:CashAndCashEquivalents
      contextRef="AsOf2026-06-30_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact008056"
      unitRef="KRW">312427000</ifrs-full:CashAndCashEquivalents>
    <cik0002058261:DisclosureOfEventAfterReportingPeriodExplanatory
      contextRef="From2026-01-012026-06-30_custom_CubebioCo.Ltd.Member"
      id="Fact008058">&lt;p id="xdx_80F_ecustom--DisclosureOfEventAfterReportingPeriodExplanatory_ziJVxYgdSxoj" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;29. &lt;span id="xdx_824_zBYm8kzgoRrg"&gt;Subsequent events&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to October&#160;13, 2026, the date when the unaudited interim condensed financial statements were available to be issued. Based upon the review, the Company did not identify any subsequent events that would have required adjustments or disclosure in the unaudited interim condensed financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;On April&#160;10, 2026, the &lt;span id="xdx_908_ecustom--BondIssuanceDescription_c20260401__20260410__ifrs-full--CounterpartiesAxis__custom--DongSungDAndCCoLtd.Member__ifrs-full--BorrowingsByNameAxis__custom--N22ndBondWithWarrantsMember_zJWKUrbP0zK2" title="Bond issuance description"&gt;Company entered into an agreement with Dong Sung D&amp;amp;C Co., Ltd. for the issuance of the 22nd series of bonds with warrants (BW) in the aggregate amount of KRW 20,000,000 thousand to finance its operations. Pursuant to the agreement, the Company received an advance payment of KRW 1,280,000 thousand.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;br/&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Subsequently, on July&#160;30, 2026, the Company and Dong Sung D&amp;amp;C Co., Ltd. agreed to replace the planned investment in the 22nd series of bonds with warrants with a third-party allotment of common shares in the aggregate amount of KRW 20,000,000 thousand. Under the share subscription agreement, the remaining subscription proceeds were originally scheduled to be paid on or before August&#160;31, 2026.&lt;br/&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Thereafter, on August&#160;21, 2026, the Company and Dong Sung D&amp;amp;C Co., Ltd. entered into an amendment agreement extending the payment date for the remaining subscription proceeds to November&#160;30, 2026. The advance payment of KRW 1,280,000 thousand previously received in connection with the planned BW investment will be credited against the subscription price of the common shares.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

















&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;On July&#160;2, 2026, the Company entered into a loan agreement with Golden Tree Networks Co., Ltd. and provided a loan of KRW &lt;span id="xdx_900_eifrs-full--LoansAndAdvances_iI_pn3n3_c20260702__ifrs-full--CounterpartiesAxis__custom--GoldenTreeNetworksCoLtdMember_z6wCqDM6gzPg" title="Loan"&gt;20,000&lt;/span&gt; thousand for working capital purposes. The loan bears interest at &lt;span id="xdx_90F_eifrs-full--BorrowingsInterestRate_iI_pid_c20260702__ifrs-full--CounterpartiesAxis__custom--GoldenTreeNetworksCoLtdMember_zp6gSdtCw8vf" title="Interest rate"&gt;4.6%&lt;/span&gt; per annum and matures on August&#160;1, 2026.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;On July&#160;8, 2026, the Company entered into a loan agreement with Wellcore Co., Ltd. and borrowed KRW &lt;span id="xdx_904_eifrs-full--LoansAndAdvances_iI_pn3n3_c20260708__ifrs-full--CounterpartiesAxis__custom--WellCoreCoLtdMember_zGzgzmMi0Mb8" title="Loan"&gt;400,000&lt;/span&gt; thousand for working capital purposes. The borrowing bears interest at &lt;span id="xdx_907_eifrs-full--BorrowingsInterestRate_iI_pid_c20260708__ifrs-full--CounterpartiesAxis__custom--WellCoreCoLtdMember_zkpXgMhjkSZg" title="Interest rate"&gt;4.6%&lt;/span&gt; per annum and matures on July&#160;7, 2027.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;On July&#160;16, 2026, holders of the 15th bonds with warrants exercised their warrant rights for &lt;span id="xdx_90D_ecustom--WarrantsExercised_pn3n3_c20260701__20260716__ifrs-full--BorrowingsByNameAxis__custom--N15thBondWithWarrantsMember_z6xUkGNuM0pi" title="Warrants exercised"&gt;105,000&lt;/span&gt; common shares with an aggregate exercise amount of KRW &lt;span id="xdx_90B_ecustom--ProceedsFromWarrantsExercised_pn3n3_c20260701__20260716__ifrs-full--BorrowingsByNameAxis__custom--N15thBondWithWarrantsMember_zv0UWJxPmVS3" title="Proceeds from warrants exercised"&gt;315,000&lt;/span&gt; thousand. The exercise price was paid through the offset of bond claims against the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;On July&#160;24, 2026, the Company entered into an amendment agreement with Wellcore Co., Ltd. to extend the maturity date of an existing short-term borrowing of KRW &lt;span id="xdx_905_eifrs-full--Borrowings_iI_pn3n3_c20260724__ifrs-full--CounterpartiesAxis__custom--WellCoreCoLtdMember_zpHYRdetuu8" title="Short-term borrowing"&gt;1,000,000&lt;/span&gt; thousand to December&#160;31, 2026.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The Company completed a series of treasury share disposals between July and October 2026. In aggregate, &lt;span id="xdx_902_eifrs-full--IncreaseDecreaseInNumberOfOrdinarySharesIssued_pid_c20260701__20261031_zveOCHsg1XX8" title="Number of shares sold"&gt;562,500&lt;/span&gt; treasury shares were disposed of for total proceeds of KRW &lt;span id="xdx_90E_ecustom--ProceedsFromDisposalOfTreasuryShares_pn3n3_c20260701__20261031_zsqevyiuWuef" title="Proceeds from disposal of treasury shares"&gt;1,997,500&lt;/span&gt; thousand.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Subsequent to the reporting period, a hearing was held on August&#160;27 and October 8, 2026 in connection with the lawsuit filed against the Company seeking damages and contractual penalties. The proceeding was continued and remains ongoing, with the next hearing scheduled for December&#160;10, 2026. Based on the information currently available, management&#x2019;s assessment regarding the outcome of the litigation has not changed since the reporting date, and no adjustments to the accompanying financial statements have been recognized.&lt;/span&gt;&lt;/p&gt;

</cik0002058261:DisclosureOfEventAfterReportingPeriodExplanatory>
    <cik0002058261:BondIssuanceDescription
      contextRef="From2026-04-012026-04-10_custom_DongSungDAndCCoLtd.Member_custom_N22ndBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      id="Fact008060">Company entered into an agreement with Dong Sung D&amp;C Co., Ltd. for the issuance of the 22nd series of bonds with warrants (BW) in the aggregate amount of KRW 20,000,000 thousand to finance its operations. Pursuant to the agreement, the Company received an advance payment of KRW 1,280,000 thousand.</cik0002058261:BondIssuanceDescription>
    <ifrs-full:LoansAndAdvances
      contextRef="AsOf2026-07-02_custom_GoldenTreeNetworksCoLtdMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact008069"
      unitRef="KRW">20000000</ifrs-full:LoansAndAdvances>
    <ifrs-full:BorrowingsInterestRate
      contextRef="AsOf2026-07-02_custom_GoldenTreeNetworksCoLtdMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact008071"
      unitRef="Pure">0.046</ifrs-full:BorrowingsInterestRate>
    <ifrs-full:LoansAndAdvances
      contextRef="AsOf2026-07-08_custom_WellCoreCoLtdMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact008073"
      unitRef="KRW">400000000</ifrs-full:LoansAndAdvances>
    <ifrs-full:BorrowingsInterestRate
      contextRef="AsOf2026-07-08_custom_WellCoreCoLtdMember_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact008075"
      unitRef="Pure">0.046</ifrs-full:BorrowingsInterestRate>
    <cik0002058261:WarrantsExercised
      contextRef="From2026-07-012026-07-16_custom_N15thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact008077"
      unitRef="KRW">105000000</cik0002058261:WarrantsExercised>
    <cik0002058261:ProceedsFromWarrantsExercised
      contextRef="From2026-07-012026-07-16_custom_N15thBondWithWarrantsMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact008079"
      unitRef="KRW">315000000</cik0002058261:ProceedsFromWarrantsExercised>
    <ifrs-full:Borrowings
      contextRef="AsOf2026-07-24_custom_WellCoreCoLtdMember_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact008081"
      unitRef="KRW">1000000000</ifrs-full:Borrowings>
    <ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued
      contextRef="From2026-07-012026-10-31_custom_CubebioCo.Ltd.Member"
      decimals="INF"
      id="Fact008083"
      unitRef="Shares">562500</ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued>
    <cik0002058261:ProceedsFromDisposalOfTreasuryShares
      contextRef="From2026-07-012026-10-31_custom_CubebioCo.Ltd.Member"
      decimals="-3"
      id="Fact008085"
      unitRef="KRW">1997500000</cik0002058261:ProceedsFromDisposalOfTreasuryShares>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#xdx2ixbrl0198"
          xlink:label="xdx2ixbrl0198"
          xlink:type="locator"/>
        <link:footnote id="Footnote000209" xlink:label="Footnote000209" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Details of this non-cash transaction for financing activities are included in Note 6.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl0198"
          xlink:to="Footnote000209"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000199"
          xlink:label="Fact000199"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000199"
          xlink:to="Footnote000209"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000299"
          xlink:label="Fact000299"
          xlink:type="locator"/>
        <link:footnote id="Footnote000344" xlink:label="Footnote000344" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The Company recognized interest income accrued under an agreement to issue 50,000 shares of common share in consideration for gross proceeds of $50,000 during the year ended December&#160;31, 2025, which originally commenced in 2024 and was subsequently extended from 2025 to 2026.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000299"
          xlink:to="Footnote000344"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000307"
          xlink:label="Fact000307"
          xlink:type="locator"/>
        <link:footnote id="Footnote000345" xlink:label="Footnote000345" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The Company recognized interest expense accrued under a promissory note to pay $30,000 issued for common share issuing-related costs and organization costs paid by CubeBio Co., Ltd. on behalf of the Company&#160;during the year ended December&#160;31, 2025, which originally commenced in 2024 and was subsequently extended from 2025 to 2026.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000307"
          xlink:to="Footnote000345"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000323"
          xlink:label="Fact000323"
          xlink:type="locator"/>
        <link:footnote id="Footnote000346" xlink:label="Footnote000346" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The Company recognized interest income accrued under an agreement to issue 50,000 shares of common share in consideration for gross proceeds of $50,000 during the period from September&#160;24, 2024 (inception), through December&#160;31, 2024.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000323"
          xlink:to="Footnote000346"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000331"
          xlink:label="Fact000331"
          xlink:type="locator"/>
        <link:footnote id="Footnote000347" xlink:label="Footnote000347" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The Company recognized interest expense accrued under a promissory note to pay $30,000 issued for common share issuing-related costs and organization costs paid by CubeBio Co., Ltd. on behalf of the Company during the period from September&#160;24, 2024 (inception), through December&#160;31, 2024.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000331"
          xlink:to="Footnote000347"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000637"
          xlink:label="Fact000637"
          xlink:type="locator"/>
        <link:footnote id="Footnote000665" xlink:label="Footnote000665" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The Company recognized interest income accrued under an agreement to issue 50,000 shares of common share in consideration for gross proceeds of $50,000 during the six months ended June&#160;30, 2026.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000637"
          xlink:to="Footnote000665"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000644"
          xlink:label="Fact000644"
          xlink:type="locator"/>
        <link:footnote id="Footnote000666" xlink:label="Footnote000666" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The Company recognized interest expense accrued under a promissory note to pay $30,000 issued for common share issuing-related costs and organization costs paid by CubeBio Co., Ltd. on behalf of the Company during the six months ended June&#160;30, 2026.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000644"
          xlink:to="Footnote000666"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000652"
          xlink:label="Fact000652"
          xlink:type="locator"/>
        <link:footnote id="Footnote000667" xlink:label="Footnote000667" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The Company recognized interest income accrued under an agreement to issue 50,000 shares of common share in consideration for gross proceeds of $50,000 during the six months ended June&#160;30, 2025.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000652"
          xlink:to="Footnote000667"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000660"
          xlink:label="Fact000660"
          xlink:type="locator"/>
        <link:footnote id="Footnote000668" xlink:label="Footnote000668" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The Company recognized interest expense accrued under a promissory note to pay $30,000 issued for common share issuing-related costs and organization costs paid by CubeBio Co., Ltd. on behalf of the Company during the six months ended June&#160;30, 2025.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000660"
          xlink:to="Footnote000668"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001472"
          xlink:label="Fact001472"
          xlink:type="locator"/>
        <link:footnote id="Footnote001533" xlink:label="Footnote001533" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The loan to Eun Jong Choi is a related party transaction.</link:footnote>
        <link:footnote id="Footnote001608" xlink:label="Footnote001608" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The Company recognized a full provision for the balance of loan as of December&#160;31, 2015.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001472"
          xlink:to="Footnote001533"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001472"
          xlink:to="Footnote001608"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001474"
          xlink:label="Fact001474"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001474"
          xlink:to="Footnote001533"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001474"
          xlink:to="Footnote001608"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001476"
          xlink:label="Fact001476"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001476"
          xlink:to="Footnote001533"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001476"
          xlink:to="Footnote001608"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001478"
          xlink:label="Fact001478"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001478"
          xlink:to="Footnote001533"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001478"
          xlink:to="Footnote001608"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001480"
          xlink:label="Fact001480"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001480"
          xlink:to="Footnote001533"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001480"
          xlink:to="Footnote001608"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001482"
          xlink:label="Fact001482"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001482"
          xlink:to="Footnote001533"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001482"
          xlink:to="Footnote001608"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001484"
          xlink:label="Fact001484"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001484"
          xlink:to="Footnote001533"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001484"
          xlink:to="Footnote001608"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001486"
          xlink:label="Fact001486"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001486"
          xlink:to="Footnote001533"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001486"
          xlink:to="Footnote001608"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001488"
          xlink:label="Fact001488"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001488"
          xlink:to="Footnote001533"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001488"
          xlink:to="Footnote001608"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001490"
          xlink:label="Fact001490"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001490"
          xlink:to="Footnote001533"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001490"
          xlink:to="Footnote001608"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001492"
          xlink:label="Fact001492"
          xlink:type="locator"/>
        <link:footnote id="Footnote001534" xlink:label="Footnote001534" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The loan to CubeBio Holdings Ltd. (Affiliate) is denominated in USD&#160;30,000 and presented in Korean won for reporting purposes. It is a related party transaction.</link:footnote>
        <link:footnote id="Footnote001609" xlink:label="Footnote001609" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The Company recognized a full provision for the balance of loan as of December&#160;31, 2020.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001492"
          xlink:to="Footnote001534"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001492"
          xlink:to="Footnote001609"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001494"
          xlink:label="Fact001494"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001494"
          xlink:to="Footnote001534"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001494"
          xlink:to="Footnote001609"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001496"
          xlink:label="Fact001496"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001496"
          xlink:to="Footnote001534"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001496"
          xlink:to="Footnote001609"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001498"
          xlink:label="Fact001498"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001498"
          xlink:to="Footnote001534"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001498"
          xlink:to="Footnote001609"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001500"
          xlink:label="Fact001500"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001500"
          xlink:to="Footnote001534"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001500"
          xlink:to="Footnote001609"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001518"
          xlink:label="Fact001518"
          xlink:type="locator"/>
        <link:footnote id="Footnote001535" xlink:label="Footnote001535" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The loan was classified as long-term as it is expected not to be recovered within 12 months after the December&#160;31, 2025 reporting period. In March&#160;2026, the maturity date of the loan was extended to March&#160;31, 2027.</link:footnote>
        <link:footnote id="Footnote001610" xlink:label="Footnote001610" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The loan to Eun Jong Choi is a related party transaction.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001518"
          xlink:to="Footnote001535"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001518"
          xlink:to="Footnote001610"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001520"
          xlink:label="Fact001520"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001520"
          xlink:to="Footnote001535"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001520"
          xlink:to="Footnote001610"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001522"
          xlink:label="Fact001522"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001522"
          xlink:to="Footnote001535"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001522"
          xlink:to="Footnote001610"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl1524"
          xlink:label="xdx2ixbrl1524"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl1524"
          xlink:to="Footnote001535"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl1524"
          xlink:to="Footnote001610"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001526"
          xlink:label="Fact001526"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001526"
          xlink:to="Footnote001535"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001526"
          xlink:to="Footnote001610"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001537"
          xlink:label="Fact001537"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001537"
          xlink:to="Footnote001608"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001539"
          xlink:label="Fact001539"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001539"
          xlink:to="Footnote001608"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001541"
          xlink:label="Fact001541"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001541"
          xlink:to="Footnote001608"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl1543"
          xlink:label="xdx2ixbrl1543"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl1543"
          xlink:to="Footnote001608"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl1545"
          xlink:label="xdx2ixbrl1545"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl1545"
          xlink:to="Footnote001608"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001547"
          xlink:label="Fact001547"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001547"
          xlink:to="Footnote001609"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001549"
          xlink:label="Fact001549"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001549"
          xlink:to="Footnote001609"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001551"
          xlink:label="Fact001551"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001551"
          xlink:to="Footnote001609"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl1553"
          xlink:label="xdx2ixbrl1553"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl1553"
          xlink:to="Footnote001609"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl1555"
          xlink:label="xdx2ixbrl1555"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl1555"
          xlink:to="Footnote001609"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001557"
          xlink:label="Fact001557"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001557"
          xlink:to="Footnote001610"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001559"
          xlink:label="Fact001559"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001559"
          xlink:to="Footnote001610"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001561"
          xlink:label="Fact001561"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001561"
          xlink:to="Footnote001610"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001563"
          xlink:label="Fact001563"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001563"
          xlink:to="Footnote001610"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001565"
          xlink:label="Fact001565"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001565"
          xlink:to="Footnote001610"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001567"
          xlink:label="Fact001567"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001567"
          xlink:to="Footnote001610"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001569"
          xlink:label="Fact001569"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001569"
          xlink:to="Footnote001610"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001571"
          xlink:label="Fact001571"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001571"
          xlink:to="Footnote001610"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001573"
          xlink:label="Fact001573"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001573"
          xlink:to="Footnote001610"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001575"
          xlink:label="Fact001575"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001575"
          xlink:to="Footnote001610"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001577"
          xlink:label="Fact001577"
          xlink:type="locator"/>
        <link:footnote id="Footnote001611" xlink:label="Footnote001611" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The loan to CubeBio Holdings., Ltd. (Affiliate) is denominated in USD&#160;30,000 and presented in Korean won for reporting purposes. It is a related party transaction.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001577"
          xlink:to="Footnote001611"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001579"
          xlink:label="Fact001579"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001579"
          xlink:to="Footnote001611"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001581"
          xlink:label="Fact001581"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001581"
          xlink:to="Footnote001611"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001583"
          xlink:label="Fact001583"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001583"
          xlink:to="Footnote001611"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001585"
          xlink:label="Fact001585"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001585"
          xlink:to="Footnote001611"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001593"
          xlink:label="Fact001593"
          xlink:type="locator"/>
        <link:footnote id="Footnote001612" xlink:label="Footnote001612" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The loan was classified as long-term as it is expected not to be recovered within 12 months after the December&#160;31, 2024 reporting period. In February&#160;2025, the maturity date of the loan was extended to March&#160;31, 2026.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001593"
          xlink:to="Footnote001612"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001595"
          xlink:label="Fact001595"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001595"
          xlink:to="Footnote001612"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001597"
          xlink:label="Fact001597"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001597"
          xlink:to="Footnote001612"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl1599"
          xlink:label="xdx2ixbrl1599"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl1599"
          xlink:to="Footnote001612"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001601"
          xlink:label="Fact001601"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001601"
          xlink:to="Footnote001612"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001635"
          xlink:label="Fact001635"
          xlink:type="locator"/>
        <link:footnote id="Footnote001684" xlink:label="Footnote001684" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The net amount of VAT refund receivable from, or payable to, the taxation authority is included as part of receivables or payables in the statement of financial position.</link:footnote>
        <link:footnote id="Footnote001709" xlink:label="Footnote001709" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The net amount of VAT refund receivable from, or payable to, the taxation authority is included as part of receivables or payables in the statement of financial position.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001635"
          xlink:to="Footnote001684"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001635"
          xlink:to="Footnote001709"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001637"
          xlink:label="Fact001637"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001637"
          xlink:to="Footnote001684"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001637"
          xlink:to="Footnote001709"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl1639"
          xlink:label="xdx2ixbrl1639"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl1639"
          xlink:to="Footnote001684"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl1639"
          xlink:to="Footnote001709"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001641"
          xlink:label="Fact001641"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001641"
          xlink:to="Footnote001684"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001641"
          xlink:to="Footnote001709"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001643"
          xlink:label="Fact001643"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001643"
          xlink:to="Footnote001684"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001643"
          xlink:to="Footnote001709"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001645"
          xlink:label="Fact001645"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001645"
          xlink:to="Footnote001684"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001645"
          xlink:to="Footnote001709"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001647"
          xlink:label="Fact001647"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001647"
          xlink:to="Footnote001684"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001647"
          xlink:to="Footnote001709"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001649"
          xlink:label="Fact001649"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001649"
          xlink:to="Footnote001684"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001649"
          xlink:to="Footnote001709"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001661"
          xlink:label="Fact001661"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001661"
          xlink:to="Footnote001684"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001661"
          xlink:to="Footnote001709"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl1663"
          xlink:label="xdx2ixbrl1663"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl1663"
          xlink:to="Footnote001684"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl1663"
          xlink:to="Footnote001709"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001665"
          xlink:label="Fact001665"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001665"
          xlink:to="Footnote001684"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001665"
          xlink:to="Footnote001709"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001692"
          xlink:label="Fact001692"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001692"
          xlink:to="Footnote001709"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001696"
          xlink:label="Fact001696"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001696"
          xlink:to="Footnote001709"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl1744"
          xlink:label="xdx2ixbrl1744"
          xlink:type="locator"/>
        <link:footnote id="Footnote001749" xlink:label="Footnote001749" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">For the year ended December&#160;31, 2021, the Company recognized a 100% valuation allowance against custom-made inventory intended for the Russian market due to delivery restrictions arising from the Russia-Ukraine conflict. As of December&#160;31, 2025, this inventory, with a net carrying amount of nil, has been written off.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl1744"
          xlink:to="Footnote001749"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001745"
          xlink:label="Fact001745"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001745"
          xlink:to="Footnote001749"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001790"
          xlink:label="Fact001790"
          xlink:type="locator"/>
        <link:footnote id="Footnote001813" xlink:label="Footnote001813" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Represents the early redemption rights of the issuer and the investor, which are embedded derivatives of bonds with warrants issued to fund the operations.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001790"
          xlink:to="Footnote001813"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001792"
          xlink:label="Fact001792"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001792"
          xlink:to="Footnote001813"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl1794"
          xlink:label="xdx2ixbrl1794"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl1794"
          xlink:to="Footnote001813"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl1796"
          xlink:label="xdx2ixbrl1796"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl1796"
          xlink:to="Footnote001813"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001798"
          xlink:label="Fact001798"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001798"
          xlink:to="Footnote001813"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001800"
          xlink:label="Fact001800"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001800"
          xlink:to="Footnote001813"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001802"
          xlink:label="Fact001802"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001802"
          xlink:to="Footnote001813"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001804"
          xlink:label="Fact001804"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001804"
          xlink:to="Footnote001813"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl1806"
          xlink:label="xdx2ixbrl1806"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl1806"
          xlink:to="Footnote001813"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl1808"
          xlink:label="xdx2ixbrl1808"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl1808"
          xlink:to="Footnote001813"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001810"
          xlink:label="Fact001810"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001810"
          xlink:to="Footnote001813"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001812"
          xlink:label="Fact001812"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001812"
          xlink:to="Footnote001813"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001841"
          xlink:label="Fact001841"
          xlink:type="locator"/>
        <link:footnote id="Footnote001848" xlink:label="Footnote001848" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">For early redemption rights, changes in fair value are calculated by shifting principal unobservable input parameters such as correlation between risk free discount rates (-1%p~1%p).</link:footnote>
        <link:footnote id="Footnote001857" xlink:label="Footnote001857" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">For early redemption rights, changes in fair value are calculated by shifting principal unobservable input parameters such as correlation between risk free discount rates (-1%p~1%p).</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001841"
          xlink:to="Footnote001857"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001841"
          xlink:to="Footnote001848"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001843"
          xlink:label="Fact001843"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001843"
          xlink:to="Footnote001857"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001843"
          xlink:to="Footnote001848"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl1845"
          xlink:label="xdx2ixbrl1845"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl1845"
          xlink:to="Footnote001857"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl1845"
          xlink:to="Footnote001848"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl1847"
          xlink:label="xdx2ixbrl1847"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl1847"
          xlink:to="Footnote001857"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl1847"
          xlink:to="Footnote001848"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001850"
          xlink:label="Fact001850"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001850"
          xlink:to="Footnote001857"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001852"
          xlink:label="Fact001852"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001852"
          xlink:to="Footnote001857"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl1854"
          xlink:label="xdx2ixbrl1854"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl1854"
          xlink:to="Footnote001857"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl1856"
          xlink:label="xdx2ixbrl1856"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl1856"
          xlink:to="Footnote001857"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001912"
          xlink:label="Fact001912"
          xlink:type="locator"/>
        <link:footnote id="Footnote001943" xlink:label="Footnote001943" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Accounts payable that are not financial liabilities are excluded.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001912"
          xlink:to="Footnote001943"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001913"
          xlink:label="Fact001913"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001913"
          xlink:to="Footnote001943"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001914"
          xlink:label="Fact001914"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001914"
          xlink:to="Footnote001943"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl1915"
          xlink:label="xdx2ixbrl1915"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl1915"
          xlink:to="Footnote001943"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl1916"
          xlink:label="xdx2ixbrl1916"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl1916"
          xlink:to="Footnote001943"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl1917"
          xlink:label="xdx2ixbrl1917"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl1917"
          xlink:to="Footnote001943"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001918"
          xlink:label="Fact001918"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001918"
          xlink:to="Footnote001943"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001953"
          xlink:label="Fact001953"
          xlink:type="locator"/>
        <link:footnote id="Footnote001984" xlink:label="Footnote001984" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Accounts payable that are not financial liabilities are excluded.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001953"
          xlink:to="Footnote001984"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001954"
          xlink:label="Fact001954"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001954"
          xlink:to="Footnote001984"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001955"
          xlink:label="Fact001955"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001955"
          xlink:to="Footnote001984"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl1956"
          xlink:label="xdx2ixbrl1956"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl1956"
          xlink:to="Footnote001984"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl1957"
          xlink:label="xdx2ixbrl1957"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl1957"
          xlink:to="Footnote001984"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl1958"
          xlink:label="xdx2ixbrl1958"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl1958"
          xlink:to="Footnote001984"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001959"
          xlink:label="Fact001959"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001959"
          xlink:to="Footnote001984"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002459"
          xlink:label="Fact002459"
          xlink:type="locator"/>
        <link:footnote id="Footnote002462" xlink:label="Footnote002462" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The deferred balance includes the non-refundable amount paid to Mountain Crest Global Holdings LLC (the &#x201c;Sponsor&#x201d;) to purchase 300,000 founder shares, which will subsequently be transitioned into the Pubco ordinary shares upon completion of the Business Combination. The shares will be transferred at the closing of the business combination and the deferred balances will be charged against equity via treasury shares.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002459"
          xlink:to="Footnote002462"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002461"
          xlink:label="Fact002461"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002461"
          xlink:to="Footnote002462"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002503"
          xlink:label="Fact002503"
          xlink:type="locator"/>
        <link:footnote id="Footnote002505" xlink:label="Footnote002505" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The effective tax rate is not calculated as the Company incurred a loss before income taxes for the years ended December&#160;31, 2025 and 2024.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002503"
          xlink:to="Footnote002505"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002504"
          xlink:label="Fact002504"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002504"
          xlink:to="Footnote002505"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002875"
          xlink:label="Fact002875"
          xlink:type="locator"/>
        <link:footnote id="Footnote002878" xlink:label="Footnote002878" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">As of December&#160;31, 2025, the exercise period for 1,000,000 shares of the 21st series bonds with warrants had not yet commenced.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002875"
          xlink:to="Footnote002878"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002877"
          xlink:label="Fact002877"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002877"
          xlink:to="Footnote002878"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002897"
          xlink:label="Fact002897"
          xlink:type="locator"/>
        <link:footnote id="Footnote002905" xlink:label="Footnote002905" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Other payables consist primarily of professional service payable, credit card payables, and refundable deposit for disposal of treasury shares of Korean won of 2,110,000 thousand.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002897"
          xlink:to="Footnote002905"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002900"
          xlink:label="Fact002900"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002900"
          xlink:to="Footnote002905"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002903"
          xlink:label="Fact002903"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002903"
          xlink:to="Footnote002905"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003158"
          xlink:label="Fact003158"
          xlink:type="locator"/>
        <link:footnote id="Footnote003175" xlink:label="Footnote003175" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">During the period, the detachable warrants were exercised through debt-to-equity swap (non-cash settlement). The amounts presented under &#x201c;Settled through debt-to-equity swap&#x201d; relate solely to warrants exercised through the non-cash settlement method, whereby bond principal was settled through conversion. Accordingly, no cash inflows arose from the transactions reflected in this table during the period. As a result of the exercise of warrants through non-cash settlement during the period, 320,000 ordinary shares were issued in connection with the 12th series, and 196,000 ordinary shares were issued in connection with the 13th series, and 5,000 ordinary shares were issued in connection with the 15th series.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003158"
          xlink:to="Footnote003175"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003159"
          xlink:label="Fact003159"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003159"
          xlink:to="Footnote003175"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003160"
          xlink:label="Fact003160"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003160"
          xlink:to="Footnote003175"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3161"
          xlink:label="xdx2ixbrl3161"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3161"
          xlink:to="Footnote003175"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3162"
          xlink:label="xdx2ixbrl3162"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3162"
          xlink:to="Footnote003175"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3163"
          xlink:label="xdx2ixbrl3163"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3163"
          xlink:to="Footnote003175"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3164"
          xlink:label="xdx2ixbrl3164"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3164"
          xlink:to="Footnote003175"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003165"
          xlink:label="Fact003165"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003165"
          xlink:to="Footnote003175"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3201"
          xlink:label="xdx2ixbrl3201"
          xlink:type="locator"/>
        <link:footnote id="Footnote003216" xlink:label="Footnote003216" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">During the period, the detachable warrants were exercised through two methods: cash settlement and debt-to-equity swap (non-cash settlement). The amounts presented under &#x201c;Settled through debt-to-equity swap&#x201d; relate solely to warrants exercised through the non-cash settlement method, whereby bond principal was settled through conversion. Accordingly, no cash inflows arose from the transactions reflected in this table during the period. As a result of the exercise of warrants through non-cash settlement during the period, 1,344,000 ordinary shares were issued in connection with the 13th series, and 266,665 ordinary shares were issued in connection with the 15th series. In addition, as a result of the exercise of warrants through cash settlement during the period, 14,000 ordinary shares were issued in connection with the 13th series and 1,000,000 ordinary shares in connection with the 16th series, for which the related bonds had been fully settled prior to the warrant exercise. The Company recognized increases in share capital equal to the number of shares exercised multiplied by par value, and in share premium equal to the number of shares exercised multiplied by the excess of the exercise price over par value.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3201"
          xlink:to="Footnote003216"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003202"
          xlink:label="Fact003202"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003202"
          xlink:to="Footnote003216"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3203"
          xlink:label="xdx2ixbrl3203"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3203"
          xlink:to="Footnote003216"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003204"
          xlink:label="Fact003204"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003204"
          xlink:to="Footnote003216"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3205"
          xlink:label="xdx2ixbrl3205"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3205"
          xlink:to="Footnote003216"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3206"
          xlink:label="xdx2ixbrl3206"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3206"
          xlink:to="Footnote003216"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003207"
          xlink:label="Fact003207"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003207"
          xlink:to="Footnote003216"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003380"
          xlink:label="Fact003380"
          xlink:type="locator"/>
        <link:footnote id="Footnote003422" xlink:label="Footnote003422" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The exercise price for the 12th series was finalized in February&#160;2023.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003380"
          xlink:to="Footnote003422"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003382"
          xlink:label="Fact003382"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003382"
          xlink:to="Footnote003422"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003384"
          xlink:label="Fact003384"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003384"
          xlink:to="Footnote003422"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003473"
          xlink:label="Fact003473"
          xlink:type="locator"/>
        <link:footnote id="Footnote003978" xlink:label="Footnote003978" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The Company disposed of treasury shares at per-share prices ranging from Korean won 2,000 to Korean won 5,000.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003473"
          xlink:to="Footnote003978"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003475"
          xlink:label="Fact003475"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003475"
          xlink:to="Footnote003978"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003477"
          xlink:label="Fact003477"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003477"
          xlink:to="Footnote003978"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003565"
          xlink:label="Fact003565"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003565"
          xlink:to="Footnote003978"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003567"
          xlink:label="Fact003567"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003567"
          xlink:to="Footnote003978"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003569"
          xlink:label="Fact003569"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003569"
          xlink:to="Footnote003978"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003643"
          xlink:label="Fact003643"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003643"
          xlink:to="Footnote003978"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003645"
          xlink:label="Fact003645"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003645"
          xlink:to="Footnote003978"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003963"
          xlink:label="Fact003963"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003963"
          xlink:to="Footnote003978"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003965"
          xlink:label="Fact003965"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003965"
          xlink:to="Footnote003978"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003967"
          xlink:label="Fact003967"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003967"
          xlink:to="Footnote003978"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003969"
          xlink:label="Fact003969"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003969"
          xlink:to="Footnote003978"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3996"
          xlink:label="xdx2ixbrl3996"
          xlink:type="locator"/>
        <link:footnote id="Footnote003998" xlink:label="Footnote003998" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Net debt to total equity ratio is not calculated as total equity is negative.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3996"
          xlink:to="Footnote003998"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003997"
          xlink:label="Fact003997"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003997"
          xlink:to="Footnote003998"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact004011"
          xlink:label="Fact004011"
          xlink:type="locator"/>
        <link:footnote id="Footnote004042" xlink:label="Footnote004042" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The options granted as of October&#160;1, 2015 have been fully vested. Certain of these options were exercised, and the remaining options expired upon reaching the end of their contractual life. As of December&#160;31, 2025, there were no exercisable options outstanding related to this grant</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact004011"
          xlink:to="Footnote004042"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact004013"
          xlink:label="Fact004013"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact004013"
          xlink:to="Footnote004042"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact004015"
          xlink:label="Fact004015"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact004015"
          xlink:to="Footnote004042"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact004017"
          xlink:label="Fact004017"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact004017"
          xlink:to="Footnote004042"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact004019"
          xlink:label="Fact004019"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact004019"
          xlink:to="Footnote004042"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact004021"
          xlink:label="Fact004021"
          xlink:type="locator"/>
        <link:footnote id="Footnote004043" xlink:label="Footnote004043" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The options granted as of June&#160;29, 2016 have been fully vested and exercised. As of December&#160;31, 2025, there were no exercisable options outstanding related to this grant.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact004021"
          xlink:to="Footnote004043"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact004023"
          xlink:label="Fact004023"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact004023"
          xlink:to="Footnote004043"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact004025"
          xlink:label="Fact004025"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact004025"
          xlink:to="Footnote004043"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact004027"
          xlink:label="Fact004027"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact004027"
          xlink:to="Footnote004043"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact004029"
          xlink:label="Fact004029"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact004029"
          xlink:to="Footnote004043"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact004055"
          xlink:label="Fact004055"
          xlink:type="locator"/>
        <link:footnote id="Footnote004062" xlink:label="Footnote004062" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Volatility has been calculated based on an evaluation of the historical volatility of other companies&#x2019; share prices, which are listed in KOSDAQ, particularly over the historical period commensurate with the prior year.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact004055"
          xlink:to="Footnote004062"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact004075"
          xlink:label="Fact004075"
          xlink:type="locator"/>
        <link:footnote id="Footnote004108" xlink:label="Footnote004108" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Weighted average exercise price per share.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact004075"
          xlink:to="Footnote004108"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact004079"
          xlink:label="Fact004079"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact004079"
          xlink:to="Footnote004108"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl4085"
          xlink:label="xdx2ixbrl4085"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl4085"
          xlink:to="Footnote004108"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact004091"
          xlink:label="Fact004091"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact004091"
          xlink:to="Footnote004108"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact004095"
          xlink:label="Fact004095"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact004095"
          xlink:to="Footnote004108"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact004099"
          xlink:label="Fact004099"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact004099"
          xlink:to="Footnote004108"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact004103"
          xlink:label="Fact004103"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact004103"
          xlink:to="Footnote004108"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact004107"
          xlink:label="Fact004107"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact004107"
          xlink:to="Footnote004108"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact004244"
          xlink:label="Fact004244"
          xlink:type="locator"/>
        <link:footnote id="Footnote004369" xlink:label="Footnote004369" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Well Core Co., Ltd. (&#x201c;Well Core&#x201d;) is an entity that has significant influence over the Company.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact004244"
          xlink:to="Footnote004369"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact004256"
          xlink:label="Fact004256"
          xlink:type="locator"/>
        <link:footnote id="Footnote004370" xlink:label="Footnote004370" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Dongsung D&amp;C., Ltd. (&#x201c;Dongsung D&amp;C&#x201d;) was identified as a related party because it is controlled by a member of the Company&#x2019;s key management personnel.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact004256"
          xlink:to="Footnote004370"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact004390"
          xlink:label="Fact004390"
          xlink:type="locator"/>
        <link:footnote id="Footnote004437" xlink:label="Footnote004437" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The Company provided a loan to Eun Jong Choi, the CEO of the Company, who resigned as CEO on January&#160;30, 2026. As of December&#160;31, 2025, compensation payable to the CEO was recorded as other payable and remained unpaid. Pursuant to a mutual agreement between the Company and the CEO, the unpaid compensation is expected to be applied against the outstanding loan receivable from the CEO.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact004390"
          xlink:to="Footnote004437"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact004392"
          xlink:label="Fact004392"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact004392"
          xlink:to="Footnote004437"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl4394"
          xlink:label="xdx2ixbrl4394"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl4394"
          xlink:to="Footnote004437"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact004396"
          xlink:label="Fact004396"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact004396"
          xlink:to="Footnote004437"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact004504"
          xlink:label="Fact004504"
          xlink:type="locator"/>
        <link:footnote id="Footnote004543" xlink:label="Footnote004543" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The amounts are presented in principal of bonds.</link:footnote>
        <link:footnote id="Footnote004655" xlink:label="Footnote004655" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The amounts are presented in principal of bonds.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact004504"
          xlink:to="Footnote004655"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact004504"
          xlink:to="Footnote004543"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl4506"
          xlink:label="xdx2ixbrl4506"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl4506"
          xlink:to="Footnote004655"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl4506"
          xlink:to="Footnote004543"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact004508"
          xlink:label="Fact004508"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact004508"
          xlink:to="Footnote004655"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact004508"
          xlink:to="Footnote004543"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl4510"
          xlink:label="xdx2ixbrl4510"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl4510"
          xlink:to="Footnote004655"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl4510"
          xlink:to="Footnote004543"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact004512"
          xlink:label="Fact004512"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact004512"
          xlink:to="Footnote004655"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact004512"
          xlink:to="Footnote004543"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl4514"
          xlink:label="xdx2ixbrl4514"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl4514"
          xlink:to="Footnote004655"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl4514"
          xlink:to="Footnote004543"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact004516"
          xlink:label="Fact004516"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact004516"
          xlink:to="Footnote004655"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact004516"
          xlink:to="Footnote004543"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl4518"
          xlink:label="xdx2ixbrl4518"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl4518"
          xlink:to="Footnote004655"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl4518"
          xlink:to="Footnote004543"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl4520"
          xlink:label="xdx2ixbrl4520"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl4520"
          xlink:to="Footnote004655"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl4520"
          xlink:to="Footnote004543"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact004522"
          xlink:label="Fact004522"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact004522"
          xlink:to="Footnote004655"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact004522"
          xlink:to="Footnote004543"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl4524"
          xlink:label="xdx2ixbrl4524"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl4524"
          xlink:to="Footnote004655"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl4524"
          xlink:to="Footnote004543"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact004528"
          xlink:label="Fact004528"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact004528"
          xlink:to="Footnote004655"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact004528"
          xlink:to="Footnote004543"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl4530"
          xlink:label="xdx2ixbrl4530"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl4530"
          xlink:to="Footnote004655"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl4530"
          xlink:to="Footnote004543"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact004532"
          xlink:label="Fact004532"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact004532"
          xlink:to="Footnote004655"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact004532"
          xlink:to="Footnote004543"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl4534"
          xlink:label="xdx2ixbrl4534"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl4534"
          xlink:to="Footnote004655"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl4534"
          xlink:to="Footnote004543"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact004600"
          xlink:label="Fact004600"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact004600"
          xlink:to="Footnote004655"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl4602"
          xlink:label="xdx2ixbrl4602"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl4602"
          xlink:to="Footnote004655"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact004604"
          xlink:label="Fact004604"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact004604"
          xlink:to="Footnote004655"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl4606"
          xlink:label="xdx2ixbrl4606"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl4606"
          xlink:to="Footnote004655"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact004608"
          xlink:label="Fact004608"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact004608"
          xlink:to="Footnote004655"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl4610"
          xlink:label="xdx2ixbrl4610"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl4610"
          xlink:to="Footnote004655"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl4612"
          xlink:label="xdx2ixbrl4612"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl4612"
          xlink:to="Footnote004655"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact004614"
          xlink:label="Fact004614"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact004614"
          xlink:to="Footnote004655"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact004616"
          xlink:label="Fact004616"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact004616"
          xlink:to="Footnote004655"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl4618"
          xlink:label="xdx2ixbrl4618"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl4618"
          xlink:to="Footnote004655"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl4620"
          xlink:label="xdx2ixbrl4620"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl4620"
          xlink:to="Footnote004655"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact004622"
          xlink:label="Fact004622"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact004622"
          xlink:to="Footnote004655"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact004624"
          xlink:label="Fact004624"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact004624"
          xlink:to="Footnote004655"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl4626"
          xlink:label="xdx2ixbrl4626"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl4626"
          xlink:to="Footnote004655"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact004628"
          xlink:label="Fact004628"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact004628"
          xlink:to="Footnote004655"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl4630"
          xlink:label="xdx2ixbrl4630"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl4630"
          xlink:to="Footnote004655"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact004632"
          xlink:label="Fact004632"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact004632"
          xlink:to="Footnote004655"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl4634"
          xlink:label="xdx2ixbrl4634"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl4634"
          xlink:to="Footnote004655"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl4636"
          xlink:label="xdx2ixbrl4636"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl4636"
          xlink:to="Footnote004655"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact004638"
          xlink:label="Fact004638"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact004638"
          xlink:to="Footnote004655"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact004640"
          xlink:label="Fact004640"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact004640"
          xlink:to="Footnote004655"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl4642"
          xlink:label="xdx2ixbrl4642"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl4642"
          xlink:to="Footnote004655"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact004644"
          xlink:label="Fact004644"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact004644"
          xlink:to="Footnote004655"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl4646"
          xlink:label="xdx2ixbrl4646"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl4646"
          xlink:to="Footnote004655"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact004954"
          xlink:label="Fact004954"
          xlink:type="locator"/>
        <link:footnote id="Footnote004961" xlink:label="Footnote004961" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The Company provides current portion of long-term bank deposit as collateral for the borrowing.</link:footnote>
        <link:footnote id="Footnote004974" xlink:label="Footnote004974" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The Company provides Long-term bank deposit as collateral for the borrowing.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact004954"
          xlink:to="Footnote004974"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact004954"
          xlink:to="Footnote004961"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact004956"
          xlink:label="Fact004956"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact004956"
          xlink:to="Footnote004974"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact004956"
          xlink:to="Footnote004961"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact004967"
          xlink:label="Fact004967"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact004967"
          xlink:to="Footnote004974"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact004969"
          xlink:label="Fact004969"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact004969"
          xlink:to="Footnote004974"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact005556"
          xlink:label="Fact005556"
          xlink:type="locator"/>
        <link:footnote id="Footnote005655" xlink:label="Footnote005655" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The loan to Eun Jong Choi is a related party transaction.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact005556"
          xlink:to="Footnote005655"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact005560"
          xlink:label="Fact005560"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact005560"
          xlink:to="Footnote005655"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact005562"
          xlink:label="Fact005562"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact005562"
          xlink:to="Footnote005655"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact005564"
          xlink:label="Fact005564"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact005564"
          xlink:to="Footnote005655"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact005566"
          xlink:label="Fact005566"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact005566"
          xlink:to="Footnote005655"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact005568"
          xlink:label="Fact005568"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact005568"
          xlink:to="Footnote005655"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact005572"
          xlink:label="Fact005572"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact005572"
          xlink:to="Footnote005655"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact005574"
          xlink:label="Fact005574"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact005574"
          xlink:to="Footnote005655"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact005576"
          xlink:label="Fact005576"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact005576"
          xlink:to="Footnote005655"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact005578"
          xlink:label="Fact005578"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact005578"
          xlink:to="Footnote005655"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact005580"
          xlink:label="Fact005580"
          xlink:type="locator"/>
        <link:footnote id="Footnote005656" xlink:label="Footnote005656" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The loan to CubeBio Holdings Ltd. is denominated in USD&#160;33,700 and presented in Korean won for reporting purposes. It is a related party transaction.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact005580"
          xlink:to="Footnote005656"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact005584"
          xlink:label="Fact005584"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact005584"
          xlink:to="Footnote005656"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact005586"
          xlink:label="Fact005586"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact005586"
          xlink:to="Footnote005656"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact005588"
          xlink:label="Fact005588"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact005588"
          xlink:to="Footnote005656"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact005590"
          xlink:label="Fact005590"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact005590"
          xlink:to="Footnote005656"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact005592"
          xlink:label="Fact005592"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact005592"
          xlink:to="Footnote005656"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact005596"
          xlink:label="Fact005596"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact005596"
          xlink:to="Footnote005656"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact005598"
          xlink:label="Fact005598"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact005598"
          xlink:to="Footnote005656"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl5600"
          xlink:label="xdx2ixbrl5600"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl5600"
          xlink:to="Footnote005656"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl5602"
          xlink:label="xdx2ixbrl5602"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl5602"
          xlink:to="Footnote005656"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact005604"
          xlink:label="Fact005604"
          xlink:type="locator"/>
        <link:footnote id="Footnote005657" xlink:label="Footnote005657" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The loan to Dongsung D&amp;C is denominated in KRW 320,000,000 and presented in Korean won for reporting purposes. The loan to Dongsung D&amp;C is a related party transaction.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact005604"
          xlink:to="Footnote005657"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact005608"
          xlink:label="Fact005608"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact005608"
          xlink:to="Footnote005657"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact005610"
          xlink:label="Fact005610"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact005610"
          xlink:to="Footnote005657"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact005612"
          xlink:label="Fact005612"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact005612"
          xlink:to="Footnote005657"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact005614"
          xlink:label="Fact005614"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact005614"
          xlink:to="Footnote005657"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact005616"
          xlink:label="Fact005616"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact005616"
          xlink:to="Footnote005657"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact005620"
          xlink:label="Fact005620"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact005620"
          xlink:to="Footnote005657"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact005622"
          xlink:label="Fact005622"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact005622"
          xlink:to="Footnote005657"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl5624"
          xlink:label="xdx2ixbrl5624"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl5624"
          xlink:to="Footnote005657"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl5626"
          xlink:label="xdx2ixbrl5626"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl5626"
          xlink:to="Footnote005657"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact005636"
          xlink:label="Fact005636"
          xlink:type="locator"/>
        <link:footnote id="Footnote005658" xlink:label="Footnote005658" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The loan was classified as long-term as it is not expected to be recovered within 12 months after the June&#160;30, 2026 reporting period. In March&#160;2026, the maturity date of the loan was extended to March&#160;31, 2027, and the Company intends to further extend the maturity by one year in March&#160;2027.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact005636"
          xlink:to="Footnote005658"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact005640"
          xlink:label="Fact005640"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact005640"
          xlink:to="Footnote005658"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact005642"
          xlink:label="Fact005642"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact005642"
          xlink:to="Footnote005658"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact005644"
          xlink:label="Fact005644"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact005644"
          xlink:to="Footnote005658"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact005646"
          xlink:label="Fact005646"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact005646"
          xlink:to="Footnote005658"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact005695"
          xlink:label="Fact005695"
          xlink:type="locator"/>
        <link:footnote id="Footnote005706" xlink:label="Footnote005706" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Represents the early redemption rights of the issuer and the investor, which are embedded derivatives of bonds with warrants issued to fund the operations.</link:footnote>
        <link:footnote id="Footnote005726" xlink:label="Footnote005726" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Represents the early redemption rights of the issuer and the investor, which are embedded derivatives of bonds with warrants issued to fund the operations.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact005695"
          xlink:to="Footnote005726"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact005695"
          xlink:to="Footnote005706"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact005697"
          xlink:label="Fact005697"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact005697"
          xlink:to="Footnote005726"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact005697"
          xlink:to="Footnote005706"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl5699"
          xlink:label="xdx2ixbrl5699"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl5699"
          xlink:to="Footnote005726"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl5699"
          xlink:to="Footnote005706"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl5701"
          xlink:label="xdx2ixbrl5701"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl5701"
          xlink:to="Footnote005726"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl5701"
          xlink:to="Footnote005706"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact005703"
          xlink:label="Fact005703"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact005703"
          xlink:to="Footnote005726"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact005703"
          xlink:to="Footnote005706"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact005705"
          xlink:label="Fact005705"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact005705"
          xlink:to="Footnote005726"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact005705"
          xlink:to="Footnote005706"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact005715"
          xlink:label="Fact005715"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact005715"
          xlink:to="Footnote005726"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact005717"
          xlink:label="Fact005717"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact005717"
          xlink:to="Footnote005726"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl5719"
          xlink:label="xdx2ixbrl5719"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl5719"
          xlink:to="Footnote005726"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl5721"
          xlink:label="xdx2ixbrl5721"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl5721"
          xlink:to="Footnote005726"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact005723"
          xlink:label="Fact005723"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact005723"
          xlink:to="Footnote005726"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact005725"
          xlink:label="Fact005725"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact005725"
          xlink:to="Footnote005726"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact005747"
          xlink:label="Fact005747"
          xlink:type="locator"/>
        <link:footnote id="Footnote005754" xlink:label="Footnote005754" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">For early redemption rights, changes in fair value are calculated by shifting principal unobservable input parameters such as correlation between risk-adjusted discount rates (-1%p~1%p).</link:footnote>
        <link:footnote id="Footnote005770" xlink:label="Footnote005770" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">For early redemption rights, changes in fair value are calculated by shifting principal unobservable input parameters such as correlation between risk-adjusted discount rates (-1%p~1%p).</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact005747"
          xlink:to="Footnote005754"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact005747"
          xlink:to="Footnote005770"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact005749"
          xlink:label="Fact005749"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact005749"
          xlink:to="Footnote005754"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact005749"
          xlink:to="Footnote005770"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl5751"
          xlink:label="xdx2ixbrl5751"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl5751"
          xlink:to="Footnote005754"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl5751"
          xlink:to="Footnote005770"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl5753"
          xlink:label="xdx2ixbrl5753"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl5753"
          xlink:to="Footnote005754"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl5753"
          xlink:to="Footnote005770"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact005763"
          xlink:label="Fact005763"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact005763"
          xlink:to="Footnote005770"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact005765"
          xlink:label="Fact005765"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact005765"
          xlink:to="Footnote005770"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl5767"
          xlink:label="xdx2ixbrl5767"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl5767"
          xlink:to="Footnote005770"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl5769"
          xlink:label="xdx2ixbrl5769"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl5769"
          xlink:to="Footnote005770"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact006202"
          xlink:label="Fact006202"
          xlink:type="locator"/>
        <link:footnote id="Footnote006205" xlink:label="Footnote006205" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The deferred balance includes the non-refundable amount paid to Mountain Crest Global Holdings LLC (the &#x201c;Sponsor&#x201d;) to purchase 325,000 founder shares, which will subsequently be transitioned into the Pubco ordinary shares upon completion of the Business Combination. The shares will be transferred at the closing of the business combination and the deferred balances will be charged against equity via treasury shares.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact006202"
          xlink:to="Footnote006205"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact006204"
          xlink:label="Fact006204"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact006204"
          xlink:to="Footnote006205"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact006283"
          xlink:label="Fact006283"
          xlink:type="locator"/>
        <link:footnote id="Footnote006294" xlink:label="Footnote006294" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Other payables consist primarily of professional service payable, credit card payables, and refundable deposit for disposal of treasury shares of Korean won 4,180,000 and 2,110,000 thousand as of June&#160;30, 2026 and December&#160;31, 2025, respectively.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact006283"
          xlink:to="Footnote006294"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact006285"
          xlink:label="Fact006285"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact006285"
          xlink:to="Footnote006294"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact006287"
          xlink:label="Fact006287"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact006287"
          xlink:to="Footnote006294"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact006289"
          xlink:label="Fact006289"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact006289"
          xlink:to="Footnote006294"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact006291"
          xlink:label="Fact006291"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact006291"
          xlink:to="Footnote006294"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact006293"
          xlink:label="Fact006293"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact006293"
          xlink:to="Footnote006294"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact006396"
          xlink:label="Fact006396"
          xlink:type="locator"/>
        <link:footnote id="Footnote006407" xlink:label="Footnote006407" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The borrowing from Well Core Co., Ltd is a related party transaction.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact006396"
          xlink:to="Footnote006407"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact006398"
          xlink:label="Fact006398"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact006398"
          xlink:to="Footnote006407"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact006400"
          xlink:label="Fact006400"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact006400"
          xlink:to="Footnote006407"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl6402"
          xlink:label="xdx2ixbrl6402"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl6402"
          xlink:to="Footnote006407"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact006404"
          xlink:label="Fact006404"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact006404"
          xlink:to="Footnote006407"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl6406"
          xlink:label="xdx2ixbrl6406"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl6406"
          xlink:to="Footnote006407"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact006565"
          xlink:label="Fact006565"
          xlink:type="locator"/>
        <link:footnote id="Footnote006607" xlink:label="Footnote006607" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The exercise price for the 12th series was finalized in February&#160;2023.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact006565"
          xlink:to="Footnote006607"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact006567"
          xlink:label="Fact006567"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact006567"
          xlink:to="Footnote006607"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact006569"
          xlink:label="Fact006569"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact006569"
          xlink:to="Footnote006607"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact006658"
          xlink:label="Fact006658"
          xlink:type="locator"/>
        <link:footnote id="Footnote007002" xlink:label="Footnote007002" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Accounts payable that are not financial liabilities are excluded.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact006658"
          xlink:to="Footnote007002"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact006660"
          xlink:label="Fact006660"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact006660"
          xlink:to="Footnote007002"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact006662"
          xlink:label="Fact006662"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact006662"
          xlink:to="Footnote007002"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact006750"
          xlink:label="Fact006750"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact006750"
          xlink:to="Footnote007002"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact006752"
          xlink:label="Fact006752"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact006752"
          xlink:to="Footnote007002"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact006754"
          xlink:label="Fact006754"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact006754"
          xlink:to="Footnote007002"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact006821"
          xlink:label="Fact006821"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact006821"
          xlink:to="Footnote007002"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact006823"
          xlink:label="Fact006823"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact006823"
          xlink:to="Footnote007002"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact006979"
          xlink:label="Fact006979"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact006979"
          xlink:to="Footnote007002"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact006981"
          xlink:label="Fact006981"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact006981"
          xlink:to="Footnote007002"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact007200"
          xlink:label="Fact007200"
          xlink:type="locator"/>
        <link:footnote id="Footnote007215" xlink:label="Footnote007215" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The Company disposed of treasury shares at per-share prices ranging from Korean won 2,000 to Korean won 3,200.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact007200"
          xlink:to="Footnote007215"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact007202"
          xlink:label="Fact007202"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact007202"
          xlink:to="Footnote007215"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact007204"
          xlink:label="Fact007204"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact007204"
          xlink:to="Footnote007215"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact007206"
          xlink:label="Fact007206"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact007206"
          xlink:to="Footnote007215"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl7233"
          xlink:label="xdx2ixbrl7233"
          xlink:type="locator"/>
        <link:footnote id="Footnote007235" xlink:label="Footnote007235" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Net debt to total equity ratio is not calculated as total equity is negative.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl7233"
          xlink:to="Footnote007235"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl7234"
          xlink:label="xdx2ixbrl7234"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl7234"
          xlink:to="Footnote007235"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact007248"
          xlink:label="Fact007248"
          xlink:type="locator"/>
        <link:footnote id="Footnote007279" xlink:label="Footnote007279" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The options granted as of October&#160;1, 2015 have been fully vested. Certain of these options were exercised, and the remaining options expired upon reaching the end of their contractual life. As of June&#160;30, 2026, there were no exercisable options outstanding related to this grant.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact007248"
          xlink:to="Footnote007279"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact007250"
          xlink:label="Fact007250"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact007250"
          xlink:to="Footnote007279"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact007252"
          xlink:label="Fact007252"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact007252"
          xlink:to="Footnote007279"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact007254"
          xlink:label="Fact007254"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact007254"
          xlink:to="Footnote007279"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact007256"
          xlink:label="Fact007256"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact007256"
          xlink:to="Footnote007279"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact007258"
          xlink:label="Fact007258"
          xlink:type="locator"/>
        <link:footnote id="Footnote007280" xlink:label="Footnote007280" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The options granted as of June&#160;29, 2016 have been fully vested and exercised. As of June&#160;30, 2026, there were no exercisable options outstanding related to this grant.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact007258"
          xlink:to="Footnote007280"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact007260"
          xlink:label="Fact007260"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact007260"
          xlink:to="Footnote007280"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact007262"
          xlink:label="Fact007262"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact007262"
          xlink:to="Footnote007280"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact007264"
          xlink:label="Fact007264"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact007264"
          xlink:to="Footnote007280"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact007266"
          xlink:label="Fact007266"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact007266"
          xlink:to="Footnote007280"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact007292"
          xlink:label="Fact007292"
          xlink:type="locator"/>
        <link:footnote id="Footnote007299" xlink:label="Footnote007299" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Volatility has been calculated based on an evaluation of the historical volatility of other companies&#x2019; share prices, which are listed in KOSDAQ, particularly over the historical period commensurate with the prior year.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact007292"
          xlink:to="Footnote007299"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact007312"
          xlink:label="Fact007312"
          xlink:type="locator"/>
        <link:footnote id="Footnote007337" xlink:label="Footnote007337" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Weighted average exercise price per share.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact007312"
          xlink:to="Footnote007337"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact007316"
          xlink:label="Fact007316"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact007316"
          xlink:to="Footnote007337"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact007324"
          xlink:label="Fact007324"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact007324"
          xlink:to="Footnote007337"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact007328"
          xlink:label="Fact007328"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact007328"
          xlink:to="Footnote007337"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact007332"
          xlink:label="Fact007332"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact007332"
          xlink:to="Footnote007337"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact007336"
          xlink:label="Fact007336"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact007336"
          xlink:to="Footnote007337"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact007468"
          xlink:label="Fact007468"
          xlink:type="locator"/>
        <link:footnote id="Footnote007499" xlink:label="Footnote007499" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The Company provided a loan to Eun Jong Choi, a director of the Company, who resigned as CEO on January&#160;30, 2026. As of June&#160;30, 2026, compensation payable to the director was recorded as other payable and remained unpaid. Pursuant to a mutual agreement between the Company and the director, the unpaid compensation is expected to be applied against the outstanding loan receivable from the director. As the offsetting has not been executed as of June&#160;30, 2026, the loan receivable and other payable are presented on a gross basis.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact007468"
          xlink:to="Footnote007499"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact007470"
          xlink:label="Fact007470"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact007470"
          xlink:to="Footnote007499"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact007472"
          xlink:label="Fact007472"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact007472"
          xlink:to="Footnote007499"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact007474"
          xlink:label="Fact007474"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact007474"
          xlink:to="Footnote007499"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl7478"
          xlink:label="xdx2ixbrl7478"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl7478"
          xlink:to="Footnote007499"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl7482"
          xlink:label="xdx2ixbrl7482"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl7482"
          xlink:to="Footnote007499"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl7542"
          xlink:label="xdx2ixbrl7542"
          xlink:type="locator"/>
        <link:footnote id="Footnote007597" xlink:label="Footnote007597" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The Company received an advance payment of KRW 1,280,000 thousand from Dongsung D&amp;C in connection with a planned investment, which was recorded within other payables as of June&#160;30, 2026, as no shares had been issued. Subsequent to the reporting date, the transaction was finalized as a third-party allotment of common shares, under which the advance payment will be applied as share subscription proceeds (refer to Note 29).</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl7542"
          xlink:to="Footnote007597"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact007544"
          xlink:label="Fact007544"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact007544"
          xlink:to="Footnote007597"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl7546"
          xlink:label="xdx2ixbrl7546"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl7546"
          xlink:to="Footnote007597"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact007548"
          xlink:label="Fact007548"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact007548"
          xlink:to="Footnote007597"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact007582"
          xlink:label="Fact007582"
          xlink:type="locator"/>
        <link:footnote id="Footnote007598" xlink:label="Footnote007598" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">On November&#160;4, 2025, the Company entered into an agreement with Jung Gon Kim to dispose of 1,000,000 treasury shares at KRW 3,000 per share, for total consideration of KRW 3,000,000 thousand. The Company received a down payment of KRW 300,000 thousand in the prior year and an interim payment of KRW 1,600,000 thousand during the six-month period ended June&#160;30, 2026. As the shares had not been transferred as of June&#160;30, 2026, the cumulative amount received of KRW 1,900,000 thousand was recorded as other payable.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact007582"
          xlink:to="Footnote007598"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact007584"
          xlink:label="Fact007584"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact007584"
          xlink:to="Footnote007598"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl7586"
          xlink:label="xdx2ixbrl7586"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl7586"
          xlink:to="Footnote007598"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact007588"
          xlink:label="Fact007588"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact007588"
          xlink:to="Footnote007598"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact008013"
          xlink:label="Fact008013"
          xlink:type="locator"/>
        <link:footnote id="Footnote008020" xlink:label="Footnote008020" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The Company provides long-term bank deposit as collateral for the borrowing.</link:footnote>
        <link:footnote id="Footnote008033" xlink:label="Footnote008033" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The Company provides current portion of long-term bank deposit as collateral for the borrowing.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact008013"
          xlink:to="Footnote008033"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact008013"
          xlink:to="Footnote008020"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact008015"
          xlink:label="Fact008015"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact008015"
          xlink:to="Footnote008033"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact008015"
          xlink:to="Footnote008020"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact008026"
          xlink:label="Fact008026"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact008026"
          xlink:to="Footnote008033"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact008028"
          xlink:label="Fact008028"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact008028"
          xlink:to="Footnote008033"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
